PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Portegijs, E; Tsai, LT; Rantanen, T; Rantakokko, M				Portegijs, Erja; Tsai, Li-Tang; Rantanen, Taina; Rantakokko, Merja			Moving through Life-Space Areas and Objectively Measured Physical Activity of Older People	PLOS ONE			English	Article							ENVIRONMENTAL CHARACTERISTICS; NEIGHBORHOOD ENVIRONMENT; BUILT ENVIRONMENT; GOING OUTDOORS; PUBLIC-HEALTH; RATED HEALTH; ADULTS; MOBILITY; ACCELEROMETER; ASSOCIATIONS	Objectives Physical activity-an important determinant of health and function in old age-may vary according to the life-space area reached. Our aim was to study how moving through greater life-space areas is associated with greater physical activity of community-dwelling older people. The association between objectively measured physical activity and life-space area reached on different days by the same individual was studied using one-week longitudinal data, to provide insight in causal relationships. Methods One-week surveillance of objectively assessed physical activity of community-dwelling 70-90-year-old people in central Finland from the "Life-space mobility in old age" cohort substudy (N = 174). In spring 2012, participants wore an accelerometer for 7 days and completed a daily diary including the largest life-space area reached (inside home, outside home, neighborhood, town, and beyond town). The daily step count, and the time in moderate (incl. walking) and low activity and sedentary behavior were assessed. Differences in physical activity between days on which different life-space areas were reached were tested using Generalized Estimation Equation models (within-group comparison). Results Participants' mean age was 80.4 +/- 4.2 years and 63.5% were female. Participants had higher average step counts (p < .001) and greater moderate and low activity time (p < .001) on days when greater life-space areas were reached, from the home to the town area. Only low activity time continued to increase when moving beyond the town. Conclusion Community-dwelling older people were more physically active on days when they moved through greater life-space areas. While it is unknown whether physical activity was a motivator to leave the home, intervention studies are needed to determine whether facilitation of daily outdoor mobility, regardless of the purpose, may be beneficial in terms of promoting physical activity.	[Portegijs, Erja; Tsai, Li-Tang; Rantanen, Taina; Rantakokko, Merja] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Portegijs, E (corresponding author), Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland.	erja.portegijs@jyu.fi	Tsai, Li-Tang/AAE-7900-2021; Rantanen, Taina/O-6579-2016; Portegijs, Erja/K-4223-2014; Rantakokko, Merja/HHC-5689-2022; Rantakokko, Merja/I-9779-2019	Tsai, Li-Tang/0000-0001-6571-3376; Rantanen, Taina/0000-0002-1604-1945; Portegijs, Erja/0000-0002-5205-9616; Rantakokko, Merja/0000-0003-3546-1600	Academy of Finland (The Future of Living and Housing - program ASU-LIVE grant) [255403]; Finnish Ministry of Education and Culture	Academy of Finland (The Future of Living and Housing - program ASU-LIVE grant); Finnish Ministry of Education and Culture	This work was supported by the Academy of Finland (The Future of Living and Housing - program ASU-LIVE grant number 255403 to TR), and the Finnish Ministry of Education and Culture to EP and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Barnes LL, 2007, EXP AGING RES, V33, P77, DOI 10.1080/03610730601006420; Barnett A, 2015, J AGING PHYS ACTIV, V23, P144, DOI [10.1123/JAPA.2013-0026, 10.1123/japa.2013-0026]; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Clarke P, 2013, J URBAN HEALTH, V90, P997, DOI 10.1007/s11524-013-9800-4; Cress ME, 2005, J AGING PHYS ACTIV, V13, P61, DOI 10.1123/japa.13.1.61; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Ding D, 2014, J AGING PHYS ACTIV, V22, P421, DOI [10.1123/japa.2012-0332, 10.1123/JAPA.2012-0332]; Fujita K, 2006, J EPIDEMIOL, V16, P261, DOI 10.2188/jea.16.261; Hardy SE, 2009, J AM GERIATR SOC, V57, P722, DOI 10.1111/j.1532-5415.2008.02168.x; Hutto B, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-120; Jacobs JM, 2008, J AGING HEALTH, V20, P259, DOI 10.1177/0898264308315427; Kerr J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-89; King AC, 2011, SOC SCI MED, V73, P1525, DOI 10.1016/j.socscimed.2011.08.032; Kowalski K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-148; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Millward H, 2013, J TRANSP GEOGR, V28, P101, DOI 10.1016/j.jtrangeo.2012.11.012; Murayama H, 2012, ARCH GERONTOL GERIAT, V54, P67, DOI 10.1016/j.archger.2011.03.016; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Parkka J, 2007, P ANN INT IEEE EMBS, P1511, DOI 10.1109/IEMBS.2007.4352588; Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008; Portegijs E, 2014, J AM GERIATR SOC, V62, P615, DOI 10.1111/jgs.12763; Pruitt LA, 2008, J AGING PHYS ACTIV, V16, P416, DOI 10.1123/japa.16.4.416; Rantakokko M, 2015, J AGING HEALTH, V27, P606, DOI 10.1177/0898264314555328; Rantanen T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1018; Rosso AL, 2013, J AGING HEALTH, V25, P617, DOI 10.1177/0898264313482489; Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631; Sawyer P, 2010, FRONTIERS RESILIENT, P310, DOI DOI 10.1017/CB09780511763151.014; Shah RC, 2012, J GERONTOL A-BIOL, V67, P984, DOI 10.1093/gerona/gls133; Shimada H, 2010, ARCH GERONTOL GERIAT, V50, P140, DOI 10.1016/j.archger.2009.02.015; Simonsick EM, 2005, J AM GERIATR SOC, V53, P198, DOI 10.1111/j.1532-5415.2005.53103.x; Strath SJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-40; Togo F, 2008, MED SCI SPORT EXER, V40, P1058, DOI 10.1249/MSS.0b013e318167469a; Tsai LT, 2015, J AGING PHY IN PRESS; Tsai LT, 2015, SCAN J MED IN PRESS; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80; Tudor-Locke C, 2011, J PHYS ACT HEALTH, V8, P693, DOI 10.1123/jpah.8.5.693; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; Varma VR, 2014, J APPL GERONTOL, V33, P870, DOI 10.1177/0733464813512896	41	51	51	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135308	10.1371/journal.pone.0135308	http://dx.doi.org/10.1371/journal.pone.0135308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252537	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100150
J	Rajpoot, K; Riaz, A; Majeed, W; Rajpoot, N				Rajpoot, Kashif; Riaz, Atif; Majeed, Waqas; Rajpoot, Nasir			Functional Connectivity Alterations in Epilepsy from Resting-State Functional MRI	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; FMRI; NETWORKS; DISEASE	The study of functional brain connectivity alterations induced by neurological disorders and their analysis from resting state functional Magnetic Resonance Imaging (rfMRI) is generally considered to be a challenging task. The main challenge lies in determining and interpreting the large-scale connectivity of brain regions when studying neurological disorders such as epilepsy. We tackle this challenging task by studying the cortical region connectivity using a novel approach for clustering the rfMRI time series signals and by identifying discriminant functional connections using a novel difference statistic measure. The proposed approach is then used in conjunction with the difference statistic to conduct automatic classification experiments for epileptic and healthy subjects using the rfMRI data. Our results show that the proposed difference statistic measure has the potential to extract promising discriminant neuroimaging markers. The extracted neuroimaging markers yield 93.08% classification accuracy on unseen data as compared to 80.20% accuracy on the same dataset by a recent state-of-the-art algorithm. The results demonstrate that for epilepsy the proposed approach confirms known functional connectivity alterations between cortical regions, reveals some new connectivity alterations, suggests potential neuroimaging markers, and predicts epilepsy with high accuracy from rfMRI scans.	[Rajpoot, Kashif] King Faisal Univ, Coll Comp Sci & Informat Technol, Al Hasa, Saudi Arabia; [Rajpoot, Kashif; Riaz, Atif] Natl Univ Sci & Technol, Sch Elect Engn & Comp Sci, Islamabad, Pakistan; [Majeed, Waqas] Lahore Univ Management Sci, Sch Sci & Engn, Lahore, Pakistan; [Rajpoot, Nasir] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar; [Rajpoot, Nasir] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England	King Faisal University; National University of Sciences & Technology - Pakistan; Lahore University of Management Sciences; Qatar University; University of Warwick	Rajpoot, K (corresponding author), King Faisal Univ, Coll Comp Sci & Informat Technol, Al Hasa, Saudi Arabia.	kashif.rajpoot@oxfordalumni.org		Rajpoot, Nasir/0000-0002-4706-1308				BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chao-Gan Y, 2010, FRONTIERS SYSTEMS NE, V14, P4; Chen SH, 2012, NEUROIMAGE, V60, P299, DOI 10.1016/j.neuroimage.2011.11.092; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Dey S, 2012, FRONTIERS SYSTEM NEU, P6; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Friston K.J., 2003, NEUROSCIENCE DATABAS, P237, DOI DOI 10.1007/978-1-4615-1079-6_16; Gordon E.M., 2014, CEREB CORTEX; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Haneef Z, 2012, EPILEPSY BEHAV, V25, P350, DOI 10.1016/j.yebeh.2012.07.019; Ji GJ, 2014, RADIOLOGY, V271, P839, DOI 10.1148/radiol.13131638; Jiang Z, 2010, 2 INT C COMP AUT ENG; Kielhorn J, 2006, HEPTACHLOR; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Lee MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040370; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu DZ, 2010, LECT NOTES ARTIF INT, V6334, P399; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Venkataraman A, 2010, IEEE COMP SOC C COMP; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang JA, 2011, COMPUT METHOD BIOMEC, V14, P271, DOI 10.1080/10255841003766829; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036733; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040; Zung W, ARCHIVES OF GENERAL, V12, P63	34	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134944	10.1371/journal.pone.0134944	http://dx.doi.org/10.1371/journal.pone.0134944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252668	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100087
J	Vicedo, E; Schlessinger, A; Rost, B				Vicedo, Esmeralda; Schlessinger, Avner; Rost, Burkhard			Environmental Pressure May Change the Composition Protein Disorder in Prokaryotes	PLOS ONE			English	Article							INTRINSIC DISORDER; GENOME SEQUENCE; DEINOCOCCUS-RADIODURANS; UNSTRUCTURED REGIONS; AEROPYRUM-PERNIX; INTERACTIVE TREE; AMINO-ACID; ONE-WAY; SP-NOV; DATABASE	Many prokaryotic organisms have adapted to incredibly extreme habitats. The genomes of such extremophiles differ from their non-extremophile relatives. For example, some proteins in thermophiles sustain high temperatures by being more compact than homologs in non-extremophiles. Conversely, some proteins have increased volumes to compensate for freezing effects in psychrophiles that survive in the cold. Here, we revealed that some differences in organisms surviving in extreme habitats correlate with a simple single feature, namely the fraction of proteins predicted to have long disordered regions. We predicted disorder with different methods for 46 completely sequenced organisms from diverse habitats and found a correlation between protein disorder and the extremity of the environment. More specifically, the overall percentage of proteins with long disordered regions tended to be more similar between organisms of similar habitats than between organisms of similar taxonomy. For example, predictions tended to detect substantially more proteins with long disordered regions in prokaryotic halophiles (survive high salt) than in their taxonomic neighbors. Another peculiar environment is that of high radiation survived, e.g. by Deinococcus radiodurans. The relatively high fraction of disorder predicted in this extremophile might provide a shield against mutations. Although our analysis fails to establish causation, the observed correlation between such a simplistic, coarse-grained, microscopic molecular feature (disorder content) and a macroscopic variable (habitat) remains stunning.	[Vicedo, Esmeralda; Rost, Burkhard] TUM, Dept Informat Bioinformat & Computat Biol I12, D-85748 Munich, Germany; [Vicedo, Esmeralda] TUM Grad Sch Informat Sci Hlth GSISH, D-85748 Munich, Germany; [Schlessinger, Avner] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Rost, Burkhard] Inst Adv Study TUM IAS, D-85748 Munich, Germany; [Rost, Burkhard] Inst Food & Plant Sci WZW Weihenstephan, Freising Weihenstephan, Germany	Technical University of Munich; Icahn School of Medicine at Mount Sinai	Vicedo, E (corresponding author), TUM, Dept Informat Bioinformat & Computat Biol I12, Boltzmannstr 3, D-85748 Munich, Germany.	assistant@rostlab.org	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424				Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Burra PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012069; Chan Y, 1997, PHYS THER, V77, P1755, DOI 10.1093/ptj/77.12.1755; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Christie-Oleza JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-73; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Esnouf RM, 2006, ACTA CRYSTALLOGR D, V62, P1260, DOI 10.1107/S0907444906033580; Fan CP, 2012, J BIOPHARM STAT, V22, P1162, DOI 10.1080/10543406.2011.578313; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Fitzgerald Shawn, 2001, Work, V16, P287; Fox J, 2011, AN R AND S PLUS COMP; Fox J., 2008, APPLIED REGRESSION A; Fukuhara H, 2006, BIOCHEM BIOPH RES CO, V343, P956, DOI 10.1016/j.bbrc.2006.02.192; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; Gerstein M, 1997, P NATL ACAD SCI USA, V94, P11911, DOI 10.1073/pnas.94.22.11911; Goo YA, 2003, MOL CELL PROTEOMICS, V2, P506, DOI 10.1074/mcp.M300044-MCP200; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Gunbin KV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-639; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hopkin M, 2006, NATURE; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; Kawarabayasi Y, 1999, DNA Res, V6, P83, DOI 10.1093/dnares/6.2.83; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee DY, 2004, BIOCHEM BIOPH RES CO, V320, P900, DOI 10.1016/j.bbrc.2004.06.031; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Milek I, 2005, CAN J MICROBIOL, V51, P805, DOI 10.1139/W05-060; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Montanari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024989; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; MORITA RY, 1980, ORIGINS LIFE EVOL B, V10, P215, DOI 10.1007/BF00928399; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Ohta Y, 2004, APPL MICROBIOL BIOT, V66, P266, DOI 10.1007/s00253-004-1757-5; OREN A, 1990, INT J SYST BACTERIOL, V40, P209, DOI 10.1099/00207713-40-2-209; Otgonbayar GE, 2011, J MICROBIOL BIOTECHN, V21, P968, DOI 10.4014/jmb.1105.05034; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Pavlovic-Lazetic GM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-66; Pe'er I, 2004, PROTEINS, V54, P20, DOI 10.1002/prot.10559; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 2002, CURR OPIN STRUC BIOL, V12, P409, DOI 10.1016/S0959-440X(02)00337-8; ROST B, 1995, PROTEIN SCI, V4, P521; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; SHOTT S, 1991, J AM VET MED ASSOC, V198, P1126; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Tantos A, 2009, FEBS LETT, V583, P465, DOI 10.1016/j.febslet.2008.12.054; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Team R. c, 2013, R A LANGUAGE AND ENV; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Usui K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r98; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Walsh I, 2015, BIOINFORMATICS, V31, P201, DOI 10.1093/bioinformatics/btu625; Wolfe MHaDA, 1973, NONPARAMETRIC STAT, P27; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu P, 2014, STAT MED, V33, P1261, DOI 10.1002/sim.6026; Xia QW, 2006, MOL CELL PROTEOMICS, V5, P868, DOI 10.1074/mcp.M500369-MCP200; Yi H, 2007, INT J SYST EVOL MICR, V57, P815, DOI 10.1099/ijs.0.64568-0	102	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133990	10.1371/journal.pone.0133990	http://dx.doi.org/10.1371/journal.pone.0133990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252577	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100030
J	Esteban, DJ; Hysa, B; Bartow-McKenney, C				Esteban, David J.; Hysa, Bledi; Bartow-McKenney, Casey			Temporal and Spatial Distribution of the Microbial Community of Winogradsky Columns	PLOS ONE			English	Article							SP-NOV.; BACTERIAL COMMUNITIES; GLOBAL PATTERNS; GEN. NOV.; DIVERSITY; VIRUSES; SOIL; ENRICHMENT; SEQUENCES; SEDIMENT	Winogradsky columns are model microbial ecosystems prepared by adding pond sediment to a clear cylinder with additional supplements and incubated with light. Environmental gradients develop within the column creating diverse niches that allow enrichment of specific bacteria. The enrichment culture can be used to study soil and sediment microbial community structure and function. In this study we used a 16S rRNA gene survey to characterize the microbial community dynamics during Winogradsky column development to determine the rate and extent of change from the source sediment community. Over a period of 60 days, the microbial community changed from the founding pond sediment population: Cyanobacteria, Chloroflexi, Nitrospirae, and Planctomycetes increased in relative abundance over time, while most Proteobacteria decreased in relative abundance. A unique, lightdependent surface biofilm community formed by 60 days that was less diverse and dominated by a few highly abundant bacteria. 67-72% of the surface community was comprised of highly enriched taxa that were rare in the source pond sediment, including the Cyanobacteria Anabaena, a member of the Gemmatimonadetes phylum, and a member of the Chloroflexi class Anaerolinea. This indicates that rare taxa can become abundant under appropriate environmental conditions and supports the hypothesis that rare taxa serve as a microbial seed bank. We also present preliminary findings that suggest that bacteriophages may be active in the Winogradsky community. The dynamics of certain taxa, most notably the Cyanobacteria, showed a bloom-and-decline pattern, consistent with bacteriophage predation as predicted in the kill-the-winner hypothesis. Time-lapse photography also supported the possibility of bacteriophage activity, revealing a pattern of colony clearance similar to formation of viral plaques. The Winogradsky column, a technique developed early in the history of microbial ecology to enrich soil microbes, may therefore be a useful model system to investigate both microbial and viral ecology.	[Esteban, David J.; Hysa, Bledi; Bartow-McKenney, Casey] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA	Vassar College	Esteban, DJ (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.	daesteban@vassar.edu		Bartow-McKenney, Casey/0000-0002-8292-6063	Vassar College start-up funds; Tatlock Fund for Faculty Advancement; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465] Funding Source: NIH RePORTER	Vassar College start-up funds; Tatlock Fund for Faculty Advancement; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by Vassar College start-up funds and the Tatlock Fund for Faculty Advancement granted to DJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach LA, 2001, INT J SYST EVOL MICR, V51, P527, DOI 10.1099/00207713-51-2-527; Anderson DC, 1999, AM BIOL TEACH, V61, P453; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Banta LM, 2012, CBE-LIFE SCI EDUC, V11, P203, DOI 10.1187/cbe.11-12-0105; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Caporaso JG, 2012, ISME J, V6, P1089, DOI 10.1038/ismej.2011.162; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlton PJ, 1997, J MICROBIOL METH, V30, P161, DOI 10.1016/S0167-7012(97)00051-1; Chou JH, 2008, INT J SYST EVOL MICR, V58, P2051, DOI 10.1099/ijs.0.65684-0; Cohen Y, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1074, DOI 10.1007/0-387-30744-3_39; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Cunningham MA, 2009, PHYS GEOGR, V30, P269, DOI 10.2747/0272-3646.30.3.269; de Sousa ML, 2012, ENVIRON ENG SCI, V29, P180, DOI 10.1089/ees.2010.0259; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Ettwig KF, 2008, ENVIRON MICROBIOL, V10, P3164, DOI 10.1111/j.1462-2920.2008.01724.x; Ettwig KF, 2009, APPL ENVIRON MICROB, V75, P3656, DOI 10.1128/AEM.00067-09; Farag IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092139; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Finkmann W, 2000, INT J SYST EVOL MICR, V50, P273, DOI 10.1099/00207713-50-1-273; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gibbons SM, 2013, P NATL ACAD SCI USA, V110, P4651, DOI 10.1073/pnas.1217767110; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P41, DOI 10.1007/0-387-30745-1_2; Jackson EF, 2008, FRESHWATER BIOL, V53, P1214, DOI 10.1111/j.1365-2427.2007.01929.x; Jeraldo P, 2012, P NATL ACAD SCI USA, V109, P9692, DOI 10.1073/pnas.1206721109; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Koblizek M, 2003, ARCH MICROBIOL, V180, P327, DOI 10.1007/s00203-003-0596-6; KUDO H, 1987, CAN J MICROBIOL, V33, P244, DOI 10.1139/m87-041; Liu JR, 2002, INT J SYST EVOL MICR, V52, P1113, DOI 10.1099/00207713-52-4-1113; Loss RA, 2013, RENEW ENERG, V50, P648, DOI 10.1016/j.renene.2012.07.011; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; MCINERNEY MJ, 1981, APPL ENVIRON MICROB, V41, P1029, DOI 10.1128/AEM.41.4.1029-1039.1981; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Ravot G, 1999, INT J SYST BACTERIOL, V49, P1141, DOI 10.1099/00207713-49-3-1141; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rogan B, 2005, AM BIOL TEACH, V67, P348, DOI 10.1662/0002-7685(2005)067[0348:ETSNCU]2.0.CO;2; Rundell EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104134; Sandaa RA, 2009, ENVIRON MICROBIOL, V11, P2585, DOI 10.1111/j.1462-2920.2009.01983.x; Shade A, 2014, MBIO, V5, DOI 10.1128/mBio.01371-14; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang J, 2013, ISME J; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes G., GPLOTS VARIOUS R PRO; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S	61	19	19	6	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134588	10.1371/journal.pone.0134588	http://dx.doi.org/10.1371/journal.pone.0134588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248298	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300050
J	Flageng, MH; Knappskog, S; Gjerde, J; Lonning, PE; Mellgren, G				Flageng, Marianne Hauglid; Knappskog, Stian; Gjerde, Jennifer; Lonning, Per Eystein; Mellgren, Gunnar			Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer	PLOS ONE			English	Article							GLUTAMIC-ACID-RICH; ESTRONE SULFATE; PROLINE-RICH; RECEPTOR; CELLS; COREGULATOR; ESTRADIOL; DISPOSITION; ACTIVATION; RESISTANCE	The Proline-, glutamic acid-and leucine-rich protein 1 (PELP1) is an estrogen receptor (ER) coactivator and a proto-oncogene known to be deregulated in endocrine cancers. In breast cancer, PELP1 overexpression has been associated with endocrine therapy resistance. Although PELP1 is known to be regulated by estrogens in vitro, its association with estrogen levels within the tissue of breast cancer patients has not previously been assessed. Here, we determined PELP1 mRNA expression levels in paired samples of normal and malignant breast tissue obtained from 32 postmenopausal and 11 premenopausal women. In the total sample set, PELP1 levels were higher in tumors compared to normal breast tissue (P = 0.041). Among postmenopausal women, PELP1 tumor levels correlated positively with estrone (E-1) and estradiol (E-2) levels in both normal tissue (r = 0.543, P = 0.003 and r = 0.601, P = 0.001, respectively) and plasma (r = 0.392, P = 0.053 and r = 0.403, P = 0.046, respectively). Analyzing all ER+tumors (n = 26), PELP1 correlated positively with E-1 and E-2 in tumor tissue (r = 0.562, P = 0.003 and r = 0.411, P = 0.037, respectively) and normal tissue (r = 0.461, P = 0.018 and r = 0.427, P = 0.030, respectively) in addition to plasma E-1, E-2 and estrone sulphate (E1S) concentrations (r = 0.576, P = 0.003, r = 0.456, P = 0.025 and r = 0.406, P = 0.049, respectively). Finally, PELP1 correlated positively with ER mRNA (ESR1) (r = 0.553, P = 0.026) in ER+tumors, whereas a negative association between PELP1 and ESR1 (r = -0.733, P = 0.010) was observed in ER-breast tumors. Taken together, tumor PELP1 mRNA expression is associated with estrogen levels in breast cancer, suggesting a potentially important role of PELP1 in ER+breast cancer growth in vivo.	[Flageng, Marianne Hauglid; Gjerde, Jennifer; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Flageng, Marianne Hauglid; Knappskog, Stian; Gjerde, Jennifer; Lonning, Per Eystein; Mellgren, Gunnar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Knappskog, Stian; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Mellgren, G (corresponding author), Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway.	gunnar.mellgren@med.uib.no	Gjerde, Jennifer/AAZ-5811-2021; Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Knappskog, Stian/0000-0002-4153-1655; Gjerde, Jennifer/0000-0001-5329-2666; Lonning, Per Eystein/0000-0002-8890-6303	Norwegian Cancer Society; Western Norway Regional Health Authority; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	Norwegian Cancer Society(Norwegian Cancer Society); Western Norway Regional Health Authority; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	The study was funded by the Norwegian Cancer Society (https://kreftforeningen.no), The Western Norway Regional Health Authority (http://www.helse-bergen.no/forskning/samarbeidsorganet), Odd Fellow Medisinsk Vitenskapelig Forskningsfond (oddfellow.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barletta F, 2004, MOL ENDOCRINOL, V18, P1096, DOI 10.1210/me.2003-0335; Cheskis BJ, 2008, STEROIDS, V73, P901, DOI 10.1016/j.steroids.2007.12.028; Cortez V, 2014, CANCER RES, V74, P7395, DOI 10.1158/0008-5472.CAN-14-0993; Cortez V, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3229; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Flageng MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074618; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Geisler J, 2000, J STEROID BIOCHEM, V72, P259, DOI 10.1016/S0960-0760(00)00036-4; Geisler J, 2008, J STEROID BIOCHEM, V109, P90, DOI 10.1016/j.jsbmb.2007.12.011; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Haynes BP, 2010, CLIN CANCER RES, V16, P1790, DOI 10.1158/1078-0432.CCR-09-2481; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Lonning PE, 2009, J STEROID BIOCHEM, V117, P31, DOI 10.1016/j.jsbmb.2009.06.005; Lonning PE, 2011, CLIN CANCER RES, V17, P4948, DOI 10.1158/1078-0432.CCR-11-0043; Mann M, 2014, MOL ONCOL, V8, P389, DOI 10.1016/j.molonc.2013.12.012; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; Mann Monica, 2011, Cancers (Basel), V3, P1691, DOI 10.3390/cancers3021691; McBryan J, 2012, CANCER RES, V72, P548, DOI 10.1158/0008-5472.CAN-11-2073; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Mishra SK, 2004, GENE, V330, P115, DOI 10.1016/j.gene.2004.01.011; Nagpal JK, 2008, MOL CANCER RES, V6, P851, DOI 10.1158/1541-7786.MCR-07-2030; Nair SS, 2004, CANCER RES, V64, P6416, DOI 10.1158/0008-5472.CAN-04-1786; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Rajhans R, 2008, MOL ENDOCRINOL, V22, P649, DOI 10.1210/me.2007-0350; Rajhans R, 2007, CANCER RES, V67, P5505, DOI 10.1158/0008-5472.CAN-06-3647; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272	32	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134351	10.1371/journal.pone.0134351	http://dx.doi.org/10.1371/journal.pone.0134351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247365	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300033
J	Kowalewski, JM; Shafqat-Abbasi, H; Jafari-Mamaghani, M; Ganebo, BE; Gong, XW; Stromblad, S; Lock, JG				Kowalewski, Jacob M.; Shafqat-Abbasi, Hamdah; Jafari-Mamaghani, Mehrdad; Ganebo, Bereket Endrias; Gong, Xiaowei; Stromblad, Staffan; Lock, John G.			Disentangling Membrane Dynamics and Cell Migration; Differential Influences of F-actin and Cell-Matrix Adhesions	PLOS ONE			English	Article							INTEGRIN ADHESOME; MOTILE CELLS; PAXILLIN; PROTRUSION; POLARIZATION; MICROSCOPY; COMPLEXES; TENSION; SHAPE	Cell migration is heavily interconnected with plasma membrane protrusion and retraction (collectively termed "membrane dynamics"). This makes it difficult to distinguish regulatory mechanisms that differentially influence migration and membrane dynamics. Yet such distinctions may be valuable given evidence that cancer cell invasion in 3D may be better predicted by 2D membrane dynamics than by 2D cell migration, implying a degree of functional independence between these processes. Here, we applied multi-scale single cell imaging and a systematic statistical approach to disentangle regulatory associations underlying either migration or membrane dynamics. This revealed preferential correlations between membrane dynamics and F-actin features, contrasting with an enrichment of links between cell migration and adhesion complex properties. These correlative linkages were often nonlinear and therefore context-dependent, strengthening or weakening with spontaneous heterogeneity in cell behavior. More broadly, we observed that slow moving cells tend to increase in area, while fast moving cells tend to shrink, and that the size of dynamic membrane domains is independent of cell area. Overall, we define macromolecular features preferentially associated with either cell migration or membrane dynamics, enabling more specific interrogation and targeting of these processes in future.	[Kowalewski, Jacob M.; Shafqat-Abbasi, Hamdah; Jafari-Mamaghani, Mehrdad; Ganebo, Bereket Endrias; Gong, Xiaowei; Stromblad, Staffan; Lock, John G.] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Jafari-Mamaghani, Mehrdad] Stockholm Univ, Div Math Stat, Dept Math, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Lock, JG (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	john.lock@ki.se	Abbasi, Hamdah Shafqat/Z-3514-2019	Stromblad, Staffan/0000-0002-1236-6339; Lock, John/0000-0002-3880-4106; Gong, Xiaowei/0000-0002-5120-8587	EU [HEALTH-F4-2010-258068]; Center for Innovative Medicine at Karolinska Institutet; Swedish Research Council [340-2012-6001, 521-2012-3180]; Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Swedish Research Council; Centre for Innovative Medicine; Higher Education Commission of Pakistan; Magnus Bergvalls stiftelse	EU(European Commission); Center for Innovative Medicine at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Innovative Medicine; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Magnus Bergvalls stiftelse	This work was supported by grants to SS from the EU-FP7-Systems Microscopy NoE (Grant No. HEALTH-F4-2010-258068, www.systemsmicroscopy.eu), the Center for Innovative Medicine at Karolinska Institutet (www.ki.se), the Swedish Research Council (Grants No. 340-2012-6001 and 521-2012-3180, www.vr.se), and the Swedish Cancer Society (www.cancerfonden.se). Imaging was performed at the Live Cell Imaging unit/Nikon Center of Excellence, Department of Biosciences and Nutrition, Karolinska Institutet, Sweden, supported by grants from the Knut and Alice Wallenberg Foundation (www.wallenberg.com/kaw), the Swedish Research Council, the Centre for Innovative Medicine and the Jonasson donation to the School of Technology and Health, Kungliga Tekniska Hogskolan (www.kth.se), Sweden. HSA was supported by a scholarship by the Higher Education Commission of Pakistan (www.hec.gov.pk). JMK was supported by Magnus Bergvalls stiftelse (www.magnbergvallsstiftelse.nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl ME, 2012, J MICROSC-OXFORD, V245, P161, DOI 10.1111/j.1365-2818.2011.03558.x; Barnhart E, 2015, P NATL ACAD SCI USA, V112, P5045, DOI 10.1073/pnas.1417257112; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Byron A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001827; Chiu CL, 2013, BIOPHYS J, V105, P1746, DOI 10.1016/j.bpj.2013.07.057; Cramer LP, 2010, NAT CELL BIOL, V12, P628, DOI 10.1038/ncb0710-628; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gabella C, 2014, CURR BIOL, V24, P1126, DOI 10.1016/j.cub.2014.03.050; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hernandez-Varas P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8524; Horwitz R, 2003, CURR BIOL, V13, pR756, DOI 10.1016/j.cub.2003.09.014; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kiss A, 2015, INTEGR BIOL-UK, V7, P1171, DOI 10.1039/c4ib00291a; Ku CJ, 2012, CELL, V149, P1073, DOI 10.1016/j.cell.2012.03.044; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Lock JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090593; Lock JG, 2010, EXP CELL RES, V316, P1438, DOI 10.1016/j.yexcr.2010.04.001; Lou SS, 2015, J CELL BIOL, V209, P275, DOI 10.1083/jcb.201409001; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Meyer AS, 2012, J CELL BIOL, V197, P721, DOI 10.1083/jcb.201201003; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Sero JE, 2012, CELL ADHES MIGR, V6, P502, DOI 10.4161/cam.21672; Sero JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028303; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Veronika M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S19; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vilela M, 2011, NAT CELL BIOL, V13, P1011, DOI 10.1038/ncb2325; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769	43	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135204	10.1371/journal.pone.0135204	http://dx.doi.org/10.1371/journal.pone.0135204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248038	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300108
J	Lee, DH; Zhang, Y; Kassam, AB; Park, MJ; Gardner, P; Prevedello, D; Henry, S; Horbinski, C; Beumer, JH; Tawbi, H; Williams, BJ; Shaffrey, ME; Egorin, MJ; Abounader, R; Park, DM				Lee, Dae-Hee; Zhang, Ying; Kassam, Amin B.; Park, Myung-Jin; Gardner, Paul; Prevedello, Daniel; Henry, Stephanie; Horbinski, Craig; Beumer, Jan H.; Tawbi, Hussein; Williams, Brian J.; Shaffrey, Mark E.; Egorin, Merrill J.; Abounader, Roger; Park, Deric M.			Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma	PLOS ONE			English	Article							PHASE-II; PROSTATE-CANCER; CELL-SURVIVAL; EXPRESSION; GENE; AKT; BRACHYURY; PROTEIN; GROWTH; CHK1	Background The majority of chordomas show activation of the platelet-derived growth factor receptor (PDGFR). Based on in vitro intertumoral variation in response to recombinant PDGF protein and PDGFR inhibition, and variable tumor response to imatinib, we hypothesized that chordomas resistant to PDGFR inhibition may possess downstream activation of the pathway. Methods Molecular profiling was performed on 23 consecutive chordoma primary tissue specimens. Primary cultures established from 20 of the 23 specimens, and chordoma cell lines, UCH-1 and UCH-2, were used for in vitro experiments. Results Loss of heterozygosity (LOH) at the phosphatase and tensin homolog (PTEN) locus was observed in 6 specimens (26%). PTEN disruption statistically correlated with increased Ki-67 proliferation index, an established marker of poor outcome for chordoma. Compared to wild type, PTEN deficient chordomas displayed increased proliferative rate, and responded less favorably to PDGFR inhibition. PTEN gene restoration abrogated this growth advantage. Chordomas are characterized by intratumoral hypoxia and local invasion, and histone deacetylase (HDAC) inhibitors are capable of attenuating both hypoxic signaling and cell migration. The combination of PDGFR and HDAC inhibition effectively disrupted growth and invasion of PTEN deficient chordoma cells. Conclusions Loss of heterozygosity of the PTEN gene seen in a subset of chordomas is associated with aggressive in vitro behavior and strongly correlates with increased Ki-67 proliferative index. Combined inhibition of PDGFR and HDAC attenuates proliferation and invasion in chordoma cells deficient for PTEN.	[Lee, Dae-Hee; Williams, Brian J.; Shaffrey, Mark E.; Park, Deric M.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Zhang, Ying; Abounader, Roger] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Kassam, Amin B.; Park, Myung-Jin; Gardner, Paul; Prevedello, Daniel; Henry, Stephanie] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Horbinski, Craig] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Beumer, Jan H.; Tawbi, Hussein; Egorin, Merrill J.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Park, Deric M.] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA	University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Park, DM (corresponding author), Univ Virginia, Dept Neurol Surg, POB 800212, Charlottesville, VA 22908 USA.	deric.park@nih.gov		Beumer, Jan/0000-0002-8978-9401	NCI [U01-CA099168]; ASCO Career Development Award; Novartis; NATIONAL CANCER INSTITUTE [P30CA044579, U01CA099168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045209] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ASCO Career Development Award; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by U01-CA099168 from the NCI to Jan Beumer, ASCO Career Development Award to Deric M. Park and Merrill J. Egorin (mentor), and by research support to Deric M. Park, Jan Beumer, and Merrill J. Egorin from Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2001, FASEB J, V15, P108, DOI 10.1096/fj.01-0421fje; Abounader R, 2004, ONCOGENE, V23, P9173, DOI 10.1038/sj.onc.1208146; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chugh R, 2005, J CLIN ONCOL, V23, P3597, DOI 10.1200/JCO.2005.02.170; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ehlers JP, 2008, CLIN CANCER RES, V14, P115, DOI 10.1158/1078-0432.CCR-07-1825; Han S, 2009, CLIN CANCER RES, V15, P1940, DOI 10.1158/1078-0432.CCR-08-2364; Hoch BL, 2006, AM J SURG PATHOL, V30, P811, DOI 10.1097/01.pas.0000209828.39477.ab; Hug EB, 1999, J NEUROSURG, V91, P432, DOI 10.3171/jns.1999.91.3.0432; Ji ZG, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-158; Kano H, 2010, NEUROSURGERY, V68, P379; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Mammar H, 2012, INT J RADIAT ONCOL, V84, P681, DOI 10.1016/j.ijrobp.2011.12.047; McMaster ML, 2001, CANCER CAUSE CONTROL, V12, P1, DOI 10.1023/A:1008947301735; MCSWEENEY AJ, 1959, ARCH SURG-CHICAGO, V79, P152, DOI 10.1001/archsurg.1959.04320070156027; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Park MJ, 2008, NEURO-ONCOLOGY, V10, P764; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Puc J, 2005, CELL CYCLE, V4, P927, DOI 10.4161/cc.4.7.1795; RAZIS DV, 1974, J MED, V5, P274; Romeo S, 2006, J PATHOL, V209, P143, DOI 10.1002/path.1987; SALISBURY JR, 1993, J PATHOL, V171, P59, DOI 10.1002/path.1711710112; SALISBURY JR, 1993, J PATHOL, V171, P253, DOI 10.1002/path.1711710404; Scheipl S, 2013, J ORTHOP RES, V31, P1999, DOI 10.1002/jor.22447; Scimeca PG, 1996, J PEDIAT HEMATOL ONC, V18, P237, DOI 10.1097/00043426-199605000-00032; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stacchiotti S, 2013, ANN ONCOL, V24, P1931, DOI 10.1093/annonc/mdt117; Stacchiotti S, 2012, J CLIN ONCOL, V30, P914, DOI 10.1200/JCO.2011.35.3656; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamborini E, 2006, CLIN CANCER RES, V12, P6920, DOI 10.1158/1078-0432.CCR-06-1584; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vujovic S, 2006, J PATHOL, V209, P157, DOI 10.1002/path.1969; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Williams BJ, 2013, J NATL COMPR CANC NE, V11, P726, DOI 10.6004/jnccn.2013.0089; Xia MH, 2013, CANCER BIOL THER, V14, P638, DOI 10.4161/cbt.24596; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zundel W, 2000, GENE DEV, V14, P391	46	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134426	10.1371/journal.pone.0134426	http://dx.doi.org/10.1371/journal.pone.0134426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247786	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000359062300036
J	Ristic, GG; Subota, V; Lepic, T; Stanisavljevic, D; Glisic, B; Ristic, AD; Petronijevic, M; Stefanovic, DZ				Ristic, Gorica G.; Subota, Vesna; Lepic, Toplica; Stanisavljevic, Dejana; Glisic, Branislava; Ristic, Arsen D.; Petronijevic, Milan; Stefanovic, Dusan Z.			Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ARTERIAL-WALL THICKNESS; INCREASED PREVALENCE; CAROTID ULTRASOUND; SERUM-LEVELS; DISEASE; MARKERS; INFLAMMATION; ACTIVATION; SMOKING	Background To evaluate association between von Willebrand factor (vWF) activity, inflammation markers, disease activity, and subclinical atherosclerosis in patients with rheumatoid arthritis (RA) and low cardiovascular risk. Methods Above mentioned parameters were determined in blood samples of 74 non-diabetic, normotensive, female subjects, with no dyslipidemia(42 patients, 32 matched healthy controls, age 45.3 +/- 10.0 vs. 45.2 +/- 9.8 years). Intima-media thickness (IMT) was measured bilaterally, at common carotid, bifurcation, and internal carotid arteries. Subclinical atherosclerosis was defined as IMT>IMTmean+ 2SD in controlsat each carotid level and atherosclerotic plaque as IMT>1.5 mm. Majority of RA patients were on methotrexate (83.3%), none on steroids > 10 mg/day or biologic drugs. All findings were analysed in the entire study population and in RA group separately. Results RA patients with subclinical atherosclerosis had higher vWF activity than those without (133.5 +/- 69.3% vs. 95.3 +/- 36.8%, p<0.05). Predictive value of vWF activity for subclinical atherosclerosis was confirmed by logistic regression. vWF activity correlated significantly with erythrocyte sedimentation rate, fibrinogen, modified disease activity scores (mDAS28-ESR, mDAS28-CRP), modified Health Assessment Questionnaire (p<0.01 for all), duration of smoking, number of cigarettes/day, rheumatoid factor concentration (p<0.05 for all), and anti-CCP antibodies (p<0.01). In the entire study population, vWF activity was higher in participants with subclinical atherosclerosis (130 +/- 68% vs. 97 +/- 38%, p<0.05) or atherosclerotic plaques (123 +/- 57% vs. 99 +/- 45%, p<0.05) than in those without. Duration of smoking was significantly associated with vWF activity (beta 0.026, p = 0.039). Conclusions We demonstrated association of vWF activity and subclinical atherosclerosis in low-risk RA patients as well as its correlation with inflammation markers, all parameters of disease activity, and seropositivity. Therefore, vWF might be a valuable marker of early atherosclerosis in RA patients.	[Ristic, Gorica G.; Glisic, Branislava; Petronijevic, Milan; Stefanovic, Dusan Z.] Mil Med Acad, Dept Rheumatol & Clin Immunol, Belgrade 11002, Serbia; [Ristic, Gorica G.; Lepic, Toplica; Glisic, Branislava; Petronijevic, Milan; Stefanovic, Dusan Z.] Belgrade Def Univ, Fac Med, Belgrade, Serbia; [Subota, Vesna] Mil Med Acad, Inst Med Biochem, Belgrade 11002, Serbia; [Lepic, Toplica] Mil Med Acad, Dept Neurol, Belgrade 11002, Serbia; [Stanisavljevic, Dejana] Univ Belgrade, Sch Med, Inst Med Stat, Belgrade, Serbia; [Ristic, Arsen D.] Clin Ctr Serbia, Dept Cardiol, Belgrade, Serbia; [Ristic, Arsen D.] Univ Belgrade, Sch Med, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Ristic, GG (corresponding author), Mil Med Acad, Dept Rheumatol & Clin Immunol, Belgrade 11002, Serbia.	goricaris@eunet.rs		Ristic, Arsen/0000-0002-0713-1180	Department of Rheumatology and Clinical Immunology of the Military Medical Academy, Belgrade, Serbia; Institute of Medical Biochemistry of the Military Medical Academy, Belgrade, Serbia	Department of Rheumatology and Clinical Immunology of the Military Medical Academy, Belgrade, Serbia; Institute of Medical Biochemistry of the Military Medical Academy, Belgrade, Serbia	This work was fully supported by the research funds of the Department of Rheumatology and Clinical Immunology of the Military Medical Academy, Belgrade, Serbia and the Institute of Medical Biochemistry of the Military Medical Academy, Belgrade, Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; Caponnetto P, 2011, EUR J CLIN INVEST, V41, P616, DOI 10.1111/j.1365-2362.2010.02449.x; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Corrales A, 2014, ANN RHEUM DIS, V73, P722, DOI 10.1136/annrheumdis-2012-203101; Daza L, 2007, CLIN RHEUMATOL, V26, P533, DOI 10.1007/s10067-006-0338-7; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Fan FL, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0029-0; Foster W, 2010, J THROMB THROMBOLYS, V29, P437, DOI 10.1007/s11239-009-0370-y; Foster W, 2009, THROMB RES, V123, P659, DOI 10.1016/j.thromres.2008.06.014; Gerli R, 2005, ANN NY ACAD SCI, V1051, P281, DOI 10.1196/annals.1361.069; Gonzalez-Juanatey C, 2003, MEDICINE, V82, P407, DOI 10.1097/01.md.0000101572.76273.60; Grover S, 2006, J RHEUMATOL, V33, P244; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Kumari M, 2000, ARTERIOSCL THROM VAS, V20, P1842, DOI 10.1161/01.ATV.20.7.1842; Martin-Martinez MA, 2014, SEMIN ARTHRITIS RHEU, V44, P1, DOI 10.1016/j.semarthrit.2014.01.002; Nurmohamed MT, 2015, ARTHRITIS RHEUMATOL, V67, P1412, DOI 10.1002/art.39096; Paramo JA, 2005, J THROMB HAEMOST, V3, P662, DOI 10.1111/j.1538-7836.2005.01305.x; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Prisco D, 1999, INT J CLIN LAB RES, V29, P150, DOI 10.1007/s005990050082; Ristic GG, 2010, RHEUMATOLOGY, V49, P1076, DOI 10.1093/rheumatology/kep456; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Solomon DH, 2015, ARTHRITIS RHEUMATOL, V67, P1449, DOI 10.1002/art.39098; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Tomasson G, 2010, ANN RHEUM DIS, V69, P1649, DOI 10.1136/ard.2009.110536; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; Veselinovic M, 2012, CLIN RHEUMATOL, V31, P1727, DOI 10.1007/s10067-012-2079-0; Veyradier A, 1998, INT J CLIN LAB RES, V28, P201, DOI 10.1007/s005990050046; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Vischer UM, 2005, J THROMB HAEMOST, V3, P794, DOI 10.1111/j.1538-7836.2005.01242.x; Wallberg-Jonsson S, 2004, SCAND J RHEUMATOL, V33, P373, DOI 10.1080/03009740410010308; Wallberg-Jonsson S, 2002, J RHEUMATOL, V29, P875; Westlake SL, 2010, RHEUMATOLOGY, V49, P295, DOI 10.1093/rheumatology/kep366; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615	36	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0130462	10.1371/journal.pone.0130462	http://dx.doi.org/10.1371/journal.pone.0130462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247590	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300005
J	Burzynska, AZ; Wong, CN; Voss, MW; Cooke, GE; Gothe, NP; Fanning, J; McAuley, E; Kramer, AF				Burzynska, Agnieszka Z.; Wong, Chelsea N.; Voss, Michelle W.; Cooke, Gillian E.; Gothe, Neha P.; Fanning, Jason; McAuley, Edward; Kramer, Arthur F.			Physical Activity Is Linked to Greater Moment-To-Moment Variability in Spontaneous Brain Activity in Older Adults	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; C-REACTIVE PROTEIN; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR FITNESS; VOXELWISE ANALYSIS; EXERCISE; DIFFUSION; ORGANIZATION; ROBUST; HEART	Higher cardiorespiratory fitness (CRF) and physical activity (PA) in old age are associated with greater brain structural and functional integrity, and higher cognitive functioning. However, it is not known how different aspects of lifestyle such as sedentariness, light PA (LIPA), or moderate-to-vigorous physical activity (MV-PA) relate to neural activity in aging. In addition, it is not known whether the effects of PA on brain function differ or overlap with those of CRF. Here, we objectively measured CRF as oxygen consumption during a maximal exercise test and measured PA with an accelerometer worn for 7 days in 100 healthy but low active older adults (aged 60-80 years). We modeled the relationships between CRF, PA, and brain functional integrity using multivariate partial least squares analysis. As an index of functional brain integrity we used spontaneous moment-to-moment variability in the blood oxygenation level-dependent signal (SDBOLD), known to be associated with better cognitive functioning in aging. We found that older adults who engaged more in LI-PA and MV-PA had greater SDBOLD in brain regions that play a role in integrating segregated functional domains in the brain and benefit from greater CRF or PA, such as precuneus, hippocampus, medial and lateral prefrontal, and temporal cortices. Our results suggest that engaging in higher intensity PA may have protective effects on neural processing in aging. Finally, we demonstrated that older adults with greater overall WM microstructure were those showing more LI-PA and MV-PA and greater SDBOLD. We conclude that SDBOLD is a promising correlate of functional brain health in aging. Future analyses will evaluate whether SDBOLD is modifiable with interventions aimed to increase PA and CRF in older adults.	[Burzynska, Agnieszka Z.; Wong, Chelsea N.; Cooke, Gillian E.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Gothe, Neha P.; McAuley, Edward] Wayne State Univ, Dept Kinesiol Hlth & Sport Studies, Detroit, MI USA; [Fanning, Jason] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; Wayne State University; University of Illinois System; University of Illinois Urbana-Champaign	Burzynska, AZ (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	agaburza@illinois.edu	Gothe, Neha/B-2781-2016; Kramer, Arthur/AAB-2937-2019; burzynska, agnieszka/ACX-5166-2022	Gothe, Neha/0000-0002-2736-757X; Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging (NIA) [R37-AG025667]; Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois; Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING [R37AG025667] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois; Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIA) grant (R37-AG025667) and a grant from Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois. A.Z.B was supported by the "Changing Viewpoints" grant from the Robert Bosch Foundation (http://www.bosch-stiftung.de/content/language2/html/39607.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, CIRCULATION, DOI DOI 10.1161/CIRCULATIONAHA.107.185649; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Belleville S, 2012, CURR GERIATR REP, V1, P104, DOI 10.1007/s13670-012-0014-5; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Brown LM, 2005, INT J GERIATR PSYCH, V20, P911, DOI 10.1002/gps.1375; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burzynska AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120315; Burzynska AZ, 2013, J NEUROSCI, V 33, P17150, DOI 10.1523/JNEUROSCI.1426-13.2013; Burzynska AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107413; Burzynska AZ, 2009, NEUROIMAGE; Camiletti-Moiron D, 2013, SCAND J MED SCI SPOR, V23, pe202, DOI 10.1111/sms.12065; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Douw L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088202; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Gonzales MM, 2014, HUM BRAIN MAPP, V35, P2898, DOI 10.1002/hbm.22372; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grayson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088297; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Hart TL, 2011, J PHYS ACT HEALTH, V8, P848, DOI 10.1123/jpah.8.6.848; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Holzschneider K, 2012, NEUROIMAGE, V59, P3003, DOI 10.1016/j.neuroimage.2011.10.021; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Johnson NF, 2012, NEUROIMAGE, V59, P1514, DOI 10.1016/j.neuroimage.2011.08.032; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lakka TA, 2005, EUR HEART J, V26, P2018, DOI 10.1093/eurheartj/ehi394; Liu-Ambrose T, 2012, NEUROBIOL AGING, V33, P1690, DOI 10.1016/j.neurobiolaging.2011.05.010; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Marks BL, 2007, ANN NY ACAD SCI, V1097, P171, DOI 10.1196/annals.1379.022; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; ROVNER BW, 1987, HOSP PRACT, V22, P99; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; SPINA RJ, 1993, J APPL PHYSIOL, V75, P849, DOI 10.1152/jappl.1993.75.2.849; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tseng BY, 2013, J MAGN RESON IMAGING, V38, P1169, DOI 10.1002/jmri.24085; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Varma VR, 2014, HIPPOCAMPUS; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Voss MW, 2012, HUM BRAIN MAPP; Voss MW, 2014, MENT HLTH PHYS ACT; Wang Q, 2013, BEHAV BRAIN RES, V256, P618, DOI 10.1016/j.bbr.2013.09.024; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	76	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134819	10.1371/journal.pone.0134819	http://dx.doi.org/10.1371/journal.pone.0134819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244873	gold, Green Published			2022-12-26	WOS:000359061400106
J	Di Luccia, B; Crescenzo, R; Mazzoli, A; Cigliano, L; Venditti, P; Walser, JC; Widmer, A; Baccigalupi, L; Ricca, E; Iossa, S				Di Luccia, Blanda; Crescenzo, Raffaella; Mazzoli, Arianna; Cigliano, Luisa; Venditti, Paola; Walser, Jean-Claude; Widmer, Alex; Baccigalupi, Loredana; Ricca, Ezio; Iossa, Susanna			Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity	PLOS ONE			English	Article							GUT MICROBIOTA; INSULIN-RESISTANCE; DIET; ENDOTOXEMIA; CONSUMPTION; MODULATION; SEQUENCES; EPIDEMIC	A fructose-rich diet can induce metabolic syndrome, a combination of health disorders that increases the risk of diabetes and cardiovascular diseases. Diet is also known to alter the microbial composition of the gut, although it is not clear whether such alteration contributes to the development of metabolic syndrome. The aim of this work was to assess the possible link between the gut microbiota and the development of diet-induced metabolic syndrome in a rat model of obesity. Rats were fed either a standard or high-fructose diet. Groups of fructose- fed rats were treated with either antibiotics or faecal samples from control rats by oral gavage. Body composition, plasma metabolic parameters and markers of tissue oxidative stress were measured in all groups. A 16S DNA-sequencing approach was used to evaluate the bacterial composition of the gut of animals under different diets. The fructose-rich diet induced markers of metabolic syndrome, inflammation and oxidative stress, that were all significantly reduced when the animals were treated with antibiotic or faecal samples. The number of members of two bacterial genera, Coprococcus and Ruminococcus, was increased by the fructose-rich diet and reduced by both antibiotic and faecal treatments, pointing to a correlation between their abundance and the development of the metabolic syndrome. Our data indicate that in rats fed a fructose-rich diet the development of metabolic syndrome is directly correlated with variations of the gut content of specific bacterial taxa.	[Di Luccia, Blanda; Crescenzo, Raffaella; Mazzoli, Arianna; Cigliano, Luisa; Venditti, Paola; Baccigalupi, Loredana; Ricca, Ezio; Iossa, Susanna] Univ Naples Federico II, Dept Biol, Naples, Italy; [Walser, Jean-Claude] ETH, Genet Div Ctr, Zurich, Switzerland; [Widmer, Alex] ETH, Inst Integrat Biol IBZ, Zurich, Switzerland	University of Naples Federico II; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Iossa, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	susiossa@unina.it	iossa, susanna/O-1625-2016; Widmer, Alex/B-6841-2009; Cigliano, Luisa/AEL-3260-2022; Ricca, Ezio/AAG-2998-2020	iossa, susanna/0000-0001-6103-718X; Widmer, Alex/0000-0001-8253-5137; Ricca, Ezio/0000-0002-7355-0332; mazzoli, arianna/0000-0003-4096-443X; Baccigalupi, Loredana/0000-0003-3070-161X; Walser, Jean-Claude/0000-0003-1513-0783	Universita Federico II di napoli, Project FARO	Universita Federico II di napoli, Project FARO	This work was supported by the Universita Federico II di napoli, Project FARO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Crescenzo R, 2014, EUR J NUTR, V53, P413, DOI 10.1007/s00394-013-0538-2; Crescenzo R, 2013, BRIT J NUTR, V110, P1996, DOI 10.1017/S0007114513001566; Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y; Crescenzo R, 2008, OBESITY, V16, P958, DOI 10.1038/oby.2008.10; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; HEATH RL, 1976, ANAL BIOCHEM, V76, P184, DOI 10.1016/0003-2697(76)90277-3; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2013, J EQUINE VET SCI, V33, P120, DOI 10.1016/j.jevs.2012.05.004; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kavanagh K, 2013, AM J CLIN NUTR, V98, P349, DOI 10.3945/ajcn.112.057331; Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; McNulty NP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001637; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nishio K, 2013, REDOX BIOL, V1, P97, DOI 10.1016/j.redox.2012.10.002; Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x; Piya MK, 2013, CURR OPIN LIPIDOL, V24, P78, DOI 10.1097/MOL.0b013e32835b4431; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; van de Woestijne AP, 2011, OBES REV, V12, P829, DOI 10.1111/j.1467-789X.2011.00900.x; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401	46	108	112	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134893	10.1371/journal.pone.0134893	http://dx.doi.org/10.1371/journal.pone.0134893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244577	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400124
J	Grimm, M; Peters, J				Grimm, Michael; Peters, Joerg			Beer, Wood, and Welfare - The Impact of Improved Stove Use Among Dolo-Beer Breweries	PLOS ONE			English	Article							IMPROVED COOKING STOVES; TECHNOLOGY ADOPTION; PROPENSITY SCORE; DEFORESTATION; BARRIERS; RETURNS; SENEGAL; HEALTH; GROWTH; CARBON	Local beer breweries in Burkina Faso absorb a considerable amount of urban woodfuel demand. We assess the woodfuel savings caused by the adoption of improved brewing stoves by these micro-breweries and estimate the implied welfare effects through the woodfuel market on private households as well as the environmental effect. We find substantial wood savings among the breweries, 36% to 38% if they fully switch to an improved stove. In absolute amounts, they save about 0.176 kg of fuelwood per litre of dolo brewed. These savings imply huge reductions in CO2-emissions and reduce the overall demand for woodfuel, which is predominantly used by the poorer strata for cooking purposes. We provide estimates for the price decrease that might result from this and show that the urban poor are likely to benefit. Thus, the intervention under study is an example for a green growth intervention with pro-poor welfare gains - something green growth strategies should look for.	[Grimm, Michael] Univ Passau, Dept Econ, D-94032 Passau, Germany; [Grimm, Michael] Erasmus Univ, Int Inst Social Studies, Rotterdam, Netherlands; [Grimm, Michael] Inst Study Labor IZA, Bonn, Germany; [Peters, Joerg] Rheinisch Westfal Inst Wirtschaftsforsch RWI, Essen, Germany; [Peters, Joerg] Univ Witwatersrand, African Microecon Res Unit AMERU, Johannesburg, South Africa	University of Passau; Erasmus University Rotterdam; IZA Institute Labor Economics; RWI - Leibniz Institut fur Wirtschaftsforschung; University of Witwatersrand	Grimm, M (corresponding author), Univ Passau, Dept Econ, D-94032 Passau, Germany.	michael.grimm@uni-passau.de			IOB	IOB	The data underlying this research was collected for an impact evaluation commissioned by the Policy and Evaluation Department of the Ministry of Foreign Affairs of the Netherlands (IOB, http://www.iob-evaluatie.nl/en). There is no specific grant number. Both authors MG and JP were involved in this evaluation. The submitted paper just uses the data that was collected with funding from IOB. The submitted paper is different from the above mentioned impact evaluation and it has not been commissioned by IOB. IOB had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JEM, 2006, WORLD DEV, V34, P596, DOI 10.1016/j.worlddev.2005.08.008; Bailis R, 2015, NAT CLIM CH IN PRESS; Bandiera O, 2006, ECON J, V116, P869, DOI 10.1111/j.1468-0297.2006.01115.x; Baron R. E., 2009, ANAL BLACK CARBON MI; Bensch G, 2015, J ECON BEHAV ORGAN, V116, P187, DOI 10.1016/j.jebo.2015.04.023; Bensch G, 2015, J HEALTH ECON, V42, P44, DOI 10.1016/j.jhealeco.2015.03.006; Bensch G, 2013, LAND ECON, V89, P676, DOI 10.3368/le.89.4.676; Blackman A, 1998, J ENVIRON ECON MANAG, V35, P1, DOI 10.1006/jeem.1998.1019; Brunell TL, 2004, POLIT ANAL, V12, P28, DOI 10.1093/pan/mph002; Conley TG, 2010, AM ECON REV, V100, P35, DOI 10.1257/aer.100.1.35; Deaton A., 2003, ECON POLIT WEEKLY, V38, P362; Dercon S, 2014, WORLD BANK RES OBSER, V29, P163, DOI 10.1093/wbro/lku007; Duflo E, 2011, AM ECON REV, V101, P2350, DOI 10.1257/aer.101.6.2350; FOSTER AD, 1995, J POLIT ECON, V103, P1176, DOI 10.1086/601447; Freedman DA, 2008, EVALUATION REV, V32, P392, DOI 10.1177/0193841X08317586; Greenstone M, 2012, 1210 MIT DEP EC; Grimm M, 2011, REV INCOME WEALTH, V57, pS27, DOI 10.1111/j.1475-4991.2011.00453.x; Gunther I, 2007, J DEV ECON, V82, P245, DOI 10.1016/j.jdeveco.2005.07.002; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jeuland M, 2013, DUKE ENV ENERGY EC W; Jeuland M., 2014, PREFERENCE HETEROGEN; Johnson M, 2009, ENVIRON SCI TECHNOL, V43, P2456, DOI 10.1021/es801564u; Lewis JJ, 2012, ENVIRON HEALTH PERSP, V120, P637, DOI 10.1289/ehp.1104194; Malla S., 2014, 6903 WORLD BANK; Martin WJ, 2011, SCIENCE, V334, P180, DOI 10.1126/science.1213088; Pant K.P., 2014, ENV DEV EC ESSAYS P, P145, DOI DOI 10.1093/ACPROF:OSO/9780199677856.003.0005; Pattanayak SK, 2009, ANNU REV RESOUR ECON, V1, P183, DOI 10.1146/annurev.resource.050708.144053; Posner MA, 2012, COMP WEIGHTING UNPUB; PRAIS SJ, 1958, REV ECON STUD, V26, P126; Ramanathan V., 2007, ROLE BLACK CARBON GL; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Ribot JC, 1999, GLOBAL ECOL BIOGEOGR, V8, P291, DOI 10.1046/j.1365-2699.1999.00146.x; Sanogo O., 2011, ETUDE PRODUCTION DOL; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Smith-Sivertsen T, 2009, AM J EPIDEMIOL, V170, P211, DOI 10.1093/aje/kwp100; Wallack JS, 2009, FOREIGN AFF, V88, P105; WHO, 2010, LANCET, V380, P2224; Wodon QT, 2008, WORLD BANK POLICY RE; World Bank, 2011, HOUS COOK STOV ENV H; Yu F, 2011, ENVIRON RESOUR ECON, V50, P495, DOI 10.1007/s10640-011-9479-5	42	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132603	10.1371/journal.pone.0132603	http://dx.doi.org/10.1371/journal.pone.0132603			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244341	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400024
J	Gunay, SD				Gunay, Seckin D.			Swelling Mechanisms of UO2 Lattices with Defect Ingrowths	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; INTERATOMIC POTENTIALS; THERMAL-PROPERTIES; URANIUM-DIOXIDE; RECOVERY	The swelling that occurs in uranium dioxide as a result of radiation-induced defect ingrowth is not fully understood. Experimental and theoretical groups have attempted to explain this phenomenon with various complex theories. In this study, experimental lattice expansion and lattice super saturation were accurately reproduced using a molecular dynamics simulation method. Based on their resemblance to experimental data, the simulation results presented here show that fission induces only oxygen Frenkel pairs while alpha particle irradiation results in both oxygen and uranium Frenkel pair defects. Moreover, in this work, defects are divided into two sub-groups, obstruction type defects and distortion type defects. It is shown that obstruction type Frenkel pairs are responsible for both fission-and alpha-particle-induced lattice swelling. Relative lattice expansion was found to vary linearly with the number of obstruction type uranium Frenkel defects. Additionally, at high concentrations, some of the obstruction type uranium Frenkel pairs formed diatomic and triatomic structures with oxygen ions in their octahedral cages, increasing the slope of the linear dependence.	Yildiz Tech Univ, Dept Phys, Fac Sci, Istanbul, Turkey	Yildiz Technical University	Gunay, SD (corresponding author), Yildiz Tech Univ, Dept Phys, Fac Sci, Istanbul, Turkey.	sgunay@yildiz.edu.tr		Gunay, Seckin D./0000-0003-0507-0166				Aidhy DS, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104107; Arima T, 2005, J ALLOY COMPD, V400, P43, DOI 10.1016/j.jallcom.2005.04.003; Basak CB, 2003, J ALLOY COMPD, V360, P210, DOI 10.1016/S0925-8388(03)00350-5; CATLOW CRA, 1977, P ROY SOC LOND A MAT, V353, P533, DOI 10.1098/rspa.1977.0049; Devanathan R, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3125967; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Govers K, 2008, J NUCL MATER, V376, P66, DOI 10.1016/j.jnucmat.2008.01.023; Govers K, 2007, J NUCL MATER, V366, P161, DOI 10.1016/j.jnucmat.2006.12.070; GRIMES RW, 1991, PHILOS T R SOC A, V335, P609, DOI 10.1098/rsta.1991.0062; Gunay SD, 2011, INT J MOD PHYS B, V25, P3211, DOI 10.1142/S0217979211101806; Gunay SD, 2011, INT J MOD PHYS B, V25, P1201, DOI 10.1142/S0217979211100138; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACKSON RA, 1986, PHILOS MAG A, V53, P27, DOI 10.1080/01418618608242805; KARAKASIDIS T, 1994, J PHYS-CONDENS MAT, V6, P2965, DOI 10.1088/0953-8984/6/15/019; LEWIS GV, 1985, J PHYS C SOLID STATE, V18, P1149, DOI 10.1088/0022-3719/18/6/010; MATZKE H, 1982, RADIAT EFF DEFECT S, V64, P3, DOI 10.1080/00337578208222984; Meis C, 1998, MAT SCI ENG B-SOLID, V57, P52, DOI 10.1016/S0921-5107(98)00253-0; Morelon ND, 2003, PHILOS MAG, V83, P1533, DOI 10.1080/1478643031000091454; NAKAE N, 1979, J NUCL MATER, V80, P314, DOI 10.1016/0022-3115(79)90194-6; NAKAE N, 1978, J NUCL MATER, V74, P1, DOI 10.1016/0022-3115(78)90526-3; NAKAE N, 1978, J NUCL MATER, V71, P314, DOI 10.1016/0022-3115(78)90430-0; Refson K, 2000, COMPUT PHYS COMMUN, V126, P310, DOI 10.1016/S0010-4655(99)00496-8; SINDZINGRE P, 1988, J PHYS C SOLID STATE, V21, P4017, DOI 10.1088/0022-3719/21/22/017; TUROS A, 1993, NUCL INSTRUM METH B, V80-1, P1259, DOI 10.1016/0168-583X(93)90779-6; WEBER WJ, 1981, J NUCL MATER, V98, P206, DOI 10.1016/0022-3115(81)90400-1; WEBER WJ, 1983, J NUCL MATER, V114, P213, DOI 10.1016/0022-3115(83)90259-3; Yakub E, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2764484; Yamada K, 2000, J ALLOY COMPD, V307, P10, DOI 10.1016/S0925-8388(00)00806-9	28	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134500	10.1371/journal.pone.0134500	http://dx.doi.org/10.1371/journal.pone.0134500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244777	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400084
J	Hyma, KE; Barba, P; Wang, MH; Londo, JP; Acharya, CB; Mitchell, SE; Sun, Q; Reisch, B; Cadle-Davidson, L				Hyma, Katie E.; Barba, Paola; Wang, Minghui; Londo, Jason P.; Acharya, Charlotte B.; Mitchell, Sharon E.; Sun, Qi; Reisch, Bruce; Cadle-Davidson, Lance			Heterozygous Mapping Strategy (HetMappS) for High Resolution Genotyping-By-Sequencing Markers: A Case Study in Grapevine	PLOS ONE			English	Article							VITIS-VINIFERA L.; GENETIC-LINKAGE MAPS; POWDERY MILDEW RESISTANCE; GENUS VITIS; GENOME; SEX; CONSTRUCTION; LOCUS; SSR; IDENTIFICATION	Genotyping by sequencing (GBS) provides opportunities to generate high-resolution genetic maps at a low genotyping cost, but for highly heterozygous species, missing data and heterozygote undercalling complicate the creation of GBS genetic maps. To overcome these issues, we developed a publicly available, modular approach called HetMappS, which functions independently of parental genotypes and corrects for genotyping errors associated with heterozygosity. For linkage group formation, HetMappS includes both a reference-guided synteny pipeline and a reference-independent de novo pipeline. The de novo pipeline can be utilized for under-characterized or high diversity families that lack an appropriate reference. We applied both HetMappS pipelines in five half-sib F-1 families involving genetically diverse Vitis spp. Starting with at least 116,466 putative SNPs per family, the HetMappS pipelines identified 10,440 to 17,267 phased pseudo-testcross (Pt) markers and generated high-confidence maps. Pt marker density exceeded crossover resolution in all cases; up to 5,560 non-redundant markers were used to generate parental maps ranging from 1,047 cM to 1,696 cM. The number of markers used was strongly correlated with family size in both de novo and synteny maps (r = 0.92 and 0.91, respectively). Comparisons between allele and tag frequencies suggested that many markers were in tandem repeats and mapped as single loci, while markers in regions of more than two repeats were removed during map curation. Both pipelines generated similar genetic maps, and genetic order was strongly correlated with the reference genome physical order in all cases. Independently created genetic maps from shared parents exhibited nearly identical results. Flower sex was mapped in three families and correctly localized to the known sex locus in all cases. The HetMappS pipeline could have wide application for genetic mapping in highly heterozygous species, and its modularity provides opportunities to adapt portions of the pipeline to other family types, genotyping technologies or applications.	[Hyma, Katie E.; Wang, Minghui; Sun, Qi] Cornell Univ, Inst Biotechnol, Bioinformat Facil, Ithaca, NY USA; [Hyma, Katie E.; Acharya, Charlotte B.; Mitchell, Sharon E.] Cornell Univ, Inst Biotechnol, Genom Div Facil, Ithaca, NY USA; [Barba, Paola] Cornell Univ, Sch Integrat Plant Sci, Plant Breeding & Genet Sect, Ithaca, NY USA; [Londo, Jason P.; Cadle-Davidson, Lance] USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA; [Reisch, Bruce] Cornell Univ, Hort Sect, Sch Integrat Plant Sci, Geneva, NY USA	Cornell University; Cornell University; Cornell University; United States Department of Agriculture (USDA); Cornell University	Cadle-Davidson, L (corresponding author), USDA ARS, Grape Genet Res Unit, Geneva, NY 14456 USA.	Lance.CadleDavidson@ars.usda.gov		Londo, Jason/0000-0003-0535-4820; Barba, Paola/0000-0001-9485-4733	U.S. Department of Agriculture-Specialty Crops Research Initiative grant [2011-51181-30635]; Comision Nacional de Investigacion Cientifica y Tecnologica "Becas Chile"; U.S. National Institutes of Health [1S10OD010693-01]	U.S. Department of Agriculture-Specialty Crops Research Initiative grant; Comision Nacional de Investigacion Cientifica y Tecnologica "Becas Chile"; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. Department of Agriculture-Specialty Crops Research Initiative grant number 2011-51181-30635 to BR; by a PhD fellowship from Comision Nacional de Investigacion Cientifica y Tecnologica "Becas Chile" to PB; and by the U.S. National Institutes of Health grant number 1S10OD010693-01 to the Cornell University Biotechnology Resource Center for data collected on the Illumina HiSeq 2500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon A-F, 2011, GENETICS GENOMICS BR; Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Adam-Blondon AF, 2011, GENETICS GENOMICS AN; ANTCLIFF AJ, 1980, ANN AMELIOR PLANT, V30, P113; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Barnaud A, 2010, HEREDITY, V104, P431, DOI 10.1038/hdy.2009.143; Battilana J, 2013, MOL BIOTECHNOL, V54, P1031, DOI 10.1007/s12033-013-9657-5; Blanc S, 2012, THEOR APPL GENET, V125, P1663, DOI 10.1007/s00122-012-1942-3; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, GENETIC MAP CONSTRUC; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Chen J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0428-2; Dalbo MA, 2000, GENOME, V43, P333, DOI 10.1139/gen-43-2-333; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Di Gaspero G, 2000, THEOR APPL GENET, V101, P301, DOI 10.1007/s001220051483; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; Duchene E, 2012, THEOR APPL GENET, V124, P623, DOI 10.1007/s00122-011-1734-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Fechter I, 2012, MOL GENET GENOMICS, V287, P247, DOI 10.1007/s00438-012-0674-z; Fernandez L, 2006, GENOME, V49, P721, DOI 10.1139/G06-034; Gardner KM, 2014, G3-GENES GENOM GENET, V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Hart JP, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0058; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Mahanil S, 2012, THEOR APPL GENET, V124, P23, DOI 10.1007/s00122-011-1684-7; Marguerit E, 2009, THEOR APPL GENET, V118, P1261, DOI 10.1007/s00122-009-0979-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mejia N, 2007, AM J ENOL VITICULT, V58, P499; Myles S, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0288-3; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Picq S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0229-z; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2021, R PROJECT STAT COMPU; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Riaz S, 2006, THEOR APPL GENET, V113, P1317, DOI 10.1007/s00122-006-0385-0; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Swarts K, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.05.0023; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; URGI, 2014, 12X 2 VERS GRAP REF; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Vitulo N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-99; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107	59	75	76	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134880	10.1371/journal.pone.0134880	http://dx.doi.org/10.1371/journal.pone.0134880			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244767	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400119
J	Singh, GM; Micha, R; Khatibzadeh, S; Shi, PL; Lim, S; Andrews, KG; Engell, RE; Ezzati, M; Mozaffarian, D				Singh, Gitanjali M.; Micha, Renata; Khatibzadeh, Shahab; Shi, Peilin; Lim, Stephen; Andrews, Kathryn G.; Engell, Rebecca E.; Ezzati, Majid; Mozaffarian, Dariush		Global Burden Dis Nutr & Chronic D	Global, Regional, and National Consumption of Sugar-Sweetened Beverages, Fruit Juices, and Milk: A Systematic Assessment of Beverage Intake in 187 Countries	PLOS ONE			English	Article							GBD 2010; CHILDREN; ADULTS; RISK; NUTRITION; DISEASE; OBESITY; TRENDS; PATTERNS; WEIGHT	Background Sugar-sweetened beverages (SSBs), fruit juice, and milk are components of diet of major public health interest. To-date, assessment of their global distributions and health impacts has been limited by insufficient comparable and reliable data by country, age, and sex. Objective To quantify global, regional, and national levels of SSB, fruit juice, and milk intake by age and sex in adults over age 20 in 2010. Methods We identified, obtained, and assessed data on intakes of these beverages in adults, by age and sex, from 193 nationally- or subnationally-representative diet surveys worldwide, representing over half the world's population. We also extracted data relevant to milk, fruit juice, and SSB availability for 187 countries from annual food balance information collected by the United Nations Food and Agriculture Organization. We developed a hierarchical Bayesian model to account for measurement incomparability, study representativeness, and sampling and modeling uncertainty, and to combine and harmonize nationally representative dietary survey data and food availability data. Results In 2010, global average intakes were 0.58 (95% UI: 0.37, 0.89) 8 oz servings/day for SSBs, 0.16 (0.10, 0.26) for fruit juice, and 0.57 (0.39, 0.83) for milk. There was significant heterogeneity in consumption of each beverage by region and age. Intakes of SSB were highest in the Caribbean (1.9 servings/day; 1.2, 3.0); fruit juice consumption was highest in Australia and New Zealand (0.66; 0.35, 1.13); and milk intake was highest in Central Latin America and parts of Europe (1.06; 0.68, 1.59). Intakes of all three beverages were lowest in East Asia and Oceania. Globally and within regions, SSB consumption was highest in younger adults; fruit juice consumption showed little relation with age; and milk intakes were highest in older adults. Conclusions Our analysis highlights the enormous spectrum of beverage intakes worldwide, by country, age, and sex. These data are valuable for highlighting gaps in dietary surveillance, determining the impacts of these beverages on global health, and targeting dietary policy.	[Singh, Gitanjali M.; Micha, Renata; Shi, Peilin; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Hlth Policy, Boston, MA 02111 USA; [Khatibzadeh, Shahab] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lim, Stephen; Andrews, Kathryn G.; Engell, Rebecca E.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Global Environm Hlth, London, England; [Micha, Renata] Agr Univ Athens, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece	Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; Imperial College London; Agricultural University of Athens	Mozaffarian, D (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Hlth Policy, Boston, MA 02111 USA.	Dariush.Mozaffarian@tufts.edu	Castetbon, Katia/F-2686-2017; Mozaffarian, Dariush/ABC-2822-2020; Turrini, Aida/K-5353-2016; Pekcan, A Gulden/AAI-6040-2021; TURRINI, AIDA/P-2413-2019; Fisberg, Regina Mara/Q-6494-2019; Fisberg, Regina M/C-4069-2012; Calleja, Neville/E-3895-2019; Bjerregaard, Peter/ABD-8894-2020; Houshyarrad, Anahita/AHD-8649-2022; Li, Yanping/H-6437-2011; Gulliford, Martin/I-8606-2018; , Sahar/L-7112-2013; Mensink, Gert/B-2447-2009; Thorsdottir, Inga/M-3260-2015; Nagalla, Balakrishna/GRR-4393-2022; Veerman, Lennert/A-9973-2011	Turrini, Aida/0000-0002-2188-9406; Pekcan, A Gulden/0000-0002-2037-3037; TURRINI, AIDA/0000-0002-2188-9406; Fisberg, Regina Mara/0000-0002-4490-9035; Fisberg, Regina M/0000-0002-4490-9035; Calleja, Neville/0000-0003-1800-2103; Bjerregaard, Peter/0000-0001-7153-8447; Houshyarrad, Anahita/0000-0001-5698-8239; Li, Yanping/0000-0002-0412-2748; Gulliford, Martin/0000-0003-1898-9075; , Sahar/0000-0003-0705-8013; Mensink, Gert/0000-0001-6268-5998; Gauci, Dorothy/0000-0002-1524-584X; Thorsdottir, Inga/0000-0002-2946-287X; Waskiewicz, Anna/0000-0001-5091-2145; Haerpfer, Christian/0000-0002-7350-9049; lipoeto, nurindrawaty/0000-0003-4119-3593; Naska, Androniki/0000-0002-1610-1813; Abdollahi, Morteza/0000-0003-0310-2021; Lucjan, szponar/0000-0003-4225-8299; Nagalla, Balakrishna/0000-0002-5613-0942; Ding, Eric/0000-0002-5881-8097; Veerman, Lennert/0000-0002-3206-8232; Sibai, Abla/0000-0002-1851-5606; Orfanos, Philippos/0000-0002-9949-3137; Jackson, Maria/0000-0002-7031-7244; Farzadfar, Farshad/0000-0001-8288-4046; THANOPOULOU, ANASTASIA/0000-0002-2902-8053	T32 Training Grant in Academic Nutrition from the National Institute of Diabetes, Digestive and Kidney Diseases [DK007703]; K99/R00 Pathway to Independence Award from the National Heart, Lung, and Blood Institute [1K99HL124321]; Bill & Melinda Gates Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL124321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	T32 Training Grant in Academic Nutrition from the National Institute of Diabetes, Digestive and Kidney Diseases; K99/R00 Pathway to Independence Award from the National Heart, Lung, and Blood Institute; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Singh was supported by a T32 Training Grant in Academic Nutrition (DK007703) from the National Institute of Diabetes, Digestive and Kidney Diseases and a K99/R00 Pathway to Independence Award (1K99HL124321) from the National Heart, Lung, and Blood Institute. Initial data collection for this work was supported by a grant from the Bill & Melinda Gates Foundation to the 2010 Global Burden of Diseases study. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Bonfiglioli C, 2011, AUST NZ J PUBL HEAL, V35, P325, DOI 10.1111/j.1753-6405.2011.00726.x; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Del Gobbo LC, 2015, AMERICAN JOURNAL OF; Dennison BA, 1997, PEDIATRICS, V99, P15; Dennison BA, 1996, J AM COLL NUTR, V15, pS4, DOI 10.1080/07315724.1996.10720475; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; ERS U, 2010, FOOD AVAILABILITY PE; FAO, 2007, PROMISES AND CHALLEN; Federal Trade Commission, 2012, REV FOOD MARK CHILDR; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gibson S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-9; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Han E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-195; Hjartaker A, 2002, PUBLIC HEALTH NUTR, V5, P1259, DOI 10.1079/PHN2002403; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; International Dairy Federation, 2014, BULLETIN OF THE INTE; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943; Lee HS, 2012, ASIA PAC J CLIN NUTR, V21, P618; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marshall TA, 2013, J AM DENT ASSOC, V144, P1148, DOI 10.14219/jada.archive.2013.0033; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Micha Renata, 2014, BMJ, V348, pg2272, DOI 10.1136/bmj.g2272; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Nikpartow N, 2012, PUBLIC HEALTH NUTR, V15, P2175, DOI 10.1017/S1368980012003898; O'Neil CE, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-17; Oi Y, 2003, J AGR FOOD CHEM, V51, P7029, DOI 10.1021/jf030085y; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Rice BH, 2013, NUTR REV, V71, P209, DOI 10.1111/nure.12007; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Song Y, 2013, J NUTR, V143, P189, DOI 10.3945/jn.112.168484; Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; USDA, 2010, 2010 DIETARY GUIDELI; WANG YF, 1984, HUM GENET, V67, P103; WHO/FAO, 2003, WHO TECHNICAL REPORT, V160; Willett WC, 2013, NUTRITIONAL EPIDEMIO	43	288	297	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0124845	10.1371/journal.pone.0124845	http://dx.doi.org/10.1371/journal.pone.0124845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244332	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400003
J	Mendes, FA; Aguiar, JMC; Kahn, SA; Reis, AH; Dubois, LG; Romao, LF; Ferreira, LSS; Chneiweiss, H; Neto, VM; Abreu, JG				Mendes, Fabio A.; Aguiar, Juliana M. Coelho; Kahn, Suzana A.; Reis, Alice H.; Dubois, Luiz Gustavo; Romao, Luciana Ferreira; Ferreira, Lais S. S.; Chneiweiss, Herve; Moura Neto, Vivaldo; Abreu, Jose G.			Connective-Tissue Growth Factor (CTGF/CCN2) Induces Astrogenesis and Fibronectin Expression of Embryonic Neural Cells In Vitro	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; CHONDROCYTE-SPECIFIC GENE; FACTOR CTGF; FACTOR-BETA; ASTROCYTIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; MATRIX PRODUCTION; MESANGIAL CELLS; BONE-FORMATION; MAP KINASE	Connective-tissue growth factor (CTGF) is a modular secreted protein implicated in multiple cellular events such as chondrogenesis, skeletogenesis, angiogenesis and wound healing. CTGF contains four different structural modules. This modular organization is characteristic of members of the CCN family. The acronym was derived from the first three members discovered, cysteine-rich 61 (CYR61), CTGF and nephroblastoma overexpressed (NOV). CTGF is implicated as a mediator of important cell processes such as adhesion, migration, proliferation and differentiation. Extensive data have shown that CTGF interacts particularly with the TGF beta, WNT and MAPK signaling pathways. The capacity of CTGF to interact with different growth factors lends it an important role during early and late development, especially in the anterior region of the embryo. ctgf knockout mice have several cranio-facial defects, and the skeletal system is also greatly affected due to an impairment of the vascular-system development during chondrogenesis. This study, for the first time, indicated that CTGF is a potent inductor of gliogenesis during development. Our results showed that in vitro addition of recombinant CTGF protein to an embryonic mouse neural precursor cell culture increased the number of GFAP- and GFAP/Nestin-positive cells. Surprisingly, CTGF also increased the number of Sox2-positive cells. Moreover, this induction seemed not to involve cell proliferation. In addition, exogenous CTGF activated p44/42 but not p38 or JNK MAPK signaling, and increased the expression and deposition of the fibronectin extracellular matrix protein. Finally, CTGF was also able to induce GFAP as well as Nestin expression in a human malignant glioma stem cell line, suggesting a possible role in the differentiation process of gliomas. These results implicate ctgf as a key gene for astrogenesis during development, and suggest that its mechanism may involve activation of p44/42 MAPK signaling. Additionally, CTGF-induced differentiation of glioblastoma stem cells into	[Mendes, Fabio A.; Aguiar, Juliana M. Coelho; Kahn, Suzana A.; Reis, Alice H.; Ferreira, Lais S. S.; Abreu, Jose G.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, RJ, Brazil; [Kahn, Suzana A.; Chneiweiss, Herve] Univ Paris 05, INSERM, Team Glial Plast, UMR894, Paris, France; [Dubois, Luiz Gustavo; Moura Neto, Vivaldo] Inst Estadual Cerebro Paulo Niemeyer IEC, Rio De Janeiro, RJ, Brazil; [Romao, Luciana Ferreira] Univ Fed Rio de Janeiro, Polo Xerem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Rio de Janeiro	Abreu, JG (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Biol Celular & Desenvolvimento, Rio De Janeiro, RJ, Brazil.	garciajr@icb.ufrj.br	Abreu, Jose G/ABB-1199-2021; Ferreira, Laís S S/W-3640-2018; Abreu, Jose G/G-6159-2010; herve, chneiweiss/Q-6818-2019; Feijo Dubois, Luiz Gustavo/O-9904-2015	Abreu, Jose G/0000-0002-1363-1755; Ferreira, Laís S S/0000-0002-0152-459X; Abreu, Jose G/0000-0002-9875-7786; herve, chneiweiss/0000-0001-7675-5061; Feijo Dubois, Luiz Gustavo/0000-0002-9765-5315; Reis, Alice/0000-0002-7431-5502	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Nucleos de Excelencia (PRONEX)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (JGA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (JGA); Programa de Nucleos de Excelencia (PRONEX) (JGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aguiar DP, 2011, BIOCHEM BIOPH RES CO, V413, P582, DOI 10.1016/j.bbrc.2011.09.005; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Cooker LA, 2007, AM J PHYSIOL-RENAL, V293, pF157, DOI 10.1152/ajprenal.00508.2006; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; CREUZET C, 1995, J NEUROCHEM, V64, P1541; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; FRANZIER K, 1996, J INVEST DERMATOL, V107, P404; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I; Gomes FCA, 2005, INT J DEV NEUROSCI, V23, P413, DOI 10.1016/j.ijdevneu.2005.04.001; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kawaki H, 2008, BIOCHEM BIOPH RES CO, V366, P450, DOI 10.1016/j.bbrc.2007.11.155; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Kothapalli D, 1997, CELL GROWTH DIFFER, V8, P61; Lee SM, 2004, BIOCHEM BIOPH RES CO, V320, P1087, DOI 10.1016/j.bbrc.2004.06.060; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu B, 2006, J CELL BIOCHEM, V97, P1104, DOI 10.1002/jcb.20709; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Mendes FA, 2003, DEV BRAIN RES, V142, P111, DOI 10.1016/S0165-3806(03)00036-1; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; NORTHROP J, 1995, DEV BIOL, V172, P242, DOI 10.1006/dbio.1995.0019; Obayashi S, 2009, CELL MOL NEUROBIOL, V29, P423, DOI 10.1007/s10571-008-9338-2; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Onofre GR, 2001, BRAZ J MED BIOL RES, V34, P251, DOI 10.1590/S0100-879X2001000200014; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Pacheco MS, 2008, CELLS TISSUES ORGANS, V187, P199, DOI 10.1159/000112640; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Phanish MK, 2005, NEPHRON EXP NEPHROL, V100, pE156, DOI 10.1159/000085445; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rachfal AW, 2003, HEPATOL RES, V26, P1, DOI 10.1016/S1386-6346(03)00115-3; Rajan P, 1998, J NEUROSCI, V18, P3620; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; SANCHOTELLO M, 1995, GLIA, V15, P157, DOI 10.1002/glia.440150208; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Silvestre DC, 2011, STEM CELLS, V29, P440, DOI 10.1002/stem.600; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tan JTM, 2008, AM J PHYSIOL-CELL PH, V295, pC740, DOI 10.1152/ajpcell.00333.2007; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang W, 2008, J CELL PHYSIOL, V214, P38, DOI 10.1002/jcp.21159; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Yuan LQ, 2007, AMINO ACIDS, V32, P425, DOI 10.1007/s00726-006-0380-4	70	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133689	10.1371/journal.pone.0133689	http://dx.doi.org/10.1371/journal.pone.0133689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241738	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700018
J	Meng, M; Cheng, DJ; Peng, J; Qian, WL; Li, JR; Dai, DD; Zhang, TL; Xia, QY				Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you			The Homeodomain Transcription Factors Antennapedia and POU-M2 Regulate the Transcription of the Steroidogenic Enzyme Gene Phantom in the Silkworm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBYX-MORI; PROTHORACICOTROPIC HORMONE; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; ECDYSTEROID BIOSYNTHESIS; MIDGUT MORPHOGENESIS; PROTEIN INTERACTIONS; INSECT DEVELOPMENT; MOLTING HORMONE; MOLECULAR-BASIS	The steroid hormone ecdysone, which controls insect molting and metamorphosis, is synthesized in the prothoracic gland (PG), and several steroidogenic enzymes that are expressed specifically in the PG are involved in ecdysteroidogenesis. In this study, we identified new regulators that are involved in the transcriptional control of the silkworm steroidogenic enzyme genes. In silico analysis predicted several potential cis-regulatory elements ((REs) for the homedomain transcription factors Antennapedia (Antp) and POU-M2 in the proximal promoters of steroidogenic enzyme genes. Antp and POLI-M2 are expressed dynamically in the PG during larval development, and their overexpression in silkworm embryo-derived (BmE) cells induced the expression of steroidogenic enzyme genes. Importantly, luciferase reporter analyses, electrophoretic mobility shift assays, and chromatin immunoprecipitation assays revealed that Antp and POU-M2 promote the transcription of the silkworm steroidogenic enzyme gene Phantom (Phm) by binding directly to specific motifs within overlapping CREs in the Phm promoter. Mutations of these CREs in the Phm promoter suppressed the transcriptional activities of both Antp and POU-M2 in BmE cells and decreased the activities of mutated Phm promoters in the silkworm PG. In addition, pulldown and co-immunoprecipitation assays demonstrated that Antp can interact with POU-M2. Moreover, RNA interferencemediated down-regulation of either Antp or POU-M2 during silkworm wandering not only decreased the ecdysone titer but also led to the failure of metamorphosis. In summary, our results suggest that Antp and POU-M2 coordinate the transcription of the silkworm Phm gene directly, indicating new roles for homeodomain proteins in regulating insect ecdysteroidogenesis.	[Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you] Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Meng, Meng; Cheng, Dao-jun; Peng, Jian; Qian, Wen-liang; Li, Jia-rui; Dai, Dan-dan; Zhang, Tian-lei; Xia, Qing-you] Southwest Univ, Coll Biotechnol, Minist Agr, Key Sericultural Lab, Chongqing 400715, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Cheng, DJ (corresponding author), Southwest Univ, Coll Biotechnol, Minist Agr, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	chengdj@swu.edu.cn; xiagy@swu.edu.cn			National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31172267, 31272503]; National Hi-Tech Research and Development Program of China [2011AA100306]; Municipal Natural Science Foundation of Chongqing [cstc2012jjA80023]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Municipal Natural Science Foundation of Chongqing	This work was supported by National Basic Research Program of China Grant 2012CB114600, National Natural Science Foundation of China Grants 31172267 and 31272503, National Hi-Tech Research and Development Program of China Grant 2011AA100306, and Municipal Natural Science Foundation of Chongqing Grant cstc2012jjA80023. The authors declare that they have no conflicts of interest with the contents of this article.	Akin ZN, 2005, CELL MOL NEUROBIOL, V25, P697, DOI 10.1007/s10571-005-3971-9; Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Burglin TR, 2011, SUBCELL BIOCHEM, V52, P95, DOI 10.1007/978-90-481-9069-0_5; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cai XY, 2014, GENE, V542, P232, DOI 10.1016/j.gene.2014.03.012; Chen P, 2013, HEREDITY, V111, P182, DOI 10.1038/hdy.2013.36; Cheng CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004425; Cheng DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109111; Cohen LE, 1996, ENDOCRIN METAB CLIN, V25, P523, DOI 10.1016/S0889-8529(05)70339-X; Danielsen ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004343; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Gilbert Lawrence I., 1997, Invertebrate Neuroscience, V3, P205, DOI 10.1007/BF02480376; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu SH, 1997, MOL CELL ENDOCRINOL, V127, P109, DOI 10.1016/S0303-7207(96)03995-0; Gu SH, 2015, J INSECT PHYSIOL, V72, P61, DOI 10.1016/j.jinsphys.2014.11.007; Heffer A, 2013, ANNU REV ENTOMOL, V58, P161, DOI 10.1146/annurev-ento-120811-153601; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HEUER JG, 1995, DEVELOPMENT, V121, P3861; Hua YJ, 1999, J BIOL CHEM, V274, P31169, DOI 10.1074/jbc.274.44.31169; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73, DOI 10.1080/00021369.1991.10870535; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Lelli KM, 2011, P NATL ACAD SCI USA, V108, P21122, DOI 10.1073/pnas.1114118109; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu QX, 2000, DEV BIOL, V225, P437, DOI 10.1006/dbio.2000.9836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Nagata T, 1996, GENES CELLS, V1, P555, DOI 10.1046/j.1365-2443.1996.d01-260.x; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Papadopoulos DK, 2012, DEV BIOL, V367, P78, DOI 10.1016/j.ydbio.2012.04.021; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802; Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105; Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028; Rewitz KF, 2013, CURR TOP DEV BIOL, V103, P1, DOI 10.1016/B978-0-12-385979-2.00001-0; Rezsohazy R, 2014, DEV DYNAM, V243, P117, DOI 10.1002/dvdy.24060; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; Smith WA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00019; Spindler KD, 2009, CELL MOL LIFE SCI, V66, P3837, DOI 10.1007/s00018-009-0112-5; Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009; Truman JW, 2006, P NATL ACAD SCI USA, V103, P8909, DOI 10.1073/pnas.0603252103; Vershon AK, 1996, CURR OPIN BIOTECH, V7, P392, DOI 10.1016/S0958-1669(96)80113-3; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Wierman ME, 1997, MOL CELL BIOL, V17, P1652, DOI 10.1128/MCB.17.3.1652; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Zhang TY, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-25; Zhang TY, 2004, BIOCHEM J, V380, P255, DOI 10.1042/BJ20031482; Zhao GD, 2014, GENE, V551, P152, DOI 10.1016/j.gene.2014.08.050	73	20	20	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24438	24452		10.1074/jbc.M115.651810	http://dx.doi.org/10.1074/jbc.M115.651810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26253172	hybrid, Green Published			2022-12-26	WOS:000362218900031
J	Park, JY; Lee, SH; Shin, MJ; Hwang, GS				Park, Ju Yeon; Lee, Sang-Hak; Shin, Min-Jeong; Hwang, Geum-Sook			Alteration in Metabolic Signature and Lipid Metabolism in Patients with Angina Pectoris and Myocardial Infarction	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; UNSATURATED FATTY-ACIDS; MONOCYTE ADHESION; ENDOTHELIAL-CELLS; LDL OXIDATION; PHOSPHATIDYLCHOLINE; ACETYLHYDROLASE; INFLAMMATION; ASSOCIATION; PLATELET	Lipid metabolites are indispensable regulators of physiological and pathological processes, including atherosclerosis and coronary artery disease (CAD). However, the complex changes in lipid metabolites and metabolism that occur in patients with these conditions are incompletely understood. We performed lipid profiling to identify alterations in lipid metabolism in patients with angina and myocardial infarction (MI). Global lipid profiling was applied to serum samples from patients with CAD (angina and MI) and age-, sex-, and body mass index-matched healthy subjects using ultra-performance liquid chromatography/quadruple time-of-flight mass spectrometry and multivariate statistical analysis. A multivariate analysis showed a clear separation between the patients with CAD and normal controls. Lysophosphatidylcholine (lysoPC) and lysophosphatidylethanolamine (lysoPE) species containing unsaturated fatty acids and free fatty acids were associated with an increased risk of CAD, whereas species of lysoPC and lyso-alkyl PC containing saturated fatty acids were associated with a decreased risk. Additionally, PC species containing palmitic acid, diacylglycerol, sphingomyelin, and ceramide were associated with an increased risk of MI, whereas PE-plasmalogen and phosphatidylinositol species were associated with a decreased risk. In MI patients, we found strong positive correlation between lipid metabolites related to the sphingolipid pathway, sphingomyelin, and ceramide and acute inflammatory markers (high-sensitivity C-reactive protein). The results of this study demonstrate altered signatures in lipid metabolism in patients with angina or MI. Lipidomic profiling could provide the information to identity the specific lipid metabolites under the presence of disturbed metabolic pathways in patients with CAD.	[Park, Ju Yeon; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea; [Lee, Sang-Hak] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 120749, South Korea; [Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea; [Hwang, Geum-Sook] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea	Korea Basic Science Institute (KBSI); Yonsei University; Yonsei University Health System; Korea University; Ewha Womans University	Hwang, GS (corresponding author), Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea.	gshwang@kbsi.re.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea [2010-0019394, 2013M3A9B6046418]; Creative Allied Project (CAP) and Degree & Research Center program by National Research Council of Science and Technology [DRC-14-3-KBSI]; Korea Basic Science Institute [T35705]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea; Creative Allied Project (CAP) and Degree & Research Center program by National Research Council of Science and Technology; Korea Basic Science Institute	This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea (2010-0019394 and 2013M3A9B6046418), the Creative Allied Project (CAP) and Degree & Research Center program (DRC-14-3-KBSI) by the National Research Council of Science and Technology, and the Korea Basic Science Institute (T35705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, Circulation, V59, P607; Chen L, 1997, J LIPID RES, V38, P546; Chisolm GM, 2000, FREE RADICAL BIO MED, V28, P1697, DOI 10.1016/S0891-5849(00)00227-6; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Cui Z, 2002, BBA-MOL CELL BIOL L, V1585, P87, DOI 10.1016/S1388-1981(02)00328-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontaine-Bisson B, 2007, METABOLISM, V56, P649, DOI 10.1016/j.metabol.2006.12.013; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hu CX, 2009, J CHROMATOGR B, V877, P2836, DOI 10.1016/j.jchromb.2009.01.038; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Jove M, 2013, CARDIOVASC RES, V97, P642, DOI 10.1093/cvr/cvs368; Karabina SAP, 1997, EUR J CLIN INVEST, V27, P595, DOI 10.1046/j.1365-2362.1997.1570706.x; Kien CL, 2013, DIABETES, V62, P1054, DOI 10.2337/db12-0363; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; Lourida ES, 2006, PROSTAG LEUKOTR ESS, V75, P117, DOI 10.1016/j.plefa.2006.03.012; Lozanski G, 1997, BIOCHEM J, V328, P271, DOI 10.1042/bj3280271; Mata P, 1996, ARTERIOSCL THROM VAS, V16, P1347, DOI 10.1161/01.ATV.16.11.1347; Meikle PJ, 2011, ARTERIOSCL THROM VAS, V31, P2723, DOI 10.1161/ATVBAHA.111.234096; Murakami M, 2011, EXP ANIM TOKYO, V60, P7, DOI 10.1538/expanim.60.7; Oka H, 2000, ARTERIOSCL THROM VAS, V20, P244, DOI 10.1161/01.ATV.20.1.244; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; PARK JH, 2010, J LIPID RES, P1, DOI DOI 10.1194/JLR.M010330; PELECH SL, 1983, J BIOL CHEM, V258, P6782; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Rosenblat M, 2005, ATHEROSCLEROSIS, V179, P69, DOI 10.1016/j.atherosclerosis.2004.10.028; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Toborek M, 1996, J LIPID RES, V37, P123; Toborek M, 2002, AM J CLIN NUTR, V75, P119, DOI 10.1093/ajcn/75.1.119; VASDIAS FW, 1982, ATHEROSCLEROSIS, V43, P245, DOI 10.1016/0021-9150(82)90026-0; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; WEBER C, 1995, BIOCHEM BIOPH RES CO, V206, P621, DOI 10.1006/bbrc.1995.1088; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; YAO ZM, 1988, J BIOL CHEM, V263, P2998	36	72	75	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135228	10.1371/journal.pone.0135228	http://dx.doi.org/10.1371/journal.pone.0135228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258408	Green Published, gold, Green Submitted			2022-12-26	WOS:000359352600048
J	Huhns, M; Ropenack, P; Erbersdobler, A				Huehns, Maja; Roepenack, Paula; Erbersdobler, Andreas			Molecular and Immunohistochemical Characterization of Historical Long-Term Preserved Fixed Tissues from Different Human Organs	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; POLYMERASE CHAIN-REACTION; NUCLEIC-ACIDS; FORMALIN FIXATION; DNA EXTRACTION; PALEOPATHOLOGY; SECTIONS; AMPLIFICATION; MUSEUM	University and museum collections are very important sources of biological samples that can be used to asses the past and present genetic diversity of many species. Modern genetic and immunohistochemical techniques can be used on long-term preserved fixed tissues from museum specimens to answer epidemiological questions. A proof of principle was established to apply modern molecular genetics and immunohistochemical methods to these old specimens and to verify the original diagnosis. We analysed 19 specimens from our university collection including human organs that had been in fixative for more than 80 years. The tissues originated from lung, colon, brain, heart, adrenal gland, uterus and skin. We isolated amplifiable DNA from these wet preparations and performed mutational analysis of BRAF, KRAS and EGFR. The tissues were also embedded in paraffin and used for modern histology and immunohistochemistry. Our data show that amplifiable DNA is extractable and ranged from 0.25 to 22.77 mu g of total DNA. In three specimens BRAF(V600E) or KRAS(G12D) mutations were found. Additionally, expression of different proteins like vimentin and GFAP was detected immunohistochemical in six investigated specimens. On the basis of our results the original diagnosis was altered in three specimens. Our work showed that it is possible to extract amplifiable DNA suitable for sequence analysis from long-term fixed tissue. Furthermore, histology and immunohistochemistry is feasible in specimens fixed long time ago. We conclude that these old preparations are suitable for further epidemiological research and that our methods open up new opportunities for future studies.	[Huehns, Maja; Roepenack, Paula; Erbersdobler, Andreas] Univ Med Rostock, Inst Pathol, Rostock, Germany	University of Rostock	Huhns, M (corresponding author), Univ Med Rostock, Inst Pathol, Rostock, Germany.	maja.huehns@med.uni-rostock.de		Rocktaschel, Paula/0000-0001-6069-476X				Akalu A, 1999, GENET ANAL-BIOMOL E, V15, P229, DOI 10.1016/S1050-3862(99)00050-9; Anastasiou E, 2013, GENE, V528, P33, DOI 10.1016/j.gene.2013.06.017; BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393; Blum F., 1893, ZOOL ANZ, P229; CHAW YFM, 1980, BIOCHEMISTRY-US, V19, P5525, DOI 10.1021/bi00565a010; Coombs N J, 1999, Nucleic Acids Res, V27, pe12, DOI 10.1093/nar/27.16.e12; de Melo FL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000575; Duval K, 2010, FORENSIC SCI INT-GEN, V4, P80, DOI 10.1016/j.fsigen.2009.06.003; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; Fornaciari G, 2012, PATHOBIOLOGY, V79, P257, DOI 10.1159/000337292; Fox Herbert, 1926, Ann Med Hist, V8, P370; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Graeber MB, 1998, NEUROGENETICS, V1, P223, DOI 10.1007/s100480050033; JACKSON DP, 1990, J CLIN PATHOL, V43, P499, DOI 10.1136/jcp.43.6.499; KARLSEN F, 1994, LAB INVEST, V71, P604; Lyck L, 2008, J HISTOCHEM CYTOCHEM, V56, P201, DOI 10.1369/jhc.7A7187.2007; Miller MA, 2005, J VET DIAGN INVEST, V17, P461, DOI 10.1177/104063870501700509; Moller HJ, 1998, EUR ARCH PSY CLIN N, V248, P111, DOI 10.1007/s004060050027; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Paireder S, 2013, ANAL BIOCHEM, V439, P152, DOI 10.1016/j.ab.2013.04.006; Petrov DB, 2003, EUR J CARDIO-THORAC, V23, P461, DOI 10.1016/S1010-7940(03)00024-1; REMMELE W, 1987, PATHOLOGE, V8, P138; Rocken C, 2009, PATHOLOGE, V30, P226, DOI 10.1007/s00292-009-1135-2; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos MCLG, 2008, PATHOL RES PRACT, V204, P633, DOI 10.1016/j.prp.2008.04.005; Santos S, 2009, RES VET SCI, V86, P421, DOI 10.1016/j.rvsc.2008.08.007; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Tsutsumi Y, 2003, ACTA HISTOCHEM CYTOC, V36, P511, DOI 10.1267/ahc.36.511; Wasielewski R, 1998, BREAST J, V4, P33; Webster JD, 2009, J HISTOCHEM CYTOCHEM, V57, P753, DOI 10.1369/jhc.2009.953877; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; WESTERMARK P, 1984, ARCH PATHOL LAB MED, V108, P217; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Yasui M, 2001, NUCLEIC ACIDS RES, V29, P1994, DOI 10.1093/nar/29.9.1994	35	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135297	10.1371/journal.pone.0135297	http://dx.doi.org/10.1371/journal.pone.0135297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252375	Green Published, gold			2022-12-26	WOS:000359121100148
J	Khodadadi, L; Cheng, QY; Alexander, T; Sercan-Alp, O; Klotsche, J; Radbruch, A; Hiepe, F; Hoyer, BF; Taddeo, A				Khodadadi, Laleh; Cheng, Qingyu; Alexander, Tobias; Sercan-Alp, Oezen; Klotsche, Jens; Radbruch, Andreas; Hiepe, Falk; Hoyer, Bimba F.; Taddeo, Adriano			Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice	PLOS ONE			English	Article							BONE-MARROW; MAJOR SITE; MICE; ERYTHEMATOSUS; MEMORY; AUTOIMMUNITY; AUTOANTIBODY; INFLAMMATION; MAINTENANCE; ANTIBODIES	Long-lived plasma cells (LLPCs) are an unmet therapeutic challenge, and developing strategies for their targeting is an emerging goal of autoantibody-mediated diseases such as systemic lupus erythematosus (SLE). It was previously shown that plasma cells can be depleted by agents such as bortezomib (Bz) or by blocking LFA-1 and VLA-4 integrins. However, they regenerate quickly after depletion due to B cell hyperactivity in autoimmune conditions. Therefore, we compared different therapies for the elimination of LLPCs combined with selective B-cell targeting in order to identify the most effective treatment to eliminate LLPCs and prevent their regeneration in lupus-prone NZB/WF1 mice. Methods NZB/W F1 mice were treated with: 1) anti-CD20, 2) anti-CD20 plus bortezomib, 3) anti-CD20 plus anti-LFA-1/anti-VLA-4 blocking antibodies, 4) anti-CD20 plus bortezomib and anti-LFA-1/anti-VLA4 blocking antibodies. Short-and long-lived plasma cells including autoreactive cells in the bone marrow and spleen were enumerated by flow cytometry and ELISPOT seven days after treatment. Based on these data in another experiment, mice received one cycle of anti-CD20 plus bortezomib followed by four cycles of anti-CD20 therapy every 10 days and were monitored for its effect on plasma cells and disease. Results Short-lived plasma cells in bone marrow and spleen were efficiently depleted by all regimens targeting plasma cells. Conversely, LLPCs and anti-dsDNA-secreting plasma cells in bone marrow and spleen showed resistance to depletion and were strongly reduced by bortezomib plus anti-CD20. The effective depletion of plasma cells by bortezomib complemented by the continuous depletion of their precursor B cells using anti-CD20 promoted the persistent reduction of IgG anti-dsDNA antibodies, delayed nephritis and prolonged survival in NZB/W F1 mice. Conclusions These findings suggest that the effective depletion of LLPCs using bortezomib in combination with a therapy that continuously targeting B cells as their precursors may prevent the regeneration of autoreactive LLPCs and, thus, might represent a promising treatment strategy for SLE and other (auto) antibody-mediated diseases.	[Khodadadi, Laleh; Cheng, Qingyu; Alexander, Tobias; Sercan-Alp, Oezen; Klotsche, Jens; Radbruch, Andreas; Hiepe, Falk; Hoyer, Bimba F.; Taddeo, Adriano] German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany; [Khodadadi, Laleh; Cheng, Qingyu; Alexander, Tobias; Hiepe, Falk; Hoyer, Bimba F.; Taddeo, Adriano] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hiepe, F (corresponding author), German Rheumatism Res Ctr Berlin DRFZ, Berlin, Germany.	falk.hiepe@charite.de	Hoyer, Bimba Franziska/F-3174-2016; Taddeo, Adriano/AAW-3861-2021	Hoyer, Bimba Franziska/0000-0002-5252-1719; Taddeo, Adriano/0000-0003-3281-1548; Radbruch, Andreas/0000-0001-5753-0000; Hiepe, Falk/0000-0003-3584-5292; Sercan Alp, Oezen/0000-0001-5150-3618	Berlin-Brandenburg School for Regenerative Therapies; IMI BTCure; Rahel Hirsch grant from the Charite;  [Sonderforschungsbereich 650]	Berlin-Brandenburg School for Regenerative Therapies; IMI BTCure; Rahel Hirsch grant from the Charite; 	This work was supported by the Sonderforschungsbereich 650, Subproject 12 and 17. L.K. received a grant from the Berlin-Brandenburg School for Regenerative Therapies and A.T. from IMI BTCure. B.F.H. was supported by a Rahel Hirsch grant from the Charite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Alexander T, 2015, ANN RHEUM DIS, V74, P1474, DOI 10.1136/annrheumdis-2014-206016; Alexander T, 2009, BLOOD, V113, P214, DOI 10.1182/blood-2008-07-168286; Anolik J, 2004, CURR OPIN RHEUMATOL, V16, P505, DOI 10.1097/01.bor.0000133660.52599.f6; Bekar KW, 2010, ARTHRITIS RHEUM-US, V62, P2443, DOI 10.1002/art.27515; BENNER R, 1981, CLIN EXP IMMUNOL, V46, P1; Cambridge G, 2006, ARTHRITIS RHEUM-US, V54, P3612, DOI 10.1002/art.22211; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Cheng QY, 2013, ANN RHEUM DIS, V72, P2011, DOI 10.1136/annrheumdis-2013-203455; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Corso A, 2010, LEUKEMIA RES, V34, P471, DOI 10.1016/j.leukres.2009.07.022; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mumtaz IM, 2012, J AUTOIMMUN, V39, P180, DOI 10.1016/j.jaut.2012.05.010; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; OHNISHI K, 1994, INT IMMUNOL, V6, P817, DOI 10.1093/intimm/6.6.817; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Taddeo A, 2012, 32 EWRR FEBR 23 25 2, V32nd; Taddeo A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0551-3; Vincent FB, 2014, NAT REV RHEUMATOL, V10, P365, DOI 10.1038/nrrheum.2014.33; Vital EM, 2011, ARTHRITIS RHEUM-US, V63, P3038, DOI 10.1002/art.30466; Wang A, 2010, ARTHRITIS RHEUM-US, V62, P3436, DOI 10.1002/art.27685; Wang WS, 2014, J IMMUNOL, V192, P3011, DOI 10.4049/jimmunol.1302003; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001	32	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135081	10.1371/journal.pone.0135081	http://dx.doi.org/10.1371/journal.pone.0135081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252021	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100114
J	Mikulska, JE				Mikulska, Joanna E.			Analysis of Response Elements Involved in the Regulation of the Human Neonatal Fc Receptor Gene (FCGRT)	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; FUNCTIONAL EXPRESSION; BINDING-PROPERTIES; MUCOSAL BARRIERS; MHC; TRANSCRIPTION; IGG; TRANSPORT; PROMOTER; SP1	Human epithelial, endothelial and PMA-differentiated THP-1 cell lines were used as model systems to study the transcriptional regulation of the human FCGRT gene encoding the alpha chain of hFcRn. The data obtained from site-directed mutagenesis in transient transfection experiments indicate that the Sp1 sites at positions -641, -635, and -313, CF1/YY1 elements at positions -586 and -357, and the AP-1 motif at -276 within the-660/-233 fragment of the human FCGRT promoter (hFCGRT) participate in the regulation of human FCGRT in all selected cell lines. However, their individual contribution to promoter activity is not equivalent. The Sp1 binding site at -313 and the AP-1 site at -276 are critical for the activity of the hFCGRT promoter in epithelial and endothelial cells. Moreover, the CF1/YY1 site at -586 in differentiated THP-1 cells, plays an essential role in the transcriptional activity of the promoter. In addition, the C/EBPbeta binding site at -497 of the hFCGRT promoter in epithelial and endothelial cells, and the C/EBPbeta motif located at -497 and -233 within the hFCGRT promoter in differentiated THP-1 cells may function as positive regulatory sequences in response to LPS or PMA stimulation. EMSA and supershift analyses showed that the functionally identified binding motifs in the hFCGRT promoter were able to specifically interact with their corresponding (Sp1, Sp2, Sp3, c-Fos, c-Jun, YY1, and C/EBPbeta or C/EBPdelta) transcription factors (TFs), suggesting their possible involvement in the regulation of the human FCGRT gene expression.	Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Mikulska, JE (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland.	mikulska@iitd.pan.wroc.pl		Mikulska, Joanna/0000-0002-5953-7473	Polish Ministry of Science and Higher Education/National Science Centre [N N407 173434]; Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW) programme	Polish Ministry of Science and Higher Education/National Science Centre; Wroclaw Centre of Biotechnology; Leading National Research Centre (KNOW) programme	This work was supported by Polish Ministry of Science and Higher Education/National Science Centre (grant N N407 173434). The authors thank the Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) programme for years 2014-2018 for covering the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHOUSE JJ, 1993, J IMMUNOL, V151, P6076; Akilesh S, 2004, J CLIN INVEST, V113, P1328, DOI 10.1172/JCI200418838; Andersen JT, 2010, CLIN BIOCHEM, V43, P367, DOI 10.1016/j.clinbiochem.2009.12.001; Antohe F, 2001, HUM IMMUNOL, V62, P93, DOI 10.1016/S0198-8859(00)00244-5; Berrier A, 1998, J IMMUNOL, V161, P2267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cervenak J, 2013, MABS-AUSTIN, V5, P860, DOI 10.4161/mabs.26507; Chen GK, 2004, MOL PHARMACOL, V65, P906, DOI 10.1124/mol.65.4.906; Cianga P, 2007, VIRCHOWS ARCH, V451, P859, DOI 10.1007/s00428-007-0467-7; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; Gan Z, 2009, TRAFFIC, V10, P600, DOI 10.1111/j.1600-0854.2009.00887.x; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gosselin EJ, 2009, ARCH IMMUNOL THER EX, V57, P311, DOI 10.1007/s00005-009-0040-y; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; Jiang LL, 2004, AM J PHYSIOL-GASTR L, V286, pG922, DOI 10.1152/ajpgi.00131.2003; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KANDIL E, 1995, J IMMUNOL, V154, P5907; Kieda C, 2002, ENDOTHELIUM-J ENDOTH, V9, P247, DOI 10.1080/10623320214736; Kobayashi N, 2002, AM J PHYSIOL-RENAL, V282, pF358, DOI 10.1152/ajprenal.0164.2001; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Liu XD, 2008, J IMMUNOL, V181, P449, DOI 10.4049/jimmunol.181.1.449; Liu XD, 2007, J IMMUNOL, V179, P2999, DOI 10.4049/jimmunol.179.5.2999; Mikulska JE, 2000, EUR J IMMUNOGENET, V27, P231, DOI 10.1046/j.1365-2370.2000.00225.x; Mikulska JE, 2000, BBA-GENE STRUCT EXPR, V1492, P180, DOI 10.1016/S0167-4781(00)00068-3; Powner MB, 2014, INVEST OPHTH VIS SCI, V55, P1607, DOI 10.1167/iovs.13-12574; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; ROBERTS DM, 1990, J CELL BIOL, V111, P1867, DOI 10.1083/jcb.111.5.1867; Sato K, 2009, LIFE SCI, V85, P800, DOI 10.1016/j.lfs.2009.10.012; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; Shah U, 2003, PEDIATR RES, V53, P295, DOI 10.1203/01.PDR.0000047663.81816.E3; SIMISTER NE, 1985, EUR J IMMUNOL, V15, P733, DOI 10.1002/eji.1830150718; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; STORY CM, 1994, J EXP MED, V180, P2377, DOI 10.1084/jem.180.6.2377; Szlauer R, 2009, PLACENTA, V30, P507, DOI 10.1016/j.placenta.2009.03.009; Tiwari B, 2005, BBA-GENE STRUCT EXPR, V1681, P88, DOI 10.1016/j.bbaexp.2004.10.002; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Wani MA, 2006, P NATL ACAD SCI USA, V103, P5084, DOI 10.1073/pnas.0600548103; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Ye LL, 2008, J IMMUNOL, V181, P2572, DOI 10.4049/jimmunol.181.4.2572; Yoshida M, 2006, SPRINGER SEMIN IMMUN, V28, P397, DOI 10.1007/s00281-006-0054-z; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135141	10.1371/journal.pone.0135141	http://dx.doi.org/10.1371/journal.pone.0135141			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252948	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100121
J	Park, N; Baek, HS; Chun, YJ				Park, Nahee; Baek, Hyoung Seok; Chun, Young-Jin			Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and beta-Catenin Signaling	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT ANION CHANNEL; MATRIX METALLOPROTEINASES; CYTOCHROME-C; MITOCHONDRIA; PROTEIN; INHIBITION; PATHWAY; DEATH; VDAC	There is increasing evidence that embelin, an active component of Embelia ribes, induces apoptosis in human cancer cells, but the detailed mechanisms are still unclear. Here, we have investigated the effect of embelin on the growth of human prostate cancer cells. Embelin strongly inhibited cell growth especially in human prostate cancer cell lines, including PC3, DU145, LNCaP-LN3 and normal prostate epithelial cell, RWPE-1 compared to breast cancer (MDA-MB-231, MCF-7, and T47D), hepatoma (HepG2, Hep3B, and HuH-7), or choriocarcinoma (JEG-3). We observed that embelin induced apoptosis of PC3 cells in a time-dependent manner correlated with decreased expression of Bcl-2, Bcl-xL, and Mcl-1, increased translocation of Bax into mitochondria, and a reduction in the mitochondrial membrane potential. Furthermore, embelin induced voltage-dependent anion channel (VDAC) 1 expression and oligomerization, which may promote cytochrome c and AIF release. Because embelin was able to inhibit Akt activation and cyclooxygenase-2 expression, the effects on Wnt/beta-catenin signaling were determined. Embelin activated glycogen synthase kinase (GSK)-3 beta by preventing phosphorylation and suppressed beta-catenin expression. Attenuation of beta-catenin-mediated TCF transcriptional activity and gene transcription, such as cyclin D1, c-myc, and matrix metalloproteinase (MMP)-7, were shown in embelin-treated cells. The changes in beta-catenin levels in response to embelin were blocked by lithium chloride, a GSK-3 inhibitor, indicating that embelin may decrease beta-catenin expression via GSK-3 beta activation. Furthermore, exposure of PC3 cells to embelin resulted in a significant decrease in cell migration and invasion. In conclusion, these findings suggest that inhibition of Akt signaling and activation of GSK-3 beta partially contributes to the pro-apoptotic effect of embelin in prostate cancer cells.	[Park, Nahee; Baek, Hyoung Seok; Chun, Young-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Chun, YJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	yjchun@cau.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [2015R1A5A1008958]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2015R1A5A1008958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2007, MOL PHARMACOL, V71, P209, DOI 10.1124/mol.106.028787; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Chitra M, 2003, FITOTERAPIA, V74, P401, DOI 10.1016/S0367-326X(03)00066-2; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Dash R, 2010, CANCER RES, V70, P5034, DOI 10.1158/0008-5472.CAN-10-0563; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Feng ZB, 2011, HUM PATHOL, V42, P659, DOI 10.1016/j.humpath.2010.07.021; Feresin GE, 2003, J ETHNOPHARMACOL, V88, P241, DOI 10.1016/S0378-8741(03)00258-7; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Heo JY, 2011, CANCER LETT, V308, P71, DOI 10.1016/j.canlet.2011.04.015; Hong M, 2014, BIOMOL THER, V22, P519, DOI 10.4062/biomolther.2014.112; Huang MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092161; Iqbal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030764; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mahendran S, 2011, PHYTOMEDICINE, V18, P186, DOI 10.1016/j.phymed.2010.04.002; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Moses MA, 1998, CANCER RES, V58, P1395; Nikolovska-Coleska Z, 2004, J MED CHEM, V47, P2430, DOI 10.1021/jm030420+; Papenfuss K, 2008, J CELL MOL MED, V12, P2566, DOI 10.1111/j.1582-4934.2008.00514.x; Reuter S, 2010, MOL CANCER RES, V8, P1425, DOI 10.1158/1541-7786.MCR-10-0141; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Sreepriya M, 2006, MOL CELL BIOCHEM, V284, P49, DOI 10.1007/s11010-005-9012-7; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xu MJ, 2005, PLANTA MED, V71, P944, DOI 10.1055/s-2005-871250; Yamanaka K, 2005, MOL CANCER THER, V4, P1689, DOI 10.1158/1535-7163.MCT-05-0064; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356	38	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134760	10.1371/journal.pone.0134760	http://dx.doi.org/10.1371/journal.pone.0134760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252009	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100074
J	Williams, SH; Lozier, NR; Montuelle, SJ; de Lacalle, S				Williams, Susan H.; Lozier, Nicholas R.; Montuelle, Stephane J.; de Lacalle, Sonsoles			Effect of Postnatal Myostatin Inhibition on Bite Mechanics in Mice	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; MUSCLE MASS; DIETARY CONSISTENCY; SKELETAL-MUSCLE; DEFICIENT MICE; CRANIOFACIAL MORPHOLOGY; CONTRACTILE PROPERTIES; TEMPORALIS MUSCLE; FORCE; MOUSE	As a negative regulator of muscle size, myostatin (Mstn) impacts the force-production capabilities of skeletal muscles. In the masticatory system, measures of temporalis-stimulated bite forces in constitutive myostatin KOs suggest an absolute, but not relative, increase in jaw-muscle force. Here, we assess the phenotypic and physiologic impact of postnatal myostatin inhibition on bite mechanics using an inducible conditional KO mouse in which myostatin is inhibited with doxycycline (DOX). Given the increased control over the timing of gene inactivation in this model, it may be more clinically-relevant for developing interventions for age-associated changes in the musculoskeletal system. DOX was administered for 12 weeks starting at age 4 months, during which time food intake was monitored. Sex, age and strain-matched controls were given the same food without DOX. Bite forces were recorded just prior to euthanasia after which muscle and skeletal data were collected. Food intake did not differ between control or DOX animals within each sex. DOX males were significantly larger and had significantly larger masseters than controls, but DOX and control females did not differ. Although there was a tendency towards higher absolute bite forces in DOX animals, this was not significant, and bite forces normalized to masseter mass did not differ. Mechanical advantage for incisor biting increased in the DOX group due to longer masseter moment arms, likely due to a more anteriorly-placed masseter insertion. Despite only a moderate increase in bite force in DOX males and none in DOX females, the increase in masseter mass in males indicates a potentially positive impact on jaw muscles. Our data suggest a sexual dimorphism in the role of mstn, and as such investigations into the sex-specific outcomes is warranted.	[Williams, Susan H.; Lozier, Nicholas R.; Montuelle, Stephane J.; de Lacalle, Sonsoles] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	University System of Ohio; Ohio University	Williams, SH (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	willias7@ohio.edu		Montuelle, Stephane/0000-0002-8638-9779; Williams, Susan/0000-0003-4167-678X				Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Arounleut P, 2013, EXP GERONTOL, V48, P898, DOI 10.1016/j.exger.2013.06.004; Baligand C, 2010, GENE THER, V17, P328, DOI 10.1038/gt.2009.141; Bouvier M, 1982, Prog Clin Biol Res, V101, P569; BOUVIER M, 1984, AM J ANAT, V170, P117, DOI 10.1002/aja.1001700109; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; Byron CD, 2008, INTEGR COMP BIOL, V48, P338, DOI 10.1093/icb/icn020; Byron CD, 2006, ARCH ORAL BIOL, V51, P396, DOI 10.1016/j.archoralbio.2005.09.006; Ciochon RL, 1997, J CRAN GENET DEV BIO, V17, P96; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Hengstler JG, 1999, DRUG METAB REV, V31, P917, DOI 10.1081/DMR-100101946; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; JABLONSKI NG, 1993, THEROPITHECUS, P299, DOI 10.1017/CBO9780511565540.012; Jeffery N, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140187; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Miwa Yoko, 2009, Okajimas Folia Anatomica Japonica, V86, P105; Murakami M, 2014, GERIATR GERONTOL INT; Murphy KT, 2011, AM J PHYSIOL-REG I, V301, pR716, DOI 10.1152/ajpregu.00121.2011; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; Ploquin C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1000, DOI 10.1152/ajpendo.00652.2011; Ravosa MJ, 2008, INTEGR COMP BIOL, V48, P345, DOI 10.1093/icb/icn050; Schirwis E, 2013, EXP GERONTOL, V48, P183, DOI 10.1016/j.exger.2012.11.008; Tanaka E, 2007, ANN BIOMED ENG, V35, P1617, DOI 10.1007/s10439-007-9330-x; Vecchione L, 2007, J DENT RES, V86, P1068, DOI 10.1177/154405910708601109; Vecchione L, 2010, ANAT REC, V293, P32, DOI 10.1002/ar.21024; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Welle S, 2009, AM J PHYSIOL-ENDOC M, V297, pE935, DOI 10.1152/ajpendo.00179.2009; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761; YAMADA K, 1991, ARCH ORAL BIOL, V36, P129, DOI 10.1016/0003-9969(91)90075-6	37	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134854	10.1371/journal.pone.0134854	http://dx.doi.org/10.1371/journal.pone.0134854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252892	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100081
J	Zhang, K; Wang, ZF; Zhang, LM; Yao, J; Yan, X				Zhang, Kai; Wang, Zengfei; Zhang, Liming; Yao, Jun; Yan, Xia			A Hybrid Optimization Method for Solving Bayesian Inverse Problems under Uncertainty	PLOS ONE			English	Article							MODEL-REDUCTION; QUANTIFICATION; INFERENCE	In this paper, we investigate the application of a new method, the Finite Difference and Stochastic Gradient (Hybrid method), for history matching in reservoirmodels. History matching is one of the processes of solving an inverse problem by calibrating reservoir models to dynamic behaviour of the reservoir in which an objective function is formulated based on a Bayesian approach for optimization. The goal of history matching is to identify the minimum value of an objective function that expresses the misfit between the predicted and measured data of a reservoir. To address the optimization problem, we present a novel application using a combination of the stochastic gradient and finite difference methods for solving inverse problems. The optimization is constrained by a linear equation that contains the reservoir parameters. We reformulate the reservoir model's parameters and dynamic data by operating the objective function, the approximate gradient of which can guarantee convergence. At each iteration step, we obtain the relatively 'important' elements of the gradient, which are subsequently substituted by the values from the Finite Difference method through comparing the magnitude of the components of the stochastic gradient, which forms a new gradient, and we subsequently iterate with the new gradient. Through the application of the Hybrid method, we efficiently and accurately optimize the objective function. We present a number numerical simulations in this paper that show that the method is accurate and computationally efficient.	[Zhang, Kai; Wang, Zengfei; Zhang, Liming; Yao, Jun] China Univ Petr, Qingdao 266555, Shandong, Peoples R China; [Yan, Xia] PetroChina Coalbed Methane Co Ltd, Beijing 100028, Peoples R China	China University of Petroleum; China National Petroleum Corporation	Zhang, LM (corresponding author), China Univ Petr, 66 Changjiang West Rd, Qingdao 266555, Shandong, Peoples R China.	reservoirs@163.com	Yao, Jun/HCI-2731-2022		China Important National Science & Technology Specific Projects [2011ZX05024-002-008]; National Natural Science Foundation of China [61004095, 61104170]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100133120003]; Fundamental Research Funds for the Central Universities [13CX02053A]; Changjiang Scholars and Innovative Reserch Team in University [IRT1294]; 863 Important Project [2013AA09A215]; PetroChina Coalbed Methane Company Limited	China Important National Science & Technology Specific Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Changjiang Scholars and Innovative Reserch Team in University; 863 Important Project; PetroChina Coalbed Methane Company Limited	China Important National Science & Technology Specific Projects" under Grant 2011ZX05024-002-008, "The National Natural Science Foundation of China" under Grant 61004095 and 61104170, the Specialized Research Fund for the Doctoral Program of Higher Education of China" under Grant 20100133120003, "the Fundamental Research Funds for the Central Universities" under Grant 13CX02053A, and "Changjiang Scholars and Innovative Reserch Team in University" under Grant IRT1294, and "863 Important Project" under Grant 2013AA09A215. PetroChina Coalbed Methane Company Limited provided support in the form of salary for author XY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Cai J, 2006, ELECTR POW SYST RES, V77, P1373; Emanuel AS, 1998, SPE ANN TECHN C EXH; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Galbally D, 2010, INT J NUMER METH ENG, V81, P1581, DOI 10.1002/nme.2746; Gao GH, 2007, SPE J, V12, P196, DOI 10.2118/90065-PA; Gao GH, 2006, SPE J, V11, P506, DOI 10.2118/93324-PA; Jensen HA, 2014, COMPUT METHOD APPL M, V279, P301, DOI 10.1016/j.cma.2014.06.032; Klie H, 2006, SEG TECHN PROGR EXP, V26; Li GM, 2011, COMPUTAT GEOSCI, V15, P451, DOI 10.1007/s10596-010-9214-2; Li LX, 2014, P NATL ACAD SCI USA, V111, P8392, DOI 10.1073/pnas.1407083111; Lieberman C, 2010, SIAM J SCI COMPUT, V32, P2523, DOI 10.1137/090775622; Ma X, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/3/035013; Marzouk Y, 2009, COMMUN COMPUT PHYS, V6, P826, DOI 10.4208/cicp.2009.v6.p826; Oliver D.S., 1996, P 5 EUR C MATH OIL R; Pradlwarter HJ, 2007, COMPUT MECH, V40, P627, DOI 10.1007/s00466-006-0127-9; Soize C, 2011, COMPUT METHOD APPL M, V200, P3083, DOI 10.1016/j.cma.2011.07.005; Soleng H, 1999, C EV COMP, P2; SPALL JC, 1992, IEEE T AUTOMAT CONTR, V37, P332, DOI 10.1109/9.119632; SPALL JC, 1994, PROCEEDINGS OF THE 1994 AMERICAN CONTROL CONFERENCE, VOLS 1-3, P2560; Vasco DW, 1999, SPE J, V4, P389, DOI 10.2118/59253-PA; Wang JB, 2004, INT J HEAT MASS TRAN, V47, P3927, DOI [10.1016/j.ijheatmasstransfer.2004.02.028, 10.1016/j.ijheatmasstransfer.2004.03.028]; Wang Y, 2000, SPE J, V5, P353, DOI 10.2118/58350-PA; Yan X, 2014, SPE J, V19, P873, DOI 10.2118/163613-PA; Yang P.H., 1988, SPE RESERVOIR ENG, V3, P995, DOI [10.2118/16977-PA, DOI 10.2118/16977-PA]; Zhao H, 2013, SPE J, V18, P1012, DOI 10.2118/141317-PA	26	1	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0132418	10.1371/journal.pone.0132418	http://dx.doi.org/10.1371/journal.pone.0132418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252392	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100012
J	Zhang, XY; Zhong, TY; Liu, L; Ouyang, XY				Zhang, Xiuying; Zhong, Taiyang; Liu, Lei; Ouyang, Xiaoying			Impact of Soil Heavy Metal Pollution on Food Safety in China	PLOS ONE			English	Article							RISK-ASSESSMENT; AGRICULTURAL SOILS; ARSENIC EXPOSURE; WASTE-WATER; ACCUMULATION; ELEMENTS; CONTAMINATION; CHROMIUM; PROVINCE; COUNTY	Food safety is a major concern for the Chinese public. This study collected 465 published papers on heavy metal pollution rates (the ratio of the samples exceeding the Grade II limits for Chinese soils, the Soil Environmental Quality Standard-1995) in farmland soil throughout China. The results showed that Cd had the highest pollution rate of 7.75%, followed by Hg, Cu, Ni and Zn, Pb and Cr had the lowest pollution rates at lower than 1%. The total pollution rate in Chinese farmland soil was 10.18%, mainly from Cd, Hg, Cu, and Ni. The human activities of mining and smelting, industry, irrigation by sewage, urban development, and fertilizer application released certain amounts of heavy metals into soil, which resulted in the farmland soil being polluted. Considering the spatial variations of grain production, about 13.86% of grain production was affected due to the heavy metal pollution in farmland soil. These results many provide valuable information for agricultural soil management and protection in China.	[Zhang, Xiuying; Liu, Lei] Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Int Inst Earth Syst Sci, Nanjing 210023, Jiangsu, Peoples R China; [Zhong, Taiyang] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing 210023, Jiangsu, Peoples R China; [Liu, Lei] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Ouyang, Xiaoying] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing 100101, Peoples R China	Nanjing University; Nanjing University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Zhang, XY (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Geog Informat Sci & Technol, Int Inst Earth Syst Sci, Nanjing 210023, Jiangsu, Peoples R China.	zhangxy@nju.edu.cn			Open Foundation of State Key Laboratory of Remote Sensing [OFSLRSS201312]; State Scholarship Fund of China [201208320130]; National Natural Science Foundation of China [41271190, 41301505]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Open Foundation of State Key Laboratory of Remote Sensing; State Scholarship Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study is supported by the Open Foundation of State Key Laboratory of Remote Sensing (OFSLRSS201312), State Scholarship Fund of China (No. 201208320130), the National Natural Science Foundation of China (No. 41271190 and 41301505), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullock P., 2009, SOILS URBAN ENV, P1; Center C.E.M., 1990, CHIN SOIL EL BACKGR; Cheng HX, 2014, J GEOCHEM EXPLOR, V139, P31, DOI 10.1016/j.gexplo.2013.08.012; Davis EB, 2006, FOCUS ENV RES; Dummer TJB, 2008, CAN MED ASSOC J, V178, P1177, DOI 10.1503/cmaj.071783; Ettler V, 2008, ENVIRON SCI TECHNOL, V42, P7878, DOI 10.1021/es801246c; Pereira BFF, 2012, J ENVIRON QUAL, V41, P920, DOI 10.2134/jeq2011.0047; Feng XL, 2011, J JIANGXI U SCI TECH, V32, P4; [付红波 FU Hong-bo], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1142; Khan NI, 2009, ENVIRON GEOCHEM HLTH, V31, P143, DOI 10.1007/s10653-008-9240-3; Kile ML, 2007, ENVIRON HEALTH PERSP, V115, P889, DOI 10.1289/ehp.9462; Kumar R, 2014, J RADIOANAL NUCL CH, V300, P213, DOI 10.1007/s10967-014-3006-4; Li JH, 2009, ENVIRON MONIT ASSESS, V153, P365, DOI 10.1007/s10661-008-0363-x; Li M, 2014, J GEOCHEM EXPLOR, V139, P21, DOI 10.1016/j.gexplo.2013.06.002; Liu YL, 2013, SCIENCE, V339, P1382, DOI 10.1126/science.339.6126.1382-b; Lu Y, 2011, ENVIRON GEOCHEM HLTH, V33, P93, DOI 10.1007/s10653-010-9324-8; Meng M, 2014, ENVIRON POLLUT, V184, P179, DOI 10.1016/j.envpol.2013.08.030; Muchuweti A, 2006, AGR ECOSYST ENVIRON, V112, P41, DOI 10.1016/j.agee.2005.04.028; Niu LL, 2013, ENVIRON POLLUT, V176, P55, DOI 10.1016/j.envpol.2013.01.019; Nziguheba G, 2008, SCI TOTAL ENVIRON, V390, P53, DOI 10.1016/j.scitotenv.2007.09.031; Park RM, 2004, RISK ANAL, V24, P1099, DOI 10.1111/j.0272-4332.2004.00512.x; Shan X., 2011, J GUIZHOU U NAT SCI, V28, P132, DOI DOI 10.3969/j.issn.1000-5269.2011.01.032; [杨克燕 Yang Keyang], 2011, [中国环境监测, Environmental Monitoring in China], V27, P10; Yang YG, 2006, WATER AIR SOIL POLL, V174, P321, DOI 10.1007/s11270-006-9121-2; Zaccone C, 2010, SOIL TILL RES, V107, P97, DOI 10.1016/j.still.2010.02.004; Zahra A, 2010, ENVIRON MONIT ASSESS, V160, P83, DOI DOI 10.1007/S10661-008-0659-X; Zhang XY, 2009, ENVIRON MONIT ASSESS, V154, P439, DOI 10.1007/s10661-008-0410-7; Zhang XY, 2015, ENVIRON SCI POLLUT R, V22, P4932, DOI 10.1007/s11356-014-3892-6; Zhou H, 2013, ENVIRON TOXICOL CHEM, V32, P2719, DOI 10.1002/etc.2389; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103	30	188	207	45	270	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135182	10.1371/journal.pone.0135182	http://dx.doi.org/10.1371/journal.pone.0135182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252956	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100129
J	Park, JK; Yang, W; Katsnelson, J; Lavker, RM; Peng, H				Park, Jong Kook; Yang, Wending; Katsnelson, Julia; Lavker, Robert M.; Peng, Han			MicroRNAs Enhance Keratinocyte Proliferative Capacity in a Stem Cell-Enriched Epithelium	PLOS ONE			English	Article							CORNEAL EPITHELIUM; EPIDERMAL-KERATINOCYTES; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MURINE CORNEAL; SELF-RENEWAL; BASAL-CELLS; C-MAF; DIFFERENTIATION; LIMBAL	MicroRNAs are critical regulators of stem cell behavior. The miR-103/107 family is preferentially expressed in the stem cell-enriched corneal limbal epithelium and plays an important role in coordinating several intrinsic characteristics of limbal epithelial stem cells. To elucidate further the mechanisms by which miRs-103/107 function in regulating limbal epithelial stem cells, we investigate the global effects of miRs-103/107 on gene expression in an unbiased manner. Using antagomirs-103/107, we knocked down endogenous miRs-103/107 in keratinocytes and conducted an mRNA profiling study. We show that miRs-103/107 target mitogen-activated protein kinase kinase kinase 7 (MAP3K7) and thereby negatively regulate the p38/AP-1 pathway, which directs epithelial cells towards a differentiated state. Pharmacological inhibition of p38 increases holoclone colony formation, a measure of proliferative capacity. This suggests that the negative regulation of p38 by miRs-103/107 contributes to enhanced proliferative capacity, which is a hallmark of stem cells. Since miRs-103/107 also promote increased holoclone colony formation by regulating JNK activation through non-canonical Wnt signaling, we believe that this microRNA family preserves "stemness" by mediating the crosstalk between the Wnt/JNK and MAP3K7/p38/AP-1 pathways.	[Park, Jong Kook; Yang, Wending; Lavker, Robert M.; Peng, Han] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA; [Katsnelson, Julia] Rush Univ, Med Ctr, Chicago, IL 60612 USA	Northwestern University; Rush University	Peng, H (corresponding author), Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA.	han-peng@northwestern.edu		Peng, Han/0000-0002-1105-8254; Park, Jong Kook/0000-0002-3946-5687	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; National Institutes of Health [EY06769, EY017536, EY019463]; Dermatology Foundation; MidWest Eye-Banks research grant; NATIONAL EYE INSTITUTE [R21EY017536, R01EY019463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; MidWest Eye-Banks research grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The NU-SDRC is supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (http://www.niams.nih.gov/) Grant AR057216. This research is supported by National Institutes of Health (https://www.nei.nih.gov/) Grants EY06769, EY017536 and EY019463 (to R.M.L.); a Dermatology Foundation (http://dermatologyfoundation.org/) research grant and Career Development Award (to H.P.); and a MidWest Eye-Banks (http://www.eversightvision.org/) research grant (H.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2005, STEM CELL REV, V1, P253, DOI 10.1385/SCR:1:3:253; Amitai-Lange A, 2015, STEM CELLS, V33, P230, DOI 10.1002/stem.1840; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Boehnke K, 2012, CARCINOGENESIS, V33, P1247, DOI 10.1093/carcin/bgs136; BUCK RC, 1983, J ANAT, V137, P743; Cheng CY, 2012, STEM CELL RES, V9, P9, DOI 10.1016/j.scr.2012.02.005; Chhabra R, 2014, TUMOR BIOL, V35, P8395, DOI 10.1007/s13277-014-2264-7; Chiambaretta F, 2002, INVEST OPHTH VIS SCI, V43, P3422; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; Connelly JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027259; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; GANDARILLAS A, 1995, ONCOGENE, V11, P1403; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao XC, 2014, CANCER LETT, V353, P25, DOI 10.1016/j.canlet.2014.07.011; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Humar M, 2007, INT J BIOCHEM CELL B, V39, P2278, DOI 10.1016/j.biocel.2007.06.013; Jackson SJ, 2013, DEVELOPMENT, V140, P1882, DOI 10.1242/dev.089649; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Khalaj M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00361; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LIU CY, 1993, CURR EYE RES, V12, P963, DOI 10.3109/02713689309029222; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Medvedev A, 1999, J BIOL CHEM, V274, P3887, DOI 10.1074/jbc.274.6.3887; Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486; Ning MS, 2015, STEM CELLS, V33, P1047, DOI 10.1002/stem.1922; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Pellegrini G, 2013, REGEN MED, V8, P553, DOI 10.2217/rme.13.43; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Qi W, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/358902; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Ryan D, 2006, MOL VIS, V12, P1175; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; STEVEN AC, 1994, J CELL SCI, V107, P693; Takahashi H, 1998, J BIOL CHEM, V273, P17375, DOI 10.1074/jbc.273.28.17375; Takahashi R, 2014, FRONT GENET, V4, DOI 10.3389/fgene.2013.00295; Thieu K, 2013, CANCER LETT, V338, P82, DOI 10.1016/j.canlet.2012.05.008; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; THOFT RA, 1977, INVEST OPHTH VIS SCI, V16, P14; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Tseng H, 1999, DIFFERENTIATION, V65, P221, DOI 10.1046/j.1432-0436.1999.6540221.x; VERMORKEN AJM, 1978, NATURE, V271, P779, DOI 10.1038/271779a0; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; WU H, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/920134; Xu N, 2011, J INVEST DERMATOL, V131, P1521, DOI 10.1038/jid.2011.55; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yazgan O, 2002, J BIOL CHEM, V277, P29710, DOI 10.1074/jbc.M204552200; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhao B, 2014, J CELL PHYSIOL, V229, P1141, DOI 10.1002/jcp.24540; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200	77	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134853	10.1371/journal.pone.0134853	http://dx.doi.org/10.1371/journal.pone.0134853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248284	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300070
J	Zhao, M; Gjerset, RA				Zhao, Ming; Gjerset, Ruth A.			Topoisomerase-I PS506 as a Dual Function Cancer Biomarker	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; ILLEGITIMATE RECOMBINATION; DNA TOPOISOMERASES; DRUGS; PROLIFERATION; CAMPTOTHECIN; ASSOCIATION; APOPTOSIS	Novel biomarkers for cancer diagnosis and therapy selection are urgently needed to facilitate early detection and improve therapy outcomes. We have previously identified a novel phosphorylation site at serine 506 (PS506) on topoisomerase-I (topo-I) and have shown that it is widely expressed in cell lines derived from several cancers, including lung cancer, but is low in cell lines derived from non-cancerous tissues. Here we have investigated how PS506 expression in lung tissue specimens correlates with their malignant status. We find that PS506 expression is significantly elevated in malignant tumors of non-small cell lung cancer (NSCLC) compared to adjacent, non-cancerous lung tissue and benign lung tumors. PS506 expression was up to 6-fold higher in malignant specimens than in paired nonmalignant tissue. Using the well-characterized NIH/NCI 60-cell line panel, we correlate the most elevated expression levels of PS506 in lung, ovarian, and colon cancer cells lines with increased sensitivity to camptothecin, a plant alkaloid that targets topo-I. This is consistent with our earlier studies in a smaller sampling of cell lines and with our finding that PS506 increases topo-I DNA binding. Two widely used chemotherapeutic drugs for ovarian and colon cancer, topotecan and irinotecan, respectively, are derived from camptothecin. Irinotecan has also displayed efficacy in clinical trials of NSCLC. Our results suggest that elevated PS506 expression may correlate with clinical chemosensitivity to these agents in ovarian, colon, and NSCLC. PS506 may therefore serve as a biomarker for diagnosis or therapy selection.	[Zhao, Ming; Gjerset, Ruth A.] RG Biopharma, San Diego, CA 92121 USA; [Gjerset, Ruth A.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Torrey Pines Institute for Molecular Studies, California	Gjerset, RA (corresponding author), RG Biopharma, 3550 Gen Atomics Court, San Diego, CA 92121 USA.	rgjerset@tpims.org			RG Biopharma	RG Biopharma	RG Biopharma provided support in the form of salaries for the authors (RAG, MZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Alegre MM, 2014, ANTICANCER RES, V34, P2145; Arlt MF, 2010, DNA REPAIR, V9, P678, DOI 10.1016/j.dnarep.2010.03.005; Bandyopadhyay K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050427; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; BEIDLER DR, 1995, MOL PHARMACOL, V47, P907; Beretta GL, 2006, CURR MED CHEM, V13, P3291, DOI 10.2174/092986706778773121; Burrow AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-59; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Casiano CA, 1998, CELL DEATH DIFFER, V5, P183, DOI 10.1038/sj.cdd.4400336; Clincal-Trials.gov, IR PREV TREAT ADV NO; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Greenberg AK, 2007, CURR OPIN PULM MED, V13, P249, DOI 10.1097/MCP.0b013e32819f8f06; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larsen A K, 1999, Pathol Oncol Res, V5, P171, DOI 10.1053/paor.1999.0209; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; National Comprehensive Cancer Network Inc, NCCN GUID CLIN RES; NCI/DTP, ONEDOSE SYN 60 CELL; NCI/DTP, HUM TUM CELL LIN SCR; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; PaxDb, PROT AB ORG TOP 1 H; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; TSAO YP, 1993, CANCER RES, V53, P5908; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Zhu J, 1996, MOL CELL BIOL, V16, P1805	43	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134929	10.1371/journal.pone.0134929	http://dx.doi.org/10.1371/journal.pone.0134929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248194	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300079
J	Bansal, R; Mittapelly, P; Cassone, BJ; Mamidala, P; Redinbaugh, MG; Michel, A				Bansal, Raman; Mittapelly, Priyanka; Cassone, Bryan J.; Mamidala, Praveen; Redinbaugh, Margaret G.; Michel, Andy			Recommended Reference Genes for Quantitative PCR Analysis in Soybean Have Variable Stabilities during Diverse Biotic Stresses	PLOS ONE			English	Article							REAL-TIME PCR; EXPRESSION NORMALIZATION; HOUSEKEEPING GENES; APHIS-GLYCINES; RT-PCR; VALIDATION; RESISTANCE; IDENTIFICATION; VIRUS; TRANSCRIPTOME	For real-time reverse transcription-PCR (qRT-PCR) in soybean, reference genes in different tissues, developmental stages, various cultivars, and under stress conditions have been suggested but their usefulness for research on soybean under various biotic stresses occurring in North-Central U.S. is not known. Here, we investigated the expression stabilities of ten previously recommended reference genes (ABCT, CYP, EF1A, FBOX, GPDH, RPL30, TUA4, TUB4, TUA5, and UNK2) in soybean under biotic stress from Bean podmottle virus (BPMV), powdery mildew (PMD), soybean aphid (SBA), and two-spotted spidermite (TSSM). BPMV, PMD, SBA, and TSSM are amongst the most common pest problems on soybean in NorthCentral U.S. and other regions. Reference gene stability was determined using three software algorithms (geNorm, NormFinder, BestKeeper) and a web-based tool (RefFinder). Reference genes showed variability in their expression as well as stability across various stressors and the best reference genes were stress-dependent. ABCT and FBOX were found to be the most stable in soybean under both BPMV and SBA stress but these genes had only minimal to moderate stability during PMD and TSSM stress. Expression of TUA4 and CYP was found to be most stable during PMD stress; TUB4 and TUA4 were stable under TSSM stress. Under various biotic stresses on soybean analyzed, GPDH expression was found to be consistently unstable. For all biotic stressors on soybean, we obtained pairwise variation (V-2/3) values less than 0.15 which suggested that combined use of the two most stable reference genes would be sufficient for normalization. Further, we demonstrated the utility of normalizing the qRT-PCR data for target genes using the most stable reference genes validated in current study. Following of the recommendations from our current study will enable an accurate and reliable normalization of qRT-PCR data in soybean under biotic stress.	[Bansal, Raman; Mittapelly, Priyanka; Michel, Andy] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA; [Cassone, Bryan J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Ctr Appl Plant Sci, Wooster, OH 44691 USA; [Mamidala, Praveen] Telangana Univ, Univ Coll Sci, Dept Biotechnol, Nizamabad 503322, Telangana, India; [Redinbaugh, Margaret G.] Ohio State Univ, Ohio Agr Res & Dev Ctr, USDA ARS, Corn & Soybean Res Unit, Wooster, OH 44691 USA; [Redinbaugh, Margaret G.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Telangana University; United States Department of Agriculture (USDA); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bansal, R (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	bansal.67@osu.edu	Mittapelly, Priyanka/Q-2940-2019; Redinbaugh, Margaret/A-3611-2013	Mamidala, Praveen/0000-0001-8587-0635; Mittapelly, Priyanka/0000-0002-1021-8789	ARS [ARS-0423065] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		American Soybean Association, 2014, SOY STAT REF GUID IM; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2005, PLANT RESISTANCE ART; Bansal R., 2013, SOYBEAN PEST RESISTA, P19, DOI [10.5772/54597, DOI 10.5772/54597]; Bansal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-972; Bansal R, 2012, J ECON ENTOMOL, V105, P1432, DOI 10.1603/EC12095; Bustin Stephen A, 2010, Expert Rev Mol Diagn, V10, P713, DOI 10.1586/erm.10.65; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Cassone BJ, 2014, GENOME BIOL EVOL, V6, P873, DOI 10.1093/gbe/evu057; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Ghabrial S, 1977, IDENTIFICATION DISTR; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hammond R, 2014, TWOSPOTTED SPIDER MI; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Hill CB, 2004, CROP SCI, V44, P98, DOI 10.2135/cropsci2004.0098; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kang ST, 2010, CAN J PLANT SCI, V90, P939, DOI 10.4141/CJPS09070; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Louie R, 2000, PLANT DIS, V84, P1133, DOI 10.1094/PDIS.2000.84.10.1133; Mabry TR, 2003, PLANT DIS, V87, P1221, DOI 10.1094/PDIS.2003.87.10.1221; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Mian MAR, 2008, CROP SCI, V48, P1055, DOI 10.2135/cropsci2007.06.0357; Miranda Vivian de Jesus, 2013, BMC Res Notes, V6, P196, DOI 10.1186/1756-0500-6-196; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Smith CM, 2012, ANNU REV ENTOMOL, V57, P309, DOI 10.1146/annurev-ento-120710-100642; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	41	30	33	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134890	10.1371/journal.pone.0134890	http://dx.doi.org/10.1371/journal.pone.0134890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244340	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400122
J	Huang, WR; Chiu, HC; Liao, TL; Chuang, KP; Shih, WL; Liu, HJ				Huang, Wei-Ru; Chiu, Hung-Chuan; Liao, Tsai-Ling; Chuang, Kuo-Pin; Shih, Wing-Ling; Liu, Hung-Jen			Avian Reovirus Protein p17 Functions as a Nucleoporin Tpr Suppressor Leading to Activation of p53, p21 and PTEN and Inactivation of PI3K/AKT/mTOR and ERK Signaling Pathways	PLOS ONE			English	Article							CELL-CYCLE REGULATION; TUMOR-SUPPRESSOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; PORE COMPLEX; PHOSPHORYLATION; KINASE; AKT; TRANSCRIPTION; APOPTOSIS; GROWTH	Avian reovirus (ARV) protein p17 has been shown to regulate cell cycle and autophagy by activation of p53/PTEN pathway; nevertheless, it is still unclear how p53 and PTEN are activated by p17. Here, we report for the first time that p17 functions as a nucleoporin Tpr suppressor that leads to p53 nuclear accumulation and consequently activates p53, p21, and PTEN. The nuclear localization signal (119IAAKRGRQLD128) of p17 has been identified for Tpr binding. This study has shown that Tpr suppression occurs by p17 interacting with Tpr and by reducing the transcription level of Tpr, which together inhibit Tpr function. In addition to upregulation of PTEN by activation of p53 pathway, this study also suggests that ARV protein p17 acts as a positive regulator of PTEN. ARV p17 stabilizes PTEN by stimulating phosphorylation of cytoplasmic PTEN and by elevating Rak-PTEN association to prevent it from E3 ligase NEDD4-1 targeting. To activate PTEN, p17 is able to promote beta-arrestin- mediated PTEN translocation from the cytoplasm to the plasma membrane via a Rock-1-dependent manner. The accumulation of p53 in the nucleus induces the PTEN-and p21-mediated downregulation of cyclin D1 and CDK4. Furthermore, Tpr and CDK4 knockdown increased virus production in contrast to depletion of p53, PTEN, and LC3 reducing virus yield. Taken together, our data suggest that p17-mediated Tpr suppression positively regulates p53, PTEN, and p21 and negatively regulates PI3K/AKT/mTOR and ERK signaling pathways, both of which are beneficial for virus replication.	[Huang, Wei-Ru; Chiu, Hung-Chuan; Liu, Hung-Jen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung 402, Taiwan; [Chuang, Kuo-Pin] Natl Pingtung Univ Sci & Technol, Grad Inst Anim Vaccine Technol, Pingtung 912, Taiwan; [Shih, Wing-Ling] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 912, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Pingtung University Science & Technology; National Pingtung University Science & Technology; National Chung Hsing University; National Chung Hsing University	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw		chiu, hung-chuan/0000-0001-6219-4937; Huang, Wei-Ru/0000-0002-2508-8374; Liu, Hung-Jen/0000-0002-1460-1494	National Science Council of Taiwan [NSC 102-2321-B-005-012]; Ministry of Education, Taiwan under the ATU plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan under the ATU plan(Ministry of Education, Taiwan)	The project was supported by the National Science Council of Taiwan (NSC 102-2321-B-005-012) and the Ministry of Education, Taiwan under the ATU plan.	Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; David-Watine B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022423; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, CELL CYCLE, V8, P1896, DOI 10.4161/cc.8.12.8809; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fernandez-Martinez J, 2012, CURR OPIN CELL BIOL, V24, P92, DOI 10.1016/j.ceb.2011.12.013; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Funasaka T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00878; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; HIERONYMUS DRK, 1983, AVIAN DIS, V27, P246, DOI 10.2307/1590390; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Ji Wen-Tsai, 2008, Recent Pat Biotechnol, V2, P218, DOI 10.2174/187220808786241042; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kobayashi A, 2015, CELL CYCLE, V14, P1447, DOI 10.1080/15384101.2015.1021518; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lee YI, 2001, J BIOL CHEM, V276, P16969, DOI 10.1074/jbc.M011263200; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lin PY, 2011, ARCH VIROL, V156, P1917, DOI 10.1007/s00705-011-1063-3; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2008, MOL CELLS, V26, P396; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Shapouri MRS, 1996, J GEN VIROL, V77, P1203, DOI 10.1099/0022-1317-77-6-1203; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Shmulevitz M, 2002, J VIROL, V76, P609, DOI 10.1128/JVI.76.2.609-618.2002; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; VANDERHEIDE L, 1976, AVIAN DIS, V20, P641, DOI 10.2307/1589443; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang S, 2012, BIOMATERIALS, V33, P2902, DOI 10.1016/j.biomaterials.2011.12.051; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	81	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133699	10.1371/journal.pone.0133699	http://dx.doi.org/10.1371/journal.pone.0133699			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244501	Green Published, gold			2022-12-26	WOS:000359061400053
J	Lee, HR; Shin, HK; Park, SY; Kim, HY; Bae, SS; Lee, WS; Rhim, BY; Hong, KW; Kim, CD				Lee, Hye Rin; Shin, Hwa Kyoung; Park, So Youn; Kim, Hye Young; Bae, Sun Sik; Lee, Won Suk; Rhim, Byung Yong; Hong, Ki Whan; Kim, Chi Dae			Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-beta Peptide and APP-CTF beta Levels in Neuronal Cells	PLOS ONE			English	Article							ONSET ALZHEIMERS-DISEASE; COGNITIVE DEFICITS; MOUSE MODEL; RESTRICTION; BECLIN-1; PROTEIN; NEUROPATHOLOGY; ACCUMULATION; INHIBITOR; PATHOLOGY	Autophagy is a vital pathway for the removal of beta-amyloid peptide (A beta) and the aggregated proteins that cause Alzheimer's disease (AD). We previously found that cilostazol induced SIRT1 expression and its activity in neuronal cells, and thus, we hypothesized that cilostazol might stimulate clearances of A beta and C-terminal APP fragment beta subunit (APP-CTF beta) by up-regulating autophagy. When N2a cells were exposed to soluble A beta 1-42, protein levels of beclin-1, autophagy-related protein5 (Atg5), and SIRT1 decreased significantly. Pretreatment with cilostazol (10-30 mu M) or resveratrol (20 mu M) prevented these A beta 1-42 evoked suppressions. LC3-II (a marker of mammalian autophagy) levels were significantly increased by cilostazol, and this increase was reduced by 3-methyladenine. To evoke endogenous A beta overproduction, N2aSwe cells (N2a cells stably expressing human APP containing the Swedish mutation) were cultured in medium with or without tetracycline (Tet(+) for 48 h and then placed in Tet(-) condition). A beta and APP-CTF beta expressions were increased after 12 similar to 24 h in Tet(-) condition, and these increased expressions were significantly reduced by pretreating cilostazol. Cilostazol-induced reductions in the expressions of A beta and APP-CTF beta were blocked by bafilomycin A1 (a blocker of autophagosome to lysosome fusion). After knockdown of the SIRT1 gene (to similar to 40% in SIRT1 protein), cilostazol failed to elevate the expressions of beclin-1, Atg5, and LC3-II, indicating that cilostazol increases these expressions by up-regulating SIRT1. Further, decreased cell viability induced by A beta was prevented by cilostazol, and this inhibition was reversed by 3-methyladenine, indicating that the protective effect of cilostazol against A beta induced neurotoxicity is, in part, ascribable to the induction of autophagy. In conclusion, cilostazol modulates autophagy by increasing the activation of SIRT1, and thereby enhances A beta clearance and increases cell viability.	[Bae, Sun Sik; Lee, Won Suk; Rhim, Byung Yong; Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongsangnam D, South Korea; [Lee, Hye Rin; Park, So Youn; Bae, Sun Sik; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Yangsan, Gyeongsangnam D, South Korea; [Lee, Hye Rin; Park, So Youn; Kim, Hye Young; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Med Res Ctr Ischem Tissue Regenerat, Yangsan, Gyeongsangnam D, South Korea; [Shin, Hwa Kyoung] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongsangnam D, South Korea.	chidkim@pusan.ac.kr			Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015R1A5A2009656]	Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A5A2009656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065367; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Lee HR, 2014, J NEUROSCI RES, V92, P206, DOI 10.1002/jnr.23310; Lee HR, 2012, J NEUROSCI RES, V90, P1566, DOI 10.1002/jnr.23037; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JA, 2008, J CLIN INVEST, V118, P2015, DOI [10.1172/JCI3S662, 10.1172/JCI35662]; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Taguchi A, 2013, PSYCHOGERIATRICS, V13, P164, DOI 10.1111/psyg.12021; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	36	29	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134486	10.1371/journal.pone.0134486	http://dx.doi.org/10.1371/journal.pone.0134486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244661	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400083
J	Ramasamy, RA; Allan, BJM; McCormick, MI				Ramasamy, Ryan A.; Allan, Bridie J. M.; McCormick, Mark I.			Plasticity of Escape Responses: Prior Predator Experience Enhances Escape Performance in a Coral Reef Fish	PLOS ONE			English	Article							RISK-ASSESSMENT; MAUTHNER CELL; COMPONENTS; HISTORY; CUES	Teleost and amphibian prey undertake fast-start escape responses during a predatory attack in an attempt to avoid being captured. Although previously viewed as a reflex reaction controlled by the autonomic nervous system, the escape responses of individuals when repeatedly startled are highly variable in their characteristics, suggesting some behavioural mediation of the response. Previous studies have shown that fishes are able to learn from past experiences, but few studies have assessed how past experience with predators affect the fast-start response. Here we determined whether prior experience with the smell or sight of a predator (the Dottyback, Pseudochromis fuscus) affected the escape response of juveniles of the Spiny Chromis (Acanthochromis polyacanthus). Results show that individuals exposed to any of the predator cues prior to being startled exhibited a stronger escape response (i.e., reduced latency, increased escape distance, mean response speed, maximum response speed and maximum acceleration) when compared with controls. This study demonstrates the plasticity of escape responses and highlights the potential for naive reef fish to take into account both visual and olfactory threat cues simultaneously to optimise the amplitude of their kinematic responses to perceived risk.	[Ramasamy, Ryan A.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Ramasamy, RA (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	ryan.ramasamy@my.jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645; Higgs, Dennis/0000-0002-0771-4642	Australian Research Council [D120101993]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Discovery Grant: D120101993 given to MIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Chivers DP, 1997, ETHOLOGY, V103, P187; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P587; Domenici P, 2011, J EXP BIOL, V214, P2463, DOI 10.1242/jeb.029652; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Ferrari MCO, 2010, CAN J ZOOL, V274, P1853; Gleeson TT, 1996, ANNU REV PHYSIOL, V58, P565, DOI 10.1146/annurev.ph.58.030196.003025; Hartman EJ, 2000, P ROY SOC B-BIOL SCI, V267, P571, DOI 10.1098/rspb.2000.1039; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Kelley JL, 2003, FISH FISH, V4, P216, DOI 10.1046/j.1467-2979.2003.00126.x; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2011, CORAL REEFS, V30, P805, DOI 10.1007/s00338-011-0768-9; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Lonnstedt OM, 2012, P R SOC LON BIOL; Manassa RP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0720; Marras S, 2011, J EXP BIOL, V214, P3102, DOI 10.1242/jeb.056648; McCormick MI, 2008, CORAL REEFS, V27, P105, DOI 10.1007/s00338-007-0296-9; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; Moyes C, 1993, SURVIVING HYPOXIA ME, P527; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Tytell ED, 2002, J EXP BIOL, V205, P2591; WEBB PW, 1986, CAN J FISH AQUAT SCI, V43, P763, DOI 10.1139/f86-094; WEIHS D, 1973, Biorheology, V10, P343; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	31	24	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132790	10.1371/journal.pone.0132790	http://dx.doi.org/10.1371/journal.pone.0132790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244861	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400029
J	Wang, J; Zhang, WW; Yu, CX; Zhang, X; Zhang, HQ; Guan, QB; Zhao, JJ; Xu, J				Wang, Jie; Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin			Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SERUM FSH; CELLS; MASS; RESORPTION; ESTROGEN; RECEPTOR; FUSION; WOMEN; LH	Objective The objectives of this study were to observe the changes in follicle-stimulating hormone (FSH) and bone mineral density (BMD) in postmenopausal women, to research the relationship between FSH and postmenopausal osteoporosis, and to observe the effects of FSH on osteoclast differentiation in RAW264.7 cells. Methods We analyzed 248 postmenopausal women with normal bone metabolism. A radioimmunoassay (RIA) was used to detect serum FSH, luteinizing hormone (LH), and estradiol (E2). Dual-energy X-ray absorptiometry was used to measure forearm BMD. Then, we analyzed the age-related changes in serum FSH, LH and E2. Additionally, FSH serum concentrations were compared between a group of postmenopausal women with osteoporosis and a control group. Osteoclasts were induced from RAW264.7 cells in vitro by receptor activator of nuclear factor kappa B ligand (RANKL), and these cells were treated with 0, 5, 10, and 20 ng/ml FSH. After the osteoclasts matured, tartrate-resistant acid phosphatase (TRAP) staining was used to identify osteoclasts, and the mRNA expression levels of genes involved in osteoclastic phenotypes and function, such as receptor activator of NF-kappa B (Rank), Trap, matrix metalloproteinase-9 (Mmp-9) and Cathepsin K, were detected in different groups using real-time PCR (polymerase chain reaction). Results 1. FSH serum concentrations in postmenopausal women with osteoporosis increased notably compared with the control group. 2. RANKL induced RAW264.7 cell differentiation into mature osteoclasts in vitro. 3. FSH increased mRNA expression of genes involved in osteoclastic phenotypes and function, such as Rank, Trap, Mmp-9 and Cathepsin K, in a dose-dependent manner. Conclusions The circulating concentration of FSH may play an important role in the acceleration of bone loss in postmenopausal women. FSH increases osteoclastogenesis in vitro.	[Wang, Jie] Weifang Med Univ, Affiliated Hosp, Dept Endocrinol, Weifang, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Clin Med Ctr Endocrinol & Metab, Jinan, Shandong, Peoples R China; [Zhang, Wenwen; Yu, Chunxiao; Zhang, Xu; Zhang, Haiqing; Guan, Qingbo; Zhao, Jiajun; Xu, Jin] Shandong Acad Clin Med, Inst Endocrinol & Metab, Jinan, Shandong, Peoples R China	Weifang Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xu, J (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Endocrinol, Jinan 250100, Shandong, Peoples R China.	xujin@medmail.com.cn	Zhao, Jiajun/W-2963-2018	Zhao, Jiajun/0000-0003-3267-9292	National Natural Science Foundation [81370892]; Technology Development Plan Project of Shandong Province [2012GSF11823]; Shandong Province Young and Middle-Aged Scientists Research Awards Fund [2007BS03004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Technology Development Plan Project of Shandong Province; Shandong Province Young and Middle-Aged Scientists Research Awards Fund	This work was supported by the National Natural Science Foundation (81370892, http://www.nsfc.gov.cn/), the Technology Development Plan Project of Shandong Province (2012GSF11823, http://www.sdstc.gov.cn/) and the Shandong Province Young and Middle-Aged Scientists Research Awards Fund (2007BS03004, http://www.sdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Manasi, 2010, Curr Osteoporos Rep, V8, P205, DOI 10.1007/s11914-010-0028-x; Anasti JN, 1998, OBSTET GYNECOL, V91, P12, DOI 10.1016/S0029-7844(97)00583-8; Ausmanas MK, 2007, CLIMACTERIC, V10, P427, DOI 10.1080/13697130701610780; Blair HC, 2011, ANN NY ACAD SCI, V1240, P26, DOI 10.1111/j.1749-6632.2011.06287.x; Cheung E, 2011, MATURITAS, V69, P50, DOI 10.1016/j.maturitas.2011.01.010; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; Devleta B, 2004, J BONE MINER METAB, V22, P360, DOI 10.1007/s00774-004-0495-1; Gallagher CM, 2010, ENVIRON RES, V110, P105, DOI 10.1016/j.envres.2009.09.012; Garcia-Martin A, 2012, ENDOCRINE, V41, P302, DOI 10.1007/s12020-011-9541-7; Geng WX, 2013, BIOCHEM BIOPH RES CO, V434, P280, DOI 10.1016/j.bbrc.2013.02.116; Gourlay ML, 2012, BONE, V50, P311, DOI 10.1016/j.bone.2011.11.001; Imai Yuuki, 2014, Clin Calcium, V24, P815, DOI CliCa1406815819; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; Iqbal J, 2010, EUR J ENDOCRINOL, V163, P173, DOI 10.1530/EJE-10-0397; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Liu S, 2010, J DENT RES, V89, P366, DOI 10.1177/0022034509358822; Liu SB, 2010, J ENDODONT, V36, P658, DOI 10.1016/j.joen.2010.01.011; Meena PD, 2007, OSTEOPOROSIS INT, V18, P923, DOI 10.1007/s00198-006-0318-4; Nicks Kristy M, 2010, Curr Osteoporos Rep, V8, P60, DOI 10.1007/s11914-010-0014-3; Qin WP, 2013, J BIOL CHEM, V288, P13511, DOI 10.1074/jbc.M113.454892; Rendina D, 2010, EUR J ENDOCRINOL, V163, P165, DOI 10.1530/EJE-10-0043; Ritter V, 2008, CALCIFIED TISSUE INT, V82, P383, DOI 10.1007/s00223-008-9134-5; Rouach V, 2011, J CELL BIOCHEM, V112, P128, DOI 10.1002/jcb.22908; Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196; Seibel MJ, 2006, CELL, V127, P1079, DOI 10.1016/j.cell.2006.12.002; Sowers MR, 2013, J CLIN ENDOCR METAB, V98, P2854, DOI 10.1210/jc.2012-4113; Sowers MR, 2006, J CLIN ENDOCR METAB, V91, P1261, DOI 10.1210/jc.2005-1836; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886; Tourkova IL, 2015, ANN NY ACAD SCI, V1335, P100, DOI 10.1111/nyas.12502; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Xu ZR, 2009, CLIN CHIM ACTA, V400, P8, DOI 10.1016/j.cca.2008.09.027; Zaidi Mone, 2009, Curr Rheumatol Rep, V11, P191; Zhang WW, 2014, J BIOMECH, V47, P1307, DOI 10.1016/j.jbiomech.2014.02.015; Zhu LL, 2012, BIOCHEM BIOPH RES CO, V422, P54, DOI 10.1016/j.bbrc.2012.04.104	35	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134986	10.1371/journal.pone.0134986	http://dx.doi.org/10.1371/journal.pone.0134986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241313	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700087
J	Ebbers, L; Satheesh, SV; Janz, K; Ruttiger, L; Blosa, M; Hofmann, F; Morawski, M; Griesemer, D; Knipper, M; Friauf, E; Nothwang, HG				Ebbers, Lena; Satheesh, Somisetty V.; Janz, Katrin; Ruettiger, Lukas; Blosa, Maren; Hofmann, Franz; Morawski, Markus; Griesemer, Desiree; Knipper, Marlies; Friauf, Eckhard; Nothwang, Hans Gerd			L-type Calcium Channel Ca(v)1.2 Is Required for Maintenance of Auditory Brainstem Nuclei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-DEPENDENT REGULATION; LONG-TERM ADAPTATION; CA2+ CHANNELS; EXTRACELLULAR-MATRIX; SPIRAL GANGLION; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; GLUA1 TRAFFICKING; PROTEIN-KINASES; GENE-EXPRESSION	Ca(v)1.2andCa(v)1.3are the major L-type voltage-gated Ca2+ channels in the CNS. Yet, their individual in vivo functions are largely unknown. Both channel subunits are expressed in the auditory brainstem, where Ca(v)1.3 is essential for proper maturation. Here, we investigated the role of Ca(v)1.2 by targeted deletion in the mouse embryonic auditory brainstem. Similar to Ca(v)1.3, loss of Ca(v)1.2 resulted in a significant decrease in the volume and cell number of auditory nuclei. Contrary to the deletion of Ca(v)1.3, the action potentials of lateral superior olive (LSO) neurons were narrower compared with controls, whereas the firing behavior and neurotransmission appeared unchanged. Furthermore, auditory brainstem responses were nearly normal in mice lacking Ca(v)1.2. Perineuronal nets were also unaffected. The medial nucleus of the trapezoid body underwent a rapid cell loss between postnatal days P0 and P4, shortly after circuit formation. Phosphorylated cAMP response element-binding protein (CREB), nuclear NFATc4, and the expression levels of p75NTR, Fas, and FasL did not correlate with cell death. These data demonstrate for the first time that both Ca(v)1.2 and Ca(v)1.3 are necessary for neuronal survival but are differentially required for the biophysical properties of neurons. Thus, they perform common as well as distinct functions in the same tissue.	[Ebbers, Lena; Satheesh, Somisetty V.; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany; [Janz, Katrin; Griesemer, Desiree; Friauf, Eckhard] Univ Kaiserlautern, Dept Biol, Anim Physiol Grp, D-67663 Kaiserslautern, Germany; [Ruettiger, Lukas; Knipper, Marlies] Univ Tubingen, Dept Otolaryngol, Hearing Res Ctr Tubingen THRC, Mol Physiol Hearing, D-72076 Tubingen, Germany; [Blosa, Maren; Morawski, Markus] Univ Leipzig, Fac Med, Paul Flechsig Inst Brain Res, D-04103 Leipzig, Germany; [Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Leipzig University; Technical University of Munich; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Morawski, Markus/X-2977-2019; Morawski, Markus/D-4877-2011; Griesemer, Désirée/A-9152-2018; Friauf, Eckhard/D-7529-2012	Morawski, Markus/0000-0002-3817-5186; Griesemer, Désirée/0000-0002-0551-038X; Friauf, Eckhard/0000-0002-1833-1698; Nothwang, Hans Gerd/0000-0001-7695-6437; Blosa, Maren/0000-0001-7680-5217	Deutsche Forschungsgemeinschaft (DFG), priority program, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing" [428/10-1, Fri1784/15-1, Mo2249/2-1, 1608]; CAVNET from European Union [MRTN-CT-2006-035367]; Cluster of Excellence Hearing4All	Deutsche Forschungsgemeinschaft (DFG), priority program, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"(German Research Foundation (DFG)); CAVNET from European Union; Cluster of Excellence Hearing4All	This work was supported by Grants 428/10-1, Fri1784/15-1, and Mo2249/2-1 from the Deutsche Forschungsgemeinschaft (DFG), priority program 1608, "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"; CAVNET Grant MRTN-CT-2006-035367 (to H. G. N.) from the European Union; and a grant from the Cluster of Excellence Hearing4All (to H. G. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Baig SM, 2011, NAT NEUROSCI, V14, P77, DOI 10.1038/nn.2694; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Berger S, 2014, CELL TISSUE RES, V357, P463, DOI 10.1007/s00441-014-1936-3; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blosa M, 2013, NEUROSCIENCE, V228, P215, DOI 10.1016/j.neuroscience.2012.10.003; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Bruckner G, 2001, EXP BRAIN RES, V137, P83; Caicedo A, 1997, J COMP NEUROL, V378, P1, DOI 10.1002/(SICI)1096-9861(19970203)378:1<1::AID-CNE1>3.0.CO;2-8; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; Chonko KT, 2013, DEV BIOL, V381, P401, DOI 10.1016/j.ydbio.2013.06.022; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Ehmann H, 2013, J BIOL CHEM, V288, P25865, DOI 10.1074/jbc.M113.490508; Ehmann H, 2008, HEARING RES, V245, P65, DOI 10.1016/j.heares.2008.08.008; ENSLEN H, 1994, J BIOL CHEM, V269, P20872; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Fulton D, 2010, GLIA, V58, P1292, DOI 10.1002/glia.21008; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; GALLI C, 1995, J NEUROSCI, V15, P1172; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hafidi A, 1996, J COMP NEUROL, V367, P454; Hafidi A, 1999, INT J DEV NEUROSCI, V17, P285, DOI 10.1016/S0736-5748(99)00043-X; Heck N, 2008, CEREB CORTEX, V18, P1335, DOI 10.1093/cercor/bhm165; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Hirtz JJ, 2012, J NEUROSCI, V32, P14602, DOI 10.1523/JNEUROSCI.0765-12.2012; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Hoffpauir BK, 2009, BRAIN RES, V1277, P115, DOI 10.1016/j.brainres.2009.02.050; Hrabetova S, 2009, J PHYSIOL-LONDON, V587, P4029, DOI 10.1113/jphysiol.2009.170092; Jager C, 2013, NEUROSCIENCE, V238, P168, DOI 10.1016/j.neuroscience.2013.02.014; Jurkovicova-Tarabova B, 2012, J NEUROPHYSIOL, V108, P365, DOI 10.1152/jn.00948.2011; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kullmann PHM, 2002, EUR J NEUROSCI, V15, P1093, DOI 10.1046/j.1460-9568.2002.01946.x; LACHICA EA, 1995, J NEUROSCI, V15, P1724, DOI 10.1523/JNEUROSCI.15-03-01724.1995; LEVIMONTALCINI R, 1949, J COMP NEUROL, V91, P209, DOI 10.1002/cne.900910204; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Lohrke S, 2005, EUR J NEUROSCI, V22, P2708, DOI 10.1111/j.1460-9568.2005.04465.x; Lv P, 2014, J NEUROSCI, V34, P7383, DOI 10.1523/JNEUROSCI.5416-13.2014; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Maroto M, 2013, J NEUROCHEM, V125, P205, DOI 10.1111/jnc.12159; Marrs GS, 2012, J PHYSIOL-LONDON, V590, P2391, DOI 10.1113/jphysiol.2011.226886; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; McKinney BC, 2006, LEARN MEMORY, V13, P584, DOI 10.1101/lm.279006; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Mostafapour SP, 2000, J COMP NEUROL, V426, P561, DOI 10.1002/1096-9861(20001030)426:4<561::AID-CNE5>3.0.CO;2-G; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce E T, 1973, Prog Brain Res, V40, P53; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rosengauer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049503; Rubel EW, 2004, PLASTICITY AUDITORY, P9; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Satheesh SV, 2012, HUM MOL GENET, V21, P3896, DOI 10.1093/hmg/dds217; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Schierberl K, 2012, CHANNELS, V6, P11, DOI 10.4161/chan.19324; Schierberl K, 2011, J NEUROSCI, V31, P13562, DOI 10.1523/JNEUROSCI.2315-11.2011; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Schweigreiter R, 2006, BIOESSAYS, V28, P583, DOI 10.1002/bies.20419; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sinnegger-Brauns MJ, 2009, MOL PHARMACOL, V75, P407, DOI 10.1124/mol.108.049981; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Sterenborg JC, 2010, HEARING RES, V270, P119, DOI 10.1016/j.heares.2010.08.013; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tierney TS, 1997, J COMP NEUROL, V378, P295, DOI 10.1002/(SICI)1096-9861(19970210)378:2<295::AID-CNE11>3.0.CO;2-R; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Vigetti D, 2008, CELL PHYSIOL BIOCHEM, V22, P137, DOI 10.1159/000149791; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Willaredt MA, 2014, HEARING RES, V312, P9, DOI 10.1016/j.heares.2014.02.004; Xiao L, 2013, NAT NEUROSCI, V16, P856, DOI 10.1038/nn.3414; YAN Q, 1988, J NEUROSCI, V8, P3481; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P283, DOI 10.1038/mp.2014.181; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zirpel L, 1998, J NEUROPHYSIOL, V79, P2288, DOI 10.1152/jn.1998.79.5.2288; Zirpel L, 2000, J NEUROSCI, V20, P6267, DOI 10.1523/JNEUROSCI.20-16-06267.2000; Zucca S, 2010, J NEUROSCI, V30, P6776, DOI 10.1523/JNEUROSCI.5405-09.2010; Zuccotti A, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00020; Zuccotti A, 2011, TRENDS PHARMACOL SCI, V32, P366, DOI 10.1016/j.tips.2011.02.012	102	14	15	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23692	23710		10.1074/jbc.M115.672675	http://dx.doi.org/10.1074/jbc.M115.672675			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242732	Green Published, hybrid			2022-12-26	WOS:000361816500019
J	Stamatakou, E; Hoyos-Flight, M; Salinas, PC				Stamatakou, Eleanna; Hoyos-Flight, Monica; Salinas, Patricia C.			Wnt Signalling Promotes Actin Dynamics during Axon Remodelling through the Actin-Binding Protein Eps8	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GROWTH-CONE; NEUROMUSCULAR-JUNCTION; CELL-GROWTH; F-ACTIN; RAC; CYTOCHALASIN; CYTOSKELETON; MICROTUBULE; ACTIVATION	Upon arrival at their synaptic targets, axons slow down their growth and extensively remodel before the assembly of presynaptic boutons. Wnt proteins are target-derived secreted factors that promote axonal remodelling and synaptic assembly. In the developing spinal cord, Wnts secreted by motor neurons promote axonal remodelling of NT-3 responsive dorsal root ganglia neurons. Axon remodelling induced by Wnts is characterised by growth cone pausing and enlargement, processes that depend on the re-organisation of microtubules. However, the contribution of the actin cytoskeleton has remained unexplored. Here, we demonstrate that Wnt3a regulates the actin cytoskeleton by rapidly inducing F-actin accumulation in growth cones from rodent DRG neurons through the scaffold protein Dishevelled-1 (Dvl1) and the serine-threonine kinase Gsk3 beta. Importantly, these changes in actin cytoskeleton occurs before enlargement of the growth cones is evident. Time-lapse imaging shows that Wnt3a increases lamellar protrusion and filopodia velocity. In addition, pharmacological inhibition of actin assembly demonstrates that Wnt3a increases actin dynamics. Through a yeast-two hybrid screen, we identified the actin-binding protein Eps8 as a direct interactor of Dvl1, a scaffold protein crucial for the Wnt signalling pathway. Gain of function of Eps8 mimics Wnt-mediated axon remodelling, whereas Eps8 silencing blocks the axon remodelling activity of Wnt3a. Importantly, blockade of the Dvl1-Eps8 interaction completely abolishes Wnt3a-mediated axonal remodelling. These findings demonstrate a novel role for Wnt-Dvl1 signalling through Eps8 in the regulation of axonal remodeling.	[Stamatakou, Eleanna; Hoyos-Flight, Monica; Salinas, Patricia C.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London	Salinas, PC (corresponding author), UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England.	p.salinas@ucl.ac.uk		Salinas, Patricia C./0000-0002-5748-083X; Hoyos Flight, Monica/0000-0002-3181-0933; Stamatakou, Eleanna/0000-0002-0665-9979	Medical Research Council [G0802241]; Wellcome trust [078764/Z/05/2]; Biotechnology and Biological Sciences Research Council [C14770/2]; BBSRC [BB/E016006/1] Funding Source: UKRI; MRC [G0800528, G0802241] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E016006/1] Funding Source: researchfish; Medical Research Council [G0800528] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council, grant number: G0802241, http://www.mrc.ac.uk/, by Wellcome trust, grant number: 078764/Z/05/2, www.wellcome.ac.uk/, and by Biotechnology and Biological Sciences Research Council, grant number: C14770/2, http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Ding XF, 2013, ONCOL REP, V29, P697, DOI 10.3892/or.2012.2160; Disanza A, 2004, NAT CELL BIOL, V6, P1180, DOI 10.1038/ncb1199; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Grabham PW, 2003, J CELL SCI, V116, P3739, DOI 10.1242/jcs.00686; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hertzog M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000387; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Inobe M, 1999, BIOCHEM BIOPH RES CO, V266, P216, DOI 10.1006/bbrc.1999.1782; Ishikawa R, 2007, J PHARMACOL SCI, V105, P6, DOI 10.1254/jphs.CP0070071; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Koles K, 2012, COLD SPRING HARB PER, V4; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Menna E, 2013, EMBO J, V32, P1730, DOI 10.1038/emboj.2013.107; Menna E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000138; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Moriguchi T, 1999, J BIOL CHEM, V274, P30957, DOI 10.1074/jbc.274.43.30957; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Offenhauser N, 2006, CELL, V127, P213, DOI 10.1016/j.cell.2006.09.011; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Roffers-Agarwal J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-36; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Salinas PC, 2012, COLD SPRING HARB PER, V4; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Stamatakou E, 2013, J NEUROSCI, V33, P2661, DOI 10.1523/JNEUROSCI.0998-12.2013; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang HX, 2010, CARCINOGENESIS, V31, P1132, DOI 10.1093/carcin/bgq058; Wang HX, 2009, CARCINOGENESIS, V30, P165, DOI 10.1093/carcin/bgn252; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010	56	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134976	10.1371/journal.pone.0134976	http://dx.doi.org/10.1371/journal.pone.0134976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252776	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100096
J	van Bemmelen, MX; Huser, D; Gautschi, I; Schild, L				van Bemmelen, Miguel Xavier; Huser, Delphine; Gautschi, Ivan; Schild, Laurent			The Human Acid-Sensing Ion Channel ASIC1a: Evidence for a Homotetrameric Assembly State at the Cell Surface	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; SUBUNIT STOICHIOMETRY; ARCHITECTURE; PORE; ENAC; SELECTIVITY; RESOLUTION; TETRAMER; COMPLEX	The chicken acid-sensing ion channel ASIC1 has been crystallized as a homotrimer. We address here the oligomeric state of the functional ASIC1 in situ at the cell surface. The oligomeric states of functional ASIC1a and mutants with additional cysteines introduced in the extracellular pore vestibule were resolved on SDS-PAGE. The functional ASIC1 complexes were stabilized at the cell surface of Xenopus laevis oocytes or CHO cells either using the sulfhydryl crosslinker BMOE, or sodium tetrathionate (NaTT). Under these different crosslinking conditions ASIC1a migrates as four distinct oligomeric states that correspond by mass to multiples of a single ASIC1a subunit. The relative importance of each of the four ASIC1a oligomers was critically dependent on the availability of cysteines in the transmembrane domain for crosslinking, consistent with the presence of ASIC1a homo-oligomers. The expression of ASIC1a monomers, trimeric or tetrameric concatemeric cDNA constructs resulted in functional channels. The resulting ASIC1a complexes are resolved as a predominant tetramer over the other oligomeric forms, after stabilization with BMOE or NaTT and SDS-PAGE/western blot analysis. Our data identify a major ASIC1a homotetramer at the surface membrane of the cell expressing functional ASIC1a channel.	[van Bemmelen, Miguel Xavier; Huser, Delphine; Gautschi, Ivan; Schild, Laurent] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Laurent.Schild@unil.ch	van Bemmelen, Miguel Xavier/A-8660-2014	van Bemmelen, Miguel Xavier/0000-0003-2762-6153	Swiss National Science Foundation [SNF 310030-135378]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant of the Swiss National Science Foundation (SNF 310030-135378) to LS.	Anantharam A, 2007, J GEN PHYSIOL, V130, P55, DOI 10.1085/jgp.200609716; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Dijkink L, 2002, PFLUG ARCH EUR J PHY, V444, P549, DOI 10.1007/s00424-002-0855-4; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kosari F, 1998, J BIOL CHEM, V273, P13469, DOI 10.1074/jbc.273.22.13469; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	26	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135191	10.1371/journal.pone.0135191	http://dx.doi.org/10.1371/journal.pone.0135191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252376	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100132
J	Xu, CC; Yang, G; Yang, M				Xu, Chanchan; Yang, Gang; Yang, Meng			Sample-Based Vegetation Distribution Information Synthesis	PLOS ONE			English	Article							TEXTURE SYNTHESIS; IMAGE	In constructing and visualizing a virtual three-dimensional forest scene, we must first obtain the vegetation distribution, namely, the location of each plant in the forest. Because the forest contains a large number of plants, the distribution of each plant is difficult to obtain from actual measurement methods. Random approaches are used as common solutions to simulate a forest distribution but fail to reflect the specific biological arrangements among types of plants. Observations show that plants in the forest tend to generate particular distribution patterns due to growth competition and specific habitats. This pattern, which represents a local feature in the distribution and occurs repeatedly in the forest, is in line with the "locality" and "static" characteristics in the "texture data", making it possible to use a sample-based texture synthesis strategy to build the distribution. We propose a vegetation distribution data generation method that uses sample-based vector pattern synthesis. A sample forest stand is obtained first and recorded as a two-dimensional vector-element distribution pattern. Next, the large-scale vegetation distribution pattern is synthesized automatically using the proposed vector pattern synthesis algorithm. The synthesized distribution pattern resembles the sample pattern in the distribution features. The vector pattern synthesis algorithm proposed in this paper adopts a neighborhood comparison technique based on histogram matching, which makes it efficient and easy to implement. Experiments show that the distribution pattern synthesized with this method can sufficiently preserve the features of the sample distribution pattern, making our method meaningful for constructing realistic forest scenes.	[Xu, Chanchan; Yang, Gang; Yang, Meng] Beijing Forestry Univ, Sch Informat Sci & Technol, Beijing, Peoples R China; [Xu, Chanchan] Commun Univ China, Sch Animat & Digital Arts, Beijing, Peoples R China	Beijing Forestry University; Communication University of China	Yang, G (corresponding author), Beijing Forestry Univ, Sch Informat Sci & Technol, Beijing, Peoples R China.	yanggang@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [YX2013-28, BLX2012049]; National Natural Science Foundation of China [61100132]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1. Fundamental Research Funds for the Central Universities (Grant No. YX2013-28), the role of the funder for the research: study design, data collection and analysis, Fundamental Research Funds for the Central Universities (No. BLX2012049), the role of the funder for the research: data collection and analysis and the National Natural Science Foundation of China (Grant No. 61100132), the role of the funder for the research: study design, data collection and analysis.	Alsweis M, 2006, WANG TILES SIMULATIO; Ashikhmin M., 2001, P ACM S INT 3D GRAPH, P217; Barla P, 2006, CS0607050 ARXIV; Barla P, 2006, COMPUT GRAPH FORUM, V25, P663, DOI 10.1111/j.1467-8659.2006.00986.x; Cohen MF, 2003, ACM T GRAPHIC, V22, P287, DOI 10.1145/882262.882265; Dietrich C, 2005, P EUR WORKSH NAT PHE, P73; Dischler JM, 2002, COMPUT GRAPH FORUM, V21, P401, DOI 10.1111/1467-8659.t01-1-00600; Efros A. A., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1033, DOI 10.1109/ICCV.1999.790383; Hurtut T., 2009, P 7 INT S NONPH AN R, P51, DOI [DOI 10.1145/1572614.1572623, 10.1145/1572614.1572623]; Ijiri T, 2008, COMPUT GRAPH FORUM, V27, P429, DOI 10.1111/j.1467-8659.2008.01140.x; Kwatra V, 2005, ACM T GRAPHIC, V24, P795, DOI 10.1145/1073204.1073263; Liu Dongwei, 2011, Journal of Computer Aided Design & Computer Graphics, V23, P144; Liu XG, 2004, IEEE T VIS COMPUT GR, V10, P278, DOI 10.1109/TVCG.2004.1272727; Moeur M., 1993, Forest Science, V39, P756; Qin L., 2004, THESIS SUN YS U; Reeves W. T., 1985, Computer Graphics, V19, P313, DOI 10.1145/325165.325250; Wei LY, 2000, COMP GRAPH, P479, DOI 10.1145/344779.345009; Xu Y. Q., 2000, MSRTR200032	19	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134009	10.1371/journal.pone.0134009	http://dx.doi.org/10.1371/journal.pone.0134009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252952	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100033
J	Choi, YM; Kim, HK; Shim, W; Anwar, MA; Kwon, JW; Kwon, HK; Kim, HJ; Jeong, H; Kim, HM; Hwang, D; Kim, HS; Choi, S				Choi, Yong-Min; Kim, Han-Kyul; Shim, Wooyoung; Anwar, Muhammad Ayaz; Kwon, Ji-Woong; Kwon, Hyuk-Kwon; Kim, Hyung Joong; Jeong, Hyobin; Kim, Hwan Myung; Hwang, Daehee; Kim, Hyung Sik; Choi, Sangdun			Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation	PLOS ONE			English	Article							TUBULAR EPITHELIAL-CELLS; OXIDATIVE STRESS; DOWN-REGULATION; AUDITORY CELLS; P53 ACTIVATION; PROTEIN-KINASE; APOPTOSIS; CANCER; NEPHROTOXICITY; DEATH	The chemotherapeutic use of cisplatin is limited by its severe side effects. In this study, by conducting different omics data analyses, we demonstrated that cisplatin induces cell death in a proximal tubular cell line by suppressing glycolysis-and tricarboxylic acid (TCA)/mitochondria-related genes. Furthermore, analysis of the urine from cisplatin-treated rats revealed the lower expression levels of enzymes involved in glycolysis, TCA cycle, and genes related to mitochondrial stability and confirmed the cisplatin-related metabolic abnormalities. Additionally, an increase in the level of p53, which directly inhibits glycolysis, has been observed. Inhibition of p53 restored glycolysis and significantly reduced the rate of cell death at 24 h and 48 h due to p53 inhibition. The foremost reason of cisplatin-related cytotoxicity has been correlated to the generation of mitochondrial reactive oxygen species (ROS) that influence multiple pathways. Abnormalities in these pathways resulted in the collapse of mitochondrial energy production, which in turn sensitized the cells to death. The quenching of ROS led to the amelioration of the affected pathways. Considering these observations, it can be concluded that there is a significant correlation between cisplatin and metabolic dysfunctions involving mROS as the major player.	[Choi, Yong-Min; Kim, Han-Kyul; Shim, Wooyoung; Anwar, Muhammad Ayaz; Kwon, Ji-Woong; Kwon, Hyuk-Kwon; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Kim, Hyung Joong; Kim, Hwan Myung] Ajou Univ, Div Energy Syst Res, Suwon 443749, South Korea; [Jeong, Hyobin; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea; [Kim, Hyung Sik] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea	Ajou University; Ajou University; Pohang University of Science & Technology (POSTECH); Sungkyunkwan University (SKKU)	Choi, S (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.	sangdunchoi@ajou.ac.kr	kwon, hyuk-kwon/AAS-4154-2021; Anwar, Muhammad Ayaz/ABC-8104-2021; kwon, hyukkwon/GRS-1775-2022	kwon, hyuk-kwon/0000-0002-4723-4061; Anwar, Muhammad Ayaz/0000-0002-8794-5589; Kim, Hankyul/0000-0002-1028-9771	Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2012R1A2A2A02016803, 2011-0028663]; grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute [HI14C1992]; Priority Research Centers Program [NRF 2012-0006687]; Ajou university research fund	Mid-Career Researcher Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute; Priority Research Centers Program; Ajou university research fund	This work was supported by the Mid-Career Researcher Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology (2012R1A2A2A02016803 and 2011-0028663) and a grant of the Korea Health Technology R & D Project through the Korea Health Industry Development Institute (HI14C1992). This work was also partially supported by a grant from the Priority Research Centers Program (NRF 2012-0006687) and the Ajou university research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborzinia H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019714; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cardaci S, 2008, MOL PHARMACOL, V74, P1234, DOI 10.1124/mol.108.048975; Rodrigues MAC, 2012, J TOXICOL ENV HEAL A, V75, P981, DOI 10.1080/15287394.2012.696512; Davidson K, 2005, NEPHRON EXP NEPHROL, V99, pE112, DOI 10.1159/000083926; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; di Pietro A, 2012, CELL CYCLE, V11, P4552, DOI 10.4161/cc.22803; Dzamitika S, 2006, J BIOENERG BIOMEMBR, V38, P11, DOI 10.1007/s10863-006-9001-x; Eguchi Y, 1997, CANCER RES, V57, P1835; Garavaglia S, 2009, FEBS J, V276, P6615, DOI 10.1111/j.1742-4658.2009.07372.x; Garrido N, 2008, BIOCHEM J, V414, P93, DOI 10.1042/BJ20071615; Godbout JP, 2002, J BIOL CHEM, V277, P2554, DOI 10.1074/jbc.M100385200; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Hagopian GS, 1999, CLIN CANCER RES, V5, P655; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; HAMERS FPT, 1993, CANCER RES, V53, P544; Hartmann JT, 1999, DRUGS, V58, P257, DOI 10.2165/00003495-199958020-00004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Jian BX, 2010, SHOCK, V34, P169, DOI 10.1097/SHK.0b013e3181cffe7d; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Karawajew L, 2005, BLOOD, V105, P4767, DOI 10.1182/blood-2004-09-3428; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kim SJ, 2009, HEARING RES, V251, P70, DOI 10.1016/j.heares.2009.03.003; Kim SY, 2014, TOXICOL SCI, V140, P247, DOI 10.1093/toxsci/kfu096; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Kuo ML, 2012, SCI REP-UK, V2, DOI 10.1038/srep00822; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu TZ, 2007, MOL CANCER THER, V6, P1814, DOI 10.1158/1535-7163.MCT-06-0279; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Masanta G, 2012, CHEM COMMUN, V48, P3518, DOI 10.1039/c2cc00034b; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Muldoon LL, 2001, J PHARMACOL EXP THER, V296, P797; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124775; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Rybak LP, 1999, LARYNGOSCOPE, V109, P1740, DOI 10.1097/00005537-199911000-00003; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shim W, 2012, ACS NANO, V6, P7665, DOI 10.1021/nn301113f; So H, 2007, JARO-J ASSOC RES OTO, V8, P338, DOI 10.1007/s10162-007-0084-9; Sohn SJ, 2013, TOXICOL LETT, V217, P235, DOI 10.1016/j.toxlet.2012.12.015; St John JC, 2006, METH MOL B, V331, P347; Tanida S., 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/862879, DOI 10.1155/2012/862879]; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wong JWH, 2008, BRIEF BIOINFORM, V9, P156, DOI 10.1093/bib/bbm046; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Xu EY, 2008, CHEM RES TOXICOL, V21, P1548, DOI 10.1021/tx800061w; Xue X, 2012, MOL PHARMACEUT, V9, P634, DOI 10.1021/mp200571k; Yoon YS, 2003, J BIOL CHEM, V278, P51577, DOI 10.1074/jbc.M308489200; Zamble DB, 1998, P NATL ACAD SCI USA, V95, P6163, DOI 10.1073/pnas.95.11.6163; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017998	73	216	219	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135083	10.1371/journal.pone.0135083	http://dx.doi.org/10.1371/journal.pone.0135083			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247588	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300095
J	de Boer, E; Crane, LMA; van Oosten, M; van der Vegt, B; van der Sluis, T; Kooijman, P; Low, PS; van der Zee, AGJ; Arts, HJG; van Dam, GM; Bart, J				de Boer, Esther; Crane, Lucia M. A.; van Oosten, Marleen; van der Vegt, Bert; van der Sluis, Tineke; Kooijman, Paulien; Low, Philip S.; van der Zee, Ate G. J.; Arts, Henriette J. G.; van Dam, Gooitzen M.; Bart, Joost			Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer	PLOS ONE			English	Article							EXPRESSION; INFLAMMATION; CLONING; ALPHA; CDNA	Aims Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (FR-alpha) has already been identified as a suitable target for cancer therapy and imaging. FR-alpha is present on similar to 40% of human cancers. FR-beta is known to be expressed on several hematologic malignancies and on activated macrophages, but little is known about FR-beta expression in solid tumors. Additional or simultaneous expression of FR-beta could help extend the indications for folate-based drugs and imaging agents. In this study, the expression pattern of FR-beta is evaluated in ovarian, breast and colorectal cancer. Methods FR-beta expression was analyzed by semi-quantitative scoring of immunohistochemical staining on tissue microarrays (TMAs) of 339 ovarian cancer patients, 418 breast cancer patients, on 20 slides of colorectal cancer samples and on 25 samples of diverticulitis. Results FR-beta expression was seen in 21% of ovarian cancer samples, 9% of breast cancer samples, and 55% of colorectal cancer samples. Expression was weak or moderate. Of the diverticulitis samples, 80% were positive for FR-beta expression in macrophages. FR-beta status neither correlated to known disease-related variables, nor showed association with overall survival and progression free survival in ovarian and breast cancer. In breast cancer, negative axillary status was significantly correlated to FR-beta expression (p=0.022). Conclusions FR-beta expression was low or absent in the majority of ovarian, breast and colorectal tumor samples. From the present study we conclude that the low FR-beta expression in ovarian and breast tumor tissue indicates limited practical use of this receptor in diagnostic imaging and therapeutic purposes. Due to weak expression, FR-beta is not regarded as a suitable target in colorectal cancer.	[de Boer, Esther; Crane, Lucia M. A.; Kooijman, Paulien] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Surg Oncol, Groningen, Netherlands; [van Oosten, Marleen] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [van der Vegt, Bert; van der Sluis, Tineke; Bart, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Mol Biol, Groningen, Netherlands; [Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [van der Zee, Ate G. J.; Arts, Henriette J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynaecol Oncol, Groningen, Netherlands; [van Dam, Gooitzen M.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg Nucl Med & Mol Imaging & Intens Care, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Groningen; University of Groningen	van Dam, GM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg Nucl Med & Mol Imaging & Intens Care, Groningen, Netherlands.	g.m.van.dam@umcg.nl	Bart, Joost/A-5642-2013; van der Vegt, Bert/G-5887-2014; van der Vegt, Bert/N-2085-2019	Bart, Joost/0000-0002-0985-071X; van der Vegt, Bert/0000-0002-2613-1506; van der Vegt, Bert/0000-0002-2613-1506; Low, Philip/0000-0001-9042-5528				Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; Crane LMA, 2012, CELL ONCOL, V35, P9, DOI 10.1007/s13402-011-0052-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jager NA, 2012, J NUCL MED, V53, P1222, DOI 10.2967/jnumed.111.099671; Kalli KR, 2008, GYNECOL ONCOL, V108, P619, DOI 10.1016/j.ygyno.2007.11.020; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Parker N, 2005, ANAL BIOCHEM, V338, P284, DOI 10.1016/j.ab.2004.12.026; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; Ross JF, 1999, CANCER-AM CANCER SOC, V85, P348, DOI 10.1002/(SICI)1097-0142(19990115)85:2<348::AID-CNCR12>3.0.CO;2-4; ROSS JF, 1994, CANCER-AM CANCER SOC, V73, P2432, DOI 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S; Sega EI, 2008, CANCER METAST REV, V27, P655, DOI 10.1007/s10555-008-9155-6; SHEN F, 1994, BIOCHEMISTRY-US, V33, P1209, DOI 10.1021/bi00171a021; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van der Vegt B, 2007, HISTOPATHOLOGY, V51, P322, DOI 10.1111/j.1365-2559.2007.02757.x; van der Vegt B, 2009, MODERN PATHOL, V22, P879, DOI 10.1038/modpathol.2009.37; Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789	20	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135012	10.1371/journal.pone.0135012	http://dx.doi.org/10.1371/journal.pone.0135012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248049	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300088
J	Mahfouz, MS; Rahim, BEEA; Solan, YMH; Makeen, AM; Alsanosy, RM				Mahfouz, Mohamed Salih; Rahim, Bahaa-eldin E. A.; Solan, Yahya M. H.; Makeen, Anwar M.; Alsanosy, Rashad Mohammed			Khat Chewing Habits in the Population of the Jazan Region, Saudi Arabia: Prevalence and Associated Factors	PLOS ONE			English	Article							SUBSTANCE USE; CATHA-EDULIS; PSYCHOSIS; STUDENTS; ABUSE; DISORDERS; COLLEGE; SCHOOL; QAT	The use of khat (Catha edulis) is a major public health and social problem that is believed to be growing globally. The khat chewing habit is prevalent in all areas of the Jazan region, Kingdom of Saudi Arabia (KSA). However, few studies have been conducted at the community level to investigate the khat chewing habits in this area. This study was conducted with the aim of assessing the prevalence and predictors of khat chewing among the Jazan community population. A cross-sectional study was conducted with a sample (n = 4,500) of the Jizani population who attended primary heath care centers in Jazan region. The participants were selected using a two-stage cluster random sampling. A structured questionnaire was used for data collection. The overall lifetime prevalence of khat chewing was 33.2%(95% CI 31.8-34.7) and was significantly higher for males 42.2% (95% CI 40.4-43.9) than for females 11.3% (95% CI 9.6-13.1) (P < 0.001). Current khat chewers accounted for 28.7% (95% CI 27.4-30.1) of the population sampled; 36.9% (95% CI 35.2-38.6) of whom were males, which is a significantly higher percentage than the 8.7% (95% CI 7.3-10.4) of current khat chewers who were females (P < 0.001). The multivariate logistic regression analysis suggests that the most important independent predictors of khat chewing were having a friend who chewed khat (OR = 20.1, P < 0.001), participant's smoking status (OR) = 3.9, P < 0.001), friend's smoking status (OR = 2.2, P < 0.001), gender (OR = 2.2, P < 0.001) and educational level (OR = 1.5, P < 0.05). A large proportion of the Jizani populations chew khat. Government and non-governmental organizations NGOs should design and strengthen community prevention programs to curb the high prevalence of khat use.	[Mahfouz, Mohamed Salih; Makeen, Anwar M.; Alsanosy, Rashad Mohammed] Jazan Univ, Fac Med, Family & Community Med Dept, Jazan, Saudi Arabia; [Rahim, Bahaa-eldin E. A.; Makeen, Anwar M.] Jazan Univ, Med Res Ctr, Populat Hlth Res Unit, Jazan, Saudi Arabia; [Solan, Yahya M. H.] Minist Hlth, Dept Primary Healthcare, Jazan, Saudi Arabia; [Alsanosy, Rashad Mohammed] Jazan Univ, Substance Abuse Res Ctr, Jazan, Saudi Arabia; [Mahfouz, Mohamed Salih] Univ Gezira, Wad Madani, Gezira State, Sudan	Jazan University; Jazan University; Ministry of Health - Saudi Arabia; Jazan University	Mahfouz, MS (corresponding author), Jazan Univ, Fac Med, Family & Community Med Dept, Jazan, Saudi Arabia.	mm.mahfouz@outlook.com	Mahfouz, Mohamed/A-7388-2012	Mahfouz, Mohamed/0000-0002-3155-6381; Alsanosy, Rashad/0000-0002-0719-9708	Substance Abuse Research Center of Jazan University	Substance Abuse Research Center of Jazan University	This study was financed by the Substance Abuse Research Center of Jazan University.	Aden A, 2006, East Afr Med J, V83, P69; Ageely HM, 2008, J FAMILY COMMUNITY M, V15; Ageely HM, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-11; Al-Sanosy RM, 2009, J FAM COMMUNITY MED, V16, P89; Alem A, 1997, ETHIOPIAN MED J, V35, P137; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Alsanosy RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065504; Alsanosy RM, 2013, KHAT CHEWING STUDENT, P7; [Anonymous], 2006, HLTH RISK FACT SOC P; Arnett JJ, 2005, J DRUG ISSUES, V35, P235, DOI 10.1177/002204260503500202; BAASHER T, 1981, BRIT J ADDICT, V76, P233; Baasher T, 1980, DRUG PROBLEMS SOCIOC; BALINT GA, 1994, HUM PSYCHOPHARM CLIN, V9, P125, DOI 10.1002/hup.470090206; Basunaid Y, 2008, CLIN RES REGUL AFF, V25, P87, DOI DOI 10.1080/10601330802064298; BELL DS, 1973, ARCH GEN PSYCHIAT, V29, P35; Dalu A, 2005, SIDAMA, V5, P15; Denise K, 1973, SCIENCE, V181, P1067; Dhaifalah Ishraq, 2004, Biomedical Papers (Olomouc), V148, P11; Elmi AS, 1983, KHAT CONSUMPTION PRO; Gatter P, 2012, JEMEN STUDIEN; GOUGH SP, 1984, LANCET, V1, P455, DOI 10.1016/S0140-6736(84)91789-6; Greenfield SF, 2003, OBSTET GYN CLIN N AM, V30, P413, DOI 10.1016/S0889-8545(03)00072-X; HALBACH H, 1972, B WORLD HEALTH ORGAN, V47, P21; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; HEACOCK RA, 1974, CAN J PHARM SCI, V9, P64; KALIX P, 1984, B WORLD HEALTH ORGAN, V62, P681; KENNEDY JG, 1983, SOC SCI MED, V17, P783, DOI 10.1016/0277-9536(83)90029-1; Laswar AKN, 2009, SAUDI J KIDNEY DIS T, V20, P862; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Mahfouz MS, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-16; Mion G, 1998, Med Trop (Mars), V58, P266; Mossie A, 2004, ETHIOPIAN MED J, V42, P125; Numan N., 2012, World Journal of Medical Sciences, V7, P210; Odenwald M, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-5; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Patel S., 2005, 4705 HOM OFF; Rahim BEEA, 2012, LIFE SCI J, V9, P2295; Schopen A, 1981, KHAT HIST YEMEN ARAB; Wedegaertner F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-735; YOUSEF G, 1995, BRIT J HOSP MED, V54, P322	40	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134545	10.1371/journal.pone.0134545	http://dx.doi.org/10.1371/journal.pone.0134545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247471	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300044
J	Mei, F; Chen, PF; Dombecki, CR; Aljabban, I; Nabeshima, K				Mei, Frank; Chen, Peter F.; Dombecki, Carolyn R.; Aljabban, Imad; Nabeshima, Kentaro			A Defective Meiotic Outcome of a Failure in Homologous Pairing and Synapsis Is Masked by Meiotic Quality Control	PLOS ONE			English	Article							C-ELEGANS; CHIASMA FORMATION; GENETIC-CONTROL; CELL-DEATH; MEIOSIS; PROTEIN; MRG-1; MECHANISMS; PROPHASE; P53	Successful gamete production is ensured by meiotic quality control, a process in which germ cells that fail in bivalent chromosome formation are eliminated during meiotic prophase. To date, numerous meiotic mutants have been isolated in a variety of model organisms, using defects associated with a failure in bivalent formation as hallmarks of the mutant. Presumably, the meiotic quality control mechanism in those mutants is overwhelmed. In these mutants, all germ cells fail in bivalent formation, and a subset of cells seem to survive the elimination process and develop into gametes. It is possible that mutants that are partially defective in bivalent formation were missed in past genetic screens, because no evident meiotic defects associated with failure in bivalent formation would have been detectable. Meiotic quality control effectively eliminates most failed germ cells, leaving predominately successful ones. Here, we provide evidence supporting this possibility. The Caenorhabditis elegans mrg-1 loss-of-function mutant does not appear to be defective in bivalent formation in diakinesis oocytes. However, defects in homologous chromosome pairing and synapsis during the preceding meiotic prophase, prerequisites for successful bivalent formation, were observed in most, but not all, germ cells. Failed bivalent formation in the oocytes became evident once meiotic quality control was abrogated in the mrg-1 mutant. Both double-strand break repair and synapsis checkpoints are partly responsible for eliminating failed germ cells in the mrg-1 mutant. Interestingly, removal of both checkpoint activities from the mrg-1 mutant is not sufficient to completely suppress the increased germline apoptosis, suggesting the presence of a novel meiotic checkpoint mechanism.	[Mei, Frank; Chen, Peter F.; Dombecki, Carolyn R.; Aljabban, Imad; Nabeshima, Kentaro] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Nabeshima, K (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	knabe@med.umich.edu		Chen, Peter/0000-0001-7012-7216	National Science Foundation [MCB-1329437]; University of Michigan Medical School [U019567, U019580]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); University of Michigan Medical School; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by a research grant from the National Science Foundation (http://www.nsf.gov/) to K.N. (MCB-1329437) and internal funding of the University of Michigan Medical School (U019567&U019580) to K.N.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Ahringer J., 2006, REVERSE GENETICS; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; BRENNER S, 1974, GENETICS, V77, P71; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Dombecki CR, 2011, DEV CELL, V21, P1092, DOI 10.1016/j.devcel.2011.09.019; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Mlynarczyk-Evans S, 2010, OOGENESIS UNIVERSAL, P117; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; Nabeshima K, 2004, GENETICS, V168, P1275, DOI 10.1534/genetics.104.030700; Nabeshima K, 2011, METHODS MOL BIOL, V745, P549, DOI 10.1007/978-1-61779-129-1_32; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Takasaki T, 2007, DEVELOPMENT, V134, P757, DOI 10.1242/dev.02771; Watanabe Y, 2012, NAT REV MOL CELL BIO, V13, P370, DOI 10.1038/nrm3349; Xu J, 2012, CELL RES, V22, P886, DOI 10.1038/cr.2012.2; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134871	10.1371/journal.pone.0134871	http://dx.doi.org/10.1371/journal.pone.0134871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247362	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300073
J	Salvatierra, E; Alvarez, MJ; Leishman, CC; Baquero, ER; Lutzky, VP; Chuluyan, HE; Podhajcer, OL				Salvatierra, Edgardo; Alvarez, Mariano J.; Leishman, Claudia C.; Rivas Baquero, Elvia; Lutzky, Viviana P.; Eduardo Chuluyan, H.; Podhajcer, Osvaldo L.			SPARC Controls Melanoma Cell Plasticity through Rac1	PLOS ONE			English	Article							MATRICELLULAR PROTEIN SPARC; SECRETED PROTEIN; MESENCHYMAL TRANSITION; SIGNALING PATHWAY; CYSTEINE SPARC; CANCER-CELLS; ACTIVATION; EXPRESSION; MIGRATION; INTEGRIN	Cell transition to a more aggressive mesenchymal-like phenotype is a hallmark of cancer progression that involves different steps and requires tightly regulated cell plasticity. SPARC (Secreted Protein Acidic and Rich in Cysteine) is a matricellular protein that promotes this transition in various malignant cell types, including melanoma cells. We found that suppression of SPARC expression in human melanoma cells compromised cell migration, adhesion, cytoskeleton structure, and cell size. These changes involved the Akt/mTOR pathway. Re-expression of SPARC or protein addition restored all the cell features. Suppression of SPARC expression was associated with increased Rac1-GTP levels and its membrane localization. Expression of the dominant negative mutant of Rac1 counteracted almost all the changes observed in SPARC-deficient cells. Overall, these data suggest that most of the SPARC-mediated effects occurred mainly through the blockade of Rac1 activity.	[Salvatierra, Edgardo; Alvarez, Mariano J.; Leishman, Claudia C.; Rivas Baquero, Elvia; Podhajcer, Osvaldo L.] Inst Leloir CONICET, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina; [Lutzky, Viviana P.; Eduardo Chuluyan, H.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecnol CONICET, Ctr Estudios Farmacol & Boton CEFYBO, Lab Immunomodulators,Sch Med, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Podhajcer, OL (corresponding author), Inst Leloir CONICET, Lab Mol & Cellular Therapy, C1405, Buenos Aires, DF, Argentina.	opodhajcer@leloir.org.ar	Chuluyan, Eduardo/H-3702-2019	podhajcer, osvaldo/0000-0002-6512-8553; Salvatierra, Edgardo/0000-0003-1201-7427; Chuluyan, Eduardo/0000-0003-3084-2500				Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Alvarez MJ, 2005, CANCER RES, V65, P5123, DOI 10.1158/0008-5472.CAN-04-1102; Arnold SA, 2010, DIS MODEL MECH, V3, P57, DOI 10.1242/dmm.003228; Bizama C, 2014, INT J CANCER, V134, P755, DOI 10.1002/ijc.28405; Bolontrade MF, 2012, STEM CELLS DEV, V21, P2689, DOI 10.1089/scd.2011.0643; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chakraborty AK, 2009, MELANOMA RES, V19, P343, DOI 10.1097/CMR.0b013e32832fe121; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Davies MA, 2012, CANCER J, V18, P142, DOI 10.1097/PPO.0b013e31824d448c; Dhanesuan N, 2002, BREAST CANCER RES TR, V75, P73, DOI 10.1023/A:1016536725958; Dubois JM, 2012, PROG BIOPHYS MOL BIO, V108, P93, DOI 10.1016/j.pbiomolbio.2011.12.001; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fenouille N, 2011, ONCOGENE, V30, P4887, DOI 10.1038/onc.2011.198; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Girotti MR, 2011, J INVEST DERMATOL, V131, P2438, DOI 10.1038/jid.2011.239; Haber CL, 2008, INT J CANCER, V122, P1465, DOI 10.1002/ijc.23216; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; Lee SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067149; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Monaghan-Benson E, 2013, ONCOGENE, V32, P4836, DOI 10.1038/onc.2012.492; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Prada F, 2007, J INVEST DERMATOL; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Ridley AJ, 2001, J CELL SCI, V114, P2713; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Llera AS, 2010, CYTOKINE GROWTH F R, V21, P67, DOI 10.1016/j.cytogfr.2009.11.010; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sage EH, 1997, NAT MED, V3, P144; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Sosa MS, 2007, PROTEOMICS, V7, P4123, DOI 10.1002/pmic.200700255; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Werzowa J, 2009, BRIT J DERMATOL, V160, P955, DOI 10.1111/j.1365-2133.2008.08991.x; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Workman G, 2011, J CELL BIOCHEM, V112, P1003, DOI 10.1002/jcb.23015	54	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134714	10.1371/journal.pone.0134714	http://dx.doi.org/10.1371/journal.pone.0134714			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248315	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300060
J	Stone, E; Zeale, MRK; Newson, SE; Browne, WJ; Harris, S; Jones, G				Stone, Emma; Zeale, Matt R. K.; Newson, Stuart E.; Browne, William J.; Harris, Stephen; Jones, Gareth			Managing Conflict between Bats and Humans: The Response of Soprano Pipistrelles (Pipistrellus pygmaeus) to Exclusion from Roosts in Houses	PLOS ONE			English	Article							BIG BROWN BATS; EPTESICUS-FUSCUS; HABITAT SELECTION; FORAGING BEHAVIOR; CONSERVATION; CHIROPTERA; DYNAMICS; MYOTIS; CALLS	Conflict can arise when bats roost in human dwellings and householders are affected adversely by their presence. In the United Kingdom, the exclusion of bats from roosts can be licensed under exceptional circumstances to alleviate conflict, but the fate of excluded bats and the impact on their survival and reproduction is not well understood. Using radiotracking, we investigated the effects of exclusion on the soprano pipistrelle Pipistrellus pygmaeus, a species that commonly roosts in buildings in Europe. Exclusions were performed under licence at five roosts in England in spring, when females were in the early stages of pregnancy. Following exclusion, all bats found alternative roosts and colonies congregated in nearby known roosts that had been used by radio-tagged bats prior to exclusion. We found no difference in roosting behaviour before and after exclusion. Both the frequency of roost switching and the type of roosts used by bats remained unchanged. We also found no change in foraging behaviour. Bats foraged in the same areas, travelled similar distances to reach foraging areas and showed similar patterns of habitat selection before and after exclusion. Population modelling suggested that any reduction in survival following exclusion could have a negative impact on population growth, whereas a reduction in productivity would have less effect. While the number of soprano pipistrelle exclusions currently licensed each year is likely to have little effect on local populations, the cumulative impacts of licensing the destruction of large numbers of roosts may be of concern.	[Stone, Emma; Zeale, Matt R. K.; Harris, Stephen; Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Newson, Stuart E.] Nunnery, British Trust Ornithol, Thetford IP24 2PU, Norfolk, England; [Browne, William J.] Univ Bristol, Grad Sch Educ, Bristol BS8 1TX, Avon, England; [Browne, William J.] Univ Bristol, Ctr Multilevel Modelling, Bristol BS8 1TX, Avon, England	University of Bristol; British Trust for Ornithology; University of Bristol; University of Bristol	Zeale, MRK (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	matt.zeale@bristol.ac.uk	Browne, William J/A-8686-2010	Browne, William J/0000-0002-6659-6885; Zeale, Matt/0000-0002-4997-9577; Jones, Gareth/0000-0002-1904-3735; Stone, Emma/0000-0002-3415-3967	Department for Environment, Food and Rural Affairs (Defra);  [WM0322]	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); 	The project was funded by the Department for Environment, Food and Rural Affairs (Defra). The Funders website is: https://www.gov.uk/government/organisations/department-for-environment-food-ruralaffairs. The grant number for the project is: WM0322. The funding was received by GJ and SH. The funder provided a project brief on which experimental procedures were designed. Members of a Project Advisory Group (PAG) provided advice and support throughout the project.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Altringham JD, 1996, BATS BIOL BEHAV; Amelon Sybill K., 2009, P57; [Anonymous], 1988, CONSERVATION EUROPEA; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; Barlow KE, 1999, Z SAUGETIERKD, V64, P257; Bartonicka T, 2008, ANN ZOOL FENN, V45, P503, DOI 10.5735/086.045.0605; Bishop CM, 1992, MOL ECOL, V1, P255, DOI 10.1111/j.1365-294X.1992.tb00185.x; Briggs P, 2004, MAMMALIA, V68, P353, DOI 10.1515/mamm.2004.035; BRIGHAM RM, 1986, CAN J ZOOL, V64, P1128, DOI 10.1139/z86-169; Davidson-Watts I, 2006, J ZOOL, V268, P55, DOI 10.1111/j.1469-7998.2005.00016.x; Davidson-Watts I, 2007, THESIS U BRISTOL; Davidson-Watts I, 2006, BIOL CONSERV, V133, P118, DOI 10.1016/j.biocon.2006.05.027; de Fanis E, 1994, THESIS U BRISTOL; deFanis E, 1996, J ZOOL, V240, P781, DOI 10.1111/j.1469-7998.1996.tb05324.x; Entwistle AC, 1997, J APPL ECOL, V34, P399, DOI 10.2307/2404885; HUGHES PM, 1989, J ZOOL, V219, P665, DOI 10.1111/j.1469-7998.1989.tb02607.x; Kenward RE., 2000, MANUAL WILDLIFE RADI; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lourenco SI, 2004, BIOL CONSERV, V119, P237, DOI 10.1016/j.biocon.2003.11.006; Mitchell-Jones A.J., 2004, BAT WORKERS MANUAL, V3rd; NEILSON AL, 1994, WILDLIFE SOC B, V22, P8; Nicholls B, 2006, BEHAV ECOL SOCIOBIOL, V61, P131, DOI 10.1007/s00265-006-0244-7; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; RACEY PA, 1974, J ZOOL, V173, P264, DOI 10.1111/j.1469-7998.1974.tb03136.x; Rasbash J, 2009, MLWIN VERSION 21; Reckardt K, 2007, OECOLOGIA, V154, P581, DOI 10.1007/s00442-007-0843-7; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Speakman JR, 2003, BAT ECOLOGY, P430; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Stone EL, 2013, CONSERV BIOL, V27, P1324, DOI 10.1111/cobi.12154; STONES ROBERT C., 1967, P97; THOMPSON MJA, 1992, J ZOOL, V228, P673, DOI 10.1111/j.1469-7998.1992.tb04466.x; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Vonhof MJ, 1996, CAN J ZOOL, V74, P1797, DOI 10.1139/z96-200; WHITAKER JO, 1992, J MAMMAL, V73, P312, DOI 10.2307/1382062; Whitaker JO, 2000, AM MIDL NAT, V143, P389, DOI 10.1674/0003-0031(2000)143[0389:PSADOB]2.0.CO;2; Willis CKR, 2004, ANIM BEHAV, V68, P495, DOI 10.1016/j.anbehav.2003.08.028; Zeale MRK, 2012, J MAMMAL, V93, P1110, DOI 10.1644/11-MAMM-A-366.1	40	9	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131825	10.1371/journal.pone.0131825	http://dx.doi.org/10.1371/journal.pone.0131825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244667	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400013
J	Bingold, TM; Lefering, R; Zacharowski, K; Meybohm, P; Waydhas, C; Rosenberger, P; Scheller, B				Bingold, Tobias M.; Lefering, Rolf; Zacharowski, Kai; Meybohm, Patrick; Waydhas, Christian; Rosenberger, Peter; Scheller, Bertram		Divi Intensive Care Registry Grp	Individual Organ Failure and Concomitant Risk of Mortality Differs According to the Type of Admission to ICU - A Retrospective Study of SOFA Score of 23,795 Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; DYSFUNCTION/FAILURE; REQUIREMENTS; MULTICENTER; SEPSIS; SAPS-3	Introduction Organ dysfunction or failure after the first days of ICU treatment and subsequent mortality with respect to the type of intensive care unit (ICU) admission is poorly elucidated. Therefore we analyzed the association of ICU mortality and admission for medical (M), scheduled surgery (ScS) or unscheduled surgery (US) patients mirrored by the occurrence of organ dysfunction/failure (OD/OF) after the first 72h of ICU stay. Methods For this retrospective cohort study (23,795 patients; DIVI registry; German Interdisciplinary Association for Intensive Care Medicine (DIVI)) organ dysfunction or failure were derived from the Sequential Organ Failure Assessment (SOFA) score (excluding the Glasgow Coma Scale). SOFA scores were collected on admission to ICU and 72h later. For patients with a length of stay of at least five days, a multivariate analysis was performed for individual OD/OF on day three. Results M patients had the lowest prevalence of cardiovascular failure (M 31%; ScS 35%; US 38%), and the highest prevalence of respiratory (M 24%; ScS 13%; US 17%) and renal failure (M 10%; ScS 6%; US 7%). Risk of death was highest for M-and ScS-patients in those with respiratory failure (OR; M 2.4; ScS 2.4; US 1.4) and for surgical patients with renal failure (OR; M 1.7; ScS 2.7; US 2.4). Conclusion The dynamic evolution of OD/OF within 72h after ICU admission and mortality differed between patients depending on their types of admission. This has to be considered to exclude a systematic bias during multi-center trials.	[Bingold, Tobias M.; Zacharowski, Kai; Meybohm, Patrick; Scheller, Bertram] Univ Hosp Frankfurt Main, Dept Anesthesiol Intens Care Med & Pain Therapy, D-60590 Frankfurt, Germany; [Lefering, Rolf] Univ Witten Herdecke, Cologne Merheim Med Ctr CMMC, Inst Res Operat Med IFOM, D-51109 Cologne, Germany; [Waydhas, Christian] Univ Hosp Essen, Dept Trauma Surg, D-45122 Essen, Germany; [Rosenberger, Peter] Univ Tubingen, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Witten Herdecke University; University of Duisburg Essen; Eberhard Karls University of Tubingen	Bingold, TM (corresponding author), Univ Hosp Frankfurt Main, Dept Anesthesiol Intens Care Med & Pain Therapy, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	tobias.bingold@kgu.de	Meybohm, Patrick/K-4066-2017; Bingold, Tobias/AAM-9204-2021	Meybohm, Patrick/0000-0002-2666-8696; Bingold, Tobias/0000-0002-4046-135X; Pauldurai, Jona/0000-0002-7217-0872				Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lone NI, 2012, AM J RESP CRIT CARE, V186, P640, DOI 10.1164/rccm.201201-0059OC; Martin J, 2004, ANASTH INTENSIVMED, V45, P207; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Valentin A, 2011, INTENS CARE MED, V37, P1575, DOI 10.1007/s00134-011-2300-7; Vincent JL, 2012, RESUSCITATION, V83, P537, DOI 10.1016/j.resuscitation.2012.02.024; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waydhas C., 2000, Intensivmedizin und Notfallmedizin, V37, P454, DOI 10.1007/s003900070059; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	16	25	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134329	10.1371/journal.pone.0134329	http://dx.doi.org/10.1371/journal.pone.0134329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241475	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700040
J	Mladenovic, D; Petronijevic, N; Stojkovic, T; Velimirovic, M; Jevtic, G; Hrncic, D; Radosavljevic, T; Rasic-Markovic, A; Maksic, N; Djuric, D; Stanojlovic, O				Mladenovic, Dusan; Petronijevic, Natasa; Stojkovic, Tihomir; Velimirovic, Milica; Jevtic, Gordana; Hrncic, Dragan; Radosavljevic, Tatjana; Rasic-Markovic, Aleksandra; Maksic, Nebojsa; Djuric, Dragan; Stanojlovic, Olivera			Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats	PLOS ONE			English	Article							ACUTE AMMONIA INTOXICATION; IN-VIVO; LIPID-PEROXIDATION; ENERGY-METABOLISM; LIVER-FAILURE; NEUROSTEROIDS; ALLOPREGNANOLONE; HYPERAMMONEMIA; CEREBELLUM; ACTIVATION	Finasteride (FIN) inhibits neurosteroid synthesis and potentially improves the course of hepatic encephalopathy (HE). This study aimed to investigate the effects of FIN on brain oxidative stress and acetylcholinesterase (AchE) activity in acute thioacetamide-induced HE in rats. Male Wistar rats were divided into groups: 1. control; 2. thioacetamide-treated group (TAA; 900 mg/kg); 3. finasteride-treated group (FIN; 150 mg/kg); 4. group treated with FIN and TAA (FIN+TAA). Daily doses of FIN (50 mg/kg) and TAA (300 mg/kg) were administered intraperitoneally during three days and in FIN+TAA group FIN was administered 2h before every dose of TAA. FIN pretreatment prevented TAA-induced rise in malondialdehyde level in the cortex due to restoration of catalase activity and increased expression of superoxide dismutase 1 (SOD1) and induced an increase in malondialdehyde level in the thalamus due to reduction of glutathione peroxidase (GPx) and glutathione reductase (GR) activity. Although FIN pretreatment did not affect malondialdehyde level in hippocampus and caudate nucleus, hippocampal SOD1 expression was higher (p<0.05) and GR activity lower in FIN+TAA vs. TAA group (p<0.05). GPx activity was lower in caudate nucleus in FIN + TAA vs. TAA group (p<0.01). FIN pretreatment prevented TAA-induced rise in AchE activity in the thalamus and caudate nucleus and AchE activity correlates inversely in the thalamus (p<0.05) and positively in caudate nucleus (p<0.01) with malondialdehyde level. FIN has regionally selective effects on oxidative stress and AchE activity in the brain in acute TAA-induced HE in rats. The prooxidant role of FIN in the thalamus may be causally linked with inhibition of AchE.	[Mladenovic, Dusan; Radosavljevic, Tatjana] Univ Belgrade, Fac Med, Inst Pathophysiol Ljubodrag Buba Mihailovic, Belgrade, Serbia; [Petronijevic, Natasa; Stojkovic, Tihomir; Velimirovic, Milica; Jevtic, Gordana] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Hrncic, Dragan; Rasic-Markovic, Aleksandra; Djuric, Dragan; Stanojlovic, Olivera] Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Belgrade, Serbia; [Maksic, Nebojsa] Clin Ctr Serbia, Ctr Med Biochem, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Stanojlovic, O (corresponding author), Univ Belgrade, Fac Med, Inst Med Physiol Richard Burian, Visegradska 26-2, Belgrade, Serbia.	solja@afrodita.rcub.bg.ac.rs	Radosavljević, Tatjana/AAE-2792-2020; Rasic Markovic, Aleksandra/AAA-9441-2022; Hrncic, Dragan/AAT-2544-2021; Velimirovic, Milica D/R-9449-2017; Rasic-Markovic, Aleksandra/AAT-5675-2021	Radosavljević, Tatjana/0000-0002-1701-3313; Rasic Markovic, Aleksandra/0000-0003-1131-2328; Hrncic, Dragan/0000-0003-0806-444X; Velimirovic, Milica D/0000-0002-0495-0316; Djuric, Dragan M./0000-0003-2196-9438; Stojkovic, Tihomir/0000-0002-2400-6066; Petronijevic, Natasa/0000-0002-4338-1953; Stanojlovic, Olivera/0000-0001-5317-3827	Ministry of Education and Science of Serbia [175032, 175058]	Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Serbia, Grant No 175032 and 175058.	Ahboucha S, 2008, NEUROCHEM INT, V52, P575, DOI 10.1016/j.neuint.2007.05.004; Ahboucha S, 2012, NEUROCHEM INT, V60, P707, DOI 10.1016/j.neuint.2011.10.003; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; Ali MI, 2013, EUR J PHARMACOL, V698, P397, DOI 10.1016/j.ejphar.2012.10.028; Alvarez VM, 2011, J NEUROSCI RES, V89, P2028, DOI 10.1002/jnr.22708; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Bishnoi M, 2008, PROG NEURO-PSYCHOPH, V32, P451, DOI 10.1016/j.pnpbp.2007.09.017; Bismuth M, 2011, EUR J GASTROEN HEPAT, V23, P8, DOI 10.1097/MEG.0b013e3283417567; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Cauli O, 2009, GASTROENTEROLOGY, V136, P1359, DOI 10.1053/j.gastro.2008.12.057; Cauli O, 2009, METAB BRAIN DIS, V24, P69, DOI 10.1007/s11011-008-9115-4; Cayatte C, 2006, MOL CELL PROTEOMICS, V5, P2031, DOI 10.1074/mcp.M600165-MCP200; Duborija-Kovacevic N, 2008, EUR J DRUG METAB PH, V33, P181; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Ena S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00047; Finn DA, 2004, PHARMACOL THERAPEUT, V101, P91, DOI 10.1016/j.pharmthera.2003.10.006; Ford MA, 2005, ALCOHOL, V37, P23, DOI 10.1016/j.alcohol.2005.11.002; GAMMAL SH, 1989, MED CLIN N AM, V73, P793, DOI 10.1016/S0025-7125(16)30639-3; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010; Gonzalez-Usano A, 2013, J NEUROCHEM, V125, P133, DOI 10.1111/jnc.12119; GOTH L, 1991, CLIN CHEM, V37, P2043; GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Haussinger D, 2005, METAB BRAIN DIS, V20, P285, DOI 10.1007/s11011-005-7908-2; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; Kalb A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062679; Kosenko E, 2000, BRAIN RES, V880, P139, DOI 10.1016/S0006-8993(00)02785-2; Lassiter TL, 1998, DEV BRAIN RES, V105, P109, DOI 10.1016/S0165-3806(97)00177-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCANDLESS DW, 1985, J LAB CLIN MED, V106, P183; Mendez M, 2011, ACTA HISTOCHEM, V113, P358, DOI 10.1016/j.acthis.2010.01.009; Milatovic D, 2006, THESCIENTIFICWORLDJO, V6, P295, DOI 10.1100/tsw.2006.38; Mladenovic D, 2014, AM J PHYSIOL-GASTR L, V307, pG931, DOI 10.1152/ajpgi.00463.2013; Mladenovic D, 2012, CAN J PHYSIOL PHARM, V90, P1219, DOI [10.1139/Y2012-088, 10.1139/y2012-088]; Mladenovic D, 2012, MED CHEM, V8, P52, DOI 10.2174/157340612799278603; Mukai Y, 2008, BIOL PHARM BULL, V31, P1646, DOI 10.1248/bpb.31.1646; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; REHNCRONA S, 1980, J NEUROCHEM, V34, P1630, DOI 10.1111/j.1471-4159.1980.tb11254.x; Rodriguez-Rodriguez P, 2013, NEUROCHEM INT, V62, P750, DOI 10.1016/j.neuint.2013.02.005; Rosello DM, 2008, HEPATOL RES, V38, P1148, DOI 10.1111/j.1872-034X.2008.00377.x; Sathyasaikumar KV, 2007, NEUROCHEM RES, V32, P517, DOI 10.1007/s11064-006-9265-x; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Swapna I, 2007, BRAIN RES, V1153, P188, DOI 10.1016/j.brainres.2007.02.095; Traish AM, 2014, HORM MOL BIOL CLIN I, V20, P73, DOI 10.1515/hmbci-2014-0025; Ugale RR, 2007, BRAIN RES, V1184, P193, DOI 10.1016/j.brainres.2007.09.041; Wang XK, 2005, MOL BRAIN RES, V140, P120, DOI 10.1016/j.molbrainres.2005.07.018; Whittaker V. P., 1972, METHODS NEUROCHEMIST, V2, P1; Zarros A, 2008, METAB BRAIN DIS, V23, P255, DOI 10.1007/s11011-008-9091-8	53	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134434	10.1371/journal.pone.0134434	http://dx.doi.org/10.1371/journal.pone.0134434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241899	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700044
J	Wang, YS; Mao, ZC; Yan, J; Cheng, XY; Liu, F; Xiao, L; Dai, LY; Luo, F; Xie, BY				Wang, Yunsheng; Mao, Zhenchuan; Yan, Jin; Cheng, Xinyue; Liu, Feng; Xiao, Luo; Dai, Liangying; Luo, Feng; Xie, Bingyan			Identification of MicroRNAs in Meloidogyne incognita Using Deep Sequencing	PLOS ONE			English	Article							SMALL RNAS; COMPUTATIONAL IDENTIFICATION; REGULATORY ROLES; GENOME; GENES; ALIGNMENT; PLANT; BIOGENESIS; 21U-RNAS; MIR-124	MicroRNAs play important regulatory roles in eukaryotic lineages. In this paper, we employed deep sequencing technology to sequence and identify microRNAs in M. incognita genome, which is one of the important plant parasitic nematodes. We identified 102 M. incognita microRNA genes, which can be grouped into 71 nonredundant miRNAs based on mature sequences. Among the 71 miRANs, 27 are known miRNAs and 44 are novel miRNAs. We identified seven miRNA clusters in M. incognita genome. Four of the seven clusters, miR-100/let-7, miR-71-1/miR-2a-1, miR-71-2/miR-2a-2 and miR-279/miR-2b are conserved in other species. We validated the expressions of 5 M. incognita microRNAs, including 3 known microRNAs (miR-71, miR-100b and let-7) and 2 novel microRNAs (NOVEL-1 and NOVEL-2), using RT-PCR. We can detect all 5 microRNAs. The expression levels of four microRNAs obtained using RT-PCR were consistent with those obtained by high-throughput sequencing except for those of let-7. We also examined how M. incognita miRNAs are conserved in four other nematodes species: C. elegans, A. suum, B. malayi and P. pacificus. We found that four microRNAs, miR-100, miR-92, miR-279 and miR-137, exist only in genomes of parasitic nematodes, but do not exist in the genomes of the free living nematode C. elegans. Our research created a unique resource for the research of plant parasitic nematodes. The candidate microRNAs could help elucidate the genomic structure, gene regulation, evolutionary processes, and developmental features of plant parasitic nematodes and nematode-plant interaction.	[Wang, Yunsheng; Yan, Jin; Xiao, Luo; Dai, Liangying] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China; [Wang, Yunsheng; Mao, Zhenchuan; Liu, Feng; Xie, Bingyan] CAAS, Inst Vegetables & Flowers, Beijing, Peoples R China; [Cheng, Xinyue] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Beijing Normal University; Clemson University	Wang, YS (corresponding author), Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Changsha, Hunan, Peoples R China.	wyunsheng@gmail.com; xieby@mail.caas.net.cn		Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China (NSFC) [30900925]; National Basic Research and Development Program of China [2009CB119000]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	This work was partially supported by National Natural Science Foundation of China (NSFC) (30900925) and National Basic Research and Development Program of China (2009CB119000).	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Boissonneault V, 2008, ANAL BIOCHEM, V381, P166, DOI 10.1016/j.ab.2008.06.026; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Burnside J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-185; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hsieh YW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002864; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2005, ACTA BIOCH BIOPH SIN, V37, P75, DOI 10.1093/abbs/37.2.75; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Nagao A, 2010, RNA, V16, P2503, DOI 10.1261/rna.2270710; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sarkies P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002061; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shi Z, 2013, GENOME RES, V23, P497, DOI 10.1101/gr.149112.112; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Tsuchida A, 2011, CANCER SCI, V102, P2264, DOI 10.1111/j.1349-7006.2011.02081.x; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Warf MB, 2011, RNA, V17, P563, DOI 10.1261/rna.2432311; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Winter AD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-4; Yousef M, 2009, FEBS J, V276, P2150, DOI 10.1111/j.1742-4658.2009.06933.x; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208; ZUO T, 2010, J HENAN AGR SCI, V12	65	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133491	10.1371/journal.pone.0133491	http://dx.doi.org/10.1371/journal.pone.0133491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241472	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700016
J	Zhao, WY; Zhao, TQ; Chen, YJ; Zhao, FB; Gu, QQ; Williams, RW; Bhattacharya, SK; Lu, L; Sun, Y				Zhao, Wenyuan; Zhao, Tieqiang; Chen, Yuanjian; Zhao, Fengbo; Gu, Qingqing; Williams, Robert W.; Bhattacharya, Syamal K.; Lu, Lu; Sun, Yao			A Murine Hypertrophic Cardiomyopathy Model: The DBA/2J Strain	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; LEFT-VENTRICULAR HYPERTROPHY; TISSUE-REPAIR; MOUSE GENOME; RAT-HEART; MICE; MUTATIONS; POLYMORPHISM; PHENOTYPES; GENETICS	Familial hypertrophic cardiomyopathy (HCM) is attributed to mutations in genes that encode for the sarcomere proteins, especially Mybpc3 and Myh7. Genotype-phenotype correlation studies show significant variability in HCM phenotypes among affected individuals with identical causal mutations. Morphological changes and clinical expression of HCM are the result of interactions with modifier genes. With the exceptions of angiotensin converting enzyme, these modifiers have not been identified. Although mouse models have been used to investigate the genetics of many complex diseases, natural murine models for HCM are still lacking. In this study we show that the DBA/2J (D2) strain of mouse has sequence variants in Mybpc3 and Myh7, relative to widely used C57BL/6J (B6) reference strain and the key features of human HCM. Four-month-old of male D2 mice exhibit hallmarks of HCM including increased heart weight and cardiomyocyte size relative to B6 mice, as well as elevated markers for cardiac hypertrophy including beta-myosin heavy chain (MHC), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and skeletal muscle alpha actin (alpha 1-actin). Furthermore, cardiac interstitial fibrosis, another feature of HCM, is also evident in the D2 strain, and is accompanied by up-regulation of type I collagen and a-smooth muscle actin (SMA)-markers of fibrosis. Of great interest, blood pressure and cardiac function are within the normal range in the D2 strain, demonstrating that cardiac hypertrophy and fibrosis are not secondary to hypertension, myocardial infarction, or heart failure. Because D2 and B6 strains have been used to generate a large family of recombinant inbred strains, the BXD cohort, the D2 model can be effectively exploited for in-depth genetic analysis of HCM susceptibility and modifier screens.	[Zhao, Wenyuan; Zhao, Tieqiang; Chen, Yuanjian; Zhao, Fengbo; Bhattacharya, Syamal K.; Sun, Yao] Univ Tennessee, Dept Med, HealthSci Ctr, Div Cardiovasc Dis, Memphis, TN 38104 USA; [Gu, Qingqing; Williams, Robert W.; Lu, Lu] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Lu, Lu] Nantong Univ, Jiangsu Key Lab Neuroregenert, Nantong, Jiangsu, Peoples R China	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Nantong University	Lu, L (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	llu@uthsc.edu; yasun@uthsc.edu	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447	NIH Heart, Lung and Blood Institute [R01-HL096503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096503] Funding Source: NIH RePORTER	NIH Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by NIH Heart, Lung and Blood Institute (R01-HL096503 to Yao Sun). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; Dhalla NS, 2012, HEART FAIL REV, V17, P671, DOI 10.1007/s10741-011-9278-7; Doolan G, 2004, INT J CARDIOL, V96, P157, DOI 10.1016/j.ijcard.2004.05.003; Enriquez AD, 2014, ANN GLOB HEALTH, V80, P35, DOI 10.1016/j.aogh.2013.12.004; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; LIEBSON PR, 1990, AM J HYPERTENS, V3, P512, DOI 10.1093/ajh/3.6.512; Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939; Marian AJ, 2002, CURR OPIN CARDIOL, V17, P242, DOI 10.1097/00001573-200205000-00006; MARIAN AJ, 1993, LANCET, V342, P1085, DOI 10.1016/0140-6736(93)92064-Z; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MATSUSHIMA Y, 1984, EXP ANIM TOKYO, V33, P539, DOI 10.1538/expanim1978.33.4_539; Meng WX, 2014, AM J HYPERTENS, V27, P775, DOI 10.1093/ajh/hpt270; Mulligan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034586; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; POLIKAR R, 1993, CIRCULATION, V87, P1435, DOI 10.1161/01.CIR.87.5.1435; Prinz C, 2013, EXPERT REV CARDIOVAS, V11, P495, DOI [10.1586/ERC.13.24, 10.1586/erc.13.24]; Rice R, 2010, J MOL CELL CARDIOL, V48, P979, DOI 10.1016/j.yjmcc.2009.11.018; Rosker C, 2011, CIRC RES, V109, P1120, DOI 10.1161/CIRCRESAHA.111.244798; Subasic K, 2013, NURS CLIN N AM, V48, P571, DOI 10.1016/j.cnur.2013.09.001; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Sun Y, 1996, J MOL CELL CARDIOL, V28, P851, DOI 10.1006/jmcc.1996.0080; Swaminathan S, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12106; Talishinsky A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044236; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Veldink H, 2013, NEPHROL DIAL TRANSPL, V28, P1434, DOI 10.1093/ndt/gfs554; Wang XS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-O7; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Zhao TQ, 2011, INT J CARDIOL, V152, P307, DOI 10.1016/j.ijcard.2010.07.024; Zhao WY, 2009, CARDIOVASC PATHOL, V18, P156, DOI 10.1016/j.carpath.2007.12.013	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133132	10.1371/journal.pone.0133132	http://dx.doi.org/10.1371/journal.pone.0133132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241864	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700011
J	Huang, L; Han, JJ; Ben-Hail, D; He, LW; Li, BW; Chen, ZH; Wang, YY; Yang, YL; Liu, L; Zhu, YS; Shoshan-Barmatz, V; Liu, HW; Chen, Q				Huang, Li; Han, Junjie; Ben-Hail, Danya; He, Luwei; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Zhu, Yushan; Shoshan-Barmatz, Varda; Liu, Hongwei; Chen, Quan			A New Fungal Diterpene Induces VDAC1-dependent Apoptosis in Bax/Bak-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; OUTER MITOCHONDRIAL-MEMBRANE; CYTOCHROME-C RELEASE; VDAC1 N-TERMINUS; BCL-2 FAMILY; MUTATIONAL INACTIVATION; MELANOMA-CELLS; BAX; PROTEIN	The pro-apoptotic Bax and Bak proteins are considered central to apoptosis, yet apoptosis occurs in their absence. Here, we asked whether the mitochondrial protein VDAC1 mediates apoptosis independently of Bax/Bak. Upon screening a fungal secondary metabolite library for compounds inducing apoptosis in Bax/Bak-deficient mouse embryonic fibroblasts, we identified cyathin-R, a new cyathane diterpenoid compound able to activate apoptosis in the absence of Bax/Bak via promotion of the VDAC1 oligomerization that mediates cytochrome c release. Diphenylamine-2-carboxilic acid, an inhibitor of VDAC1 conductance and oligomerization, inhibited cyathin-R-induced VDAC1 oligomerization and apoptosis. Similarly, Bcl-2 overexpression conferred resistance to cyathin-R-induced apoptosis and VDAC1 oligomerization. Silencing of VDAC1 expression prevented cyathin-R-induced apoptosis. Finally, cyathin-R effectively attenuated tumor growth and induced apoptosis in Bax/Bak-deficient cells implanted into a xenograft mouse model. Hence, this study identified a new compound promoting VDAC1-dependent apoptosis as a potential therapeutic option for cancerous cells lacking or presenting inactivated Bax/Bak.	[Huang, Li; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Huang, Li; Li, Baowei; Chen, Ziheng; Wang, Yueying; Yang, Yanlei; Liu, Lei; Chen, Quan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Han, Junjie; He, Luwei; Liu, Hongwei] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100101, Peoples R China; [Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ben-Hail, Danya; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Zhu, Yushan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 30071, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Ben Gurion University; Ben Gurion University; Nankai University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il; liuhw@im.ac.cn; chenq@ioz.ac.cn	yang, yanlei/GQH-5514-2022	Ben-Hail, Danya/0000-0002-8210-3446; Chen, Quan/0000-0001-7539-8728	Natural Science Foundation of China [91213304, 8113004]; Ministry of Science and Technology of China [2014CB138304]; Israel Science Foundation [307/13]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Israel Science Foundation(Israel Science Foundation)	This work was supported by key projects of the Natural Science Foundation of China (Grants 91213304 and 8113004) and the Ministry of Science and Technology of China (Grant 2014CB138304) and by Israel Science Foundation Grant 307/13 (to V.S.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Betaneli V, 2012, BIOPHYS J, V102, P523, DOI 10.1016/j.bpj.2011.12.049; Brustovetsky T, 2010, BBA-BIOENERGETICS, V1797, P1795, DOI 10.1016/j.bbabio.2010.07.006; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Chacko AD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-380; Cheng SL, 2007, J BIOMED SCI, V14, P87, DOI 10.1007/s11373-006-9130-6; Claveria C, 2004, J BIOL CHEM, V279, P1368, DOI 10.1074/jbc.M309819200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; el Dein OS, 2012, BIOCHEM PHARMACOL, V83, P1172, DOI 10.1016/j.bcp.2012.01.017; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Geula S, 2012, J BIOL CHEM, V287, P2179, DOI 10.1074/jbc.M111.268920; Ghosh T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001170; Godbole A, 2003, BBA-MOL CELL RES, V1642, P87, DOI 10.1016/S0167-4889(03)00102-2; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Han JJ, 2013, FITOTERAPIA, V84, P22, DOI 10.1016/j.fitote.2012.10.001; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; Jiang N, 2011, J PROTEOMICS, V74, P843, DOI 10.1016/j.jprot.2011.02.034; Jung JY, 2007, NEUROSCI LETT, V411, P222, DOI 10.1016/j.neulet.2006.09.089; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lai JC, 2006, P NATL ACAD SCI USA, V103, P7494, DOI 10.1073/pnas.0602217103; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu JH, 2013, FREE RADICAL BIO MED, V63, P485, DOI 10.1016/j.freeradbiomed.2013.05.038; Lu AJ, 2007, FISH SHELLFISH IMMUN, V23, P601, DOI 10.1016/j.fsi.2007.01.007; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Martel C, 2014, MITOCHONDRION, V19, P69, DOI 10.1016/j.mito.2014.07.009; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mizuta T, 2007, J BIOL CHEM, V282, P16623, DOI 10.1074/jbc.M611060200; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2013, PROG MOL BIOL TRANSL, V117, P303, DOI 10.1016/B978-0-12-386931-9.00011-8; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; Tajeddine N, 2008, ONCOGENE, V27, P4221, DOI 10.1038/onc.2008.63; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Wan KF, 2008, J BIOL CHEM, V283, P8423, DOI 10.1074/jbc.M707687200; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Yuan SP, 2008, FASEB J, V22, P2809, DOI 10.1096/fj.08-107417; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	66	37	41	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23563	23578		10.1074/jbc.M115.648774	http://dx.doi.org/10.1074/jbc.M115.648774			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26253170	Green Published, hybrid			2022-12-26	WOS:000361816500009
J	Sumption, N; Goodhead, DT; Anderson, RM				Sumption, Natalia; Goodhead, Dudley T.; Anderson, Rhona M.			Alpha-Particle-Induced Complex Chromosome Exchanges Transmitted through Extra-Thymic Lymphopoiesis In Vitro Show Evidence of Emerging Genomic Instability	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; HIGH-LET; PROGENITOR CELLS; MFISH ANALYSIS; BIOLOGICAL EFFECTIVENESS; COLLABORATIVE ANALYSIS; HUMAN-LYMPHOCYTES; INDIVIDUAL DATA; LUNG-CANCER; ABERRATIONS	Human exposure to high-linear energy transfer alpha-particles includes environmental (e.g. radon gas and its decay progeny), medical (e.g. radiopharmaceuticals) and occupational (nuclear industry) sources. The associated health risks of alpha-particle exposure for lung cancer are well documented however the risk estimates for leukaemia remain uncertain. To further our understanding of alpha-particle effects in target cells for leukaemogenesis and also to seek general markers of individual exposure to alpha-particles, this study assessed the transmission of chromosomal damage initially-induced in human haemopoietic stem and progenitor cells after exposure to high-LET alpha-particles. Cells surviving exposure were differentiated into mature T-cells by extra-thymic T-cell differentiation in vitro. Multiplex fluorescence in situ hybridisation (M-FISH) analysis of naive T-cell populations showed the occurrence of stable (clonal) complex chromosome aberrations consistent with those that are characteristically induced in spherical cells by the traversal of a single alpha-particle track. Additionally, complex chromosome exchanges were observed in the progeny of irradiated mature T-cell populations. In addition to this, newly arising de novo chromosome aberrations were detected in cells which possessed clonal markers of alpha-particle exposure and also in cells which did not show any evidence of previous exposure, suggesting ongoing genomic instability in these populations. Our findings support the usefulness and reliability of employing complex chromosome exchanges as indicators of past or ongoing exposure to high-LET radiation and demonstrate the potential applicability to evaluate health risks associated with alpha-particle exposure.	[Sumption, Natalia; Goodhead, Dudley T.; Anderson, Rhona M.] MRC, Didcot, Oxon, England; [Anderson, Rhona M.] Brunel Univ, Coll Hlth & Life Sci, Dept Life Sci, Div Biosci, London, England	MRC Harwell; Brunel University	Anderson, RM (corresponding author), MRC, Didcot, Oxon, England.	rhona.anderson@brunel.ac.uk			Department of Health, UK [RRX95]	Department of Health, UK	This work was supported by the Department of Health, UK. Contract RRX95 (RMA NS DTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NS is currently affiliated with GSK, however all contributions made by NS were undertaken at the MRC Harwell. The authors confirm that GSK had no role (direct or indirect) in the study design, data collection and analysis, decision to publish or preparation of manuscript.	AHMAD M, 1986, CELL IMMUNOL, V103, P299, DOI 10.1016/0008-8749(86)90091-2; Al-Harthi L, 2000, J IMMUNOL METHODS, V237, P187, DOI 10.1016/S0022-1759(00)00136-8; ALEXANDER FE, 1990, LANCET, V335, P1336; Anderson RM, 2007, RADIAT RES, V167, P541, DOI 10.1667/RR0813.1; Anderson RM, 2000, INT J RADIAT BIOL, V76, P31, DOI 10.1080/095530000138989; Anderson RM, 2003, RADIAT RES, V159, P40, DOI 10.1667/0033-7587(2003)159[0040:TANCCA]2.0.CO;2; Anderson RM, 2005, RADIAT RES, V163, P26, DOI 10.1667/RR3286; Anderson RM, 2002, P NATL ACAD SCI USA, V99, P12167, DOI 10.1073/pnas.182426799; [Anonymous], 2007, ICRP PUBL, V103; Becker D, 2009, INT J RADIAT BIOL, V85, P1051, DOI 10.3109/09553000903232850; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chakraborty S, 2012, BLOOD, V119, P6187, DOI 10.1182/blood-2011-05-352252; Cornforth MN, 2001, RADIAT RES, V155, P643, DOI 10.1667/0033-7587(2001)155[0643:ARICCR]2.0.CO;2; Curwen GB, 2015, RADIAT ENVIRON BIOPH, V54, P195, DOI 10.1007/s00411-015-0585-6; Curwen GB, 2012, RADIAT RES, V178, P414, DOI 10.1667/RR3020.1.2; Darby S, 2006, SCAND J WORK ENV HEA, V32, P1; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Duran A, 2009, RADIAT RES, V171, P425, DOI 10.1667/RR1504.1; Durante M, 2010, RADIAT RES, V174, P20, DOI 10.1667/RR2063.1; Edwards AA, 2005, RADIAT PROT DOSIM, V113, P396, DOI 10.1093/rpd/nch452; Foster HA, 2013, MUTAT RES-GEN TOX EN, V756, P66, DOI 10.1016/j.mrgentox.2013.06.003; Friedland W, 2013, MUTAT RES-GEN TOX EN, V756, P213, DOI 10.1016/j.mrgentox.2013.06.013; George KA, 2013, RADIAT RES, V180, P25, DOI 10.1667/RR3291.1; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; GOODHEAD DT, 1991, INT J RADIAT BIOL, V59, P195, DOI 10.1080/09553009114550181; Greulich KM, 2000, MUTAT RES-FUND MOL M, V452, P73, DOI 10.1016/S0027-5107(00)00057-9; GRIFFIN CS, 1995, INT J RADIAT BIOL, V67, P431, DOI 10.1080/09553009514550491; Harrison JD, 2003, INT J RADIAT BIOL, V79, P1, DOI 10.1080/0955300021000038671; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; HENSHAW DL, 1990, LANCET, V335, P1008, DOI 10.1016/0140-6736(90)91071-H; Hobbs RF, 2014, RADIAT RES, V181, P90, DOI 10.1667/RR13483.1; IAEA, 2011, CYT DOS APPL PREP RE; Jadvar H, 2013, CLIN NUCL MED, V38, P966, DOI 10.1097/RLU.0000000000000290; Johnson KL, 1999, RADIAT RES, V152, P1, DOI 10.2307/3580043; Kadhim MA, 2001, RADIAT RES, V155, P122, DOI 10.1667/0033-7587(2001)155[0122:LTGIIH]2.0.CO;2; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kadhim MA, 1998, ADV SPACE RES, V22, P587, DOI 10.1016/S0273-1177(98)00081-7; KADHIM MA, 1995, INT J RADIAT BIOL, V67, P287, DOI 10.1080/09553009514550341; KADHIM MA, 1994, LANCET, V344, P987, DOI 10.1016/S0140-6736(94)91643-8; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; Kendall G, 2011, LEUKEMIA RES, V35, P1039, DOI 10.1016/j.leukres.2011.01.023; Kodama Y, 2005, RADIAT RES, V164, P618, DOI 10.1667/RR3455.1; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Limoli CL, 1998, CANCER RES, V58, P3712; Littlefield LG, 1997, RADIAT RES, V148, P135, DOI 10.2307/3579570; Loucas BD, 2001, RADIAT RES, V155, P660, DOI 10.1667/0033-7587(2001)155[0660:CCEIBG]2.0.CO;2; Moquet JE, 2001, CELL MOL BIOL, V47, P549; Morgan WF, 2015, CANCER LETT, V356, P17, DOI 10.1016/j.canlet.2013.09.009; Nikjoo H, 1999, RADIAT ENVIRON BIOPH, V38, P31, DOI 10.1007/s004110050135; NRC, 1998, HLTH EFF EXP RAD; Paretzke HG., 1987, KINETICS NONHOMOGENE, P89; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; RAMSEY MJ, 1995, MUTAT RES-DNAGING G, V338, P95, DOI 10.1016/0921-8734(95)00015-X; SAMET JM, 1989, J NATL CANCER I, V81, P745, DOI 10.1007/s00484-020-01860-w; SAVAGE JRK, 1994, MUTAT RES, V312, P51, DOI 10.1016/0165-1161(94)90008-6; SEVC J, 1988, HEALTH PHYS, V54, P27, DOI 10.1097/00004032-198801000-00001; Sotnik NV, 2014, RADIAT ENVIRON BIOPH, V53, P347, DOI 10.1007/s00411-014-0536-7; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Themis M, 2013, INT J RADIAT BIOL, V89, P66; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2008, EXP PUBL WORK VAR SO; Vuong W, 2014, ASIAN J ANDROL, V16, P348, DOI 10.4103/1008-682X.127812; Watson GE, 1996, INT J RADIAT BIOL, V69, P175, DOI 10.1080/095530096146002; Watson GE, 2001, INT J RADIAT BIOL, V77, P409, DOI 10.1080/09553000010028476; Whitehouse CA, 1998, RADIAT RES, V150, P459, DOI 10.2307/3579666; Wright EG, 2010, MUTAT RES-FUND MOL M, V687, P28, DOI 10.1016/j.mrfmmm.2010.01.014	66	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134046	10.1371/journal.pone.0134046	http://dx.doi.org/10.1371/journal.pone.0134046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252014	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100034
J	Yun, KW; Lee, H; Choi, EH; Lee, HJ				Yun, Ki Wook; Lee, Hyunju; Choi, Eun Hwa; Lee, Hoan Jong			Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children	PLOS ONE			English	Article							VACCINE CANDIDATE; IMMUNOGENICITY; SAFETY; IMMUNIZATION; INFECTIONS; RESISTANCE; SEROTYPES	Pneumolysin (Ply) and pneumococcal histidine triad protein D (PhtD) are candidate proteins for a next-generation pneumococcal vaccine. We aimed to analyze the genetic diversity and antigenic heterogeneity of Ply and PhtD for 173 pneumococci isolated from invasive diseases in Korean children. Allele was designated based on the variation of amino acid sequence. Antigenicity was predicted by the amino acid hydrophobicity of the region. There were seven and 39 allele types for the ply and phtD genes, respectively. The nucleotide sequence identity was 97.2%-99.9% for ply and 91.4%-98.0% for phtD gene. Only minor variations in hydrophobicity were noted among the antigenicity plots of Ply and PhtD. Overall, the allele types of the ply and phtD genes were remarkably homogeneous, and the antigenic diversity of the corresponding proteins was very limited. The Ply and PhtD could be useful antigens for universal pneumococcal vaccines.	[Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Lee, Hyunju] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	hoanlee@snu.ac.kr		Yun, Ki Wook/0000-0002-0798-6779	Basic Science Research Program through the National Research Foundation (NRF) of Korea; Ministry of Education, Science, and Technology [2011-0023092]	Basic Science Research Program through the National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, which is funded by the Ministry of Education, Science, and Technology (2011-0023092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JE, 1994, INFECT IMMUN, V62, P5683, DOI 10.1128/IAI.62.12.5683-5688.1994; Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; Bersch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081168; Bologa M, 2012, VACCINE, V30, P7461, DOI 10.1016/j.vaccine.2012.10.076; Cho EY, 2014, DIAGN MICR INFEC DIS, V78, P481, DOI 10.1016/j.diagmicrobio.2013.12.016; Choi EH, 2010, EMERG INFECT DIS, V16, P1751, DOI 10.3201/eid1611.100941; Denoel P, 2011, VACCINE, V29, P5495, DOI 10.1016/j.vaccine.2011.05.051; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jefferies JMC, 2010, J MED MICROBIOL, V59, P808, DOI 10.1099/jmm.0.018663-0; Kamtchoua T, 2013, VACCINE, V31, P327, DOI 10.1016/j.vaccine.2012.11.005; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; MITCHELL TJ, 1990, NUCLEIC ACIDS RES, V18, P4010, DOI 10.1093/nar/18.13.4010; Norcross EW, 2011, INVEST OPHTH VIS SCI, V52, P9232, DOI 10.1167/iovs.10-6968; Plumptre CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078916; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Seiberling M, 2012, VACCINE, V30, P7455, DOI 10.1016/j.vaccine.2012.10.080; Selva L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041587; Shak JR, 2013, MBIO, V4, DOI 10.1128/mBio.00655-13; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wu Xiaomeng, 2006, Int J Bioinform Res Appl, V2, P219; Yoo IH, 2010, FEMS IMMUNOL MED MIC, V60, P28, DOI 10.1111/j.1574-695X.2010.00699.x	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134055	10.1371/journal.pone.0134055	http://dx.doi.org/10.1371/journal.pone.0134055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252211	Green Published, gold			2022-12-26	WOS:000359121100035
J	Beaurepaire, AL; Truong, TA; Fajardo, AC; Dinh, TQ; Cervancia, C; Moritz, RFA				Beaurepaire, Alexis L.; Truong, Tuan A.; Fajardo, Alejandro C.; Dinh, Tam Q.; Cervancia, Cleofas; Moritz, Robin F. A.			Host Specificity in the Honeybee Parasitic Mite, Varroa spp. in Apis mellifera and Apis cerana	PLOS ONE			English	Article							BEE; DESTRUCTOR; JACOBSONI; ACARI; SOFTWARE; PACKAGE; WORLD	The ectoparasitic mite Varroa destructor is a major global threat to the Western honeybee Apis mellifera. This mite was originally a parasite of A. cerana in Asia but managed to spill over into colonies of A. mellifera which had been introduced to this continent for honey production. To date, only two almost clonal types of V. destructor from Korea and Japan have been detected in A. mellifera colonies. However, since both A. mellifera and A. cerana colonies are kept in close proximity throughout Asia, not only new spill overs but also spill backs of highly virulent types may be possible, with unpredictable consequences for both honeybee species. We studied the dispersal and hybridisation potential of Varroa from sympatric colonies of the two hosts in Northern Vietnam and the Philippines using mitochondrial and microsatellite DNA markers. We found a very distinct mtDNA haplotype equally invading both A. mellifera and A. cerana in the Philippines. In contrast, we observed a complete reproductive isolation of various Vietnamese Varroa populations in A. mellifera and A. cerana colonies even if kept in the same apiaries. In light of this variance in host specificity, the adaptation of the mite to its hosts seems to have generated much more genetic diversity than previously recognised and the Varroa species complex may include substantial cryptic speciation.	[Beaurepaire, Alexis L.; Moritz, Robin F. A.] Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany; [Truong, Tuan A.; Dinh, Tam Q.] Bee Res & Dev Ctr, Dong Da Hanoi, Vietnam; [Fajardo, Alejandro C.; Cervancia, Cleofas] Univ Philippines Los Banos, Inst Biol Sci, UPLB Bee Program, Los Banos, Philippines; [Moritz, Robin F. A.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	Martin Luther University Halle Wittenberg; University of the Philippines System; University of the Philippines Los Banos; University of Pretoria	Beaurepaire, AL (corresponding author), Univ Halle Wittenberg, Inst Biol, Halle, Saale, Germany.	alexis.beaurepaire@zoologie.uni-halle.de	Beaurepaire, Alexis L./H-5236-2019; Moritz, Robin FA/K-6053-2012	Beaurepaire, Alexis L./0000-0002-9832-5609; Moritz, Robin FA/0000-0003-0791-887X	German Federal Ministry for Education and Research [FKZ01LL0917A-01LL0917O]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry for Education and Research under research grant no. FKZ01LL0917A-01LL0917O for the LEGATO project.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Anderson DL, 2007, EXP APPL ACAROL, V43, P1, DOI 10.1007/s10493-007-9103-0; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Benjamin A, 2008, A WORLD WITHOUT BEES; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; CRANE E, 1978, BEE WORLD, V59, P164, DOI 10.1080/0005772X.1978.11097718; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; De la Rua P, 2000, HEREDITY, V84, P124, DOI 10.1046/j.1365-2540.2000.00646.x; DEJONG D, 1982, ANNU REV ENTOMOL, V27, P229, DOI 10.1146/annurev.en.27.010182.001305; DOBZHANSKY T., 1951, Genetics and the origin of species.; Evans JD, 2000, MOL ECOL, V9, P1436, DOI 10.1046/j.1365-294x.2000.00998-3.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fries I, 1996, APIDOLOGIE, V27, P3, DOI 10.1051/apido:19960101; Fuchs S, 2000, APIDOLOGIE, V31, P459, DOI 10.1051/apido:2000138; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hepburn HR, 2011, HONEYBEES OF ASIA, P1, DOI 10.1007/978-3-642-16422-4; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Le Conte Y, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0233; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034486; Martin C, 2001, INSECT BIOCHEM MOLEC, V31, P365, DOI 10.1016/S0965-1748(00)00130-2; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mehlhorn H, 2008, ENCY PARASITOLOGY; Moritz RFA, 2005, ECOSCIENCE, V12, P289, DOI 10.2980/i1195-6860-12-3-289.1; NATION JL, 1992, EXP APPL ACAROL, V16, P331, DOI 10.1007/BF01218575; Navajas M, 2010, APIDOLOGIE, V41, P181, DOI 10.1051/apido/2009068; Roberts JMK, 2015, MOL ECOL, V24, P2379, DOI 10.1111/mec.13185; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sakai T., 1973, Gleanings in Bee Culture, V101, P356; Sambrook J., 2001, MOL CLONING LAB MANU; Smith DR, 1991, DIVERSITY GENUS APIS; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	39	34	37	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135103	10.1371/journal.pone.0135103	http://dx.doi.org/10.1371/journal.pone.0135103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248192	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300099
J	de Souza, PC; Mallory, S; Smith, N; Saunders, D; Li, XN; McNall-Knapp, RY; Fung, KM; Towner, RA				de Souza, Patricia Coutinho; Mallory, Samantha; Smith, Nataliya; Saunders, Debra; Li, Xiao-Nan; McNall-Knapp, Rene Y.; Fung, Kar-Ming; Towner, Rheal A.			Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-GRADE GLIOMA; HEPARAN-SULFATE ENDOSULFATASE; INTRINSIC PONTINE GLIOMA; PRIMARY BRAIN-TUMORS; IN-VIVO; MALIGNANT GLIOMA; MR SPECTROSCOPY; HEPATOCELLULAR-CARCINOMA; ANTIANGIOGENIC THERAPY	Pediatric glioblastomas (pGBM), although rare, are one of the leading causes of cancer-related deaths in children, with tumors essentially refractory to existing treatments. Here, we describe the use of conventional and advanced in vivo magnetic resonance imaging (MRI) techniques to assess a novel orthotopic xenograft pGBM mouse (IC-3752GBM patient-derived culture) model, and to monitor the effects of the anti-cancer agent OKN-007 as an inhibitor of pGBM tumor growth. Immunohistochemistry support data is also presented for cell proliferation and tumor growth signaling. OKN-007 was found to significantly decrease tumor volumes (p<0.05) and increase animal survival (p<0.05) in all OKN-007-treated mice compared to untreated animals. In a responsive cohort of treated animals, OKN-007 was able to significantly decrease tumor volumes (p<0.0001), increase survival (p<0.001), and increase diffusion (p<0.01) and perfusion rates (p<0.05). OKN-007 also significantly reduced lipid tumor metabolism in responsive animals [(Lip1.3 and Lip0.9)-to-creatine ratio (p<0.05)], as well as significantly decrease tumor cell proliferation (p<0.05) and microvessel density (p<0.05). Furthermore, in relationship to the PDGFR alpha pathway, OKN-007 was able to significantly decrease SULF2 (p<0.05) and PDGFR-alpha (platelet-derived growth factor receptor-alpha) (p<0.05) immunoexpression, and significantly increase decorin expression (p<0.05) in responsive mice. This study indicates that OKN-007 may be an effective anti-cancer agent for some patients with pGBMs by inhibiting cell proliferation and angiogenesis, possibly via the PDGFR alpha pathway, and could be considered as an additional therapy for pediatric brain tumor patients.	[de Souza, Patricia Coutinho; Smith, Nataliya; Saunders, Debra; Towner, Rheal A.] Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, Oklahoma City, OK 73104 USA; [de Souza, Patricia Coutinho; Towner, Rheal A.] Oklahoma State Univ, Coll Vet Med, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Mallory, Samantha; McNall-Knapp, Rene Y.] Univ Oklahoma, Childrens Hosp, Oklahoma City, OK USA; [Li, Xiao-Nan] Texas Childrens Hosp, Mol Neurooncol Lab, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Fung, Kar-Ming; Towner, Rheal A.] Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Fung, Kar-Ming] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Fung, Kar-Ming] Oklahoma City Vet Affairs Med Ctr, Dept Pathol, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center; Baylor College of Medicine; Texas Children's Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Towner, RA (corresponding author), Oklahoma Med Res Fdn, Adv Magnet Resonance Ctr, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Rheal-Towner@omrf.org	Coutinho de Souza, Patricia/U-8641-2017	Towner, Rheal/0000-0001-7368-8983	National Institutes of Health [P20 GM103639]; Oklahoma State University [AE-1-50060]; Musella Foundation; Childhood Brain Tumor Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma State University; Musella Foundation; Childhood Brain Tumor Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (P20 GM103639, KMF) http://nih.gov/, Oklahoma State University (AE-1-50060; PCS) http://go.okstate.edu/, Musella Foundation (No. number; RAT) http://www.virtualtrials.com/musella.cfm, and Childhood Brain Tumor Foundation (No. number; RAT) http://www.childhoodbraintumor.org/.	Al-Saffar NMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103835; Albers MJ, 2005, MAGN RESON MED, V53, P22, DOI 10.1002/mrm.20312; Anda T, 1997, NEUROL RES, V19, P369, DOI 10.1080/01616412.1997.11758599; Astrakas LG, 2004, CLIN CANCER RES, V10, P8220, DOI 10.1158/1078-0432.CCR-04-0603; Baghy K, 2013, FEBS J, V280, P2150, DOI 10.1111/febs.12215; Banerjee ER., 2014, PERSPECTIVES REGENER; Baskerville TA, 2012, J CEREBR BLOOD F MET, V32, P973, DOI 10.1038/jcbfm.2012.19; Bernstein M, 2014, NEUROONCOLOGY ESSENT; Bielen A, 2011, MOL CANCER THER, V10, P1407, DOI 10.1158/1535-7163.MCT-11-0205; Blamek S, 2010, ACTA NEUROCHIR SUPPL, V106, P183, DOI 10.1007/978-3-211-98811-4_33; Blom T, 2010, J NEURO-ONCOL, V97, P217, DOI 10.1007/s11060-009-0014-2; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Bozgeyik Z, 2013, QUANT IMAGING MED SU, V3, P269, DOI 10.3978/j.issn.2223-4292.2013.10.07; Broniscer A, 2004, ONCOLOGIST, V9, P197, DOI 10.1634/theoncologist.9-2-197; Broniscer A, 2009, CLIN CANCER RES, V15, P701, DOI 10.1158/1078-0432.CCR-08-1923; Bucci MK, 2004, CANCER-AM CANCER SOC, V101, P817, DOI 10.1002/cncr.20422; Bulik M, 2013, CLIN NEUROL NEUROSUR, V115, P146, DOI 10.1016/j.clineuro.2012.11.002; Castillo M, 2001, AM J NEURORADIOL, V22, P60; Chen J, 2006, NEURORADIOLOGY, V48, P312, DOI 10.1007/s00234-006-0066-3; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Choudhri AF, 2014, AM J NEURORADIOL, V35, P2382, DOI 10.3174/ajnr.A4040; Colagrande S, 2006, RADIOL MED, V111, P392, DOI 10.1007/s11547-006-0037-0; de Certaines JD, 2007, CURR ORG CHEM, V11, P529, DOI 10.2174/138527207780368247; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Delikatny EJ, 2002, CANCER RES, V62, P1394; Doblas S, 2012, NMR BIOMED, V25, P685, DOI 10.1002/nbm.1785; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Floyd RA, 2011, ANTI-CANCER AGENT ME, V11, P373; Fouladi M, 2010, J CLIN ONCOL, V28, P4221, DOI 10.1200/JCO.2010.28.4687; Garteiser P, 2010, J MAGN RESON IMAGING, V31, P796, DOI 10.1002/jmri.22106; Geoerger B, 2009, EUR J CANCER, V45, P2342, DOI 10.1016/j.ejca.2009.03.007; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Griffin JL, 2003, CANCER RES, V63, P3195; He T, 2011, FREE RADICAL BIO MED, V51, P490, DOI 10.1016/j.freeradbiomed.2011.04.037; Heijmen L, 2012, CRIT REV ONCOL HEMAT, V83, P194, DOI 10.1016/j.critrevonc.2011.12.008; Hocking AM, 1998, MATRIX BIOL, V17, P1; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Hur K, 2012, J PATHOL, V228, P88, DOI 10.1002/path.4055; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kao HW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970586; Kim SG, 2012, NEUROIMAGE, V62, P672, DOI 10.1016/j.neuroimage.2012.01.015; Kousi E, 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/546171; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; KUESEL AC, 1994, NMR BIOMED, V7, P149, DOI 10.1002/nbm.1940070308; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Li XJ, 2005, AM J NEURORADIOL, V26, P760; Liu ZG, 2013, NEURO-ONCOLOGY, V15, P1173, DOI 10.1093/neuonc/not065; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lupo JM, 2007, AM J NEURORADIOL, V28, P1455, DOI 10.3174/ajnr.A0586; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Malisza KL, 1998, BIOCHEM CELL BIOL, V76, P487, DOI 10.1139/bcb-76-2-3-487; Marcus KJ, 2007, INT J ONCOL, V30, P651; McKnight TR, 2007, J NEUROSURG, V106, P660, DOI 10.3171/jns.2007.106.4.660; Merle B, 1999, J CELL BIOCHEM, V75, P538; Merle B, 1997, J CELL BIOCHEM, V67, P75; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Murphy PS, 2003, BRIT J RADIOL, V76, P459, DOI 10.1259/bjr/16316438; Narayana A, 2007, BRIT J RADIOL, V80, P347, DOI 10.1259/bjr/65349468; Nash MA, 1999, CANCER RES, V59, P6192; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Panigrahy A, 2006, AM J NEURORADIOL, V27, P560; Paugh BS, 2011, J CLIN ONCOL, V29, P3999, DOI 10.1200/JCO.2011.35.5677; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Porto L, 2010, BRAIN TUMOR PATHOL, V27, P65, DOI 10.1007/s10014-010-0268-6; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Ralte Angela Mercy, 2001, Pathology and Oncology Research, V7, P267; Ramin Sérgio Luiz, 2003, Sao Paulo Med. J., V121, P254, DOI 10.1590/S1516-31802003000600008; Ross BD, 2003, MOL CANCER THER, V2, P581; Sankar T, 2008, J NEURO-ONCOL, V90, P63, DOI 10.1007/s11060-008-9632-3; Santra M, 2006, J CEREBR BLOOD F MET, V26, P1311, DOI 10.1038/sj.jcbfm.9600285; Schraml C., 2013, CURR RADIOL REP, V1, P93, DOI [10.1007/s40134-013-0009-9, DOI 10.1007/S40134-013-0009-9]; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Silva AC, 2000, MAGN RESON MED, V44, P169, DOI 10.1002/1522-2594(200008)44:2<169::AID-MRM1>3.0.CO;2-U; Sorensen AG, 2006, J CLIN ONCOL, V24, P3274, DOI 10.1200/JCO.2006.06.6597; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Srinivasan R, 2010, NEURO-ONCOLOGY, V12, P1152, DOI 10.1093/neuonc/noq075; Stadlbauer A, 2011, CENT EUR NEUROSURG, V72, P63, DOI 10.1055/s-0030-1253410; Steffen-Smith EA, 2011, J NEURO-ONCOL, V105, P365, DOI 10.1007/s11060-011-0601-x; THIESZEN SL, 1995, MATRIX BIOL, V14, P573, DOI 10.1016/S0945-053X(05)80006-X; Thorarinsdottir HK, 2008, CLIN CANCER RES, V14, P3386, DOI 10.1158/1078-0432.CCR-07-1616; Towner RA, 2013, NEURO-ONCOLOGY, V15, P330, DOI 10.1093/neuonc/nos337; Tzika AA, 2004, CANCER, V100, P1246, DOI 10.1002/cncr.20096; Tzika AA, 2002, J NEUROSURG, V96, P1023, DOI 10.3171/jns.2002.96.6.1023; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Warren KE, 2000, J CLIN ONCOL, V18, P1020, DOI 10.1200/JCO.2000.18.5.1020; Wilson M, 2013, EUR J CANCER, V49, P457, DOI 10.1016/j.ejca.2012.09.002; Xu JY, 2012, J NEURO-ONCOL, V107, P269, DOI 10.1007/s11060-011-0756-5; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yamada J, 2014, HIPPOCAMPUS, V24, P1017, DOI 10.1002/hipo.22287; Yeom KW, 2014, AM J NEURORADIOL, V35, P395, DOI 10.3174/ajnr.A3670; Yeom KW, 2013, J NEURO-ONCOL, V113, P479, DOI 10.1007/s11060-013-1140-4; Zarghooni M, 2010, J CLIN ONCOL, V28, P1337, DOI 10.1200/JCO.2009.25.5463; Zheng X, 2013, GENE CHROMOSOME CANC, V52, P225, DOI 10.1002/gcc.22022; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	105	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134276	10.1371/journal.pone.0134276	http://dx.doi.org/10.1371/journal.pone.0134276			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248280	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300030
J	Arcinue, CA; Bartsch, DU; El-Emam, SY; Ma, FY; Doede, A; Sharpsten, L; Gomez, ML; Freeman, WR				Arcinue, Cheryl A.; Bartsch, Dirk-Uwe; El-Emam, Sharif Y.; Ma, Feiyan; Doede, Aubrey; Sharpsten, Lucie; Gomez, Maria Laura; Freeman, William R.			Retinal Thickening and Photoreceptor Loss in HIV Eyes without Retinitis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; VISUAL-FIELD FUNCTION; NERVE-FIBER LAYER; POSITIVE PATIENTS; MULTIFOCAL ELECTRORETINOGRAM; INFECTED INDIVIDUALS; CONE PHOTORECEPTORS; OBJECTIVE ANALYSIS; HIGH-RESOLUTION; COLOR-VISION	Purpose To determine the presence of structural changes in HIV retinae (i.e., photoreceptor density and retinal thickness in the macula) compared with age-matched HIV-negative controls. Methods Cohort of patients with known HIV under CART (combination Antiretroviral Therapy) treatment were examined with a flood-illuminated retinal AO camera to assess the cone photoreceptor mosaic and spectral-domain optical coherence tomography (SD-OCT) to assess retinal layers and retinal thickness. Results Twenty-four eyes of 12 patients (n = 6 HIV-positive and 6 HIV-negative) were imaged with the adaptive optics camera. In each of the regions of interest studied (nasal, temporal, superior, inferior), the HIV group had significantly less mean cone photoreceptor density compared with age-matched controls (difference range, 4,308-6,872 cones/mm(2)). A different subset of forty eyes of 20 patients (n = 10 HIV-positive and 10 HIV-negative) was included in the retinal thickness measurements and retinal layer segmentation with the SD-OCT. We observed significant thickening in HIV positive eyes in the total retinal thickness at the foveal center, and in each of the three horizontal B-scans (through the macular center, superior, and inferior to the fovea). We also noted that the inner retina (combined thickness from ILM through RNFL to GCL layer) was also significantly thickened in all the different locations scanned compared with HIV-negative controls. Conclusion Our present study shows that the cone photoreceptor density is significantly reduced in HIV retinae compared with age-matched controls. HIV retinae also have increased macular retinal thickness that may be caused by inner retinal edema secondary to retinovascular disease in HIV. The interaction of photoreceptors with the aging RPE, as well as possible low-grade ocular inflammation causing diffuse inner retinal edema, may be the key to the progressive vision changes in HIV-positive patients without overt retinitis.	[Arcinue, Cheryl A.; Bartsch, Dirk-Uwe; El-Emam, Sharif Y.; Ma, Feiyan; Doede, Aubrey; Sharpsten, Lucie; Gomez, Maria Laura; Freeman, William R.] Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Inst, La Jolla, CA 92093 USA; [El-Emam, Sharif Y.] Tanta Univ, Ophthalmol, Tanta, Egypt	University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Tanta University	Bartsch, DU (corresponding author), Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Inst, La Jolla, CA 92093 USA.	dbartsch@ucsd.edu	Emam, Sharif El/AAA-6627-2020; Doede, Aubrey L/N-9859-2016	Emam, Sharif El/0000-0001-6357-0471; Doede, Aubrey L/0000-0002-9977-2806	NIH [R01EY007366, R01EY016323, R01EY018589]; NEI [P30EY022589]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018589, R01EY016323, R01EY007366, P30EY022589] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants R01EY007366, R01EY016323 and R01EY018589, NEI vision core grant P30EY022589, and Research to Prevent Blindness. The funding organizations had no role in the design or conduct of this research.	Ahn SJ, 2015, AM J OPHTHALMOL, V159, P667, DOI 10.1016/j.ajo.2015.01.001; Andreoli MT, 2014, AM J OPHTHALMOL, V158, P567, DOI 10.1016/j.ajo.2014.05.028; Arantes TE, 2012, RETINA-J RET VIT DIS, V32, P152, DOI 10.1097/IAE.0b013e31821502e1; Barrett L, 2012, AIDS REV, V14, P159; Bigelow CE, 2007, J OPT SOC AM A, V24, P1327, DOI 10.1364/JOSAA.24.001327; Burns SA, 2007, J OPT SOC AM A, V24, P1313, DOI 10.1364/JOSAA.24.001313; Choi John Y., 2005, International Ophthalmology Clinics, V45, P143, DOI 10.1097/01.iio.0000176354.56990.f5; DREHER AW, 1989, APPL OPTICS, V28, P804, DOI 10.1364/AO.28.000804; Falkenstein I, 2006, RETINA-J RET VIT DIS, V26, P928, DOI 10.1097/01.iae.0000250009.60908.35; Falkenstein IA, 2008, AM J OPHTHALMOL, V146, P579, DOI 10.1016/j.ajo.2007.12.021; Fernandez EJ, 2008, OPT EXPRESS, V16, P11083, DOI 10.1364/OE.16.011083; Freeman WR, 2008, AM J OPHTHALMOL, V145, P453, DOI 10.1016/j.ajo.2007.10.013; Gabrielian A, 2013, JAMA OPHTHALMOL, V131, P255, DOI 10.1001/jamaophthalmol.2013.579; GEIER SA, 1994, INVEST OPHTH VIS SCI, V35, P3011; Goldbaum MH, 2011, GRAEF ARCH CLIN EXP, V249, P491, DOI 10.1007/s00417-010-1511-x; Goldbaum Michael H, 2008, Trans Am Ophthalmol Soc, V106, P196; Guex-Crosier Y, 1999, DOC OPHTHALMOL, V97, P297, DOI 10.1023/A:1002130005227; Gupta P, 2013, INVEST OPHTH VIS SCI, V54, P7968, DOI 10.1167/iovs.13-12436; Habot-Wilner Z, 2011, EYE, V25, P1064, DOI 10.1038/eye.2011.125; Hermann B, 2004, OPT LETT, V29, P2142, DOI 10.1364/OL.29.002142; Iester M, 2015, EUR J OPHTHALMOL; Kalyani PS, 2012, AM J OPHTHALMOL, V153, P734, DOI 10.1016/j.ajo.2011.09.019; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Kozak Igor, 2007, Trans Am Ophthalmol Soc, V105, P111; Kozak I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074712; Kozak I, 2012, OCUL IMMUNOL INFLAMM, V20, P342, DOI 10.3109/09273948.2012.694552; Kurup SP, 2014, RETINA-J RET VIT DIS, V34, P2233, DOI 10.1097/IAE.0000000000000218; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Lombardo M, 2012, OPHTHALMOLOGY, V119, P1498, DOI 10.1016/j.ophtha.2012.03.019; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Moschos MM, 2011, CLIN EXP OPTOM, V94, P291, DOI 10.1111/j.1444-0938.2011.00603.x; Moschos MM, 2007, OCUL IMMUNOL INFLAMM, V15, P319, DOI 10.1080/09273940701375154; Mrejen S, 2014, OPHTHALMOLOGY, V121, P545, DOI 10.1016/j.ophtha.2013.09.026; Mueller AJ, 1997, AM J OPHTHALMOL, V124, P158, DOI 10.1016/S0002-9394(14)70780-9; MUTLUKAN E, 1992, EYE, V6, P39, DOI 10.1038/eye.1992.6; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Pathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073694; QUICENO JI, 1992, AM J OPHTHALMOL, V113, P8, DOI 10.1016/S0002-9394(14)75745-9; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Sample PA, 1999, ARCH OPHTHALMOL-CHIC, V117, P755; Shah KH, 2006, AM J OPHTHALMOL, V142, P284, DOI 10.1016/j.ajo.2006.03.046; Sim DA, 2014, INVEST OPHTH VIS SCI, V55, P417, DOI 10.1167/iovs.13-12677; Sommerhalder J, 1998, VISION RES, V38, P3441, DOI 10.1016/S0042-6989(98)00011-X; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Spaide RF, 2012, OPHTHALMOLOGY, V119, P2203, DOI 10.1016/j.ophtha.2012.09.009; Tojo N, 2013, CLIN OPHTHALMOL, V7, P203, DOI 10.2147/OPTH.S39879; Zawadzki RJ, 2005, OPT EXPRESS, V13, P8532, DOI 10.1364/OPEX.13.008532; Zawadzki RJ, 2008, OPT EXPRESS, V16, P8126, DOI 10.1364/OE.16.008126; Zhang Y, 2006, OPT EXPRESS, V14, P4380, DOI 10.1364/OE.14.004380	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132996	10.1371/journal.pone.0132996	http://dx.doi.org/10.1371/journal.pone.0132996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244973	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400030
J	Aryal, KK; Mehata, S; Neupane, S; Vaidya, A; Dhimal, M; Dhakal, P; Rana, S; Bhusal, CL; Lohani, GR; Paulin, FH; Garg, RM; Guthold, R; Cowan, M; Riley, LM; Karki, KB				Aryal, Krishna Kumar; Mehata, Suresh; Neupane, Sushhama; Vaidya, Abhinav; Dhimal, Meghnath; Dhakal, Purushottam; Rana, Sangeeta; Bhusal, Chop Lal; Lohani, Guna Raj; Paulin, Frank Herbert; Garg, Renu Madanlal; Guthold, Regina; Cowan, Melanie; Riley, Leanne Margaret; Karki, Khem Bahadur			The Burden and Determinants of Non Communicable Diseases Risk Factors in Nepal: Findings from a Nationwide STEPS Survey	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; PHYSICAL-ACTIVITY; LOW-INCOME; PREVALENCE; OBESITY; DISTRICT; ADULTS; TRENDS	Background World Health Organization (WHO) estimates for deaths attributed to Non Communicable Diseases (NCDs) in Nepal have risen from 51% in 2010 to 60% in 2014. This study assessed the distribution and determinants of NCD risk factors among the Nepalese adult population. Methods and Findings A nationally representative cross-sectional survey was conducted from Jan to June 2013 on the prevalence of NCD risk factors using the WHO NCD STEPS instrument. A multistage cluster sampling method was used to randomly select the 4,200 respondents. The adjusted prevalence ratio (APR) was used to assess the determinants of NCD risk factors using a Poisson regression model. The prevalence of current smoking (last 30 days) was 19% (95% CI: 16.6-20.6), and harmful alcohol consumption (>= 60 g of pure alcohol for men and >= 40 g of pure alcohol for women on an average day) was 2% (95% CI: 1.4-2.9). Almost all (99%, 95% CI: 98.3-99.3) of the respondents consumed less than five servings of fruits and vegetables combined on an average day and 3% (95% CI: 2.7-4.3) had low physical activity. Around 21% (95% CI: 19.3-23.7) were overweight or obese (BMI >= 25). The prevalence of raised blood pressure (SBP >= 140 mm of Hg or DBP >= 90 mm of Hg) and raised blood glucose (fasting blood glucose >= 126 mg/dl), including those on medication were 26% (95% CI: 23.6-28.0) and 4% (95% CI: 2.9-4.5) respectively. Almost one quarter of respondents, 23% (95% CI: 20.5-24.9), had raised total cholesterol (total cholesterol >= 190 mg/dl or under current medication for raised cholesterol). he study revealed a lower prevalence of smoking among women than men (APR: 0.30; 95% CI: 0.25-0.36), and in those who had higher education levels compared to those with no formal education (APR: 0.39; 95% CI: 0.26-0.58). Harmful alcohol use was also lower in women than men (APR: 0.26; 95% CI: 0.14-0.48), and in Terai residents compared to hill residents (APR: 0.16; 95% CI: 0.07-0.36). Physical inactivity was lower among women than men (APR: 0.55; 95% CI: 0.38-0.80), however women were significantly more overweight and obese (APR: 1.19; 95% CI: 1.02-1.39). Being overweight or obese was significantly less prevalent in mountain residents than in hill residents (APR: 0.41; 95% CI: 0.21-0.80), and in rural compared to urban residents (APR: 1.39; 95% CI: 1.15-1.67). Lower prevalence of raised blood pressure was observed among women than men (APR: 0.69; 95% CI: 0.60-0.80). Higher prevalence of raised blood glucose was observed among urban residents compared to rural residents (APR: 2.05; 95% CI: 1.29-3.25). A higher prevalence of raised total cholesterol was observed among the respondents having higher education levels compared to those respondents having no formal education (APR: 1.76; 95% CI: 1.35-2.28). Conclusion The prevalence of low fruit and vegetable consumption, overweight and obesity, raised blood pressure and raised total cholesterol is markedly high among the Nepalese population, with variation by demographic and ecological factors and urbanization. Prevention, treatment and control of NCDs and their risk factors in Nepal is an emerging public health problem in the country, and targeted interventions with a multi-sectoral approach need to be urgently implemented.	[Aryal, Krishna Kumar; Neupane, Sushhama; Dhimal, Meghnath; Dhakal, Purushottam; Rana, Sangeeta; Karki, Khem Bahadur] Govt Nepal, Nepal Hlth Res Council, Kathmandu, Nepal; [Mehata, Suresh] Govt Nepal, Minist Hlth & Populat, Nepal Hlth Sect Support Programme, Kathmandu, Nepal; [Vaidya, Abhinav] Kathmandu Med Coll, Kathmandu, Nepal; [Bhusal, Chop Lal] Tribhuvan Univ Teaching Hosp, Inst Med, Kathmandu, Nepal; [Lohani, Guna Raj] Govt Nepal, Minist Hlth & Populat, Kathmandu, Nepal; [Paulin, Frank Herbert] WHO, Country Off, Kathmandu, Nepal; [Garg, Renu Madanlal] WHO, Reg Off South East Asia, New Delhi, India; [Guthold, Regina; Cowan, Melanie; Riley, Leanne Margaret] World Hlth Org Headquarter, Geneva, Switzerland	Tribhuvan University; Institute of Medicine (IoM) - Nepal; World Health Organization; World Health Organization; World Health Organization	Aryal, KK (corresponding author), Govt Nepal, Nepal Hlth Res Council, Kathmandu, Nepal.	krish.aryal@gmail.com	Karki, Khem/AAM-8242-2021; Guthold, Regina/AAD-9998-2021; Dhimal, Meghnath/AAD-7261-2021	Guthold, Regina/0000-0003-3073-6468; Dhimal, Meghnath/0000-0001-7176-7821; Karki, Khem/0000-0002-4318-1126; Dhakal, Purushottam/0000-0002-9882-6892	Government of Nepal; WHO Country Office Nepal	Government of Nepal; WHO Country Office Nepal	This study was funded by Government of Nepal and WHO Country Office Nepal.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], VEG PROD CONS NEP; [Anonymous], 2012, AUSTR HLTH SURV 1 RE; Aryal K.K., 2014, NONC DIS RISK FACT S; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bhagyalaxmi A, 2013, J HEALTH POPUL NUTR, V31, P78; Bhandari GP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-23; CBS, 2012, NAT POP HOUS CENS 20; Dhital R, 2001, ALCOHOL DRUG USE NEP; DoHS, 2013, ANN REP DEP HLTH SER; Estero-Botaro A, 2014, LECT NOTES COMPUT SC, V8763, P1, DOI 10.1007/978-3-662-44857-1_1; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; IDF, 2014, S E AS DIAB ATL; Jayawardena R, 2013, OBESITY FACTS, V6, P405, DOI 10.1159/000355598; Karki KB, 2008, WHO STEPS SURVEILLAN; Khan FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056008; Kinra S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4974; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Msyamboza KP, 2012, INT HEALTH, V4, P246, DOI 10.1016/j.inhe.2012.09.005; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; Neupane D, 2013, J Nepal Health Res Counc, V11, P225; NHS (National Health Service) Information Centre, 2012, STAT OB PHYS ACT DIE; Oli N, 2013, EPIDEMIOLOGY RES INT, V2013; Organization WH, 2016, GLOBAL STATUS REPORT; Pham LH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-291; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Vaidya A, 2013, J KATHMANDU MED COLL, V2, P3; Vaidya A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-39; Vaidya Abhinav, 2012, Indian Heart J, V64, P128, DOI 10.1016/S0019-4832(12)60045-5; Vaidya A, 2010, INT J ENV RES PUB HE, V7, P2726, DOI 10.3390/ijerph7062726; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, NONC DIS RISK FACT S; WHO, 2015, GLOB REC PHYS ACT HL; WHO HPA, 2014, WHO STEPS SURV RISK; World Health Organization, 2014, STEPS INSTR SUPP MAT; World Health Organization, 2011, NONCOMMUNICABLE DIS; World Health Organization, 2014, STEPS MAN; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization (WHO), 2015, PHYS ACTIVITY	46	138	138	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134834	10.1371/journal.pone.0134834	http://dx.doi.org/10.1371/journal.pone.0134834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244512	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400109
J	Kamphuis, CBM; Jansen, T; Mackenbach, JP; van Lenthe, FJ				Kamphuis, Carlijn B. M.; Jansen, Tessa; Mackenbach, Johan P.; van Lenthe, Frank J.			Bourdieu's Cultural Capital in Relation to Food Choices: A Systematic Review of Cultural Capital Indicators and an Empirical Proof of Concept	PLOS ONE			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC INEQUALITIES; LIFE-STYLES; NUTRITION KNOWLEDGE; HUMAN-VALUES; SOCIAL-CLASS; CONSUMPTION; VALIDITY; DIET; QUESTIONNAIRE	Objective Unhealthy food choices follow a socioeconomic gradient that may partly be explained by one's 'cultural capital', as defined by Bourdieu. We aim 1) to carry out a systematic review to identify existing quantitative measures of cultural capital, 2) to develop a questionnaire to measure cultural capital for food choices, and 3) to empirically test associations of socioeconomic position with cultural capital and food choices, and of cultural capital with food choices. Design We systematically searched large databases for the key-word 'cultural capital' in title or abstract. Indicators of objectivised cultural capital and family institutionalised cultural capital, as identified by the review, were translated to food choice relevant indicators. For incorporated cultural capital, we used existing questionnaires that measured the concepts underlying the variety of indicators as identified by the review, i.e. participation, skills, knowledge, values. The questionnaire was empirically tested in a postal survey completed by 2,953 adults participating in the GLOBE cohort study, The Netherlands, in 2011. Results The review yielded 113 studies that fulfilled our inclusion criteria. Several indicators of family institutionalised (e.g. parents' education completed) and objectivised cultural capital (e.g. possession of books, art) were consistently used. Incorporated cultural capital was measured with a large variety of indicators (e.g. cultural participation, skills). Based on this, we developed a questionnaire to measure cultural capital in relation to food choices. An empirical test of the questionnaire showed acceptable overall internal consistency (Cronbach's alpha of .654; 56 items), and positive associations between socioeconomic position and cultural capital, and between cultural capital and healthy food choices. Conclusions Cultural capital may be a promising determinant for (socioeconomic inequalities in) food choices.	[Kamphuis, Carlijn B. M.; Jansen, Tessa; Mackenbach, Johan P.; van Lenthe, Frank J.] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kamphuis, CBM (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands.	c.b.m.kamphuis@uu.nl			Healthy Nutrition program of the Netherlands Organisation for Health Research and Development	Healthy Nutrition program of the Netherlands Organisation for Health Research and Development	This work was supported by the Healthy Nutrition program of the Netherlands Organisation for Health Research and Development (http://www.zonmw.nl/en/programmes/healthy-nutrition/programme/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Abel T., 2007, HLTH MODERNITY, P43; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; [Anonymous], 1984, DISTINCTION SOCIAL C; Aschaffenburg K, 1997, AM SOCIOL REV, V62, P573, DOI 10.2307/2657427; Bambra C, 2010, J EPIDEMIOL COMMUN H, V64, P284, DOI 10.1136/jech.2008.082743; Bilsky W, 2011, J CROSS CULT PSYCHOL, V42, P759, DOI 10.1177/0022022110362757; Blasius J, 2008, POETICS, V36, P24, DOI 10.1016/j.poetic.2007.12.001; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Bourdieu P, 2010, DISTIONCTION A SOCIA; Caraher M., 1999, British Food Journal, V101, P590, DOI 10.1108/00070709910288289; Chew LD, 2004, FAM MED, V36, P588; Christensen VT, 2011, SOC SCI MED, V72, P469, DOI 10.1016/j.socscimed.2010.11.037; Cockerham WC, 2005, J HEALTH SOC BEHAV, V46, P51, DOI 10.1177/002214650504600105; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; de Almeida JF, 2006, PORT J SOC SCI, V5, P95, DOI 10.1386/pjss.5.2.95/1; de Boer J, 2007, FOOD QUAL PREFER, V18, P985, DOI 10.1016/j.foodqual.2007.04.002; Dreezens E, 2005, APPETITE, V44, P115, DOI 10.1016/j.appet.2004.07.003; Drewnowski A, 1999, AM J CLIN NUTR, V70, P28; Droomers M, 2004, SOC SCI MED, V58, P2023, DOI 10.1016/S0277-9536(03)00411-8; ESS, 2011, DOCUMENTATION REPORT; Giskes K, 2006, PUBLIC HEALTH NUTR, V9, P75, DOI 10.1079/PHN2005758; Giskes K, 2006, TOB CONTROL, V15, P485, DOI 10.1136/tc.2006.015750; Grootaert C., 2004, MEASURING SOCIAL CAP, DOI DOI 10.1007/978-90-481-9606-7_3; Khawaja M, 2007, CHILD CARE HLTH DEV, V33, P117, DOI 10.1111/j.1365-2214.2006.00660.x; Khawaja M, 2007, SCAND J PUBLIC HEALT, V35, P475, DOI 10.1080/14034940701256958; Khawaja M, 2006, J URBAN HEALTH, V83, P444, DOI 10.1007/s11524-006-9051-8; Lamont M., 1988, SOCIOL THEOR, V6, P153, DOI DOI 10.2307/202113; Lareau A, 1999, SOCIOL EDUC, V72, P37, DOI 10.2307/2673185; Lareau A, 2003, THEOR SOC, V32, P567, DOI 10.1023/B:RYSO.0000004951.04408.b0; Lynch J, 2004, MILBANK Q, V82, P355, DOI 10.1111/j.0887-378X.2004.00312.x; MacIntyre S, 1997, SOC SCI MED, V44, P723, DOI 10.1016/S0277-9536(96)00183-9; MACKENBACH JP, 1994, SOC SCI MED, V38, P299, DOI 10.1016/0277-9536(94)90399-9; Maria Kamphuis CB, 2008, MED SCI SPORT EXER, V40, P71, DOI 10.1249/mss.0b013e318158e467; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Parmenter K, 1999, EUR J CLIN NUTR, V53, P298, DOI 10.1038/sj.ejcn.1600726; Scholderer J, 2004, APPETITE, V42, P197, DOI 10.1016/j.appet.2003.11.005; Schwartz SH, 2000, J CROSS CULT PSYCHOL, V31, P465, DOI 10.1177/0022022100031004003; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Schwartz SH, 2001, J CROSS CULT PSYCHOL, V32, P519, DOI 10.1177/0022022101032005001; SCHWARTZ SH, 1987, J PERS SOC PSYCHOL, V53, P550, DOI 10.1037/0022-3514.53.3.550; Shim JK, 2010, J HEALTH SOC BEHAV, V51, P1, DOI 10.1177/0022146509361185; Singh-Manoux A, 2005, SOC SCI MED, V60, P2129, DOI 10.1016/j.socscimed.2004.08.070; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Turrell G, 2006, PUBLIC HEALTH NUTR, V9, P375, DOI 10.1079/PHN2006850; Van Berkel-Van Schaik AB, 1990, TOWARDS A STANDARD O; van der Horst KD, 2011, PUBLIC HEALTH NUTR, V14, P239, DOI 10.1017/S1368980010002624; van Genugten L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-649; van Lenthe FJ, 2004, EUR J PUBLIC HEALTH, V14, P63, DOI 10.1093/eurpub/14.1.63; van Lenthe FJ, 2013, INT J EPIDEMIOL; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; Veenstra G, 2007, HEALTH PLACE, V13, P14, DOI 10.1016/j.healthplace.2005.09.011; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; WILLIAMS SJ, 1995, SOCIOL HEALTH ILL, V17, P577, DOI 10.1111/1467-9566.ep10932093; World Health Organization, 2003, DIET NUTRITION AND T	56	35	37	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0130695	10.1371/journal.pone.0130695	http://dx.doi.org/10.1371/journal.pone.0130695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244763	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400007
J	Kernaleguen, L; Cherel, Y; Knox, TC; Baylis, AMM; Arnould, JPY				Kernaleguen, Laetitia; Cherel, Yves; Knox, Travis C.; Baylis, Alastair M. M.; Arnould, John P. Y.			Sexual Niche Segregation and Gender-Specific Individual Specialisation in a Highly Dimorphic Marine Mammal	PLOS ONE			English	Article							AUSTRALIAN FUR SEALS; ARCTOCEPHALUS-PUSILLUS-DORIFERUS; STABLE-ISOTOPES; FORAGING SPECIALIZATION; TEMPORAL VARIATION; ECOLOGICAL CAUSES; SIZE DIMORPHISM; DIVING BEHAVIOR; SOUTHERN-OCEAN; GROWTH-RATES	While sexual segregation is expected in highly dimorphic species, the local environment is a major factor driving the degree of resource partitioning within a population. Sexual and individual niche segregation was investigated in the Australian fur seal (Arctocephalus pusillus doriferus), which is a benthic foraging species restricted to the shallow continental shelf region of south-eastern Australia. Tracking data and the isotopic values of plasma, red blood cells and whiskers were combined to document spatial and dietary niche segregation throughout the year. Tracking data indicated that, in winter, males and females overlapped in their foraging habitat. All individuals stayed within central Bass Strait, relatively close (< 220 km) to the breeding colony. Accordingly, both genders exhibited similar plasma and red cell delta C-13 values. However, males exhibited greater delta C-13 intra-individual variation along the length of their whisker than females. This suggests that males exploited a greater diversity of foraging habitats throughout the year than their female counterparts, which are restricted in their foraging grounds by the need to regularly return to the breeding colony to suckle their pup. The degree of dietary sexual segregation was also surprisingly low, both sexes exhibiting a great overlap in their delta N-15 values. Yet, males displayed higher delta N-15 values than females, suggesting they fed upon a higher proportion of higher trophic level prey. Given that males and females exploit different resources (mainly foraging habitats), the degree of individual specialisation might differ between the sexes. Higher degrees of individual specialisation would be expected in males which exploit a greater range of resources. However, comparable levels of inter-individual variation in delta N-15 whisker values were found in the sampled males and females, and, surprisingly, all males exhibited similar seasonal and inter-annual variation in their delta C-13 whisker values, suggesting they all followed the same general dispersion pattern throughout the year.	[Kernaleguen, Laetitia; Knox, Travis C.; Baylis, Alastair M. M.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Cherel, Yves] Univ La Rochelle, Ctr Etud Biol Chize, CNRS, UMR 7372, Villiers En Bois, France; [Baylis, Alastair M. M.] South Atlantic Environm Res Inst, FIQQ1ZZ, Stanley, Hong Kong, Peoples R China	Deakin University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Kernaleguen, L (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	lkernale@deakin.edu.au	Baylis, Alastair/H-9471-2019	Baylis, Alastair/0000-0002-5167-0472	Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment	The research was financially supported by the Winifred Violet Scott Charitable Trust and the Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2002, AUST J ZOOL, V50, P53, DOI 10.1071/ZO01077; Arnould JPY, 2002, J ZOOL, V256, P351, DOI 10.1017/S0952836902000389; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Baylis AMM, 2015, MAR MAMMAL SCI, V31, P322, DOI 10.1111/mms.12148; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bonner W.N., 1984, Symposia of the Zoological Society of London, P253; Boyd IL, 2002, J APPL ECOL, V39, P103, DOI 10.1046/j.1365-2664.2002.00697.x; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campagna C, 2001, J ZOOL, V255, P205, DOI 10.1017/S0952836901001285; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Davenport SR, 2002, CAN J FISH AQUAT SCI, V59, P514, DOI 10.1139/F02-031; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Evangelista C, 2014, J ANIM ECOL, V83, P1025, DOI 10.1111/1365-2656.12208; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Franco-Trecu V, 2014, MAR BIOL, V161, P609, DOI 10.1007/s00227-013-2363-9; GIBBS CF, 1992, EMU, V91, P395, DOI 10.1071/MU9910395; Herrera LG, 2008, J MAMMAL, V89, P1184, DOI 10.1644/07-MAMM-A-263.1; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; Hindell MA, 1997, MAR MAMMAL SCI, V13, P219, DOI 10.1111/j.1748-7692.1997.tb00629.x; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hoskins AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117997; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Kamilar JM, 2008, BEHAVIOUR, V145, P1211, DOI 10.1163/156853908785387601; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kernaleguen L, 2016, OECOLOGIA, V180, P657, DOI 10.1007/s00442-015-3407-2; Kernaleguen L, 2015, J ANIM ECOL, V84, P1081, DOI 10.1111/1365-2656.12347; Kernaleguen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032916; Kirkwood R, 2006, CAN J ZOOL, V84, P1781, DOI 10.1139/Z06-164; Kirkwood R, 2010, MAR FRESHWATER RES, V61, P695, DOI 10.1071/MF09213; Knox TC, 2014, MAR MAMMAL SCI, V30, P763, DOI 10.1111/mms.12078; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; LEWIS RK, 1981, AUST J MAR FRESH RES, V32, P843; Littnan CL, 2007, MAR ECOL PROG SER, V338, P257, DOI 10.3354/meps338257; Longhlin TR, 1999, UASGCP REP, V99, P615; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Mysterud A, 2000, OECOLOGIA, V124, P40, DOI 10.1007/s004420050023; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rea LD, 2015, MARINE MAMMAL SCI; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; ROUGHGARDEN J, 1974, AM NAT, V108, P429, DOI 10.1086/282924; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Shaughnessy PD, 1984, 51 NOAA NMFS; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Smith EAE, 2015, OECOLOGIA, V178, P17, DOI 10.1007/s00442-014-3206-1; Staniland Iain J., 2005, P53; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Sterling JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093068; Svanback R, 2005, EVOL ECOL RES, V7, P993; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vales DG, 2015, MAR ECOL PROG SER, V525, P245, DOI 10.3354/meps11214; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Warneke R.M., 1985, P53; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zaccarelli N, 2013, METHODS ECOL EVOL, V4, P1018, DOI 10.1111/2041-210X.12079	78	36	35	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133018	10.1371/journal.pone.0133018	http://dx.doi.org/10.1371/journal.pone.0133018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244371	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400031
J	Klippel, AH; Oliveira, PV; Britto, KB; Freire, BF; Moreno, MR; dos Santos, AR; Banhos, A; Paneto, GG				Klippel, Angelica H.; Oliveira, Pablo V.; Britto, Karollini B.; Freire, Barbara F.; Moreno, Marcel R.; dos Santos, Alexandre R.; Banhos, Aureo; Paneto, Greiciane G.			Using DNA Barcodes to Identify Road-Killed Animals in Two Atlantic Forest Nature Reserves, Brazil	PLOS ONE			English	Article							ESPIRITO-SANTO; STATE; IDENTIFICATION; BIODIVERSITY; MORTALITY; DISCOVERY; ABUNDANCE; SPECIMEN; PRIMERS; BATS	Road mortality is the leading source of biodiversity loss in the world, especially due to fragmentation of natural habitats and loss of wildlife. The survey of the main species victims of roadkill is of fundamental importance for the better understanding of the problem, being necessary, for this, the correct species identification. The aim of this study was to verify if DNA barcodes can be applied to identify road-killed samples that often cannot be determined morphologically. For this purpose, 222 vertebrate samples were collected in a stretch of the BR-101 highway that crosses two Discovery Coast Atlantic Forest Natural Reserves, the Sooretama Biological Reserve and the Vale Natural Reserve, in Espirito Santo, Brazil. The mitochondrial COI gene was amplified, sequenced and confronted with the BOLD database. It was possible to identify 62.16% of samples, totaling 62 different species, including Pyrrhura cruentata, Chaetomys subspinosus, Puma yagouaroundi and Leopardus wiedii considered Vulnerable in the National Official List of Species of Endangered Wildlife. The most commonly identified animals were a bat (Molossus molossus), an opossum (Didelphis aurita) and a frog (Trachycephalus mesophaeus) species. Only one reptile was identified using the technique, probably due to lack of reference sequences in BOLD. These data may contribute to a better understanding of the impact of roads on species biodiversity loss and to introduce the DNA barcode technique to road ecology scenarios.	[Klippel, Angelica H.; Oliveira, Pablo V.; Britto, Karollini B.; Freire, Barbara F.; dos Santos, Alexandre R.; Banhos, Aureo; Paneto, Greiciane G.] Univ Fed Espirito Santo, Ctr Agr Sci, BR-29500000 Alegre, Espirito Santo, Brazil; [Moreno, Marcel R.] Chico Mendes Inst Biodivers Conservat, Sooretama Biol Reserve, Linhares, Espirito Santo, Brazil	Universidade Federal do Espirito Santo	Paneto, GG (corresponding author), Univ Fed Espirito Santo, Ctr Agr Sci, Alto Univ S-N, BR-29500000 Alegre, Espirito Santo, Brazil.	greiciane.paneto@ufes.br	Santos, Alexandre Rosa dos/J-5983-2019; Paneto, Greiciane/Q-6489-2019; Paneto, Greiciane G/I-1242-2012; Viana Oliveira, Pablo/D-5689-2015	Santos, Alexandre Rosa dos/0000-0003-2617-9451; Viana Oliveira, Pablo/0000-0002-1785-178X; Hollunder Klippel, Angelica/0000-0002-4376-6626	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [475862/2012-0]; Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo - FAPES [61901857/13]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo - FAPES	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (grant number 475862/2012-0; www.cnpq.br) and the Fundacao de Amparo a Pesquisa e Inovacao do Espirito Santo - FAPES (grant number 61901857/13; www.fapes.es.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Antonio de Padua, 2011, Check List, V7, P542; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Chaves BRN, 2015, MOL ECOL RESOUR, V15, P921, DOI 10.1111/1755-0998.12344; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Chithravel Vadivalagan, 2012, African Journal of Biotechnology, V11, P14433; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021460; da Rosa CA, 2012, J ENVIRON MANAGE, V97, P1, DOI 10.1016/j.jenvman.2011.11.004; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Ecosystem Environmental Consulting, 2009, REL AV EC RAP SEG VE; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Glista DJ, 2008, HERPETOL CONSERV BIO, V3, P77; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hawkins MA, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1540.1.3; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hobday AJ, 2008, WILDLIFE RES, V35, P712, DOI 10.1071/WR08067; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Instituto Brasileiro de Desenvolvimento Florestal, 1981, PLAN MAN RES BIOL SO; Isler Morton L., 1997, Ornithological Monographs, V48, P355; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Ivanova NV, 2009, MOL ECOL RESOUR, V9, P35, DOI 10.1111/j.1755-0998.2009.02630.x; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Lacerda DR., 2007, Braz. J. Biol., V67, P873, DOI 10.1590/S1519-69842007000500010; Lorenzutti Ricardo, 2006, Boletim do Museu de Biologia Mello Leitao Nova Serie, V19, P59; Luz J. L., 2009, CHECK LIST, V4, P364, DOI DOI 10.15560/5.2.364; Mendes Poliana, 2009, Boletim do Museu de Biologia Mello Leitao Nova Serie, V25, P87; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Moreira Danielle de Oliveira, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000200017; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y; PERACCHI AL, 2011, CHIROPTERA NEOTROPIC, V17, P842; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Sanches Alexandra, 2012, Investig Genet, V3, P17, DOI 10.1186/2041-2223-3-17; SAVAGE JM, 1995, BIOSCIENCE, V45, P673, DOI 10.2307/1312672; Scudeller VV, 2001, PLANT ECOL, V152, P185, DOI 10.1023/A:1011494228661; Serpa GA, 2009, ATUAL ORNITOL ON LIN, V151, P39; Simon JE., 2009, 17 C BRAS ORN AR ES; TONINI JFR, 2011, HEPATOL NOTES, V4, P435; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; United Nations Educational Scientific and Cultural Organization, 1999, CONV PROT WORLD CULT; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Willis Edwin O., 2002, Pap. Avulsos Zool. (São Paulo), V42, P193, DOI 10.1590/S0031-10492002000900001; Xia Y, 2012, MOL ECOL RESOUR, V12, P48, DOI 10.1111/j.1755-0998.2011.03055.x	53	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134877	10.1371/journal.pone.0134877	http://dx.doi.org/10.1371/journal.pone.0134877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244644	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400118
J	Caldas, GFR; Oliveira, ARD; Araujo, AV; Lafayette, SSL; Albuquerque, GS; Silva-Neto, JD; Costa-Silva, JH; Ferreira, F; da Costa, JGM; Wanderley, AG				Rocha Caldas, Germana Freire; da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Lopes Lafayette, Simone Sette; Albuquerque, Giwellington Silva; Silva-Neto, Jacinto da Costa; Costa-Silva, Joao Henrique; Ferreira, Fabiano; Martins da Costa, Jose Galberto; Wanderley, Almir Goncalves			Gastroprotective Mechanisms of the Monoterpene 1,8-Cineole (Eucalyptol)	PLOS ONE			English	Article							GASTRIC-MUCOSAL INJURY; ACID-SECRETION; NITRIC-OXIDE; RATS; ULCER; PROSTAGLANDINS; PROLIFERATION; CONSTITUENTS; PATHOGENESIS; SULFHYDRYLS	Recently, our research group identified and reported 1,8-cineole (CIN), a monoterpene that naturally occur in many aromatic plants, as one of the major constituent of the essential oil from leaves of Hyptis martiusii (EOHM), as well as characterized the gastroprotective action of this oil. The aim of this study was to investigate the mechanisms of action involved in the antiulcer and healing activity of CIN, in order to confirm its correlation with the gastroprotective effect of EOHM. Wistar rats were exposed to different protocols (acute ulceration, gastrointestinal motility and antisecretory activity). In addition, were determinated the involvement of nitric oxide and sulphydryl groups; the levels of gastric mucus, lipid peroxidation, sulphydryl groups and myeloperoxidase activity. The healing ability was evaluated by acetic acid-induced chronic ulcer and histological and immunohistochemical analysis (PCNA, Ki-67 and BrdU). The treatment with CIN inhibited ethanol-, ethanol/HCl-and indomethacin-induced gastric lesions. The highest doses of CIN inhibited gastric emptying, but did not affect intestinal transit. CIN (100 mg/kg) reduced the volume of basal but not stimulated acid secretion. CIN increased levels of mucus (89.3%), prevented depletion of -SH groups (62.6%) and reduced the level of lipid peroxidation (55.3%) and myeloperoxidase activity (59.4%) in the gastric mucosa. In chronic ulcer model, CIN reduced in 43.1% the gastric area lesion, promoted significant regeneration and restoration of the levels of mucus in glandular cells as confirmed by histological analysis; and promoted increase in cell proliferation as evidenced by reactivity for PCNA, Ki-67 and BrdU. This findings demonstrate the role of 1,8-cineole as an important ulcer healing agent and indicate the involvement of antioxidant and cytoprotective mechanisms in the gastroprotective effect of compound. This study also provides evidence that 1,8-cineole is related to the gastroprotective effect of the essential oil of Hyptis martiusii.	[Rocha Caldas, Germana Freire; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Pharmaceut Sci, BR-50740521 Recife, PE, Brazil; [da Silva Oliveira, Alisson Rodrigo; Araujo, Alice Valenca; Lopes Lafayette, Simone Sette; Ferreira, Fabiano; Wanderley, Almir Goncalves] Univ Fed Pernambuco, Dept Physiol & Pharmacol, BR-50670901 Recife, PE, Brazil; [Albuquerque, Giwellington Silva; Silva-Neto, Jacinto da Costa] Univ Fed Pernambuco, Dept Histol & Embryol, BR-50670901 Recife, PE, Brazil; [Costa-Silva, Joao Henrique] Univ Fed Pernambuco, Dept Phys Educ & Sport Sci, BR-55608680 Vitoria De Santo Antao, PE, Brazil; [Martins da Costa, Jose Galberto] Univ Reg Cariri, Dept Biol Chem, BR-63105000 Crato, CE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Regional do Cariri	Wanderley, AG (corresponding author), Univ Fed Pernambuco, Dept Pharmaceut Sci, BR-50740521 Recife, PE, Brazil.	almirgw@globo.com	WANDERLEY, ALMIR GONÇALVES/T-3087-2019; Costa-Silva, João Henrique/D-1372-2014; Costa, Jose Galberto/L-6022-2016; Costa, Jose Galberto Martins/AFP-6381-2022	WANDERLEY, ALMIR GONÇALVES/0000-0001-5193-1153; Costa-Silva, João Henrique/0000-0002-9794-1418; Costa, Jose Galberto/0000-0002-0730-7246; Costa, Jose Galberto Martins/0000-0003-4268-663X; Albuquerque, Giwellington/0000-0001-6610-963X	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE [APQ-0591-4.03/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq from GFRC [554207/2010-9]	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq from GFRC(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE, project no.: APQ-0591-4.03/10) http://www.facepe.br/; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq Grants doctoral scholarship from GFRC (process no.: 554207/2010-9), http://www.cnpq.br/.	AHMAD A, 1994, PHYTOCHEMISTRY, V37, P183, DOI 10.1016/0031-9422(94)85021-6; Al Mofleh IA, 2010, WORLD J GASTROENTERO, V16, P2710, DOI 10.3748/wjg.v16.i22.2710; ANDREWS FJ, 1994, AM J PHYSIOL, V266, pG48, DOI 10.1152/ajpgi.1994.266.1.G48; Arakawa T, 2012, WORLD J GASTROENTERO, V18, P4811, DOI 10.3748/wjg.v18.i35.4811; Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s; Arrieta J, 2003, PLANTA MED, V69, P905, DOI 10.1055/s-2003-45098; Avila JR, 1996, INFLAMM RES, V45, P83, DOI 10.1007/BF02265120; Balacs T, 1997, INT J AROMATHER, V8, P15, DOI DOI 10.1016/S0962-4562(97)80020-3; Corne S.J., 1974, J PHYSL, V242, P116; Derin N, 1994, CELL BIOCHEM FUNCT, V24, P437; DEYOUNG LM, 1989, AGENTS ACTIONS, V26, P335; DJAHANGUIRI B, 1969, SCAND J GASTROENTERO, V4, P265; Fulop K, 2005, EUR J PHARMACOL, V528, P150, DOI 10.1016/j.ejphar.2005.10.025; GLAVIN GB, 1992, FASEB J, V6, P825, DOI 10.1096/fasebj.6.3.1740232; GUPTA M, 1978, PEDIATRICS, V62, P26; Hussain AI, 2011, LWT-FOOD SCI TECHNOL, V44, P1199, DOI 10.1016/j.lwt.2010.10.005; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; MADYASTHA KM, 1986, B ENVIRON CONTAM TOX, V37, P759, DOI 10.1007/BF01607836; Magalhaes PJC, 1998, PHYTOTHER RES, V12, P172, DOI 10.1002/(SICI)1099-1573(199805)12:3&lt;172::AID-PTR212&gt;3.0.CO;2-E; Matsuda H, 1999, LIFE SCI, V65, pPL27, DOI 10.1016/S0024-3205(99)00241-6; McNeil M, 2011, NAT PROD COMMUN, V6, P1775; MIZUI T, 1983, JPN J PHARMACOL, V33, P939, DOI 10.1254/jjp.33.939; Moteki H, 2002, ONCOL REP, V9, P757; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Nguyen VN, 2000, ACTA HISTOCHEM, V102, P323, DOI 10.1078/S0065-1281(04)70039-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; Repetto MG, 2002, BRAZ J MED BIOL RES, V35, P523, DOI 10.1590/S0100-879X2002000500003; ROBERT A, 1979, GASTROENTEROLOGY, V77, P433; Caldas GFR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084400; Santos FA, 2004, FOOD CHEM TOXICOL, V42, P579, DOI 10.1016/j.fct.2003.11.001; Santos FA, 1998, PHYTOMEDICINE, V5, P115, DOI 10.1016/S0944-7113(98)80007-X; Santos FA, 2001, DIGEST DIS SCI, V46, P331, DOI 10.1023/A:1005604932760; Santos FA, 2001, J PHARM PHARMACOL, V53, P505, DOI 10.1211/0022357011775604; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; STICKNEY JC, 1959, P SOC EXP BIOL MED, V101, P582; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Tanaka J, 2001, EUR J PHARMACOL, V424, P69, DOI 10.1016/S0014-2999(01)01119-0; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Vela SM, 1997, PLANTA MED, V63, P36, DOI 10.1055/s-2006-957599; Vilela GR, 2009, J STORED PROD RES, V45, P108, DOI 10.1016/j.jspr.2008.10.006; Webster AF, 2014, TOXICOLOGY, V323, P26, DOI 10.1016/j.tox.2014.06.002	43	59	64	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134558	10.1371/journal.pone.0134558	http://dx.doi.org/10.1371/journal.pone.0134558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244547	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400089
J	Stevens, G; McCluskey, B; King, A; O'Hearn, E; Mayr, G				Stevens, G.; McCluskey, B.; King, A.; O'Hearn, E.; Mayr, G.			Review of the 2012 Epizootic Hemorrhagic Disease Outbreak in Domestic Ruminants in the United States	PLOS ONE			English	Article							NORTH-DAKOTA; SOUTH-DAKOTA; BLUETONGUE; CATTLE; VIRUS; CERATOPOGONIDAE; EPIDEMIOLOGY; TRANSMISSION; NEBRASKA; DIPTERA	An unusually large number of cases of Epizootic hemorrhagic disease (EHD) were observed in United States cattle and white-tailed deer in the summer and fall of 2012. USDA APHIS Veterinary Services area offices were asked to report on foreign animal disease investigations and state diagnostic laboratory submissions which resulted in a diagnosis of EHD based on positive PCR results. EHD was reported in the following species: cattle (129 herds), captive white-tailed deer (65 herds), bison (8 herds), yak (6 herds), elk (1 herd), and sheep (1 flock). A majority of the cases in cattle and bison were found in Nebraska, South Dakota, and Iowa. The majority of cases in captive white-tailed deer were found in Ohio, Iowa, Michigan, and Missouri. The most common clinical sign observed in the cattle and bison herds was oral lesions. The major observation in captive white-tailed deer herds was death. Average within-herd morbidity was 7% in cattle and bison herds, and 46% in captive white-tailed deer herds. The average within-herd mortality in captive white-tailed deer herds was 42%.	[Stevens, G.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Lincoln, NE 68516 USA; [McCluskey, B.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Ft Collins, CO USA; [King, A.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Jefferson City, MO USA; [O'Hearn, E.; Mayr, G.] Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Foreign Anim Dis Diagnost Lab, Plum Isl, NY USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Stevens, G (corresponding author), Anim & Plant Hlth Inspect Serv, USDA, Vet Serv, Lincoln, NE 68516 USA.	Gary.E.Stevens@aphis.usda.gov	McCluskey, Brian/AAF-8223-2019					Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; Barber T. L., 1975, Proceedings of the Eighteenth Annual Meeting of the American Association of Veterinary Laboratory Diagnosticians, Portland, Oregon, USA., P149; Barnard BJH, 1998, ONDERSTEPOORT J VET, V65, P145; Boyer TC, 2008, AM J VET RES, V69, P1286, DOI 10.2460/ajvr.69.10.1286; Chalmers HNV G.A., 1964, J WILDLIFE DIS, V15, P1; Couvillion C. E., 1981, Proceedings of the United States Animal Health Association, V85, P522; Gard G. P., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P85; Green AL, 2005, AM J VET RES, V66, P853, DOI 10.2460/ajvr.2005.66.853; Holbrook FR, 2000, J MED ENTOMOL, V37, P65, DOI 10.1603/0022-2585-37.1.65; House C, 1998, ANN NY ACAD SCI, V849, P497, DOI 10.1111/j.1749-6632.1998.tb11105.x; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Metcalf H. E., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P222; Nettles V. F., 1992, Bluetongue, African horse sickness, and related orbiviruses: Proceedings of the Second International Symposium., P238; NOAA National Climatic Data Center, STAT CLIM NAT OV ANN; OMORI T, 1969, JPN J MICROBIOL, V13, P139, DOI 10.1111/j.1348-0421.1969.tb00447.x; Savini G, 2011, RES VET SCI, V91, P1, DOI 10.1016/j.rvsc.2011.05.004; Schmidtmann ET, 2011, J MED ENTOMOL, V48, P634, DOI 10.1603/ME10231; SHOPE RE, 1960, J EXP MED, V111, P155, DOI 10.1084/jem.111.2.155; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Van Campen H, 2013, J VET DIAGN INVEST, V25, P443, DOI 10.1177/1040638713485369; Wilson WC, 2009, J VET DIAGN INVEST, V21, P220, DOI 10.1177/104063870902100207; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x	23	34	35	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133359	10.1371/journal.pone.0133359	http://dx.doi.org/10.1371/journal.pone.0133359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244773	gold, Green Published			2022-12-26	WOS:000359061400042
J	Sutton, NB; Atashgahi, S; Saccenti, E; Grotenhuis, T; Smidt, H; Rijnaarts, HHM				Sutton, Nora B.; Atashgahi, Siavash; Saccenti, Edoardo; Grotenhuis, Tim; Smidt, Hauke; Rijnaarts, Huub H. M.			Microbial Community Response of an Organohalide Respiring Enrichment Culture to Permanganate Oxidation	PLOS ONE			English	Article							SITU CHEMICAL OXIDATION; REDUCTIVE DECHLORINATION; BACTERIAL COMMUNITIES; TETRACHLOROETHENE; TRICHLOROETHENE; MANGANESE; BIOREMEDIATION; POPULATIONS; HYDROGEN; ACETATE	While in situ chemical oxidation is often used to remediate tetrachloroethene (PCE) contaminated locations, very little is known about its influence on microbial composition and organohalide respiration (OHR) activity. Here, we investigate the impact of oxidation with permanganate on OHR rates, the abundance of organohalide respiring bacteria (OHRB) and reductive dehalogenase (rdh) genes using quantitative PCR, and microbial community composition through sequencing of 16S rRNA genes. A PCE degrading enrichment was repeatedly treated with low (25 mu mol), medium (50 mu mol), or high (100 mu mol) permanganate doses, or no oxidant treatment (biotic control). Low and medium treatments led to higher OHR rates and enrichment of several OHRB and rdh genes, as compared to the biotic control. Improved degradation rates can be attributed to enrichment of (1) OHRB able to also utilize Mn oxides as a terminal electron acceptor and (2) non-dechlorinating community members of the Clostridiales and Deltaproteobacteria possibly supporting OHRB by providing essential co-factors. In contrast, high permanganate treatment disrupted dechlorination beyond cis-dichloroethene and caused at least a 2-4 orders of magnitude reduction in the abundance of all measured OHRB and rdh genes, as compared to the biotic control. High permanganate treatments resulted in a notably divergent microbial community, with increased abundances of organisms affiliated with Campylobacterales and Oceanospirillales capable of dissimilatory Mn reduction, and decreased abundance of presumed supporters of OHRB. Although OTUs classified within the OHR-supportive order Clostridiales and OHRB increased in abundance over the course of 213 days following the final 100 mu mol permanganate treatment, only limited regeneration of PCE dechlorination was observed in one of three microcosms, suggesting strong chemical oxidation treatments can irreversibly disrupt OHR. Overall, this detailed investigation into dose-dependent changes of microbial composition and activity due to permanganate treatment provides insight into the mechanisms of OHR stimulation or disruption upon chemical oxidation.	[Sutton, Nora B.; Grotenhuis, Tim; Rijnaarts, Huub H. M.] Wageningen Univ, Environm Technol, NL-6700 AP Wageningen, Netherlands; [Atashgahi, Siavash; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Saccenti, Edoardo] Wageningen Univ, Lab Syst & Synthet Biol, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Sutton, NB (corresponding author), Wageningen Univ, Environm Technol, NL-6700 AP Wageningen, Netherlands.	Nora.Sutton@wur.nl	Grotenhuis, Tim/C-3006-2013; Atashgahi, Siavash/H-4024-2019; Sutton, Nora/A-9565-2013; Smidt, Hauke/D-7054-2014; Rijnaarts, Huub/A-4268-2014	Atashgahi, Siavash/0000-0002-2793-2321; Smidt, Hauke/0000-0002-6138-5026; Grotenhuis, Tim/0000-0002-1075-3407; Saccenti, Edoardo/0000-0001-8284-4829; Sutton, Nora B./0000-0002-6504-6371; Rijnaarts, Huub/0000-0001-6607-1256	European Union [226956]; BE-BASIC grant [F08.004.01]	European Union(European Commission); BE-BASIC grant	Funding for NBS, TG and HHMR provided by the European Union's Seventh Framework Program within Theme 6, grant number 226956 (www.upsoil.eu). Additional funding for SA and HS is provided by BE-BASIC grant F08.004.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos BK, 2008, ENVIRON SCI TECHNOL, V42, P5718, DOI 10.1021/es703227g; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brisson VL, 2012, ISME J, V6, P1702, DOI 10.1038/ismej.2012.15; Bunge M, 2008, ENVIRON MICROBIOL, V10, P2670, DOI 10.1111/j.1462-2920.2008.01688.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cummings DE, 1999, ARCH MICROBIOL, V171, P183, DOI 10.1007/s002030050697; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; David MM, 2015, ENVIRON MICROBIOL, V17, P4835, DOI 10.1111/1462-2920.12413; Delgado AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100654; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dogan-Subasi E, 2013, J HAZARD MATER, V262, P598, DOI 10.1016/j.jhazmat.2013.09.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fletcher KE, 2008, APPL ENVIRON MICROB, V74, P6141, DOI 10.1128/AEM.00994-08; Goris T, 2014, ENVIRON MICROBIOL, V16, P3562, DOI 10.1111/1462-2920.12589; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; He JZ, 2008, GEOMICROBIOL J, V25, P14, DOI 10.1080/01490450701829014; He JZ, 2002, ENVIRON SCI TECHNOL, V36, P3945, DOI 10.1021/es025528d; He JZ, 2003, APPL ENVIRON MICROB, V69, P996, DOI 10.1128/AEM.69.2.996-1003.2003; HOLLIGER C, 1993, APPL ENVIRON MICROB, V59, P2991, DOI 10.1128/AEM.59.9.2991-2997.1993; Hrapovic L, 2005, ENVIRON SCI TECHNOL, V39, P2888, DOI 10.1021/es049017y; Hug LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-327; Keijzer T, 2006, SITU SOIL GROUNDWATE; Knight VK, 1999, FEMS MICROBIOL ECOL, V29, P137, DOI 10.1111/j.1574-6941.1999.tb00605.x; Kotik M, 2013, SCI TOTAL ENVIRON, V454, P517, DOI 10.1016/j.scitotenv.2013.02.082; Kulik N, 2006, J ENVIRON MANAGE, V78, P382, DOI 10.1016/j.jenvman.2005.05.005; Lee J, 2011, BIODEGRADATION, V22, P687, DOI 10.1007/s10532-010-9429-x; Lee PKH, 2008, APPL ENVIRON MICROB, V74, P2728, DOI 10.1128/AEM.02199-07; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Lovley D, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P635, DOI 10.1007/0-387-30742-7_21; LOVLEY DR, 1989, APPL ENVIRON MICROB, V55, P700, DOI 10.1128/AEM.55.3.700-706.1989; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Luijten MLGC, 2003, INT J SYST EVOL MICR, V53, P787, DOI 10.1099/ijs.0.02417-0; Macbeth TW, 2004, APPL ENVIRON MICROB, V70, P7329, DOI 10.1128/AEM.70.12.7329-7341.2004; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; Men YJ, 2013, APPL MICROBIOL BIOT, V97, P6439, DOI 10.1007/s00253-013-4896-8; Men YJ, 2012, ISME J, V6, P410, DOI 10.1038/ismej.2011.111; Munakata-Marr J, 2011, SERDP ESTCP REMEDIAT, P285, DOI 10.1007/978-1-4419-7826-4_7; Mundle K, 2007, GROUND WATER, V45, P692, DOI 10.1111/j.1745-6584.2007.00359.x; Philips J, 2012, FEMS MICROBIOL ECOL, V81, P636, DOI 10.1111/j.1574-6941.2012.01395.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sahl JW, 2007, WATER ENVIRON RES, V79, P5, DOI 10.2175/106143006X136720; Sercu B, 2013, MICROB ECOL, V65, P39, DOI 10.1007/s00248-012-0092-0; Siegrist RL, 2011, SERDP ESTCP REMEDIAT, P1, DOI 10.1007/978-1-4419-7826-4_1; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; Sutton NB, 2015, GROUNDWATER, V53, P261, DOI 10.1111/gwat.12209; Sutton NB, 2014, APPL MICROBIOL BIOT, V98, P2751, DOI 10.1007/s00253-013-5256-4; Sutton NB, 2014, ENVIRON SCI TECHNOL, V48, P2352, DOI 10.1021/es404512a; Tsitonaki A, 2008, WATER RES, V42, P1013, DOI 10.1016/j.watres.2007.09.018; Valderrama C, 2009, J HAZARD MATER, V166, P594, DOI 10.1016/j.jhazmat.2008.11.108; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vandieken V, 2012, ISME J, V6, P2078, DOI 10.1038/ismej.2012.41; Wagner DD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-327, 10.1186/1471-2164-13-200]; Xie GB, 2003, ENVIRON SCI TECHNOL, V37, P4751, DOI 10.1021/es026260t; Xu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030439; Yan J, 2012, APPL ENVIRON MICROB, V78, P6630, DOI 10.1128/AEM.01535-12; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	57	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134615	10.1371/journal.pone.0134615	http://dx.doi.org/10.1371/journal.pone.0134615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244346	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400094
J	Puhr, M; Hoefer, J; Eigentler, A; Dietrich, D; van Leenders, G; Uhl, B; Hoogland, M; Handle, F; Schlick, B; Neuwirt, H; Sailer, V; Kristiansen, G; Klocker, H; Culig, Z				Puhr, M.; Hoefer, J.; Eigentler, A.; Dietrich, D.; van Leenders, G.; Uhl, B.; Hoogland, M.; Handle, F.; Schlick, B.; Neuwirt, H.; Sailer, V.; Kristiansen, G.; Klocker, H.; Culig, Z.			PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer	ONCOGENE			English	Article							ANDROGEN RECEPTOR; SPLICE VARIANTS; SUMOYLATION; DOCETAXEL; ENZALUTAMIDE; ABIRATERONE; RESISTANCE; PATHWAY; PROLIFERATION; MITOXANTRONE	Novel drugs like Abiraterone or Enzalutamide, which target androgen receptor (AR) signaling to improve androgen deprivation therapy (ADT), have been developed during the past years. However, the application of these drugs is limited because of occurrence of inherent or acquired therapy resistances during the treatment. Thus, identification of new molecular targets is urgently required to improve current therapeutic prostate cancer (PCa) treatment strategies. PIAS1 (protein inhibitor of activated STAT1 (signal transducer and activator of transcription-1)) is known to be an important cell cycle regulator and PIAS1-mediated SUMOylation is essential for DNA repair. In this context, elevated PIAS1 expression has already been associated with cancer initiation. Thus, in the present study, we addressed the question of whether PIAS1 targeting can be used as a basis for an improved PCa therapy in combination with anti-androgens. We show that PIAS1 significantly correlates with AR expression in PCa tissue and in cell lines and demonstrate that high PIAS1 levels predict shorter relapse-free survival. Our patient data are complemented by mechanistic and functional in vitro experiments that identify PIAS1 as an androgen-responsive gene and a crucial factor for AR signaling via prevention of AR degradation. Furthermore, PIAS1 knockdown is sufficient to decrease cell proliferation as well as cell viability. Strikingly, Abiraterone or Enzalutamide treatment in combination with PIAS1 depletion is even more effective than singledrug treatment in multiple PCa cell models, rendering PIAS1 as a promising target protein for a combined treatment approach to improve future PCa therapies.	[Puhr, M.; Hoefer, J.; Eigentler, A.; Handle, F.; Schlick, B.; Klocker, H.; Culig, Z.] Med Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria; [Dietrich, D.; Uhl, B.; Sailer, V.; Kristiansen, G.] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [van Leenders, G.; Hoogland, M.] Erasmus MC, Inst Pathol, Rotterdam, Netherlands; [Neuwirt, H.] Med Univ Innsbruck, Dept Internal Med Nephrol & Hypertens 4, A-6020 Innsbruck, Austria	Medical University of Innsbruck; University of Bonn; Erasmus University Rotterdam; Erasmus MC; Medical University of Innsbruck	Puhr, M (corresponding author), Med Univ Innsbruck, Dept Urol, Expt Urol, Anichstr 35, A-6020 Innsbruck, Austria.	martin.puhr@i-med.ac.at	Handle, Florian/S-5447-2019; Neuwirt, Hannes/AAF-1090-2019; Klocker, Helmut/AAI-7130-2020	Handle, Florian/0000-0002-7558-5635; Neuwirt, Hannes/0000-0003-1064-0098; Hoefer, Julia/0000-0003-1138-3134	Austrian Cancer Society/Tirol; intramural funding program of the Medical University of Innsbruck for young scientists MUI-START [2010012007]; Austrian Science Fund (FWF) [P 25639-B19, W1101-B18]; Anniversary Fund Austrian National Bank (ONB) Grant [15374]; Austrian Science Fund (FWF) [P 25639] Funding Source: researchfish	Austrian Cancer Society/Tirol; intramural funding program of the Medical University of Innsbruck for young scientists MUI-START; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Anniversary Fund Austrian National Bank (ONB) Grant; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank Irma Sottsas for TMA preparation, paraffin embedding and immunohistochemistry (IHC) stainings, Mag Eberhard Steiner for patient selection and statistical analysis, Dr Walter Parson for cell line authentication and Dr Yaron Galanty (University of Cambridge) for generously sharing PIAS1 constructs. This work was supported by the Austrian Cancer Society/Tirol, the intramural funding program of the Medical University of Innsbruck for young scientists MUI-START, Project 2010012007, Austrian Science Fund (FWF) Grants P 25639-B19 (to MP) and W1101-B18 (to ZC) and Anniversary Fund Austrian National Bank (ONB) Grant 15374 (to ZC).	Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Driscoll JJ, 2010, BLOOD, V115, P2827, DOI 10.1182/blood-2009-03-211045; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geney R, 2002, CLIN CHEM LAB MED, V40, P918, DOI 10.1515/CCLM.2002.161; Gross M, 2001, ONCOGENE, V20, P3880, DOI 10.1038/sj.onc.1204489; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Heidegger I, 2014, ANTICANCER RES, V34, P307; Hobisch A, 2006, PROSTATE, V66, P413, DOI 10.1002/pros.20365; Hobisch A, 2001, CLIN CANCER RES, V7, P2941; Hoefer J, 2012, AM J PATHOL, V180, P2097, DOI 10.1016/j.ajpath.2012.01.026; Hoogland AM, 2012, MODERN PATHOL, V25, P471, DOI 10.1038/modpathol.2011.176; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089464; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Nadal R, 2014, PROSTATE, V74, P1560, DOI 10.1002/pros.22874; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Puhr M, 2014, ONCOTARGET, V5, P12043, DOI 10.18632/oncotarget.2658; Puhr M, 2012, AM J PATHOL, V181, P2188, DOI 10.1016/j.ajpath.2012.08.011; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Rytinki M, 2012, MOL CELL BIOL, V32, P4195, DOI 10.1128/MCB.00753-12; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shima H, 2013, J CELL SCI, V126, P5284, DOI 10.1242/jcs.133744; Sutinen P, 2014, NUCLEIC ACIDS RES, V42, P8310, DOI 10.1093/nar/gku543; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; van der Steen T, 2013, INT J MOL SCI, V14, P14833, DOI 10.3390/ijms140714833; van Soest RJ, 2013, EUR J CANCER, V49, P3821, DOI 10.1016/j.ejca.2013.09.026	39	29	31	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2322	2332		10.1038/onc.2015.292	http://dx.doi.org/10.1038/onc.2015.292			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26257066	Green Published, hybrid			2022-12-26	WOS:000376165000005
J	Patterson, MA; Bandyopadhyay, A; Devaraneni, PK; Woodward, J; Rooney, L; Yang, ZY; Skach, WR				Patterson, Melissa A.; Bandyopadhyay, Anannya; Devaraneni, Prasanna K.; Woodward, Josha; Rooney, LeeAnn; Yang, Zhongying; Skach, William R.			The Ribosome-Sec61 Translocon Complex Forms a Cytosolically Restricted Environment for Early Polytopic Membrane Protein Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aquaporin; endoplasmic reticulum (ER); membrane protein; protein folding; protein translocation; ribosome function; polytopic membrane protein; ribosome translocon complex; sec61 translocon	ENDOPLASMIC-RETICULUM MEMBRANE; TRANSMEMBRANE CONDUCTANCE REGULATOR; ER MEMBRANE; SEC61 TRANSLOCON; SIGNAL SEQUENCE; WATER CHANNELS; INTEGRATION; SEGMENTS; BIOGENESIS; INSERTION	Transmembrane topology of polytopic membrane proteins (PMPs) is established in the endoplasmic reticulum (ER) by the ribosome Sec61-translocon complex (RTC) through iterative cycles of translocation initiation and termination. It remains unknown, however, whether tertiary folding of transmembrane domains begins after the nascent polypeptide integrates into the lipid bilayer or within a proteinaceous environment proximal to translocon components. To address this question, we used cysteine scanning mutagenesis to monitor aqueous accessibility of stalled translation intermediates to determine when, during biogenesis, hydrophilic peptide loops of the aquaporin-4 (AQP4) water channel are delivered to cytosolic and lumenal compartments. Results showed that following ribosome docking on the ER membrane, the nascent polypeptide was shielded from the cytosol as it emerged from the ribosome exit tunnel. Extracellular loops followed a well defined path through the ribosome, the ribosome translocon junction, the Sec61-translocon pore, and into the ER lumen coincident with chain elongation. In contrast, intracellular loops (ICLs) and C-terminalresidues exited the ribosome into a cytosolically shielded environment and remained inaccessible to both cytosolic and lumenal compartments until translation was terminated. Shielding of ICL1 and ICL2, but not the C terminus, became resistant to maneuvers that disrupt electrostatic ribosome interactions. Thus, the early folding landscape of polytopic proteins is shaped by a spatially restricted environment localized within the assembled ribosome translocon complex.	[Patterson, Melissa A.; Bandyopadhyay, Anannya; Devaraneni, Prasanna K.; Woodward, Josha; Rooney, LeeAnn; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem Mol Biol, Portland, OR 97239 USA; [Skach, William R.] Cyst Fibrosis Fdn, CFFT, Bethesda, MD 20814 USA	Oregon Health & Science University; Cystic Fibrosis Foundation	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	skachw@ohsu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK51818, GM53457, T32 HL083808]; Cystic Fibrosis Foundation Therapeutics Inc. [SKACH05X0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51818 (to W. R. S.), GM53457 (to W. R. S.), and T32 HL083808 (to M. A. P.), and Cystic Fibrosis Foundation Therapeutics Inc. Grant SKACH05X0 (to W. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Carveth K, 2002, J BIOL CHEM, V277, P39507, DOI 10.1074/jbc.M205759200; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Conti BJ, 2014, NAT STRUCT MOL BIOL, V21, P228, DOI 10.1038/nsmb.2779; Cross BCS, 2009, J CELL SCI, V122, P1768, DOI 10.1242/jcs.046094; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25; HIGH S, 1992, Current Opinion in Cell Biology, V4, P581, DOI 10.1016/0955-0674(92)90075-N; HIGH S, 1993, J BIOL CHEM, V268, P26745; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kelkar DA, 2012, J BIOL CHEM, V287, P2568, DOI 10.1074/jbc.M111.318766; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; LIN JL, 1995, J BIOL CHEM, V270, P6935, DOI 10.1074/jbc.270.12.6935; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matsumura Y, 2011, METHODS MOL BIOL, V741, P233, DOI 10.1007/978-1-61779-117-8_16; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Oberdorf J, 2005, J BIOL CHEM, V280, P38193, DOI 10.1074/jbc.M504200200; Ojemalm K, 2013, J CELL SCI, V126, P464, DOI 10.1242/jcs.111773; Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pfeffer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4072; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Sauri A, 2005, J BIOL CHEM, V280, P25907, DOI 10.1074/jbc.M412476200; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; SKACH WR, 1993, J BIOL CHEM, V268, P6903; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VERKMAN AS, 1995, KIDNEY INT, V48, P1069, DOI 10.1038/ki.1995.390; Virkki M, 2014, J MOL BIOL, V426, P2529, DOI 10.1016/j.jmb.2014.04.020; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1986, ANNU REV CELL BIOL, V2, P499, DOI 10.1146/annurev.cellbio.2.1.499; White SH, 2004, CURR OPIN STRUC BIOL, V14, P397, DOI 10.1016/j.sbi.2004.07.003; YOST CS, 1983, CELL, V34, P759	83	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28944	28952		10.1074/jbc.M115.672261	http://dx.doi.org/10.1074/jbc.M115.672261			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26254469	hybrid, Green Published			2022-12-26	WOS:000365762300033
J	Qi, YF; Wang, W; Chen, JB; Dai, L; Kaczorowski, D; Gao, X; Xia, P				Qi, Yanfei; Wang, Wei; Chen, Jinbiao; Dai, Lan; Kaczorowski, Dominik; Gao, Xin; Xia, Pu			Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1 alpha Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; ER STRESS; INHIBITS APOPTOSIS; ENDOTHELIAL-CELLS; UP-REGULATION; CANCER CELLS; 1-PHOSPHATE; PATHWAY; DISEASE	Aberrant deposition of fat including free fatty acids in the liver often causes damage to hepatocytes, namely lipotoxicity, which is a key pathogenic event in the development and progression of fatty liver diseases. This study demonstrates a pivotal role of sphingosine kinase 1 (SphK1) in protecting hepatocytes from lipotoxicity. Exposure of primary murine hepatocytes to palmitate resulted in dose-dependent cell death, which was enhanced significantly in Sphk1-deficient cells. In keeping with this, expression of dominant-negative mutant SphK1 also markedly promoted palmitate-induced cell death. In contrast, overexpression of wild-type SphK1 profoundly protected hepatocytes from lipotoxicity. Mechanistically, the protective effect of SphK1 is attributable to suppression of ER stress-mediated proapoptotic pathways, as reflected in the inhibition of IRE1 alpha activation, XBP1 splicing, JNK phosphorylation, and CHOP induction. Of note, SphK1 inhibited the IRE1 alpha pathway by reducing IRE1 alpha expression at the transcriptional level. Moreover, S1P mimicked the effect of SphK1, suppressing IRE1 alpha expression in a receptor-dependent manner. Furthermore, enforced overexpression of IRE1 alpha significantly blocked the protective effect of SphK1 against lipotoxicity. Therefore, this study provides new insights into the role of SphK1 in hepatocyte survival and uncovers a novel mechanism for protection against ER stress-mediated cell death.	[Qi, Yanfei; Chen, Jinbiao; Dai, Lan; Kaczorowski, Dominik; Xia, Pu] Univ Sydney, Centenary Inst, Signal Transduct Program, Sydney, NSW 2042, Australia; [Wang, Wei; Gao, Xin; Xia, Pu] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China	University of Sydney; Centenary Institute; Fudan University	Xia, P (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200032, Peoples R China.	xiapu_fudan@163.com	Xia, Pu/G-3090-2010; Chen, Jinbiao/N-9905-2019; Qi, Yanfei/ABC-1242-2021; Chen, Jinbiao/J-5868-2013	Xia, Pu/0000-0003-4705-8878; Chen, Jinbiao/0000-0003-0339-5880; Qi, Yanfei/0000-0003-1391-4111; Chen, Jinbiao/0000-0003-0339-5880; Gao, Xin/0000-0003-1864-7796	Australian National Health and Medical Research Council [571408]; National Natural Science Foundation of China [81370937]; Fudan University	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fudan University	This work was supported by grants from the Australian National Health and Medical Research Council (Program 571408), National Natural Science Foundation of China Grant 81370937, and a Fudan University distinguished professorship (to P. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Chatzakos V, 2012, BIOCHEM PHARMACOL, V84, P712, DOI 10.1016/j.bcp.2012.06.009; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Fayyaz S, 2014, DIABETOLOGIA, V57, P373, DOI 10.1007/s00125-013-3123-6; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; Fuchs M, 2012, J HEPATOL, V56, P291, DOI 10.1016/j.jhep.2011.05.019; Gandy KAO, 2013, BBA-MOL CELL BIOL L, V1831, P157, DOI 10.1016/j.bbalip.2012.07.002; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Guo FJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.194; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Karimian G, 2013, BBA-MOL BASIS DIS, V1832, P1922, DOI 10.1016/j.bbadis.2013.06.011; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Qi YF, 2012, J BIOL CHEM, V287, P32236, DOI 10.1074/jbc.M112.362160; RICHIERI GV, 1995, J LIPID RES, V36, P229; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Targher G, 2010, J HEPATOL, V53, P713, DOI 10.1016/j.jhep.2010.04.030; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xia P, 2011, CYTOKINE GROWTH F R, V22, P45, DOI 10.1016/j.cytogfr.2010.09.004; Zhang N, 2010, AUTOPHAGY, V6, P1157, DOI 10.4161/auto.6.8.13614	42	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23282	23290		10.1074/jbc.M115.677542	http://dx.doi.org/10.1074/jbc.M115.677542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240153	Green Published, hybrid			2022-12-26	WOS:000361685500036
J	Rushworth, D; Mathews, A; Alpert, A; Cooper, LJN				Rushworth, David; Mathews, Amber; Alpert, Amir; Cooper, Laurence J. N.			Dihydrofolate Reductase and Thymidylate Synthase Transgenes Resistant to Methotrexate Interact to Permit Novel Transgene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CODING REGION; MESSENGER-RNA; GENE-TRANSFER; FUSION GENE; CELLS; INTERLEUKIN-12; IDENTIFICATION; IMMUNOTHERAPY; TRANSLATION; EXPRESSION	Methotrexate (MTX) is an anti-folate that inhibits de novo purine and thymidine nucleotide synthesis. MTX induces death in rapidly replicating cells and is used in the treatment of multiple cancers. MTX inhibits thymidine synthesis by targeting dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS). The use of MTX to treat cancer also causes bone marrow suppression and inhibits the immune system. This has led to the development of an MTX-resistant DHFR, DHFR L22F, F31S (DHFRFS), to rescue healthy cells. 5-Fluorouracil-resistant TYMS T51S, G52S (TYMSSS) is resistant to MTX and improves MTX resistance of DHFRFS in primary T cells. Here we find that a known mechanism of MTX-induced increase in DHFR expression persists with DHFRFS and cis-expressed transgenes. We also find that TYMSSS expression of cis-expressed transgenes is similarly decreased in an MTX-inducible manner. MTX-inducible changes in DHFRFS and TYMSSS expression changes are lost when both genes are expressed together. In fact, expression of the DHFRFS and TYMSSS cis-expressed transgenes becomes correlated. These findings provide the basis for an unrecognized post-transcriptional mechanism that functionally links expression of DHFR and TYMS. These findings were made in genetically modified primary human T cells and have a clear potential for use in clinical applications where gene expression needs to be regulated by drug or maintained at a specific expression level. We demonstrate a potential application of this system in the controlled expression of systemically toxic cytokine IL-12.	[Rushworth, David; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr MDACC, Div Pediat, Childrens Canc Hosp, Houston, TX 77030 USA; [Rushworth, David; Mathews, Amber; Alpert, Amir; Cooper, Laurence J. N.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr MDACC, Div Pediat, Childrens Canc Hosp, Houston, TX 77030 USA.	ljncooper@mdanderson.org		alpert, amir/0000-0002-1274-1813	NCI Cancer Center through the National Institutes of Health [P30CA16672]; Cancer Center Core Grant [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA120956, R01CA141303, P01CA148600, R01CA124782] Funding Source: NIH RePORTER	NCI Cancer Center through the National Institutes of Health; Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We extend gratitude to the dedicated work of Helen Huls, Tiejuan Mi, and Drs. Kumar, Belousova, and Singh for laboratory support. We thank Drs. Dat Tran, Dean Lee, and George McNamara for assistance in manuscript preparation, and Dr. David Spencer for assistance in developing and utilizing iC9. We thank the MDACC South Campus Flow Cytometry Facility, supported by the NCI Cancer Center Support Grant P30CA16672 through the National Institutes of Health and Cancer Center Core Grant (CA16672), for use of their facilities.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120; Capiaux GM, 2004, CANCER GENE THER, V11, P767, DOI 10.1038/sj.cgt.7700683; Capiaux GM, 2003, HUM GENE THER, V14, P435, DOI 10.1089/104303403321467207; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Corrigan-Curay J, 2014, MOL THER, V22, P1564, DOI 10.1038/mt.2014.148; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; ErcikanAbali EA, 1996, CANCER RES, V56, P4142; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Jonnalagadda M, 2013, GENE THER, V20, P853, DOI 10.1038/gt.2012.97; Jonnalagadda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065519; Kacherovsky N, 2015, BIOTECHNOL BIOENG, V112, P1429, DOI 10.1002/bit.25538; Kerkar SP, 2010, CANCER RES, V70, P6725, DOI 10.1158/0008-5472.CAN-10-0735; Landis DM, 2001, CANCER RES, V61, P666; Leonard JP, 1997, BLOOD, V90, P2541; Lin XK, 2000, NUCLEIC ACIDS RES, V28, P1381, DOI 10.1093/nar/28.6.1381; Mayer-Kuckuk P, 2002, P NATL ACAD SCI USA, V99, P3400, DOI 10.1073/pnas.062036899; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Rushworth D, 2016, GENE THER, V23, P119, DOI 10.1038/gt.2015.88; Rushworth D, 2014, J IMMUNOTHER, V37, P204, DOI 10.1097/CJI.0000000000000032; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Skacel N, 2005, J BIOL CHEM, V280, P22721, DOI 10.1074/jbc.M500277200; Sorrentino BR, 2002, NAT REV CANCER, V2, P431, DOI 10.1038/nrc823; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; Tai NW, 2002, NUCLEIC ACIDS RES, V30, P4481, DOI 10.1093/nar/gkf562; Walling J, 2006, INVEST NEW DRUG, V24, P37, DOI 10.1007/s10637-005-4541-1; Zhang L, 2015, CLIN CANCER RES, V21, P2278, DOI 10.1158/1078-0432.CCR-14-2085	30	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22970	22976		10.1074/jbc.C115.671123	http://dx.doi.org/10.1074/jbc.C115.671123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242737	Green Published, hybrid			2022-12-26	WOS:000361685500010
J	Liao, YT; Wang, SM; Wang, JR; Yu, CK; Liu, CC				Liao, Yu-Ting; Wang, Shih-Min; Wang, Jen-Ren; Yu, Chun-Keung; Liu, Ching-Chuan			Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71	PLOS ONE			English	Article							BRAIN-STEM ENCEPHALITIS; ANTIBODY-DEPENDENT ENHANCEMENT; TUMOR-NECROSIS-FACTOR; NERVOUS-SYSTEM; IMMUNE-SYSTEM; INTERLEUKIN-10 PRODUCTION; CEREBROSPINAL-FLUID; PULMONARY-EDEMA; T-CELLS; PATHOGENESIS	Background Enterovirus 71 (EV71) infections may be associated with neurological complications, including brainstem encephalitis (BE). Severe EV71 BE may be complicated with autonomic nervous system (ANS) dysregulation and/or pulmonary edema (PE). ANS dysregulation is related to the overactivation of the sympathetic nervous system, which results from catecholamine release. Objective The aims of this study were to explore the effects of catecholamines on severe EV71 infection and to investigate the changes in the percentages of EV71-infected cells, virus titer, and cytokine production on the involvement of catecholamines. Study Design Plasma levels of norepinephrine (NE) and epinephrine (EP) in EV71-infected patients were measured using an enzyme-linked immunoassay. The expression of adrenergic receptors (ADRs) on RD, A549, SK-N-SH, THP-1, Jurkat and human peripheral blood mononuclear cells (hPBMCs) were detected using flow cytometry. The percentages of EV71-infected cells, virus titer, and cytokine production were investigated after treatment with NE and EP. Results The plasma levels of NE and EP were significantly higher in EV71-infected patients with ANS dysregulation and PE than in controls. Both alpha(1A)-and beta(2)-ADRs were expressed on A549, RD, SK-N-SH, HL-60, THP-1, Jurkat cells and hPBMCs. NE treatment elevated the percentages of EV71-infected cells to 62.9% and 22.7% in THP-1 and Jurkat cells, respectively. Via treatment with EP, the percentages of EV71-infected cells were increased to 64.6% and 26.9% in THP-1 and Jurkat cells. The percentage of EV71-infected cells increased upon NE or EP treatment while the alpha- and beta-blockers reduced the percentages of EV71-infected cells with NE or EP treatment. At least two-fold increase in virus titer was observed in EV71-infected A549, SK-N-SH and hPBMCs after treatment with NE or EP. IL6 production was enhanced in EV71-infected hPBMCs at a concentration of 10(2) pg/mL NE. Conclusion The plasma levels of NE and EP elevated in EV71-infected patients with ANS dysregulation and PE. Both NE and EP enhanced the percentages of infected cells and virus titers in EV71 infection in vitro. NE and EP may play a role in the pathogenesis of EV71 BE complicated with ANS dysregulation and PE.	[Liao, Yu-Ting; Wang, Shih-Min; Wang, Jen-Ren; Yu, Chun-Keung; Liu, Ching-Chuan] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Liao, Yu-Ting; Yu, Chun-Keung] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan 70101, Taiwan; [Wang, Shih-Min] Natl Cheng Kung Univ, Dept Emergency Med, Natl Cheng Kung Univ Hosp, Coll Med, Tainan 70101, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ, Dept Med Lab Sci, Coll Med, Tainan 70101, Taiwan; [Wang, Shih-Min; Liu, Ching-Chuan] Natl Cheng Kung Univ, Dept Pediat, Natl Cheng Kung Univ Hosp, Coll Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Wang, SM (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan.	pedwang@mail.ncku.edu.tw; liucc@mail.ncku.edu.tw	Wang, Shih-Min/V-7886-2019; Wang, Jen-Ren/F-5254-2011	Wang, Jen-Ren/0000-0002-4127-4046	National Science Council Taiwan [NSC 101-2314-B-006-014-MY3]; Ministry of Science and Technology Taiwan [MOST 104-2321-B-006-016]; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology Taiwan(Ministry of Science and Technology, Taiwan); Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan	This study was supported by grants from the National Science Council Taiwan (NSC 101-2314-B-006-014-MY3), and Ministry of Science and Technology Taiwan (MOST 104-2321-B-006-016); and the Center of Infectious Disease and Signaling Research, National Cheng Kung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1993, LIFE SCI, V52, P2101, DOI 10.1016/0024-3205(93)90725-I; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Benovic Jeffrey L., 2002, Journal of Allergy and Clinical Immunology, V110, pS229, DOI 10.1067/mai.2002.129370; BREESE GR, 1970, J PHARMACOL EXP THER, V174, P413; Chen IC, 2013, MED MICROBIOL IMMUN, V202, P259, DOI 10.1007/s00430-013-0289-y; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Elenkov IJ, 1996, P ASSOC AM PHYSICIAN, V108, P374; Eng JWL, 2014, CANCER IMMUNOL IMMUN, V63, P1115, DOI 10.1007/s00262-014-1617-9; Fu YC, 2004, ARCH DIS CHILD, V89, P368, DOI 10.1136/adc.2003.029645; Ghanemi A, 2015, NEUROPEPTIDES, V49, P25, DOI 10.1016/j.npep.2014.11.003; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Grisanti LA, 2011, J PHARMACOL EXP THER, V338, P648, DOI 10.1124/jpet.110.178012; Hasko G, 1998, BIOCHEM PHARMACOL, V56, P1079, DOI 10.1016/S0006-2952(98)00153-1; Khong WX, 2011, J VIROL, V85, P3067, DOI 10.1128/JVI.01779-10; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Kohm AP, 2000, IMMUNOL TODAY, V21, P539, DOI 10.1016/S0167-5699(00)01747-3; Kolinski M, 2012, CURR MED CHEM, V19, P1155, DOI 10.2174/092986712799320547; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; Leo NA, 2000, ANN NY ACAD SCI, V917, P923; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Marino F, 2013, AMINO ACIDS, V45, P55, DOI 10.1007/s00726-011-1186-6; Matkovic K, 2006, LEUKEMIA, V20, P941, DOI 10.1038/sj.leu.2404204; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Padro CJ, 2014, SEMIN IMMUNOL, V26, P357, DOI 10.1016/j.smim.2014.01.003; PaninaBordignon P, 1997, J CLIN INVEST, V100, P1513, DOI 10.1172/JCI119674; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Sanders VM, 2012, BRAIN BEHAV IMMUN, V26, P195, DOI 10.1016/j.bbi.2011.08.001; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Vance BA, 1997, J BIOL CHEM, V272, P23117, DOI 10.1074/jbc.272.37.23117; VANDERPOLL T, 1994, INFECT IMMUN, V62, P2046, DOI 10.1128/IAI.62.5.2046-2050.1994; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Verburg-van Kemenade BML, 2013, GEN COMP ENDOCR, V188, P94, DOI 10.1016/j.ygcen.2012.11.010; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102025; Wang SM, 2014, EXPERT REV ANTI-INFE, V12, P447, DOI 10.1586/14787210.2014.895666; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang SM, 2010, CLIN VACCINE IMMUNOL, V17, P1517, DOI 10.1128/CVI.00108-10; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Wang SM, 2005, PEDIATR PULM, V39, P219, DOI 10.1002/ppul.20157; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wirth T, 2014, BRAIN BEHAV IMMUN, V38, P100, DOI 10.1016/j.bbi.2014.01.007	48	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135154	10.1371/journal.pone.0135154	http://dx.doi.org/10.1371/journal.pone.0135154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252639	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100126
J	Niu, XY; Lu, C; Xiao, C; Ge, N; Jiang, M; Li, L; Bian, YQ; Xu, G; Bian, ZX; Zhang, G; Lu, AP				Niu, Xuyan; Lu, Cheng; Xiao, Cheng; Ge, Na; Jiang, Miao; Li, Li; Bian, Yanqin; Xu, Gang; Bian, Zhaoxiang; Zhang, Ge; Lu, Aiping			The Crosstalk of Pathways Involved in Immune Response Maybe the Shared Molecular Basis of Rheumatoid Arthritis and Type 2 Diabetes	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ANTI-TNF TREATMENT; INSULIN-RESISTANCE; COMPLEMENT-SYSTEM; MONONUCLEAR-CELLS; INFLAMMATION; ASSOCIATION; GENES; DISEASE; ALPHA	Rheumatoid arthritis (RA) and Type 2 diabetes (T2D) are both systemic diseases linked with altered immune response, moderate mortality when present together. The treatment for both RA and T2D are not satisfied, partly because of the linkage between them has not yet been appreciated. A comprehensive study for the potential associations between the two disorders is needed. In this study, we used RNA sequencing to explore the differently expressed genes (DEGs) in peripheral blood mononuclear cells (PBMC) of 10 RA and 10 T2D patients comparing with 10 healthy volunteers (control). We used bioinformatics analysis and the Ingenuity Pathways Analysis (IPA) to predict the commonalities on signaling pathways and molecular networks between those two diseases. 212 DEGs in RA and 114 DEGs in T2D patients were identified compared with healthy controls, respectively. 32 DEGs were shared between the two comparisons. The top 10 shared pathways interacted in cross-talking networks, regulated by 5 shared predicted upstream regulators, leading to the activated immune response were explored, which was considered as partly of the association mechanism of this two disorders. These discoveries would be considered as new understanding on the associations between RA and T2D, and provide novel treatment or prevention strategy.	[Niu, Xuyan; Lu, Cheng; Ge, Na; Jiang, Miao; Li, Li] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Beijing, Peoples R China; [Lu, Cheng; Xu, Gang; Bian, Zhaoxiang; Zhang, Ge; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Bian, Yanqin; Lu, Aiping] Shanghai Municipal Educ Commiss, E Inst Chinese Tradit Internal Med, Shanghai, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China-Japan Friendship Hospital; Hong Kong Baptist University; Shanghai Municipal Education Commission (SHMEC)	Lu, AP (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China.	aipinglu@hkbu.edu.hk	Xiao, Cheng/AAM-7764-2020; Zhang, Ge/K-9118-2019; Na, Ge/AAO-8156-2020	Zhang, Ge/0000-0002-7807-7695; Na, Ge/0000-0003-3535-1874	National Natural Science Foundation of China [81403209]; International Cooperation Project of Ministry of Science and Technology [2014DFA31490]; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University [RC-IRMS/13-14/03]; Science and Technology Projects for Supervisors of Beijing Outstanding Doctorate Dissertation [20118450201]; Beijing Nova Program [xx2014B073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Ministry of Science and Technology; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University; Science and Technology Projects for Supervisors of Beijing Outstanding Doctorate Dissertation; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China (No. 81403209), to XN (data collection and analysis), preparation of the manuscript, by International Cooperation Project of Ministry of Science and Technology (Project ID: 2014DFA31490), to CX (data collection and analysis), by Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University (Project ID: RC-IRMS/13-14/03), to AL (the study design, decision to publish), by Science and Technology Projects for Supervisors of Beijing Outstanding Doctorate Dissertation (Project ID: 20118450201), to AL (the study design, decision to publish), and by Beijing Nova Program (Project ID: xx2014B073), to CL (data collection and analysis).	[Anonymous], 2012, CLIN CHIM ACTA, V413, P1163, DOI [10.1016/j.cca.2012.03.021, DOI 10.1016/J.CCA.2012.03.021]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bogunia-Kubik K, 2015, ARCH IMMUNOL THER EX, V63, P215, DOI 10.1007/s00005-014-0319-5; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; da Rocha LF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/926060; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; Dessein PH, 2005, ARTHRITIS RES THER, V7, pR634, DOI 10.1186/ar1717; Di Muzio G, 2011, INT J IMMUNOPATH PH, V24, P357, DOI 10.1177/039463201102400209; Doran M, 2007, J RHEUMATOL, V34, P460; Ergen A, 2014, FOLIA BIOL-PRAGUE, V60, P108; Faveeuw C, 2001, BLOOD, V98, P688, DOI 10.1182/blood.V98.3.688; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; GARCIA OC, 1995, J IMMUNOL, V155, P4037; Grayson BL, 2011, GENES IMMUN, V12, P341, DOI 10.1038/gene.2011.13; Han CL, 2006, J RHEUMATOL, V33, P2167; Hogan AE, 2011, DIABETOLOGIA, V54, P2745, DOI 10.1007/s00125-011-2232-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Janus ED, 2000, DIABETIC MED, V17, P741, DOI 10.1046/j.1464-5491.2000.00376.x; Julia A, 2013, CURRENT TOPICS IN ME; Kamei M, 2010, CURR OPIN HEMATOL, V17, P43, DOI 10.1097/MOH.0b013e3283333949; Kasakura K, 2014, FEBS LETT, V588, P4645, DOI 10.1016/j.febslet.2014.10.036; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Manivel VA, 2014, ANN RHEUM DIS, V73, pA5, DOI 10.1136/annrheumdis-2013-205124.11; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Marder W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000441; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; MORIMOTO Y, 1988, DIABETES RES CLIN PR, V5, P309, DOI 10.1016/S0168-8227(88)80067-6; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nair S, 2008, J NEPHROL, V21, P400; Nakamura N, 2006, DNA RES, V13, P169, DOI 10.1093/dnares/dsl006; O'Gradaigh D, 2003, RHEUMATOLOGY, V42, P1429, DOI 10.1093/rheumatology/keg375; Oncul O, 2002, J INT MED RES, V30, P386, DOI 10.1177/147323000203000404; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Park MC, 2008, SCAND J RHEUMATOL, V37, P173, DOI 10.1080/03009740801898608; Pavlovic V, 2014, J RES MED SCI, V19, P18; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Porzio O, 2007, Hum Mutat, V28, P1150, DOI 10.1002/humu.9511; Ralph JA, 2008, EXPERT OPIN THER TAR, V12, P795, DOI 10.1517/14728222.12.7.795 ; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Rodriguez-Lopez J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1849; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shegarfi H, 2012, SCI WORLD J, P1, DOI 10.1100/2012/491974; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Simard JF, 2007, J RHEUMATOL, V34, P469; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Somani R, 2012, DIABETES CARE, V35, P894, DOI 10.2337/dc11-1483; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Taber KAJ, 2015, APPL CLIN GENET, V8, P1, DOI 10.2147/TACG.S75583; Takeshita Y, 2006, METABOLISM, V55, P1464, DOI 10.1016/j.metabol.2006.06.016; Takeuchi T, 2014, MOD RHEUMATOL, V24, P8, DOI 10.3109/14397595.2013.854074; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Wang XD, 2013, BONE, V52, P111, DOI 10.1016/j.bone.2012.09.018; Wasko MC, 2011, ARTHRIT CARE RES, V63, P512, DOI 10.1002/acr.20414; Yang CA, 2015, J AUTOIMMUN, V61, P1, DOI 10.1016/j.jaut.2015.05.001; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Zhou B, 2013, ENDOCRINOLOGY, V154, P1055, DOI 10.1210/en.2012-2144; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	71	13	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134990	10.1371/journal.pone.0134990	http://dx.doi.org/10.1371/journal.pone.0134990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252209	Green Published, gold			2022-12-26	WOS:000359121100099
J	Pal, D; Jones, JM; Wisidagamage, S; Meisler, MH; Mashour, GA				Pal, Dinesh; Jones, Julie M.; Wisidagamage, Stella; Meisler, Miriam H.; Mashour, George A.			Reduced Na(v)1.6 Sodium Channel Activity in Mice Increases In Vivo Sensitivity to Volatile Anesthetics	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; GATED NA+ CHANNEL; GENERAL-ANESTHESIA; SLEEP-DEPRIVATION; PYRAMIDAL NEURONS; ABSENCE EPILEPSY; NERVOUS-SYSTEM; SCN8A; ISOFLURANE; DISEASE	Na(v)1.6 is a major voltage-gated sodium channel in the central and peripheral nervous systems. Within neurons, the channel protein is concentrated at the axon initial segment and nodes of Ranvier, where it functions in initiation and propagation of action potentials. We examined the role of Nav1.6 in general anesthesia using two mouse mutants with reduced activity of Na(v)1.6, Scn8a(medJ/medJ) and Scn8a(9J/9J). The mice were exposed to the general anesthetics isoflurane and sevoflurane in step-wise increments; the concentration required to produce loss of righting reflex, a surrogate for anesthetic-induced unconsciousness in rodents, was determined. Mice homozygous for these mutations exhibited increased sensitivity to both isoflurane and sevoflurane. The increased sensitivity was observed during induction of unconsciousness but not during the recovery phase, suggesting that the effect is not attributable to compromised systemic physiology. Electroencephalographic theta power during baseline waking was lower in mutants, suggesting decreased arousal and reduced neuronal excitability. This is the first report linking reduced activity of a specific voltage- gated sodium channel to increased sensitivity to general anesthetics in vivo.	[Pal, Dinesh; Wisidagamage, Stella; Mashour, George A.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Pal, Dinesh; Mashour, George A.] Univ Michigan, Ctr Consciousness Sci, Ann Arbor, MI 48109 USA; [Jones, Julie M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Mashour, George A.] Univ Michigan, Grad Program Neurosci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mashour, GA (corresponding author), Univ Michigan, Dept Anesthesiol, 7433 Med Sci Bldg 1,1150,West Med Ctr Dr, Ann Arbor, MI 48109 USA.	gmashour@med.umich.edu			NIH [R01 NS34509, RO1 GM098578]; Department of Anesthesiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by NIH R01 NS34509 (M.M.), NIH RO1 GM098578 (G.A.M.) and the Department of Anesthesiology (G.A.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AF, 2014, P NATL ACAD SCI USA, V111, P6726, DOI 10.1073/pnas.1405768111; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Buchner DA, 2003, SCIENCE, V301, P967, DOI 10.1126/science.1086187; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Herold KE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00050; Hodgson PS, 1999, ANESTHESIOLOGY, V91, P1687, DOI 10.1097/00000542-199912000-00021; Howell VM, 2007, HUM MOL GENET, V16, P2506, DOI 10.1093/hmg/ddm206; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Kearney JA, 2002, HUM MOL GENET, V11, P2765, DOI 10.1093/hmg/11.22.2765; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mangia AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00601; Mashour George A, 2012, Anesthesiol Clin, V30, P385, DOI 10.1016/j.anclin.2012.05.003; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; Mhuircheartaigh RN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006007; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; Oliva MK, 2014, NEUROBIOL DIS, V67, P180, DOI 10.1016/j.nbd.2014.03.007; Osorio N, 2010, J PHYSIOL-LONDON, V588, P651, DOI 10.1113/jphysiol.2010.183798; Ouyang W, 2009, ANESTHESIOLOGY, V110, P582, DOI 10.1097/ALN.0b013e318197941e; Pal D, 2012, ANESTH ANALG, V114, P297, DOI 10.1213/ANE.0b013e31823ede22; Pal D, 2011, ANESTHESIOLOGY, V114, P302, DOI 10.1097/ALN.0b013e318204e064; Papale LA, 2009, HUM MOL GENET, V18, P1633, DOI 10.1093/hmg/ddp081; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; Rehberg B, 1996, ANESTHESIOLOGY, V84, p27A; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; SCHALLER KL, 1995, J NEUROSCI, V15, P3231; Shiraishi M, 2004, J PHARMACOL EXP THER, V309, P987, DOI 10.1124/jpet.103.064063; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Sonner JM, 1999, ANESTH ANALG, V89, P1030, DOI 10.1097/00000539-199910000-00039; Sonner JM, 2000, ANESTH ANALG, V91, P720, DOI 10.1213/00000539-200009000-00042; Tung A, 2002, ANESTHESIOLOGY, V97, P906, DOI 10.1097/00000542-200210000-00024; Tzoumaka E, 2000, J NEUROSCI RES, V60, P37, DOI 10.1002/(SICI)1097-4547(20000401)60:1<37::AID-JNR4>3.0.CO;2-W; Vanini G, 2014, EUR J NEUROSCI, V40, P2264, DOI 10.1111/ejn.12571; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; Wagnon JL, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00104; Yokoyama T, 2011, J ANESTH, V25, P609, DOI 10.1007/s00540-011-1167-7; Zhang Y, 2010, BRIT J PHARMACOL, V159, P872, DOI 10.1111/j.1476-5381.2009.00583.x	50	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134960	10.1371/journal.pone.0134960	http://dx.doi.org/10.1371/journal.pone.0134960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252017	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100090
J	Qu, XX; Pu, X; Chen, F; Yang, Y; Yang, LX; Zhang, GL; Luo, YG				Qu, Xixing; Pu, Xiang; Chen, Fei; Yang, Yun; Yang, Lixia; Zhang, Guolin; Luo, Yinggang			Molecular Cloning, Heterologous Expression, and Functional Characterization of an NADPH-Cytochrome P450 Reductase Gene from Camptotheca acuminata, a Camptothecin-Producing Plant	PLOS ONE			English	Article							ALKALOID BIOSYNTHESIS; CATHARANTHUS-ROSEUS; ENZYME; SYNTHASE; SITE	Camptothecin (CAM), a complex pentacyclic pyrroloqinoline alkaloid, is the starting material for CAM-type drugs that are well-known antitumor plant drugs. Although many chemical and biological research efforts have been performed to produce CAM, a few attempts have been made to uncover the enzymatic mechanism involved in the biosynthesis of CAM. Enzyme-catalyzed oxidoreduction reactions are ubiquitously presented in living organisms, especially in the biosynthetic pathway of most secondary metabolites such as CAM. Due to a lack of its reduction partner, most catalytic oxidation steps involved in the biosynthesis of CAM have not been established. In the present study, an NADPH-cytochrome P450 reductase (CPR) encoding gene CamCPR was cloned from Camptotheca acuminata, a CAM-producing plant. The full length of CamCPR cDNA contained an open reading frame of 2127-bp nucleotides, corresponding to 708-amino acid residues. CamCPR showed 70 similar to 85% identities to other characterized plant CPRs and it was categorized to the group II of CPRs on the basis of the results of multiple sequence alignment of the N-terminal hydrophobic regions. The intact and truncate CamCPRs with N- or C-terminal His6-tag were heterologously overexpressed in Escherichia coli. The recombinant enzymes showed NADPH-dependent reductase activity toward a chemical substrate ferricyanide and a protein substrate cytochrome c. The N-terminal His6-tagged CamCPR showed 18- similar to 30-fold reduction activity higher than the C-terminal His6-tagged CamCPR, which supported a reported conclusion, i.e., the last C-terminal tryptophan of CPRs plays an important role in the discrimination between NADPH and NADH. Co-expression of CamCPR and a P450 monooxygenase, CYP73A25, a cinnamate 4-hydroxylase from cotton, and the following catalytic formation of p-coumaric acid suggested that CamCPR transforms electrons from NADPH to the heme center of P450 to support its oxidation reaction. Quantitative real-time PCR analysis showed that CamCPR was expressed in the roots, stems, and leaves of C. acuminata seedlings. The relative transcript level of CamCPR in leaves was 2.2-fold higher than that of roots and the stems showed 1.5-fold transcript level higher than the roots. The functional characterization of CamCPR will be helpful to disclose the mysterious mechanisms of the biosynthesis of CAM. The present study established a platform to characterize the P450 enzymes involved in the growth, development, and metabolism of eukaryotic organisms.	[Qu, Xixing; Pu, Xiang; Chen, Fei; Yang, Yun; Yang, Lixia; Zhang, Guolin; Luo, Yinggang] Chinese Acad Sci, Chengdu Inst Biol, Ctr Nat Prod Res, Chengdu, Peoples R China; [Luo, Yinggang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Qu, Xixing; Pu, Xiang; Chen, Fei; Yang, Yun; Yang, Lixia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Luo, YG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Ctr Nat Prod Res, Chengdu, Peoples R China.	yinggluo@cib.ac.cn	Pu, Xiang/AAQ-3596-2021	Pu, Xiang/0000-0003-1439-8657	Chinese Academy of Sciences [KSCX2-EW-Q-6]; National Natural Science Foundation of China [21172216]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Science and Technology Project for Outstanding Youths in Life Science (KSCX2-EW-Q-6) from the Chinese Academy of Sciences (www.cas.cn) and the project 21172216 from the National Natural Science Foundation of China (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIMI N, 1989, TETRAHEDRON LETT, V30, P4991, DOI 10.1016/S0040-4039(01)80563-3; Bhat WW, 2014, FUNCT INTEGR GENOMIC, V14, P381, DOI 10.1007/s10142-014-0362-7; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; Demain AL, 2011, MICROB BIOTECHNOL, V4, P687, DOI 10.1111/j.1751-7915.2010.00221.x; Elmore CL, 2002, J BIOL CHEM, V277, P48960, DOI 10.1074/jbc.M210173200; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Girhard M, 2013, APPL MICROBIOL BIOT, V97, P1625, DOI 10.1007/s00253-012-4026-z; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Huang FC, 2012, PLANT SCI, V190, P16, DOI 10.1016/j.plantsci.2012.03.007; HUTCHINSON CR, 1979, J AM CHEM SOC, V101, P3358, DOI 10.1021/ja00506a037; Irmler S, 2000, PLANT J, V24, P797, DOI 10.1046/j.1365-313x.2000.00922.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kaewpa D, 2007, J ECON ENTOMOL, V100, P946, DOI 10.1603/0022-0493(2007)100[946:FEOMNP]2.0.CO;2; Kitajima M, 2002, TETRAHEDRON, V58, P9169, DOI 10.1016/S0040-4020(02)01196-1; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Lee GY, 2014, PLANT PHYSIOL BIOCH, V82, P116, DOI 10.1016/j.plaphy.2014.05.010; LopezMeyer M, 1997, PLANT J, V11, P1167, DOI 10.1046/j.1365-313X.1997.11061167.x; Lorence A, 2004, PHYTOCHEMISTRY, V65, P2735, DOI 10.1016/j.phytochem.2004.09.001; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Peng ZhiHong, 2010, Progress in Modern Biomedicine, V10, P3175; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; Shaanker R. Uma, 2008, P197, DOI 10.1007/978-3-540-74603-4_10; SHEN SH H, 2011, TRADITIONAL HERBAL D, V42, p1 862; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Simpson RJ, 2003, PROTEINS PROTEOMICS; Sirikantaramas S, 2007, CURR PHARM BIOTECHNO, V8, P196; Stockigt J, 2008, PLANT PHYSIOL BIOCH, V46, P340, DOI 10.1016/j.plaphy.2007.12.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas CJ, 2004, BIOORGAN MED CHEM, V12, P1585, DOI 10.1016/j.bmc.2003.11.036; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Yang CQ, 2010, PHYTOCHEMISTRY, V71, P27, DOI 10.1016/j.phytochem.2009.09.026	37	22	25	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135397	10.1371/journal.pone.0135397	http://dx.doi.org/10.1371/journal.pone.0135397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252645	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100158
J	Guasch, A; Aranguren-Ibanez, A; Perez-Luque, R; Aparicio, D; Martinez-Hoyer, S; Mulero, MC; Serrano-Candelas, E; Perez-Riba, M; Fita, I				Guasch, Alicia; Aranguren-Ibanez, Alvaro; Perez-Luque, Rosa; Aparicio, David; Martinez-Hoyer, Sergio; Carmen Mulero, M.; Serrano-Candelas, Eva; Perez-Riba, Merce; Fita, Ignacio			Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CYCLOSPORINE-A; BETA-12-BETA-13 LOOP; PHOSPHATASE-ACTIVITY; MECHANISM; RECOGNITION; MUTAGENESIS; ACTIVATION; INHIBITOR; ALIGNMENT	A limited repertoire of PPP family of serine/threonine phosphatases with a highly conserved catalytic domain acts on thousands of protein targets to orchestrate myriad central biological roles. A major structural reorganization of human calcineurin, a ubiquitous Ser/Thr PPP regulated by calcium and calmodulin and targeted by immunosuppressant drugs cyclosporin A and FK506, is unveiled here. The new conformation involves trans- to cis- isomerization of proline in the SAPNY sequence, highly conserved across PPPs, and remodels the main regulatory site where NFATc transcription factors bind. Transitions between cis- and trans- conformations may involve peptidyl prolyl isomerases such as cyclophilin A and FKBP12, which are known to physically interact with and modulate calcineurin even in the absence of immunosuppressant drugs. Alternative conformations in PPPs provide a new perspective on interactions with substrates and other protein partners and may foster development of more specific inhibitors as drug candidates.	[Guasch, Alicia; Perez-Luque, Rosa; Aparicio, David; Fita, Ignacio] Inst Biol Mol Barcelona, CSIC, Barcelona 08028, Spain; [Aranguren-Ibanez, Alvaro; Martinez-Hoyer, Sergio; Carmen Mulero, M.; Serrano-Candelas, Eva; Perez-Riba, Merce] Inst Invest Biomed Bellvitge IDIBELL, Human Mol Genet Lab, Barcelona 08908, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Perez-Riba, M (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Human Mol Genet Lab, Gran Via Hosp 199, Barcelona 08908, Spain.	mpr@idibell.cat; ifrcri@ibmb.csic.es	Perez-Riba, Merce/AAA-6880-2019; Aparicio, David/AAX-7388-2020; Guasch, Alicia/ABH-3427-2020; Aparicio, David/R-4640-2019; Fita, Ignasi/R-4515-2019; Serrano Candelas, Eva/I-1892-2015	Aparicio, David/0000-0002-1971-5335; Fita, Ignasi/0000-0002-7521-2679; Perez Luque, Rosa/0000-0003-0759-0608; Serrano Candelas, Eva/0000-0002-8929-5364; Perez-Riba, Merce/0000-0003-1604-4617; Aranguren-Ibanez, Alvaro/0000-0001-8929-3521	Ministerio de Ciencia e Innovacion [SAF2009-08216-BFU2012-36827]; Generalitat de Catalunya [2009SGR1490-2014SGR987]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants SAF2009-08216-BFU2012-36827 from Ministerio de Ciencia e Innovacion and 2009SGR1490-2014SGR987 from the Generalitat de Catalunya. A. A.-I. was a recipient of an FI PhD fellowship from Generalitat de Catalunya.	Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; CHAN CP, 1986, J BIOL CHEM, V261, P9890; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaston RS, 2009, CLIN J AM SOC NEPHRO, V4, P2029, DOI 10.2215/CJN.03820609; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Martinez-Hoyer S, 2013, BBA-MOL CELL RES, V1833, P2311, DOI 10.1016/j.bbamcr.2013.05.021; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Maynes JT, 2004, J BIOL CHEM, V279, P43198, DOI 10.1074/jbc.M407184200; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Perrino BA, 1999, ARCH BIOCHEM BIOPHYS, V372, P159, DOI 10.1006/abbi.1999.1485; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Stie J, 2008, EUKARYOT CELL, V7, P177, DOI 10.1128/EC.00326-07; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei Q, 1997, BIOCHEMISTRY-US, V36, P7418, DOI 10.1021/bi962703s; Xie XJ, 2006, BIOL CHEM, V387, P1461, DOI 10.1515/BC.2006.183; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122	39	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134569	10.1371/journal.pone.0134569	http://dx.doi.org/10.1371/journal.pone.0134569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248042	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300048
J	Matsuo, K; Ban, R; Hama, Y; Yuzuriha, S				Matsuo, Kiyoshi; Ban, Ryokuya; Hama, Yuki; Yuzuriha, Shunsuke			Eyelid Opening with Trigeminal Proprioceptive Activation Regulates a Brainstem Arousal Mechanism	PLOS ONE			English	Article							INVOLUNTARY REFLEX CONTRACTION; NUCLEUS LOCUS-CERULEUS; RECEPTOR MESSENGER-RNA; OCCIPITOFRONTALIS MUSCLE; SURGICAL-CORRECTION; LEVATOR MUSCLE; RAT-BRAIN; ELECTRICAL-STIMULATION; EFFERENT PROJECTIONS; BLOOD-FLOW	Eyelid opening stretches mechanoreceptors in the supratarsal Muller muscle to activate the proprioceptive fiber supplied by the trigeminal mesencephalic nucleus. This proprioception induces reflex contractions of the slow-twitch fibers in the levator palpebrae superioris and frontalis muscles to sustain eyelid and eyebrow positions against gravity. The cell bodies of the trigeminal proprioceptive neurons in the mesencephalon potentially make gap-junctional connections with the locus coeruleus neurons. The locus coeruleus is implicated in arousal and autonomic function. Due to the relationship between arousal, ventromedial prefrontal cortex, and skin conductance, we assessed whether upgaze with trigeminal proprioceptive evocation activates sympathetically innervated sweat glands and the ventromedial prefrontal cortex. Specifically, we examined whether 60 degrees upgaze induces palmar sweating and hemodynamic changes in the prefrontal cortex in 16 subjects. Sweating was monitored using a thumb-mounted perspiration meter, and prefrontal cortex activity was measured with 45-channel, functional near-infrared spectroscopy (fNIRS) and 2-channel NIRS at Fp1 and Fp2. In 16 subjects, palmar sweating was induced by upgaze and decreased in response to downgaze. Upgaze activated the ventromedial prefrontal cortex with an accumulation of integrated concentration changes in deoxyhemoglobin, oxyhemoglobin, and total hemoglobin levels in 12 subjects. Upgaze phasically and degree-dependently increased deoxyhemoglobin level at Fp1 and Fp2, whereas downgaze phasically decreased it in 16 subjects. Unilateral anesthetization of mechanoreceptors in the supratarsal Muller muscle used to significantly reduce trigeminal proprioceptive evocation ipsilaterally impaired the increased deoxyhemoglobin level by 60 degrees upgaze at Fp1 or Fp2 in 6 subjects. We concluded that upgaze with strong trigeminal proprioceptive evocation was sufficient to phasically activate sympathetically innervated sweat glands and appeared to induce rapid oxygen consumption in the ventromedial prefrontal cortex and to rapidly produce deoxyhemoglobin to regulate physiological arousal. Thus, eyelid opening with trigeminal proprioceptive evocation may activate the ventromedial prefrontal cortex via the mesencephalic trigeminal nucleus and locus coeruleus.	[Matsuo, Kiyoshi; Ban, Ryokuya; Hama, Yuki; Yuzuriha, Shunsuke] Shinshu Univ, Sch Med, Dept Plast & Reconstruct Surg, Matsumoto, Nagano 390, Japan	Shinshu University	Matsuo, K (corresponding author), Shinshu Univ, Sch Med, Dept Plast & Reconstruct Surg, Matsumoto, Nagano 390, Japan.	kiyoshi.matsuo@gmail.com			Japan Society for the Promotion of Science [26462728]; Preventive Medical Center of Shinshu University Hospital	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Preventive Medical Center of Shinshu University Hospital	This work was funded by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 26462728) and the Preventive Medical Center of Shinshu University Hospital.	Abe K, 2006, WORLD J BIOL PSYCHIA, V7, P70, DOI 10.1080/15622970500222443; AJILORE O, 1995, PSYCHOPHYSIOLOGY, V32, P92, DOI 10.1111/j.1469-8986.1995.tb03410.x; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1991, PROG BRAIN RES, V88, P47; ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Atienza M, 2004, J SLEEP RES, V13, P25, DOI 10.1046/j.1365-2869.2003.00382.x; BAKER R, 1971, J PHYSIOL-LONDON, V212, P45, DOI 10.1113/jphysiol.1971.sp009309; Ban Ryokuya, 2013, Eplasty, V13, pe33; Ban R, 2010, J PLAST RECONSTR AES, V63, P59, DOI 10.1016/j.bjps.2008.07.021; Bremer F, 1935, CR SOC BIOL, V118, P1235; BYERS MR, 1989, J COMP NEUROL, V279, P117, DOI 10.1002/cne.902790110; Cantero JL, 2002, SLEEP, V25, P238, DOI 10.1093/sleep/25.2.238; CARPENTER MB, 1992, J HIRNFORSCH, V33, P151; Chib VS, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.44; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Domyancic AV, 1997, J COMP NEUROL, V386, P358, DOI 10.1002/(SICI)1096-9861(19970929)386:3<358::AID-CNE3>3.0.CO;2-0; Dringenberg HC, 1997, EXP BRAIN RES, V116, P160, DOI 10.1007/PL00005736; Dringenberg HC, 1998, NEUROSCI BIOBEHAV R, V22, P243, DOI 10.1016/S0149-7634(97)00012-2; Evinger C, 1988, Rev Oculomot Res, V2, P81; EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387; FOOTE SL, 1991, PROG BRAIN RES, V88, P521; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; FUCHS AF, 1992, J NEUROPHYSIOL, V68, P233, DOI 10.1152/jn.1992.68.1.233; Fujita K, 2012, J PLAST SURG HAND SU, V46, P383, DOI 10.3109/2000656X.2012.722094; GILMORE RL, 1994, J CLIN NEUROPHYSIOL, V11, P1, DOI 10.1097/00004691-199401000-00001; Harriman DGF, 1996, MUSCLE NERVE, V19, P1447, DOI 10.1002/(SICI)1097-4598(199611)19:11<1447::AID-MUS9>3.0.CO;2-C; Hirasawa C, 2006, ANN PLAS SURG, V57, P529, DOI 10.1097/01.sap.0000227484.76120.97; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; HOMMA S, 1994, ELECTROEN CLIN NEURO, V91, P374, DOI 10.1016/0013-4694(94)90122-8; Homma S, 1998, NEUROSCI LETT, V247, P25, DOI 10.1016/S0304-3940(98)00274-2; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; Ikeda E, 2013, PSYCHIAT RES-NEUROIM, V214, P254, DOI 10.1016/j.pscychresns.2013.07.009; Ishimatsu M, 1996, J NEUROSCI, V16, P5196; JONES BE, 1985, J COMP NEUROL, V242, P56, DOI 10.1002/cne.902420105; Kobayashi M, 2003, AUTON NEUROSCI-BASIC, V104, P58, DOI 10.1016/S1566-0702(02)00264-3; Koch C, 2004, QUEST CONSCIOUSNESS, P16; Kondoh S, 2006, ANN PLAS SURG, V57, P142, DOI 10.1097/01.sap.0000214172.63510.ab; Kushima H, 2005, BRIT J PLAST SURG, V58, P681, DOI 10.1016/j.bjps.2005.01.006; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marzo A, 2014, J NEUROPHYSIOL, V111, P2570, DOI 10.1152/jn.00920.2013; Matsunami K, 2001, JPN J PHYSIOL, V51, P621, DOI 10.2170/jjphysiol.51.621; Matsuo K, 2005, BRIT J PLAST SURG, V58, P668, DOI 10.1016/j.bjps.2004.12.032; Matsuo K, 2002, OPHTHALMIC PLAST REC, V18, P5, DOI 10.1097/00002341-200201000-00002; Matsuo K, 2003, SCAND J PLAST RECONS, V37, P81, DOI 10.1080/02844310310005603; Matsuo K, 2007, ANN PLAS SURG, V58, P166, DOI 10.1097/01.sap.0000232794.75209.21; Matsuo Kiyoshi, 2014, Eplasty, V14, pe30; Matsuo K, 2013, J PLAST SURG HAND SU, V47, P14, DOI 10.3109/2000656X.2012.718282; Matsuo K, 2013, J PLAST SURG HAND SU, V47, P21, DOI 10.3109/2000656X.2012.717896; Matsuo K, 2009, J PLAST RECONSTR AES, V62, P480, DOI 10.1016/j.bjps.2007.11.042; May PJ, 2012, J COMP NEUROL, V520, P2218, DOI 10.1002/cne.23039; May PJ, 1998, EXP BRAIN RES, V123, P368, DOI 10.1007/s002210050582; MESSINA C, 1976, J NEUROL SCI, V30, P303, DOI 10.1016/0022-510X(76)90136-2; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Myers-Schulz B, 2012, MOL PSYCHIATR, V17, P132, DOI 10.1038/mp.2011.88; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; NYGREN LG, 1977, BRAIN RES, V132, P85, DOI 10.1016/0006-8993(77)90707-7; Pfaff DW, 2012, TRENDS NEUROSCI, V35, P468, DOI 10.1016/j.tins.2012.04.008; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; PIERIBONE VA, 1994, J NEUROSCI, V14, P4252; Proudlock FA, 2007, PROG RETIN EYE RES, V26, P486, DOI 10.1016/j.preteyeres.2007.03.004; ROGER A, 1956, ELECTROEN CLIN NEURO, V8, P1, DOI 10.1016/0013-4694(56)90027-X; Rosca T, 1981, Morphol Embryol (Bucur), V27, P3; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Simpson KL, 1997, J COMP NEUROL, V385, P135; Song HS, 1997, PLAST RECONSTR SURG, V99, P51, DOI 10.1097/00006534-199701000-00008; Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1; Spoormaker VI, 2011, NEUROIMAGE, V54, P2250, DOI 10.1016/j.neuroimage.2010.09.042; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tanaka S, 2006, J NEUROSCI RES, V83, P1362, DOI 10.1002/jnr.20822; TEASDALE G, 1974, LANCET, V2, P81; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tucker DM, 2007, EPILEPSY BEHAV, V11, P546, DOI 10.1016/j.yebeh.2007.04.023; WESTLUND KN, 1983, BRAIN RES, V263, P15, DOI 10.1016/0006-8993(83)91196-4; Williams LM, 2005, NEUROREPORT, V16, P49, DOI 10.1097/00001756-200501190-00012; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Yuzuriha S, 2005, BRIT J PLAST SURG, V58, P42, DOI 10.1016/j.bjps.2004.06.006; Yuzuriha S, 2012, EPLASTY, V12, pe40; Yuzuriha S, 2009, J PLAST RECONSTR AES, V62, P1403, DOI 10.1016/j.bjps.2008.06.046; Zhang S, 2014, SOC COGN AFFECT NEUR, V9, P900, DOI 10.1093/scan/nst064	87	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134659	10.1371/journal.pone.0134659	http://dx.doi.org/10.1371/journal.pone.0134659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244675	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400097
J	Miron-Shatz, T; Bhargave, R; Doniger, GM				Miron-Shatz, Talya; Bhargave, Rajesh; Doniger, Glen M.			Milestone Age Affects the Role of Health and Emotions in Life Satisfaction: A Preliminary Inquiry	PLOS ONE			English	Article							COGNITIVE REFERENCE POINTS; EXPERIENCE; US	Jill turns 40. Should this change how she evaluates her life, and would a similar change occur when she turns 41 ? Milestone age (e.g., 30, 40, 50)-a naturally occurring feature in personal timelines-has received much attention is popular culture, but little attention in academic inquiry. This study examines whether milestone birthdays change the way people evaluate their life. We show that life outlook is impacted by this temporal landmark, which appears to punctuate people's mental maps of their life cycle. At these milestone junctures, people take stock of where they stand and have a more evaluative perspective towards their lives when making life satisfaction judgments. Correspondingly, they place less emphasis on daily emotional experiences. We find that milestone agers (vs. other individuals) place greater weight on health satisfaction and BMI and lesser weight on daily positive emotions in their overall life satisfaction judgments, whereas negative emotions remain influential.	[Miron-Shatz, Talya; Doniger, Glen M.] Ono Acad Coll, Ctr Med Decis Making, Kiryat Ono, Israel; [Bhargave, Rajesh] Univ Texas San Antonio, Dept Mkt, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Miron-Shatz, T (corresponding author), Ono Acad Coll, Ctr Med Decis Making, Kiryat Ono, Israel.	talyam@ono.ac.il		Doniger, Glen M/0000-0003-2690-3569				Aerts W, 2008, J ECON PSYCHOL, V29, P276, DOI 10.1016/j.joep.2007.10.003; Alter AL, 2014, P NATL ACAD SCI USA, V111, P17066, DOI 10.1073/pnas.1415086111; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Hubley AM, 2009, INT J BEHAV DEV, V33, P12, DOI 10.1177/0165025408099486; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Kahneman D., 1999, WELL BEING FDN HEDON, P3, DOI DOI 10.7758/9781610443258; Krueger AB, 2009, SOC INDIC RES, V93, P7, DOI 10.1007/s11205-008-9415-4; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Madsen KA, 2009, ARCH PEDIAT ADOL MED, V163, P1014, DOI 10.1001/archpediatrics.2009.181; Miron-Shatz T, 2009, EMOTION, V9, P885, DOI 10.1037/a0017823; Miron-Shatz T, 2009, JUDGM DECIS MAK, V4, P102; Miron-Shatz T, 2009, EMOTION, V9, P206, DOI 10.1037/a0015295; Neugarten BL, 1976, HDB AGING SOCIAL SCI, P35; Oishi S, 1999, PERS SOC PSYCHOL B, V25, P980, DOI 10.1177/01461672992511006; Phillips David P., 1991, LIFE SPAN PERSPECTIV, P81, DOI DOI 10.1007/978-1-4899-0724-0_7; PHILLIPS DP, 1992, PSYCHOSOM MED, V54, P532, DOI 10.1097/00006842-199209000-00001; Pope D, 2011, PSYCHOL SCI, V22, P71, DOI 10.1177/0956797610391098; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P532, DOI 10.1016/0010-0285(75)90021-3; Schaupp D, 2007, PRIME TIME FLOURISHI; Schimmack U, 2010, SOC INDIC RES, V95, P19, DOI 10.1007/s11205-009-9443-8; Siedlecki KL, 2014, SOC INDIC RES, V117, P561, DOI 10.1007/s11205-013-0361-4; Suh EM, 2008, J CROSS CULT PSYCHOL, V39, P3, DOI 10.1177/0022022107311769; Tiberius V., 2014, ENCY QUALITY LIFE WE, P3591; Uthayakumar R, 2010, J VOCAT BEHAV, V77, P196, DOI 10.1016/j.jvb.2010.07.002; Westheimer RK, 2005, RUTHS SEX 50 REVVING; Wirtz D, 2009, J PERS, V77, P1167, DOI 10.1111/j.1467-6494.2009.00578.x	28	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133254	10.1371/journal.pone.0133254	http://dx.doi.org/10.1371/journal.pone.0133254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244348	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400038
J	Nagatomo, S; Nagai, Y; Aki, Y; Sakurai, H; Imai, K; Mizusawa, N; Ogura, T; Kitagawa, T; Nagai, M				Nagatomo, Shigenori; Nagai, Yukifumi; Aki, Yayoi; Sakurai, Hiroshi; Imai, Kiyohiro; Mizusawa, Naoki; Ogura, Takashi; Kitagawa, Teizo; Nagai, Masako			An Origin of Cooperative Oxygen Binding of Human Adult Hemoglobin: Different Roles of the alpha and beta Subunits in the alpha(2)beta(2) Tetramer	PLOS ONE			English	Article							ULTRAVIOLET RESONANCE RAMAN; NUCLEAR-MAGNETIC-RESONANCE; NI(II)-FE(II) HYBRID HEMOGLOBINS; QUATERNARY STRUCTURE CHANGES; GEL-ENCAPSULATED HEMOGLOBIN; UV CIRCULAR-DICHROISM; LIGAND-BINDING; T-STATE; NEAR-UV; ALLOSTERIC TRANSITIONS	Human hemoglobin (Hb), which is an alpha(2)beta(2) tetramer and binds four O-2 molecules, changes its O-2-affinity from low to high as an increase of bound O-2, that is characterized by 'cooperativity'. This property is indispensable for its function of O-2 transfer from a lung to tissues and is accounted for in terms of T/R quaternary structure change, assuming the presence of a strain on the Fe-histidine (His) bond in the T state caused by the formation of hydrogen bonds at the subunit interfaces. However, the difference between the alpha and beta subunits has been neglected. To investigate the different roles of the Fe-His(F8) bonds in the alpha and beta subunits, we investigated cavity mutant Hbs in which the Fe-His(F8) in either alpha or beta subunits was replaced by Fe-imidazole and F8-glycine. Thus, in cavity mutant Hbs, the movement of Fe upon O-2-binding is detached from the movement of the F-helix, which is supposed to play a role of communication. Recombinant Hb (rHb)(alpha H87G), in which only the Fe-His in the a subunits is replaced by Fe-imidazole, showed a biphasic O-2-binding with no cooperativity, indicating the coexistence of two independent hemes with different O-2-affinities. In contrast, rHb(beta H92G), in which only the Fe-His in the beta subunits is replaced by Fe-imidazole, gave a simple high-affinity O-2-binding curve with no cooperativity. Resonance Raman, H-1 NMR, and near-UV circular dichroism measurements revealed that the quaternary structure change did not occur upon O-2-binding to rHb(alpha H87G), but it did partially occur with O-2-binding to rHb(beta H92G). The quaternary structure of rHb(alpha H87G) appears to be frozen in T while its tertiary structure is changeable. Thus, the absence of the Fe-His bond in the alpha subunit inhibits the T to R quaternary structure change upon O-2-binding, but its absence in the beta subunit simply enhances the O-2-affinity of a subunit.	[Nagatomo, Shigenori] Univ Tsukuba, Dept Chem, Tsukuba, Ibaraki 305, Japan; [Nagai, Yukifumi; Mizusawa, Naoki; Nagai, Masako] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo 184, Japan; [Aki, Yayoi; Sakurai, Hiroshi; Nagai, Masako] Kanazawa Univ, Sch Hlth Sci, Coll Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Imai, Kiyohiro; Mizusawa, Naoki] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Ogura, Takashi; Kitagawa, Teizo] Univ Hyogo, Picobiol Inst, Grad Sch Life Sci, RSC UH Leading Program Ctr, Sayo, Hyogo, Japan	University of Tsukuba; Hosei University; Kanazawa University; Hosei University; University of Hyogo	Nagatomo, S (corresponding author), Univ Tsukuba, Dept Chem, Tsukuba, Ibaraki 305, Japan.	nagatomo@chem.tsukuba.ac.jp; teizo@sci.u-hyogo.ac.jp; masako.nagai.34@hosei.ac.jp	SAKURAI, Hiroshi/L-3693-2015	Sakurai, Hiroshi/0000-0002-0336-2301	Ministry of Education, Culture, Sports, Science, and Technology [24350086, 22570217, 25109540]; Research Center for Micro-Nano Technology, Hosei University	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Micro-Nano Technology, Hosei University	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology for Scientific Research (B) to TK (24350086) and to KI (22570217), and for Priority Area to TO (25109540), and also by a research grant from Research Center for Micro-Nano Technology, Hosei University (to MN, KI, and NM).	Ackers GK, 2006, J BIOL CHEM, V281, P11441, DOI 10.1074/jbc.R500019200; Adair GS, 1925, J BIOL CHEM, V63, P529; Aki-Jin Y, 2007, ACS SYM SER, V963, P297; ASAKURA T, 1976, J MOL BIOL, V104, P185, DOI 10.1016/0022-2836(76)90008-5; Balakrishnan G, 2009, BIOCHEMISTRY-US, V48, P3120, DOI 10.1021/bi802190f; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Barrick D, 2001, BIOCHEMISTRY-US, V40, P3780, DOI 10.1021/bi002165q; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Chang R., 2000, PHYS CHEM CHEM BIOL; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; Chi ZH, 1998, J PHYS CHEM B, V102, P9595, DOI 10.1021/jp9828336; Das TK, 1999, BIOSPECTROSCOPY, V5, pS64, DOI 10.1002/(SICI)1520-6343(1999)5:5+<S64::AID-BSPY7>3.0.CO;2-W; Fan JS, 2013, BIOCHEMISTRY-US, V52, P5809, DOI 10.1021/bi4005683; FUJII M, 1993, J BIOL CHEM, V268, P15386; FUNG LWM, 1976, P NATL ACAD SCI USA, V73, P1581, DOI 10.1073/pnas.73.5.1581; HARADA I, 1986, SPECTROCHIM ACTA A, V42, P307, DOI 10.1016/0584-8539(86)80193-3; HAYASHI A, 1967, BIOCHIM BIOPHYS ACTA, V147, P407, DOI 10.1016/0005-2795(67)90426-6; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HO C, 1992, ADV PROTEIN CHEM, V43, P153, DOI 10.1016/S0065-3233(08)60555-0; Hori H, 2012, J INORG BIOCHEM, V116, P53, DOI 10.1016/j.jinorgbio.2012.07.019; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Hu XH, 1997, BIOCHEMISTRY-US, V36, P15701, DOI 10.1021/bi971136l; Imai K, 1981, Methods Enzymol, V76, P470; Imai K., 1982, ALLOSTERIC EFFECTS H; INUBUSHI T, 1983, BIOCHEMISTRY-US, V22, P2904, DOI 10.1021/bi00281a019; JAYARAMAN V, 1995, SCIENCE, V269, P1843, DOI 10.1126/science.7569921; Jin Y, 2004, BIOPOLYMERS, V74, P60, DOI 10.1002/bip.20044; JOHNSON ME, 1974, BIOCHEMISTRY-US, V13, P3653, DOI 10.1021/bi00715a005; Jones EM, 2014, J AM CHEM SOC, V136, P10325, DOI 10.1021/ja503328a; Jones EM, 2012, J AM CHEM SOC, V134, P3461, DOI 10.1021/ja210126j; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P6101, DOI 10.1021/bi047813a; KITAGAWA T, 1979, FEBS LETT, V104, P376, DOI 10.1016/0014-5793(79)80856-X; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Li R, 2000, J INORG BIOCHEM, V82, P93, DOI 10.1016/S0162-0134(00)00151-3; LIDDINGTON R, 1988, NATURE, V331, P725, DOI 10.1038/331725a0; LYNCH RE, 1976, J BIOL CHEM, V251, P1015; MATSUKAWA S, 1985, J AM CHEM SOC, V107, P1108, DOI 10.1021/ja00291a004; Matsuno M, 1998, B CHEM SOC JPN, V71, P851, DOI 10.1246/bcsj.71.851; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; NAGAI K, 1980, P NATL ACAD SCI-BIOL, V77, P2033, DOI 10.1073/pnas.77.4.2033; NAGAI M, 1995, J BIOL CHEM, V270, P1636, DOI 10.1074/jbc.270.4.1636; Nagai M, 1999, BIOCHEMISTRY-US, V38, P1243, DOI 10.1021/bi982269p; Nagai M, 1996, J MOL STRUCT, V379, P65, DOI 10.1016/0022-2860(95)09177-7; Nagai M, 2011, HEMOGLOBIN RECENT DE, P63; Nagai M, 2008, BIOCHEMISTRY-US, V47, P517, DOI 10.1021/bi7015519; Nagatomo S, 1999, BIOCHEMISTRY-US, V38, P9659, DOI 10.1021/bi990567w; Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5; Nagatomo S, 2002, BIOCHEMISTRY-US, V41, P10010, DOI 10.1021/bi0200460; Nagatomo S, 2011, J PHYS CHEM B, V115, P12971, DOI 10.1021/jp205010m; Nagatomo S, 2011, J AM CHEM SOC, V133, P10101, DOI 10.1021/ja111370f; ONDRIAS MR, 1982, J BIOL CHEM, V257, P8766; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2163, DOI 10.1021/bi00707a026; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P4346, DOI 10.1021/bi9708693; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Ronda L, 2006, PROTEIN SCI, V15, P1961, DOI 10.1110/ps.062272306; ROUSSEAU DL, 1984, BIOCHEMISTRY-US, V23, P2857, DOI 10.1021/bi00308a003; RUSSU IM, 1987, BIOCHIM BIOPHYS ACTA, V914, P40, DOI 10.1016/0167-4838(87)90159-2; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Sato A, 2011, B CHEM SOC JPN, V84, P1107, DOI 10.1246/bcsj.20110104; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; SHIBAYAMA N, 1986, J MOL BIOL, V192, P331, DOI 10.1016/0022-2836(86)90368-2; SHIBAYAMA N, 1986, J MOL BIOL, V192, P323, DOI 10.1016/0022-2836(86)90367-0; SHIBAYAMA N, 1987, BIOCHEMISTRY-US, V26, P2194, DOI 10.1021/bi00382a019; Shibayama N, 2001, FEBS LETT, V492, P50, DOI 10.1016/S0014-5793(01)02225-6; Song XJ, 2008, BIOCHEMISTRY-US, V47, P4907, DOI 10.1021/bi7023699; TAKAHASHI S, 1980, BIOCHEMISTRY-US, V19, P5196, DOI 10.1021/bi00564a007; TERAOKA J, 1981, J BIOL CHEM, V256, P3969; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; VIGGIANO G, 1979, P NATL ACAD SCI USA, V76, P3673, DOI 10.1073/pnas.76.8.3673; Voet D., 2005, BIOCHEMISTRY-US; Wang DJ, 2000, J PHYS CHEM A, V104, P4149, DOI 10.1021/jp992423x; WINTERBOURN CC, 1976, BIOCHEM J, V155, P493, DOI 10.1042/bj1550493; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323	83	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135080	10.1371/journal.pone.0135080	http://dx.doi.org/10.1371/journal.pone.0135080			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244770	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400140
J	Olivan, S; Calvo, AC; Gasco, S; Munoz, MJ; Zaragoza, P; Osta, R				Olivan, Sara; Cristina Calvo, Ana; Gasco, Samanta; Jesus Munoz, Maria; Zaragoza, Pilar; Osta, Rosario			Time-Point Dependent Activation of Autophagy and the UPS in SOD1G93A Mice Skeletal Muscle	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL DYSFUNCTION; MOUSE MODEL; PROTEIN; ALS; NEURODEGENERATION; MACROAUTOPHAGY; DEGRADATION; EXPRESSION; DIAGNOSIS	Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by a selective loss of motor neurons together with a progressive muscle weakness. Albeit the pathophysiological mechanisms of the disease remain unknown, growing evidence suggests that skeletal muscle can be a target of ALS toxicity. In particular, the two main intracellular degradation mechanisms, autophagy and the ubiquitin-proteasome degradative system (UPS) have been poorly studied in this tissue. In this study we investigated the activation of autophagy and the UPS as well as apoptosis in the skeletal muscle from SOD1G93A mice along disease progression. Our results showed a significant upregulation of proteasome activity at early symptomatic stage, while the autophagy activation was found at presymptomatic and terminal stages. The mRNA upregulated levels of LC3, p62, Beclin1, Atg5 and E2f1 were only observed at symptomatic and terminal stages, which reinforced the time-point activation of autophagy. Furthermore, no apoptosis activation was observed along disease progression. The combined data provided clear evidence for the first time that there is a time-point dependent activation of autophagy and UPS in the skeletal muscle from SOD1G93A mice.	[Olivan, Sara; Cristina Calvo, Ana; Gasco, Samanta; Jesus Munoz, Maria; Zaragoza, Pilar; Osta, Rosario] Univ Zaragoza, Lab Genet & Bioquim LAGENBIO, Fac Vet, Inst Agroalimentario Aragon IA2,Inst Invest Sanit, Zaragoza, Spain	University of Zaragoza	Osta, R (corresponding author), Univ Zaragoza, Lab Genet & Bioquim LAGENBIO, Fac Vet, Inst Agroalimentario Aragon IA2,Inst Invest Sanit, Zaragoza, Spain.	osta@unizar.es	Calvo, Ana/L-2826-2017; Osta, Rosario/R-5410-2019; OLIVAN, SARA/AAR-6768-2020; zaragoza, pilar/AAN-9479-2021; Muñoz, Maria/L-3968-2017	Calvo, Ana/0000-0001-5193-7782; OLIVAN, SARA/0000-0003-0156-4230; Muñoz, Maria/0000-0001-8301-6902; Osta, Rosario/0000-0001-5687-6704; Gasco, Samanta/0000-0002-3318-4286	Fondo de Investigacion Sanitaria of Spain [PI14/00947]	Fondo de Investigacion Sanitaria of Spain(Instituto de Salud Carlos III)	This work was supported by PI14/00947 from Fondo de Investigacion Sanitaria of Spain.	Araki W, 2014, MOL NEUROBIOL, V50, P1049, DOI 10.1007/s12035-014-8644-6; Battistelli Michela, 2013, Muscles Ligaments Tendons J, V3, P267; Burgunder JM, 2011, EUR J NEUROL, V18, P207, DOI 10.1111/j.1468-1331.2010.03069.x; Carra S, 2012, PROG NEUROBIOL, V97, P83, DOI 10.1016/j.pneurobio.2011.09.009; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Crippa V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00234; Crippa V, 2010, AUTOPHAGY, V6, P958, DOI 10.4161/auto.6.7.13042; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dobrowolny G, 2008, NEUROL RES, V30, P131, DOI 10.1179/174313208X281235; Dobrowolny G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-3; Douglass CP, 2010, J NEUROL NEUROSUR PS, V81, P646, DOI 10.1136/jnnp.2009.197434; Ferrucci M, 2011, ARCH ITAL BIOL, V149, P121, DOI 10.4449/aib.v149i1.1258; Garcia-Garcia A, 2012, CANCER BIOL THER, V13, P1091, DOI 10.4161/cbt.21143; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kabashi E, 2008, J NEUROCHEM, V105, P2353, DOI 10.1111/j.1471-4159.2008.05317.x; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mori A, 2011, NEUROCHEM INT, V58, P344, DOI 10.1016/j.neuint.2010.12.010; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Mukhopadhyay S, 2014, APOPTOSIS, V19, P555, DOI 10.1007/s10495-014-0967-2; Musaro Antonio, 2010, World J Biol Chem, V1, P62, DOI 10.4331/wjbc.v1.i5.62; Nassif M, 2014, AUTOPHAGY, V10, P1256, DOI 10.4161/auto.28784; Nassif M, 2011, AUTOPHAGY, V7, P450, DOI 10.4161/auto.7.4.14700; Olivan S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652817; Onesto E, 2011, J NEUROCHEM, V118, P266, DOI 10.1111/j.1471-4159.2011.07298.x; Otomo A, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/498428; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pansarasa O, 2014, MOL NEUROBIOL, V49, P984, DOI 10.1007/s12035-013-8578-4; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tian FF, 2011, AUTOPHAGY, V7, P985, DOI 10.4161/auto.7.9.16012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei R, 2012, BIOCHEM BIOPH RES CO, V417, P1275, DOI 10.1016/j.bbrc.2011.12.126; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Xiao YJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12271; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134830	10.1371/journal.pone.0134830	http://dx.doi.org/10.1371/journal.pone.0134830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244336	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400108
J	Yu, XL; Sun, Z; Huang, R; Zhang, Y; Huang, YQ				Yu, Xiaoli; Sun, Zheng; Huang, Rui; Zhang, Yu; Huang, Yuqi			A Thermal Equilibrium Analysis of Line Contact Hydrodynamic Lubrication Considering the Influences of Reynolds Number, Load and Temperature	PLOS ONE			English	Article							SPEED JOURNAL BEARING; PAD THRUST-BEARINGS; OIL FILM THICKNESS; THERMOHYDRODYNAMIC PERFORMANCE; DIESEL-ENGINE; HEAT-TRANSFER; PISTON-RING; FLOW; BEHAVIOR; REGIMES	Thermal effects such as conduction, convection and viscous dissipation are important to lubrication performance, and they vary with the friction conditions. These variations have caused some inconsistencies in the conclusions of different researchers regarding the relative contributions of these thermal effects. To reveal the relationship between the contributions of the thermal effects and the friction conditions, a steady-state THD analysis model was presented. The results indicate that the contribution of each thermal effect sharply varies with the Reynolds number and temperature. Convective effect could be dominant under certain conditions. Additionally, the accuracy of some simplified methods of thermohydrodynamic analysis is further discussed.	[Yu, Xiaoli; Sun, Zheng; Huang, Rui; Zhang, Yu; Huang, Yuqi] Zhejiang Univ, Dept Energy Engn, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University	Huang, YQ (corresponding author), Zhejiang Univ, Dept Energy Engn, Hangzhou 310027, Zhejiang, Peoples R China.	huangyuqi@zju.edu.cn			National Natural Science Foundation of China [51206141]; National Basic Research Program of China (973 Program) [2011CB707205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The authors would like to thank the National Natural Science Foundation of China for their support of this work under grant No. 51206141, and the National Basic Research Program of China (973 Program) under the grant number 2011CB707205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MA, 2014, TRIBOL INT, V74, P79, DOI 10.1016/j.triboint.2014.02.012; Assanis DN, 1988, TRANSIENT ANAL PISTO; Boncompain R, 1986, T ASME, V108, P219; Chauhan A, 2010, TRIBOL INT, V43, P1970, DOI 10.1016/j.triboint.2010.03.017; Chun SM, 2004, TRIBOL INT, V37, P405, DOI 10.1016/j.triboint.2003.12.009; Chun SM, 2001, TRIBOL INT, V34, P397; Dobrica MB, 2006, J TRIBOL-T ASME, V128, P312, DOI 10.1115/1.2162914; Dowson D., 1966, P I MECH ENG J, V181, P70, DOI DOI 10.1243/PIME_CONF_1966_181_034_02; Dowson D, 1962, INT J MECH SCI, V4, P159, DOI [10.1016/S0020-7403(62)80038-1, DOI 10.1016/S0020-7403(62)80038-1]; Durany J, 2014, MATH COMPUT SIMULAT, V102, P90, DOI 10.1016/j.matcom.2013.09.005; ELSAIE YMHA, 1988, P I MECH ENG C-J MEC, V202, P51, DOI 10.1243/PIME_PROC_1988_202_085_02; Hamrock BJ, 2004, FUNDAMENTALS FLUID F, P221; HAN T, 1990, J TRIBOL-T ASME, V112, P557, DOI 10.1115/1.2920293; Harigaya Y, 2003, J ENG GAS TURB POWER, V125, P596, DOI 10.1115/1.1501078; Harigaya Y, 2006, J ENG GAS TURB POWER, V128, P685, DOI 10.1115/1.1924403; Harnoy A., 2002, BEARING DESIGN MACHI, P105; Hatakenaka K, 2002, P I MECH ENG J-J ENG, V216, P315, DOI 10.1243/135065002760364859; Kim KW, 1982, 3 DIMENSIONAL ANAL T; Kingsbury A, 1933, MECH ENG, V55, P685; Long Z., 2011, STUDY COUPLED MECH H; Meng FM, 2007, TRIBOL INT, V40, P1089, DOI 10.1016/j.triboint.2006.10.006; NEAL PB, 1982, P I MECH ENG, V196, P217, DOI 10.1243/PIME_PROC_1982_196_023_02; Pierre I, 2000, P I MECH ENG J-J ENG, V214, P445, DOI 10.1243/1350650001543322; Rakopoulos CD, 1997, INTEGRATED TRANSIENT; Swift HW, 1937, P IMECHE GEN DISCUSS, V1, P309; TANIGUCHI S, 1990, J TRIBOL-T ASME, V112, P542, DOI 10.1115/1.2920291; van Ostayen RAJ, 2009, TRIBOL INT, V42, P23, DOI 10.1016/j.triboint.2008.05.013; Wang XL, 2006, TRIBOL INT, V39, P227, DOI 10.1016/j.triboint.2005.01.028; Wodtke M, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023086	29	3	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134806	10.1371/journal.pone.0134806	http://dx.doi.org/10.1371/journal.pone.0134806			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244665	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400104
J	Bounafaa, A; Berrougui, H; Ghalim, N; Nasser, B; Bagri, A; Moujahld, A; Ikhlef, S; Camponova, P; Yamoul, N; Simo, OK; Essamadi, A; Khalil, A				Bounafaa, Abdelghani; Berrougui, Hicham; Ghalim, Noreddine; Nasser, Boubker; Bagri, Abdallah; Moujahld, Abderrahmane; Ikhlef, Souad; Camponova, Pamela; Yamoul, Najoua; Simo, Olivier Kamtchueng; Essamadi, Abdelkhalid; Khalil, Abdelouahed			Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population	PLOS ONE			English	Article							Q192R GENE POLYMORPHISMS; ARTERY-DISEASE; SERUM PARAOXONASE; HEART-DISEASE; CARDIOVASCULAR RISK; OXIDATIVE STRESS; GLN-ARG192 POLYMORPHISM; OXIDIZED PHOSPHOLIPIDS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE	The purpose of the present study was to investigate the distribution of PON1 Q192R and L55M polymorphisms and activities in a North African population and to determine their association with cardiovascular complications. The prevalence of the QQ, QR, RR, LL, LM, and MM genotypes in the study population was 55.4%, 34.09%, 9.83%, 41.97%, 48.20%, and 9.83% respectively. The Q, R, L, and M alleles had a gene frequency of 0.755, 0.245, 0.67, and 0.33, respectively. The PON1 192 RR genotype was significantly more prevalent among ACS patients than among healthy subjects. There was a 4.33-fold increase in the risk of ACS in subjects presenting the PON1 192 RR genotype compared to those with the QQ genotype (OR=4.33; 95% CI=1.27-17.7). There was a significantly different distribution of PON1 L55M in the ACS patient groups (UA, STEMI, NSTEMI). Moreover, individuals presenting the PON1 55MM genotype present a higher risk for ACS than those with LL genotype (OR=3.69; 95% CI=1.61-11.80). Paraoxonase activities were significantly lower in coronary patients than in healthy subjects. The decrease in PON1 activity was inversely correlated with the number of concomitant risk factors for CVD (r= 0.57, p<0.0001). The results of the present study suggested that the PON1 R and M alleles may play a role in the pathogenesis of cardiac ischemia in our North African population and that a decrease in PON1 activity may be a valuable marker for monitoring the development of the atherosclerosis process and the associated cardiovascular complications.	[Bounafaa, Abdelghani; Nasser, Boubker; Bagri, Abdallah; Moujahld, Abderrahmane; Essamadi, Abdelkhalid] Hassan First Univ, Lab Biochem & Neurosci, Appl Biochem & Toxicol Team, Fac Sci & Technol, Settat, Morocco; [Bounafaa, Abdelghani; Berrougui, Hicham; Ikhlef, Souad; Camponova, Pamela; Simo, Olivier Kamtchueng; Khalil, Abdelouahed] Univ Sherbrooke, Dept Med, Geriatr Serv, Fac Med & Biol Sci, Sherbrooke, PQ J1K 2R1, Canada; [Berrougui, Hicham] Sultan Moulay Sliman Univ, Dept Biol, Polydisciplinary Fac, Beni Mellal, Morocco; [Ghalim, Noreddine] Pasteur Inst Morocco, Biochem Lab, Casablanca, Morocco; [Yamoul, Najoua] Ibn Rochd Univ Hosp Ctr, Serv Cardiol, Casablanca, Morocco	Hassan First University of Settat; University of Sherbrooke; Sultan Moulay Slimane University of Beni Mellal; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca	Khalil, A (corresponding author), Univ Sherbrooke, Dept Med, Geriatr Serv, Fac Med & Biol Sci, Sherbrooke, PQ J1K 2R1, Canada.	a.khalil@usherbrooke.ca		Khalil, Abdelouahed/0000-0003-0817-3160; berrougui, hicham/0000-0002-0546-6534; ABDELKHALID, ESSAMADI/0000-0003-4537-1684	Canadian Institutes of Health Research [MOP-89912, IAO-134212]; FST of Settat; Pasteur Institute of Casablanca, Morocco	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FST of Settat; Pasteur Institute of Casablanca, Morocco	This work was supported by grants from the Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca (MOP-89912 and IAO-134212), FST of Settat and Pasteur Institute of Casablanca, Morocco.	ALDRIDGE WN, 1953, BIOCHEM J, V53, P110, DOI 10.1042/bj0530110; Amabile N, 2015, EUR HEART J-CARD IMG, V16, P433, DOI 10.1093/ehjci/jeu228; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeradbiomed.2004.06.030; Ayub A, 1999, ARTERIOSCL THROM VAS, V19, P330, DOI 10.1161/01.ATV.19.2.330; Barbieri M, 2002, J CLIN ENDOCR METAB, V87, P222, DOI 10.1210/jc.87.1.222; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bounafaa A, 2014, CLIN BIOCH; Brunzell JD, 2008, DIABETES CARE, V31, P811, DOI 10.2337/dc08-9018; Chen CC, 2013, CLIN BIOCHEM, V46, P1664, DOI 10.1016/j.clinbiochem.2013.05.066; Cherki M, 2007, EXP GERONTOL, V42, P815, DOI 10.1016/j.exger.2007.04.006; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; Flekac M, 2008, PHYSIOL RES, V57, P717, DOI 10.33549/physiolres.931285; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Furlong CE, 2007, J BIOCHEM MOL TOXIC, V21, P197, DOI 10.1002/jbt.20181; Garin MCB, 1997, J CLIN INVEST, V99, P62, DOI 10.1172/JCI119134; Gbandjaba NY, 2012, CLIN BIOCHEM, V45, P470, DOI 10.1016/j.clinbiochem.2012.01.005; Gupta N, 2012, GENE, V498, P13, DOI 10.1016/j.gene.2012.01.091; Hassan MA, 2013, MOL CELL BIOCHEM, V380, P121, DOI 10.1007/s11010-013-1665-z; HEGELE RA, 1995, ARTERIOSCL THROM VAS, V15, P89, DOI 10.1161/01.ATV.15.1.89; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Imai Y, 2000, ATHEROSCLEROSIS, V149, P435, DOI 10.1016/S0021-9150(99)00340-8; Inoue M, 2000, METABOLISM, V49, P1400, DOI 10.1053/meta.2000.17724; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Kallel A, 2010, CLIN BIOCHEM, V43, P1461, DOI 10.1016/j.clinbiochem.2010.08.029; Ko YL, 1998, ATHEROSCLEROSIS, V141, P259, DOI 10.1016/S0021-9150(98)00179-8; Kockx MM, 2006, HEART, V92, P1557, DOI 10.1136/hrt.2005.086942; Lawlor DA, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-17; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Loued S, 2013, BR J NUTR, P1; Loued S, 2012, LIFE SCI, V90, P82, DOI 10.1016/j.lfs.2011.10.018; Luersen Kai, 2011, BMC Res Notes, V4, P141, DOI 10.1186/1756-0500-4-141; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; Mahrooz A, 2014, J NEUROL SCI, V338, P197, DOI 10.1016/j.jns.2014.01.006; Malin R, 2001, ATHEROSCLEROSIS, V157, P301, DOI 10.1016/S0021-9150(00)00728-0; Manresa JM, 2004, MED CLIN-BARCELONA, V122, P126; Martinelli N, 2005, CLIN EXP MED, V5, P20, DOI 10.1007/s10238-005-0060-9; Mendonca MI, 2010, REV PORT CARDIOL, V29, P571; Milochevitch C, 2001, PROSTAG LEUKOTR ESS, V65, P241, DOI 10.1054/plef.2001.0320; Mohamed RH, 2010, CLIN BIOCHEM, V43, P553, DOI 10.1016/j.clinbiochem.2009.12.015; Mouhamed Dhouha Haj, 2012, Environmental Health and Preventive Medicine, V17, P316, DOI 10.1007/s12199-011-0256-4; Ombres D, 1998, ARTERIOSCL THROM VAS, V18, P1611, DOI 10.1161/01.ATV.18.10.1611; Paragh G, 1999, NEPHRON, V83, P126, DOI 10.1159/000045489; Quillen EE, 2012, J LIPIDS, V2012, DOI 10.1155/2012/189681; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; SAHA N, 1991, CLIN GENET, V40, P277; Sanghera DK, 1997, ARTERIOSCL THROM VAS, V17, P1067, DOI 10.1161/01.ATV.17.6.1067; Scacchi R, 2003, HUM BIOL, V75, P365, DOI 10.1353/hub.2003.0049; Scacchi R, 2003, NEUROSCI LETT, V339, P17, DOI 10.1016/S0304-3940(02)01437-4; Seres I, 2004, EXP GERONTOL, V39, P59, DOI 10.1016/j.exger.2003.08.001; Seres I, 1996, ATHEROSCLEROSIS, V121, P175, DOI 10.1016/0021-9150(95)05714-5; Serrato M, 1995, J CLIN INVEST, V96, P3005, DOI 10.1172/JCI118373; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Taskiran P, 2009, TURK KARDIYOL DERN A, V37, P473; Tazi MA, 2003, J HYPERTENS, V21, P897, DOI 10.1097/00004872-200305000-00013; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Vaisi-Raygani A, 2011, MOLECULAR BIOLOGY RE; Veiga L, 2011, EUR J ENDOCRINOL, V164, P213, DOI 10.1530/EJE-10-0825; Voetsch B, 2002, STROKE, V33, P1459, DOI 10.1161/01.STR.0000016928.60995.BD; Wang Q, 2005, CURR OPIN CARDIOL, V20, P182, DOI 10.1097/01.hco.0000160373.77190.f1; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yamada Y, 2003, J HUM GENET, V48, P469, DOI 10.1007/s10038-003-0063-x; Zama T, 1997, ARTERIOSCL THROM VAS, V17, P3565, DOI 10.1161/01.ATV.17.12.3565; Zhou CY, 2013, DIS MARKERS, V2013, P97, DOI 10.1155/2013/816189	73	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133719	10.1371/journal.pone.0133719	http://dx.doi.org/10.1371/journal.pone.0133719			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241956	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942700021
J	Sinha, AK; AbdElgawad, H; Zinta, G; Dasan, AF; Rasoloniriana, R; Asard, H; Blust, R; De Boeck, G				Sinha, Amit Kumar; AbdElgawad, Hamada; Zinta, Gaurav; Dasan, Antony Franklin; Rasoloniriana, Rindra; Asard, Han; Blust, Ronny; De Boeck, Gudrun			Nutritional Status as the Key Modulator of Antioxidant Responses Induced by High Environmental Ammonia and Salinity Stress in European Sea Bass (Dicentrarchus labrax)	PLOS ONE			English	Article								Salinity fluctuation is one of the main factors affecting the overall fitness of marine fish. In addition, water borne ammonia may occur simultaneously with salinity stress. Additionally, under such stressful circumstances, fish may encounter food deprivation. The physiological and ion-osmo regulatory adaptive capacities to cope with all these stressors alone or in combination are extensively addressed in fish. To date, studies revealing the modulation of antioxidant potential as compensatory response to multiple stressors are rather lacking. Therefore, the present work evaluated the individual and combined effects of salinity challenge, ammonia toxicity and nutritional status on oxidative stress and antioxidant status in a marine teleost, European sea bass (Dicentrarchus labrax). Fish were acclimated to normal seawater (32 ppt), to brackish water (20 ppt and 10 ppt) and to hypo-saline water (2.5 ppt). Following acclimation to different salinities for two weeks, fish were exposed to high environmental ammonia (HEA, 20 mg/L representing 50% of 96h LC50 value for ammonia) for 12 h, 48 h, 84 h and 180 h, and were either fed (2% body weight) or fasted (unfed for 7 days prior to HEA exposure). Results show that in response to decreasing salinities, oxidative stress indices such as xanthine oxidase activity, levels of hydrogen peroxide (H2O2) and lipid peroxidation (malondialdehyde, MDA) increased in the hepatic tissue of fasted fish but remained unaffected in fed fish. HEA exposure at normal salinity (32 ppt) and at reduced salinities (20 ppt and 10 ppt) increased ammonia accumulation significantly (84 h-180 h) in both feeding regimes which was associated with an increment of H2O2 and MDA contents. Unlike in fasted fish, H2O2 and MDA levels in fed fish were restored to control levels (84 h-180 h); with a concomitant increase in superoxide dismutase (SOD), catalase (CAT), components of the glutathione redox cycle (reduced glutathione, glutathione peroxidase and glutathione reductase), ascorbate peroxidase (APX) activity and reduced ascorbate (ASC) content. On the contrary, fasted fish could not activate many of these protective systems and rely mainly on CAT and ASC dependent pathways as antioxidative sentinels. The present findings exemplify that in fed fish single factors and a combination of HEA exposure and reduced seawater salinities (upto 10 ppt) were insufficient to cause oxidative damage due to the highly competent antioxidant system compared to fasted fish. However, the impact of HEA exposure at a hypo-saline environment (2.5 ppt) also defied antioxidant defence system in fed fish, suggesting this combined factor is beyond the tolerance range for both feeding groups. Overall, our results indicate that the oxidative stress mediated by the experimental conditions were exacerbated during starvation, and also suggest that feed deprivation particularly at reduced seawater salinities can instigate fish more susceptible to ammonia toxicity.	[Sinha, Amit Kumar; Dasan, Antony Franklin; Rasoloniriana, Rindra; Blust, Ronny; De Boeck, Gudrun] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium; [AbdElgawad, Hamada; Zinta, Gaurav; Asard, Han] Univ Antwerp, Dept Biol, Mol Plant Physiol & Biotechnol Grp, B-2020 Antwerp, Belgium; [AbdElgawad, Hamada] Univ Beni Sueif, Fac Sci, Dept Bot, Bani Suwayf, Egypt	University of Antwerp; University of Antwerp; Egyptian Knowledge Bank (EKB); Beni Suef University	Sinha, AK (corresponding author), Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res, B-2020 Antwerp, Belgium.	sinha_cife@rediffmail.com	De Boeck, Gudrun/A-1938-2015; Zinta, Gaurav/A-1530-2015; AbdElgawad, Hamada/N-2488-2017	De Boeck, Gudrun/0000-0003-0941-3488; Zinta, Gaurav/0000-0002-5503-8618; Sinha, Amit Kumar/0000-0003-0419-7640; AbdElgawad, Hamada/0000-0001-9764-9006	Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO] [12A8814N]; GOA-BOF-UA	Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO](FWO); GOA-BOF-UA	AKS is a research fellow supported by the Fonds Wetenschappelijk Onderzoek-Vlaanderen [FWO Grant 12A8814N]. This research was also supported by GOA-BOF-UA-2007 grant to H.A.		0	52	58	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135091	10.1371/journal.pone.0135091	http://dx.doi.org/10.1371/journal.pone.0135091			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241315	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700095
J	Sours, C; Zhuo, JC; Roys, S; Shanmuganathan, K; Gullapalli, RP				Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.			Disruptions in Resting State Functional Connectivity and Cerebral Blood Flow in Mild Traumatic Brain Injury Patients	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT METRICS; MODE NETWORK CONNECTIVITY; DEFAULT-MODE; HEAD-INJURY; PERFUSION; DEFICITS; RELIABILITY; PERFORMANCE; TASK; RECOVERY	Mild traumatic brain injury (mTBI) is often occult to conventional imaging techniques. However, there is growing evidence that mTBI patients who lack evidence of structural intracranial injury may develop post-concussive syndrome (PCS). We investigated longitudinal alterations in resting state functional connectivity (rs-FC) in brain networks in a population of 28 patients compared to 28 matched control participants. Rs-FC and cerebral blood flow (CBF) within the nodes of the Default Mode Network (DMN) and Task Positive Network (TPN) were assessed at three time points including acute, sub-acute, and chronic stages following mTBI. Participants received the Automated Neuropsychological Assessment Metrics (ANAM) to assess cognitive performance. Main findings indicate that despite normalized cognitive performance, chronic mTBI patients demonstrate increased rs-FC between the DMN and regions associated with the salience network (SN) and TPN compared to the control populations, as well as reduced strength of rs-FC within the DMN at the acute stage of injury. In addition, chronic mTBI patients demonstrate an imbalance in the ratio of CBF between nodes of the DMN and TPN. Furthermore, preliminary exploratory analysis suggests that compared to those without chronic PCS, patients with chronic PCS reveal an imbalance in the ratio of CBF between the DMN nodes and TPN nodes across multiple stages of recovery. Findings suggest that the altered network perfusion with the associated changes in rs-FC may be a possible predictor of which mTBI patients will develop chronic PCS.	[Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Sours, Chandler; Zhuo, Jiachen; Roys, Steven; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sours, C (corresponding author), Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA.	csours001@umm.edu			Department of Defense [W81XWH-08-1-0725, W81XWH-12-1-0098]; National Institute of Neurological Disorders and Stroke [1F31NS081984]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081984] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was in part provided by the Department of Defense (W81XWH-08-1-0725 & W81XWH-12-1-0098 to RPG). CS was supported by an predoctoral grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Franco AR, 2013, BRAIN CONNECT, V3, P363, DOI 10.1089/brain.2012.0134; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jann K, 2013, BRAIN TOPOGR, V26, P569, DOI 10.1007/s10548-013-0280-3; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kindler J, 2013, SCHIZOPHR B; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu TT, 2013, NEUROIMAGE, V80, P339, DOI 10.1016/j.neuroimage.2013.04.071; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Mannfolk P, 2011, J MAGN RESON IMAGING, V34, P511, DOI 10.1002/jmri.22654; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M., 2000, STANDARDIZED ASSESSM; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ponsford J, 2013, J NEUROTRAUMA; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reich S, 2005, VALIDATION ANAM TEST; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sours C, 2014, BRAIN IMAGING BEHAV; Sours C, 2015, BRAIN CONNECT, V5, P442, DOI 10.1089/brain.2014.0333; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Wang JJ, 2003, J MAGN RESON IMAGING, V18, P404, DOI 10.1002/jmri.10372; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; World Health Organization, 2010, INT CLASS DIS; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	67	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134019	10.1371/journal.pone.0134019	http://dx.doi.org/10.1371/journal.pone.0134019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241476	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700032
J	Tieu, HV; Liu, TY; Hussen, S; Connor, M; Wang, L; Buchbinder, S; Wilton, L; Gorbach, P; Mayer, K; Griffith, S; Kelly, C; Elharrar, V; Phillips, G; Cummings, V; Koblin, B; Latkin, C				Tieu, Hong-Van; Liu, Ting-Yuan; Hussen, Sophia; Connor, Matthew; Wang, Lei; Buchbinder, Susan; Wilton, Leo; Gorbach, Pamina; Mayer, Kenneth; Griffith, Sam; Kelly, Corey; Elharrar, Vanessa; Phillips, Gregory; Cummings, Vanessa; Koblin, Beryl; Latkin, Carl		HPTN061	Sexual Networks and HIV Risk among Black Men Who Have Sex with Men in 6 US Cities	PLOS ONE			English	Article							OLDER PARTNER SELECTION; AFRICAN-AMERICAN MEN; MIXING PATTERNS; INFECTION; TRANSMISSION; DISPARITIES; BEHAVIORS; SPREAD	Background Sexual networks may place U.S. Black men who have sex with men (MSM) at increased HIV risk. Methods Self-reported egocentric sexual network data from the prior six months were collected from 1,349 community-recruited Black MSM in HPTN 061, a multi-component HIV prevention intervention feasibility study. Sexual network composition, size, and density (extent to which members are having sex with one another) were compared by self-reported HIV serostatus and age of the men. GEE models assessed network and other factors associated with having a Black sex partner, having a partner with at least two age category difference (age difference between participant and partner of at least two age group categories), and having serodiscordant/serostatus unknown unprotected anal/vaginal intercourse (SDUI) in the last six months. Results Over half had exclusively Black partners in the last six months, 46% had a partner of at least two age category difference, 87% had <= 5 partners. Nearly 90% had sex partners who were also part of their social networks. Among HIV-negative men, not having anonymous/exchange/trade partners and lower density were associated with having a Black partner; larger sexual network size and having non-primary partners were associated with having a partner with at least two age category difference; and having anonymous/exchange/trade partners was associated with SDUI. Among HIV-positive men, not having non-primary partners was associated with having a Black partner; no sexual network characteristics were associated with having a partner with at least two age category difference and SDUI. Conclusions Black MSM sexual networks were relatively small and often overlapped with the social networks. Sexual risk was associated with having non-primary partners and larger network size. Network interventions that engage the social networks of Black MSM, such as interventions utilizing peer influence, should be developed to address stable partnerships, number of partners, and serostatus disclosure.	[Tieu, Hong-Van; Koblin, Beryl] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Tieu, Hong-Van] Columbia Univ, Dept Med, Med Ctr, Div Infect Dis, New York, NY USA; [Liu, Ting-Yuan; Connor, Matthew; Wang, Lei; Kelly, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hussen, Sophia] Emory Sch Med, Div Infect Dis, Atlanta, GA USA; [Buchbinder, Susan] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Gorbach, Pamina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Epidemiol, Sch Publ Hlth,Div InfectiousDis, Los Angeles, CA 90095 USA; [Mayer, Kenneth] Fenway Community Hlth Ctr, Boston, MA USA; [Griffith, Sam] FHI 360, Res Triangle Pk, NC USA; [Elharrar, Vanessa] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Phillips, Gregory] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Epidemiol & Biostat, Washington, DC USA; [Cummings, Vanessa] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	New York Blood Center; Columbia University; Fred Hutchinson Cancer Center; Emory University; San Francisco Department of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; FHI 360; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tieu, HV (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA.	htieu@nybloodcenter.org	DSILVA, BROOKE/HCI-4879-2022	Phillips II, Gregory/0000-0001-8396-1170	National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1 AI068619, UM1 AI068617, UM1 AI068613]; Fenway Institute Clinical Research Site (CRS): Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069418, UM1AI069418, UM1AI069480, UM1AI069496, UM1AI068619, U01AI069424, P30AI060354, UM1AI068617, UM1AI069470, UM1AI068613, P30AI087714, U01AI069496, U01AI069466, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute Clinical Research Site (CRS): Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA; Hope Clinic of the Emory Vaccine Center CRS; Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	HPTN 061 grant support was provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding - Fenway Institute Clinical Research Site (CRS): Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The funder had a role in the design of the study by providing input into the design. The funder did not have a role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Berry M, 2007, AIDS, V21, P2349, DOI 10.1097/QAD.0b013e3282f12f41; Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613; Bocour A, 2011, JAIDS-J ACQ IMM DEF, V58, P417, DOI 10.1097/QAI.0b013e318230e6d9; Bohl DD, 2011, SEX TRANSM INFECT, V87, P616, DOI 10.1136/sextrans-2011-050103; Brewer RA, 2013, J ACQUIR IMMUNE DEFI; Burt RS, 2013, ANNU REV PSYCHOL, V64, P527, DOI 10.1146/annurev-psych-113011-143828; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; Chen I, 2015, J ACQUIR IMMUNE DEFI; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Doherty IA, 2009, JAIDS-J ACQ IMM DEF, V52, P114, DOI 10.1097/QAI.0b013e3181ab5e10; Dyer TP, 2012, J URBAN HEALTH, V89, P697, DOI 10.1007/s11524-012-9674-x; Eaton LA, AM J PUBLIC HEALTH, V100, P503, DOI [10.2105/AJPH.2008., DOI 10.2105/AJPH.2008]; Friedman MR, 2015, EFFECTS SYNDEMICS HI; Friedman SR, 1997, AM J PUBLIC HEALTH, V87, P1289, DOI 10.2105/AJPH.87.8.1289; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Tieu HV, 2011, SEX TRANSM DIS, V38, P548, DOI 10.1097/OLQ.0b013e318203e2d7; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Jolly AM, 2002, SEX TRANSM INFECT, V78, pI145, DOI 10.1136/sti.78.suppl_1.i145; Jolly AM, 2001, J URBAN HEALTH, V78, P433, DOI 10.1093/jurban/78.3.433; Joseph HA, 2011, SEX TRANSM INFECT, V87, P442, DOI 10.1136/sextrans-2011-050010; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Knoke D., 2008, SOCIAL NETWORK ANAL; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Magnus M, 2010, AIDS PATIENT CARE ST, V24, P615, DOI 10.1089/apc.2010.0111; Malebranche DJ, 2003, AM J PUBLIC HEALTH, V93, P862, DOI 10.2105/AJPH.93.6.862; Mannheimer SB, 2014, JAIDS-J ACQ IMM DEF, V67, P438, DOI 10.1097/QAI.0000000000000334; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Marzinke MA, 2014, CLIN INFECT DIS, V58, P117, DOI 10.1093/cid/cit672; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mimiaga MJ, 2009, J URBAN HLTH; Morris M, 2004, NETWORK EPIDEMIOLOGY; Newcomb ME, J ACQUIR IMMUNE DEFI; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Oster AM, 2011, AIDS, V25, P2157, DOI 10.1097/QAD.0b013e32834bfde9; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Oster AM, 2011, AM J PUBLIC HEALTH, V101, P137, DOI 10.2105/AJPH.2009.185850; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raymond HF, 2009, AIDS BEHAV; Rosenberg ES, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-189; Rothenberg R, 2007, SEX TRANSM INFECT, V83, P10, DOI 10.1136/sti.2006.017269; Rothenberg RB, 2000, AIDS, V14, P2191, DOI 10.1097/00002030-200009290-00016; Rothenberg R, 2009, CURR OPIN HIV AIDS, V4, P260, DOI 10.1097/COH.0b013e32832c7cfc; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Shah NS, 2013, AIDS BEHAV; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tieu HV, 2010, J URBAN HEALTH, V87, P113, DOI 10.1007/s11524-009-9416-x; UNAIDS Reference Group on Estimates MaP, 2013, CONS CONC PARTN 2009; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; Voetsch AC, 2012, SEX TRANSM DIS, V39, P229, DOI 10.1097/OLQ.0b013e31823d2b24; Wasserman S., 1994, SOCIAL NETWORKS, V8, P825; Wei CY, 2011, AIDS BEHAV, V15, P22, DOI 10.1007/s10461-010-9683-2; Wejnert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076878; Winter AK, 2012, JAIDS-J ACQ IMM DEF, V60, P525, DOI 10.1097/QAI.0b013e318257d0ac; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	65	44	46	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134085	10.1371/journal.pone.0134085	http://dx.doi.org/10.1371/journal.pone.0134085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241742	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700034
J	Wunderlich, KA; Tanimoto, N; Grosche, A; Zrenner, E; Pekny, M; Reichenbach, A; Seeliger, MW; Pannicke, T; Perez, MT				Wunderlich, Kirsten A.; Tanimoto, Naoyuki; Grosche, Antje; Zrenner, Eberhart; Pekny, Milos; Reichenbach, Andreas; Seeliger, Mathias W.; Pannicke, Thomas; Perez, Maria-Thereza			Retinal functional alterations in mice lacking intermediate filament proteins glial fibrillary acidic protein and vimentin	FASEB JOURNAL			English	Article						GFAP; Muller glia; electroretinogram; Kir channels; retinal ischemia	MULLER CELLS; ASTROCYTE ACTIVATION; REACTIVE ASTROCYTES; GENE-EXPRESSION; K+ CHANNELS; MOUSE; DEFICIENT; KIR4.1; INTEGRATION; DETACHMENT	Vimentin (Vim) and glial fibrillary acidic protein (GFAP) are important components of the intermediate filament (IF) (or nanofilament) system of astroglial cells. We conducted full-field electroretinogram (ERG) recordings and found that whereas photoreceptor responses (a-wave) were normal in uninjured GFAP(-/-)Vim(-/-) mice, b-wave amplitudes were increased. Moreover, we found that Kir (inward rectifier K+) channel protein expression was reduced in the retinas of GFAP(-/-)Vim(-/-) mice and that Kir-mediated current amplitudes were lower in Muller glial cells isolated from these mice. Studies have shown that the IF system, in addition, is involved in the retinal response to injury and that attenuated Muller cell reactivity and reduced photoreceptor cell loss are observed in IF-deficient mice after experimental retinal detachment. We investigated whether the lack of IF proteins would affect cell survival in a retinal ischemia-reperfusion model. We found that although cell loss was induced in both genotypes, the number of surviving cells in the inner retina was lower in IF-deficient mice. Our findings thus show that the inability to produce GFAP and Vim affects normal retinal physiology and that the effect of IF deficiency on retinal cell survival differs, depending on the underlying pathologic condition.	[Wunderlich, Kirsten A.; Perez, Maria-Thereza] Lund Univ, Div Ophthalmol, Dept Clin Sci, SE-22184 Lund, Sweden; [Perez, Maria-Thereza] Lund Univ, NanoLund, Nanometer Struct Consortium, SE-22184 Lund, Sweden; [Wunderlich, Kirsten A.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Wunderlich, Kirsten A.; Zrenner, Eberhart] Univ Tubingen, CIN, Tubingen, Germany; [Tanimoto, Naoyuki; Seeliger, Mathias W.] Univ Tubingen, Div Ocular Neurodegenerat, Inst Ophthalm Res, Tubingen, Germany; [Grosche, Antje] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden; [Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Pekny, Milos] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [Reichenbach, Andreas; Pannicke, Thomas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Lund University; Lund University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Regensburg; University of Gothenburg; Florey Institute of Neuroscience & Mental Health; Hunter Medical Research Institute; University of Newcastle; Leipzig University	Perez, MT (corresponding author), Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, BMC B11,Klin Gatan 26, SE-22184 Lund, Sweden.	maria_thereza.perez@med.lu.se	Grosche, Antje/N-1978-2014; Pannicke, Thomas/A-5078-2017; Reichenbach, Andreas/B-2510-2017	Grosche, Antje/0000-0003-0338-7530; Pannicke, Thomas/0000-0001-7435-9540; 	VELUX Stiftung; Crown Princess Margareta's Committee for the Blind; Stiftelse for Synskadade i fd Malmohus Lan; Thorsten och Elsa Segerfalks Stiftelse; European Union [020235-NEUROTRAIN, 512036-GENORET, 237956-EduGlia, 279017-TargetBraIn]; Deutsche Forschungsgemeinschaft [RE 849/16-1, SPP 1757, KFO134-Se837/5-2, Se837/6-2]; PRO RETINA-Stiftung; Center of Integrative Neuroscience [EXC 307]; Center of Excellence of the German Research Council; Bernstein Center for Computational Neuroscience, Tubingen; Swedish Medical Research Council [11548]; Avtal om Lakarutbildning och Forskning (ALF) Gothenburg [11392]; Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; NanoNet COST Action Grant [BM1002]	VELUX Stiftung; Crown Princess Margareta's Committee for the Blind; Stiftelse for Synskadade i fd Malmohus Lan; Thorsten och Elsa Segerfalks Stiftelse; European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); PRO RETINA-Stiftung; Center of Integrative Neuroscience; Center of Excellence of the German Research Council; Bernstein Center for Computational Neuroscience, Tubingen; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Avtal om Lakarutbildning och Forskning (ALF) Gothenburg; Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Hjarnfonden; Hagstromer's Foundation Millennium; NanoNet COST Action Grant	The authors thank B. Sandstrom for maintaining the animal colonies; H. Abdshill for tissue sectioning; Drs. U. Wilhelmsson and Y. de Pablo for crossing, breeding and genotyping of some of the mice; and Dr. R. S. Molday (University of British Columbia, Vancouver, BC, Canada) for the generous gift of antibodies against rhodopsin. This work was supported by grants from the VELUX Stiftung (to M.T.P.); Crown Princess Margareta's Committee for the Blind (to M.T.P.), Stiftelse for Synskadade i fd Malmohus Lan (to M.T.P.), Thorsten och Elsa Segerfalks Stiftelse (to M.T.P.); the European Union projects 020235-NEUROTRAIN (to M.T.P), 512036-GENORET (to M.T.P.), 237956-EduGlia (to M.P.), and 279017-TargetBraIn (to M.P.); Deutsche Forschungsgemeinschaft Grants RE 849/16-1 (to A. R. and T.P.), SPP 1757 (to A.R.), KFO134-Se837/5-2 (to M.W.S. and N.T.), and Se837/6-2 (to M.W.S.); the PRO RETINA-Stiftung (to A.G.); the Center of Integrative Neuroscience (EXC 307), a Center of Excellence of the German Research Council and the Bernstein Center for Computational Neuroscience, Tubingen (to E.Z.); and Swedish Medical Research Council Grant 11548, Avtal om Lakarutbildning och Forskning (ALF) Gothenburg (11392), the Arbetsmarknadens Forsakringsaktiebolag (AFA) Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, and NanoNet COST Action Grant BM1002 (to M.P.).	Azadi S, 2007, BRAIN RES, V1129, P116, DOI 10.1016/j.brainres.2006.10.031; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Eckes B, 1998, J CELL SCI, V111, P1897; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Frishman L. J., 2006, PRINCIPLES PRACTICE, P139; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Johnson LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055456; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lewis GP, 2010, MOL VIS, V16, P1361; LEWIS GP, 1989, EXP EYE RES, V49, P93, DOI 10.1016/0014-4835(89)90079-1; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Marmor MF, 2004, DOC OPHTHALMOL, V108, P107, DOI 10.1023/B:DOOP.0000036793.44912.45; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Newman E. A., 2009, ENCY NEUROSCIENCE, P225, DOI 10.1016/B978-008045046-9.00919-0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.317; Pannicke T, 2002, GLIA, V38, P268, DOI 10.1002/glia.10068; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Raz-Prag D, 2010, P NATL ACAD SCI USA, V107, P12710, DOI 10.1073/pnas.0913472107; Rehak M, 2009, INVEST OPHTH VIS SCI, V50, P2359, DOI 10.1167/iovs.08-2332; Reichenbach A., 2010, MULLER CELLS HLTH DI; Roesch Karin, 2012, Mol Vis, V18, P1197; Sarthy V., 2001, PERSP VIS R; Seeliger MW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1540; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Tatzelt J, 1996, NEUROLOGY, V47, P449, DOI 10.1212/WNL.47.2.449; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Wu J, 2004, MOL VIS, V10, P650; Wunderlich KA, 2010, INVEST OPHTH VIS SCI, V51, P4809, DOI 10.1167/iovs.09-5073; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Zhang Y, 2007, J NEUROSCI, V27, P4499, DOI 10.1523/JNEUROSCI.0200-07.2007; Zhang YQ, 2004, INVEST OPHTH VIS SCI, V45, P4440, DOI 10.1167/iovs.04-0165; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P324, DOI 10.1167/iovs.02-0132	58	21	21	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4815	4828		10.1096/fj.15-272963	http://dx.doi.org/10.1096/fj.15-272963			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26251181				2022-12-26	WOS:000365523600009
J	Hong, W; Lang, YG; Li, T; Zeng, ZY; Song, Y; Wu, YL; Li, WX; Cao, ZJ				Hong, Wei; Lang, Yange; Li, Tian; Zeng, Zhengyang; Song, Yu; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLUS RIBAVIRIN; PROTEIN; ARCHITECTURE; MECHANISM; VIROPORIN; DESIGN; ENTRY; NS5A	Viral infection is an early stage of its life cycle and represents a promising target for antiviral drug development. Here we designed and characterized three peptide inhibitors of hepatitis C virus (HCV) infection based on the structural features of the membrane-associated p7 polypeptide of HCV. The three peptides exhibited low toxicity and high stability while potently inhibiting initial HCV infection and suppressed established HCV infection at non-cytotoxic concentrations in vitro. The most efficient peptide (designated H2-3), which is derived from the H2 helical region of HCV p7 ion channel, inhibited HCV infection by inactivating both intracellular and extracellular viral particles. The H2-3 peptide inactivated free HCV with an EC50 (50% effective concentration) of 82.11 nM, which is >1000-fold lower than the CC50 (50% cytotoxic concentration) of Huh7.5.1 cells. H2-3 peptide also bound to cell membrane and protected host cells from viral infection. The peptide H2-3 did not alter the normal electrophysiological profile of the p7 ion channel or block viral release from Huh7.5.1 cells. Our work highlights a new anti-viral peptide design strategy based on ion channel, giving the possibility that ion channels are potential resources to generate antiviral peptides.	[Hong, Wei; Lang, Yange; Li, Tian; Zeng, Zhengyang; Song, Yu; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	zjcao@whu.edu.cn	Hong, Wei/AAJ-6912-2020	Hong, Wei/0000-0001-7410-4679	National Science Fund for Excellent Young Scholars [31422049]; Hubei Science Fund for Excellent Scholars [2015CFA042]; Fundamental Research Fund for the Central Universities in China [2042014kf0205]; China Scholarship Council [201308420306]	National Science Fund for Excellent Young Scholars; Hubei Science Fund for Excellent Scholars; Fundamental Research Fund for the Central Universities in China; China Scholarship Council(China Scholarship Council)	This work was supported by the grants from National Science Fund for Excellent Young Scholars (31422049), Hubei Science Fund for Excellent Scholars (2015CFA042), Fundamental Research Fund for the Central Universities in China (2042014kf0205), and the China Scholarship Council (201308420306).	Alter HJ, 2005, J HEPATOL, V43, P550, DOI 10.1016/j.jhep.2005.07.002; Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bobardt MD, 2008, P NATL ACAD SCI USA, V105, P5525, DOI 10.1073/pnas.0801388105; Bultmann H, 2002, J BIOL CHEM, V277, P36018, DOI 10.1074/jbc.M204849200; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Chevaliez S, 2006, HEPATITIS C VIRUSES; Cook GA, 2011, BBA-BIOMEMBRANES, V1808, P1448, DOI 10.1016/j.bbamem.2010.08.010; de Witte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018917; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013; Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Liu XY, 2013, J VIROL, V87, P1649, DOI 10.1128/JVI.02201-12; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Qin Z, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13053-8; Steinmann E, 2010, VIRUSES-BASEL, V2, P2078, DOI 10.3390/v2092078; Vieyres G, 2013, J VIROL, V87, P1664, DOI 10.1128/JVI.02782-12; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoon J, 2011, ANTIVIR RES, V92, P470, DOI 10.1016/j.antiviral.2011.10.009; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	30	3	4	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23254	23263		10.1074/jbc.M115.662452	http://dx.doi.org/10.1074/jbc.M115.662452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26251517	hybrid, Green Published			2022-12-26	WOS:000361685500034
J	Chan, B; Lopez, A; Sarkar, U				Chan, Brian; Lopez, Andrea; Sarkar, Urmimala			The Canary in the Coal Mine Tweets: Social Media Reveals Public Perceptions of Non-Medical Use of Opioids	PLOS ONE			English	Article							CHRONIC PAIN PATIENTS; UNITED-STATES; TWITTER; SAFETY; EPIDEMIC; PRODUCTS; TOBACCO; MISUSE	Objective Non-medical prescription opioid use is a growing public health concern. Social media is an emerging tool to understand health attitudes, beliefs, and behaviors. Methods We retrieved a sample of publicly available Twitter messages in early 2014, using common opioid medication names and slang search terms. We used content analysis to code messages by user, context of message (personal vs general experiences), and key content themes. Results We reviewed 540 messages, of which 375 (69%) messages were related to opioid behaviors. Of these, 316 (84%) originated from individual user accounts; 125 messages expressed personal experience with opioids. The majority of personal messages referenced using opioids to obtain a "high", use for sleep, or other non-intended use (87,70%). General attitudes regarding opioid use included positive sentiment (52, 27%), comments on others peoples opioid use (57, 30%), and messages containing public health information or links (48, 25%). Conclusions In a sample of social media messages mentioning opioid medications, the most common theme amongst English users related to various forms of opioid misuse. Social media can provide insights into the types of misuse of opioids that might aid public health efforts to reduce non-medical opioid use.	[Chan, Brian; Lopez, Andrea; Sarkar, Urmimala] Univ Calif San Francisco, Sch Med, Div Gen Internal Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sarkar, U (corresponding author), Univ Calif San Francisco, Sch Med, Div Gen Internal Med, San Francisco, CA 94143 USA.	urmimala.sarkar@ucsf.edu	Lopez, Andrea/GQQ-3059-2022	Lopez, Andrea/0000-0002-9488-4622	National Cancer Institute [R01CA178875]; Ruth L Kirschstein National Research Service Award [T32HP19025]; NATIONAL CANCER INSTITUTE [R01CA178875] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The National Cancer Institute (http://www.cancer.gov/) R01CA178875 Ruth L Kirschstein National Research Service Award (http://grants.nih.gov/training/nrsa.htm) T32HP19025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2012, JAMA-J AM MED ASSOC, V308, P1865, DOI 10.1001/jama.2012.14282; Becker WC, 2013, PAIN, V154, P905, DOI 10.1016/j.pain.2013.02.031; Becker WC, 2011, ARCH INTERN MED, V171, P1034, DOI 10.1001/archinternmed.2011.217; Borzekowski DLG, 2010, AM J PUBLIC HEALTH, V100, P1526, DOI 10.2105/AJPH.2009.172700; Butler SF, 2007, PAIN, V130, P144, DOI 10.1016/j.pain.2007.01.014; Chabal C, 1997, CLIN J PAIN, V13, P150, DOI 10.1097/00002508-199706000-00009; Creswell JW, 2013, QUALITATIVE INQUIRY, Vxxi; Duggan M SA, 2013, SOCIAL MEDIA UPDATE; Fishbain DA, 1999, CLIN J PAIN, V15, P184, DOI 10.1097/00002508-199909000-00005; Freifeld CC, 2014, DRUG SAFETY, V37, P343, DOI 10.1007/s40264-014-0155-x; Hanson CL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2503; Jenssen BP, 2009, PEDIATRICS, V124, pE180, DOI 10.1542/peds.2008-3838; John CA, 2012, EPIDEMIOLOGY, V23, P764, DOI 10.1097/EDE.0b013e3182625e5d; Kim Annice E., 2013, Journal of the National Cancer Institute Monographs, P140, DOI 10.1093/jncimonographs/lgt026; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Lopez A, 2012, J GEN INTERN MED, V27, P685, DOI 10.1007/s11606-011-1958-4; Lyles CR, 2013, J CANCER EDUC, V28, P127, DOI 10.1007/s13187-012-0432-2; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Moreno MA, 2011, J ADOLESCENT HEALTH, V49, P29, DOI 10.1016/j.jadohealth.2011.04.015; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Paul MW BC., 2013, WHAT AFFECTS PATIENT; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Roehr B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e386; Tobias Ed, 2011, J Bus Contin Emer Plan, V5, P208; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Wachholtz A, 2011, SUBST ABUSE REHABIL, V2, P145, DOI 10.2147/SAR.S12944	27	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135072	10.1371/journal.pone.0135072	http://dx.doi.org/10.1371/journal.pone.0135072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252774	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100112
J	Hallier, B; Hoffmann, J; Roeder, T; Togel, M; Meyer, H; Paululat, A				Hallier, Benjamin; Hoffmann, Julia; Roeder, Thomas; Toegel, Markus; Meyer, Heiko; Paululat, Achim			The bHLH Transcription Factor Hand Regulates the Expression of Genes Critical to Heart and Muscle Function in Drosophila melanogaster	PLOS ONE			English	Article							CARDIAC MORPHOGENESIS; ADULT HEART; DNA-BINDING; LIMB BUD; DHAND; EHAND; DIFFERENTIATION; PROTEINS; CARDIOGENESIS; HEMATOPOIESIS	Hand proteins belong to the highly conserved family of basic Helix-Loop-Helix transcription factors and are critical to distinct developmental processes, including cardiogenesis and neurogenesis in vertebrates. In Drosophila melanogaster a single orthologous hand gene is expressed with absence of the respective protein causing semilethality during early larval instars. Surviving adult animals suffer from shortened lifespan associated with a disorganized myofibrillar structure being apparent in the dorsal vessel, the wing hearts and in midgut tissue. Based on these data, the major biological significance of Hand seems to be related to muscle development, maintenance or function; however, up to now the physiological basis for Hand functionality remains elusive. Thus, the identification of genes whose expression is, directly or indirectly, regulated by Hand has considerable relevance with respect to understanding its biological functionality in flies and vertebrates. Beneficially, hand mutants are viable and exhibit affected tissues, which renders Drosophila an ideal model to investigate up-or downregulated target genes by a comparative microarray approach focusing on the respective tissues from mutant specimens. Our present work reveals for the first time that Drosophila Hand regulates the expression of numerous genes of diverse physiological relevancy, including distinct factors required for proper muscle development and function such as Zasp52 or Msp-300. These results relate Hand activity to muscle integrity and functionality and may thus be highly beneficial to the evaluation of corresponding hand phenotypes.	[Hallier, Benjamin; Meyer, Heiko; Paululat, Achim] Univ Osnabruck, Dept Zool Dev Biol, D-49069 Osnabruck, Germany; [Hoffmann, Julia; Roeder, Thomas] Univ Kiel, Dept Anim Physiol, D-24098 Kiel, Germany; [Toegel, Markus] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University Osnabruck; University of Kiel; University of Oxford	Paululat, A (corresponding author), Univ Osnabruck, Dept Zool Dev Biol, D-49069 Osnabruck, Germany.	Paululat@biologie.uni-osnabrueck.de	Roeder, Thomas/B-9016-2011	Roeder, Thomas/0000-0002-3489-3834; Harten, Heiko/0000-0002-3304-4523; Paululat, Achim/0000-0002-8845-6859	German Research Foundation (Physiology and dynamics of cellular microcompartments) [SFB 944]; "Incentive Award of the Faculty of Biology/Chemistry" (University of Osnabruck); FAZIT foundation; German Research Foundation (Inflammation at Interfaces) [Cluster of Excellence 306]	German Research Foundation (Physiology and dynamics of cellular microcompartments); "Incentive Award of the Faculty of Biology/Chemistry" (University of Osnabruck); FAZIT foundation; German Research Foundation (Inflammation at Interfaces)	This work was supported by grants from the German Research Foundation to A.P. (SFB 944: Physiology and dynamics of cellular microcompartments) and T.R. (Cluster of Excellence 306: Inflammation at Interfaces), by the "Incentive Award of the Faculty of Biology/Chemistry" (University of Osnabruck) to H.M., and by a grant from the FAZIT foundation to B.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; CROSS JC, 1995, DEVELOPMENT, V121, P2513; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; D'Autreaux F, 2007, DEVELOPMENT, V134, P2237, DOI 10.1242/dev.003814; Dai YS, 2002, J BIOL CHEM, V277, P12604, DOI 10.1074/jbc.M200283200; Doxakis E, 2008, EMBO REP, V9, P1041, DOI 10.1038/embor.2008.161; Drechsler M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003616; Elhanany-Tamir H, 2012, J CELL BIOL, V198, P833, DOI 10.1083/jcb.201204102; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Harpaz N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003597; Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553; Holler KL, 2010, DEV BIOL, V341, P291, DOI 10.1016/j.ydbio.2010.02.001; Howard MJ, 2000, DEVELOPMENT, V127, P4073; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; Katzemich A, 2011, GENE EXPR PATTERNS, V11, P484, DOI 10.1016/j.gep.2011.08.004; Kolsch V, 2002, DEV GENES EVOL, V212, P473, DOI 10.1007/s00427-002-0268-6; Lo PCH, 2007, DEV BIOL, V311, P287, DOI 10.1016/j.ydbio.2007.08.024; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Morikawa Y, 2008, CIRC RES, V103, P1422, DOI 10.1161/CIRCRESAHA.108.180083; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Natarajan A, 2001, J MOL CELL CARDIOL, V33, P1607, DOI 10.1006/jmcc.2001.1434; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Osterwalder M, 2014, DEV CELL, V31, P345, DOI 10.1016/j.devcel.2014.09.018; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schmidt M, 2009, DEV BIOL, V329, P191, DOI 10.1016/j.ydbio.2009.02.020; Schramm G, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e96; Sellin J, 2006, GENE EXPR PATTERNS, V6, P360, DOI 10.1016/j.modgep.2005.09.012; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Togel M, 2013, DEV BIOL, V381, P446, DOI 10.1016/j.ydbio.2013.05.027; Wagner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-446; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134204	10.1371/journal.pone.0134204	http://dx.doi.org/10.1371/journal.pone.0134204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252215	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100043
J	Yang, YM; Qu, AL; Liu, JK; Wang, R; Liu, YJ; Li, G; Duan, WL; Fang, Q; Jiang, XM; Wang, LL; Zheng, GX; Du, LT; Zhang, X; Wang, CX				Yang, Yongmei; Qu, Ailin; Liu, Jingkang; Wang, Rui; Liu, Yingjie; Li, Gang; Duan, Weili; Fang, Qian; Jiang, Xiumei; Wang, Lili; Zheng, Guixi; Du, Lutao; Zhang, Xin; Wang, Chuanxin			Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer	PLOS ONE			English	Article							MICRORNAS; PROLIFERATION; EXPRESSION; BIOMARKERS; DIAGNOSIS; IDENTIFICATION; SENSITIVITY; CARCINOMA; CYTOLOGY; MARKERS	MiR-210 is the master hypoxamir that generally exhibits oncogenic properties in most human solid tumors including bladder cancer (BC). However, it remains unknown about the clinical significance of circulating miR-210 levels in BC. In this study, we found that serum miR-210 was up-regulated in patients with BC, and serum levels of miR-210 increased with advancing stage and grade. Moreover, serum miR-210 expression was found to be significantly reduced in paired post-operative samples and elevated in most patients with relapsed BC. Taken together, our data suggest that serum miR-210 could be a potential noninvasive biomarker for screening, predicting and monitoring BC.	[Yang, Yongmei; Qu, Ailin; Liu, Jingkang; Wang, Rui; Liu, Yingjie; Duan, Weili; Fang, Qian; Jiang, Xiumei; Wang, Lili; Zheng, Guixi; Du, Lutao; Zhang, Xin; Wang, Chuanxin] Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Li, Gang] Honggang Hosp, Dept Urol, Dongying, Shandong, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Dept Clin Lab, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	cxwang@sdu.edu.cn	wang, lili/HDL-7210-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Natural Science Foundation of China [81271916]; Shandong Province Natural Science Foundation of China [ZR2010H004, ZR2013HQ063, ZR2014HP001]; Fundamental Research Funds of Shandong University [2014QLKY03]; Research Fund for the Doctoral Program of Higher Education of China [20120131110055]; National Key Clinical Medical Specialties Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation of China; Fundamental Research Funds of Shandong University; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Key Clinical Medical Specialties Foundation	This study was supported by National Natural Science Foundation of China (No. 81271916); Shandong Province Natural Science Foundation of China (Nos. ZR2010H004, ZR2013HQ063 and ZR2014HP001); Fundamental Research Funds of Shandong University (No. 2014QLKY03); Research Fund for the Doctoral Program of Higher Education of China (No. 20120131110055) and National Key Clinical Medical Specialties Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Chan KCA, 2007, BRIT J CANCER, V96, P681, DOI 10.1038/sj.bjc.6603625; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Grossman HB, 2006, JAMA-J AM MED ASSOC, V295, P299, DOI 10.1001/jama.295.3.299; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Karakiewicz PI, 2006, BJU INT, V97, P997, DOI 10.1111/j.1464-410X.2006.06036.x; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Li L, 2014, INT J ONCOL, V44, P2111, DOI 10.3892/ijo.2014.2368; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052280; Lotan Y, 2003, UROLOGY, V61, P109, DOI 10.1016/S0090-4295(02)02136-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Qu AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090952; Redova M, 2013, FUTURE ONCOL, V9, P387, DOI [10.2217/FON.12.192, 10.2217/fon.12.192]; Redova M, 2013, TUMOR BIOL, V34, P481, DOI 10.1007/s13277-012-0573-2; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; VARGA J, 1988, SEMIN ARTHRITIS RHEU, V18, P14, DOI 10.1016/0049-0172(88)90031-5; Wang LS, 2015, MOL MED REP, V12, P615, DOI 10.3892/mmr.2015.3428; Whelan P, 2008, EUR UROL, V53, P24, DOI 10.1016/j.eururo.2007.08.056; Xiao JN, 2007, J BIOL CHEM, V282, P12363, DOI 10.1074/jbc.C700015200; Yun SJ, 2012, INT J ONCOL, V41, P1871, DOI 10.3892/ijo.2012.1622; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215; Zhao A, 2013, EXP MOL PATHOL, V94, P115, DOI 10.1016/j.yexmp.2012.10.005	36	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135168	10.1371/journal.pone.0135168	http://dx.doi.org/10.1371/journal.pone.0135168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252880	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100128
J	Despard, J; Ternes, AM; Dimech-Betancourt, B; Poudel, G; Churchyard, A; Georgiou-Karistianis, N				Despard, Jessica; Ternes, Anne-Marie; Dimech-Betancourt, Bleydy; Poudel, Govinda; Churchyard, Andrew; Georgiou-Karistianis, Nellie			Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues	PLOS ONE			English	Article							MONKEY GLOBUS-PALLIDUS; MOTOR FUNCTION; ONLINE CONTROL; BASAL GANGLIA; INFORMATION CAPACITY; PARKINSONS-DISEASE; ARM MOVEMENTS; PREMANIFEST; FEEDBACK; ACCURACY	Background Voluntary motor deficits are a common feature in Huntington's disease (HD), characterised by movement slowing and performance inaccuracies. This deficit may be exacerbated when visual cues are restricted. Objective To characterize the upper limb motor profile in HD with various levels of difficulty, with and without visual targets. Methods Nine premanifest HD (pre-HD), nine early symptomatic HD (symp-HD) and nine matched controls completed a motor task incorporating Fitts' law, a model of human movement enabling the quantification of movement timing, via the manipulation of task difficulty (i.e., target size, and distance between targets). The task required participants to make reciprocal movements under cued and blind conditions. Dwell times (time stationary between movements), speed, accuracy and variability of movements were compared between groups. Results Symp-HD showed significantly prolonged and less consistent movement times, compared with controls and pre-HD. Furthermore, movement planning and online control were significantly impaired in symp-HD, compared with controls and pre-HD, evidenced by prolonged dwell times and deceleration times. Speed and accuracy were comparable across groups, suggesting that group differences observed in movement time, variability, dwell time and deceleration time were evident over and above simple performance measures. The presence of cues resulted in greater movement time variability in symp-HD, compared with pre-HD and controls, suggesting that the deficit in movement consistency manifested only in response to targeted movements. Conclusions Collectively, these findings provide evidence of a deficiency in both motor planning, particularly in relation to movement timing and online control, which became exacerbated as a function of task difficulty during symp-HD stages. These variables may provide a more sensitive measure of motor dysfunction than speed and/or accuracy alone in symp-HD.	[Despard, Jessica; Ternes, Anne-Marie; Dimech-Betancourt, Bleydy; Poudel, Govinda; Georgiou-Karistianis, Nellie] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic, Australia; [Poudel, Govinda] Monash Univ, Monash Biomed Imaging, Melbourne, Vic 3004, Australia; [Poudel, Govinda] Life Sci Computat Ctr, Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia; [Churchyard, Andrew] Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Georgiou-Karistianis, N (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Psychol Sci, Clayton, Vic, Australia.	nellie.georgiou-karistianis@monash.edu	Georgiou-Karistianis, Nellie/ABC-5623-2020; Poudel, Govinda/AAR-8078-2020	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Poudel, Govinda/0000-0002-0043-7531; Dimech-Betancourt, Bleydy/0000-0001-6990-7338	School of Psychological Sciences, Monash University	School of Psychological Sciences, Monash University	This research was supported by funds from the School of Psychological Sciences, Monash University.	Andrich J, 2007, J NEUROL NEUROSUR PS, V78, P405, DOI 10.1136/jnnp.2006.105338; Aylward EH, 2011, J NEUROL NEUROSUR PS, V82, P405, DOI 10.1136/jnnp.2010.208264; Bapi RS, 2006, NEUROIMAGE, V32, P714, DOI 10.1016/j.neuroimage.2006.04.205; Bartenstein P, 1997, BRAIN, V120, P1553, DOI 10.1093/brain/120.9.1553; Bechtel N, 2010, NEUROLOGY, V75, P2150, DOI 10.1212/WNL.0b013e3182020123; Beck AT, 1996, MANUAL FOR THE BECK; Biglan KM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00012; Biglan KM, 2010, NEUROLOGY, V75, P2142, DOI 10.1212/WNL.0b013e318203f0cd; Boulet C, 2005, BRAIN COGNITION, V57, P236, DOI 10.1016/j.bandc.2004.09.001; BROTCHIE P, 1991, BRAIN, V114, P1667, DOI 10.1093/brain/114.4.1667; BROTCHIE P, 1991, BRAIN, V114, P1685, DOI 10.1093/brain/114.4.1685; Carella F, 2003, NEUROL SCI, V23, P287, DOI 10.1007/s100720300003; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; CHUA R, 1993, HUM MOVEMENT SCI, V12, P365, DOI 10.1016/0167-9457(93)90026-L; Corben LA, 2011, NEUROSCIENCE, V192, P382, DOI 10.1016/j.neuroscience.2011.06.057; Craik KJW, 1947, B J PSYCHOL-GEN SECT, V38, P56, DOI 10.1111/j.2044-8295.1947.tb01141.x; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; Curra A, 2000, CLIN NEUROPHYSIOL, V111, P1184, DOI 10.1016/S1388-2457(00)00302-3; Delval A, 2011, GAIT POSTURE, V34, P202, DOI 10.1016/j.gaitpost.2011.04.011; Elliott D, 2004, J MOTOR BEHAV, V36, P339, DOI 10.3200/JMBR.36.3.339-351; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Elliott D, 2010, PSYCHOL BULL, V136, P1023, DOI 10.1037/a0020958; Fautrelle L, 2012, BRAIN RES BULL, V89, P57, DOI 10.1016/j.brainresbull.2012.07.005; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605; Frank S, 2014, NEUROTHERAPEUTICS, V11, P153, DOI 10.1007/s13311-013-0244-z; GEORGIOU N, 1995, MOVEMENT DISORD, V10, P472, DOI 10.1002/mds.870100412; GEORGIOU N, 1993, BRAIN, V116, P1575, DOI 10.1093/brain/116.6.1575; Georgiou-Karistianis N, 2013, NEUROBIOL DIS, V51, P82, DOI 10.1016/j.nbd.2012.10.001; Georgiou-Karistianis N, 2014, WORLD J BIOL PSYCHIA, V15, P459, DOI 10.3109/15622975.2014.895042; Georgiou-Karistianis N, 2013, NEUROSCI BIOBEHAV R, V37, P480, DOI 10.1016/j.neubiorev.2013.01.022; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Glover S, 2012, EUR J NEUROSCI, V35, P909, DOI 10.1111/j.1460-9568.2012.08018.x; HAYWARD L, 1985, AUST NZ J PSYCHIAT, V19, P384; Hinton SC, 2007, J INT NEUROPSYCH SOC, V13, P539, DOI 10.1017/S1355617707070671; Hocking DR, 2011, J NEUROL SCI, V301, P51, DOI 10.1016/j.jns.2010.11.001; Jeannerod M., 1997, THE COGNITIVE NEUROS; Jeannerod M, 1988, THE NEURAL AND BAHAV; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Lemay M, 2005, EXP BRAIN RES, V165, P454, DOI 10.1007/s00221-005-2315-9; Lemay M, 2008, BEHAV BRAIN RES, V187, P153, DOI 10.1016/j.bbr.2007.09.016; Lo DC, 2011, NEUROBIOLOGY OF HUNT; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; Michell AW, 2008, J NEUROL, V255, P1145, DOI 10.1007/s00415-008-0859-x; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; Moisello C, 2011, PARKINSONISM RELAT D, V17, P642, DOI 10.1016/j.parkreldis.2011.06.021; NELSON HE, 1991, TEST MANUAL; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papadopoulos N, 2012, RES AUTISM SPECT DIS, V6, P286, DOI 10.1016/j.rasd.2011.05.010; Parsa MA, 1997, J CLIN PSYCHOPHARM, V17, P134, DOI 10.1097/00004714-199704000-00023; Paulsen JS, 2010, MOVEMENT DISORD, V25, P2595, DOI 10.1002/mds.23337; PEIRIS JB, 1976, MED J AUSTRALIA, V1, P225; Peng Q, 2008, EXP NEUROL, V210, P154, DOI 10.1016/j.expneurol.2007.10.015; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Phillips JG, 1996, NEUROPSYCHOLOGIA, V34, P1241, DOI 10.1016/0028-3932(96)00049-8; Philpott AL, 2013, NEUROSCI BIOBEHAV R, V37, P1420, DOI 10.1016/j.neubiorev.2013.05.009; Quinn L, 1997, J NEUROL REHABIL, V11, P47; Rao AK, 2014, VARIABILITY IN INTER; Rao AK, 2011, PLOS CURR; Reilmann R, 2010, MOVEMENT DISORD, V25, P2195, DOI 10.1002/mds.23243; Saft C, 2003, J NEUROL, V250, P1469, DOI 10.1007/s00415-003-0256-4; Saft C, 2006, MOVEMENT DISORD, V21, P1208, DOI 10.1002/mds.20939; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Say MJ, 2011, NEUROPSYCHOLOGIA, V49, P264, DOI 10.1016/j.neuropsychologia.2010.11.016; Sheppard D, 1996, NEUROPSY NEUROPSY BE, V9, P91; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; Sturrock A, 2010, J GERIATR PSYCH NEUR, V23, P243, DOI 10.1177/0891988710383573; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Temprado JJ, 2013, EXP BRAIN RES, V228, P105, DOI 10.1007/s00221-013-3542-0; Ternes AMS, 2014, COGN BEHAV NEUROL, V27, P139, DOI 10.1097/WNN.0000000000000036; van Vugt JPP, 2004, MOVEMENT DISORD, V19, P285, DOI 10.1002/mds.10718; Venuto CS, 2012, MOVEMENT DISORD, V27, P31, DOI 10.1002/mds.23953; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; Yaguez L, 2006, J NEUROL, V253, P186, DOI 10.1007/s00415-005-0951-4	86	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133709	10.1371/journal.pone.0133709	http://dx.doi.org/10.1371/journal.pone.0133709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248012	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300018
J	Yuan, ZY; Hu, YL; Gao, JQ				Yuan, Zhong-Yue; Hu, Yu-Lan; Gao, Jian-Qing			Brain Localization and Neurotoxicity Evaluation of Polysorbate 80-Modified Chitosan Nanoparticles in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; SILVER NANOPARTICLES; PROTEIN EXPRESSION; LOADED CHITOSAN; DECREASE; TOXICITY; DRUG	The toxicity evaluation of inorganic nanoparticles has been reported by an increasing number of studies, but toxicity studies concerned with biodegradable nanoparticles, especially the neurotoxicity evaluation, are still limited. For example, the potential neurotoxicity of Polysorbate 80-modified chitosan nanoparticles (Tween 80-modified chitosan nanoparticles, TmCS-NPs), one of the most widely used brain targeting vehicles, remains unknown. In the present study, TmCS-NPs with a particle size of 240 nm were firstly prepared by ionic cross-linking of chitosan with tripolyphosphate. Then, these TmCS-NPs were demonstrated to be entered into the brain and specially deposited in the frontal cortex and cerebellum after systemic injection. Moreover, the concentration of TmCS-NPs in these two regions was found to decrease over time. Although no obvious changes were observed for oxidative stress in the in vivo rat model, the body weight was found to remarkably decreased in a dose-dependent manner after exposure to TmCS-NPs for seven days. Besides, apoptosis and necrosis of neurons, slight inflammatory response in the frontal cortex, and decrease of GFAP expression in the cerebellum were also detected in mouse injected with TmCS-NPs. This study is the first report on the sub-brain biodistribution and neurotoxicity studies of TmCS-NPs. Our results provide new insights into the toxicity evaluation of nanoparticles and our findings would help contribute to a better understanding of the neurotoxicity of biodegradable nanomaterials used in pharmaceutics.	[Yuan, Zhong-Yue; Hu, Yu-Lan; Gao, Jian-Qing] Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Hu, YL (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Pharmaceut, Hangzhou 310058, Zhejiang, Peoples R China.	hu_yulan@hotmail.com; gaojianqing@zju.edu.cn			Scientific Research Fund by the Department of Health of Zhejiang Province [2013KYA056]; Natural Science Foundation of Zhejiang Province, China [LZ14H300001]	Scientific Research Fund by the Department of Health of Zhejiang Province; Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Scientific Research Fund provided by the Department of Health of Zhejiang Province (2013KYA056) to YLH (URL: http://www.zjwst.gov.cn/). Additional support was provided by the Natural Science Foundation of Zhejiang Province, China (LZ14H300001) to JQG (URL: http://www.zjnsf.gov.cn/).	Akhtar S, 2013, INT J PHARMACEUT, V448, P239, DOI 10.1016/j.ijpharm.2013.03.039; Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; BURTRUM D, 1994, EXP NEUROL, V126, P112, DOI 10.1006/exnr.1994.1047; Chaudhury A, 2011, AAPS PHARMSCITECH, V12, P10, DOI 10.1208/s12249-010-9561-2; Chiao SH, 2012, INT J NANOMED, V7, P2421, DOI 10.2147/IJN.S31594; Everett WN, 2014, TOXICOL LETT, V225, P177, DOI 10.1016/j.toxlet.2013.12.005; Hao LH, 2012, ECOTOX ENVIRON SAFE, V80, P103, DOI 10.1016/j.ecoenv.2012.02.017; Hazell AS, 2009, NEUROCHEM INT, V55, P129, DOI 10.1016/j.neuint.2009.02.020; Hong JS, 2014, NANOTOXICOLOGY, V8, P349, DOI 10.3109/17435390.2013.780108; Hu YL, 2011, INT J NANOMED, V6, P3351, DOI 10.2147/IJN.S25853; Hu YL, 2010, INT J PHARMACEUT, V394, P115, DOI 10.1016/j.ijpharm.2010.04.026; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Li RB, 2013, ACS NANO, V7, P2352, DOI 10.1021/nn305567s; Li X, 2014, SCI REP-UK, V4, DOI 10.1038/srep03810; Linkov I, 2008, NANOMED-NANOTECHNOL, V4, P167, DOI 10.1016/j.nano.2008.01.001; Monte S., 2004, AM J PSYCHIAT, V161, P2178; Nagpal K, 2013, DRUG DELIV, V20, P112, DOI 10.3109/10717544.2013.779330; Nagpal K, 2013, CHEM PHARM BULL, V61, P258, DOI 10.1248/cpb.c12-00732; Nagpal K, 2010, CHEM PHARM BULL, V58, P1423, DOI 10.1248/cpb.58.1423; Park MR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107532; Qi LF, 2005, WORLD J GASTROENTERO, V11, P5136; Rintala J, 2001, ALCOHOL, V23, P1, DOI 10.1016/S0741-8329(00)00116-6; Saracino GAA, 2013, CHEM SOC REV, V42, P225, DOI 10.1039/c2cs35065c; Setyawati MI, 2013, BIOMATERIALS, V34, P10133, DOI 10.1016/j.biomaterials.2013.09.024; Shinde SK., 2012, ASIAN PACIFIC J TROP, p[2, 331], DOI DOI 10.1016/S2222-1808(12)60072-3; Skaper SD, 1999, ANN NY ACAD SCI, V890, P107, DOI 10.1111/j.1749-6632.1999.tb07985.x; Sousa F, 2010, NANOSCALE, V2, P2826, DOI 10.1039/c0nr00345j; Tomassoni D, 2013, NEUROSCI LETT, V543, P136, DOI 10.1016/j.neulet.2013.03.025; Trapani A, 2011, AAPS PHARMSCITECH, V12, P1302, DOI 10.1208/s12249-011-9695-x; Williams MR, 2013, EUR ARCH PSY CLIN N, V263, P41, DOI 10.1007/s00406-012-0328-5; Wu J, 2011, ACS NANO, V5, P4476, DOI 10.1021/nn103530b; Xu B, 2009, LANGMUIR, V25, P8375, DOI 10.1021/la900987r; Xu YL, 2010, ANTICANCER RES, V30, P1033; Zhang YB, 2013, SMALL, V9, P1715, DOI 10.1002/smll.201201548	35	35	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134722	10.1371/journal.pone.0134722	http://dx.doi.org/10.1371/journal.pone.0134722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248340	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300061
J	Carasatorre, M; Ochoa-Alvarez, A; Velazquez-Campos, G; Lozano-Flores, C; Diaz-Cintra, SY; Ramirez-Amaya, V				Carasatorre, Mariana; Ochoa-Alvarez, Adrian; Velazquez-Campos, Giovanna; Lozano-Flores, Carlos; Diaz-Cintra, Sofia Y.; Ramirez-Amaya, Victor			Hippocampal Synaptic Expansion Induced by Spatial Experience in Rats Correlates with Improved Information Processing in the Hippocampus	PLOS ONE			English	Article							MOSSY FIBER SYNAPTOGENESIS; IMMEDIATE-EARLY GENE; LONG-TERM-MEMORY; PATTERN SEPARATION; DENTATE GYRUS; DOUBLE DISSOCIATION; DORSAL HIPPOCAMPUS; RECURRENT SYNAPSES; SOCIAL-ISOLATION; BDNF EXPRESSION	Spatial water maze (WM) overtraining induces hippocampal mossy fiber (MF) expansion, and it has been suggested that spatial pattern separation depends on the MF pathway. We hypothesized that WM experience inducing MF expansion in rats would improve spatial pattern separation in the hippocampal network. We first tested this by using the the delayed non-matching to place task (DNMP), in animals that had been previously trained on the water maze (WM) and found that these animals, as well as animals treated as swim controls (SC), performed better than home cage control animals the DNMP task. The "catFISH" imaging method provided neurophysiological evidence that hippocampal pattern separation improved in animals treated as SC, and this improvement was even clearer in animals that experienced the WM training. Moreover, these behavioral treatments also enhance network reliability and improve partial pattern separation in CA1 and pattern completion in CA3. By measuring the area occupied by synaptophysin staining in both the stratum oriens and the stratun lucidum of the distal CA3, we found evidence of structural synaptic plasticity that likely includes MF expansion. Finally, the measures of hippocampal network coding obtained with catFISH correlate significantly with the increased density of synaptophysin staining, strongly suggesting that structural synaptic plasticity in the hippocampus induced by the WM and SC experience is related to the improvement of spatial information processing in the hippocampus.	[Carasatorre, Mariana; Ochoa-Alvarez, Adrian; Lozano-Flores, Carlos; Diaz-Cintra, Sofia Y.] Univ Nacl Autonoma Queretaro, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico; [Velazquez-Campos, Giovanna] Univ Nacl Autonoma Queretaro, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico; [Velazquez-Campos, Giovanna; Ramirez-Amaya, Victor] Univ Autonoma Queretaro, Fac Ciencias Nat, Dept Microbiol Maestria Neurometab & Maestria Nut, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Queretaro	Ramirez-Amaya, V (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Dept Microbiol Maestria Neurometab & Maestria Nut, Queretaro, Mexico.	vramirez@unam.mx	Miranda, Sofía/AAS-8499-2021	Lozano-Flores, Carlos/0000-0002-4238-0190; diaz cintra, sofia/0000-0002-3354-2717	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [P 51028325, 130802]; Direccion General de Asuntos del Personal Academico (DGAPA) de la Universidad Nacional Autenoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (PAPIIT) [IN216510-23]; FOFI-UAQ [Fondos para el fomento de la investigacion, Universidad Autonoma de Queretaro];  [CONACyT-239669]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA) de la Universidad Nacional Autenoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (PAPIIT); FOFI-UAQ [Fondos para el fomento de la investigacion, Universidad Autonoma de Queretaro]; 	Funding was provided by: Consejo Nacional de Ciencia y Tecnologia (CONACyT) P 51028325 and 130802 (VRA) and Direccion General de Asuntos del Personal Academico (DGAPA) de la Universidad Nacional Autenoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (PAPIIT) IN216510-23 (VRA). http://www.conacyt.mx/ http://dgapa.unam.mx/. Additional funding was received from FOFI-UAQ2014 [Fondos para el fomento de la investigacion, Universidad Autonoma de Queretaro 2014]. M. Carasatorre also wants to gratefully acknowledge that she received a graduate scholarship from CONACyT-239669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 1998, J NEUROSCI, V18, P3386; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Badowska-Szalewska E, 2009, ACTA NEUROBIOL EXP, V69, P448; Bailey CH, 2008, PROG BRAIN RES, V169, P179, DOI 10.1016/S0079-6123(07)00010-6; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bischofberger J, 2006, PFLUG ARCH EUR J PHY, V453, P361, DOI 10.1007/s00424-006-0093-2; Boerlin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003258; Burke SN, 2010, BEHAV NEUROSCI, V124, P559, DOI 10.1037/a0020893; CACERES A, 1984, DEV BRAIN RES, V13, P314, DOI 10.1016/0165-3806(84)90167-6; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cerasti E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000759; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Di Stefano G, 2006, REJUV RES, V9, P94; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Galimberti I, 2006, NEURON, V50, P749, DOI 10.1016/j.neuron.2006.04.026; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Han X, 2011, BRAIN RES BULL, V86, P173, DOI 10.1016/j.brainresbull.2011.07.008; Hanson JE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-96; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hayman RM, 2008, HIPPOCAMPUS, V18, P1301, DOI 10.1002/hipo.20513; Hebb DO, 1945, ORG BEHAV NEUROPSYCH; Hoang LT, 2008, BEHAV NEUROSCI, V122, P9, DOI 10.1037/0735-7044.122.1.9; Holahan MR, 2007, HIPPOCAMPUS, V17, P58, DOI 10.1002/hipo.20242; Holahan MR, 2006, HIPPOCAMPUS, V16, P560, DOI 10.1002/hipo.20185; Hunsaker MR, 2013, NEUROSCI BIOBEHAV R, V37, P36, DOI 10.1016/j.neubiorev.2012.09.014; Jaffe DB, 2007, PROG BRAIN RES, V163, P109, DOI 10.1016/S0079-6123(07)63006-4; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Keeley RJ, 2010, LEARN MEMORY, V17, P344, DOI 10.1101/lm.1849910; Kesner RP, 2013, BEHAV BRAIN RES, V254, P1, DOI 10.1016/j.bbr.2013.01.012; Khabour OF, 2013, BRAIN RES BULL, V90, P19, DOI 10.1016/j.brainresbull.2012.08.005; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Lacy JW, 2011, LEARN MEMORY, V18, P15, DOI [10.1101/lm.1971110, 10.1101/lm.1971111]; Lassalle JM, 2000, NEUROBIOL LEARN MEM, V73, P243, DOI 10.1006/nlme.1999.3931; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Masquelier T, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00007; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Middei S, 2007, NEUROBIOL LEARN MEM, V87, P174, DOI 10.1016/j.nlm.2006.08.004; Morris AM, 2012, NEUROBIOL LEARN MEM, V97, P326, DOI 10.1016/j.nlm.2012.02.005; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Ni H, 2009, TOXICOL LETT, V191, P26, DOI 10.1016/j.toxlet.2009.07.028; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pleskacheva MG, 2000, HIPPOCAMPUS, V10, P17, DOI 10.1002/(SICI)1098-1063(2000)10:1<17::AID-HIPO2>3.0.CO;2-O; Pozzo-Miller LD, 1999, J NEUROPHYSIOL, V81, P1404, DOI 10.1152/jn.1999.81.3.1404; Ramirez-Amaya V, 1999, HIPPOCAMPUS, V9, P631, DOI 10.1002/(SICI)1098-1063(1999)9:6<631::AID-HIPO3>3.0.CO;2-3; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Rosi S, 2009, BRAIN, V132, P2464, DOI 10.1093/brain/awp148; Ruediger S, 2011, NATURE, V473, P514, DOI 10.1038/nature09946; SCHWEGLER H, 1993, HIPPOCAMPUS, V3, P1, DOI 10.1002/hipo.450030102; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Toscano-Silva M, 2010, PHYSIOL BEHAV, V101, P302, DOI 10.1016/j.physbeh.2010.05.012; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; WILLSHAW DJ, 1990, PHILOS T R SOC B, V329, P205, DOI 10.1098/rstb.1990.0165; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006	66	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132676	10.1371/journal.pone.0132676	http://dx.doi.org/10.1371/journal.pone.0132676			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244549	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400026
J	Gare, J; Kelly-Hanku, A; Ryan, CE; David, M; Kaima, P; Imara, U; Lote, N; Crowe, SM; Hearps, AC				Gare, Janet; Kelly-Hanku, Angela; Ryan, Claire E.; David, Matthew; Kaima, Petronia; Imara, Ulato; Lote, Namarola; Crowe, Suzanne M.; Hearps, Anna C.			Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; DRUG-RESISTANCE; THERAPY; PREDICTORS; BARRIERS	Adherence to antiretroviral therapy (ART) is paramount for virological suppression and positive treatment outcomes. ART has been rapidly scaled up in Papua New Guinea (PNG) in recent years, however clinical monitoring of HIV+ individuals on ART is limited. A cross-sectional study was conducted at two major sexual health clinics in high HIV prevalence provinces in the Highlands Region of PNG to assess ART adherence, factors affecting adherence and the relationship between ART adherence and virological outcomes. Ninety-five HIV+ individuals were recruited and administered a questionnaire to gather demographic and ART adherence information whilst clinical data and pill counts were extracted from patient charts and blood was collected for viral load testing. Bivariate analysis was performed to identify independent predictors of ART adherence. Fourteen percent (n = 12) of participants showed evidence of virological failure. Although the majority of participants self-reported excellent ART adherence in the last seven days (78.9%, 75/91), pill count measurements indicated only 40% (34/84) with >95% adherence in the last month. Taking other medications while on ART (p = 0.01) and taking ART for >= 1 year (p = 0.037) were positively associated with adherence by self-report and pill count, respectively. Participants who had never heard of drug resistance were more likely to show virological failure (p = 0.033). Misconception on routes of HIV transmission still persists in the studied population. These findings indicate that non-adherence to ART is high in this region of PNG and continued education and strategies to improve adherence are required to ensure the efficacy of ART and prevent HIV drug resistance.	[Gare, Janet; Kelly-Hanku, Angela; David, Matthew; Lote, Namarola] Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, Goroka, Eastern Highlan, Papua N Guinea; [Gare, Janet; Ryan, Claire E.; Crowe, Suzanne M.; Hearps, Anna C.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Gare, Janet; Crowe, Suzanne M.; Hearps, Anna C.] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Kelly-Hanku, Angela] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Kaima, Petronia] Natl Dept Hlth, HIV STI Highlands Reg, Mt Hagen, Western Highlan, Papua N Guinea; [Imara, Ulato] Goroka Gen Hosp, Michael Alpers Clin, Goroka, Eastern Highlan, Papua N Guinea	PNG Institute Of Medical Research; Burnet Institute; Monash University; University of New South Wales Sydney	Gare, J (corresponding author), Papua New Guinea Inst Med Res, Sexual & Reprod Hlth Unit, POB 60, Goroka, Eastern Highlan, Papua N Guinea.	jgare@burnet.edu.au	Nightingale, Claire Elizabeth/K-1667-2019	Nightingale, Claire Elizabeth/0000-0002-4103-6240	National AIDS Council Secretariat - Papua New Guinea [RES090012]	National AIDS Council Secretariat - Papua New Guinea	The National AIDS Council Secretariat - Papua New Guinea (Grant number: RES090012) funded this study. JG and CER received the funds. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; [Anonymous], 2010, STI HIV AIDS 2 Q SUR; [Anonymous], PAP NEW GUIN 2013 HI; [Anonymous], 2012, GLOB AIDS REP; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Daoni E, 2012, CLIN INFECT DIS, V54, pS303, DOI 10.1093/cid/cir994; Gare J, 2014, J ANTIMICROB CHEMOTH, V69, P2183, DOI 10.1093/jac/dku089; Gill CJ, 2010, AIDS BEHAV, V14, P785, DOI 10.1007/s10461-009-9555-9; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Greengrass VL, 2009, J CLIN MICROBIOL, V47, P3011, DOI 10.1128/JCM.00805-09; HIV/AIDS Fact Sheets, 2014, PORT MOR; Kaldor J., 2006, IMPACTS HIVAIDS 2005; Kelly A, 2011, PAPUA NEW GUINEA MED, V54, P23; Kelly A, 2010, CURR HIV RES, V8, P630, DOI 10.2174/157016210794088191; Kelly A, 2011, AIDS CARE, V23, P734, DOI 10.1080/09540121.2010.532533; Kelly-Hanku A, 2014, SOC SCI MED, V119, P106, DOI 10.1016/j.socscimed.2014.08.020; Kelly-Hanku A, 2014, AIDS BEHAV, V18, P573, DOI 10.1007/s10461-013-0624-8; Kelly-Hanku A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1108; Kisenyi RN, 2013, J RELIG HEALTH, V52, P307, DOI 10.1007/s10943-011-9473-9; Larson EC, 2014, J ETHNOPHARMACOL, V155, P1433, DOI 10.1016/j.jep.2014.07.023; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Liam C, 2014, FAITH HEALING REPLAC; Maibani G, 2011, PAPUA NEW GUINEA AUS, P1; Malagun M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112173; McBride William J, 2005, Emerg Med Australas, V17, P304, DOI 10.1111/j.1742-6723.2005.00751.x; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mosha F, 2014, J INFECT DEV COUNTR, V8, P845, DOI 10.3855/jidc.3879; Obirikorang Christian, 2013, ISRN AIDS, V2013, P873939, DOI 10.1155/2013/873939; Portelli MS, 2012, ASIA PAC J PUBLIC HL; Rodrigues R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040723; Schonnesson LN, 2006, AIDS CARE, V18, P406, DOI 10.1080/09540120500456631a; Tadios Yonas, 2006, Ethiop Med J, V44, P237; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Tumwine C, 2012, RELIGIONS, V3, P817, DOI 10.3390/rel3030817; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Wouters E, 2009, SOC SCI MED, V69, P1177, DOI 10.1016/j.socscimed.2009.07.034	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134918	10.1371/journal.pone.0134918	http://dx.doi.org/10.1371/journal.pone.0134918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244516	Green Published, gold			2022-12-26	WOS:000359061400130
J	Kiselar, JG; Wang, XW; Dubyak, GR; El Sanadi, C; Ghosh, SK; Lundberg, K; Williams, WM				Kiselar, Janna G.; Wang, Xiaowei; Dubyak, George R.; El Sanadi, Caroline; Ghosh, Santosh K.; Lundberg, Kathleen; Williams, Wesley M.			Modification of beta-Defensin-2 by Dicarbonyls Methylglyoxal and Glyoxal Inhibits Antibacterial and Chemotactic Function In Vitro	PLOS ONE			English	Article							BETA-DEFENSIN 2; ANTIMICROBIAL PEPTIDES; ENDOTHELIAL-CELLS; ARGININE RESIDUES; MASS-SPECTROMETRY; PERIPHERAL-BLOOD; GLYCATION; PROTEINS; GLUCOSE; PROLIFERATION	Background Beta-defensins (hBDs) provide antimicrobial and chemotactic defense against bacterial, viral and fungal infections. Human beta-defensin-2 (hBD-2) acts against gram-negative bacteria and chemoattracts immature dendritic cells, thus regulating innate and adaptive immunity. Immunosuppression due to hyperglycemia underlies chronic infection in Type 2 diabetes. Hyperglycemia also elevates production of dicarbonyls methylgloxal (MGO) and glyoxal (GO). Methods The effect of dicarbonyl on defensin peptide structure was tested by exposing recombinant hBD-2 (rhBD-2) to MGO or GO with subsequent analysis by MALDI-TOF MS and LC/MS/MS. Antimicrobial function of untreated rhBD-2 vs. rhBD-2 exposed to dicarbonyl against strains of both gram-negative and gram-positive bacteria in culture was determined by radial diffusion assay. The effect of dicarbonyl on rhBD-2 chemotactic function was determined by chemotaxis assay in CEM-SS cells. Results MGO or GO in vitro irreversibly adducts to the rhBD-2 peptide, and significantly reduces antimicrobial and chemotactic functions. Adducts derive from two arginine residues, Arg(22) and Arg(23) near the C-terminus, and the N-terminal glycine (Gly(1)). We show by radial diffusion testing on gram-negative E. coli and P. aeruginosa, and gram-positive S. aureus, and a chemotaxis assay for CEM-SS cells, that antimicrobial activity and chemotactic function of rhBD-2 are significantly reduced by MGO. Conclusions Dicarbonyl modification of cationic antimicrobial peptides represents a potential link between hyperglycemia and the clinical manifestation of increased susceptibility to infection, protracted wound healing, and chronic inflammation in undiagnosed and uncontrolled Type 2 diabetes.	[Kiselar, Janna G.; Lundberg, Kathleen] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Xiaowei] Case Western Reserve Univ, Dept Periodont, Cleveland, OH 44106 USA; [Dubyak, George R.; El Sanadi, Caroline] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ghosh, Santosh K.; Williams, Wesley M.] Case Western Reserve Univ, Dept Biol Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Williams, WM (corresponding author), Case Western Reserve Univ, Dept Biol Sci, Cleveland, OH 44106 USA.	wmw5@case.edu	Wang, Xiaowei/K-8352-2013; Ghosh, Santosh K/I-5461-2019	Ghosh, Santosh K/0000-0001-5669-7853; Dubyak, George/0000-0001-9720-4226	Clinical and Translational Science Collaborative (CTSC), Case Western Reserve University; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036387] Funding Source: NIH RePORTER	Clinical and Translational Science Collaborative (CTSC), Case Western Reserve University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part through a grant from the Clinical and Translational Science Collaborative (CTSC), Case Western Reserve University, to WMW, and from a grant from the National Institutes of Health to GRD.	BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Baroni A, 2009, PEPTIDES, V30, P267, DOI 10.1016/j.peptides.2008.11.001; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; BORENSTEIN LA, 1991, INFECT IMMUN, V59, P1368, DOI 10.1128/IAI.59.4.1368-1377.1991; Chetyrkin S, 2011, BIOCHEMISTRY-US, V50, P6102, DOI 10.1021/bi200757d; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; GANZ T, 1990, EUR J HAEMATOL, V44, P1; Gao Y, 2006, BIOCHEMISTRY-US, V45, P15654, DOI 10.1021/bi061410o; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Guglielmotto M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.026; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hunter SJ, 2003, DIABETES, V52, P492, DOI 10.2337/diabetes.52.2.492; Jana CK, 2002, ARCH BIOCHEM BIOPHYS, V397, P433, DOI 10.1006/abbi.2001.2690; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kawsar HI, 2010, PEPTIDES, V31, P195, DOI 10.1016/j.peptides.2009.12.008; Lan CCE, 2012, BRIT J DERMATOL, V166, P1221, DOI 10.1111/j.1365-2133.2012.10847.x; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Livingstone C, 2007, BRIT J DIABETES VASC, V7, P258, DOI [10.1177/14746514070070060201, DOI 10.1177/14746514070070060201]; Lo TW, 1994, J BIOL CHEM, V289, P32299; Mahida Y R, 2004, Novartis Found Symp, V263, P71; Meade SJ, 2003, BIOORGAN MED CHEM, V11, P853, DOI 10.1016/S0968-0896(02)00564-3; Messier C, 2000, J Nutr Health Aging, V4, P208; MORENKOVA SA, 1987, ACTA DIABETOL LAT, V24, P119, DOI 10.1007/BF02742850; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Murata-Kamiya N, 2001, NUCLEIC ACIDS RES, V29, P3433, DOI 10.1093/nar/29.16.3433; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; NARA PL, 1987, AIDS RES HUM RETROV, V3, P283, DOI 10.1089/aid.1987.3.283; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Niyonsaba Francois, 2003, Current Drug Targets - Inflammation and Allergy, V2, P224, DOI 10.2174/1568010033484115; Pazgier M, 2007, J BIOL CHEM, V282, P1819, DOI 10.1074/jbc.M607210200; Poggioli S, 2002, EXP GERONTOL, V37, P1207, DOI 10.1016/S0531-5565(02)00145-6; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Saraiva MA, 2006, J MASS SPECTROM, V41, P1346, DOI 10.1002/jms.1109; Saraiva MA, 2006, J MASS SPECTROM, V41, P755, DOI 10.1002/jms.1031; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Seo ES, 2010, BIOCHEMISTRY-US, V49, P10486, DOI 10.1021/bi1011749; Steinberg D A, 1997, Methods Mol Biol, V78, P169; Suji G, 2004, BIOGERONTOLOGY, V5, P365, DOI 10.1007/s10522-004-3189-0; Tang M, 2009, BBA-BIOMEMBRANES, V1788, P514, DOI 10.1016/j.bbamem.2008.10.027; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vila-Perello M, 2005, BIOPOLYMERS, V80, P697, DOI 10.1002/bip.20270; Wang XN, 2010, EXP GERONTOL, V45, P904, DOI 10.1016/j.exger.2010.07.004; Westwood ME, 1997, BBA-MOL CELL RES, V1356, P84, DOI 10.1016/S0167-4889(96)00154-1; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yamawaki H, 2008, AM J PHYSIOL-CELL PH, V295, pC1510, DOI 10.1152/ajpcell.00252.2008; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang Y, 2012, AM J PHYSIOL-CELL PH, V303, pC1045, DOI 10.1152/ajpcell.00020.2012; Yin L, 2007, J MED MICROBIOL, V56, P976, DOI 10.1099/jmm.0.47198-0; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106	58	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0130533	10.1371/journal.pone.0130533	http://dx.doi.org/10.1371/journal.pone.0130533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244639	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400006
J	Lidfeldt, J; Bendahl, PO; Forsare, C; Malmstrom, P; Ferno, M; Belting, M				Lidfeldt, Jon; Bendahl, Par-Ola; Forsare, Carina; Malmstrom, Per; Ferno, Marten; Belting, Mattias			Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; PRIMARY THERAPY; INVASION; CELLS; PAR1; PHOSPHORYLATION; TRANSACTIVATION; HETERODIMER	Experimental models implicate protease activated receptors (PARs) as important sensors of the proteolytic tumor microenvironment during breast cancer development. However, the role of the major PARs, PAR-1 and PAR-2, in human breast tumors remains to be elucidated. Here, we have investigated how PAR-1 and PAR-2 protein expression correlate with established clinicopathological variables and patient outcome in a well-characterized cohort of 221 breast cancer patients. Univariable and multivariable hazard ratios (HR) were estimated by the Cox proportional hazards model, distant disease-free survival (DDFS) and overall survival by the Kaplan-Meier method, and survival in different strata was determined by the log-rank test. Associations between PARs and clinicopathological variables were analyzed using Pearson's x(2)-test. We find that PAR-2 associates with DDFS (HR = 3.1, P = 0.003), whereas no such association was found with PAR-1 (HR = 1.2, P = 0.6). Interestingly, the effect of PAR-2 was confined to the ER-positive sub-group (HR = 5.5, P = 0.003 vs. HR = 1.2 in ER-negative; P = 0.045 for differential effect), and PAR-2 was an independent prognostic factor specifically in ER-positive tumors (HR = 3.9, P = 0.045). On the contrary, PAR-1 correlated with worse prognosis specifically in the ER-negative group (HR = 2.6, P = 0.069 vs. HR = 0.5, P = 0.19 in ER-positive; P = 0.026 for differential effect). This study provides novel insight into the respective roles of PAR-1 and PAR-2 in human breast cancer and suggests a hitherto unknown association between PARs and ER signaling that warrants further investigation.	[Lidfeldt, Jon; Bendahl, Par-Ola; Forsare, Carina; Malmstrom, Per; Ferno, Marten; Belting, Mattias] Lund Univ, Sect Oncol & Pathol, Dept Clin Sci, Lund, Sweden; [Malmstrom, Per; Belting, Mattias] Skane Univ Hosp, Dept Oncol, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Belting, M (corresponding author), Lund Univ, Sect Oncol & Pathol, Dept Clin Sci, Lund, Sweden.	mattias.belting@med.lu.se	Forsare, Carina/AAG-4690-2019	Lidfeldt, Jon/0000-0002-8440-6512; Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Swedish Society of Medicine; Physiographic Society, Lund; Gunnar Nilsson Foundation; Anna Lisa Foundation; Sven Eric Lundgren Foundation; Kamprad Foundation; Skane University Hospital donation funds; Skane County Research Foundation; Governmental funding of clinical research within the national health services	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Physiographic Society, Lund; Gunnar Nilsson Foundation; Anna Lisa Foundation; Sven Eric Lundgren Foundation; Kamprad Foundation; Skane University Hospital donation funds; Skane County Research Foundation; Governmental funding of clinical research within the national health services	This work was supported by grants from the Swedish Cancer Fund (MB); the Swedish Research Council (MB); the Swedish Society of Medicine (MB); the Physiographic Society, Lund (MB); the Gunnar Nilsson, Anna Lisa and Sven Eric Lundgren, and Kamprad Foundations (MB); the Skane University Hospital donation funds (MB); the Skane County Research Foundation (PM); and the Governmental funding of clinical research within the national health services (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Cascio S, 2007, J BIOL CHEM, V282, P3498, DOI 10.1074/jbc.M606244200; Cohen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011135; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Jaber M, 2014, CELL MOL LIFE SCI, V71, P2517, DOI 10.1007/s00018-013-1498-7; Kamath L, 2001, CANCER RES, V61, P5933; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lin HL, 2013, J BIOL CHEM, V288, P11203, DOI 10.1074/jbc.M112.439950; Malmstrom P, 2001, J CLIN ONCOL, V19, P2010, DOI 10.1200/JCO.2001.19.7.2010; Marubini Ettore, 2004, ANAL SURVIVAL DATA C, V15; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Pawlinski R, 2011, ARTERIOSCL THROM VAS, V31, P2775, DOI 10.1161/ATVBAHA.111.238865; Ryden L, 2010, INT J CANCER, V126, P2330, DOI 10.1002/ijc.24921; Salah Z, 2012, FASEB J, V26, P2031, DOI 10.1096/fj.11-194704; Schiff R, 2005, BREAST CANCER RES, V7, P205, DOI 10.1186/bcr1287; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134932	10.1371/journal.pone.0134932	http://dx.doi.org/10.1371/journal.pone.0134932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244666	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400132
J	Morris, DP; Lei, BL; Longo, LD; Bomsztyk, K; Schwinn, DA; Michelotti, GA				Morris, Daniel P.; Lei, Beilei; Longo, Lawrence D.; Bomsztyk, Karol; Schwinn, Debra A.; Michelotti, Gregory A.			Temporal Dissection of Rate Limiting Transcriptional Events Using Pol II ChIP and RNA Analysis of Adrenergic Stress Gene Activation	PLOS ONE			English	Article							POLYMERASE-II; MESSENGER-RNA; POLY(A) SIGNAL; IN-VIVO; CHROMATIN IMMUNOPRECIPITATION; STIMULATED TRANSCRIPTION; POLYADENYLATION SIGNAL; EXPRESSION CHANGES; PROCESSING FACTORS; ELONGATION RATE	In mammals, increasing evidence supports mechanisms of co-transcriptional gene regulation and the generality of genetic control subsequent to RNA polymerase II (Pol II) recruitment. In this report, we use Pol II Chromatin Immunoprecipitation to investigate relationships between the mechanistic events controlling immediate early gene (IEG) activation following stimulation of the alpha(1a)-Adrenergic Receptor expressed in rat-1 fibroblasts. We validate our Pol II ChIP assay by comparison to major transcriptional events assessable by microarray and PCR analysis of precursor and mature mRNA. Temporal analysis of Pol II density suggests that reduced proximal pausing often enhances gene expression and was essential for Nr4a3 expression. Nevertheless, for Nr4a3 and several other genes, proximal pausing delayed the time required for initiation of productive elongation, consistent with a role in ensuring transcriptional fidelity. Arrival of Pol II at the 3' cleavage site usually correlated with increased polyadenylated mRNA; however, for Nfil3 and probably Gprc5a expression was delayed and accompanied by apparent pre-mRNA degradation. Intragenic pausing not associated with polyadenylation was also found to regulate and delay Gprc5a expression. Temporal analysis of Nr4a3, Dusp5 and Nfil3 shows that transcription of native IEG genes can proceed at velocities of 3.5 to 4 kilobases/min immediately after activation. Of note, all of the genes studied here also used increased Pol II recruitment as an important regulator of expression. Nevertheless, the generality of co-transcriptional regulation during IEG activation suggests temporal and integrated analysis will often be necessary to distinguish causative from potential rate limiting mechanisms.	[Morris, Daniel P.; Longo, Lawrence D.] Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA; [Lei, Beilei] Duke Univ Med Ctr, Dept Anesthesiol, Durham, NC USA; [Bomsztyk, Karol] Univ Washington, Dept Med, Seattle, WA USA; [Schwinn, Debra A.] Univ Iowa Carver Coll Med, Dept Anesthesiol, Iowa City, IA USA; [Schwinn, Debra A.] Univ Iowa Carver Coll Med, Dept Pharmacol, Iowa City, IA USA; [Schwinn, Debra A.] Univ Iowa Carver Coll Med, Dept Biochem, Iowa City, IA USA; [Michelotti, Gregory A.] Duke Univ Med Ctr, Div Gastroenterol, Dept Med, Durham, NC USA	Loma Linda University; Duke University; University of Washington; University of Washington Seattle; University of Iowa; University of Iowa; University of Iowa; Duke University	Morris, DP (corresponding author), Loma Linda Univ, Ctr Perinatal Biol, Loma Linda, CA 92350 USA.	dpmorris9@llu.edu		, Gregory/0000-0002-3936-4675; Schwinn, Debra/0000-0002-9696-5231	Department of Anesthesiology, Duke University Medical Center; AHA SDG [0530175N]; NIH/NHLBI [R37 HL49103, 5R37HL049103-19]; NIH [R01 DK083310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083310] Funding Source: NIH RePORTER	Department of Anesthesiology, Duke University Medical Center; AHA SDG(American Heart Association); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work received Start-Up support from the Department of Anesthesiology, Duke University Medical Center (2007-2009) and AHA SDG #0530175N (2005-2009) to DPM. It was also supported by 2005-2016 NIH/NHLBI R37 HL49103 (MERIT AWARD): Subcellular Distribution & Regulation of a1a-Adrenoceptors, Project Number: 5R37HL049103-19; $1,250,000/5 years (Years 16-20; MERIT award began in year 11) to DAS and NIH R01 DK083310 to KB.	AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; Ardehali MB, 2009, NAT STRUCT MOL BIOL, V16, P1123, DOI 10.1038/nsmb1109-1123; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; BANERJEE A, 1993, CIRC RES, V73, P656, DOI 10.1161/01.RES.73.4.656; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; CARSWELL S, 1989, MOL CELL BIOL, V9, P4248, DOI 10.1128/MCB.9.10.4248; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chao LC, 1999, MOL CELL BIOL, V19, P5588; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; Cooke C, 1999, MOL CELL BIOL, V19, P4971; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cotecchia S, 2010, J RECEPT SIG TRANSD, V30, P410, DOI 10.3109/10799893.2010.518152; Cullingford TE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r32; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; EDWALDSGILBERT G, 1993, MOL CELL BIOL, V13, P3472, DOI 10.1128/MCB.13.6.3472; EICK D, 1994, ANAL BIOCHEM, V218, P347, DOI 10.1006/abio.1994.1190; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Fujita T, 2007, NUCLEIC ACIDS RES, V35, P1007, DOI 10.1093/nar/gkl1138; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Galbraith MD, 2011, CURR OPIN GENET DEV, V21, P160, DOI 10.1016/j.gde.2011.01.011; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Ghorbel MT, 2010, PHYSIOL GENOMICS, V42, P67, DOI 10.1152/physiolgenomics.00174.2009; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Gonzalez-Cabrera PJ, 2003, MOL PHARMACOL, V63, P1104, DOI 10.1124/mol.63.5.1104; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Grosso AR, 2012, GENOME RES, V22, P1447, DOI 10.1101/gr.138057.112; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kadara H, 2010, NEOPLASIA, V12, P499, DOI 10.1593/neo.10390; Kazerouninia A, 2010, RNA, V16, P197, DOI 10.1261/rna.1622010; Keene JD, 2010, ENDOCRINOLOGY, V151, P1391, DOI 10.1210/en.2009-1250; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Kurakula K, 2014, BBA-MOL CELL RES, V1843, P2543, DOI 10.1016/j.bbamcr.2014.06.010; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Lei BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072430; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Michelotti Gregory A, 2004, Curr Urol Rep, V5, P258, DOI 10.1007/s11934-004-0048-0; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Nag A, 2006, RNA, V12, P1534, DOI 10.1261/rna.103206; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Peterson ML, 2002, MOL CELL BIOL, V22, P5606, DOI 10.1128/MCB.22.15.5606-5615.2002; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Rigo F, 2009, RNA, V15, P823, DOI 10.1261/rna.1409209; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Ruel M, 2003, J THORAC CARDIOV SUR, V126, P1521, DOI 10.1016/S0022-5223(03)00969-3; Saeed AE, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-47; Salvi S, 2001, CHEST, V119, P1242, DOI 10.1378/chest.119.4.1242; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Severin J, 2014, NAT BIOTECHNOL, V32, P217, DOI 10.1038/nbt.2840; SIMPSON PC, 1988, AM J CARDIOL, V62, pG13; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Tietjen JR, 2010, NAT STRUCT MOL BIOL, V17, P1154, DOI 10.1038/nsmb.1900; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Voisine P, 2004, CIRCULATION, V110, pII280, DOI 10.1161/01.CIR.0000138974.18839.02; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Weng YJ, 2010, MOL CELL BIOCHEM, V340, P187, DOI 10.1007/s11010-010-0417-6; West S, 2009, MOL CELL, V33, P354, DOI 10.1016/j.molcel.2009.01.008; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Woodcock EA, 2008, CARDIOVASC RES, V77, P452, DOI 10.1093/cvr/cvm078; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	112	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134442	10.1371/journal.pone.0134442	http://dx.doi.org/10.1371/journal.pone.0134442			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244980	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400079
J	Valenti, L; Maloberti, A; Signorini, S; Milano, M; Cesana, F; Cappellini, F; Dongiovanni, P; Porzio, M; Soriano, F; Brambilla, M; Cesana, G; Brambilla, P; Giannattasio, C; Fargion, S				Valenti, Luca; Maloberti, Alessandro; Signorini, Stefano; Milano, Marta; Cesana, Francesca; Cappellini, Fabrizio; Dongiovanni, Paola; Porzio, Marianna; Soriano, Francesco; Brambilla, Maura; Cesana, Giancarlo; Brambilla, Paolo; Giannattasio, Cristina; Fargion, Silvia			Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; FOAM CELL-FORMATION; ARTERIAL STIFFNESS; FATTY LIVER; DISEASE; HEMOCHROMATOSIS; OVERLOAD; EFFLUX; PLAQUE	Background & Aims Iron accumulation within the arterial wall has been hypothesized to promote atherosclerosis progression. Aim of this study was to evaluate whether the hormone hepcidin and iron stores are associated with arterial stiffness in subjects with essential hypertension. Methods Circulating hepcidin, ferritin, and mutations in the hemochromatosis gene were compared between subjects included in the first vs. third tertile (n=284 each) of carotid-femoral pulse wave velocity (PWV) in an unselected cohort of patients with arterial hypertension. Results At univariate logistic regression analysis, high PWV was associated with higher ferritin levels (p=0.010), but lower hepcidin (p=0.045), and hepcidin ferritin/ratio (p<0.001). Hemochromatosis mutations predisposing to iron overload were associated with high PWV (p=0.025). At multivariate logistic regression analysis, high aortic stiffness was associated with older age, male sex, lower BMI, higher systolic blood pressure and heart rate, hyperferritinemia (OR 2.05, 95% c.i. 1.11-3.17 per log ng/ml; p=0.022), and lower circulating hepcidin concentration (OR 0.29, 95% c.i. 0.16-0.51 per log ng/ml; p<0.001). In subgroup analyses, high PWV was associated with indices of target organ damage, including micro-albuminuria (n=125, p=0.038), lower ejection fraction (n=175, p=0.031), cardiac diastolic dysfunction (p=0.004), and lower S wave peak systolic velocity (p<0.001). Ferritin was associated with cardiac diastolic dysfunction, independently of confounders (p=0.006). Conclusions In conclusion, hyperferritinemia is associated with high aortic stiffness and cardiac diastolic dysfunction, while low circulating hepcidin with high aortic stiffness.	[Valenti, Luca; Milano, Marta; Dongiovanni, Paola; Porzio, Marianna; Fargion, Silvia] Univ Milan, Fdn IRCCS Ca Granda Osped Policlin, Internal Med & Metab Dis, Milan, Italy; [Maloberti, Alessandro; Cesana, Francesca; Soriano, Francesco; Giannattasio, Cristina] Univ Milano Bicocca, Niguarda Ca Granda Hosp, De Gasperi Dept, Cardiol 4, Milan, Italy; [Maloberti, Alessandro; Cesana, Francesca; Soriano, Francesco; Giannattasio, Cristina] Univ Milano Bicocca, Dept Med, Milan, Italy; [Signorini, Stefano; Cappellini, Fabrizio; Brambilla, Maura; Brambilla, Paolo] Univ Milano Bicocca, Desio Hosp, Lab Med, Milan, Italy; [Cesana, Giancarlo] Univ Milano Bicocca, Fdn IRCCS Ca Granda Osped Policlin, Gen Direct, Res Ctr Publ Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milano-Bicocca	Valenti, L (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Policlin, Internal Med & Metab Dis, Milan, Italy.	luca.valenti@unimi.it	Dongiovanni, Paola/AAC-9965-2019; brambilla, paolo/B-4184-2010; Maloberti, Alessandro/Q-1244-2017; Valenti, Luca/B-3695-2009	Dongiovanni, Paola/0000-0003-4343-7213; brambilla, paolo/0000-0002-4021-8456; Maloberti, Alessandro/0000-0002-2612-6264; Valenti, Luca/0000-0001-8909-0345				Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Bories G, 2013, CIRC RES, V113, P1196, DOI 10.1161/CIRCRESAHA.113.301656; Canavesi Elena, 2012, World J Nephrol, V1, P166, DOI 10.5527/wjn.v1.i6.166; Cesana F, 2013, BLOOD PRESSURE, V22, P302, DOI 10.3109/08037051.2013.765627; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Failla M, 2000, HEPATOLOGY, V32, P569, DOI 10.1053/jhep.2000.16265; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; Galesloot TE, 2014, ARTERIOSCL THROM VAS, V34, P446, DOI 10.1161/ATVBAHA.113.302381; Jain S, 2014, ATHEROSCLEROSIS, V237, P381, DOI 10.1016/j.atherosclerosis.2014.09.011; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kuragano T, 2011, NEPHROL DIAL TRANSPL, V26, P2663, DOI 10.1093/ndt/gfq760; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Maloberti A, 2015, HIGH BLOOD PRESS CAR, V22, P373, DOI 10.1007/s40292-015-0100-9; MANGONI AA, 1995, HYPERTENSION, V26, P984, DOI 10.1161/01.HYP.26.6.984; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mozos I., 2014, Healthmed, V8, P442; Muckenthaler MU, 2008, CELL METAB, V8, P1, DOI 10.1016/j.cmet.2008.06.009; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nilsson PM, 2014, BLOOD PRESSURE, V23, P17, DOI 10.3109/08037051.2013.796142; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Pichler G, 2015, J HYPERTENS, V33, P308, DOI 10.1097/HJH.0000000000000393; Piperno A, 2002, J HYPERTENS, V20, P1513, DOI 10.1097/00004872-200208000-00013; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saeed O, 2012, ARTERIOSCL THROM VAS, V32, P299, DOI 10.1161/ATVBAHA.111.240101; Sullivan JL, 2007, EXP BIOL MED, V232, P1014, DOI 10.3181/0703-MR-54; SULLIVAN JL, 1981, LANCET, V1, P1293; Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588; Valenti L, 2011, NUTR METAB CARDIOVAS, V21, P568, DOI 10.1016/j.numecd.2010.01.003; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Valenti L, 2010, J HEPATOL, V53, P927, DOI 10.1016/j.jhep.2010.05.023; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488; Wang HY, 2014, DIABETES, V63, P1506, DOI 10.2337/db13-1195; Winner MW, 2015, J VASC SURG, V61, P1556, DOI 10.1016/j.jvs.2014.02.006	35	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134635	10.1371/journal.pone.0134635	http://dx.doi.org/10.1371/journal.pone.0134635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244503	Green Published, gold			2022-12-26	WOS:000359061400095
J	Charron, S; Roubertie, F; Benoist, D; Dubes, V; Gilbert, SH; Constantin, M; Vieillot, D; Elbes, D; Quesson, B; Bordachar, P; Haissaguerre, M; Bernus, O; Thambo, JB; Rooryck, C				Charron, Sabine; Roubertie, Francois; Benoist, David; Dubes, Virginie; Gilbert, Stephen H.; Constantin, Marion; Vieillot, Delphine; Elbes, Delphine; Quesson, Bruno; Bordachar, Pierre; Haissaguerre, Michel; Bernus, Olivier; Thambo, Jean-Benoit; Rooryck, Caroline			Identification of Region-Specific Myocardial Gene Expression Patterns in a Chronic Swine Model of Repaired Tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; BUNDLE-BRANCH BLOCK; RETICULUM CA2+ ATPASE; ION CHANNELS; PROTEINS; HYPERTROPHY; SARCOLIPIN; FAILURE; PHOSPHOLAMBAN; RESOURCES	Surgical repair of Tetralogy of Fallot (TOF) is highly successful but may be complicated in adulthood by arrhythmias, sudden death, and right ventricular or biventricular dysfunction. To better understand the molecular and cellular mechanisms of these delayed cardiac events, a chronic animal model of postoperative TOF was studied using microarrays to perform cardiac transcriptomic studies. The experimental study included 12 piglets (7 rTOF and 5 controls) that underwent surgery at age 2 months and were further studied after 23 (+/-1) weeks of postoperative recovery. Two distinct regions (endocardium and epicardium) from both ventricles were analyzed. Expression levels from each localization were compared in order to decipher mechanisms and signaling pathways leading to ventricular dysfunction and arrhythmias in surgically repaired TOF. Several genes were confirmed to participate in ventricular remodeling and cardiac failure and some new candidate genes were described. In particular, these data pointed out FRZB as a heart failure marker. Moreover, calcium handling and contractile function genes (SLN, ACTC1, PLCD4, PLCZ), potential arrhythmia-related genes (MYO5B, KCNA5), and cytoskeleton and cellular organization-related genes (XIRP2, COL8A1, KCNA6) were among the most deregulated genes in rTOF ventricles. To our knowledge, this is the first comprehensive report on global gene expression profiling in the heart of a long-term swine model of repaired TOF.	[Charron, Sabine; Roubertie, Francois; Benoist, David; Dubes, Virginie; Gilbert, Stephen H.; Constantin, Marion; Elbes, Delphine; Quesson, Bruno; Bordachar, Pierre; Haissaguerre, Michel; Bernus, Olivier; Thambo, Jean-Benoit; Rooryck, Caroline] Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France; [Charron, Sabine; Roubertie, Francois; Benoist, David; Dubes, Virginie; Gilbert, Stephen H.; Constantin, Marion; Elbes, Delphine; Quesson, Bruno; Bordachar, Pierre; Haissaguerre, Michel; Bernus, Olivier; Thambo, Jean-Benoit] Univ Bordeaux, CRCTB, INSERM, U1045, Bordeaux, France; [Roubertie, Francois; Bordachar, Pierre; Haissaguerre, Michel; Thambo, Jean-Benoit; Rooryck, Caroline] CHU Bordeaux, Hop Cardiol Haut Leveque, Pessac, France; [Gilbert, Stephen H.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Vieillot, Delphine] Univ Bordeaux, Plateforme Technol Innovat Biomed, Pessac, France; [Elbes, Delphine] Univ Oxford, Inst Biomed Engn, Oxford, England; [Rooryck, Caroline] Univ Bordeaux, Lab Malad Rares Genet & Metab MRGM, EA 4576, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Helmholtz Association; Max Delbruck Center for Molecular Medicine; UDICE-French Research Universities; Universite de Bordeaux; University of Oxford; UDICE-French Research Universities; Universite de Bordeaux	Rooryck, C (corresponding author), Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France.	caroline.rooryck-thambo@chu-bordeaux.fr	; Bernus, Olivier/B-9956-2015	quesson, bruno/0000-0001-6434-3684; Rooryck, Caroline/0000-0002-9789-3591; Benoist, David/0000-0002-7159-3451; Bernus, Olivier/0000-0003-3917-5791				Abd El Rahman MY, 2005, J AM COLL CARDIOL, V45, P915, DOI 10.1016/j.jacc.2004.11.049; Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Askevold ET, 2014, J INTERN MED, V275, P621, DOI 10.1111/joim.12175; Benoist D, 2014, PROG BIOPHYS MOL BIO, V115, P162, DOI 10.1016/j.pbiomolbio.2014.06.008; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Bordachar P, 2008, EUROPACE, V10, P967, DOI 10.1093/europace/eun178; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Dawson K, 2013, J PHYSIOL-LONDON, V591, P1409, DOI 10.1113/jphysiol.2012.235382; Gitler AD, 2003, DEV DYNAM, V228, P643, DOI 10.1002/dvdy.10418; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Han Y, 2010, AM J PHYSIOL-CELL PH, V298, pC1109, DOI 10.1152/ajpcell.00207.2009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang HK, 2010, CIRC J, V74, P2410, DOI 10.1253/circj.CJ-10-0234; Kreymborg KG, 2010, J MOL CELL CARDIOL, V49, P598, DOI 10.1016/j.yjmcc.2010.07.014; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Lu B, 2012, PHYSIOL GENOMICS, V44, P443, DOI 10.1152/physiolgenomics.00148.2011; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; Odagiri F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101838; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Poparic I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026524; Ronkainen VP, 2011, J MOL CELL CARDIOL, V50, P1008, DOI 10.1016/j.yjmcc.2011.02.017; Schumacher-Bass SM, 2014, CIRC RES, V114, P982, DOI 10.1161/CIRCRESAHA.114.302711; Schumann H, 2000, CARDIOVASC RES, V45, P720, DOI 10.1016/S0008-6363(99)00376-4; Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003; Sridhar A, 2007, BRIT J PHARMACOL, V152, P870, DOI 10.1038/sj.bjp.0707403; Thambo JB, 2012, INT J CARDIOL, V154, P38, DOI 10.1016/j.ijcard.2010.08.063; Uebing A, 2007, CIRCULATION, V116, P1532, DOI 10.1161/CIRCULATIONAHA.107.688770; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Wang QC, 2014, INT REV CEL MOL BIO, V310, P89, DOI 10.1016/B978-0-12-800180-6.00003-7; Wang QC, 2010, CIRC RES, V106, P1468, DOI 10.1161/CIRCRESAHA.109.212787; Wu YH, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-67; Zhang Weihua, 2003, Exp Clin Cardiol, V8, P173	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134146	10.1371/journal.pone.0134146	http://dx.doi.org/10.1371/journal.pone.0134146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252659	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000359121100039
J	Fang, WB; Mafuvadze, B; Yao, M; Zou, A; Portsche, M; Cheng, N				Fang, Wei Bin; Mafuvadze, Benford; Yao, Min; Zou, An; Portsche, Mike; Cheng, Nikki			TGF-beta Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; NF-KAPPA-B; SMALL-MOLECULE INHIBITOR; HUMAN BREAST CARCINOMAS; PROMOTE TUMOR-GROWTH; C-MET; GENE-EXPRESSION; CELL LINES; IN-VIVO; CANCER	Fibroblasts are major cellular components of the breast cancer stroma, and influence the growth, survival and invasion of epithelial cells. Compared to normal tissue fibroblasts, carcinoma associated fibroblasts (CAFs) show increased expression of numerous soluble factors including growth factors and cytokines. However, the mechanisms regulating expression of these factors remain poorly understood. Recent studies have shown that breast CAFs overexpress the chemokine CXCL1, a key regulator of tumor invasion and chemo-resistance. Increased expression of CXCL1 in CAFs correlated with poor patient prognosis, and was associated with decreased expression of TGF-beta signaling components. The goal of these studies was to understand the role of TGF-beta in regulating CXCL1 expression in CAFs, using cell culture and biochemical approaches. We found that TGF-beta treatment decreased CXCL1 expression in CAFs, through Smad2/3 dependent mechanisms. Chromatin immunoprecipitation and site-directed mutagenesis assays revealed two new binding sites in the CXCL1 promoter important for Smad2/3 modulation of CXCL1 expression. Smad2/3 proteins also negatively regulated expression of Hepatocyte Growth Factor (HGF), which was found to positively regulate CXCL1 expression in CAFs through c-Met receptor dependent mechanisms. HGF/c-Met signaling in CAFs was required for activity of NF-kappa B, a transcriptional activator of CXCL1 expression. These studies indicate that TGF-beta negatively regulates CXCL1 expression in CAFs through Smad2/3 binding to the promoter, and through suppression of HGF/c-Met autocrine signaling. These studies reveal novel insight into how TGF-beta and HGF, key tumor promoting factors modulate CXCL1 chemokine expression in CAFs.	[Fang, Wei Bin; Mafuvadze, Benford; Yao, Min; Zou, An; Portsche, Mike; Cheng, Nikki] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Cheng, N (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	ncheng@kumc.edu	Mafuvadze, Benford/L-7141-2019	Yao, Min/0000-0002-3743-8300	National Cancer Institute [R00CA127357]; Kansas Bioscience Authority; University of Kansas Endowment; NATIONAL CANCER INSTITUTE [R00CA127357] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kansas Bioscience Authority; University of Kansas Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute (grant no. R00CA127357), Kansas Bioscience Authority, and University of Kansas Endowment to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Beviglia L, 1997, INT J CANCER, V74, P301, DOI 10.1002/(SICI)1097-0215(19970620)74:3<301::AID-IJC12>3.0.CO;2-E; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381; Cheng N, 2011, JOVE-J VIS EXP, DOI 10.3791/2716; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Christensen JG, 2003, CANCER RES, V63, P7345; Coyle-Rink J, 2002, VIROLOGY, V299, P240, DOI 10.1006/viro.2002.1439; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Dandekar DH, 2004, NUCLEIC ACIDS RES, V32, P1270, DOI 10.1093/nar/gkh289; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dunn NR, 2005, GENE DEV, V19, P152, DOI 10.1101/gad.1243205; Esencay M, 2010, J NEURO-ONCOL, V99, P33, DOI 10.1007/s11060-010-0111-2; Fang WB, 2012, J BIOL CHEM, V287, P36593, DOI 10.1074/jbc.M112.365999; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Follenzi A, 2000, ONCOGENE, V19, P3041, DOI 10.1038/sj.onc.1203620; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Frings O, 2013, AM J PATHOL, V182, P2037, DOI 10.1016/j.ajpath.2013.02.018; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Grantab RH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-214; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Henningfeld KA, 2000, J BIOL CHEM, V275, P21827, DOI 10.1074/jbc.M000978200; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877; Kawanishi H, 2008, CLIN CANCER RES, V14, P2579, DOI 10.1158/1078-0432.CCR-07-1922; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Krieg RC, 2004, ANTICANCER RES, V24, P1791; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Lin YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050924; Liu XY, 2000, J BIOL CHEM, V275, P16774; LONGATI P, 1994, ONCOGENE, V9, P49; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miguez DG, 2013, J CELL SCI, V126, P5335, DOI 10.1242/jcs.130435; Miyake M, 2014, PATHOL RES PRACT, V210, P74, DOI 10.1016/j.prp.2013.08.013; Mueller KL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3224; Offersen BV, 2003, AM J PATHOL, V163, P1887, DOI 10.1016/S0002-9440(10)63547-X; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ou Zhou-luo, 2006, Zhonghua Zhongliu Zazhi, V28, P586; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; RAHIMI N, 1994, DNA CELL BIOL, V13, P1189, DOI 10.1089/dna.1994.13.1189; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; Sadlonova A, 2007, AM J PATHOL, V170, P1064, DOI 10.2353/ajpath.2007.060031; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shinde AV, 2014, J MOL CELL CARDIOL, V70, P74, DOI 10.1016/j.yjmcc.2013.11.015; Son DS, 2006, MOL ENDOCRINOL, V20, P2999, DOI 10.1210/me.2006-0001; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Vaquez-martin A, 2007, EUR J CANCER, V43, P1117, DOI 10.1016/j.ejca.2007.01.037; Vered M, 2010, CANCER SCI, V101, P274, DOI 10.1111/j.1349-7006.2009.01357.x; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yang YA, 2002, CELL GROWTH DIFFER, V13, P123; Zaja-Milatovic S, 2008, HISTOL HISTOPATHOL, V23, P1399, DOI 10.14670/HH-23.1399; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zou A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-781; Zu XY, 2012, CELL TISSUE RES, V347, P73, DOI 10.1007/s00441-011-1225-3	74	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135063	10.1371/journal.pone.0135063	http://dx.doi.org/10.1371/journal.pone.0135063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252654	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100111
J	Jeong, Y; Yoon, SM; Han, S; Shim, JH; Kim, KM; Lim, YS; Lee, HC; Kim, SY; Park, JH; Lee, SW; Do Ahn, S; Choi, EK; Kim, JH				Jeong, Yuri; Yoon, Sang Min; Han, Seungbong; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Kim, So Yeon; Park, Jin-hong; Lee, Sang-wook; Do Ahn, Seung; Choi, Eun Kyung; Kim, Jong Hoon			Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; SURVIVAL; RECURRENCE; SORAFENIB; PREDICTOR; HEPATITIS; OUTCOMES	Background and Aim To investigate the value of changes in alpha-fetoprotein (AFP) levels for the prediction of radiologic response and survival outcomes in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT) who received combined treatment of 3-dimensional conformal radiotherapy (3D-CRT) and transarterial chemoembolization (TACE). Methods A database of 154 HCC patients with PVTT and elevated AFP levels (>20 ng/mL) treated with 3D-CRT and TACE as an initial treatment between August 2002 and August 2008 was retrospectively reviewed. AFP levels were determined 1 month after radiotherapy, and AFP response was defined as an AFP level reduction of >20% from the initial level. Radiologic response, overall survival (OS), and progression-free survival (PFS) rates were compared between AFP responders and non-responders. Propensity-score based matching analysis was performed to minimize the effect of potential confounding bias. Results The median follow-up period was 11.1 months (range, 3.1-82.7 months). In the propensity-score matching cohort (92 pairs), a best radiologic response of CR or PR occurred in more AFP responders than AFP non-responders (41.3% vs. 10.9%, p < 0.001). OS and PFS were also longer in AFP responders than in non-responders (median OS 13.2 months vs. 5.6 months, p < 0.001; median PFS 8.7 months vs. 3.5 months, p < 0.001). Conclusions AFP response is a significant predictive factor for radiologic response. Furthermore, AFP response is significant for OS and PFS outcomes. AFP evaluation after combined radiotherapy and TACE appears to be a useful predictor of clinical outcomes in HCC patients with PVTT.	[Jeong, Yuri; Yoon, Sang Min; Park, Jin-hong; Lee, Sang-wook; Do Ahn, Seung; Choi, Eun Kyung; Kim, Jong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Han, Seungbong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biostat, Seoul, South Korea; [Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Kim, So Yeon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Yoon, Sang Min; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Kim, So Yeon; Kim, Jong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Liver Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Yoon, SM (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	drsmyoon@amc.seoul.kr		Park, Jin-hong/0000-0002-1088-0174; Shim, Ju Hyun/0000-0002-7336-1371				BLOOMER JR, 1975, GASTROENTEROLOGY, V68, P342; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Chen Chien-Jen, 1995, Journal of the Formosan Medical Association, V94, pS94; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Ishikura S, 2002, AM J CLIN ONCOL-CANC, V25, P189, DOI 10.1097/00000421-200204000-00019; Kim BK, 2011, LIVER INT, V31, P369, DOI 10.1111/j.1478-3231.2010.02368.x; Kim DY, 2005, CANCER-AM CANCER SOC, V103, P2419, DOI 10.1002/cncr.21043; Lee MH, 2012, J GASTROEN HEPATOL, V27, P313, DOI 10.1111/j.1440-1746.2011.06867.x; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lim YS, 2014, GASTROENTEROLOGY, V147, P152, DOI 10.1053/j.gastro.2014.02.033; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Memon K, 2012, J HEPATOL, V56, P1112, DOI 10.1016/j.jhep.2011.11.020; Nobuoka D, 2010, ONCOL REP, V24, P521, DOI 10.3892/or_00000888; Personeni N, 2012, J HEPATOL, V57, P101, DOI 10.1016/j.jhep.2012.02.016; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Shim JH, 2013, ANN SURG, V257, P708, DOI 10.1097/SLA.0b013e318273be70; Tsai MC, 2010, J GASTROEN HEPATOL, V25, P605, DOI 10.1111/j.1440-1746.2009.06115.x; Yamada K, 2003, INT J RADIAT ONCOL, V57, P113, DOI 10.1016/S0360-3016(03)00434-6; Yeung YP, 2005, AM J GASTROENTEROL, V100, P1995, DOI 10.1111/j.1572-0241.2005.00229.x; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019; Zeng ZC, 2005, INT J RADIAT ONCOL, V61, P432, DOI 10.1016/j.ijrobp.2004.05.025	22	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135298	10.1371/journal.pone.0135298	http://dx.doi.org/10.1371/journal.pone.0135298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252472	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100149
J	Pires, MV; da Cunha, DA; Carlos, SD; Costa, MH				Pires, Marcel Viana; da Cunha, Denis Antonio; Carlos, Sabrina de Matos; Costa, Marcos Heil			Nitrogen-Use Efficiency, Nitrous Oxide Emissions, and Cereal Production in Brazil: Current Trends and Forecasts	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; WINTER-WHEAT; FERTILIZER NITROGEN; N2O; AGRICULTURE; MAIZE; SOIL; MANAGEMENT; RESPONSES; FIXATION	The agriculture sector has historically been a major source of greenhouse gas (GHG) emissions into the atmosphere. Although the use of synthetic fertilizers is one of the most common widespread agricultural practices, over-fertilization can lead to negative economic and environmental consequences, such as high production costs, depletion of energy resources, and increased GHG emissions. Here, we provide an analysis to understand the evolution of cereal production and consumption of nitrogen (N) fertilizers in Brazil and to correlate N use efficiency (NUE) with economic and environmental losses as N2O emissions. Our results show that the increased consumption of N fertilizers is associated with a large decrease in NUE in recent years. The CO2 eq. of N2O emissions originating from N fertilization for cereal production were approximately 12 times higher in 2011 than in 1970, indicating that the inefficient use of N fertilizers is directly related to environmental losses. The projected N fertilizer forecasts are 2.09 and 2.37 million ton for 2015 and 2023, respectively. An increase of 0.02% per year in the projected NUE was predicted for the same time period. However, decreases in the projected CO2 eq. emissions for future years were not predicted. In a hypothetical scenario, a 2.39% increase in cereal NUE would lead to $ 21 million savings in N fertilizer costs. Thus, increases in NUE rates would lead not only to agronomic and environmental benefits but also to economic improvement.	[Pires, Marcel Viana; da Cunha, Denis Antonio; Carlos, Sabrina de Matos] Univ Fed Vicosa, Dept Rural Econ, Vicosa, MG, Brazil; [Costa, Marcos Heil] Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	da Cunha, DA (corresponding author), Univ Fed Vicosa, Dept Rural Econ, Vicosa, MG, Brazil.	denis.cunha@ufv.br	da Cunha, Dênis Antônio/L-6029-2013; Pires, Marcel/K-5161-2012; da Cunha, Dênis Antônio/ABI-7436-2020; Costa, Marcos H/A-5695-2009	Pires, Marcel/0000-0002-4929-8608; da Cunha, Dênis Antônio/0000-0003-4838-3795; Costa, Marcos H/0000-0001-6874-9315	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (Fapemig) [CSA-PPM-00022-14]; Fundacao Arthur Bernardes (Funarbe) [FUNARPEX-IV-2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao Arthur Bernardes (Funarbe); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (Fapemig, Grant CSA-PPM-00022-14) and Fundacao Arthur Bernardes (Funarbe, FUNARPEX-IV-2014) to DAC. A Postdoctoral scholarship granted by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to MVP is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Ainsworth EA, 2008, PLANT PHYSIOL, V147, P13, DOI 10.1104/pp.108.117101; Alexandratos N., 1995, WORLD AGR 2010 FAO S; Allen PG, 2001, INT SER OPER RES MAN, V30, P303; Anbessa Y, 2009, CROP SCI, V49, P1259, DOI 10.2135/cropsci2008.09.0566; Angelo C., 2012, NATURE, V485, P368; [Anonymous], 2014, FAOSTAT; Beddington JR, 2012, SCIENCE, V335, P289, DOI 10.1126/science.1217941; Fenilli TAB, 2007, SCI AGR, V64, P541, DOI 10.1590/S0103-90162007000500012; Boaretto RM, 2010, SOIL SOLUTIONS CHANG; Bodirsky BL, 2012, BIOGEOSCIENCES, V9, P4169, DOI 10.5194/bg-9-4169-2012; Bodirsky BL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/111005; BOHLOOL BB, 1992, PLANT SOIL, V141, P1, DOI 10.1007/BF00011307; Brentrup F., 2010, NITROGEN USE EFFICIE; Bumb B. L., 1996, ROLE FERTILIZER SUST; Cabezas WARL, 2005, REV BRAS CIENC SOLO, V29, P215, DOI 10.1590/S0100-06832005000200007; Coelho A. M., 1991, Revista Brasileira de Ciencia do Solo, V15, P187; Cole L, 2008, SOIL BIOL BIOCHEM, V40, P505, DOI 10.1016/j.soilbio.2007.09.018; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; DAIGGER LA, 1976, AGRON J, V68, P815, DOI 10.2134/agronj1976.00021962006800050033x; De Klein C, 2006, AGR FORESTRY OTHER L, V4, P54; Dobermann AR, 2006, GROUND BREAKING STUF; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; Food and Agriculture Organization of the United Nations (FAO), 2006, WORLD AGR 2030 2050; Food and Agriculture Organization of the United Nations-FAO, 2000, FERT REQ 2015 2030; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FRANCIS DD, 1993, AGRON J, V85, P659, DOI 10.2134/agronj1993.00021962008500030026x; Freeman KW, 2005, WHEAT PRODUCTION STR; Goulding K, 2008, PHILOS T R SOC B, V363, P667, DOI 10.1098/rstb.2007.2177; HARDY RWF, 1975, SCIENCE, V188, P633, DOI 10.1126/science.188.4188.633; HARPER LA, 1987, AGRON J, V79, P965, DOI 10.2134/agronj1987.00021962007900060004x; Hirose T, 2011, OECOLOGIA, V166, P863, DOI 10.1007/s00442-011-1942-z; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; HOLMES W, 1957, P NUTR SOC, V16, P9, DOI 10.1079/PNS19570004; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; International Fertilizer Industry Association International Ferlilizer Development Center Food and Agriculture Organization, 2002, FERT US CROP; Jarecki MK, 2009, AGR ECOSYST ENVIRON, V134, P29, DOI 10.1016/j.agee.2009.05.008; Johnson JA, 2014, P NATL ACAD SCI USA, V111, P12342, DOI 10.1073/pnas.1412835111; Johnston AE, 2009, P INT FERTILISER SOC; Jones CA, 2013, AM J AGR ECON, V95, P1309, DOI 10.1093/ajae/aat035; Ju XT, 2004, AMBIO, V33, P300, DOI 10.1639/0044-7447(2004)033[0300:NFSNAA]2.0.CO;2; Keeney DR, 1982, NITROGEN AGR SOILS, P605; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Lassaletta L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105011; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Linquist B, 2012, GLOBAL CHANGE BIOL, V18, P194, DOI 10.1111/j.1365-2486.2011.02502.x; Lowrance R, 1997, ENVIRON MANAGE, V21, P687, DOI 10.1007/s002679900060; McSwiney CP, 2005, GLOBAL CHANGE BIOL, V11, P1712, DOI 10.1111/j.1365-2486.2005.01040.x; MCTI, 2013, EST AN EM GAS EF EST; Medici LO, 2004, J AGR SCI-CAMBRIDGE, V142, P535, DOI 10.1017/S002185960400468X; Medina LC, 2008, HORTTECHNOLOGY, V18, P475, DOI 10.21273/HORTTECH.18.3.475; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; OLSON RV, 1984, SOIL SCI SOC AM J, V48, P583, DOI 10.2136/sssaj1984.03615995004800030023x; Peoples MB, 2001, PLANT SOIL, V228, P29, DOI [10.1023/A:1004799703040, 10.1007/BF00011308]; Pinder RW, 2013, BIOGEOCHEMISTRY, V114, P25, DOI 10.1007/s10533-012-9787-z; POMARESGARCIA F, 1978, SOIL SCI SOC AM J, V42, P717, DOI 10.2136/sssaj1978.03615995004200050012x; Puckett LJ, 1999, J ENVIRON QUAL, V28, P2015, DOI 10.2134/jeq1999.00472425002800060043x; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2004, SCOPE SER, V62, P493; Rosenzweig C., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P855, DOI 10.1007/s11027-007-9103-8; Sinebo W, 2004, FIELD CROP RES, V85, P43, DOI 10.1016/S0378-4290(03)00135-7; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Snyder CS, 2000, AGRIBRIEFS, P6; Soares-Filho BS, 2012, CHALLENGES LOW CARBO; Souza L. S., 2006, Planta Daninha, V24, P657, DOI 10.1590/S0100-83582006000400006; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Subbarao GV, 2007, PLANT SOIL, V294, P5, DOI 10.1007/s11104-006-9159-3; Sylvester-Bradley R, 2009, J EXP BOT, V60, P1939, DOI 10.1093/jxb/erp116; Tenkorang F, 2009, NUTR CYCL AGROECOSYS, V83, P233, DOI 10.1007/s10705-008-9214-y; Tisdale S.L., 1985, SOIL FERTILITY FERTI, V4th; TKACHUK R, 1977, NUTR STANDARDS METHO, P78; United Nations, 2013, WORLD POP AG 2013; VARVEL GE, 1990, AGRON J, V82, P935, DOI 10.2134/agronj1990.00021962008200050019x; Vieira-Megda MX, 2015, NUTR CYCL AGROECOSYS, V101, P241, DOI [10.1007/s10705-015-9676-7, 10.1007/s10705-015-96]; Wang RF, 2011, CROP PASTURE SCI, V62, P504, DOI 10.1071/CP10383; Zhao Bin, 2013, TOBACCO SCI TECHNOLO, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0070569; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	83	27	29	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135234	10.1371/journal.pone.0135234	http://dx.doi.org/10.1371/journal.pone.0135234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252377	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100140
J	Quintana, MI; Andreoli, SB; Peluffo, MP; Ribeiro, WS; Feijo, MM; Bressan, RA; Coutinho, ESF; Mari, JD				Quintana, Maria Ines; Andreoli, Sergio Baxter; Peluffo, Marcela Poctich; Ribeiro, Wagner Silva; Feijo, Marcelo M.; Bressan, Rodrigo Affonseca; Coutinho, Evandro S. F.; Mari, Jair de Jesus			Psychotropic Drug Use in Sao Paulo, Brazil - An Epidemiological Survey	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-DISORDERS; MEDICATION USE; GENERAL-POPULATION; HEALTH; ANTIDEPRESSANT; PATTERNS; TRENDS; RELIABILITY; PREVALENCE	Objective To estimate the prevalence of one month psychotropic drug use in Sao Paulo, Brazil, and to assess the gap treatment between the presence of mental disorders and psychotropic drug users. Method A probabilistic sample of non-institutionalized individuals from the general population of Sao Paulo (n = 2336; turnout: 84.5%) who were 15 years or older were interviewed by a trained research staff, applying the Composite International Diagnostic Interview 2.1 (CIDI WHO) (depression, anxiety-phobia, OCD\PTSD, alcoholism sections), and an inventory investigating psychotropic drug use during the 12-month and one-month periods immediately preceding the interview. Logistic models were fitted to investigate associations between psychotropic drug use as well as socio-demographic and clinical variables. Results The one month prevalence of psychotropic drug use in Sao Paulo was 5.89%, the most commonly used drugs were antidepressants (3.15%) and tranquilizers (2.67%). A higher consumption of psychotropic drugs (overall, antidepressants and tranquilizers) was observed among women (OR:2.42), older individuals (OR:1.04), individuals with higher levels of formal education (1.06), and individuals with a family (OR:2.29) or personal history of mental illness (OR:3.27). The main psychotropic drug prescribers were psychiatrists (41%), followed by general practitioners (30%); 60% of psychotropic drugs were obtained through a government-run dispensing program. Most individuals who obtained a positive diagnosis on the CIDI 2.1 during the previous month were not using psychotropic medication (85%). Among individuals with a diagnosis of moderate to severe depression, 67.5% were not on any pharmacological treatment. Conclusion There is a change in the type of psychotropic more often used in Sao Paulo, from benzodiazepines to antidepressants, this event is observed in different cultures. The prevalence of use is similar to other developing countries. Most of the patients presenting a psychiatric illness in the month prior to testing were not receiving any sort of psychiatric medication. This may be explained by a failure to identify cases in primary care, which could be improved (and access to treatment could be facilitated) if professionals received more specialized training in managing cases with mental health problems.	[Quintana, Maria Ines; Andreoli, Sergio Baxter; Ribeiro, Wagner Silva; Feijo, Marcelo M.; Bressan, Rodrigo Affonseca; Mari, Jair de Jesus] Univ Fed Sao Paulo, Escola Paulista Med, Dept Psychiat, Sao Paulo, Brazil; [Andreoli, Sergio Baxter; Peluffo, Marcela Poctich] Univ Catolica Santos, Santos, Brazil; [Coutinho, Evandro S. F.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Catolica de Santos; Fundacao Oswaldo Cruz	Quintana, MI (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Psychiat, Sao Paulo, Brazil.	inesquintana@uol.com.br	Bressan, Rodrigo A/E-9178-2010; Ribeiro, Wagner Silva/O-2927-2018; Andreoli, Sergio Baxter/D-9568-2012; de Jesus Mari, Jair/A-7309-2008; Andreoli, Sergio Baxter/M-7112-2019	Bressan, Rodrigo A/0000-0002-0868-4449; Ribeiro, Wagner Silva/0000-0001-6735-3861; Andreoli, Sergio Baxter/0000-0002-1976-0881; de Jesus Mari, Jair/0000-0002-5403-0112; Andreoli, Sergio Baxter/0000-0002-1976-0881; Coutinho, Evandro/0000-0002-4649-7353	State of Sao Paulo Research Foundation - FAPESP [2004/15039-0]; National Research and Technology Development Council - CNPq [420122/2005-2]; National Council for Scientific and Technological Development (CNPq) [306575/2011-6]	State of Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research and Technology Development Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the State of Sao Paulo Research Foundation - FAPESP (www.fapesp.br) through the grant 2004/15039-0, and the National Research and Technology Development Council - CNPq (www.cnpq.br) through the grant 420122/2005-2. ESFC was partially supported by the National Council for Scientific and Technological Development (CNPq), process no. 306575/2011-6. JJM, MMF, and RAB are I-A researchers from the CNPq. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 2008, CIENC SAUDE COLETIVA, V13, P1421, DOI 10.1590/S1413-81232008000500008; Almeida L M, 1994, Cad Saude Publica, V10, P5; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P55; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; Andrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943; Andrade LH, 2012, EVID-BASED MENT HEAL, V15, P105, DOI 10.1136/ebmental-2012-100849; Andrade LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031879; Andrade MV, 2013, EC APLICADA, V4, P623; Andreoli SB, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-34; Arroll B, 2005, ANN FAM MED, V3, P449, DOI 10.1370/afm.349; Beck CA, 2005, SOC PSYCH PSYCH EPID, V40, P799, DOI 10.1007/s00127-005-0968-0; Beck CA, 2005, CAN J PSYCHIAT, V50, P605, DOI 10.1177/070674370505001006; Benson T, 2014, EPIDEMIOL PSYCH SCI, P1; Blay SL, 2014, INT CLIN PSYCHOPHARM, V29, P157, DOI 10.1097/YIC.0000000000000008; Bruffaerts R, 2005, Rev Med Liege, V60, P181; Brunoni AR, 2013, J AFFECT DISORDERS, V151, P71, DOI 10.1016/j.jad.2013.05.054; Busnello ED, 1999, REV SAUDE PUBL, V33, P487, DOI 10.1590/S0034-89101999000500008; Carvalho Marcelo Felga de, 2005, Cad. Saúde Pública, V21, pS100, DOI 10.1590/S0102-311X2005000700011; Chien IC, 2011, SOC PSYCH PSYCH EPID, V46, P77, DOI 10.1007/s00127-009-0169-3; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Codony M, 2007, Actas Esp Psiquiatr, V35 Suppl 2, P29; De Lima MS, 1999, SOC PSYCH PSYCH EPID, V34, P316, DOI 10.1007/s001270050150; Gasquet I, 2005, ENCEPHALE, V31, P195; Goldney Robert, 2006, Australas Psychiatry, V14, P379, DOI 10.1111/j.1440-1665.2006.02308.x; Grinshpoon Alexander, 2007, Prim Care Companion J Clin Psychiatry, V9, P356; Kaye JA, 2003, BRIT J CLIN PHARMACO, V56, P569, DOI 10.1046/j.1365-2125.2003.01905.x; Kemp AH, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00009; Kish L., 1949, J AM STAT ASS, V44; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; MARI JD, 1993, PSYCHOL MED, V23, P467; Ohayon MM, 1998, J CLIN EPIDEMIOL, V51, P273, DOI 10.1016/S0895-4356(97)00238-2; Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817, DOI 10.4088/JCP.v63n0912; Olfson M, 2004, J CLIN PSYCHIAT, V65, P1166, DOI 10.4088/JCP.v65n0903; Paulose-Ram R, 2004, J CLIN EPIDEMIOL, V57, P309, DOI 10.1016/j.jclinepi.2003.05.001; Paulose-Ram R, 2007, PHARMACOEPIDEM DR S, V16, P560, DOI 10.1002/pds.1367; Lima MCP, 2008, REV SAUDE PUBL, V42, P717, DOI 10.1590/S0034-89102008005000034; Pini S, 1999, J AFFECT DISORDERS, V56, P37, DOI 10.1016/S0165-0327(99)00141-X; Pratt Laura A, 2011, NCHS Data Brief, P1; Quintana MI, 2007, REV BRAS PSIQUIATR, V29, P18, DOI 10.1590/S1516-44462007000100007; Quintana MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062270; Quintana MI, 2012, CAD SAUDE PUBLICA, V28, P1312, DOI 10.1590/S0102-311X2012000700009; Quintana MI, 2004, BRAZ J MED BIOL RES, V37, P1739, DOI 10.1590/S0100-879X2004001100020; Ribeiro WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063545; Rojas G, 2005, J MENTAL HLTH, V14, P407, DOI DOI 10.1080/09638230500195221; SICILIANI O, 1985, PSYCHOL MED, V15, P821, DOI 10.1017/S0033291700005055; Tancredi FB., 1979, THESIS U SAO PAULO S; VAZQUEZBARQUERO JL, 1989, BRIT J PSYCHIAT, V155, P633; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Zuvekas SH, 2005, HEALTH AFFAIR, V24, P195, DOI 10.1377/hlthaff.24.1.195	51	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135059	10.1371/journal.pone.0135059	http://dx.doi.org/10.1371/journal.pone.0135059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252517	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100110
J	Schartner, M; Seth, A; Noirhomme, Q; Boly, M; Bruno, MA; Laureys, S; Barrett, A				Schartner, Michael; Seth, Anil; Noirhomme, Quentin; Boly, Melanie; Bruno, Marie-Aurelie; Laureys, Steven; Barrett, Adam			Complexity of Multi-Dimensional Spontaneous EEG Decreases during Propofol Induced General Anaesthesia	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; APPROXIMATE ENTROPY; CONSCIOUSNESS; INFORMATION; ELECTROENCEPHALOGRAM; UNCONSCIOUSNESS; INTEGRATION; NETWORKS; DENSITY; PATTERN	Emerging neural theories of consciousness suggest a correlation between a specific type of neural dynamical complexity and the level of consciousness: When awake and aware, causal interactions between brain regions are both integrated (all regions are to a certain extent connected) and differentiated (there is inhomogeneity and variety in the interactions). In support of this, recent work by Casali et al (2013) has shown that Lempel-Ziv complexity correlates strongly with conscious level, when computed on the EEG response to transcranial magnetic stimulation. Here we investigated complexity of spontaneous high-density EEG data during propofol-induced general anaesthesia. We consider three distinct measures: (i) Lempel-Ziv complexity, which is derived from how compressible the data are; (ii) amplitude coalition entropy, which measures the variability in the constitution of the set of active channels; and (iii) the novel synchrony coalition entropy (SCE), which measures the variability in the constitution of the set of synchronous channels. After some simulations on Kuramoto oscillator models which demonstrate that these measures capture distinct 'flavours' of complexity, we show that there is a robustly measurable decrease in the complexity of spontaneous EEG during general anaesthesia.	[Schartner, Michael; Seth, Anil; Barrett, Adam] Univ Sussex, Dept Informat, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England; [Noirhomme, Quentin; Bruno, Marie-Aurelie; Laureys, Steven] Univ Liege, Coma Sci Grp, Liege, Belgium; [Boly, Melanie] Univ Wisconsin, Dept Neurol, Madison, WI USA; [Boly, Melanie] Univ Wisconsin, Dept Psychiat, Madison, WI USA; [Barrett, Adam] Univ Milan, Dept Clin Sci, Milan, Italy	University of Sussex; University of Liege; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Milan	Schartner, M (corresponding author), Univ Sussex, Dept Informat, Sackler Ctr Consciousness Sci, Brighton, E Sussex, England.	m.schartner@sussex.ac.uk	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Seth, Anil/AAE-8499-2019	Laureys, Steven/0000-0002-3096-3807; Seth, Anil/0000-0002-1421-6051; Noirhomme, Quentin/0000-0001-8247-4493; Schartner, Michael/0000-0002-4854-3034; Boly, Melanie/0000-0001-9584-0907	GTA of the Department of Informatics, University of Sussex; Engineering and Physical Sciences Research Council fellowship [EP/L005131/1]; Dr. Mortimer and Theresa Sackler Foundation, Sackler Centre for Consciousness Science; European Commission (DECODER); Fondazione Europea di Ricerca Biomedica; McDonnell Foundation; Mind Science Foundation; Public Utility Foundation "Universite Europeenne du Travail''; University of Liege; EPSRC [EP/G007543/1, EP/L005131/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L005131/1, EP/G007543/1] Funding Source: researchfish	GTA of the Department of Informatics, University of Sussex; Engineering and Physical Sciences Research Council fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Dr. Mortimer and Theresa Sackler Foundation, Sackler Centre for Consciousness Science; European Commission (DECODER); Fondazione Europea di Ricerca Biomedica; McDonnell Foundation; Mind Science Foundation; Public Utility Foundation "Universite Europeenne du Travail''; University of Liege(University of Liege); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MMS is supported by a GTA of the Department of Informatics, University of Sussex. ABB is supported by Engineering and Physical Sciences Research Council fellowship EP/L005131/1. AKS is supported from The Dr. Mortimer and Theresa Sackler Foundation, as part of their support of the Sackler Centre for Consciousness Science. SL is a Belgian Funds for Scientific Research (FRS) Senior Research Associate and MAB, QN and MB are FRS Postdoctoral Researchers. This work was also supported by the European Commission (DECODER), Fondazione Europea di Ricerca Biomedica, McDonnell Foundation, Mind Science Foundation, Public Utility Foundation "Universite Europeenne du Travail'' and the University of Liege. Possible inaccuracies of information are the responsibility of the project team. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars B. J., 1988, COGNITIVE THEORY CON; Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Botcharova M, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00176; Bruhn J, 2000, ANESTHESIOLOGY, V93, P981, DOI 10.1097/00000542-200010000-00018; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Burioka N, 2005, CLIN EEG NEUROSCI, V36, P21, DOI 10.1177/155005940503600106; Carhart-Harris RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00020; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Chang JY, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00317; Chennu S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003887; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; Crick F., 1990, Seminars in the Neurosciences, V2, P263; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edelman G, 2003, P NATL ACAD SCI US; Edlund JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002236; Ferenets R, 2007, BEHAV ENTROPY COMPLE; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Fingelkurts AA, 2013, CLIN EEG NEUROSCI, V44, P209, DOI 10.1177/1550059412474929; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Kaskinoro K, 2011, BRIT J ANAESTH, V107, P573, DOI 10.1093/bja/aer196; King JR, 2013, CURR BIOL, V23, P1914, DOI 10.1016/j.cub.2013.07.075; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; RAMSAY MAE, 1974, BRIT MED J, V2, P656, DOI 10.1136/bmj.2.5920.656; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Sara M, 2010, NONLIN DYNAM PSYCHOL, V14, P1; Sarasso S, 2014, CLIN EEG NEUROSCI, V45, P40, DOI 10.1177/1550059413513723; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth A, 2009, COGN COMPUT, V1, P50, DOI 10.1007/s12559-009-9007-x; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Seth AK, 2011, PHILOS T R SOC A, V369, P3748, DOI 10.1098/rsta.2011.0079; Shanahan M, 2010, CHAOS, V20, DOI 10.1063/1.3305451; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Wildie M, 2012, CHAOS, V22, DOI 10.1063/1.4766592; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601	54	126	127	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133532	10.1371/journal.pone.0133532	http://dx.doi.org/10.1371/journal.pone.0133532			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252378	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100020
J	Curtis, SA; Danda, N; Etzion, Z; Cohen, HW; Billett, HH				Curtis, Susanna A.; Danda, Neeraja; Etzion, Zipora; Cohen, Hillel W.; Billett, Henny H.			Elevated Steady State WBC and Platelet Counts Are Associated with Frequent Emergency Room Use in Adults with Sickle Cell Anemia	PLOS ONE			English	Article							PAINFUL CRISIS; DISEASE; HYDROXYUREA; MORTALITY; CARE; HOSPITALIZATION; EVOLUTION; PLASMA; URBAN	Introduction Sickle cell anemia has many sequelae that result in emergency department (ED) use, but a minority of patients with sickle cell disease are frequent utilizers and make up the majority of ED visits. If patients who are likely to be frequent ED can be identified in steady state, they can be treated with disease modifying agents in an attempt to reduce ED use frequency. We sought to identify steady state markers for frequent ED use. Methods We identified all patients with SS/S beta 0 seen at our facilities in 2012. Health care utilization over the entire year was calculated and ED visit numbers categorized as either 0-1, 2-5, or 6 or more visits a year. Steady state and acutely active laboratory parameters were collected and analyzed using analysis of variance models and odds ratios. Results 432 adult sickle cell patients were identified, ages 18-87, 54% female, and 38% had been prescribed hydroxyurea. Of the 432 patients, 192 had 0-1 visits in the year, 144 had 2-5 visits in the year, and 96 had >6 visits for a total of 2259 visits. Those who had >6 visits accounted for 1750 (77%) of the total visits for the year. When steady state laboratory markers were examined, each additional 50x109/L platelets was associated with 22% greater risk (p < .001); each 1x109/L of WBC was associated with 11% greater risk (p = .003), and each 1g/dL Hb was associated with 23% lower risk (p = .007) of >6 ED visits/year. We did not observe a relationship between baseline HbF, LDH or reticulocyte count with >6 ED visits. Conclusion Patients with elevated white blood cell counts, elevated platelet counts, and low hemoglobin levels exhibited higher risk for frequent ED utilization and could be candidates for early and aggressive therapy with disease modifying agents.	[Curtis, Susanna A.; Danda, Neeraja; Etzion, Zipora; Billett, Henny H.] Montefiore Med Ctr, Dept Med, Div Hematol, Bronx, NY 10467 USA; [Curtis, Susanna A.; Danda, Neeraja; Etzion, Zipora; Billett, Henny H.] Montefiore Med Ctr, Dept Oncol, Bronx, NY 10467 USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Curtis, SA (corresponding author), Montefiore Med Ctr, Dept Med, Div Hematol, Bronx, NY 10467 USA.	susanna.curtis@yale.edu		Curtis, Susanna/0000-0002-2281-0843	CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR025750, KL2 RR025749, TL1 RR025748]; NIH roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750, TL1RR025748, KL2RR025749] Funding Source: NIH RePORTER	CTSA Grant from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication was supported in part by the CTSA Grant UL1 RR025750, KL2 RR025749 and TL1 RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessary represent the official view of the NCRR or NIH.	Aisiku IP, 2009, ANN EMERG MED, V53, P587, DOI 10.1016/j.annemergmed.2008.07.050; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; BILLETT HH, 1988, AM J MED SCI, V296, P293, DOI 10.1097/00000441-198811000-00001; Brawley OW, 2008, ANN INTERN MED, V148, P932, DOI 10.7326/0003-4819-148-12-200806170-00220; Carroll CP, 2009, AM J HEMATOL, V84, P666, DOI 10.1002/ajh.21515; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Conran N, 2004, AM J HEMATOL, V76, P343, DOI 10.1002/ajh.20129; Duits AJ, 1996, CLIN IMMUNOL IMMUNOP, V81, P96, DOI 10.1006/clin.1996.0163; Elmariah H, 2014, AM J HEMATOL, V89, P530, DOI 10.1002/ajh.23683; Epstein K, 2006, J NATL MED ASSOC, V98, P1109; Gladwin MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099489; Kato GJ, 2005, BRIT J HAEMATOL, V130, P943, DOI 10.1111/j.1365-2141.2005.05701.x; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Lanzkron S, 2010, AM J HEMATOL, V85, P797, DOI 10.1002/ajh.21807; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; McKerrell TDH, 2004, AM J HEMATOL, V76, P101, DOI 10.1002/ajh.20075; National Heart Lung, 2014, EV BAS MAN SICKL CEL, DOI [10.1001/jama.2014.10517, DOI 10.1001/JAMA.2014.10517]; NEELY CL, 1969, AM J CLIN PATHOL, V52, P167; Olatunji P O, 2000, Afr J Med Med Sci, V29, P27; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Shankar SM, 2005, AM J HEMATOL, V80, P262, DOI 10.1002/ajh.20485; Smith WR, 2008, ANN INTERN MED, V148, P94, DOI 10.7326/0003-4819-148-2-200801150-00004; Stallworth JR, 2010, AM J HEMATOL, V85, P795, DOI 10.1002/ajh.21772; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Wun Ted, 2001, Hematology, V5, P403; Yusuf HR, 2010, AM J PREV MED, V38, pS536, DOI 10.1016/j.amepre.2010.01.001	28	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133116	10.1371/journal.pone.0133116	http://dx.doi.org/10.1371/journal.pone.0133116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248283	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300010
J	Kuroda, H; Sakao, Y; Mun, M; Uehara, H; Nakao, M; Matsuura, Y; Mizuno, T; Sakakura, N; Motoi, N; Ishikawa, Y; Yatabe, Y; Nakagawa, K; Okumura, S				Kuroda, Hiroaki; Sakao, Yukinori; Mun, Mingyon; Uehara, Hirofumi; Nakao, Masayuki; Matsuura, Yousuke; Mizuno, Tetsuya; Sakakura, Noriaki; Motoi, Noriko; Ishikawa, Yuichi; Yatabe, Yasushi; Nakagawa, Ken; Okumura, Sakae			Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis	PLOS ONE			English	Article							RANDOMIZED-TRIAL; ADJUVANT CHEMOTHERAPY; LIMITED RESECTION; DISSECTION; TUMORS; N0; CLASSIFICATION; SEGMENTECTOMY; LOBECTOMY; CARCINOMA	Background Left upper division segmentectomy is one of the major pulmonary procedures; however, it is sometimes difficult to completely dissect interlobar lymph nodes. We attempted to clarify the prognostic importance of hilar and mediastinal nodes, especially of interlobar lymph nodes, in patients with primary non-small cell lung cancer (NSCLC) located in the left upper division. Methods We retrospectively studied patients with primary left upper lobe NSCLC undergoing surgical pulmonary resection (at least lobectomy) with radical lymphadenectomy. The representative evaluation of therapeutic value from the lymph node dissection was determined using Sasako's method. This analysis was calculated by multiplying the frequency of metastasis to the station and the 5-year survival rate of the patients with metastasis to the station. Results We enrolled 417 patients (237 men, 180 women). Tumors were located in the lingular lobe and at the upper division of left upper lobe in 69 and 348 patients, respectively. The pathological nodal statuses were pN0 in 263 patients, pN1 in 70 patients, and pN2 in 84 patients. Lymph nodes #11 and #7 were significantly correlated with differences in node involvement in patients with left upper lobe NSCLC. Among those with left upper division NSCLC, the 5-year overall survival in pN1 was 31.5% for #10, 39.3% for #11, and 50.4% for #12U. The involvement of node #11 was 1.89-fold higher in the anterior segment than that in the apicoposterior segment. The therapeutic index of estimated benefit from lymph node dissection for #11 was 3.38, #4L was 1.93, and the aortopulmonary window was 4.86 in primary left upper division NSCLC. Conclusions Interlobar node involvement is not rare in left upper division NSCLC, occurring in >20% cases. Furthermore, dissection of interlobar nodes was found to be beneficial in patients with left upper division NSCLC.	[Kuroda, Hiroaki; Mun, Mingyon; Uehara, Hirofumi; Nakao, Masayuki; Matsuura, Yousuke; Nakagawa, Ken; Okumura, Sakae] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan; [Mizuno, Tetsuya; Sakakura, Noriaki] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan; [Motoi, Noriko; Ishikawa, Yuichi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diag, Nagoya, Aichi 464, Japan	Japanese Foundation for Cancer Research; Aichi Cancer Center; Japanese Foundation for Cancer Research; Aichi Cancer Center	Sakao, Y (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Surg Oncol, Tokyo, Japan.	ysakao@aichi-cc.jp	YATABE, Yasushi/J-6461-2014; Sakakura, Noriaki/HCI-9070-2022; Motoi, Noriko/AAO-5642-2020; Motoi, Noriko/A-9718-2009	YATABE, Yasushi/0000-0003-1788-559X; Motoi, Noriko/0000-0001-7098-3311; Motoi, Noriko/0000-0001-7098-3311; Sakakura, Noriaki/0000-0002-9598-9629; Sakao, Yukinori/0000-0002-6826-2280				Asamura H, 1999, J THORAC CARDIOV SUR, V117, P1102, DOI 10.1016/S0022-5223(99)70246-1; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Blackwell W., 2009, TNM CLASSIFICATION M; CAHAN WG, 1960, J THORAC CARDIOV SUR, V39, P555; Darling GE, 2011, J THORAC CARDIOV SUR, V141, P662, DOI 10.1016/j.jtcvs.2010.11.008; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; HOLMES CE, 1995, ANN THORAC SURG, V60, P615, DOI 10.1016/0003-4975(95)00537-u; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kim AW, 2009, SEMIN THORAC CARDIOV, V21, P298, DOI 10.1053/j.semtcvs.2009.11.001; Kodama K, 1997, J THORAC CARDIOV SUR, V114, P347, DOI 10.1016/S0022-5223(97)70179-X; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Nomori H, 2004, LUNG CANCER, V46, P49, DOI 10.1016/j.lungcan.2004.03.008; Nomori H, 2007, J THORAC CARDIOV SUR, V133, P780, DOI 10.1016/j.jtcvs.2006.10.027; Nomori H, 2012, J THORAC CARDIOV SUR, V144, P87, DOI 10.1016/j.jtcvs.2012.03.034; Okada M, 2005, J THORAC CARDIOV SUR, V129, P825, DOI 10.1016/j.jtcvs.2004.06.016; Okada M, 2006, J THORAC CARDIOV SUR, V132, P769, DOI 10.1016/j.jtcvs.2006.02.063; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Riquet M, 2015, EUR J CARDIO-THORAC, V47, P543, DOI 10.1093/ejcts/ezu226; Sakao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110305; Sasako M, 1995, BRIT J SURG, V82, P356; Shimada Y, 2012, WORLD J SURG, V36, P2865, DOI 10.1007/s00268-012-1743-5; Wu YL, 2002, LUNG CANCER-J IASLC, V36, P1, DOI 10.1016/S0169-5002(01)00445-7	22	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134674	10.1371/journal.pone.0134674	http://dx.doi.org/10.1371/journal.pone.0134674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247881	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300057
J	Lu, ZY; Liu, FR; Chen, LL; Zhang, HD; Ding, YM; Liu, JX; Wong, M; Zeng, LH				Lu, Zhenya; Liu, Furong; Chen, Linglin; Zhang, Huadan; Ding, Yuemin; Liu, Jianxiang; Wong, Michael; Zeng, Ling-Hui			Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; TEMPORAL-LOBE EPILEPSY; MAMMALIAN TARGET; MOUSE MODEL; TRANSPLANT RECIPIENTS; LIFE-SPAN; PATHWAY; MICE; SEIZURES; EVEROLIMUS	Mammalian target of rapamycin (mTOR) regulates cell growth, cell differentiation and protein synthesis. Rapamycin, an inhibitor of mTOR, has been widely used as an immunosuppressant and anti-cancer drug. Recently, mTOR inhibitors have also been reported to be a potential anti-epileptic drug, which may be effective when used in young patients with genetic epilepsy. Thus, a suitable dose of rapamycin which can maintain the normal function of mTOR and has fewer side effects ideally should be identified. In the present study, we first detected changes in marker proteins of mTOR signaling pathway during development. Then we determined the dose of rapamycin by treating rats of 2 weeks of age with different doses of rapamycin for 3 days and detected its effect on mTOR pathway. Young rats were then treated with a suitable dose of rapamycin for 4 weeks and the effect of rapamycin on mTOR, development and immunity were investigated. We found that the expression of the marker proteins of mTOR pathway was changed during development in brain hippocampus and neocortex. After 3 days of treanent, 0.03 mg/kg rapamycin had no effect on phospho-S6, whereas 0.1, 0.3, 1.0 and 3.0 mg/kg rapamycin inhibited phospho-S6 in a dose-dependent manner. However, only 1.0 mg/kg and 3.0 mg/kg rapamycin inhibited phospho-S6 after 4 weeks treatment of rapamycin. Parallel to this result, rats treated with 0.1 and 0.3 mg/kg rapamycin had no obvious adverse effects, whereas rats treated with 1.0 and 3.0 mg/kg rapamycin showed significant decreases in body, spleen and thymus weight. Additionally, rats treated with 1.0 and 3.0 mg/kg rapamycin exhibited cognitive impairment and anxiety as evident by maze and open field experiments. Furthermore, the content of IL-1 beta, IL-2, IFN-gamma, TNF-alpha in serum and cerebral cortex were significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. The expression of DCX was also significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. However, rats treated with 1.0 mg/kg rapamycin exhibited fewer and milder side effects than those treated with 3.0 mg/kg. In summary, all these data suggest that there is not a rapamycin dose that can inhibit mTOR for epilepsy without causing any side effects, but 1 mg /kg may be the optimal dose for young rats for suppressing mTOR with relatively few side effects.	[Lu, Zhenya; Zeng, Ling-Hui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Internal Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Furong; Chen, Linglin; Zhang, Huadan; Ding, Yuemin; Liu, Jianxiang; Zeng, Ling-Hui] Zhejiang Univ City Coll, Sch Med, Dept Pharm, Hangzhou 310003, Zhejiang, Peoples R China; [Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wong, Michael] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Zhejiang University; Zhejiang University City College; Washington University (WUSTL); Washington University (WUSTL)	Zeng, LH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Internal Med, Hangzhou 310003, Zhejiang, Peoples R China.	zenglh@zucc.edu.cn			National Natural Science Foundation of China [81371429]; Department of Science and Technology of Zhejiang Province, Project of Experiment Animal Platform [2013C37026]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China; National Institutes of Health [R01 NS056872]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056872] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Zhejiang Province, Project of Experiment Animal Platform; Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by National Natural Science Foundation of China(81371429), Department of Science and Technology of Zhejiang Province, Project of Experiment Animal Platform (2013C37026), Scientific Research Foundation for Returned Scholars, Ministry of Education of China (2011), National Institutes of Health (R01 NS056872). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboujaoude W, 2004, TRANSPLANTATION, V77, P1094, DOI 10.1097/01.TP.0000118406.01509.75; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; Blagosklonny MV, 2013, AGING-US, V5, P592, DOI 10.18632/aging.100591; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Cambiaghi M, 2013, NEUROPHARMACOLOGY, V67, P1, DOI 10.1016/j.neuropharm.2012.11.003; CHAN CC, 1995, J OCUL PHARMACOL TH, V11, P177, DOI 10.1089/jop.1995.11.177; Chen LL, 2013, NEUROSCI BULL, V29, P295, DOI 10.1007/s12264-013-1310-6; Chen LL, 2012, EPILEPSIA, V53, P2026, DOI 10.1111/epi.12013; De Simone P, 2009, LIVER TRANSPLANT, V15, P1262, DOI 10.1002/lt.21827; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Gangarossa G, 2014, HIPPOCAMPUS, V24, P1466, DOI 10.1002/hipo.22327; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013; Kawatsu S, 2007, ANN THORAC SURG, V84, P560, DOI 10.1016/j.athoracsur.2007.02.034; Klehm J, 2014, PEDIATR NEUROL, V51, P60, DOI 10.1016/j.pediatrneurol.2014.01.025; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kotulska K, 2013, EUR J PAEDIATR NEURO, V17, P479, DOI 10.1016/j.ejpn.2013.03.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin AL, 2013, J CEREBR BLOOD F MET, V33, P1412, DOI 10.1038/jcbfm.2013.82; Maitre NL, 2013, J PERINATOL, V33, P841, DOI 10.1038/jp.2013.116; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535; Raman L, 2013, NEUROSCI LETT, V541, P9, DOI 10.1016/j.neulet.2013.01.045; Rangel EB, 2014, EXPERT OPIN DRUG MET, V10, P1585, DOI 10.1517/17425255.2014.964205; Stallone G, 2009, TRANSPLANTATION, V87, pS23, DOI 10.1097/TP.0b013e3181a05b7a; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TAYLORFISHWICK DA, 1993, TRANSPLANTATION, V56, P368, DOI 10.1097/00007890-199308000-00023; Tsai PT, 2013, BEHAV GENET, V43, P51, DOI 10.1007/s10519-012-9571-9; Way SW, 2012, HUM MOL GENET, V21, P3226, DOI 10.1093/hmg/dds156; Wiebe Samuel, 2007, Epilepsy Curr, V7, P145, DOI 10.1111/j.1535-7511.2007.00207.x; Wong M, 2013, EXPERT REV NEUROTHER, V13, P657, DOI [10.1586/ern.13.48, 10.1586/ERN.13.48]; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	41	22	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135256	10.1371/journal.pone.0135256	http://dx.doi.org/10.1371/journal.pone.0135256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248290	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300110
J	McDonald, CR; Darling, AM; Conroy, AL; Tran, V; Cabrera, A; Liles, WC; Wang, M; Aboud, S; Urassa, W; Fawzi, WW; Kain, KC				McDonald, Chloe R.; Darling, Anne M.; Conroy, Andrea L.; Tran, Vanessa; Cabrera, Ana; Liles, W. Conrad; Wang, Molin; Aboud, Said; Urassa, Willy; Fawzi, Wafaie W.; Kain, Kevin C.			Inflammatory and Angiogenic Factors at Mid-Pregnancy Are Associated with Spontaneous Preterm Birth in a Cohort of Tanzanian Women	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; CIRCULATING CYTOKINES; ADHESION MOLECULES; GROWTH RESTRICTION; INTRAUTERINE; LABOR; ULTRASOUND; BIOMARKERS; CHEMOKINES; PROTEINS	Research Question Preterm birth (PTB) is the leading cause of perinatal mortality worldwide, with the greatest burden occurring in resource-constrained settings. Based on the hypothesis that altered placental angiogenesis and inflammation early in pregnancy lead to PTB, we examined whether levels of inflammatory and angiogenic mediators, measured early in pregnancy, were predictive of spontaneous PTB (sPTB). Study Design Plasma samples were collected from a prospective cohort of primigravid Tanzanian women between 12-27 weeks gestation. A panel of 18 markers was screened on a training cohort of 426 women. Markers associated with sPTB in the training cohort were repeated in a test cohort of 628 women. All markers were measured by ELISA. Findings In both the training and test cohorts plasma levels of IL-18BP, sICAM-1, sEndoglin and CHI3L1 were elevated and Leptin was lower at enrollment in women who subsequently experienced sPTB. In multivariate analysis women with plasma levels of CHI3L1, C5a, sICAM-1, AngptL3, sEndgolin, sFlt-1 and IL-18BP in the highest quartile had an increased risk of sPTB compared with those in the lowest quartile. Women with Leptin and Ang2 in the highest quartile had a reduced risk of sPTB compared with women in the lowest quartile.	[McDonald, Chloe R.; Conroy, Andrea L.; Tran, Vanessa; Cabrera, Ana; Kain, Kevin C.] Univ Toronto, SAR Labs, Sandra Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada; [McDonald, Chloe R.; Kain, Kevin C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Darling, Anne M.; Wang, Molin; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Darling, Anne M.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Liles, W. Conrad] Univ Washington, Dept Med, Seattle, WA USA; [Wang, Molin; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Aboud, Said; Urassa, Willy] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Kain, Kevin C.] Univ Toronto, Trop Dis Unit, Div Infect Dis, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; University of Toronto	Kain, KC (corresponding author), Univ Toronto, SAR Labs, Sandra Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada.	Kevin.kain@uhn.ca	Conroy, Andrea/ABC-5715-2020; Cabrera, Ana/AES-5002-2022; Conroy, Andrea/AAA-8356-2020	Conroy, Andrea/0000-0002-5328-6511; Cabrera, Ana/0000-0003-2246-3471; Conroy, Andrea/0000-0002-5328-6511; Kain, Kevin/0000-0001-6068-1272	Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative [12003]; Canadian Institutes of Health Research (CIHR) [MOP-115160, 13721]; Canada Research Chair; CIHR Doctoral Research Award; National Institute of Child Health and Human Development [NICHD R01 37701]	Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Global Alliance to Prevent Prematurity and Stillbirth and Grand Challenges in Global Health: Preventing Preterm Birth Initiative Grant No. 12003 (KCK), the Canadian Institutes of Health Research (CIHR) MOP-115160 and 13721 (KCK), Canada Research Chair (KCK), a CIHR Doctoral Research Award (CRM), and the National Institute of Child Health and Human Development (NICHD R01 37701 (WWF)).	Andraweera PH, 2012, HUM REPROD UPDATE, V18, P436, DOI 10.1093/humupd/dms011; [Anonymous], 2007, PRETERM BIRTH CAUSES; Arias F, 1997, OBSTET GYNECOL, V89, P265, DOI 10.1016/S0029-7844(96)00451-6; Bhat G, 2014, REPROD SCI, V21, P340, DOI 10.1177/1933719113497285; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chaiworapongsa T, 2009, J MATERN-FETAL NEO M, V22, P1122, DOI 10.3109/14767050902994838; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Conde-Agudelo A, 2013, BJOG-INT J OBSTET GY, V120, P681, DOI 10.1111/1471-0528.12172; Conroy AL, 2013, CELL HOST MICROBE, V13, P215, DOI 10.1016/j.chom.2013.01.010; Fawzi WW, 2007, NEW ENGL J MED, V356, P1423, DOI 10.1056/NEJMoa064868; George A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000380; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2001, AM J OBSTET GYNECOL, V185, P643, DOI 10.1067/mob.2001.116752; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hoffman CS, 2008, PAEDIATR PERINAT EP, V22, P587, DOI 10.1111/j.1365-3016.2008.00965.x; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Krauss T, 2002, CLIN CHEM, V48, P1418; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mantzoros CS, 2000, ANN NY ACAD SCI, V900, P174, DOI 10.1111/j.1749-6632.2000.tb06228.x; Menon R, 2011, REPROD SCI, V18, P1046, DOI 10.1177/1933719111415548; Molvarec A, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-124; Molvarec A, 2011, CLIN CHIM ACTA, V412, P1957, DOI 10.1016/j.cca.2011.06.042; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Schneuer FJ, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.012; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Steinborn A, 1999, CYTOKINE, V11, P66, DOI 10.1006/cyto.1998.0399; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; World Health Organiation, 2012, BORN TOO SOON THE GL	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134619	10.1371/journal.pone.0134619	http://dx.doi.org/10.1371/journal.pone.0134619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247200	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300052
J	O'Donovan, TR; Rajendran, S; O'Reilly, S; O'Sullivan, GC; McKenna, SL				O'Donovan, Tracey R.; Rajendran, Simon; O'Reilly, Seamus; O'Sullivan, Gerald C.; McKenna, Sharon L.			Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo	PLOS ONE			English	Article							TUMOR STROMA MODEL; ISCHEMIA/REPERFUSION INJURY; MEMBRANE PERMEABILIZATION; CARDIOMYOCYTE DEATH; OXIDATIVE STRESS; FLOW-CYTOMETRY; INHIBITION; DEGRADATION; GROWTH; DRUG	Many epithelial cancers, particularly gastrointestinal tract cancers, remain poor prognosis diseases, due to resistance to cytotoxic therapy and local or metastatic recurrence. We have previously shown that apoptosis incompetent esophageal cancer cells induce autophagy in response to chemotherapeutic agents and this can facilitate their recovery. However, known pharmacological inhibitors of autophagy could not enhance cytotoxicity. In this study, we have examined two well known, clinically approved autophagy inducers, rapamycin and lithium, for their effects on chemosensitivity in apoptosis incompetent cancer cells. Both lithium and rapamycin were shown to induce autophagosomes in esophageal and colorectal cancer cells by western blot analysis of LC3 isoforms, morphology and FACS quantitation of Cyto-ID or mCherry-GFP-LC3. Analysis of autophagic flux indicates inefficient autophagosome processing in lithium treated cells, whereas rapamycin treated cells showed efficient flux. Viability and recovery was assessed by clonogenic assays. When combined with the chemotherapeutic agent 5-fluorouracil, rapamycin was protective. In contrast, lithium showed strong enhancement of non-apoptotic cell death. The combination of lithium with 5-fluorouracil or oxaliplatin was then tested in the syngenic mouse (balb/c) colorectal cancer model-CT26. When either chemotherapeutic agent was combined with lithium a significant reduction in tumor volume was achieved. In addition, survival was dramatically increased in the combination group (p < 0.0001), with > 50% of animals achieving long term cure without re-occurrence (> 1 year tumor free). Thus, combination treatment with lithium can substantially improve the efficacy of chemotherapeutic agents in apoptosis deficient cancer cells. Induction of compromised autophagy may contribute to this cytotoxicity.	[O'Donovan, Tracey R.; Rajendran, Simon; O'Sullivan, Gerald C.; McKenna, Sharon L.] Natl Univ Ireland Univ Coll Cork, Leslie C Quick Lab, Cork Canc Res Ctr, BioSci Inst, Cork, Ireland; [O'Reilly, Seamus] Cork Univ Hosp, Dept Med Oncol, Cork, Ireland	University College Cork; University College Cork	McKenna, SL (corresponding author), Natl Univ Ireland Univ Coll Cork, Leslie C Quick Lab, Cork Canc Res Ctr, BioSci Inst, Cork, Ireland.	s.mckenna@ucc.ie	McKenna, Sharon/AAD-9432-2020	McKenna, Sharon/0000-0002-6764-6274	Health Research Board [HRA_POR/2011/55]	Health Research Board	Funding was provided by Health Research Board HRA_POR/2011/55.	Aissat N, 2008, CANCER CHEMOTH PHARM, V62, P305, DOI 10.1007/s00280-007-0609-2; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Crowley LC, 2013, ONCOL REP, V29, P2261, DOI 10.3892/or.2013.2377; Delbaldo C, 2011, TARGET ONCOL, V6, P119, DOI 10.1007/s11523-011-0177-6; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dou HY, 2005, J NEUROSCI, V25, P8375, DOI 10.1523/JNEUROSCI.2164-05.2005; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Grandjean EM, 2009, CNS DRUGS, V23, P331, DOI 10.2165/00023210-200923040-00005; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Hsin IL, 2012, BRIT J PHARMACOL, V167, P1287, DOI 10.1111/j.1476-5381.2012.02073.x; Hundeshagen P, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-38; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kessler L, 2014, ENDOCR PRACT, V20, P737, DOI 10.4158/EP13504.RA; Kitazawa M, 2008, ANN NEUROL, V64, P15, DOI 10.1002/ana.21325; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kubisch R, 2014, INT J CANCER, V134, P2478, DOI 10.1002/ijc.28562; Lam D, 2008, MOL BIOL CELL, V19, P691, DOI 10.1091/mbc.E07-08-0823; Lamy L, 2013, CANCER CELL, V23, P435, DOI 10.1016/j.ccr.2013.02.017; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Loos B, 2013, AUTOPHAGY, V9, P1270, DOI 10.4161/auto.25560; Lorin S, 2013, SEMIN CANCER BIOL, V23, P361, DOI 10.1016/j.semcancer.2013.06.007; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Ma XC, 2012, AUTOPHAGY, V8, P297, DOI 10.4161/auto.18658; Malhi GS, 2012, LANCET, V379, P690, DOI 10.1016/S0140-6736(11)61703-0; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mrschtik M, 2015, FEBS J, V282, P1858, DOI 10.1111/febs.13253; Nciri R, 2009, HUM EXP TOXICOL, V28, P641, DOI 10.1177/0960327109106486; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Peng ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061457; Polivka J, 2014, PHARMACOL THERAPEUT, V142, P164, DOI 10.1016/j.pharmthera.2013.12.004; Ren SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063641; Repnik U, 2014, MITOCHONDRION, V19, P49, DOI 10.1016/j.mito.2014.06.006; Repnik U, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008755; Ronchi A, 2010, INT J ONCOL, V37, P745, DOI 10.3892/ijo_00000724; Rouhani M, 2014, GEN PHYSIOL BIOPHYS, V33, P235, DOI 10.4149/gpb_2013080; Sabanci PA, 2014, NEUROL RES, V36, P189, DOI 10.1179/1743132813Y.0000000283; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schotte P, 2001, J BIOL CHEM, V276, P25939, DOI 10.1074/jbc.M104014200; Shimizu S, 2014, INT J MOL SCI, V15, P3145, DOI 10.3390/ijms15023145; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; Thakker-Varia S, 2010, J NEUROSCI, V30, P9368, DOI 10.1523/JNEUROSCI.5987-09.2010; Vidal F, 2011, INT J ONCOL, V38, P1365, DOI 10.3892/ijo.2011.955; Voss V, 2010, MOL CANCER RES, V8, P1002, DOI 10.1158/1541-7786.MCR-09-0562; Weiner LM, 2012, NEW ENGL J MED, V366, P1156, DOI 10.1056/NEJMcibr1114526; Wiersma VR, 2015, AUTOPHAGY, V11, P1373, DOI 10.1080/15548627.2015.1063767; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Yao XF, 2014, FOOD CHEM TOXICOL, V67, P96, DOI 10.1016/j.fct.2014.02.017; Yazlovitskaya EM, 2006, CANCER RES, V66, P11179, DOI 10.1158/0008-5472.CAN-06-2740; Yue W, 2013, AUTOPHAGY, V9, P714, DOI 10.4161/auto.23997; Zhou HY, 2012, CHIN J CANCER, V31, P8, DOI 10.5732/cjc.011.10281; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	69	29	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134676	10.1371/journal.pone.0134676	http://dx.doi.org/10.1371/journal.pone.0134676			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248051	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300058
J	Ravishankar, S; Ambady, A; Ramu, H; Mudugal, NV; Tunduguru, R; Anbarasu, A; Sharma, UK; Sambandamurthy, VK; Ramaiah, S				Ravishankar, Sudha; Ambady, Anisha; Ramu, Haripriya; Mudugal, Naina Vinay; Tunduguru, Ragadeepthi; Anbarasu, Anand; Sharma, Umender K.; Sambandamurthy, Vasan K.; Ramaiah, Sudha			An IPTG Inducible Conditional Expression System for Mycobacteria	PLOS ONE			English	Article							CONTROLLING GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; IN-VITRO; ANTIBACTERIAL DISCOVERY; SMALL-MOLECULE; CELL-DIVISION; TUBERCULOSIS; INHIBITORS; TARGET; VIVO	Conditional expression strains serve as a valuable tool to study the essentiality and to establish the vulnerability of a target under investigation in a drug discovery program. While essentiality implies an absolute requirement of a target function, vulnerability provides valuable information on the extent to which a target function needs to be depleted to achieve bacterial growth inhibition followed by cell death. The critical feature of an ideal conditional expression system is its ability to tightly regulate gene expression to achieve the full spectrum spanning from a high level of expression in order to support growth and near zero level of expression to mimic conditions of gene knockout. A number of bacterial conditional expression systems have been reported for use in mycobacteria. The utility of an isopro-pylthiogalactoside ( IPTG) inducible system in mycobacteria has been reported for protein overexpression and anti-sense gene expression from a replicating multi-copy plasmid. Herein, we report the development of a versatile set of non-replicating IPTG inducible vectors for mycobacteria which can be used for generation of conditional expression strains through homologous recombination. The role of a single lac operator versus a double lac operator to regulate gene expression was evaluated by monitoring the expression levels of beta-galactosidase in Mycobacterium smegmatis. These studies indicated a significant level of leaky expression from the vector with a single lac operator but none from the vector with double lac operator. The significance of the double lac operator vector for target validation was established by monitoring the growth kinetics of an inhA, a rpoB and a ftsZ conditional expression strain grown in the presence of different concentrations of IPTG. The utility of this inducible system in identifying target specific inhibitors was established by screening a focussed library of small molecules using an inhA and a rpoB conditional expression strain.	[Ravishankar, Sudha; Ambady, Anisha; Ramu, Haripriya; Mudugal, Naina Vinay; Tunduguru, Ragadeepthi; Sharma, Umender K.; Sambandamurthy, Vasan K.] AstraZeneca India Pvt Ltd, Bengaluru, Karnataka, India; [Anbarasu, Anand; Ramaiah, Sudha] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India	AstraZeneca; Vellore Institute of Technology	Ravishankar, S (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	mailsuravi01@gmail.com	Anbarasu, Anand/U-6323-2019; Tunduguru, Ragadeepthi/AAU-6056-2020; Ramaiah, Sudha/T-3682-2019; Anbarasu, Anand/K-4076-2017	Tunduguru, Ragadeepthi/0000-0001-7075-5511; Anbarasu, Anand/0000-0003-2216-7488	AstraZeneca India Pvt Ltd.	AstraZeneca India Pvt Ltd.	AstraZeneca India Pvt Ltd. provided support in the form of salaries for authors SR, AA, HR, NVM, RT, UKS, and VKS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Awasthy D, 2010, MICROBIOL-SGM, V156, P2691, DOI 10.1099/mic.0.040717-0; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barbosa MDFS, 2002, ANTIMICROB AGENTS CH, V46, P3549, DOI 10.1128/AAC.46.11.3549-3554.2002; Bhat J, 2013, J MICROBIOL METH, V94, P152, DOI 10.1016/j.mimet.2013.05.010; Bhat J, 2006, J BIOMOL SCREEN, V11, P968, DOI 10.1177/1087057106291978; Blumenthal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015667; Boldrin F, 2014, J BACTERIOL, V196, P3441, DOI 10.1128/JB.01346-13; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Chan Pan F., 2002, Current Drug Targets - Infectious Disorders, V2, P291, DOI 10.2174/1568005023342227; Chen XP, 2007, DRUG DISCOV THER, V1, P23; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Cronin CA, 2001, GENE DEV, V15, P1506, DOI 10.1101/gad.892001; DeVito JA, 2002, NAT BIOTECHNOL, V20, P478, DOI 10.1038/nbt0502-478; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; HARTMANN GR, 1985, ANGEW CHEM INT EDIT, V24, P1009, DOI 10.1002/anie.198510093; Hoelder S, 2012, MOL ONCOL, V6, P155, DOI 10.1016/j.molonc.2012.02.004; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Hussey MA, 2008, ACID FAST STAIN PROT; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Khlebnikov A, 2000, J BACTERIOL, V182, P7029, DOI 10.1128/JB.182.24.7029-7034.2000; Kleinhammer Aljoscha, 2013, Methods Mol Biol, V986, P307, DOI 10.1007/978-1-62703-311-4_19; Kolly GS, 2014, MOL MICROBIOL, V92, P194, DOI 10.1111/mmi.12546; Lee BY, 2008, MOL MICROBIOL, V68, P1047, DOI 10.1111/j.1365-2958.2008.06214.x; Lew BM, 2002, GENE, V282, P169, DOI 10.1016/S0378-1119(01)00836-8; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; Parish T, 2005, TUBERCULOSIS, V85, P197, DOI 10.1016/j.tube.2005.01.002; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raghunandan TR, 2006, J ANTIMICROBIAL AGEN, V8, P36; Ravishankar S, 2015, GENETIC CHEM VALIDAT; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; SARTORIUS J, 1989, EMBO J, V8, P1265, DOI 10.1002/j.1460-2075.1989.tb03500.x; Seeliger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029266; Shirude PS, 2013, J MED CHEM, V56, P8533, DOI 10.1021/jm4012033; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Smith C, 2003, NATURE, V422, P341, DOI 10.1038/422341a; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Streker K, 2008, ANTIMICROB AGENTS CH, V52, P4470, DOI 10.1128/AAC.00548-07; Tobbell DA, 2002, PROTEIN EXPRES PURIF, V24, P242, DOI 10.1006/prep.2001.1573; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Xu HH, 2010, ANTIMICROB AGENTS CH, V54, P3659, DOI 10.1128/AAC.00308-10; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5	50	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134562	10.1371/journal.pone.0134562	http://dx.doi.org/10.1371/journal.pone.0134562			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247874	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300047
J	Simard, E; Sollradl, T; Maltais, JS; Boucher, J; D'Orleans-Juste, P; Grandbois, M				Simard, Elie; Soellradl, Thomas; Maltais, Jean-Sebastien; Boucher, Julie; D'Orleans-Juste, Pedro; Grandbois, Michel			Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MAILLARD REACTION-PRODUCTS; NF-KAPPA-B; IN-VITRO; ACTIN CYTOSKELETON; GENE-EXPRESSION; DIFFERENTIATION; PROTEINS; RAGE; N-EPSILON-(CARBOXYMETHYL)LYSINE	Increased blood glucose concentrations promote reactions between glucose and proteins to form advanced glycation endproducts (AGE). Circulating AGE in the blood plasma can activate the receptor for advanced endproducts (RAGE), which is present on both endothelial and vascular smooth muscle cells (VSMC). RAGE exhibits a complex signaling that involves small Gproteins and mitogen activated protein kinases (MAPK), which lead to increased nuclear factor kappa B (NF-kappa B) activity. While RAGE signaling has been previously addressed in endothelial cells, little is known regarding its impact on the function of VSMC. Therefore, we hypothesized that RAGE signaling leads to alterations in the mechanical and functional properties of VSMC, which could contribute to complications associated with diabetes. We demonstrated that RAGE is expressed and functional in the A7r5 VSMC model, and its activation by AGE significantly increased NF-kappa B activity, which is known to interfere with the contractile phenotype of VSMC. The protein levels of the contraction-related transcription factor myocardin were also decreased by RAGE activation with a concomitant decrease in the mRNA and protein levels of transgelin (SM22 alpha), a regulator of VSMC contraction. Interestingly, we demonstrated that RAGE activation increased the overall cell rigidity, an effect that can be related to an increase in myosin activity. Finally, although RAGE stimulation amplified calcium signaling and slightly myosin activity in VSMC challenged with vasopressin, their contractile capacity was negatively affected. Overall, RAGE activation in VSMC could represent a keystone in the development of vascular diseases associated with diabetes by interfering with the contractile phenotype of VSMC through the modification of their mechanical and functional properties.	[Simard, Elie; Soellradl, Thomas; Maltais, Jean-Sebastien; Boucher, Julie; D'Orleans-Juste, Pedro; Grandbois, Michel] Univ Sherbrooke, Fac Med & Sci Sante, Dept Physiol & Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [D'Orleans-Juste, Pedro; Grandbois, Michel] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Grandbois, Michel] Univ Sherbrooke, Fac Med & Sci Sante, Chaire Rech Canadienne Nanopharmacol & Microscopi, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Grandbois, M (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Physiol & Pharmacol, Sherbrooke, PQ J1K 2R1, Canada.	Michel.Grandbois@USherbrooke.ca			Natural Sciences and Engineering Research Council of Canada [90463874]; Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique	This work was supported by the Natural Sciences and Engineering Research Council of Canada (90463874) and Chaire de Recherche Canadienne en Nanopharmacologie et Microscopie a Force Atomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY AJ, 1995, BIOCHEM J, V305, P385, DOI 10.1042/bj3050385; Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007; Boucher J, 2014, INTEGR BIOL CAMB; Bovenzi V, 2010, J CELL PHYSIOL, V222, P168, DOI 10.1002/jcp.21933; Briones AM, 2010, CURR OPIN NEPHROL HY, V19, P187, DOI 10.1097/MNH.0b013e328335eec9; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Bucala R, 1992, Adv Pharmacol, V23, P1; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Cayot P, 1997, ANAL BIOCHEM, V249, P184, DOI 10.1006/abio.1997.2161; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Chuong C, 2009, J CELL PHYSIOL, V221, P430, DOI 10.1002/jcp.21873; Cuerrier CM, 2008, CELL MOL BIOENG, V1, P229, DOI 10.1007/s12195-008-0028-4; Cuerrier CM, 2009, PFLUG ARCH EUR J PHY, V457, P1361, DOI 10.1007/s00424-008-0596-0; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Halka AT, 2008, CARDIOVASC PATHOL, V17, P98, DOI 10.1016/j.carpath.2007.03.001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Holle AW, 2010, NAT MATER, V9, P4, DOI 10.1038/nmat2589; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Hubmayr RD, 1996, AM J PHYSIOL-CELL PH, V271, pC1660, DOI 10.1152/ajpcell.1996.271.5.C1660; Ikebe R, 1999, J BIOL CHEM, V274, P30122, DOI 10.1074/jbc.274.42.30122; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Miyazaki H, 2003, BIORHEOLOGY, V40, P207; Nguyen N, 2013, BBA-MOL CELL RES, V1833, P1294, DOI 10.1016/j.bbamcr.2013.02.027; Olson ES, 2006, ORL-J OTO-RHIN-LARYN, V68, P359, DOI 10.1159/000095278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; RASMUSSEN H, 1987, FASEB J, V1, P177, DOI 10.1096/fasebj.1.3.3040504; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schad JF, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-21; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simard E, 2013, PLOS ONE IN PRESS; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Suga T, 2011, J ATHEROSCLER THROMB, V18, P670, DOI 10.5551/jat.7120; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Temple A, 2006, J AM SOC MASS SPECTR, V17, P1172, DOI 10.1016/j.jasms.2006.04.030; Thatcher SE, 2007, MLCK ACTIN INTERACTI; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Ulrich P, 1997, DIABETOLOGIA, V40, pS157, DOI 10.1007/s001250051437; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Xi XP, 1999, ARTERIOSCL THROM VAS, V19, P73, DOI 10.1161/01.ATV.19.1.73; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Xie P, 2009, MOL CELL BIOL, V29, P2398, DOI 10.1128/MCB.01737-08; Yamamoto Yasuhiko, 2013, Front Endocrinol (Lausanne), V4, P105, DOI 10.3389/fendo.2013.00105; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Zhang XJ, 2013, INT J BIOCHEM CELL B, V45, P1274, DOI 10.1016/j.biocel.2013.03.020	73	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0128881	10.1371/journal.pone.0128881	http://dx.doi.org/10.1371/journal.pone.0128881			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248341	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300001
J	Moller-Acuna, P; Contreras-Riquelme, JS; Rojas-Fuentes, C; Nunez-Vivanco, G; Alzate-Morales, J; Iturriaga-Vasquez, P; Arias, HR; Reyes-Parada, M				Moeller-Acuna, Patricia; Sebastian Contreras-Riquelme, J.; Rojas-Fuentes, Cecilia; Nunez-Vivanco, Gabriel; Alzate-Morales, Jans; Iturriaga-Vasquez, Patricio; Arias, Hugo R.; Reyes-Parada, Miguel			Similarities between the Binding Sites of SB-206553 at Serotonin Type 2 and Alpha7 Acetylcholine Nicotinic Receptors: Rationale for Its Polypharmacological Profile	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATORS; MOLECULAR DETERMINANTS; INVERSE AGONISTS; LIGAND-BINDING; DOCKING; AFFINITY; NETWORK; 5-HT2A; PHARMACOLOGY; DERIVATIVES	Evidence from systems biology indicates that promiscuous drugs, i.e. those that act simultaneously at various protein targets, are clinically better in terms of efficacy, than those that act in a more selective fashion. This has generated a new trend in drug development called polypharmacology. However, the rational design of promiscuous compounds is a difficult task, particularly when the drugs are aimed to act at receptors with diverse structure, function and endogenous ligand. In the present work, using docking and molecular dynamics methodologies, we established the most probable binding sites of SB-206553, a drug originally described as a competitive antagonist of serotonin type 2B/2C metabotropic receptors (5-HT(2B/2C)Rs) and more recently as a positive allosteric modulator of the ionotropic alpha 7 nicotinic acetylcholine receptor (nAChR). To this end, we employed the crystal structures of the 5-HT2BR and acetylcholine binding protein as templates to build homology models of the 5-HT2CR and alpha 7 nAChR, respectively. Then, using a statistical algorithm, the similarity between these binding sites was determined. Our analysis showed that the most plausible binding sites for SB-206553 at 5-HT(2)Rs and alpha 7 nAChR are remarkably similar, both in size and chemical nature of the amino acid residues lining these pockets, thus providing a rationale to explain its affinity towards both receptor types. Finally, using a computational tool for multiple binding site alignment, we determined a consensus binding site, which should be useful for the rational design of novel compounds acting simultaneously at these two types of highly different protein targets.	[Moeller-Acuna, Patricia; Sebastian Contreras-Riquelme, J.; Rojas-Fuentes, Cecilia; Nunez-Vivanco, Gabriel; Alzate-Morales, Jans] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, Talca, Chile; [Moeller-Acuna, Patricia] Univ Santiago Chile, Programa Doctorado Biotecnol, Santiago, Chile; [Sebastian Contreras-Riquelme, J.] Fdn Ciencia & Vida, Lab Biol Computac, Santiago, Chile; [Iturriaga-Vasquez, Patricio] Univ La Frontera, Fac Ingn & Ciencias, Temuco, Chile; [Arias, Hugo R.] Calif Northstate Univ, Coll Med, Dept Med Educ, Elk Grove, CA USA; [Reyes-Parada, Miguel] Univ Santiago Chile, Fac Ciencias Med, Escuela Med, Santiago, Chile; [Reyes-Parada, Miguel] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Talca; Universidad de Santiago de Chile; Universidad de La Frontera; Universidad de Santiago de Chile; Universidad Autonoma de Chile	Moller-Acuna, P (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.	pmoller@utalca.cl; miguel.reyes@usach.cl	Jans, Alzate-Morales/A-5407-2008	Jans, Alzate-Morales/0000-0001-9624-7849; Nunez Vivanco, Gabriel/0000-0002-2858-1789	Fondo Nacional de Deasarrollo Cientifico y Tecnologico (FONDECYT-Chile) [1130185, 1150615, 1140618]; CONICYT (Chile)	Fondo Nacional de Deasarrollo Cientifico y Tecnologico (FONDECYT-Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Deasarrollo Cientifico y Tecnologico (FONDECYT-Chile, Research Grant) projects 1130185 (MR-P), 1150615 (PI-V) and 1140618 (JA-M) (http://www.conicyt.cl/fondecyt). PM-A was the recipient of a CONICYT (Chile) doctoral fellowship (http://www.conicyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alzate-Morales JH, 2010, J CHEM INF MODEL, V50, P1101, DOI 10.1021/ci100049h; Anighoro A, 2014, J MED CHEM, V57, P7874, DOI 10.1021/jm5006463; [Anonymous], 2011, MAESTR DESM INT TOOL; [Anonymous], 2011, SCHROD SUIT 2009 PRO; Arias HR, 2011, BIOCHEMISTRY-US, V50, P5263, DOI 10.1021/bi102001m; Berg KA, 1999, MOL PHARMACOL, V55, P863; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; Braden MR, 2006, MOL PHARMACOL, V70, P1956, DOI 10.1124/mol.106.028720; Castillo M, 2006, FEBS LETT, V580, P256, DOI 10.1016/j.febslet.2005.12.010; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Cordova-Sintjago T, 2014, MOL PHYS, V112, P398, DOI 10.1080/00268976.2013.833656; Cordova-Sintjago T, 2012, INT J QUANTUM CHEM, V112, P3807, DOI 10.1002/qua.24237; Dunlop J, 2009, J PHARMACOL EXP THER, V328, P766, DOI 10.1124/jpet.108.146514; Faundez-Parraguez M, 2013, BIOORGAN MED CHEM, V21, P2687, DOI 10.1016/j.bmc.2013.03.024; Fierro A, 2013, INTEGR VIEW MOL RECO, P405; FORBES IT, 1995, J MED CHEM, V38, P2524, DOI 10.1021/jm00014a004; Galeazzi R, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2120-0; Garcia-Sosa AT, 2013, J CHEM INF MODEL, V53, P1388, DOI 10.1021/ci3005786; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Graves SM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-65; Grutter T, 2004, CURR TOP MED CHEM, V4, P645, DOI 10.2174/1568026043451177; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Iorga B, 2006, J MOL MODEL, V12, P366, DOI 10.1007/s00894-005-0057-z; Isberg V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078515; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Kennett GA, 1996, BRIT J PHARMACOL, V117, P427, DOI 10.1111/j.1476-5381.1996.tb15208.x; Kim SK, 2011, J CHEM INF MODEL, V51, P420, DOI 10.1021/ci100375b; Knight AR, 2004, N-S ARCH PHARMACOL, V370, P114, DOI 10.1007/s00210-004-0951-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu CH, 2011, J MOL MODEL, V17, P2513, DOI 10.1007/s00894-010-0936-9; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; National Center for Biotechnology Information, PUBCHEM COMP DAT; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Pessoa-Mahana H, 2013, BIOORGAN MED CHEM, V21, P7604, DOI 10.1016/j.bmc.2013.10.036; Pessoa-Mahana H, 2012, CHEM PHARM BULL, V60, P632, DOI 10.1248/cpb.60.632; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrattenholz A, 2008, CURR MED CHEM, V15, P1520, DOI 10.2174/092986708784638843; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Sotomayor-Zarate R, 2012, BASIC CLIN PHARMACOL, V111, P371, DOI 10.1111/j.1742-7843.2012.00926.x; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Stewart JJP, 1990, QCPE B, V10, P86; Stone J, 2007, VMD MOL GRAPHICS TUT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; WOLFSON HJ, 1990, LECT NOTES COMPUT SC, V427, P526, DOI 10.1007/BFb0014902; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520	57	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134444	10.1371/journal.pone.0134444	http://dx.doi.org/10.1371/journal.pone.0134444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244344	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400080
J	Tanner, AL; Leroux, SJ				Tanner, Amy L.; Leroux, Shawn J.			Effect of Roadside Vegetation Cutting on Moose Browsing	PLOS ONE			English	Article							DEER-VEHICLE COLLISIONS; WHITE-TAILED DEER; SWAREFLEX REFLECTORS; WILDLIFE; MANAGEMENT; SELECTION; RATES; DIET	Moose (Alces americanus) vehicle collisions (MVCs) are an issue throughout the distribution of moose. Many mitigation strategies have been tested and implemented to reduce the number of MVCs, but there have been few empirical analyses of the effectiveness of roadside vegetation cutting. The goal of this study was to determine if roadside vegetation cutting attracted moose into roadside areas to browse on the vegetation regrowth. We hypothesized that moose would be attracted to roadside areas with cut vegetation. Consequently, we predicted that there would be higher levels of browsing in cut areas compared to uncut areas. To determine if moose were browsing more in cut or uncut areas, we measured the number of plants browsed by moose in paired treatment (cut on or after 2008) and control (not cut since at least 2008) sites, along with a suite of potential environmental covariates. Using a model selection approach, we fit generalized linear mixed-effects models to determine the most parsimonious set of environmental variables to explain variation in the proportion of moose browse among sites. In contrast to our hypothesis, our results show that the proportion of moose browse in the uncut control areas was significantly higher than in the cut treatment areas. The results of this study suggest that recently cut roadside areas (7 years or less based on our work) may create a less attractive foraging habitat for moose. The majority of the variance in the proportion of moose browse among sites was explained by treatment type and nested plot number within site identification (34.16%), with additional variance explained by traffic region (5.00%) and moose density (4.35%). Based on our study, we recommend that vegetation cutting be continued in roadside areas in Newfoundland as recently cut areas may be less attractive browsing sites for moose.	[Tanner, Amy L.; Leroux, Shawn J.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	Memorial University Newfoundland	Tanner, AL (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	alt608@mun.ca	Leroux, Shawn/AAY-9390-2020	Leroux, Shawn/0000-0001-9580-0294	Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship; Research and Development Corporation of Newfoundland's Ignite RD program [5404.1696.101]; NSERC [RGPIN 435372-2013]; Memorial University of Newfoundland	Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Research and Development Corporation of Newfoundland's Ignite RD program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Memorial University of Newfoundland	ALT was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship (http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/CGSM-BESCM_eng.asp). SJL funds were provided by the Research and Development Corporation of Newfoundland's Ignite R&D program (http://www.rdc.org/funding/ignite.htm) grant # 5404.1696.101, an NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) #RGPIN 435372-2013, and Memorial University of Newfoundland (http://www.mun.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEC Earth & Environmental, 2004, MAINL MOOS STAT POT; Anderson D. R., 2008, MODEL BASED INFERENC; Andreassen HP, 2005, J WILDLIFE MANAGE, V69, P1125, DOI 10.2193/0022-541X(2005)069[1125:TEOSFC]2.0.CO;2; BASHORE TL, 1985, J WILDLIFE MANAGE, V49, P769, DOI 10.2307/3801709; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann JP, 2010, REDUCING WILDLIFE VE, P61; Bell T, ECOREGIONS NEWFOUNDL; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Child Kenneth N., 1991, Alces, V27, P41; Child Kenneth N., 1998, P275; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; CONOVER MR, 1995, WILDLIFE SOC B, V23, P407; Crete M, 1999, ACTA VET HUNG, V47, P1, DOI 10.1556/AVet.47.1999.1.1; Cumming HG, 1987, ALCES, V23, P125; DELFRATE GG, 1991, ALCES, VOL 27, P1; Dodd NL, 2007, EVALUATION MEASURES; DODDS DONALD G., 1960, JOUR WILDLIFE MANAGEMENT, V24, P52, DOI 10.2307/3797356; Dussault C, 2007, J WILDLIFE MANAGE, V71, P2338, DOI 10.2193/2006-499; Eldegard K, 2012, EUR J WILDLIFE RES, V58, P969, DOI 10.1007/s10344-012-0640-4; FELDHAMER GA, 1986, J WILDLIFE MANAGE, V50, P497, DOI 10.2307/3801112; Franzmann AW, 1978, BIG GAME N AM ECOLOG; Frerker K, 2013, FOREST ECOL MANAG, V291, P55, DOI 10.1016/j.foreco.2012.11.041; Gosse John, 2002, Alces, V38, P47; HUGHES JW, 1991, FOREST SCI, V37, P261; Huijser MP, 2009, ECOL SOC, V14; Huijser MP., 2008, WILDLIFE VEHICLE COL; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jaren Vemund, 1991, Alces, V27, P93; Joyce TL, 2001, WILDLIFE SOC B, V29, P281; Knapp KK, 2006, DVCIC04 U WISC MIDW; Laurian C, 2008, J WILDLIFE MANAGE, V72, P1550, DOI 10.2193/2008-063; McLaren BE, 2000, FOREST ECOL MANAG, V133, P179, DOI 10.1016/S0378-1127(99)00223-6; Muggeo V.M., 2008, R NEWS, V8, P20; Olsson MPO, 2008, WILDLIFE BIOL, V14, P111, DOI 10.2981/0909-6396(2008)14[111:EOHFAW]2.0.CO;2; POJAR TM, 1975, J WILDLIFE MANAGE, V39, P87, DOI 10.2307/3800469; Rea RV, 2010, ENVIRON MANAGE, V46, P101, DOI 10.1007/s00267-010-9502-6; Rea RV, 2003, WILDLIFE BIOL, V9, P81, DOI 10.2981/wlb.2003.030; REEVE AF, 1993, WILDLIFE SOC B, V21, P127; Renecker Lyle A., 1998, P403; Routledge Robert G., 2004, Alces, V40, P95; SCHAFER JA, 1985, J WILDLIFE MANAGE, V49, P774, DOI 10.2307/3801710; Sullivan TL, 2004, WILDLIFE SOC B, V32, P907, DOI 10.2193/0091-7648(2004)032[0907:EOTWSI]2.0.CO;2; Tanner AL, 2015, EFFECT ROADSIDE VEGE; Tardif L-P and Associates Inc, 2003, COLL INV MOT VEH LAR; Ujvari M, 1998, J WILDLIFE MANAGE, V62, P1094, DOI 10.2307/3802562; Walters C., 1986, ADAPTIVE MANAGEMENT; Wam HK, 2010, RANGELAND ECOL MANAG, V63, P387, DOI 10.2111/REM-D-09-00039.1	48	8	8	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133155	10.1371/journal.pone.0133155	http://dx.doi.org/10.1371/journal.pone.0133155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244576	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400033
J	Wittbrodt, BT; Squires, DA; Walbeck, J; Campbell, E; Campbell, WH; Pearce, JM				Wittbrodt, B. T.; Squires, D. A.; Walbeck, J.; Campbell, E.; Campbell, W. H.; Pearce, J. M.			Open-Source Photometric System for Enzymatic Nitrate Quantification	PLOS ONE			English	Article							OPEN-SOURCE HARDWARE; APPROPRIATE TECHNOLOGY; NITROGEN-CYCLE; LOW-COST; POLYMER; DESIGN; EQUIPMENT; PLATFORM; ARDUINO; REPRAP	Nitrate, the most oxidized form of nitrogen, is regulated to protect people and animals from harmful levels as there is a large over abundance due to anthropogenic factors. Widespread field testing for nitrate could begin to address the nitrate pollution problem, however, the Cadmium Reduction Method, the leading certified method to detect and quantify nitrate, demands the use of a toxic heavy metal. An alternative, the recently proposed Environmental Protection Agency Nitrate Reductase Nitrate-Nitrogen Analysis Method, eliminates this problem but requires an expensive proprietary spectrophotometer. The development of an inexpensive portable, handheld photometer will greatly expedite field nitrate analysis to combat pollution. To accomplish this goal, a methodology for the design, development, and technical validation of an improved open-source water testing platform capable of performing Nitrate Reductase Nitrate-Nitrogen Analysis Method. This approach is evaluated for its potential to i) eliminate the need for toxic chemicals in water testing for nitrate and nitrite, ii) reduce the cost of equipment to perform this method for measurement for water quality, and iii) make the method easier to carryout in the field. The device is able to perform as well as commercial proprietary systems for less than 15% of the cost for materials. This allows for greater access to the technology and the new, safer nitrate testing technique.	[Wittbrodt, B. T.; Pearce, J. M.] Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA; [Squires, D. A.; Walbeck, J.; Campbell, E.; Campbell, W. H.] Nitrate Eliminat Co Inc, Lake Linden, MI USA; [Pearce, J. M.] Michigan Technol Univ, Dept Elect & Comp Engn, Houghton, MI 49931 USA	Michigan Technological University; Michigan Technological University	Pearce, JM (corresponding author), Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.	pearce@mtu.edu	Pearce, J.M/C-9240-2013; Pearce, Joshua M/D-2052-2010	Pearce, J.M/0000-0001-9802-3056; Pearce, Joshua M/0000-0001-9802-3056; Campbell, Wilbur/0000-0001-6432-7537	National Science Foundation (NSF STTR Phase I Grant) [IIP-1417061]	National Science Foundation (NSF STTR Phase I Grant)(National Science Foundation (NSF))	This research was supported by the National Science Foundation (NSF STTR Phase I Grant #IIP-1417061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NITR TEST KIT MOD NI; [Anonymous], 2015, FED REG, V80, P8962; Anzalone GC, 2013, SENSORS-BASEL, V13, P5338, DOI 10.3390/s130405338; Arnott R., 2008, REPRAP PROJECT OPEN; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002175; Baechler C, 2013, RAPID PROTOTYPING J, V19, P118, DOI 10.1108/13552541311302978; Bergquist M, 2011, IFIP ADV INF COMM TE, V365, P196; Buitenhuis AJ, 2012, ENERGY SUSTAIN DEV, V16, P379, DOI 10.1016/j.esd.2012.06.006; Campbell WH, 2006, ENVIRON CHEM LETT, V4, P69, DOI 10.1007/s10311-006-0035-4; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Carvalho MC, 2013, METHODS OCEANOGR, V8, P23, DOI DOI 10.1016/J.MIO.2014.06.001; CNET, SURV 98 PERC ENT US; D'Ausilio A, 2012, BEHAV RES METHODS, V44, P305, DOI 10.3758/s13428-011-0163-z; Deek FP, 2008, OPEN SOURCE: TECHNOLOGY AND POLICY, P1; Duca M, 2012, ENERG ENVIRON SCI, V5, P9726, DOI 10.1039/c2ee23062c; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Feeley SR, 2014, J SUSTAINABLE DEV, V7, P1, DOI [10.5539/jsd.v7n5p1, DOI 10.5539/JSD.V7N5P1]; Fisher D.K., 2012, MOD INSTRUM, V2012, P8, DOI DOI 10.4236/MI.2012.12002; Fobel R, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807118; Gibb A, 2014, BUILDING OPEN SOURCE, V1; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gualda EJ, 2013, NAT METHODS, V10, P599, DOI 10.1038/nmeth.2508; Gwamuri J, 2014, CHALL SUSTAIN, V2, P30, DOI 10.12924/cis2014.02010030; Heyer S., 2012, DESIGN INNOVATIVE VA, P110, DOI DOI 10.1007/978-94-007-3010-6_; Hunt EJ, 2015, RESOUR CONSERV RECY, V97, P24, DOI 10.1016/j.resconrec.2015.02.004; Johnson A, 2015, AM SCI, V103, P98, DOI 10.1511/2015.113.98; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Kersebaum KC, 2005, PHYS CHEM EARTH, V30, P59, DOI 10.1016/j.pce.2004.08.021; Korukonda AR, 2011, INT J MANAG RES, V2, P31; Kreiger M., 2013, MRS P, V1492, P91, DOI [10.1557/opl.2013.258, DOI 10.1557/OPL.2013.258, 10.1557/OPL.2013.258]; Kreiger M, 2013, S D G MAT SUST DEV C, P85, DOI [10.1557/opl.2013.319, DOI 10.1557/OPL.2013.319]; Kreiger M, 2013, ACS SUSTAIN CHEM ENG, V1, P1511, DOI 10.1021/sc400093k; Lapeyre M., 2014, THESIS U BORDEAUX; Murphy L, 2014, ANR BLOGS; Patton C.J., 2011, COLORIMETRIC DETERMI, P34, DOI [10.3133/tm5B8, DOI 10.3133/TM5B8]; Patton CJ, 2013, 20135033 US GEOL SUR, P36; Pearce J., 2012, SUSTAIN SCI PRACT PO, V8; Pearce J. M., 2015, Organic Farming, V1, P19; Pearce J.M., 2015, MOD EC, V6, P1, DOI [DOI 10.4236/ME.2015.61001, 10.4236/me.2015.61001]; Pearce J.M., 2010, J SUSTAINABLE DEV, V3, P17, DOI [DOI 10.5539/JSD.V3N4P17, 10.5539/jsd.v3n4p17]; Pearce JM, 2014, OPEN SOURCE LAB; Pearce JM, 2014, NATURE, V505, P618, DOI 10.1038/505618d; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Pearce Joshua M., 2012, Environment Development and Sustainability, V14, P425, DOI 10.1007/s10668-012-9337-9; Russell L, 2012, IEEE IMTC P, P2695; Ryswyk HV, 2007, J CHEM EDUC, V84, P306; Sells E, 2010, 1594475 ID SOC SCI R; Sianipar CPM, 2013, SUSTAINABILITY-BASEL, V5, P3382, DOI 10.3390/su5083382; Teikari P, 2012, J NEUROSCI METH, V211, P227, DOI 10.1016/j.jneumeth.2012.09.012; U. S. Environmental Protection Agency, 1993, DET NITR NITR NITR A; Wijnen B, 2014, J WATER SANIT HYG DE, V4, P532, DOI 10.2166/washdev.2014.137; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Wittbrodt BT, 2013, MECHATRONICS, V23, P713, DOI 10.1016/j.mechatronics.2013.06.002; Wohlers, 2014, WOHLERS REPORT 2014; Yang Q, 2013, APPL MECH MATER, V437, P901, DOI 10.4028/www.scientific.net/AMM.437.901; Zelenika I., 2011, Journal of Sustainable Development, V4, P12; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840	57	28	28	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134989	10.1371/journal.pone.0134989	http://dx.doi.org/10.1371/journal.pone.0134989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244342	Green Published, gold			2022-12-26	WOS:000359061400136
J	Yandow, LH; Chalfoun, AD; Doak, DF				Yandow, Leah H.; Chalfoun, Anna D.; Doak, Daniel F.			Climate Tolerances and Habitat Requirements Jointly Shape the Elevational Distribution of the American Pika (Ochotona princeps), with Implications for Climate Change Effects	PLOS ONE			English	Article							HARE POPULATION-DENSITY; ALPINE TUNDRA; RANGE SHIFTS; RESPONSES; DISPERSAL; BEHAVIOR; CONNECTIVITY; DETERMINANTS; COMMUNITIES; TEMPERATURE	Some of the most compelling examples of ecological responses to climate change are elevational range shifts of individual species, which have been observed throughout the world. A growing body of evidence, however, suggests substantial mediation of simple range shifts due to climate change by other limiting factors. Understanding limiting factors for a species within different contexts, therefore, is critical for predicting responses to climate change. The American pika (Ochotona princeps) is an ideal species for investigating distributions in relation to climate because of their unusual and well-understood natural history as well as observed shifts to higher elevation in parts of their range. We tested three hypotheses for the climatic or habitat characteristics that may limit pika presence and abundance: summer heat, winter snowpack, and forage availability. We performed these tests using an index of pika abundance gathered in a region where environmental influences on pika distribution have not been well-characterized. We estimated relative pika abundance via scat surveys and quantified climatic and habitat characteristics across two North-Central Rocky Mountain Ranges, the Wind River and Bighorn ranges in Wyoming, USA. Pika scat density was highest at mid-elevations and increased linearly with forage availability in both ranges. Scat density also increased with temperatures conducive to forage plant growth, and showed a unimodal relationship with the number of days below -5 degrees C, which is modulated by insulating snowpack. Our results provide support for both the forage availability and winter snowpack hypotheses. Especially in montane systems, considering the context-dependent nature of climate effects across regions and elevations as well as interactions between climatic and other critical habitat characteristics, will be essential for predicting future species distributions.	[Yandow, Leah H.; Doak, Daniel F.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Yandow, Leah H.] Univ Wyoming, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol 3166, Laramie, WY 82071 USA; [Chalfoun, Anna D.] Univ Wyoming, US Geol Survey, Wyoming Cooperat Fish & Wildlife Res Unit, Dept Zool & Physiol 3166, Laramie, WY 82071 USA; [Doak, Daniel F.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA	University of Wyoming; University of Wyoming; United States Department of the Interior; United States Geological Survey; University of Wyoming; University of Colorado System; University of Colorado Boulder	Yandow, LH (corresponding author), Univ Wyoming, Dept Zool & Physiol, 1000 East Univ Ave, Laramie, WY 82071 USA.	lyandow@gmail.com			Wyoming Governor's Big Game License Coalition; CU Boulder; American Society of Mammalogists	Wyoming Governor's Big Game License Coalition; CU Boulder; American Society of Mammalogists	This work was funded by the following: Wyoming Governor's Big Game License Coalition (two years of funding) to ADC (http://www.wyomingwildlifefoundation.org/), Doak Startup from CU Boulder to DFD (http://www.colorado.edu/envs/people/dan-doak), and American Society of Mammalogists Grants In Aid to LHY (http://www.mammalsociety.org/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Barea-Azcon JM, 2007, BIODIVERS CONSERV, V16, P1213, DOI 10.1007/s10531-006-9114-x; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, 2008, WEST N AM NATURALIST, V68, P8, DOI 10.3398/1527-0904(2008)68[8:APOPIN]2.0.CO;2; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Benson D, 2011, GYRFALCONS AND PTARM, VI, P237; Bouche P, 2007, PACHYDERM, P58; Brennan A, 2013, ECOL APPL, V23, P643, DOI 10.1890/12-0959.1; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Canon J, 2011, INT J REMOTE SENS, V32, P5665, DOI 10.1080/01431161.2010.507259; Carlson BZ, 2011, ARCT ANTARCT ALP RES, V43, P331, DOI 10.1657/1938-4246-43.3.331; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Dearing MD, 1997, OECOLOGIA, V109, P122, DOI 10.1007/s004420050066; Dearing MD, 1996, OECOLOGIA, V108, P467, DOI 10.1007/BF00333723; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Erb LP, 2014, ECOL APPL, V24, P429, DOI 10.1890/13-1072.1; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Fleishman E, 2002, CONSERV BIOL, V16, P706, DOI 10.1046/j.1523-1739.2002.00539.x; Franken RJ, 2004, J ANIM ECOL, V73, P889, DOI 10.1111/j.0021-8790.2004.00865.x; Golian SC, 1985, THESIS; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Haslett JR, 1997, GLOBAL ECOL BIOGEOGR, V6, P3, DOI 10.2307/2997522; Hayward MW, 2005, WILDLIFE RES, V32, P503, DOI 10.1071/WR03046; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; HUNTLY NJ, 1987, ECOLOGY, V68, P274, DOI 10.2307/1939258; HUNTLY NJ, 1986, J MAMMAL, V67, P139, DOI 10.2307/1381010; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Korner C, 2003, ALPINE PLANT LIFE FU, P47; KREBS CJ, 1987, CAN J ZOOL, V65, P565, DOI 10.1139/z87-087; Krebs CJ, 2001, CAN J ZOOL, V79, P1, DOI 10.1139/z00-177; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Luckman B, 2000, AMBIO, V29, P371, DOI 10.1639/0044-7447(2000)029[0371:IOCFOM]2.0.CO;2; MACARTHUR RA, 1973, CAN J ZOOL, V51, P11, DOI 10.1139/z73-002; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McKelvey KS, 2011, ECOL APPL, V21, P2882, DOI 10.1890/10-2206.1; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; Mills LS, 2005, J WILDLIFE MANAGE, V69, P1053, DOI 10.2193/0022-541X(2005)069[1053:PCICTM]2.0.CO;2; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; Morrison SF, 2009, OECOLOGIA, V159, P107, DOI 10.1007/s00442-008-1197-5; Murray DL, 2002, CAN J ZOOL, V80, P771, DOI 10.1139/Z02-027; Nichols LB, 2010, WEST N AM NATURALIST, V70, P500; Palomares F, 2001, WILDLIFE SOC B, V29, P578; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PENNINGTON W, 1986, VEGETATIO, V67, P105, DOI 10.1007/BF00037361; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Rodhouse TJ, 2010, J MAMMAL, V91, P1287, DOI 10.1644/09-MAMM-A-334.1; Ross S, 2010, J MAMMAL, V91, P811, DOI 10.1644/09-MAMM-A-342.1; RUZICKA V, 1993, EKOL BRATISLAVA, V12, P291; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Simpson WG, 2009, WEST N AM NATURALIST, V69, P243, DOI 10.3398/064.069.0213; SMITH AT, 1978, ECOLOGY, V59, P133, DOI 10.2307/1936639; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; SMITH AT, 1980, ECOLOGY, V61, P8, DOI 10.2307/1937147; Totland O, 1997, CAN J BOT, V75, P137, DOI 10.1139/b97-016; Walker MD, 1999, HYDROL PROCESS, V13, P2315, DOI 10.1002/(SICI)1099-1085(199910)13:14/15&lt;2315::AID-HYP888&gt;3.0.CO;2-A; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilkening JL, 2011, QUATERN INT, V235, P77, DOI 10.1016/j.quaint.2010.05.004; Wipf S, 2009, CLIMATIC CHANGE, V94, P105, DOI [10.1007/s10584-009-9546-x, 10.1007/s10584-009-9546-X]	63	24	24	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131082	10.1371/journal.pone.0131082	http://dx.doi.org/10.1371/journal.pone.0131082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244851	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400008
J	Bungert, M; Koppe, G; Niedtfeld, I; Vollstaedt-Klein, S; Schmahl, C; Lis, S; Bohus, M				Bungert, Melanie; Koppe, Georgia; Niedtfeld, Inga; Vollstaedt-Klein, Sabine; Schmahl, Christian; Lis, Stefanie; Bohus, Martin			Pain Processing after Social Exclusion and Its Relation to Rejection Sensitivity in Borderline Personality Disorder	PLOS ONE			English	Article							SIGNAL-DETECTION ANALYSIS; SELF-INJURIOUS-BEHAVIOR; BRAIN RESPONSES; PHYSICAL PAIN; PERCEPTION; CORTEX; PROPRIOCEPTION; DISSOCIATION; METAANALYSIS; THRESHOLDS	Objective There is a general agreement that physical pain serves as an alarm signal for the prevention of and reaction to physical harm. It has recently been hypothesized that "social pain," as induced by social rejection or abandonment, may rely on comparable, phylogenetically old brain structures. As plausible as this theory may sound, scientific evidence for this idea is sparse. This study therefore attempts to link both types of pain directly. We studied patients with borderline personality disorder (BPD) because BPD is characterized by opposing alterations in physical and social pain; hyposensitivity to physical pain is associated with hypersensitivity to social pain, as indicated by an enhanced rejection sensitivity. Method Twenty unmedicated female BPD patients and 20 healthy participants (HC, matched for age and education) played a virtual ball-tossing game (cyberball), with the conditions for exclusion, inclusion, and a control condition with predefined game rules. Each cyberball block was followed by a temperature stimulus (with a subjective pain intensity of 60% in half the cases). The cerebral responses were measured by functional magnetic resonance imaging. The Adult Rejection Sensitivity Questionnaire was used to assess rejection sensitivity. Results Higher temperature heat stimuli had to be applied to BPD patients relative to HCs to reach a comparable subjective experience of painfulness in both groups, which suggested a general hyposensitivity to pain in BPD patients. Social exclusion led to a subjectively reported hypersensitivity to physical pain in both groups that was accompanied by an enhanced activation in the anterior insula and the thalamus. In BPD, physical pain processing after exclusion was additionally linked to enhanced posterior insula activation. After inclusion, BPD patients showed reduced amygdala activation during pain in comparison with HC. In BPD patients, higher rejection sensitivity was associated with lower activation differences during pain processing following social exclusion and inclusion in the insula and in the amygdala. Discussion Despite the similar behavioral effects in both groups, BPD patients differed from HC in their neural processing of physical pain depending on the preceding social situation. Rejection sensitivity further modulated the impact of social exclusion on neural pain processing in BPD, but not in healthy controls.	[Bungert, Melanie; Koppe, Georgia; Niedtfeld, Inga; Schmahl, Christian; Lis, Stefanie; Bohus, Martin] Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Vollstaedt-Klein, Sabine] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Bungert, M (corresponding author), Heidelberg Univ, Dept Psychosomat Med & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany.	melanie.bungert@zi-mannheim.de	Koppe, Georgia/ABD-4179-2020; Schmahl, Christian/E-8760-2012; Niedtfeld, Inga/GLV-3573-2022; Vollstädt-Klein, Sabine/C-6744-2012	Koppe, Georgia/0000-0003-2941-9238; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Schmahl, Christian/0000-0003-0141-0821; Niedtfeld, Inga/0000-0002-6118-1664	Deutsche Forschungsgemeinschaft [KFO-256 BO 1487/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) to Martin Bohus: KFO-256 BO 1487/11-1.	Bar KJ, 2007, BIOL PSYCHIAT, V62, P1281, DOI 10.1016/j.biopsych.2007.02.011; Battle CL, 2004, J PERS DISORD, V18, P193, DOI 10.1521/pedi.18.2.193.32777; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berenson KR, 2009, J RES PERS, V43, P1064, DOI 10.1016/j.jrp.2009.07.007; Bernstein MJ, 2012, PERS SOC PSYCHOL B, V38, P185, DOI 10.1177/0146167211422449; Boettger MK, 2013, PSYCHOSOM MED, V75, P281, DOI 10.1097/PSY.0b013e3182881a9c; Bohus M, 2000, PSYCHIAT RES, V95, P251, DOI 10.1016/S0165-1781(00)00179-7; Bohus M, 2009, INTERAKTIVES FERTIGK; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Cardenas-Morales L, 2011, PSYCHIAT RES, V186, P458, DOI 10.1016/j.psychres.2010.07.050; Carpenter RW, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0335-2; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; DeWall CN, 2006, J PERS SOC PSYCHOL, V91, P1, DOI 10.1037/0022-3514.91.1.1; Dickens C, 2003, PSYCHOSOM MED, V65, P369, DOI 10.1097/01.PSY.0000041622.69462.06; Domsalla M, 2014, SOC COGN AFFECT NEUR, V9, P1789, DOI 10.1093/scan/nst176; Downey G, 1996, J PERS SOC PSYCHOL, V70, P1327, DOI 10.1037/0022-3514.70.6.1327; Ducasse D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0443-2; Eisenberger NI, 2006, PAIN, V126, P132, DOI 10.1016/j.pain.2006.06.024; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; First M. B., 1997, USERS GUIDE FOR THE; Hayes A. F., 2013, INTRODUCTION TO MEDI; HERPERTZ S, 1995, ACTA PSYCHIAT SCAND, V91, P57, DOI 10.1111/j.1600-0447.1995.tb09743.x; Kemperman I, 1997, PSYCHIAT RES, V70, P175, DOI 10.1016/S0165-1781(97)00034-6; Kleindienst N, 2008, J NERV MENT DIS, V196, P230, DOI 10.1097/NMD.0b013e3181663026; Klossika I, 2006, PAIN, V124, P264, DOI 10.1016/j.pain.2006.08.007; Kraus A, 2009, BIOL PSYCHIAT, V65, P819, DOI 10.1016/j.biopsych.2008.10.028; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Lawrence KA, 2011, J PERS DISORD, V25, P702, DOI 10.1521/pedi.2011.25.5.702; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lin CS, 2013, BRAIN RES, V1493, P40, DOI 10.1016/j.brainres.2012.11.035; Loranger A. W., 1999, INTERNATIONAL PERSON; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Ludascher P, 2007, PSYCHIAT RES, V149, P291, DOI 10.1016/j.psychres.2005.04.009; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; MacDonald Geoff., 2005, SOCIAL OUTCAST OSTRA, P77; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Niedtfeld I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033293; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Pavony MT, 2014, PERSONAL DISORD, V5, P164, DOI 10.1037/per0000017; Pavony MT, 2013, J PERS DISORD, V27, P208, DOI 10.1521/pedi.2013.27.2.208; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Peyron R, 1999, BRAIN, V122, P1765, DOI 10.1093/brain/122.9.1765; Ploner M, 2004, NERVENARZT, V75, P962, DOI 10.1007/s00115-004-1739-y; Pomares FB, 2013, NEUROIMAGE, V64, P466, DOI 10.1016/j.neuroimage.2012.09.038; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Renneberg B, 2012, CLIN PSYCHOL PSYCHOT, V19, P473, DOI 10.1002/cpp.772; Ruocco AC, 2010, PSYCHIAT RES-NEUROIM, V181, P233, DOI 10.1016/j.pscychresns.2009.12.001; RUSS MJ, 1992, BIOL PSYCHIAT, V32, P501, DOI 10.1016/0006-3223(92)90218-O; Schmahl C, 2006, ARCH GEN PSYCHIAT, V63, P659, DOI 10.1001/archpsyc.63.6.659; Schmahl C, 2004, PAIN, V110, P470, DOI 10.1016/j.pain.2004.04.035; Schmahl C, 2010, WORLD J BIOL PSYCHIA, V11, P364, DOI 10.3109/15622970701849952; Schneider P, 2014, EUR NEUROPSYCHOPHARM, V24, P290, DOI 10.1016/j.euroneuro.2013.04.004; Simons LE, 2014, HUM BRAIN MAPP, V35, P527, DOI 10.1002/hbm.22199; Staebler K, 2011, PSYCHOL MED, V41, P1929, DOI 10.1017/S0033291711000080; Staebler K, 2011, CLIN PSYCHOL PSYCHOT, V18, P275, DOI 10.1002/cpp.705; Stiglmayr C, 2009, PSYCHOPATHOLOGY, V42, P370, DOI 10.1159/000236908; Way BM, 2009, P NATL ACAD SCI USA, V106, P15079, DOI 10.1073/pnas.0812612106; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Zanarini MC, 1997, AM J PSYCHIAT, V154, P1101	65	35	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133693	10.1371/journal.pone.0133693	http://dx.doi.org/10.1371/journal.pone.0133693			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241850	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700019
J	Wu, HL; Chang, WK; Hu, KH; Langford, RM; Tsou, MY; Chang, KY				Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Langford, Richard M.; Tsou, Mei-Yung; Chang, Kuang-Yi			A Quantile Regression Approach to Estimating the Distribution of Anesthetic Procedure Time during Induction	PLOS ONE			English	Article							OPERATING-ROOM; DAY STARTS; VARIABILITY; STRATEGIES; EFFICIENCY	Although procedure time analyses are important for operating room management, it is not easy to extract useful information from clinical procedure time data. A novel approach was proposed to analyze procedure time during anesthetic induction. A two-step regression analysis was performed to explore influential factors of anesthetic induction time (AIT). Linear regression with stepwise model selection was used to select significant correlates of AIT and then quantile regression was employed to illustrate the dynamic relationships between AIT and selected variables at distinct quantiles. A total of 1,060 patients were analyzed. The first and second-year residents (R1-R2) required longer AIT than the third and fourth-year residents and attending anesthesiologists (p = 0.006). Factors prolonging AIT included American Society of Anesthesiologist physical status. III, arterial, central venous and epidural catheterization, and use of bronchoscopy. Presence of surgeon before induction would decrease AIT (p < 0.001). Types of surgery also had significant influence on AIT. Quantile regression satisfactorily estimated extra time needed to complete induction for each influential factor at distinct quantiles. Our analysis on AIT demonstrated the benefit of quantile regression analysis to provide more comprehensive view of the relationships between procedure time and related factors. This novel two-step regression approach has potential applications to procedure time analysis in operating room management.	[Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Tsou, Mei-Yung; Chang, Kuang-Yi] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei 112, Taiwan; [Wu, Hsin-Lun; Chang, Wen-Kuei; Hu, Ken-Hua; Tsou, Mei-Yung; Chang, Kuang-Yi] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wu, Hsin-Lun] Hsinchu Mackay Mem Hosp, Dept Anesthesiol, Hsinchu, Taiwan; [Langford, Richard M.] Univ London, Queen Mary Coll, Barts & London Sch Med & Dent, Pain & Anaesthesia Res Ctr,William Harvey Res Ins, London EC1A 7BE, England	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; University of London; Queen Mary University London	Chang, KY (corresponding author), Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei 112, Taiwan.	kychang@vghtpe.gov.tw			Taipei Veterans General Hospital, Taipei, Taiwan [V97A-109]; Anesthesiology Research and Development Foundation, Taipei, Taiwan [ARDF9905]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Anesthesiology Research and Development Foundation, Taipei, Taiwan	This study was supported by grants from Taipei Veterans General Hospital, Taipei, Taiwan (V97A-109) (www.vghtpe.gov.tw) and Anesthesiology Research and Development Foundation, Taipei, Taiwan (ARDF9905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum MG, 2004, ANN THORAC SURG, V78, P287, DOI 10.1016/j.athoracsur.2003.11.058; Davis EA, 2006, ANESTH ANALG, V103, P932, DOI 10.1213/01.ane.0000232444.52274.7a; Dexter EU, 2009, ANESTH ANALG, V108, P1257, DOI 10.1213/ane.0b013e31819a6dd4; Dexter F, 1999, ANESTHESIOLOGY, V91, P262, DOI 10.1097/00000542-199907000-00035; Dexter Franklin, 2006, Health Care Manag Sci, V9, P325, DOI 10.1007/s10729-006-9997-9; Dexter F, 2009, ANESTH ANALG, V108, P1262, DOI 10.1213/ane.0b013e31819775cd; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Eappen S, 2004, ANESTHESIOLOGY, V101, P1210, DOI 10.1097/00000542-200411000-00022; Hao L, 2007, QUANTILE REGRESSION; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; McIntosh C, 2006, ANESTH ANALG, V103, P1499, DOI 10.1213/01.ane.0000244535.54710.28; Nargozian Charles D, 2004, Curr Opin Anaesthesiol, V17, P511, DOI 10.1097/00001503-200412000-00011; Overdyk FJ, 1998, ANESTH ANALG, V86, P896, DOI 10.1097/00000539-199804000-00039; Peat J., 2005, MED STAT GUIDE DATA; Schuster M, 2008, BRIT J ANAESTH, V101, P640, DOI 10.1093/bja/aen239; Strum DP, 2000, ANESTHESIOLOGY, V92, P1454, DOI 10.1097/00000542-200005000-00036; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134838	10.1371/journal.pone.0134838	http://dx.doi.org/10.1371/journal.pone.0134838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241647	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700073
J	Li, HJ; Yu, PN; Huang, KY; Su, HY; Hsiao, TH; Chang, CP; Yu, MH; Lin, YW				Li, H-J; Yu, P-N; Huang, K-Y; Su, H-Y; Hsiao, T-H; Chang, C-P; Yu, M-H; Lin, Y-W			NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transition	ONCOGENE			English	Article							PANCREATIC BETA-CELLS; E-CADHERIN REPRESSION; VENTRAL NEURAL-TUBE; CANCER STEM-CELLS; CERVICAL-CANCER; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; NEURONAL FATE; COMPLEX	The transcription factor NKX6.1 (NK6 homeobox 1) is important in the development of pancreatic beta-cells and neurons. Although recent publications show that NKX6.1 is hypermethylated and downregulated during tumorigenesis, the function of NKX6.1 in carcinogenesis remains elusive. Here, we address the metastasis suppressor function of human NKX6.1 using cell, animal and clinical analyses. Our data show that NKX6.1 represses tumor formation and metastatic ability both in vitro and in vivo. Mechanistically, NKX6.1 suppresses cell invasion by inhibiting the epithelial-to-mesenchymal transition (EMT). NKX6.1 directly enhances the mRNA level of E-cadherin by recruiting BAF155 coactivator and represses that of vimentin and N-cadherin by recruiting RBBP7 (retinoblastoma binding protein 7) corepressor. Clinical cancer tumors with metastasis show low NKX6.1 protein expression coinciding with low E-cadherin and high vimentin expression. Our results demonstrate that NKX6.1 functions as an EMT suppressor by interacting with different epigenetic modifiers, making it a potential novel therapeutic option.	[Li, H-J; Huang, K-Y; Lin, Y-W] Natl Def Med Ctr, Grad Inst Life Sci, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan; [Yu, P-N; Chang, C-P; Lin, Y-W] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan; [Su, H-Y; Yu, M-H] Natl Def Med Ctr, Dept Obstet & Gynecol, Triserv Gen Hosp, Taipei, Taiwan; [Hsiao, T-H] Taichung Vet Gen Hosp, Dept Med Res, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taichung Veterans General Hospital	Lin, YW (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan.; Lin, YW (corresponding author), Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, 161,Sect 6,Min Chuan East Rd, Taipei, Taiwan.	ndmc.yawen@msa.hinet.net	Huang, Kuo-Yen/AAC-9247-2019		National Research Program for Genomic Medicine Grants of NSC [NSC 97-3112-B-001-016]; Ministry of Science and Technology, Taiwan, Republic of China [NSC 100-2314-B-016-021, NSC 102-2320-B-016-016-MY3, MOST 103-2314-B-016-008, MOST 103-2321-B-016-007]; Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China	National Research Program for Genomic Medicine Grants of NSC; Ministry of Science and Technology, Taiwan, Republic of China; Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China	We thank Yong-Jang Chen for technical assistance. RNA interference reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016). This work was supported by the following grants: NSC 100-2314-B-016-021, NSC 102-2320-B-016-016-MY3, MOST 103-2314-B-016-008 and MOST 103-2321-B-016-007 from the Ministry of Science and Technology, Taiwan, Republic of China, and the Liver Disease Prevention and Treatment Research Foundation, Taiwan, Republic of China.	Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dave B, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2938; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DelBove J, 2011, EPIGENETICS-US, V6, P1444, DOI 10.4161/epi.6.12.18492; Donelan W, 2010, J BIOL CHEM, V285, P12181, DOI 10.1074/jbc.M109.064238; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Iype T, 2004, MOL ENDOCRINOL, V18, P1363, DOI 10.1210/me.2004-0006; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Lai HC, 2010, CANCER-AM CANCER SOC, V116, P4266, DOI 10.1002/cncr.25252; Lin WC, 2013, BBA-MOL CELL RES, V1833, P3206, DOI 10.1016/j.bbamcr.2013.08.020; Lin YW, 2013, GYNECOL ONCOL, V131, P174, DOI 10.1016/j.ygyno.2013.07.111; Liu CY, 2009, J PATHOL, V219, P222, DOI 10.1002/path.2589; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matsuno Y, 2012, INT J BIOCHEM CELL B, V44, P776, DOI 10.1016/j.biocel.2012.01.021; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Micalizzi DS, 2009, FUTURE ONCOL, V5, P1129, DOI 10.2217/FON.09.94; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; PECORARO G, 1991, AM J PATHOL, V138, P1; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Syu LJ, 2009, BRAIN RES, V1266, P8, DOI 10.1016/j.brainres.2009.01.068; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108	43	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2266	2278		10.1038/onc.2015.289	http://dx.doi.org/10.1038/onc.2015.289			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26257059	Green Published, hybrid			2022-12-26	WOS:000374986000011
J	Vasilev, VV; Noe, R; Dragon-Durey, MA; Chauvet, S; Lazarov, VJ; Deliyska, BP; Fremeaux-Bacchi, V; Dimitrov, JD; Roumenina, LT				Vasilev, Vasil V.; Noe, Remi; Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Lazarov, Valentin J.; Deliyska, Boriana P.; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.			Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; LINKED-IMMUNOSORBENT-ASSAY; FACTOR-H; ANTI-C1Q ANTIBODIES; DISEASE-ACTIVITY; FACTOR-B; NEPHROTIC SYNDROME; RECEPTORS CR-1; ERYTHEMATOSUS; SLE	Lupus nephritis (LN) is a complication of the autoimmune disease systemic lupus erythematosus. Because the complement system plays a critical role in orchestrating inflammatory and immune responses as well as in the clearance of immune complexes, autoreactivity to complement components may have considerable pathological consequences. Autoantibodies against the central complement component C3 have been reported in systemic lupus erythematosus, but their molecular mechanism and functional relevance are not well understood. The objective of this study was to evaluate the frequency and the functional properties of the anti-C3 autoantibodies. Anti-C3 autoantibodies were measured in plasma of 39 LN patients, and identification of their epitopes on the C3 molecule was performed. By using surface plasmon resonance, we analyzed the influence of patient-derived IgG antibodies on the interaction of C3b with Factor B, Factor H, and complement receptor 1. The capacity of these antibodies to dysregulate the C3 convertase on the surface of endothelial cell was measured by flow cytometry. Here we report that the frequency of anti-C3 autoantibodies in LNis similar to 30%. They inhibited interactions of the negative complement regulators Factor H and complement receptor 1 with C3b. An enhanced C3 deposition was also observed on human endothelial cells in the presence of C3 autoantibodies. In addition, anti-C3 autoantibody levels correlated with disease activity. In conclusion, the anti-C3 autoantibodies in LN may contribute to the autoimmune pathology by their capacity to overactivate the complement system.	[Vasilev, Vasil V.; Lazarov, Valentin J.; Deliyska, Boriana P.] Med Univ, Univ Hosp Tsaritsa Yoanna ISUL, Nephrol Clin, Sofia 1527, Bulgaria; [Noe, Remi; Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Cordeliers Res Ctr, INSERM UMRS 1138, F-75006 Paris, France; [Noe, Remi] Ecole Prat Hautes Etud, F-75014 Paris, France; [Dragon-Durey, Marie-Agnes; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Univ Paris 05, Cordeliers Res Ctr, UMR S 1138, Sorbonne Paris Cite, F-75006 Paris, France; [Dragon-Durey, Marie-Agnes; Chauvet, Sophie; Fremeaux-Bacchi, Veronique; Dimitrov, Jordan D.; Roumenina, Lubka T.] Univ Paris 06, Univ Paris 04, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Dragon-Durey, Marie-Agnes; Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, F-75015 Paris, France; [Chauvet, Sophie] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, F-75015 Paris, France	Medical University Sofia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Roumenina, LT (corresponding author), Cordeliers Res Ctr, INSERM UMRS 1138, 15 Rue Ecole Med,Entrance E,Floor 3, F-75006 Paris, France.	lubka.roumenina@crc.jussieu.fr	, Dragon-Durey/AGM-3653-2022; Vasilev, Vasil/D-5995-2016; Roumenina, Lubka/P-5906-2019; Roumenina, Lubka/L-2638-2017; Dimitrov, Jordan/N-2141-2014	Vasilev, Vasil/0000-0001-7588-2165; Roumenina, Lubka/0000-0002-9940-0324; Dragon-Durey, Marie-Agnes/0000-0002-5809-8122; Dimitrov, Jordan/0000-0001-8536-8995; Noe, Remi/0000-0003-3474-4035	INSERM; Agence Nationale de la Recherche Grant [ANR-13-JCV1-006-01]; EMBO Long Term Fellowship [ALTF 444-2007]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche Grant(French National Research Agency (ANR)); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO))	This work was supported by INSERM and by Agence Nationale de la Recherche Grant ANR-13-JCV1-006-01. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of EMBO Long Term Fellowship ALTF 444-2007.	Arora M, 2000, LUPUS, V9, P127, DOI 10.1191/096120300678828154; Bao LH, 2011, J AM SOC NEPHROL, V22, P285, DOI 10.1681/ASN.2010060647; Ben Ghorbel I, 2010, REV MED INTERNE, V31, P372, DOI 10.1016/j.revmed.2009.10.434; Birmingham DJ, 2006, CLIN EXP IMMUNOL, V143, P274, DOI 10.1111/j.1365-2249.2005.02983.x; Chen Q, 2011, NEW ENGL J MED, V365, P2340, DOI 10.1056/NEJMc1107484; Churg J., 1995, RENAL DIS CLASSIFICA, P152; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; CORVETTA A, 1991, J RHEUMATOL, V18, P1021; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dragon-Durey MA, 2005, J AM SOC NEPHROL, V16, P555, DOI 10.1681/ASN.2004050380; Dragon-Durey MA, 2013, MOL IMMUNOL, V56, P213, DOI 10.1016/j.molimm.2013.05.009; DURAND CG, 1984, J IMMUNOL METHODS, V73, P57, DOI 10.1016/0022-1759(84)90031-0; Frimat M, 2013, BLOOD, V122, P282, DOI 10.1182/blood-2013-03-489245; FYFE A, 1987, CLIN EXP IMMUNOL, V67, P300; HAUTANEN A, 1984, CLIN EXP RHEUMATOL, V2, P125; HAY EM, 1993, Q J MED, V86, P447; JASIN HE, 1979, J RHEUMATOL, V6, P43; Jozsi M, 2014, IMMUNOL LETT, V160, P163, DOI 10.1016/j.imlet.2014.01.014; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kavai M, 2008, AUTOIMMUN REV, V8, P160, DOI 10.1016/j.autrev.2008.06.002; Kenyon KD, 2011, J IMMUNOL, V187, P2101, DOI 10.4049/jimmunol.1003468; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kitahara M, 1999, CLIN NEPHROL, V51, P314; Lachmann P J, 1967, Adv Immunol, V6, P479, DOI 10.1016/S0065-2776(08)60527-1; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; LACHMANN PJ, 1966, IMMUNOLOGY, V11, P255; Lambris JD, 1996, J IMMUNOL, V156, P4821; Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287; Marinozzi MC, 2014, J AM SOC NEPHROL, V25, P2053, DOI 10.1681/ASN.2013070796; Marto N, 2005, ANN RHEUM DIS, V64, P444, DOI 10.1136/ard.2004.024943; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; NGU JL, 1969, CLIN EXP IMMUNOL, V5, P557; NGU JL, 1970, J TROP MED HYG, V73, P250; NGU JL, 1970, CLIN EXP IMMUNOL, V6, P109; NILSSON B, 1992, CLIN EXP IMMUNOL, V90, P251; NILSSON B, 1990, CLIN EXP IMMUNOL, V82, P262; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Paixao-Cavalcante D, 2012, KIDNEY INT, V82, P1084, DOI 10.1038/ki.2012.250; Pickering MC, 2010, NAT REV RHEUMATOL, V6, P490, DOI 10.1038/nrrheum.2010.56; POTTER BJ, 1980, GUT, V21, P1030, DOI 10.1136/gut.21.12.1030; Radanova M, 2012, IMMUNOBIOLOGY, V217, P684, DOI 10.1016/j.imbio.2011.11.007; Raju KR, 2001, ASIAN PAC J ALLERGY, V19, P23; Rekvig OP, 2012, AUTOIMMUN REV, V11, P596, DOI 10.1016/j.autrev.2011.10.021; ROSS GD, 1985, J IMMUNOL, V135, P2005; Roumenina LT, 2012, BLOOD, V119, P4182, DOI 10.1182/blood-2011-10-383281; Roumenina LT, 2011, J IMMUNOL, V187, P4369, DOI 10.4049/jimmunol.1101749; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; Schramm EC, 2015, BLOOD, V125, P2359, DOI 10.1182/blood-2014-10-609073; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Vanhecke D, 2012, ARTHRITIS RHEUM-US, V64, P3706, DOI 10.1002/art.34605; WALPORT MJ, 1994, Q J MED, V87, P609; Wang FM, 2012, RHEUMATOLOGY, V51, P2269, DOI 10.1093/rheumatology/kes218; WILSON JG, 1986, ARTHRITIS RHEUM, V29, P739, DOI 10.1002/art.1780290606; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003	58	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25343	25355		10.1074/jbc.M115.647008	http://dx.doi.org/10.1074/jbc.M115.647008			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26245903	hybrid, Green Published			2022-12-26	WOS:000362962800013
J	Baumann, A; Lehmann, R; Beckert, A; Vilcinskas, A; Franta, Z				Baumann, Andre; Lehmann, Ruediger; Beckert, Annika; Vilcinskas, Andreas; Franta, Zdenek			Selection and Evaluation of Tissue Specific Reference Genes in Lucilia sericata during an Immune Challenge	PLOS ONE			English	Article							REAL-TIME PCR; MAGGOT EXCRETIONS/SECRETIONS; RT-PCR; ANTIBACTERIAL ACTIVITY; MEDICINAL MAGGOTS; IN-VITRO; QUANTIFICATION; DROSOPHILA; EXPRESSION; LARVAE	The larvae of the common green bottle fly Lucilia sericata (Diptera: Calliphoridae) have been used for centuries to promote wound healing, but the molecular basis of their antimicrobial, debridement and healing functions remains largely unknown. The analysis of differential gene expression in specific larval tissues before and after immune challenge could be used to identify key molecular factors, but the most sensitive and reproducible method qRT-PCR requires validated reference genes. We therefore selected 10 candidate reference genes encoding products from different functional classes (18S rRNA, 28S rRNA, actin, beta-tubulin, RPS3, RPLP0, EF1 alpha, PKA, GAPDH and GST1). Two widely applied algorithms (GeNorm and Normfinder) were used to analyze reference gene candidates in different larval tissues associated with secretion, digestion, and antimicrobial activity (midgut, hindgut, salivary glands, crop and fat body). The Gram-negative bacterium Pseudomonas aeruginosa was then used to boost the larval immune system and the stability of reference gene expression was tested in comparison to three immune genes (lucimycin, defensin-1 and attacin-2), which target different pathogen classes. We observed no differential expression of the antifungal peptide lucimycin, whereas the representative targeting Gram-positive bacteria (defensin-1) was upregulated in salivary glands, crop, nerve ganglion and reached its maximum in fat body (up to 300-fold). The strongest upregulation in all immune challenged tissues (over 50,000-fold induction in the fat body) was monitored for attacin-2, the representative targeting Gramnegative bacteria. Here we identified and validated a set of reference genes that allows the accurate normalization of gene expression in specific tissues of L. sericata after immune challenge.	[Baumann, Andre; Lehmann, Ruediger; Beckert, Annika; Vilcinskas, Andreas; Franta, Zdenek] Fraunhofer Inst Mol Biol & Appl Ecol, Dept Bioresources, Giessen, Germany; [Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Fraunhofer Gesellschaft; Justus Liebig University Giessen	Franta, Z (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, Dept Bioresources, Giessen, Germany.	zdenek.franta@ime.fraunhofer.de		Franta, Zdenek/0000-0002-7709-0097	Alexander von Humboldt foundation; Hessen State Ministry of Higher Education, Research and the Arts (HMWK)	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Hessen State Ministry of Higher Education, Research and the Arts (HMWK)	This study was funded by the Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via a generous grant for the LOEWE Center for "Insect Biotechnology and Bioresources". This work was also supported by the Alexander von Humboldt foundation.	Altincicek B, 2009, INSECT MOL BIOL, V18, P119, DOI 10.1111/j.1365-2583.2008.00856.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Araujo LU, 2010, ACTA CIR BRAS, V25, P460, DOI 10.1590/S0102-86502010000500014; Bagnall NH, 2010, MED VET ENTOMOL, V24, P176, DOI 10.1111/j.1365-2915.2010.00866.x; Barnes KM, 2010, J MICROBIOL METH, V82, P234, DOI 10.1016/j.mimet.2010.06.005; Beckert A, 2015, DEV COMP IMMUNOL, V49, P303, DOI 10.1016/j.dci.2014.11.020; Bexfield A, 2008, MICROBES INFECT, V10, P325, DOI 10.1016/j.micinf.2007.12.011; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Brown A, 2012, MED VET ENTOMOL, V26, P432, DOI 10.1111/j.1365-2915.2012.01029.x; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cazander G, 2009, J Tissue Viability, V18, P80, DOI 10.1016/j.jtv.2009.02.005; Cazander G, 2013, BIOESSAYS, V35, P1083, DOI 10.1002/bies.201300071; Cazander G, 2012, WOUND REPAIR REGEN, V20, P879, DOI 10.1111/j.1524-475X.2012.00850.x; Cerovsky V, 2014, PHARMACEUTICALS-BASE, V7, P251, DOI 10.3390/ph7030251; Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Davydov Liya, 2011, J Pharm Pract, V24, P89, DOI 10.1177/0897190010366938; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Freeman WH, 1971, ATLAS INVERTEBRATE S; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gokcen A, 2013, VIRULENCE, V4, P260, DOI 10.4161/viru.23560; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han YS, 1999, DEV COMP IMMUNOL, V23, P553, DOI 10.1016/S0145-305X(99)00047-6; Harris LG, 2013, APPL ENVIRON MICROB, V79, P1393, DOI 10.1128/AEM.03689-12; Hetru C, 2003, J INFECT DIS, V187, pS327, DOI 10.1086/374758; Hobson RP, 1931, BIOCHEM J, V25, P1458, DOI 10.1042/bj0251458; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Horobin AJ, 2005, WOUND REPAIR REGEN, V13, P422, DOI 10.1111/j.1067-1927.2005.130410.x; Huberman L, 2007, J Wound Care, V16, P123; Huberman L, 2007, MED VET ENTOMOL, V21, P127, DOI 10.1111/j.1365-2915.2007.00668.x; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jaklic D, 2008, J MED MICROBIOL, V57, P617, DOI 10.1099/jmm.0.47515-0; Kahl M, 2015, THROMB HAEMOSTASIS, V114, P277, DOI 10.1160/TH14-06-0499; Kawabata T, 2010, MED VET ENTOMOL, V24, P375, DOI 10.1111/j.1365-2915.2010.00902.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; Meriin AB, 2012, J CELL SCI, V125, P2665, DOI 10.1242/jcs.098954; Mihai MM, 2014, ROM J MORPHOL EMBRYO, V55, P1401; MONNER DA, 1971, J BACTERIOL, V107, P420, DOI 10.1128/JB.107.2.420-432.1971; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Mumcuoglu KY, 2001, J MED ENTOMOL, V38, P161, DOI 10.1603/0022-2585-38.2.161; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poppel AK, 2015, ANTIMICROB AGENTS CH, V59, P2508, DOI 10.1128/AAC.05180-14; Poppel AK, 2014, BIOL CHEM, V395, P649, DOI 10.1515/hsz-2013-0263; POLAKIEWCZ RD, 1995, GENOMICS, V25, P577, DOI 10.1016/0888-7543(95)80063-R; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Prete PE, 1997, LIFE SCI, V60, P505, DOI 10.1016/S0024-3205(96)00688-1; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROBINSON W., 1935, Journal of Parasitology, V21, P354, DOI 10.2307/3271945; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmidtchen A, 2003, ACTA DERM-VENEREOL, V83, P310, DOI 10.1080/00015550310016689; Sherman RA, 2000, ANNU REV ENTOMOL, V45, P55, DOI 10.1146/annurev.ento.45.1.55; Sherman RA, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/592419; Sun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115979; Tantawi T I, 2007, J Wound Care, V16, P379; Tolker-Nielsen T, 2014, APMIS, V122, P1, DOI 10.1111/apm.12335; Toutges MJ, 2010, J AGR FOOD CHEM, V58, P8948, DOI 10.1021/jf101603j; van der Plas MJA, 2008, J ANTIMICROB CHEMOTH, V61, P117, DOI 10.1093/jac/dkm407; van der Plas MJA, 2007, MICROBES INFECT, V9, P507, DOI 10.1016/j.micinf.2007.01.008; van der Plas MJA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008071; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vilcinskas A, 2011, BIOL INSPIR SYST, V2, P67, DOI 10.1007/978-90-481-9641-8_4; Walker SE, 2013, METHOD ENZYMOL, V530, P337, DOI 10.1016/B978-0-12-420037-1.00019-1; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wu M, 2015, INT J LOW EXTR WOUND; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503	74	20	22	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135093	10.1371/journal.pone.0135093	http://dx.doi.org/10.1371/journal.pone.0135093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252388	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100116
J	Boydell, N; Fergie, GM; McDaid, LM; Hilton, S				Boydell, Nicola; Fergie, Gillian May; McDaid, Lisa Margaret; Hilton, Shona			Understandings of Participation in Behavioural Research: A Qualitative Study of Gay and Bisexual Men in Scotland	PLOS ONE			English	Article							HEALTH-SERVICES; HIV PREVENTION; COMMUNITY; PEOPLE; MOTIVATIONS; IDENTITY; ETHICS; RISK; SEX	An array of empirical research has emerged related to public participation in health research. To date, few studies have explored the particular perspectives of gay and bisexual men taking part in behavioural surveillance research, which includes the donation of saliva swabs to investigate HIV prevalence and rates of undiagnosed HIV. Semi-structured interviews were conducted with twenty-nine gay and bisexual men in Scotland who had participated in a bar-based survey. Thematic analysis of men's accounts of their motives for participation and their perceptions of not receiving individual feedback on HIV status suggested a shared understanding of participation in research as a means of contributing to 'community' efforts to prevent the spread of HIV. Most men expressed sophisticated understandings of the purpose of behavioural research and distinguished between this and individual diagnostic testing. Despite calls for feedback on HIV results broadly, for these men feedback on HIV status was not deemed crucial.	[Boydell, Nicola; Fergie, Gillian May; McDaid, Lisa Margaret; Hilton, Shona] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Boydell, N (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	Nicola.Boydell@glasgow.ac.uk		McDaid, Lisa/0000-0002-7711-8723; Boydell, Nicola/0000-0002-2260-8020; Hilton, Shona/0000-0003-0633-8152; Fergie, Gillian/0000-0001-9693-0357	UK Medical Research Council; MRC [MC_UU_12017/15, MC_UU_12017/6, MC_UU_12017/11, MC_U130085862, MC_UU_12017/2] Funding Source: UKRI; Medical Research Council [MC_UU_12017/15, MC_UU_12017/11, MC_UU_12017/2, MC_UU_12017/6] Funding Source: researchfish; Chief Scientist Office [SPHSU15, SPHSU11] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: UK Medical Research Council. The UK Medical Research Council funds Nicola Boydell (previously Boydell-Wright) and Lisa McDaid as part of the Sexual Health Programme (MC_U130031238 /MC_UU_12017/2), and Gillian Fergie and Shona Hilton as part of the Understandings and Uses of Public Health Research Programme (MC_U130085862 /MC_UU_12017/6) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 1983, IMAGINED COMMUNITIES; Baker L, 2005, BIRTH-ISS PERINAT C, V32, P60, DOI 10.1111/j.0730-7659.2005.00346.x; BRANNEN J, 1993, SOCIOL REV, V41, P328, DOI 10.1111/j.1467-954X.1993.tb00068.x; Brown M, 2014, PROG HUM GEOG, V38, P457, DOI 10.1177/0309132513484215; Davis M, 2006, SOCIOL HEALTH ILL, V28, P457, DOI 10.1111/j.1467-9566.2006.00501.x; Davis M, 2008, SOCIOL HEALTH ILL, V30, P182, DOI 10.1111/j.1467-9566.2007.01050.x; Davis M, 2006, CULT HEALTH SEX, V8, P161, DOI 10.1080/13691050500526126; Dixon-Woods M, 2009, SOC SCI MED, V68, P2215, DOI 10.1016/j.socscimed.2009.03.034; Frankis J, 2013, SOCIAL MEDIA MEN WHO; Frankis J, 2014, SOCIAL MEDIA LANARKS; Fraser S, 2004, CHANGING COMMUNITY C; Fraser S, 2008, J HOMOSEXUAL, V55, P245, DOI 10.1080/00918360802129519; Gammelgaard A, 2009, CLIN ETHICS, V4, P79, DOI [DOI 10.1258/CE.2009.009004, 10.1258/ce.2009.009004]; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Hallowell N, 2010, J MED ETHICS, V36, P37, DOI 10.1136/jme.2009.029264; Holt M, 2011, CULT HEALTH SEX, V13, P857, DOI 10.1080/13691058.2011.581390; Hunter J, 2012, J EMPIR RES HUM RES, V7, P84, DOI 10.1525/jer.2012.7.3.84; Kessel AS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001427; Kippax S., 1993, SUSTAINING SAFE SEX; Kippax S, 1992, IMPORTANCE GAY COMMU, P85; Knussen C, 2011, SEX TRANSM INFECT, V87, P257, DOI 10.1136/sti.2010.045047; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Lowes L, 2006, J ADV NURS, V55, P587, DOI 10.1111/j.1365-2648.2006.03950.x; Maher D, 2013, B WORLD HEALTH ORGAN, V91, P950, DOI 10.2471/BLT.13.117309; McDaid LM, 2012, AIDS BEHAV, V16, P1420, DOI 10.1007/s10461-011-0044-6; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; Parsons S., 2010, UNDERSTANDING PARTIC; Patterson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129924; Peel E, 2006, QUAL HEALTH RES, V16, P1335, DOI 10.1177/1049732306294511; Rennie S, 2009, PLOS MED, V6, P30, DOI 10.1371/journal.pmed.1000004; Reynolds R., 2007, WHAT HAPPENED GAY LI; Reynolds R, 2009, J AUST STUD, V33, P79, DOI 10.1080/14443050802672551; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Rosser BRS, 2008, AIDS CARE, V20, P588, DOI 10.1080/09540120701867156; Sikweyiya Y, 2013, QUAL HEALTH RES, V23, P999, DOI 10.1177/1049732313490076; Townsend A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-40; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; White C., 2003, QUALITATIVE RES PRAC, V1st ed., P287; Williamson LM, 2007, JAIDS-J ACQ IMM DEF, V45, P224, DOI 10.1097/QAI.0b013e318058a01e; Williamson LM, 2001, SEX TRANSM INFECT, V77, P427, DOI 10.1136/sti.77.6.427; Woolwine D, 2000, J HOMOSEXUAL, V38, P5, DOI 10.1300/J082v38n04_02; Zablotska IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113167; Zablotska IB, 2012, AIDS BEHAV, V16, P669, DOI 10.1007/s10461-011-9919-9	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135001	10.1371/journal.pone.0135001	http://dx.doi.org/10.1371/journal.pone.0135001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252480	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000359121100101
J	Poelking, VGD; Giordano, A; Ricci-Silva, ME; Williams, TCR; Pecanha, DA; Ventrella, MC; Rencoret, J; Ralph, J; Barbosa, MHP; Loureiro, M				de Carli Poelking, Viviane Guzzo; Giordano, Andrea; Ricci-Silva, Maria Esther; Rhys Williams, Thomas Christopher; Pecanha, Diego Alves; Ventrella, Marilia Contin; Rencoret, Jorge; Ralph, John; Pereira Barbosa, Marcio Henrique; Loureiro, Marcelo			Analysis of a Modern Hybrid and an Ancient Sugarcane Implicates a Complex Interplay of Factors in Affecting Recalcitrance to Cellulosic Ethanol Production	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS PERTURBATIONS; HYDROXYCINNAMIC ACID CONTENT; CELL-WALL DEGRADABILITY; CINNAMOYL-COA REDUCTASE; STRUCTURAL-CHARACTERIZATION; IMPROVED SACCHARIFICATION; BIOMASS DIGESTIBILITY; ENZYMATIC DEGRADATION; REDUCES RECALCITRANCE; ARABIDOPSIS-THALIANA	Abundant evidence exists to support a role for lignin as an important element in biomass recalcitrance. However, several independent studies have also shown that factors apart from lignin are also relevant and overall, the relative importance of different recalcitrance traits remains in dispute. In this study we used two genetically distant sugarcane genotypes, and performed a correlational study with the variation in anatomical parameters, cell wall composition, and recalcitrance factors between these genotypes. In addition we also tracked alterations in these characteristics in internodes at different stages of development. Significant differences in the development of the culm between the genotypes were associated with clear differential distributions of lignin content and composition that were not correlated with saccharification and fermentation yield. Given the strong influence of the environment on lignin content and composition, we hypothesized that sampling within a single plant could allow us to more easily interpret recalcitrance and changes in lignin biosynthesis than analysing variations between different genotypes with extensive changes in plant morphology and culm anatomy. The syringyl/guaiacyl (S/G) ratio was higher in the oldest internode of the modern genotype, but S/G ratio was not correlated with enzymatic hydrolysis yield nor fermentation efficiency. Curiously we observed a strong positive correlation between ferulate ester level and cellulose conversion efficiency. Together, these data support the hypothesis that biomass enzymatic hydrolysis recalcitrance is governed by a quantitative heritage rather than a single trait.	[de Carli Poelking, Viviane Guzzo; Giordano, Andrea; Ricci-Silva, Maria Esther; Rhys Williams, Thomas Christopher; Pecanha, Diego Alves; Ventrella, Marilia Contin; Loureiro, Marcelo] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [Rencoret, Jorge; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Rencoret, Jorge; Ralph, John] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Pereira Barbosa, Marcio Henrique] Univ Fed Vicosa, Dept Fitotecnia, Vicosa, MG, Brazil	Universidade Federal de Vicosa; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Universidade Federal de Vicosa	Loureiro, M (corresponding author), Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil.	mehlersloureiro@gmail.com	Ralph, John/C-3161-2009; RENCORET, JORGE/E-1747-2013; Giordano, Andrea M/J-8535-2015; RENCORET, JORGE/ABE-4139-2020	Ralph, John/0000-0002-6093-4521; RENCORET, JORGE/0000-0003-2728-7331; Giordano, Andrea M/0000-0001-5652-4282; RENCORET, JORGE/0000-0003-2728-7331; Williams, Thomas/0000-0003-1954-2961	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Coordenacao de Projetos, Pesquisas e Estudos Tecnologicos; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; Fondo Social Europeo (FSE)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Coordenacao de Projetos, Pesquisas e Estudos Tecnologicos; DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); Fondo Social Europeo (FSE)(European Social Fund (ESF)European Commission)	VCGP was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http:// www.cnpq.br/) and AG by Fundacao Coordenacao de Projetos, Pesquisas e Estudos Tecnologicos (http:// www.coppetec.coppe.ufrj.br/site/). JR and JR were funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494); Jorge Rencoret also thanks the CSIC for a JAE-DOC contract of the program "Junta para la Ampliacion de Estudios" cofinanced by Fondo Social Europeo (FSE).	Achyuthan KE, 2010, MOLECULES, V15, P8641, DOI 10.3390/molecules15118641; Barriere Y, 2005, PLANT SCI, V168, P1235, DOI 10.1016/j.plantsci.2005.01.001; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; BernardVailhe MA, 1996, J AGR FOOD CHEM, V44, P1164, DOI 10.1021/jf950481j; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; D'Hont A, 2008, GENOMICS TROPICAL CR; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; del Rio JC, 2012, J AGR FOOD CHEM, V60, P3619, DOI 10.1021/jf300099g; DeMartini JD, 2011, ENERG ENVIRON SCI, V4, P4332, DOI 10.1039/c1ee02112e; Dence C.W., 1992, METHODES LIGNIN CHEM; Dien BS, 2011, BIORESOURCE TECHNOL, V102, P6479, DOI 10.1016/j.biortech.2011.03.022; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Fornale S, 2012, MOL PLANT, V5, P817, DOI 10.1093/mp/ssr097; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; GABRIELSEN BC, 1990, CROP SCI, V30, P1313, DOI 10.2135/cropsci1990.0011183X003000060032x; GERLACH G, 1969, BOT MICROTECHNIK EIN; Gille S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00012; Goldschinid O, 1971, LIGNINS OCCURRENCE F; Gomide J. L., 1986, O PAPEL, V47, P36, DOI DOI 10.1590/S0100-67622005000100014.G0MIDE; Goujon T, 2003, PLANTA, V217, P218, DOI 10.1007/s00425-003-0987-6; Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A; Grabber JH, 2004, CR BIOL, V327, P455, DOI 10.1016/j.crvi.2004.02.009; Grabber JH, 1998, J AGR FOOD CHEM, V46, P2609, DOI 10.1021/jf9800099; Grabber JH, 1997, J AGR FOOD CHEM, V45, P2530, DOI 10.1021/jf970029v; Grabber JH, 2009, J SCI FOOD AGR, V89, P122, DOI 10.1002/jsfa.3418; HE LF, 1990, J WOOD CHEM TECHNOL, V10, P435, DOI 10.1080/02773819008050251; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Ju XH, 2013, BIORESOURCE TECHNOL, V144, P232, DOI 10.1016/j.biortech.2013.06.100; Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014; JUNG HG, 1989, AGRON J, V81, P33, DOI 10.2134/agronj1989.00021962008100010006x; Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x; Kaur H, 2012, PLANT PHYSIOL, V159, P1545, DOI 10.1104/pp.112.196717; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; LAM TBT, 1994, PHYTOCHEMISTRY, V36, P773, DOI 10.1016/S0031-9422(00)89815-5; Lam TBT, 2003, PHYTOCHEMISTRY, V64, P603, DOI 10.1016/S0031-9422(03)00301-7; Lam TBT, 2001, PHYTOCHEMISTRY, V57, P987, DOI 10.1016/S0031-9422(01)00052-8; LAM TBT, 1992, PHYTOCHEMISTRY, V31, P1179, DOI 10.1016/0031-9422(92)80256-E; Li ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105115; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Lionetti V, 2010, P NATL ACAD SCI USA, V107, P616, DOI 10.1073/pnas.0907549107; Lorenz AJ, 2008, APPL BIOCHEM BIOTECH, V148, P261, DOI 10.1007/s12010-007-8116-9; Lorenz AJ, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-5; Loureiro ME, 2011, ROUTES TO CELLULOSIC ETHANOL, P199, DOI 10.1007/978-0-387-92740-4_13; Lozovaya VV, 1999, PHYTOCHEMISTRY, V50, P395, DOI 10.1016/S0031-9422(98)00575-5; Lu J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/276278; Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Marriott PE, 2014, P NATL ACAD SCI USA, V111, P14601, DOI 10.1073/pnas.1414020111; Masarin F, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-55; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nakagame S, 2010, BIOTECHNOL BIOENG, V105, P871, DOI 10.1002/bit.22626; O'Brien TP, 1981, STUDY PLANT STRUCTUR, DOI DOI 10.2307/2259948; Papa G, 2012, BIORESOURCE TECHNOL, V117, P352, DOI 10.1016/j.biortech.2012.04.065; Patten AM, 2010, MOL BIOSYST, V6, P499, DOI 10.1039/b819206e; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Penning BW, 2014, PLANT PHYSIOL, V165, P1475, DOI 10.1104/pp.114.242446; Persson P, 2002, J AGR FOOD CHEM, V50, P5318, DOI 10.1021/jf025565o; Piperidis G, 2010, MOL GENET GENOMICS, V284, P65, DOI 10.1007/s00438-010-0546-3; Pu YQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-15; Qing Q, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-18; RALPH J, 1998, LIGNIN LIGNAN BIOSYN, P209, DOI DOI 10.1021/BK-1998-0697.CH016; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Rencoret J, 2013, J AGR FOOD CHEM, V61, P2434, DOI 10.1021/jf304686x; Riboulet C, 2008, MAYDICA, V53, P11; Saito K, 2012, PLANT J, V69, P542, DOI 10.1111/j.1365-313X.2011.04811.x; Saulnier L, 1999, CARBOHYD RES, V320, P82, DOI 10.1016/S0008-6215(99)00152-4; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; SCOTT RW, 1979, ANAL CHEM, V51, P936, DOI 10.1021/ac50043a036; Selig MJ, 2009, CELLULOSE, V16, P711, DOI 10.1007/s10570-009-9322-0; Shen H, 2009, BIOENERG RES, V2, P233, DOI 10.1007/s12155-009-9058-6; Shi C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-22; Solar R., 1987, NORD PULP PAP RES J, V4, P139, DOI [10.3183/npprj-1987-02-04-p139-141, DOI 10.3183/NPPRJ-1987-02-04-P139-141]; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Sun Y, 2005, BIORESOURCE TECHNOL, V96, P1599, DOI 10.1016/j.biortech.2004.12.022; Taboada A, 2010, J SCI FOOD AGR, V90, P1155, DOI 10.1002/jsfa.3933; Tamasloukht B, 2011, J EXP BOT, V62, P3837, DOI 10.1093/jxb/err077; TAPPI, 2002, TAPPI STAND TEST MET; Van Acker R, 2014, P NATL ACAD SCI USA, V111, P845, DOI 10.1073/pnas.1321673111; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; van der Rest B, 2006, J EXP BOT, V57, P1399, DOI 10.1093/jxb/erj120; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vermerris W, 2007, CROP SCI, V47, pS142, DOI 10.2135/cropsci2007.04.0013IPBS; Wallis AFA, 1996, APPITA J, V49, P258; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Withers S, 2012, J BIOL CHEM, V287, P8347, DOI 10.1074/jbc.M111.284497; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang Y, 2011, J AGR FOOD CHEM, V59, P10129, DOI 10.1021/jf2028279; Zhou CZ, 2011, ANAL CHEM, V83, P7020, DOI 10.1021/ac200903y	98	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134964	10.1371/journal.pone.0134964	http://dx.doi.org/10.1371/journal.pone.0134964			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252208	gold, Green Published			2022-12-26	WOS:000359121100091
J	Ruben, JM; Visser, LL; Heinhuis, KM; O'Toole, T; Bontkes, HJ; Westers, TM; Ossenkoppele, GJ; de Gruijl, TD; van de Loosdrecht, AA				Ruben, Jurjen M.; Visser, Lindy L.; Heinhuis, Kimberley M.; O'Toole, Tom; Bontkes, Hetty J.; Westers, Theresia M.; Ossenkoppele, Gert J.; de Gruijl, Tanja D.; van de Loosdrecht, Arjan A.			A Human Cell Line Model for Interferon-alpha Driven Dendritic Cell Differentiation	PLOS ONE			English	Article							T-LYMPHOCYTES; IN-VITRO; IFN; PRECURSORS; ANTIGEN; MUTZ-3; PARTICIPATE; GENERATION; MATURATION; PATHWAY	The CD34(+) MUTZ-3 acute myeloid leukemia cell line has been used as a dendritic cell (DC) differentiation model. This cell line can be cultured into Langerhans cell (LC) or interstitial DC-like cells using the same cytokine cocktails used for the differentiation of their primary counterparts. Currently, there is an increasing interest in the study and clinical application of DC generated in the presence of IFN alpha, as these IFN alpha-DC produce high levels of inflammatory cytokines and have been suggested to be more potent in their ability to cross-present protein antigens, as compared to the more commonly used IL-4-DC. Here, we report on the generation of IFN alpha-induced MUTZ-DC. We show that IFN alpha MUTZ-DC morphologically and phenotypically display characteristic DC features and are functionally equivalent to "classic" IL-4 MUTZ-DC. IFN alpha MUTZ-DC ingest exogenous antigens and can subsequently cross-present HLA class-I restricted epitopes to specific CD8(+) T cells. Importantly, mature IFN alpha MUTZ-DC express CCR7, migrate in response to CCL21, and are capable of priming naive antigen-specific CD8(+) T cells. In conclusion, we show that the MUTZ-3 cell line offers a viable and sustainable model system to study IFN alpha driven DC development and functionality.	[Ruben, Jurjen M.; Visser, Lindy L.; Heinhuis, Kimberley M.; Bontkes, Hetty J.; Westers, Theresia M.; Ossenkoppele, Gert J.; van de Loosdrecht, Arjan A.] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Hematol, NL-1081 HV Amsterdam, Netherlands; [O'Toole, Tom] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Canc Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands; [de Gruijl, Tanja D.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Canc Ctr Amsterdam, NL-1081 HV Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van de Loosdrecht, AA (corresponding author), Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Hematol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	a.vandeloosdrecht@vumc.nl		Bontkes, Hetty/0000-0002-3562-293X	Cancer Center Amsterdam (CCA)/VU Institute of Cancer immunology (V-ICI) [CCA 2007-5-09]	Cancer Center Amsterdam (CCA)/VU Institute of Cancer immunology (V-ICI)	This work was funded by Cancer Center Amsterdam (CCA)/VU Institute of Cancer immunology (V-ICI) 'Vaccination in acute myeloid leukemia; towards a cure by innovative dendritic cell-based immunotherapy strategies' # CCA 2007-5-09 Name: A.A. van de Loosdrecht	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Blackwell SE, 2003, J IMMUNOL, V170, P4061, DOI 10.4049/jimmunol.170.8.4061; Bontkes HJ, 2002, J LEUKOCYTE BIOL, V72, P321; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Encabo A, 2004, STEM CELLS, V22, P725, DOI 10.1634/stemcells.22-5-725; Fehres CM, 2014, EUR J IMMUNOL, V44, P2415, DOI 10.1002/eji.201344094; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Hu ZB, 1996, LEUKEMIA, V10, P1025; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Molldrem JJ, 2000, NAT MED, V6, P1018, DOI 10.1038/79526; Paquette RL, 2002, LEUKEMIA, V16, P1484, DOI 10.1038/sj.leu.2402602; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; PETERS JH, 1991, PATHOBIOLOGY, V59, P122, DOI 10.1159/000163628; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Ruben JM, 2015, CANC IMMUNO IN PRESS; Ruben JM, 2014, CANCER IMMUNOL IMMUN, V63, P335, DOI 10.1007/s00262-013-1515-6; RUPPERT J, 1993, ADV EXP MED BIOL, V329, P281; Saeki H, 1999, J IMMUNOL, V162, P2472; Santegoets SJAM, 2008, J LEUKOCYTE BIOL, V84, P1364, DOI 10.1189/jlb.0208092; Santegoets SJAM, 2008, J IMMUNOL, V180, P4540, DOI 10.4049/jimmunol.180.7.4540; Santegoets SJAM, 2006, CANCER IMMUNOL IMMUN, V55, P1480, DOI 10.1007/s00262-006-0142-x; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; van de Ven R, 2012, CANCER IMMUNOL IMMUN, V61, P181, DOI 10.1007/s00262-011-1039-x; van Helden SFG, 2008, IMMUNOL LETT, V117, P191, DOI 10.1016/j.imlet.2008.02.003; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172; YOUNG JW, 1995, J EXP MED, V182, P1111, DOI 10.1084/jem.182.4.1111; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135219	10.1371/journal.pone.0135219	http://dx.doi.org/10.1371/journal.pone.0135219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252775	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100136
J	Ehrensberger, AH; Franchini, DM; East, P; George, R; Matthews, N; Maslen, SL; Svejstrup, JQ				Ehrensberger, Andreas H.; Franchini, Don-Marc; East, Philip; George, Roger; Matthews, Nik; Maslen, Sarah L.; Svejstrup, Jesper Q.			Retention of the Native Epigenome in Purified Mammalian Chromatin	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA METHYLATION; CPG ISLANDS; NUCLEOSOME; TRANSCRIPTION; PURIFICATION; HISTONES; GENOME; ORGANIZATION; REPRESSION	A protocol is presented for the isolation of native mammalian chromatin as fibers of 25-250 nucleosomes under conditions that preserve the natural epigenetic signature. The material is composed almost exclusively of histones and DNA and conforms to the structure expected by electron microscopy. All sequences probed for were retained, indicating that the material is representative of the majority of the genome. DNA methylation marks and histone marks resembled the patterns observed in vivo. Importantly, nucleosome positions also remained largely unchanged, except on CpG islands, where nucleosomes were found to be unstable. The technical challenges of reconstituting biochemical reactions with native mammalian chromatin are discussed.	[Ehrensberger, Andreas H.; Svejstrup, Jesper Q.] London Res Inst, Francis Crick Inst, Clare Hall Labs, Mech Transcript Lab, South Mimms, Herts, England; [Franchini, Don-Marc] Canc Res UK London Res Inst, Clare Hall Labs, DNA Editing Lab, South Mimms, Herts, England; [Franchini, Don-Marc] IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [East, Philip] London Res Inst, Francis Crick Inst, Bioinformat & Biostat Grp, London, England; [George, Roger] London Res Inst, Francis Crick Inst, Prot Purificat Facil, London, England; [Matthews, Nik] London Res Inst, Francis Crick Inst, Adv Sequencing Facil, London, England; [Maslen, Sarah L.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Cancer Research UK; IFOM - FIRC Institute of Molecular Oncology; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; MRC Laboratory Molecular Biology	Svejstrup, JQ (corresponding author), London Res Inst, Francis Crick Inst, Clare Hall Labs, Mech Transcript Lab, South Mimms, Herts, England.	jesper.svejstrup@crick.ac.uk	Franchini, Don Marc/A-5203-2015	Franchini, Don Marc/0000-0002-2562-5643; East, Philip/0000-0001-5801-5713; Svejstrup, Jesper/0000-0003-4964-6147	European Research Council [268797]; Cancer Research UK; Cancer Research UK [11567] Funding Source: researchfish; The Francis Crick Institute [10002, 10001, 10166, 10168] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); The Francis Crick Institute	Funding was provided by Cancer Research UK, http://www.cancerresearchuk.org/, European Research Council grant number 268797.	BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Hamperl S, 2014, METHODS MOL BIOL, V1094, P329, DOI 10.1007/978-1-62703-706-8_26; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; McArthur M, 1996, EMBO J, V15, P1705, DOI 10.1002/j.1460-2075.1996.tb00516.x; Mizuguchi G, 2012, METHOD ENZYMOL, V512, P275, DOI 10.1016/B978-0-12-391940-3.00012-3; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rhee HS, 2014, CELL, V159, P1377, DOI 10.1016/j.cell.2014.10.054; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Simon M.D., 2010, CURR PROTOCOLS MOL B, VChapter 21, pUNIT 21.18.1, DOI [10.1002/0471142727.mb2118s90, DOI 10.1002/0471142727.MB2118S90]; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Unnikrishnan A, 2012, METHODS MOL BIOL, V833, P115, DOI 10.1007/978-1-61779-477-3_8; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; Wippo CJ, 2011, EMBO J, V30, P1277, DOI 10.1038/emboj.2011.43; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133246	10.1371/journal.pone.0133246	http://dx.doi.org/10.1371/journal.pone.0133246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248330	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300011
J	Madsen, J; Christensen, TK; Balsby, TJS; Tombre, IM				Madsen, Jesper; Christensen, Thomas Kjaer; Balsby, Thorsten J. S.; Tombre, Ingunn M.			Could Have Gone Wrong: Effects of Abrupt Changes in Migratory Behaviour on Harvest in a Waterbird Population	PLOS ONE			English	Article							GOOSE POPULATION; SURVIVAL; GEESE; INFORMATION; DYNAMICS; EUROPE; IMPACT; SIZES; RATES	To sustainably exploit a population, it is crucial to understand and reduce uncertainties about population processes and effects of harvest. In migratory species, management is challenged by geographically separated changing environmental conditions, which may cause unexpected changes in species distribution and harvest. We describe the development in the harvest of Svalbard-breeding pink-footed geese (Anser brachyrhynchus) in relation to the observed trajectory and migratory behaviour of the population. In autumn, geese migrate via stopover sites in Norway and Denmark (where they are hunted) to wintering grounds in the Netherlands and Belgium (where they are protected). In Denmark and Norway harvesting increased stepwise during the 2000s. The increase in the population size only partly explained the change. The change corresponded to a simultaneous stepwise increase in numbers of geese staging in Denmark throughout autumn and winter; geese also moved further inland to feed which collectively increased their exposure to hunting. In Norway the increase in harvest reflected greater utilisation of lowland farmland areas by geese, increasing their hunting exposure. The study demonstrates how changes in migratory behaviour can abruptly affect exposure to hunting, which showed a functional response to increased temporal and spatial availability of geese. The harvest has now reached a level likely to cause a population decline. It highlights the need for flexible, internationally coordinated hunting regulations and reliable up-to-date population estimates and hunting bag statistics, which are rare in European management of migratory waterbirds. Without such information decisions are left with judgments based on population estimates, which often have time lags of several years between recording and reporting, hampering possibilities for the timely adjustment of management actions.	[Madsen, Jesper; Christensen, Thomas Kjaer] Aarhus Univ, Dept Biosci, DK-8410 Kalo, Ronde, Denmark; [Balsby, Thorsten J. S.] Aarhus Univ, Dept Biosci, DK-8600 Silkeborg, Denmark; [Tombre, Ingunn M.] Norwegian Inst Nat Res, Arctic Ecol Dept, Fram Ctr, N-9296 Tromso, Norway	Aarhus University; Aarhus University; Norwegian Institute Nature Research	Madsen, J (corresponding author), Aarhus Univ, Dept Biosci, Grenavej 14, DK-8410 Kalo, Ronde, Denmark.	jm@bios.au.dk	Christensen, Thomas/J-4915-2013; Madsen, Jesper/J-7853-2013	Madsen, Jesper/0000-0003-3246-0215; Balsby, Thorsten J. S./0000-0001-6855-4040	Norwegian Research Council (project GOOSEHUNT) [207968/110]; Danish Nature Agency (project under Vildtkontrakt/videnopbygning); Norwegian Environment Agency (projects under Viltfondet)	Norwegian Research Council (project GOOSEHUNT); Danish Nature Agency (project under Vildtkontrakt/videnopbygning); Norwegian Environment Agency (projects under Viltfondet)	This work was funded by the Norwegian Research Council (project GOOSEHUNT id 207968/110; http://www.forskningsradet.no/en/Home_page/1177315753906; grant holder: IMT); the Danish Nature Agency (project under Vildtkontrakt/videnopbygning; http://www.nst.dk; grantholder: JM); and the Norwegian Environment Agency (projects under Viltfondet; http://www.miljodirektoratet.no/; grantholder: IMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEWA, 2008, STRAT PLAN 2009 2017; Alisauskas RT, 2006, J WILDLIFE MANAGE, V70, P89, DOI 10.2193/0022-541X(2006)70[89:NHASOR]2.0.CO;2; [Anonymous], 2013, WATERBIRD POPULATION; Bunnefeld N, 2011, J ANIM ECOL, V80, P1258, DOI 10.1111/j.1365-2656.2011.01862.x; Carstensen J, 2012, AMBIO, V41, P34, DOI 10.1007/s13280-011-0223-8; Christensen T.K, 2013, DANISH WING SURVEY; Cottaar F, 2009, LIMOSA, V82, P23; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Elmberg J, 2006, WILDLIFE BIOL, V12, P121, DOI 10.2981/0909-6396(2006)12[121:TSBFNA]2.0.CO;2; Fox Anthony D., 2010, Ornis Svecica, V20, P115; Gill JA, 1996, BIOL CONSERV, V76, P95, DOI 10.1016/0006-3207(95)00111-5; Grauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130159; Greenberg Russell, 2005, P336; Gunnarsson G, 2012, IBIS, V154, P307, DOI 10.1111/j.1474-919X.2011.01206.x; Heusmann HW, 2002, WILDLIFE SOC B, V30, P666; HILBORN R, 1995, ANNU REV ECOL SYST, V26, P45, DOI 10.1146/annurev.es.26.110195.000401; Hornman M., 2013, WATERVOGELS NEDERLAN; Jensen GH, 2015, THESIS AARHUS U AARH; Johnson FA, 2014, 40 DCE; Johnson FA, 2014, ECOL MODEL, V273, P186, DOI 10.1016/j.ecolmodel.2013.10.031; Kuijken E., 2006, WATERBIRDS WORLD, P508; Laland KN, 2004, LEARN BEHAV, V32, P4; Lehikoinen A, 2013, GLOBAL CHANGE BIOL, V19, P2071, DOI 10.1111/gcb.12200; Madsen J., 1999, GOOSE POPULATIONS W; Madsen J., 1999, GOOSE POPULATIONS W, P82; Madsen J., 2015, SUSTAINABLE MANAGEME; Madsen J, 2012, 48 UNEPAEWA; Madsen J, 2014, J APPL ECOL, V51, P183, DOI 10.1111/1365-2664.12183; Madsen J, 2010, EUR J WILDLIFE RES, V56, P577, DOI 10.1007/s10344-009-0349-1; Menu S, 2002, J APPL ECOL, V39, P91, DOI 10.1046/j.1365-2664.2002.00692.x; Nemeth Z, 2014, AUK, V131, P186, DOI 10.1642/AUK-13-195.1; Newton I., 1998, POPULATION LIMITATIO; Owen M, 1980, WILD GEESE WORLD THE; Peron G, 2013, J ANIM ECOL, V82, P408, DOI 10.1111/1365-2656.12014; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ridgill, 1990, COLD WEATHER MOVEMEN; Rivrud IM, 2013, J APPL ECOL, V50, P168, DOI 10.1111/1365-2664.12004; Runge MC, 2004, TECH ECOL CONSERVAT, P303; Saether BE, 1996, OIKOS, V76, P40, DOI 10.2307/3545746; Sunde P, 2014, WILDLIFE BIOL, V20, P176, DOI 10.2981/wlb.00021	40	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135100	10.1371/journal.pone.0135100	http://dx.doi.org/10.1371/journal.pone.0135100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247849	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300097
J	Xiong, Y; Kotian, S; Zeiger, MA; Zhang, L; Kebebew, E				Xiong, Yin; Kotian, Shweta; Zeiger, Martha A.; Zhang, Lisa; Kebebew, Electron			miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER-1; TUMOR-SUPPRESSOR; MESSENGER-RNA; LUNG-CANCER; EXPRESSION; MICRORNAS; ADAM9; ANGIOGENESIS; LAT1; OVEREXPRESSION	Background Previous studies have shown that microRNAs are dysregulated in thyroid cancer and play important roles in the post-transcriptional regulation of target oncogenes and/or tumor suppressor genes. Methodology/Principal Findings We studied the function of miR-126-3p in thyroid cancer cells, and as a marker of disease aggressiveness. We found that miR-126-3p expression was significantly lower in larger tumors, in tumor samples with extrathyroidal invasion, and in higher risk group thyroid cancer in 496 papillary thyroid cancer samples from The Cancer Genome Atlas study cohort. In an independent sample set, lower miR-126-3p expression was observed in follicular thyroid cancers (which have capsular and angioinvasion) as compared to follicular adenomas. Mechanistically, ectopic overexpression of miR-126-3p significantly inhibited thyroid cancer cell proliferation, in vitro (p<0.01) and in vivo (p<0.01), colony formation (p<0.01), tumor spheroid formation (p<0.05), cellular migration (p<0.05), VEGF secretion and endothelial tube formation, and lung metastasis in vivo. We found 14 predicted target genes, which were significantly altered upon miR-126-3p transfection in thyroid cancer cells, and which are involved in cancer biology. Of these 14 genes, SLC7A5 and ADAM9 were confirmed to be inhibited by miR-126-3p overexpression and to be direct targets of miR-136-3p. Conclusions/Significance To our knowledge, this is the first study to demonstrate that miR-126-3p has a tumor-suppressive function in thyroid cancer cells, and is associated with aggressive disease phenotype.	[Xiong, Yin; Kotian, Shweta; Zhang, Lisa; Kebebew, Electron] NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Zeiger, Martha A.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University	Kebebew, E (corresponding author), NCI, Endocrine Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.	kebebewe@mail.nih.gov	Kotian, Shweta/GMX-3418-2022		intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health	intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the intramural research program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicts of interests to disclose.	Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Du CL, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0259-1; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fan XT, 2010, BIOCHEM PHARMACOL, V80, P811, DOI 10.1016/j.bcp.2010.05.021; Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Fritzsche FR, 2008, EUR UROL, V54, P1097, DOI 10.1016/j.eururo.2007.11.034; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Herrero-Gonzalez S, 2011, CANCER DISCOV, V1, P106, DOI 10.1158/2159-8290.CD-11-0116; Hirao T, 2006, EXP CELL RES, V312, P331, DOI 10.1016/j.yexcr.2005.10.032; Institute NC, 2011, THYR CANC; Jia AY, 2014, BRIT J CANCER, V110, P2945, DOI 10.1038/bjc.2014.245; Kaira K, 2009, ANN SURG ONCOL, V16, P3473, DOI 10.1245/s10434-009-0685-0; Kinne A, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S7; Kitano M, 2012, THYROID, V22, P285, DOI 10.1089/thy.2011.0313; Kitano M, 2011, ANN SURG ONCOL, V18, P3443, DOI 10.1245/s10434-011-1766-4; Li XM, 2011, MED ONCOL, V28, P1054, DOI 10.1007/s12032-010-9637-6; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Miko E, 2011, FEBS LETT, V585, P1191, DOI 10.1016/j.febslet.2011.03.039; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; O'Shea C, 2003, INT J CANCER, V105, P754, DOI 10.1002/ijc.11161; Ochiai H, 2012, J VET MED SCI, V74, P917, DOI 10.1292/jvms.11-0353; Oda K, 2010, CANCER SCI, V101, P173, DOI 10.1111/j.1349-7006.2009.01386.x; Peduto L, 2009, CURR PHARM DESIGN, V15, P2282, DOI 10.2174/138161209788682415; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Shennan DB, 2008, ONCOL REP, V20, P885, DOI 10.3892/or_00000087; Shintani Y, 2004, CANCER RES, V64, P4190, DOI 10.1158/0008-5472.CAN-03-3235; Sun X, 2014, INT J ONCOL, V44, P1678, DOI 10.3892/ijo.2014.2321; Tannapfel A, 2003, J PATHOL, V201, P238, DOI 10.1002/path.1420; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weber F, 2006, J CLIN ENDOCR METAB, V91, P3584, DOI 10.1210/jc.2006-0693; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024717; Yamada D, 2007, ANTICANCER RES, V27, P793; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhang L, 2013, THYROID; Zhang Y, 2013, ONCOL REP, V30, P1976, DOI 10.3892/or.2013.2633; Zigrino P, 2005, INT J CANCER, V116, P853, DOI 10.1002/ijc.21087	50	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0130496	10.1371/journal.pone.0130496	http://dx.doi.org/10.1371/journal.pone.0130496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244545	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400005
J	Yang, CX; Li, H; Pan, HP; Ma, YB; Zhang, DY; Liu, Y; Zhang, ZH; Zheng, CY; Chu, D				Yang, Chunxiao; Li, Hui; Pan, Huipeng; Ma, Yabin; Zhang, Deyong; Liu, Yong; Zhang, Zhanhong; Zheng, Changying; Chu, Dong			Stable Reference Gene Selection for RT-qPCR Analysis in Nonviruliferous and Viruliferous Frankliniella occidentalis	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; WESTERN FLOWER THRIPS; PLANT-VIRUSES; PCR; TRANSMISSION; EXPRESSION; INFECTION	Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is a reliable technique for measuring and evaluating gene expression during variable biological processes. To facilitate gene expression studies, normalization of genes of interest relative to stable reference genes is crucial. The western flower thrips Frankliniella occidentalis (Pergande) (Thysanoptera: Thripidae), the main vector of tomato spotted wilt virus (TSWV), is a destructive invasive species. In this study, the expression profiles of 11 candidate reference genes from nonviruliferous and viruliferous F. occidentalis were investigated. Five distinct algorithms, geNorm, NormFinder, BestKeeper, the Delta C-t method, and RefFinder, were used to determine the performance of these genes. geNorm, NormFinder, BestKeeper, and RefFinder identified heat shock protein 70 (HSP70), heat shock protein 60 (HSP60), elongation factor 1 alpha, and ribosomal protein l32 (RPL32) as the most stable reference genes, and the Delta C-t method identified HSP60, HSP70, RPL32, and heat shock protein 90 as the most stable reference genes. Additionally, two reference genes were sufficient for reliable normalization in nonviruliferous and viruliferous F. occidentalis. This work provides a foundation for investigating the molecular mechanisms of TSWV and F. occidentalis interactions.	[Yang, Chunxiao; Zhang, Deyong; Liu, Yong] Hunan Acad Agr Sci, Inst Plant Protect, Changsha, Hunan, Peoples R China; [Li, Hui; Ma, Yabin; Zheng, Changying; Chu, Dong] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China; [Pan, Huipeng] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Zhang, Zhanhong] Hunan Acad Agr Sci, Hunan Vegetable Inst, Changsha, Hunan, Peoples R China	Hunan Academy of Agricultural Sciences; Qingdao Agricultural University; University of Kentucky; Hunan Academy of Agricultural Sciences	Zheng, CY (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China.	zhengcy67@qau.edu.cn; chinachudong@qau.edu.cn	Chu, Dong/AAS-3914-2020; CHU, DONG/AAI-1892-2020	Chu, Dong/0000-0001-5716-4979; 	Special Fund for Agroscience Research in the Public Interest [201303028]; Shandong Modern Agricultural Technology & Industry System [SDAIT-02-021-11]; Science and Technology Development Planning Program of Qingdao [13-1-3-108-nsh]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China	Special Fund for Agroscience Research in the Public Interest; Shandong Modern Agricultural Technology & Industry System; Science and Technology Development Planning Program of Qingdao; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China	This work was supported by the Special Fund for Agroscience Research in the Public Interest (201303028), the Shandong Modern Agricultural Technology & Industry System (SDAIT-02-021-11), the Science and Technology Development Planning Program of Qingdao (13-1-3-108-nsh), and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Badillo-Vargas I E, 2012, J Virol, V86, P8793, DOI 10.1128/JVI.00285-12; Badillo-Vargas IE, 2015, J INSECT PHYSIOL, V76, P36, DOI 10.1016/j.jinsphys.2015.03.009; Boonham N, 2002, J VIROL METHODS, V101, P37, DOI 10.1016/S0166-0934(01)00418-9; BRODSGAARD HF, 1994, J APPL ENTOMOL, V117, P498, DOI 10.1111/j.1439-0418.1994.tb00767.x; Brunner PC, 2010, J EVOLUTION BIOL, V23, P797, DOI 10.1111/j.1420-9101.2010.01946.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Guo JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07042; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Liang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087514; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margaria P, 2014, J VIROL, V88, P5788, DOI 10.1128/JVI.00079-14; Mason G, 2003, J VIROL METHODS, V109, P69, DOI 10.1016/S0166-0934(03)00048-X; Pan HP, 2013, J ECON ENTOMOL, V106, P924, DOI 10.1603/EC12365; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rotenberg D, 2010, INSECT MOL BIOL, V19, P537, DOI 10.1111/j.1365-2583.2010.01012.x; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Stafford-Banks CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094447; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110454; Zhang ZJ, 2013, GENOMICS, V101, P296, DOI 10.1016/j.ygeno.2013.02.005; Zheng YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111369	31	12	13	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135207	10.1371/journal.pone.0135207	http://dx.doi.org/10.1371/journal.pone.0135207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244556	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400145
J	Zheng, W; Ruan, JS; Hu, G; Wang, K; Hanlon, M; Gao, JZ				Zheng, Wei; Ruan, Jishou; Hu, Gang; Wang, Kui; Hanlon, Michelle; Gao, Jianzhao			Analysis of Conformational B-Cell Epitopes in the Antibody-Antigen Complex Using the Depth Function and the Convex Hull	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTOR; AMINO-ACID; PROTEIN-STRUCTURE; LINEAR EPITOPES; ATOM DEPTH; WEB-SERVER; DETERMINANTS; RESIDUES; LOCATION; SITES	The prediction of conformational b-cell epitopes plays an important role in immunoinformatics. Several computational methods are proposed on the basis of discrimination determined by the solvent-accessible surface between epitopes and non-epitopes, but the performance of existing methods is far from satisfying. In this paper, depth functions and the k-th surface convex hull are used to analyze epitopes and exposed non-epitopes. On each layer of the protein, we compute relative solvent accessibility and four different types of depth functions, i.e., Chakravarty depth, DPX, half-sphere exposure and half space depth, to analyze the location of epitopes on different layers of the proteins. We found that conformational b-cell epitopes are rich in charged residues Asp, Glu, Lys, Arg, His; aliphatic residues Gly, Pro; non- charged residues Asn, Gln; and aromatic residue Tyr. Conformational b-cell epitopes are rich in coils. Conservation of epitopes is not significantly lower than that of exposed non-epitopes. The average depths (obtained by four methods) for epitopes are significantly lower than that of non-epitopes on the surface using the Wilcoxon rank sum test. Epitopes are more likely to be located in the outer layer of the convex hull of a protein. On the benchmark dataset, the cumulate 10th convex hull covers 84.6% of exposed residues on the protein surface area, and nearly 95% of epitope sites. These findings may be helpful in building a predictor for epitopes.	[Zheng, Wei; Ruan, Jishou; Hu, Gang; Wang, Kui; Gao, Jianzhao] Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China; [Zheng, Wei; Ruan, Jishou; Hu, Gang; Wang, Kui; Gao, Jianzhao] Nankai Univ, LPMC, Tianjin 300071, Peoples R China; [Ruan, Jishou] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Hanlon, Michelle] Grant MacEwan Univ, Dept Phys Sci, Edmonton, AB, Canada	Nankai University; Nankai University; Nankai University	Gao, JZ (corresponding author), Nankai Univ, Sch Math Sci, Tianjin 300071, Peoples R China.	gaojz@nankai.edu.cn		Gao, Jianzhao/0000-0002-9943-4786; Hu, Gang/0000-0002-7134-3380; Zheng, Wei/0000-0002-2984-9003	Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130031120001]; Nankai University [68150003]; International Development Research Center, Ottawa, Canada [104519-010]; National Natural Science Foundation of China (NSFC) [31050110432, 31150110577, 61170099]; NSFC [11101226, 11301286]	Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Nankai University; International Development Research Center, Ottawa, Canada; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	JG was supported by Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP grant number 20130031120001). WZ was supported by the Ph.D. Candidate Research Innovation Fund of Nankai University (no. 68150003). JR was supported by the International Development Research Center, Ottawa, Canada (no. 104519-010) and the National Natural Science Foundation of China (NSFC, grant numbers 31050110432, 31150110577). GH was supported by NSFC (grant number 11101226). KW was supported by NSFC (grant number 11301286). This work was also supported by the National Natural Science Foundation of China (NSFC, grant number 61170099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; [Anonymous], 2000, ALGORITHMS APPL, DOI DOI 10.1007/978-3-662-04245-8_1; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Chang HT, 2008, J MOL RECOGNIT, V21, P431, DOI 10.1002/jmr.910; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Gao Jianzhao, 2014, Methods Mol Biol, V1184, P197, DOI 10.1007/978-1-4939-1115-8_11; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hubbard SJ, 1993, NACCESS COMPUTER PRO, V2; Jia JH, 2015, J THEOR BIOL, V377, P47, DOI 10.1016/j.jtbi.2015.04.011; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu R., 2011, J PROTEOM BIOINFORM, V4, P10; Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1991, METHOD ENZYMOL, V203, P176; Pintar A, 2003, TRENDS BIOCHEM SCI, V28, P593, DOI 10.1016/j.tibs.2003.09.004; Pintar A, 2003, BIOPHYS J, V84, P2553, DOI 10.1016/S0006-3495(03)75060-7; Pintar A, 2003, BIOINFORMATICS, V19, P313, DOI 10.1093/bioinformatics/19.2.313; Reineke Ulrich, 2009, Methods Mol Biol, V524, pv; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rubinstein ND, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-287; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Shen SY, 2007, PROTEIN J, V26, P183, DOI 10.1007/s10930-006-9060-1; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Sun J, 2009, NUCLEIC ACIDS RES, V37, pW612, DOI 10.1093/nar/gkp417; Sweredoski MJ, 2008, BIOINFORMATICS, V24, P1459, DOI 10.1093/bioinformatics/btn199; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Tukey J. W., 1975, P INT C MATH ZUR 199; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Wang HW, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432830; Wang K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/409658; Wang YL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-251; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Yao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045152; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341; Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6; Zheng W, 2014, COMPUT BIOL CHEM, V49, P51, DOI 10.1016/j.compbiolchem.2014.02.002	64	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134835	10.1371/journal.pone.0134835	http://dx.doi.org/10.1371/journal.pone.0134835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244562	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400110
J	Lee, SK; Bae, SY; Lee, JH; Lee, HC; Yi, H; Kil, WH; Lee, JE; Kim, SW; Nam, SJ				Lee, Se Kyung; Bae, Soo Youn; Lee, Jun Ho; Lee, Hyun-Chul; Yi, Hawoo; Kil, Won Ho; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin			Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; RECURRENCE SCORE; ESTROGEN-RECEPTOR; TUMOR PHENOTYPE; OVEREXPRESSION; THERAPY; ACCUMULATION; EXPRESSION; DIVERSITY	Overexpression of p53 is the most frequent genetic alteration in breast cancer. Recently, many studies have shown that the expression of mutant p53 differs for each subtype of breast cancer and is associated with different prognoses. In this study, we aimed to determine the suitable cut-off value to predict the clinical outcome of p53 overexpression and its usefulness as a prognostic factor in each subtype of breast cancer, especially in luminal A breast cancer. Approval was granted by the Institutional Review Board of Samsung Medical Center. We analyzed a total of 7,739 patients who were surgically treated for invasive breast cancer at Samsung Medical Center between Dec 1995 and Apr 2013. Luminal A subtype was defined as ER&PR + and HER2- and was further subclassified according to Ki-67 and p53 expression as follows: luminal A (Ki-67-,p53-), luminal A (Ki-67+, p53-), luminal A (Ki-67-, p53+) and luminal A (Ki-67+, p53+). Low-risk luminal A subtype was defined as negative for both Ki-67 and p53 (luminal A [ki-67-,p53-]), and others subtypes were considered to be high-risk luminal A breast cancer. A cut-off value of 10% for p53 was a good predictor of clinical outcome in all patients and luminal A breast cancer patients. The prognostic role of p53 overexpression for OS and DFS was only significant in luminal A subtype. The combination of p53 and Ki-67 has been shown to have the best predictive power as calculated by the area under curve (AUC), especially for long-term overall survival. In this study, we have shown that overexpression of p53 and Ki-67 could be used to discriminate low-risk luminal A subtype in breast cancer. Therefore, using the combination of p53 and Ki-67 expression in discriminating low-risk luminal A breast cancer may improve the prognostic power and provide the greatest clinical utility.	[Lee, Se Kyung; Bae, Soo Youn; Lee, Jun Ho; Lee, Hyun-Chul; Yi, Hawoo; Kil, Won Ho; Lee, Jeong Eon; Kim, Seok Won; Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Nam, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea.	seokjin.nam@samsung.com		Bae, Soo Youn/0000-0003-0551-7618				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Ahn SH, 2013, J BREAST CANCER, V16, P386, DOI 10.4048/jbc.2013.16.4.386; Allison KH, 2012, BREAST CANCER RES TR, V131, P413, DOI 10.1007/s10549-011-1416-3; Allred DC, 1998, MODERN PATHOL, V11, P155; Asad J, 2008, AM J SURG, V196, P527, DOI 10.1016/j.amjsurg.2008.06.021; Ciriello G, 2013, BREAST CANCER RES TR, V141, P409, DOI 10.1007/s10549-013-2699-3; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Desmedt C, 2012, CURR OPIN ONCOL, V24, P597, DOI 10.1097/CCO.0b013e328359554e; Dumay A, 2013, INT J CANCER, V132, P1227, DOI 10.1002/ijc.27767; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Feeley LP, 2014, MODERN PATHOL, V27, P554, DOI 10.1038/modpathol.2013.153; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Guarneri V, 2010, INT J BIOL MARKER, V25, P104, DOI 10.1177/172460081002500208; Hasebe T, 2010, MODERN PATHOL, V23, P662, DOI 10.1038/modpathol.2010.47; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kikuchi S, 2013, ANTICANCER RES, V33, P3891; Kim HS, 2010, BREAST CANCER RES TR, V121, P777, DOI 10.1007/s10549-009-0560-5; Lara JF, 2011, CLIN CANCER RES, V17, P5170, DOI 10.1158/1078-0432.CCR-11-0484; MARKS JR, 1994, ANN SURG, V219, P332, DOI 10.1097/00000658-199404000-00002; Mattes MD, 2013, CANCER INVEST, V31, P604, DOI 10.3109/07357907.2013.849725; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Talley LI, 2008, BIOTECH HISTOCHEM, V83, P5, DOI 10.1080/10520290701822436; Yamamoto M, 2014, CANCER SCI, V105, P81, DOI 10.1111/cas.12302; Yamashita H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1536	31	16	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0124658	10.1371/journal.pone.0124658	http://dx.doi.org/10.1371/journal.pone.0124658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241661	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700001
J	Borek, A; Kuleta, P; Ekiert, R; Pietras, R; Sarewicz, M; Osyczka, A				Borek, Arkadiusz; Kuleta, Patryk; Ekiert, Robert; Pietras, Rafal; Sarewicz, Marcin; Osyczka, Artur			Mitochondrial Disease-related Mutation G167P in Cytochrome b of Rhodobacter capsulatus Cytochrome bc(1) (S151P in Human) Affects the Equilibrium Distribution of [2Fe-2S] Cluster and Generation of Superoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE BYPASS REACTIONS; IRON-SULFUR SUBUNIT; Q(O) SITE; COMPLEX-III; ELECTRON-TRANSFER; UBIHYDROQUINONE OXIDATION; DOMAIN MOVEMENT; BC1 COMPLEX; HEAD DOMAIN; PROTEIN	Cytochrome bc(1) is one of the key enzymes of many bioenergetic systems. Its operation involves a large scale movement of a head domain of iron-sulfur protein (ISP-HD), which functionally connects the catalytic quinol oxidation Q(o) site in cytochrome b with cytochrome c(1). The Q(o) site under certain conditions can generate reactive oxygen species in the reaction scheme depending on the actual position of ISP-HD in respect to the Q(o) site. Here, using a bacterial system, we show that mutation G167P in cytochrome b shifts the equilibrium distribution of ISP-HD toward positions remote from the Q(o) site. This renders cytochrome bc(1) non-functional in vivo. This effect is remediated by addition of alanine insertions (1Ala and 2Ala) in the neck region of the ISP subunit. These insertions, which on their own shift the equilibrium distribution of ISP-HD in the opposite direction (i.e. toward the Q(o) site), also act in this manner in the presence of G167P. Changes in the equilibrium distribution of ISP-HD in G167P lead to an increased propensity of cytochrome bc(1) to generate superoxide, which becomes evident when the concentration of quinone increases. This result corroborates the recently proposed model in which "semireverse" electron transfer back to the Q(o) site, occurring when ISP-HD is remote from the site, favors reactive oxygen species production. G167P suggests possible molecular effects of S151P (corresponding in sequence to G167P) identified as a mitochondrial disease-related mutation in human cytochrome b. These effects may be valid for other human mutations that change the equilibrium distribution of ISP-HD in a manner similar to G167P.	[Borek, Arkadiusz; Kuleta, Patryk; Ekiert, Robert; Pietras, Rafal; Sarewicz, Marcin; Osyczka, Artur] Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University	Osyczka, A (corresponding author), Jagiellonian Univ, Dept Mol Biophys, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland.	artur.osyczka@uj.edu.pl		Osyczka, Artur/0000-0002-1637-2365; Borek, Arkadiusz/0000-0003-3195-3579; Pietras, Rafal/0000-0001-8424-6590; Ekiert, Robert/0000-0002-8879-0646; Kuleta, Patryk/0000-0002-5533-1400; Sarewicz, Marcin/0000-0001-6813-5997	Ministry of Science and Higher Education	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. We thank Dr. Monika Czapla for generating the G167P single mutant.	ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Berry Edward A., 2009, V28, P425; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; Borek A, 2008, BIOCHEMISTRY-US, V47, P12365, DOI 10.1021/bi801207f; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4; Cape JL, 2006, TRENDS PLANT SCI, V11, P46, DOI 10.1016/j.tplants.2005.11.007; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cieluch E, 2010, BBA-BIOENERGETICS, V1797, P296, DOI 10.1016/j.bbabio.2009.11.003; Cooley JW, 2004, BIOCHEMISTRY-US, V43, P2217, DOI 10.1021/bi035938u; Crofts AR, 2013, BBA-BIOENERGETICS, V1827, P1362, DOI 10.1016/j.bbabio.2013.01.009; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Czapla M, 2012, PROTEIN ENG DES SEL, V25, P15, DOI 10.1093/protein/gzr055; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3464, DOI 10.1074/jbc.M107973200; Darrouzet E, 2002, J BIOL CHEM, V277, P3471, DOI 10.1074/jbc.M107974200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011; Dutton P L, 1978, Methods Enzymol, V54, P411; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kramer D, 2004, METHOD ENZYMOL, V382, P21; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lanciano P, 2011, BIOCHEMISTRY-US, V50, P1651, DOI 10.1021/bi101736v; Legros F, 2001, EUR J HUM GENET, V9, P510, DOI 10.1038/sj.ejhg.5200678; Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MITCHELL P, 1975, FEBS LETT, V59, P137, DOI 10.1016/0014-5793(75)80359-0; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2006, BIOCHEMISTRY-US, V45, P10492, DOI 10.1021/bi060013a; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; ROBERTSON DE, 1990, BIOCHEMISTRY-US, V29, P11249, DOI 10.1021/bi00503a014; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Sarewicz M, 2015, PHYSIOL REV, V95, P219, DOI 10.1152/physrev.00006.2014; Sarewicz M, 2013, BIOCHEMISTRY-US, V52, P6388, DOI 10.1021/bi400624m; Sarewicz M, 2010, BBA-BIOENERGETICS, V1797, P1820, DOI 10.1016/j.bbabio.2010.07.005; Sarewicz M, 2009, BIOCHEMISTRY-US, V48, P5708, DOI 10.1021/bi900511b; Shinkarev VP, 2002, BIOCHEMISTRY-US, V41, P14372, DOI 10.1021/bi026198c; SIEDOW JN, 1978, J BIOL CHEM, V253, P2392; Swierczek M, 2010, SCIENCE, V329, P451, DOI 10.1126/science.1190899; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	59	12	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23781	23792		10.1074/jbc.M115.661314	http://dx.doi.org/10.1074/jbc.M115.661314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245902	Green Published, hybrid			2022-12-26	WOS:000361816500025
J	Title, AC; Denzler, R; Stoffel, M				Title, Alexandra C.; Denzler, Remy; Stoffel, Markus			Uptake and Function Studies of Maternal Milk-derived MicroRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOMES; MIRNAS; CANCER; DIET; RNA; EXPRESSION; BIOMARKERS; XENOMIRS; MIR-375; DISEASE	MicroRNAs (miRNAs) are important regulators of cell-autonomous gene expression that influence many biological processes. They are also released from cells and are present in virtually all body fluids, including blood, urine, saliva, sweat, and milk. The functional role of nutritionally obtained extracellular miRNAs is controversial, and irrefutable demonstration of exogenous miRNA uptake by cells and canonical miRNA function is still lacking. Here we show that miRNAs are present at high levels in the milk of lactating mice. To investigate intestinal uptake of miRNAs in newborn mice, we employed genetic models in which newborn miR-375 and miR-200c/141 knockout mice received milk from wild-type foster mothers. Analysis of the intestinal epithelium, blood, liver, and spleen revealed no evidence for miRNA uptake. miR-375 levels in hepatocytes were at the limit of detection and remained orders of magnitude below the threshold for target gene regulation (between 1000 and 10,000 copies/cell). Furthermore, our study revealed rapid degradation of milk miRNAs in intestinal fluid. Together, our results indicate a nutritional rather than gene-regulatory role of miRNAs in the milk of newborn mice.	[Title, Alexandra C.; Denzler, Remy; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), Eidgenoss Tech Hsch Zurich, Swiss Fed Inst Technol, Inst Mol Hlth Sci, Otto Stern Weg 7,HPL H36, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch		Stoffel, Markus/0000-0003-1304-5817	Excellence and Opportunity Scholarship of Eidgenossische Technische Hochschule Zurich; European Research Council Grant "Metabolomirs"; Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease; Starr Foundation International	Excellence and Opportunity Scholarship of Eidgenossische Technische Hochschule Zurich; European Research Council Grant "Metabolomirs"; Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease; Starr Foundation International	This work was supported by an Excellence and Opportunity Scholarship of the Eidgenossische Technische Hochschule Zurich (to A. C. T), European Research Council Grant "Metabolomirs," the Starr Foundation International, and the Swiss National Science Foundation National Center of Competence in Research on RNA Biology and Disease (to M. S.). M. S. is a member of the scientific advisory board of Regulus Therapeutics and Alnylam Pharmaceuticals.	Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Aslam MF, 2014, FASEB J, V28, P3671, DOI 10.1096/fj.14-251520; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Biton M, 2011, NAT IMMUNOL, V12, P239, DOI 10.1038/ni.1994; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Fujita M, 2007, MED MOL MORPHOL, V40, P1, DOI 10.1007/s00795-006-0346-3; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hassiotou F, 2015, ADV NUTR, V6, P267, DOI 10.3945/an.114.007377; Hasuwa H, 2013, SCIENCE, V341, P71, DOI 10.1126/science.1237999; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Laubier J, 2015, RNA BIOL, V12, P26, DOI 10.1080/15476286.2015.1017212; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P600; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2014, J NUTR, V144, P1880, DOI 10.3945/jn.114.202523; Witwer KW, 2014, BIOESSAYS, V36, P394, DOI 10.1002/bies.201300150; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Witwer KW, 2012, RNA BIOL, V9, P1147, DOI 10.4161/rna.21619; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	42	99	104	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23680	23691		10.1074/jbc.M115.676734	http://dx.doi.org/10.1074/jbc.M115.676734			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26240150	Green Published, hybrid			2022-12-26	WOS:000361816500018
J	Beam, J; Botta, A; Ye, JY; Soliman, H; Matier, BJ; Forrest, M; MacLeod, KM; Ghosh, S				Beam, Julianne; Botta, Amy; Ye, Jiayu; Soliman, Hesham; Matier, Brieanne J.; Forrest, Mary; MacLeod, Kathleen M.; Ghosh, Sanjoy			Excess Linoleic Acid Increases Collagen I/III Ratio and "Stiffens" the Heart Muscle Following High Fat Diets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; OXIDATIVE STRESS; I COLLAGEN; EJECTION FRACTION; ENZYME-ACTIVITY; SATURATED FAT; N-6 PUFA; TGF-BETA; DISEASE; MICE	Controversy exists on the benefits versus harms of n-6 polyunsaturated fatty acids (n-6 PUFA). Although n-6 PUFA demonstrates anti-atherosclerotic properties, survival following cardiac remodeling may be compromised. We hypothesized that n-6 PUFA like linoleic acid (LA) or other downstream PUFAs like gamma-linolenic acid or arachidonic acid alter the transforming growth factor-beta (TGF beta)-collagen axis in the heart. Excess dietary LA increased the collagen I/III ratio in the mouse myocardium, leading to cardiac "stiffening" characterized by impaired transmitral flow indicative of early diastolic dysfunction within 5 weeks. In vitro, LA under TGF beta 1 stimulation increased collagen I and lysyl oxidase (LOX), the enzyme that cross-links soluble collagen resulting in deposited collagen. Overexpression of fatty acid desaturase 2 (fads2), which metabolizes LA to downstream PUFAs, reduced collagen deposits, LOX maturation, and activity with LA, whereas overexpressing fads1, unrelated to LA desaturation, did not. Furthermore, fads2 knockdown by RNAi elevated LOX activity and collagen deposits in fibroblasts with LA but not oleic acid, implying a buildup of LA for aggravating such pro-fibrotic effects. As direct incubation with gamma-linolenic acid or arachidonic acid also attenuated collagen deposits and LOX activity, we concluded that LA itself, independent of other downstream PUFAs, promotes the pro-fibrotic effects of n-6 PUFA. Overall, these results attempt to reconcile opposing views of n-6 PUFA on the cardiovascular system and present evidence supporting a cardiac muscle-specific effect of n-6 PUFAs. Therefore, aggravation of the collagen I/III ratio and cardiac stiffening by excess n-6 PUFA represent a novel pathway of cardiac lipotoxicity caused by high n-6 PUFA diets.	[Beam, Julianne; Botta, Amy; Ye, Jiayu; Matier, Brieanne J.; Forrest, Mary; Ghosh, Sanjoy] Univ British Columbia Okanagan, Dept Biol, IK Barber Sch Arts & Sci, Kelowna, BC V1V 1V7, Canada; [Soliman, Hesham; MacLeod, Kathleen M.; Ghosh, Sanjoy] Univ British Columbia Okanagan, Mol & Cellular Pharmacol Res Grp, Fac Pharmaceut Sci, Kelowna, BC V1V 1V7, Canada; [Soliman, Hesham] Menia Univ, Fac Pharm, Dept Pharmacol & Toxicol, Al Minya 11432, Egypt	University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia Okanagan; Egyptian Knowledge Bank (EKB); Minia University	Ghosh, S (corresponding author), Univ British Columbia Okanagan, ASC 369, Dept Biol, 3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	sanjoy.ghosh@ubc.ca		MacLeod, Kathleen/0000-0002-4280-6083; ye, jiayu/0000-0002-1704-6780	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada Masters award; Canadian Institutes of Health Research doctoral award; China Scholarship Council	Canadian Diabetes Association; Natural Sciences and Engineering Research Council of Canada Masters award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research doctoral award(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council)	This work was supported by operating grants from Canadian Diabetes Association (to S. G. and K. M. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Natural Sciences and Engineering Research Council of Canada Masters award.; Supported by a Canadian Institutes of Health Research doctoral award.; Supported by the China Scholarship Council.	Balogun KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082399; Baylin A, 2007, AM J CLIN NUTR, V85, P554, DOI 10.1093/ajcn/85.2.554; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Botta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070248; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Briest W, 2004, HYPERTENSION, V44, P410, DOI 10.1161/01.HYP.0000141414.87026.4d; Buskohl PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042527; Cardoso CR, 2011, IMMUNOBIOLOGY, V216, P409, DOI 10.1016/j.imbio.2010.06.007; Chen C, 2013, ADV EXP MED BIOL, V765, P47, DOI 10.1007/978-1-4614-4989-8_7; Collier P, 2012, J MOL CELL CARDIOL, V52, P148, DOI 10.1016/j.yjmcc.2011.10.002; COLLINS FD, 1971, NUTR METAB, V13, P150; Das UN, 2007, PROSTAG LEUKOTR ESS, V76, P251, DOI 10.1016/j.plefa.2007.03.001; Galvao TF, 2012, CARDIOVASC RES, V93, P24, DOI 10.1093/cvr/cvr258; Ge L, 2003, J INVEST DERMATOL, V120, P707, DOI 10.1046/j.1523-1747.2003.12123.x; Ghosh S, 2004, AM J PHYSIOL-HEART C, V287, pH2518, DOI 10.1152/ajpheart.00480.2004; Ghosh S, 2007, AM J PHYSIOL-HEART C, V293, pH2919, DOI 10.1152/ajpheart.00324.2007; Ghosh S, 2006, FREE RADICAL BIO MED, V41, P1413, DOI 10.1016/j.freeradbiomed.2006.07.021; Ghosh S, 2013, BRIT J NUTR, V110, P515, DOI 10.1017/S0007114512005326; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Guillou H, 2003, J LIPID RES, V44, P450, DOI 10.1194/jlr.C200019-JLR200; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; HICKS M, 1989, ARCH BIOCHEM BIOPHYS, V268, P249, DOI 10.1016/0003-9861(89)90586-9; Hong SH, 2013, CLIN INTERV AGING, V8, P585, DOI 10.2147/CIA.S42096; Hosokawa R, 2003, J DENT RES, V82, P558, DOI 10.1177/154405910308200714; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Knott L, 2011, OSTEOARTHR CARTILAGE, V19, P1150, DOI 10.1016/j.joca.2011.06.005; Laher I, 2013, FREE RADICAL RES, V47, P44, DOI 10.3109/10715762.2012.737463; LAST JA, 1983, THORAX, V38, P364, DOI 10.1136/thx.38.5.364; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Ling TY, 2003, FASEB J, V17, P1559, DOI 10.1096/fj.02-1063fje; LITTLE WC, 1995, CIRCULATION, V92, P1933, DOI 10.1161/01.CIR.92.7.1933; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lopez B, 2009, HYPERTENSION, V53, P236, DOI 10.1161/HYPERTENSIONAHA.108.125278; LOSTY TA, 1985, P SOC EXP BIOL MED, V179, P155; MARIJIANOWSKI MMH, 1994, J AM COLL CARDIOL, V23, P1204, DOI 10.1016/0735-1097(94)90612-2; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; MURATA K, 1984, HEPATO-GASTROENTEROL, V31, P158; Norton GR, 1997, CIRCULATION, V96, P1991, DOI 10.1161/01.CIR.96.6.1991; Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970; Omori Y, 2012, J HYPERTENS, V30, P1834, DOI 10.1097/HJH.0b013e3283569c5a; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149; Ram R, 2011, AM J PHYSIOL-HEART C, V301, pH1765, DOI 10.1152/ajpheart.00559.2011; Ramsden CE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8707; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; Roy R, 1996, J CELL BIOCHEM, V62, P411, DOI 10.1002/(SICI)1097-4644(199609)62:3<411::AID-JCB11>3.0.CO;2-L; Saraswathi V, 2004, J LIPID RES, V45, P794, DOI 10.1194/jlr.M300497-JLR200; Schmidt AG, 2002, J AM SOC ECHOCARDIOG, V15, P1065, DOI 10.1067/mje.2002.121863; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Schwingshackl L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004487; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; Shanley CJ, 1997, J VASC SURG, V25, P446, DOI 10.1016/S0741-5214(97)70254-4; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P502, DOI 10.3945/ajcn.2008.26285; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SUDA K, 1992, ARCH PATHOL LAB MED, V116, P934; Tanaka N, 2009, J GASTROENTEROL, V44, P983, DOI 10.1007/s00535-009-0088-9; Toborek M, 1996, J LIPID RES, V37, P123; Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Zibadi S, 2010, CARDIOVASC TOXICOL, V10, P190, DOI 10.1007/s12012-010-9078-7; Zouein FA, 2013, J CARDIOVASC PHARM, V62, P13, DOI 10.1097/FJC.0b013e31829a4e61	65	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23371	23384		10.1074/jbc.M115.682195	http://dx.doi.org/10.1074/jbc.M115.682195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240151	Green Published, hybrid			2022-12-26	WOS:000361685500043
J	Yan, LL; Lee, S; Lazzaro, DR; Aranda, J; Grant, MB; Chaqour, B				Yan, Lulu; Lee, Sangmi; Lazzaro, Douglas R.; Aranda, Jacob; Grant, Maria B.; Chaqour, Brahim			Single and Compound Knock-outs of MicroRNA (miRNA)-155 and Its Angiogenic Gene Target CCN1 in Mice Alter Vascular and Neovascular Growth in the Retina via Resident Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRICELLULAR PROTEIN CCN1; OXYGEN-INDUCED RETINOPATHY; IMMEDIATE-EARLY GENE; PATHOLOGICAL ANGIOGENESIS; REGULATES HEMATOPOIESIS; DEPENDENT MANNER; CYR61 CCN1; STEM-CELL; IN-VIVO; TISSUE	The response of the retina to ischemic insult typically leads to aberrant retinal neovascularization, a major cause of blindness. The epigenetic regulation of angiogenic gene expression by miRNAs provides new prospects for their therapeutic utility in retinal neovascularization. Here, we focus on miR-155, a microRNA functionally important in inflammation, which is of paramount importance in the pathogenesis of retinal neovascularization. Whereas constitutive miR-155-deficiency in mice results in mild vascular defects, forced expression of miR-155 causes endothelial hyperplasia and increases microglia count and activation. The mouse model of oxygen-induced retinopathy, which recapitulates ischemia-induced aberrant neovessel growth, is characterized by increased expression of miR-155 and localized areas of microglia activation. Interestingly, miR-155 deficiency in mice reduces microglial activation, curtails abnormal vessel growth, and allows for rapid normalization of the retinal vasculature following ischemic insult. miR-155 binds to the 3'-UTR and represses the expression of the CCN1 gene, which encodes an extracellular matrix-associated integrin-binding protein that both promotes physiological angiogenesis and harnesses growth factor-induced abnormal angiogenic responses. Single CCN1 deficiency or double CCN1 and miR-155 knock-out in mice causes retinal vascular malformations typical of faulty maturation, mimicking the vascular alterations of miR-155 gain of function. During development, the miR-155/ CCN1 regulatory axis balances the proangiogenic and proinflammatory activities of microglia to allow for their function as guideposts for sprout fusion and anastomosis. Under ischemic conditions, dysregulated miR-155 and CCN1 expression increases the inflammatory load and microglial activation, prompting aberrant angiogenic responses. Thus, miR-155 functions in tandem with CCN1 to modulate inflammation-induced vascular homeostasis and repair.	[Yan, Lulu; Lee, Sangmi; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Lazzaro, Douglas R.; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Aranda, Jacob] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Chaqour, Brahim] Suny Downstate Med Ctr, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Grant, Maria B.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Grant, Maria B.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Chaqour, B (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave,MSC 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324; Lee, Sangmi/0000-0002-2362-7733	National Institutes of Health, NEI [EY022091, EY019387, EY007739]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY019387, R29EY007739, R01EY022091, R01EY007739] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY022091 and EY019387 (to B. C.) and EY007739 (to M. B. G.). This work was also supported by a grant from Research to Prevent Blindness (to D. R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal Saloni, 2014, World J Biol Chem, V5, P1, DOI 10.4331/wjbc.v5.i1.1; Apte RS, 2010, ADV EXP MED BIOL, V664, P15, DOI 10.1007/978-1-4419-1399-9_2; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bodeutsch N, 2000, GLIA, V32, P91, DOI 10.1002/1098-1136(200010)32:1<91::AID-GLIA90>3.0.CO;2-X; Cai M, 2015, BRIT J OPHTHALMOL, V99, P125, DOI 10.1136/bjophthalmol-2014-305690; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour Brahim, 2013, Trends Dev Biol, V7, P59; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Chintala H, 2015, DEVELOPMENT, V142, P2364, DOI 10.1242/dev.121913; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Choi J, 2013, J BIOL CHEM, V288, P23075, DOI 10.1074/jbc.M113.475418; Couturier A, 2014, MOL VIS, V20, P908; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Rodriguez AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048485; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hasan A, 2011, J BIOL CHEM, V286, P9542, DOI 10.1074/jbc.M110.198689; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Marshall B, 2014, INVEST OPHTH VIS SCI, V55, P4151, DOI 10.1167/iovs.14-14375; Mizushina Y, 2015, J BIOL CHEM, V290, P5065, DOI 10.1074/jbc.M114.603217; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Nakagawa Y, 2013, J CELL COMMUN SIGNAL, V7, P207, DOI 10.1007/s12079-013-0202-x; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Rivera JC, 2013, ARTERIOSCL THROM VAS, V33, P1881, DOI 10.1161/ATVBAHA.113.301331; Robertson ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113050; Roitbak T, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-25; Rojas B, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-133; Roy S, 2012, MICROCIRCULATION, V19, P224, DOI 10.1111/j.1549-8719.2011.00156.x; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Rymo SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015846; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tien T, 2014, MOL VIS, V20, P732; Tolentino MJ, 2009, CURR MOL MED, V9, P973, DOI 10.2174/156652409789712783; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Wijngaarden P, 2007, MOL VIS, V13, P1508; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang L, 2014, CELL STEM CELL, V15, P51, DOI 10.1016/j.stem.2014.04.021; Weber T, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.024.2009; Weigelt K, 2007, J LEUKOCYTE BIOL, V82, P1564, DOI 10.1189/jlb.0707447; Yan LL, 2013, J CELL COMMUN SIGNAL, V7, P253, DOI 10.1007/s12079-013-0206-6; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao RB, 2015, INT J MOL SCI, V16, P840, DOI 10.3390/ijms16010840; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	73	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23264	23281		10.1074/jbc.M115.646950	http://dx.doi.org/10.1074/jbc.M115.646950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242736	Green Published, hybrid			2022-12-26	WOS:000361685500035
J	Asher, DE; Oros, N; Krichmar, JL				Asher, Derrik E.; Oros, Nicolas; Krichmar, Jeffrey L.			The Importance of Lateral Connections in the Parietal Cortex for Generating Motor Plans	PLOS ONE			English	Article							VISUALLY GUIDED MOVEMENTS; REACHING MOVEMENTS; SENSORIMOTOR TRANSFORMATIONS; INTRAPARIETAL AREA; OPTIC ATAXIA; REFERENCE FRAME; VISUOMOTOR TRANSFORMATIONS; MULTIMODAL INTEGRATION; INTENTION ACTIVITY; PREMOTOR CORTEX	Substantial evidence has highlighted the significant role of associative brain areas, such as the posterior parietal cortex (PPC) in transforming multimodal sensory information into motor plans. However, little is known about how different sensory information, which can have different delays or be absent, combines to produce a motor plan, such as executing a reaching movement. To address these issues, we constructed four biologically plausible network architectures to simulate PPC: 1) feedforward from sensory input to the PPC to a motor output area, 2) feedforward with the addition of an efference copy from the motor area, 3) feedforward with the addition of lateral or recurrent connectivity across PPC neurons, and 4) feedforward plus efference copy, and lateral connections. Using an evolutionary strategy, the connectivity of these network architectures was evolved to execute visually guided movements, where the target stimulus provided visual input for the entirety of each trial. The models were then tested on a memory guided motor task, where the visual target disappeared after a short duration. Sensory input to the neural networks had sensory delays consistent with results from monkey studies. We found that lateral connections within the PPC resulted in smoother movements and were necessary for accurate movements in the absence of visual input. The addition of lateral connections resulted in velocity profiles consistent with those observed in human and non-human primate visually guided studies of reaching, and allowed for smooth, rapid, and accurate movements under all conditions. In contrast, Feedforward or Feedback architectures were insufficient to overcome these challenges. Our results suggest that intrinsic lateral connections are critical for executing accurate, smooth motor plans.	[Asher, Derrik E.; Oros, Nicolas; Krichmar, Jeffrey L.] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Krichmar, Jeffrey L.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Asher, DE (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.	derrikasher@gmail.com		Asher, Derrik/0000-0002-1217-8581; Krichmar, Jeffrey/0000-0003-0739-2468				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1987, EXP BRAIN RES, V67, P316; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; [Anonymous], 2010, FUNDAMENTALS COMPUTA; Archambault PS, 2011, J NEUROSCI, V31, P742, DOI 10.1523/JNEUROSCI.2623-10.2011; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; Bisley James W, 2003, Adv Neurol, V93, P141; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; Brozovic M, 2007, J NEUROSCI, V27, P10588, DOI 10.1523/JNEUROSCI.2685-07.2007; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; Buxbaum LJ, 1998, COGN NEUROPSYCHOL, V15, P279, DOI 10.1080/026432998381186; Buxbaum LJ, 1997, NEUROCASE, V3, P159, DOI 10.1080/13554799708404050; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Chang SWC, 2010, P NATL ACAD SCI USA, V107, P7951, DOI 10.1073/pnas.0913209107; Chang SWC, 2009, NEURON, V64, P744, DOI 10.1016/j.neuron.2009.11.005; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Critchley M., 1953, PARIETAL LOBES, pvii; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; d'Avella A, 2011, J NEUROPHYSIOL, V106, P2796, DOI 10.1152/jn.00675.2010; Danckert J, 2009, EXP BRAIN RES, V195, P183, DOI 10.1007/s00221-009-1766-9; Darling WG, 2001, NEUROPSYCHOLOGIA, V39, P237, DOI 10.1016/S0028-3932(00)00113-5; Davare M, 2012, CEREB CORTEX, V22, P1382, DOI 10.1093/cercor/bhr210; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 1998, EXP BRAIN RES, V118, P373, DOI 10.1007/s002210050291; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hawkins KM, 2013, J COGNITIVE NEUROSCI, V25, P436, DOI 10.1162/jocn_a_00318; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Hwang EJ, 2012, NEURON, V76, P1021, DOI 10.1016/j.neuron.2012.10.030; Hwang EJ, 2011, J NEUROPHYSIOL, V105, P1850, DOI 10.1152/jn.00802.2010; Hyvarinen J., 1982, PARIETAL CORTEX MONK, Vxi; Inouchi M, 2013, CLIN NEUROPHYSIOL, V124, P2230, DOI 10.1016/j.clinph.2013.05.011; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KAWATO M, 1990, BIOL CYBERN, V62, P275, DOI 10.1007/BF00201442; Keijzer M, 2002, LECT NOTES COMPUT SC, V2310, P231; Kita E, 2011, EVOLUTIONARY ALGORITHMS, P1, DOI 10.5772/627; Klaes C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002774; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Loetscher T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00176; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; McGuire LMM, 2011, J NEUROSCI, V31, P6661, DOI 10.1523/JNEUROSCI.2921-10.2011; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; MEL BW, 1991, J COGNITIVE NEUROSCI, V3, P273, DOI 10.1162/jocn.1991.3.3.273; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Ogawa K, 2012, J COGNITIVE NEUROSCI, V24, P171, DOI 10.1162/jocn_a_00132; Opris I, 2011, J COGNITIVE NEUROSCI, V23, P1507, DOI 10.1162/jocn.2010.21534; Passot JB, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00095; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Sabes PN, 2011, PROG BRAIN RES, V191, P195, DOI 10.1016/B978-0-444-53752-2.00004-7; Shadmehr R., 2005, COMPUTATIONAL NEUROB; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; Thaler L, 2009, NEUROPSYCHOLOGIA, V47, P1227, DOI 10.1016/j.neuropsychologia.2008.12.039; Vesia M, 2006, J NEUROPHYSIOL, V96, P3016, DOI 10.1152/jn.00411.2006; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	90	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134669	10.1371/journal.pone.0134669	http://dx.doi.org/10.1371/journal.pone.0134669			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252871	Green Published, gold			2022-12-26	WOS:000359121100064
J	Schrempft, S; van Jaarsveld, CHM; Fisher, A; Wardle, J				Schrempft, Stephanie; van Jaarsveld, Cornelia H. M.; Fisher, Abigail; Wardle, Jane			The Obesogenic Quality of the Home Environment: Associations with Diet, Physical Activity, TV Viewing, and BMI in Preschool Children	PLOS ONE			English	Article							BODY-MASS INDEX; LOW-INCOME; SOCIOECONOMIC-STATUS; ETHNIC-DIFFERENCES; CHILDHOOD OBESITY; FOOD ENVIRONMENT; ENERGY-BALANCE; WEIGHT; TELEVISION; OVERWEIGHT	Objectives The home environment is thought to play a key role in early weight trajectories, although direct evidence is limited. There is general agreement that multiple factors exert small individual effects on weight-related outcomes, so use of composite measures could demonstrate stronger effects. This study therefore examined whether composite measures reflecting the 'obesogenic' home environment are associated with diet, physical activity, TV viewing, and BMI in preschool children. Methods Families from the Gemini cohort (n = 1096) completed a telephone interview (Home Environment Interview; HEI) when their children were 4 years old. Diet, physical activity, and TV viewing were reported at interview. Child height and weight measurements were taken by the parents (using standard scales and height charts) and reported at interview. Responses to the HEI were standardized and summed to create four composite scores representing the food (sum of 21 variables), activity (sum of 6 variables), media (sum of 5 variables), and overall (food composite/21 + activity composite/6 + media composite/5) home environments. These were categorized into 'obesogenic risk' tertiles. Results Children in 'higher-risk' food environments consumed less fruit (OR; 95% CI = 0.39; 0.27-0.57) and vegetables (0.47; 0.34-0.64), and more energy-dense snacks (3.48; 2.16-5.62) and sweetened drinks (3.49; 2.10-5.81) than children in 'lower-risk' food environments. Children in 'higher-risk' activity environments were less physically active (0.43; 0.32-0.59) than children in 'lower-risk' activity environments. Children in 'higher-risk' media environments watched more TV (3.51; 2.48-4.96) than children in 'lower-risk' media environments. Neither the individual nor the overall composite measures were associated with BMI. Conclusions Composite measures of the obesogenic home environment were associated as expected with diet, physical activity, and TV viewing. Associations with BMI were not apparent at this age.	[Schrempft, Stephanie; van Jaarsveld, Cornelia H. M.; Fisher, Abigail; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behaviour Res Ctr, London, England; [van Jaarsveld, Cornelia H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6525 ED Nijmegen, Netherlands; [van Jaarsveld, Cornelia H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands	University of London; University College London; Radboud University Nijmegen; Radboud University Nijmegen	Schrempft, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Hlth Behaviour Res Ctr, London, England.	s.schrempft@ucl.ac.uk	Van Jaarsveld, Ellen CHM/A-4632-2016	Van Jaarsveld, Ellen CHM/0000-0002-4269-0041	Cancer Research UK [C1418/A7974]; Cancer Research UK [14133] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The Gemini Study was funded by a grant from Cancer Research UK to Professor JW (C1418/A7974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Mejia AM, 2007, INT J OBESITY, V31, P644, DOI 10.1038/sj.ijo.0803455; ANDERSON DR, 1985, CHILD DEV, V56, P1345, DOI 10.1111/j.1467-8624.1985.tb00202.x; Anderson SE, 2010, PEDIATRICS, V125, P420, DOI 10.1542/peds.2009-0417; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Bryant MJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-23; Cameron AJ, 2013, PEDIATR OBES, V8, P130, DOI 10.1111/j.2047-6310.2012.00094.x; Chuang RJ, 2013, AM J HEALTH PROMOT, V27, P270, DOI 10.4278/ajhp.110427-QUAN-171; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; De Craemer M, 2012, OBES REV, V13, P13, DOI 10.1111/j.1467-789X.2011.00941.x; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; Dennison BA, 2008, PROG PEDIATR CARDIOL, V25, P191, DOI 10.1016/j.ppedcard.2008.05.010; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gattshall ML, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-3; Golan M, 2006, INT J PEDIATR OBES, V1, P66, DOI 10.1080/17477160600644272; Gorin AA, 2013, HEALTH PSYCHOL, V32, P128, DOI 10.1037/a0026959; Grunseit AC, 2011, PEDIATRICS, V128, pE308, DOI 10.1542/peds.2010-3331; Huybrechts I, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-63; Ihmels MA, 2009, ANN BEHAV MED, V38, P60, DOI 10.1007/s12160-009-9126-3; Keller KL, 2012, PHYSIOL BEHAV, V106, P379, DOI 10.1016/j.physbeh.2012.03.011; Kelly B, 2010, AM J PUBLIC HEALTH, V100, P1730, DOI 10.2105/AJPH.2009.179267; LEMISH D, 1987, NATURAL AUDIENCES QU, P33; Little R.J.A., 2002, STAT ANAL MISSING DA; Macfarlane A, 2009, INT J PEDIATR OBES, V4, P343, DOI 10.3109/17477160902846211; Martinson BC, 2011, ANN BEHAV MED, V42, P210, DOI 10.1007/s12160-011-9286-9; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Nardo M., 2008, HDB CONSTRUCTING COM; National Health Service, HLTH WEIGHT CHILDR A; National Institute for Health and Care Excellence, 2008, MAT CHILD NUTR REC P; National Obesity Observatory, 2011, SIMPL GUID CLASS BMI; Ogden J, 2006, APPETITE, V47, P100, DOI 10.1016/j.appet.2006.03.330; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Pinard CA, 2014, HEALTH PROMOT PRACT, V15, P109, DOI 10.1177/1524839913477863; Purslow LR, 2009, PREV MED, V49, P28, DOI 10.1016/j.ypmed.2009.04.010; Ree MJ, 1998, ORGAN RES METHODS, V1, P407, DOI 10.1177/109442819814003; Reilly JJ, 2008, P NUTR SOC, V67, P317, DOI 10.1017/S0029665108008604; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Semmler C, 2009, OBESITY, V17, P814, DOI 10.1038/oby.2008.621; Showell NN, 2013, PEDIATRICS, V132, pE193, DOI 10.1542/peds.2013-0786; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sisson SB, 2011, PREV MED, V52, P104, DOI 10.1016/j.ypmed.2010.11.019; Skala K, 2012, J IMMIGR MINOR HEALT, V14, P1014, DOI 10.1007/s10903-012-9575-9; Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001; Taveras EM, 2006, OBESITY, V14, P2034, DOI 10.1038/oby.2006.238; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; van Jaarsveld CHM, 2010, TWIN RES HUM GENET, V13, P72, DOI 10.1375/twin.13.1.72; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wardle J, 2002, OBES RES, V10, P453, DOI 10.1038/oby.2002.63; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; World Health Organization, FRUIT VEG PROM IN M; World Health Organization, OB OV	57	33	34	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134490	10.1371/journal.pone.0134490	http://dx.doi.org/10.1371/journal.pone.0134490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26248313	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300040
J	Zhai, LL; Liu, JH; Zhao, J; Liu, JX; Bai, YL; Jia, LH; Yao, XJ				Zhai, Lingling; Liu, Jihong; Zhao, Jian; Liu, Junxiu; Bai, Yinglong; Jia, Lihong; Yao, Xingjia			Association of Obesity with Onset of Puberty and Sex Hormones in Chinese Girls: A 4-Year Longitudinal Study	PLOS ONE			English	Article							CANCER RISK-FACTORS; BODY-MASS INDEX; SALIVARY TESTOSTERONE; PERIPUBERTAL GIRLS; YOUNG GIRLS; AGE; HYPERANDROGENEMIA; MENARCHE; TRANSITION; MATURATION	Objective To examine the influence of childhood obesity on the early onset of puberty and sex hormones in girls. Methods Healthy girls with different percentages of body fat at baseline (40 obese, 40 normal, and 40 lean) were recruited from three elementary schools in Shenyang, China. These girls (mean age 8.5 years) were also matched by height, school grade, Tanner stage, and family economic status at baseline. Anthropometry, puberty characteristics, and sex hormone concentrations were measured at baseline and at each follow-up visit. The generalized estimating equation model and analysis of variance for repeated measures using a generalized linear model were used to determine the differences in puberty characteristics and sex hormones among three groups. Results Over 4 years, mean age of breast II onset was earlier among obese girls (8.8 years) than normal girls (9.2 years) and lean girls (9.3 years). The prevalence (%) of early-maturation in the obese, normal, and lean groups was 25.9%, 11.1%, and 7.4%, respectively. Obesity was associated with an increased risk for breast stage II (year 2: RR, 6.3; 95% CI, 1.9-21.1 and year 3: RR, 6.9; 95% CI, 0.8-60.1). None of the girls experienced menarche in the first year; however, by the fourth year 50.0% of obese girls had menarche onset, which was higher than normal weight (27.5%) and lean girls (8.1%). The mean estradiol level increased with age in the obese, normal, and lean groups. The mean estradiol concentration was higher in obese girls than in normal and lean girls throughout the 4-year period (P<0.05). Conclusions Childhood obesity contributes to early onset of puberty and elevated levels of estradiol in girls.	[Zhai, Lingling; Bai, Yinglong; Jia, Lihong; Yao, Xingjia] China Med Univ, Dept Maternal & Child Hlth, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Liu, Jihong; Liu, Junxiu] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Zhao, Jian] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Liaoning, Peoples R China	China Medical University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Shenyang Pharmaceutical University	Zhai, LL (corresponding author), China Med Univ, Dept Maternal & Child Hlth, Shenyang North New Area, Sch Publ Hlth, 77 Pu He Rd, Shenyang, Liaoning, Peoples R China.	zll09240924@hotmail.com	Liu, Jihong/Q-1364-2015; 白, 英龙/AAF-6124-2020	Liu, Jihong/0000-0001-8685-3036; 	National Natural Science Foundation of China [39870683, 30800920, 81202227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (Grant No: 39870683, 30800920, 81202227).	Biro FM, 2010, PEDIATRICS, V126, pE583, DOI 10.1542/peds.2009-3079; Blumenthal H, 2009, J ADOLESCENT HEALTH, V44, P401, DOI 10.1016/j.jadohealth.2008.08.023; Bogaert AF, 2005, J ADOLESCENCE, V28, P541, DOI 10.1016/j.adolescence.2004.10.008; Cao Jianping, 1998, CHINESE J SCH DOCTOR, V12, P26; Chinese students' physical fitness and health research group, 2010, REP PHYS FITN HLTH S; DANN TC, 1993, J BIOSOC SCI, V25, P531, DOI 10.1017/S0021932000021908; Davison KK, 2003, PEDIATRICS, V111, P815, DOI 10.1542/peds.111.4.815; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Gluckman PD, 2006, MOL CELL ENDOCRINOL, V254, P26, DOI 10.1016/j.mce.2006.04.005; Granger DA, 1999, HORM BEHAV, V35, P18, DOI 10.1006/hbeh.1998.1492; Groschl M, 2008, CLIN CHEM, V54, P1759, DOI 10.1373/clinchem.2008.108910; He Q, 2001, PEDIATR RES, V49, P244, DOI 10.1203/00006450-200102000-00019; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; HUENEMANN RL, 1966, FED PROC, V25, P4; Jasik CB, 2008, ANN NY ACAD SCI, V1135, P265, DOI 10.1196/annals.1429.009; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Knudsen KL, 2010, OBESITY, V18, P2118, DOI 10.1038/oby.2010.58; Koenis MMG, 2013, J CLIN ENDOCR METAB, V98, pE518, DOI 10.1210/jc.2012-3361; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lee JM, 2007, PEDIATRICS, V119, pE624, DOI 10.1542/peds.2006-2188; Lu X, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-24; Ma HM, 2009, PEDIATRICS, V124, pE269, DOI 10.1542/peds.2008-2638; McCartney CR, 2007, J CLIN ENDOCR METAB, V92, P430, DOI 10.1210/jc.2006-2002; McCartney CR, 2009, J CLIN ENDOCR METAB, V94, P56, DOI 10.1210/jc.2008-1252; McCartney CR, 2006, J CLIN ENDOCR METAB, V91, P1714, DOI 10.1210/jc.2005-1852; Moorman PG, 2009, AM J EPIDEMIOL, V170, P598, DOI 10.1093/aje/kwp176; Oeffinger DJ, 2014, DEV MED CHILD NEUROL, V56, P475, DOI 10.1111/dmcn.12342; Pierson RN, 1997, HORM RES, V48, P56, DOI 10.1159/000191271; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Solorzano CMB, 2010, REPRODUCTION, V140, P399, DOI 10.1530/REP-10-0119; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053069; Tanner J. M., 1962, GROWTH AT ADOLESCENT; Walvoord EC, 2010, J ADOLESCENT HEALTH, V47, P433, DOI 10.1016/j.jadohealth.2010.05.018; WANG C, 1981, J CLIN ENDOCR METAB, V53, P1021, DOI 10.1210/jcem-53-5-1021; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707; Yao Xing-Jia, 1994, Zhonghua Yufang Yixue Zazhi, V28, P213; Yu Ruimin, 1997, CHINESE J SCH HLTH, V18, P367	39	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134656	10.1371/journal.pone.0134656	http://dx.doi.org/10.1371/journal.pone.0134656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26247479	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300054
J	Cao, WL; Li, LN; Mii, S; Amoh, Y; Liu, F; Hoffman, RM				Cao, Wenluo; Li, Lingna; Mii, Sumiyuki; Amoh, Yasuyuki; Liu, Fang; Hoffman, Robert M.			Long-Term Extensive Ectopic Hair Growth on the Spinal Cord of Mice from Transplanted Whisker Follicles	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; REPAIR; NERVE	We have previously demonstrated that hair follicles contain nestin-expressing pluripotent stem cells that can effect nerve and spinal cord repair upon transplantation. In the present study, isolated whisker follicles from nestin-driven green fluorescent protein (ND-GFP) mice were histocultured on Gelfoam for 3 weeks for the purpose of transplantation to the spinal cord to heal an induced injury. The hair shaft was cut off from Gelfoam-histocultured whisker follicles, and the remaining part of the whisker follicles containing GFP-nestin expressing pluripotent stem cells were transplanted into the injured spinal cord of nude mice, along with the Gelfoam. After 90 days, the mice were sacrificed and the spinal cord lesion was observed to have healed. ND-GFP expression was intense at the healed area of the spinal cord, as observed by fluorescence microscopy, demonstrating that the hair follicle stem cells were involved in healing the spinal cord. Unexpectedly, the transplanted whisker follicles sprouted out remarkably long hair shafts in the spinal cord during the 90 days after transplantation of Gelfoam whisker histocultures to the injured spine. The pigmented hair fibers, grown from the transplanted whisker histocultures, curved and enclosed the spinal cord. The unanticipated results demonstrate the great potential of hair growth after transplantation of Gelfoam hair follicle histocultures, even at an ectopic site.	[Cao, Wenluo; Li, Lingna] AntiCancer Inc, San Diego, CA USA; [Cao, Wenluo; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Cao, Wenluo; Liu, Fang; Hoffman, Robert M.] Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China; [Mii, Sumiyuki; Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sagamihara, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Naval Medical University; Kitasato University	Liu, F (corresponding author), Second Mil Med Univ, Dept Anat, Shanghai, Peoples R China.	liu_fang403@163.com; all@anticancer.com			National Institute of Neurological Disorders and Stroke [NS086217]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS086217] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke grant NS086217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Duong J, 2012, IN VITRO CELL DEV-AN, V48, P301, DOI 10.1007/s11626-012-9514-z; Hoffman RM, 2014, CELLS TISSUES ORGANS, V200, P42, DOI 10.1159/000366098; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Mii S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067153; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509	9	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133475	10.1371/journal.pone.0133475	http://dx.doi.org/10.1371/journal.pone.0133475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244638	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400048
J	Figueiredo, R; Card, R; Nunes, C; AbuOun, M; Bagnall, MC; Nunez, J; Mendonca, N; Anjum, MF; da Silva, GJ				Figueiredo, Rui; Card, Roderick; Nunes, Carla; AbuOun, Manal; Bagnall, Mary C.; Nunez, Javier; Mendonca, Nuno; Anjum, Muna F.; da Silva, Gabriela Jorge			Virulence Characterization of Salmonella enterica by a New Microarray: Detection and Evaluation of the Cytolethal Distending Toxin Gene Activity in the Unusual Host S. Typhimurium	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE GENES; IDENTIFICATION; SEQUENCE; GENOME; FOOD	Salmonella enterica is a zoonotic foodborne pathogen that causes acute gastroenteritis in humans. We assessed the virulence potential of one-hundred and six Salmonella strains isolated from food animals and products. A high through-put virulence genes microarray demonstrated Salmonella Pathogenicity Islands (SPI) and adherence genes were highly conserved, while prophages and virulence plasmid genes were variably present. Isolates were grouped by serotype, and virulence plasmids separated S. Typhimurium in two clusters. Atypical microarray results lead to whole genome sequencing (WGS) of S. Infantis Sal147, which identified deletion of thirty-eight SPI-1 genes. Sal147 was unable to invade HeLa cells and showed reduced mortality in Galleria mellonella infection model, in comparison to a SPI-1 harbouring S. Infantis. Microarray and WGS of S. Typhimurium Sal199, established for the first time in S. Typhimurium presence of cdtB and other Typhi-related genes. Characterization of Sal199 showed cdtB genes were upstream of transposase IS911, and co-expressed with other Typhi-related genes. Cell cycle arrest, cytoplasmic distension, and nuclear enlargement were detected in HeLa cells infected by Sal199, but not with S. Typhimurium LT2. Increased mortality of Galleria was detected on infection with Sal199 compared to LT2. Thus, Salmonella isolates were rapidly characterized using a high through-put microarray; helping to identify unusual virulence features which were corroborated by further characterisation. This work demonstrates that the use of suitable screening methods for Salmonella virulence can help assess the potential risk associated with certain Salmonella to humans. Incorporation of such methodology into surveillance could help reduce the risk of emergence of epidemic Salmonella strains.	[Figueiredo, Rui; Nunes, Carla; Mendonca, Nuno; da Silva, Gabriela Jorge] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Figueiredo, Rui; Nunes, Carla; Mendonca, Nuno; da Silva, Gabriela Jorge] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Figueiredo, Rui; Card, Roderick; AbuOun, Manal; Bagnall, Mary C.; Anjum, Muna F.] Anim & Plant Hlth Agcy, Dept Bacteriol, Addlestone KT15 3NB, Surrey, England; [Nunez, Javier] Anim & Plant Hlth Agcy, Specialist Sci Support, Addlestone KT15 3NB, Surrey, England	Universidade de Coimbra; Universidade de Coimbra; Animal & Plant Health Agency UK; Animal & Plant Health Agency UK	da Silva, GJ (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	silva.gj@gmail.com	Nunes, Carla/AAM-3056-2021; Nunez, Javier/B-1981-2016; anjum, muna/C-5213-2011; Da Silva, Gabriela Jorge/B-7246-2019; Da Silva, Gabriela Jorge/ABG-3784-2020; Nunes, Carla/L-3456-2017; Mendonca, Nuno/D-1238-2012	Nunes, Carla/0000-0002-7452-1592; Da Silva, Gabriela Jorge/0000-0002-7479-8540; Nunes, Carla/0000-0002-7452-1592; Mendonca, Nuno/0000-0002-5567-282X	Fundacao para a Ciencia e Tecnologia [PTDC/AGR-ALI/113953/2009, SFRH/BD/78833/2011, SFRH/BPD/45815/2008]; Center for Pharmaceutical Studies, University of Coimbra, Portugal [PEst-OE/SAU/UI0177/2014]; UK government Department for Environment, Food and Rural Affairs	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Center for Pharmaceutical Studies, University of Coimbra, Portugal; UK government Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported financially by the project PTDC/AGR-ALI/113953/2009 from Fundacao para a Ciencia e Tecnologia and by PEst-OE/SAU/UI0177/2014 of the Center for Pharmaceutical Studies, University of Coimbra, Portugal. Rui Figueiredo was supported by grant SFRH/BD/78833/2011, and Nuno Mendonca by the grant from SFRH/BPD/45815/2008 from Fundacao para a Ciencia e Tecnologia. Work undertaken at the Animal and Plant Health Agency was funded by the UK government Department for Environment, Food and Rural Affairs.	AbuOun M, 2005, INFECT IMMUN, V73, P3053, DOI 10.1128/IAI.73.5.3053-3062.2005; Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Anjum MF, 2007, APPL ENVIRON MICROB, V73, P5692, DOI 10.1128/AEM.00419-07; Anjum MF, 2011, J ANTIMICROB CHEMOTH, V66, P550, DOI 10.1093/jac/dkq498; Batchelor M, 2008, INT J ANTIMICROB AG, V31, P440, DOI 10.1016/j.ijantimicag.2007.11.017; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braun SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046489; Card R, 2015, ANTIMICROB IN PRESS; Figueiredo R, 2015, FOODBORNE PATHOG DIS, V12, P110, DOI 10.1089/fpd.2014.1836; Franklin K, 2011, J CLIN MICROBIOL, V49, P2954, DOI 10.1128/JCM.02347-10; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Huehn S, 2010, FOODBORNE PATHOG DIS, V7, P523, DOI 10.1089/fpd.2009.0447; Kirchner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084142; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mezal EH, 2014, PATHOG DIS, V72, P95, DOI 10.1111/2049-632X.12191; Mezal EH, 2013, INT J FOOD MICROBIOL, V164, P113, DOI 10.1016/j.ijfoodmicro.2013.03.021; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Rotger R, 1999, Int Microbiol, V2, P177; Scaria J, 2008, MOL CELL PROBE, V22, P238, DOI 10.1016/j.mcp.2008.04.002; Searle LEJ, 2010, J MED MICROBIOL, V59, P1428, DOI 10.1099/jmm.0.022780-0; Skyberg JA, 2006, AVIAN DIS, V50, P77, DOI 10.1637/7417.1; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Suez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058449; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Yoshida C, 2014, DIAGN MICR INFEC DIS, V80, P185, DOI 10.1016/j.diagmicrobio.2014.08.006	30	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135010	10.1371/journal.pone.0135010	http://dx.doi.org/10.1371/journal.pone.0135010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244504	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400137
J	Mochan-Keef, E; Swigon, D; Ermentrout, GB; Clermont, G				Mochan-Keef, Ericka; Swigon, David; Ermentrout, G. Bard; Clermont, Gilles			A Three-Tiered Study of Differences in Murine Intrahost Immune Response to Multiple Pneumococcal Strains	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-TRACT; PNEUMOLYSIN; INFECTION; VIRULENCE; PHAGOCYTOSIS; COMPLEMENT; ACTIVATION; ANTIBODIES; RESISTANCE	We apply a previously developed 4-variable ordinary differential equation model of in-host immune response to pneumococcal pneumonia to study the variability of the immune response of MF1 mice and to explore bacteria-driven differences in disease progression and outcome. In particular, we study the immune response to D39 strain of bacteria missing portions of the pneumolysin protein controlling either the hemolytic activity or complement-activating activity, the response to D39 bacteria deficient in either neuraminidase A or B, and the differences in the response to D39 (serotype 2), 0100993 (serotype 3), and TIGR4 (serotype 4) bacteria. The model accurately reproduces infection kinetics in all cases and provides information about which mechanisms in the immune response have the greatest effect in each case. Results suggest that differences in the ability of bacteria to defeat immune response are primarily due to the ability of the bacteria to elude nonspecific clearance in the lung tissue as well as the ability to create damage to the lung epithelium.	[Mochan-Keef, Ericka] Joint Carnegie Mellon Univ Univ Pittsburgh PhD Pr, Pittsburgh, PA 15213 USA; [Swigon, David; Ermentrout, G. Bard] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Clermont, Gilles] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mochan-Keef, E (corresponding author), Joint Carnegie Mellon Univ Univ Pittsburgh PhD Pr, Pittsburgh, PA 15213 USA.	edm29@pitt.edu	Mochan, Ericka/AAT-4947-2020	Mochan, Ericka/0000-0002-3804-387X	National Institutes of Health (NIH) [R56AI093930]; National Institute of General Medical Sciences MIDAS grant [U54GM088491]; National Institutes of Health [R01GM105728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, R01GM105728] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences MIDAS grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) Grant R56AI093930. This work was also supported by the National Institute of General Medical Sciences MIDAS grant U54GM088491 and National Institutes of Health Grant R01GM105728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JE, 1998, MICROB PATHOGENESIS, V24, P167, DOI 10.1006/mpat.1997.0185; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; BOULNOIS GJ, 1991, MOL MICROBIOL, V5, P2611, DOI 10.1111/j.1365-2958.1991.tb01969.x; Braun JS, 2002, J CLIN INVEST, V109, P19; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; BRUYN GAW, 1992, CLIN INFECT DIS, V14, P251, DOI 10.1093/clinids/14.1.251; CAMARA M, 1994, INFECT IMMUN, V62, P3688; CHUDWIN DS, 1985, INFECT IMMUN, V50, P213, DOI 10.1128/IAI.50.1.213-217.1985; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; FINE DP, 1975, INFECT IMMUN, V12, P772, DOI 10.1128/IAI.12.4.772-778.1975; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4; GIEBINK GS, 1977, INFECT IMMUN, V18, P291, DOI 10.1128/IAI.18.2.291-297.1977; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HOSTETTER MK, 1986, J INFECT DIS, V153, P682, DOI 10.1093/infdis/153.4.682; JAY SJ, 1976, J CLIN INVEST, V57, P811, DOI 10.1172/JCI108356; Jounblat R, 2003, INFECT IMMUN, V71, P1813, DOI 10.1128/IAI.71.4.1813-1819.2003; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2002, INFECT IMMUN, V70, P2886, DOI 10.1128/IAI.70.6.2886-2890.2002; KALIN M, 1987, J CLIN MICROBIOL, V25, P226, DOI 10.1128/JCM.25.2.226-229.1987; Kalin M, 1998, THORAX, V53, P159, DOI 10.1136/thx.53.3.159; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LEE CJ, 1991, CRIT REV MICROBIOL, V18, P89, DOI 10.3109/10408419109113510; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mitchell TJ, 1997, J APPL MICROBIOL, V83, pS62, DOI 10.1046/j.1365-2672.83.s1.7.x; Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639; Mochan E, 2014, J THEOR BIOL, V353, P44, DOI 10.1016/j.jtbi.2014.02.021; Mohler J, 2003, INTENS CARE MED, V29, P808, DOI 10.1007/s00134-003-1699-x; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; READ RC, 1991, J INFECT DIS, V163, P549, DOI 10.1093/infdis/163.3.549; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; SPENCER H, 1967, ANNU REV MED, V18, P423, DOI 10.1146/annurev.me.18.020167.002231; Todar K., 2008, ONLINE TXB BACTERIOL; Watson DA, 1990, INFECT IMMUN, V17, P913	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134012	10.1371/journal.pone.0134012	http://dx.doi.org/10.1371/journal.pone.0134012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244863	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000359061400064
J	Bucukovski, J; Latorre-Margalef, N; Stallknecht, DE; Miller, BL				Bucukovski, Joseph; Latorre-Margalef, Neus; Stallknecht, David E.; Miller, Benjamin L.			A Multiplex Label-Free Approach to Avian Influenza Surveillance and Serology	PLOS ONE			English	Article							ARRAYED IMAGING REFLECTOMETRY; PROTEIN MICROARRAY; VIRUS; RESPONSES; ANTIBODIES; INFECTION; VACCINE; ASSAYS	l;Influenza serology has traditionally relied on techniques such as hemagglutination inhibition, microneutralization, and ELISA. These assays are complex, challenging to implement in a format allowing detection of several types of antibody-analyte interactions at once (multiplex), and troublesome to implement in the field. As an alternative, we have developed a hemagglutinin microarray on the Arrayed Imaging Reflectometry (AIR) platform. AIR provides sensitive, rapid, and label-free multiplex detection of targets in complex analyte samples such as serum. In preliminary work, we demonstrated the application of this array to the testing of human samples from a vaccine trial. Here, we report the application of an expanded label-free hemagglutinin microarray to the analysis of avian serum samples. Samples from influenza virus challenge experiments in mallards yielded strong, selective detection of antibodies to the challenge antigen in most cases. Samples acquired in the field from mallards were also analyzed, and compared with viral hemagglutinin inhibition and microneutralization assays. We find that the AIR hemagglutinin microarray can provide a simple and robust alternative to standard methods, offering substantially greater information density from a simple workflow.	[Bucukovski, Joseph; Miller, Benjamin L.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA; [Bucukovski, Joseph; Miller, Benjamin L.] Univ Rochester, Dept Dermatol, Rochester, NY 14627 USA; [Latorre-Margalef, Neus; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA	University of Rochester; University of Rochester; University System of Georgia; University of Georgia	Miller, BL (corresponding author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA.	Benjamin_Miller@urmc.rochester.edu			NIH, NIAID Respiratory Pathogens Research Center [HHSN272201200005C]; Wenner-Gren Foundations, Sweden; Swedish Research Council	NIH, NIAID Respiratory Pathogens Research Center; Wenner-Gren Foundations, Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project has been funded in whole or in part with federal funds from the NIH, NIAID Respiratory Pathogens Research Center, under contract HHSN272201200005C. The findings and conclusions in this report are the authors' and do not necessarily reflect the views of the funding agency. N. Latorre-Margalef was supported by postdoctoral grants from the Wenner-Gren Foundations, Sweden, and the Swedish Research Council. The following reagents were obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Polyclonal Anti-Influenza Virus H3 Hemagglutinin (HA), A/Hong Kong/1/68 (H3N2), (antiserum, Goat), NR-3118; Polyclonal Anti-Influenza Virus H1 Hemagglutinin (HA), A/Brisbane/59/2007 (H1N1), (antiserum, Goat), NR-28613; Polyclonal Anti-Influenza Virus H6 Hemagglutinin (HA), A/Teal/HK/W312/97 (H6N1), (antiserum, Goat), NR-663; Polyclonal Anti-Influenza Virus H2 Hemagglutinin (HA), A/Singapore/1/57 (H2N2), (antiserum, Goat), NR-4523; Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Chicken/HK/G9/97 (H9N2), (antiserum, Goat), NR-668; Polyclonal Anti-Influenza Virus H7 Hemagglutinin (HA), A/Netherlands/219/03 (H7N7), (antiserum, Goat), NR-9226; Polyclonal Anti-Influenza Virus H5 Hemagglutinin (HA), A/HK/213/03 (H5N1), (antiserum, Goat), NR-163; Polyclonal Anti-Influenza Virus B Hemagglutinin (HA), B/Florida/04/2006, (antiserum, Goat), NR-28669.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brown JD, 2012, J WILDLIFE DIS, V48, P991, DOI 10.7589/2011-09-280; Carney PJ, 2010, CLIN VACCINE IMMUNOL, V17, P1407, DOI 10.1128/CVI.00509-09; Carter JA, 2011, BIOSENS BIOELECTRON, V26, P3944, DOI 10.1016/j.bios.2011.02.025; Desbien AL, 2013, BIOTECHNIQUES, V54, P345, DOI 10.2144/000114041; Freidl GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108043; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; Lebarbenchon C, 2012, J VET DIAGN INVEST, V24, P161, DOI 10.1177/1040638711416626; Legutki JB, 2010, VACCINE, V28, P4529, DOI 10.1016/j.vaccine.2010.04.061; Mace CR, 2008, LANGMUIR, V24, P12754, DOI 10.1021/la801712m; Mace CR, 2008, BIOSENS BIOELECTRON, V24, P334, DOI 10.1016/j.bios.2008.05.003; Mace CR, 2006, ANAL CHEM, V78, P5578, DOI 10.1021/ac060473+; Mace CR, 2011, TALANTA, V83, P1000, DOI 10.1016/j.talanta.2010.11.002; Price JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064555; Ramey AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095620; Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0; Sriram R, 2011, ANAL CHEM, V83, P3750, DOI 10.1021/ac2001302; Washington JA, 1996, MED MICROBIOLOGY; Webster RG, 2002, VACCINE, V20, pS16, DOI 10.1016/S0264-410X(02)00123-8; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Yadav AR, 2014, ANAL CHEM, V86, P1067, DOI 10.1021/ac402603j	23	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134484	10.1371/journal.pone.0134484	http://dx.doi.org/10.1371/journal.pone.0134484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241048	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700046
J	Tzeng, J; Byun, J; Park, JY; Yamamoto, T; Schesing, K; Tian, B; Sadoshima, J; Oka, S				Tzeng, John; Byun, Jaemin; Park, Ji Yeon; Yamamoto, Takanobu; Schesing, Kevin; Tian, Bin; Sadoshima, Junichi; Oka, Shin-ichi			An Ideal PPAR Response Element Bound to and Activated by PPAR alpha	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; BINDING-SITES; RECEPTOR PPAR; GENE; MICE; RXR; DNA; ADIPOGENESIS; HETERODIMERS; METABOLISM	Peroxisome proliferator-activated receptor-alpha (PPAR alpha), a nuclear receptor, plays an important role in the transcription of genes involved in fatty acid metabolism through heterodimerization with the retinoid x receptor (RXR). The consensus sequence of the PPAR response element (PPRE) is composed of two AGGTCA-like sequences directionally aligned with a single nucleotide spacer. PPAR alpha and RXR bind to the 5' and 3' hexad sequences, respectively. However, the precise sequence definition of the PPRE remains obscure, and thus, the consensus sequence currently available remains AGGTCANAGGTCA with unknown redundancy. The vague PPRE sequence definition poses an obstacle to understanding how PPAR alpha regulates fatty acid metabolism. Here we show that, rather than the generally accepted 6-bp sequence, PPAR alpha actually recognized a 12-bp DNA sequence, of which the preferred binding sequence was WAWVTRGGBBAH. Additionally, the optimized RXR alpha hexad binding sequence was RGKTYA. Thus, the optimal PPAR alpha/RXR alpha heterodimer binding sequence was WAWVTRGGBBAHRGKTYA. The single nucleotide substitution, which reduces binding of RXR alpha to DNA, attenuated PPAR alpha-induced transcriptional activation, but this is not always true for PPAR alpha. Using the definition of the PPRE sequence, novel PPREs were successfully identified. Taken altogether, the provided PPRE sequence definition contributes to the understanding of PPAR alpha signaling by identifying PPAR alpha direct target genes with functional PPAR alpha response elements.	[Tzeng, John; Byun, Jaemin; Yamamoto, Takanobu; Schesing, Kevin; Sadoshima, Junichi; Oka, Shin-ichi] Rutgers Biomed Hlth Sci, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Park, Ji Yeon; Tian, Bin] Rutgers Biomed Hlth Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Oka, S (corresponding author), Rutgers Biomed Hlth Sci, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	okash@njms.rutgers.edu	Masutani, Hiroshi/B-5114-2014	Sadoshima, Junichi/0000-0003-3724-4132	American Heart Association (AHA) [12SDG11890014]; AHA; Glorney-Raisbeck Medical Student Grant; Foundation Leducq Transatlantic Networks; US Public Health Service [HL9469]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091469, R01HL102738, R01HL067724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023039] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); AHA(American Heart Association); Glorney-Raisbeck Medical Student Grant; Foundation Leducq Transatlantic Networks; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by American Heart Association (AHA) Scientist Developmental Grant 12SDG11890014 (SO), an AHA student scholarship (KS), the Glorney-Raisbeck Medical Student Grant (KS), Foundation Leducq Transatlantic Networks (JS), and US Public Health Service Grant HL9469 (JS).	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Loichot C, 2006, AM J PHYSIOL-HEART C, V291, pH161, DOI 10.1152/ajpheart.01065.2004; Madrazo JA, 2008, J MOL CELL CARDIOL, V44, P968, DOI 10.1016/j.yjmcc.2008.03.021; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 2009, MOL ENDOCRINOL, V23, P740, DOI 10.1210/me.2009-0135; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Schoonjans K, 1996, J LIPID RES, V37, P907; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012	25	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134996	10.1371/journal.pone.0134996	http://dx.doi.org/10.1371/journal.pone.0134996			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241474	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700088
J	Zou, Y; Bao, JJ; Pan, XF; Lu, Y; Liao, SH; Wang, XC; Wang, GY; Lin, DJ				Zou, Yong; Bao, Junjie; Pan, Xingfei; Lu, Ying; Liao, Sihong; Wang, Xicheng; Wang, Guoying; Lin, Dongjun			NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECEPTOR NKP30; CYTOKINE; LIGAND; IL-32; ACTIVATION	Background and Aims Previous work conducted by our group has shown that the accumulation of hepatic natural killer (NK) cells and the up-regulation of natural cytotoxicity receptors (NKP30 and NKP46) on NK cells from patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) were correlated with disease progression in HBV-ACLF. The natural cytotoxicity receptors expressed on NK cells are believed to be probable candidates involved in the NK cell-mediated hepatocyte damage in HBV-ACLF. However, the underlying mechanisms remain to be elucidated. In the present study, we aimed to discover the role of NKP30-B7-H6 interaction in NK cells-mediated hepatocyte damage in HBV-ACLF. Methods Hepatic expressions of B7-H6 and interleukin-32 (IL-32) were examined by immunochemistry staining in samples from patients with HBV-ACLF or mild chronic hepatitis B (CHB). The cytotoxicity of NK-92 cell against target cells (Huh-7 and LO2) was evaluated by CCK8 assay. Expression of IL-32 in liver NK cell, T cells and NK-92 cell line was detected by the flow cytometric analysis. The effect of IL-32 on the apoptosis of Huh7 cells was evaluated using Annexin V/PI staining analysis. Results An enhancement of hepatic B7-H6 and IL-32 expression was associated with the severity of liver injury in HBV-ACLF. And there was a positive association between hepatic B7-H6 and IL-32 expression. Expressions of IL-32 in liver NK cells and T cells were increased in HBV-ACLF patients. In vitro NK-92 cells are highly capable of killing the high B7-H6 expressing Huh7 cells and B7-H6-tansfected hepatocyte line LO2 cells dependent on NKP30 and B7-H6 interaction. Furthermore, NK-92 cells exhibited elevated IL-32 expression when stimulated with anti-NKP30 antibodies or when co-cultured with Huh7 cells. IL-32 can induce the apoptosis of Huh7 cells in a dose-dependent manner. Conclusion Our results suggest that NKP30-B7-H6 interaction can aggravate hepatocyte damage, probably through up-regulation of IL-32 expression in HBV-ACLF.	[Zou, Yong; Lu, Ying; Liao, Sihong; Lin, Dongjun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Blood Transfus, Guangzhou 510275, Guangdong, Peoples R China; [Bao, Junjie] Guangzhou Women & Childrens Med Ctr, Dept Obstet, Preterm Birth Prevent & Treatment Res Unit, Guangzhou, Guangdong, Peoples R China; [Pan, Xingfei] Guangzhou Med Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Wang, Xicheng] Zhangqiu Peoples Hosp, Dept Oncol, Jinan, Peoples R China; [Wang, Guoying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Transplantat Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Dongjun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hematol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Zou, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Blood Transfus, Guangzhou 510275, Guangdong, Peoples R China.	zouyong0205@163.com; wanggy3@126.com; dongjunlin0205@163.com			National Natural Science Fund of China [81000180]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund of China (Grant No.81000180).	Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Cheon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.159756; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; DAHL CA, 1992, J IMMUNOL, V148, P597; Dinarello CA, 2006, ANN RHEUM DIS, V65, P61, DOI 10.1136/ard.2006.058511; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Jung MY, 2011, J IMMUNOL, V186, P6848, DOI 10.4049/jimmunol.1003996; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liu M, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002812; Liu Q, 2007, J GASTROEN HEPATOL, V22, P2101, DOI 10.1111/j.1440-1746.2006.04362.x; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; Park MH, 2012, IMMUNOLOGY, V135, P63, DOI 10.1111/j.1365-2567.2011.03513.x; Roth E, 2004, J IMMUNOL, V172, P1588, DOI 10.4049/jimmunol.172.3.1588; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Xu QH, 2012, J INFECTION, V65, P336, DOI 10.1016/j.jinf.2012.05.009; Zhang Z, 2008, J HEPATOL, V49, P396, DOI 10.1016/j.jhep.2008.05.017; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	24	10	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134568	10.1371/journal.pone.0134568	http://dx.doi.org/10.1371/journal.pone.0134568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241657	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700049
J	Birner, A; Seiler, S; Lackner, N; Bengesser, SA; Queissner, R; Fellendorf, FT; Platzer, M; Ropele, S; Enzinger, C; Schwingenschuh, P; Mangge, H; Pirpamer, L; Deutschmann, H; McIntyre, RS; Kapfhammer, HP; Reininghaus, B; Reininghaus, EZ				Birner, Armin; Seiler, Stephan; Lackner, Nina; Bengesser, Susanne A.; Queissner, Robert; Fellendorf, Frederike T.; Platzer, Martina; Ropele, Stefan; Enzinger, Christian; Schwingenschuh, Petra; Mangge, Harald; Pirpamer, Lukas; Deutschmann, Hannes; McIntyre, Roger S.; Kapfhammer, Hans-Peter; Reininghaus, Bernd; Reininghaus, Eva Z.			Cerebral White Matter Lesions and Affective Episodes Correlate in Male Individuals with Bipolar Disorder	PLOS ONE			English	Article							AUSTRIAN STROKE PREVENTION; INDUCED LIPID-PEROXIDATION; MAGNETIC-RESONANCE IMAGES; MAJOR AFFECTIVE-DISORDERS; SIGNAL HYPERINTENSITIES; OXIDATIVE STRESS; RATING-SCALE; I DISORDER; LATE-ONSET; BRAIN	Background Cerebral white matter lesions (WML) have been found in normal aging, vascular disease and several neuropsychiatric conditions. Correlations of WML with clinical parameters in BD have been described, but not with the number of affective episodes, illness duration, age of onset and Body Mass Index in a well characterized group of euthymic bipolar adults. Herein, we aimed to evaluate the associations between bipolar course of illness parameters and WML measured with volumetric analysis. Methods In a cross-sectional study 100 euthymic individuals with BD as well as 54 healthy controls (HC) were enrolled to undergo brain magnetic resonance imaging using 3T including a FLAIR sequence for volumetric assessment of WML-load using FSL-software. Additionally, clinical characteristics and psychometric measures including Structured Clinical Interview according to DSM-IV, Hamilton-Depression, Young Mania Rating Scale and Beck's Depression Inventory were evaluated. Results Individuals with BD had significantly more (F = 3.968, p < .05) WML (Mdn = 3710mm3; IQR = 2961mm3) than HC (Mdn = 2185mm3; IQR = 1665mm3). BD men (Mdn = 4095mm3; IQR = 3295mm3) and BD women (Mdn = 3032mm3; IQR = 2816mm3) did not significantly differ as to the WML-load or the number and type of risk factors for WML. However, in men only, the number of manic/hypomanic episodes (r = 0.72; p < .001) as well as depressive episodes (r = 0.51; p < .001) correlated positively with WML-load. Conclusions WML-load strongly correlated with the number of manic episodes in male BD patients, suggesting that men might be more vulnerable to mania in the context of cerebral white matter changes.	[Birner, Armin; Lackner, Nina; Bengesser, Susanne A.; Queissner, Robert; Fellendorf, Frederike T.; Platzer, Martina; Kapfhammer, Hans-Peter; Reininghaus, Bernd; Reininghaus, Eva Z.] Med Univ Graz, Dept Psychiat, Graz, Austria; [Seiler, Stephan; Ropele, Stefan; Enzinger, Christian; Schwingenschuh, Petra; Pirpamer, Lukas] Med Univ Graz, Dept Neurol, Graz, Austria; [Enzinger, Christian; Schwingenschuh, Petra; Deutschmann, Hannes] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria; [Mangge, Harald] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Res Unit Lifestyle & Inflammation Associated Risk, Graz, Austria; [McIntyre, Roger S.] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Seiler, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	stephan.seiler@medunigraz.at	McIntyre, Roger/AAU-1000-2020	McIntyre, Roger/0000-0003-4733-2523; Fellendorf, Frederike/0000-0001-7215-3848; Reininghaus, Eva/0000-0001-5964-4087; Mangge, Harald/0000-0003-4067-247X; Deutschmann, Hannes/0000-0003-4552-699X	"Stadt Graz" (City of Graz, Austria)	"Stadt Graz" (City of Graz, Austria)	The present study is part of the BIPFAT-study, which was funded by the "Stadt Graz" (City of Graz, Austria) (original project name: "Fettstoffwechselstorungen und anthropometrische Besonderheiten bei PatientInnen mit bipolarer affektiver Storung"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2006, PSYCHOSOM MED, V68, P778, DOI 10.1097/01.psy.0000237779.56500.af; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Bae S, 2010, J PSYCHOPHARMACOL, V24, P717, DOI 10.1177/0269881108098476; Bae SC, 2006, DRUG ALCOHOL DEPEN, V81, P83, DOI 10.1016/j.drugalcdep.2005.05.016; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Bengesser SA, 2015, J AFFECT DISORDERS, V172, P367, DOI 10.1016/j.jad.2014.10.014; Beyer JL, 2009, INT REV PSYCHIATR, V21, P394, DOI 10.1080/09540260902962198; BOTTERON KN, 1992, J AM ACAD CHILD PSY, V31, P258, DOI 10.1097/00004583-199203000-00012; BOTTERON KN, 1995, J AM ACAD CHILD PSY, V34, P742, DOI 10.1097/00004583-199506000-00014; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P320, DOI 10.1192/bjp.166.3.320; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; Dietrich AK, 2013, J STEROID BIOCHEM, V138, P410, DOI 10.1016/j.jsbmb.2013.07.007; DUPONT RM, 1990, ARCH GEN PSYCHIAT, V47, P55; Fagiolini A, 2005, BIPOLAR DISORD, V7, P424, DOI 10.1111/j.1399-5618.2005.00234.x; Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fein G, 2009, ALCOHOL CLIN EXP RES, V33, P70, DOI 10.1111/j.1530-0277.2008.00812.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frey BN, 2014, BIPOLAR DISORD, V16, P48, DOI 10.1111/bdi.12151; GALLUCCI M, 1989, J COMPUT ASSIST TOMO, V13, P395, DOI 10.1097/00004728-198905000-00004; Goldstein BI, 2009, BIPOLAR DISORD, V11, P657, DOI 10.1111/j.1399-5618.2009.00735.x; Goldstein BI, 2013, BIPOLAR DISORD; Grangeon MC, 2010, CNS SPECTRUMS, V15, P375, DOI 10.1017/S1092852900029242; Gunde E, 2011, J PSYCHIATR RES, V45, P76, DOI 10.1016/j.jpsychires.2010.04.019; Gustafson DR, 2004, INT PSYCHOGERIATR, V16, P327, DOI 10.1017/s1041610204000353; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hautzinger M., 1994, BEARBEITUNG DTSCH AU; Hendrick V, 2000, J CLIN PSYCHIAT, V61, P393, DOI 10.4088/JCP.v61n0514; Heron P, 2000, METAB BRAIN DIS, V15, P267; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kawa I, 2005, BIPOLAR DISORD, V7, P119, DOI 10.1111/j.1399-5618.2004.00180.x; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kiray M, 2007, ACTA HISTOCHEM, V109, P480, DOI 10.1016/j.acthis.2007.04.008; Kruit MC, 2010, CEPHALALGIA, V30, P129, DOI 10.1111/j.1468-2982.2009.01904.x; Lackner N, 2014, EUR ARCH PSYCHIAT CL; Leboyer M, 2012, J AFFECT DISORDERS, V141, P1, DOI 10.1016/j.jad.2011.12.049; Lyoo IK, 2004, PSYCHIAT RES-NEUROIM, V131, P135, DOI 10.1016/j.pscychresns.2004.04.001; Lyoo IK, 2002, COMPR PSYCHIAT, V43, P361, DOI 10.1053/comp.2002.34636; McIntyre RS, 2010, J AFFECT DISORDERS, V126, P366, DOI 10.1016/j.jad.2010.04.012; Moore PB, 2001, BRIT J PSYCHIAT, V178, P172, DOI 10.1192/bjp.178.2.172; Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004; O'Brien JT, 2006, AM J GERIAT PSYCHIAT, V14, P834, DOI 10.1097/01.JGP.0000214558.63358.94; Palm-Meinders IH, 2012, JAMA-J AM MED ASSOC, V308, P1889, DOI 10.1001/jama.2012.14276; Pillai JJ, 2002, PSYCHIAT RES-NEUROIM, V114, P51, DOI 10.1016/S0925-4927(01)00129-9; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Pompili M, 2007, EUR ARCH PSY CLIN N, V257, P494, DOI 10.1007/s00406-007-0755-x; Regenold WT, 2008, BIPOLAR DISORD, V10, P753, DOI 10.1111/j.1399-5618.2008.00626.x; Regenold WT, 2005, J AFFECT DISORDERS, V85, P341, DOI 10.1016/j.jad.2004.10.010; Reininghaus EZ, 2015, J AFFECT DISORDERS, V171, P33, DOI 10.1016/j.jad.2014.09.006; Reininghaus EZ, 2014, BIPOLAR DISORD, V16, P432, DOI 10.1111/bdi.12166; Requintina PJ, 2005, ANN NY ACAD SCI, V1053, P400, DOI 10.1196/annals.1344.035; Rivkin P, 2000, INT J GERIATR PSYCH, V15, P1085, DOI 10.1002/1099-1166(200012)15:12<1085::AID-GPS250>3.0.CO;2-X; Robinson, 1997, Semin Clin Neuropsychiatry, V2, P244; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; Santos CO, 2011, CEREBROVASC DIS, V32, P11, DOI 10.1159/000327032; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; Schmidt R, 1999, NEUROLOGY, V53, P132, DOI 10.1212/WNL.53.1.132; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schmidt R, 2011, ACTA NEUROPATHOL, V122, P171, DOI 10.1007/s00401-011-0851-x; Schubert MF, 2006, KLIN NEUROPSYCHOLOGI, P303; Seiler S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00263; Serafini G, 2014, CNS SPECTRUMS, V10, P1; Serafini G, 2010, BIPOLAR DISORD, V12, P755, DOI 10.1111/j.1399-5618.2010.00867.x; Shaywitz SE, 2003, MENOPAUSE, V10, P420, DOI 10.1097/01.GME.0000060241.02837.29; Sherwin BB, 2003, ENDOCR REV, V24, P133, DOI 10.1210/er.2001-0016; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; STARKSTEIN SE, 1991, BIOL PSYCHIAT, V29, P149, DOI 10.1016/0006-3223(91)90043-L; Tighe SK, 2012, BIPOLAR DISORD, V14, P888, DOI 10.1111/bdi.12019; Tondo L, 1998, AM J PSYCHIAT, V155, P1434, DOI 10.1176/ajp.155.10.1434; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Wang L, 2014, J PSYCHIATR RES, V56, P56, DOI 10.1016/j.jpsychires.2014.05.005; Yim CY, 2011, EUR PSYCHIAT; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	78	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135313	10.1371/journal.pone.0135313	http://dx.doi.org/10.1371/journal.pone.0135313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252714	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100151
J	Haider, DG; Lindner, G; Wolzt, M; Ahmad, SS; Sauter, T; Leichtle, AB; Fiedler, GM; Fuhrmann, V; Exadaktylos, AK				Haider, Dominik G.; Lindner, Gregor; Wolzt, Michael; Ahmad, Sufian S.; Sauter, Thomas; Leichtle, Alexander Benedikt; Fiedler, Georg-Martin; Fuhrmann, Valentin; Exadaktylos, Aristomenis K.			Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SEVERE HYPOPHOSPHATEMIA; CARDIOVASCULAR-DISEASE; SERUM PHOSPHORUS; HOSPITAL POPULATION; PHOSPHATE LEVELS; COMMUNITY; CALCIUM; ATHEROSCLEROSIS; HEMODIALYSIS	Background Phosphate imbalances or disorders have a high risk of morbidity and mortality in patients with chronic kidney disease. It is unknown if this finding extends to mortality in patients presenting at an emergency room with or without normal kidney function. Methods and Patients This cross sectional analysis included all emergency room patients between 2010 and 2011 at the Inselspital Bern, Switzerland. A multivariable cox regression model was applied to assess the association between phosphate levels and in-hospital mortality up to 28 days. Results 22,239 subjects were screened for the study. Plasma phosphate concentrations were measured in 2,390 patients on hospital admission and were included in the analysis. 3.5% of the 480 patients with hypophosphatemia and 10.7% of the 215 patients with hyperphosphatemia died. In univariate analysis, phosphate levels were associated with mortality, age, diuretic therapy and kidney function (all p<0.001). In a multivariate Cox regression model, hyperphosphatemia (OR 3.29, p<0.001) was a strong independent risk factor for mortality. Hypophosphatemia was not associated with mortality (p>0.05). Conclusion Hyperphosphatemia is associated with 28-day in-hospital mortality in an unselected cohort of patients presenting in an emergency room.	[Haider, Dominik G.; Lindner, Gregor; Ahmad, Sufian S.; Sauter, Thomas; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Wolzt, Michael] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Leichtle, Alexander Benedikt; Fiedler, Georg-Martin] Univ Hosp Bern, Inselspital, Ctr Lab Med, CH-3010 Bern, Switzerland; [Fuhrmann, Valentin] Univ Hosp Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany	University of Bern; University Hospital of Bern; Medical University of Vienna; University of Bern; University Hospital of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf	Haider, DG (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, Freiburgstr, CH-3010 Bern, Switzerland.	dominikhaider2003@yahoo.de	Ahmad, Sufian S/H-3881-2014; Lindner, Gregor/AAR-6761-2020; Leichtle, Alexander/C-7262-2011; Fiedler, Georg Martin/C-8341-2011	Ahmad, Sufian S/0000-0001-9763-092X; Lindner, Gregor/0000-0001-5551-8227; Fiedler, Georg Martin/0000-0001-5689-4574; Sauter, Thomas C/0000-0002-6646-5789; Wolzt, Michael/0000-0001-6049-1890				BETRO MG, 1972, BRIT MED J, V1, P273, DOI 10.1136/bmj.1.5795.273; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Buell JF, 1998, ARCH SURG-CHICAGO, V133, P757, DOI 10.1001/archsurg.133.7.757; CAMP MA, 1990, MINER ELECTROL METAB, V16, P365; Chung PY, 2003, LIVER TRANSPLANT, V9, P248, DOI 10.1053/jlts.2003.50053; Cohen J, 2004, EUR J CARDIO-THORAC, V26, P306, DOI 10.1016/j.ejcts.2004.03.004; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; FISHER J, 1983, CHEST, V83, P504, DOI 10.1378/chest.83.3.504; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; GOLDSTEIN J, 1985, INTENS CARE MED, V11, P144; Hoffmann M, 2008, J CLIN PATHOL, V61, P1104, DOI 10.1136/jcp.2007.054940; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; KING AL, 1987, SOUTH MED J, V80, P831, DOI 10.1097/00007611-198707000-00008; LARSSON L, 1983, ACTA MED SCAND, V214, P221; Sankaran RT, 1997, CHEST, V111, P595, DOI 10.1378/chest.111.3.595; Shor R, 2006, ANN CLIN LAB SCI, V36, P67; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vaidyanathan Duraiswamy, 2000, Indian Journal of Physiology and Pharmacology, V44, P225; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; WILSON HK, 1982, ARCH INTERN MED, V142, P517, DOI 10.1001/archinte.142.3.517; WOODHEAD MA, 1986, THORAX, V41, P635, DOI 10.1136/thx.41.8.635; ZAZZO JF, 1995, INTENS CARE MED, V21, P826, DOI 10.1007/BF01700966	27	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133426	10.1371/journal.pone.0133426	http://dx.doi.org/10.1371/journal.pone.0133426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252874	gold, Green Published			2022-12-26	WOS:000359121100016
J	Liu, YX; Dong, X; Gong, F; Su, N; Li, SB; Zhang, HT; Liu, JL; Xue, JH; Ji, SP; Zhang, ZW				Liu, Yu-xiao; Dong, Xing; Gong, Feng; Su, Ning; Li, Su-bo; Zhang, Hai-tao; Liu, Jia-ling; Xue, Jing-hui; Ji, Shou-ping; Zhang, Zhi-wen			Promotion of Erythropoietic Differentiation in Hematopoietic Stem Cells by SOCS3 Knock-Down	PLOS ONE			English	Article							RED-BLOOD-CELLS; LIVER STROMA CELL; ERYTHROID-DIFFERENTIATION; CYTOKINE SIGNALING-3; PERIPHERAL-BLOOD; CD34(+) CELLS; GROWTH-FACTOR; GENERATION; CD34+CELLS; PROGENITOR	Suppressor of cytokine signaling 3 (SOCS3) plays an important role in mice fetal liver erythropoiesis, but the roles of SOCS3 in human hematopoietic stem cells (HSCs) have not been well investigated. In the present study, lentiviral small interference RNA expression vectors (shRNA) of SOCS3 were constructed and stably transferred into HSCs. We found that SOCS3 knockdown induced erythroid expansion in HSCs. Conversely, Ectopic expression of SOCS3 in progenitor cells blocked erythroid expansion and erythroid colony formation of HSCs. To further explore the involved mechanism, we compared gene expression profiles of SOCS3-shRNA tranduced HSCs with that of control HSCs by whole genome microarrays. The results indicated that cell developmental process related genes, especially hematopoietic lineage-specific genes, associated with the responses to SOCS3 in HSCs. Downexpression of SOCS3 in HSCs or differentiated erythroid progenitor cells induced a transcriptional program enriched for erythroid development relative genes. Our results proved that SOCS3 down-expression induced lineage commitment towards erythroid progenitor cell fate by activation of erythroid-specific gene in HSCs and provided new insight into the mechanism of erythropoietic development.	[Liu, Yu-xiao; Su, Ning; Zhang, Hai-tao; Liu, Jia-ling; Xue, Jing-hui; Zhang, Zhi-wen] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Beijing, Peoples R China; [Gong, Feng; Li, Su-bo; Ji, Shou-ping] Beijing Inst Transfus Med, Beijing, Peoples R China; [Dong, Xing] Third Mil Med Univ, Chongqing, Peoples R China; [Dong, Xing] Beijing Mil Command, Gen Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Army Medical University; Seventh Medical Center of Chinese PLA General Hospital	Xue, JH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Beijing, Peoples R China.	xuejh629@163.com; jishouping@yahoo.com; zhangzhiwen301@yahoo.com	Ji, Shou-Ping/AAA-3851-2020		National Natural Sciences foundation of China [81100329]; International Science & Technology Cooperation Program of China [2011DFA30550]	National Natural Sciences foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China	This study was supported by grant from the National Natural Sciences foundation of China (Grant number, 81100329) and a grant from International Science & Technology Cooperation Program of China (2011DFA30550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel S, 2003, STEM CELLS, V21, P557, DOI 10.1634/stemcells.21-5-557; Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Baek EJ, 2008, TRANSFUSION, V48, P2235, DOI 10.1111/j.1537-2995.2008.01828.x; Boehm D, 2009, J BIOTECHNOL, V144, P127, DOI 10.1016/j.jbiotec.2009.08.017; Cantu C, 2011, BLOOD, V117, P3669, DOI 10.1182/blood-2010-04-282350; Chao RH, 2015, STEM CELL RES, V14, P30, DOI 10.1016/j.scr.2014.11.002; Chen L, 2007, EXP HEMATOL, V35, P1047, DOI 10.1016/j.exphem.2007.04.003; Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; Di Giacomo V, 2005, J CELL PHYSIOL, V202, P831, DOI 10.1002/jcp.20179; Dorn I, 2008, TRANSFUSION, V48, P1122, DOI 10.1111/j.1537-2995.2008.01653.x; Fauzi I, 2012, STEM CELLS DEV, V21, P3152, DOI 10.1089/scd.2012.0030; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Ji L, 2007, PROG BIOCHEM BIOPHYS, V34, P1040; Kershaw NJ, 2014, GROWTH FACTORS, V32, P1, DOI 10.3109/08977194.2013.877005; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Lee KY, 2011, STEM CELLS DEV, V20, P31, DOI 10.1089/scd.2010.0196; Liu SR, 2013, MOL CELL BIOL, V33, P2241, DOI 10.1128/MCB.01734-12; Liu YX, 2008, PROG BIOCHEM BIOPHYS, V35, P778; Liu YX, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-85; Luo Z, 2012, EXP HEMATOL, V40, P828, DOI 10.1016/j.exphem.2012.06.002; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Mancini E, 2012, EMBO J, V31, P351, DOI 10.1038/emboj.2011.390; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403; Ramana CV, 2005, BIOCHEM BIOPH RES CO, V327, P727, DOI 10.1016/j.bbrc.2004.12.074; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Ronzoni L, 2008, BLOOD CELL MOL DIS, V40, P148, DOI 10.1016/j.bcmd.2007.07.006; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Wessely O, 1999, BIOL CHEM, V380, P187, DOI 10.1515/BC.1999.027; Xi JF, 2007, PROG BIOCHEM BIOPHYS, V34, P207; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135259	10.1371/journal.pone.0135259	http://dx.doi.org/10.1371/journal.pone.0135259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252772	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100144
J	Prohl, A; Wolf, K; Weber, C; Muller, KE; Menge, C; Sachse, K; Rodel, J; Reinhold, P; Berndt, A				Prohl, Annette; Wolf, Katharina; Weber, Corinna; Mueller, Kerstin E.; Menge, Christian; Sachse, Konrad; Roedel, Juergen; Reinhold, Petra; Berndt, Angela			Kinetics of Local and Systemic Leucocyte and Cytokine Reaction of Calves to Intrabronchial Infection with Chlamydia psittaci	PLOS ONE			English	Article							L-SELECTIN CD62L; DELTA-T-CELLS; CHLAMYDOPHILA SPP.; LIPOPOLYSACCHARIDE LPS; BOVINE BRONCHOALVEOLAR; MONOCLONAL-ANTIBODIES; ADHESION MOLECULES; DENDRITIC CELLS; EXPRESSION; RECEPTOR	Infection of cattle with chlamydiae is ubiquitous and, even in the absence of clinical sequeleae, has a quantifiable negative impact on livestock productivity. Despite recent progress, our knowledge about immune response mechanisms capable of counteracting the infection and preventing its detrimental effects is still limited. A well-established model of bovine acute respiratory Chlamydia (C.) psittaci infection was used here to characterize the kinetics of the local and systemic immune reactions in calves. In the course of two weeks following inoculation, leukocyte surface marker expression was monitored by flow cytometry in blood and bronchoalveolar lavage fluid (BALF). Immune-related protein and receptor transcription were determined by quantitative real-time reverse transcription PCR in blood, BALF and lung tissue. An early increase of IL2RA, IL10 and HSPA1A mRNA expressions was followed by a rise of lymphocytes, monocytes, and granulocytes exhibiting activated phenotypes in blood. Monocytes showed elevated expression rates of CD11b, CD14 and MHC class II. The rates of CD62L expression on CD8(hi) T cells in blood and on CD4(+) T cells in BALF were also augmented and peaked between 2 and 4 dpi. Notably, CD25 antigen expression was significantly elevated, not only on CD8d(im)/CD62L(+) and CD8(-)/CD62L(+) cells in blood, but also on granulocytes in blood and BALF between 2-3 dpi. From 4 dpi onwards, changes declined and the calves recovered from the infection until 10 dpi. The findings highlight the effectiveness of rapid local and systemic immune reaction and indicate activated T cells, monocytes and granulocytes being essential for rapid eradication of the C. psittaci infection.	[Prohl, Annette; Menge, Christian; Sachse, Konrad; Reinhold, Petra; Berndt, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Wolf, Katharina; Roedel, Juergen] Univ Jena, Inst Med Microbiol, Jena, Germany; [Weber, Corinna; Mueller, Kerstin E.] Free Univ Berlin, Ruminant & Swine Clin, Berlin, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Schiller University of Jena; Free University of Berlin	Reinhold, P (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany.	petra.reinhold@fli.bund.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786; Weber, Corinna/0000-0003-4858-2188	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]; European Regional Development Fund (EFRE); Thuringer Aufbaubank [2013 VF 0024, 2013 FE 9077]	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF)); European Regional Development Fund (EFRE)(European Commission); Thuringer Aufbaubank	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany under Grant no. 01 KI 0720 "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals" and the European Regional Development Fund (EFRE) and the Thuringer Aufbaubank (Grant no 2013 VF 0024, Project no. 2013 FE 9077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SR, 2000, J LEUKOCYTE BIOL, V67, P415, DOI 10.1002/jlb.67.3.415; Appana G, 2013, EUR J MICROBIOL IMMU, V3, P241, DOI 10.1556/EuJMI.3.2013.4.2; Bednarek D, 2005, B VET I PULAWY, V49, P157; Biesenkamp-Uhe C, 2007, INFECT IMMUN, V75, P870, DOI 10.1128/IAI.00691-06; CARLOS TM, 1994, BLOOD, V84, P2068; Caswell JL, 1998, VET PATHOL, V35, P124, DOI 10.1177/030098589803500206; Darville T, 2001, INFECT IMMUN, V69, P3556, DOI 10.1128/IAI.69.6.3556-3561.2001; Davis WC, 1996, VET IMMUNOL IMMUNOP, V52, P275, DOI 10.1016/0165-2427(96)05578-X; Diez-Fraile A, 2002, VET IMMUNOL IMMUNOP, V86, P1, DOI 10.1016/S0165-2427(01)00432-9; Foote MR, 2005, J DAIRY SCI, V88, P2718, DOI 10.3168/jds.S0022-0302(05)72951-9; GLASS EJ, 1990, J IMMUNOL METHODS, V128, P267, DOI 10.1016/0022-1759(90)90219-L; Guzman E, 2014, J IMMUNOL, V193, P208, DOI 10.4049/jimmunol.1303398; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Harbo SJ, 2004, VET CLIN PATH, V33, P163, DOI 10.1111/j.1939-165X.2004.tb00368.x; Hoek A, 2009, VET RES, V40, DOI 10.1051/vetres:2008044; Hothorn T, 2008, J STAT SOFTW, V28, P1; HOWARD CJ, 1991, VET IMMUNOL IMMUNOP, V27, P21, DOI 10.1016/0165-2427(91)90072-K; HOWARD CJ, 1992, IMMUNOLOGY, V77, P228; Hussen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071502; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; Jee JB, 2004, J CLIN MICROBIOL, V42, P5664, DOI 10.1128/JCM.42.12.5664-5672.2004; Jendro MC, 2000, INFECT IMMUN, V68, P6704, DOI 10.1128/IAI.68.12.6704-6711.2000; Kaltenboeck B, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0832-4; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kemmerling K, 2009, J DAIRY SCI, V92, P4347, DOI 10.3168/jds.2009-2051; Knittler MR, 2014, INT J MED MICROBIOL, V304, P877, DOI 10.1016/j.ijmm.2014.06.010; Langelaar MFM, 2005, VET IMMUNOL IMMUNOP, V107, P153, DOI 10.1016/j.vetimm.2005.04.009; LUNDJOHANSEN F, 1993, J LEUKOCYTE BIOL, V54, P47, DOI 10.1002/jlb.54.1.47; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; McBride JW, 1999, VET IMMUNOL IMMUNOP, V67, P161, DOI 10.1016/S0165-2427(98)00218-9; McBride JW, 1997, VET IMMUNOL IMMUNOP, V58, P55, DOI 10.1016/S0165-2427(96)05777-7; Menge C, 2008, J DAIRY SCI, V91, P2284, DOI 10.3168/jds.2007-0937; Mitchell GB, 2003, INFECT IMMUN, V71, P1643, DOI 10.1128/IAI.71.4.1643-1649.2003; Mohle K, 2011, HOST PATHOGEN INTERA; NAESSENS J, 1992, IMMUNOLOGY, V76, P305; Olivier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030430; Ostermann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064066; Ostermann C, 2013, VET J, V196, P351, DOI 10.1016/j.tvjl.2012.10.035; Otter P, 2003, VET REC, V152, P787; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Prohl A, 2015, PATHOG DIS, V73, DOI 10.1111/2049-632X.12212; Prohl A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119736; Prohl A, 2014, JOVE-J VIS EXP, DOI 10.3791/51557; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rank RG, 2012, INFECT IMMUN, V80, P612, DOI 10.1128/IAI.06054-11; Raymond CR, 2005, VET IMMUNOL IMMUNOP, V107, P235, DOI 10.1016/j.vetimm.2005.05.008; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Saalmuller A, 2007, VET IMMUNOL IMMUNOP, V119, P2, DOI 10.1016/j.vetimm.2007.06.009; Sachse K, 2009, VET MICROBIOL, V135, P22, DOI 10.1016/j.vetmic.2008.09.041; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Storz J, 1993, RICKETTSIAL CHLAMYDI, P27; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Twomey DF, 2006, VET J, V171, P574, DOI 10.1016/j.tvjl.2004.12.012; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zoldan K, 2014, DEV COMP IMMUNOL, V47, P254, DOI 10.1016/j.dci.2014.08.002	60	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135161	10.1371/journal.pone.0135161	http://dx.doi.org/10.1371/journal.pone.0135161			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252769	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100127
J	Rovatsos, M; Kratochvil, L; Altmanova, M; Pokorna, MJ				Rovatsos, Michail; Kratochvil, Lukas; Altmanova, Marie; Pokorna, Martina Johnson			Interstitial Telomeric Motifs in Squamate Reptiles: When the Exceptions Outnumber the Rule	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DIPLOID CHROMOSOME-NUMBER; SEQUENCE (T(2)AG(3))(N); MACROPODOIDEA MARSUPIALIA; (TTAGGG)(N) SEQUENCES; NONTELOMERIC SITES; BANDING-PATTERNS; FISSION YEAST; GREEN ANOLE; EVOLUTION	Telomeres are nucleoprotein complexes protecting the physical ends of linear eukaryotic chromosomes and therefore helping to ensure their stability and integrity. Additionally, telomeric sequences can be localized in non-terminal regions of chromosomes, forming so-called interstitial telomeric sequences (ITSs). ITSs are traditionally considered to be relics of chromosomal rearrangements and thus very informative in the reconstruction of the evolutionary history of karyotype formation. We examined the distribution of the telomeric motifs (TTAGGG)(n) using fluorescence in situ hybridization (FISH) in 30 species, representing 17 families of squamate reptiles, and compared them with the collected data from another 38 species from literature. Out of the 68 squamate species analyzed, 35 possess ITSs in pericentromeric regions, centromeric regions and/or within chromosome arms. We conclude that the occurrence of ITSs is rather common in squamates, despite their generally conserved karyotypes, suggesting frequent and independent cryptic chromosomal rearrangements in this vertebrate group.	[Rovatsos, Michail; Kratochvil, Lukas; Altmanova, Marie; Pokorna, Martina Johnson] Charles Univ Prague, Fac Sci, Dept Ecol, CR-12844 Prague, Czech Republic; [Pokorna, Martina Johnson] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Libechov 27721, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Kratochvil, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, CR-12844 Prague, Czech Republic.	lukas.kratochvil@natur.cuni.cz	Altmanova, Marie/C-9645-2015; Kratochvíl, Lukáš/A-1997-2008; Kratochvil, Lukas/M-2134-2019; Pokorna, Martina Johnson/C-8274-2013; Rovatsos, Michail/D-3559-2013	Altmanova, Marie/0000-0001-7193-8918; Kratochvíl, Lukáš/0000-0002-3515-729X; Pokorna, Martina Johnson/0000-0003-1499-2170; Rovatsos, Michail/0000-0002-8429-5680	Czech Science Foundation [506/10/0718]; Grant Agency of Charles University [GAUK 591712]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University	This project was supported by the Czech Science Foundation (506/10/0718) and the Grant Agency of Charles University (GAUK 591712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Amrichova J, 2003, EXP CELL RES, V289, P11, DOI 10.1016/S0014-4827(03)00208-8; Azzalin CM, 2001, CHROMOSOMA, V110, P75, DOI 10.1007/s004120100135; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bertolotto CEV, 2001, CARYOLOGIA, V54, P217, DOI 10.1080/00087114.2001.10589229; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blackburn EH, 1995, TELOMERES; Bolzan AD, 2006, MUTAT RES-REV MUTAT, V612, P189, DOI 10.1016/j.mrrev.2005.12.003; Christiansen JL, 2001, P IOWA SPACE GRANT C, V2001, P1; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Ezaz T., 2014, ADV EVOL BIOL, DOI [10.1155/2014/104683, DOI 10.3389/FGENE.2018.00071]; Farre M, 2009, CYTOGENET GENOME RES, V124, P128, DOI 10.1159/000207517; Gamble T, 2014, EVOLUTION, V68, P1027, DOI 10.1111/evo.12328; Garagna S, 1997, CHROMOSOME RES, V5, P487, DOI 10.1023/A:1018425215516; Giovannotti M, 2009, CYTOGENET GENOME RES, V127, P224, DOI 10.1159/000295002; Gomes NMV, 2010, FEBS LETT, V584, P3741, DOI 10.1016/j.febslet.2010.07.031; Gorman G.C., 1973, P349; Gornung E, 2013, COMP CYTOGENET, V7, P153, DOI 10.3897/CompCytogen.v7i2.4881; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; King M, 1991, EVOLUTION SPECIATION, P262; Koubova M, 2014, CHROMOSOME RES, V22, P441, DOI 10.1007/s10577-014-9430-z; Laguna MM, 2010, GENET MOL BIOL, V33, P57, DOI 10.1590/S1415-47572010005000009; LEE C, 1993, CYTOGENET CELL GENET, V63, P156, DOI 10.1159/000133525; Lin KW, 2008, MUTAT RES-REV MUTAT, V658, P95, DOI 10.1016/j.mrrev.2007.08.006; Lithgow PE, 2014, CHROMOSOME RES, V22, P85, DOI 10.1007/s10577-014-9412-1; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Luderus ME, 1996, J CELL BIOL, V135, P867, DOI 10.1083/jcb.135.4.867; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; Maddison WP, 2011, MESQUITE MODULAR SYS; MATTHEY R., 1931, REV SUISSE ZOOL, V38, P117; Metcalfe CJ, 2007, CYTOGENET GENOME RES, V116, P212, DOI 10.1159/000098189; Metcalfe CJ, 2002, CYTOGENET GENOME RES, V96, P169, DOI 10.1159/000063037; Metcalfe CJ, 1998, CHROMOSOME RES, V6, P603, DOI 10.1023/A:1009249325574; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nagamachi CY, 2013, CHROMOSOME RES, V21, P107, DOI 10.1007/s10577-013-9341-4; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Nergadze SG, 2004, GENOME RES, V14, P1704, DOI 10.1101/gr.2778904; Nergadze SG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r260; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pellegrino KCM, 2009, CYTOGENET GENOME RES, V127, P191, DOI 10.1159/000295175; Pellegrino KCM, 1999, HEREDITAS, V131, P15, DOI 10.1111/j.1601-5223.1999.00015.x; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Pokorna M, 2012, CHROMOSOMA, V121, P409, DOI 10.1007/s00412-012-0371-z; Pokorna M, 2011, CHROMOSOMA, V120, P455, DOI 10.1007/s00412-011-0322-0; Pokorna M, 2010, CHROMOSOME RES, V18, P809, DOI 10.1007/s10577-010-9154-7; Pokorna MJ, 2015, CHROMOSOME RES, V23, P299, DOI 10.1007/s10577-015-9468-6; Pokorna MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104716; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rojo V, 2014, CYTOGENET GENOME RES, V142, P28, DOI 10.1159/000356049; Rovatsos MT, 2011, CHROMOSOME RES, V19, P869, DOI 10.1007/s10577-011-9242-3; Rovatsos M, 2014, G3-GENES GENOM GENET, V4, P2107, DOI 10.1534/g3.114.014084; Rovatsos M, 2014, EVOLUTION, V68, P2079, DOI 10.1111/evo.12357; Rovatsos M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1093; Rovatsos MT, 2014, CYTOGENET GENOME RES, V144, P131, DOI 10.1159/000368648; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; SCHMID M, 1994, J HERED, V85, P255, DOI 10.1093/oxfordjournals.jhered.a111452; Schmid M, 2014, CYTOGENET GENOME RES, V144, P47, DOI 10.1159/000367929; Skinner BM, 2012, HEREDITY, V108, P37, DOI 10.1038/hdy.2011.99; Slijepcevic P, 1998, CHROMOSOMA, V107, P136, DOI 10.1007/s004120050289; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2011, GENET MOL BIOL, V34, P582, DOI 10.1590/S1415-47572011005000042; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; Ventura K, 2006, CYTOGENET GENOME RES, V115, P169, DOI 10.1159/000095238; Volker M, 2010, GENOME RES, V20, P503, DOI 10.1101/gr.103663.109; WILEY JE, 1992, CYTOGENET CELL GENET, V61, P55, DOI 10.1159/000133368; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	81	53	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134985	10.1371/journal.pone.0134985	http://dx.doi.org/10.1371/journal.pone.0134985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252002	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100098
J	Salmon, M; Salmon, C; Bissinger, A; Muller, MM; Gebreyesus, A; Geremew, H; Wendell, S; Azaza, A; Salumu, M; Benfield, N				Salmon, Margaret; Salmon, Christian; Bissinger, Alexa; Muller, Mundenga Mutendi; Gebreyesus, Alegnta; Geremew, Haimanot; Wendell, Sarah; Azaza, Aklilu; Salumu, Maurice; Benfield, Nerys			Alternative Ultrasound Gel for a Sustainable Ultrasound Program: Application of Human Centered Design	PLOS ONE			English	Article							OIL	This paper describes design of a low cost, ultrasound gel from local products applying aspects of Human Centered Design methodology. A multidisciplinary team worked with clinicians who use ultrasound where commercial gel is cost prohibitive and scarce. The team followed the format outlined in the Ideo Took Kit. Research began by defining the challenge "how to create locally available alternative ultrasound gel for a low-resourced environment? The "End-Users," were identified as clinicians who use ultrasound in Democratic Republic of the Congo and Ethiopia. An expert group was identified and queried for possible alternatives to commercial gel. Responses included shampoo, oils, water and cornstarch. Cornstarch, while a reasonable solution, was either not available or too expensive. We then sought deeper knowledge of locally sources materials from local experts, market vendors, to develop a similar product. Suggested solutions gleaned from these interviews were collected and used to create ultrasound gel accounting for cost, image quality, manufacturing capability. Initial prototypes used cassava root flour from Great Lakes Region (DRC, Rwanda, Uganda, Tanzania) and West Africa, and bula from Ethiopia. Prototypes were tested in the field and resulting images evaluated by our user group. A final prototype was then selected. Cassava and bula at a 32 part water, 8 part flour and 4 part salt, heated, mixed then cooled was the product design of choice.	[Salmon, Margaret] Univ Toronto, Univ Hlth Network, Dept Emergency Med, Toronto, ON, Canada; [Salmon, Christian] Western New England Univ, Dept Ind Engn & Engn Management, Springfield, MA USA; [Bissinger, Alexa] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Muller, Mundenga Mutendi] HEAL Africa Hosp, Dept Emergency Med, Goma, DEM REP CONGO; [Gebreyesus, Alegnta] Black Lion Hosp, Dept Emergency Med, Addis Ababa, Ethiopia; [Geremew, Haimanot] Black Lion Hosp, Emergency Med Res Ctr, Addis Ababa, Ethiopia; [Wendell, Sarah] Georgetown Univ, Sch Med, Washington, DC USA; [Azaza, Aklilu] Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Dept Emergency Med, Addis Ababa, Ethiopia; [Salumu, Maurice] Kindu Gen Hosp, Dept Internal Med, Kindu, DEM REP CONGO; [Benfield, Nerys] Yeshiva Univ, Albert Einstein Coll Med, Dept Obstet & Gynecol, New York, NY 10033 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western New England University; University of California System; University of California San Francisco; Georgetown University; Addis Ababa University; Yeshiva University	Salmon, M (corresponding author), Univ Toronto, Univ Hlth Network, Dept Emergency Med, Toronto, ON, Canada.	margiesalmon@gmail.com						[Anonymous], 2013, HUMAN CENTERED DESIG; Binkowski A, 2014, J EMERG MED, V47, pE5, DOI 10.1016/j.jemermed.2013.08.073; Gorny KR, 2007, PHYS MED BIOL, V52, pN13, DOI 10.1088/0031-9155/52/1/N02; Groen RS, 2011, TROP MED INT HEALTH, V16, P1525, DOI 10.1111/j.1365-3156.2011.02868.x; IFEM, 2014, POINT CAR ULT CURR G; Luewan Suchaya, 2007, Journal of the Medical Association of Thailand, V90, P624; Lutz H., 2011, MAN DIAGN ULTR; Niwke N, 2013, P VAL CASS AFR P FOO; Shah SP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-4; Sippel S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-72; Spencer JK, 2008, J ULTRAS MED, V27, P1735, DOI 10.7863/jum.2008.27.12.1735; Steinmetz JP, 1999, AM J TROP MED HYG, V60, P119, DOI 10.4269/ajtmh.1999.60.119; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	13	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134332	10.1371/journal.pone.0134332	http://dx.doi.org/10.1371/journal.pone.0134332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252003	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100050
J	Tachibana, SI; Touhara, K; Ejima, A				Tachibana, Shin-Ichiro; Touhara, Kazushige; Ejima, Aki			Modification of Male Courtship Motivation by Olfactory Habituation via the GABA(A) Receptor in Drosophila melanogaster	PLOS ONE			English	Article							CIS-VACCENYL ACETATE; LOCAL INTERNEURONS; GABAERGIC INTERNEURONS; INDUCED RESPONSES; ANTENNAL LOBE; NEURONS; PHEROMONE; INHIBITION; PLASTICITY; CELLS	A male-specific component, 11-cis-vaccenyl acetate (cVA) works as an anti-aphrodisiac pheromone in Drosophila melanogaster. The presence of cVA on a male suppresses the courtship motivation of other males and contributes to suppression of male-male homosexual courtship, while the absence of cVA on a female stimulates the sexual motivation of nearby males and enhances the male-female interaction. However, little is known how a male distinguishes the presence or absence of cVA on a target fly from either self-produced cVA or secondhand cVA from other males in the vicinity. In this study, we demonstrate that male flies have keen sensitivity to cVA; therefore, the presence of another male in the area reduces courtship toward a female. This reduced level of sexual motivation, however, could be overcome by pretest odor exposure via olfactory habituation to cVA. Real-time imaging of cVA-responsive sensory neurons using the neural activity sensor revealed that prolonged exposure to cVA decreased the levels of cVA responses in the primary olfactory center. Pharmacological and genetic screening revealed that signal transduction via GABA(A) receptors contributed to this olfactory habituation. We also found that the habituation experience increased the copulation success of wild-type males in a group. In contrast, transgenic males, in which GABA input in a small subset of local neurons was blocked by RNAi, failed to acquire the sexual advantage conferred by habituation. Thus, we illustrate a novel phenomenon in which olfactory habituation positively affects sexual capability in a competitive environment.	[Tachibana, Shin-Ichiro; Ejima, Aki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Tachibana, Shin-Ichiro] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan; [Touhara, Kazushige; Ejima, Aki] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Touhara, Kazushige; Ejima, Aki] Univ Tokyo, ERATO Touhara Chemosensory Signal Project, JST, Tokyo 1138657, Japan	Kyoto University; Osaka Metropolitan University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Ejima, A (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan.	aki@mail.ecc.u-tokyo.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI Grant [22680026, 23657055, 25115008]; ERATO Touhara Chemosensory Signal Project from JST	JSPS (Japan Society for the Promotion of Science) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ERATO Touhara Chemosensory Signal Project from JST	This work was funded by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers 22680026, 23657055, 25115008 to AE, and the ERATO Touhara Chemosensory Signal Project from JST to KT and AE (https://www.jsps.go.jp/english/index.html; http://www.jst.go.jp/EN/index.html).	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BRIEGER G, 1970, Science (Washington D C), V167, P1262, DOI 10.1126/science.167.3922.1262; Bristol AS, 2005, LEARN MEMORY, V12, P52, DOI 10.1101/lm.83405; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Chertemps T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-56; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; de Bruyne M, 1999, J NEUROSCI, V19, P4520; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Eastwood L, 1977, NEURON, V82, P1216; Eisenstein EM, 2001, INTEGR PHYS BEH SCI, V36, P251, DOI 10.1007/BF02688794; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2011, COLD SPRING HARB PRO; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ejima A, 2015, J COMP PHYSIOL A, V201, P927, DOI 10.1007/s00359-015-1020-9; Engel JE, 2009, NEUROBIOL LEARN MEM, V92, P166, DOI 10.1016/j.nlm.2008.08.003; Feng GP, 1996, J NEUROSCI, V16, P3925; FERRERMONTIEL AV, 1995, P NATL ACAD SCI USA, V92, P8021, DOI 10.1073/pnas.92.17.8021; Fischer TM, 1997, NATURE, V389, P860, DOI 10.1038/39892; GAILEY DA, 1982, GENETICS, V102, P771; Giles AC, 2009, NEUROBIOL LEARN MEM, V92, P139, DOI 10.1016/j.nlm.2008.08.004; Glanzman DL, 2009, NEUROBIOL LEARN MEM, V92, P147, DOI 10.1016/j.nlm.2009.03.005; Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Huang J, 2010, NEURON, V67, P1021, DOI 10.1016/j.neuron.2010.08.025; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Koh TW, 2014, NEURON, V83, P850, DOI 10.1016/j.neuron.2014.07.012; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Liu WW, 2013, CURR BIOL, V23, P1202, DOI 10.1016/j.cub.2013.05.016; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Martin JR, 1998, LEARN MEMORY, V5, P179; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Murmu MS, 2010, J EXP BIOL, V213, P4163, DOI 10.1242/jeb.046474; ODELL KMC, 1994, BEHAV GENET, V24, P381, DOI 10.1007/BF01067539; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; R Core Team, 2021, R LANGUAGE ENV STAT; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Sachse S, 2007, NEURON, V56, P838, DOI 10.1016/j.neuron.2007.10.035; Sadanandappa MK, 2013, J NEUROSCI, V33, P16576, DOI 10.1523/JNEUROSCI.3142-13.2013; Scott D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023645; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Slawson JB, 2011, GENETICS, V187, P171, DOI 10.1534/genetics.110.123406; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; VANDERMEER RK, 1986, J INSECT PHYSIOL, V32, P681, DOI 10.1016/0022-1910(86)90109-5; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	83	6	6	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135186	10.1371/journal.pone.0135186	http://dx.doi.org/10.1371/journal.pone.0135186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252206	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100131
J	Christensen, AB; Herman, JL; Elphick, MR; Kober, KM; Janies, D; Linchangco, G; Semmens, DC; Bailly, X; Vinogradov, SN; Hoogewijs, D				Christensen, Ana B.; Herman, Joseph L.; Elphick, Maurice R.; Kober, Kord M.; Janies, Daniel; Linchangco, Gregorio; Semmens, Dean C.; Bailly, Xavier; Vinogradov, Serge N.; Hoogewijs, David			Phylogeny of Echinoderm Hemoglobins	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; COOPERATIVE DIMERIC HEMOGLOBIN; SEA-CUCUMBER; GLOBIN GENE; OXYGEN EQUILIBRIUM; ALIGNMENT; GENOME; MODEL; CYTOGLOBIN; EVOLUTION	Background Recent genomic information has revealed that neuroglobin and cytoglobin are the two principal lineages of vertebrate hemoglobins, with the latter encompassing the familiar myoglobin and alpha-globin/beta-globin tetramer hemoglobin, and several minor groups. In contrast, very little is known about hemoglobins in echinoderms, a phylum of exclusively marine organisms closely related to vertebrates, beyond the presence of coelomic hemoglobins in sea cucumbers and brittle stars. We identified about 50 hemoglobins in sea urchin, starfish and sea cucumber genomes and transcriptomes, and used Bayesian inference to carry out a molecular phylogenetic analysis of their relationship to vertebrate sequences, specifically, to assess the hypothesis that the neuroglobin and cytoglobin lineages are also present in echinoderms. Results The genome of the sea urchin Strongylocentrotus purpuratus encodes several hemoglobins, including a unique chimeric 14-domain globin, 2 androglobin isoforms and a unique single androglobin domain protein. Other strongylocentrotid genomes appear to have similar repertoires of globin genes. We carried out molecular phylogenetic analyses of 52 hemoglobins identified in sea urchin, brittle star and sea cucumber genomes and transcriptomes, using different multiple sequence alignment methods coupled with Bayesian and maximum likelihood approaches. The results demonstrate that there are two major globin lineages in echinoderms, which are related to the vertebrate neuroglobin and cytoglobin lineages. Furthermore, the brittle star and sea cucumber coelomic hemoglobins appear to have evolved independently from the cytoglobin lineage, similar to the evolution of erythroid oxygen binding globins in cyclostomes and vertebrates. Conclusion The presence of echinoderm globins related to the vertebrate neuroglobin and cytoglobin lineages suggests that the split between neuroglobins and cytoglobins occurred in the deuterostome ancestor shared by echinoderms and vertebrates.	[Christensen, Ana B.] Lamar Univ, Dept Biol, Beaumont, TX 77710 USA; [Herman, Joseph L.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Herman, Joseph L.] Natl Inst Med Res, Div Math Biol, London NW7 1AA, England; [Elphick, Maurice R.; Semmens, Dean C.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Kober, Kord M.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Janies, Daniel; Linchangco, Gregorio] Univ N Carolina, Coll Comp & Informat, Charlotte, NC 28223 USA; [Bailly, Xavier] Stn Biol Roscoff, Marine Plants & Biomol, F-2968 Roscoff, France; [Vinogradov, Serge N.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Hoogewijs, David] Univ Duisburg Essen, Inst Physiol, Essen, Germany	Texas State University System; Lamar University; University of Oxford; MRC National Institute for Medical Research; University of London; Queen Mary University London; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Charlotte; UDICE-French Research Universities; Sorbonne Universite; Wayne State University; University of Duisburg Essen	Hoogewijs, D (corresponding author), Univ Duisburg Essen, Inst Physiol, Essen, Germany.	david.hoogewijs@uni-due.de	Hoogewijs, David/L-5144-2016; Semmens, Dean C/E-5897-2013; Kober, Kord/ABF-2657-2020	Semmens, Dean C/0000-0002-7933-805X; Kober, Kord/0000-0001-9732-3321; Elphick, Maurice/0000-0002-9169-0048; Christensen, Ana/0000-0003-2513-7479	National Science Foundation [1036416]; Division Of Environmental Biology [1322141] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under Grant Number 1036416, "Collaborative Research: Assembling the Echinoderm Tree of Life". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bailly X, 2008, DIOXYGEN BINDING AND; BAKER SM, 1993, BIOL BULL-US, V185, P115, DOI 10.2307/1542135; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; BONAVENTURA C, 1976, BIOCHIM BIOPHYS ACTA, V428, P779, DOI 10.1016/0304-4165(76)90209-9; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Challis CJ, 2012, MOL BIOL EVOL, V29, P3575, DOI 10.1093/molbev/mss167; Christensen AB, 2013, ECHINODERMS IN A CHANGING WORLD, P127; Christensen A. B., 1998, American Zoologist, V38, p120A; Christensen AB, 2003, BIOL BULL-US, V205, P54, DOI 10.2307/1543445; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Droge J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-54; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foettinger A, 1880, ARCH BIOL, V1, P405; Fuchs C, 2006, CYTOGENET GENOME RES, V112, P296, DOI 10.1159/000089884; HAJDUK SL, 1975, AM ZOOL, V15, P808; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herman JL, 2014, MOL BIOL EVOL, V31, P2251, DOI 10.1093/molbev/msu184; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Hoffmann FG, 2011, GENOME BIOL EVOL, V3, P588, DOI 10.1093/gbe/evr055; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Hoogewijs D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031856; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hyman L.H., 1955, THE INVERTEBRATES, VIV; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kitto GB, 1998, J EXP ZOOL, V282, P120, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2<120::AID-JEZ13>3.0.CO;2-Y; Kober KM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-88; Kondo M, 2012, CURR GENOMICS, V13, P134, DOI 10.2174/138920212799860643; Kugelstadt D, 2004, BIOCHEM BIOPH RES CO, V325, P719, DOI 10.1016/j.bbrc.2004.10.080; Lankester E.R, 1872, P ROY SOC LONDON, V21, P70; Lawrence J. M., 1987, FUNCTIONAL BIOL ECHI, DOI 10.1002/iroh.19890740316; Lechauve C, 2013, J BIOL CHEM, V288, P6957, DOI 10.1074/jbc.M112.407601; Mangum CP, 1992, ADV COMP ENVIRON PHY, V13, P118; MANWELL C, 1960, ANNU REV PHYSIOL, V22, P191, DOI 10.1146/annurev.ph.22.030160.001203; MANWELL C, 1959, J CELL COMPAR PHYSL, V53, P75, DOI 10.1002/jcp.1030530108; MANWELL C, 1966, SCIENCE, V152, P1393, DOI 10.1126/science.152.3727.1393; MAURI F, 1991, BIOCHIM BIOPHYS ACTA, V1078, P63, DOI 10.1016/0167-4838(91)90093-F; MCDONALD GD, 1992, J PROTEIN CHEM, V11, P29, DOI 10.1007/BF01025089; Miller M.A., 2010, P GAT COMP ENV WORKS; MITCHELL DT, 1995, J MOL BIOL, V251, P421, DOI 10.1006/jmbi.1995.0445; Mulcrone RS, 2005, ECHINODERMATA; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; PARKHURST LJ, 1979, BIOCHEMISTRY-US, V18, P4651, DOI 10.1021/bi00588a028; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rowe ML, 2012, GEN COMP ENDOCR, V179, P331, DOI 10.1016/j.ygcen.2012.09.009; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith DR, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-7; Smith VJ, 1981, VERTEBRATE BLOOD CEL, P513; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEINMEIER RC, 1979, BIOCHEMISTRY-US, V18, P4645, DOI 10.1021/bi00588a027; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; SUZUKI T, 1989, BIOCHIM BIOPHYS ACTA, V998, P292, DOI 10.1016/0167-4838(89)90287-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERWILLIGER RC, 1972, COMP BIOCHEM PHYSIOL, V42, P65, DOI 10.1016/0305-0491(72)90059-4; TERWILLIGER RC, 1975, BIOCHIM BIOPHYS ACTA, V386, P62, DOI 10.1016/0005-2795(75)90246-9; Terwilliger RC, 1998, ECHINODERM BIOLOGY P, P589; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; Vinogradov SN, 2013, ADV MICROB PHYSIOL, V63, P391, DOI 10.1016/B978-0-12-407693-8.00009-1; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Vinogradov SN, 2011, MOL PLANT, V4, P42, DOI 10.1093/mp/ssq040; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762	81	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0129668	10.1371/journal.pone.0129668	http://dx.doi.org/10.1371/journal.pone.0129668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247465	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300004
J	Malfacini, D; Ambrosio, C; Gro', MC; Sbraccia, M; Trapella, C; Guerrini, R; Bonora, M; Pinton, P; Costa, T; Calo, G				Malfacini, D.; Ambrosio, C.; Gro', M. C.; Sbraccia, M.; Trapella, C.; Guerrini, R.; Bonora, M.; Pinton, P.; Costa, T.; Calo, G.			Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and beta-Arrestins 2	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; IN-VITRO; COUPLED RECEPTORS; REGULATED INTERNALIZATION; CONSTITUTIVE ACTIVATION; SELECTIVE ANTAGONIST; PARTIAL AGONIST; BIASED AGONISM; ORPHANIN-FQ; MORPHINE	Nociceptin/orphanin FQ (N/OFQ) controls several biological functions by selectively activating an opioid like receptor named N/OFQ peptide receptor (NOP). Biased agonism is emerging as an important and therapeutically relevant pharmacological concept in the field of G protein coupled receptors including opioids. To evaluate the relevance of this phenomenon in the NOP receptor, we used a bioluminescence resonance energy transfer technology to measure the interactions of the NOP receptor with either G proteins or beta-arrestin 2 in the absence and in presence of increasing concentration of ligands. A large panel of receptor ligands was investigated by comparing their ability to promote or block NOP/G protein and NOP/arrestin interactions. In this study we report a systematic analysis of the functional selectivity of NOP receptor ligands. NOP/G protein interactions (investigated in cell membranes) allowed a precise estimation of both ligand potency and efficacy yielding data highly consistent with the known pharmacological profile of this receptor. The same panel of ligands displayed marked differences in the ability to promote NOP/beta-arrestin 2 interactions (evaluated in whole cells). In particular, full agonists displayed a general lower potency and for some ligands an inverted rank order of potency was noted. Most partial agonists behaved as pure competitive antagonists of receptor/arrestin interaction. Antagonists displayed similar values of potency for NOP/G beta 1 or NOP/beta-arrestin 2 interaction. Using N/OFQ as reference ligand we computed the bias factors of NOP ligands and a number of agonists with greater efficacy at G protein coupling were identified.	[Malfacini, D.; Calo, G.] Univ Ferrara, Pharmacol Sect, Dept Med Sci, I-44100 Ferrara, Italy; [Malfacini, D.; Calo, G.] Univ Ferrara, Natl Inst Neurosci, I-44100 Ferrara, Italy; [Ambrosio, C.; Gro', M. C.; Sbraccia, M.; Costa, T.] Ist Super Sanita, Dept Pharmacol, I-00161 Rome, Italy; [Trapella, C.; Guerrini, R.] Univ Ferrara, Dept Chem & Pharmaceut Sci, I-44100 Ferrara, Italy; [Trapella, C.; Guerrini, R.; Bonora, M.; Pinton, P.] Univ Ferrara, LTTA, I-44100 Ferrara, Italy; [Bonora, M.; Pinton, P.] Univ Ferrara, Dept Morphol Surg & Expt Med, Sect Pathol Oncol & Expt Biol, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; Istituto Superiore di Sanita (ISS); University of Ferrara; University of Ferrara; University of Ferrara	Calo, G (corresponding author), Univ Ferrara, Pharmacol Sect, Dept Med Sci, I-44100 Ferrara, Italy.	g.calo@unife.it	Pinton, Paolo/J-8025-2012; Trapella, Claudio/I-2128-2012; Bonora, Massimo/AAC-3609-2022; costa, tommaso/AAD-3714-2019; ambrosio, caterina/M-7952-2017	Pinton, Paolo/0000-0001-7108-6508; Trapella, Claudio/0000-0002-6666-143X; Bonora, Massimo/0000-0002-5752-3318; costa, tommaso/0000-0002-8729-3357; Malfacini, Davide/0000-0003-4562-9550; ambrosio, caterina/0000-0002-0807-9003; gro, maria cristina/0000-0001-9106-2191	Italian Ministry of University [RBFR109SBM]; University of Ferrara (FAR grant)	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); University of Ferrara (FAR grant)	This work was supported by funds from the Italian Ministry of University (RBFR109SBM FIRB grant to CT), and the University of Ferrara (FAR grant to GC).	Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Arduin M, 2007, BIOORGAN MED CHEM, V15, P4434, DOI 10.1016/j.bmc.2007.04.026; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2002, J NEUROSCI, V22, P10494; Calo G, 2000, PEPTIDES, V21, P935, DOI 10.1016/S0196-9781(00)00230-8; Calo G, 2005, CNS DRUG REV, V11, P97; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; Calo' G, 2000, BRIT J PHARMACOL, V129, P1183, DOI 10.1038/sj.bjp.0703169; Calo' G, 2013, ACS SYM SER, V1131, P275; Chen XT, 2013, J MED CHEM, V56, P8019, DOI 10.1021/jm4010829; Cheng ZJ, 1997, NEUROREPORT, V8, P1913, DOI 10.1097/00001756-199705260-00024; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Dooley CT, 1997, J PHARMACOL EXP THER, V283, P735; Felker GM, 2015, JACC-HEART FAIL, V3, P193, DOI 10.1016/j.jchf.2014.09.008; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Filizola M, 2013, TRENDS PHARMACOL SCI, V34, P6, DOI 10.1016/j.tips.2012.10.002; Fischetti C, 2009, EUR J PHARMACOL, V614, P50, DOI 10.1016/j.ejphar.2009.04.054; Furchgott RF, 1966, ADVANCES IN DRUG RES; Goto Y, 2006, J MED CHEM, V49, P847, DOI 10.1021/jm0509851; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; Guerrini R, 1997, J MED CHEM, V40, P1789, DOI 10.1021/jm970011b; Guerrini R, 1998, BRIT J PHARMACOL, V123, P163, DOI 10.1038/sj.bjp.0701640; Guerrini R, 2014, BIOORGAN MED CHEM, V22, P3703, DOI 10.1016/j.bmc.2014.05.005; Hu E, 2010, PAIN, V148, P107, DOI 10.1016/j.pain.2009.10.026; Kam KWL, 2002, J NEUROCHEM, V83, P1461, DOI 10.1046/j.1471-4159.2002.01231.x; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kawamoto H, 1999, J MED CHEM, V42, P5061, DOI 10.1021/jm990517p; KENAKIN TP, 1982, J PHARMACOL EXP THER, V220, P77; Kenakin TP, 2014, PHARM PRIMER, P119; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lamberts JT, 2013, CURR PHARM DESIGN, V19, P7333; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Mahmoud S, 2010, MOL PHARMACOL, V77, P804, DOI 10.1124/mol.109.062208; Margas W, 2008, J NEUROPHYSIOL, V100, P1420, DOI 10.1152/jn.90405.2008; McDonald J, 2003, BRIT J PHARMACOL, V140, P61, DOI 10.1038/sj.bjp.0705401; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; Molinari P, 2008, BIOCHEM J, V409, P251, DOI 10.1042/BJ20070803; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Mustazza C, 2011, MED RES REV, V31, P605, DOI 10.1002/med.20197; Okada K, 2000, BIOCHEM BIOPH RES CO, V278, P493, DOI 10.1006/bbrc.2000.3822; Onaran HO, 2014, TRENDS PHARMACOL SCI, V35, P639, DOI 10.1016/j.tips.2014.09.010; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rizzi A, 2014, BRIT J PHARMACOL, V171, P4138, DOI 10.1111/bph.12799; Rizzi A, 2007, PEPTIDES, V28, P1240, DOI 10.1016/j.peptides.2007.04.020; Schroder W, 2014, BRIT J PHARMACOL, V171, P3777, DOI 10.1111/bph.12744; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Spagnolo B, 2007, J PHARMACOL EXP THER, V321, P961, DOI 10.1124/jpet.106.116764; Spampinato S, 2007, CURR DRUG TARGETS, V8, P137, DOI 10.2174/138945007779315641; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; VACHON L, 1987, BIOCHEM PHARMACOL, V36, P2889, DOI 10.1016/0006-2952(87)90199-7; Varty GB, 2008, J PHARMACOL EXP THER, V326, P672, DOI 10.1124/jpet.108.136937; Vezzi V, 2013, J BIOL CHEM, V288, P23964, DOI 10.1074/jbc.M113.474452; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wichmann J, 1999, BIOORG MED CHEM LETT, V9, P2343, DOI 10.1016/S0960-894X(99)00385-6; Zaratin PF, 2004, J PHARMACOL EXP THER, V308, P454, DOI 10.1124/jpet.103.055848; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhang NR, 2012, J BIOL CHEM, V287, P42019, DOI 10.1074/jbc.M112.405696	65	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0132865	10.1371/journal.pone.0132865	http://dx.doi.org/10.1371/journal.pone.0132865			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248189	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300009
J	McDonnell, TC; Sloat, MR; Sullivan, TJ; Dolloff, CA; Hessburg, PF; Povak, NA; Jackson, WA; Sams, C				McDonnell, T. C.; Sloat, M. R.; Sullivan, T. J.; Dolloff, C. A.; Hessburg, P. F.; Povak, N. A.; Jackson, W. A.; Sams, C.			Downstream Warming and Headwater Acidity May Diminish Coldwater Habitat in Southern Appalachian Mountain Streams	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; CLIMATE-CHANGE; WATER; TEMPERATURE; MODELS	Stream-dwelling species in the U.S. southern Appalachian Mountains region are particularly vulnerable to climate change and acidification. The objectives of this study were to quantify the spatial extent of contemporary suitable habitat for acid-and thermally sensitive aquatic species and to forecast future habitat loss resulting from expected temperature increases on national forest lands in the southern Appalachian Mountain region. The goal of this study was to help watershed managers identify and assess stream reaches that are potentially vulnerable to warming, acidification, or both. To our knowledge, these results represent the first regional assessment of aquatic habitat suitability with respect to the combined effects of stream water temperature and acid-base status in the United States. Statistical models were developed to predict July mean daily maximum water temperatures and air-water temperature relations to determine potential changes in future stream water temperatures. The length of stream considered suitable habitat for acid-and thermally sensitive species, based on temperature and acid neutralizing capacity thresholds of 20 degrees C and 50 mu eq/L, was variable throughout the national forests considered. Stream length displaying temperature above 20 degrees C was generally more than five times greater than the length predicted to have acid neutralizing capacity below 50 mu eq/L. It was uncommon for these two stressors to occur within the same stream segment. Results suggested that species' distributional shifts to colder, higher elevation habitats under a warming climate can be constrained by acidification of headwater streams. The approach used in this study can be applied to evaluate climate change impacts to stream water resources in other regions.	[McDonnell, T. C.] E&S Environm Chem Inc, Corvallis, OR 97330 USA; [Sloat, M. R.] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA; [Dolloff, C. A.] US Forest Serv, USDA, Southern Res Stn, Blacksburg, VA USA; [Hessburg, P. F.; Povak, N. A.] US Forest Serv, USDA, Pacific NW Res Stn, Forestry Sci Lab, Washington, DC 20250 USA; [Jackson, W. A.] US Forest Serv, USDA, Asheville, NC USA; [Sams, C.] US Forest Serv, USDA, Reg Air Qual Program 8, Atlanta, GA USA; [Sams, C.] US Forest Serv, USDA, Reg Air Qual Program 9, Atlanta, GA USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	McDonnell, TC (corresponding author), E&S Environm Chem Inc, Corvallis, OR 97330 USA.	todd.mcdonnell@esenvironmental.com		McDonnell, Todd/0000-0002-5231-105X; Povak, Nicholas/0000-0003-1220-7095	U.S. Department of Agriculture Forest Service [AG-3187-C-09-0029]; E&S Environmental Chemistry, Inc.	U.S. Department of Agriculture Forest Service(United States Department of Agriculture (USDA)United States Forest Service); E&S Environmental Chemistry, Inc.	This research was supported by a contract from the U.S. Department of Agriculture Forest Service to E&S Environmental Chemistry, Inc. under Contract No. AG-3187-C-09-0029. No official agency endorsement is implied. E&S Environmental Chemistry, Inc. provided support in the form of salaries for authors T.C. McDonnell and T.J. Sullivan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. T.C. McDonnell and T.J. Sullivan coordinated and conducted data analysis and wrote manuscript text.	Al-Chokhachy R, 2013, T AM FISH SOC, V142, P793, DOI 10.1080/00028487.2013.778900; [Anonymous], 2010, SOIL SURVEY GEOGRAPH; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Braun EL, 1950, DECIDUOUS FOREST OF; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Burns DA, 2011, NATIONAL ACID PRECIP; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; COSBY BJ, 1985, WATER RESOUR RES, V21, P51, DOI 10.1029/WR021i001p00051; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eby LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098812; FLEBBE PA, 1994, T AM FISH SOC, V123, P657, DOI 10.1577/1548-8659(1994)123<0657:ARVOTM>2.3.CO;2; Flebbe PA, 2006, T AM FISH SOC, V135, P1371, DOI 10.1577/T05-217.1; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoef JMV, 2014, J STAT SOFTW, V56, P1; Isaak DJ, 2014, WIRES WATER, V1, P277, DOI 10.1002/wat2.1023; Isaak DJ, 2010, ECOL APPL, V20, P1350, DOI 10.1890/09-0822.1; Isaak DJ, 2011, STREAM NOTES USDA FO; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Magnuson JJ, 1997, HYDROL PROCESS, V11, P825; Maurer E. P., 2007, EOS T AM GEOPHYS UN, V88, P504, DOI DOI 10.1029/2007EO470006; McCabe GJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010630; McDonnell TC, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1733-8; McDonnell TC, 2012, ENVIRON POLLUT, V162, P338, DOI 10.1016/j.envpol.2011.11.025; Peterson EE, 2014, J STAT SOFTW, V56, P1; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Potyondy JP, 2011, FOREST SERVICE WATER; Povak NA, 2014, WATER RESOUR RES, V50, P2798, DOI 10.1002/2013WR014203; Povak NA, 2013, WATER RESOUR RES, V49, P3531, DOI 10.1002/wrcr.20308; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Reynolds KM, 2012, P 45 HAW INT C SYST; Sloat MR, 2005, N AM J FISH MANAGE, V25, P225, DOI 10.1577/M03-165.1; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sullivan TJ, 2007, WATER AIR SOIL POLL, V182, P57, DOI 10.1007/s11270-006-9320-x; Sullivan TJ, 2011, WATER AIR SOIL POLL, V219, P11, DOI 10.1007/s11270-010-0680-x; Sullivan TJ, 2007, FINAL REPORT PREPARE; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Trumbo BA, 2014, T AM FISH SOC, V143, P173, DOI 10.1080/00028487.2013.835282; U.S. Environmental Protection Agency, 2008, EPA 600 R 08 082F; U.S. Environmental Protection Agency (USEPA) and U.S. Geological Survey (USGS), 2012, NAT HYDR DAT PLUS NH; U.S. EPA, 2009, EPA 452 R 09 008A; U.S. Geological Survey (USGS), HIGH RES NHDFLOWL; USDA, WEB SOIL SURV; Webb J. R., 2006, NPSNERNRTR2006066 US; Wolock DM, BASE FLOW INDEX GRID	50	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134757	10.1371/journal.pone.0134757	http://dx.doi.org/10.1371/journal.pone.0134757			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247361	Green Published, gold			2022-12-26	WOS:000359062300063
J	Morrison, M; Duncan, R; Parton, K				Morrison, Mark; Duncan, Roderick; Parton, Kevin			Religion Does Matter for Climate Change Attitudes and Behavior	PLOS ONE			English	Article							ENVIRONMENTAL CONCERN; BELIEFS; FAITH	Little research has focused on the relationship between religion and climate change attitudes and behavior. Further, while there have been some studies examining the relationship between environmental attitudes and religion, most are focused on Christian denominations and secularism, and few have examined other religions such as Buddhism. Using an online survey of 1,927 Australians we examined links between membership of four religious groupings (Buddhists, Christian literalists and non-literalists, and Secularists) and climate change attitudes and behaviors. Differences were found across religious groups in terms of their belief in: (a) human induced climate change, (b) the level of consensus among scientists, (c) their own efficacy, and (d) the need for policy responses. We show, using ordinal regression, that religion explains these differences even after taking into account socio-demographic factors, knowledge and environmental attitude, including belief in man's dominion over nature. Differences in attitude and behavior between these religious groups suggest the importance of engaging denominations to encourage change in attitudes and behavior among their members.	[Morrison, Mark; Parton, Kevin] Charles Sturt Univ, Sch Management & Mkt, Bathurst, NSW 2795, Australia; [Morrison, Mark; Parton, Kevin] Charles Sturt Univ, Inst Land Water & Soc, Bathurst, NSW 2795, Australia; [Duncan, Roderick] Charles Sturt Univ, Sch Accounting & Finance, Bathurst, NSW 2795, Australia	Charles Sturt University; Charles Sturt University; Charles Sturt University	Parton, K (corresponding author), Charles Sturt Univ, Sch Management & Mkt, Bathurst, NSW 2795, Australia.	kparton@csu.edu.au	Parton, Kevin/Q-7695-2019	Morrison, Mark/0000-0002-8761-0682; Parton, Kevin/0000-0003-3378-799X				Agliardo M., 2014, WORLDS RELIG ARE RES, P174; Akter S, 2012, GLOBAL ENVIRON CHANG, V22, P736, DOI 10.1016/j.gloenvcha.2012.05.004; Akter S, 2011, CLIMATIC CHANGE, V109, P417, DOI 10.1007/s10584-011-0034-8; Alwin DF, 2006, PUBLIC OPIN QUART, V70, P530, DOI 10.1093/poq/nfl024; Anglican Diocese of Canberra and Goulburn, 2007, ANGL DIOC CANB GOULB; [Anonymous], 2007, ONE 3 AM BELIEVE BIB; Australian Bureau of Statistics, 2007, AUSTR DEM STAT; Ayre CW, 2012, AUSTR J MISSION STUD, V6, P20; Biel A, 2005, SOC SCI QUART, V86, P178, DOI 10.1111/j.0038-4941.2005.00297.x; Boyd HH, 1999, J SCI STUD RELIG, V38, P36, DOI 10.2307/1387582; CATHOLIC EARTHCARE AUSTRALIA, 2005, CLIM CHANG OUR RESP; Dixon R, 2013, AUSTRALAS CATHOL REC, V90, P439; Dunlap RE, 1994, GREEN GLOBE YB INT C, P115; GREELEY A, 1993, J SCI STUD RELIG, V32, P19, DOI 10.2307/1386911; GUTH JL, 1995, AM J POLIT SCI, V39, P364, DOI 10.2307/2111617; HAND CM, 1984, SOC FORCES, V63, P555, DOI 10.2307/2579062; HARRIS I, 1991, RELIGION, V21, P101, DOI 10.1016/0048-721X(91)90058-X; Hayes BC, 2001, BRIT J SOCIOL, V52, P139; Hoffman AJ, 2011, ORGAN ENVIRON, V24, P3, DOI 10.1177/1086026611404336; Ives C, 2013, J BUDDHIST ETH, V20, P541; KANAGY CL, 1995, REV RELIG RES, V37, P33, DOI 10.2307/3512069; Lawson J. T., 2011, International Journal of Environmental Studies, V68, P965, DOI 10.1080/00207233.2011.614094; Maibach EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017571; Morrison M, 2013, AUSTRALAS J ENV MAN, V20, P87, DOI 10.1080/14486563.2012.762946; National Church Life Survey, 2015, RESEARCH; Parker D, 1985, EVANGELICAL Q, V57, P43; Posas P.J., 2007, ETHICS SCI ENV POLIT, V2007, P31, DOI DOI 10.3354/ESEP00080; SCHAHN J, 1990, ENVIRON BEHAV, V22, P767, DOI 10.1177/0013916590226003; Sherkat DE, 2007, J SCI STUD RELIG, V46, P71, DOI 10.1111/j.1468-5906.2007.00341.x; Smith N, 2013, GLOBAL ENVIRON CHANG, V23, P1009, DOI 10.1016/j.gloenvcha.2013.04.001; Steensland B, 2000, SOC FORCES, V79, P291, DOI 10.2307/2675572; Swearer DK, 2006, HARVARD THEOL REV, V99, P123; The Evangelical Climate Initiative, 2006, CLIM CHANG EV CALL A; Tjernstrom E, 2008, ECOL ECON, V65, P315, DOI 10.1016/j.ecolecon.2007.06.019; Tomalin E, 2002, WORLDVIEWS ENV CULT, V6, P12, DOI DOI 10.1163/156853502760184577; Townsend PK, 2014, WORLDS REL RESP CLIM, P193; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Tranter B, 2011, ENVIRON POLIT, V20, P78, DOI 10.1080/09644016.2011.538167; Truelove HB, 2009, ENVIRON BEHAV, V41, P806, DOI 10.1177/0013916508328905; Union of Concerned Scientists, 2015, EACH COUNTR SHAR CO2; United Church of Christ, 2007, RES CLIM CHANG; Wardekker JA, 2009, GLOBAL ENVIRON CHANG, V19, P512, DOI 10.1016/j.gloenvcha.2009.07.008; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203; Wolkomir M, 1997, SOC SCI QUART, V78, P96; Yale, 2014, YAL PROJ CLIM CHANG; Yale, 2014, FOR REL EC YAL; Zaleha RD, 2014, WORLDS REL RESP CLIM, P174	47	63	63	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134868	10.1371/journal.pone.0134868	http://dx.doi.org/10.1371/journal.pone.0134868			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CO3MQ	26247206	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300072
J	Osakunor, DNM; Obirikorang, C; Fianu, V; Asare, I; Dakorah, M				Osakunor, Derick Nii Mensah; Obirikorang, Christian; Fianu, Vincent; Asare, Isaac; Dakorah, Mavis			Hepatic Enzyme Alterations in HIV Patients on Antiretroviral Therapy: A Case-Control Study in a Hospital Setting in Ghana	PLOS ONE			English	Article							RISK-FACTORS; C VIRUS; HEPATOTOXICITY; NEVIRAPINE; MORTALITY; TRIAL	Background Diagnosing hepatic injury in HIV infection can be a herculean task for clinicians as several factors may be involved. In this study, we sought to determine the effects of antiretroviral therapy (ART) and disease progression on hepatic enzymes in HIV patients. Methods A case-control study conducted from January to May 2014 at the Akwatia Government Hospital, Eastern region, Ghana, The study included 209 HIV patients on ART (designated HIV-ART) and 132 ART-naive HIV patients (designated HIV-Controls). Data gathered included demography, clinical history and results of blood tests for hepatic enzymes. We employed the Fisher's, Chi-square, unpaired t-test and Pearson's correlation in analysis, using Graph-Pad Prism and SPSS. A P value < 0.05 was considered significant. Results Median CD4 lymphocyte count of HIV-ART participants (604.00 cells/mm(3)) was higher than that of HIV-Controls (491.50 cells/mm(3); P = 0.0005). Mean values of ALP, ALT, AST and GGT did not differ between the two groups compared (P > 0.05). There was a significant positive correlation between hepatic enzymes (ALP, ALT, AST and GGT) for both groups (p < 0.01 each). Duration of ART correlated positively with ALT (p < 0.05). The effect size of disease progression on hepatic enzymes for both groups was small. Conclusion Antiretroviral therapy amongst this population has minimal effects on hepatic enzymes and does not suggest modifications in therapy. Hepatic injury may occur in HIV, even in the absence of ART and other traditional factors. Monitoring of hepatic enzymes is still important in HIV patients.	[Osakunor, Derick Nii Mensah; Obirikorang, Christian] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Fianu, Vincent] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Med Lab Technol, Kumasi, Ghana; [Asare, Isaac; Dakorah, Mavis] St Dominic Catholic Hosp, Dept Lab Med, Akwatia, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Osakunor, DNM (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	osakunor@gmail.com	Obirikorang, Christian/F-5843-2011	Obirikorang, Christian/0000-0002-6128-1358; Osakunor, Derick Nii Mensah/0000-0002-4853-5384				Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Ayelagbe OG, 2014, IOSR JDMS, V13, P67; Berns JS, 2006, CLIN J AM SOC NEPHRO, V1, P117, DOI 10.2215/CJN.00370705; *CDC, 1993, MMWR-MORBID MORTAL W, V41, P961; Chu KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009183; Cohen J., 1998, STAT POWER ANAL BEHA; Cooper CL, 2002, CLIN INFECT DIS, V34, P1259, DOI 10.1086/339867; Hann HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047687; Heil EL, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/856542; Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16; Kontorinis Nickolas, 2003, AIDS Reviews, V5, P36; KREISBERG R, 1995, NEW ENGL J MED, V332, P945, DOI 10.1056/NEJM199504063321409; Kubota S, 2008, THYROID, V18, P283, DOI 10.1089/thy.2007.0189; Littner Y, 2007, NEUROSCI BIOBEHAV R, V31, P261, DOI 10.1016/j.neubiorev.2006.06.025; Lucien K. F. H., 2010, African Journal of Clinical and Experimental Microbiology, V11, P174; Mandy Francis F, 2003, MMWR Recomm Rep, V52, P1; Mokondjimobe E, 2012, INT J GEN MED, V5, P961, DOI 10.2147/IJGM.S31199; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Nunez M, 2005, DRUG SAFETY, V28, P53; Nunez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002; Obirikorang Christian, 2013, ISRN AIDS, V2013, P873939, DOI 10.1155/2013/873939; Obirikorang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099469; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pol S, 2004, CLIN INFECT DIS, V38, pS65, DOI 10.1086/381499; Rodriguez-Rosado R, 1998, AIDS, V12, P1256, DOI 10.1097/00002030-199810000-00025; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Spengler U, 2002, ANTIRETROVIRAL DRUG; Teklay G., 2013, J PHARMA, V1, P115, DOI DOI 10.4172/2329-6887.1000115; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Yamada J, 2006, ATHEROSCLEROSIS, V189, P198, DOI 10.1016/j.atherosclerosis.2005.11.036	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134449	10.1371/journal.pone.0134449	http://dx.doi.org/10.1371/journal.pone.0134449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247879	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300037
J	Bandu, R; Ahn, HS; Lee, JW; Kim, YW; Choi, SH; Kim, HJ; Kim, KP				Bandu, Raju; Ahn, Hyun Soo; Lee, Joon Won; Kim, Yong Woo; Choi, Seon Hee; Kim, Hak Jin; Kim, Kwang Pyo			Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange Study	PLOS ONE			English	Article							CONJUGATE BETA-LYASE; POSTCOLUMN DERIVATIZATION; INTRACELLULAR METABOLITES; INDUCED NEPHROTOXICITY; CIS-PLATINUM; URINE; ION; PLASMA; PHARMACOKINETICS; DISPOSITION	In vivo rat kidney tissue metabolites of an anticancer drug, cisplatin (cis-diamminedichloroplatinum [II]) (CP) which is used for the treatment of testicular, ovarian, bladder, cervical, esophageal, small cell lung, head and neck cancers, have been identified and characterized by using liquid chromatography positive ion electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS) in combination with on line hydrogen/deuterium exchange (HDX) experiments. To identify in vivo metabolites, kidney tissues were collected after intravenous administration of CP to adult male Sprague-Dawley rats (n = 3 per group). The tissue samples were homogenized and extracted using newly optimized metabolite extraction procedure which involves liquid extraction with phosphate buffer containing ethyl acetate and protein precipitation with mixed solvents of methanol-water-chloroform followed by solid-phase clean-up procedure on Oasis HLB 3cc cartridges and then subjected to LC/ESI-HRMS analysis. A total of thirty one unknown in vivo metabolites have been identified and the structures of metabolites were elucidated using LC-MS/MS experiments combined with accurate mass measurements. Online HDX experiments have been used to further support the structural characterization of metabolites. The results showed that CP undergoes a series of ligand exchange biotransformation reactions with water and other nucleophiles like thio groups of methionine, cysteine, acetylcysteine, glutathione and thioether. This is the first research approach focused on the structure elucidation of biotransformation products of CP in rats, and the identification of metabolites provides essential information for further pharmacological and clinical studies of CP, and may also be useful to develop various effective new anticancer agents.	[Bandu, Raju; Ahn, Hyun Soo; Lee, Joon Won; Kim, Kwang Pyo] Kyung Hee Univ, Dept Appl Chem, Coll Appl Sci, Yong In City, South Korea; [Choi, Seon Hee; Kim, Hak Jin] Pusan Natl Univ Sch Med, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Radiol, Busan, South Korea; [Kim, Yong Woo] Pusan Natl Univ Sch Med, Yangsan Hosp, Pusan Natl Univ, Dept Radiol,Biomed Res Inst, Yangsan, South Korea	Kyung Hee University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Kim, HJ (corresponding author), Pusan Natl Univ Sch Med, Pusan Natl Univ Hosp, Biomed Res Inst, Dept Radiol, Busan, South Korea.	hakjink@pusan.ac.kr; kimkp@khu.ac.kr	Kim, Kwang Pyo/AAG-1815-2020	Kim, Kwang Pyo/0000-0003-0095-3787	Proteogenomic Research Program; Bio- and Medical Technology Development Program through the National Research Foundation of Korea - Korean Ministry of Education, Science and Technology, Republic of Korea [2012M3A9B6055305]	Proteogenomic Research Program; Bio- and Medical Technology Development Program through the National Research Foundation of Korea - Korean Ministry of Education, Science and Technology, Republic of Korea	This work was supported by Proteogenomic Research Program, and the Bio- and Medical Technology Development Program (Project No. 2012M3A9B6055305) through the National Research Foundation of Korea funded by the Korean Ministry of Education, Science and Technology (to K.P.K.), Republic of Korea.	ANDERSSON A, 1994, J CHROMATOGR B, V652, P203, DOI 10.1016/0378-4347(93)E0403-D; BANNISTER SJ, 1983, J CHROMATOGR, V273, P301, DOI 10.1016/S0378-4347(00)80951-2; BAUMANN RA, 1987, J PHARMACEUT BIOMED, V5, P165, DOI 10.1016/0731-7085(87)80019-5; Beuck S, 2011, J MASS SPECTROM, V46, P112, DOI 10.1002/jms.1878; Cleare MJ, 1980, CISPLATIN CURRENT ST, P149; COLE WC, 1981, CHEM-BIOL INTERACT, V35, P341, DOI 10.1016/0009-2797(81)90009-0; DALEYYATES PT, 1984, BIOCHEM PHARMACOL, V33, P3063, DOI 10.1016/0006-2952(84)90610-5; DALEYYATES PT, 1985, BIOCHEM PHARMACOL, V34, P1423, DOI 10.1016/0006-2952(85)90679-3; DALEYYATES PT, 1983, BIOCHEM PHARMACOL, V32, P181, DOI 10.1016/0006-2952(83)90677-9; DEDON PC, 1987, BIOCHEM PHARMACOL, V36, P1955, DOI 10.1016/0006-2952(87)90494-1; Du YG, 2012, RAPID COMMUN MASS SP, V26, P2832, DOI 10.1002/rcm.6408; EHRSSON HC, 1995, ANAL CHEM, V67, P3608, DOI 10.1021/ac00115a035; Ekborn A, 2003, CANCER CHEMOTH PHARM, V51, P36, DOI 10.1007/s00280-002-0540-5; El-Khateeb M, 1999, J PHARM SCI-US, V88, P319, DOI 10.1021/js980287m; Fan YM, 2014, BIOMED CHROMATOGR, V28, P1808, DOI 10.1002/bmc.3224; FARRISH HH, 1994, J PHARMACEUT BIOMED, V12, P265, DOI 10.1016/0731-7085(94)90038-8; Giaccone G, 2000, DRUGS, V59, P9, DOI 10.2165/00003495-200059004-00002; GULLO JJ, 1980, CANCER CHEMOTH PHARM, V5, P21, DOI 10.1007/BF00578558; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; HAMILTON CR, 1989, EUR J CANCER CLIN ON, V25, P185, DOI 10.1016/0277-5379(89)90006-0; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Jia YW, 2014, J CHROMATOGR A, V1358, P110, DOI 10.1016/j.chroma.2014.06.080; Jirasko R, 2011, RAPID COMMUN MASS SP, V25, P2153, DOI 10.1002/rcm.5097; JONES MM, 1991, CANCER CHEMOTH PHARM, V29, P29, DOI 10.1007/BF00686332; JONES MM, 1989, ANTICANCER RES, V9, P1937; KINOSHITA M, 1990, J CHROMATOGR-BIOMED, V529, P462, DOI 10.1016/S0378-4347(00)83855-4; KIZU R, 1989, BIOMED CHROMATOGR, V3, P14, DOI 10.1002/bmc.1130030105; Lam W, 2002, J AM SOC MASS SPECTR, V13, P345, DOI 10.1016/S1044-0305(02)00346-X; LIM MC, 1976, J INORG NUCL CHEM, V38, P1911, DOI 10.1016/0022-1902(76)80121-2; LITTERST CL, 1976, CANCER RES, V36, P2340; LITTERST CL, 1981, TOXICOL APPL PHARM, V61, P99, DOI 10.1016/0041-008X(81)90011-9; LITTERST CL, 1979, CANCER TREAT REP, V63, P1485; Liu DY, 2011, RAPID COMMUN MASS SP, V25, P2131, DOI 10.1002/rcm.5061; Liu DQ, 2005, J PHARMACEUT BIOMED, V37, P1, DOI 10.1016/j.jpba.2004.09.003; Liu ZY, 2010, ANAL BIOANAL CHEM, V396, P1259, DOI 10.1007/s00216-009-3245-3; MADIAS NE, 1978, AM J MED, V65, P307, DOI 10.1016/0002-9343(78)90825-2; MAESSEN FJMJ, 1984, SPECTROCHIM ACTA B, V39, P1171, DOI 10.1016/0584-8547(84)80203-7; MARSH KC, 1984, ANAL CHEM, V56, P491, DOI 10.1021/ac00267a045; Matabosch X, 2012, ANAL BIOANAL CHEM, V404, P325, DOI 10.1007/s00216-012-6037-0; MAULDIN SK, 1986, ANAL BIOCHEM, V157, P129, DOI 10.1016/0003-2697(86)90206-X; MELVIK JE, 1987, INORG CHIM A-BIOINOR, V137, P115, DOI 10.1016/S0020-1693(00)87128-5; Michopoulos F, 2014, J CHROMATOGR A, V1349, P60, DOI 10.1016/j.chroma.2014.05.019; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; MILLER SE, 1990, INORG CHIM ACTA, V173, P53, DOI 10.1016/S0020-1693(00)91054-5; MISTRY P, 1989, CANCER CHEMOTH PHARM, V24, P73; Peterman SM, 2006, J AM SOC MASS SPECTR, V17, P363, DOI 10.1016/j.jasms.2005.11.014; Pinedo HM, 1996, PLATINUM OTHER METAL, P1; REECE PA, 1987, CLIN PHARMACOL THER, V42, P320, DOI 10.1038/clpt.1987.155; ROSENBERG B, 1978, BIOCHIMIE, V60, P859, DOI 10.1016/S0300-9084(78)80570-7; SADZUKA Y, 1994, BIOCHEM PHARMACOL, V48, P453; SAFIRSTEIN R, 1983, CANCER LETT, V18, P329, DOI 10.1016/0304-3835(83)90244-6; STEWART DJ, 1985, J CLIN ONCOL, V3, P1251, DOI 10.1200/JCO.1985.3.9.1251; Strom T, 2011, J MASS SPECTROM, V46, P615, DOI 10.1002/jms.1930; Townsend DM, 2009, BIOMED PHARMACOTHER, V63, P79, DOI 10.1016/j.biopha.2008.08.004; Townsend DM, 2003, J AM SOC NEPHROL, V14, P1, DOI 10.1097/01.ASN.0000042803.28024.92; Townsend DM, 2002, J PHARMACOL EXP THER, V300, P142, DOI 10.1124/jpet.300.1.142; Wang Y, 2014, J CHROMATOGR A, V1359, P60, DOI 10.1016/j.chroma.2014.07.006; Yachnin JR, 1998, CANCER LETT, V132, P175, DOI 10.1016/S0304-3835(98)00175-X; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zhang L, 2003, J PHARMACOL EXP THER, V306, P988, DOI 10.1124/jpet.103.052225; ZHAO Z, 1993, J CHROMATOGR-BIOMED, V615, P83, DOI 10.1016/0378-4347(93)80293-D; ZUNINO F, 1989, CHEM-BIOL INTERACT, V70, P89, DOI 10.1016/0009-2797(89)90065-3	62	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134027	10.1371/journal.pone.0134027	http://dx.doi.org/10.1371/journal.pone.0134027			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244343	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400066
J	Jagger, TH; Elsner, JB; Widen, HM				Jagger, Thomas H.; Elsner, James B.; Widen, Holly M.			A Statistical Model for Regional Tornado Climate Studies	PLOS ONE			English	Article							UNITED-STATES; GREAT-PLAINS; SWIRL RATIO; PROBABILITY	Tornado reports are locally rare, often clustered, and of variable quality making it difficult to use them directly to describe regional tornado climatology. Here a statistical model is demonstrated that overcomes some of these difficulties and produces a smoothed regional-scale climatology of tornado occurrences. The model is applied to data aggregated at the level of counties. These data include annual population, annual tornado counts and an index of terrain roughness. The model has a term to capture the smoothed frequency relative to the state average. The model is used to examine whether terrain roughness is related to tornado frequency and whether there are differences in tornado activity by County Warning Area (CWA). A key finding is that tornado reports increase by 13% for a two-fold increase in population across Kansas after accounting for improvements in rating procedures. Independent of this relationship, tornadoes have been increasing at an annual rate of 1.9%. Another finding is the pattern of correlated residuals showing more Kansas tornadoes in a corridor of counties running roughly north to south across the west central part of the state consistent with the dryline climatology. The model is significantly improved by adding terrain roughness. The effect amounts to an 18% reduction in the number of tornadoes for every ten meter increase in elevation standard deviation. The model indicates that tornadoes are 51% more likely to occur in counties served by the CWAs of DDC and GID than elsewhere in the state. Flexibility of the model is illustrated by fitting it to data from Illinois, Mississippi, South Dakota, and Ohio.	[Jagger, Thomas H.; Elsner, James B.; Widen, Holly M.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Jagger, TH (corresponding author), Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA.	tjagger@fsu.edu		Elsner, James/0000-0001-6805-7431				Anderson CJ, 2007, WEATHER FORECAST, V22, P571, DOI 10.1175/WAF997.1; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Bivand R, 2014, R PACKAGE VERSION 0; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Brooks HE, 2013, ATMOS RES, V123, P129, DOI 10.1016/j.atmosres.2012.04.002; Brooks HE, 2003, WEATHER FORECAST, V18, P626, DOI 10.1175/1520-0434(2003)018<0626:CEOLDT>2.0.CO;2; Brooks HE, 2001, WEATHER FORECAST, V16, P168, DOI 10.1175/1520-0434(2001)016<0168:NDFMTI>2.0.CO;2; CHURCH CR, 1979, J ATMOS SCI, V36, P1755, DOI 10.1175/1520-0469(1979)036<1755:COTLVA>2.0.CO;2; Coleman TA, 2014, WEATHER FORECAST, V29, P366, DOI 10.1175/WAF-D-13-00057.1; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; DAVIESJO.RP, 1973, J ATMOS SCI, V30, P1427, DOI 10.1175/1520-0469(1973)030<1427:TDOCRO>2.0.CO;2; Dessens J.  Jr., 1972, Journal of Applied Meteorology, V11, P72, DOI 10.1175/1520-0450(1972)011<0072:IOGROT>2.0.CO;2; Diffenbaugh N.S., 2008, EOS T AM GEOPHYS UN, V89, P553, DOI DOI 10.1029/2008EO530001; Dixon PG, 2014, EARTH INTERACT, V18, DOI 10.1175/2013EI000559.1; Dixon PG, 2011, B AM METEOROL SOC, V92, P433, DOI 10.1175/2010BAMS3102.1; Doswell CA, 2005, WEATHER FORECAST, V20, P577, DOI 10.1175/WAF866.1; DOSWELL CA, 1988, MON WEATHER REV, V116, P495, DOI 10.1175/1520-0493(1988)116<0495:OSIOUS>2.0.CO;2; Doswell CA, 1999, WEATHER FORECAST, V14, P544, DOI 10.1175/1520-0434(1999)014<0544:SSAPAS>2.0.CO;2; Doswell III CA, 2007, ELECT J SEVERE STORM, V2, P1; Edwards R, 2013, B AM METEOROL SOC, V94, P641, DOI 10.1175/BAMS-D-11-00006.1; Elsner J.B., 2013, HURRICANE CLIMATOLOG; Elsner JB, 2013, WEATHER CLIM SOC, V5, P221, DOI 10.1175/WCAS-D-12-00040.1; Elsner JB, 2014, MON WEATHER REV, V142, P259, DOI 10.1175/MWR-D-13-00014.1; Fujita T.T., 1973, P 8 C SEV LOC STORMS, P142; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Karpman D, 2013, STAT, V2, P1, DOI 10.1002/sta4.14; LANICCI JM, 1987, MON WEATHER REV, V115, P2660, DOI 10.1175/1520-0493(1987)115<2660:SOTGPS>2.0.CO;2; LESLIE FW, 1977, J ATMOS SCI, V34, P1022, DOI 10.1175/1520-0469(1977)034<1022:SREOSV>2.0.CO;2; LEWELLEN WS, 1962, J FLUID MECH, V14, P420, DOI 10.1017/S0022112062001330; Potter S, 2007, WEATHERWISE, V60, P64, DOI DOI 10.3200/WEWI.60.2.64-71; Ramsdell Jr JV, 2007, NUREG CR 4461; Rue H., 2014, R PACKAGE VERSION 0; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schaefer JT, 1999, 11TH CONFERENCE ON A; Schrodle B, 2011, ENVIRONMETRICS, V22, P725, DOI 10.1002/env.1065; Schultz DM, 2007, MON WEATHER REV, V135, P1699, DOI 10.1175/MWR3376.1; Schultz DM, 2014, B AM METEOROL SOC, V95, P1704, DOI 10.1175/BAMS-D-13-00252.1; Shafer C.M., 2011, ELECT J SEVERE STORM, V6, P1; SNIDER CR, 1977, MON WEATHER REV, V105, P1341, DOI 10.1175/1520-0493(1977)105<1341:ALAMTS>2.0.CO;2; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1; Wilson JW, 1971, ILLINOIS TORNADOES	41	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131876	10.1371/journal.pone.0131876	http://dx.doi.org/10.1371/journal.pone.0131876			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244881	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400015
J	Yester, JW; Bryan, L; Waters, MR; Mierzenski, B; Biswas, DD; Gupta, AS; Bhardwaj, R; Surace, MJ; Eltit, JM; Milstien, S; Spiegel, S; Kordula, T				Yester, Jessie W.; Bryan, Lauren; Waters, Michael R.; Mierzenski, Bartosz; Biswas, Debolina D.; Gupta, Angela S.; Bhardwaj, Reetika; Surace, Michael J.; Eltit, Jose M.; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz			Sphingosine-1-phosphate inhibits IL-1-induced expression of C-C motif ligand 5 via c-Fos-dependent suppression of IFN-beta amplification loop	FASEB JOURNAL			English	Article						astrocytes; chemokines; GPCR; inflammation	NF-KAPPA B; SPHINGOSINE 1-PHOSPHATE; MULTIPLE-SCLEROSIS; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; SIGNALING PATHWAYS; LYMPHOCYTE EGRESS; RANTES PRODUCTION; CHEMOKINE RANTES; PROMOTER MODULE	The neuroinflammation associated with multiple sclerosis involves activation of astrocytes that secrete and respond to inflammatory mediators such as IL-1. IL-1 stimulates expression of many chemokines, including C-C motif ligand (CCL) 5, that recruit immune cells, but it also stimulates sphingosine kinase-1, an enzyme that generates sphingosine-1-phosphate (S1P), a bioactive lipid mediator essential for inflammation. We found that whereas S1P promotes IL-1-induced expression of IL-6, it inhibits IL-1-induced CCL5 expression in astrocytes. This inhibition is mediated by the S1P receptor (S1PR)-2 via an inhibitory G-dependent mechanism. Consistent with this surprising finding, infiltration of macrophages into sites of inflammation increased significantly in S1PR2(-/-) animals. However, activation of NF-kappa B, IFN regulatory factor-1, and MAPKs, all of which regulate CCL5 expression in response to IL-1, was not diminished by the S1P in astrocytes. Instead, S1PR2 stimulated inositol 1,4,5-trisphosphate-dependent Ca++ release and Elk-1 phosphorylation and enhanced c-Fos expression. In our study, IL-1 induced the IFN beta production that supports CCL5 expression. An intriguing finding was that S1P induced c-Fos-inhibited CCL5 directly and also indirectly through inhibition of the IFN-beta amplification loop. We propose that in addition to S1PR1, which promotes inflammation, S1PR2 mediates opposing inhibitory functions that limit CCL5 expression and diminish the recruitment of immune cells.	[Yester, Jessie W.; Bryan, Lauren; Waters, Michael R.; Mierzenski, Bartosz; Biswas, Debolina D.; Gupta, Angela S.; Bhardwaj, Reetika; Surace, Michael J.; Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA; [Milstien, Sheldon; Spiegel, Sarah; Kordula, Tomasz] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	tkordula@vcu.edu			U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant [R01AI093718]; NIH National Institute of General Medical Sciences Grant [R01GM043880]; NIH National Cancer Institute Fellowship [F30CA174231]; NATIONAL CANCER INSTITUTE [F30CA174231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant; NIH National Institute of General Medical Sciences Grant; NIH National Cancer Institute Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute on Allergy and Infectious Diseases Grant R01AI093718 (to T.K.); NIH National Institute of General Medical Sciences Grant R01GM043880 (to S.S.); and NIH National Cancer Institute Fellowship F30CA174231 (to J.Y.). The authors declare no conflicts of interest.	Bhardwaj R, 2015, J IMMUNOL, V194, P2862, DOI 10.4049/jimmunol.1400874; Boehlk S, 2000, EUR J IMMUNOL, V30, P1102, DOI 10.1002/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X; Borzani I, 2010, EUR J NEUROL, V17, P930, DOI 10.1111/j.1468-1331.2010.02952.x; BOUTILLIER AL, 1992, J BIOL CHEM, V267, P23520; BRANDI ML, 1984, ACTA ENDOCRINOL-COP, V107, P225, DOI 10.1530/acta.0.1070225; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Edling Y, 2007, GLIA, V55, P328, DOI 10.1002/glia.20464; El-Dahr SS, 1998, AM J PHYSIOL-RENAL, V275, pF343, DOI 10.1152/ajprenal.1998.275.3.F343; Fessele S, 2001, FASEB J, V15, P577; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Huang CD, 2005, J BIOMED SCI, V12, P763, DOI 10.1007/s11373-005-9008-z; John GR, 2001, J NEUROSCI, V21, P4134, DOI 10.1523/JNEUROSCI.21-12-04134.2001; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Kawata T, 2005, BIOCHEM BIOPH RES CO, V331, P640, DOI 10.1016/j.bbrc.2005.03.223; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kim W, 2015, J CLIN NEUROL, V11, P9, DOI 10.3988/jcn.2015.11.1.9; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Kulakowska A, 2010, NEUROSCI LETT, V477, P149, DOI 10.1016/j.neulet.2010.04.052; Leon LR, 1996, AM J PHYSIOL-REG I, V271, pR1668, DOI 10.1152/ajpregu.1996.271.6.R1668; Li QJ, 2000, BLOOD, V96, P3696, DOI 10.1182/blood.V96.12.3696.h8003696_3696_3706; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mann CLA, 2002, J NEUROIMMUNOL, V129, P197, DOI 10.1016/S0165-5728(02)00181-9; Manni A, 1996, BIOCHEM BIOPH RES CO, V220, P120, DOI 10.1006/bbrc.1996.0367; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuzaki S, 2010, J IMMUNOL, V185, P4863, DOI 10.4049/jimmunol.1000904; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Muller H, 2005, EUR J IMMUNOL, V35, P533, DOI 10.1002/eji.200425556; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Okada S, 2003, INT IMMUNOL, V15, P1275, DOI 10.1093/intimm/dxg126; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Proudfoot AEI, 2008, J NEUROIMMUNOL, V198, P27, DOI 10.1016/j.jneuroim.2008.04.007; Ren ZH, 2011, J NEUROIMMUNOL, V233, P147, DOI 10.1016/j.jneuroim.2011.01.001; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stefano L, 2007, J CELL PHYSIOL, V213, P36, DOI 10.1002/jcp.21085; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szczucinski A, 2011, NEUROIMMUNOMODULAT, V18, P67, DOI 10.1159/000317394; Tada Y, 1997, J EXP MED, V185, P231, DOI 10.1084/jem.185.2.231; Tseng JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50690; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x	62	13	14	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4853	4865		10.1096/fj.15-275180	http://dx.doi.org/10.1096/fj.15-275180			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26246404	Green Published			2022-12-26	WOS:000365523600012
J	Cao, D; Su, ZQ; Wang, WW; Wu, HH; Liu, X; Akram, S; Qin, B; Zhou, JJ; Zhuang, XX; Adams, G; Jin, CJ; Wang, XW; Liu, LF; Hill, DL; Wang, DM; Ding, X; Yao, XB				Cao, Dan; Su, Zeqi; Wang, Wenwen; Wu, Huihui; Liu, Xing; Akram, Saima; Qin, Bo; Zhou, Jiajia; Zhuang, Xiaoxuan; Adams, Gregory; Jin, Changjiang; Wang, Xiwei; Liu, Lifang; Hill, Donald L.; Wang, Dongmei; Ding, Xia; Yao, Xuebiao			Signaling Scaffold Protein IQGAP1 Interacts with Microtubule Plus-end Tracking Protein SKAP and Links Dynamic Microtubule Plus-end to Steer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHECKPOINT; BINDING-PROTEINS; CHROMOSOME STABILITY; SPINDLE MICROTUBULES; ACTIN-FILAMENTS; EB1; KINETOCHORES; MITOSIS; CLASP2; PLASTICITY	Cell migration is orchestrated by dynamic interaction of microtubules with the plasma membrane cortex. However, the regulatory mechanisms underlying the cortical actin cytoskeleton and microtubule dynamics are less characterized. Our earlier study showed that small GTPase-activating proteins, IQGAPs, regulate polarized secretion in epithelial cells (1). Here, we show that IQGAP1 links dynamic microtubules to steer cell migration via interacting with the plus-end tracking protein, SKAP. Biochemical characterizations revealed that IQGAP1 and SKAP form a cognate complex and that their binding interfaces map to the WWIQ motif and the C-terminal of SKAP, respectively. The WWIQ peptide disrupts the biochemical interaction between IQGAP1 and SKAP in vitro, and perturbation of the IQGAP1-SKAP interaction in vivo using a membrane-permeable TAT-WWIQ peptide results in inhibition of directional cell migration elicited by EGF. Mechanistically, the N-terminal of SKAP binds to EB1, and its C terminus binds to IQGAP1 in migrating cells. Thus, we reason that a novel IQGAP1 complex orchestrates directional cell migration via coupling dynamic microtubule plus-ends to the cell cortex.	[Cao, Dan; Su, Zeqi; Wang, Wenwen; Wu, Huihui; Liu, Xing; Akram, Saima; Qin, Bo; Zhou, Jiajia; Zhuang, Xiaoxuan; Adams, Gregory; Jin, Changjiang; Wang, Xiwei; Wang, Dongmei; Ding, Xia; Yao, Xuebiao] Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam & Chem Bio, Hefei 230027, Peoples R China; [Cao, Dan; Su, Zeqi; Wang, Wenwen; Liu, Xing; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Cao, Dan; Wang, Wenwen; Wu, Huihui; Liu, Xing; Qin, Bo; Adams, Gregory; Wang, Xiwei] Morehouse Sch Med, Atlanta, GA 30310 USA; [Wu, Huihui; Qin, Bo; Zhou, Jiajia; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China; [Hill, Donald L.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham	Liu, X (corresponding author), Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam & Chem Bio, Hefei 230027, Peoples R China.	xing1017@ustc.edu.cn; wangdm@ustc.edu.cn; ding-bucm@hotmail.com	WANG, WENWEN/AAF-1080-2020; Regan, Clinton/E-6250-2012; Liu, Xing/H-2989-2018; liu, li/HGC-0900-2022; Zhuang, Xiaoxuan/R-7836-2019; Yao, Xuebiao/P-5771-2014	WANG, WENWEN/0000-0002-1545-4369; Liu, Xing/0000-0002-7480-5085; Zhuang, Xiaoxuan/0000-0003-4004-5329; 	National Institutes of Health [DK56292, CA164133, G12RR03034]; Chinese 973 Project [2012CB917204, 2013CB911203, 2014CB964803]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project [08040102005]; Chinese Natural Science Foundation [31320103904, 91313303, 31430054, 90913016, 31171300, 31100992, 31471275, 31301121, 20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018, WK2340000021]; MOE Innovative Team [IRT13038];  [MOST2009DFA31010]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); MOE Innovative Team; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, and G12RR03034, Chinese 973 Project Grants 2012CB917204, 2013CB911203, and 2014CB964803, Chinese Academy of Science Grant KSCX2-YW-H-10, Anhui Province Key Project Grant 08040102005, International Collaboration Grant MOST2009DFA31010, Chinese Natural Science Foundation Grants 31320103904, 91313303, 31430054, 90913016, 31171300, and 31100992, 31471275, 31301121, MOE20113402130010, Fundamental Research Funds for Central Universities Grants WK2060190018 and WK2340000021, and MOE Innovative Team IRT13038. The authors declare no competing financial interests.	Adachi M, 2014, GENES CELLS, V19, P803, DOI 10.1111/gtc.12179; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gireesh KK, 2014, BIOCHEMISTRY-US, V53, P5551, DOI 10.1021/bi5007942; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Rokavec M, 2014, J MOL CELL BIOL, V6, P214, DOI 10.1093/jmcb/mju003; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Ward T, 2013, J BIOL CHEM, V288, P15771, DOI 10.1074/jbc.M112.448886; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zhao LL, 2010, J BIOL CHEM, V285, P2488, DOI 10.1074/jbc.M109.042614; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	45	19	20	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23766	23780		10.1074/jbc.M115.673517	http://dx.doi.org/10.1074/jbc.M115.673517			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242911	Green Published, hybrid			2022-12-26	WOS:000361816500024
J	Aptekar, S; Arora, M; Lawrence, CL; Lea, RW; Ashton, K; Dawson, T; Alder, JE; Shaw, L				Aptekar, Shraddha; Arora, Mohit; Lawrence, Clare Louise; Lea, Robert William; Ashton, Katherine; Dawson, Tim; Alder, Jane Elizabeth; Shaw, Lisa			Selective Targeting to Glioma with Nucleic Acid Aptamers	PLOS ONE			English	Article							END-JOINING REPAIR; SYSTEMATIC EVOLUTION; BINDING-ACTIVITY; DNA; CANCER; PROTEIN; EXPRESSION; DELIVERY; KU70/80; BREAST	Malignant glioma is characterised by a rapid growth rate and high capacity for invasive infiltration to surrounding brain tissue; hence, diagnosis and treatment is difficult and patient survival is poor. Aptamers contribute a promising and unique technology for the in vitro imaging of live cells and tissues, with a potentially bright future in clinical diagnostics and therapeutics for malignant glioma. The binding selectivity, uptake capacity and binding target of two DNA aptamers, SA43 and SA44, were investigated in glioma cells and patient tissues. The binding assay showed that SA43 and SA44 bound with strong affinity (K-d, 21.56 +/- 4.60 nM and K-d, 21.11 +/- 3.30 nM respectively) to the target U87MG cells. Quantitative analysis by flow cytometry showed that the aptamers were able to actively internalise in U87MG and 1321N1 glioma cells compared to the non-cancerous and non-glioma cell types. Confocal microscopy confirmed staining in the cytoplasm, and co-localisation studies with endoplasmic reticulum, Golgi apparatus and lysosomal markers suggested internalisation and compartmentalisation within the endomembrane system. Both aptamers selectively bound to Ku 70 and Ku 80 DNA repair proteins as determined by aptoprecipitation (AP) followed by mass spectrometry analysis and confirmation by Western blot. In addition, aptohistochemical (AHC) staining on paraffin embedded, formalin fixed patient tissues revealed that the binding selectivity was significantly higher for SA43 aptamer in glioma tissues (grade I, II, III and IV) compared to the non-cancerous tissues, whereas SA44 did not show selectivity towards glioma tissues. The results indicate that SA43 aptamer can differentiate between glioma and non-cancerous cells and tissues and therefore, shows promise for histological diagnosis of glioma.	[Aptekar, Shraddha; Arora, Mohit; Lawrence, Clare Louise; Lea, Robert William; Alder, Jane Elizabeth; Shaw, Lisa] Univ Cent Lancashire, Coll Clin & Biomed Sci, Sch Pharm & Biomed Sci, Preston PR1 2HE, Lancs, England; [Arora, Mohit; Ashton, Katherine; Dawson, Tim] Lancashire Teaching Hosp NHS Trust, Dept Neuropathol, Preston PR2 9HT, Lancs, England	University of Central Lancashire	Shaw, L (corresponding author), Univ Cent Lancashire, Coll Clin & Biomed Sci, Sch Pharm & Biomed Sci, Preston PR1 2HE, Lancs, England.	Lshaw1@uclan.ac.uk	Shaw, Lisa/I-5560-2019	Shaw, Lisa/0000-0002-6226-6467; Lawrence, Clare/0000-0003-0170-0079; Alder, Jane Elizabeth/0000-0003-4463-0349				Alshareeda AT, 2013, BREAST CANCER RES TR, V139, P301, DOI 10.1007/s10549-013-2542-x; Baldrich E, 2004, ANAL CHEM, V76, P7053, DOI 10.1021/ac049258o; Bayrac AT, 2011, ACS CHEM NEUROSCI, V2, P175, DOI 10.1021/cn100114k; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Blank M, 2005, CURR OPIN CHEM BIOL, V9, P336, DOI 10.1016/j.cbpa.2005.06.011; Blind M, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.74; Bouchaert P, 2012, INT J RADIAT ONCOL, V84, P1179, DOI 10.1016/j.ijrobp.2012.02.014; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Chang HW, 2006, ORAL ONCOL, V42, P979, DOI 10.1016/j.oraloncology.2005.12.016; Chu TC, 2006, CANCER RES, V66, P5859; Cibiel A, 2011, PHARMACEUTICALS-BASE, V4, P1216, DOI 10.3390/ph4091216; DALZIEL RG, 1992, AUTOIMMUNITY, V13, P265, DOI 10.3109/08916939209112334; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esposito CL, 2014, MOL THER, V22, P1151, DOI 10.1038/mt.2014.5; Esposito CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024071; Fransson J, 2006, INT J CANCER, V119, P2492, DOI 10.1002/ijc.22212; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hicke BJ, 2006, J NUCL MED, V47, P668; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Kang DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042731; Kim E, 2010, BIOMATERIALS, V31, P4592, DOI 10.1016/j.biomaterials.2010.02.030; Kim YM, 2009, BIOMARK MED, V3, P193, DOI 10.2217/BMM.09.5; Klussman S., 2006, APTAMER HDB FUNCTION; KOMAI T, 1992, BIOCHEM PHARMACOL, V43, P667, DOI 10.1016/0006-2952(92)90228-B; Kotula JW, 2012, NUCLEIC ACID THER, V22, P187, DOI 10.1089/nat.2012.0347; Leake R, 2000, J CLIN PATHOL, V53, P634, DOI 10.1136/jcp.53.8.634; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Li N, 2010, CHEM COMMUN, V46, P392, DOI 10.1039/b920865h; Liang C, 2015, ANALYST, V140, P3439, DOI 10.1039/c5an00244c; Liu HY, 2013, SCI REP-UK, V3, DOI 10.1038/srep03129; Liu KC, 2013, J CELL BIOCHEM, V114, P250, DOI 10.1002/jcb.24373; Lloret M, 2009, INT J RADIAT ONCOL, V73, P976, DOI 10.1016/j.ijrobp.2008.11.013; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mann AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013050; Mazzarelli P, 2005, WORLD J GASTROENTERO, V11, P6694, DOI 10.3748/wjg.v11.i42.6694; Mencin N, 2013, J PHARM BIOCH ANAL, V91, P151; Meyer C, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/904750; Moll U, 1999, ONCOGENE, V18, P3114, DOI 10.1038/sj.onc.1202640; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morokoff A, 2015, J CLIN NEUROSCI; Neryl AA, 2009, J SEP SCI, V32, P1523, DOI 10.1002/jssc.200800695; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nicol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064781; Persson O, 2010, J NEURO-ONCOL, V97, P207, DOI 10.1007/s11060-009-0013-3; PRABHAKAR BS, 1990, J CLIN INVEST, V86, P1301, DOI 10.1172/JCI114838; Pucci S, 2001, ONCOGENE, V20, P739, DOI 10.1038/sj.onc.1204148; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sefah K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014269; Sehmer EAJ, 2014, NEURO-ONCOLOGY, P1; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; Sun H, OLIGONUCLEOTIDE APTA; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Toh SY, 2015, BIOSENS BIOELECTRON, V64, P392, DOI 10.1016/j.bios.2014.09.026; Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Xu JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125863; Yang ML, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-5; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463; Zeng T, 2015, FRONT BIOSCI-LANDMRK, V20, P1104, DOI 10.2741/4362; Zhang MZ, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/48/485104; Zhao Q, 2012, TRAC-TREND ANAL CHEM, V41, P46, DOI 10.1016/j.trac.2012.08.005	76	12	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134957	10.1371/journal.pone.0134957	http://dx.doi.org/10.1371/journal.pone.0134957			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252900	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000359121100089
J	Jujo, T; Sakao, S; Ishibashi-Ueda, H; Ishida, K; Naito, A; Sugiura, T; Shigeta, A; Tanabe, N; Masuda, M; Tatsumi, K				Jujo, Takayuki; Sakao, Seiichiro; Ishibashi-Ueda, Hatsue; Ishida, Keiichi; Naito, Akira; Sugiura, Toshihiko; Shigeta, Ayako; Tanabe, Nobuhiro; Masuda, Masahisa; Tatsumi, Koichiro			Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance	PLOS ONE			English	Article							MICROVASCULAR DISEASE; THROMBOENDARTERECTOMY; ENDARTERECTOMY; CROSSTALK; PATHOLOGY; PERFUSION; LESIONS	Background Chronic thromboembolic pulmonary hypertension (CTEPH) is generally recognized to be caused by persistent organized thrombi that occlude the pulmonary arteries. The aim of this study was to investigate the characteristics of small vessel remodeling and its impact on the hemodynamics in CTEPH patients. Methods and Results Hemodynamic data were obtained from right heart catheterization in 17 CTEPH patients before pulmonary endarterectomy (PEA). Lung tissue specimens were obtained at the time of PEA. Pathological observations and evaluation of quantitative changes in pulmonary muscular arteries and veins were performed using light microscopy on 423 slides in 17 patients. The relationship between the results and the hemodynamics of CTEPH was investigated. Pulmonary arteriopathy and venopathy were recognized in most cases, although no plexiform lesions and no capillary-hemangiomatosis-like lesions were detected in any of the specimens. The severity of pulmonary arteriopathy was correlated with pulmonary vascular resistance (PVR) in the postoperative and follow-up periods. The PVR and mean pulmonary arterial pressure were significantly higher in the high-obstruction group than in the low-obstruction group. The findings in pulmonary venopathy were similar to the findings seen in pulmonary veno-occlusive disease in some cases, although severe venopathy was only observed in a portion of the pulmonary veins. There was a significant correlation between the extent of pulmonary arteriopathy and venopathy, although an effect of pulmonary venopathy to hemodynamics, including pulmonary arterial wedged pressure (PAWP), could not be identified. Conclusion The vascular remodeling of the pulmonary muscular arteries was closely associated with the hemodynamics of CTEPH. Severe pulmonary arteriopathy might be related to residual pulmonary hypertension after PEA. Those altered pulmonary arteries might be a new target for the persistent PH after the operation.	[Jujo, Takayuki; Sakao, Seiichiro; Naito, Akira; Sugiura, Toshihiko; Shigeta, Ayako; Tanabe, Nobuhiro; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol B2, Chuo Ku, Chiba 2608670, Japan; [Jujo, Takayuki; Shigeta, Ayako; Tanabe, Nobuhiro] Chiba Univ, Grad Sch Med, Dept Adv Med Pulm Hypertens, Chuo Ku, Chiba 2608670, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan; [Ishida, Keiichi] Chiba Univ, Grad Sch Med, Dept Cardiovasc Surg, Chuo Ku, Chiba 2608670, Japan; [Masuda, Masahisa] Natl Hosp Org, Chiba Med Ctr, Dept Cardiovasc Surg, Chuo Ku, Chiba 2608606, Japan	Chiba University; Chiba University; National Cerebral & Cardiovascular Center - Japan; Chiba University	Jujo, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol B2, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	naikamo_resp19184@chiba-u.jp	Jujo, Takayuki/Q-7627-2018	Jujo, Takayuki/0000-0001-5725-1810	Cardiovascular Research Fund; Japan Society for the Promotion of Science [22590851, 25461148, 25462158]; Ministry of Health, Labour and Welfare, Japan [23162501]	Cardiovascular Research Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Dr. Jujo was supported by The Cardiovascular Research Fund. Drs. Sakao, Tanabe and Ishida were supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [No. 22590851 to Dr. Sakao, No. 25461148 to Dr. Tanabe and No. 25462158 to Dr. Ishida]. Dr. Tatsumi was supported by Research Grants for the Respiratory Failure Research Group and the Cardiovascular Diseases from the Ministry of Health, Labour and Welfare, Japan [No. 23162501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EG, 1973, J PATHOL, V110, P273, DOI 10.1002/path.1711100402; Azarian R, 1997, J NUCL MED, V38, P980; Bergin CJ, 2000, AM J ROENTGENOL, V174, P509, DOI 10.2214/ajr.174.2.1740509; CHAZOVA I, 1995, AM J PATHOL, V146, P389; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Delcroix M, 2013, EUR RESPIR J, V41, P224, DOI 10.1183/09031936.00047712; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; Dorfmuller P, 2014, EUR RESPIR J, V44, P1275, DOI 10.1183/09031936.00169113; Frazier AA, 2007, RADIOGRAPHICS, V27, P867, DOI 10.1148/rg.273065194; Galie Nazzareno, 2006, Proc Am Thorac Soc, V3, P571, DOI 10.1513/pats.200605-113LR; GARVEY W, 1984, STAIN TECHNOL, V59, P213, DOI 10.3109/10520298409113858; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Ishida K, 2012, J THORAC CARDIOV SUR, V144, P321, DOI 10.1016/j.jtcvs.2011.09.004; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim NHS, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000111841.28126.D4; Lang IM, 2013, EUR RESPIR J, V41, P462, DOI 10.1183/09031936.00049312; Maruoka M, 2012, INT J CARDIOL, V159, P119, DOI 10.1016/j.ijcard.2011.02.037; MICHEL RP, 1991, J APPL PHYSIOL, V71, P601, DOI 10.1152/jappl.1991.71.2.601; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; MOSER KM, 1992, EUR RESPIR J, V5, P334; MOSER KM, 1987, ANN INTERN MED, V107, P560, DOI 10.7326/0003-4819-107-4-560; MOSER KM, 1973, CHEST, V64, P29, DOI 10.1378/chest.64.1.29; MOSER KM, 1993, CHEST, V104, P1441, DOI 10.1378/chest.104.5.1441; Rose A, 2001, CARDIOVASC PATHOL, P166; Sacks RS, 2006, SEMIN THORAC CARDIOV, V18, P265, DOI 10.1053/j.semtcvs.2006.09.004; Sakao S, 2013, HISTOL HISTOPATHOL, V28, P185, DOI 10.14670/HH-28.185; Sakao S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-109; Tanabe N, 2013, RESPIR INVESTIG, V51, P134, DOI 10.1016/j.resinv.2013.02.005; Tanabe N, 2012, CHEST, V141, P929, DOI 10.1378/chest.11-0769; Toshner M, 2012, EUR RESPIR J, V40, P612, DOI 10.1183/09031936.00134111; WAGENVOORT CA, 1995, CHEST, V107, pS10, DOI 10.1378/chest.107.1_Supplement.10S; Wagenvoort CA, 1979, PULMONARY VASCULAR D, P1; Yamaki S, 2014, CIRC J, V78, P476, DOI 10.1253/circj.CJ-13-1016; Yi ES, 2000, AM J RESP CRIT CARE, V162, P1577, DOI 10.1164/ajrccm.162.4.9912131	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133167	10.1371/journal.pone.0133167	http://dx.doi.org/10.1371/journal.pone.0133167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252755	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100015
J	Kumari, J; Mathur, A; Rajeshwari, A; Venkatesan, A; Satyavati, S; Pulimi, M; Chandrasekaran, N; Nagarajan, R; Mukherjee, A				Kumari, Jyoti; Mathur, Ankita; Rajeshwari, A.; Venkatesan, Arthi; Satyavati, S.; Pulimi, Mrudula; Chandrasekaran, Natarajan; Nagarajan, R.; Mukherjee, Amitava			Individual and Co Transport Study of Titanium Dioxide NPs and Zinc Oxide NPs in Porous Media	PLOS ONE			English	Article							IONIC-STRENGTH; TIO2 NANOPARTICLES; CANCER-CELLS; ZNO; DEPOSITION; RETENTION; PHYTOTOXICITY; AGGREGATION; COTRANSPORT; FABRICATION	The impact of pH and ionic strength on the mobility (individual and co-transport) and deposition kinetics of TiO2 and ZnO NPs in porous media was systematically investigated in this study. Packed column experiments were performed over a series of environmentally relevant ionic strengths with both NaCl (0.1 - 10 mM) and CaCl2 (0.01-0.1mM) solutions and at pH 5, 7, and 9. The transport of TiO2 NPs at pH 5 was not significantly affected by ZnO NPs in solution. At pH 7, a decrease in TiO2 NP transport was noted with co-existence of ZnO NPs, while at pH 9 an increase in the transport was observed. At pH 5 and 7, the transport of ZnO NPs was decreased when TiO2 NPs was present in the solution, and at pH 9, an increase was noted. The breakthrough curves (BTC) were noted to be sensitive to the solution chemistries; the decrease in the breakthrough plateau with increasing ionic strength was observed under all examined pH (5, 7, and 9). The retention profiles were the inverse of the plateaus of BTCs, as expected from mass balance considerations. Overall, the results from this study suggest that solution chemistries (ionic strength and pH) are likely the key factors that govern the individual and co-transport behavior of TiO2 and ZnO NPs in sand.	[Kumari, Jyoti; Mathur, Ankita; Rajeshwari, A.; Venkatesan, Arthi; Pulimi, Mrudula; Chandrasekaran, Natarajan; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India; [Satyavati, S.] IISc, Dept Microbiol & Cell Biol, Bangalore, Karnataka, India; [Nagarajan, R.] IIT Madras, Dept Chem Engn, Madras, Tamil Nadu, India	Vellore Institute of Technology; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amit.mookerjea@gmail.com	Chandrasekaran, Natarajan/F-2312-2018; Mukherjee, Amitava/H-5560-2011; Pulimi, Mrudula/T-3347-2019; Venkatesan, Arthi/B-4309-2016	Chandrasekaran, Natarajan/0000-0002-0586-134X; Mukherjee, Amitava/0000-0001-8682-4278; Nagarajan, R/0000-0003-1430-6644; Venkatesan, Arthi/0000-0002-2923-3946				Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Ben-Moshe T, 2010, CHEMOSPHERE, V81, P387, DOI 10.1016/j.chemosphere.2010.07.007; Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h; Cai L, 2014, ENVIRON SCI TECHNOL, V48, P7323, DOI 10.1021/es5019652; Cai L, 2013, ENVIRON SCI TECHNOL, V47, P5703, DOI 10.1021/es400256d; Chen GX, 2011, LANGMUIR, V27, P5393, DOI 10.1021/la200251v; Chowdhury I, 2011, J COLLOID INTERF SCI, V360, P548, DOI 10.1016/j.jcis.2011.04.111; Darlington TK, 2009, ENVIRON TOXICOL CHEM, V28, P1191, DOI 10.1897/08-341.1; Dutta S, 2009, PROG MATER SCI, V54, P89, DOI 10.1016/j.pmatsci.2008.07.002; Fang J, 2013, WATER RES, V47, P1399, DOI 10.1016/j.watres.2012.12.005; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Guzman KAD, 2006, ENVIRON SCI TECHNOL, V40, P7688, DOI 10.1021/es060847g; Han P, 2014, COLLOID SURFACE A, V454, P119, DOI 10.1016/j.colsurfa.2014.04.020; Hanada T, 2009, ADV MATER RES-GER, V12, P1; Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177; Jin X, 2012, ADV MATER, V24, P5676, DOI 10.1002/adma.201201780; Kanel SR, 2011, J NANOPART RES, V13, P4035, DOI 10.1007/s11051-011-0345-8; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kumari J, 2014, ENVIRON RES, V135, P333, DOI 10.1016/j.envres.2014.09.025; Li YZ, 2010, LANGMUIR, V26, P591, DOI 10.1021/la902117c; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P5580, DOI 10.1021/es800422x; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Marinel S, 2013, CERAM INT, V39, P299, DOI 10.1016/j.ceramint.2012.06.025; Martinez A., 2001, MODELING DIELECTRIC; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2014, KONA POWDER PART J, P92; Othman SH, 2012, J NANOMATER, V2012, DOI 10.1155/2012/718214; Reddy S, 2013, RES J MAT SCI, V1, P11; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Sadiq IM, 2011, ECOTOX ENVIRON SAFE, V74, P1180, DOI 10.1016/j.ecoenv.2011.03.006; Soares JW, 2008, LANGMUIR, V24, P371, DOI 10.1021/la702834w; Solovitch N, 2010, ENVIRON SCI TECHNOL, V44, P4897, DOI 10.1021/es1000819; Syngouna VI, 2013, COLLOID SURFACE A, V416, P56, DOI 10.1016/j.colsurfa.2012.10.018; Tong MP, 2010, ENVIRON SCI TECHNOL, V44, P2393, DOI 10.1021/es9027937; Tong MP, 2005, ENVIRON SCI TECHNOL, V39, P3679, DOI 10.1021/es048850s; Vasiliadou IA, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009560; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2014, J PHARM INNOV, V9, P48, DOI 10.1007/s12247-014-9174-5; Wahab R, 2013, J BIOMED NANOTECHNOL, V9, P1181, DOI 10.1166/jbn.2013.1652; Wang Q, 2009, ENVIRON SCI TECHNOL, V43, P8968, DOI 10.1021/es902568h; Wei XZ, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/726872; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Zamiri R, 2012, J ALLOY COMPD, V516, P41, DOI 10.1016/j.jallcom.2011.11.118	47	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134796	10.1371/journal.pone.0134796	http://dx.doi.org/10.1371/journal.pone.0134796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252479	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100077
J	Thomas, AG; Sattler, R; Tendyke, K; Loiacono, KA; Hansen, H; Sahni, V; Hashizume, Y; Rojas, C; Slusher, BS				Thomas, Ajit G.; Sattler, Rita; Tendyke, Karen; Loiacono, Kara A.; Hansen, Hans; Sahni, Vishal; Hashizume, Yutaka; Rojas, Camilo; Slusher, Barbara S.			High-Throughput Assay Development for Cystine-Glutamate Antiporter (x(c)(-)) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; PRIMARY BRAIN-TUMORS; FACTOR-KAPPA-B; SYSTEM X(C)(-); OXIDATIVE STRESS; CYSTINE/GLUTAMATE ANTIPORTER; MALIGNANT GLIOMAS; INHIBITION; TRANSPORT; GROWTH	The cystine-glutamate antiporter (system x(c)(-)) is a Na+-independent amino acid transporter that exchanges extracellular cystine for intracellular glutamate. It is thought to play a critical role in cellular redox processes through regulation of intracellular glutathione synthesis via cystine uptake. In gliomas, system x(c)(-) expression is universally up-regulated while that of glutamate transporters down-regulated, leading to a progressive accumulation of extracellular glutamate and excitotoxic cell death of the surrounding non-tumorous tissue. Additionally, up-regulation of system x(c)(-) in activated microglia has been implicated in the pathogenesis of several neurodegenerative disorders mediated by excess glutamate. Consequently, system x(c)(-) is a new drug target for brain cancer and neuroinflammatory diseases associated with excess extracellular glutamate. Unfortunately no potent and selective small molecule system x(c)(-) inhibitors exist and to our knowledge, no high throughput screening (HTS) assay has been developed to identify new scaffolds for inhibitor design. To develop such an assay, various neuronal and non-neuronal human cells were evaluated as sources of system x(c)(-). Human glioma cells were chosen based on their high system x(c)(-) activity. Using these cells, [C-14]-cystine uptake and cystine-induced glutamate release assays were characterized and optimized with respect to cystine and protein concentrations and time of incubation. A pilot screen of the LOPAC/NINDS libraries using glutamate release demonstrated that the logistics of the assay were in place but unfortunately, did not yield meaningful pharmacophores. A larger, HTS campaign using the 384-well cystine-induced glutamate release as primary assay and the 96-well C-14-cystine uptake as confirmatory assay is currently underway. Unexpectedly, we observed that the rate of cystine uptake was significantly faster than the rate of glutamate release in human glioma cells. This was in contrast to the same rates of cystine uptake and glutamate release previously reported in normal human fibroblast cells.	[Thomas, Ajit G.; Sattler, Rita; Rojas, Camilo; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA; [Sattler, Rita; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Tendyke, Karen; Loiacono, Kara A.; Hansen, Hans] Eisai Inc, Next Generat Syst CFU, Andover, MA 01810 USA; [Sahni, Vishal; Hashizume, Yutaka] Eisai Inc, Neurosci & Gen Med PCU, Andover, MA 01810 USA; [Rojas, Camilo] Johns Hopkins Univ, Sch Med, Dept Comparat Med & Mol Pathobiol, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Eisai Co Ltd; Eisai Co Ltd; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rojas, C (corresponding author), Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA.	crojas2@jhmi.edu; bslusher@jhmi.edu			NIH [R21NSO74062A1, 2P30 MH075673-06]; Eisai Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eisai Inc.(Eisai Co Ltd); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported through the NIH R21NSO74062A1 and the 2P30 MH075673-06 grants awarded to BSS. Eisai Inc., provided support in the form of salaries for authors KT, KAL, HH, VS, and YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are listed in the authors contributions section.	Albrecht P, 2010, CNS NEUROL DISORD-DR, V9, P373, DOI 10.2174/187152710791292567; Audi G, 2003, NUCL PHYS A, V729, P3, DOI 10.1016/j.nuclphysa.2003.11.001; BANNAI S, 1980, J BIOL CHEM, V255, P2372; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Domercq M, 2007, J IMMUNOL, V178, P6549, DOI 10.4049/jimmunol.178.10.6549; Etoga JLG, 2010, BIOORG MED CHEM LETT, V20, P2680, DOI 10.1016/j.bmcl.2009.10.020; Figuera-Losada M, 2014, J BIOMOL SCREEN, V19, P17, DOI 10.1177/1087057113499406; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gupta S, 2010, NEUROSCI LETT, V485, P233, DOI 10.1016/j.neulet.2010.09.019; Hayes D, 2005, NEUROCHEM INT, V46, P585, DOI 10.1016/j.neuint.2005.03.001; Hosoya KI, 2002, J PHARMACOL EXP THER, V302, P225, DOI 10.1124/jpet.302.1.225; IGLEHART JD, 1977, J BIOL CHEM, V252, P7184; Iida M, 1997, J CANCER RES CLIN, V123, P619, DOI 10.1007/s004320050115; Kigerl KA, 2012, EXP NEUROL, V233, P333, DOI 10.1016/j.expneurol.2011.10.025; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; McElroy KE, 2000, ANAL BIOCHEM, V284, P382, DOI 10.1006/abio.2000.4740; McMullan SM, 2012, ASN NEURO, V4, P323, DOI 10.1042/AN20120044; MITCHELL JB, 1989, INT J RADIAT ONCOL, V16, P1289, DOI 10.1016/0360-3016(89)90301-5; Munoz-Pinedo C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.123; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; Pampliega O, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-63; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Patel SA, 2010, BIOORGAN MED CHEM, V18, P202, DOI 10.1016/j.bmc.2009.11.001; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shukla K, 2011, BIOORG MED CHEM LETT, V21, P6184, DOI 10.1016/j.bmcl.2011.07.081; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Taylor DL, 2003, J NEUROSCI, V23, P2150; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999	50	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0127785	10.1371/journal.pone.0127785	http://dx.doi.org/10.1371/journal.pone.0127785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252954	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100001
J	Burgess, TI				Burgess, Treena I.			Molecular Characterization of Natural Hybrids Formed between Five Related Indigenous Clade 6 Phytophthora Species	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; MITOCHONDRIAL-DNA; PATHOGEN PHYTOPHTHORA; MULTILOCUS PHYLOGENY; EVOLUTIONARY BIOLOGY; RIPARIAN ECOSYSTEMS; ARTIFICIAL HYBRIDS; FUNGAL; SPECIATION; INHERITANCE	Most Phytophthora hybrids characterized to date have emerged from nurseries and managed landscapes, most likely generated as a consequence of biological invasions associated with the movement of living plants and germplasm for ornamental, horticultural and agricultural purposes. Presented here is evidence for natural hybridization among a group of five closely related indigenous clade 6 Phytophthora species isolated from waterways and riparian ecosystems in Western Australia. Molecular characterization of hybrids consisted of cloning and sequencing two nuclear genes (ITS and ASF), sequencing of two further nuclear loci (BT and HSP) and of two mitochondrial loci (COI and NADH). Additionally, phenotypic traits including morphology of sporangia and optima and maxima temperatures for growth were also determined. In most cases the nuclear genes were biparentally and in all cases the mtDNA were uniparentally inherited, indicating hybrid formation through sexual crosses. Some isolates bear the molecular signature of three parents suggesting additional hybrid events, although it cannot be determined from the data if these were sequential or simultaneous. These species and their hybrids co-exist in riparian ecosystems and waterways where their ability for rapid asexual proliferation would enable them to rapidly colonize green plant litter. The apparent ease of hybridization could eventually lead to the merging of species through introgression. However, at this point in time, species integrity has been maintained and a more likely scenario is that the hybrids are not stable evolutionary lineages, but rather transient hybrid clones.	Murdoch Univ, Ctr Phytophthora Sci & Management, Sch Vet & Life Sci, Murdoch, WA 6150, Australia	Murdoch University	Burgess, TI (corresponding author), Murdoch Univ, Ctr Phytophthora Sci & Management, Sch Vet & Life Sci, 90 South St, Murdoch, WA 6150, Australia.	tburgess@murdoch.edu.au	Burgess, Treena/AAB-9587-2021; Burgess, Treena/G-4770-2011	Burgess, Treena/0000-0002-7962-219X; Burgess, Treena/0000-0002-7962-219X	Murdoch University; Centre of Phytophthora Science and Management	Murdoch University; Centre of Phytophthora Science and Management	The work was conducted over several years on funds received through the Centre of Phytophthora Science and Management and from small internal research grants from Murdoch University.	Aghighi S, 2012, EUR J PLANT PATHOL, V133, P841, DOI 10.1007/s10658-012-0006-5; Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; Andjic V, 2007, FEMS MICROBIOL LETT, V268, P22, DOI 10.1111/j.1574-6968.2007.00637.x; Bakonyi J., 2002, Acta Phytopathologica et Entomologica Hungarica, V37, P33, DOI 10.1556/APhyt.37.2002.1-3.5; Beakes GW, 2009, OOMYCETE GENETICS GE; Bertier L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085385; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bonants PJM, 2000, PHYTOPATHOLOGY, V90, P867, DOI 10.1094/PHYTO.2000.90.8.867; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P173, DOI 10.1146/annurev.py.30.090192.001133; BRASIER CM, 1992, ANNU REV PHYTOPATHOL, V30, P153, DOI 10.1146/annurev.py.30.090192.001101; Brasier CM, 2004, MYCOL RES, V108, P1172, DOI 10.1017/S0953756204001005; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; BRASIER CM, 1995, CAN J BOT, V73, pS1213, DOI 10.1139/b95-381; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; BRASIER CM, 1978, T BRIT MYCOL SOC, V70, P297, DOI 10.1016/S0007-1536(78)80050-3; Brasier CM, 2012, P 4 INT WORKSH GEN H; Cooke DEL, 2000, FUNGAL GENET BIOL, V30, P17, DOI 10.1006/fgbi.2000.1202; Coyer JA, 2002, EUR J PHYCOL, V37, P173, DOI 10.1017/S0967026202003682; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Crous PW, 2014, PERSOONIA, V33, P212, DOI 10.3767/003158514X685680; Crous PW, 2012, PERSOONIA, V28, P138, DOI 10.3767/003158512X652633; Crous PW, 2011, PERSOONIA, V26, P108, DOI 10.3767/003158511X581723; Delcan J, 2001, FOREST PATHOL, V31, P65, DOI 10.1046/j.1439-0329.2001.00223.x; ERSEK T, 1995, PHYTOPATHOLOGY, V85, P1343, DOI 10.1094/Phyto-85-1343; Ersek T, 2008, EUR J PLANT PATHOL, V122, P31, DOI 10.1007/s10658-008-9296-z; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; FORSTER H, 1990, EXP MYCOL, V14, P351, DOI 10.1016/0147-5975(90)90058-2; Gonthier P, 2011, MOL ECOL, V20, P2756, DOI 10.1111/j.1365-294X.2011.05121.x; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; Gu YH, 1998, CURR GENET, V34, P120, DOI 10.1007/s002940050375; Hansen E. M., 2015, North American Fungi, V10, P1; Hansen EM, 2012, MYCOLOGIA, V104, P1133, DOI 10.3852/11-349; Hoarau G, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140538; Huberli D, 2013, AUSTRALAS PLANT PATH, V42, P251, DOI 10.1007/s13313-012-0195-6; Hurtado-Gonzales OP, 2009, MYCOLOGIA, V101, P496, DOI 10.3852/08-079; Husson C, 2015, FUNGAL GENET BIOL, V77, P12, DOI 10.1016/j.fgb.2015.02.013; 't Veld WAMI, 2007, EUR J PLANT PATHOL, V117, P25, DOI 10.1007/s10658-006-9065-9; in 't Veld WAM, 2012, MYCOLOGIA, V104, P1390, DOI 10.3852/11-272; Ioos R, 2006, FUNGAL GENET BIOL, V43, P511, DOI 10.1016/j.fgb.2006.02.006; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Judelson H.S., 2009, OOMYCETE GENETICS GE, P121, DOI DOI 10.1002/9780470475898.CH6; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Layton AC, 1998, EXPT MYCOLOGY, V12, P180; LUCAS JA, 1990, PHYSIOL MOL PLANT P, V36, P175, DOI 10.1016/0885-5765(90)90105-7; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MARTIN FN, 1989, CURR GENET, V16, P373, DOI 10.1007/BF00340717; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Nagel JH, 2013, FUNGAL BIOL-UK, V117, P329, DOI 10.1016/j.funbio.2013.03.004; Nechwatal J, 2013, PLANT PATHOL, V62, P355, DOI 10.1111/j.1365-3059.2012.02638.x; Nechwatal J, 2009, PLANT PATHOL, V58, P261, DOI 10.1111/j.1365-3059.2008.01955.x; Nirenberg HI, 2009, MYCOLOGIA, V101, P220, DOI 10.3852/06-157; Oberhofer M, 2012, MOL ECOL, V21, P2713, DOI 10.1111/j.1365-294X.2012.05459.x; Oh E, 2013, IMA FUNGUS, V4, P123, DOI 10.5598/imafungus.2013.04.01.12; Ortiz-Barrientos D, 2009, ANN NY ACAD SCI, V1168, P156, DOI 10.1111/j.1749-6632.2009.04919.x; Peters AF, 2004, EUR J PHYCOL, V39, P235, DOI 10.1080/09670260410001683241; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reeser PW, 2011, MYCOLOGIA, V103, P22, DOI 10.3852/10-013; Restrepo S, 2014, ANNU REV PHYTOPATHOL, V52, P289, DOI 10.1146/annurev-phyto-102313-050056; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sakalidis ML, 2011, FUNGAL ECOL, V4, P1, DOI 10.1016/j.funeco.2010.06.001; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Stukenbrock EH, 2013, NEW PHYTOL, V199, P895, DOI 10.1111/nph.12374; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WHITTAKER SL, 1994, MYCOL RES, V98, P569, DOI 10.1016/S0953-7562(09)80481-4; Yamaji H, 2007, MOL PHYLOGENET EVOL, V44, P863, DOI 10.1016/j.ympev.2007.01.011; Yang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103450	75	40	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134225	10.1371/journal.pone.0134225	http://dx.doi.org/10.1371/journal.pone.0134225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248187	Green Published, gold			2022-12-26	WOS:000359062300029
J	Grosjean, F; Nasi, S; Schneider, P; Chobaz, V; Liu, A; Mordasini, V; Moullec, K; Vezzoni, P; Lavanchy, C; Busso, N; Acha-Orbea, H; Ehirchiou, D				Grosjean, Frederic; Nasi, Sonia; Schneider, Pascal; Chobaz, Veronique; Liu, Alexandra; Mordasini, Vanessa; Moullec, Kristell; Vezzoni, Paolo; Lavanchy, Christine; Busso, Nathalie; Acha-Orbea, Hans; Ehirchiou, Driss			Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis	PLOS ONE			English	Article							T-CELLS; MALIGNANT HISTIOCYTOSIS; OSTEOCLASTS; TRANSDIFFERENTIATION; DIFFERENTIATION; ARTHRITIS; PATHWAY; MICE	Langerhans cell histiocytosis (LCH) is a rare disease caused by the clonal accumulation of dendritic Langerhans cells, which is often accompanied by osteolytic lesions. It has been reported that osteoclast-like cells play a major role in the pathogenic bone destruction seen in patients with LCH and these cells are postulated to originate from the fusion of DCs. However, due to the lack of reliable animal models the pathogenesis of LCH is still poorly understood. In this study, we have established a mouse model of histiocytosis-recapitulating human disease for osteolytic lesions seen in LCH patients. At 12 weeks after birth, severe bone lesions were observed in our multisystem histiocytosis (Mushi) model, when CD8 alpha conventional dendritic cells (DCs) are transformed (MuTuDC) and accumulate. Most importantly, our study demonstrates that bone loss in LCH can be accounted for the transdifferentiation of MuTuDCs into functional osteoclasts both in vivo and in vitro. Moreover, we have shown that injected MuTuDCs reverse the osteopetrotic phenotype of oc/oc mice in vivo. In conclusion, our results support a crucial role of DCs in bone lesions in histiocytosis patients. Furthermore, our new model of LCH based on adoptive transfer of MuTuDC lines, leading to bone lesions within 1-2 weeks, will be an important tool for investigating the pathophysiology of this disease and ultimately for evaluating the potential of anti-resorptive drugs for the treatment of bone lesions.	[Grosjean, Frederic; Schneider, Pascal; Liu, Alexandra; Mordasini, Vanessa; Moullec, Kristell; Lavanchy, Christine; Acha-Orbea, Hans; Ehirchiou, Driss] Univ Lausanne, Dept Biochem CIIL, CH-1066 Epalinges, Switzerland; [Nasi, Sonia; Chobaz, Veronique; Busso, Nathalie] Univ Lausanne, DAL, Serv Rheumatol, Lab Rheumatol,CHUV, CH-1066 Epalinges, Switzerland; [Vezzoni, Paolo] CNR, Milan Unit, UOS IRGB, I-20138 Milan, Italy; [Vezzoni, Paolo] Humanitas Res Ctr, Rozzano, Italy	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital	Acha-Orbea, H (corresponding author), Univ Lausanne, Dept Biochem CIIL, CH-1066 Epalinges, Switzerland.	Hans.Acha-Orbea@unil.ch	Vezzoni, Paolo/R-3416-2019; Vezzoni, Paolo/K-3197-2018	Vezzoni, Paolo/0000-0002-6382-3923; Nasi, Sonia/0000-0002-6625-8309; Grosjean, Frederic/0000-0003-4959-7517; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Histiocytosis Research Trust; FIRB [RBAP11H2R9-OO4]; Progetto Invecchiamento	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Histiocytosis Research Trust; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Progetto Invecchiamento	The work was supported by grants from the Swiss National Science Foundation to HAO and PS, the Histiocytosis Research Trust to HAO and FIRB RBAP11H2R9-OO4 and Progetto Invecchiamento to PV.	Allen CE, 2009, NAT MED, V15, P483, DOI 10.1038/nm0509-483; Alnaeeli M, 2006, J IMMUNOL, V177, P3314, DOI 10.4049/jimmunol.177.5.3314; Alnaeeli M, 2009, BLOOD, V113, P264, DOI 10.1182/blood-2008-09-180836; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Berres ML, 2013, ADV IMMUNOL, V120, P127, DOI 10.1016/B978-0-12-417028-5.00005-3; Cantu MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043257; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Duval A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00338; Egeler RM, 2010, IMMUNOL REV, V234, P213, DOI 10.1111/j.0105-2896.2009.00883.x; FRANZ T, 1985, NATURE, V315, P149, DOI 10.1038/315149a0; Frattini A, 2005, P NATL ACAD SCI USA, V102, P14629, DOI 10.1073/pnas.0507637102; Gallois A, 2010, J BONE MINER RES, V25, P661, DOI 10.1359/jbmr.090829; Johansson M, 2006, EXP HEMATOL, V34, P242, DOI 10.1016/j.exphem.2005.11.010; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; LOHLER J, 1987, LEUKEMIA, V1, P58; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Marraco SAF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00331; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Montella L, 2009, J BONE MINER METAB, V27, P110, DOI 10.1007/s00774-008-0001-2; Morimoto A, 2010, PEDIATR BLOOD CANCER, V54, P98, DOI 10.1002/pbc.22224; Peters TL, 2011, MOL THER, V19, P1433, DOI 10.1038/mt.2011.106; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Ruggiero SL, 2011, ANN NY ACAD SCI, V1218, P38, DOI 10.1111/j.1749-6632.2010.05768.x; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Steiner OG, 2008, BLOOD, V111, P2073, DOI 10.1182/blood-2007-06-097576; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Wakkach A, 2008, BLOOD, V112, P5074, DOI 10.1182/blood-2008-01-132787; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Weitzmann MN, 2001, J BONE MINER RES, V16, P328, DOI 10.1359/jbmr.2001.16.2.328	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133917	10.1371/journal.pone.0133917	http://dx.doi.org/10.1371/journal.pone.0133917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247358	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300023
J	Jia, N; Du, J; Ding, MZ; Gao, F; Yuan, YJ				Jia, Nan; Du, Jin; Ding, Ming-Zhu; Gao, Feng; Yuan, Ying-Jin			Genome Sequence of Bacillus endophyticus and Analysis of Its Companion Mechanism in the Ketogulonigenium vulgare-Bacillus Strain Consortium	PLOS ONE			English	Article							2-KETO-L-GULONIC ACID PRODUCTION; SIGMA-FACTOR; KETOGULONICIGENIUM-VULGARE; GLUCONOBACTER-OXYDANS; STATIONARY-PHASE; LOCAL ALIGNMENT; SUBTILIS; MEGATERIUM; GENE; SPORULATION	Bacillus strains have been widely used as the companion strain of Ketogulonigenium vulgare in the process of vitamin C fermentation. Different Bacillus strains generate different effects on the growth of K. vulgare and ultimately influence the productivity. First, we identified that Bacillus endophyticus Hbe603 was an appropriate strain to cooperate with K. vulgare and the product conversion rate exceeded 90% in industrial vitamin C fermentation. Here, we report the genome sequencing of the B. endophyticus Hbe603 industrial companion strain and speculate its possible advantage in the consortium. The circular chromosome of B. endophyticus Hbe603 has a size of 4.87 Mb with GC content of 36.64% and has the highest similarity with that of Bacillus megaterium among all the bacteria with complete genomes. By comparing the distribution of COGs with that of Bacillus thuringiensis, Bacillus cereus and B. megaterium, B. endophyticus has less genes related to cell envelope biogenesis and signal transduction mechanisms, and more genes related to carbohydrate transport and metabolism, energy production and conversion, as well as lipid transport and metabolism. Genome-based functional studies revealed the specific capability of B. endophyticus in sporulation, transcription regulation, environmental resistance, membrane transportation, extracellular proteins and nutrients synthesis, which would be beneficial for K. vulgare. In particular, B. endophyticus lacks the Rap-Phr signal cascade system and, in part, spore coat related proteins. In addition, it has specific pathways for vitamin B12 synthesis and sorbitol metabolism. The genome analysis of the industrial B. endophyticus will help us understand its cooperative mechanism in the K. vulgare-Bacillus strain consortium to improve the fermentation of vitamin C.	[Jia, Nan; Du, Jin; Ding, Ming-Zhu; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China; [Jia, Nan; Du, Jin; Ding, Ming-Zhu; Yuan, Ying-Jin] Tianjin Univ, Sch Chem Engn & Technol, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, SynBio Res Platform, Tianjin 300072, Peoples R China; [Gao, Feng] Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University; Tianjin University	Gao, F (corresponding author), Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China.	fgao@tju.edu.cn; yjyuan@tju.edu.cn	Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841	Ministry of Science and Technology of China ("973" Program) [2014CB745102]; Ministry of Science and Technology of China ("863" Program) [2012AA02A701, 2015AA020101]; National Natural Science Foundation of China [21390203, 31171238]	Ministry of Science and Technology of China ("973" Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Ministry of Science and Technology of China ("863" Program)(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Ministry of Science and Technology of China ("973" Program: 2014CB745102, "863" Program: 2012AA02A701, 2015AA020101), and the National Natural Science Foundation of China (Major Program: 21390203, general program: 31171238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Derre I, 1999, MOL MICROBIOL, V32, P581, DOI 10.1046/j.1365-2958.1999.01374.x; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; Ding MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094889; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Du J, 2012, METABOLOMICS, V8, P960, DOI 10.1007/s11306-011-0392-2; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Eppinger M, 2011, J BACTERIOL, V193, P4199, DOI 10.1128/JB.00449-11; Feng S, 2000, J APPL ECOL, V11, P119; Figueiredo MVB, 2008, WORLD J MICROB BIOT, V24, P1187, DOI 10.1007/s11274-007-9591-4; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Horsburgh MJ, 1999, MOL MICROBIOL, V32, P41, DOI 10.1046/j.1365-2958.1999.01323.x; Hua ZG, 2015, NUCLEIC ACIDS RES, V43, pW85, DOI 10.1093/nar/gkv491; Huang Z, 2013, J BIOTECHNOL, V164, P454, DOI 10.1016/j.jbiotec.2013.01.007; Ito M, 1999, J BACTERIOL, V181, P2394, DOI 10.1128/JB.181.8.2394-2402.1999; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; Lee YJ, 2012, J BACTERIOL, V194, P5705, DOI 10.1128/JB.01316-12; Li Y, 2001, WEI SHENG WU XUE ZA, V22, P32; Li Y, 2001, WEI SHENG WU XUE ZA, V22, P26; Liu LM, 2011, J BACTERIOL, V193, P6389, DOI 10.1128/JB.06066-11; Liu LM, 2011, J BIOTECHNOL, V156, P182, DOI 10.1016/j.jbiotec.2011.08.007; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Ma Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091789; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032156; Ma Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026108; Mandlaa, 2013, BIOTECHNOL LETT, V35, P1853, DOI 10.1007/s10529-013-1292-5; Martin-Verstraete I, 1999, J BACTERIOL, V181, P2966, DOI 10.1128/JB.181.9.2966-2969.1999; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Prasad A, 2011, IIOAB J, V2, P55; Reva ON, 2002, INT J SYST EVOL MICR, V52, P101, DOI 10.1099/00207713-52-1-101; RONNER U, 1990, J APPL BACTERIOL, V69, P550, DOI 10.1111/j.1365-2672.1990.tb01547.x; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takagi Y, 2009, APPL MICROBIOL BIOT, V82, P1049, DOI 10.1007/s00253-008-1822-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; VOELKER U, 1995, J BACTERIOL, V177, P3771, DOI 10.1128/jb.177.13.3771-3780.1995; Wang FY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004027; WOLF JB, 1986, J BACTERIOL, V166, P51, DOI 10.1128/jb.166.1.51-58.1986; Xu A, 2004, J APPL MICROBIOL, V96, P1317, DOI 10.1111/j.1365-2672.2004.02270.x; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Ye C, 2014, J BIOTECHNOL, V182, P61, DOI 10.1016/j.jbiotec.2014.04.027; Yin GL, 1997, IND MICROBIOL, V27, P1; YUAN ZY, 1992, ANN NY ACAD SCI, V672, P628; Zhang J, 2011, BIORESOURCE TECHNOL, V102, P4807, DOI 10.1016/j.biortech.2010.10.124; Zhou J, 2012, OMICS, V16, P387, DOI 10.1089/omi.2011.0047; Zhou J, 2011, APPL ENVIRON MICROB, V77, P7023, DOI 10.1128/AEM.05123-11; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zhu YB, 2012, BIORESOURCE TECHNOL, V107, P399, DOI 10.1016/j.biortech.2011.12.080	77	16	23	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135104	10.1371/journal.pone.0135104	http://dx.doi.org/10.1371/journal.pone.0135104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248285	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300100
J	Markham, BE; Kernodle, S; Nemzek, J; Wilkinson, JE; Sigler, R				Markham, Bruce E.; Kernodle, Stace; Nemzek, Jean; Wilkinson, John E.; Sigler, Robert			Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin(-/-) Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HEART-FAILURE; UTROPHIN; SKELETAL; MODEL; MOUSE; CARDIOMYOPATHY; MECHANISMS; FIBROSIS; FENTANYL	Poloxamer 188 NF (national formulary (NF) grade of P-188) improves cardiac muscle function in the mdx mouse and golden retriever muscular dystrophy models. However in vivo effects on skeletal muscle have not been reported. We postulated that P-188 NF might protect diaphragm muscle membranes from contraction-induced injury in mdx and mdx/utrophin(-/-) (dko) muscular dystrophy models. In the first study 7-month old mdx mice were treated for 22 weeks with subcutaneous (s.c.) injections of saline or P-188 NF at 3 mg/Kg. In the second, dkos were treated with saline or P-188 NF (1 mg/Kg) for 8 weeks beginning at age 3 weeks. Prednisone was the positive control in both studies. Respiratory function was monitored using unrestrained whole body plethysmography. P-188 NF treatment affected several respiratory parameters including tidal volume/BW and minute volume/BW in mdx mice. In the more severe dko model, P-188 NF (1 mg/Kg) significantly slowed the decline in multiple respiratory parameters compared with saline-treated dko mice. Prednisone's effects were similar to those seen with P-188 NF. Diaphragms from P-188 NF or prednisone treated mdx and dko mice showed signs of muscle fiber protection including less centralized nuclei, less variation in fiber size, greater fiber density, and exhibited a decreased amount of collagen deposition. P-188 NF at 3 mg/Kg s.c. also improved parameters of systolic and diastolic function in mdx mouse hearts. These results suggest that P-188 NF may be useful in treating respiratory and cardiac dysfunction, the leading causes of death in Duchenne muscular dystrophy patients.	[Markham, Bruce E.; Kernodle, Stace] Phrixus Pharmaceut Inc, Ann Arbor, MI 48104 USA; [Nemzek, Jean; Wilkinson, John E.; Sigler, Robert] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI USA; [Wilkinson, John E.] Univ Michigan, Sch Med, Dept Pathol & Comparat Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Markham, BE (corresponding author), Phrixus Pharmaceut Inc, Ann Arbor, MI 48104 USA.	bruce.markham@phrixuspharmaceuticals.com			Small Business Innovative Research Grants from the NINDS [R43 NS070327]; NHLBI [R43 HL110464]; Duchenne Alliance; Phrixus Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL110464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS070327] Funding Source: NIH RePORTER	Small Business Innovative Research Grants from the NINDS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Duchenne Alliance; Phrixus Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Small Business Innovative Research Grants R43 NS070327 from the NINDS, and R43 HL110464 from the NHLBI and a grant from the Duchenne Alliance to BEM. Phrixus Pharmaceuticals provided support in the form of salaries for authors [BEM, SK]. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agarwal J, 2005, ANN NY ACAD SCI, V1066, P295, DOI 10.1196/annals.1363.027; Allen DG, 2011, INT J BIOCHEM CELL B, V43, P290, DOI 10.1016/j.biocel.2010.11.005; Bach JR, 2010, AM J PHYS MED REHAB, V89, P620, DOI 10.1097/PHM.0b013e3181e72207; BLAIR JR, 1989, ANESTHESIOLOGY, V71, P565, DOI 10.1097/00000542-198910000-00015; BOYD Y, 1986, J MED GENET, V23, P484, DOI 10.1136/jmg.23.6.484; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brookes ZLS, 2003, ANESTH ANALG, V96, P456, DOI 10.1097/00000539-200302000-00030; Call JA, 2011, J APPL PHYSIOL, V111, P200, DOI 10.1152/japplphysiol.00248.2011; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Chetboul V, 2004, EUR HEART J, V25, P1934, DOI 10.1016/j.ehj.2004.09.007; Cui GL, 2002, SCAND J GASTROENTERO, V37, P750, DOI 10.1080/00365520213249; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dubach-Powell J, 2008, QUANTITATIVE DETERMI; Duncan DJ, 2007, BRIT J PHARMACOL, V150, P720, DOI 10.1038/sj.bjp.0707147; EDMONDSSEAL J, 1970, BRIT J ANAESTH, V42, P207, DOI 10.1093/bja/42.3.207; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Finsterer J, 2013, CARDIOVASC PATHOL, V22, P389, DOI 10.1016/j.carpath.2012.12.008; Fisher A, 2010, INT J CLIN PHARM TH, V48, P138; Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1; Goonasekera SA, 2014, HUM MOL GENET, V23, P3706, DOI 10.1093/hmg/ddu079; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Harisseh R, 2013, AM J PHYSIOL-CELL PH, V304, pC881, DOI 10.1152/ajpcell.00182.2012; HERTSENS R, 1984, BIOCHIM BIOPHYS ACTA, V769, P411, DOI 10.1016/0005-2736(84)90325-0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Houang EM, 2015, MDA SCI SESS MARCH 2; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Ilsar I, 2010, J AM COL CARDIOL, V55; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Juneman EB, 2012, J CARDIOVASC PHARM, V60, P293, DOI 10.1097/FJC.0b013e31825f6f88; Kamogawa Y, 2001, CARDIOVASC RES, V50, P509, DOI 10.1016/S0008-6363(01)00205-X; Khurana TS, 2008, RESP SYSTEM EVALUATI; Lee B, 2008, BIOMACROMOLECULES, V9, P1541, DOI 10.1021/bm701348r; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Liu F, 2001, Mol Interv, V1, P168; Lorin C, 2015, CARDIOVASC RES, V106, P153, DOI 10.1093/cvr/cvv021; Lynch GS, 2004, CLIN EXP PHARMACOL P, V31, P557, DOI 10.1111/j.1440-1681.2004.04026.x; Manzur AY, 2008, ARCH DIS CHILD, V93, P986, DOI 10.1136/adc.2007.118141; Maskarinec SA, 2005, ANN NY ACAD SCI, V1066, P310, DOI 10.1196/annals.1363.018; Melacini P, 1998, NEUROMUSCULAR DISORD, V8, P585, DOI 10.1016/S0960-8966(98)00071-6; MENKE A, 1995, J CELL SCI, V108, P727; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Ng R, 2008, AM J PHYSIOL-CELL PH, V295, pC146, DOI 10.1152/ajpcell.00017.2008; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; PADANILAM JT, 1994, ANN NY ACAD SCI, V720, P111, DOI 10.1111/j.1749-6632.1994.tb30439.x; Quinlan JG, 2006, NEUROMUSCULAR DISORD, V16, P855, DOI 10.1016/j.nmd.2006.09.016; Ryall JG, 2007, FASEB J, V21, pA945; Schaer GL, 1996, CIRCULATION, V94, P298, DOI 10.1161/01.CIR.94.3.298; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Steinhardt RA, 2005, ANN NY ACAD SCI, V1066, P152, DOI 10.1196/annals.1363.017; Suzuki N, 2012, NEUROSCI RES, V72, P181, DOI 10.1016/j.neures.2011.10.005; Terry RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091221; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	62	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134832	10.1371/journal.pone.0134832	http://dx.doi.org/10.1371/journal.pone.0134832			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248188	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300069
J	Braverman, ER; Blum, K; Hussman, KL; Han, D; Dushaj, K; Li, M; Marin, G; Badgaiyan, RD; Smayda, R; Gold, MS				Braverman, Eric R.; Blum, Kenneth; Hussman, Karl L.; Han, David; Dushaj, Kristina; Li, Mona; Marin, Gabriela; Badgaiyan, Rajendra D.; Smayda, Richard; Gold, Mark S.			Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CORTICAL THICKNESS; SEX-DIFFERENCES; OLDER-ADULTS; SCALE-III; MEMORY; DEFICITS; DECLINE; VOLUMES; VARIABILITY	To our knowledge, this is the largest study evaluating relationships between 3T Magnetic Resonance Imaging (MRI) and P300 and memory/cognitive tests in the literature. The 3T MRI using NeuroQuant has an increased resolution 15 times that of 1.5T MRI. Utilizing NeuroQuant 3T MRI as a diagnostic tool in primary care, subjects (N=169; 19-90 years) displayed increased areas of anatomical atrophy: 34.62% hippocampal atrophy (N=54), 57.14% central atrophy (N=88), and 44.52% temporal atrophy (N=69). A majority of these patients exhibited overlap in measured areas of atrophy and were cognitively impaired. These results positively correlated with decreased P300 values and WMS-III (WMS-III) scores differentially across various brain loci. Delayed latency (p=0.0740) was marginally associated with temporal atrophy; reduced fractional anisotropy (FA) in frontal lobes correlated with aging, delayed P300 latency, and decreased visual and working memory (p=0.0115). Aging and delayed P300 latency correlated with lower FA. The correlation between working memory and reduced FA in frontal lobes is marginally significant (p=0.0787). In the centrum semiovale (CS), reduced FA correlated with visual memory (p=0.0622). Lower demyelination correlated with higher P300 amplitude (p=0.0002). Compared to males, females have higher demyelination (p=0.0064). Along these lines, the higher the P300 amplitude, the lower the bilateral atrophy (p=0.0165). Hippocampal atrophy correlated with increased auditory memory and gender, especially in males (p=0.0087). In considering temporal lobe atrophy correlations: delayed P300 latency and high temporal atrophy (p=0.0740); high auditory memory and low temporal atrophy (p=0.0417); and high working memory and low temporal atrophy (p=0.0166). Central atrophy correlated with aging and immediate memory (p=0.0294): the higher the immediate memory, the lower the central atrophy. Generally, the validation of brain atrophy by P300 and WMS-III could lead to cost-effective methods utilizable in primary care medicine following further confirmation.	[Braverman, Eric R.; Blum, Kenneth; Gold, Mark S.] Univ Florida, Coll Med, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Braverman, Eric R.; Blum, Kenneth; Dushaj, Kristina; Li, Mona; Marin, Gabriela; Smayda, Richard] PATH Fdn NY, Dept Clin Neurol, New York, NY USA; [Blum, Kenneth] Univ Vermont, Coll Med, Human Integrated Serv, Ctr Clin & Translat Sci, Burlington, VT 05401 USA; [Blum, Kenneth] Domin Diagnost LLC, Dept Addict Serv, North Kingstown, RI USA; [Hussman, Karl L.] Alpha 3T MRI & Diagnost Imaging, New York, NY USA; [Han, David] Univ Texas San Antonio, Dept Management Sci & Stat, San Antonio, TX USA; [Badgaiyan, Rajendra D.] Univ Minnesota, Sch Med, Dept Psychiat, Neuroimaging Ctr, Minneapolis, MN 55455 USA	State University System of Florida; University of Florida; University of Vermont; University of Texas System; University of Texas at San Antonio (UTSA); University of Minnesota System; University of Minnesota Twin Cities	Braverman, ER (corresponding author), Univ Florida, Coll Med, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA.	info@pathfoundationny.org	Badgaiyan, Rajendra D/B-8183-2012; Braverman, Eric new/ABC-1152-2021		Life Extension Foundation; National Institutes of Health grants [1R01NS073884, 1R21MH073624]; VA Merit Review Awards [CX000479, CX000780]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073884] Funding Source: NIH RePORTER	Life Extension Foundation; National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Awards(US Department of Veterans Affairs); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All authors are grateful to the Life Extension Foundation for their generous financial support. RDB is supported by the National Institutes of Health grants 1R01NS073884 and 1R21MH073624, and VA Merit Review Awards CX000479 and CX000780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Balota DA, 1999, COGNITIVE NEUROPSYCH, V16, P361, DOI 10.1080/026432999380834; Bozzali M, 2012, HUM BRAIN MAPP, V33, P1295, DOI 10.1002/hbm.21287; Braverman ER, 2003, CLIN ELECTROENCEPHAL, V34, P124, DOI 10.1177/155005940303400306; Braverman ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055398; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Castellazzi G, 2014, FRONT NEUROSCI-SWITZ, V8, P1, DOI 10.3389/fnins.2014.00223; Cover KS, 2014, PSYCHIAT RES-NEUROIM, V224, P14, DOI 10.1016/j.pscychresns.2014.07.002; COWELL PE, 1994, J NEUROSCI, V14, P4748; Croes EA, 2003, ANN NEUROL, V54, P275, DOI 10.1002/ana.10658; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; Del'Guidice T, 2014, NEUROPSYCHOPHARMACOL, V39, P1125, DOI 10.1038/npp.2013.313; Derix J, 2014, HUM BRAIN MAPP, V35, P4316, DOI 10.1002/hbm.22477; Di Maria E, 2010, J ALZHEIMERS DIS, V19, P909, DOI 10.3233/JAD-2010-1285; Doxey CR, 2015, HIPPOCAMPUS, V25, P524, DOI 10.1002/hipo.22389; Dube JB, 2013, J ALZHEIMERS DIS, V33, P831, DOI 10.3233/JAD-2012-121477; Erten-Lyons D, 2013, NEUROLOGY, V81, P977, DOI 10.1212/WNL.0b013e3182a43e45; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Fortea J, 2014, ANN NEUROL, V76, P223, DOI 10.1002/ana.24186; Gottesman RF, 2014, JAMA NEUROL, V71, P1218, DOI 10.1001/jamaneurol.2014.1646; Helbecque N, 2008, DEMENT GERIATR COGN, V25, P97, DOI 10.1159/000112176; Herholz K, 2002, J NUCL MED, V43, P21; Hurtz S, 2014, DEMENT GER COGN D EX, V4, P221, DOI 10.1159/000362872; Iidaka T, 2014, BRAIN RES, V1591, P74, DOI 10.1016/j.brainres.2014.10.003; Ivanoiu A, 2015, J ALZHEIMERS DIS, V43, P835, DOI 10.3233/JAD-140651; Kemmotsu N, 2012, J NEUROSCI, V32, P12204, DOI 10.1523/JNEUROSCI.0136-12.2012; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Li WJ, 2014, HUM BRAIN MAPP, V35, P238, DOI 10.1002/hbm.22168; Lindenberger U, 2008, FRONT NEUROSCI-SWITZ, V2, P234, DOI 10.3389/neuro.01.039.2008; Lopez-Oloriz J, 2014, CEREBROVASC DIS, V38, P24, DOI 10.1159/000363620; Miki Yukio, 2013, Brain Nerve, V65, P789; Moller C, 2014, EUR RADIOL, V24, P397, DOI 10.1007/s00330-013-3025-5; Nadkarni NK, 2014, J GERONTOL A-BIOL, V69, P996, DOI 10.1093/gerona/glt151; Nguyen VQ, 2014, J CLIN EXP NEUROPSYC, V36, P607, DOI 10.1080/13803395.2014.919992; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU, P314; Nieves-Martinez E, 2010, J ENDOCRINOL, V204, P31, DOI 10.1677/JOE-09-0323; Olichney JM, 2011, J ALZHEIMERS DIS, V26, P215, DOI 10.3233/JAD-2011-0047; ONOFRJ M, 1995, ELECTROEN CLIN NEURO, V94, P432, DOI 10.1016/0013-4694(94)00332-F; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Petersen R. C., 2003, MILD COGNITIVE IMPAI; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Richter A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00250; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Rudenko A, 2014, NEUROPHARMACOLOGY, V80, P70, DOI 10.1016/j.neuropharm.2014.01.043; Sauvage C, 2014, J NEURORADIOLOGY; Seelye AM, 2009, J CLIN EXP NEUROPSYC, V31, P682, DOI 10.1080/13803390802484763; Serra L, 2010, J ALZHEIMERS DIS, V21, P627, DOI 10.3233/JAD-2010-100048; SMITH CD, 1995, ANN NEUROL, V38, P194, DOI 10.1002/ana.410380211; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Suades-Gonzalez E, 2009, REV NEUROLOGIA, V49, P623, DOI 10.33588/rn.4912.2009048; Sumelahti ML, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/186950; Szamosi A, 2013, CORTEX, V49, P1892, DOI 10.1016/j.cortex.2012.11.001; Talfournier J, 2013, Diabetes Metab, V39, P418, DOI 10.1016/j.diabet.2013.02.008; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Tiedt HO, 2013, NEUROSCI LETT, V544, P115, DOI 10.1016/j.neulet.2013.03.056; Toth Cory, 2014, Handb Clin Neurol, V126, P489, DOI 10.1016/B978-0-444-53480-4.00035-7; Vallender EJ, 2009, AM J MED GENET B, V150B, P467, DOI 10.1002/ajmg.b.30835; van der Vlies AE, 2013, J ALZHEIMERS DIS, V35, P169, DOI 10.3233/JAD-121291; van Dinteren R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087347; Weaver ICG, 2014, ADV GENET, V86, P277, DOI 10.1016/B978-0-12-800222-3.00011-5; Wollenweber FA, 2014, J NEUROL, V261, P277, DOI 10.1007/s00415-013-7181-y; Woodard JL, 2009, BRAIN, V132, P2068, DOI 10.1093/brain/awp157	63	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133609	10.1371/journal.pone.0133609	http://dx.doi.org/10.1371/journal.pone.0133609			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244349	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400052
J	Garcia-Lazaro, JA; Shepard, KN; Miranda, JA; Liu, RC; Lesica, NA				Garcia-Lazaro, Jose A.; Shepard, Kathryn N.; Miranda, Jason A.; Liu, Robert C.; Lesica, Nicholas A.			An Overrepresentation of High Frequencies in the Mouse Inferior Colliculus Supports the Processing of Ultrasonic Vocalizations	PLOS ONE			English	Article							COMBINATION-SENSITIVE NEURONS; BRAIN-STEM RESPONSE; AUDITORY-CORTEX; TONOTOPIC ORGANIZATION; COCHLEAR NUCLEUS; INBRED STRAINS; HEARING-LOSS; HOUSE MOUSE; REPRESENTATION; BAT	Mice are of paramount importance in biomedical research and their vocalizations are a subject of interest for researchers across a wide range of health-related disciplines due to their increasingly important value as a phenotyping tool in models of neural, speech and language disorders. However, the mechanisms underlying the auditory processing of vocalizations in mice are not well understood. The mouse audiogram shows a peak in sensitivity at frequencies between 15-25 kHz, but weaker sensitivity for the higher ultrasonic frequencies at which they typically vocalize. To investigate the auditory processing of vocalizations in mice, we measured evoked potential, single-unit, and multi-unit responses to tones and vocalizations at three different stages along the auditory pathway: the auditory nerve and the cochlear nucleus in the periphery, and the inferior colliculus in the midbrain. Auditory brainstem response measurements suggested stronger responses in the midbrain relative to the periphery for frequencies higher than 32 kHz. This result was confirmed by single- and multi-unit recordings showing that high ultrasonic frequency tones and vocalizations elicited responses from only a small fraction of cells in the periphery, while a much larger fraction of cells responded in the inferior colliculus. These results suggest that the processing of communication calls in mice is supported by a specialization of the auditory system for high frequencies that emerges at central stations of the auditory pathway.	[Garcia-Lazaro, Jose A.; Lesica, Nicholas A.] UCL, Ear Inst, London WC1X 8EE, England; [Shepard, Kathryn N.; Miranda, Jason A.; Liu, Robert C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	University of London; University College London; Emory University	Garcia-Lazaro, JA (corresponding author), UCL, Ear Inst, 332 Grays Inn Rd, London WC1X 8EE, England.	jose.garcia-lazaro@ucl.ac.uk	Miranda, Jason/B-8043-2009	Miranda, Jason/0000-0002-1459-2022; Liu, Robert/0000-0003-2450-8194; Lesica, Nicholas/0000-0001-5238-4462	German Research Foundation (DFG); Wellcome Trust; National Institute of Deafness and Communication Disorders Grant [DC008343]; NIH Institutional Research and Academic Career Development Award [K12 GM000680]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008343] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Deafness and Communication Disorders Grant; NIH Institutional Research and Academic Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the German Research Foundation (DFG), the Wellcome Trust (NAL), the National Institute of Deafness and Communication Disorders Grant DC008343 (RCL, KNS & JAM) and the NIH Institutional Research and Academic Career Development Award K12 GM000680 (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUNS V, 1980, HEARING RES, V3, P27, DOI 10.1016/0378-5955(80)90006-4; Choi YS, 2010, IEEE T BIO-MED ENG, V57, P2771, DOI 10.1109/TBME.2010.2049266; CHUNG SH, 1987, J NEUROSCI METH, V19, P125, DOI 10.1016/0165-0270(87)90027-6; Don M, 1998, J ACOUST SOC AM, V104, P2280, DOI 10.1121/1.423741; EHRET G, 1984, HEARING RES, V14, P45, DOI 10.1016/0378-5955(84)90068-6; EHRET G, 1974, NATURWISSENSCHAFTEN, V61, P506, DOI 10.1007/BF00622976; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; FITZPATRICK DC, 1993, J NEUROSCI, V13, P931; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; HOFSTETTER KM, 1992, J COMP NEUROL, V323, P370, DOI 10.1002/cne.903230306; Honma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068113; Ingham NJ, 1998, ACTA OTO-LARYNGOL, V118, P673; Kayser C, 2007, J NEUROPHYSIOL, V98, P1806, DOI 10.1152/jn.00358.2007; KING AJ, 1994, HEARING RES, V81, P137, DOI 10.1016/0378-5955(94)90161-9; KOSSL M, 1985, J COMP PHYSIOL A, V157, P687, DOI 10.1007/BF01351362; Lieggi CC, 2005, CONTEMP TOP LAB ANIM, V44, P17; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; McGinley MJ, 2012, J NEUROSCI, V32, P9301, DOI 10.1523/JNEUROSCI.0272-12.2012; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Miranda JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101630; MITTMANN DH, 1995, HEARING RES, V90, P185, DOI 10.1016/0378-5955(95)00164-X; MULLER M, 1992, J COMP PHYSIOL A, V171, P469; Muniak MA, 2014, J COMP NEUROL, V522, P937, DOI 10.1002/cne.23454; Muniak MA, 2013, J COMP NEUROL, V521, P1510, DOI 10.1002/cne.23238; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2009, NEUROSCIENCE, V162, P486, DOI 10.1016/j.neuroscience.2009.04.056; Portfors CV, 2005, NEUROSCIENCE, V136, P1159, DOI 10.1016/j.neuroscience.2005.08.031; Portfors CV, 2002, HEARING RES, V168, P131, DOI 10.1016/S0378-5955(02)00376-3; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044816; Schmitzer-Torbert N, 2005, NEUROSCIENCE, V131, P1, DOI 10.1016/j.neuroscience.2004.09.066; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; STIEBLER I, 1985, J COMP NEUROL, V238, P65, DOI 10.1002/cne.902380106; Stiebler I, 1997, J COMP PHYSIOL A, V181, P559, DOI 10.1007/s003590050140; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Woolley SMN, 2013, HEARING RES, V305, P45, DOI 10.1016/j.heares.2013.05.005; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	51	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133251	10.1371/journal.pone.0133251	http://dx.doi.org/10.1371/journal.pone.0133251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244986	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400037
J	Genchi, M; Prati, P; Vicari, N; Manfredini, A; Sacchi, L; Clementi, E; Bandi, C; Epis, S; Fabbi, M				Genchi, Marco; Prati, Paola; Vicari, Nadia; Manfredini, Andrea; Sacchi, Luciano; Clementi, Emanuela; Bandi, Claudio; Epis, Sara; Fabbi, Massimo			Francisella tularensis: No Evidence for Transovarial Transmission in the Tularemia Tick Vectors Dermacentor reticulatus and Ixodes ricinus	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTION; HOST	Background Tularemia is a zoonosis caused by the Francisella tularensis, a highly infectious Gram-negative coccobacillus. Due to easy dissemination, multiple routes of infection, high environmental contamination and morbidity and mortality rates, Francisella is considered a potential bioterrorism threat and classified as a category A select agent by the CDC. Tick bites are among the most prevalent modes of transmission, and ticks have been indicated as a possible reservoir, although their reservoir competence has yet to be defined. Tick-borne transmission of F. tularensis was recognized in 1923, and transstadial transmission has been demonstrated in several tick species. Studies on transovarial transmission, however, have reported conflicting results. Objective The aim of this study was to evaluate the role of ticks as reservoirs for Francisella, assessing the transovarial transmission of F. tularensis subsp. holarctica in ticks, using experimentally-infected females of Dermacentor reticulatus and Ixodes ricinus. Results Transmission electron microscopy and fluorescence in situ hybridization showed F. tularensis within oocytes. However, cultures and bioassays of eggs and larvae were negative; in addition, microscopy techniques revealed bacterial degeneration/death in the oocytes. Conclusions These results suggest that bacterial death might occur in oocytes, preventing the transovarial transmission of Francisella. We can speculate that Francisella does not have a defined reservoir, but that rather various biological niches (e.g. ticks, rodents), that allow the bacterium to persist in the environment. Our results, suggesting that ticks are not competent for the bacterium vertical transmission, are congruent with this view.	[Genchi, Marco; Prati, Paola; Vicari, Nadia; Manfredini, Andrea; Fabbi, Massimo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Natl Reference Lab Tularemia, Pavia, Italy; [Sacchi, Luciano; Clementi, Emanuela] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Bandi, Claudio; Epis, Sara] Univ Milan, Dept Vet Sci & Publ Hlth Divet, Milan, Italy	IZS Lombardia e Emilia; University of Pavia; University of Milan	Genchi, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Natl Reference Lab Tularemia, Pavia, Italy.	marco.genchi@libero.it	EPIS, SARA/B-7708-2017; Genchi, Marco/L-2244-2019; Vicari, Nadia/HCH-8694-2022; Bandi, Claudio/J-7835-2018	EPIS, SARA/0000-0001-8807-4802; Genchi, Marco/0000-0003-3768-2482; Bandi, Claudio/0000-0002-0181-4618; Vicari, Nadia/0000-0001-8156-0138	Italian Ministry of Health [PRC 2010/001]	Italian Ministry of Health(Ministry of Health, Italy)	Support was provided by the Italian Ministry of Health: Current research funds PRC 2010/001 [http://www.salute.gov.it/] to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BELL JF, 1945, J INFECT DIS, V76, P83, DOI 10.1093/infdis/76.2.83; Brown RN, 2005, TICK-BORNE DISEASES OF HUMANS, P363; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; Carvalho CL, 2014, COMP IMMUNOL MICROB, V37, P85, DOI 10.1016/j.cimid.2014.01.002; Cringoli G., 2005, MAPPE PARASSITOLOGIC; El-Etr SH, 2009, APPL ENVIRON MICROB, V75, P7488, DOI 10.1128/AEM.01829-09; Epis S, 2013, TICKS TICK-BORNE DIS, V4, P39, DOI 10.1016/j.ttbdis.2012.06.005; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Friedel M., 2006, 1297 US GEOL SURV, P1; Goethert HK, 2011, VECTOR-BORNE ZOONOT, V11, P1263, DOI 10.1089/vbz.2010.0237; Gurycova D, 2010, EPIDEMIOL MIKROBI IM, V59, P39; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; HOPLA C. E., 1953, JOUR KANSAS ENT SOC, V26, P72; HOPLA CE, 1955, AM J HYG, V61, P371, DOI 10.1093/oxfordjournals.aje.a119761; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; Hubalek Z, 1996, MED VET ENTOMOL, V10, P241, DOI 10.1111/j.1365-2915.1996.tb00737.x; Krocova Z, 2003, J PARASITOL, V89, P14, DOI 10.1645/0022-3395(2003)089[0014:TSGEAP]2.0.CO;2; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Mailles A, 2013, BILAN 10 ANNEES SURV; Mani RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035441; Manilla G., 1998, ACARI IXODIDA, V36; Milutinovic M, 2008, EXP APPL ACAROL, V45, P171, DOI 10.1007/s10493-008-9166-6; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Olsufiev NG, 1941, C PAR PROBL, p[10, 60]; PARKER R. R., 1926, Public Health Reports, V41, P1403, DOI 10.2307/4577933; Parker RR, 1924, PUBLIC HEALTH REP, V39, P1057, DOI 10.2307/4577151; Petersen JM, 2010, FUTURE MICROBIOL, V5, P649, DOI 10.2217/FMB.10.17; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; Petersen JM, 2005, VET RES, V36, P455, DOI 10.1051/vetres:2005006; PETROV V. G., 1962, MED PARAZITOL I PARAZITAR BOLEZNI, V31, P62; PETROV VG, 1960, J PARASITOL, V46, P877, DOI 10.2307/3275554; PHILIP C. B., 1934, Public Health Reports, V49, P386, DOI 10.2307/4581119; Reese SM, 2011, J MED ENTOMOL, V48, P884, DOI 10.1603/ME11005; ROMANOVA V. P., 1955, Materials for the Study of a Nidus of Tularaemia in a flooded Area., P83; SAITO YUTAKA, 1962, ACTA MED ET BIOL, V10, P147; Splettstoesser W, 2010, J CLIN MICROBIOL, V48, P1629, DOI 10.1128/JCM.01475-09; Thelaus J, 2014, MICROB ECOL, V67, P96, DOI 10.1007/s00248-013-0285-1; van Hoek ML, 2013, VIRULENCE, V4, P833, DOI 10.4161/viru.27023; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003	40	19	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133593	10.1371/journal.pone.0133593	http://dx.doi.org/10.1371/journal.pone.0133593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244842	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400050
J	Kaplan, RM; Irvin, VL				Kaplan, Robert M.; Irvin, Veronica L.			Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time	PLOS ONE			English	Article							PIPELINE; CLINICALTRIALS.GOV; PUBLICATION	Background We explore whether the number of null results in large National Heart Lung, and Blood Institute (NHLBI) funded trials has increased over time. Methods We identified all large NHLBI supported RCTs between 1970 and 2012 evaluating drugs or dietary supplements for the treatment or prevention of cardiovascular disease. Trials were included if direct costs >$500,000/year, participants were adult humans, and the primary outcome was cardiovascular risk, disease or death. The 55 trials meeting these criteria were coded for whether they were published prior to or after the year 2000, whether they registered in clinicaltrials.gov prior to publication, used active or placebo comparator, and whether or not the trial had industry co-sponsorship. We tabulated whether the study reported a positive, negative, or null result on the primary outcome variable and for total mortality. Results 17 of 30 studies (57%) published prior to 2000 showed a significant benefit of intervention on the primary outcome in comparison to only 2 among the 25 (8%) trials published after 2000 (chi(2)=12.2, df= 1, p=0.0005). There has been no change in the proportion of trials that compared treatment to placebo versus active comparator. Industry co-sponsorship was unrelated to the probability of reporting a significant benefit. Pre-registration in clinical trials.gov was strongly associated with the trend toward null findings. Conclusions The number NHLBI trials reporting positive results declined after the year 2000. Prospective declaration of outcomes in RCTs, and the adoption of transparent reporting standards, as required by clinicaltrials. gov, may have contributed to the trend toward null findings.	[Kaplan, Robert M.] US Dept HHS, Agcy Healthcare Res & Qual, Rockville, MD 20852 USA; [Irvin, Veronica L.] Oregon State Univ, Corvallis, OR 97331 USA	Agency for Healthcare Research & Quality; Oregon State University	Kaplan, RM (corresponding author), US Dept HHS, Agcy Healthcare Res & Qual, Rockville, MD 20852 USA.	Robert.Kaplan@ahrq.hhs.gov	KAPLAN, Robert/AAK-7342-2021	Irvin, Veronica/0000-0001-6337-9108	NIH intramural program	NIH intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was completed while both authors were employees of the National Institutes of Health. The work was supported by the NIH intramural program.	Cottingham MD, 2014, CTS-CLIN TRANSL SCI, V7, P297, DOI 10.1111/cts.12163; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fisher JA, 2015, SOC SCI MED, V131, P322, DOI 10.1016/j.socscimed.2014.08.023; Fordyce CB, 2015, J AM COLL CARDIOL, V65, P1567, DOI 10.1016/j.jacc.2015.03.016; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Roth JA, 2014, ANN INTERN MED, V160, P594, DOI 10.7326/M13-2348; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	11	144	149	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132382	10.1371/journal.pone.0132382	http://dx.doi.org/10.1371/journal.pone.0132382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244868	Green Published, gold			2022-12-26	WOS:000359061400022
J	Kittinger, JN; Teneva, LT; Koike, H; Stamoulis, KA; Kittinger, DS; Oleson, KLL; Conklin, E; Gomes, M; Wilcox, B; Friedlander, AM				Kittinger, John N.; Teneva, Lida T.; Koike, Haruko; Stamoulis, Kostantinos A.; Kittinger, Daniela S.; Oleson, Kirsten L. L.; Conklin, Eric; Gomes, Mahana; Wilcox, Bart; Friedlander, Alan M.			From Reef to Table: Social and Ecological Factors Affecting Coral Reef Fisheries, Artisanal Seafood Supply Chains, and Seafood Security	PLOS ONE			English	Article							SMALL-SCALE FISHERIES; MARINE RESOURCE-MANAGEMENT; FOOD SECURITY; HUMAN DIMENSIONS; AMERICAN-SAMOA; MARKET ACCESS; FISH; COMANAGEMENT; KNOWLEDGE; BIOMASS	Ocean and coastal ecosystems provide critical fisheries, coastal protection, and cultural benefits to communities worldwide, but these services are diminishing due to local and global threats. In response, place-based strategies involve communities and resource users in management have proliferated. Here, we present a transferable community-based approach to assess the social and ecological factors affecting resource sustainability and food security in a small-scale, coral reef fishery. Our results show that this small-scale fishery provides large-scale benefits to communities, including 7,353 +/- 1547 kg yr(-1) (mean +/- SE) of seafood per year, equating to >30,000 meals with an economic value of $78,432. The vast majority of the catch is used for subsistence, contributing to community food security: 58% is kept, 33.5% is given away, and 8.5% is sold. Our spatial analysis assesses the geographic distribution of community beneficiaries from the fishery (the "food shed" for the fishery), and we document that 20% of seafood procured from the fishery is used for sociocultural events that are important for social cohesion. This approach provides a method for assessing social, economic, and cultural values provided by small-scale food systems, as well as important contributions to food security, with significant implications for conservation and management. This interdisciplinary effort aims to demonstrate a transferable participatory research approach useful for resource-dependent communities as they cope with socioeconomic, cultural, and environmental change.	[Kittinger, John N.; Teneva, Lida T.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Honolulu, HI 96825 USA; [Kittinger, John N.; Kittinger, Daniela S.] Stanford Univ, Ctr Ocean Solut, Stanford Woods Inst Environm, Monterey, CA USA; [Koike, Haruko; Stamoulis, Kostantinos A.; Friedlander, Alan M.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Oleson, Kirsten L. L.] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Conklin, Eric] Nat Conservancy Hawaii, Honolulu, HI USA; [Gomes, Mahana; Wilcox, Bart] Hui Aloha Kiholo, Kiholo Bay, HI USA; [Friedlander, Alan M.] Pristine Seas, Natl Geog Soc, Washington, DE USA	Conservation International; Stanford University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Nature Conservancy; National Geographic Society	Kittinger, JN (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, 7192 Kalanianaole Hwy, Honolulu, HI 96825 USA.	jkittinger@gmail.com	Oleson, Kirsten/M-7741-2015	Oleson, Kirsten/0000-0002-7992-5051; Stamoulis, Kostantinos/0000-0003-2688-4695	NSF grant [OCE 1325874]; Conservation International's Hawai'i program; National Oceanic and Atmospheric Administration Coral Reef Conservation Program [NA14NOS4820095]	NSF grant(National Science Foundation (NSF)); Conservation International's Hawai'i program; National Oceanic and Atmospheric Administration Coral Reef Conservation Program	Partial support for the work was provided by NSF grant OCE 1325874. In addition, this research was supported by grants from Conservation International's Hawai'i program to the Hui Aloha Kiholo program, and from the National Oceanic and Atmospheric Administration Coral Reef Conservation Program, as administered by the Office of Ocean and Coastal Resource Management, to The Nature Conservancy (NA14NOS4820095). The funders (Conservation International - Hawai'i) had a role in designing the study, collecting the data and performing the data analysis.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Aguilera S, PLOS ONE; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], 1994, COLLABORATIVE COMMUN; Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Ayers AL, 2014, GLOBAL ENVIRON CHANG, V28, P251, DOI 10.1016/j.gloenvcha.2014.07.006; Babcock EA, 2011, CAN J FISH AQUAT SCI, V68, P343, DOI 10.1139/F10-146; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Basurto X, 2012, HUM ECOL, V40, P597, DOI 10.1007/s10745-012-9508-1; Battista T. A, 2007, 61 NOAA NOS NCCOS, V61; Bell, 2011, VULNERABILITY TROPIC; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Bene C, 2010, WORLD DEV, V38, P933, DOI 10.1016/j.worlddev.2009.12.010; Bergseth BJ, 2013, FISH FISHER IN PRESS; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Berkes F, 2010, ENVIRON CONSERV, V37, P489, DOI 10.1017/S037689291000072X; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Brewer T. D., 2011, CORAL REEF FISH VALU; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; BROCK RE, 1982, B MAR SCI, V32, P269; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; California Environmental Associates, 2012, CHART COURS SUST FIS; Cesar H., 2003, EC WORLDWIDE CORAL R; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Chuenpagdee R, 2007, MAR POLICY, V31, P657, DOI 10.1016/j.marpol.2007.03.013; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Conservation Alliance for Sustainable Seafood, 2014, GUID SUPP FISH IMPR; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Fabinyi M, 2010, COAST MANAGE, V38, P617, DOI 10.1080/08920753.2010.523412; FAO, 2007, FAO FISHERIES TECHNI; Feagan R, 2007, PROG HUM GEOG, V31, P23, DOI 10.1177/0309132507073527; Finkbeiner EM, 2015, MAR POLICY, V51, P433, DOI 10.1016/j.marpol.2014.10.010; Friedlander A. M., 2012, DESIGN DEV IMPLEMENT; Friedlander AM, 2013, PAC SCI, V67, P441, DOI 10.2984/67.3.10; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 1997, FISH RES, V32, P33, DOI 10.1016/S0165-7836(97)00038-6; Friedlander AM, 2014, MARINE HIST ECOLOGY; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Glazier E. W., 2012, FISHING SEAFOOD COMM; Glazier E, 2013, PAC SCI, V67, P345, DOI 10.2984/67.3.4; Glazier EW, 2007, CASE STUDIES CULTURA, P1; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hicks CC, 2011, COAST MANAGE, V39, P358, DOI 10.1080/08920753.2011.589219; Hicks CC, 2009, ECOL SOC, V14; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Iles A, 2007, J CLEAN PROD, V15, P577, DOI 10.1016/j.jclepro.2006.06.001; Jacquet J, 2010, AFR J MAR SCI, V32, P197, DOI 10.2989/1814232X.2010.501559; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; JENTOFT S, 1989, MAR POLICY, V13, P137, DOI 10.1016/0308-597X(89)90004-3; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Jones C, 2006, CREEL SURVEYS ENCY E; Karr KA, 2015, J APPL ECOL, V52, P402, DOI 10.1111/1365-2664.12388; Kittinger JN, 2013, PAC SCI, V67, P361, DOI 10.2984/67.3.5; Kittinger JN, 2013, PAC SCI, V67, P315, DOI 10.2984/67.3.1; Kittinger JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025460; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Levine AS, 2014, ECOL SOC, V19, DOI 10.5751/ES-06191-190124; Loper C, 2008, SOCIOECONOMIC CONDIT; Loring PA, 2013, J AGRIC FOOD SYST CO, V3, P13, DOI 10.5304/jafscd.2013.033.006; Lowitt K, 2013, J HUNGER ENVIRON NUT, V8, P221, DOI 10.1080/19320248.2013.786668; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Malvestuto S.P., 1983, P397; MALVESTUTO SP, 1978, T AM FISH SOC, V107, P255, DOI 10.1577/1548-8659(1978)107<255:AEOTRC>2.0.CO;2; Malvestuto Stephen P., 1996, P591; Marjolein BAV, 2002, GLOBAL ENVIRON CHANG, V12, P167; Matsuoka Jon K., 1994, GOVERNORS MOLOKAI SU; McClanahan T, 2013, FISH FISHERIES; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; McGregor D, 2007, N KUAINA LIVING HAWA; McGregor Davianna Pomaika'i, 2003, Pac Health Dialog, V10, P106; McGregor DP., 1998, PACIFIC HLTH DIALOG, V5, P361; Milne NA, 2012, CORAL REEF FISH DEAL; Moberg F, 2003, OCEAN COAST MANAGE, V46, P27, DOI 10.1016/S0964-5691(02)00119-9; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nowlis J, NOVEL TECHNIQU UNPUB; Nystrom M, 2012, TANZANIA MARINE POLI, P246, DOI DOI 10.1016/J.MARP0L.2012.05.041; O'Rourke D, 2014, SCIENCE, V344, P1124, DOI 10.1126/science.1248526; Osorio Jonathan Kamakawioole., 2002, DISMEMBERING LAHUI H; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pauly D, 2014, CURR OPIN ENV SUST, V7, P44, DOI 10.1016/j.cosust.2013.11.027; Peters CJ, 2009, RENEW AGR FOOD SYST, V24, P1, DOI 10.1017/S1742170508002433; Pinkerton Evelyn, 1989, COOPERATIVE MANAGEME; Pomeroy RS, 1997, MAR POLICY, V21, P465, DOI 10.1016/S0308-597X(97)00017-1; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Scholz A, 2004, MAR POLICY, V28, P335, DOI 10.1016/j.marpol.2003.09.003; Severance C, 2013, PAC SCI, V67, P383, DOI 10.2984/67.3.6; Smith BG, 2008, PHILOS T R SOC B, V363, P849, DOI 10.1098/rstb.2007.2187; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; Sustainable Fisheries Partnership, 2014, FISH IMPR PROJ TOOLK; Teh LSL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065397; Teh LSL, 2011, FISH RES, V110, P450, DOI 10.1016/j.fishres.2011.06.001; Thompson Jr E., 2008, THINK GLOBALLY EAT L; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; US Census Bureau, 2014, SMALL AR INC POV EST; Van Barneveld Wendy, 1996, Proceedings of the Gulf and Caribbean Fisheries Institute, V44, P195; Vaughan MB, MARINE POLICY UNPUB; Vaughan MB, 2013, PAC SCI, V67, P329, DOI 10.2984/67.3.3; Wamukota A, 2014, MAR POLICY, V48, P93, DOI 10.1016/j.marpol.2014.03.013; Weeratunge N., 2013, FISH FISHERIES; WHYTE WF, 1989, AM BEHAV SCI, V32, P513, DOI 10.1177/0002764289032005003; Zeller D, 2006, CORAL REEFS, V25, P144, DOI 10.1007/s00338-005-0067-4	109	67	70	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0123856	10.1371/journal.pone.0123856	http://dx.doi.org/10.1371/journal.pone.0123856			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244910	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400002
J	Hamers, AAJ; van Dam, L; Duarte, JMT; Vos, M; Marinkovic, G; van Tiel, CM; Meijer, SL; van Stalborch, AM; Huveneers, S; Velde, AAT; de Jonge, WJ; de Vries, CJM				Hamers, Anouk A. J.; van Dam, Laura; Duarte, Jose M. Teixeira; Vos, Mariska; Marinkovic, Goran; van Tiel, Claudia M.; Meijer, Sybren L.; van Stalborch, Anne-Marieke; Huveneers, Stephan; Velde, Anje A. te; de Jonge, Wouter J.; de Vries, Carlie J. M.			Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFkB Activity in Macrophages	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESTABLISHED EXPERIMENTAL COLITIS; INTESTINAL EPITHELIAL-CELLS; REGULATORY T-CELLS; FACTOR-KAPPA-B; CROHNS-DISEASE; ULCERATIVE-COLITIS; ORPHAN RECEPTOR; TRANSGENIC MICE; GENE-EXPRESSION	Nuclear receptor Nur77, also referred to as NR4A1 or TR3, plays an important role in innate and adaptive immunity. Nur77 is crucial in regulating the T helper 1/regulatory T-cell balance, is expressed in macrophages and drives M2 macrophage polarization. In this study we aimed to define the function of Nur77 in inflammatory bowel disease. In wild-type and Nur77(-/-) mice, colitis development was studied in dextran sodium sulphate (DSS)- and 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced models. To understand the underlying mechanism, Nur77 was overexpressed in macrophages and gut epithelial cells. Nur77 protein is expressed in colon tissues from Crohn's disease and Ulcerative colitis patients and colons from colitic mice in inflammatory cells and epithelium. In both mouse colitis models inflammation was increased in Nur77(-/-) mice. A higher neutrophil influx and enhanced IL-6, MCP-1 and KC production was observed in Nur77-deficient colons after DSS-treatment. TNBS-induced influx of T-cells and inflammatory monocytes into the colon was higher in Nur77(-/-) mice, along with increased expression of MCP-1, TNF alpha and IL-6, and decreased Foxp3 RNA expression, compared to wild-type mice. Overexpression of Nur77 in lipopolysaccharide activated RAW macrophages resulted in up-regulated IL-10 and downregulated TNF alpha, MIF-1 and MCP-1 mRNA expression through NFkB repression. Nur77 also strongly decreased expression of MCP-1, CXCL1, IL-8, MIP-1 alpha and TNFa in gut epithelial Caco-2 cells. Nur77 overexpression suppresses the inflammatory status of both macrophages and gut epithelial cells and together with the in vivo mouse data this supports that Nur77 has a protective function in experimental colitis. These findings may have implications for development of novel targeted treatment strategies regarding inflammatory bowel disease and other inflammatory diseases.	[Hamers, Anouk A. J.; van Dam, Laura; Vos, Mariska; Marinkovic, Goran; van Tiel, Claudia M.; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Duarte, Jose M. Teixeira; Velde, Anje A. te; de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst, NL-1105 AZ Amsterdam, Netherlands; [Meijer, Sybren L.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van Stalborch, Anne-Marieke; Huveneers, Stephan] Univ Amsterdam, Dept Mol Cell Biol, Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; [van Stalborch, Anne-Marieke; Huveneers, Stephan] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.uva.nl	Marinkovic, Goran/ABC-6786-2020; Duarte, José Maurício Barbanti/AAG-5149-2019	Duarte, José Maurício Barbanti/0000-0002-7805-0265; Meijer, Sybren/0000-0002-6953-2406; Marinkovic, Goran/0000-0002-3581-9900; Huveneers, Stephan/0000-0002-1091-475X; van Dam, Laura/0000-0001-6373-7673	Netherlands Heart Foundation, The Hague [2008B037]; VIDI [91796310]; GlaxoSmithKline corporation; VENI [863.10.003]	Netherlands Heart Foundation, The Hague(Netherlands Heart Foundation); VIDI(Netherlands Organization for Scientific Research (NWO)); GlaxoSmithKline corporation(GlaxoSmithKline); VENI(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Netherlands Heart Foundation, The Hague; grant #2008B037 (https://www.hartstichting.nl/wetenschappers/subsidiewijzer). Wouter de Jonge was supported by a VIDI grant 91796310, and receives financial support from GlaxoSmithKline corporation (http://www.nwo.nl/financiering/onze-financieringsinstrumenten/nwo/vernieuwingsimpuls/vidi/index.html) (http://www.gsk.com/). Stephan Huveneers was supported by a VENI grant #863.10.003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Alzoghaibi Mohammed Abdullah, 2005, Saudi J Gastroenterol, V11, P63; Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Bonta PI, 2006, ARTERIOSCL THROM VAS, V26, P2288, DOI 10.1161/01.ATV.0000238346.84458.5d; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Camoglio L, 1998, INFLAMM BOWEL DIS, V4, P285, DOI 10.1002/ibd.3780040406; Camoglio L, 2000, EUR J IMMUNOL, V30, P1486, DOI 10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; COOPER HS, 1993, LAB INVEST, V69, P238; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Dassopoulos T, 2013, GASTROENTEROLOGY, V145, P1464, DOI 10.1053/j.gastro.2013.10.046; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Diatchenko L, 2005, J LEUKOCYTE BIOL, V78, P1366, DOI 10.1189/jlb.0405211; Edens HA, 2002, J IMMUNOL, V169, P476, DOI 10.4049/jimmunol.169.1.476; Fassett MS, 2012, P NATL ACAD SCI USA, V109, P3891, DOI 10.1073/pnas.1200090109; Foell D, 2008, J PATHOL, V216, P183, DOI 10.1002/path.2394; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hamers AAJ, 2014, INFECT IMMUN, V82, P253, DOI 10.1128/IAI.00721-13; Hamers AAJ, 2012, CIRC RES, V110, P428, DOI 10.1161/CIRCRESAHA.111.260760; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hansen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081491; Harant H, 2004, NUCLEIC ACIDS RES, V32, P5280, DOI 10.1093/nar/gkh856; He X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03416; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hilgendorf I, 2014, CIRC RES, V114, P1611, DOI 10.1161/CIRCRESAHA.114.303204; ISHIOKA T, 1987, CRIT REV TOXICOL, V17, P215, DOI 10.3109/10408448709071209; Kim P, 2010, NAT METHODS, V7, P303, DOI [10.1038/NMETH.1440, 10.1038/nmeth.1440]; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; KUMAR NB, 1982, AM J SURG PATHOL, V6, P523, DOI 10.1097/00000478-198209000-00004; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Loftus CG, 2007, INFLAMM BOWEL DIS, V13, P254, DOI 10.1002/ibd.20029; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; MacDonald TT, 2012, DIGEST DIS, V30, P392, DOI 10.1159/000338136; MACDONALD TT, 1990, CLIN EXP IMMUNOL, V81, P301; Marinkovic G, 2014, INFLAMM BOWEL DIS, V20, P1487, DOI 10.1097/MIB.0000000000000122; Marsal J, 2012, J INTERN MED, V272, P411, DOI 10.1111/j.1365-2796.2012.02588.x; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5688, DOI 10.3748/wjg.v18.i40.5688; Natoli M, 2012, TOXICOL IN VITRO, V26, P1243, DOI 10.1016/j.tiv.2012.03.009; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Pols TWH, 2007, CURR OPIN LIPIDOL, V18, P515, DOI 10.1097/MOL.0b013e3282ef77d1; Pols TWH, 2010, ARTERIOSCL THROM VAS, V30, P1591, DOI 10.1161/ATVBAHA.110.205674; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Scharl M, 2012, CURR OPIN GASTROEN, V28, P301, DOI 10.1097/MOG.0b013e328353e61e; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shao Q, 2010, J MOL CELL CARDIOL, V49, P304, DOI 10.1016/j.yjmcc.2010.03.023; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Stuber E, 1996, J EXP MED, V183, P693, DOI 10.1084/jem.183.2.693; Varga T, 2013, J IMMUNOL, V191, P5695, DOI 10.4049/jimmunol.1301445; Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995, DOI 10.1097/01.mib.0000227817.54969.5e; Verstege MI, 2008, J HISTOCHEM CYTOCHEM, V56, P233, DOI 10.1369/jhc.7A7308.2007; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; Wansa KDSA, 2003, J BIOL CHEM, V278, P24776, DOI 10.1074/jbc.M300088200; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Yu CH, 2014, EUR J PHARMACOL, V741, P90, DOI 10.1016/j.ejphar.2014.07.039; Zhao DZ, 2011, P NATL ACAD SCI USA, V108, P12066, DOI 10.1073/pnas.1018438108; Zheng J, 2008, INFECT IMMUN, V76, P4498, DOI 10.1128/IAI.01317-07; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	79	42	43	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133598	10.1371/journal.pone.0133598	http://dx.doi.org/10.1371/journal.pone.0133598			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241646	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700017
J	Saravia, G; Civeira, F; Hurtado-Roca, Y; Andres, E; Leon, M; Pocovi, M; Ordovas, J; Guallar, E; Fernandez-Ortiz, A; Casasnovas, JA; Laclaustra, M				Saravia, Gabriela; Civeira, Fernando; Hurtado-Roca, Yamilee; Andres, Eva; Leon, Montserrat; Pocovi, Miguel; Ordovas, Jose; Guallar, Eliseo; Fernandez-Ortiz, Antonio; Antonio Casasnovas, Jose; Laclaustra, Martin			Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline	PLOS ONE			English	Article							CARDIOVASCULAR RISK; DIABETES-MELLITUS; HYPERINSULINEMIA; ASSOCIATION; RESISTANCE; GLUCOSE; A1C; SENSITIVITY; DEFINITION; CRITERION	Background and Aims Glycated hemoglobin (HbA1c) is currently used to diagnose diabetes mellitus, while insulin has been relegated to research. Both, however, may help understanding the metabolic syndrome and profiling patients. We examined the association of HbA1c and fasting insulin with clustering of metabolic syndrome criteria and insulin resistance as two essential characteristics of the metabolic syndrome. Methods We used baseline data from 3200 non-diabetic male participants in the Aragon Workers' Health Study. We conducted analysis to estimate age-adjusted odds ratios (ORs) across tertiles of HbA1c and insulin. Fasting glucose and Homeostatic model assessment - Insulin Resistance were used as reference. Here we report the uppermost-to-lowest tertile ORs (95% CI). Results Mean age (SD) was 48.5 (8.8) years and 23% of participants had metabolic syndrome. The ORs for metabolic syndrome criteria tended to be higher across HbA1c than across glucose, except for high blood pressure. Insulin was associated with the criteria more strongly than HbA1c and similarly to Homeostatic model assessment - Insulin Resistance (HOMA-IR). For metabolic syndrome, the OR of HbA1c was 2.68, of insulin, 11.36, of glucose, 7.03, and of HOMA-IR, 14.40. For the clustering of 2 or more non-glycemic criteria, the OR of HbA1c was 2.10, of insulin, 8.94, of glucose, 1.73, and of HOMA-IR, 7.83. All ORs were statistically significant. The areas under the receiver operating characteristics curves for metabolic syndrome were 0.670 (across HbA1c values) and 0.770 (across insulin values), and, for insulin resistance, 0.647 (HbA1c) and 0.995 (insulin). Among non-metabolic syndrome patients, a small insulin elevation identified risk factor clustering. Conclusions HbA1c and specially insulin levels were associated with metabolic syndrome criteria, their clustering, and insulin resistance. Insulin could provide early information in subjects prone to develop metabolic syndrome.	[Saravia, Gabriela; Hurtado-Roca, Yamilee; Ordovas, Jose; Fernandez-Ortiz, Antonio; Laclaustra, Martin] Spanish Natl Ctr Cardiovasc Res CNIC, Dept Epidemi Atherothrombosis & Imaging, Madrid, Spain; [Civeira, Fernando; Leon, Montserrat; Pocovi, Miguel; Antonio Casasnovas, Jose] Inst Aragones Ciencias Salud I CS, Zaragoza, Spain; [Hurtado-Roca, Yamilee] Boca Raton Clin Res Global Peru, Lima, Peru; [Andres, Eva] CIBER Epidemiol Salud Publ, Inst Invest Octubre 12, Madrid, Spain; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Fernandez-Ortiz, Antonio] Univ Complutense, Hosp Clin San Carlos, E-28040 Madrid, Spain; [Laclaustra, Martin] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, Madrid, Spain; [Laclaustra, Martin] St Louis Univ, Dept Epidemiol, St Louis, MO 63103 USA	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Saint Louis University	Laclaustra, M (corresponding author), Spanish Natl Ctr Cardiovasc Res CNIC, Dept Epidemi Atherothrombosis & Imaging, Madrid, Spain.	mlaclaustra@cnic.es	Fernandez-Ortiz, Antonio/B-2227-2017; Lenguas, José Antonio Casasnovas/F-4038-2010; Laclaustra, Martín/C-6709-2015	Fernandez-Ortiz, Antonio/0000-0002-3239-1910; Lenguas, José Antonio Casasnovas/0000-0002-9887-2629; Laclaustra, Martín/0000-0003-3963-0846; HURTADO-ROCA, YAMILEE/0000-0003-1993-6223	Instituto de Salud Carlos III [FIS CP08/00112]; Peruvian government [088-FINCyT-BDE-2014]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III [PI14/00009, PI12/01087, PI12/01703, PI10/00021]; Fondo Europeo de Desarrollo Regional; RETIC RIC from Instituto de Salud Carlos III [RD12/0042/0055]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Peruvian government; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional(European Commission); RETIC RIC from Instituto de Salud Carlos III(Instituto de Salud Carlos III)	M. Laclaustra was supported in part by grant FIS CP08/00112 from Instituto de Salud Carlos III. Y. Hurtado-Roca was supported by Scholarship No 088-FINCyT-BDE-2014 from Peruvian government. This study was supported in part by grants PI14/00009, PI12/01087, PI12/01703, PI10/00021 (Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III), co-funding by Fondo Europeo de Desarrollo Regional (FEDER 2007-2013), and RETIC RIC RD12/0042/0055 from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Fabiola M S, 2006, Acta Med Indones, V38, P179; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; Casasnovas JA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-45; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Dilley J, 2007, DIABETES CARE, V30, P1527, DOI 10.2337/dc06-2414; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Howard G, 1998, ANN EPIDEMIOL, V8, P358, DOI 10.1016/S1047-2797(98)00002-7; Janghorbani M, 2012, DIABETES METAB SYND, V6, P136, DOI 10.1016/j.dsx.2012.09.011; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kawada T, 2012, J OCCUP ENVIRON MED, V54, P984, DOI 10.1097/JOM.0b013e31825335ae; Kim HK, 2012, DIABETES RES CLIN PR, V95, P333, DOI 10.1016/j.diabres.2011.10.012; Kim SH, 2011, DIABETIC MED, V28, P1487, DOI 10.1111/j.1464-5491.2011.03409.x; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Laclaustra M, 2007, NUTR METAB CARDIOVAS, V17, P125, DOI [10.1016/j.numecd.2006.10.005, 10.1038/ki.2008.517]; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ong KL, 2010, DIABETES CARE, V33, P1856, DOI 10.2337/dc10-0190; Park SH, 2012, J KOREAN MED SCI, V27, P1057, DOI 10.3346/jkms.2012.27.9.1057; R Core Team, 2021, R LANGUAGE ENV STAT; Rutter MK, 2008, CIRCULATION, V117, P1003, DOI 10.1161/CIRCULATIONAHA.107.727727; Sacks DB, 2012, DIABETES CARE, V35, P2674, DOI 10.2337/dc12-1348; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Staten MA, 2010, DIABETES CARE, V33, P205, DOI 10.2337/dc09-1206; Succurro E, 2011, AM J CARDIOL, V107, P1650, DOI 10.1016/j.amjcard.2011.01.055; Sung KC, 2007, DIABETIC MED, V24, P848, DOI 10.1111/j.1464-5491.2007.02146.x; Turchiano M, 2012, ARCH PEDIAT ADOL MED, V166, P1030, DOI 10.1001/archpediatrics.2012.1263; Voidonikola PT, 2008, OBESITY, V16, P2658, DOI 10.1038/oby.2008.431; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132244	10.1371/journal.pone.0132244	http://dx.doi.org/10.1371/journal.pone.0132244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241903	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700004
J	Byun, S; Lim, S; Mun, JY; Kim, KH; Ramadhar, TR; Farrand, L; Shin, SH; Thimmegowda, NR; Lee, HJ; Frank, DA; Clardy, J; Lee, SW; Lee, KW				Byun, Sanguine; Lim, Semi; Mun, Ji Young; Kim, Ki Hyun; Ramadhar, Timothy R.; Farrand, Lee; Shin, Seung Ho; Thimmegowda, N. R.; Lee, Hyong Joo; Frank, David A.; Clardy, Jon; Lee, Sam W.; Lee, Ki Won			Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-PRODUCTS; GROWTH-FACTOR; CANCER-CELLS; EXPRESSION; APOPTOSIS; ACTIVATION; DRUG; BIM; 6-SHOGAOL; EXTRACT	Bioactive phytochemicals can suppress the growth of malignant cells, and investigation of the mechanisms responsible can assist in the identification of novel therapeutic strategies for cancer therapy. Ginger has been reported to exhibit potent anticancer effects, although previous reports have often focused on a narrow range of specific compounds. Through a direct comparison of various ginger compounds, we determined that gingerenone A selectively kills cancer cells while exhibiting minimal toxicity toward normal cells. Kinase array screening revealed JAK2 and S6K1 as the molecular targets primarily responsible for gingerenone A-induced cancer cell death. The effect of gingerenone A was strongly associated with relative phosphorylation levels of JAK2 and S6K1, and administration of gingerenone A significantly suppressed tumor growth in vivo. More importantly, the combined inhibition of JAK2 and S6K1 by commercial inhibitors selectively induced apoptosis in cancer cells, whereas treatment with either agent alone did not. These findings provide rationale for dual targeting of JAK2 and S6K1 in cancer for a combinatorial therapeutic approach.	[Byun, Sanguine; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Byun, Sanguine; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Byun, Sanguine; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea; [Lim, Semi; Lee, Hyong Joo; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul 151742, South Korea; [Mun, Ji Young] Eulji Univ, Coll Hlth Sci, Dept Biomed Lab Sci, Songnam 461463, South Korea; [Kim, Ki Hyun; Ramadhar, Timothy R.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Ki Hyun] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Farrand, Lee] Yuhan Corp, Yuhan Res Inst, Yongin 446902, South Korea; [Shin, Seung Ho] Univ Minnesota, Program Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA; [Thimmegowda, N. R.] Govt Sri Krishnarajendra Silver Jubilee Technol I, Dept Chem, Bangalore 560001, Karnataka, India; [Frank, David A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Thimmegowda, N. R.] Korea Res Inst Biosci & Biotechnol, World Class Inst, Ochang 363883, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU); Seoul National University (SNU); Eulji University; Harvard University; Harvard Medical School; Sungkyunkwan University (SKKU); University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Dana-Farber Cancer Institute; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; swlee@mgh.harvard.edu; kiwon@snu.ac.kr	Ramadhar, Timothy R./AAF-5820-2019; Regan, Clinton/E-6250-2012; Byun, Sanguine/AAR-5451-2021; Lee, Ki Won/M-4114-2018	Ramadhar, Timothy R./0000-0002-7063-5445; Byun, Sanguine/0000-0003-3903-5887; Shin, Seung Ho/0000-0002-2694-3889	National Institutes of Health [1RO1CA142805, 1RO1CA149477]; National Leap Research Program through National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea [2010-0029233]; F32 postdoctoral fellowship from the National Institutes of Health [GM108415]; NATIONAL CANCER INSTITUTE [R01CA142805, R01CA149477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Leap Research Program through National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea; F32 postdoctoral fellowship from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA142805 and 1RO1CA149477 (NCI). This work was also supported by the National Leap Research Program (2010-0029233) through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (MSIP) of Korea, Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an F32 postdoctoral fellowship from the National Institutes of Health (GM108415).	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bode AM, 2011, HERBAL MED BIOMOLECU, V2nd, P129; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Byun S, 2013, CARCINOGENESIS, V34, P397, DOI 10.1093/carcin/bgs358; Chakraborty D, 2012, EUR J PHARMACOL, V694, P20, DOI 10.1016/j.ejphar.2012.08.001; Chen BJ, 2014, CANCER LETT, V354, P378, DOI 10.1016/j.canlet.2014.08.045; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Filonenko VV, 2004, EXP ONCOL, V26, P294; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillings AS, 2009, FEBS J, V276, P6050, DOI 10.1111/j.1742-4658.2009.07329.x; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; GOVINDARAJAN VS, 1982, CRC CR REV FOOD SCI, V17, P1; Gundala SR, 2014, CARCINOGENESIS, V35, P1320, DOI 10.1093/carcin/bgu011; Hart S, 2011, LEUKEMIA, V25, P1751, DOI 10.1038/leu.2011.148; Ip CKM, 2012, EXPERT OPIN THER TAR, V16, P619, DOI 10.1517/14728222.2012.684680; Karna P, 2012, BRIT J NUTR, V107, P473, DOI 10.1017/S0007114511003308; Katiyar SK, 1996, CANCER RES, V56, P1023; Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t; Koh EM, 2009, PLANTA MED, V75, P148, DOI 10.1055/s-0028-1088347; Kundu JK, 2009, FORUM NUTR, V61, P182, DOI 10.1159/000212750; LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li FF, 2014, INT J CANCER, V134, P1257, DOI 10.1002/ijc.28261; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Liu Q, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-135; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pan MH, 2008, MOL NUTR FOOD RES, V52, P1467, DOI 10.1002/mnfr.200700515; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Peng F, 2012, FITOTERAPIA, V83, P568, DOI 10.1016/j.fitote.2011.12.028; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Saha A, 2014, CANCER PREV RES, V7, P627, DOI 10.1158/1940-6207.CAPR-13-0420; Sahin F, 2004, CLIN CANCER RES, V10, P8421, DOI 10.1158/1078-0432.CCR-04-0941; Sakamoto K, 2009, CANCER RES, V69, P6642, DOI 10.1158/0008-5472.CAN-09-0746; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Seavey MM, 2012, BIOCHEM PHARMACOL, V83, P1136, DOI 10.1016/j.bcp.2011.12.024; Sehrawat A, 2014, BREAST CANCER RES TR, V146, P543, DOI 10.1007/s10549-014-3059-7; Sung BK, 2012, NUTR CANCER, V64, P173, DOI 10.1080/01635581.2012.630551; Tao Y, 2009, J AGR FOOD CHEM, V57, P10014, DOI 10.1021/jf9020224; Taylor IW, 2012, PROTEOMICS, V12, P1706, DOI 10.1002/pmic.201100594; Venkateswarlu S, 2001, INDIAN J CHEM B, V40, P495; Weigert O, 2012, J EXP MED, V209, P259, DOI 10.1084/jem.20111694; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404; Zick SM, 2011, CANCER PREV RES, V4, P1929, DOI 10.1158/1940-6207.CAPR-11-0224	60	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23553	23562		10.1074/jbc.M115.662445	http://dx.doi.org/10.1074/jbc.M115.662445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242912	Green Published, hybrid			2022-12-26	WOS:000361816500008
J	Bacher, JW; Sievers, CK; Albrecht, DM; Grimes, IC; Weiss, JM; Matkowskyj, KA; Agni, RM; Vyazunova, I; Clipson, L; Storts, DR; Thliveris, AT; Halberg, RB				Bacher, Jeffery W.; Sievers, Chelsie K.; Albrecht, Dawn M.; Grimes, Ian C.; Weiss, Jennifer M.; Matkowskyj, Kristina A.; Agni, Rashmi M.; Vyazunova, Irina; Clipson, Linda; Storts, Douglas R.; Thliveris, Andrew T.; Halberg, Richard B.			Improved Detection of Microsatellite Instability in Early Colorectal Lesions	PLOS ONE			English	Article							DNA MISMATCH REPAIR; LYNCH-SYNDROME; SERRATED PATHWAY; CANCER-PATIENTS; ADENOMAS; MUTATION; IDENTIFICATION; GUIDELINES; COLON; CARCINOMAS	Microsatellite instability (MSI) occurs in over 90% of Lynch syndrome cancers and is considered a hallmark of the disease. MSI is an early event in colon tumor development, but screening polyps for MSI remains controversial because of reduced sensitivity compared to more advanced neoplasms. To increase sensitivity, we investigated the use of a novel type of marker consisting of long mononucleotide repeat (LMR) tracts. Adenomas from 160 patients, ranging in age from 29-55 years old, were screened for MSI using the newmarkers and compared with current marker panels and immunohistochemistry standards. Overall, 15 tumors were scored as MSI-High using the LMRs compared to 9 for the NCI panel and 8 for the MSI Analysis System (Promega). This difference represents at least a 1.7-fold increase in detection of MSI-High lesions over currently available markers. Moreover, the number of MSI-positive markers per sample and the size of allelic changes were significantly greater with the LMRs (p = 0.001), which increased confidence in MSI classification. The overall sensitivity and specificity of the LMR panel for detection of mismatch repair deficient lesions were 100% and 96%, respectively. In comparison, the sensitivity and specificity of the MSI Analysis System were 67% and 100%; and for the NCI panel, 75% and 97%. The difference in sensitivity between the LMR panel and the other panels was statistically significant (p<0.001). The increased sensitivity for detection of MSI-High phenotype in early colorectal lesions with the new LMR markers indicates that MSI screening for the early detection of Lynch syndrome might be feasible.	[Bacher, Jeffery W.; Vyazunova, Irina; Storts, Douglas R.] Promega Corp, Genet Anal Grp, Madison, WI USA; [Sievers, Chelsie K.; Matkowskyj, Kristina A.; Agni, Rashmi M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA; [Bacher, Jeffery W.; Albrecht, Dawn M.; Grimes, Ian C.; Weiss, Jennifer M.; Halberg, Richard B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Clipson, Linda] Univ Wisconsin Madison, Dept Oncol, Madison, WI USA; [Thliveris, Andrew T.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	Promega Corporation; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Halberg, RB (corresponding author), Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rbhalberg@medicine.wisc.edu		Sievers, Chelsie/0000-0003-0088-753X; Weiss, Jennifer/0000-0002-4927-2133	Promega Corporation; School of Public Health and Medicine, the Department of Medicine, Division of Gastroenterology and Hepatology; Carbone Cancer Center at University of Wisconsin [P30 CA014520]; Mentored Research Scholar Grant in Applied and Clinical Research from the American Cancer Society [MRSG-13-144-01-CPHPS]; University of Wisconsin Institute for Clinical and Translational Research through the National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Promega Corporation; School of Public Health and Medicine, the Department of Medicine, Division of Gastroenterology and Hepatology; Carbone Cancer Center at University of Wisconsin; Mentored Research Scholar Grant in Applied and Clinical Research from the American Cancer Society; University of Wisconsin Institute for Clinical and Translational Research through the National Center for Advancing Translational Sciences (NCATS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was a collaboration between investigators at the Promega Corporation and the University of Wisconsin. Support was provided to JWB and RBH from the Promega Corporation and to RBH from the School of Public Health and Medicine, the Department of Medicine, Division of Gastroenterology and Hepatology, as well as Carbone Cancer Center (P30 CA014520) at University of Wisconsin. JMW was supported by a Mentored Research Scholar Grant in Applied and Clinical Research, MRSG-13-144-01-CPHPS from the American Cancer Society and by the University of Wisconsin Institute for Clinical and Translational Research through the National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The funder, Promega Corporation, provided support in the form of salaries for authors JWB, IV, and DRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bacher JW, 2005, MOL CARCINOGEN, V44, P285, DOI 10.1002/mc.20146; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Bartley AN, 2012, CANCER PREV RES, V5, P320, DOI 10.1158/1940-6207.CAPR-11-0288; Beggs AD, 2013, ONCOGENE, V32, P5333, DOI 10.1038/onc.2012.584; Bettington M, 2013, HISTOPATHOLOGY, V62, P367, DOI 10.1111/his.12055; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; Ferreira AM, 2009, J PATHOL, V219, P96, DOI 10.1002/path.2573; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Giuffre G, 2005, J MOL DIAGN, V7, P160, DOI 10.1016/S1525-1578(10)60542-9; Hampel H, 2008, J CLIN ONCOL, V26, P5783, DOI 10.1200/JCO.2008.17.5950; Hartman DJ, 2013, HUM PATHOL, V44, P2518, DOI 10.1016/j.humpath.2013.06.012; Heinen CD, 1996, CANCER RES, V56, P5339; Heitman SJ, 2009, CLIN GASTROENTEROL H, V7, P1272, DOI 10.1016/j.cgh.2009.05.032; Huang TG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-3; Iino H, 2000, GUT, V47, P37, DOI 10.1136/gut.47.1.37; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; KIM HG, 1994, AM J PATHOL, V145, P148; Klarskov L, 2011, AM J SURG PATHOL, V35, P1391, DOI 10.1097/PAS.0b013e318225c3f0; Klarskov L, 2010, HUM PATHOL, V41, P1387, DOI 10.1016/j.humpath.2010.03.003; Kloor M, 2012, LANCET ONCOL, V13, P598, DOI 10.1016/S1470-2045(12)70109-2; Koole W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt615; Laiho P, 2002, CANCER RES, V62, P1166; Lang GI, 2013, G3-GENES GENOM GENET, V3, P1453, DOI 10.1534/g3.113.006429; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; Loukola A, 1999, J MED GENET, V36, P819; Megid WA, 2007, RADIAT ENVIRON BIOPH, V46, P147, DOI 10.1007/s00411-006-0072-1; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Muller A, 2006, INT J COLORECTAL DIS, V21, P632, DOI 10.1007/s00384-005-0073-6; National Comprehensive Cancer Network, 2014, LYNCH SYNDROME GUIDE; Patil DT, 2012, MODERN PATHOL, V25, P1423, DOI 10.1038/modpathol.2012.98; Patil DT, 2012, DIAGN MOL PATHOL, V21, P127, DOI 10.1097/PDM.0b013e3182461cc3; Pino MS, 2009, J MOL DIAGN, V11, P238, DOI 10.2353/jmoldx.2009.080142; Rijcken FEM, 2002, GUT, V50, P382, DOI 10.1136/gut.50.3.382; Scahill E, 2013, STATEWIDE SCREENING; Shia J, 2005, AM J SURG PATHOL, V29, P96, DOI 10.1097/01.pas.0000146009.85309.3b; Sijmons RH, 2013, FAM CANCER, V12, P181, DOI 10.1007/s10689-013-9629-8; Steffen LS, 2013, MUTAGENESIS, V28, P71, DOI 10.1093/mutage/ges055; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Umar A, 2004, NAT REV CANCER, V4, P153, DOI 10.1038/nrc1278; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Vasen HFA, 2010, GASTROENTEROLOGY, V138, P2300, DOI 10.1053/j.gastro.2010.02.053; Walsh MD, 2012, MODERN PATHOL, V25, P722, DOI 10.1038/modpathol.2011.209; Yurgelun MB, 2012, CANCER PREV RES, V5, P574, DOI 10.1158/1940-6207.CAPR-11-0519; Zhang LY, 2008, J MOL DIAGN, V10, P301, DOI 10.2353/jmoldx.2008.080062; Zhang XC, 2013, WORLD J GASTRO ONCOL, V5, P12, DOI 10.4251/wjgo.v5.i2.12	49	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0132727	10.1371/journal.pone.0132727	http://dx.doi.org/10.1371/journal.pone.0132727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252492	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100013
J	Hui, WQ; Jiang, S; Tang, JS; Hou, HY; Chen, S; Jia, B; Ban, Q				Hui, Wenqiao; Jiang, Song; Tang, Jishun; Hou, Hongyan; Chen, Sheng; Jia, Bin; Ban, Qian			An Immediate Innate Immune Response Occurred In the Early Stage of E-granulosus Eggs Infection in Sheep: Evidence from Microarray Analysis	PLOS ONE			English	Article							MAST-CELL PROTEINASE; GENE-EXPRESSION PROFILE; ECHINOCOCCUS-GRANULOSUS; CYSTIC ECHINOCOCCOSIS; CYTOKINE; RESISTANCE; SYSTEM	Background Cystic Echinococcosis(CE), caused by infection with the larval stage of the cestode Echinococcus granulosus (E. granulosus), is a chronic parasitic zoonosis, with highly susceptible infection in sheep. However, the comprehensive molecular mechanisms that underlie the process of E. granulosus infection in the early stage remain largely unknown. The objective of this present study was to gain a cluster of genes expression profiles in the intestine tissue of sheep infected with CE. Methods Nine healthy sheep were divided into infection group and healthy controls, with six infected perorally 5000 E. granulosus eggs suspended in 1000 mu l physiological saline and three controls perorally injected 1000 mu l physiological saline. All animals were sacrificed at 4 hours post-infection, respectively. The intestine tissue was removed and the RNA was extracted. In the infection group, the biology replicates were designed to make sure the accuracy of the data. The ovine microarrays were used to analyze changes of gene expression in the intestine tissue between CE infected sheep and healthy controls. Real-time PCR was used to assess reliability of the microarray data. Results By biology repeats, a total of 195 differentially expressed genes were identified between infected group and controls at 4 hours post-infection, with 105 genes related to immune responses, while 90 genes associated with functions including energy metabolism, fat soluble transport, etc. Among the 105 immunity genes, 72 genes showed up-regulated expression levels while 33 showed down-regulation levels. Function analysis showed that most of up-regulated genes were related to innate immune responses, such as mast cell, NK cell, cytokines, chemokines and complement. In addition, Real-time PCR analysis of a random selection of nine genes confirmed the reliability of the microarray data. Conclusion To our knowledge, this is the first report describing gene expression profiles in the intestine tissue of CE infection sheep. These results suggested that the innate immune system was activated to elicit immediate defense in the intestine tissue where E. granulosus invaded in at 4 hour-post infection. Furthermore, future interest will also focus on unraveling similar events, especially for the function of adaptive immunity, but at late stage infection.	[Hui, Wenqiao; Tang, Jishun; Hou, Hongyan; Chen, Sheng] Anhui Acad Agr Sci, Inst Anim Husb & Vet Med, Hefei 230031, Anhui, Peoples R China; [Hui, Wenqiao; Jiang, Song; Jia, Bin] Shihezi Univ, Coll Anim Sci & Technol, Shihezi 832003, Xinjiang, Peoples R China; [Ban, Qian] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230000, Anhui, Peoples R China	Anhui Academy of Agricultural Sciences; Shihezi University; Anhui University	Chen, S (corresponding author), Anhui Acad Agr Sci, Inst Anim Husb & Vet Med, Rd Nongkenan, Hefei 230031, Anhui, Peoples R China.	ahchensheng2005@163.com; jiabinxj@126.com; bqashi@sina.com			National Natural Science Foundation of China [31402048]; Dean Outstanding Youth Fund of Anhui Academy of Agriculture Sciences [14B0403]; Xinjiang Key-Lab Projects [SKLIB-XJMDR-2012-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dean Outstanding Youth Fund of Anhui Academy of Agriculture Sciences; Xinjiang Key-Lab Projects	This study was funded by the National Natural Science Foundation of China (Grant No. 31402048), the Dean Outstanding Youth Fund of Anhui Academy of Agriculture Sciences (Grant No. 14B0403), and the Xinjiang Key-Lab Projects (Grant No. SKLIB-XJMDR-2012-1).	Amri M, 2007, J INTERF CYTOK RES, V27, P781, DOI 10.1089/jir.2007.0003; Amri M, 2009, EUR CYTOKINE NETW, V20, P63, DOI 10.1684/ecn.2009.0154; Andronicos N, 2010, INT J PARASITOL, V40, P417, DOI 10.1016/j.ijpara.2009.09.007; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Cardona GA, 2013, VET PARASITOL, V192, P10, DOI 10.1016/j.vetpar.2012.09.027; Conchedda M, 2008, ACTA TROP, V105, P215, DOI 10.1016/j.actatropica.2007.12.006; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; Elson CO, 2015, DIGEST DIS, V33, P131, DOI 10.1159/000369534; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Filali H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019909; Gottstein B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009779; He W, 2010, MED IMMUNOLOGY; Huang Juanjun, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P932, DOI 10.3760/cma.j.issn.1007-3418.2014.12.011; Hui WQ, 2012, PARASITOL RES, V110, P2075, DOI 10.1007/s00436-011-2714-8; Hui WQ, 2013, PAK VET J, V33, P205; HUNTLEY JF, 1992, PARASITE IMMUNOL, V14, P429, DOI 10.1111/j.1365-3024.1992.tb00017.x; HUNTLEY JF, 1990, PARASITE IMMUNOL, V12, P85, DOI 10.1111/j.1365-3024.1990.tb00938.x; HUNTLEY JF, 1987, PARASITE IMMUNOL, V9, P603, DOI 10.1111/j.1365-3024.1987.tb00533.x; Keane OM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-42; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Li RY, 2011, PARASITOL RES, V108, P1131, DOI 10.1007/s00436-010-2155-9; Lin RY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014557; Liu L, 2014, FASEB J, V28; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V130, P210, DOI 10.1016/j.vetimm.2009.02.013; Magambo Japhet K., 1995, Afr J Health Sci, V2, P250; McManus DP, 2014, PARASITE IMMUNOL, V36, P125, DOI 10.1111/pim.12072; Mezioug D, 2009, PARASITE, V16, P57, DOI 10.1051/parasite/2009161057; Olsen L, 2015, VET RES, V46, DOI 10.1186/s13567-014-0136-1; Pater C, 1998, PARASITE IMMUNOL, V20, P623, DOI 10.1046/j.1365-3024.1998.00195.x; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Slodka A, 2013, POSTEP HIG MED DOSW, V67, P164; Suurmond J, 2015, CLIN EXP ALLERGY, V45, P788, DOI 10.1111/cea.12509; Tian J, 2011, PHYSIOL GENOMICS, V43, P87, DOI 10.1152/physiolgenomics.00135.2010; Torgerson PR, 2003, ACTA TROP, V85, P113, DOI 10.1016/S0001-706X(02)00228-0; VEIT P, 1995, PARASITOLOGY, V110, P79, DOI 10.1017/S0031182000081075; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Zhang WB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/101895; Zhu X. Q., 1991, Chinese Journal of Veterinary Science and Technology, V21, P6; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135096	10.1371/journal.pone.0135096	http://dx.doi.org/10.1371/journal.pone.0135096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252489	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100117
J	Jamsheer, KM; Mannully, CT; Gopan, N; Laxmi, A				Jamsheer, Muhammed K.; Mannully, Chanchal Thomas; Gopan, Nandu; Laxmi, Ashverya			Comprehensive Evolutionary and Expression Analysis of FCS-Like Zinc finger Gene Family Yields Insights into Their Origin, Expansion and Divergence	PLOS ONE			English	Article							DUPLICATED GENES; GENOME SEQUENCE; DRAFT GENOME; ARABIDOPSIS; PROTEIN; MODEL; CONSEQUENCES; POLYPLOIDY; REVEAL; GROWTH	Plant evolution is characterized by frequent genome duplication events. Expansion of habitat resulted in the origin of many novel genes and genome duplication events which in turn resulted in the expansion of many regulatory gene families. The plant-specific FCS-Like Zinc finger (FLZ) gene family is characterized by the presence of a FCS-Like Zinc finger (FLZ) domain which mediates the protein-protein interaction. In this study, we identified that the expansion of FLZ gene family size in different species is correlated with ancestral and lineage-specific whole genome duplication events. The subsequent gene loss found to have a greater role in determining the size of this gene family in many species. However, genomic block duplications played the significant role in the expansion of FLZ gene family in some species. Comparison of Arabidopsis thaliana and Oryza sativa FLZ gene family revealed monocot and dicot specific evolutionary trends. The FLZ genes were found to be under high purifying selection. The spatiotemporal expression analyses of Arabidopsis thaliana FLZ gene family revealed that majority of the members are highly expressed in reproductive organs. FLZ genes were also found to be highly expressed during vegetative-to- reproductive phase transition which is correlated with the proposed role of this gene family in sugar signaling. The comparison of sequence, structural and expression features of duplicated genes identified lineage-specific redundancy and divergence. This extensive evolutionary analysis and expression analysis of Arabidopsis thaliana FLZ genes will pave the way for further functional analysis of FLZ genes.	[Jamsheer, Muhammed K.; Mannully, Chanchal Thomas; Laxmi, Ashverya] Natl Inst Plant Genome Res, New Delhi 110067, India; [Gopan, Nandu] Jawaharlal Nehru Ctr Adv Sci Res, Bengaluru 560064, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Laxmi, A (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Rd, New Delhi 110067, India.	ashverya_laxmi@nipgr.ac.in		Jamsheer K, Muhammed/0000-0002-2135-8760; Gopan, Nandu/0000-0002-7227-3441	National Institute of Plant Genome Research (NIPGR); University Grants Commission, Government of India	National Institute of Plant Genome Research (NIPGR)(Department of Biotechnology (DBT) India); University Grants Commission, Government of India(University Grants Commission, India)	This work was financially supported by the National Institute of Plant Genome Research (NIPGR) core grant to AL and Senior Research Fellowship from University Grants Commission, Government of India to MJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Buschiazzo E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-8; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chen X.Y., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0070914; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; De Smet R, 2012, CURR OPIN PLANT BIOL, V15, P168, DOI 10.1016/j.pbi.2012.01.003; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Duan WK, 2015, GENOME BIOL EVOL, V7, P299, DOI 10.1093/gbe/evu293; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo YL, 2013, PLANT J, V73, P941, DOI 10.1111/tpj.12089; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; He YH, 2004, PLANT MOL BIOL, V54, P1, DOI 10.1023/B:PLAN.0000028730.10834.e3; He YH, 2001, PLANT PHYSIOL, V126, P707, DOI 10.1104/pp.126.2.707; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jamsheer KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099074; Jaramillo-Correa JP, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-22; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Li Z, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Nietzsche M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00054; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Proost S, 2015, NUCLEIC ACIDS RES, V43, pD974, DOI 10.1093/nar/gku986; Proost S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr955; Rambout A., 2012, FIGTREE V 1 4; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schmutz J, 2010, NATURE, V465, P120, DOI 10.1038/nature08957; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yu S, 2013, ELIFE, V2, DOI 10.7554/eLife.00269; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	73	15	16	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134328	10.1371/journal.pone.0134328	http://dx.doi.org/10.1371/journal.pone.0134328			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252898	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100049
J	Laukka, EJ; Lovden, M; Kalpouzos, G; Papenberg, G; Keller, L; Graff, C; Li, TQ; Fratiglioni, L; Backman, L				Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Papenberg, Goran; Keller, Lina; Graff, Caroline; Li, Tie-Qiang; Fratiglioni, Laura; Backman, Lars			Microstructural White Matter Properties Mediate the Association between APOE and Perceptual Speed in Very Old Persons without Dementia	PLOS ONE			English	Article							APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; HEALTHY-ADULTS; MISSING DATA; COGNITIVE DECLINE; EPSILON-4 ALLELE; TRACT INTEGRITY; HUMAN BRAIN; LIFE-SPAN; AGE	Background Reduced white matter integrity, as indicated by lower fractional anisotropy (FA) and higher mean diffusivity (MD), has been related to poorer perceptual speed (PS) performance. As the epsilon 4 allele has been associated with lower white matter integrity in old age, this represents a potential mechanism through which APOE may affect PS. Objective To examine whether the association between APOE and PS is mediated by white matter microstructure in very old persons without dementia. Method Participants were selected from the population-based SNAC-K study. After excluding persons with dementia, preclinical dementia, and other neurological disorders, 652 persons (age range 78-90) were included in the study, of which 89 had data on diffusion tensor imaging (DTI). We used structural equation modeling to form seven latent white matter factors (FA and MD) and one latent PS factor. Separate analyses were performed for FA and MD and mediational analyses were carried out for tracts where significant associations were observed to both APOE and PS. Results APOE was associated with white matter microstructure in 2 out of 14 tracts; e4 carriers had significantly lower FA in forceps major and higher MD in the cortico-spinal tract. Allowing the white matter microstructure indicators in these tracts to mediate the association between APOE and PS resulted in a markedly attenuated association between these variables. Bootstrapping statistics in the subsample with DTI data (n = 89) indicated that FA in forceps major significantly mediated the association between APOE and PS (indirect effect: -0.070, 95% bias corrected CIs -0.197 to -0.004). Conclusion Lower white matter integrity may represent one of several mechanisms through which APOE affects PS performance in elderly persons free of dementia and preclinical dementia.	[Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Papenberg, Goran; Keller, Lina; Fratiglioni, Laura; Backman, Lars] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Laukka, Erika J.; Lovden, Martin; Kalpouzos, Gregoria; Papenberg, Goran; Keller, Lina; Fratiglioni, Laura; Backman, Lars] Stockholm Univ, S-10691 Stockholm, Sweden; [Keller, Lina; Graff, Caroline] Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Stockholm, Sweden; [Graff, Caroline] Karolinska Univ, Huddinge Hosp, Dept Geriatr Med, Stockholm, Sweden; [Li, Tie-Qiang] Karolinska Univ, Huddinge Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Fratiglioni, Laura; Backman, Lars] Stockholm Gerontol Res Ctr, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Laukka, EJ (corresponding author), Karolinska Inst, Aging Res Ctr, Stockholm, Sweden.	Erika.Jonsson.Laukka@ki.se	graff, caroline/A-2545-2009; Papenberg, Goran/HCH-1851-2022	Papenberg, Goran/0000-0003-0279-1988; Li, Tie-Qiang/0000-0002-4866-5904; Graff, Caroline/0000-0002-9949-2951	Swedish Ministry of Health and Social Affairs; Swedish Research Council; Swedish Council for Working Life and Social Research; Swedish Brain Power; Gun and Bertil Stohne's foundation; Osterman's foundation; foundation for age-related diseases at Karolinska Institutet; Alexander von Humboldt Research Award; participating County Councils and Municipalities	Swedish Ministry of Health and Social Affairs; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Brain Power; Gun and Bertil Stohne's foundation; Osterman's foundation; foundation for age-related diseases at Karolinska Institutet; Alexander von Humboldt Research Award(Alexander von Humboldt Foundation); participating County Councils and Municipalities	SNAC-K is financially supported by the Swedish Ministry of Health and Social Affairs, the participating County Councils and Municipalities, and the Swedish Research Council. This work was further funded by grants from the Swedish Council for Working Life and Social Research (EL, ML, LF, LB), the Swedish Research Council (EL, ML, LF, LB), Swedish Brain Power (LF, LB), Gun and Bertil Stohne's foundation (GK), Osterman's foundation (GK), the foundation for age-related diseases at Karolinska Institutet (EL), an Alexander von Humboldt Research Award (LB), and a donation from the af Jochnick Foundation (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartzokis G, 2006, ARCH GEN PSYCHIAT, V63, P63, DOI 10.1001/archpsyc.63.1.63; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bennett IJ, 2014, NEUROSCIENCE, V276, P187, DOI 10.1016/j.neuroscience.2013.11.026; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; FINKBEINER C, 1979, PSYCHOMETRIKA, V44, P409, DOI 10.1007/BF02296204; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Kanchibhotla C, 2013, AGEING RES REV, V12, P391, DOI 10.1016/j.arr.2012.10.003; Kantarci K, 2012, NEUROLOGY, V78, P232, DOI 10.1212/WNL.0b013e31824365ab; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Lagergren M, 2004, AGING CLIN EXP RES, V16, P158; Laukka EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081419; Laukka EJ, 2013, PSYCHOL AGING, V28, P262, DOI 10.1037/a0030829; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Lovden M, 2014, NEUROIMAGE, V102, P520, DOI 10.1016/j.neuroimage.2014.08.020; Lovden M, 2013, HUM BRAIN MAPP, V34, P1386, DOI 10.1002/hbm.21518; Lyall DM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.89; Lyall DM, 2014, NEUROBIOL AGING, V35; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Maillard P, 2011, STROKE, V42, P1917, DOI 10.1161/STROKEAHA.110.609768; Nyberg L, 2014, SCAND J PSYCHOL, V55, P263, DOI 10.1111/sjop.12099; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Ringman JM, 2007, BRAIN, V130, P1767, DOI 10.1093/brain/awm102; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schilling S, 2013, NEUROLOGY, V81, P292, DOI 10.1212/WNL.0b013e31829bfda4; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sun SW, 2008, NEUROIMAGE, V40, P1, DOI 10.1016/j.neuroimage.2007.11.049; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Welmer AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065815; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003; Zade D, 2010, J STROKE CEREBROVASC, V19, P261, DOI 10.1016/j.jstrokecerebrovasdis.2009.05.001; Zazzo R., 1974, ACTUALITES PEDAGOGIQ, V7	63	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134766	10.1371/journal.pone.0134766	http://dx.doi.org/10.1371/journal.pone.0134766			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252210	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100075
J	Mupfudze, TG; Stoltzfus, RJ; Rukobo, S; Moulton, LH; Humphrey, JH; Prendergast, AJ				Mupfudze, Tatenda G.; Stoltzfus, Rebecca J.; Rukobo, Sandra; Moulton, Lawrence H.; Humphrey, Jean H.; Prendergast, Andrew J.		SHINE Trial Team	Plasma Concentrations of Hepcidin in Anemic Zimbabwean Infants	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; IRON-DEFICIENCY; SERUM HEPCIDIN; SEX-DIFFERENCES; RISK-FACTORS; HIV; INFECTION; SUPPLEMENTATION; TRANSMISSION; INFLAMMATION	Objective Anemia in infancy is a global public health problem. We evaluated the relative contributions of iron deficiency and inflammation to infant anemia. Methods We measured plasma hepcidin, ferritin, soluble transferrin receptor (sTfR), alpha-1-acid glycoprotein and C-reactive protein (CRP) by ELISA on archived plasma from 289 HIV-unexposed anemic or non-anemic Zimbabwean infants at ages 3mo, 6mo and 12mo. Among anemic infants, we determined the proportion with iron-deficiency anemia (IDA) and anemia of inflammation (AI). We undertook regression analyses of plasma hepcidin and anemia status, adjusting for sex, age and birthweight. Results Anemic infants at 3mo were more stunted and had higher CRP (median 0.45 vs 0.21mg/L; P = 0.037) and hepcidin (median 14.7 vs 9.7ng/mL; P = 0.022) than non-anemic infants, but similar levels of ferritin and sTfR; 11% infants had IDA and 15% had AI. Anemic infants at 6mo had higher hepcidin (median 7.9 vs 4.5ng/mL; P = 0.016) and CRP (median 2.33 vs 0.32mg/L; P<0.001), but lower ferritin (median 13.2 vs 25.1 mu g/L; P<0.001) than non-anemic infants; 56% infants had IDA and 12% had AI. Anemic infants at 12mo had lower ferritin (median 3.2 vs 22.2 mu g/L; P<0.001) and hepcidin (median 0.9 vs 1.9ng/mL; P = 0.019), but similar CRP levels; 48% infants had IDA and 8% had AI. Comparing anemic with non-anemic infants, plasma hepcidin was 568% higher, 405% higher and 64% lower at 3mo, 6mo and 12mo, respectively, after adjusting for sex and birthweight (all p<0.01). Plasma hepcidin declined significantly with age among anemic but not non-anemic infants. Girls had 61% higher hepcidin than boys, after adjusting for age, anemia and birthweight (p<0.001). Conclusion Anemia is driven partly by inflammation early in infancy, and by iron deficiency later in infancy, with plasma hepcidin concentrations reflecting the relative contribution of each. However, there is need to better characterize the drivers of hepcidin during infancy in developing countries.	[Mupfudze, Tatenda G.; Moulton, Lawrence H.; Humphrey, Jean H.; Prendergast, Andrew J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Mupfudze, Tatenda G.; Rukobo, Sandra; Humphrey, Jean H.; Prendergast, Andrew J.] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe; [Stoltzfus, Rebecca J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, London, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Cornell University; University of London; Queen Mary University London	Mupfudze, TG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	tmupfud1@jhu.edu	Mupfudze, Tatenda/ABG-9531-2021	Prendergast, Andrew/0000-0001-7904-7992; Mupfudze, Tatenda/0000-0001-7887-649X	Bill and Melinda Gates Foundation [OPP1021542]; Department for International Development, UK; National Institutes of Child Health and Human Development [R01HD060338-01]; Wellcome Trust [093768/Z/10/Z]; Swiss Agency for Development and Cooperation [81016727]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060338] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development, UK; National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss Agency for Development and Cooperation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The SHINE project is supported by the Bill and Melinda Gates Foundation (OPP1021542); Department for International Development, UK; National Institutes of Child Health and Human Development (R01HD060338-01); Wellcome Trust (093768/Z/10/Z); and The Swiss Agency for Development and Cooperation (Contract no. 81016727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SH, 2014, BLOOD, V123, P3221, DOI 10.1182/blood-2013-10-533000; Barr DB, 2006, ENVIRON HEALTH PERSP, V114, P961, DOI 10.1289/ehp.8528; Berglund S, 2014, CURR OPIN CLIN NUTR, V17, P267, DOI 10.1097/MCO.0000000000000043; Berglund S, 2011, AM J CLIN NUTR, V94, P1553, DOI 10.3945/ajcn.111.013938; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; CDC W, 2007, ASS IR STAT POP INCL; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; DALLMAN PR, 1980, AM J CLIN NUTR, V33, P86, DOI 10.1093/ajcn/33.1.86; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Domellof M, 2002, PEDIATRICS, V110, P545, DOI 10.1542/peds.110.3.545; Domellof M, 2002, J NUTR, V132, P3680, DOI 10.1093/jn/132.12.3680; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Eneroth H, 2011, ACTA PAEDIATR, V100, P220, DOI 10.1111/j.1651-2227.2010.02011.x; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Gordeuk VR, 2001, J CLIN VIROL, V20, P111, DOI 10.1016/S1386-6532(00)00134-7; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; Humphrey JH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6580; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Humphrey JH, 2006, J INFECT DIS, V193, P960; [ICF International Zimbabwe National Statistics Agency (ZIMSTAT)], 2012, ZIMB DEM HLTH SURV 2; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Kroot JJC, 2012, AM J HEMATOL, V87, P977, DOI 10.1002/ajh.23289; Lokeshwar MR, 2011, INDIAN J PEDIATR, V78, P593, DOI 10.1007/s12098-010-0130-1; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Miller MF, 2003, J NUTR, V133, P3461; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Muller KF, 2012, J PEDIATR-US, V160, P949, DOI 10.1016/j.jpeds.2011.12.030; Mupfudze TG, 2014, BRIT J HAEMATOL, V164, P150, DOI 10.1111/bjh.12567; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Prendergast AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086928; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Rao R, 2002, ACTA PAEDIATR, V91, P124; Rehu M, 2010, EUR J HAEMATOL, V85, P345, DOI 10.1111/j.1600-0609.2010.01479.x; Schneider JM, 2008, AM J CLIN NUTR, V87, P614, DOI 10.1093/ajcn/87.3.614; Thorisdottir AV, 2011, ANEMIA, V2011, DOI 10.1155/2011/986303; Thurnham DI MG, 2010, REPORT PRIORITIES AS; WALTER T, 1989, PEDIATRICS, V84, P7; WALTER T, 1994, BAILLIERE CLIN HAEM, V7, P815, DOI 10.1016/S0950-3536(05)80126-X; Wang CY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00114; WHO, WHONMHNHDMNM111; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; World Health Organization, 2012, SICKL CELL DIS PREV; Wu TW, 2013, J PEDIATR-US, V162, P67, DOI 10.1016/j.jpeds.2012.06.010; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	50	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135227	10.1371/journal.pone.0135227	http://dx.doi.org/10.1371/journal.pone.0135227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252205	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100139
J	Nabawy, MRA; Crowthe, WJ				Nabawy, Mostafa R. A.; Crowthe, William J.			A Quasi-Steady Lifting Line Theory for Insect-Like Hovering Flight	PLOS ONE			English	Article							LEADING-EDGE VORTEX; MICRO-AIR VEHICLES; FLAPPING FLIGHT; REVOLVING WINGS; AERODYNAMIC FORCES; POWER REQUIREMENTS; ADVANCE RATIO; MODEL; ROTATION; STALL	A novel lifting line formulation is presented for the quasi-steady aerodynamic evaluation of insect-like wings in hovering flight. The approach allows accurate estimation of aerodynamic forces from geometry and kinematic information alone and provides for the first time quantitative information on the relative contribution of induced and profile drag associated with lift production for insect-like wings in hover. The main adaptation to the existing lifting line theory is the use of an equivalent angle of attack, which enables capture of the steady non-linear aerodynamics at high angles of attack. A simple methodology to include non-ideal induced effects due to wake periodicity and effective actuator disc area within the lifting line theory is included in the model. Low Reynolds number effects as well as the edge velocity correction required to account for different wing planform shapes are incorporated through appropriate modification of the wing section lift curve slope. The model has been successfully validated against measurements from revolving wing experiments and high order computational fluid dynamics simulations. Model predicted mean lift to weight ratio results have an average error of 4% compared to values from computational fluid dynamics for eight different insect cases. Application of an unmodified linear lifting line approach leads on average to a 60% overestimation in the mean lift force required for weight support, with most of the discrepancy due to use of linear aerodynamics. It is shown that on average for the eight insects considered, the induced drag contributes 22% of the total drag based on the mean cycle values and 29% of the total drag based on the mid half-stroke values.	[Nabawy, Mostafa R. A.; Crowthe, William J.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England	University of Manchester	Nabawy, MRA (corresponding author), Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England.	mostafa.ahmednabawy@manchester.ac.uk	Nabawy, Mostafa R A/N-3945-2016	Nabawy, Mostafa/0000-0002-4252-1635; Crowther, William/0000-0002-0613-9375				Abbott IH., 1959, THEORY WING SECTIONS; Altshuler DL, 2004, J ZOOL, V264, P327, DOI 10.1017/s0952836904005813; Anderson J.D., 2011, FUNDAMENTALS AERODYN, P357; ANDERSON JD, 1980, J AIRCRAFT, V17, P898, DOI 10.2514/3.44690; Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001; Azuma A., 2006, BIOKINETICS FLYING S; Berman GJ, 2007, J FLUID MECH, V582, P153, DOI 10.1017/S0022112007006209; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Conlisk AT, 2001, PROG AEROSP SCI, V37, P419, DOI 10.1016/S0376-0421(01)00011-2; Dickson WB, 2004, J EXP BIOL, V207, P4269, DOI 10.1242/jeb.01266; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P145, DOI 10.1098/rstb.1984.0054; Ellington CP, 1999, J EXP BIOL, V202, P3439; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; Glauert H., 1947, ELEMENTS AEROFOIL AI; Gradinaru S., 2011, ANAL U SPIRU HARE MI, V7, P19; Harbig RR, 2014, J FLUID MECH, V751, P71, DOI 10.1017/jfm.2014.262; Johnson W., 1994, HELICOPTER THEORY; Jones RT, 1941, TN817 NACA; Kruyt JW, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0585; Leishman JG, 2006, PRINCIPLES HELICOPTE; Lentink D, 2009, J EXP BIOL, V212, P2705, DOI 10.1242/jeb.022269; Mehrle AH, 2009, ACTA MECH, V202, P135, DOI 10.1007/s00707-008-0017-7; Nabawy MRA, 2012, AERONAUT J, V116, P685, DOI 10.1017/S000192400000717X; Nabawy MRA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1197; Nabawy MRA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1196; Nabawy MR., 32 AIAA APPL AERODYN, DOI [10.2514/6.2014-2277, DOI 10.2514/6.2014-2277]; Nabawy MRA, 2015, BIOINSPIR B IN PRESS; Okamoto M, 1996, J EXP BIOL, V199, P281; Paul RC, 2014, INT J NUMER METH FL, V76, P199, DOI 10.1002/fld.3931; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Phillips WF, 2006, J AIRCRAFT, V43, P437, DOI 10.2514/1.15089; Phillips WF, 2000, J AIRCRAFT, V37, P662, DOI 10.2514/2.2649; PHLIPS PJ, 1981, J FLUID MECH, V112, P97, DOI 10.1017/S0022112081000311; Pope A., 1951, BASIC WING AIRFOIL T; Prandtl L., 1918, NACHRICHTEN GESELLSC, P451; Prandtl L., 1923, 116 NACA TR, V116; Ramamurti R, 2002, J EXP BIOL, V205, P1507; Rasmussen ML, 1999, J AIRCRAFT, V36, P340, DOI 10.2514/2.2463; Rayner JMV, 2001, MATH METHOD APPL SCI, V24, P1485, DOI 10.1002/mma.196; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Sane SP, 2006, J EXP BIOL, V209, P32, DOI 10.1242/jeb.01957; Sane SP, 2002, J EXP BIOL, V205, P1087; Schlichting H, 1979, AERODYNAMICS AIRPLAN; SCLAVOUNOS PD, 1987, J ENG MATH, V21, P201, DOI 10.1007/BF00127464; Smith MJC, 1996, J EXP BIOL, V199, P1073; Sun M, 2003, ACTA MECH SINICA, V19, P458; Taha HE, 2014, AEROSP SCI TECHNOL, V34, P1, DOI 10.1016/j.ast.2014.01.011; Tietjens O. G., 1957, APPL HYDRO AEROMECHA; Traub LW, 2004, J AIRCRAFT, V41, P284, DOI 10.2514/1.9323; Usherwood JR, 2009, EXP FLUIDS, V46, P991, DOI 10.1007/s00348-008-0596-z; Usherwood JR, 2002, J EXP BIOL, V205, P1547; Usherwood JR, 2002, J EXP BIOL, V205, P1565; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Walker JA, 2002, J EXP BIOL, V205, P3783; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Wang ZJ, 2004, J EXP BIOL, V207, P4147, DOI 10.1242/jeb.01239; Whitney JP, 2010, J FLUID MECH, V660, P197, DOI 10.1017/S002211201000265X; Zhao L, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036007	60	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134972	10.1371/journal.pone.0134972	http://dx.doi.org/10.1371/journal.pone.0134972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252657	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100095
J	Zhang, DJ; Lees, RS; Xi, ZY; Gilles, JRL; Bourtzis, K				Zhang, Dongjing; Lees, Rosemary Susan; Xi, Zhiyong; Gilles, Jeremie R. L.; Bourtzis, Kostas			Combining the Sterile Insect Technique with Wolbachia-Based Approaches: II-A Safer Approach to Aedes albopictus Population Suppression Programmes, Designed to Minimize the Consequences of Inadvertent Female Release	PLOS ONE			English	Article							CULEX-PIPIENS COMPLEX; CYTOPLASMIC INCOMPATIBILITY; DIPTERA-CULICIDAE; BLOCKS DENGUE; IRRADIATION; STRAIN; TEPHRITIDAE; RADIATION; MALES; COMPETITIVENESS	Due to the absence of a perfect method for mosquito sex separation, the combination of the sterile insect technique and the incompatible insect technique is now being considered as a potentially effective method to control Aedes albopictus. In this present study first we examine the minimum pupal irradiation dose required to induce complete sterility in Wolbachia triple-infected (HC), double-infected (GUA) and uninfected (GT) female Ae. albopictus. The HC line is a candidate for Ae. albopictus population suppression programmes, but due to the risk of population replacement which characterizes this triple infected line, the individuals to be released need to be additionally irradiated. After determining the minimum irradiation dose required for complete female sterility, we test whether sterilization is sufficient to prevent invasion of the triple infection from the HC females into double-infected (GUA) populations. Our results indicate that irradiated Ae. albopictus HC, GUA and GT strain females have decreased fecundity and egg hatch rate when irradiated, inversely proportional to the dose, and the complete sterilization of females can be acquired by pupal irradiation with doses above 28 Gy. PCR-based analysis of F-1 and F-2 progeny indicate that the irradiated HC females, cannot spread the new Wolbachia wPip strain into a small cage GUA population, released at a 1:5 ratio. Considering the above results, we conclude that irradiation can be used to reduce the risk of population replacement caused by an unintentional release of Wolbachia triple-infected Ae. albopictus HC strain females during male release for population suppression.	[Zhang, Dongjing; Lees, Rosemary Susan; Gilles, Jeremie R. L.; Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Zhang, Dongjing; Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Sun Yat Sen University; Michigan State University	Bourtzis, K (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	K.Bourtzis@iaea.org	Xi, Zhiyong/AAD-7936-2022; Lees, Rosemary Susan/H-3425-2019	Xi, Zhiyong/0000-0001-7786-012X; Lees, Rosemary Susan/0000-0002-4232-9125	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI080597]; Key Project of Chinese Ministry of Education [311030]; Guangdong Innovative Research Team Program [2011S009]; Scientific and Technological Leading Talents of Guangzhou Development District [2013L-P116]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080597] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Guangdong Innovative Research Team Program; Scientific and Technological Leading Talents of Guangzhou Development District; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in Prof. Zhiyong Xi's laboratory was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI080597, Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Allinghi A, 2007, FLA ENTOMOL, V90, P27, DOI 10.1653/0015-4040(2007)90[27:CACOAL]2.0.CO;2; ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648; Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Atyame CM, 2015, MOL ECOL, V24, P508, DOI 10.1111/mec.13035; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bourtzis K, 2003, CONT T ENT, P217; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Dobson SL, 2004, EVOLUTION, V58, P2156, DOI 10.1111/j.0014-3820.2004.tb01594.x; Dyck V.A., 2006, STERILE INSECT TECHN; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; FAY R. W., 1959, MOSQUITO NEWS, V19, P144; FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; International Atomic Engrgy Agency (IAEA), NUCL INT DAT INS DIS; Ito Y., 2003, Journal of Asia-Pacific Entomology, V6, P119, DOI 10.1016/S1226-8615(08)60177-6; KNIPLING EF, 1960, SCI AM, V203, P54, DOI 10.1038/scientificamerican1060-54; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Mastrangelo T, 2010, J ECON ENTOMOL, V103, P85, DOI 10.1603/EC09139; Ndo C, 2014, ACTA TROP, V131, P124, DOI 10.1016/j.actatropica.2013.11.027; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Rasgon JL, 2008, ADV EXP MED BIOL, V627, P114, DOI 10.1007/978-0-387-78225-6_10; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Rull J, 2007, J ECON ENTOMOL, V100, P1153, DOI 10.1603/0022-0493(2007)100[1153:IOALDT]2.0.CO;2; Salem HM, 2014, J RADIAT RES APPL SI, V7, P110, DOI 10.1016/j.jrras.2013.12.007; Salwa M. A. B., 2011, Journal of Agricultural Biotechnology and Sustainable Development, V3, P105; Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x; TERZIAN LA, 1958, BIOL BULL, V115, P536, DOI 10.2307/1539116; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Walder JMM, 1993, SCI AGR, V50, P157, DOI DOI 10.1590/S0103-90161993000200001; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Wu Y, 2010, J INSECT PHYSIOL, V56, P1599, DOI 10.1016/j.jinsphys.2010.05.021; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126; Zhang DJ, 2014, PARASITOL RES, V113, P399, DOI 10.1007/s00436-013-3668-9	50	73	77	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135194	10.1371/journal.pone.0135194	http://dx.doi.org/10.1371/journal.pone.0135194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252474	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100133
J	Gu, C; Liao, L; Zhou, H; Wang, L; Deng, XB; Han, YP				Gu, Chao; Liao, Liao; Zhou, Hui; Wang, Lu; Deng, Xianbao; Han, Yuepeng			Constitutive Activation of an Anthocyanin Regulatory Gene PcMYB10.6 Is Related to Red Coloration in Purple-Foliage Plum	PLOS ONE			English	Article							MYB TRANSCRIPTION FACTOR; PRUNUS-PERSICA; FLAVONOID BIOSYNTHESIS; ECTOPIC EXPRESSION; PYRUS-COMMUNIS; FRUIT; APPLE; ARABIDOPSIS; PROANTHOCYANIDIN; FLOWERS	Cherry plum is a popular ornamental tree worldwide and most cultivars are selected for purple foliage. Here, we report the investigation of molecular mechanism underlying red pigmentation in purple-leaf plum 'Ziyeli' (Prunus cerasifera Ehrhar f. atropurpurea (Jacq.) Rehd.), which shows red color pigmentation in fruit (flesh and skin) and foliage. Six anthocyanin-activating MYB genes, designated PcMYB10.1 to PcMYB10.6, were isolated based on RNA-Seq data from leaves of cv. Ziyeli. Of these PcMYB10 genes, five (PcMYB10.1 through PcMYB10.5) show distinct spatial and temporal expression patterns, while the PcMYB10.6 gene is highly expressed in all the purple-coloured organs of cv. Ziyeli. Constitutive activation of PcMYB10.6 is closely related to red pigmentation in the leaf, fruit (flesh and skin), and sepal. However, the PcMYB10.6 activation cannot induce red pigmentation in the petal of cv. Ziyeli during late stages of flower development due to due to a lack of expression of PcUFGT. The inhibition of red pigmentation in the petal of cherry plum could be attributed to the high-level expression of PcANR that directs anthocyanidin flux to proanthocyanidin biosynthesis. In addition, PcMYB10.2 is highly expressed in fruit and sepal, but its expression cannot induce red pigmentation. This suggests the PcMYB10 gene family in cherry plum may have diverged in function and PcMYB10.2 plays little role in the regulation of red pigmentation. Our study provides for the first time an example of constitutive activation of an anthocyanin-activating MYB gene in Prunus although its underlying mechanism remains unclear.	[Gu, Chao; Liao, Liao; Zhou, Hui; Wang, Lu; Deng, Xianbao; Han, Yuepeng] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Zhou, Hui] Grad Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Han, YP (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China.	yphan@wbgcas.cn		Gu, Chao/0000-0002-4381-6910	National Natural Science Foundation of China [31471856, 31201604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31471856 and 31201604).	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Biswajit Das, 2011, International Journal of Biodiversity and Conservation, V3, P721; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Chiou CY, 2008, PLANT MOL BIOL, V66, P379, DOI 10.1007/s11103-007-9275-3; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; FORKMANN G, 1991, PLANT BREEDING, V106, P1, DOI 10.1111/j.1439-0523.1991.tb00474.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Han YP, 2012, J EXP BOT, V63, P2437, DOI 10.1093/jxb/err415; Han YP, 2010, PLANT PHYSIOL, V153, P806, DOI 10.1104/pp.109.152801; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Jung S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-81; Kim S, 2004, MOL BREEDING, V14, P253, DOI 10.1023/B:MOLB.0000047770.92977.04; Kleindt Christiane Katja, 2010, BMC Res Notes, V3, P255, DOI 10.1186/1756-0500-3-255; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Laitinen RAE, 2008, J EXP BOT, V59, P3691, DOI 10.1093/jxb/ern216; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Moyano E, 1996, PLANT CELL, V8, P1519, DOI 10.1105/tpc.8.9.1519; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Palapol Y, 2009, PLANTA, V229, P1323, DOI 10.1007/s00425-009-0917-3; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Pierantoni L, 2010, PLANT PHYSIOL BIOCH, V48, P1020, DOI 10.1016/j.plaphy.2010.09.002; Quattrocchio F, 2006, PLANT CELL, V18, P1274, DOI 10.1105/tpc.105.034041; Rahim MA, 2014, PLANTA, V240, P913, DOI 10.1007/s00425-014-2078-2; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Sun Y, 2012, MOL PLANT, V5, P387, DOI 10.1093/mp/ssr110; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Uematsu C, 2014, J EXP BOT, V65, P1081, DOI 10.1093/jxb/ert456; Uimari A, 1997, PLANT J, V12, P1273, DOI 10.1046/j.1365-313x.1997.12061273.x; Usenik V, 2009, FOOD CHEM, V114, P529, DOI 10.1016/j.foodchem.2008.09.083; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vimolmangkang S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-176; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang ZG, 2013, PLANT PHYSIOL, V162, P885, DOI 10.1104/pp.113.214700; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Wu J, 2013, TREE GENET GENOMES, V9, P75, DOI 10.1007/s11295-012-0534-3; Ying Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0388-y; Yoshida K, 2015, PLANT PHYSIOL, V167, P693, DOI 10.1104/pp.114.253674; Zhou H, 2015, PLANT J, V82, P105, DOI 10.1111/tpj.12792; Zhou Y, 2013, TREE GENET GENOMES, V9, P265, DOI 10.1007/s11295-012-0552-1	57	23	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135159	10.1371/journal.pone.0135159	http://dx.doi.org/10.1371/journal.pone.0135159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247780	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300106
J	Takeda, YS; Xu, QB				Takeda, Yuji S.; Xu, Qiaobing			Neuronal Differentiation of Human Mesenchymal Stem Cells Using Exosomes Derived from Differentiating Neuronal Cells	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SCIATIC-NERVE INJURY; BONE-MARROW; MICRORNA EXPRESSION; MEDIATED TRANSFER; PROGENITOR CELLS; STROMAL CELLS; PROLIFERATION; REGENERATION	Exosomes deliver functional proteins and genetic materials to neighboring cells, and have potential applications for tissue regeneration. One possible mechanism of exosome-promoted tissue regeneration is through the delivery of microRNA (miRNA). In this study, we hypothesized that exosomes derived from neuronal progenitor cells contain miRNAs that promote neuronal differentiation. We treated mesenchymal stem cells (MSCs) daily with exosomes derived from PC12 cells, a neuronal cell line, for 1 week. After the treatment with PC12-derived exosomes, MSCs developed neuron-like morphology, and gene and protein expressions of neuronal markers were upregulated. Microarray analysis showed that the expression of miR-125b, which is known to play a role in neuronal differentiation of stem cells, was much higher in PC12-derived exosomes than in exosomes from B16-F10 melanoma cells. These results suggest that the delivery of miRNAs contained in PC12-derived exosomes is a possible mechanism explaining the neuronal differentiation of MSC.	[Takeda, Yuji S.; Xu, Qiaobing] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University	Xu, QB (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	qiaobing.xu@tufts.edu		Takeda, Yuji/0000-0002-0065-2063	Pew Charitable Trusts	Pew Charitable Trusts	QX received a grant from The Pew Charitable Trusts (http://www.pewtrusts.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KA, 2014, BIOMATERIALS, V35, P3551, DOI 10.1016/j.biomaterials.2013.12.082; Aldrich BT, 2009, NEUROSCIENCE, V164, P711, DOI 10.1016/j.neuroscience.2009.08.033; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Chen XP, 2014, CANCER LETT, V353, P201, DOI 10.1016/j.canlet.2014.07.026; Cvjetkovic A, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23111; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115; Kennea NL, 2009, CELL CYCLE, V8, P1069, DOI 10.4161/cc.8.7.8121; Kim BM, 2012, BIOCHEM BIOPH RES CO, V426, P183, DOI 10.1016/j.bbrc.2012.08.058; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Kumar AA, 2009, EXP CLIN TRANSPLANT, V7, P241; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lattanzi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067411; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Li WG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-55; Liu DZ, 2012, GENE, V495, P120, DOI 10.1016/j.gene.2011.12.041; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Rehfeld F, 2015, CELL TISSUE RES, V359, P145, DOI 10.1007/s00441-014-1872-2; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Scuteri A, 2011, CURR STEM CELL RES T, V6, P82, DOI 10.2174/157488811795495486; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharma A, 2012, CELL TRANSPLANT, V21, pS79, DOI 10.3727/096368912X633798; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2; Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002; Takeda YS, 2015, NEURAL REGEN RES, V10, P689, DOI 10.4103/1673-5374.156946; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Wu R, 2013, CELL BIOL INT, V37, P812, DOI 10.1002/cbin.10103; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Yau WWY, 2012, BIOMATERIALS, V33, P2608, DOI 10.1016/j.biomaterials.2011.12.021; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	56	100	109	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135111	10.1371/journal.pone.0135111	http://dx.doi.org/10.1371/journal.pone.0135111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248331	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300101
J	Jara-Ettinger, AC; Lopez-Tavera, JC; Zavala-Cerna, MG; Torres-Bugarin, O				Cecilia Jara-Ettinger, Ana; Carlos Lopez-Tavera, Juan; Guadalupe Zavala-Cerna, Maria; Torres-Bugarin, Olivia			Genotoxic Evaluation of Mexican Welders Occupationally Exposed to Welding-Fumes Using the Micronucleus Test on Exfoliated Oral Mucosa Cells: A Cross-Sectional, Case-Control Study	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; LUNG-CANCER; CYTOME ASSAY; BUCCAL CELLS; WORKERS; METAANALYSIS; MECHANISMS; INDUCTION; FREQUENCY; APOPTOSIS	Background An estimated 800,000 people worldwide are occupationally exposed to welding-fumes. Previous studies show that the exposure to such fumes is associated with damage to genetic material and increased cancer risk. In this study, we evaluate the genotoxic effect of welding-fumes using the Micronucleus Test on oral mucosa cells of Mexican welders. Material and Methods We conducted a cross-sectional, matched case-control study of n = 66 (33 exposed welders, and 33 healthy controls). Buccal mucosa smears were collected and stained with acridine orange, observed under 100x optical amplification with a fluorescence lamp, and a single-blinded observer counted the number of micronuclei and other nuclear abnormalities per 2,000 observed cells. We compared the frequencies of micronuclei and other nuclear abnormalities, and fitted generalised linear models to investigate the interactions between nuclear abnormalities and the exposure to welding-fumes, while controlling for smoking and age. Results Binucleated cells and condensed-chromatin cells showed statistically significant differences between cases and controls. The frequency of micronuclei and the rest of nuclear abnormalities (lobed-nuclei, pyknosis, karyolysis, and karyorrhexis) did not differ significantly between the groups. After adjusting for smoking, the regression results showed that the occurrence of binucleated cells could be predicted by the exposure to welding-fumes plus the presence of tobacco consumption; for the condensed-chromatin cells, our model showed that the exposure to welding-fumes is the only reliable predictor. Conclusions Our findings suggest that Mexican welders who are occupationally exposed to welding-fumes have increased counts of binucleated and condensed-chromatin cells. Nevertheless, the frequencies of micronuclei and the rest of nuclear abnormalities did not differ between cases and controls. Further studies should shed more light on this subject.	[Cecilia Jara-Ettinger, Ana; Carlos Lopez-Tavera, Juan] Univ Autonoma Guadalajara, Fac Med, Zapopan, Jalisco, Mexico; [Guadalupe Zavala-Cerna, Maria; Torres-Bugarin, Olivia] Univ Autonoma Guadalajara, Fac Med, Int Program, Zapopan, Jalisco, Mexico	Universidad Autonoma de Guadalajara; Universidad Autonoma de Guadalajara	Jara-Ettinger, AC (corresponding author), Univ Autonoma Guadalajara, Fac Med, Zapopan, Jalisco, Mexico.	ana.ceci.jara@gmail.com	Zavala, Maria/AAJ-7139-2020	Lopez Tavera, Juan Carlos/0000-0002-6666-960X; Torres Bugarin, Olivia/0000-0003-4541-8067; Zavala-Cerna, Maria Guadalupe/0000-0001-6508-9657	Universidad Autonoma de Guadalajara	Universidad Autonoma de Guadalajara	The work was supported by Universidad Autonoma de Guadalajara.	Ambroise D, 2006, SCAND J WORK ENV HEA, V32, P22, DOI 10.5271/sjweh.973; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; [Anonymous], SJPLOT DATA VISUALIZ; Antonini JM, 2005, MOL CELL BIOCHEM, V279, P17, DOI 10.1007/s11010-005-8211-6; Antonini JM, 2003, CRIT REV TOXICOL, V33, P61, DOI 10.1080/713611032; Banasik A, 2005, ENVIRON TOXICOL, V20, P402, DOI 10.1002/tox.20125; Barquera S, 2009, SALUD PUBLICA MEXICO, V51, pS595; Bolognesi C, 2015, MUTAT RES, V753, P100, DOI 10.1016/j.mrrev.2013.07.002; Burgaz S, 2011, MUTAGENESIS, V26, P351, DOI 10.1093/mutage/geq101; Burgoyne LA, 1999, EXP CELL RES, V248, P214, DOI 10.1006/excr.1999.4406; Celik A, 2013, ECOTOX ENVIRON SAFE, V92, P265, DOI 10.1016/j.ecoenv.2013.01.030; Ceppi M, 2010, MUTAT RES-REV MUTAT, V705, P11, DOI 10.1016/j.mrrev.2009.11.001; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Danadevi K, 2004, MUTAGENESIS, V19, P35, DOI 10.1093/mutage/geh001; Dey P, 2012, DIAGN CYTOPATHOL, V40, P664, DOI 10.1002/dc.21589; Diler SB, 2011, DNA CELL BIOL, V30, P821, DOI 10.1089/dna.2011.1216; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2011, MUTAGENESIS, V26, P239, DOI 10.1093/mutage/geq051; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; HEDDLE JA, 1983, MUTAT RES, V123, P61, DOI 10.1016/0165-1110(83)90047-7; Iarmarcovai G, 2008, MUTAT RES-REV MUTAT, V658, P215, DOI 10.1016/j.mrrev.2007.10.001; Lammerding J, 2011, COMPR PHYSIOL, V1, P783, DOI 10.1002/cphy.c100038; Liu S, 2011, ANN OCCUP HYG, V55, P305, DOI 10.1093/annhyg/meq088; Nefic H, 2013, MUTAT RES-GEN TOX EN, V753, P1, DOI 10.1016/j.mrgentox.2013.03.001; Nersesyan A, 2006, CANCER EPIDEM BIOMAR, V15, P1835, DOI 10.1158/1055-9965.EPI-06-0248; OECD, 2014, TEST NO 487 IN VITRO; Revelle W, 2011, USING PSYCH PACKAGE, P1; RODILLA V, 1993, MUTAT RES, V300, P281, DOI 10.1016/0165-1218(93)90062-I; SCHMID W, 1975, MUTAT RES, V31, P9, DOI 10.1016/0165-1161(75)90058-8; Siew SS, 2008, SCAND J WORK ENV HEA, V34, P444, DOI 10.5271/sjweh.1296; Singaravelu SR, 2015, ENVIRON SCI POLLUT R, V22, P2721, DOI 10.1007/s11356-014-3543-y; SJOGREN B, 1994, OCCUP ENVIRON MED, V51, P335, DOI 10.1136/oem.51.5.335; Sudha S, 2011, ASIAN PAC J CANCER P, V12, P1041; Team RDC, 2009, R LANG ENV STAT COMP; Tejedor Isidro A, 2011, BIOMONITOREO CELULAS; Thomas P, 2009, NAT PROTOC, V4, P825, DOI 10.1038/nprot.2009.53; TOLBERT PE, 1992, MUTAT RES, V271, P69, DOI 10.1016/0165-1161(92)90033-I; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-38798141-3, DOI 10.1007/978-0-38798141-3]; Wultsch G, 2014, INT J HYG ENVIR HEAL, V217, P492, DOI 10.1016/j.ijheh.2013.09.005; Yabuki Munehisa, 1999, Physiological Chemistry and Physics and Medical NMR, V31, P77; Yildirim IH, 2006, RUSS J GENET+, V42, P573, DOI 10.1134/S1022795406050152; Yu IJ, 2004, TOXICOL LETT, V154, P105, DOI 10.1016/j.toxlet.2004.07.009	43	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131548	10.1371/journal.pone.0131548	http://dx.doi.org/10.1371/journal.pone.0131548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244938	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400009
J	Ehler, J; Koball, S; Sauer, M; Mitzner, S; Hickstein, H; Benecke, R; Zettl, UK				Ehler, Johannes; Koball, Sebastian; Sauer, Martin; Mitzner, Steffen; Hickstein, Heiko; Benecke, Reiner; Zettl, Uwe K.			Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CNS DEMYELINATION; OPTIC NEURITIS; RELAPSES; PLASMAPHERESIS; PREDICTORS; IMMUNOGLOBULIN; COMPLICATIONS; MANAGEMENT; ATTACKS	Objectives Experience with therapeutic plasma exchange (TPE) for acute relapses in clinically isolated syndrome (CIS) or multiple sclerosis (MS) patients has been derived from small and inhomogeneous patient populations so far. In the present study, we retrospectively evaluated features associated with TPE response in a larger cohort of CIS and MS patients with acute worsening of disease. Participants Ninety CIS and MS patients with acute relapses or acute worsening of symptoms were firstly treated with TPE. The population consisted of 62 women and 28 men with a median age of 38 years (range 18-69 years). Outcome Measures Primary endpoint was the clinical response to TPE, focused on the functional improvement of the target neurologic deficit. Secondary endpoint was an improvement in expanded disability status scale (EDSS) scoring. Results A clinical response to TPE was observed in 65 out of 90 patients (72.2%), with marked improvement in 18 (20.0%) and moderate improvement in 47 out of 90 patients (52.2%). The median EDSS was reduced from 3.75 before to 3.0 after TPE (p = 0.001). Response to TPE was significantly more frequent in patients with relapsing courses of disease (CIS, RR-MS, p = 0.001), no disease modifying drugs (p = 0.017), gadolinium-positive (Gd+) MRI lesions (p = 0.001) and EDSS <= 5.0 before TPE (p = 0.014). In the multiple logistic regression analysis only the detection of Gd+ MRI lesions was significantly altered (p = 0.004). Conclusion Clinical response to TPE was achieved in the majority of our patients. We identified clinical and diagnostic features in CIS and MS relapses that might be helpful to identify patients responding to TPE. Gd+ MRI lesions before treatment were the best predictor of the response to TPE in our cohort.	[Ehler, Johannes; Sauer, Martin] Univ Rostock, Dept Anaesthesiol & Intens Care Med, D-18055 Rostock, Germany; [Ehler, Johannes; Benecke, Reiner; Zettl, Uwe K.] Univ Rostock, Dept Neurol, Neuroimmunol Sect, D-18055 Rostock, Germany; [Koball, Sebastian; Mitzner, Steffen; Hickstein, Heiko] Univ Rostock, Div Nephrol, Dept Internal Med, D-18055 Rostock, Germany; [Hickstein, Heiko] KfH Dialysis Ctr Wismar, Wismar, Germany	University of Rostock; University of Rostock; University of Rostock	Ehler, J (corresponding author), Univ Rostock, Dept Anaesthesiol & Intens Care Med, D-18055 Rostock, Germany.	johannes.ehler@med.uni-rostock.de	Sauer, Martin/GZK-4547-2022; Sauer, Martin/N-3933-2019		Merz Pharmaceuticals; Bayer Healthcare; Biogen Idec; Genzyme; Merck-Serono; Novartis; Teva; Fresenius Medical Care	Merz Pharmaceuticals; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Biogen Idec(Biogen); Genzyme(Sanofi-AventisGenzyme Corporation); Merck-Serono(Merck & Company); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); Fresenius Medical Care	JE MS SM and HH have declared that no competing interests exist. The corresponding author has read the journal's policy and the authors of this manuscript have the following competing interests: RB received research support from Merz Pharmaceuticals. UKZ received speaker fees from Bayer Healthcare, Biogen Idec, Genzyme, Merck-Serono, Novartis and Teva. SK received speaker fees from Fresenius Medical Care. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bennetto L, 2004, J NEUROL, V251, P1515, DOI 10.1007/s00415-004-0588-8; Bevan C, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0345-6; Bohlega S, 2014, MULT SCLER RELAT DIS, V3, P766; Bramlage CP, 2009, J CLIN APHERESIS, V24, P225, DOI 10.1002/jca.20217; Chhibber V, 2012, SEMIN DIALYSIS, V25, P132, DOI 10.1111/j.1525-139X.2011.01023.x; DAU PC, 1980, NEUROLOGY, V30, P1023, DOI 10.1212/WNL.30.10.1023; Ehler J, 2014, THER APHER DIAL, V18, P489, DOI 10.1111/1744-9987.12176; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; Habek M, 2010, THER APHER DIAL, V14, P298, DOI 10.1111/j.1744-9987.2009.00794.x; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Hommes OR, 2004, LANCET, V364, P1149, DOI 10.1016/S0140-6736(04)17101-8; Kantarci OH, 2014, CLIN PHARMACOL THER, V95, P32, DOI 10.1038/clpt.2013.196; KAPLAN AA, 1992, SEMIN DIALYSIS, V5, P227, DOI 10.1111/j.1525-139X.1992.tb00482.x; Kaplan A, 2012, SEMIN DIALYSIS, V25, P152, DOI 10.1111/j.1525-139X.2011.01026.x; Kaya E, 2013, TRANSFUS APHER SCI, V48, P349, DOI 10.1016/j.transci.2013.04.015; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Khatri B O, 2000, Ther Apher, V4, P263, DOI 10.1046/j.1526-0968.2000.004004263.x; Kingwell E, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-128; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2014, EXP NEUROL, V262, P2, DOI 10.1016/j.expneurol.2013.12.003; Lehmann HC, 2006, ARCH NEUROL-CHICAGO, V63, P930, DOI 10.1001/archneur.63.7.930; Linker RA, 2007, J NEUROL, V254, P1288, DOI 10.1007/s00415-006-0497-0; Llufriu S, 2009, NEUROLOGY, V73, P949, DOI 10.1212/WNL.0b013e3181b879be; Lublin FD, 2003, NEUROLOGY, V61, P1528, DOI 10.1212/01.WNL.0000096175.39831.21; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Magana SM, 2011, ARCH NEUROL-CHICAGO, V68, P870, DOI 10.1001/archneurol.2011.34; Matzke B, 2011, MULT SCLER J, V17, P759, DOI 10.1177/1352458511401461; McDonald WI, 2000, NEW ENGL J MED, V343, P1486, DOI 10.1056/NEJM200011163432010; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McLeod BC, 2003, J CLIN APHERESIS, V18, P72, DOI 10.1002/jca.10058; Meca-Lallana JE, 2013, CLIN THER, V35, P474, DOI 10.1016/j.clinthera.2013.02.027; NOSEWORTHY JH, 1991, LANCET, V337, P441; Roesner S, 2012, ACTA NEUROL SCAND, V126, P103, DOI 10.1111/j.1600-0404.2011.01612.x; Ruprecht K, 2004, NEUROLOGY, V63, P1081, DOI 10.1212/01.WNL.0000138437.99046.6B; Sastre-Garriga J, 2003, MULT SCLER J, V9, P39, DOI 10.1191/1352458503ms847oa; Schroeder A, 2009, EXPERT REV NEUROTHER, V9, P1331, DOI 10.1586/ERN.09.81; Sellebjerg F, 2005, EUR J NEUROL, V12, P939, DOI 10.1111/j.1468-1331.2005.01352.x; Selmi C, 2012, AUTOIMMUN REV, V11, P159, DOI 10.1016/j.autrev.2011.05.006; Sorensen PS, 2014, CURR OPIN NEUROL, V27, P246, DOI 10.1097/WCO.0000000000000096; Sprenger K B, 1987, J Clin Apher, V3, P185, DOI 10.1002/jca.2920030313; Trebst C, 2009, BLOOD PURIFICAT, V28, P108, DOI 10.1159/000224630; WEINER HL, 1980, NEUROLOGY, V30, P1029, DOI 10.1212/WNL.30.10.1029; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q; Wiendl H, 2008, J NEUROL, V255, P1449, DOI 10.1007/s00415-008-0061-1	47	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134583	10.1371/journal.pone.0134583	http://dx.doi.org/10.1371/journal.pone.0134583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244762	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400091
J	Li, JQ; Shen, CP; Liu, Y; Li, YZ; Sun, L; Jiao, L; Jiao, WW; Xiao, J; Shen, C; Qi, H; Xu, F; Ma, L				Li, Jieqiong; Shen, Chunping; Liu, Ying; Li, Yunzhu; Sun, Lin; Jiao, Lei; Jiao, Weiwei; Xiao, Jing; Shen, Chen; Qi, Hui; Xu, Fang; Ma, Lin			Impaired Function of CD5(+)CD19(+)CD1d(hi) B10 Cells on IgE Secretion in an Atopic Dermatitis-Like Mouse Model	PLOS ONE			English	Article							REGULATORY B-CELLS; SUPPRESSIVE ROLE; T-CELLS; AUTOIMMUNITY; INITIATION; TOLERANCE; RESPONSES; PATHWAYS; COLITIS; ROLES	Atopic dermatitis (AD) is a chronic inflammatory pruritic skin disease in which the pathogenic mechanism is complicated and not completely understood. Reports on the role of regulated cells in AD have recently evolved to regulate B cells, which may play a role in allergic inflammation as well. In the present study, we examined the frequency and regulatory function of CD5(+)CD19(+)CD1d(hi) B10 cells in an AD-like mouse model. Our results showed that the percentage of CD5(+)CD19(+)CD1d(hi) B10 cells increased while the frequency of IL-10-producing B cells in CD19(+)B cells decreased in the mice of AD group. Moreover, no difference in the percentage of B10pro+B10 cells was observed between the AD and control groups. Strikingly, B10 cells from control mice effectively inhibited IgE secretion, whereas the suppressive function of B10 cells from the AD mice was significantly decreased, which was similar to that observed in the group without B10. Altogether, these results suggest that the number of IL-10-producing B cells decreased in the AD group and these cells showed a defective regulatory function on IgE secretion.	[Li, Jieqiong; Sun, Lin; Jiao, Weiwei; Xiao, Jing; Shen, Chen; Qi, Hui; Xu, Fang] Capital Med Univ, Key Lab Major Dis Children,Beijing Childrens Hosp, Beijing Key Lab Pediat Resp Infect Dis,Minist Edu, Natl Key Discipline Pediat,Beijing Pediat Res Ins, Beijing 100045, Peoples R China; [Shen, Chunping; Liu, Ying; Li, Yunzhu; Jiao, Lei; Ma, Lin] Capital Med Univ, Beijing Childrens Hosp, Dept Dermatol, Beijing 100045, Peoples R China	Capital Medical University; Capital Medical University	Ma, L (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Dermatol, Beijing 100045, Peoples R China.	bch_maleen@aliyun.com	shen, chen/AAC-2458-2020; 孙, 琳/HGE-6966-2022		Beijing Natural Science Foundation of China [7122064]	Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by grants 7122064 from the Beijing Natural Science Foundation of China.	Auriemma M, 2013, EUR CYTOKINE NETW, V24, P37, DOI 10.1684/ecn.2013.0333; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Chesneau M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00497; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Huu DL, 2013, BLOOD, V121, P3274, DOI 10.1182/blood-2012-11-465658; Engebretsen KA, 2015, J EURACADDERMATOLVEN; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017; Kasperkiewicz M, 2014, JAMA DERMATOL, V150, P1350, DOI 10.1001/jamadermatol.2014.2082; Leonardi S, 2015, ALLERGY ASTHMA PROC, V36, P74, DOI 10.2500/aap.2015.36.3808; LI YZ, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/907016; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Noh J, 2012, CELL IMMUNOL, V274, P109, DOI 10.1016/j.cellimm.2012.01.005; Noh J, 2010, CELL IMMUNOL, V264, P143, DOI 10.1016/j.cellimm.2010.05.013; Ray A, 2014, METHODS MOL BIOL, V1190, P243, DOI 10.1007/978-1-4939-1161-5_17; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Verhagen J, 2006, J ALLERGY CLIN IMMUN, V117, P176, DOI 10.1016/j.jaci.2005.10.040; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Yanaba K, J IMMUNO, V182, P7459; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2013, AM J PATHOL, V182, P2214, DOI 10.1016/j.ajpath.2013.02.042; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4; Zhu HQ, 2015, BRIT J DERMATOL, V172, P101, DOI 10.1111/bjd.13192	35	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132173	10.1371/journal.pone.0132173	http://dx.doi.org/10.1371/journal.pone.0132173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244559	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400019
J	Wu, F; Song, HB; Zhang, Y; Zhang, YZ; Mu, Q; Jiang, M; Wang, F; Zhang, W; Li, L; Li, HJ; Wang, YS; Zhang, MX; Li, SW; Yang, LJ; Meng, Y; Tang, DQ				Wu, Fei; Song, Haibo; Zhang, Yuan; Zhang, Yuzhu; Mu, Qian; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Li, Huanjie; Wang, Yunshan; Zhang, Mingxiang; Li, Shiwu; Yang, Lijun; Meng, Yan; Tang, Dongqi			Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; EXPRESSION; GROWTH; MOUSE; DIFFERENTIATION; ADIPOCYTES; MARKERS; MODEL; FAT; JNK	As a link between exercise and metabolism, irisin is assumed to be involved in increased total body energy expenditure, reduced body weight, and increased insulin sensitivity. Although our recent evidence supported the contribution of irisin to vascular endothelial cell (ECs) proliferation and apoptosis, further research of irisin involvement in the angiogenesis of ECs was not conclusive. In the current study, it was found that irisin promoted Human Umbilical Vein Endothelial Cell (HUVEC) angiogenesis via increasing migration and tube formation, and attenuated chemically-induced intersegmental vessel (ISV) angiogenic impairment in transgenic TG (fli1:GFP) zebrafish. It was further demonstrated that expression of matrix metalloproteinase (MMP) 2 and 9 were also up-regulated in endothelial cells. We also found that irisin activated extracellular signal-related kinase (ERK) signaling pathways. Inhibition of ERK signaling by using U0126 decreased the pro-migration and proangiogenic effect of irisin on HUVEC. Also, U0126 inhibited the elevated expression of MMP-2 and MMP-9 when they were treated with irisin. In summary, these findings provided direct evidence that irisin may play a pivotal role in maintaining endothelium homeostasis by promoting endothelial cell angiogenesis via the ERK signaling pathway.	[Wu, Fei; Song, Haibo; Zhang, Yuan; Zhang, Yuzhu; Mu, Qian; Jiang, Miao; Wang, Fang; Zhang, Wen; Li, Liang; Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan 250012, Peoples R China; [Li, Huanjie; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Jinan 250012, Peoples R China; [Zhang, Mingxiang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China; [Li, Shiwu; Yang, Lijun] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Meng, Yan] Shandong Univ, Hosp 2, Dept Urol, Jinan 250012, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; State University System of Florida; University of Florida; Shandong University	Meng, Y (corresponding author), Shandong Univ, Hosp 2, Dept Urol, Jinan 250012, Peoples R China.	mengyan2000@126.com; tangdq@sdu.edu.cn	Zhang, Yuan/B-3806-2019		Taishan Scholar Special Funding of Shandong Province [21300084963048]	Taishan Scholar Special Funding of Shandong Province	This work was supported by Taishan Scholar Special Funding of Shandong Province (Grant number 21300084963048) to DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, CLIN EXP METASTAS, V27, P419, DOI 10.1007/s10585-010-9312-5; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Aronis K, 2013, INTERNATIONAL JOURNA; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dong FY, 2014, CANCER BIOL THER, V15, P1479, DOI 10.4161/15384047.2014.955728; Ebrahimian TG, 2005, ARTERIOSCL THROM VAS, V25, P65, DOI 10.1161/01.ATV.0000149377.90852.d8; Ellis LM, 2001, SEMINARS ONCOLOGY; Gannon NP, 2015, INT J CANCER, V136, pE197, DOI 10.1002/ijc.29142; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; HERRON GS, 1986, J BIOL CHEM, V261, P2814; Hunter J, 2007, CLIN ORTHOP RELAT R, P27, DOI 10.1097/BLO.0b013e31803dd01c; Iacobazzi D, 2015, CELL PHYSIOL BIOCHEM, V36, P384, DOI 10.1159/000430257; Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim BS, 2014, BIOCHEM BIOPH RES CO, V450, P1333, DOI 10.1016/j.bbrc.2014.06.137; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Li SW, 2010, PROTEIN EXPRES PURIF, V72, P157, DOI 10.1016/j.pep.2010.04.004; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Lu J, 2010, CANCER RESEARCH SUPP, V70, P5760; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Park YS, 2015, J CELL PHYSIOL, V230, P140, DOI 10.1002/jcp.24690; Pourgholami MH, 2010, BIOCHEM BIOPH RES CO, V397, P729, DOI 10.1016/j.bbrc.2010.06.019; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Tal TL, 2014, REPROD TOXICOL, V48, P51, DOI 10.1016/j.reprotox.2014.05.014; Williams SB, 1998, CIRCULATION, V97, P1695, DOI 10.1161/01.CIR.97.17.1695; Wood JM, 2000, CANCER RES, V60, P2178; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhang CB, 2015, CELL BIOCHEM BIOPHYS, V71, P1319, DOI 10.1007/s12013-014-0351-4; Zhang M, 2014, EUR REV MED PHARMACO, V18, P1567; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	40	71	76	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134662	10.1371/journal.pone.0134662	http://dx.doi.org/10.1371/journal.pone.0134662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241478	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942700056
J	Ansong, M; Pickering, C				Ansong, Michael; Pickering, Catherine			What's a Weed? Knowledge, Attitude and Behaviour of Park Visitors about Weeds	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; SPECIES RICHNESS; URBAN PARKS; NEW-ZEALAND; IMPACTS; CONSERVATION; PREFERENCES; PERCEPTIONS; VEGETATION; SEEDS	Weeds are a major threat to biodiversity globally degrading natural areas of high conservation value. But what are our attitudes about weeds and their management including weeds in national parks? Do we know what a weed is? Do we consider weeds a problem? Do we support their management? Are we unintentionally spreading weeds in parks? To answer these questions, we surveyed visitors entering a large popular national park near the city of Brisbane, Australia. Park visitors were knowledgeable about weeds; with >75% correctly defining weeds as 'plants that grow where they are not wanted'. About 10% of the visitors, however, provided their own sophisticated definitions. This capacity to define weeds did not vary with people's age, sex or level of education. We constructed a scale measuring visitors' overall concern about weeds in parks using the responses to ten Likert scale statements. Over 85% of visitors were concerned about weeds with older visitors, hikers, and those who could correctly define weeds more concerned than their counterparts. The majority think visitors unintentionally introduce seeds into parks, with many (63%) having found seeds on their own clothing. However, over a third disposed of these seeds in ways that could facilitate weed spread. Therefore, although most visitors were knowledgeable and concerned about weeds, and support their control, there is a clear need for more effective communication regarding the risk of visitors unintentionally dispersing weed seeds in parks.	[Ansong, Michael; Pickering, Catherine] Griffith Univ, Environm Futures Res Inst, Gold Coast, Qld, Australia	Griffith University	Ansong, M (corresponding author), Griffith Univ, Environm Futures Res Inst, Gold Coast, Qld, Australia.	michael.ansong@griffithuni.edu.au	Ansong, Michael/GXG-4349-2022	Ansong, Michael/0000-0003-3811-3230; Pickering, Catherine/0000-0002-3731-5407	Griffith University Postgraduate Research Scholarship Scheme	Griffith University Postgraduate Research Scholarship Scheme	One of the authors (Michael Ansong) would like to acknowledge financial support from the Griffith University Postgraduate Research Scholarship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong M, 2014, J ENVIRON MANAGE, V144, P203, DOI 10.1016/j.jenvman.2014.05.026; Ansong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080275; Ansong Michael, 2013, Ecological Management & Restoration, V14, P216, DOI 10.1111/emr.12057; Arnberger A, 2007, ENVIRON MANAGE, V40, P34, DOI 10.1007/s00267-004-0355-8; Australian Bureau of Statistics, 2011, CENS FACT SHEET; Bardsley D, 2006, GEOJOURNAL, V65, P199, DOI 10.1007/s10708-005-2755-6; Bhandari AK, 2010, J TRAVEL TOUR MARK, V27, P612, DOI 10.1080/10548408.2010.507156; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Csurhes S., 1998, POTENTIAL ENV WEEDS; Czech B, 2001, WILDLIFE SOC B, V29, P187; Dowling R, 2010, USE CAMERAS MONITOR; Eagly A. H., 1993, PSYCHOL ATTITUDES; Eiswerth ME, 2011, ECOL ECON, V70, P1672, DOI 10.1016/j.ecolecon.2011.04.012; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Florgard Clas, 2006, Urban Forestry & Urban Greening, V5, P83, DOI 10.1016/j.ufug.2006.06.002; Foxcroft LC, 2013, INVAD NAT SPRING SER, V7, P1, DOI 10.1007/978-94-007-7750-7; Garcia-Llorente M, 2008, BIOL CONSERV, V141, P2969, DOI 10.1016/j.biocon.2008.09.003; Gilleard C, 2007, RES AGING, V29, P590, DOI 10.1177/0164027507305730; Groves R. H., 2005, JUMPING GARDEN FENCE; Hill W, 2006, J ENVIRON MANAGE, V78, P24, DOI 10.1016/j.jenvman.2005.04.007; Jackson E. L., 1986, Leisure Studies, V5, P1, DOI 10.1080/02614368600390011; Jetter K, 2004, BIOL CONTROL, V30, P312, DOI 10.1016/j.biocontrol.2003.08.004; LIDDLE M, 1997, RECREATION ECOLOGY; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; LONSDALE WM, 1994, BIOL CONSERV, V69, P277, DOI 10.1016/0006-3207(94)90427-8; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Mount A, 2009, J ENVIRON MANAGE, V91, P168, DOI 10.1016/j.jenvman.2009.08.002; Newsome D, 2013, NATURAL AREA TOURISM; Ngugi MR, 2014, AUSTRALAS J ENV MAN, V21, P413, DOI 10.1080/14486563.2014.952788; Nielsen AB, 2014, URBAN ECOSYST, V17, P305, DOI 10.1007/s11252-013-0316-1; Nikodinoska N, 2014, KOEDOE, V56, DOI 10.4102/koedoe.v56i1.1214; Pickering C, 2007, MT RES DEV, V27, P359, DOI 10.1659/mrd.0805; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Pickering CM, 2007, J ENVIRON MANAGE, V85, P791, DOI 10.1016/j.jenvman.2006.11.021; Pickering CM, 2011, BIOL INVASIONS, V13, P1869, DOI 10.1007/s10530-011-0006-y; Rossi S. D., 2013, ATTITUDES LOCAL PARK; Sharp RL, 2011, BIOL CONSERV, V144, P2097, DOI 10.1016/j.biocon.2011.04.032; Sheley RL, 1996, WEED TECHNOL, V10, P592, DOI 10.1017/S0890037X00040495; Sinden J., 2004, EC IMPACT WEEDS AUST; TIMMINS SM, 1991, NEW ZEAL J ECOL, V15, P153; Tindall DB, 2003, SOC NATUR RESOUR, V16, P909, DOI 10.1080/716100620; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VIRDEN RJ, 1988, ENVIRON BEHAV, V20, P721, DOI 10.1177/0013916588206004; Weaver DB, 2013, J TRAVEL RES, V52, P377, DOI 10.1177/0047287512467704; Williams JA, 2000, AUSTRAL ECOL, V25, P425, DOI 10.1046/j.1442-9993.2000.01081.x; Wolf-Watz D, 2011, SCAND J HOSP TOUR, V11, P190, DOI 10.1080/15022250.2011.583066; Zelezny LC, 2000, J SOC ISSUES, V56, P443, DOI 10.1111/0022-4537.00177	49	15	16	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135026	10.1371/journal.pone.0135026	http://dx.doi.org/10.1371/journal.pone.0135026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252004	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100106
J	Asgeirsson, AG; Nordfang, M; Sorensen, TA				Asgeirsson, Arni Gunnar; Nordfang, Maria; Sorensen, Thomas Alrik			Components of Attention in Grapheme-Color Synesthesia: A Modeling Approach	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; POP-OUT; SYNAESTHESIA; CAPACITY; SELECTION; SET; IDENTIFICATION; INTERFERENCE; AUTOMATICITY	Grapheme-color synesthesia is a condition where the perception of graphemes consistently and automatically evokes an experience of non-physical color. Many have studied how synesthesia affects the processing of achromatic graphemes, but less is known about the synesthetic processing of physically colored graphemes. Here, we investigated how the visual processing of colored letters is affected by the congruence or incongruence of synesthetic grapheme-color associations. We briefly presented graphemes (10-150 ms) to 9 grapheme-color synesthetes and to 9 control observers. Their task was to report as many letters (targets) as possible, while ignoring digit (distractors). Graphemes were either congruently or incongruently colored with the synesthetes' reported grapheme-color association. A mathematical model, based on Bundesen's (1990) Theory of Visual Attention (TVA), was fitted to each observer's data, allowing us to estimate discrete components of visual attention. The models suggested that the synesthetes processed congruent letters faster than incongruent ones, and that they were able to retain more congruent letters in visual short-term memory, while the control group's model parameters were not significantly affected by congruence. The increase in processing speed, when synesthetes process congruent letters, suggests that synesthesia affects the processing of letters at a perceptual level. To account for the benefit in processing speed, we propose that synesthetic associations become integrated into the categories of graphemes, and that letter colors are considered as evidence for making certain perceptual categorizations in the visual system. We also propose that enhanced visual short-term memory capacity for congruently colored graphemes can be explained by the synesthetes' expertise regarding their specific grapheme-color associations.	[Asgeirsson, Arni Gunnar] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; [Asgeirsson, Arni Gunnar; Sorensen, Thomas Alrik] Aarhus Univ, Dept Clin Med, Ctr Funct Integrat Neurosci, Cognit Neurosci Res Unit, Aarhus, Denmark; [Asgeirsson, Arni Gunnar] Univ Iceland, Sch Hlth Sci, Dept Psychol, Reykjavik, Iceland; [Nordfang, Maria] Univ Copenhagen, Dept Psychol, Ctr Visual Cognit, Copenhagen, Denmark; [Sorensen, Thomas Alrik] Aalborg Univ, Ctr Cognit Neurosci, Dept Commun & Psychol, Aalborg, Denmark	Leiden University; Leiden University - Excl LUMC; Aarhus University; University of Iceland; University of Copenhagen; Aalborg University	Asgeirsson, AG (corresponding author), Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands.	arnigunnarasgeirsson@gmail.com		Asgeirsson, Arni/0000-0001-5445-4620; Sorensen, Thomas Alrik/0000-0002-2429-6550; Nordfang, Maria/0000-0002-2183-0447	Kristian Holt-Hansen foundation	Kristian Holt-Hansen foundation	The operating costs of this research were covered by a grant from the Kristian Holt-Hansen foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Asgeirsson AG, 2014, ATTEN PERCEPT PSYCHO, V76, P40, DOI 10.3758/s13414-013-0546-6; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baron-Cohen S, 2007, J CONSCIOUSNESS STUD, V14, P237; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Brang D, 2010, NEUROIMAGE, V53, P268, DOI 10.1016/j.neuroimage.2010.06.008; Brang D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001205; BUNDESEN C, 1987, PSYCHOL RES-PSYCH FO, V49, P113, DOI 10.1007/BF00308676; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Bundesen C, 2008, OXFORD PSYCHOLOGY SE; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Colizoli O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039799; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N, DEV SCI IN PRESS; Curby KM, 2009, J EXP PSYCHOL HUMAN, V35, P94, DOI 10.1037/0096-1523.35.1.94; Dixon MJ, 2000, NATURE, V406, P365, DOI 10.1038/35019148; Dyrholm M, 2011, J MATH PSYCHOL, V55, P416, DOI 10.1016/j.jmp.2011.08.005; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Edquist J, 2006, CORTEX, V42, P222, DOI 10.1016/S0010-9452(08)70347-2; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Grossenbacher PG, 2001, TRENDS COGN SCI, V5, P36, DOI 10.1016/S1364-6613(00)01571-0; Habekost T, 2007, NEUROPSYCHOLOGIA, V45, P1474, DOI 10.1016/j.neuropsychologia.2006.11.006; Hubbard EM, 2011, J NEUROPSYCHOL, V5, P152, DOI 10.1111/j.1748-6653.2011.02014.x; Jewanski J, 2009, J HIST NEUROSCI, V18, P293, DOI 10.1080/09647040802431946; Laeng B, 2004, PSYCHOL SCI, V15, P277, DOI 10.1111/j.0956-7976.2004.00666.x; Laeng B, 2009, ATTEN PERCEPT PSYCHO, V71, P1461, DOI 10.3758/APP.71.7.1461; Lamers MJM, 2010, MEM COGNITION, V38, P893, DOI 10.3758/MC.38.7.893; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Lupianez J, 2006, CORTEX, V42, P204, DOI 10.1016/S0010-9452(08)70345-9; Luria AR., 1968, THE MIND OF A MNEMON; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mattingley JB, 2006, CORTEX, V42, P213, DOI 10.1016/S0010-9452(08)70346-0; Mattingley JB, 2009, ANN NY ACAD SCI, V1156, P141, DOI 10.1111/j.1749-6632.2009.04422.x; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Maxfield JT, 2014, J VISION, V14, DOI 10.1167/14.12.1; Meier B, 2013, OXFORD HDB SYNESTHES, P692; Meier B, 2013, FRONT PSYCHOL, V4, P1; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; Monahan JS, 2001, J GEN PSYCHOL, V128, P98, DOI 10.1080/00221300109598901; Mulvenna C.M., 2013, OXFORD HDB SYNESTHES, P607; Nordfang M, 2013, J EXP PSYCHOL GEN, V142, P510, DOI 10.1037/a0029631; Palmeri TJ, 2002, P NATL ACAD SCI USA, V99, P4127, DOI 10.1073/pnas.022049399; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Petersen A, 2012, J EXP PSYCHOL HUMAN, V38, P498, DOI 10.1037/a0026728; Pritchard J, 2013, COGNITION, V127, P230, DOI 10.1016/j.cognition.2012.12.012; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2004, SYNESTHESIA PERSPECT, P108; Rich AN, 2013, COGN NEUROPSYCHOL, V30, P110, DOI 10.1080/02643294.2013.805686; Rothen N, 2012, NEUROSCI BIOBEHAV R, V36, P1952, DOI 10.1016/j.neubiorev.2012.05.004; Rothen N, 2010, MEMORY, V18, P258, DOI 10.1080/09658210903527308; Rothen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005037; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Sagiv N, 2006, CORTEX, V42, P232, DOI 10.1016/S0010-9452(08)70348-4; SHIBUYA H, 1988, J EXP PSYCHOL HUMAN, V14, P591, DOI 10.1037/0096-1523.14.4.591; Simner J., 2013, OXFORD HDB SYNAESTHE, P728, DOI DOI 10.1093/OXFORDHB/9780199603329.013.0037; Simner J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00603; Smilek D, 2001, J COGNITIVE NEUROSCI, V13, P930, DOI 10.1162/089892901753165845; Smith PL, 2009, VISION RES, V49, P1363, DOI 10.1016/j.visres.2008.04.024; Sorensen TA, 2014, J EXP PSYCHOL LEARN; Sorensen TA, 2012, ACTA PSYCHOL, V140, P158, DOI 10.1016/j.actpsy.2012.04.004; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; STIRLING N, 1979, Q J EXP PSYCHOL, V31, P121, DOI 10.1080/14640747908400712; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Terhune DB, 2013, COGNITION, V129, P123, DOI 10.1016/j.cognition.2013.06.009; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V9, P40, DOI 10.3758/BF03213026; Vangkilde S, 2011, PSYCHOPHARMACOLOGY, P1; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Volberg G, 2013, J COGNITIVE NEUROSCI, V25, P1148, DOI 10.1162/jocn_a_00374; Ward J, 2010, P R SOC B, V277, P1021, DOI 10.1098/rspb.2009.1765; Witthoft N, 2006, CORTEX, V42, P175, DOI 10.1016/S0010-9452(08)70342-3; Witthoft N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118996; Witthoft N, 2013, PSYCHOL SCI, V24, P258, DOI 10.1177/0956797612452573; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yaro C, 2007, Q J EXP PSYCHOL, V60, P681, DOI 10.1080/17470210600785208; Zhang W, 2011, J VIS, V11, P1248, DOI [10.1167/11.11.1248, DOI 10.1167/11.11.1248]; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	78	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134456	10.1371/journal.pone.0134456	http://dx.doi.org/10.1371/journal.pone.0134456			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252019	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100058
J	Cizkova, J; Hribova, E; Christelova, P; Van den Houwe, I; Hakkinen, M; Roux, N; Swennen, R; Dolezel, J				Cizkova, Jana; Hribova, Eva; Christelova, Pavla; Van den Houwe, Ines; Hakkinen, Markku; Roux, Nicolas; Swennen, Rony; Dolezel, Jaroslav			Molecular and Cytogenetic Characterization of Wild Musa Species	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; GENETIC DIVERSITY; RIBOSOMAL DNA; SECTIONAL RELATIONSHIPS; CONCERTED EVOLUTION; GENOME SIZE; PCR-RFLP; ACUMINATA; IDENTIFICATION; SEQUENCES	The production of bananas is threatened by rapid spreading of various diseases and adverse environmental conditions. The preservation and characterization of banana diversity is essential for the purposes of crop improvement. The world's largest banana germplasm collection maintained at the Bioversity International Transit Centre (ITC) in Belgium is continuously expanded by new accessions of edible cultivars and wild species. Detailed morphological and molecular characterization of the accessions is necessary for efficient management of the collection and utilization of banana diversity. In this work, nuclear DNA content and genomic distribution of 45S and 5S rDNA were examined in 21 diploid accessions recently added to ITC collection, representing both sections of the genus Musa. 2C DNA content in the section Musa ranged from 1.217 to 1.315 pg. Species belonging to section Callimusa had 2C DNA contents ranging from 1.390 to 1.772 pg. While the number of 45S rDNA loci was conserved in the section Musa, it was highly variable in Callimusa species. 5S rRNA gene clusters were found on two to eight chromosomes per diploid cell. The accessions were genotyped using a set of 19 microsatellite markers to establish their relationships with the remaining accessions held at ITC. Genetic diversity done by SSR genotyping platform was extended by phylogenetic analysis of ITS region. ITS sequence data supported the clustering obtained by SSR analysis for most of the accessions. High level of nucleotide diversity and presence of more than two types of ITS sequences in eight wild diploids pointed to their origin by hybridization of different genotypes. This study significantly expands the number of wild Musa species where nuclear genome size and genomic distribution of rDNA loci is known. SSR genotyping identified Musa species that are closely related to the previously characterized accessions and provided data to aid in their classification. Sequence analysis of ITS region provided further information about evolutionary relationships between individual accessions and suggested that some of analyzed accessions were interspecific hybrids and/or backcross progeny.	[Cizkova, Jana; Hribova, Eva; Christelova, Pavla; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic; [Van den Houwe, Ines; Swennen, Rony] Biovers Int, B-3001 Leuven, Belgium; [Hakkinen, Markku] Univ Helsinki, Finnish Museum Nat Hist, FI-00014 Helsinki, Finland; [Roux, Nicolas] Biovers Int, F-34397 Montpellier 5, France; [Swennen, Rony] Katholieke Univ Leuven, Div Crop Biotech, B-3001 Leuven, Belgium; [Swennen, Rony] Int Inst Trop Agr, Arusha, Tanzania	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Alliance; Bioversity International; University of Helsinki; Alliance; Bioversity International; KU Leuven	Dolezel, J (corresponding author), Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, CZ-78371 Olomouc, Czech Republic.	dolezel@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008; Roux, Nicolas/ABG-4156-2020	Dolezel, Jaroslav/0000-0002-6263-0492; Hribova, Eva/0000-0002-6868-4344; Cizkova, Jana/0000-0001-7787-1849	Ministry of Education, Youth and Sports of the Czech Republic [LG12021]; Bioversity International [LoA CfL 2010/58, LoA CfL 2011/51, LoA CfL 2012/43]; National Program of Sustainability I [LO1204]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Bioversity International; National Program of Sustainability I	Funded by the Ministry of Education, Youth and Sports of the Czech Republic (award INGO II No. LG12021), Bioversity International (LoA CfL 2010/58, LoA CfL 2011/51, LoA CfL 2012/43), and the grant LO1204 from the National Program of Sustainability I (JD).	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; [Anonymous], MUS GEN CTR WAS EST; ARGENT G C G, 1976, Notes from the Royal Botanic Garden Edinburgh, V35, P77; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; Bekele E, 2011, GENET RESOUR CROP EV, V58, P259, DOI 10.1007/s10722-010-9568-2; CARREEL F, 1994, GENET SEL EVOL, V26, pS125, DOI 10.1051/gse:19940709; CARREEL F, 1994, THESIS I NATL AGRONO; CHEESMAN E. E., 1947, Kew Bulletin, P106, DOI 10.2307/4109207; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Cizkova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054808; Crouch HK, 1998, CROP SCI, V38, P211, DOI 10.2135/cropsci1998.0011183X003800010035x; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezelova M, 1998, BIOL PLANTARUM, V41, P497, DOI 10.1023/A:1001880030275; Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x; GAWEL NJ, 1992, THEOR APPL GENET, V84, P286, DOI 10.1007/BF00229484; Hakkinen M, 2013, TAXON, V62, P809, DOI 10.12705/624.3; Hakkinen Markku, 2007, Acta Phytotaxonomica et Geobotanica, V58, P110; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Hayden MJ, 2008, MOL BREEDING, V21, P271, DOI 10.1007/s11032-007-9127-5; Hippolyte I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-65; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kamate K, 2001, GENOME, V44, P622, DOI 10.1139/gen-44-4-622; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2004, BIOL J LINN SOC, V82, P615, DOI 10.1111/j.1095-8312.2004.00345.x; Lagoda PJL, 1998, MOL ECOL, V7, P659; Li LF, 2010, MOL PHYLOGENET EVOL, V57, P1, DOI 10.1016/j.ympev.2010.06.021; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Liu AZ, 2010, TAXON, V59, P20, DOI 10.1002/tax.591003; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lysak MA, 1999, THEOR APPL GENET, V98, P1344, DOI 10.1007/s001220051201; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; Nwakanma DC, 2003, THEOR APPL GENET, V107, P850, DOI 10.1007/s00122-003-1340-y; Osuji JO, 1998, ANN BOT-LONDON, V82, P243, DOI 10.1006/anbo.1998.0674; Otto F, 1990, Methods Cell Biol, V33, P105; Pessoa-Filho M, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-23; Pillay M, 2001, THEOR APPL GENET, V102, P965, DOI 10.1007/s001220000500; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Shepherd K, 1999, CYTOGENETICS GENUS M; SIMMONDS N. W., 1962, The Evolution of the Bananas.; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; Ude G, 2002, THEOR APPL GENET, V104, P1239, DOI 10.1007/s00122-001-0802-3; Valarik M, 2002, CHROMOSOME RES, V10, P89, DOI 10.1023/A:1014945730035; Wong C, 2002, ANN BOT-LONDON, V90, P231, DOI 10.1093/aob/mcf170; Wong C, 2001, ANN BOT-LONDON, V88, P1017, DOI 10.1006/anbo.2001.1542	51	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134096	10.1371/journal.pone.0134096	http://dx.doi.org/10.1371/journal.pone.0134096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252482	gold, Green Published			2022-12-26	WOS:000359121100037
J	Ferreira, JAG; Penner, JC; Moss, RB; Haagensen, JAJ; Clemons, KV; Spormann, AM; Nazik, H; Cohen, K; Banaei, N; Carolino, E; Stevens, DA				Ferreira, Jose A. G.; Penner, John C.; Moss, Richard B.; Haagensen, Janus A. J.; Clemons, Karl V.; Spormann, Alfred M.; Nazik, Hasan; Cohen, Kevin; Banaei, Niaz; Carolino, Elisabete; Stevens, David A.			Inhibition of Aspergillus fumigatus and Its Biofilm by Pseudomonas aeruginosa Is Dependent on the Source, Phenotype and Growth Conditions of the Bacterium	PLOS ONE			English	Article							CYSTIC-FIBROSIS; LUNG-FUNCTION; FILAMENTOUS FUNGI; CHRONIC INFECTION; EPIDEMIC STRAIN; COLONIZATION; SUSCEPTIBILITY; DISEASE; ANTIBODIES; FREQUENCY	Aspergillus fumigatus (Af) and Pseudomonas aeruginosa (Pa) are leading fungal and bacterial pathogens, respectively, in many clinical situations. Relevant to this, their interface and co-existence has been studied. In some experiments in vitro, Pa products have been defined that are inhibitory to Af. In some clinical situations, both can be biofilm producers, and biofilm could alter their physiology and affect their interaction. That may be most relevant to airways in cystic fibrosis (CF), where both are often prominent residents. We have studied clinical Pa isolates from several sources for their effects on Af, including testing involving their biofilms. We show that the described inhibition of Af is related to the source and phenotype of the Pa isolate. Pa cells inhibited the growth and formation of Af biofilm from conidia, with CF isolates more inhibitory than non-CF isolates, and non-mucoid CF isolates most inhibitory. Inhibition did not require live Pa contact, as culture filtrates were also inhibitory, and again non-mucoid>mucoid CF>non-CF. Preformed Af biofilm was more resistant to Pa, and inhibition that occurred could be reproduced with filtrates. Inhibition of Af biofilm appears also dependent on bacterial growth conditions; filtrates from Pa grown as biofilm were more inhibitory than from Pa grown planktonically. The differences in Pa shown from these different sources are consistent with the extensive evolutionary Pa changes that have been described in association with chronic residence in CF airways, and may reflect adaptive changes to life in a polymicrobial environment.	[Ferreira, Jose A. G.; Penner, John C.; Clemons, Karl V.; Nazik, Hasan; Cohen, Kevin; Stevens, David A.] Calif Inst Med Res, San Jose, CA 95128 USA; [Ferreira, Jose A. G.; Clemons, Karl V.; Nazik, Hasan; Stevens, David A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Moss, Richard B.] Stanford Univ, Dept Pediat, Div Pulmonol, Stanford, CA 94305 USA; [Haagensen, Janus A. J.; Spormann, Alfred M.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Nazik, Hasan] Istanbul Univ, Istanbul Fac Med, Dept Med Microbiol, Istanbul, Turkey; [Banaei, Niaz] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Carolino, Elisabete] Lisbon Sch Hlth Technol, Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Stanford University; Stanford University; Stanford University; Istanbul University; Stanford University; Universidade de Lisboa	Stevens, DA (corresponding author), Calif Inst Med Res, San Jose, CA 95128 USA.	stevens@stanford.edu	Moss, Richard B./S-9218-2019; Carolino, Elisabete/F-1012-2015	Moss, Richard B./0000-0003-3611-4221; Carolino, Elisabete/0000-0003-4165-7052; Banaei, Niaz/0000-0001-8501-3000; Spormann, Alfred/0000-0001-5103-9704	Child Health Research Institute, Stanford Transdisciplinary Initiatives Program; Brazilian National Council for Scientific and Technological Development (CNPq); Scientific and Technological Research Council of Turkey (TUBITAK)	Child Health Research Institute, Stanford Transdisciplinary Initiatives Program; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	These studies were partially supported by a grant from the Child Health Research Institute, Stanford Transdisciplinary Initiatives Program (to DAS and RBM) and a gift from Mr. John Flatley (to DAS). JAGF and HN were partially supported by grants from the Brazilian National Council for Scientific and Technological Development (CNPq), and by The Scientific and Technological Research Council of Turkey (TUBITAK), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; [Anonymous], CYSTIC FIBROSIS FOUN; Bandara HMHN, 2013, MOL ORAL MICROBIOL, V28, P54, DOI 10.1111/omi.12006; Beaudoin T, 2013, J INFECT DIS, V207, P1544, DOI 10.1093/infdis/jit059; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; BLYTH W, 1971, SABOURAUD, V9, P273; Botha P, 2008, TRANSPLANTATION, V85, P771, DOI 10.1097/TP.0b013e31816651de; Cahill BC, 1997, CHEST, V112, P1160, DOI 10.1378/chest.112.5.1160; Clemons KV, 2009, MED MYCOL, V47, pS132, DOI 10.1080/13693780802213340; Clinical Laboratory Standards Institute, 2008, DOCUMENT M38 A2; Coughlan CA, 2012, AM J RESP CRIT CARE, V186, P999, DOI 10.1164/rccm.201203-0478OC; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; de Boer K, 2011, THORAX, V66, P680, DOI 10.1136/thx.2011.161117; Dekimpe V, 2009, MICROBIOL-SGM, V155, P712, DOI 10.1099/mic.0.022764-0; DENNING DW, 1991, ANTIMICROB AGENTS CH, V35, P1329, DOI 10.1128/AAC.35.7.1329; DENNING DW, 1990, J INFECT DIS, V162, P1151, DOI 10.1093/infdis/162.5.1151; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09; Fillaux J, 2012, SCAND J INFECT DIS, V44, P842, DOI 10.3109/00365548.2012.695454; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; FORSYTH KD, 1988, ARCH DIS CHILD, V63, P953, DOI 10.1136/adc.63.8.953; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Garantziotis S, 2009, AM J TRANSPLANT, V9, P1705, DOI 10.1111/j.1600-6143.2009.02709.x; Gaspar MC, 2013, EUR J CLIN MICROBIOL, V32, P1231, DOI 10.1007/s10096-013-1876-y; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Holcombe LJ, 2010, MICROBIOL-SGM, V156, P1476, DOI 10.1099/mic.0.037549-0; Horre R, 2010, MED MYCOL, V48, pS1, DOI 10.3109/13693786.2010.529304; Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592; Kerr JR, 1999, J CLIN PATHOL, V52, P385, DOI 10.1136/jcp.52.5.385; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53; MANGAN A, 1969, J GEN MICROBIOL, V58, P261, DOI 10.1099/00221287-58-2-261; Masoud-Landgraf L, 2014, MED MYCOL, V52, P179, DOI 10.3109/13693786.2013.792438; Mayer-Hamblett N, 2014, CLIN INFECT DIS, V59, P624, DOI 10.1093/cid/ciu385; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Moree WJ, 2012, P NATL ACAD SCI USA, V109, P13811, DOI 10.1073/pnas.1206855109; Moss BJ, 2008, BIOTECHNOL PROGR, V24, P780, DOI 10.1021/bp070334t; Mowat E, 2009, MED MYCOL, V47, pS120, DOI 10.1080/13693780802238834; Mowat E, 2008, J ANTIMICROB CHEMOTH, V62, P1281, DOI 10.1093/jac/dkn402; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Muller FMC, 2011, MED MYCOL, V49, pS96, DOI 10.3109/13693786.2010.502190; Nagano Y, 2007, REV MED MICROBIOL, V18, P11; NICOLAI T, 1990, PEDIATR PULM, V8, P12, DOI 10.1002/ppul.1950080106; Noni M, 2014, MED MYCOL, V52, P715, DOI 10.1093/mmy/myu038; Nunley DR, 1998, CHEST, V113, P1235, DOI 10.1378/chest.113.5.1235; Penner JC, 2014, ABSTR 54TH INTERSCI; Phelan VV, 2014, J BACTERIOL, V196, P1683, DOI 10.1128/JB.01258-13; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Pressler T, 2006, J CYST FIBROS, V5, P9, DOI 10.1016/j.jcf.2005.11.002; Ramsey KA, 2014, AM J RESP CRIT CARE, V190, P1111, DOI 10.1164/rccm.201407-1277OC; Perez LRR, 2012, CURR MICROBIOL, V64, P81, DOI 10.1007/s00284-011-0041-z; Sabino R, 2015, J CYST FIBROS, V14, P474, DOI 10.1016/j.jcf.2014.10.005; Sabino R, 2014, MED MYCOL, V52, P517, DOI 10.1093/mmy/myu006; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; SCHONHEYDER H, 1985, ACTA PATH MICRO IM B, V93, P105; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309; Shoseyov D, 2006, CHEST, V130, P222, DOI 10.1378/chest.130.1.222; Singh G, 2005, ANTIMICROB AGENTS CH, V49, P1369, DOI 10.1128/AAC.49.4.1369-1376.2005; Smyth AR, 2010, DRUG FUTURE, V35, P1007, DOI 10.1358/dof.2010.035.012.1537937; Speirs JJ, 2012, CURR OPIN PULM MED, V18, P632, DOI 10.1097/MCP.0b013e328358d50b; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Tomee JFC, 1996, ANN INTERN MED, V125, P197, DOI 10.7326/0003-4819-125-3-199608010-00006; Tramper-Stranders GA, 2012, CLIN MICROBIOL INFEC, V18, P567, DOI 10.1111/j.1469-0691.2011.03627.x; Waite RD, 2012, J BACTERIOL, V194, P4521, DOI 10.1128/JB.06678-11; Whiley RA, 2014, J INFECT DIS, V209, P769, DOI 10.1093/infdis/jit568; Williams HD, 2012, THORAX, V67, P465, DOI 10.1136/thoraxjnl-2011-201498; Yang L, 2008, J BACTERIOL, V190, P2767, DOI 10.1128/JB.01581-07; YELDANDI V, 1995, J HEART LUNG TRANSPL, V14, P883; Zeglen S, 2009, TRANSPL P, V41, P3222, DOI 10.1016/j.transproceed.2009.07.063	75	63	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134692	10.1371/journal.pone.0134692	http://dx.doi.org/10.1371/journal.pone.0134692			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252384	gold, Green Published			2022-12-26	WOS:000359121100068
J	Haigh, CL; Tumpach, C; Drew, SC; Collins, SJ				Haigh, Cathryn L.; Tumpach, Carolin; Drew, Simon C.; Collins, Steven J.			The Prion Protein N1 and N2 Cleavage Fragments Bind to Phosphatidylserine and Phosphatidic Acid; Relevance to Stress-Protection Responses	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; AMINO-TERMINUS; LIPID RAFTS; IN-VITRO; MEMBRANES; COPPER; ENDOCYTOSIS; DOMAIN; CONFORMATION	Internal cleavage of the cellular prion protein generates two well characterised N-terminal fragments, N1 and N2. These fragments have been shown to bind to anionic phospholipids at low pH. We sought to investigate binding with other lipid moieties and queried how such interactions could be relevant to the cellular functions of these fragments. Both N1 and N2 bound phosphatidylserine (PS), as previously reported, and a further interaction with phosphatidic acid (PA) was also identified. The specificity of this interaction required the N-terminus, especially the proline motif within the basic amino acids at the N-terminus, together with the copper-binding region (unrelated to copper saturation). Previously, the fragments have been shown to be protective against cellular stresses. In the current study, serum deprivation was used to induce changes in the cellular lipid environment, including externalisation of plasma membrane PS and increased cellular levels of PA. When copper-saturated, N2 could reverse these changes, but N1 could not, suggesting that direct binding of N2 to cellular lipids may be part of the mechanism by which this peptide signals its protective response.	[Haigh, Cathryn L.; Collins, Steven J.] Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Tumpach, Carolin; Drew, Simon C.; Collins, Steven J.] Univ Melbourne, Melbourne Brain Ctr, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia	Royal Melbourne Hospital; University of Melbourne; University of Melbourne	Haigh, CL (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia.	chaigh@unimelb.edu.au; stevenjc@unimelb.edu.au	Drew, Simon/ABB-8102-2021	Drew, Simon/0000-0002-1459-9865; Haigh, Cathryn/0000-0001-7591-1149; Tumpach, Carolin/0000-0002-4851-652X	National Health and Medical Research Council (NHMRC) [628946]; NH&MRC Practitioner Fellowship [APP100581]; Australian Research Council Future Fellowship [FT110100199]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by a National Health and Medical Research Council (NH & MRC; https://www.nhmrc.gov.au/) program grant (#628946) and SJC is supported by an NH&MRC Practitioner Fellowship (#APP100581). SCD is funded by an Australian Research Council Future Fellowship (FT110100199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Boland MP, 2010, J BIOL CHEM, V285, P32282, DOI 10.1074/jbc.M110.123398; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cisse M, 2011, J BIOL CHEM, V286, P29192, DOI 10.1074/jbc.M110.208249; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Dong SL, 2007, BIOPOLYMERS, V88, P840, DOI 10.1002/bip.20860; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Drew SC, 2011, J NEUROPATH EXP NEUR, V70, P143, DOI 10.1097/NEN.0b013e3182084a8c; Greil CS, 2008, VIROLOGY, V379, P284, DOI 10.1016/j.virol.2008.07.006; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haigh CL, 2015, CELL MOL LIFE SCI, V72, P1613, DOI 10.1007/s00018-014-1777-y; Haigh CL, 2011, FREE RADICAL BIO MED, V51, P594, DOI 10.1016/j.freeradbiomed.2011.03.035; Haigh CL, 2009, CELL RES, V19, P1062, DOI 10.1038/cr.2009.86; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; Haigh CL, 2014, CELLULAR MOL LIFE SC; Hugel B, 2004, CELL MOL LIFE SCI, V61, P2998, DOI 10.1007/s00018-004-4318-2; Karas JA, 2012, INT J PEPT RES THER, V18, P21, DOI 10.1007/s10989-011-9275-7; Le Brun AP, 2014, BIOPHYS J, V107, P2313, DOI 10.1016/j.bpj.2014.09.027; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Martins VR, 2002, NEUROCHEM INT, V41, P353, DOI 10.1016/S0197-0186(02)00054-2; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Miller MB, 2013, STRUCTURE, V21, P2061, DOI 10.1016/j.str.2013.08.025; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PARASASSI T, 1992, EXP CELL RES, V202, P432, DOI 10.1016/0014-4827(92)90096-Q; Robinson PJ, 2010, BIOPHYS J, V98, P1520, DOI 10.1016/j.bpj.2009.12.4304; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Sinclair L, 2013, DIS MODEL MECH, V6, P952, DOI 10.1242/dmm.010678; Stuermer CAO, 2005, BIOCHEM SOC SYMP, V72, P109, DOI 10.1042/bss0720109; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Suzuki KGN, 2012, BIOTECHNOL J, V7, P753, DOI 10.1002/biot.201100360; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; You JS, 2014, J BIOL CHEM, V289, P1551, DOI 10.1074/jbc.M113.531392; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004	41	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134680	10.1371/journal.pone.0134680	http://dx.doi.org/10.1371/journal.pone.0134680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252007	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100066
J	Hotta, H; Watanabe, N				Hotta, Harumi; Watanabe, Nobuhiro			Gentle Mechanical Skin Stimulation Inhibits Micturition Contractions via the Spinal Opioidergic System and by Decreasing Both Ascending and Descending Transmissions of the Micturition Reflex in the Spinal Cord	PLOS ONE			English	Article							SACRAL PARASYMPATHETIC NEURONS; URINARY-BLADDER; BARRINGTONS NUCLEUS; CUTANEOUS STIMULATION; ABDOMINAL VISCERA; NERVOUS-SYSTEM; PELVIC NERVE; BLOOD-FLOW; RAT; MODULATION	Recently, we found that gentle mechanical skin stimulation inhibits the micturition reflex in anesthetized rats. However, the central mechanisms underlying this inhibition have not been determined. This study aimed to clarify the central neural mechanisms underlying this inhibitory effect. In urethane-anesthetized rats, cutaneous stimuli were applied for 1 min to the skin of the perineum using an elastic polymer roller with a smooth, soft surface. Inhibition of rhythmic micturition contractions by perineal stimulation was abolished by naloxone, an antagonist of opioidergic receptors, administered into the intrathecal space of the lumbosacral spinal cord at doses of 2-20 mu g but was not affected by the same doses of naloxone administered into the subarachnoid space of the cisterna magna. Next, we examined whether perineal rolling stimulation inhibited the descending and ascending limbs of the micturition reflex. Perineal rolling stimulation inhibited bladder contractions induced by electrical stimulation of the pontine micturition center (PMC) or the descending tract of the micturition reflex pathway. It also inhibited the bladder distension-induced increase in the blood flow of the dorsal cord at L5-S1, reflecting the neural activity of this area, as well as pelvic afferent-evoked field potentials in the dorsal commissure at the lumbosacral level; these areas contain long ascending neurons to the PMC. Neuronal activities in this center were also inhibited by the rolling stimulation. These results suggest that the perineal rolling stimulation activates the spinal opioidergic system and inhibits both ascending and descending transmissions of the micturition reflex pathway in the spinal cord. These inhibitions would lead to the shutting down of positive feedback between the bladder and the PMC, resulting in inhibition of the micturition reflex. Based on the central neural mechanisms we show here, gentle perineal stimulation may be applicable to several different types of overactive bladder.	[Hotta, Harumi; Watanabe, Nobuhiro] Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology	Hotta, H (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Auton Neurosci, Tokyo, Japan.	hhotta@tmig.or.jp		Hotta, Harumi/0000-0002-4590-7162	Toyoresin	Toyoresin	This work was supported by a grant from Toyoresin, in addition to internal support to the authors' organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI T, 1992, NEUROSCI RES, V15, P281, DOI 10.1016/0168-0102(92)90049-I; Andersson KE, 1997, UROLOGY, V50, P74, DOI 10.1016/S0090-4295(97)00595-5; Banrezes B, 2002, NEUROSCIENCE, V115, P97, DOI 10.1016/S0306-4522(02)00405-0; BIRDER LA, 1993, AM J PHYSIOL, V265, pR326, DOI 10.1152/ajpregu.1993.265.2.R326; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; DEGROAT WC, 1971, BRAIN RES, V33, P499, DOI 10.1016/0006-8993(71)90125-9; DEGROAT WC, 1969, J PHYSIOL-LONDON, V200, P87, DOI 10.1113/jphysiol.1969.sp008683; DICKENSON AH, 2006, TXB PAIN, P427; Ding YQ, 1997, J COMP NEUROL, V389, P149, DOI 10.1002/(SICI)1096-9861(19971208)389:1<149::AID-CNE11>3.0.CO;2-G; Dou XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062028; DRAY A, 1984, J PHARMACOL EXP THER, V231, P254; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FEDIRCHUK B, 1991, EXP BRAIN RES, V84, P635; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; GLAZER EJ, 1980, SCIENCE, V208, P1479, DOI 10.1126/science.6155697; Guo ZF, 2014, CLIN INTERV AGING, V9, P851, DOI 10.2147/CIA.S61084; Hebel R., 1976, ANATOMY LAB RAT; HONDA CN, 1985, J NEUROPHYSIOL, V53, P1059, DOI 10.1152/jn.1985.53.4.1059; Hotta H, 2014, PROCEEDINGS OF THE 4, P53; Hotta H, 2013, J PHYSIOL SCI, V63, pS63; Hotta H, 2012, AUTON NEUROSCI-BASIC, V167, P12, DOI 10.1016/j.autneu.2011.11.002; Hotta H, 2010, GERIATR GERONTOL INT, V10, pS127, DOI 10.1111/j.1447-0594.2010.00592.x; IGAWA Y, 1993, BRIT J PHARMACOL, V110, P257, DOI 10.1111/j.1476-5381.1993.tb13802.x; Iimura K, 2014, AUTON NERV SYST, V51, P168; KRUSE MN, 1992, AM J PHYSIOL, V262, pR478, DOI 10.1152/ajpregu.1992.262.3.R478; KRUSE MN, 1991, BRAIN RES, V556, P6, DOI 10.1016/0006-8993(91)90541-3; Kurosawa M, 2006, AUTON NEUROSCI-BASIC, V126, P185, DOI 10.1016/j.autneu.2006.03.008; LINDSTROM S, 1983, J UROLOGY, V129, P405, DOI 10.1016/S0022-5347(17)52127-8; MCMAHON SB, 1982, J PHYSIOL-LONDON, V322, P21, DOI 10.1113/jphysiol.1982.sp014019; MCMAHON SB, 1982, J PHYSIOL-LONDON, V322, P1; MORRISON JFB, 1995, NEUROSCI RES, V23, P195, DOI 10.1016/0168-0102(95)00942-M; NADELHAFT I, 1995, J COMP NEUROL, V359, P443, DOI 10.1002/cne.903590307; NADELHAFT I, 1984, J COMP NEUROL, V226, P238, DOI 10.1002/cne.902260207; Nakayama H, 1998, J AUTONOM NERV SYST, V69, P148, DOI 10.1016/S0165-1838(98)00013-7; Paik SH, 2013, EXP THER MED, V6, P773, DOI 10.3892/etm.2013.1210; Piche M, 2010, J PHYSIOL-LONDON, V588, P2163, DOI 10.1113/jphysiol.2010.187633; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Rogers MJ, 2015, AM J PHYSIOL-REG I, V308, pR42, DOI 10.1152/ajpregu.00368.2014; Sasaki M, 2004, J PHYSIOL-LONDON, V557, P287, DOI 10.1113/jphysiol.2003.059352; Sasaki M, 2002, J COMP NEUROL, V449, P355, DOI 10.1002/cne.10290; Sasaki M, 2013, NEUROSCI RES, V75, P150, DOI 10.1016/j.neures.2012.11.008; SATO A, 1992, NEUROSCI RES, V15, P189, DOI 10.1016/0168-0102(92)90004-V; Sato A, 1997, REV PHYSIOL BIOCH P, V130, P1, DOI 10.1007/BFb0046598; SATO A, 1975, BRAIN RES, V94, P465, DOI 10.1016/0006-8993(75)90229-2; SATO A, 1977, NEUROSCIENCE, V2, P111, DOI 10.1016/0306-4522(77)90072-0; SATOH K, 1978, NEUROSCI LETT, V8, P27, DOI 10.1016/0304-3940(78)90092-7; Su X, 2013, AM J PHYSIOL-RENAL, V305, pF52, DOI 10.1152/ajprenal.00090.2013; Tanaka Y, 2003, BRAIN RES, V965, P146, DOI 10.1016/S0006-8993(02)04154-9; VanderHorst VGJM, 1996, J COMP NEUROL, V376, P361, DOI 10.1002/(SICI)1096-9861(19961216)376:3<361::AID-CNE2>3.0.CO;2-0; Wang H, 2012, NEUROSCI RES, V72, P43, DOI 10.1016/j.neures.2011.09.007; Watanabe N, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0001-x; Xiao ZY, 2014, AM J PHYSIOL-RENAL, V307, pF673, DOI 10.1152/ajprenal.00308.2014; Yamao Y, 2001, BRAIN RES, V912, P162, DOI 10.1016/S0006-8993(01)02725-1	53	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135185	10.1371/journal.pone.0135185	http://dx.doi.org/10.1371/journal.pone.0135185			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252000	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100130
J	Nagasundaram, N; Zhu, HL; Liu, JM; Karthick, V; Doss, CGP; Chakraborty, C; Chen, LN				Nagasundaram, N.; Zhu, Hailong; Liu, Jiming; Karthick, V; Doss, George Priya C.; Chakraborty, Chiranjib; Chen, Luonan			Analysing the Effect of Mutation on Protein Function and Discovering Potential Inhibitors of CDK4: Molecular Modelling and Dynamics Studies	PLOS ONE			English	Article							CELL LINES; IDENTIFICATION; DOCKING; OPTIMIZATION; EFFICIENT; COMPLEX; BINDING; DESIGN; ARREST; CANCER	The cyclin-dependent kinase 4 (CDK4)-cyclin D1 complex plays a crucial role in the transition from the G1 phase to S phase of the cell cycle. Among the CDKs, CDK4 is one of the genes most frequently affected by somatic genetic variations that are associated with various forms of cancer. Thus, because the abnormal function of the CDK4-cyclin D1 protein complex might play a vital role in causing cancer, CDK4 can be considered a genetically validated therapeutic target. In this study, we used a systematic, integrated computational approach to identify deleterious nsSNPs and predict their effects on protein-protein (CDK4-cyclin D1) and protein-ligand (CDK4-flavopiridol) interactions. This analysis resulted in the identification of possible inhibitors of mutant CDK4 proteins that bind the conformations induced by deleterious nsSNPs. Using computational prediction methods, we identified five nsSNPs as highly deleterious: R24C, Y180H, A205T, R210P, and R246C. From molecular docking and molecular dynamic studies, we observed that these deleterious nsSNPs affected CDK4-cyclin D1 and CDK4-flavopiridol interactions. Furthermore, in a virtual screening approach, the drug 5_7_DIHYDROXY_2_(3_4_5_TRI HYDROXYPHENYL)_4H_CHROMEN_4_ONE displayed good binding affinity for proteins with the mutations R24C or R246C, the drug diosmin displayed good binding affinity for the protein with the mutation Y180H, and the drug rutin displayed good binding affinity for proteins with the mutations A205T and R210P. Overall, this computational investigation of the CDK4 gene highlights the link between genetic variation and biological phenomena in human cancer and aids in the discovery of molecularly targeted therapies for personalized treatment.	[Nagasundaram, N.; Zhu, Hailong; Liu, Jiming; Karthick, V; Doss, George Priya C.; Chakraborty, Chiranjib] Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China; [Doss, George Priya C.] VIT Univ, Sch Biosci & Technol, Med Biotechnol Div, Vellore, Tamil Nadu, India; [Chakraborty, Chiranjib] Galgotias Univ, Sch Comp & Informat Sci, Dept Bioinformat, Greater Noida, Uttra Pradesh, India; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Hong Kong Baptist University; Vellore Institute of Technology; Galgotias University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhu, HL (corresponding author), Hong Kong Baptist Univ, Dept Comp Sci, Kowloon Tong, Hong Kong, Peoples R China.	hlzhu@comp.hkbu.edu.hk	Nagarajan, Nagasundaram/AAT-8337-2021; C, George/ABE-4676-2021; Chakraborty, Chiranjib/J-4847-2013	Chakraborty, Chiranjib/0000-0002-3958-239X; Nagarajan, Nagasundaram/0000-0002-9581-4781; C, George Priya Doss/0000-0002-5971-8290; vasudevan, karthick/0000-0001-7471-2527	Research Grants Council of Hong Kong [212111, 212613]; Faculty Research Grant of Hong Kong Baptist University [FRG2/12-13/061, FRG2/13-14/056]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Faculty Research Grant of Hong Kong Baptist University	This work was supported by the Research Grants Council of Hong Kong [212111], [212613] and Faculty Research Grant of Hong Kong Baptist University [FRG2/12-13/061] and [FRG2/13-14/056].	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Barvian M, 2000, J MED CHEM, V43, P4606, DOI 10.1021/jm000271k; Beattie JF, 2003, BIOORG MED CHEM LETT, V13, P2955, DOI 10.1016/S0960-894X(03)00202-6; Becker O.M., 2001, COMPUTATIONAL BIOCH; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Carini DJ, 2001, BIOORG MED CHEM LETT, V11, P2209, DOI 10.1016/S0960-894X(01)00416-4; Carlson BA, 1996, CANCER RES, V56, P2973; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; CHERFILS J, 1991, PROTEINS, V11, P271, DOI 10.1002/prot.340110406; Clark DE, 2008, EXPERT OPIN DRUG DIS, V3, P841, DOI 10.1517/17460441.3.8.841; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Creighton T. E., 1993, PROTEINS STRUCTURES; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Doss CGP, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-10; Doss GPC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05868; Drees M, 1997, CLIN CANCER RES, V3, P273; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; George Doss C Priya, 2014, Theranostics, V4, P366, DOI 10.7150/thno.7473; Gerlt JA, 1997, CHEM BIOL, V4, P259, DOI 10.1016/S1074-5521(97)90069-7; Gunsteren W. F. V., 1996, BIOMOLECULAR SIMULAT, P1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Honma T, 2001, J MED CHEM, V44, P4615, DOI 10.1021/jm0103256; Honma T, 2001, J MED CHEM, V44, P4628, DOI 10.1021/jm010326y; Huang RS, 2009, CA-CANCER J CLIN, V59, P42, DOI 10.3322/caac.20002; KAUR G, 1992, J NATL CANCER I, V84, P1736, DOI 10.1093/jnci/84.22.1736; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kubo A, 1999, CLIN CANCER RES, V5, P4279; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagasundaram N, 2013, CELL BIOCHEM BIOPHYS, V66, P681, DOI 10.1007/s12013-012-9512-5; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; NOVOTNY J, 1992, PROG BIOPHYS MOL BIO, V58, P203, DOI 10.1016/0079-6107(92)90006-R; Nugiel DA, 2002, J MED CHEM, V45, P5224, DOI 10.1021/jm020171+; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Parker BW, 1998, BLOOD, V91, P458, DOI 10.1182/blood.V91.2.458.458_458_465; Ripphausen P, 2010, J MED CHEM, V53, P8461, DOI 10.1021/jm101020z; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Steward RE, 2003, TRENDS GENET, V19, P505, DOI 10.1016/S0168-9525(03)00195-1; Stitziel NO, 2004, NUCLEIC ACIDS RES, V32, pD520, DOI 10.1093/nar/gkh104; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turner, 2005, XMGRACE VERSION 51 1; Uzun A, 2007, NUCLEIC ACIDS RES, V35, pW384, DOI 10.1093/nar/gkm232; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; Ye Yuzhen, 2006, Pac Symp Biocomput, P439, DOI 10.1142/9789812701626_0040; Yip Yum Lina, 2007, J Bioinform Comput Biol, V5, P1215, DOI 10.1142/S021972000700320X; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025	57	42	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133969	10.1371/journal.pone.0133969	http://dx.doi.org/10.1371/journal.pone.0133969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252490	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100029
J	Wu, J; Cheng, Z; Gu, Y; Zou, WS; Zhang, MJ; Zhu, PF; Hu, S				Wu, Jie; Cheng, Zhong; Gu, Ye; Zou, Wusong; Zhang, Mingjing; Zhu, Pengfei; Hu, Shao			Aggravated Cardiac Remodeling post Aortocaval Fistula in Unilateral Nephrectomized Rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEART-FAILURE; RENAL DYSFUNCTION; HEMODYNAMICS; IMPACT; MODEL	Background Aortocaval fistula (AV) in rat is a unique model of volume-overload congestive heart failure and cardiac hypertrophy. Living donor kidney transplantation is regarded as beneficial to allograft recipients and not particularly detrimental to the donors. Impact of AV on animals with mild renal dysfunction is not fully understood. In this study, we explored the effects of AV in unilateral nephrectomized (UNX) rats. Methods Adult male Sprague-Dawley (SD) rats were divided into Sham (n = 10), UNX (right kidney remove, n = 10), AV (AV established between the levels of renal arteries and iliac bifurcation, n = 18) and UNX+AV (AV at one week after UNX, n = 22), respectively. Renal outcome was measured by glomerular filtration rate, effective renal plasma flow, fractional excretion of sodium, albuminuria, plasma creatinine, and cystatin C. Focal glomerulosclerosis (FGS) incidence was evaluated by renal histology. Cardiac function was measured by echocardiography and hemodynamic measurements. Results UNX alone induced compensatory left kidney enlargement, increased plasma creatinine and cystatin C levels, and slightly reduced glomerular filtration rate and increased FGS. AV induced significant cardiac enlargement and hypertrophy and reduced cardiac function and increased FGS, these changes were aggravated in UNX+AV rats. Conclusions Although UNX only induces minor renal dysfunction, additional chronic volume overload placement during the adaptation phase of the remaining kidney is associated with aggravated cardiac dysfunction and remodeling in UNX rats, suggesting special medical care is required for UNX or congenital monokidney subjects in case of chronic volume overload as in the case of pregnancy and hyperthyroidism to prevent further adverse cardiorenal events in these individuals.	[Wu, Jie; Cheng, Zhong; Gu, Ye; Zou, Wusong; Zhang, Mingjing; Zhu, Pengfei; Hu, Shao] Huazhong Univ Sci & Technol, Wuhan Puai Hosp, Puai Hosp, Ctr Heart, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Hu, S (corresponding author), Huazhong Univ Sci & Technol, Wuhan Puai Hosp, Puai Hosp, Ctr Heart, Wuhan 430074, Hubei, Peoples R China.	hushao_puai@163.com						Cleland JGF, 2012, HEART FAIL REV, V17, P133, DOI 10.1007/s10741-012-9306-2; Dupont M, 2011, EUR J HEART FAIL, V13, P820, DOI 10.1093/eurjhf/hfr092; FLAIM SF, 1980, PFLUG ARCH EUR J PHY, V385, P203, DOI 10.1007/BF00647458; GARCIA R, 1990, CARDIOVASC RES, V24, P430, DOI 10.1093/cvr/24.5.430; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Homma T, 2012, AM J PHYSIOL-RENAL, V302, pF750, DOI 10.1152/ajprenal.00494.2011; Ibrahim HN, 2009, AM J TRANSPLANT, V9, P825, DOI 10.1111/j.1600-6143.2009.02548.x; Joles JA, 1998, KIDNEY INT, V53, P862, DOI 10.1111/j.1523-1755.1998.00825.x; LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642; LIU Z, 1991, CIRC RES, V69, P59, DOI 10.1161/01.RES.69.1.59; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; McAlister FA, 2012, CIRC-HEART FAIL, V5, P309, DOI 10.1161/CIRCHEARTFAILURE.111.966242; Metra M, 2012, EUR HEART J, V33, P2135, DOI 10.1093/eurheartj/ehs205; Metra M, 2012, CIRC-HEART FAIL, V5, P54, DOI 10.1161/CIRCHEARTFAILURE.111.963413; Moody WE, 2012, J HUM HYPERTENS, V26, P141, DOI 10.1038/jhh.2011.46; Mullins CD, 2003, TRANSPLANTATION, V75, P1505, DOI 10.1097/01.TP.0000060280.28204.3C; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; van Dokkum RPE, 2004, J AM SOC NEPHROL, V15, P3103, DOI 10.1097/01.ASN.0000145895.62896.98; Vargas-Uricoechea H, 2014, HORM MOL BIOL CLIN I, V18, P15, DOI 10.1515/hmbci-2013-0059; ZUCKER IH, 1977, J CLIN INVEST, V60, P323, DOI 10.1172/JCI108780; Zunic G, 2013, CLIN BIOCHEM, V46, P1394, DOI 10.1016/j.clinbiochem.2013.04.031	22	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134579	10.1371/journal.pone.0134579	http://dx.doi.org/10.1371/journal.pone.0134579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252578	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100062
J	Pearson-Stuttard, J; Critchley, J; Capewell, S; O'Flaherty, M				Pearson-Stuttard, Jonathan; Critchley, Julia; Capewell, Simon; O'Flaherty, Martin			Quantifying the Socio-Economic Benefits of Reducing Industrial Dietary Trans Fats: Modelling Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CASE-FATALITY; ENGLAND; MORTALITY; HEALTH; TRENDS; WALES; POLICIES; BURDEN	Background Coronary Heart Disease (CHD) remains a leading cause of UK mortality, generating a large and unequal burden of disease. Dietary trans fatty acids (TFA) represent a powerful CHD risk factor, yet to be addressed in the UK (approximately 1% daily energy) as successfully as in other nations. Potential outcomes of such measures, including effects upon health inequalities, have not been well quantified. We modelled the potential effects of specific reductions in TFA intake on CHD mortality, CHD related admissions, and effects upon socioeconomic inequalities. Methods & Results We extended the previously validated IMPACTsec model, to estimate the potential effects of reductions (0.5% & 1% reductions in daily energy) in TFA intake in England and Wales, stratified by age, sex and socioeconomic circumstances. We estimated reductions in expected CHD deaths in 2030 attributable to these two specific reductions. Output measures were deaths prevented or postponed, life years gained and hospital admissions. A 1% reduction in TFA intake energy intake would generate approximately 3,900 (95% confidence interval (CI) 3,300-4,500) fewer deaths, 10,000 (8,800-10,300) (7% total) fewer hospital admissions and 37,000 (30,100-44,700) life years gained. This would also reduce health inequalities, preventing five times as many deaths and gaining six times as many life years in the most deprived quintile compared with the most affluent. A more modest reduction (0.5%) would still yield substantial health gains. Conclusions Reducing intake of industrial TFA could substantially decrease CHD mortality and hospital admissions, and gain tens of thousands of life years. Crucially, this policy could also reduce health inequalities. UK strategies should therefore aim to minimise industrial TFA intake.	[Pearson-Stuttard, Jonathan] Univ Oxford, Clin Acad Grad Sch, Div Med Sci, Oxford, England; [Critchley, Julia] Univ London, Populat Hlth Res Inst, London, England; [Pearson-Stuttard, Jonathan; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England	University of Oxford; University of London; University of Liverpool	Pearson-Stuttard, J (corresponding author), Univ Oxford, Clin Acad Grad Sch, Div Med Sci, Oxford, England.	jonathan.pearson-stuttard@medsci.ox.ac.uk	Shao, Ruitai/AAU-7642-2021	Critchley, Julia/0000-0002-5248-4188; O'Flaherty, Martin/0000-0001-8944-4131	MRC; EU - EC [223705]; School of Public Health; National Institute for Health Research [ACF-2015-21-015] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU - EC(European CommissionEuropean Commission Joint Research Centre); School of Public Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the MRC NPRI3 scheme, & EU MedCHAMPS project financed by EC FP7 grant no. 223705. Title: Prevention IMPACT: developing and evaluating economic models for planning optimal cardiovascular prevention strategies. This project was also a School of Public Health funded project: SPHR-LIL-PH1-MCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LOW INCOME DIETARY N, V2; [Anonymous], 2013, IN DIS FREE LIF EXP; Bajekal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059608; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Barton P., 2010, PREVENTION CARDIOVAS; Bell R, 2010, J LAW MED ETHICS, V38, P470, DOI 10.1111/j.1748-720X.2010.00506.x; British Heart Foundation, 2012, TACKL CARD DIS PRIOR; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Castillo MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099482; Craig RJM, 2008, HLTH SURVEY ENGLAND; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020; Hawkins NM, 2013, CIRC-CARDIOVASC QUAL, V6, P208, DOI 10.1161/CIRCOUTCOMES.111.000058; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MacIntyre K, 2000, CIRCULATION, V102, P1126, DOI 10.1161/01.CIR.102.10.1126; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; Mozaffarian D, 2007, EUR J CLIN NUTR, V61, P1004, DOI 10.1038/sj.ejcn.1602608; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Noble M, 2007, ENGLISH INDICES DEPR; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; Otite FO, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120198; Pearson-Stuttard J, 2012, HEART, V98, P1573, DOI 10.1136/heartjnl-2012-302435; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; Smolina K, 2012, CIRC-CARDIOVASC QUAL, V5, P532, DOI 10.1161/CIRCOUTCOMES.111.964700; Stender S, 2006, ATHEROSCLEROSIS SUPP, V7, P47, DOI 10.1016/j.atherosclerosissup.2006.04.011; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112	31	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0132524	10.1371/journal.pone.0132524	http://dx.doi.org/10.1371/journal.pone.0132524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26247848	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000359062300007
J	Zhikrevetskaya, S; Peregudova, D; Danilov, A; Plyusnina, E; Krasnov, G; Dmitriev, A; Kudryavtseva, A; Shaposhnikov, M; Moskalev, A				Zhikrevetskaya, Svetlana; Peregudova, Darya; Danilov, Anton; Plyusnina, Ekaterina; Krasnov, George; Dmitriev, Alexey; Kudryavtseva, Anna; Shaposhnikov, Mikhail; Moskalev, Alexey			Effect of Low Doses (5-40 cGy) of Gamma-irradiation on Lifespan and Stress-related Genes Expression Profile in Drosophila melanogaster	PLOS ONE			English	Article							EXCISION-REPAIR PROTEIN; CELL NUCLEAR ANTIGEN; GENOME-WIDE ANALYSIS; STRAND BREAK REPAIR; DNA-DAMAGE; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; HOUSEKEEPING GENES; HUMAN-LYMPHOCYTES; OXIDATIVE STRESS	Studying of the effects of low doses of gamma-irradiation is a crucial issue in different areas of interest, from environmental safety and industrial monitoring to aerospace and medicine. The goal of this work is to identify changes of lifespan and expression stress-sensitive genes in Drosophila melanogaster, exposed to low doses of gamma-irradiation (5 - 40 cGy) on the imaginal stage of development. Although some changes in life extensity in males were identified (the effect of hormesis after the exposure to 5, 10 and 40 cGy) as well as in females (the effect of hormesis after the exposure to 5 and 40 cGy), they were not caused by the organism "physiological" changes. This means that the observed changes in life expectancy are not related to the changes of organism physiological functions after the exposure to low doses of ionizing radiation. The identified changes in gene expression are not dose-dependent, there is not any proportionality between dose and its impact on expression. These results reflect nonlinear effects of low dose radiation and sex-specific radio-resistance of the postmitotic cell state of Drosophila melanogaster imago.	[Zhikrevetskaya, Svetlana; Krasnov, George; Dmitriev, Alexey; Kudryavtseva, Anna; Moskalev, Alexey] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Postgenom Res, Moscow, Russia; [Peregudova, Darya; Danilov, Anton; Plyusnina, Ekaterina; Shaposhnikov, Mikhail; Moskalev, Alexey] RAS, Komi Sci Ctr, Lab Mol Radiobiol & Gerontol, Inst Biol, Syktyvkar, Russia; [Zhikrevetskaya, Svetlana; Moskalev, Alexey] Moscow Inst Phys & Technol, Lab Genet Aging & Longev, Dolgoprudnyi, Russia; [Plyusnina, Ekaterina; Shaposhnikov, Mikhail; Moskalev, Alexey] Syktyvkar State Univ, Dept Ecol, Syktyvkar, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Institute of Biology, Komi Scientific Centre, Ural Branch RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Syktyvkar State University	Moskalev, A (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Postgenom Res, Moscow, Russia.	amoskalev@list.ru	Peregudova, Darya/O-3467-2014; Dmitriev, Alexey A./D-6109-2011; Krasnov, George S/E-6529-2014; Zhikrivetskaya, Svetlana O/G-8034-2014; Shaposhnikov, Mikhail/M-7514-2013; Proshkina, Ekaterina N/F-7948-2014; Moskalev, Alexey/H-4856-2013; Kudryavtseva, Anna V/C-9032-2014	Peregudova, Darya/0000-0001-6872-1013; Dmitriev, Alexey A./0000-0002-6827-9584; Krasnov, George S/0000-0002-6493-8378; Shaposhnikov, Mikhail/0000-0002-4625-6488; Proshkina, Ekaterina N/0000-0003-4558-1796; Moskalev, Alexey/0000-0002-3248-1633; Kudryavtseva, Anna V/0000-0002-3722-8207	RFBR grant [N 14-04-01596]; President Grant for Government Support of Young Russian Scientists [MD-1090.2014.4]; Ministry of Education and Science of the Russian Federation [14.621.21.0001, RFMEFI62114X0001]	RFBR grant(Russian Foundation for Basic Research (RFBR)); President Grant for Government Support of Young Russian Scientists; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by RFBR grant N 14-04-01596 (http://www.rfbr.ru/rffi/eng) and the President Grant for Government Support of Young Russian Scientists MD-1090.2014.4. (http://grants.extech.ru). Part of this work (qPCR analysis) was performed using the equipment of EIMB RAS "Genome" center (http://www.eimb.ru/RUSSIAN_NEW/INSTITUTE/ccu_genome_c.php) under the financial support by the Ministry of Education and Science of the Russian Federation (Contract 14.621.21.0001, project's unique identifier RFMEFI62114X0001, http://www.eimb.ru/RUSSIAN_NEW/INSTITUTE/ccu_genome_c.php).	Abdu U, 2003, GENETICS, V165, P197; Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anedchenko EA, 2007, MOL BIOL+, V41, P77, DOI 10.1134/S0026893307010116; Antosh M, 2014, DOSE-RESPONSE, V12, P551, DOI 10.2203/dose-response.13-047.Antosh; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bi XL, 2005, GENETICS, V171, P845, DOI 10.1534/genetics.105.047720; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brodsky MH, 2000, GENE DEV, V14, P666; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Burger Joep M S, 2004, Sci Aging Knowledge Environ, V2004, ppe30, DOI 10.1126/sageke.2004.28.pe30; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Enns L, 2004, MOL CANCER RES, V2, P557; Fachin AL, 2007, RADIAT RES, V168, P650, DOI 10.1667/RR0487.1; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; FLEMING TR, 1980, BIOMETRICS, V36, P607, DOI 10.2307/2556114; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gavrilov LA, 1991, REV UPDATED ENGLISH, P385; Ghabrial A, 1998, GENE DEV, V12, P2711, DOI 10.1101/gad.12.17.2711; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gotoh T, 2015, MOL BIOL CELL, V26, P359, DOI 10.1091/mbc.E14-05-0994; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; HIRSCH HR, 1995, EXP GERONTOL, V30, P147, DOI 10.1016/0531-5565(94)00070-0; Horne I, 2009, INSECT BIOCHEM MOLEC, V39, P547, DOI 10.1016/j.ibmb.2009.06.002; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Joyce EF, 2009, GENETICS, V181, P335, DOI 10.1534/genetics.108.093104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kalajdzic P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040296; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karpac J, 2013, CELL REP, V4, P1250, DOI 10.1016/j.celrep.2013.08.004; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kelty JD, 2001, J EXP BIOL, V204, P1659; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kooistra R, 1997, MOL CELL BIOL, V17, P6097, DOI 10.1128/MCB.17.10.6097; Kozhakhanov TE, 2014, J ENVIRON RADIOACTIV, V137, P217, DOI 10.1016/j.jenvrad.2014.06.026; Kusano K, 1999, GENETICS, V151, P1027; LaRocque JR, 2007, GENETICS, V175, P1023, DOI 10.1534/genetics.106.067330; Lavelle C, 2014, INT J BIOCHEM CELL B, V49, P84, DOI 10.1016/j.biocel.2014.01.012; Leszczynski D, 2004, PROTEOMICS, V4, P426, DOI 10.1002/pmic.200300646; Lou Y, 2013, J RADIOL PROT, V33, P661, DOI 10.1088/0952-4746/33/3/661; McGeoghegan D., 2000, Journal of Radiological Protection, V20, P111, DOI 10.1088/0952-4746/20/2/301; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Moller AP, 2013, BIOL REV, V88, P226, DOI 10.1111/j.1469-185X.2012.00249.x; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Moskalev AA, 2011, BIOGERONTOLOGY, V12, P253, DOI 10.1007/s10522-011-9320-0; Moskalev A A, 2007, Radiats Biol Radioecol, V47, P571; Moskalev A, 2007, BIOGERONTOLOGY, V8, P499, DOI 10.1007/s10522-007-9090-x; Moskalev A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086051; Mukhopadhyay I, 2006, ARCH ENVIRON CON TOX, V51, P673, DOI 10.1007/s00244-005-0169-6; Nakamura N, 2013, ANNU REV GENET, V47, P33, DOI 10.1146/annurev-genet-111212-133501; NG L, 1990, J BIOL CHEM, V265, P11948; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; Nies H, 1999, SCI TOTAL ENVIRON, V238, P181, DOI 10.1016/S0048-9697(99)00134-5; OGAKI M, 1966, MUTAT RES, V3, P438, DOI 10.1016/0027-5107(66)90053-4; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; PAYNE CM, 1992, J LEUKOCYTE BIOL, V52, P433, DOI 10.1002/jlb.52.4.433; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pittendrigh BR, 1996, GENE, V179, P295, DOI 10.1016/S0378-1119(96)00378-2; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Robin C, 2007, TRENDS GENET, V23, P51, DOI 10.1016/j.tig.2006.12.005; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Saini D, 2012, MOL CELL BIOCHEM, V364, P271, DOI 10.1007/s11010-012-1227-9; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Sarantseva S. V., 2001, Genetika, V37, P770; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; Segev E, 2001, MECH DEVELOP, V106, P197, DOI 10.1016/S0925-4773(01)00437-3; SEKELSKY JJ, 1995, GENETICS, V141, P619; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Seong KM, 2011, BIOGERONTOLOGY, V12, P93, DOI 10.1007/s10522-010-9295-2; SETO NOL, 1987, NUCLEIC ACIDS RES, V15, P10601, DOI 10.1093/nar/15.24.10601; Shahbazi-Gahrouei Daryoush, 2013, Adv Biomed Res, V2, P65, DOI 10.4103/2277-9175.115821; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shilova LA, 2014, P KSC URAL BRANCH RA, V2, P41; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Song YH, 2005, MOL CELLS, V19, P167; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Strehler BL., 1959, Q REV BIOL, P34; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Telonis-Scott M, 2009, J INSECT PHYSIOL, V55, P549, DOI 10.1016/j.jinsphys.2009.01.010; Tollefsbol TO, 2013, METHOD MOL BIOL, P354; Tu CPD, 2005, METHOD ENZYMOL, V401, P204, DOI 10.1016/S0076-6879(05)01013-X; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaiserman AM, 2003, BIOGERONTOLOGY, V4, P9, DOI 10.1023/A:1022460817227; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verzi MP, 2002, DEV BIOL, V249, P174, DOI 10.1006/dbio.2002.0753; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	112	36	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133840	10.1371/journal.pone.0133840	http://dx.doi.org/10.1371/journal.pone.0133840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248317	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300021
J	Roggia, MF; Ueta, T				Roggia, Murilo F.; Ueta, Takashi			alpha v beta 5 Integrin/FAK/PGC-1 alpha Pathway Confers Protective Effects on Retinal Pigment Epithelium	PLOS ONE			English	Article							OUTER SEGMENT PHAGOCYTOSIS; OXIDATIVE STRESS; MACULAR DEGENERATION; LYSOSOMAL BIOGENESIS; BRUCHS MEMBRANE; RPE CELLS; INTEGRIN; AUTOPHAGY; DISEASE; EXPRESSION	Purpose To elucidate the mechanism of the induction of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) by photoreceptor outer segments (POS) and its effects on retinal pigment epithelium (RPE). Methods PGC-1 alpha upregulation by POS was confirmed in ARPE-19 cells and in RPE ex vivo. To elucidate the mechanism, siRNAs against beta 5 integrin, CD36, Mer tyrosine kinase (MerTK), and Atg5, blocking antibodies against CD36 and MerTK, and a specific inhibitor for focal adhesion kinase (FAK) were used. We examined the effect of POS-induced PGC-1 alpha upregulation on the levels of reactive oxygen species (ROS), mitochondrial biogenesis, senescence-associated beta-galactosidase (SA-beta-gal) after H2O2 treatment, and lysosomal activity. Lysosomal activity was evaluated through transcriptional factor EB and its target genes, and the activity of cathepsin D. Lipid metabolism after POS treatment was assessed using Oil Red O and BODIPY C11. RPE phenotypes of PGC-1 alpha-deficient mice were examined. Results POS-induced PGC-1 alpha upregulation was suppressed by siRNA against beta 5 integrin and a FAK inhibitor. siRNAs and blocking antibodies against CD36 and MerTK enhanced the effect of POS on PGC-1 alpha. The upregulation of PGC-1 alpha increased the levels of mRNA for antioxidant enzymes and stimulated mitochondrial biogenesis, decreased ROS levels, and reduced SA-beta-gal staining in H2O2-treated ARPE-19 cells. PGC-1 alpha was critical for lysosomal activity and lipid metabolism after POS treatment. PGC-1 alpha-deficient mice demonstrated an accumulation of type 2 lysosomes in RPE, thickening of Bruch's membrane, and poor choriocapillaris vasculature. Conclusions The binding, but not the internalization of POS confers protective effects on RPE cells through the alpha v beta 5 integrin/FAK/PGC-1 alpha pathway.	[Ueta, Takashi] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan; Univ Tokyo, Fac Med, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Ueta, T (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	ueta-tky@umin.ac.jp			Japan Society for the Promotion of Science [26861437]; Nakayama Foundation for Human Science; Mitsui Sumitomo Insurance Welfare Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakayama Foundation for Human Science; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation)	Takashi Ueta received fundings from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (26861437), Nakayama Foundation for Human Science (http://nakayamashoten.jp/wordpress/zaidan/feed/?post_type=post), and Mitsui Sumitomo Insurance Welfare Foundation (http://www.kousei-zigyodan.or.jp/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesemeier A, 2014, NEUROBIOL AGING, V35, P2562, DOI 10.1016/j.neurobiolaging.2014.05.003; Bok D, 1979, THE RETINAL PIGMENT, P148; Burke JM, 2009, INVEST OPHTH VIS SCI, V50, P1940, DOI 10.1167/iovs.08-2671; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Chowers I, 2004, INVEST OPHTH VIS SCI, V45, P2098, DOI 10.1167/iovs.03-0863; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Egger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031272; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Gouras P, 2011, EXP EYE RES, V93, P937, DOI 10.1016/j.exer.2011.10.011; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kannan R, 2006, MOL VIS, V12, P1649; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Mukherjee PK, 2007, P NATL ACAD SCI USA, V104, P13158, DOI 10.1073/pnas.0705963104; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2012, BIOL CELL, V104, P326, DOI 10.1111/boc.201100076; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Olchawa MM, 2013, INVEST OPHTH VIS SCI, V54, P2276, DOI 10.1167/iovs.12-11154; Qin SF, 2012, EXP EYE RES, V94, P63, DOI 10.1016/j.exer.2011.11.007; Rakoczy PE, 1997, BIOCHEM J, V324, P935, DOI 10.1042/bj3240935; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun K, 2007, MOL VIS, V13, P2310; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Ueta T, 2012, ARTERIOSCL THROM VAS, V32, P1366, DOI 10.1161/ATVBAHA.112.248021; Ueta T, 2012, J BIOL CHEM, V287, P7675, DOI 10.1074/jbc.M111.335174; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Westenskow PD, 2012, INVEST OPHTH VIS SCI, V53, P6282, DOI 10.1167/iovs.12-9721; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P926, DOI 10.1167/iovs.07-1003	47	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134870	10.1371/journal.pone.0134870	http://dx.doi.org/10.1371/journal.pone.0134870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244551	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400117
J	Alawieh, A; Sabra, M; Sabra, Z; Tomlinson, S; Zaraket, FA				Alawieh, Ali; Sabra, Mohammed; Sabra, Zahraa; Tomlinson, Stephen; Zaraket, Fadi A.			Molecular Architecture of Spinal Cord Injury Protein Interaction Network	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; PROTEOMIC ANALYSIS; DATABASE; ORGANIZATION; INFLAMMATION; PERMEABILITY; MECHANISMS; NEUROTROPHIN-3; DEGENERATION; APOPTOSIS	Spinal cord injury (SCI) is associated with complex pathophysiological processes that follow the primary traumatic event and determine the extent of secondary damage and functional recovery. Numerous reports have used global and hypothesis-driven approaches to identify protein changes that contribute to the overall pathology of SCI in an effort to identify potential therapeutic interventions. In this study, we use a semi-automatic annotation approach to detect terms referring to genes or proteins dysregulated in the SCI literature and develop a curated SCI interactome. Network analysis of the SCI interactome revealed the presence of a rich-club organization corresponding to a "powerhouse" of highly interacting hub-proteins. Studying the modular organization of the network have shown that rich-club proteins cluster into modules that are specifically enriched for biological processes that fall under the categories of cell death, inflammation, injury recognition and systems development. Pathway analysis of the interactome and the rich-club revealed high similarity indicating the role of the rich-club proteins as hubs of the most prominent pathways in disease pathophysiology and illustrating the centrality of pro-and anti-survival signal competition in the pathology of SCI. In addition, evaluation of centrality measures of single nodes within the rich-club have revealed that neuronal growth factor (NGF), caspase 3, and H-Ras are the most central nodes and potentially an interesting targets for therapy. Our integrative approach uncovers the molecular architecture of SCI interactome, and provide an essential resource for evaluating significant therapeutic candidates.	[Alawieh, Ali; Sabra, Zahraa; Tomlinson, Stephen] Med Univ S Carolina, Dept Neurosci, Inst Neurosci, Charleston, SC 29425 USA; [Alawieh, Ali; Sabra, Mohammed; Sabra, Zahraa; Zaraket, Fadi A.] Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon; [Tomlinson, Stephen] Med Univ S Carolina, Childrens Res Inst, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Tomlinson, Stephen] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; American University of Beirut; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Tomlinson, S (corresponding author), Med Univ S Carolina, Dept Neurosci, Inst Neurosci, Charleston, SC 29425 USA.	tomlinss@musc.edu; fz11@aub.edu.lb	Alawieh, Ali/AAM-1898-2020; Alawieh, Ali/AAM-1420-2020	Alawieh, Ali/0000-0003-2601-8850; 	Veterans Affairs merit awards [BX001218, RX001141]; Farouk Jabre Award [2013/14]; Veterans Affairs [I01RX001141] Funding Source: NIH RePORTER	Veterans Affairs merit awards(US Department of Veterans Affairs); Farouk Jabre Award; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs merit awards [BX001218 and RX001141] to S.T. and the Farouk Jabre Award [2013/14] to F.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SK, 2000, NEUROSCIENCE, V99, P179, DOI 10.1016/S0306-4522(00)00165-2; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; [Anonymous], 2009, ON DEGR SEP PAR SPIN; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Bhat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116404; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Chen AS, 2013, NEUROCHEM RES, V38, P2247, DOI 10.1007/s11064-013-1132-y; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Ditunno JF, 2004, SPINAL CORD, V42, P383, DOI 10.1038/sj.sc.3101603; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Grill R, 1997, J NEUROSCI, V17, P5560; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Konganti K, 2013, EVOL BIOINFORM, V9, P355, DOI 10.4137/EBO.S12012; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li JJ, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145487; McAuley JJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773951; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Shanahan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036579; Sharma HS, 2003, ACT NEUR S, V86, P383; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wuchty S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000335; Xu W, 2005, SPINAL CORD, V43, P204, DOI 10.1038/sj.sc.3101674	46	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135024	10.1371/journal.pone.0135024	http://dx.doi.org/10.1371/journal.pone.0135024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241741	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700090
J	Wu, JJ; Xiong, ST; Jing, J; Chen, X; Wang, WM; Gui, JF; Mei, J				Wu, Junjie; Xiong, Shuting; Jing, Jing; Chen, Xin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie			Comparative Transcriptome Analysis of Differentially Expressed Genes and Signaling Pathways between XY and YY Testis in Yellow Catfish	PLOS ONE			English	Article							SEX-DETERMINING REGION; GERM-CELL DEVELOPMENT; TYROSINE PHOSPHORYLATION; ONCORHYNCHUS-MYKISS; MICRORNA TARGETS; BOAR SPERMATOZOA; RAINBOW-TROUT; FISH; MARKERS; ACTIVATION	YY super-males have rarely been detected in nature and only been artificially created in some fish species including tilapia and yellow catfish (Pelteobagrusfulvidraco), which provides a promising model for testis development and spermatogenesis. In our previous study, significant differences in morphology and miRNA expression were detected between XY and YY testis of yellow catfish. Here, solexa sequencing technology was further performed to compare mRNA expression between XY and YY testis. Compared with unigenes expressed in XY testis, 1146 and 1235 unigenes have significantly higher and lower expression in YY testis, respectively. 605 differentially expressed unigenes were annotated to 1604 GO terms with 319 and 286 genes having relative higher expression in XY and YY testis. KEGG analysis suggested different levels of PI3K-AKT and G protein-coupled receptor (GPCR) signaling pathways between XY and YY testis. Down-regulation of miR-141/429 in YY testis was speculated to promote testis development and maturation, and several factors in PI3K-AKT and GPCR signaling pathways were found as predicted targets of miR-141/429, several of which were confirmed by dual-luciferase reporter assays. Our study provides a comparative transcriptome analysis between XY and YY testis, and reveals interactions between miRNAs and their target genes that are possibly involved in regulating testis development and spermatogenesis.	[Wu, Junjie; Xiong, Shuting; Jing, Jing; Chen, Xin; Wang, Weimin; Gui, Jian-Fang; Mei, Jie] Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Agr, Wuhan 430070, Peoples R China; [Gui, Jian-Fang] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; University of Chinese Academy of Sciences, CAS	Gui, JF (corresponding author), Huazhong Agr Univ, Freshwater Aquaculture Collaborat Innovat Ctr Hub, Key Lab Freshwater Anim Breeding, Coll Fisheries,Minist Agr, Wuhan 430070, Peoples R China.	jfgui@ihb.ac.cn; jmei@mail.hzau.edu.cn			National Natural Science Foundation of China [31301931]; Fundamental Research Funds for the Central Universities [52204-12018, 2013PY068]; State Key Laboratory of Freshwater Ecology and Biotechnology [2015FB03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31301931), the Fundamental Research Funds for the Central Universities (52204-12018, 2013PY068), and State Key Laboratory of Freshwater Ecology and Biotechnology (2015FB03).	Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen X, 2015, MAR BIOTECHNOL, V17, P190, DOI 10.1007/s10126-014-9607-7; Ciraolo E, 2010, MOL BIOL CELL, V21, P704, DOI 10.1091/mbc.E09-08-0744; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cutting A, 2013, DEV DYNAM, V242, P380, DOI 10.1002/dvdy.23944; Dan C, 2013, INT J BIOL SCI, V9, P1043, DOI 10.7150/ijbs.7203; Lacerda SMDN, 2014, GEN COMP ENDOCR, V207, P56, DOI 10.1016/j.ygcen.2014.06.018; Enright AJ, 2004, GENOME BIOL, V5; Galas JE, 2009, ANN NY ACAD SCI, V1163, P398, DOI 10.1111/j.1749-6632.2008.03663.x; Gennotte V, 2012, THERIOGENOLOGY, V78, P210, DOI 10.1016/j.theriogenology.2012.02.002; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harayama H, 2005, J ANDROL, V26, P732, DOI 10.2164/jandrol.05053; Harayama H, 2004, MOL REPROD DEV, V69, P436, DOI 10.1002/mrd.20176; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Herrera AA, 2001, SCI DILIMAN, V13, P33; Heule C, 2014, GENETICS, V196, P579, DOI 10.1534/genetics.114.161158; Jing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107946; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kobayashi Y, 2013, SEX DEV, V7, P115, DOI 10.1159/000342009; Kotula-Balak M, 2008, COMP BIOCHEM PHYS A, V149, P188, DOI 10.1016/j.cbpa.2007.11.009; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Long JA., 2010, RISE FISHES 500 MILL; Lu JG, 2014, PHYSIOL GENOMICS, V46, P798, DOI 10.1152/physiolgenomics.00088.2014; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Mei J, 2014, INT J BIOL SCI, V10, P15, DOI 10.7150/ijbs.7490; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; Tan WX, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112896; Tomes CN, 1996, MOL REPROD DEV, V43, P196, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;196::AID-MRD9&gt;3.0.CO;2-M; Wang D, 2009, ANIM GENET, V40, P978, DOI 10.1111/j.1365-2052.2009.01941.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu W, 2013, HUM REPROD, V28, P1827, DOI 10.1093/humrep/det099; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xiong ST, 2015, GEN COMP ENDOCR, V216, P90, DOI 10.1016/j.ygcen.2015.04.015; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045	46	22	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134626	10.1371/journal.pone.0134626	http://dx.doi.org/10.1371/journal.pone.0134626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241040	gold, Green Submitted, Green Published			2022-12-26	WOS:000358942700054
J	Cardinale, A; Paldino, E; Giampa, C; Bernardi, G; Fusco, FR				Cardinale, Antonella; Paldino, Emanuela; Giampa, Carmela; Bernardi, Giorgio; Fusco, Francesca R.			PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITION; APOPTOSIS-RELATED MARKERS; NEUROTROPHIC FACTOR BDNF; ISCHEMIC BRAIN-INJURY; NF-KAPPA-B; CELL-DEATH; NEURONAL VULNERABILITY; MEDIATED TRANSCRIPTION; NAD(+) DEPLETION; MEMORY DEFICITS	Poly (ADP-ribose) polymerase 1 (PARP-1) is a nuclear enzyme that is involved in physiological processes as DNA repair, genomic stability, and apoptosis. Moreover, published studies demonstrated that PARP-1 mediates necrotic cell death in response to excessive DNA damage under certain pathological conditions. In Huntington's disease brains, PARP immunoreactivity was described in neurons and in glial cells, thereby suggesting the involvement of apoptosis in HD. In this study, we sought to determine if the PARP-1 inhibitor exerts a neuroprotective effect in R6/2 mutant mice, which recapitulates, in many aspects, human HD. Transgenic mice were treated with the PARP-1 inhibitor INO-1001 mg/Kg daily starting from 4 weeks of age. After transcardial perfusion, histological and immunohistochemical studies were performed. We found that INO 1001-treated R6/2 mice survived longer and displayed less severe signs of neurological dysfunction than the vehicle treated ones. Primary outcome measures such as striatal atrophy, morphology of striatal neurons, neuronal intranuclear inclusions and microglial reaction confirmed a neuroprotective effect of the compound. INO-1001 was effective in significantly increasing activated CREB and BDNF in the striatal spiny neurons, which might account for the beneficial effects observed in this model. Our findings show that PARP-1 inhibition could be considered as a valid therapeutic approach for HD.	[Cardinale, Antonella; Paldino, Emanuela; Giampa, Carmela; Bernardi, Giorgio; Fusco, Francesca R.] Fdn Santa Lucia IRCCS, Lab Neuroanat, Rome, Italy; [Giampa, Carmela] Univ Cattolica Sacro Cuore, Dipartimento Anat & Biol, Rome, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Cardinale, Antonella] Univ Roma 3, Rome, Italy	IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Roma Tre University	Fusco, FR (corresponding author), Fdn Santa Lucia IRCCS, Lab Neuroanat, Rome, Italy.	f.fusco@hsantalucia.it	Fusco, Francesca R/K-1080-2018; Paldino, Emanuela/AAC-2594-2022; Cardinale, Antonella/B-1008-2019	Fusco, Francesca R/0000-0003-2226-523X; Paldino, Emanuela/0000-0002-8483-543X; Cardinale, Antonella/0000-0002-3185-1006; , Giampa/0000-0002-1763-5665	Italian Department of Health [RC14C, GR GR-2010-2316475]	Italian Department of Health	This study was supported by grant #RC14C Italian Department of Health and by grant #GR GR-2010-2316475 Italian Department of Health.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; Ali T, 2015, J PINEAL RES, V59, P47, DOI 10.1111/jpi.12238; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Beneke S, 2004, INT J CANCER, V111, P813, DOI 10.1002/ijc.20342; Berry MD, 2003, PROG NEURO-PSYCHOPH, V27, P197, DOI 10.1016/S0278-5846(03)00015-0; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Carson MJ, 2007, NEUROTHERAPEUTICS, V4, P571, DOI 10.1016/j.nurt.2007.07.002; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Conner JM, 1997, J NEUROSCI, V17, P2295; COSI C, 1994, J NEUROSCI RES, V39, P38, DOI 10.1002/jnr.490390106; Czapski GA, 2006, NEUROCHEM INT, V49, P751, DOI 10.1016/j.neuint.2006.06.006; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, EUR J NEUROSCI, V18, P1093, DOI 10.1046/j.1460-9568.2003.02844.x; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; Giampa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064037; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hersch Steven M, 2004, NeuroRx, V1, P298, DOI 10.1007/BF03206614; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khodagholi F, 2013, BEHAV BRAIN RES, V241, P62, DOI 10.1016/j.bbr.2012.11.026; Koh SH, 2005, TOXICOLOGY, V214, P131, DOI 10.1016/j.tox.2005.06.023; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; Kriz Jasna, 2006, Critical Reviews in Neurobiology, V18, P145; Kumar A, 2013, EUR J PHARMACOL, V709, P1, DOI 10.1016/j.ejphar.2013.03.042; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Love S, 1999, NEUROPATH APPL NEURO, V25, P98; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Moller T, 2010, J NEURAL TRANSM, V117, P1001, DOI 10.1007/s00702-010-0430-7; Moroni F, 2009, BRIT J PHARMACOL, V157, P854, DOI 10.1111/j.1476-5381.2009.00232.x; Nasrabady SE, 2012, NEUROPHARMACOLOGY, V63, P415, DOI 10.1016/j.neuropharm.2012.04.014; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Petersen A, 1999, EXP NEUROL, V157, P1; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roesner JP, 2010, SHOCK, V33, P507, DOI 10.1097/SHK.0b013e3181c4fb08; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Silva A, 2015, NEURODEGENER DIS, V15, P207, DOI 10.1159/000375447; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Stack EC, 2007, EXPERT OPIN INV DRUG, V16, P1933, DOI 10.1517/13543784.16.12.1933; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Tentori L, 2005, PHARMACOL RES, V52, P25, DOI 10.1016/j.phrs.2005.02.010; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Vis JC, 2005, ACTA NEUROPATHOL, V109, P321, DOI 10.1007/s00401-004-0957-5; Vis JC, 2001, NEUROPATH APPL NEURO, V27, P68, DOI 10.1046/j.0305-1846.2001.00305.x; Wang SH, 2012, NEUROPHARMACOLOGY, V63, P1085, DOI 10.1016/j.neuropharm.2012.06.050; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WILSON RS, 1987, J CLIN EXP NEUROPSYC, V9, P147, DOI 10.1080/01688638708405354; Xu BY, 2008, DIABETES-METAB RES, V24, P404, DOI 10.1002/dmrr.842; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Young D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075108; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	85	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134482	10.1371/journal.pone.0134482	http://dx.doi.org/10.1371/journal.pone.0134482			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252217	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100059
J	Hura, T; Dziurka, M; Hura, K; Ostrowska, A; Dziurka, K				Hura, Tomasz; Dziurka, Michal; Hura, Katarzyna; Ostrowska, Agnieszka; Dziurka, Kinga			Free and Cell Wall-Bound Polyamines under Long-Term Water Stress Applied at Different Growth Stages of x Triticosecale Wittm	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; EXOGENOUS SPERMIDINE; DROUGHT-TOLERANCE; WINTER TRITICALE; BARLEY LEAVES; ABSCISIC-ACID; SOIL DROUGHT; ARABIDOPSIS-THALIANA; ADAPTIVE RESPONSES; SCAVENGING SYSTEM	Background Long-stemmed and semi-dwarf cultivars of triticale were exposed to water stress at tillering, heading and anthesis stage. Quantitative determination of free and cell wall-bound polyamines, i.e. agmatine, cadaverine, putrescine, spermidine and spermine, was supplemented with an analysis of quantitative relationships between free and cell wall-bound polyamines. Results The content of free and cell wall-bound polyamines varied depending on the development stage, both under optimal and water stress conditions. Drought-induced increase in free agmatine content was observed at all developmental stages in long-stemmed cultivar. A depletion of spermidine and putrescine was also reported in this cultivar, and spermidine was less abundant in semi-dwarf cultivar exposed to drought stress at the three analyzed developmental stages. Changes in the content of the other free polyamines did not follow a steady pattern reflecting the developmental stages. On the contrary, the content of cell wall-bound polyamines gradually increased from tillering, through heading and until anthesis period. Conclusion Water stress seemed to induce a progressive decrease in the content of free polyamines and an accumulation of cell wall-bound polyamines.	[Hura, Tomasz; Dziurka, Michal; Ostrowska, Agnieszka; Dziurka, Kinga] Polish Acad Sci, Franciszek Gorski Inst Plant Physiol, PL-30239 Krakow, Poland; [Hura, Katarzyna] Univ Agr, Fac Agr & Econ, Dept Plant Physiol, PL-30239 Krakow, Poland	Polish Academy of Sciences; Franciszek Gorski Institute of Plant Physiology Polish Academy of Sciences; Agricultural University Krakow	Hura, T (corresponding author), Polish Acad Sci, Franciszek Gorski Inst Plant Physiol, PL-30239 Krakow, Poland.	t.hura@ifr-pan.edu.pl	Hura, Tomasz/M-9774-2018; Hura, Katarzyna/AAC-9375-2021; Ostrowska, Agnieszka/U-6313-2018; Dziurka, Michal/H-1228-2016; Dziurka, Kinga/J-4997-2018	Hura, Tomasz/0000-0001-8537-4455; Ostrowska, Agnieszka/0000-0002-9611-6336; Dziurka, Michal/0000-0002-8265-6243; Dziurka, Kinga/0000-0003-4749-0935; Hura, Katarzyna/0000-0001-5697-2886	National Science Centre (NCN) [2011/01/B/NZ9/00019]	National Science Centre (NCN)	The authors are grateful to the National Science Centre (NCN) for financial support (Project No. 2011/01/B/NZ9/00019).	Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; Alcazar R, 2011, PLANT SCI, V180, P31, DOI 10.1016/j.plantsci.2010.07.022; Alcazar R, 2010, PLANT PHYSIOL BIOCH, V48, P547, DOI 10.1016/j.plaphy.2010.02.002; Alcazar R, 2010, PLANTA, V231, P1237, DOI 10.1007/s00425-010-1130-0; Alcazar R, 2006, BIOTECHNOL LETT, V28, P1867, DOI 10.1007/s10529-006-9179-3; ALTAMURA MM, 1993, PROTOPLASMA, V175, P9, DOI 10.1007/BF01403280; Arasimowicz-Jelonek M, 2009, J PLANT GROWTH REGUL, V28, P177, DOI 10.1007/s00344-009-9086-7; Belda-Palazon B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046907; Berta G, 1997, NEW PHYTOL, V137, P569, DOI 10.1046/j.1469-8137.1997.00868.x; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; Cvikrova M, 2013, PLANT PHYSIOL BIOCH, V73, P7, DOI 10.1016/j.plaphy.2013.08.005; Do PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060325; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; ERDEI L, 1990, J PLANT PHYSIOL, V137, P165, DOI 10.1016/S0176-1617(11)80075-1; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; FELIX H, 1987, PHYSIOL PLANTARUM, V71, P245, DOI 10.1111/j.1399-3054.1987.tb04337.x; GALIBA G, 1989, J PLANT PHYSIOL, V134, P730, DOI 10.1016/S0176-1617(89)80035-5; Galston A.W., 1995, PLANT HORMONES PHYSL, P158, DOI DOI 10.1007/978-94-011-0473-9_; GALSTON AW, 1990, PLANT PHYSIOL, V94, P406, DOI 10.1104/pp.94.2.406; Gill SS, 2010, PLANT SIGNAL BEHAV, V5, P26, DOI 10.4161/psb.5.1.10291; Goicoechea N, 1998, J PLANT PHYSIOL, V153, P706, DOI 10.1016/S0176-1617(98)80224-1; GOLDBERG R, 1984, PLANTA, V161, P531, DOI 10.1007/BF00407085; Handa AK, 2010, PLANT PHYSIOL BIOCH, V48, P540, DOI 10.1016/j.plaphy.2010.02.009; Hoagland DR., 1948, LECT INORGANIC NUTR; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; Hura T, 2013, PLANT SOIL ENVIRON, V59, P189, DOI 10.17221/665/2012-PSE; Hura T, 2011, J AGRON CROP SCI, V197, P113, DOI 10.1111/j.1439-037X.2010.00450.x; Hura T, 2009, J PLANT PHYSIOL, V166, P1720, DOI 10.1016/j.jplph.2009.04.012; Hura T, 2007, ANN BOT-LONDON, V100, P767, DOI 10.1093/aob/mcm162; Hura T, 2012, J PLANT PHYSIOL, V169, P1728, DOI 10.1016/j.jplph.2012.07.012; Hura T, 2009, PLANT PHYSIOL BIOCH, V47, P210, DOI 10.1016/j.plaphy.2008.11.004; Hura T, 2009, Z NATURFORSCH C, V64, P85; KOTZABASIS K, 1993, PHOTOSYNTH RES, V38, P83, DOI 10.1007/BF00015064; KRAMER GF, 1991, J AM SOC HORTIC SCI, V116, P813, DOI 10.21273/JASHS.116.5.813; Kubis J, 2005, ACTA PHYSIOL PLANT, V27, P289, DOI 10.1007/s11738-005-0005-7; Kubis J, 2003, ACTA PHYSIOL PLANT, V25, P337, DOI 10.1007/s11738-003-0014-3; Kubis J, 2001, ACTA PHYSIOL PLANT, V23, P335, DOI 10.1007/s11738-001-0041-x; Kubis J, 2014, J PLANT RES, V127, P151, DOI 10.1007/s10265-013-0585-z; Kubis Jan, 2008, Wiadomosci Botaniczne, V52, P55; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Legaz ME, 1998, J EXP BOT, V49, P1723, DOI 10.1093/jexbot/49.327.1723; Liu HP, 2004, PLANT SCI, V166, P1261, DOI 10.1016/j.plantsci.2003.12.039; Marcinska I, 2013, INT J MOL SCI, V14, P13171, DOI 10.3390/ijms140713171; Nayyar H, 2005, BOT BULL ACAD SINICA, V46, P333; Perez-Vicente A, 2002, POSTHARVEST BIOL TEC, V25, P25, DOI 10.1016/S0925-5214(01)00146-6; Sanchez-Lopez J, 2009, PLANT PHYSIOL BIOCH, V47, P592, DOI 10.1016/j.plaphy.2009.02.006; Serafini-Fracassini D, 1986, BIOMEDICAL STUDIES N, P157; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; SMITH TA, 1962, BIOCHEM J, V84, P292, DOI 10.1042/bj0840292; Tassoni A, 2000, PLANT PHYSIOL BIOCH, V38, P383, DOI 10.1016/S0981-9428(00)00757-9; Tomar PC, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25850; TURNER LB, 1986, J EXP BOT, V37, P170, DOI 10.1093/jxb/37.2.170; Walters DR, 2000, PHYSIOL MOL PLANT P, V57, P137, DOI 10.1006/pmpp.2000.0286; Yamasaki H, 2006, TRENDS PLANT SCI, V11, P522, DOI 10.1016/j.tplants.2006.09.009; Yang JC, 2007, J EXP BOT, V58, P1545, DOI 10.1093/jxb/erm032; Zapata PJ, 2004, PLANT SCI, V167, P781, DOI 10.1016/j.plantsci.2004.05.014; Zhang MuQing, 1996, Acta Phytophysiologica Sinica, V22, P327; Zhou Q, 2010, PLANT PHYSIOL BIOCH, V48, P417, DOI 10.1016/j.plaphy.2010.03.003	58	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135002	10.1371/journal.pone.0135002	http://dx.doi.org/10.1371/journal.pone.0135002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247474	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300084
J	Salomao, E; Otsuki, DA; Correa, AL; Fantoni, DT; dos Santos, F; Irigoyen, MC; Auler, JO				Salomao, Edgard, Jr.; Otsuki, Denise Aya; Correa, Andre Luis; Fantoni, Denise Tabacchi; dos Santos, Fernando; Irigoyen, Maria Claudia; Costa Auler, Jose Otavio, Jr.			Heart Rate Variability Analysis in an Experimental Model of Hemorrhagic Shock and Resuscitation in Pigs	PLOS ONE			English	Article							BODY NEGATIVE-PRESSURE; LIFESAVING INTERVENTIONS; SYMPATHETIC RESPONSES; SIMULATED HEMORRHAGE; PERIOD VARIABILITY; SPECTRAL-ANALYSIS; TRAUMA PATIENTS; NERVE ACTIVITY; BRAIN-INJURY; MORTALITY	Background The analysis of heart rate variability (HRV) has been shown as a promising non-invasive technique for assessing the cardiac autonomic modulation in trauma. The aim of this study was to evaluate HRV during hemorrhagic shock and fluid resuscitation, comparing to traditional hemodynamic and metabolic parameters. Methods Twenty anesthetized and mechanically ventilated pigs were submitted to hemorrhagic shock (60% of estimated blood volume) and evaluated for 60 minutes without fluid replacement. Surviving animals were treated with Ringer solution and evaluated for an additional period of 180 minutes. HRV metrics (time and frequency domain) as well as hemodynamic and metabolic parameters were evaluated in survivors and non-survivors animals. Results Seven of the 20 animals died during hemorrhage and initial fluid resuscitation. All animals presented an increase in time-domain HRV measures during haemorrhage and fluid resuscitation restored baseline values. Although not significantly, normalized low-frequency and LF/HF ratio decreased during early stages of haemorrhage, recovering baseline values later during hemorrhagic shock, and increased after fluid resuscitation. Non-surviving animals presented significantly lower mean arterial pressure (43 +/- 7vs57 +/- 9 mmHg, P<0.05) and cardiac index (1.7 +/- 0.2vs2.6 +/- 0.5 L/min/m(2), P<0.05), and higher levels of plasma lactate (7.2 +/- 2.4vs3.7 +/- 1.4 mmol/L, P<0.05), base excess (-6.8 +/- 3.3vs-2.3 +/- 2.8 mmol/L, P<0.05) and potassium (5.3 +/- 0.6vs4.2 +/- 0.3 mmol/L, P<0.05) at 30 minutes after hemorrhagic shock compared with surviving animals. Conclusions The HRV increased early during hemorrhage but none of the evaluated HRV metrics was able to discriminate survivors from non-survivors during hemorrhagic shock. Moreover, metabolic and hemodynamic variables were more reliable to reflect hemorrhagic shock severity than HRV metrics.	[Salomao, Edgard, Jr.; Otsuki, Denise Aya; Correa, Andre Luis; Fantoni, Denise Tabacchi; Costa Auler, Jose Otavio, Jr.] Univ Sao Paulo, Fac Med, Dept Anesthesia & Surg Intens Care, Lab Anesthesiol LIM08, Sao Paulo, Brazil; [dos Santos, Fernando; Irigoyen, Maria Claudia] Univ Sao Paulo, Fac Med, Heart Inst InCor, Hypertens Unit, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Otsuki, DA (corresponding author), Univ Sao Paulo, Fac Med, Dept Anesthesia & Surg Intens Care, Lab Anesthesiol LIM08, Sao Paulo, Brazil.	lim08@usp.br	Fantoni, Denise T/C-5602-2012; Auler, José Otavio Costa/C-4492-2017; IRIGOYEN, MARIA CLAUDIA C/N-6880-2014	Fantoni, Denise T/0000-0002-8452-2038; Auler, José Otavio Costa/0000-0002-3919-1743; IRIGOYEN, MARIA CLAUDIA C/0000-0003-2097-3662	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 12/00439-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JOCA received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 12/00439-0).	[Anonymous], 1996, GUIDE CARE USE LAB A; Batchinsky AI, 2007, AUTON NEUROSCI-BASIC, V136, P43, DOI 10.1016/j.autneu.2007.03.004; Batchinsky AI, 2007, CRIT CARE MED, V35, P519, DOI 10.1097/01.CCM.0000254065.44990.77; Batchinsky AI, 2010, J TRAUMA, V68, P1178, DOI 10.1097/TA.0b013e3181bb98a6; BUTLER GC, 1994, AM J PHYSIOL, V267, pR26, DOI 10.1152/ajpregu.1994.267.1.R26; Camm AJ, 1996, CIRCULATION, V93, P1043; Cancio LC, 2013, J CRIT CARE, V28, P1093, DOI 10.1016/j.jcrc.2013.08.022; Convertino VA, 2004, AUTON NEUROSCI-BASIC, V111, P127, DOI 10.1016/j.autneu.2004.02.007; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Cooke WH, 2005, J TRAUMA, V58, P798, DOI 10.1097/01.TA.0000151345.16338.FD; Cooke WH, 2008, CRIT CARE MED, V36, P1892, DOI 10.1097/CCM.0b013e3181760d0c; EGER EI, 1988, ANESTH ANALG, V67, P1174; GLICK G, 1964, J CLIN INVEST, V43, P2112, DOI 10.1172/JCI105085; Goldstein B, 1999, CRIT CARE MED, V27, P2239, DOI 10.1097/00003246-199910000-00029; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Grossman P, 2004, AM J PHYSIOL-HEART C, V287, pH728, DOI 10.1152/ajpheart.00825.2003; Hinojosa-Laborde C, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00085; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jacob M, 2012, CRIT CARE, V16, DOI 10.1186/cc11344; KATO M, 1992, ANESTHESIOLOGY, V77, P669, DOI 10.1097/00000542-199210000-00009; KOYAMA S, 1988, AM J PHYSIOL, V254, pR761, DOI 10.1152/ajpregu.1988.254.5.R761; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; Mostarda C, 2010, CLIN EXP PHARMACOL P, V37, P447, DOI 10.1111/j.1440-1681.2009.05327.x; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; Poletto R, 2011, PHYSIOL BEHAV, V103, P188, DOI 10.1016/j.physbeh.2011.01.019; Rickards CA, 2010, CRIT CARE MED, V38, P1666, DOI 10.1097/CCM.0b013e3181e74cab; Rickards CA, 2010, J CLIN MONIT COMPUT, V24, P61, DOI 10.1007/s10877-009-9210-z; Rocha JA, 2010, J TRAUMA, V68, P1335, DOI 10.1097/TA.0b013e3181dbbb36; Rocha JA, 2009, CLINICS, V64, P591, DOI 10.1590/S1807-59322009000600016; Ryan KL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00110; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; SKOOG P, 1985, ACTA PHYSIOL SCAND, V125, P655, DOI 10.1111/j.1748-1716.1985.tb07768.x; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Torres LN, 2004, AM J PHYSIOL-HEART C, V286, pH1811, DOI 10.1152/ajpheart.00837.2003; Voss A, 2013, IEEE ENG MED BIO, P5574, DOI 10.1109/EMBC.2013.6610813; Weiskopf RB, 2003, TRANSFUSION, V43, P235, DOI 10.1046/j.1537-2995.2003.00302.x; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214	42	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134387	10.1371/journal.pone.0134387	http://dx.doi.org/10.1371/journal.pone.0134387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247476	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300034
J	Reaney, LT; Knell, RJ				Reaney, Leeann T.; Knell, Robert J.			Building a Beetle: How Larval Environment Leads to Adult Performance in a Horned Beetle	PLOS ONE			English	Article							SEXUAL SELECTION; BODY CONDITION; TRADE-OFFS; SIZE; ORNAMENTS; PATTERNS; TRAITS; DIET; DIVERSIFICATION; EXPRESSION	The link between the expression of the signals used by male animals in contests with the traits which determine success in those contests is poorly understood. This is particularly true in holometabolous insects such as horned beetles where signal expression is determined during metamorphosis and is fixed during adulthood, whereas performance is influenced by post-eclosion feeding. We used path analysis to investigate the relationships between larval and adult nutrition, horn and body size and fitness-related traits such as strength and testes mass in the horned beetle Euoniticellus intermedius. Inmales weight gain post-eclosion had a central role in determining both testesmass and strength. Weight gain was unaffected by adult nutrition but was strongly correlated with by horn length, itself determined by larval resource availability, indicating strong indirect effects of larval nutrition on the adult beetle's ability to assimilate food and grow tissues. Female strength was predicted by a simple path diagram where strength was determined by eclosion weight, itself determined by larval nutrition: weight gain post-eclosion was not a predictor of strength in this sex. Based on earlier findings we discuss the insulin-like signalling pathway as a possible mechanism by which larval nutrition could affect adult weight gain and thence traits such as strength.	[Reaney, Leeann T.; Knell, Robert J.] Univ London, Sch Biol & Chem Sci, London, England	University of London	Knell, RJ (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England.	R.Knell@qmul.ac.uk			Leverhulme Trust;  [F/07 476/AC]	Leverhulme Trust(Leverhulme Trust); 	This research was funded by The Leverhulme Trust (https://www.leverhulme.ac.uk). Project grant number F/07 476/AC) awarded to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Barnett CA, 2015, J ZOOL, V296, P1, DOI 10.1111/jzo.12213; Beaujean AA, 2014, LATENT VARIABLE MODE, DOI DOI 10.4324/9781315869780; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; Blanckenhorn WU, 2003, BEHAV ECOL, V14, P612, DOI 10.1093/beheco/arg052; Buschbeck EK, 2001, J COMP NEUROL, V433, P486, DOI 10.1002/cne.1155; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; CLUTTONBROCK TH, 1982, BEHAVIOUR, V79, P108, DOI 10.1163/156853982X00201; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Crnokrak P, 2000, THE TRADE OFF TO MAC; Emlen DJ, 2000, BIOSCIENCE, V50, P403, DOI 10.1641/0006-3568(2000)050[0403:IDWEAC]2.0.CO;2; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Henningsen JP, 2012, FUNCT ECOL, V26, P3, DOI 10.1111/j.1365-2435.2011.01893.x; Hunt J, 1998, BEHAV ECOL SOCIOBIOL, V42, P447, DOI 10.1007/s002650050459; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; Irschick DJ, 2007, FUNCT ECOL, V21, P621, DOI 10.1111/j.1365-2435.2007.01281.x; Jenssen TA, 2000, COPEIA, P140, DOI 10.1643/0045-8511(2000)2000[0140:SDIASS]2.0.CO;2; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Katsuki M, 2012, ECOL ENTOMOL, V37, P463, DOI 10.1111/j.1365-2311.2012.01390.x; Knapp M, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.0601; Knell Robert, 2011, P47; Knell RJ, 2010, P ROY SOC B-BIOL SCI, V277, P2347, DOI 10.1098/rspb.2010.0257; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Lailvaux SP, 2012, P ROY SOC B-BIOL SCI, V279, P2841, DOI 10.1098/rspb.2011.2577; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; Losos JB, 2002, J ZOOL, V258, P57, DOI 10.1017/S0952836902001206; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; O'Brien DM, 2001, J EXP ZOOL, V290, P108, DOI 10.1002/jez.1040; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; Reaney LT, 2010, BEHAV ECOL, V21, P1367, DOI 10.1093/beheco/arq139; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Sasakawa K, 2009, ECOL ENTOMOL, V34, P406, DOI 10.1111/j.1365-2311.2009.01092.x; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Simmons L., 2001, SPERM COMPETITION AN; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SIMMONS LW, 1993, BEHAV ECOL SOCIOBIOL, V32, P135, DOI 10.1007/BF00164046; Singh D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073305; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Soler C, 2012, DEVELOPMENT, V139, P1270, DOI 10.1242/dev.077875; Vanhooydonck B, 2005, FUNCT ECOL, V19, P38, DOI 10.1111/j.0269-8463.2005.00940.x; Warren IA, 2013, BIOESSAYS, V35, P889, DOI 10.1002/bies.201300031; Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203; Wilder S. M., 2015, FUNCTIONAL ECOLOGY, V30, P108, DOI [10.1111/1365-2435.12460, DOI 10.1111/1365-2435.12460]; Wilkinson Gerald S., 1997, P310, DOI 10.1017/CBO9780511721946.019; Wilson RS, 2009, J EXP BIOL, V212, P853, DOI 10.1242/jeb.024547	50	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134399	10.1371/journal.pone.0134399	http://dx.doi.org/10.1371/journal.pone.0134399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244874	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400078
J	Song, J; Chen, FJ; Campos, M; Bolgiano, D; Houck, K; Chambless, LE; Wu, KK; Folsom, AR; Couper, D; Boerwinkle, E; Dong, JF				Song, Jaewoo; Chen, Fengju; Campos, Marco; Bolgiano, Doug; Houck, Katie; Chambless, Lloyd E.; Wu, Kenneth K.; Folsom, Aaron R.; Couper, David; Boerwinkle, Eric; Dong, Jing-fei			Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects	PLOS ONE			English	Article							HUMAN VONWILLEBRAND-FACTOR; PLASMA-LEVELS; GENOMEWIDE ASSOCIATION; HEART-DISEASE; GROUP-B; GROUP-A; CARBOHYDRATE; POPULATION; CLEAVAGE; LOCUS	ABO blood groups are known to influence the plasma level of von Willebrand factor (VWF), but little is known about the relationship between ABO and coagulation factor VIII (FVIII). We analyzed the influence of ABO genotypes on VWF antigen, FVIII activity, and their quantitative relationship in 11,673 participants in the Atherosclerosis Risk in Communities (ARIC) study. VWF, FVIII, and FVIII/VWF levels varied significantly among O, A (A1 and A2), B and AB subjects, and the extent of which varied between Americans of European (EA) and African (AA) descent. We validated a strong influence of ABO blood type on VWF levels (15.2%), but also detected a direct ABO influence on FVIII activity (0.6%) and FVIII/VWF ratio (3.8%) after adjustment for VWF. We determined that FVIII activity changed 0.54% for every 1% change in VWF antigen level. This VWF-FVIII relationship differed between subjects with O and B blood types in EA, AA, and in male, but not female subjects. Variations in FVIII activity were primarily detected at low VWF levels. These new quantitative influences on VWF, FVIII and the FVIII/VWF ratio help understand how ABO genotypes differentially influence VWF, FVIII and their ratio, particularly in racial and gender specific manners.	[Song, Jaewoo; Bolgiano, Doug; Houck, Katie; Dong, Jing-fei] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Song, Jaewoo] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Chen, Fengju; Boerwinkle, Eric] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Campos, Marco] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; [Chambless, Lloyd E.; Couper, David] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Wu, Kenneth K.] Natl Hlth Res Inst, Taipei, Taiwan; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	Puget Sound Blood Center; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National Health Research Institutes - Taiwan; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	Dong, JF (corresponding author), Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA.	jfdong@psbc.org		Song, Jaewoo/0000-0002-1877-5731; Couper, David/0000-0002-4313-9235	National Heart, Lung, and Blood Institute [HL71895, HL85769];  [N01-HC-55015];  [N01-HC-55016];  [N01-HC-55018];  [N01-HC-55019];  [N01-HC-55020];  [N01-HC-55021];  [N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055018, N01HC055021, N01HC055019, N01HC055020, N01HC055022, N01HC055015] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085769, R01HL059367, R01HL071895, R01HL086694, R01HL087641, R01HL125957] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by research contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022; and Research Grants HL71895 and HL85769 from the National Heart, Lung, and Blood Institute.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Campos M, 2012, BLOOD, V119, P1929, DOI 10.1182/blood-2011-10-383661; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; Canis K, 2010, J THROMB HAEMOST, V8, P137, DOI 10.1111/j.1538-7836.2009.03665.x; CAREW JA, 1992, J CLIN INVEST, V90, P2258, DOI 10.1172/JCI116112; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; FEDERICI AB, 1988, BLOOD, V71, P947; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Kamphuisen PW, 1998, THROMB HAEMOSTASIS, V79, P323; MATSUI T, 1992, J BIOL CHEM, V267, P8723; MATSUI T, 1993, BLOOD, V82, P663; MEADE TW, 1994, BRIT J HAEMATOL, V88, P601, DOI 10.1111/j.1365-2141.1994.tb05079.x; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; Morange PE, 2005, BRIT J HAEMATOL, V128, P91, DOI 10.1111/j.1365-2141.2004.05275.x; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schleef M, 2005, BRIT J HAEMATOL, V128, P100, DOI 10.1111/j.1365-2141.2004.05249.x; Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156; SODETZ JM, 1979, J BIOL CHEM, V254, P754; Souto JC, 2000, ARTERIOSCL THROM VAS, V20, P2024, DOI 10.1161/01.ATV.20.8.2024; The ARIC Investigators, 1989, AM J EPIDEMIOL, V129, P687; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; van Schie MC, 2011, J THROMB HAEMOST, V9, P899, DOI 10.1111/j.1538-7836.2011.04243.x; van Schooten CJM, 2007, BLOOD, V109, P2430, DOI 10.1182/blood-2006-06-032706; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084810	29	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132626	10.1371/journal.pone.0132626	http://dx.doi.org/10.1371/journal.pone.0132626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244499	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400025
J	Zhang, X; Xiong, SJ; Ma, Y; Han, T; Chen, XY; Wan, F; Lu, YT; Yan, SH; Wang, Y				Zhang, Xin; Xiong, Shijiang; Ma, Yue; Han, Ting; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan			A Cone-Beam Computed Tomographic Study on Mandibular First Molars in a Chinese Subpopulation	PLOS ONE			English	Article							CANAL MORPHOLOGY; 3-DIMENSIONAL ANALYSIS; PERMANENT MOLARS; ROOT CANALS; POPULATION	The purpose of this study was to conduct a cone-beam computed tomographic (CBCT) investigation on the root and canal configuration of the mandibular first molars, especially the morphology of the disto-lingual (DL) root, in a Chinese subpopulation. A total of 910 CBCT images of the mandibular first molars were collected from 455 patients who underwent CBCT examinations as a preoperative assessment for implants or orthodontic treatment. The following information was analyzed and evaluated: tooth position, gender, root and root canal number per tooth, root canal type of the mesial root(s) and distal root(s), angle of the DL root canal curvature, distance between two distal canal orifices in the teeth with DL root, and angle of disto-buccal canal orifice-disto-lingual canal orifice-mesio-lingual canal orifice (DB-DL-ML). Most of the mandibular first molars (64.9%, n = 591) had two roots with three root canals, and most of the mesial root canals (87.7%, n = 798) were type VI. The prevalence of the DL root was 22.1%(n = 201). The right side had a higher prevalence of DL root than the left side (p<0.05). Additionally, the curvature of the DL root canal were greater in the bucco-lingual (BL) orientation (30.10 degrees+/-14.02 degrees) than in the mesio-distal (MD) orientation (14.03 degrees+/-8.56 degrees) (p<0.05). Overall there was a high prevalence of DL root in the mandibular first molars, and most of the DL roots were curved in different degrees. This study provided detailed information about the root canal morphology of the mandibular first molars in a Chinese subpopulation.	[Zhang, Xin; Xiong, Shijiang; Ma, Yue; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan] Shandong Univ, Sch & Hosp Stomatol, VIP Ctr, Jinan 250100, Shangdong, Peoples R China; [Zhang, Xin; Xiong, Shijiang; Ma, Yue; Chen, Xinyu; Wan, Fang; Lu, Yating; Yan, Songhe; Wang, Yan] Shandong Univ, Sch & Hosp Stomatol, Shandong Prov Key Lab Oral Biomed, Jinan 250100, Shangdong, Peoples R China; [Han, Ting] Shandong Univ, Sch & Hosp Stomatol, Dept Endodont, Jinan 250100, Shangdong, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, Y (corresponding author), Shandong Univ, Sch & Hosp Stomatol, VIP Ctr, Jinan 250100, Shangdong, Peoples R China.	wangyan1965@sdu.edu.cn	HAN, TINGTING/GQZ-8692-2022	Xiong, Shijiang/0000-0001-5239-7837	Shandong University [2015JC014]	Shandong University	This work was supported by the Fundamental Research Funds of Shandong University (http://www.xsyjb.sdu.edu.cn/), Grant # 2015JC014 to YW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella F, 2012, INT ENDOD J, V45, P963, DOI 10.1111/j.1365-2591.2012.02075.x; Ahmed HA, 2007, INT ENDOD J, V40, P766, DOI 10.1111/j.1365-2591.2007.01283.x; Al-Qudah AA, 2009, INT ENDOD J, V42, P775, DOI 10.1111/j.1365-2591.2009.01578.x; BYSTROM A, 1987, Endodontics and Dental Traumatology, V3, P58; Chandra SS, 2011, ORAL SURG ORAL MED O, V112, pE77, DOI 10.1016/j.tripleo.2011.02.016; Chen G, 2009, INT ENDOD J, V42, P1044, DOI 10.1111/j.1365-2591.2009.01619.x; CURZON MEJ, 1973, J DENT RES, V52, P181, DOI 10.1177/00220345730520011901; De Moor RJG, 2004, INT ENDOD J, V37, P789, DOI 10.1111/j.1365-2591.2004.00870.x; Ferraz J A, 1993, Braz Dent J, V3, P113; Grande NM, 2006, INT ENDOD J, V39, P755, DOI 10.1111/j.1365-2591.2006.01143.x; Grande NM, 2012, ANN I SUPER SANITA, V48, P26, DOI 10.4415/ANN_12_01_05; Gu YC, 2010, J ENDODONT, V36, P1341, DOI 10.1016/j.joen.2010.04.025; Gu YC, 2010, J ENDODONT, V36, P990, DOI 10.1016/j.joen.2010.02.030; Gulabivala K, 2001, INT ENDOD J, V34, P359, DOI 10.1046/j.1365-2591.2001.00399.x; Huang RY, 2010, INT ENDOD J, V43, P478, DOI 10.1111/j.1365-2591.2010.01702.x; Huang RY, 2007, J PERIODONTOL, V78, P1485, DOI 10.1902/jop.2007.060419; Jang JK, 2013, CLIN ORAL INVEST, V17, P105, DOI 10.1007/s00784-012-0687-3; Matherne RP, 2008, J ENDODONT, V34, P87, DOI 10.1016/j.joen.2007.10.016; Neelakantan P, 2010, J ENDODONT, V36, P1547, DOI 10.1016/j.joen.2010.05.008; Pattanshetti N, 2008, INT ENDOD J, V41, P755, DOI 10.1111/j.1365-2591.2008.01427.x; Plotino G, 2006, J AM DENT ASSOC, V137, P1555, DOI 10.14219/jada.archive.2006.0091; REICHART PA, 1981, COMMUNITY DENT ORAL, V9, P191, DOI 10.1111/j.1600-0528.1981.tb01053.x; SCHNEIDER SW, 1971, ORAL SURG ORAL MED O, V32, P271, DOI 10.1016/0030-4220(71)90230-1; Song JS, 2010, J ENDODONT, V36, P653, DOI 10.1016/j.joen.2009.10.007; Song JS, 2009, ORAL SURG ORAL MED O, V107, pE56, DOI 10.1016/j.tripleo.2008.09.004; Sperber GH, 1998, INT ENDOD J, V31, P117; Tu MG, 2009, J ENDODONT, V35, P503, DOI 10.1016/j.joen.2008.12.013; VERTUCCI FJ, 1984, ORAL SURG ORAL MED O, V58, P589, DOI 10.1016/0030-4220(84)90085-9; Wang Y, 2010, J ENDODONT, V36, P1786, DOI 10.1016/j.joen.2010.08.016; Yamada Masashi, 2011, Bull Tokyo Dent Coll, V52, P77; Zelada G, 2002, J ENDODONT, V28, P540, DOI 10.1097/00004770-200207000-00014; Zhang R, 2011, INT ENDOD J, V44, P990, DOI 10.1111/j.1365-2591.2011.01904.x	32	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134919	10.1371/journal.pone.0134919	http://dx.doi.org/10.1371/journal.pone.0134919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241480	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942700080
J	Nagaraja, AS; Dorniak, PL; Sadaoui, NC; Kang, Y; Lin, T; Armaiz-Pena, G; Wu, SY; Rupaimoole, R; Allen, JK; Gharpure, KM; Pradeep, S; Zand, B; Previs, RA; Hansen, JM; Ivan, C; Rodriguez-Aguayo, C; Yang, P; Lopez-Berestein, G; Lutgendorf, SK; Cole, SW; Sood, AK				Nagaraja, A. S.; Dorniak, P. L.; Sadaoui, N. C.; Kang, Y.; Lin, T.; Armaiz-Pena, G.; Wu, S. Y.; Rupaimoole, R.; Allen, J. K.; Gharpure, K. M.; Pradeep, S.; Zand, B.; Previs, R. A.; Hansen, J. M.; Ivan, C.; Rodriguez-Aguayo, C.; Yang, P.; Lopez-Berestein, G.; Lutgendorf, S. K.; Cole, S. W.; Sood, A. K.			Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis	ONCOGENE			English	Article							BREAST-CANCER; BETA-BLOCKERS; TUMOR-METASTASIS; STRESS; EXPRESSION; CYCLOOXYGENASE-2; NOREPINEPHRINE; CARCINOMA; INVASION; OUTCOMES	Adrenergic stimulation adversely affects tumor growth and metastasis, but the underlying mechanisms are not well understood. Here, we uncovered a novel mechanism by which catecholamines induce inflammation by increasing prostaglandin E2 (PGE2) levels in ovarian cancer cells. Metabolic changes in tumors isolated from patients with depression and mice subjected to restraint stress showed elevated PGE2 levels. Increased metabolites, PTGS2 and PTGES protein levels were found in Skov3-ip1 and HeyA8 cells treated with norepinephrine (NE), and these changes were shown to be mediated by ADRB2 receptor signaling. Silencing PTGS2 resulted in significantly decreased migration and invasion in ovarian cancer cells in the presence of NE and decreased tumor burden and metastasis in restraint stress orthotopic models. In human ovarian cancer samples, concurrent increased ADRB2, PTGS2 and PTGES expression was associated with reduced overall and progression-free patient survival. In conclusion, increased adrenergic stimulation results in increased PGE2 synthesis via ADRB2-Nf-kappa B-PTGS2 axis, which drives tumor growth and metastasis.	[Nagaraja, A. S.; Dorniak, P. L.; Sadaoui, N. C.; Kang, Y.; Armaiz-Pena, G.; Wu, S. Y.; Rupaimoole, R.; Allen, J. K.; Gharpure, K. M.; Pradeep, S.; Zand, B.; Previs, R. A.; Hansen, J. M.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1352,1515 Holcombe Blvd, Houston, TX 77030 USA; [Lin, T.; Yang, P.] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA; [Ivan, C.; Rodriguez-Aguayo, C.; Lopez-Berestein, G.; Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Noncoding RNA, Houston, TX 77030 USA; [Lutgendorf, S. K.] Univ Iowa, Dept Psychol, Obstet & Gynecol, Iowa City, IA 52242 USA; [Lutgendorf, S. K.] Univ Iowa, Urol, Iowa City, IA USA; [Lutgendorf, S. K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Cole, S. W.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Mol Biol Inst, Norman Cousins Ctr,Dept Med,Div Hematol Oncol, Los Angeles, CA 90095 USA; [Cole, S. W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Sood, A. K.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Iowa; University of Iowa; University of Iowa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Unit 1352,1515 Holcombe Blvd, Houston, TX 77030 USA.; Sood, AK (corresponding author), Univ Texas MD Anderson Canc Ctr, Canc Biol, Unit 1352,1515 Holcombe Blvd, Houston, TX 77030 USA.	asood@mdanderson.org	Nagaraja, Archana/AAE-8529-2021; Sood, Anoop Kumar/A-7344-2013; Nagaraja, Archana Sidalaghatta/AAE-2205-2021; Rupaimoole, Rajesha/K-3272-2016	Sood, Anoop Kumar/0000-0001-5702-4108; Rupaimoole, Rajesha/0000-0002-4795-7921; Gharpure, Kshipra/0000-0003-4954-5696; Armaiz-Pena, Guillermo N/0000-0002-9081-5339; Ivan, Cristina/0000-0002-4848-0168; Nagaraja, Archana/0000-0002-2851-9272; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Previs, Rebecca/0000-0001-8087-9120	United States National Institutes of Health [CA116778, CA104825, CA140933, CA109298, CPRIT RP140106, CPRIT RP110595, NIH CA 109298, P50CA083639, P50CA098258, AG017265, AG033590]; NIH [HHSN261200800001E]; Breast Cancer Research Foundation; United States Department of Defense [OC073399, W81XWH-10-1-0158, BC085265]; Marcus Foundation; Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer; RGK Foundation; Gilder Foundation; Blanton-Davis Ovarian Cancer Research Program; Betty Anne Asche Murray Distinguished Professorship; CPRIT Graduate Scholar Fellowship; Altman-Goldstein Discovery fellowship; Ovarian Cancer Research Fund, Inc.; Cancer Prevention and Research Institute of Texas [RP101502, RP101489]; NCI-DHHS-NIH T32 training grant [T32 CA101642]; National Cancer Institute Network on Biobehavioral Pathways in Cancer; NATIONAL CANCER INSTITUTE [P50CA083639, R01CA193249, R01CA104825, R01CA109298, R01CA116778, T32CA101642, P50CA098258, R01CA140933, P30CA016672, R01CA177909] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017265, R37AG033590] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; United States Department of Defense(United States Department of Defense); Marcus Foundation; Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer; RGK Foundation; Gilder Foundation; Blanton-Davis Ovarian Cancer Research Program; Betty Anne Asche Murray Distinguished Professorship; CPRIT Graduate Scholar Fellowship; Altman-Goldstein Discovery fellowship; Ovarian Cancer Research Fund, Inc.; Cancer Prevention and Research Institute of Texas; NCI-DHHS-NIH T32 training grant; National Cancer Institute Network on Biobehavioral Pathways in Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the following for funding support: the United States National Institutes of Health (CA116778, CA104825, CA140933, CA109298, CPRIT RP140106, CPRIT RP110595, NIH CA 109298, P50CA083639, P50CA098258, AG017265, AG033590), NIH under Contract No. HHSN261200800001E and the Breast Cancer Research Foundation, the United States Department of Defense (OC073399, W81XWH-10-1-0158, and BC085265); the Marcus Foundation; the Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer; the RGK Foundation; the Gilder Foundation; the Blanton-Davis Ovarian Cancer Research Program and the Betty Anne Asche Murray Distinguished Professorship (AKS). ASN is supported in part by the CPRIT Graduate Scholar Fellowship. KMG is supported by the Altman-Goldstein Discovery fellowship. SYW is supported by the Ovarian Cancer Research Fund, Inc., and by Cancer Prevention and Research Institute of Texas training grants (RP101502 and RP101489). RAP, BZ and JH are supported by the NCI-DHHS-NIH T32 training grant (T32 CA101642). We thank Laila Dahmoush at the University of Iowa for her help analyzing patient tumor slides. This research was supported by the National Cancer Institute Network on Biobehavioral Pathways in Cancer. We also thank Erica Goodoff at MD Anderson for help with scientific editing.	Athanassiadou P, 2008, PATHOL RES PRACT, V204, P241, DOI 10.1016/j.prp.2007.11.004; Benish M, 2008, ANN SURG ONCOL, V15, P2042, DOI 10.1245/s10434-008-9890-5; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Costanzo ES, 2005, CANCER-AM CANCER SOC, V104, P305, DOI 10.1002/cncr.21147; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Gosain A, 2006, J TRAUMA, V60, P736, DOI 10.1097/01.ta.0000196802.91829.cc; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; KOSAKA T, 1994, EUR J BIOCHEM, V221, P889, DOI 10.1111/j.1432-1033.1994.tb18804.x; Kruk J, 2004, CANCER DETECT PREV, V28, P399, DOI 10.1016/j.cdp.2004.07.009; Lin Y, 2014, MOL MED REP, V9, P2499, DOI 10.3892/mmr.2014.2131; Lutgendorf SK, 2012, J CLIN ONCOL, V30, P2885, DOI 10.1200/JCO.2011.39.4411; Lutgendorf SK, 2011, BRAIN BEHAV IMMUN, V25, P250, DOI 10.1016/j.bbi.2010.10.012; Lutgendorf SK, 2009, BRAIN BEHAV IMMUN, V23, P176, DOI 10.1016/j.bbi.2008.04.155; Matsumoto Y, 2001, INT J MOL MED, V8, P31; Qiu X, 2014, ENDOCR-RELAT CANCER, V21, P533, DOI 10.1530/ERC-13-0450; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAMIREZ AJ, 1989, BRIT MED J, V298, P291, DOI 10.1136/bmj.298.6669.291; Sethi J, 2010, METHOD FIND EXP CLIN, V32, P233, DOI 10.1358/mf.2010.32.4.1423889; Shakhar G, 1998, J IMMUNOL, V160, P3251; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Sood AK, 2006, CLIN CANCER RES, V12, P369, DOI 10.1158/1078-0432.CCR-05-1698; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Yang EV, 2009, BRAIN BEHAV IMMUN, V23, P267, DOI 10.1016/j.bbi.2008.10.005	29	51	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2390	2397		10.1038/onc.2015.302	http://dx.doi.org/10.1038/onc.2015.302			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26257064	Green Accepted			2022-12-26	WOS:000376165000011
J	Lyukmanova, EN; Shenkarev, ZO; Shulepko, MA; Paramonov, AS; Chugunov, AO; Janickova, H; Dolejsi, E; Dolezal, V; Utkin, YN; Tsetlin, VI; Arseniev, AS; Efremov, RG; Dolgikh, DA; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Janickova, Helena; Dolejsi, Eva; Dolezal, Vladimir; Utkin, Yuri N.; Tsetlin, Victor I.; Arseniev, Alexander S.; Efremov, Roman G.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.			Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BACTERIAL EXPRESSION; CONFORMATIONAL HETEROGENEITY; ALLOSTERIC MODULATION; MOLECULAR-DYNAMICS; ALPHA-NEUROTOXINS; BINDING; SNAKE; NEUROMODULATOR; RELAXATION	Weak toxin from Naja kaouthia (WTX) belongs to the group of nonconventional "three-finger" snake neurotoxins. It irreversibly inhibits nicotinic acetylcholine receptors and allosterically interacts with muscarinic acetylcholine receptors (mAChRs). Using site-directed mutagenesis, NMR spectroscopy, and computer modeling, we investigated the recombinant mutant WTX analogue (rWTX) which, compared with the native toxin, has an additional N-terminal methionine residue. In comparison with the wild-type toxin, rWTX demonstrated an altered pharmacological profile, decreased binding of orthosteric antagonist N-methylscopolamine to human M1- and M2-mAChRs, and increased antagonist binding to M3-mAChR. Positively charged arginine residues located in the flexible loop II were found to be crucial for rWTX interactions with all types of mAChR. Computer modeling suggested that the rWTX loop II protrudes to the M1-mAChR allosteric ligand-binding site blocking the entrance to the orthosteric site. In contrast, toxin interacts with M3-mAChR by loop II without penetration into the allosteric site. Data obtained provide new structural insight into the target-specific allosteric regulation of mAChRs by "three-finger" snake neurotoxins.	[Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Utkin, Yuri N.; Tsetlin, Victor I.; Arseniev, Alexander S.; Efremov, Roman G.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Lyukmanova, Ekaterina N.; Shenkarev, Zakhar O.; Shulepko, Mikhail A.; Paramonov, Alexander S.; Chugunov, Anton O.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Janickova, Helena; Dolejsi, Eva; Dolezal, Vladimir] Acad Sci Czech Republ, Inst Physiol, Publ Res Inst, CR-14220 Prague, Czech Republic; [Shenkarev, Zakhar O.; Arseniev, Alexander S.; Efremov, Roman G.] Moscow Inst Phys & Technol, Inst Pereulok 9, Dolgoprudnyi 141700, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Moscow Institute of Physics & Technology	Lyukmanova, EN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str, Moscow 117997, Russia.	ekaterina-lyukmanova@yandex.ru	Chugunov, Anton O/D-1058-2009; Tsetlin, Victor/X-2491-2018; Dolezal, Vladimir/A-8732-2008; Janickova, Helena/Q-7211-2017; Dolejsi, Eva/G-1341-2016; Utkin, Yuri N./F-1958-2014; Utkin, Yuri/L-2952-2019; Dolejsi, Eva/AAM-9473-2020; Shenkarev, Zakhar O./P-1808-2015; Shulepko, Mikhail/N-9124-2016; Dolgikh, Dmitry A/F-2369-2014; Lyukmanova, Ekaterina/F-2340-2014; Roman, Efremov/A-7460-2014	Chugunov, Anton O/0000-0003-1331-3949; Dolezal, Vladimir/0000-0003-3412-256X; Janickova, Helena/0000-0003-0310-7893; Dolejsi, Eva/0000-0002-5845-182X; Utkin, Yuri N./0000-0002-4609-970X; Utkin, Yuri/0000-0002-4609-970X; Dolejsi, Eva/0000-0002-5845-182X; Shenkarev, Zakhar O./0000-0003-1383-3522; Lyukmanova, Ekaterina/0000-0002-9728-9407; Roman, Efremov/0000-0002-5474-4721; Shulepko, Mikhail/0000-0002-0436-2127; Kirpichnikov, Mikhail/0000-0001-8170-1607; Dolgikh, Dmitry/0000-0002-9880-7202	Russian Academy of Sciences (Program Molecular and Cellular Biology); Russian Federation [SS-1766.2014.4, YC-6310.2015.4]; Russian Foundation for Basic Research [13-04-00825, 14-04-31634]; Grant Agency of the Czech Republic [14-05696S]; Institute of Physiology of the Academy of Sciences of the Czech Republic [RVO:67985823]; Russian Scientific Foundation [14-14-00255]	Russian Academy of Sciences (Program Molecular and Cellular Biology)(Russian Academy of Sciences); Russian Federation(Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology of the Academy of Sciences of the Czech Republic; Russian Scientific Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Academy of Sciences (Program Molecular and Cellular Biology), President of the Russian Federation Grants SS-1766.2014.4 and YC-6310.2015.4, Russian Foundation for Basic Research Grants 13-04-00825 and 14-04-31634, Grant Agency of the Czech Republic Grant 14-05696S (to V. D.), Institute of Physiology of the Academy of Sciences of the Czech Republic Project RVO:67985823 (to H. J., E. D., and V. D.), and Russian Scientific Foundation Project 14-14-00255 (to E. N. L., Z. O. S., M. A. S., A. S. P., A. O. C., and D. A. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P781, DOI 10.1016/B978-012164491-8/50012-9; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; Eletsky AV, 2001, RUSS J BIOORG CHEM+, V27, P72, DOI 10.1023/A:1011376918514; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He Y, 2014, PROTEIN CELL, V5, P658, DOI 10.1007/s13238-014-0086-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hu JX, 2013, J BIOL CHEM, V288, P34777, DOI 10.1074/jbc.M113.503714; Jakubik J, 2006, MOL PHARMACOL, V70, P656, DOI 10.1124/mol.106.023762; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kudryavtsev DS, 2015, J BIOL CHEM, V290, P22747, DOI 10.1074/jbc.M115.648824; Lazareno S, 1998, MOL PHARMACOL, V53, P573, DOI 10.1124/mol.53.3.573; Lyukmanova EN, 2014, ACTA NATURAE, V6, P60, DOI 10.32607/20758251-2014-6-4-60-66; Lyukmanova EN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1142, DOI 10.1134/S0006297909100101; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Mordvitsev DY, 2007, COMPUT BIOL CHEM, V31, P72, DOI 10.1016/j.compbiolchem.2007.02.011; Nirthanan S, 2003, TOXICON, V41, P397, DOI 10.1016/S0041-0101(02)00388-4; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; PILLET L, 1993, J BIOL CHEM, V268, P909; Pyrkov TV, 2007, PROTEINS, V66, P388, DOI 10.1002/prot.21122; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; RYCKAERT JP, 1975, CHEM PHYS LETT, V30, P123, DOI 10.1016/0009-2614(75)85513-8; Servent D, 2011, TOXICON, V58, P455, DOI 10.1016/j.toxicon.2011.08.004; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Utkin YN, 2001, TOXICON, V39, P921, DOI 10.1016/S0041-0101(00)00223-3; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379	47	29	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23616	23630		10.1074/jbc.M115.656595	http://dx.doi.org/10.1074/jbc.M115.656595			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242733	hybrid, Green Published			2022-12-26	WOS:000361816500013
J	Baker, SA; Lombardi, LM; Zoghbi, HY				Baker, Steven Andrew; Lombardi, Laura Marie; Zoghbi, Huda Yahya			Karyopherin alpha 3 and Karyopherin alpha 4 Proteins Mediate the Nuclear Import of Methyl-CpG Binding Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETT-SYNDROME; MECP2; MUTATIONS; PHENOTYPE; LOCALIZATION; DOMAIN	Methyl-CpG binding protein 2 (MeCP2) is a nuclear protein with important roles in regulating chromatin structure and gene expression, and mutations in MECP2 cause Rett syndrome (RTT). Within the MeCP2 protein sequence, the nuclear localization signal (NLS) is reported to reside between amino acids 255-271, and certain RTT-causing mutations overlap with the MeCP2 NLS, suggesting that they may alter nuclear localization. One such mutation, R270X, is predicted to interfere with the localization of MeCP2, but recent in vivo studies have demonstrated that this mutant remains entirely nuclear. To clarify the mechanism of MeCP2 nuclear import, we isolated proteins that interact with the NLS and identified karyopherin alpha 3 (KPNA3 or Kap-alpha 3) and karyopherin alpha 4 (KPNA4 or Kap-alpha 4) as key binding partners of MeCP2. MeCP2-R270X did not interact with KPNA4, consistent with a requirement for an intact NLS in this interaction. However, this mutant retains binding to KPNA3, accounting for the normal localization of MeCP2-R270X to the nucleus. These data provide a mechanism for MeCP2 nuclear import and have implications for the design of therapeutics aimed at modulating the function of MeCP2 in RTT patients.	[Baker, Steven Andrew; Zoghbi, Huda Yahya] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Baker, Steven Andrew] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Lombardi, Laura Marie; Zoghbi, Huda Yahya] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lombardi, Laura Marie; Zoghbi, Huda Yahya] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Yahya] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Baker, Steven Andrew; Lombardi, Laura Marie; Zoghbi, Huda Yahya] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Lombardi, Laura/0000-0002-1793-7524; Zoghbi, Huda/0000-0002-0700-3349	NINDS/National Institutes of Health [NS057819, F30NS066527]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, F30NS066527] Funding Source: NIH RePORTER	NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NINDS/National Institutes of Health Grants NS057819 (to H. Y. Z.) and F30NS066527 (to S. A. B.). This work was also supported by the Howard Hughes Medical Institute and services from the cores of the Baylor College of Medicine IDDRC (HD024064). The authors declare they have no conflicts of interest with the contents of this article.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baker SA, 2013, CELL, V152, P984, DOI 10.1016/j.cell.2013.01.038; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Colvin L, 2004, J MED GENET, V41, P25, DOI 10.1136/jmg.2003.011130; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Heckman LD, 2014, ELIFE, V3, DOI 10.7554/eLife.02676; Huppke P, 2002, NEUROPEDIATRICS, V33, P63, DOI 10.1055/s-2002-32365; Jian L, 2005, EUR J HUM GENET, V13, P1235, DOI 10.1038/sj.ejhg.5201479; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kifayathullah LA, 2010, CYTOGENET GENOME RES, V129, P290, DOI 10.1159/000315906; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Miltenberger-Miltenyi G, 2003, HUM MUTAT, V22, P107, DOI 10.1002/humu.10243; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; PAINE PL, 1972, EXP CELL RES, V74, P81, DOI 10.1016/0014-4827(72)90483-1; Pitcher MR, 2015, HUM MOL GENET, V24, P2662, DOI 10.1093/hmg/ddv030; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082	24	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22485	22493		10.1074/jbc.M115.658104	http://dx.doi.org/10.1074/jbc.M115.658104			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26245896	Green Published, hybrid			2022-12-26	WOS:000361171500016
J	Soares, APG; Guillin, EA; Borges, LL; da Silva, ACT; de Almeida, AMR; Grijalba, PE; Gottlieb, AM; Bluhm, BH; de Oliveira, LO				Gomes Soares, Ana Paula; Guillin, Eduardo A.; Borges, Leandro Luiz; da Silva, Amanda C. T.; de Almeida, Alvaro M. R.; Grijalba, Pablo E.; Gottlieb, Alexandra M.; Bluhm, Burton H.; de Oliveira, Luiz Orlando			More Cercospora Species Infect Soybeans across the Americas than Meets the Eye	PLOS ONE			English	Article							PURPLE SEED STAIN; TOXIN CERCOSPORIN; GENETIC DIVERSITY; CAUSAL AGENT; LEAF-BLIGHT; KIKUCHII; RESISTANCE; ACCUMULATION; POPULATIONS; GENOTYPES	Diseases of soybean caused by Cercospora spp. are endemic throughout the world's soybean production regions. Species diversity in the genus Cercospora has been underestimated due to overdependence on morphological characteristics, symptoms, and host associations. Currently, only two species (Cercospora kikuchii and C. sojina) are recognized to infect soybean; C. kikuchii causes Cercospora leaf blight (CLB) and purple seed stain (PSS), whereas C. sojina causes frogeye leaf spot. To assess cryptic speciation among pathogens causing CLB and PSS, phylogenetic and phylogeographic analyses were performed with isolates from the top three soybean producing countries (USA, Brazil, and Argentina; collectively accounting for similar to 80% of global production). Eight nuclear genes and one mitochondrial gene were partially sequenced and analyzed. Additionally, amino acid substitutions conferring fungicide resistance were surveyed, and the production of cercosporin (a polyketide toxin produced bymany Cercospora spp.) was assessed. From these analyses, the long-held assumption of C. kikuchii as the single causal agent of CLB and PSS was rejected experimentally. Four cercosporin-producing lineages were uncovered with origins (about 1 Mya) predicted to predate agriculture. Some of the Cercospora spp. newly associated with CLB and PSS appear to represent undescribed species; others were not previously reported to infect soybeans. Lineage 1, which contained the ex-type strain of C. kikuchii, was monophyletic and occurred in Argentina and Brazil. In contrast, lineages 2 and 3 were polyphyletic and contained wide-host range species complexes. Lineage 4 was monophyletic, thrived in Argentina and the USA, and included the generalist Cercospora cf. flagellaris. Interlineage recombination was detected, along with a high frequency of mutations linked to fungicide resistance in lineages 2 and 3. These findings point to cryptic Cercospora species as under-appreciated global considerations for soybean production and phytosanitary vigilance, and urge a reassessment of host-specificity as a diagnostic tool for Cercospora.	[Gomes Soares, Ana Paula; Borges, Leandro Luiz; da Silva, Amanda C. T.; de Oliveira, Luiz Orlando] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Guillin, Eduardo A.] INTA Castelar, CNIA, Inst Genet Ewald A Favret, Buenos Aires, DF, Argentina; [de Almeida, Alvaro M. R.] Embrapa Soja, Empresa Brasileira Pesquisa Agr, Londrina, PR, Brazil; [Grijalba, Pablo E.] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina; [Gottlieb, Alexandra M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Gottlieb, Alexandra M.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Bluhm, Burton H.] Univ Arkansas, Fayetteville, AR 72701 USA	Universidade Federal de Vicosa; Instituto Nacional de Tecnologia Agropecuaria (INTA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Arkansas System; University of Arkansas Fayetteville	de Oliveira, LO (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil.	luiz.ufv@hotmail.com	Oliveira, Luiz/D-6435-2013; Borges, Leandro Luiz/A-8396-2017	Oliveira, Luiz/0000-0002-5578-2260; Borges, Leandro Luiz/0000-0001-8635-3808	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology) [478752/2013-0]; CAPES Foundation (Brazilian Ministry of Education) - Secretaria de Politicas Universitarias (Ministerio de Educacion, Argentina) [PPCP-Mercosul 015/2011]; CNPq [PQ 304153/2012-5]; Minas Gerais State Foundation of Research Aid (FAPEMIG) [PPM 00291-13]; CAPES (PNPD); U.S. National Science Foundation [1253256]	National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation (Brazilian Ministry of Education) - Secretaria de Politicas Universitarias (Ministerio de Educacion, Argentina); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. National Science Foundation(National Science Foundation (NSF))	The financial support was provided by the National Council of Scientific and Technological Development (CNPq, Brazilian Ministry of Science and Technology, Processo: 478752/2013-0) and CAPES Foundation (Brazilian Ministry of Education) - Secretaria de Politicas Universitarias (Ministerio de Educacion, Argentina) PPCP-Mercosul 015/2011. LOO received fellowships from CNPq (PQ 304153/2012-5) and Minas Gerais State Foundation of Research Aid (FAPEMIG, PPM 00291-13). APGS received a fellowship from CAPES (PNPD 2010). Support for BHB was provided by the U.S. National Science Foundation (Award # 1253256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Almeida A. M. R., 2005, Fitopatologia Brasileira, V30, P594, DOI 10.1590/S0100-41582005000600005; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bolton MD, 2013, PEST MANAG SCI, V69, P35, DOI 10.1002/ps.3358; BOYETTE CD, 1985, PHYTOPATHOLOGY, V75, P183, DOI 10.1094/Phyto-75-183; Cai G, 2008, PHYTOPATHOLOGY, V98, P823, DOI 10.1094/PHYTO-98-7-0823; Cai G, 2005, PHYTOPATHOLOGY, V95, P257, DOI 10.1094/PHYTO-95-0257; Cai GH, 2009, PLANT DIS, V93, P868, DOI 10.1094/PDIS-93-9-0868; Chupp C., 1954, MONOGRAPH FUNGUS GEN; Lura MC, 2011, MYCOPATHOLOGIA, V171, P361, DOI 10.1007/s11046-010-9362-x; Crous PW, 2006, STUD MYCOL, P189, DOI 10.3114/sim.55.1.189; Crous PW, 2005, AUSTRALAS PLANT PATH, V34, P463, DOI 10.1071/AP05082; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; Daub ME, 2000, ANNU REV PHYTOPATHOL, V38, P461, DOI 10.1146/annurev.phyto.38.1.461; Davidson RM, 2006, J PHYTOPATHOL, V154, P321, DOI 10.1111/j.1439-0434.2006.01080.x; Dorrance A. E., 2007, USING FOLIAR FUNGICI; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EHRENSHAFT M, 1993, PHYSIOL MOL PLANT P, V43, P95, DOI 10.1006/pmpp.1993.1043; Fuckel KWGL., 1863, HEDWIGIA, V2, P132; Goodwin SB, 2001, PHYTOPATHOLOGY, V91, P648, DOI 10.1094/PHYTO.2001.91.7.648; Groenewald J.Z., 2012, STUD MYCOL, V75, P115, DOI [10.3114/sim0012, DOI 10.3114/SIM0012]; Groenewald M, 2005, PHYTOPATHOLOGY, V95, P951, DOI 10.1094/PHYTO-95-0951; Groenewald M, 2006, FUNGAL GENET BIOL, V43, P813, DOI 10.1016/j.fgb.2006.05.008; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Imazaki I, 2006, PHYTOPATHOLOGY, V96, P1000, DOI 10.1094/PHYTO-96-1000; Imazaki Iori, 2006, Journal of General Plant Pathology, V72, P292, DOI [10.1007/s10327-006-0285-9, 10.1007/s10327-005-0260-x]; Jackson EW, 2006, CROP SCI, V46, P1462, DOI 10.2135/cropsci2004.0621; JENNS AE, 1989, PHYTOPATHOLOGY, V79, P213, DOI 10.1094/Phyto-79-213; Kasuga T, 2002, MOL BIOL EVOL, V19, P2318, DOI 10.1093/oxfordjournals.molbev.a004056; Kim H, 2013, PHYTOPATHOLOGY, V103, P1045, DOI 10.1094/PHYTO-09-12-0229-R; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; MATSUMOTO T., 1925, Annals of the Phytopathological Society of Japan, V1, P1; Nylander JAA, MRMODELTEST V2 SOFTW; Pollack FG., 1987, MYCOLOGICAL MEMOIR, V12, P1; Quaedvlieg W, 2013, STUD MYCOL, P307, DOI 10.3114/sim0017; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouxel M, 2013, NEW PHYTOL, V197, P251, DOI 10.1111/nph.12016; ROY KW, 1976, PHYTOPATHOLOGY, V66, P1045, DOI 10.1094/Phyto-66-1045; Shivas RG, 2012, MICROBIOL AUST, V33, P36; Srisombun S., 1993, Soybean Genetics Newsletter, V20, P92; Stewart JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-38; TAJIMA F, 1989, GENETICS, V123, P585; WALTERS H J, 1980, Plant Disease, V64, P961, DOI 10.1094/PD-64-961; WILCOX JR, 1975, CROP SCI, V15, P525, DOI 10.2135/cropsci1975.0011183X001500040022x; Wrather JA, 1997, PLANT DIS, V81, P107, DOI 10.1094/PDIS.1997.81.1.107	49	38	45	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133495	10.1371/journal.pone.0133495	http://dx.doi.org/10.1371/journal.pone.0133495			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252018	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100018
J	Gorzelak, MA; Gill, SK; Tasnim, N; Ahmadi-Vand, Z; Jay, M; Gibson, DL				Gorzelak, Monika A.; Gill, Sandeep K.; Tasnim, Nishat; Ahmadi-Vand, Zahra; Jay, Michael; Gibson, Deanna L.			Methods for Improving Human Gut Microbiome Data by Reducing Variability through Sample Processing and Storage of Stool	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; REAL-TIME PCR; INTESTINAL MICROBIOTA; LACTOBACILLUS; DIVERSITY; FECES; OBESE; FIRMICUTES; CHILDREN; SOIL	Gut microbiome community analysis is used to understand many diseases like inflammatory bowel disease, obesity, and diabetes. Sampling methods are an important consideration for human microbiome research, yet are not emphasized in many studies. In this study, we demonstrate that the preparation, handling, and storage of human faeces are critical processes that alter the outcomes of downstream DNA-based bacterial community analyses via qPCR. We found that stool subsampling resulted in large variability of gut microbiome data due to different microenvironments harbouring various taxa within an individual stool. However, we reduced intra-sample variability by homogenizing the entire stool sample in liquid nitrogen and subsampling from the resulting crushed powder prior to DNA extraction. We experimentally determined that the bacterial taxa varied with room temperature storage beyond 15 minutes and beyond three days storage in a domestic frost-free freezer. While freeze thawing only had an effect on bacterial taxa abundance beyond four cycles, the use of samples stored in RNAlater should be avoided as overall DNA yields were reduced as well as the detection of bacterial taxa. Overall we provide solutions for processing and storing human stool samples that reduce variability of microbiome data. We recommend that stool is frozen within 15 minutes of being defecated, stored in a domestic frost-free freezer for less than three days, and homogenized prior to DNA extraction. Adoption of these simple protocols will have a significant and positive impact on future human microbiome research.	[Gorzelak, Monika A.; Gill, Sandeep K.; Tasnim, Nishat; Ahmadi-Vand, Zahra; Jay, Michael; Gibson, Deanna L.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC V1V 1V7, Canada	University of British Columbia; University of British Columbia Okanagan	Gibson, DL (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC V1V 1V7, Canada.	deanna.gibson@ubc.ca	Tasnim, Nishat/AAV-6848-2020; Gibson, Deanna L/CAF-4166-2022	Tasnim, Nishat/0000-0002-9899-2014; Gibson, Deanna L/0000-0003-0052-7550; Gorzelak, Monika/0000-0002-4115-5282; Gill, Sandeep K/0000-0002-2117-1517	Natural Science and Engineering Research Council; Crohn's and Colitis Canada	Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Crohn's and Colitis Canada	N.T. was an I.K. Barber Undergraduate Research Awardee; S.K.G. was a Canadian Association of Gastroenterology Awardee and M.J. was a National Science and Engineering Research Council Awardee. This work was supported by grants funded through Natural Science and Engineering Research Council and Crohn's and Colitis Canada to D.L.G.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Chan YK, 2013, ANN NUTR METAB, V63, P28, DOI 10.1159/000354902; Costello EK, 2009, SCIENCE, P326; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Ferrer M, 2013, ENVIRON MICROBIOL, V15, P211, DOI 10.1111/j.1462-2920.2012.02845.x; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; McInnes P, 2010, MANUAL PROCEDURES 12; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Rose C, 2015, CRIT REV ENV SCI TEC, V45, P1827, DOI 10.1080/10643389.2014.1000761; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walker AW, 2013, SCIENCE, V341, P1069, DOI 10.1126/science.1243787; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Xu PR, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-283; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	36	142	146	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134802	10.1371/journal.pone.0134802	http://dx.doi.org/10.1371/journal.pone.0134802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252519	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100078
J	Harmer, CJ; Wynn, M; Pinto, R; Cordwell, S; Rose, BR; Harbour, C; Triccas, JA; Manos, J				Harmer, Christopher J.; Wynn, Matthew; Pinto, Rachel; Cordwell, Stuart; Rose, Barbara R.; Harbour, Colin; Triccas, James A.; Manos, Jim			Homogentisate 1-2-Dioxygenase Downregulation in the Chronic Persistence of Pseudomonas aeruginosa Australian Epidemic Strain-1 in the CF Lung	PLOS ONE			English	Article							CYSTIC-FIBROSIS SPUTUM; GENE-EXPRESSION; ANAEROBIC RESPIRATION; PULMONARY INFECTION; GROWTH; PATHOGENESIS; BIOFILMS; MUTANTS	Some Pseudomonas aeruginosa strains including Australian Epidemic Strain-1 (AES-1 or AUS-01) cause persistent chronic infection in cystic fibrosis (CF) patients, with greater morbidity and mortality. Factors conferring persistence are largely unknown. Previously we analysed the transcriptomes of AES-1 grown in Luria broth, nematode growth medium for Caenorhabditis elegans assay (both aerobic) and artificial sputum medium (mainly hypoxic). Transcriptional comparisons included chronic AES-1 strains against PAO1 and acute AES-1 (AES-1R) against its chronic isogen (AES-1M), isolated 10.5 years apart from a CF patient and not eradicated in the meantime. Prominent amongst genes downregulated in AES-1M in all comparisons was homogentisate-1-2-dioxygenase (hmgA); an oxygen-dependent gene known to be mutationally deactivated in many chronic infection strains of P. aeruginosa. To investigate if hmgA downregulation and deactivation gave similar virulence persistence profiles, a hmgA mutant made in UCBPP-PA14 utilising RedS-recombinase and AES-1M were assessed in the C. elegans virulence assay, and the C57BL/6 mouse for pulmonary colonisation and TNF-alpha response. In C. elegans, hmgA deactivation resulted in significantly increased PA14 virulence while hmgA downregulation reduced AES-1M virulence. AES-1M was significantly more persistent in mouse lung and showed a significant increase in TNF-alpha (p<0.0001), sustained even with no detectable bacteria. PA14 Delta hmgA did not show increased TNF-alpha. This study suggests that hmgA may have a role in P. aeruginosa persistence in chronic infection and the results provide a starting point for clarifying the role of hmgA in chronic AES-1.	[Harmer, Christopher J.; Wynn, Matthew; Rose, Barbara R.; Harbour, Colin; Manos, Jim] Univ Sydney, Dept Immunol & Infect Dis, Bacterial Pathogens Cyst Fibrosis Grp, Cent Clin Sch, Sydney, NSW 2006, Australia; [Harmer, Christopher J.; Cordwell, Stuart] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Pinto, Rachel; Triccas, James A.] Univ Sydney, Dept Immunol & Infect Dis, Microbial Pathogenesis & Immun Grp, Cent Clin Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Manos, J (corresponding author), Univ Sydney, Dept Immunol & Infect Dis, Bacterial Pathogens Cyst Fibrosis Grp, Cent Clin Sch, Sydney, NSW 2006, Australia.	jim.manos@sydney.edu.au	Wynn, Matthew/AAG-6807-2021; Triccas, Jamie/AAD-7629-2020; Harmer, Christopher/Z-2630-2019; Wynn, Matthew/T-7100-2018	Wynn, Matthew/0000-0002-6773-6325; Harmer, Christopher/0000-0003-1486-454X; Wynn, Matthew/0000-0002-6773-6325; Triccas, James/0000-0003-3730-2339; Cordwell, Stuart/0000-0002-0995-0171; Manos, Jim/0000-0002-5765-1563	Early Career Research Award from the University of Sydney [K9424-R5554]; project of the National Health and Medical Research Council of Australia (NHMRC) [632788]	Early Career Research Award from the University of Sydney; project of the National Health and Medical Research Council of Australia (NHMRC)	This study was funded by an Early Career Research Award to Dr. Manos from the University of Sydney (K9424-R5554) and by project grant #632788 of the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Armstrong D, 1999, PEDIAT PULMONOL S19, V28, P269; Herrera MC, 2010, ENVIRON MICROBIOL, V12, P1427, DOI 10.1111/j.1462-2920.2009.02124.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Corteling Randolph, 2002, BMC Pharmacology, V2, P1, DOI 10.1186/1471-2210-2-1; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Griffiths AL, 2012, J CYST FIBROS, V11, P49, DOI 10.1016/j.jcf.2011.08.005; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Harmer C, 2013, MICROBIOL-SGM, V159, P2354, DOI 10.1099/mic.0.066985-0; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Imlay JA, 2011, OXIDATIVE STRESS NIT; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; Naughton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024526; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Palmer GC, 2010, J BACTERIOL, V192, P2722, DOI 10.1128/JB.00112-10; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2007, J BACTERIOL, V189, P4449, DOI 10.1128/JB.00162-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Yates SP, 2004, BIOCHEM J, V379, P563, DOI 10.1042/BJ20031731; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	30	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134229	10.1371/journal.pone.0134229	http://dx.doi.org/10.1371/journal.pone.0134229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252386	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100044
J	Maddaloni, E; Lessan, N; Al Tikriti, A; Buzzetti, R; Pozzilli, P; Barakat, MT				Maddaloni, Ernesto; Lessan, Nader; Al Tikriti, Alia; Buzzetti, Raffaella; Pozzilli, Paolo; Barakat, Maha T.			Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement	PLOS ONE			English	Article							LADA; TYPE-1; AUTOANTIBODIES; PHENOTYPE; PATHOGENESIS; DIAGNOSIS	Aims To describe and to characterize clinical features of latent autoimmune diabetes in adults (LADA) compared to type 1 and type 2 diabetes in the UAE. Methods In this cross-sectional study a dataset including 18,101 subjects with adult-onset (>30 years) diabetes was accessed. 17,072 subjects fulfilled the inclusion/exclusion criteria. Data about anthropometrics, demographics, autoantibodies to Glutamic Acid Decarboxylase (GADA) and to Islet Antigen 2 (anti-IA2), HbA1c, cholesterol and blood pressure were extracted. LADA was diagnosed according to GADA and/or anti-IA2 positivity and time to insulin therapy. Results 437 (2.6%) patients were identified as LADA and 34 (0.2%) as classical type 1 diabetes in adults. Mean age at diagnosis, BMI, waist circumference, systolic blood pressure and HbA1c significantly differed between, LADA, type 2 and type 1 diabetes, LADA showing halfway features between type 2 and type 1 diabetes. A decreasing trend for age at diagnosis and waist circumference was found among LADA subjects when subdivided by positivity for anti-IA2, GADA or for both antibodies (p=0.013 and p=0.011 for trend, respectively). There was a gradual downward trend in autoantibody titre in LADA subjects requiring insulin within the first year from diagnosis to subjects not requiring insulin after 10 years of follow-up (p<0.001). Conclusions This is the first study describing the clinical features of LADA in the UAE, which appear to be different from both type 1 and type 2 diabetes. Furthermore, we showed that the clinical phenotype of LADA is dependent on different patterns of antibody positivity, influencing the time to insulin requirement.	[Maddaloni, Ernesto; Pozzilli, Paolo] Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy; [Lessan, Nader; Al Tikriti, Alia; Barakat, Maha T.] Imperial Coll London Diabet Ctr, Abu Dhabi, U Arab Emirates; [Buzzetti, Raffaella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Pozzilli, Paolo] Univ London, Barts & London Sch Med, Ctr Diabet, London, England	University Campus Bio-Medico - Rome Italy; Sapienza University Rome; University of London; Queen Mary University London	Maddaloni, E (corresponding author), Univ Campus Biomed, Dept Endocrinol & Diabet, Rome, Italy.	e.maddaloni@unicampus.it	Buzzetti, Raffaella/K-3090-2016; Maddaloni, Ernesto/N-1891-2014	Buzzetti, Raffaella/0000-0003-1490-6041; Maddaloni, Ernesto/0000-0003-3844-9463	Italian Ministry of University and Technological Research (MIUR); Centro Internazionale Studi Diabete (CISD)	Italian Ministry of University and Technological Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Centro Internazionale Studi Diabete (CISD)	This study was in part supported by Italian Ministry of University and Technological Research (MIUR) and by Centro Internazionale Studi Diabete (CISD).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Appel SJ, 2009, J AM ACAD NURSE PRAC, V21, P156, DOI 10.1111/j.1745-7599.2009.00399.x; Blaslov K, 2015, ENDOCRINE, V48, P551, DOI 10.1007/s12020-014-0331-x; Buzzetti R, 2007, DIABETES CARE, V30, P932, DOI 10.2337/dc06-1696; Desai M, 2008, DIABETIC MED, V25, P30, DOI 10.1111/j.1464-5491.2008.02497.x; Desai M, 2007, DIABETOLOGIA, V50, P2052, DOI 10.1007/s00125-007-0745-6; Fourlanos S, 2005, DIABETOLOGIA, V48, P2206, DOI 10.1007/s00125-005-1960-7; Genovese S, 2006, EUR J ENDOCRINOL, V154, P441, DOI 10.1530/eje.1.02115; Guglielmi C, 2012, DIABETES-METAB RES, V28, P40, DOI 10.1002/dmrr.2345; Hawa MI, 2013, DIABETES CARE, V36, P908, DOI 10.2337/dc12-0931; Hawa MI, 2009, DIABETES CARE, V32, P160, DOI 10.2337/dc08-1419; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Lampasona V, 2010, DIABETES CARE, V33, P104, DOI 10.2337/dc08-2305; Leslie RDG, 2008, DIABETES-METAB RES, V24, P511, DOI 10.1002/dmrr.877; Leslie RDG, 2006, J CLIN ENDOCR METAB, V91, P1654, DOI 10.1210/jc.2005-1623; Maddaloni E, 2014, ENDOCRINE, V46, P3, DOI 10.1007/s12020-013-0128-3; Maioli M, 2010, EUR J ENDOCRINOL, V163, P541, DOI 10.1530/EJE-10-0427; Maruyama T, 2008, J CLIN ENDOCR METAB, V93, P2115, DOI 10.1210/jc.2007-2267; Mollo A, 2013, DIABETES-METAB RES, V29, P446, DOI 10.1002/dmrr.2411; Naik RG, 2009, J CLIN ENDOCR METAB, V94, P4635, DOI 10.1210/jc.2009-1120; Nambam B, 2010, WORLD J DIABETES, V1, P111, DOI 10.4239/wjd.v1.i4.111; Pham MN, 2011, DIABETOLOGIA, V54, P1630, DOI 10.1007/s00125-011-2088-6; Pozzilli P, 2001, DIABETES CARE, V24, P1460, DOI 10.2337/diacare.24.8.1460; Radtke MA, 2009, DIABETES CARE, V32, P245, DOI 10.2337/dc08-1468; Redondo MJ, 2013, DIABETES, V62, P339, DOI 10.2337/db12-1171; Strom A, 2012, CYTOKINE, V58, P148, DOI 10.1016/j.cyto.2012.01.002; Tuomi T, 1999, DIABETES, V48, P150, DOI 10.2337/diabetes.48.1.150; Zhou ZG, 2013, DIABETES, V62, P543, DOI 10.2337/db12-0207; ZIMMET PZ, 1995, DIABETES CARE, V18, P1050, DOI 10.2337/diacare.18.7.1050	30	55	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0131837	10.1371/journal.pone.0131837	http://dx.doi.org/10.1371/journal.pone.0131837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252955	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100009
J	Zanetti, D; Carreras-Torres, R; Esteban, E; Via, M; Moral, P				Zanetti, Daniela; Carreras-Torres, Robert; Esteban, Esther; Via, Marc; Moral, Pedro			Potential Signals of Natural Selection in the Top Risk Loci for Coronary Artery Disease: 9p21 and 10q11	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECENT POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCI; HAPLOTYPE BLOCKS; GENETICS; SNPS; ATHEROSCLEROSIS; REPLICATION; FREQUENCIES	Background Coronary artery disease (CAD) is a complex disease and the leading cause of death in the world. Populations of different ancestry do not always share the same risk markers. Natural selective processes may be the cause of some of the population differences detected for specific risk mutations. Objective In this study, 384 single nucleotide polymorphisms (SNPs) located in four genomic regions associated with CAD (1p13, 1q41, 9p21 and 10q11) are analysed in a set of 19 populations from Europe, Middle East and North Africa and also in Asian and African samples from the 1000 Genomes Project. The aim of this survey is to explore for the first time whether the genetic variability in these genomic regions is better explained by demography or by natural selection. Results The results indicate significant differences in the structure of genetic variation and in the LD patterns among populations that probably explain the population disparities found in markers of susceptibility to CAD. Conclusions The results are consistent with potential signature of positive selection in the 9p21 region and of balancing selection in the 9p21 and 10q11. Specifically, in Europe three CAD risk markers in the 9p21 region (rs9632884, rs1537371 and rs1333042) show consistent signals of positive selection. The results of this study are consistent with a potential selective role of CAD in the configuration of genetic diversity in current human populations.	[Zanetti, Daniela; Carreras-Torres, Robert; Esteban, Esther; Moral, Pedro] Univ Barcelona, Dept Anim Biol Anthropol, Barcelona, Spain; [Via, Marc] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Via, Marc] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Esteban, Esther; Moral, Pedro] Univ Barcelona, Biodivers Res Inst, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona	Moral, P (corresponding author), Univ Barcelona, Dept Anim Biol Anthropol, Barcelona, Spain.	pmoral@ub.edu	Zanetti, Daniela/AAF-2297-2020; Esteban, M. Esther/K-9900-2014; Via, Marc/L-6511-2014; Carreras-Torres, Robert/E-3887-2019; Moral, Pedro/K-9587-2014	Zanetti, Daniela/0000-0002-1225-1021; Esteban, M. Esther/0000-0002-2410-9700; Via, Marc/0000-0002-9966-9921; Carreras-Torres, Robert/0000-0002-2925-734X; Moral, Pedro/0000-0001-5072-5892	Ministerio de de Ciencia e Innovacion [CGL2011-27866]; MasterBack Grant [AF-DR-A2011B-48666-25399/2011]	Ministerio de de Ciencia e Innovacion; MasterBack Grant	This research has been supported by the Ministerio de de Ciencia e Innovacion CGL2011-27866 project to PM, and the Master&Back Grant (AF-DR-A2011B-48666-25399/2011) to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Athanasiadis G, 2013, J HUM GENET, V58, P762, DOI 10.1038/jhg.2013.94; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Carreras-Torres R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096504; Casto AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001266; Corona E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012236; Dichgans M, 2014, STROKE, V45, P24, DOI 10.1161/STROKEAHA.113.002707; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Ding KY, 2009, CIRCULATION, V119, P459, DOI 10.1161/CIRCULATIONAHA.108.809970; Disotell TR, 2012, AM J PHYS ANTHROPOL, V149, P24, DOI 10.1002/ajpa.22159; Emanuele E, 2011, NEUROBIOL AGING, V32, P1231, DOI 10.1016/j.neurobiolaging.2009.07.003; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gu S, 2005, BIOINFORMATICS, V21, P3938, DOI 10.1093/bioinformatics/bti649; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Heckman MG, 2013, EUR J NEUROL, V20, P300, DOI 10.1111/j.1468-1331.2012.03846.x; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lao O, 2008, ANN HUM GENET, V72, P48, DOI 10.1111/j.1469-1809.2007.00387.x; Larson MG, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S5; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li WQ, 2014, CARCINOGENESIS, V35, P2698, DOI 10.1093/carcin/bgu203; Li XC, 2013, ATHEROSCLEROSIS, V231, P136, DOI 10.1016/j.atherosclerosis.2013.08.031; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Munir MS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-66; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prins BP, 2012, ATHEROSCLEROSIS, V225, P1, DOI 10.1016/j.atherosclerosis.2012.05.015; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2014, NUCLEIC ACIDS RES, V42, pD903, DOI 10.1093/nar/gkt1188; R Core Team, 2021, R LANGUAGE ENV STAT; Relethford JH, 2008, AM J PHYS ANTHROPOL, V136, P1, DOI 10.1002/ajpa.20789; Roberts Robert, 2014, Methodist Debakey Cardiovasc J, V10, P7; Roberts R, 2012, J AM COLL CARDIOL, V60, P1715, DOI 10.1016/j.jacc.2011.12.062; Esparragon FR, 2012, DIS MARKERS, V32, P231, DOI [10.3233/DMA-2011-0879, 10.1155/2012/908642]; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stengard JH, 1998, HUM GENET, V103, P234, DOI 10.1007/s004390050811; TAJIMA F, 1989, GENETICS, V123, P585; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Trompet S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-131; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285; Zanetti D, 2015, J EPIDEMIOLOGY UNPUB; Zanetti D, 2014, HUM BIOL, V86, P131, DOI 10.3378/027.086.0201	67	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134840	10.1371/journal.pone.0134840	http://dx.doi.org/10.1371/journal.pone.0134840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252781	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100080
J	Frye, SA; Lang, E; Beyene, GT; Balasingham, SV; Homberset, H; Rowe, AD; Ambur, OH; Tonjum, T				Frye, Stephan A.; Lang, Emma; Beyene, Getachew Tesfaye; Balasingham, Seetha V.; Homberset, Havard; Rowe, Alexander D.; Ambur, Ole Herman; Tonjum, Tone			The Inner Membrane Protein PilG Interacts with DNA and the Secretin PilQ in Transformation	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; COMPETENT BACILLUS-SUBTILIS; NEISSERIA-MENINGITIDIS; NATURAL TRANSFORMATION; STRUCTURE PREDICTION; GENOME DYNAMICS; BINDING PROTEINS; IV PILIN; GONORRHOEAE; BIOGENESIS	Expression of type IV pili (Tfp), filamentous appendages emanating from the bacterial surface, is indispensable for efficient neisserial transformation. Tfp pass through the secretin pore consisting of the membrane protein PilQ. PilG is a polytopic membrane protein, conserved in Gram-positive and Gram-negative bacteria, that is required for the biogenesis of neisserial Tfp. PilG null mutants are devoid of pili and non-competent for transformation. Here, recombinant full-length, truncated and mutated variants of meningococcal PilG were overexpressed, purified and characterized. We report that meningococcal PilG directly binds DNA in vitro, detected by both an electromobility shift analysis and a solid phase overlay assay. PilG DNA binding activity was independent of the presence of the consensus DNA uptake sequence. PilG-mediated DNA binding affinity was mapped to the N-terminus and was inactivated by mutation of residues 43 to 45. Notably, reduced meningococcal transformation of DNA in vivo was observed when PilG residues 43 to 45 were substituted by alanine in situ, defining a biologically significant DNA binding domain. N-terminal PilG also interacted with the N-terminal region of PilQ, which previously was shown to bind DNA. Collectively, these data suggest that PilG and PilQ in concert bind DNA during Tfp-mediated transformation.	[Frye, Stephan A.; Lang, Emma; Beyene, Getachew Tesfaye; Balasingham, Seetha V.; Rowe, Alexander D.; Ambur, Ole Herman; Tonjum, Tone] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Homberset, Havard; Tonjum, Tone] Univ Oslo, Dept Microbiol, Oslo, Norway	University of Oslo; University of Oslo	Frye, SA (corresponding author), Oslo Univ Hosp, Dept Microbiol, Oslo, Norway.	stephanf@labmed.uio.no	Ambur, Ole Herman/O-5342-2019; Tønjum, Tone/J-4581-2014; Ambur, Ole/G-6641-2016	Ambur, Ole Herman/0000-0001-9870-6375; Ambur, Ole/0000-0001-9870-6375; Frye, Stephan/0000-0002-0786-8481; Tonjum, Tone/0000-0002-1709-6921	Research Council of Norway FRIMEDBIO grant [177785]; Centre of Excellence grant [146494]	Research Council of Norway FRIMEDBIO grant; Centre of Excellence grant	This work was funded by the Research Council of Norway FRIMEDBIO grant no. 177785 and the Centre of Excellence grant no. 146494 for the Centre for Molecular Biology and Neuroscience (CMBN) to TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Arts J, 2007, MICROBIOL-SGM, V153, P1582, DOI 10.1099/mic.0.2006/002840-0; Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benam AV, 2011, MICROBIOL-SGM, V157, P1329, DOI 10.1099/mic.0.046896-0; Berry JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004014; BLAKE MS, 1989, J EXP MED, V170, P1727, DOI 10.1084/jem.170.5.1727; Blank TE, 2001, J BACTERIOL, V183, P4435, DOI 10.1128/JB.183.15.4435-4450.2001; Brinton C., 1978, IMMUNOBIOLOGY NEISER, P155; Buratowski S, 1996, CURR PROT MOL BIOL; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chen I, 2001, J BACTERIOL, V183, P3160, DOI 10.1128/JB.183.10.3160-3168.2001; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Crowther LJ, 2004, MOL MICROBIOL, V52, P67, DOI 10.1111/j.1365-2958.2003.03963.x; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Davidsen T, 2007, NEUROSCIENCE, V145, P1375, DOI 10.1016/j.neuroscience.2007.01.059; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; FACIUS D, 1993, MOL MICROBIOL, V10, P699, DOI 10.1111/j.1365-2958.1993.tb00942.x; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Forest KT, 2004, ACTA CRYSTALLOGR D, V60, P978, DOI 10.1107/S0907444904006055; FRASCH CE, 1972, INFECT IMMUN, V5, P98, DOI 10.1128/IAI.5.1.98-102.1972; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; Frye SA, 2013, LOS GENETICS, V9, DOI [10.1371/journal.pgen.1003458, DOI 10.1371/JOURNAL.PGEN.1003458]; Frye SA, 2006, MICROBIOL-SGM, V152, P3751, DOI 10.1099/mic.0.2006/000315-0; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Gangel H, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004043; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kidane D, 2005, CELL, V122, P73, DOI 10.1016/j.cell.2005.04.036; Kroll JS, 1998, P NATL ACAD SCI USA, V95, P12381, DOI 10.1073/pnas.95.21.12381; Lang E, 2009, MICROBIOL-SGM, V155, P852, DOI 10.1099/mic.0.022640-0; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Maniatis T., 1982, MOL CLONING; MASSON L, 1983, J BACTERIOL, V154, P728, DOI 10.1128/JB.154.2.728-736.1983; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Qiagen,, 2003, QIAEXPRESSIONIST HDB; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tibballs KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-7; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	73	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134954	10.1371/journal.pone.0134954	http://dx.doi.org/10.1371/journal.pone.0134954			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248334	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300081
J	Gutierrez, J; Droppelmann, CA; Contreras, O; Takahashi, C; Brandan, E				Gutierrez, Jaime; Droppelmann, Cristian A.; Contreras, Osvaldo; Takahashi, Chiaki; Brandan, Enrique			RECK-Mediated beta 1-Integrin Regulation by TGF-beta 1 Is Critical for Wound Contraction in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SKELETAL-MUSCLE DIFFERENTIATION; TGF-BETA; EXTRACELLULAR-MATRIX; TISSUE-REPAIR; CANCER CELLS; METALLOPROTEINASE REGULATOR; FIBROTIC RESPONSE; FOCAL ADHESIONS; FIBROBLASTS	Fibroblasts are critical for wound contraction; a pivotal step in wound healing. They produce and modify the extracellular matrix (ECM) required for the proper tissue remodeling. Reversion-inducing cysteine-rich protein with Kazal motifs (RECK) is a key regulator of ECM homeostasis and turnover. However, its role in wound contraction is presently unknown. Here we describe that Transforming growth factor type beta 1 (TGF-beta 1), one of the main profibrotic wound-healing promoting factors, decreases RECK expression in fibroblasts through the Smad and JNK dependent pathways. This TGF-beta 1 dependent downregulation of RECK occurs with the concomitant increase of beta 1-integrin, which is required for fibroblasts adhesion and wound contraction through the activation of focal adhesion kinase (FAK). Loss and gain RECK expression experiments performed in different types of fibroblasts indicate that RECK downregulation mediates TGF-beta 1 dependent beta 1-integrin expression. Also, reduced levels of RECK potentiate TGF-beta 1 effects over fibroblasts FAK-dependent contraction, without affecting its cognate signaling. The above results were confirmed on fibroblasts derived from the Reck(+/-) mice compared to wild type-derived fibroblasts. We observed that Reck(+/-) mice heal dermal wounds more efficiently than wild type mice. Our results reveal a critical role for RECK in skin wound contraction as a key mediator in the axis: TGF-beta 1-RECK-beta 1-integrin.	[Gutierrez, Jaime] Univ San Sebastian, Fac Hlth Sci, Sch Med Technol, Cellular Signaling & Differentiat Lab, Santiago, Chile; [Gutierrez, Jaime; Droppelmann, Cristian A.; Contreras, Osvaldo; Brandan, Enrique] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Ctr Regenerac & Envejecimiento CARE, Santiago, Chile; [Droppelmann, Cristian A.] Univ Western Ontario, Robarts Res Inst, Mol Med Grp, London, ON, Canada; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Canc & Stem Cell Res Program, Oncol & Mol Biol, Kanazawa, Ishikawa 920, Japan	Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Western University (University of Western Ontario); Kanazawa University	Gutierrez, J (corresponding author), Univ San Sebastian, Fac Hlth Sci, Sch Med Technol, Cellular Signaling & Differentiat Lab, Santiago, Chile.	jaime.gutierrez@uss.cl; ebrandan@bio.puc.cl	Contreras, Osvaldo/O-4518-2019; Brandan, Enrique/A-7063-2017	Contreras, Osvaldo/0000-0002-8722-9371; Brandan, Enrique/0000-0002-6820-5059	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [11110010]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile [79090027, CARE-PFB-12/2007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) (grant number 11110010), Chile (JG), and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) (grant number 79090027 and CARE-PFB-12/2007), Chile (EB). OC holds a CONICYT-PhD (Chile) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge P, 2013, J WOUND CARE, V22, P407; Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488; Chandana EPS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-84; Clark JCM, 2007, CANCER METAST REV, V26, P675, DOI 10.1007/s10555-007-9093-8; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dogic D, 1999, CURR TOPICS PATHOL, V93, P75; Drobic V, 2007, AM J PHYSIOL-HEART C, V293, pH1053, DOI 10.1152/ajpheart.00935.2006; Droguett R, 2010, EXP CELL RES, V316, P2487, DOI 10.1016/j.yexcr.2010.04.031; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Gomes LR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-26; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Hatta M, 2009, CELL SIGNAL, V21, P1885, DOI 10.1016/j.cellsig.2009.08.005; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Hong KJ, 2014, J CELL PHYSIOL, V229, P191, DOI 10.1002/jcp.24434; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kim NY, 2008, MOL CELLS, V25, P105; Kocic J, 2012, EUR J CANCER, V48, P1550, DOI 10.1016/j.ejca.2011.06.043; Leask A, 2013, ADV WOUND CARE, V2, P247, DOI 10.1089/wound.2012.0363; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee H, 2008, J CELL BIOCHEM, V104, P1065, DOI 10.1002/jcb.21692; Li B, 2011, J TISSUE VIABILITY, V20, P108, DOI 10.1016/j.jtv.2009.11.004; Liu LT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/137049; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng N, 2008, HISTOL HISTOPATHOL, V23, P1003, DOI 10.14670/HH-23.1003; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; Midwood KS, 2006, J INVEST DERM SYMP P, V11, P73, DOI 10.1038/sj.jidsymp.5650005; Miki T, 2010, MOL CANCER RES, V8, P665, DOI 10.1158/1541-7786.MCR-09-0351; Morioka Y, 2009, ONCOGENE, V28, P1454, DOI 10.1038/onc.2008.486; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Park S, 2013, SCIENCE, V339, P324, DOI 10.1126/science.1231921; Romana-Souza B, 2014, INT J EXP PATHOL, V95, P330, DOI 10.1111/iep.12093; Rustad KC, 2013, DIFFERENTIATION, V86, P87, DOI 10.1016/j.diff.2013.02.003; Correa TCS, 2010, J CELL BIOCHEM, V110, P52, DOI 10.1002/jcb.22472; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; Stawowy P, 2004, CARDIOVASC RES, V63, P87, DOI 10.1016/j.cardiores.2004.03.010; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yuki K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04568; Zanotti S, 2013, EUR J ENDOCRINOL, V168, pR95, DOI 10.1530/EJE-13-0115	58	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135005	10.1371/journal.pone.0135005	http://dx.doi.org/10.1371/journal.pone.0135005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247610	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300085
J	Islam, A; Ghimbovschi, S; Zhai, M; Swift, JM				Islam, Aminul; Ghimbovschi, Svetlana; Zhai, Min; Swift, Joshua M.			An Exploration of Molecular Correlates Relevant to Radiation Combined Skin-Burn Trauma	PLOS ONE			English	Article							IONIZING-RADIATION; BIODOSIMETRY APPLICATIONS; CIRCULATING MICRORNAS; BIOMARKERS; CELLS; EXOSOMES; INJURY; EXPRESSION; DISEASES; IDENTIFICATION	Background Exposure to high dose radiation in combination with physical injuries such as burn or wound trauma can produce a more harmful set of medical complications requiring specialist interventions. Currently these interventions are unavailable as are the precise biomarkers needed to help both accurately assess and treat such conditions. In the present study, we tried to identify and explore the possible role of serum exosome microRNA (miRNA) signatures as potential biomarkers for radiation combined burn injury (RCBI). Methodology Female B6D2F1/J mice were assigned to four experimental groups (n = 6): sham control (SHAM), burn injury (BURN), radiation injury (RI) and combined radiation skin burn injury (CI). We performed serum multiplex cytokine analysis and serum exosome miRNA expression profiling to determine novel miRNA signatures and important biological pathways associated with radiation combined skin-burn trauma. Principal Findings Serum cytokines, IL-5 and MCP-1, were significantly induced only in CI mice (p<0.05). From 890 differentially expressed miRNAs identified, microarray analysis showed 47 distinct miRNA seed sequences significantly associated with CI mice compared to SHAM control mice (fold change >= 1.2, p<0.05). Furthermore, only two major miRNA seed sequences (miR-690 and miR-223) were validated to be differentially expressed for CI mice specifically (fold change >= 1.5, p<0.05). Conclusions Serum exosome miRNA signature data of adult mice, following RCBI, provides new insights into the molecular and biochemical pathways associated with radiation combined skin-burn trauma in vivo.	[Islam, Aminul; Zhai, Min] Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA; [Ghimbovschi, Svetlana] Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC 20010 USA; [Swift, Joshua M.] Naval Med Res Ctr, Undersea Med Dept, Silver Spring, MD USA	United States Department of Defense; Children's National Health System; Naval Medical Research Center (NMRC)	Islam, A (corresponding author), Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20889 USA.	aminul.islam.ctr@usuhs.edu			NIH Radiation and Nuclear Countermeasures Award [64248-DO-0045-AFRRI-NIAID]; Core Molecular and Functional Outcome Measures in Rehabilitation Medicine Grant [5R24 HDO50846-09 NCMRR-DC]	NIH Radiation and Nuclear Countermeasures Award; Core Molecular and Functional Outcome Measures in Rehabilitation Medicine Grant	This work was supported by NIH Radiation and Nuclear Countermeasures Award 64248-DO-0045-AFRRI-NIAID. All microarray experiments were performed in the Genomics Core of the Children's National Medical Center which is supported in part by Core Molecular and Functional Outcome Measures in Rehabilitation Medicine Grant 5R24 HDO50846-09 NCMRR-DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Alevizos I, 2010, AUTOIMMUN REV, V9, P618, DOI 10.1016/j.autrev.2010.05.009; Alevizos I, 2010, NAT REV RHEUMATOL, V6, P391, DOI 10.1038/nrrheum.2010.81; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2013, ISO ASTM INTERNATION; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Dov IZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086856; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cowan Matthew L, 2008, Expert Rev Proteomics, V5, P21, DOI 10.1586/14789450.5.1.21; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; DiCarlo AL, 2010, HEALTH PHYS, V98, P863, DOI 10.1097/HP.0b013e3181a6ee32; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Halimi M, 2014, TRANSL RES, V163, P578, DOI 10.1016/j.trsl.2014.01.009; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; HENNEBERG R, 1975, BRIT J CANCER, V32, P765, DOI 10.1038/bjc.1975.336; Islam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072258; Jacob NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057603; Jacobs LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080844; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Lau P, 2010, BRAIN RES, V1338, P14, DOI 10.1016/j.brainres.2010.04.002; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lhakhang TW, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/569731; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Lovendorf MB, 2014, J DERMATOL SCI, V75, P133, DOI 10.1016/j.jdermsci.2014.05.005; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Phoonsawat W, 2014, BIOCHEM BIOPH RES CO, V448, P261, DOI 10.1016/j.bbrc.2014.04.114; Phua LC, 2014, ONCOL REP, V32, P97, DOI 10.3892/or.2014.3193; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Scholl V, 2012, LEUKEMIA RES, V36, P119, DOI 10.1016/j.leukres.2011.08.023; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Templin T, 2012, INT J RADIAT BIOL, V88, P531, DOI 10.3109/09553002.2012.690549; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-77; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Wen T, 2014, J IMMUNOL, V192, P5481, DOI 10.4049/jimmunol.1302846; Wong JJL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-42; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	55	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134827	10.1371/journal.pone.0134827	http://dx.doi.org/10.1371/journal.pone.0134827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247844	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300067
J	Narukawa, H; Yokoyama, R; Komaki, S; Sugimoto, K; Nishitani, K				Narukawa, Hideki; Yokoyama, Ryusuke; Komaki, Shinichiro; Sugimoto, Keiko; Nishitani, Kazuhiko			Stimulation of Cell Elongation by Tetraploidy in Hypocotyls of Dark-Grown Arabidopsis Seedlings	PLOS ONE			English	Article							CUTICULAR LIPID-COMPOSITION; GENE; ENDOREDUPLICATION; NUMBER; SIZE; ENDOREPLICATION; TRANSCRIPTION; POLYPLOIDY; EXPORT	Plant size is largely determined by the size of individual cells. A number of studies showed a link between ploidy and cell size in land plants, but this link remains controversial. In this study, post-germination growth, which occurs entirely by cell elongation, was examined in diploid and autotetraploid hypocotyls of Arabidopsis thaliana (L.) Heynh. Final hypocotyl length was longer in tetraploid plants than in diploid plants, particularly when seedlings were grown in the dark. The longer hypocotyl in the tetraploid seedlings developed as a result of enhanced cell elongation rather than by an increase in cell number. DNA microarray analysis showed that genes involved in the transport of cuticle precursors were downregulated in a defined region of the tetraploid hypocotyl when compared to the diploid hypocotyl. Cuticle permeability, as assessed by toluidine-blue staining, and cuticular structure, as visualized by electron microscopy, were altered in tetraploid plants. Taken together, these data indicate that promotion of cell elongation is responsible for ploidy-dependent size determination in the Arabidopsis hypocotyl, and that this process is directly or indirectly related to cuticular function.	[Narukawa, Hideki; Yokoyama, Ryusuke; Nishitani, Kazuhiko] Tohoku Univ, Grad Sch Life Sci, Lab Plant Cell Wall Biol, Sendai, Miyagi 980, Japan; [Komaki, Shinichiro; Sugimoto, Keiko] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan	Tohoku University; RIKEN	Nishitani, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Plant Cell Wall Biol, Sendai, Miyagi 980, Japan.	nishitan@m.tohoku.ac.jp	Sugimoto, Keiko/B-3368-2010; Komaki, Shinichiro/Z-1144-2019	Sugimoto, Keiko/0000-0002-9209-8230; Yokoyama, Ryusuke/0000-0003-0326-0433; Nishitani, Kazuhiko/0000-0002-0073-9564; Narukawa, Hideki/0000-0002-8013-4097	Ministry of Education, Culture, Sports, Science and Technology of Japan [24114001, 24114005]; Grants-in-Aid for Scientific Research [24114001, 24114005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area, 'Plant cell wall as information-processing system' (grant numbers 24114001 and 24114005) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to KN (http://www.jsps.go.jp/english/e-grants/grants01.html).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bourdon M, 2012, DEVELOPMENT, V139, P3817, DOI 10.1242/dev.084053; Braidwood L, 2014, NEW PHYTOL, V201, P388, DOI 10.1111/nph.12473; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Chen XB, 2003, PLANT CELL, V15, P1170, DOI 10.1105/tpc.010926; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Doonan J, 2000, CURR OPIN PLANT BIOL, V3, P482, DOI 10.1016/S1369-5266(00)00117-5; Gendreau E, 1998, PLANT J, V13, P221, DOI 10.1046/j.1365-313X.1998.00030.x; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Go YS, 2014, PLANT CELL, V26, P1666, DOI 10.1105/tpc.114.123307; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Hayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02723; Horiguchi Gorou, 2011, Front Plant Sci, V2, P24, DOI 10.3389/fpls.2011.00024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iwamoto A, 2006, J PLANT RES, V119, P85, DOI 10.1007/s10265-005-0247-x; Kim H, 2012, PLANT CELL PHYSIOL, V53, P1391, DOI 10.1093/pcp/pcs083; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; Li XD, 2012, PLANTA, V236, P579, DOI 10.1007/s00425-012-1629-7; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnittger A, 2003, PLANT CELL, V15, P303, DOI 10.1105/tpc.008342; Stamm P, 2010, J EXP BOT, V61, P2889, DOI 10.1093/jxb/erq147; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tanaka T, 2004, PLANT J, V37, P139, DOI 10.1046/j.1365-313X.2003.01946.x; Tsukaya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083729; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Yu Z, 2009, THEOR APPL GENET, V118, P1107, DOI 10.1007/s00122-009-0966-9	38	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134547	10.1371/journal.pone.0134547	http://dx.doi.org/10.1371/journal.pone.0134547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244498	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400088
J	Yuan, LH; Geiser, F; Lin, BF; Sun, HB; Chen, JP; Zhang, SY				Yuan, Lihong; Geiser, Fritz; Lin, Benfu; Sun, Haibo; Chen, Jinping; Zhang, Shuyi			Down but Not Out: The Role of MicroRNAs in Hibernating Bats	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; GROUND-SQUIRRELS; MAMMALIAN HIBERNATION; MATURE MICRORNAS; BRAIN; HEART; IDENTIFICATION; METABOLISM; MODULATION; GENERATION	MicroRNAs (miRNAs) regulate many physiological processes through post-transcriptional control of gene expression and are a major part of the small noncoding RNAs (snRNA). As hibernators can survive at low body temperatures (T-b) for many months without suffering tissue damage, understanding the mechanisms that enable them to do so are of medical interest. Because the brain integrates peripheral physiology and white adipose tissue (WAT) is the primary energy source during hibernation, we hypothesized that both of these organs play a crucial role in hibernation, and thus, their activity would be relatively increased during hibernation. We carried out the first genomic analysis of small RNAs, specifically miRNAs, in the brain and WAT of a hibernating bat (Myotis ricketti) by comparing deeply torpid with euthermic individual bats using high-throughput sequencing (Solexa) and qPCR validation of expression levels. A total of 196 miRNAs (including 77 novel bat-specific miRNAs) were identified, and of these, 49 miRNAs showed significant differences in expression during hibernation, including 33 in the brain and 25 in WAT (P <= 0.01 & vertical bar logFC vertical bar >= 1). Stem-loop qPCR confirmed the miRNA expression patterns identified by Solexa sequencing. Moreover, 31 miRNAs showed tissue-or state-specific expression, and six miRNAs with counts > 100 were specifically expressed in the brain. Putative target gene prediction combined with KEGG pathway and GO annotation showed that many essential processes of both organs are significantly correlated with differentially expressed miRNAs during bat hibernation. This is especially evident with down-regulated miRNAs, indicating that many physiological pathways are altered during hibernation. Thus, our novel findings of miRNAs and Interspersed Elements in a hibernating bat suggest that brain and WAT are active with respect to the miRNA expression activity during hibernation.	[Yuan, Lihong; Chen, Jinping] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Yuan, Lihong; Chen, Jinping] Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Yuan, Lihong; Chen, Jinping] Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China; [Geiser, Fritz] Univ New England, Ctr Behav & Physiol Ecol, Zool, Armidale, NSW, Australia; [Lin, Benfu] Anim Husb & Vet Bur Huadu Dist, Guangzhou, Guangdong, Peoples R China; [Sun, Haibo] MininGene Biotechnol Co Ltd, Beijing, Peoples R China; [Zhang, Shuyi] E China Normal Univ, Inst Adv Interdisciplinary Res, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; University of New England; East China Normal University	Yuan, LH (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	yuanlh@gdei.gd.cn; chenjp@gdei.gd.cn; syzhang@bio.ecnu.edu.cn	Geiser, Fritz/O-4175-2018	Geiser, Fritz/0000-0001-7621-5049; Yuan, Lihong/0000-0002-8752-0572	Key Construction Program of the National "985" Project; National Natural Science Fund of China [31301012]; Guangzhou Pearl River Scientific and Technological New Star Project [2012J2200003]; Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences [rcjj201402]; Chinese Academy of Sciences; MininGene Biotechnology Co. Ltd	Key Construction Program of the National "985" Project; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Guangzhou Pearl River Scientific and Technological New Star Project; Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); MininGene Biotechnology Co. Ltd	This work was funded by grants awarded to SY Zhang under the Key Construction Program of the National "985" Project and to LH Yuan under the National Natural Science Fund of China (31301012). LH Yuan is also supported by the Guangzhou Pearl River Scientific and Technological New Star Project (2012J2200003), and Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences (rcjj201402). JP Chen is supported by the Program for Innovative Research Team of Cross-discipline and cooperation from Chinese Academy of Sciences. The authors confirm that MininGene Biotechnology Co. Ltd provided support in the form of salaries for author (HBS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Andrews MT, 1998, P NATL ACAD SCI USA, V95, P8392, DOI 10.1073/pnas.95.14.8392; Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biggar KK, 2010, J MOL CELL BIOL; Biggar KK, 2014, GENE, V544, P67, DOI 10.1016/j.gene.2014.04.048; Biggar KK, 2011, ANAL BIOCHEM, V416, P231, DOI 10.1016/j.ab.2011.05.015; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chen J, 2006, DIABETOLOGIA, V49, P1292, DOI 10.1007/s00125-006-0194-7; Chen JP, 2008, COMP BIOCHEM PHYS B, V149, P388, DOI 10.1016/j.cbpb.2007.10.011; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; DARK J, 1990, BRAIN RES, V509, P111, DOI 10.1016/0006-8993(90)90316-4; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Fahlman A, 2000, CRYOBIOLOGY, V40, P332, DOI 10.1006/cryo.2000.2254; Florant GL, 1998, AM ZOOL, V38, P331; Fragkouli A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00182; Frerichs KU, 1999, ACT NEUR S, V73, P57; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Green CD, 2001, J IMMUNOL METHODS, V250, P67, DOI 10.1016/S0022-1759(01)00306-4; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hartig G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01756; Hittel DS, 2002, J EXP BIOL, V205, P1625; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kishore S, 2011, RECEPT SER, P413, DOI 10.1007/978-1-60761-941-3_21; Kornfeld Samantha F., 2012, Genomics Proteomics & Bioinformatics, V10, P295, DOI 10.1016/j.gpb.2012.09.001; Lang-Ouellette D, 2014, MOL CELL BIOCHEM, V394, P291, DOI 10.1007/s11010-014-2105-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107746; Li M, 2014, AM J RESP CRIT CARE, V189, pA3986; Lin BF, 2012, CHINESE SCI BULL, V57, P877, DOI 10.1007/s11434-011-4862-8; Liu YT, 2010, PHYSIOL GENOMICS, V42A, P39, DOI 10.1152/physiolgenomics.00054.2010; Lyons PJ, 2013, COMP BIOCHEM PHYS D, V8, P358, DOI 10.1016/j.cbd.2013.10.001; Maistrovski Y, 2012, J COMP PHYSIOL B, V182, P849, DOI 10.1007/s00360-012-0662-y; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morin PJ, 2008, BBA-GENE REGUL MECH, V1779, P628, DOI 10.1016/j.bbagrm.2008.07.011; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ohshima Kazuhiko, 2013, Int J Evol Biol, V2013, P424726, DOI 10.1155/2013/424726; PAKHOTIN PI, 1993, PROG NEUROBIOL, V40, P123, DOI 10.1016/0301-0082(93)90021-J; Pan YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062039; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Williams DR, 2005, PHYSIOL GENOMICS, V24, P13, DOI 10.1152/physiolgenomics.00301.2004; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005; Yan J, 2008, PHYSIOL GENOMICS, V32, P170, DOI 10.1152/physiolgenomics.00075.2007; Yuan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027189; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang L, 2013, CANCER RES, V73, P6435, DOI 10.1158/0008-5472.CAN-12-3308; Zhu TT, 2014, GEN COMP ENDOCR, V204, P80, DOI 10.1016/j.ygcen.2014.04.028	68	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135064	10.1371/journal.pone.0135064	http://dx.doi.org/10.1371/journal.pone.0135064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244645	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400139
J	Dai, N; Hu, J; Liu, H				Dai, Ning; Hu, Jian; Liu, Hao			3D Simulation Modeling of the Tooth Wear Process	PLOS ONE			English	Article							INTERPOLATION; EROSION	Severe tooth wear is the most common non-caries dental disease, and it can seriously affect oral health. Studying the tooth wear process is time-consuming and difficult, and technological tools are frequently lacking. This paper presents a novel method of digital simulation modeling that represents a new way to study tooth wear. First, a feature extraction algorithm is used to obtain anatomical feature points of the tooth without attrition. Second, after the alignment of non-attrition areas, the initial homogeneous surface is generated by means of the RBF (Radial Basic Function) implicit surface and then deformed to the final homogeneous by the contraction and bounding algorithm. Finally, the method of bilinear interpolation based on Laplacian coordinates between tooth with attrition and without attrition is used to inversely reconstruct the sequence of changes of the 3D tooth morphology during gradual tooth wear process. This method can also be used to generate a process simulation of nonlinear tooth wear by means of fitting an attrition curve to the statistical data of attrition index in a certain region. The effectiveness and efficiency of the attrition simulation algorithm are verified through experimental simulation.	[Dai, Ning; Liu, Hao] Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China; [Hu, Jian] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics; Nanjing Medical University	Dai, N (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China.	dai_ning@nuaa.edu.cn			National Natural Science Foundation of China [51205192]; National High Technology Research and Development Program of China [SS2013AA040801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (51205192) and the National High Technology Research and Development Program of China (SS2013AA040801). The funders supported the authors in study design, data collection and analysis.	Alexa M, 2003, VISUAL COMPUT, V19, P105, DOI 10.1007/s00371-002-0180-0; Athanasiadis T, 2012, COMPUT AIDED GEOM D, V29, P2, DOI 10.1016/j.cagd.2011.09.004; Benazzi S, 2011, AM J PHYS ANTHROPOL, V144, P309, DOI 10.1002/ajpa.21413; Carr JC, 2001, COMP GRAPH, P67, DOI 10.1145/383259.383266; DeLong R, 2006, DENT MATER, V22, P702, DOI 10.1016/j.dental.2006.02.003; Donald AS, 2000, J PROSTHET DENT, V83, P76; Dong XL, 2007, J 4 MIL MED U, V28, P550; Evans AR, 2005, BIOL J LINN SOC, V85, P81, DOI 10.1111/j.1095-8312.2005.00474.x; Fan WM, 2000, OPERATIVE DENT ENDOD; Garland M., 1997, COMPUTER GRAPHICS, V31, P209, DOI DOI 10.1145/258734258849; Hove LH, 2013, EUR ARCH PAEDIATR DE, V14, P29, DOI 10.1007/s40368-012-0004-5; Kanai T, 1998, VISUAL COMPUT, V14, P166, DOI 10.1007/s003710050132; Lee CH, 2005, P ACM SIGGRAPH, P659; Lerios A., 1995, SIGGRAPH, V1995, P449; Mitchell HL, 2004, MED BIOL ENG COMPUT, V42, P100, DOI 10.1007/BF02351017; Mitchell HL, 2003, MED BIOL ENG COMPUT, V41, P464, DOI 10.1007/BF02348090; Parent RE, 1992, VISUALIZATION COMPUT, V3, P219; Penny FB, 2008, CLIN ORAL INVESTI S1, V12, P15; Rodriguez JM, 2012, DENT MATER, V28, P245, DOI 10.1016/j.dental.2011.10.002; SCHROEDER WJ, 1992, COMP GRAPH, V26, P65, DOI 10.1145/142920.134010; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; [宋西平 SONG Xiping], 2008, [复合材料学报, Acta Materiae Compositae Sinica], V25, P93; TEAFORD MF, 1991, J DENT RES, V70, P204, DOI 10.1177/00220345910700030901; Toledo S., 2003, TAUCS LIB SPARSE LIN; Yan HB, 2004, COMPUT ANIMAT VIRT W, V15, P443, DOI 10.1002/cav.48; Yip KH, 2006, TOOTH EROSION PREVEN; Zhang J, 2004, TRIBOLOGY, V24, P471; Zhao Wei, 2002, Zhonghua Kou Qiang Yi Xue Za Zhi, V37, P219; Zou LF, 2009, WEAR, V266, P605, DOI 10.1016/j.wear.2008.04.062	29	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134807	10.1371/journal.pone.0134807	http://dx.doi.org/10.1371/journal.pone.0134807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241942	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700069
J	Shao, GF; Li, TJ; Zuo, WD; Wu, SX; Liu, TD				Shao, Guifang; Li, Tiejun; Zuo, Wangda; Wu, Shunxiang; Liu, Tundong			A Combinational Clustering Based Method for cDNA Microarray Image Segmentation	PLOS ONE			English	Article							SPOT SEGMENTATION; MODEL	Microarray technology plays an important role in drawing useful biological conclusions by analyzing thousands of gene expressions simultaneously. Especially, image analysis is a key step in microarray analysis and its accuracy strongly depends on segmentation. The pioneering works of clustering based segmentation have shown that k-means clustering algorithm and moving k-means clustering algorithm are two commonly used methods in microarray image processing. However, they usually face unsatisfactory results because the real microarray image contains noise, artifacts and spots that vary in size, shape and contrast. To improve the segmentation accuracy, in this article we present a combination clustering based segmentation approach that may be more reliable and able to segment spots automatically. First, this new method starts with a very simple but effective contrast enhancement operation to improve the image quality. Then, an automatic gridding based on the maximum between-class variance is applied to separate the spots into independent areas. Next, among each spot region, the moving k-means clustering is first conducted to separate the spot from background and then the k-means clustering algorithms are combined for those spots failing to obtain the entire boundary. Finally, a refinement step is used to replace the false segmentation and the inseparable ones of missing spots. In addition, quantitative comparisons between the improved method and the other four segmentation algorithms-edge detection, thresholding, k-means clustering and moving k-means clustering-are carried out on cDNA microarray images from six different data sets. Experiments on six different data sets, 1) Stanford Microarray Database (SMD), 2) Gene Expression Omnibus (GEO), 3) Baylor College of Medicine (BCM), 4) Swiss Institute of Bioinformatics (SIB), 5) Joe DeRisi's individual tiff files (DeRisi), and 6) University of California, San Francisco (UCSF), indicate that the improved approach is more robust and sensitive to weak spots. More importantly, it can obtain higher segmentation accuracy in the presence of noise, artifacts and weakly expressed spots compared with the other four methods.	[Shao, Guifang; Wu, Shunxiang; Liu, Tundong] Xiamen Univ, Dept Automat, Xiamen, Peoples R China; [Li, Tiejun] Jimei Univ, Informat Engn Coll, Xiamen, Peoples R China; [Zuo, Wangda] Univ Miami, Dept Civil Architectural & Environm Engn, Coral Gables, FL 33124 USA	Xiamen University; Jimei University; University of Miami	Shao, GF (corresponding author), Xiamen Univ, Dept Automat, Xiamen, Peoples R China.	gfshao@xmu.edu.cn		shao, guifang/0000-0001-6189-2207; Zuo, Wangda/0000-0003-2102-5592	National Natural Science Foundation of China [61403318]; Natural Science Foundation of Fujian Province of China [2013J01255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China, grant no. 61403318 (http://www.nsfc.gov.cn/), and the Natural Science Foundation of Fujian Province of China, grant no. 2013J01255 (http://xmgl.fjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo Jesus, 2008, Image Analysis & Stereology, V27, P107, DOI 10.5566/ias.v27.p107-124; Athanasiadis E, 2011, COMPUT METH PROG BIO, V104, P307, DOI 10.1016/j.cmpb.2011.03.007; Athanasiadis EI, 2009, IEEE T INF TECHNOL B, V13, P1068, DOI 10.1109/TITB.2009.2032332; Bajcsy P, 2005, P IEEE CS C COMP VIS, P147; Bajcsy P, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/80163; Barrera J, 2002, REAL TIME IMAGING, V8, P491; Blekas K, 2005, IEEE T MED IMAGING, V24, P901, DOI 10.1109/TMI.2005.848358; Demirkaya O, 2003, P ANN INT IEEE EMBS, V25, P674, DOI 10.1109/IEMBS.2003.1279852; Elbs M, 2007, ANAL BIOANAL CHEM, V387, P2017, DOI 10.1007/s00216-006-1098-6; Farouk RM, 2014, INT J ARTIFICIAL INT, V5, P21; Giannakeas N, 2013, COMPUT BIOL MED, V43, P705, DOI 10.1016/j.compbiomed.2013.03.003; Giannakeas N, 2008, IEEE ENG MED BIO, P875, DOI 10.1109/IEMBS.2008.4649293; Giannakeas N, 2009, COMPUT MED IMAG GRAP, V33, P40, DOI 10.1016/j.compmedimag.2008.10.003; Harikiran J, 2014, J THEORETICAL APPL I, V65, P235; Harikiran J, 2012, INT J COMPUTER SCI I, V9, P316; Ho J, 2008, IEEE T MED IMAGING, V27, P847, DOI 10.1109/TMI.2008.915697; Kadam AB, 2012, ADV COMPUT RES, V4, P130; Katsigiannis S, 2013, 13 IEEE INT C BIOINF, P1; Kavitha MG, 2013, INT J SCI ENG RES, V4, P46; Kim JH, 2001, EXP MOL MED, V33, P83, DOI 10.1038/emm.2001.15; Larese MG, 2013, PATTERN ANAL APPL, V16, P307, DOI 10.1007/s10044-011-0234-x; Li QH, 2005, BIOINFORMATICS, V21, P2875, DOI 10.1093/bioinformatics/bti447; Liew AWC, 2003, PATTERN RECOGN, V36, P1251, DOI 10.1016/S0031-3203(02)00170-X; Lukac R, 2006, INT J IMAG SYST TECH, V16, P51, DOI 10.1002/ima.20067; Maguluri LP, 2013, INT J EMERGING SCI E, V1, P27; Manjunath SS, 2013, INT J INNOVATIVE TEC, V2, P189; Mouysset S, 2012, ADV INTEL SOFT COMPU, V154, P1; Ng MK, 2002, PATTERN RECOGN, V35, P2783, DOI 10.1016/S0031-3203(02)00021-3; Ni SH, 2009, ROM J INF SCI TECH, V12, P249; Raghavarao S, 2011, GLOBAL J COMPUTER SC, V11, P31; Rajkumar P, 2013, INT J COMPUTER SCI E, V5, P528; Rueda L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-113; Shao GF, 2013, IEEE ACM T COMPUT BI, V10, P181, DOI 10.1109/TCBB.2012.130; Sreedevi A, 2013, INT J SIGNAL IMAGE P, V4, P83; Tian MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067014; Uslan V, 2010, IEEE ENG MED BIO, P1828, DOI 10.1109/IEMBS.2010.5626430; Wang XH, 2003, IEEE T NANOBIOSCI, V2, P184, DOI 10.1109/TNB.2003.816225; Wang ZD, 2014, NEUROCOMPUTING, V142, P408, DOI 10.1016/j.neucom.2014.03.052; Wang ZD, 2013, COMPUT METH PROG BIO, V111, P189, DOI 10.1016/j.cmpb.2013.03.013; Wu H, 2003, P 1 AS PAC BIOINF C, V19, P111; Yeganeh SH, 2008, INT C COMP ELEC ENG, P619, DOI 10.1109/ICCEE.2008.92; Zacharia E, 2011, EVOLUTIONARY ALGORITHMS, P459; Zacharia E, 2010, IEEE T NANOBIOSCI, V9, P181, DOI 10.1109/TNB.2010.2050900	43	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133025	10.1371/journal.pone.0133025	http://dx.doi.org/10.1371/journal.pone.0133025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241767	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700010
J	Takashima, M; Manabe, R; Iwasaki, W; Ohyama, A; Ohkuma, M; Sugita, T				Takashima, Masako; Manabe, Ri-ichiroh; Iwasaki, Wataru; Ohyama, Akira; Ohkuma, Moriya; Sugita, Takashi			Selection of Orthologous Genes for Construction of a Highly Resolved Phylogenetic Tree and Clarification of the Phylogeny of Trichosporonales Species	PLOS ONE			English	Article							CELL-WALL POLYSACCHARIDE; OLEAGINOUS YEASTS; BASIDIOMYCETOUS YEAST; SP-NOV.; RECLASSIFICATION; CLASSIFICATION; SUBSTITUTIONS; EVOLUTION; CURVATUS; FUNGI	The order Trichosporonales (Tremellomycotina, Basidiomycota) includes various species that have clinical, agricultural and biotechnological value. Thus, understanding why and how evolutionary diversification occurred within this order is extremely important. This study clarified the phylogenetic relationships among Tricosporonales species. To select genes suitable for phylogenetic analysis, we determined the draft genomes of 17 Trichosporonales species and extracted 30 protein-coding DNA sequences (CDSs) from genomic data. The CDS regions of Trichosporon asahii and T. faecale were identified by referring to mRNA sequence data since the intron positions of the respective genes differed from those of Cryptococcus neoformans (outgroup) and are not conserved within this order. A multiple alignment of the respective gene was first constructed using the CDSs of T. asahii, T. faecale and C. neoformans, and those of other species were added and aligned based on codons. The phylogenetic trees were constructed based on each gene and a concatenated alignment. Resolution of the maximum-likelihood trees estimated from the concatenated dataset based on both nucleotide (72,531) and amino acid (24,173) sequences were greater than in previous reports. In addition, we found that several genes, such as phosphatidylinositol 3-kinase TOR1 and glutamate synthase (NADH), had good resolution in this group (even when used alone). Our study proposes a set of genes suitable for constructing a phylogenetic tree with high resolution to examine evolutionary diversification in Trichosporonales. These can also be used for epidemiological and biogeographical studies, and may also serve as the basis for a comprehensive reclassification of pleomorphic fungi.	[Takashima, Masako; Ohkuma, Moriya] RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan; [Manabe, Ri-ichiroh] RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Iwasaki, Wataru] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Ohyama, Akira] In Silico Biol Inc, SOHO Stn 706, Planning, Naka Ku, Yokohama, Kanagawa 2310023, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan	RIKEN; RIKEN; University of Tokyo; Meiji Pharmaceutical University	Takashima, M (corresponding author), RIKEN BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki 3050074, Japan.	masako@jcm.riken.jp	Ohkuma, Moriya/A-8100-2011; Iwasaki, Wataru/O-4917-2014; Takashima, Masako/N-7959-2015	Iwasaki, Wataru/0000-0002-9169-9245; 	Institute of Fermentation, Osaka; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Innovative Technology (the Cell Innovation Program) from MEXT, Japan	Institute of Fermentation, Osaka; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Innovative Technology (the Cell Innovation Program) from MEXT, Japan	This study was supported primarily by a grant from the Institute of Fermentation, Osaka, awarded to MT. RM was supported by a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies (the RIKEN Omics Science Center ceased to exist on 1 April 2013 owing to the reorganization of RIKEN) and by a grant of the Innovative Cell Biology by Innovative Technology (the Cell Innovation Program) from MEXT, Japan to Yoshihide Hayashizaki. In silico biology, inc. provided support in the form of salaries for author AO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.'	Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Boekhout T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1623, DOI 10.1016/B978-0-444-52149-1.00137-3; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Daniel HM, 2014, ANTON LEEUW INT J G, V106, P67, DOI 10.1007/s10482-014-0170-z; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Findley K, 2009, EUKARYOT CELL, V8, P353, DOI 10.1128/EC.00373-08; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fonseca A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1661, DOI 10.1016/B978-0-444-52149-1.00138-5; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guerreiro MA, 2013, EUKARYOT CELL, V12, P746, DOI 10.1128/EC.00065-13; Gujjari P, 2011, MYCOLOGIA, V103, P1110, DOI 10.3852/10-403; HASSAN M, 1995, PROCESS BIOCHEM, V30, P629, DOI 10.1016/0032-9592(94)00061-L; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ichikawa T, 2001, EUR J BIOCHEM, V268, P5098, DOI 10.1046/j.0014-2956.2001.02438.x; Ichikawa T, 2001, CARBOHYD RES, V330, P495, DOI 10.1016/S0008-6215(00)00325-6; Ikeda R, 1996, MICROBIOL IMMUNOL, V40, P813, DOI 10.1111/j.1348-0421.1996.tb01146.x; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koufopanou V, 2013, FEMS YEAST RES, V13, P574, DOI 10.1111/1567-1364.12059; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2013, FEMS YEAST RES, V13, P23, DOI 10.1111/1567-1364.12006; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Millanes AM, 2011, MOL PHYLOGENET EVOL, V61, P12, DOI 10.1016/j.ympev.2011.05.014; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; MOORE RT, 1980, BOT MAR, V23, P361; Nagy LG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5471; Okoli I, 2007, FEMS YEAST RES, V7, P339, DOI 10.1111/j.1567-1364.2006.00164.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sampaio JP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1485, DOI 10.1016/B978-0-444-52149-1.00120-8; Schulze I, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0024-0; Shertz CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-510; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Sugita T, 2005, APPL ENVIRON MICROB, V71, P7626, DOI 10.1128/AEM.71.11.7626-7629.2005; Sugita T, 2000, MICROBIOL IMMUNOL, V44, P455, DOI 10.1111/j.1348-0421.2000.tb02520.x; Sugita Takashi, 1998, Mycoscience, V39, P7, DOI 10.1007/BF02461572; Sugita T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P2015, DOI 10.1016/B978-0-444-52149-1.00161-0; Takashima M, 2001, INT J SYST EVOL MICR, V51, P2199, DOI 10.1099/00207713-51-6-2199; Takashima M., 1999, MICROBIOL CULT COLL, V15, P35; Takashima Masako, 2000, Mycoscience, V41, P357, DOI 10.1007/BF02463949; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanimura A, 2014, BIORESOURCE TECHNOL, V153, P230, DOI 10.1016/j.biortech.2013.11.086; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Weiss M, 2014, SYSTEMATICS EVOLUTIO, VVII, P331, DOI DOI 10.1007/978-3-642-55318-9_12	47	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0131217	10.1371/journal.pone.0131217	http://dx.doi.org/10.1371/journal.pone.0131217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241762	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700002
J	Zhu, MK; Chen, GP; Dong, TT; Wang, LL; Zhang, JL; Zhao, ZP; Hu, ZL				Zhu, Mingku; Chen, Guoping; Dong, Tingting; Wang, Lingling; Zhang, Jianling; Zhao, Zhiping; Hu, Zongli			SlDEAD31, a Putative DEAD-Box RNA Helicase Gene, Regulates Salt and Drought Tolerance and Stress-Related Genes in Tomato	PLOS ONE			English	Article							TIME RT-PCR; ABIOTIC STRESS; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; SALINITY STRESS; ARABIDOPSIS; RESPONSES; FAMILY; PROTEIN	The DEAD-box RNA helicases are involved in almost every aspect of RNA metabolism, associated with diverse cellular functions including plant growth and development, and their importance in response to biotic and abiotic stresses is only beginning to emerge. However, none of DEAD-box genes was well characterized in tomato so far. In this study, we reported on the identification and characterization of two putative DEAD-box RNA helicase genes, SlDEAD30 and SlDEAD31 from tomato, which were classified into stress-related DEAD-box proteins by phylogenetic analysis. Expression analysis indicated that SlDEAD30 was highly expressed in roots and mature leaves, while SlDEAD31 was constantly expressed in various tissues. Furthermore, the expression of both genes was induced mainly in roots under NaCl stress, and SlDEAD31 mRNA was also increased by heat, cold, and dehydration. In stress assays, transgenic tomato plants overexpressing SlDEAD31 exhibited dramatically enhanced salt tolerance and slightly improved drought resistance, which were simultaneously demonstrated by significantly enhanced expression of multiple biotic and abiotic stress-related genes, higher survival rate, relative water content (RWC) and chlorophyll content, and lower water loss rate and malondialdehyde (MDA) production compared to wild-type plants. Collectively, these results provide a preliminary characterization of SlDEAD30 and SlDEAD31 genes in tomato, and suggest that stress-responsive SlDEAD31 is essential for salt and drought tolerance and stress-related gene regulation in plants.	[Zhu, Mingku; Chen, Guoping; Dong, Tingting; Wang, Lingling; Zhang, Jianling; Zhao, Zhiping; Hu, Zongli] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China	Chongqing University	Hu, ZL (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.	huzongli71@163.com	朱, 明库/ABD-8211-2021		National Natural Science Foundation of China [31171968]; Natural Science Foundation of Chongqing of China [CSTC2013jcyjA0001]; Fundamental Research Funds for the Central Universities [106112015CDJZR235504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing of China(Natural Science Foundation of Chongqing); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31171968), the Natural Science Foundation of Chongqing of China (CSTC2013jcyjA0001), and the Fundamental Research Funds for the Central Universities (No. 106112015CDJZR235504). ZH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2012, MOL BREEDING, V30, P345, DOI 10.1007/s11032-011-9625-3; AN G, 1987, METHOD ENZYMOL, V153, P292; Bernadac A, NATO SCI SERIES, V3492003, P118; Boudet N, 2001, GENOME RES, V11, P2101, DOI 10.1101/gr.200801; Bussink HJ, 2001, EUR J BIOCHEM, V268, P15, DOI 10.1046/j.1432-1327.2001.01774.x; Chung E, 2009, GENE, V443, P91, DOI 10.1016/j.gene.2009.05.005; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Dhanda SS, 1998, EUPHYTICA, V104, P39, DOI 10.1023/A:1018644113378; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foolad MR, 2007, ADV MOL BREEDING DRO, P669, DOI DOI 10.1007/978-1-4020-5578-2-27; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Lee KH, 2013, PLANT J, V73, P720, DOI 10.1111/tpj.12055; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lim CJ, 2010, BIOCHEM BIOPH RES CO, V399, P750, DOI 10.1016/j.bbrc.2010.08.016; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Liu HH, 2008, J EXP BOT, V59, P633, DOI 10.1093/jxb/erm355; Liu M, 2010, J INTEGR PLANT BIOL, V52, P817, DOI 10.1111/j.1744-7909.2010.00972.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2013, AFR J BIOTECHNOL, V9, P6294; Macovei A, 2012, PLANT SIGNAL BEHAV, V7, P1138, DOI [10.4161/psb.21343, 10.4161/psb.21586]; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Najami N, 2008, MOL GENET GENOMICS, V279, P171, DOI 10.1007/s00438-007-0305-2; Nakamura T, 2004, PLANT SCI, V167, P63, DOI 10.1016/j.plantsci.2004.03.001; Nemati SH., 2011, J BIOL ENV SCI, V5, P159, DOI DOI 10.1007/S12298-011-0097-Z; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Pan Y, 2012, PLANT CELL REP, V31, P349, DOI 10.1007/s00299-011-1170-3; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Tang YM, 2012, PHYSIOL PLANTARUM, V144, P210, DOI 10.1111/j.1399-3054.2011.01539.x; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tripurani SK, 2011, PLANT MOL BIOL REP, V29, P761, DOI 10.1007/s11105-010-0282-1; Tuteja N, 2003, J EXP BOT, V54, P2201, DOI 10.1093/jxb/erg246; Tuteja N, 2009, MUTAT RES-REV MUTAT, V681, P134, DOI 10.1016/j.mrrev.2008.06.004; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Wang YC, 2000, PLANT CELL, V12, P2129, DOI 10.1105/tpc.12.11.2129; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Western TL, 2002, DEVELOPMENT, V129, P1569; Xu RR, 2013, GENE, V513, P128, DOI 10.1016/j.gene.2012.10.053; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yoine M, 2006, PLANT CELL PHYSIOL, V47, P572, DOI 10.1093/pcp/pcj035; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang WW, 2014, PLANT SOIL, V381, P143, DOI 10.1007/s11104-014-2120-y; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	59	25	30	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133849	10.1371/journal.pone.0133849	http://dx.doi.org/10.1371/journal.pone.0133849			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241658	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700025
J	Sakin, V; Richter, SM; Hsiao, HH; Urlaub, H; Melchior, F				Sakin, Volkan; Richter, Sebastian M.; Hsiao, He-Hsuan; Urlaub, Henning; Melchior, Frauke			Sumoylation of the GTPase Ran by the RanBP2 SUMO E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PROTEIN IMPORT; TRANSPORT FACTOR-2 NTF2; PORE COMPLEX; STRUCTURAL BASIS; ACTIVATING PROTEIN; LYSINE ACETYLATION; BINDING-SITES; GDP-RAN; IN-VIVO; RANGAP1	The SUMO E3 ligase complex RanBP2/RanGAP1*SUMO1/Ubc9 localizes at cytoplasmic nuclear pore complex (NPC) filaments and is a docking site in nucleocytoplasmic transport. RanBP2 has four Ran binding domains (RBDs), two of which flank RanBP2's E3 ligase region. We thus wondered whether the small GTPase Ran is a target for RanBP2-dependent sumoylation. Indeed, Ran is sumoylated both by a reconstituted and the endogenous RanBP2 complex in semi-permeabilized cells. Generic inhibition of SUMO isopeptidases or depletion of the SUMO isopeptidase SENP1 enhances sumoylation of Ran in semi-permeabilized cells. As Ran is typically associated with transport receptors, we tested the influence of Crm1, Imp beta, Transportin, and NTF2 on Ran sumoylation. Surprisingly, all inhibited Ran sumoylation. Mapping Ran sumoylation sites revealed that transport receptors may simply block access of the E2-conjugating enzyme Ubc9, however the acceptor lysines are perfectly accessible in Ran/NTF2 complexes. Isothermal titration calorimetry revealed that NTF2 prevents sumoylation by reducing RanGDP's affinity to RanBP2's RBDs to undetectable levels. Taken together, our findings indicate that RanGDP and not RanGTP is the physiological target for the RanBP2 SUMO E3 ligase complex. Recognition requires interaction of Ran with RanBP2's RBDs, which is prevented by the transport factor NTF2.	[Sakin, Volkan; Richter, Sebastian M.; Melchior, Frauke] Heidelberg Univ, Zentrum Mol Biol ZMBH, DKFZ, ZMBH Alliance, D-69120 Heidelberg, Germany; [Hsiao, He-Hsuan; Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, D-37075 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; University of Gottingen	Melchior, F (corresponding author), Heidelberg Univ, Zentrum Mol Biol ZMBH, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	f.melchior@zmbh.uni-heidelberg.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797	German Research Society [SFB 638, TPB8]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	German Research Society(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS)	This project received funding from the German Research Society (SFB 638, TPB8) and the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) and the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (HBIGS), respectively (to V. S. and S. M. R.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bibak N, 2004, ANAL BIOCHEM, V333, P57, DOI 10.1016/j.ab.2004.06.017; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Braslavsky CIV, 2000, BIOCHEMISTRY-US, V39, P11629, DOI 10.1021/bi001010f; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chow KH, 2012, NUCLEUS-PHILA, V3, P349, DOI 10.4161/nucl.20822; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Kent HM, 1996, J STRUCT BIOL, V116, P326, DOI 10.1006/jsbi.1996.0049; Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Lu M, 2014, CELL, V157, P1130, DOI 10.1016/j.cell.2014.05.006; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Melchior F, 1998, METH MOL B, V88, P265; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Nehrbass U, 1996, SCIENCE, V272, P120, DOI 10.1126/science.272.5258.120; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Paschal BM, 1996, P NATL ACAD SCI USA, V93, P7679, DOI 10.1073/pnas.93.15.7679; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Rothenbusch U, 2012, EMBO J, V31, P2461, DOI 10.1038/emboj.2012.102; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Schulz S, 2012, EMBO REP, V13, P930, DOI 10.1038/embor.2012.125; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Swaminathan S, 2004, J CELL BIOL, V164, P965, DOI 10.1083/jcb.200309126; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	75	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23589	23602		10.1074/jbc.M115.660118	http://dx.doi.org/10.1074/jbc.M115.660118			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26251516	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000361816500011
J	Acton, D; Miles, GB				Acton, David; Miles, Gareth B.			Stimulation of Glia Reveals Modulation of Mammalian Spinal Motor Networks by Adenosine	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; PURINERGIC MODULATION; VENTILATORY RESPONSE; RESPIRATORY ACTIVITY; RECEPTOR MODULATION; PATTERN GENERATION; DEPENDENT RELEASE; CORD-INJURY; RAT-BRAIN; ASTROCYTES	Despite considerable evidence that glia can release modulators to influence the excitability of neighbouring neurons, the importance of gliotransmission for the operation of neural networks and in shaping behaviour remains controversial. Here we characterise the contribution of glia to the modulation of the mammalian spinal central pattern generator for locomotion, the output of which is directly relatable to a defined behaviour. Glia were stimulated by specific activation of protease-activated receptor-1 (PAR1), an endogenous G-protein coupled receptor preferentially expressed by spinal glia during ongoing activity of the spinal central pattern generator for locomotion. Selective activation of PAR1 by the agonist TFLLR resulted in a reversible reduction in the frequency of locomotor-related bursting recorded from ventral roots of spinal cord preparations isolated from neonatal mice. In the presence of the gliotoxins methionine sulfoximine or fluoroacetate, TFLLR had no effect, confirming the specificity of PAR1 activation to glia. The modulation of burst frequency upon PAR1 activation was blocked by the non-selective adenosine-receptor antagonist theophylline and by the A(1)-receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine, but not by the A(2A)-receptor antagonist SCH5826, indicating production of extracellular adenosine upon glial stimulation, followed by A(1)-receptor mediated inhibition of neuronal activity. Modulation of network output following glial stimulation was also blocked by the ectonucleotidase inhibitor ARL67156, indicating glial release of ATP and its subsequent degradation to adenosine rather than direct release of adenosine. Glial stimulation had no effect on rhythmic activity recorded following blockade of inhibitory transmission, suggesting that glial cell-derived adenosine acts via inhibitory circuit components to modulate locomotor-related output. Finally, the modulation of network output by endogenous adenosine was found to scale with the frequency of network activity, implying activity-dependent release of adenosine. Together, these data indicate that glia play an active role in the modulation of mammalian locomotor networks, providing negative feedback control that may stabilise network activity.	[Acton, David; Miles, Gareth B.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Miles, GB (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9AJ, Fife, Scotland.	gbm4@st-andrews.ac.uk		Miles, Gareth/0000-0002-8624-4625	Wellcome Trust	Wellcome Trust(Wellcome Trust)	This work was funded by the Wellcome Trust Institutional Strategic Support Fund for University of St. Andrews.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Bracci E, 1996, J NEUROPHYSIOL, V75, P640, DOI 10.1152/jn.1996.75.2.640; Brown P, 2000, J PHYSIOL-LONDON, V525, P655, DOI 10.1111/j.1469-7793.2000.00655.x; Carlsen EM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00060; CLARKE DD, 1991, NEUROCHEM RES, V16, P1055, DOI 10.1007/BF00965850; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Daadi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041120; Dale N, 1998, J PHYSIOL-LONDON, V511, P265, DOI 10.1111/j.1469-7793.1998.265bi.x; Dale N, 1996, NATURE, V383, P259, DOI 10.1038/383259a0; Deuchars SA, 2001, J NEUROSCI, V21, P6308, DOI 10.1523/JNEUROSCI.21-16-06308.2001; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fonnum F, 1997, GLIA, V21, P106; Foster JD, 2014, J NEUROPHYSIOL, V111, P659, DOI 10.1152/jn.00378.2013; Fujita T, 2014, J NEUROSCI, V34, P16594, DOI 10.1523/JNEUROSCI.2585-14.2014; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; HASSEL B, 1992, BRAIN RES, V576, P120, DOI 10.1016/0006-8993(92)90616-H; Hulsmann S, 2000, EUR J NEUROSCI, V12, P856, DOI 10.1046/j.1460-9568.2000.00973.x; Huxtable AG, 2010, J NEUROSCI, V30, P3947, DOI 10.1523/JNEUROSCI.6027-09.2010; Huxtable AG, 2009, J NEUROSCI, V29, P14713, DOI 10.1523/JNEUROSCI.2660-09.2009; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021; KAWAI A, 1995, RESP PHYSIOL, V100, P25, DOI 10.1016/0034-5687(94)00124-I; Klyuch BP, 2012, J NEUROSCI, V32, P3842, DOI 10.1523/JNEUROSCI.6052-11.2012; Lalo U, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001747; Largo C, 1997, J NEUROPHYSIOL, V78, P295, DOI 10.1152/jn.1997.78.1.295; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Li Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2779; Liu R, 2015, J CANCER RES CLIN, V141, P993, DOI 10.1007/s00432-014-1874-1; Lorier AR, 2007, J NEUROSCI, V27, P993, DOI 10.1523/JNEUROSCI.3948-06.2007; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; Mironov SL, 1999, J NEUROPHYSIOL, V81, P247, DOI 10.1152/jn.1999.81.1.247; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Navarrete M, 2011, CELL, V146, P675, DOI 10.1016/j.cell.2011.08.006; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Orlovsky G., 1999, NEURONAL CONTROL LOC; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; PASTOR A, 1995, EUR J NEUROSCI, V7, P1188, DOI 10.1111/j.1460-9568.1995.tb01109.x; Paterniti I, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-31; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; REPPERT SM, 1991, MOL ENDOCRINOL, V5, P1037, DOI 10.1210/mend-5-8-1037; RONZIO RA, 1969, BIOCHEMISTRY-US, V8, P1066, DOI 10.1021/bi00831a038; SCHMIDT C, 1995, J PHYSIOL-LONDON, V483, P769, DOI 10.1113/jphysiol.1995.sp020621; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Taccola G, 2012, NEUROSCIENCE, V222, P191, DOI 10.1016/j.neuroscience.2012.07.030; Talpalar AE, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00019; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wall M, 2008, CURR NEUROPHARMACOL, V6, P329, DOI 10.2174/157015908787386087; Wall MJ, 2013, J PHYSIOL-LONDON, V591, P3853, DOI 10.1113/jphysiol.2013.253450; Wang FS, 2013, J NEUROSCI, V33, P17404, DOI 10.1523/JNEUROSCI.2178-13.2013; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Witts EC, 2012, 2012 NEUR M PLANN; Witts EC, 2012, J NEUROPHYSIOL, V107, P1925, DOI 10.1152/jn.00513.2011; Xu W, 2013, J NEUROSCI, V33, P5867, DOI 10.1523/JNEUROSCI.1508-12.2013; Young JK, 2005, RESP PHYSIOL NEUROBI, V147, P19, DOI 10.1016/j.resp.2005.01.009; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Ziak D, 1998, PHYSIOL RES, V47, P365	70	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134488	10.1371/journal.pone.0134488	http://dx.doi.org/10.1371/journal.pone.0134488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252389	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100060
J	Bush, JC; Pantelis, PC; Duchesne, XM; Kagemann, SA; Kennedy, DP				Bush, Jennifer Choe; Pantelis, Peter Christopher; Duchesne, Xavier Morin; Kagemann, Sebastian Alexander; Kennedy, Daniel Patrick			Viewing Complex, Dynamic Scenes "Through the Eyes" of Another Person: The Gaze-Replay Paradigm	PLOS ONE			English	Article							VISUAL-ATTENTION; AMYGDALA DAMAGE; SOCIAL SCENES; AUTISM; RECOGNITION; FIXATION; ADULTS; FACES	We present a novel "Gaze-Replay" paradigm that allows the experimenter to directly test how particular patterns of visual input-generated from people's actual gaze patternsinfluence the interpretation of the visual scene. Although this paradigm can potentially be applied across domains, here we applied it specifically to social comprehension. Participants viewed complex, dynamic scenes through a small window displaying only the foveal gaze pattern of a gaze "donor." This was intended to simulate the donor's visual selection, such that a participant could effectively view scenes "through the eyes" of another person. Throughout the presentation of scenes presented in this manner, participants completed a social comprehension task, assessing their abilities to recognize complex emotions. The primary aim of the study was to assess the viability of this novel approach by examining whether these Gaze-Replay windowed stimuli contain sufficient and meaningful social information for the viewer to complete this social perceptual and cognitive task. The results of the study suggested this to be the case; participants performed better in the Gaze-Replay condition compared to a temporally disrupted control condition, and compared to when they were provided with no visual input. This approach has great future potential for the exploration of experimental questions aiming to unpack the relationship between visual selection, perception, and cognition.	[Bush, Jennifer Choe; Pantelis, Peter Christopher; Duchesne, Xavier Morin; Kagemann, Sebastian Alexander; Kennedy, Daniel Patrick] Indiana Univ, Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bush, JC (corresponding author), Indiana Univ, Psychol & Brain Sci, Bloomington, IN 47405 USA.	jencbush@indiana.edu			National Institutes of Health T32 Grant [HD 07475]; National Institutes of Mental Health [R00-MH094409]; Brain and Behavior Research Foundation NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH094409] Funding Source: NIH RePORTER	National Institutes of Health T32 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Research Foundation NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by JCB-National Institutes of Health T32 Grant #HD 07475; DPK-National Institutes of Mental Health R00-MH094409; DPK-Brain and Behavior Research Foundation NARSAD Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Birmingham E, 2013, CHILD DEV, V84, P1407, DOI 10.1111/cdev.12039; Birmingham E, 2011, SOC NEUROSCI-UK, V6, P420, DOI 10.1080/17470919.2011.561547; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; Coutrot A, 2014, J VISION, V14, DOI 10.1167/14.8.5; Dalrymple KA, 2011, BRAIN RES, V1367, P265, DOI 10.1016/j.brainres.2010.10.022; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Gervais R, 2005, PILOT TELEVISION SER; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Kennedy DP, 2010, NEUROPSYCHOLOGIA, V48, P3392, DOI 10.1016/j.neuropsychologia.2010.06.025; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Qualtrics Labs I.s., 2011, QUALTR RES SUIT VERS; Vo MLH, 2012, J VISION, V12, DOI 10.1167/12.13.3; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	24	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134347	10.1371/journal.pone.0134347	http://dx.doi.org/10.1371/journal.pone.0134347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252493	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100053
J	Hwang, HS; Lee, SB; Jee, D				Hwang, Ho Sik; Lee, Seung Bum; Jee, Donghyun			Association between Blood Lead Levels and Age-Related Macular Degeneration	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREAN NATIONAL-HEALTH; DEVELOPMENTAL IMMUNOTOXICITY; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; GENDER-DIFFERENCES; RISK-FACTORS; EXPOSURE; CADMIUM; TOXICITY	Purpose To investigate the association between blood lead levels and prevalence of age-related macular degeneration (AMD). Methods A nationwide population-based cross-sectional study included 4,933 subjects aged over 40 years who participated in the 2008-2012 Korean National Health and Nutrition Examination Survey, and for whom fundus photographs were available. All participants underwent a standardized interview, evaluation of blood lead concentration, and a comprehensive ophthalmic examination. Digital fundus photographs (45 degrees) were taken of both eyes under physiological mydriasis. All fundus photographs were graded using an international classification and grading system. Results Mean blood lead levels were 3.15 mu g/dL in men and 2.27 mu g/dL in women (P < 0.001). After adjusting for potential confounders including age, gender, smoking status, total cholesterol levels, triglyceride levels, heart problems and strokes, the adjusted odds ratio (OR) in women for any AMD was 1.86 (95% Confidence Interval [CI], 1.03-3.36) and for early AMD was 1.92 (95% CI, 1.06-3.48), for those in the highest quintile of lead level compared with the lowest quintile. In men, however, blood lead level was not significantly associated with AMD. Conclusions Blood lead levels were higher in men, but were only associated with AMD in women. Increased levels of blood lead may be involved in the pathogenesis of AMD development in women.	[Hwang, Ho Sik] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Ophthalmol, Chunchon, South Korea; [Lee, Seung Bum] Seoul St Marys Eye Hosp, Suwon, South Korea; [Jee, Donghyun] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea	Hallym University; Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Ophthalmol & Visual Sci, Suwon, South Korea.	doj087@mail.harvard.edu			Ajou Pharm from Catholic Medical Center Research Foundation in the program [5-2013-D0383-00002]	Ajou Pharm from Catholic Medical Center Research Foundation in the program	This study was supported by the fund of Ajou Pharm (5-2013-D0383-00002) from Catholic Medical Center Research Foundation in the program year of 2012.	Ajani UA, 1999, ANN EPIDEMIOL, V9, P172, DOI 10.1016/S1047-2797(98)00053-2; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Becker K, 2002, INT J HYG ENVIR HEAL, V205, P297, DOI 10.1078/1438-4639-00155; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bjorkman L, 2000, ENVIRON HEALTH PERSP, V108, P719, DOI 10.2307/3434724; Brown D V, 1974, Trans Am Ophthalmol Soc, V72, P404; Bunn TL, 2000, J TOXICOL ENV HEAL A, V61, P677, DOI 10.1080/00984100050195152; Bunn TL, 2001, J TOXICOL ENV HEAL A, V64, P223, DOI 10.1080/15287390152543708; BUSHNELL PJ, 1977, SCIENCE, V196, P333, DOI 10.1126/science.403610; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cho BJ, 2014, INVEST OPHTH VIS SCI, V55, P1101, DOI 10.1167/iovs.13-13096; Cho EY, 2000, ARCH OPHTHALMOL-CHIC, V118, P681, DOI 10.1001/archopht.118.5.681; Erie JC, 2009, AM J OPHTHALMOL, V148, P890, DOI 10.1016/j.ajo.2009.07.001; Erie JC, 2005, AM J OPHTHALMOL, V139, P888, DOI 10.1016/j.ajo.2004.12.007; Ersoy L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413150; FOX DA, 1994, NEUROTOXICOLOGY, V15, P503; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; Gulson BL, 1997, J LAB CLIN MED, V130, P51, DOI 10.1016/S0022-2143(97)90058-5; Hsu PC, 2002, TOXICOLOGY, V180, P33, DOI 10.1016/S0300-483X(02)00380-3; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Hyman Leslie, 2002, Curr Opin Ophthalmol, V13, P171; Jacob B, 2000, ENVIRON RES, V82, P150, DOI 10.1006/enrs.1999.4011; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Junemann AGM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056734; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P5702, DOI 10.1167/iovs.14-14774; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim K, 2012, ENVIRON RES, V112, P225, DOI 10.1016/j.envres.2011.12.008; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Kim Y, 2012, ENVIRON RES, V118, P124, DOI 10.1016/j.envres.2012.06.003; La TY, 2014, CURR EYE RES, V39, P1232, DOI 10.3109/02713683.2014.907431; Lee BK, 2012, ENVIRON RES, V115, P59, DOI 10.1016/j.envres.2012.03.010; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Mecocci P, 2004, NEUROL RES, V26, P598, DOI 10.1179/016164104225017659; Montezuma Sandra R, 2007, Semin Ophthalmol, V22, P229, DOI 10.1080/08820530701745140; Mortada WI, 2004, MED SCI MONITOR, V10, pCR112; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Papanikolaou NC, 2005, MED SCI MONITOR, V11, pRA329; Parish C, 2013, PRIORITY LIST HAZARD; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Park SJ, 2015, OPHTHALMOLOGY, V122, P129, DOI 10.1016/j.ophtha.2014.07.039; Park SJ, 2014, OPHTHALMOLOGY; Park S, 2012, SCI TOTAL ENVIRON, V430, P161, DOI 10.1016/j.scitotenv.2012.05.009; Pirkle JL, 1998, ENVIRON HEALTH PERSP, V106, P745, DOI 10.2307/3434264; Popovic M, 2005, ENVIRON HEALTH PERSP, V113, P478, DOI 10.1289/ehp.7386; Rhee S.Y., 2008, CARDIOVASC DIABETOL, V9, P12; Schaumberg DA, 2004, JAMA-J AM MED ASSOC, V292, P2750, DOI 10.1001/jama.292.22.2750; Sim CS, 2014, ENVIRON RES, V130, P1, DOI 10.1016/j.envres.2014.01.004; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sui GY, 2013, BRIT J OPHTHALMOL, V97, P389, DOI 10.1136/bjophthalmol-2012-302281; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Vig EK, 2000, J AM GERIATR SOC, V48, P1501, DOI 10.1111/jgs.2000.48.11.1501; Vlaanderen J, 2014, AM J EPIDEMIOL, V179, P290, DOI 10.1093/aje/kwt273; Webber CE, 1995, ENVIRON HEALTH PERSP, V103, P1150, DOI 10.2307/3432612; Weikel KA, 2012, MOL ASPECTS MED; Won YS, 2013, J CLIN PERIODONTOL, V40, P118, DOI 10.1111/jcpe.12033; Wu EW, 2014, ENVIRON RES, V133, P178, DOI 10.1016/j.envres.2014.05.023; Yuki K, 2009, BIOL TRACE ELEM RES, V132, P1, DOI 10.1007/s12011-009-8376-z	58	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134338	10.1371/journal.pone.0134338	http://dx.doi.org/10.1371/journal.pone.0134338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252225	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100051
J	Sanchez-Sanchez, AM; Antolin, I; Puente-Moncada, N; Suarez, S; Gomez-Lobo, M; Rodriguez, C; Martin, V				Sanchez-Sanchez, Ana M.; Antolin, Isaac; Puente-Moncada, Noelia; Suarez, Santos; Gomez-Lobo, Marina; Rodriguez, Carmen; Martin, Vanesa			Melatonin Cytotoxicity Is Associated to Warburg Effect Inhibition in Ewing Sarcoma Cells	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; TUMOR PROGRESSION; IN-VITRO; METABOLISM; MECHANISMS; GROWTH; HIF-1; HIF-1-ALPHA; SENSITIVITY	Melatonin kills or inhibits the proliferation of different cancer cell types, and this is associated with an increase or a decrease in reactive oxygen species, respectively. Intracellular oxidants originate mainly from oxidative metabolism, and cancer cells frequently show alterations in this metabolic pathway, such as the Warburg effect (aerobic glycolysis). Thus, we hypothesized that melatonin could also regulate differentially oxidative metabolism in cells where it is cytotoxic (Ewing sarcoma cells) and in cells where it inhibits proliferation (chondrosarcoma cells). Ewing sarcoma cells but not chondrosarcoma cells showed a metabolic profile consistent with aerobic glycolysis, i.e. increased glucose uptake, LDH activity, lactate production and HIF-1 alpha activation. Melatonin reversed Ewing sarcoma metabolic profile and this effect was associated with its cytotoxicity. The differential regulation of metabolism by melatonin could explain why the hormone is harmless for a wide spectrum of normal and only a few tumoral cells, while it kills specific tumor cell types.	[Sanchez-Sanchez, Ana M.; Antolin, Isaac; Puente-Moncada, Noelia; Suarez, Santos; Rodriguez, Carmen; Martin, Vanesa] Univ Oviedo, Dept Morfol & Biol Celular, Fac Med, E-33006 Oviedo, Spain; [Sanchez-Sanchez, Ana M.; Antolin, Isaac; Puente-Moncada, Noelia; Gomez-Lobo, Marina; Rodriguez, Carmen; Martin, Vanesa] Inst Univ Oncol Principado Asturias, Oviedo, Spain	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Martin, V (corresponding author), Univ Oviedo, Dept Morfol & Biol Celular, Fac Med, E-33006 Oviedo, Spain.	martinvanesa@uniovi.es	MARTIN, VANESA/A-7312-2012; Moncada, Noelia Puente/AAT-5812-2021; Antolin, Isaac/L-6210-2014; Sanchez, Ana/B-5533-2015; SANCHEZ, ANA MARIA SANCHEZ/AAB-4156-2021; Rodríguez, Carmen/R-9541-2019	MARTIN, VANESA/0000-0001-6923-2529; Moncada, Noelia Puente/0000-0002-5996-2349; Antolin, Isaac/0000-0002-4232-9248; Sanchez, Ana/0000-0002-3750-4013; SANCHEZ, ANA MARIA SANCHEZ/0000-0002-3750-4013; Rodríguez, Carmen/0000-0002-3203-4753	FICYT Grant [GRUPIN14-081]; FICYT fellowship [BP10-054, BP13-108]	FICYT Grant; FICYT fellowship	This work was supported by the FICYT Grant GRUPIN14-081. Ana M Sanchez-Sanchez was supported by the FICYT fellowship BP10-054. Noelia Puente-Moncada was supported by the FICYT fellowship BP13-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Antone PD, 2012, MED HYPOTHESES, V79, P388, DOI 10.1016/j.mehy.2012.06.002; Bejarano I, 2011, BASIC CLIN PHARMACOL, V108, P14, DOI 10.1111/j.1742-7843.2010.00619.x; Bizzarri M, 2013, EXPERT OPIN THER TAR, V17, P1483, DOI 10.1517/14728222.2013.834890; Cardaci S, 2012, J BIOENERG BIOMEMBR, V44, P17, DOI 10.1007/s10863-012-9422-7; Casado-Zapico S, 2010, J PINEAL RES, V48, P72, DOI 10.1111/j.1600-079X.2009.00727.x; Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9; Dai M, 2008, J PINEAL RES, V44, P121, DOI 10.1111/j.1600-079X.2007.00498.x; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dwarakanath BS, 2009, J CANCER RES THER, V5, P27, DOI 10.4103/0973-1482.55137; Garcia-Santos G, 2012, BRIT J CANCER, V106, P1288, DOI 10.1038/bjc.2012.66; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Kim KJ, 2013, J PINEAL RES, V54, P264, DOI 10.1111/j.1600-079X.2012.01030.x; Kovar H, 2014, EXPERT OPIN THER TAR, V18, P1315, DOI 10.1517/14728222.2014.947963; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lee WNP, 2004, BRIT J CANCER, V91, P2094, DOI 10.1038/sj.bjc.6602243; Leon J, 2014, J PINEAL RES, V56, P415, DOI 10.1111/jpi.12131; Li XB, 2013, INT J ONCOL, V43, P1710, DOI 10.3892/ijo.2013.2080; Martin V, 2006, CANCER RES, V66, P1081, DOI 10.1158/0008-5472.CAN-05-2354; Mediavilla MD, 2010, CURR MED CHEM, V17, P4462, DOI 10.2174/092986710794183015; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360; Reiter RJ, 1999, ADV EXP MED BIOL, V467, P379; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Rodriguez C, 2013, INT J MOL SCI, V14, P6597, DOI 10.3390/ijms14046597; Sanchez-Sanchez AM, 2011, FREE RADICAL RES, V45, P1333, DOI 10.3109/10715762.2011.623700; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Smith DG, 2011, EXPERT REV ANTICANC, V11, P229, DOI [10.1586/era.10.224, 10.1586/ERA.10.224]; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wolfler A, 2001, FEBS LETT, V502, P127, DOI 10.1016/S0014-5793(01)02680-1; Zhang YM, 2013, J PINEAL RES, V55, P121, DOI 10.1111/jpi.12052; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	38	44	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135420	10.1371/journal.pone.0135420	http://dx.doi.org/10.1371/journal.pone.0135420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252771	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100159
J	Udy, DB; Voorhies, M; Chan, PP; Lowe, TM; Dumont, S				Udy, Dylan B.; Voorhies, Mark; Chan, Patricia P.; Lowe, Todd M.; Dumont, Sophie			Draft De Novo Transcriptome of the Rat Kangaroo Potorous tridactylus as a Tool for Cell Biology	PLOS ONE			English	Article							RNA-SEQ DATA; PROTEIN; ACCURATE; GENOME; GENES; PRC1	The rat kangaroo (long-nosed potoroo, Potorous tridactylus) is a marsupial native to Australia. Cultured rat kangaroo kidney epithelial cells (PtK) are commonly used to study cell biological processes. These mammalian cells are large, adherent, and flat, and contain large and few chromosomes-and are thus ideal for imaging intra-cellular dynamics such as those of mitosis. Despite this, neither the rat kangaroo genome nor transcriptome have been sequenced, creating a challenge for probing the molecular basis of these cellular dynamics. Here, we present the sequencing, assembly and annotation of the draft rat kangaroo de novo transcriptome. We sequenced 679 million reads that mapped to 347,323 Trinity transcripts and 20,079 Unigenes. We present statistics emerging from transcriptome-wide analyses, and analyses suggesting that the transcriptome covers full-length sequences of most genes, many with multiple isoforms. We also validate our findings with a proof-of-concept gene knockdown experiment. We expect that this high quality transcriptome will make rat kangaroo cells a more tractable system for linking molecular-scale function and cellular-scale dynamics.	[Udy, Dylan B.; Dumont, Sophie] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Voorhies, Mark] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Chan, Patricia P.; Lowe, Todd M.] Maverix Biom Inc, San Mateo, CA USA; [Chan, Patricia P.; Lowe, Todd M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Dumont, Sophie] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco	Dumont, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	sophie.dumont@ucsf.edu	Lowe, Todd Michael/ABJ-5261-2022		UCSF Helen Diller Family Comprehensive Cancer Center internal RAP grant [NIH P30CA82103, NIH R00GM09433]; Maverix Biomics, Inc.; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER	UCSF Helen Diller Family Comprehensive Cancer Center internal RAP grant(University of California System); Maverix Biomics, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a UCSF Helen Diller Family Comprehensive Cancer Center internal RAP grant (NIH P30CA82103, http://www.nih.gov/), and NIH R00GM09433 (http://www.nih.gov/) to S.D. S.D. is a Searle, Kimmel and Rita Allen Foundation Scholar, and a Sloan Research Fellow. The primary authors' funders (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maverix Biomics, Inc. provided support in the form of salaries for authors PPC and TML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond the fee-for-service transcriptome assembly work. The specific roles of PPC and TML beyond the fee-for-service work are articulated in the 'author contributions' section.	Andrews S, FASTQC A QUALITY CON; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elting MW, 2014, J CELL BIOL, V206, P245, DOI 10.1083/jcb.201401091; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayman D, 1969, COMP MAMMALIAN CYTOG, P191; InVivoGen, SIRNA WIZARD V3 1; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LifeTechnologies, BLOCK IT RNAI DESIGN; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SHARMAN GB, 1952, HEREDITY, V6, P345, DOI 10.1038/hdy.1952.43; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Stout JR, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-26; Vert J, DESIGNER OF SMALL IN; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; WALEN KH, 1962, NATURE, V194, P406, DOI 10.1038/194406a0	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134738	10.1371/journal.pone.0134738	http://dx.doi.org/10.1371/journal.pone.0134738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252667	Green Published, gold			2022-12-26	WOS:000359121100071
J	Wuyun, T; Amo, H; Xu, JS; Ma, T; Uematsu, C; Katayama, H				Wuyun, Tana; Amo, Hitomi; Xu, Jingshi; Ma, Teng; Uematsu, Chiyomi; Katayama, Hironori			Population Structure of and Conservation Strategies for Wild Pyrus ussuriensis Maxim. in China	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; GENETIC DIVERSITY; MICROSATELLITE MARKERS; HYPERVARIABLE REGIONS; CHLOROPLAST; DIFFERENTIATION; JAPANESE; NUCLEAR; DNA; COLONIZATION	Pyrus ussriensis Maxim. is native to the northern part of China, but whose habitats are currently being destroyed by environmental changes and human deforestation. An investigation of population structure and genetic diversity of wild Ussurian pear is a priority in order to acquire fundamental knowledge for conservation. A total of 153 individuals of wild Ussurian pear from the main habitats, Heilongjiang, Jilin, and Inner Mongolia in China, possessed low genetic diversity as a result of habitat fragmentation. The genetic diversity of the populations in Inner Mongolia and north east of Heilongjiang was especially low and there was the possibility of inbreeding. Wild Ussurian pears were divided into 5 groups based on the Bayesian clustering method using 20 nuclear SSRs (nSSRs) and 5 groups by haplotype distributions using 16 chloroplast SSRs (cpSSRs), and the populations in Inner Mongolia and north east of Heilongjiang represented unique genotypes. AMOVA indicated there was a 20.05% variation in nSSRs and a 44.40% variation in cpSSRs among populations. These values are relatively high when compared to those of other tree species. Haplotype E, positioned in the center of the cpSSR analysis network and showed the largest number of connections with other haplotypes, represented the most important haplotype. Inner Mongolia and the north east of Heilongjiang are two areas that need urgent conservation because of their genetic vulnerability and peculiarity. We determined 4 conservation units based on the clustering by nSSRs and cpSSRs, and geographic factor. This information is helpful in deciding the conservation strategies for wild Ussurian pear in China.	[Wuyun, Tana] CAF, Nontimber Forestry Res & Dev, Paulownia Res & Dev Ctr China, Zhengzhou 450003, Peoples R China; [Amo, Hitomi; Katayama, Hironori] Kobe Univ, Fac Agr, Food Resources Educ & Res Ctr, Kobe, Hyogo 6752103, Japan; [Ma, Teng] Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees &, Changsha 410004, Hunan, Peoples R China; [Uematsu, Chiyomi] Osaka City Univ, Grad Sch Sci, Bot Gardens, Osaka 5760004, Japan; [Xu, Jingshi] Forestry Technol Popularizat Stn Beihai City, Beihai 536000, Guang Xi, Peoples R China	Chinese Academy of Forestry; Paulownia R&D Center of State Administration of Forestry & Grassland, CAF; Kobe University; Central South University of Forestry & Technology; Osaka Metropolitan University	Katayama, H (corresponding author), Kobe Univ, Fac Agr, Food Resources Educ & Res Ctr, Kobe, Hyogo 6752103, Japan.	hkata@kobe-u.ac.jp	Katayama, Hironori/I-5219-2019		National Natural Science Foundation of China [31000309]; Ministry of Education, Science and Culture, Japan [25430191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the National Natural Science Foundation of China (31000309) and Grant-in-Aid (25430191) for Scientific Research from the Ministry of Education, Science and Culture, Japan.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreneche T, 1998, THEOR APPL GENET, V97, P1090, DOI 10.1007/s001220050996; Bell R., 1996, TREE TROPICAL FRUITS, P441; BIRKY CW, 1983, GENETICS, V103, P513; Cao Y, 2010, GENET RESOUR CROP EV, V59, P9; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Cuenca A, 2003, MOL ECOL, V12, P2087, DOI 10.1046/j.1365-294X.2003.01890.x; Cuizhi G., 2003, FLORA CHINA, V9, P173; De Andres MT, 2012, MOL ECOL, V21, P800, DOI 10.1111/j.1365-294X.2011.05395.x; DeVore ML, 2007, PLANT SYST EVOL, V266, P45, DOI 10.1007/s00606-007-0540-3; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farwig N, 2008, CONSERV GENET, V9, P317, DOI 10.1007/s10592-007-9343-x; Fernandez-Fernandez F, 2006, MOL ECOL NOTES, V6, P1039, DOI 10.1111/j.1471-8286.2006.01422.x; Francis CY, 1999, POPGENE MICROSOFT WI; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; Gianfranceschi L, 1998, THEOR APPL GENET, V96, P1069, DOI 10.1007/s001220050841; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Iketani H., 2012, TOPICS CONSERVATION, P43; Iketani Hiroyuki, 2003, Journal of Japanese Botany, V78, P119; Iketani H, 2010, CONSERV GENET, V11, P115, DOI 10.1007/s10592-009-0009-8; Jiao P, 2000, SPECIAL WILD EC ANIM, V1, P24; Katayama H, 2006, GENET RESOUR CROP EV, V53, P483, DOI 10.1007/s10722-004-1802-3; Katayama H, 2007, GENET RESOUR CROP EV, V54, P1573, DOI 10.1007/s10722-006-9170-9; Katayama H, 2012, TREE GENET GENOMES, V8, P313, DOI 10.1007/s11295-011-0442-y; LANGELLA O, 2001, POPULATIONS 1 2 24 P; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Liu J, 2013, TREE GENET GENOMES, V9, P433, DOI 10.1007/s11295-012-0564-x; Liu J, 2012, BIOCHEM SYST ECOL, V45, P69, DOI 10.1016/j.bse.2012.06.027; Ma T, 2011, GUANGDONG AGR SCI, V2; MANTEL N, 1967, CANCER RES, V27, P209; Millar C. I., 1992, New Forests, V6, P347, DOI 10.1007/BF00120652; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Nakai T, 1916, BOT MAG TOKYO, V30, P15; NEI M, 1983, GENETICS, V103, P557; Newton AC, 1999, TRENDS ECOL EVOL, V14, P140, DOI 10.1016/S0169-5347(98)01555-9; Nishitani C., 2005, PLANT AN GEN 8 C, P198; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Pakkad G, 2008, FOREST ECOL MANAG, V255, P1067, DOI 10.1016/j.foreco.2007.10.021; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Pritchard JK, 2010, DOCUMENTATION STRUCT; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Pu F, 1963, POMOLOGY OF CHINA, V3; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Rousset F, 1997, GENETICS, V145, P1219; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawamura Y, 2004, J JPN SOC HORTIC SCI, V73, P511, DOI 10.2503/jjshs.73.511; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; Ueno S, 2005, CONSERV GENET, V6, P563, DOI 10.1007/s10592-005-9011-y; Vavilov NI, 1951, CHRON BOT, V13, P1, DOI DOI 10.1097/00010694-195112000-00018; Volk GM, 2006, J AM SOC HORTIC SCI, V131, P408, DOI 10.21273/JASHS.131.3.408; Wehr W. C., 1994, WASHINGTON GEOL, V22, P27; Wuyun T, 2013, TREE GENET GENOMES, V9, P167, DOI 10.1007/s11295-012-0544-1; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2002, EUPHYTICA, V124, P129, DOI 10.1023/A:1015677505602; Yamamoto T, 2001, THEOR APPL GENET, V102, P865, DOI 10.1007/s001220000524; Yu T., 1979, TAXONOMY FRUIT TREE; Zong Y, 2014, PLANT MOL BIOL REP, V32, P644, DOI 10.1007/s11105-013-0680-2	64	17	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133686	10.1371/journal.pone.0133686	http://dx.doi.org/10.1371/journal.pone.0133686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252516	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100022
J	Zhi, F; Wang, Q; Xue, L; Shao, NY; Wang, R; Deng, DN; Wang, SN; Xia, XW; Yang, YL				Zhi, Feng; Wang, Qiang; Xue, Lian; Shao, Naiyuan; Wang, Rong; Deng, Danni; Wang, Suinuan; Xia, Xiwei; Yang, Yilin			The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; MALIGNANT GLIOMAS; CELL-CYCLE; CANCER; EXPRESSION; SURVIVAL; HOTAIR; ANGIOGENESIS; CONTRIBUTES	Long noncoding RNAs (lncRNAs) are pervasively transcribed and play a key role in tumorigenesis. The aim of the study was to determine the lncRNA expression profile in astrocytomas and to assess its potential clinical value. We performed a three-step analysis to establish the lncRNA profile for astrocytoma: a) the lncRNA expression was examined on 3 astrocytomas as well as 3 NATs (normal adjacent tissues) using the lncRNA microarray; b) the top-hits were validated in 40 astrocytomas (WHO grade II-IV) by quantitative real time-PCR (qRT-PCR); c) the hits with significant differences were re-evaluated using qRT-PCR in 90 astrocytomas. Finally, 7 lncRNAs were found to have a significantly different expression profile in astrocytoma samples compared to the NAT samples. Unsupervised clustering analysis further revealed the potential of the 7-lncRNA profile to differentiate between tumors and NAT samples. The upregulation of ENST00000545440 and NR_002809 was associated with advanced clinical stages of astrocytoma. Using Kaplan-Meier survival analysis, we showed that the low expression of BC002811 or XLOC_010967, or the high expression of NR_002809 was significantly associated with poor patient survival. Moreover, Cox proportional hazard regression analysis revealed that this prognostic impact was independent of other clinicopathological factors. Our results indicate that the lncRNA profile may be a potential prognostic biomarker for the prediction of post-surgical outcomes.	[Zhi, Feng; Xue, Lian; Wang, Rong; Deng, Danni; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou 213000, Jiangsu, Peoples R China; [Wang, Qiang; Shao, Naiyuan; Wang, Suinuan; Xia, Xiwei] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou 213000, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xia, XW (corresponding author), Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou 213000, Jiangsu, Peoples R China.	xia_xiwei@126.com; yilinyang.czfph@gmail.com			National Natural Science Foundation of China [31071046, 81302197]; Changzhou Social Development Project [CS20102010]; Changzhou Health Bureau Project [ZD201007]; Changzhou Science Technology Bureau Guiding Project [CY20119004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Social Development Project; Changzhou Health Bureau Project; Changzhou Science Technology Bureau Guiding Project	This work was supported by National Natural Science Foundation of China: 31071046 (YLY), 81302197 (FZ); Changzhou Social Development Project: CS20102010 (SNW); Changzhou Health Bureau Project: ZD201007 (SNW); Changzhou Science Technology Bureau Guiding Project: CY20119004 (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; El Hindy N, 2013, ANTICANCER RES, V33, P609; Fan YL, 2013, FEBS LETT, V587, P3892, DOI 10.1016/j.febslet.2013.09.029; Feng S, 2015, J MOL NEUROSCI; Fitzgerald KA, 2014, CURR OPIN IMMUNOL, V26, P140, DOI 10.1016/j.coi.2013.12.001; Gabayan AJ, 2006, NEUROSURGERY, V58, P701, DOI 10.1227/01.NEU.0000194836.07848.69; Guo H, 2015, GENE, V554, P114, DOI 10.1016/j.gene.2014.10.038; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hackermuller J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r48; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Li R, 2014, CNS NEUROSCI THER, V20, P339, DOI 10.1111/cns.12220; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma K. X., 2015, TUMOUR BIOL; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Qin XY, 2014, INT J CLIN EXP PATHO, V7, P3065; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086295; Sim H, 2009, J BIOL CHEM, V284, P26547, DOI 10.1074/jbc.M109.013185; Sivasankaran B, 2009, CANCER RES, V69, P458, DOI 10.1158/0008-5472.CAN-08-2610; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang P, 2015, CELL SIGNAL, V27, P275, DOI 10.1016/j.cellsig.2014.11.011; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan Y, 2014, J CANCER RES CLIN ON; Yao J, 2014, TUMOR BIOL, V35, P7935, DOI 10.1007/s13277-014-1949-2; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P1595, DOI 10.1093/neuonc/not131; Zhang KL, 2015, ONCOTARGET, V6, P537, DOI 10.18632/oncotarget.2681; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381; Zhang XQ, 2013, NEUROBIOL DIS, V58, P123, DOI 10.1016/j.nbd.2013.05.011; Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	35	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135242	10.1371/journal.pone.0135242	http://dx.doi.org/10.1371/journal.pone.0135242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252651	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100143
J	Leonard, CA; Schoborg, RV; Borel, N				Leonard, Cory Ann; Schoborg, Robert V.; Borel, Nicole			Damage/Danger Associated Molecular Patterns (DAMPs) Modulate Chlamydia pecorum and C-trachomatis Serovar E Inclusion Development In Vitro	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; EXTRACELLULAR ATP; EPITHELIAL-CELLS; ADENOSINE; INFECTION; PERSISTENCE; APOPTOSIS; STIMULATION; INHIBITION; INTERFERON	Persistence, more recently termed the chlamydial stress response, is a viable but noninfectious state constituting a divergence from the characteristic chlamydial biphasic developmental cycle. Damage/danger associated molecular patterns (DAMPs) are normal intracellular components or metabolites that, when released from cells, signal cellular damage/lysis. Purine metabolite DAMPs, including extracellular ATP and adenosine, inhibit chlamydial development in a species-specific manner. Viral co-infection has been shown to reversibly abrogate Chlamydia inclusion development, suggesting persistence/chlamydial stress. Because viral infection can cause host cell DAMP release, we hypothesized DAMPs may influence chlamydial development. Therefore, we examined the effect of extracellular ATP, adenosine, and cyclic AMP exposure, at 0 and 14 hours post infection, on C. pecorum and C. trachomatis serovar E development. In the absence of de novo host protein synthesis, exposure to DAMPs immediately post or at 14 hours post infection reduced inclusion size; however, the effect was less robust upon 14 hours post infection exposure. Additionally, upon exposure to DAMPs immediately post infection, bacteria per inclusion and subsequent infectivity were reduced in both Chlamydia species. These effects were reversible, and C. pecorum exhibited more pronounced recovery from DAMP exposure. Aberrant bodies, typical in virus-induced chlamydial persistence, were absent upon DAMP exposure. In the presence of de novo host protein synthesis, exposure to DAMPs immediately post infection reduced inclusion size, but only variably modulated chlamydial infectivity. Because chlamydial infection and other infections may increase local DAMP concentrations, DAMPs may influence Chlamydia infection in vivo, particularly in the context of poly-microbial infections.	[Leonard, Cory Ann; Borel, Nicole] Univ Zurich, Inst Vet Pathol, Dept Pathobiol, Zurich, Switzerland; [Schoborg, Robert V.] E Tennessee State Univ, James H Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Dept Biomed Sci,Ctr Inflammat, Johnson City, TN 37614 USA	University of Zurich; East Tennessee State University	Borel, N (corresponding author), Univ Zurich, Inst Vet Pathol, Dept Pathobiol, Zurich, Switzerland.	N.Borel@access.uzh.ch	Leonard, Cory Ann/ABA-4841-2021; Borel, Nicole/M-6204-2016; Borel, Nicole/GPP-1073-2022	Leonard, Cory Ann/0000-0003-0711-5006; Borel, Nicole/0000-0002-1556-9262; Borel, Nicole/0000-0002-1556-9262	 [310030_147026]		This work was supported by 310030_147026, www.snf.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA., 2010, PATHOGENESIS BACTERI, P575; BAKER DC, 1981, BIOCHEM PHARMACOL, V30, P1159, DOI 10.1016/0006-2952(81)90460-3; Bankir L, 2002, AM J PHYSIOL-RENAL, V282, pF376, DOI 10.1152/ajprenal.00202.2001; Borel N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-201; Broggi A, 2015, MOL IMMUNOL, V63, P127, DOI 10.1016/j.molimm.2014.06.037; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Coutinho-Silva R, 2001, AM J PHYSIOL-CELL PH, V280, pC81, DOI 10.1152/ajpcell.2001.280.1.C81; Coutinho-Silva R, 2009, PURINERG SIGNAL, V5, P197, DOI 10.1007/s11302-009-9130-x; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Duan EZ, 2014, VIROLOGY, V468, P1, DOI 10.1016/j.virol.2014.07.046; Engstrom P, 2015, INT J MED MICROBIOL, V305, P378, DOI 10.1016/j.ijmm.2015.02.007; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Hall JV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00158; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; HOLT S, 1967, AM J OPHTHALMOL, V63, P1057, DOI 10.1016/0002-9394(67)94083-4; KALTENBOECK B, 1992, AM J VET RES, V53, P1482; KAUL R, 1986, J BACTERIOL, V168, P722, DOI 10.1128/jb.168.2.722-727.1986; Marti H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102239; Miyairi I, 2006, CURR OPIN MICROBIOL, V9, P102, DOI 10.1016/j.mib.2005.12.004; Pettengill MA, 2012, INFECT IMMUN, V80, P4232, DOI 10.1128/IAI.00441-12; Pettengill MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008299; Pettigrew MM, 2014, INFECT IMMUN, V82, P4607, DOI 10.1128/IAI.02225-14; Prusty BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047427; Raulston JE, 1997, INFECT IMMUN, V65, P4539, DOI 10.1128/IAI.65.11.4539-4547.1997; RIPA KT, 1977, J CLIN MICROBIOL, V6, P328; Robison G., 2012, CYCLIC AMP; Roshick C, 2006, INFECT IMMUN, V74, P225, DOI 10.1128/IAI.74.1.225-238.2006; ROTHERMEL CD, 1983, INFECT IMMUN, V39, P362, DOI 10.1128/IAI.39.1.362-370.1983; Schachter J, 1999, CHLAMYDIA, P139; Schneider C, 2001, BBA-MOL CELL RES, V1538, P190, DOI 10.1016/S0167-4889(01)00069-6; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; Schoborg RV, 2014, FRONT CELL INFECT MI, V4, DOI [10.3389/fcimb.2014.00097, 10.3389/fcimb.2014.00020]; Seror C, 2011, J EXP MED, V208, P1823, DOI 10.1084/jem.20101805; Tovar-y-Romo LB, 2013, J NEUROIMMUNE PHARM, V8, P998, DOI 10.1007/s11481-013-9471-7; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; WARD ME, 1982, J GEN MICROBIOL, V128, P639; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Ying SM, 2008, J INFECT DIS, V198, P1536, DOI 10.1086/592755; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	43	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134943	10.1371/journal.pone.0134943	http://dx.doi.org/10.1371/journal.pone.0134943			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248286	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000359062300080
J	Marini, L; Baseggio, A; Drago, A; Martini, S; Manella, P; Romi, R; Mazzon, L				Marini, Lorenzo; Baseggio, Alberto; Drago, Andrea; Martini, Simone; Manella, Paolo; Romi, Roberto; Mazzon, Luca			Efficacy of Two Common Methods of Application of Residual Insecticide for Controlling the Asian Tiger Mosquito, Aedes albopictus (Skuse), in Urban Areas	PLOS ONE			English	Article							SPRAY NOZZLE SYSTEMS; ADULT MOSQUITOS; VOLUME; CHIKUNGUNYA; CALIFORNIA; OUTBREAK; DIPTERA; TRANSMISSION; PYRETHROIDS; CULICIDAE	After its first introduction in the 1980's the Asian tiger mosquito, Aedes albopictus (Skuse), has spread throughout Southern Europe. Ae. albopictus is considered an epidemiologically important vector for the transmission of many viral pathogens such as the yellow fever virus, dengue fever and Chikungunya fever, as well as several filarial nematodes such as Dirofilaria immitis or D. repens. It is therefore crucial to develop measures to reduce the risks of disease transmission by controlling the vector populations. The aim of the study was to compare the efficacy of two application techniques (mist vs. stretcher sprayer) and two insecticides (Etox based on the nonester pyrethroid Etofenprox vs. Microsin based on the pyrethroid type II Cypermetrin) in controlling adult tiger mosquito populations in highly populated areas. To test the effect of the two treatments pre- and post-treatment human landing rate counts were conducted for two years. After one day from the treatment we observed a 100% population decrease in mosquito abundance with both application methods and both insecticides. However, seven and 14 days after the application the stretcher sprayer showed larger population reductions than the mist sprayer. No effect of insecticide type after one day and 14 days was found, while Etox caused slightly higher population reduction than Microsin after seven days. Emergency measures to locally reduce the vector populations should adopt adulticide treatments using stretcher sprayers. However, more research is still needed to evaluate the potential negative effects of adulticide applications on non-target organisms.	[Marini, Lorenzo; Mazzon, Luca] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, PD, Italy; [Baseggio, Alberto] INDIA Srl, Arre, PD, Italy; [Drago, Andrea; Martini, Simone] Entostudio Snc, Brugine, PD, Italy; [Manella, Paolo] ACTIVA Srl, Milan, Italy; [Romi, Roberto] Ist Super Sanita, Vector Borne Dis & Int Hlth Unit, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy	University of Padua; Istituto Superiore di Sanita (ISS)	Mazzon, L (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, PD, Italy.		Mazzon, Luca/AAY-7312-2020; Mazzon, Luca/AAG-8378-2021; Marini, Lorenzo/B-1119-2009	Mazzon, Luca/0000-0002-8459-893X; Marini, Lorenzo/0000-0001-7429-7685	INDIA srl; Entostudio snc or ACTIVA srl	INDIA srl; Entostudio snc or ACTIVA srl	The authors received no specific funding for this work. INDIA srl, Entostudio snc or ACTIVA srl, provided support in the form of salaries for authors AB, AD, SM and PM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Amoo AOJ, 2008, J AM MOSQUITO CONTR, V24, P543, DOI 10.2987/08-5783.1; [Anonymous], 2014, R LANG ENV STAT COMP; Baldacchino F, 2015, PEST MANAG IN PRESS, DOI [10.1002/ps.04044, DOI 10.1002/PS.04044]; Bengoa M, 2014, J AM MOSQUITO CONTR, V30, P42, DOI 10.2987/13-6378.1; Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x; Boyce WM, 2007, J AM MOSQUITO CONTR, V23, P335, DOI 10.2987/8756-971X(2007)23[335:NEOTMA]2.0.CO;2; Cancrini G, 2003, VET PARASITOL, V118, P195, DOI 10.1016/j.vetpar.2003.10.011; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Chaskopoulou A, 2011, J AM MOSQUITO CONTR, V27, P414, DOI 10.2987/11-6177.1; Cilek JE, 2006, J AM MOSQUITO CONTR, V22, P725, DOI 10.2987/8756-971X(2006)22[725:REOPFA]2.0.CO;2; Dukes J, 2004, J AM MOSQUITO CONTR, V20, P27; Dukes J, 2004, J AM MOSQUITO CONTR, V20, P36; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Hawley AH, 1988, J AM MOSQUITO CONTR, V4, P2; Lothrop HD, 2008, VECTOR-BORNE ZOONOT, V8, P475, DOI 10.1089/vbz.2007.0238; Madon MB, 2003, J AM MOSQUITO CONTR, V19, P297; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; MULLA MS, 1971, J ECON ENTOMOL, V64, P300, DOI 10.1093/jee/64.1.300; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rodrigues HS, 2013, INT J COMPUT MATH, V90, P2126, DOI 10.1080/00207160.2013.790536; Romi R, 2009, GUIDELINES CONTROL P; Romi R, 2010, EUR INFECT DIS, V2, P98; Sreehari U, 2009, INDIAN J MED RES, V129, P593; TAYLOR RT, 1971, MOSQ NEWS, V31, P346; WHO, 2006, EQ VECT CONTR SPEC G	31	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134831	10.1371/journal.pone.0134831	http://dx.doi.org/10.1371/journal.pone.0134831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248028	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300068
J	Samir, P; Rahul; Slaughter, JC; Link, AJ				Samir, Parimal; Rahul; Slaughter, James C.; Link, Andrew J.			Environmental Interactions and Epistasis Are Revealed in the Proteomic Responses to Complex Stimuli	PLOS ONE			English	Article							GENE-COEXPRESSION NETWORK; SACCHAROMYCES-CEREVISIAE; MIXTURE TOXICITY; PHENOTYPIC PLASTICITY; GROWTH-RATE; TUMOR MICROENVIRONMENT; EXPRESSION; CLASSIFICATION; EVOLUTION; GLYCEROL	Ultimately, the genotype of a cell and its interaction with the environment determine the cell's biochemical state. While the cell's response to a single stimulus has been studied extensively, a conceptual framework to model the effect of multiple environmental stimuli applied concurrently is not as well developed. In this study, we developed the concepts of environmental interactions and epistasis to explain the responses of the S. cerevisiae proteome to simultaneous environmental stimuli. We hypothesize that, as an abstraction, environmental stimuli can be treated as analogous to genetic elements. This would allow modeling of the effects of multiple stimuli using the concepts and tools developed for studying gene interactions. Mirroring gene interactions, our results show that environmental interactions play a critical role in determining the state of the proteome. We show that individual and complex environmental stimuli behave similarly to genetic elements in regulating the cellular responses to stimuli, including the phenomena of dominance and suppression. Interestingly, we observed that the effect of a stimulus on a protein is dominant over other stimuli if the response to the stimulus involves the protein. Using publicly available transcriptomic data, we find that environmental interactions and epistasis regulate transcriptomic responses as well.	[Samir, Parimal; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Rahul] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Slaughter, James C.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Link, Andrew J.] Vanderbilt Univ, Dept Chem, Nashville, TN USA	Vanderbilt University; University of Waterloo; Vanderbilt University; Vanderbilt University; Vanderbilt University	Link, AJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	andrew.link@vanderbilt.edu	Samir, Parimal/N-4144-2014	Samir, Parimal/0000-0001-7655-5713; Slaughter, James/0000-0002-8770-980X	NIH [GM064779]; Vanderbilt University School of Medicine IDEAS Program grant [1-04-066-9530]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University School of Medicine IDEAS Program grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AJL and PS were supported by NIH grant GM064779 and Vanderbilt University School of Medicine IDEAS Program grant 1-04-066-9530 to AJL.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Altenburger R, 2004, ENVIRON SCI TECHNOL, V38, P6353, DOI 10.1021/es049528k; Altenburger R, 2003, ENVIRON TOXICOL CHEM, V22, P1900, DOI 10.1897/01-386; Altenburger R, 2013, ENVIRON TOXICOL CHEM, V32, P1685, DOI 10.1002/etc.2294; Altenburger R, 2012, ENVIRON SCI TECHNOL, V46, P2508, DOI 10.1021/es2038036; Amberg DC., 2005, METHODS YEAST GENETI; Bateson W, 1909, MENDELS PRINCIPLES H; Belden JB, 2007, INTEGR ENVIRON ASSES, V3, P364, DOI 10.1002/ieam.5630030307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Brachmann CB, 1998, YEAST, V14, P115; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Browne CM, 2013, MOL CELL BIOL, V33, P1041, DOI 10.1128/MCB.00811-12; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; De Nicola R, 2007, APPL ENVIRON MICROB, V73, P7680, DOI 10.1128/AEM.01445-07; de Visser JAGM, 2011, P ROY SOC B-BIOL SCI, V278, P3617, DOI 10.1098/rspb.2011.1537; Deneer JW, 2000, PEST MANAG SCI, V56, P516, DOI 10.1002/(SICI)1526-4998(200006)56:6<516::AID-PS163>3.0.CO;2-0; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faust M, 2001, AQUAT TOXICOL, V56, P13, DOI 10.1016/S0166-445X(01)00187-4; Fisher, 1958, GENETICAL THEORY NAT; Gao H, 2010, GENETICS, V184, P827, DOI 10.1534/genetics.109.111120; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GERARD JF, 1993, J THEOR BIOL, V164, P341, DOI 10.1006/jtbi.1993.1158; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hallgrimsdottir IB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-17; Hazlehurst LA, 2003, ONCOGENE, V22, P7396, DOI 10.1038/sj.onc.1206943; HERMENS J, 1985, ECOTOX ENVIRON SAFE, V9, P321, DOI 10.1016/0147-6513(85)90049-1; Hoek KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118528; Kanani Harin, 2010, BMC Syst Biol, V4, P177, DOI 10.1186/1752-0509-4-177; Knijnenburg TA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-25; Knijnenburg TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-53; Kolaczyk ED., 2014, STAT ANAL NETWORK DA; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee JH, 2006, ENVIRON SCI TECHNOL, V40, P1341, DOI 10.1021/es051120f; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Nagano AJ, 2012, CELL, V151, P1358, DOI 10.1016/j.cell.2012.10.048; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pierce BA., 2005, GENETICS CONCEPTUAL; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Riezman H, 2004, CELL CYCLE, V3, P61; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; SCHLICHTING CD, 1993, AM NAT, V142, P366, DOI 10.1086/285543; Schoen ED, 1996, FOOD CHEM TOXICOL, V34, P1059, DOI 10.1016/S0278-6915(97)00075-6; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slavov N, 2011, MOL BIOL CELL, V22, P1997, DOI 10.1091/mbc.E11-02-0132; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tonsor SJ, 2013, EVOLUTION, V67, P2923, DOI 10.1111/evo.12175; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vaga S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145112; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VAUPEL P, 1989, CANCER RES, V49, P6449; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; WILSON M, 1993, APPL ENVIRON MICROB, V59, P410, DOI 10.1128/AEM.59.2.410-416.1993; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	85	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134099	10.1371/journal.pone.0134099	http://dx.doi.org/10.1371/journal.pone.0134099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247773	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300026
J	Visseaux, B; Charpentier, C; Collin, G; Bertine, M; Peytavin, G; Damond, F; Matheron, S; Lefebvre, E; Brun-Veezinet, F; Descamps, D				Visseaux, Benoit; Charpentier, Charlotte; Collin, Gilles; Bertine, Melanie; Peytavin, Gilles; Damond, Florence; Matheron, Sophie; Lefebvre, Eric; Brun-Vezinet, Francoise; Descamps, Diane		ANRS CO5 HIV-2 Cohort	Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; PHENOTYPIC SUSCEPTIBILITY; REVERSE-TRANSCRIPTASE; CORECEPTOR USAGE; SALVAGE THERAPY; INHIBITORS; INFECTION; CELLS	Background Maraviroc activity against HIV-2, a virus naturally resistant to different HIV-1 antiretroviral drugs, has been recently demonstrated. The aim of this study was to assess HIV-2 susceptibility to cenicriviroc, a novel, once-daily, dual CCR5 and CCR2 antagonist that has completed Phase 2b development in HIV-1 infection. Methods Cenicriviroc phenotypic activity has been tested using a PBMC phenotypic susceptibility assay against four R5-, one X4-and one dual-tropic HIV-2 clinical primary isolates. All isolates were obtained by co-cultivation of PHA-activated PBMC from distinct HIV-2-infected CCR5-antagonist-naive patients included in the French HIV-2 cohort and were previously tested for maraviroc susceptibility using the same protocol. HIV-2 tropism was determined by phenotypic assay using Ghost(3) cell lines. Results Regarding the 4 R5 HIV-2 clinical isolates tested, effective concentration 50% EC50 for cenicriviroc were 0.03, 0.33, 0.45 and 0.98 nM, similar to those observed with maraviroc: 1.13, 0.58, 0.48 and 0.68 nM, respectively. Maximum percentages of inhibition (MPI) of cenicriviroc were 94, 94, 93 and 98%, similar to those observed with maraviroc (93, 90, 82, 100%, respectively). The dual-and X4-tropic HIV-2 strains were resistant to cenicriviroc with EC50 > 1000 nM and MPI at 33% and 4%, respectively. Conclusions In this first study assessing HIV-2 susceptibility to cenicriviroc, we observed an in vitro activity against HIV-2 R5-tropic strains similar to that observed with maraviroc. Thus, cenicriviroc may offer a once-daily treatment opportunity in the limited therapeutic arsenal for HIV-2. Clinical studies are warranted.	[Visseaux, Benoit; Charpentier, Charlotte; Collin, Gilles; Bertine, Melanie; Peytavin, Gilles; Damond, Florence; Matheron, Sophie; Brun-Vezinet, Francoise; Descamps, Diane] INSERM, IAME, UMR 1137, Paris, France; [Visseaux, Benoit; Charpentier, Charlotte; Collin, Gilles; Bertine, Melanie; Peytavin, Gilles; Damond, Florence; Matheron, Sophie; Brun-Vezinet, Francoise; Descamps, Diane] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, Paris, France; [Visseaux, Benoit; Charpentier, Charlotte; Collin, Gilles; Bertine, Melanie; Damond, Florence; Brun-Vezinet, Francoise; Descamps, Diane] Hop Bichat Claude Bernard, AP HP, Virol Lab, F-75877 Paris, France; [Peytavin, Gilles] Hop Bichat Claude Bernard, AP HP, Pharmacol Antiretroviraux, F-75877 Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris, France; [Lefebvre, Eric] Tobira Therapeut Inc, San Francisco, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Visseaux, B (corresponding author), INSERM, IAME, UMR 1137, Paris, France.	benoit.visseaux@aphp.fr	Charpentier, Charlotte/C-3579-2019; Matheron, Sophie/D-7420-2017	Matheron, Sophie/0000-0001-7879-6553; MARCHOU, Bruno/0000-0002-0673-2945; Arvieux, Cedric/0000-0003-2332-2507; PLANTIER, Jean-Christophe/0000-0001-6417-4083; VABRET, Astrid/0000-0002-8940-7645; Fafi-Kremer, Samira/0000-0003-3886-7833	French National Agency for Research on AIDS; Viral Hepatitis (ANRS); Tobira Pharmaceutics	French National Agency for Research on AIDS(ANRS); Viral Hepatitis (ANRS)(ANRS); Tobira Pharmaceutics	Tobira Pharmaceutics graciously provided cenicriviroc. All the other experimental costs were supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). Tobira Pharmaceutics provided support in the form of salaries for author E.L., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Armstrong-James D, 2010, ANTIVIR RES, V86, P224, DOI 10.1016/j.antiviral.2010.02.324; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Borrego P, 2012, ANTIVIR THER, V17, P565, DOI 10.3851/IMP1996; BRUNVEZINET F, 1992, J VIROL METHODS, V37, P177, DOI 10.1016/0166-0934(92)90045-F; Caixas U, 2012, J ANTIMICROB CHEMOTH, V67, P2538, DOI 10.1093/jac/dks240; Calado M, 2010, VIROLOGY, V408, P174, DOI 10.1016/j.virol.2010.09.020; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; Espirito-Santo M, 2012, AIDS RES HUM RETROV, V28, P478, DOI [10.1089/aid.2011.0124, 10.1089/AID.2011.0124]; Feinberg J, 2013, COMBINATION EMTRICIT; Gathe J, 2013, TREATMENT NAIVE HIV; Lalezari J, 2011, JAIDS-J ACQ IMM DEF, V57, P118, DOI 10.1097/QAI.0b013e318213c2c0; Marier JF, 2011, ANTIMICROB AGENTS CH, V55, P2768, DOI 10.1128/AAC.00713-10; McKnight A, 1998, J VIROL, V72, P4065, DOI 10.1128/JVI.72.5.4065-4071.1998; Menning MM, 2013, MOL PHARMACEUT, V10, P4005, DOI 10.1021/mp400286s; Morner A, 2002, AIDS RES HUM RETROV, V18, P193, DOI 10.1089/08892220252781248; Morner A, 1999, J VIROL, V73, P2343; Poveda E, 2005, AIDS REV, V7, P139; Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Stegmann S, 2010, J CLIN VIROL, V47, P79, DOI 10.1016/j.jcv.2009.11.008; Visseaux B, 2012, J INFECT DIS; Visseaux B, 2012, ANTIMICROB AGENTS CH, V56, P137, DOI 10.1128/AAC.05313-11; Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000	23	8	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134904	10.1371/journal.pone.0134904	http://dx.doi.org/10.1371/journal.pone.0134904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247470	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300074
J	Choo, MKK; El-Bassel, N; Adam, PCG; Gilbert, L; Wu, E; West, BS; Bazazi, AR; De Wit, JBF; Ismail, R; Kamarulzaman, A				Choo, Martin K. K.; El-Bassel, Nabila; Adam, Philippe C. G.; Gilbert, Louisa; Wu, Elwin; West, Brooke S.; Bazazi, Alexander R.; De Wit, John B. F.; Ismail, Rusli; Kamarulzaman, Adeeba			Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen	PLOS ONE			English	Article							INJECTING DRUG-USERS; HIDDEN POPULATIONS; GLOBAL EPIDEMIOLOGY; RESPONDENT; COMMUNITIES; FISHERFOLK; HIV/AIDS; PEOPLE	Fishermen in Southeast Asia have been found to be highly vulnerable to HIV, with research evidence highlighting the role of sexual risk behaviors. This study aims to estimate the rate of HIV as well as hepatitis C virus (HCV) infections among Malaysian fishermen, and the risky sexual and injection drug use behaviors that may contribute to these infections. The study also includes an assessment of socio-demographic, occupational and behavioral correlates of testing positive for HIV or HCV, and socio-demographic and occupational correlates of risk behaviors. The study had a cross-sectional design and recruited 406 fishermen through respondent-driven sampling (RDS). Participants self-completed a questionnaire and provided biological specimens for HIV and HCV testing. We conducted and compared results of analyses of both unweighted data and data weighted with the Respondent-Driven Sampling Analysis Tool (RDSAT). Of the participating fishermen, 12.4% were HIV positive and 48.6% had HCV infection. Contrary to expectations and findings from previous research, most fishermen (77.1%) were not sexually active. More than a third had a history of injection drug use, which often occurred during fishing trips on commercial vessels and during longer stays at sea. Of the fishermen who injected drugs, 42.5% reported unsafe injection practices in the past month. Reporting a history of injection drug use increased the odds of testing HIV positive by more than 6 times (AOR = 6.22, 95% CIs [2.74, 14.13]). Most fishermen who injected drugs tested positive for HCV. HCV infection was significantly associated with injection drug use, being older than 25 years, working on a commercial vessel and spending four or more days at sea per fishing trip. There is an urgent need to strengthen current harm reduction and drug treatment programs for Malaysian fishermen who inject drugs, especially among fishermen who work on commercial vessels and engage in deep-sea fishing.	[Choo, Martin K. K.; Ismail, Rusli; Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [El-Bassel, Nabila; Gilbert, Louisa; Wu, Elwin; West, Brooke S.] Columbia Univ, Sch Social Work, Social Intervent Grp, New York, NY USA; [Adam, Philippe C. G.; De Wit, John B. F.] UNSW Australia, Fac Arts & Social Sci, Ctr Social Res Hlth, Sydney, NSW, Australia; [Bazazi, Alexander R.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Universiti Malaya; Columbia University; University of New South Wales Sydney; Yale University	Choo, MKK (corresponding author), Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	martin.ceria@um.edu.my	KAMARULZAMAN, ADEEBA/B-5216-2010; Ismail, Rusli/B-1863-2018	West, Brooke S./0000-0003-0496-5769; Ismail, Rusli/0000-0001-5831-1504; Bazazi, Alexander/0000-0002-4284-5082	Malaysian Ministry of Education High Impact Research Grant on Mitigating the Malaysian HIV Epidemic through a Comprehensive Research Programme [E-000001-20001]; World Bank [7159547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA039716] Funding Source: NIH RePORTER	Malaysian Ministry of Education High Impact Research Grant on Mitigating the Malaysian HIV Epidemic through a Comprehensive Research Programme; World Bank(The World Bank India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Malaysian Ministry of Education High Impact Research Grant on Mitigating the Malaysian HIV Epidemic through a Comprehensive Research Programme (E-000001-20001) and the World Bank (7159547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Allison EH, 2004, FISH FISH, V5, P215, DOI 10.1111/j.1467-2679.2004.00153.x; Asian Development Bank, 2006, FISH POL SPEC EV STU; Bain I, 1998, INT MIGR, V36, P553, DOI 10.1111/1468-2435.00059; Berkes F., 2001, MANAGING SMALL SCALE; Department of Fisheries, 2010, ANN FISH STAT 2010; Department of Statistics, 2005, STAT MAL; DOWLINGGUYER S, 1994, ASSESSMENT, V0001; Entz AT, 2000, AIDS, V14, P1027, DOI 10.1097/00002030-200005260-00015; Ford K, 2008, AIDS EDUC PREV, V20, P454, DOI 10.1521/aeap.2008.20.5.454; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Janjua NZ, 2010, J VIRAL HEPATITIS, V17, P317, DOI 10.1111/j.1365-2893.2009.01230.x; Johnston L., 2008, BEHAV SURVEILLANCE I; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Len R.G., 2008, TRANSNATIONAL TRENDS, P171; Lock G, 2006, J VIRAL HEPATITIS, V13, P571, DOI 10.1111/j.1365-2893.2006.00735.x; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2009, JAIDS-J ACQ IMM DEF, V52, pS132, DOI 10.1097/QAI.0b013e3181baf0c5; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Merten S, 2007, CULT HEALTH SEX, V9, P69, DOI 10.1080/13691050600965968; Mojola SA, 2011, SOC SCI MED, V72, P149, DOI 10.1016/j.socscimed.2010.11.006; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Samnang P, 2004, INT J STD AIDS, V15, P479, DOI 10.1258/0956462041211315; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Setiawan IM, 2010, INT MARIT HEALTH, V61, P201; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Sugiyama S., 2004, STATUS POTENTIAL FIS; Tanguay P., 2011, IDPC BRIEFING PAPER; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Vicknasingam B, 2009, DRUG ALCOHOL REV, V28, P447, DOI 10.1111/j.1465-3362.2009.00087.x; Volz E., 2012, RESPONDENT DRIVEN SA; Volz E, 2008, J OFF STAT, V24, P79; Zulkifli SN, 2000, J ADOLESCENT HEALTH, V27, P276, DOI 10.1016/S1054-139X(00)00099-9	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0118422	10.1371/journal.pone.0118422	http://dx.doi.org/10.1371/journal.pone.0118422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244844	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400001
J	Mizukami, T; Abe, Y; Maki, K				Mizukami, Takuya; Abe, Yukiko; Maki, Kosuke			Evidence for a Shared Mechanism in the Formation of Urea-Induced Kinetic and Equilibrium Intermediates of Horse Apomyoglobin from Ultrarapid Mixing Experiments	PLOS ONE			English	Article							MOLTEN GLOBULE INTERMEDIATE; FOLDING INITIATION SITES; PH 4 INTERMEDIATE; MICROSECOND TIME-SCALE; SIDE-CHAIN PACKING; STRUCTURAL-CHARACTERIZATION; ALPHA-LACTALBUMIN; CYTOCHROME-C; PEPTIDE MODELS; DYNAMIC CHARACTERIZATION	In this study, the equivalence of the kinetic mechanisms of the formation of urea-induced kinetic folding intermediates and non-native equilibrium states was investigated in apomyoglobin. Despite having similar structural properties, equilibrium and kinetic intermediates accumulate under different conditions and via different mechanisms, and it remains unknown whether their formation involves shared or distinct kinetic mechanisms. To investigate the potential mechanisms of formation, the refolding and unfolding kinetics of horse apomyoglobin were measured by continuous- and stopped-flow fluorescence over a time range from approximately 100 mu s to 10 s, along with equilibrium unfolding transitions, as a function of urea concentration at pH 6.0 and 8 degrees C. The formation of a kinetic intermediate was observed over a wider range of urea concentrations (0-2.2 M) than the formation of the native state (0-1.6 M). Additionally, the kinetic intermediate remained populated as the predominant equilibrium state under conditions where the native and unfolded states were unstable (at similar to 0.7-2 M urea). A continuous shift from the kinetic to the equilibrium intermediate was observed as urea concentrations increased from 0 M to similar to 2 M, which indicates that these states share a common kinetic folding mechanism. This finding supports the conclusion that these intermediates are equivalent. Our results in turn suggest that the regions of the protein that resist denaturant perturbations form during the earlier stages of folding, which further supports the structural equivalence of transient and equilibrium intermediates. An additional folding intermediate accumulated within similar to 140 mu s of refolding and an unfolding intermediate accumulated in <1 ms of unfolding. Finally, by using quantitative modeling, we showed that a five-state sequential scheme appropriately describes the folding mechanism of horse apomyoglobin.	[Mizukami, Takuya; Abe, Yukiko; Maki, Kosuke] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan	Nagoya University	Maki, K (corresponding author), Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan.	k_maki@synapse.phys.nagoya-u.ac.jp			Japan Society for the Promotion of Science [24570181, 20570153]; Yamada Science Foundation; Research Foundation for the Electrotechnology of Chubu; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamada Science Foundation; Research Foundation for the Electrotechnology of Chubu(Research Foundation for the Electrotechnology of Chubu); Naito Foundation(Naito Memorial Foundation)	This study was supported by Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (project numbers: 24570181 and 20570153), and by a grant from the Yamada Science Foundation for the Promotion of the Natural Sciences. Funding was also received from the Research Foundation for the Electrotechnology of Chubu and The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BALESTRIERI C, 1976, FEBS LETT, V66, P60, DOI 10.1016/0014-5793(76)80585-6; BARRICK D, 1993, BIOCHEMISTRY-US, V32, P3790, DOI 10.1021/bi00065a035; BRESLOW E, 1962, J BIOL CHEM, V237, P3308; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COCCO MJ, 1994, PROTEIN SCI, V3, P267; Colon W, 1996, BIOCHEMISTRY-US, V35, P5538, DOI 10.1021/bi960052u; CRUMPTON MJ, 1965, J MOL BIOL, V11, P722, DOI 10.1016/S0022-2836(65)80030-4; Dasmeh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080308; Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Feng ZY, 1999, BIOCHEMISTRY-US, V38, P14433, DOI 10.1021/bi991933e; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; HARRISON SC, 1965, J BIOL CHEM, V240, P299; Haruta N, 2002, BIOCHEMISTRY-US, V41, P6595, DOI 10.1021/bi012027g; Huang CY, 2001, J AM CHEM SOC, V123, P9235, DOI 10.1021/ja0158814; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; IKEGUCHI M, 1986, BIOCHEMISTRY-US, V25, P6965, DOI 10.1021/bi00370a034; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jamin M, 1998, J MOL BIOL, V276, P491, DOI 10.1006/jmbi.1997.1543; Jamin M, 2005, PROTEIN PEPTIDE LETT, V12, P229, DOI 10.2174/0929866053587174; Jamin M, 1999, J MOL BIOL, V292, P731, DOI 10.1006/jmbi.1999.3074; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; KATAOKA M, 1995, J MOL BIOL, V249, P215, DOI 10.1006/jmbi.1995.0290; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010; Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055; Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1; LOH SN, 1995, P NATL ACAD SCI USA, V92, P5446, DOI 10.1073/pnas.92.12.5446; Luo YZ, 1997, NAT STRUCT BIOL, V4, P925, DOI 10.1038/nsb1197-925; Matsumoto S, 2007, J AM CHEM SOC, V129, P3840, DOI 10.1021/ja0660958; Nishiguchi S, 2007, J MOL BIOL, V373, P491, DOI 10.1016/j.jmb.2007.08.003; Nishimura C, 2003, J MOL BIOL, V334, P293, DOI 10.1016/j.jmb.2003.09.042; Onufriev A, 2003, J MOL BIOL, V325, P555, DOI 10.1016/S0022-2836(02)01207-X; Pace C N, 1986, Methods Enzymol, V131, P266; PETERMAN BF, 1979, ANAL BIOCHEM, V93, P442, DOI 10.1016/S0003-2697(79)80176-1; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Regis WCB, 2005, ARCH BIOCHEM BIOPHYS, V436, P168, DOI 10.1016/j.abb.2005.01.016; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; Roder H, 2006, CHEM REV, V106, P1836, DOI 10.1021/cr040430y; Sabelko J, 1998, J PHYS CHEM B, V102, P1806, DOI 10.1021/jp973178p; Samatova EN, 2010, BIOPHYS J, V98, P1694, DOI 10.1016/j.bpj.2009.12.4326; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Shastry MCR, 1998, BIOPHYS J, V74, P2714, DOI 10.1016/S0006-3495(98)77977-9; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; SHIN HC, 1993, BIOCHEMISTRY-US, V32, P6348, DOI 10.1021/bi00076a007; SHIN HC, 1993, BIOCHEMISTRY-US, V32, P6356, DOI 10.1021/bi00076a008; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; TIRADORIVES J, 1993, BIOCHEMISTRY-US, V32, P4175, DOI 10.1021/bi00067a004; Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45; Uzawa T, 2004, P NATL ACAD SCI USA, V101, P1171, DOI 10.1073/pnas.0305376101; Uzawa T, 2008, P NATL ACAD SCI USA, V105, P13859, DOI 10.1073/pnas.0804033105; Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476; WALTHO JP, 1993, BIOCHEMISTRY-US, V32, P6337, DOI 10.1021/bi00076a006; WRIGHT PE, 2000, MECH PROTEIN FOLDING, P309; WU LC, 1995, NAT STRUCT BIOL, V2, P281, DOI 10.1038/nsb0495-281; Xu M, 2012, J PHYS CHEM B, V116, P7014, DOI 10.1021/jp3012365; Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i; Zhu L, 2013, J PHYS CHEM B, V117, P7868, DOI 10.1021/jp400174e	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134238	10.1371/journal.pone.0134238	http://dx.doi.org/10.1371/journal.pone.0134238			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244984	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400072
J	Santos, CF; Morandini, AC; Dionisio, TJ; Faria, FA; Lima, MC; Figueiredo, CM; Colombini-Ishikiriama, BL; Sipert, CR; Maciel, RP; Akashi, AP; Souza, GP; Garlet, GP; Rodini, CO; Amaral, SL; Becari, C; Salgado, MC; Oliveira, EB; Matus, I; Didier, DN; Greene, AS				Santos, Carlos F.; Morandini, Ana C.; Dionisio, Thiago J.; Faria, Flavio A.; Lima, Marta C.; Figueiredo, Caio M.; Colombini-Ishikiriama, Bella L.; Sipert, Carla R.; Maciel, Rubens P.; Akashi, Ana P.; Souza, Gabriela P.; Garlet, Gustavo P.; Rodini, Camila O.; Amaral, Sandra L.; Becari, Christiane; Salgado, Maria C.; Oliveira, Eduardo B.; Matus, Isaac; Didier, Daniela N.; Greene, Andrew S.			Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KAPPA-B LIGAND; TNF FAMILY-MEMBER; CONVERTING-ENZYME; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; PORPHYROMONAS-GINGIVALIS; INHIBITORY FACTOR; II RECEPTORS; BONE LOSS	The initiation or progression of periodontitis might involve a local renin-angiotensin system (RAS) in periodontal tissue. The aim of this study was to further characterize the local RAS in human and rat periodontal tissues between healthy and periodontally-affected tissue. Components of the RAS were investigated using in vitro, ex vivo and in vivo experiments involving both human and Wistar rat periodontium. Although not upregulated when challenged with P. gingivalis-lipopolysaccharide, human gingival and periodontal ligament fibroblasts expressed RAS components. Likewise, healthy and inflamed human gingiva expressed RAS components, some of which were shown to be functional, yet no differences in expression were found between healthy and diseased gingiva. However, in inflamed tissue the immunoreactivity was greater for the AT(1)R compared to AT(2)R in fibroblasts. When compared to healthy tissue, ACE activity was increased in human gingiva from volunteers with gingivitis. Human-gingiva homogenates generated Ang II, Ang 1-9 and Ang 1-7 when incubated with precursors. In gingiva homogenates, Ang II formation from Ang I was nearly abolished only when captopril and chymostatin were combined. Ang 1-7 formation was significantly greater when human gingiva homogenates were incubated with chymostatin alone compared to incubation without any inhibitor, only captopril, or captopril and chymostatin. In rat gingiva, RAS components were also found; their expression was not different between healthy and experimentally induced periodontitis (EP) groups. However, renin inhibition (aliskiren) and an AT(1)R antagonist (losartan) significantly blocked EP-alveolar-bone loss in rats. Collectively, these data are consistent with the hypothesis that a local RAS system is not only present but is also functional in both human and rat periodontal tissue. Furthermore, blocking AT(1)R and renin can significantly prevent periodontal bone loss induced by EP in rats.	[Santos, Carlos F.; Morandini, Ana C.; Dionisio, Thiago J.; Faria, Flavio A.; Lima, Marta C.; Figueiredo, Caio M.; Colombini-Ishikiriama, Bella L.; Maciel, Rubens P.; Akashi, Ana P.; Souza, Gabriela P.; Garlet, Gustavo P.; Rodini, Camila O.] Univ Sao Paulo, Dept Biol Sci, Bauru Sch Dent, Sao Paulo, Brazil; [Sipert, Carla R.] Univ Sao Paulo, Sch Dent, Dept Restorat Dent, Sao Paulo, Brazil; [Amaral, Sandra L.] Sao Paulo State Univ, Fac Sci, Dept Phys Educ, Sao Paulo, Brazil; [Becari, Christiane; Salgado, Maria C.; Oliveira, Eduardo B.] Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Matus, Isaac; Didier, Daniela N.; Greene, Andrew S.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Medical College of Wisconsin	Santos, CF (corresponding author), Univ Sao Paulo, Dept Biol Sci, Bauru Sch Dent, Sao Paulo, Brazil.	cfsantos@fob.usp.br	Ishikiriama, Bella L C/GNH-1701-2022; Faria, Flavio Augusto C/J-9994-2013; Garlet, Gustavo Pompermaier/E-6762-2012; Greene, Andrew S/B-9696-2015; Becari, Christiane/J-6895-2015; Rodini, Camila Oliveira/C-4437-2012; Morandini, Ana Carolina/C-1951-2012; Ishikiriama, Bella L C/C-5054-2012; Amaral, Sandra L/D-4406-2012; Becari, Christiane/ABE-7066-2021; Santos, Carlos F/B-7676-2012; Dionisio, Thiago Jose/E-6922-2014	Ishikiriama, Bella L C/0000-0002-6671-0799; Faria, Flavio Augusto C/0000-0001-6325-3716; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Rodini, Camila Oliveira/0000-0002-8763-4967; Ishikiriama, Bella L C/0000-0002-6671-0799; Amaral, Sandra L/0000-0001-9473-3739; Becari, Christiane/0000-0001-8548-9674; Santos, Carlos F/0000-0002-0405-3500; Dionisio, Thiago Jose/0000-0002-1655-4425; Morandini, Ana Carolina/0000-0003-4749-571X; Sipert, Carla/0000-0002-5719-6505; Greene, Andrew/0000-0002-3191-2112	Sao Paulo Research Foundation [FAPESP] [2004/13479-3, 2005/60167-0, 2009/53848-1, 2009/15372-5, 2010/01230-1, 2013/16113-9]; National Council for Scientific and Technological Development [CNPq] [473856/2010-7, 558171/2010-9, 303494/2013-1, 506802/2013-2, 480160/2013-9]; Coordination for the Improvement of Higher Education Personnel [CAPES] [2435/09-9]; University of Sao Paulo [USP] [08.1.2066.25.3]	Sao Paulo Research Foundation [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development [CNPq](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel [CAPES](Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Sao Paulo [USP]	This research was supported in part by four types of research grants as follows: the Sao Paulo Research Foundation [FAPESP - 2004/13479-3 (CFS), 2005/60167-0 (CFS), 2009/53848-1 (CFS), 2009/15372-5 (CFS), 2010/01230-1 (CFS) and 2013/16113-9 (ACM); the National Council for Scientific and Technological Development [CNPq - 473856/2010-7 (CFS), 558171/2010-9 (RPM), 303494/2013-1 (CFS), 506802/2013-2 (CFS), 480160/2013-9 (CFS)]; Coordination for the Improvement of Higher Education Personnel [CAPES - 2435/09-9 (MLC)]; and University of Sao Paulo [USP - 08.1.2066.25.3 (CFS)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Araujo AA, 2013, J CLIN PERIODONTOL, V40, P1104, DOI 10.1111/jcpe.12160; Araujo AA, 2013, N-S ARCH PHARMACOL, V386, P875, DOI 10.1007/s00210-013-0886-8; Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]; Becari C, 2011, BRAZ J MED BIOL RES, V44, P914, DOI 10.1590/S0100-879X2011000900013; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Berggreen E, 2003, J DENT RES, V82, P33, DOI 10.1177/154405910308200108; Bostanci N, 2008, J DENT RES, V87, P273, DOI 10.1177/154405910808700311; Broulik PD, 2001, PHYSIOL RES, V50, P353; Chrysant Steven G, 2007, J Clin Hypertens (Greenwich), V9, P454, DOI 10.1111/j.1524-6175.2007.06602.x; Costa-Neto CM, 2014, CLIN SCI, V126, P753, DOI 10.1042/CS20130414; Deo Vikas, 2010, Dent Today, V29, P60; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; Faustino SES, 2008, INT J ORAL MAX SURG, V37, P372, DOI 10.1016/j.ijom.2007.11.021; Ferreira SB, 2009, IMPLANT DENT, V18, P334, DOI 10.1097/ID.0b013e3181a44fd8; Garlet GP, 2004, J CLIN PERIODONTOL, V31, P671, DOI 10.1111/j.1600-051X.2004.00545.x; Giannobile WV, 2008, J PERIODONTOL, V79, P1592, DOI 10.1902/jop.2008.080174; Goncalves-Zillo TO, 2013, J CLIN PERIODONTOL, V40, P653, DOI 10.1111/jcpe.12097; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Jiang YL, 2002, INFECT IMMUN, V70, P3143, DOI 10.1128/IAI.70.6.3143-3148.2002; Josien R, 1999, J IMMUNOL, V162, P2562; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kim HR, 2014, ARTHRITIS RHEUMATOL, V66, P538, DOI 10.1002/art.38286; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; Krishnan S, 2014, J INFECT DIS, V209, P409, DOI 10.1093/infdis/jit499; LEITE R, 1992, HYPERTENSION, V19, P575, DOI 10.1161/01.HYP.19.6.575; Loe H, 1993, PERIODONTOL, V2, P7; Lum L, 1999, J BIOL CHEM, V274, P13613, DOI 10.1074/jbc.274.19.13613; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Monnouchi S, 2015, J PERIODONTAL RES, V50, P231, DOI 10.1111/jre.12200; Monnouchi S, 2011, J DENT RES, V90, P181, DOI 10.1177/0022034510382118; Morandini AC, 2014, J INNATE IMMUN, V6, P831, DOI 10.1159/000363338; Morandini ACF, 2010, J PERIODONTOL, V81, P310, DOI 10.1902/jop.2009.090375; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Ohuchi N, 2004, COMP BIOCHEM PHYS C, V137, P281, DOI 10.1016/j.cca.2004.02.003; Ohuchi N, 2002, COMP BIOCHEM PHYS C, V132, P451, DOI 10.1016/S1532-0456(02)00098-4; Oliveira TM, 2008, J PERIODONTOL, V79, P1062, DOI [10.1902/jop.2008.070411, 10.1902/jop.2008.070411 ]; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; PIPPIN DJ, 1990, J CLIN PERIODONTOL, V17, P385, DOI 10.1111/j.1600-051X.1990.tb00035.x; Querques F, 2015, J CELL PHYSIOL, V230, P1466, DOI 10.1002/jcp.24887; RAHMAN S, 1992, BIOCHIM BIOPHYS ACTA, V1135, P97, DOI 10.1016/0167-4889(92)90172-8; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Riviere GR, 1996, J PERIODONTOL, V67, P109, DOI 10.1902/jop.1996.67.2.109; Rodini CO, 2008, J MOL HISTOL, V39, P275, DOI 10.1007/s10735-008-9163-4; Sakata H, 1999, VOX SANG, V77, P197, DOI 10.1159/000031127; Sakuta T, 2010, ARTHRITIS RHEUM-US, V62, P1319, DOI 10.1002/art.27384; Santos CF, 2009, J PERIODONTOL, V80, P130, DOI [10.1902/jop.2009.080264, 10.1902/jop.2009.080264 ]; Santos CF, 2002, CAN J PHYSIOL PHARM, V80, P42, DOI 10.1139/Y02-004; Santos CF, 2003, AM J PHYSIOL-HEART C, V285, pH775, DOI 10.1152/ajpheart.00818.2002; Santos CF, 2002, J CARDIOVASC PHARM, V39, P628, DOI 10.1097/00005344-200205000-00002; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Silva CR, 2016, ANN RHEUM DIS, V75, P260, DOI 10.1136/annrheumdis-2014-205739; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Souza PPC, 2007, REGUL PEPTIDES, V140, P27, DOI 10.1016/j.regpep.2006.11.008; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Suda N, 2013, INFECT IMMUN, V81, P182, DOI 10.1128/IAI.00886-12; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; YANG HYT, 1972, J NEUROCHEM, V19, P2443, DOI 10.1111/j.1471-4159.1972.tb01298.x; Zhang YQ, 2014, MOL CELL BIOCHEM, V396, P249, DOI 10.1007/s11010-014-2160-x	70	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134601	10.1371/journal.pone.0134601	http://dx.doi.org/10.1371/journal.pone.0134601			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244896	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400093
J	Kanaya, G; Suzuki, T; Kikuchi, E				Kanaya, Gen; Suzuki, Takao; Kikuchi, Eisuke			Impacts of the 2011 Tsunami on Sediment Characteristics and Macrozoobenthic Assemblages in a Shallow Eutrophic Lagoon, Sendai Bay, Japan	PLOS ONE			English	Article							ORGANIC ENRICHMENT; MARINE-SEDIMENTS; GAMO LAGOON; RECOVERY; RECOLONIZATION; COMMUNITIES	A huge tsunami is one of the greatest disturbance events in coastal benthic communities, although the ecological consequences are not fully understood. Here we examined the tsunami-induced changes in the sediment environment and macrozoobenthic assemblage in a eutrophic brackish lagoon in eastern Japan. The 7.2-m-high tsunami completely replaced muddy sediment with drifting sea sand throughout the lagoon, leading to the drastic changes in quantity and quality of sedimental organic matters, sulfide contents, and sediment redox condition. Intensive physical stress devastated the benthic community, but the disappearance of sulfidic muddy bottoms significantly improved the habitat quality for macrozoobenthos. The re-established macrozoobenthic community after 5 months was characterized by (1) a 2-fold higher total density, but sharp declines in species richness, diversity, and evenness; (2) an increased density of opportunistic taxa (e.g., polychaete Pseudopolydora spp. and amphipod Monocorophium uenoi) in newly created sandy bottoms; and (3) disappearance of several dominant taxa including bivalves and chironomid larvae. These findings indicate that the sensitivity and recovery potential of macrozoobenthos were highly taxa-specific, which was closely related to the taxa's ecological characteristics, including tolerance to physical disturbance, life-history traits, and life form. Our data revealed the rapid recolonization of opportunistic macrozoobenthos after a huge tsunami, which would contribute to the functional recovery of estuarine soft-bottom habitats shortly after a disturbance event.	[Kanaya, Gen] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Kanaya, Gen; Kikuchi, Eisuke] Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; [Suzuki, Takao] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808578, Japan; [Kikuchi, Eisuke] Miyagi Univ Educ, EEC, Sendai, Miyagi 9800845, Japan	National Institute for Environmental Studies - Japan; Tohoku University; Tohoku University; Miyagi University Education	Kanaya, G (corresponding author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	gen@nies.go.jp			National Institute for Environmental Studies (NIES); Ministry of Education, Culture, Sports, Science and Technology, Japan	National Institute for Environmental Studies (NIES); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by the research fund from National Institute for Environmental Studies (NIES) and by the fund, Tohoku Ecosystem-Associated Marine Science (TEAMS), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins S, 2002, MAR ECOL PROG SER, V245, P171, DOI 10.3354/meps245171; Beukema JJ, 1999, J SEA RES, V42, P235, DOI 10.1016/S1385-1101(99)00027-1; Cardoso PG, 2008, ESTUAR COAST SHELF S, V76, P553, DOI 10.1016/j.ecss.2007.07.026; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Council for the Promotion of Nature Restoration in Gamo Tidal Flat, 2008, TOT PLAN NAT REST GA; Gorley C.K., 2006, GETTING STARTED PRIM; GRASSLE JF, 1974, J MAR RES, V32, P253; Hargrave BT, 2008, MAR POLLUT BULL, V56, P810, DOI 10.1016/j.marpolbul.2008.02.006; Ito Kinuko, 2001, Japanese Journal of Benthology, V56, P9; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kahoku Shimpo, 2013, WATASHI GA MITA OTSU; Kanaya G, 2005, MAR ECOL PROG SER, V299, P67, DOI 10.3354/meps299067; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G., 2011, CHIKYU KANKYO, V16, P33; Kanaya G, 2007, MAR ECOL PROG SER, V345, P117, DOI 10.3354/meps07025; Kanaya G, 2014, MAR ENVIRON RES, V95, P81, DOI 10.1016/j.marenvres.2013.12.014; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kanaya G, 2011, ESTUAR COAST SHELF S, V92, P169, DOI 10.1016/j.ecss.2010.12.029; Kikuchi E, 2006, LIMNOLOGY, V7, P103, DOI 10.1007/s10201-006-0169-x; Kurihara Y, 2001, REPORT FUNDAMENTAL I; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Norio O, 2011, INT J DISAST RISK SC, V2, P34, DOI 10.1007/s13753-011-0004-9; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Suzuki T., 2011, J JAPAN SOC WATER EN, V34, P395; Szczucinski W, 2012, SEDIMENT GEOL, V282, P40, DOI 10.1016/j.sedgeo.2012.07.019; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Tomiyama T, 2010, MAR ECOL PROG SER, V406, P185, DOI 10.3354/meps08530; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Widdicombe S, 2001, LIMNOL OCEANOGR, V46, P1720, DOI 10.4319/lo.2001.46.7.1720	36	37	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135125	10.1371/journal.pone.0135125	http://dx.doi.org/10.1371/journal.pone.0135125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241654	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942700097
J	Wu, L; He, Y; Jiang, B; Sun, DL; Wang, JH; Liu, M; Yang, SS; Wang, YY				Wu, Lei; He, Yao; Jiang, Bin; Sun, Dongling; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan			Trends in Prevalence, Awareness, Treatment and Control of Hypertension during 2001-2010 in an Urban Elderly Population of China	PLOS ONE			English	Article							JOINT NATIONAL COMMITTEE; BLOOD-PRESSURE; RISK-FACTORS; US ADULTS; 33 COMMUNITIES; PREHYPERTENSION; DISEASE; HEALTH; OLDER	Objective As the most important risk factors of cardiovascular disease, pre-hypertension and hypertension are important public health challenges. Few studies have focused on the trends of pre-hypertension and hypertension specifically for the aging population in China. Given the anticipated growth of the elderly population in China, there is an urgent need to document the conditions of pre-hypertension and hypertension in this aging population. Methods We conducted two cross-sectional surveys of Chinese adults aged >= 60 years in 2001 and 2010. A total of 2,272 (943 males, 1,329 females) and 2,074 (839 males, 1,235 females) participants were included in the two surveys, respectively. Results The age-and sex-standardized prevalence of hypertension significantly increased from 60.1% to 65.2% from the 2001 to the 2010 survey. Among the participants with hypertension, the awareness, treatment and control of hypertension all significantly increased from 69.8% to 74.5%, 50.3% to 63.7%, and 15.3% to 30.3%, respectively, from 2001 to 2010. A logistic regression showed that a higher education level, a higher BMI, a family history of hypertension and doctor-diagnosed cardiovascular disease were significantly associated with hypertension awareness and treatment. Conclusion Hypertension prevalence increased rapidly between the years surveyed. Although the awareness, treatment and control of hypertension improved significantly, the values of these variables remained low. More attention should be given to the elderly because the population is aging worldwide, and urgent action, optimal treatment approaches and proper public health strategies must be taken to prevent and manage hypertension.	[Wu, Lei; He, Yao; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan] Chinese Peoples Liberat Army Gen Hosp, Dept Epidemiol, Inst Geriatr, Beijing, Peoples R China; [Wu, Lei; He, Yao; Wang, Jianhua; Liu, Miao; Yang, Shanshan; Wang, Yiyan] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Acupuncture, Beijing, Peoples R China; [Sun, Dongling] Capital Med Univ, Dept Neuroepidemiol, Beijing Neurosurg Inst, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Beijing Neurosurgical Institute; Capital Medical University	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Epidemiol, Inst Geriatr, Beijing, Peoples R China.	yhe301@x263.net	刘, 淼/X-1216-2019	He, Yao/0000-0001-6205-7895; Liu, Miao/0000-0002-7975-6702	National Natural Science Foundation of China [81373080]; Ministry of Science and Technology of China [2013CB530800]; Research Foundation by the Ministry of Health of PLA China [13CXZ029]; Beijing Municipal Science and Technology Commission [D121100004912003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Research Foundation by the Ministry of Health of PLA China; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This study was supported by research grants from the National Natural Science Foundation of China, 81373080; Ministry of Science and Technology of China, 2013CB530800; Research Foundation by the Ministry of Health of PLA China, 13CXZ029 and the Beijing Municipal Science and Technology Commission, D121100004912003.	Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Anderson G, 2004, PUBLIC HEALTH REP, V119, P263, DOI 10.1016/j.phr.2004.04.005; [Anonymous], 2008, WHO REP 2008 PRIM HL; [Anonymous], 1999, WHO REP 1999 MAK DIF; Bromfield SG, 2014, J CLIN HYPERTENS, V16, P270, DOI 10.1111/jch.12281; Cai L, 2011, PUBLIC HEALTH REP, V126, P420; Cai L, 2012, CLIN EXP HYPERTENS, V34, P45, DOI 10.3109/10641963.2011.618206; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Chiu YH, 2006, J HYPERTENS, V24, P821, DOI 10.1097/01.hjh.0000222750.82820.19; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Joshi V, 2007, ASIA-PAC J PUBLIC HE, V19, P3, DOI 10.1177/10105395070190020201; Ke L, 2015, AM J HYPERTENS, V28, P159, DOI 10.1093/ajh/hpu121; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Meng XJ, 2011, J HYPERTENS, V29, P1303, DOI 10.1097/HJH.0b013e328347f79e; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; People's republic of China ministry of health disease control division, 2003, OV OB PREV CONTR GUI; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Sheng CS, 2013, HYPERTENS RES, V36, P824, DOI 10.1038/hr.2013.57; Smith JP, 2014, J ECON AGEING, V4, P37, DOI 10.1016/j.jeoa.2014.08.006; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Sur ZQ, 2007, CLIN CARDIOL, V30, P183, DOI 10.1002/clc.20073; Tian S, 2011, HYPERTENS RES, V34, P1087, DOI 10.1038/hr.2011.99; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061779; Zhao Y, 2012, J CLIN HYPERTENS, V14, P637, DOI 10.1111/j.1751-7176.2012.00670.x	42	48	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0132814	10.1371/journal.pone.0132814	http://dx.doi.org/10.1371/journal.pone.0132814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO1VB	26241049	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700006
J	Puente, TD; Gallego-Jara, J; Castano-Cerezo, S; Sanchez, VB; Espin, VF; de la Torre, JG; Rubio, AM; Diaz, MC				de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Fernandez Espin, Vanesa; Garcia de la Torre, Jose; Manjon Rubio, Arturo; Canovas Diaz, Manuel			The Protein Acetyltransferase PatZ from Escherichia coli Is Regulated by Autoacetylation-induced Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN5-RELATED N-ACETYLTRANSFERASE; ACETYL-COA SYNTHETASE; GCN5 TRANSCRIPTIONAL COACTIVATOR; CHAIN CONFORMATIONAL ENTROPY; 1.8 ANGSTROM RESOLUTION; HISTONE-ACETYLTRANSFERASE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; GLOBULAR-PROTEINS; COENZYME-A	Lysine acetylation is an important post-translational modification in the metabolic regulation of both prokaryotes and eukaryotes. In Escherichia coli, PatZ (formerly YfiQ) is the only known acetyltransferase protein and is responsible for acetylCoA synthetase acetylation. In this study, we demonstrated PatZ-positive cooperativity in response to acetyl-CoA and the regulation of acetyl-CoA synthetase activity by the acetylation level. Furthermore, functional analysis of an E809A mutant showed that the conserved glutamate residue is not relevant for the PatZ catalytic mechanism. Biophysical studies demonstrated that PatZ is a stable tetramer in solution and is transformed to its octameric form by autoacetylation. Moreover, this modification is reversed by the sirtuin CobB. Finally, an in silico PatZ tetramerization model based on hydrophobic and electrostatic interactions is proposed and validated by three-dimensional hydrodynamic analysis. These data reveal, for the first time, the structural regulation of an acetyltransferase by autoacetylation in a prokaryotic organism.	[de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Manjon Rubio, Arturo; Canovas Diaz, Manuel] Univ Murcia, Fac Chem, Dept Biochem, Dept Mol Biol, E-30100 Murcia, Spain; [de Diego Puente, Teresa; Gallego-Jara, Julia; Castano-Cerezo, Sara; Bernal Sanchez, Vicente; Manjon Rubio, Arturo; Canovas Diaz, Manuel] Univ Murcia, Fac Chem, Dept Immunol B, E-30100 Murcia, Spain; [Fernandez Espin, Vanesa; Garcia de la Torre, Jose] Univ Murcia, Phys Chem, E-30100 Murcia, Spain	University of Murcia; University of Murcia; University of Murcia	Puente, TD (corresponding author), Univ Murcia, Fac Chem, Dept Biochem, Dept Mol Biol, Campus Espinardo, E-30100 Murcia, Spain.	tdp@um.es	Gallego, Julia/H-2395-2017; de Diego, Teresa/ABH-4509-2020; , Julia/ABH-6754-2020; Aithani, Anchal/AGX-7498-2022; de Diego, Teresa/N-9215-2013; de la Torre, Jose Garcia/A-7923-2015; Cerezo, Sara Castaño/AAW-1967-2020; Canovas, Manuel/K-3860-2014; Bernal, Vicente/M-4119-2014	Gallego, Julia/0000-0002-6680-359X; de Diego, Teresa/0000-0003-3501-5483; , Julia/0000-0002-6680-359X; Aithani, Anchal/0000-0003-1260-2554; de Diego, Teresa/0000-0003-3501-5483; de la Torre, Jose Garcia/0000-0001-9116-8957; Canovas, Manuel/0000-0003-3254-1736; Bernal, Vicente/0000-0003-2482-3477; Castano Cerezo, Sara/0000-0002-1404-4085	Ministry of Economy and Competitiveness [BIO2014-54411-C2-1-R]; Seneca Foundation Autonomous Community of the Region of Murcia [19236/PI/14]	Ministry of Economy and Competitiveness; Seneca Foundation Autonomous Community of the Region of Murcia(Fundacion Seneca)	This work was supported by Ministry of Economy and Competitiveness Grant BIO2014-54411-C2-1-R and in part by Seneca Foundation Autonomous Community of the Region of Murcia Grant 19236/PI/14. The authors declare that they have no conflicts of interest with the contents of this article.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angus-Hill ML, 1999, J MOL BIOL, V294, P1311, DOI 10.1006/jmbi.1999.3338; Avbelj F, 1998, J MOL BIOL, V279, P665, DOI 10.1006/jmbi.1998.1792; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Castano-Cerezo S, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145227; Castano-Cerezo S, 2011, MOL MICROBIOL, V82, P1110, DOI 10.1111/j.1365-2958.2011.07873.x; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Creamer TP, 2000, PROTEINS, V40, P443, DOI 10.1002/1097-0134(20000815)40:3<443::AID-PROT100>3.3.CO;2-C; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; FUKADA H, 1983, J BIOL CHEM, V258, P3193; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Langer MR, 2001, J BIOL CHEM, V276, P31321, DOI 10.1074/jbc.M103839200; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Ma Q, 2011, BIOCHEM BIOPH RES CO, V410, P846, DOI 10.1016/j.bbrc.2011.06.076; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Moulder R, 2005, PROTEOMICS, V5, P2748, DOI 10.1002/pmic.200401187; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pisithkul T, 2015, CURR OPIN MICROBIOL, V24, P29, DOI 10.1016/j.mib.2014.12.006; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P11291, DOI 10.1021/bi0003184; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Thao S, 2011, MBIO, V2, DOI 10.1128/mBio.00216-11; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Tucker AC, 2014, J BIOL CHEM, V289, P36249, DOI 10.1074/jbc.M114.613901; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Williamson J., 1969, ASSAYS INTERMEDIATES, VXIII, P494; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; Wybenga-Groot LE, 1999, STRUCTURE, V7, P497, DOI 10.1016/S0969-2126(99)80066-5; Xu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008140; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382	71	14	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23077	23093		10.1074/jbc.M115.649806	http://dx.doi.org/10.1074/jbc.M115.649806			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26251518	Green Published, hybrid			2022-12-26	WOS:000361685500021
J	Thiboonboon, K; Leelahavarong, P; Wattanasirichaigoon, D; Vatanavicharn, N; Wasant, P; Shotelersuk, V; Pangkanon, S; Kuptanon, C; Chaisomchit, S; Teerawattananon, Y				Thiboonboon, Kittiphong; Leelahavarong, Pattara; Wattanasirichaigoon, Duangrurdee; Vatanavicharn, Nithiwat; Wasant, Pornswan; Shotelersuk, Vorasuk; Pangkanon, Suthipong; Kuptanon, Chulaluck; Chaisomchit, Sumonta; Teerawattananon, Yot			An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand	PLOS ONE			English	Article							QUALITY-OF-LIFE; BUDGET IMPACT ANALYSIS; COST-UTILITY ANALYSIS; NEWBORN; HEALTH; PHENYLKETONURIA; CHILDREN; PKU; POPULATION; CHALLENGES	Background Inborn errors of metabolism (IEM) are a rare group of genetic diseases which can lead to several serious long-term complications in newborns. In order to address these issues as early as possible, a process called tandem mass spectrometry (MS/MS) can be used as it allows for rapid and simultaneous detection of the diseases. This analysis was performed to determine whether newborn screening by MS/MS is cost-effective in Thailand. Method A cost-utility analysis comprising a decision-tree and Markov model was used to estimate the cost in Thai baht (THB) and health outcomes in life-years (LYs) and quality-adjusted life year (QALYs) presented as an incremental cost-effectiveness ratio (ICER). The results were also adjusted to international dollars (I$) using purchasing power parities (PPP) (1 I$ = 17.79 THB for the year 2013). The comparisons were between 1) an expanded neonatal screening programme using MS/MS screening for six prioritised diseases: phenylketonuria (PKU); isovaleric acidemia (IVA); methylmalonic acidemia (MMA); propionic acidemia (PA); maple syrup urine disease (MSUD); and multiple carboxylase deficiency (MCD); and 2) the current practice that is existing PKU screening. A comparison of the outcome and cost of treatment before and after clinical presentations were also analysed to illustrate the potential benefit of early treatment for affected children. A budget impact analysis was conducted to illustrate the cost of implementing the programme for 10 years. Results The ICER of neonatal screening using MS/MS amounted to 1,043,331 THB per QALY gained ( 58,647 I$ per QALY gained). The potential benefits of early detection compared with late detection yielded significant results for PKU, IVA, MSUD, and MCD patients. The budget impact analysis indicated that the implementation cost of the programme was expected at approximately 2,700 million THB ( 152 million I$) over 10 years. Conclusion At the current ceiling threshold, neonatal screening using MS/MS in the Thai context is not cost-effective. However, the treatment of patients who were detected early for PKU, IVA, MSUD, and MCD, are considered favourable. The budget impact analysis suggests that the implementation of the programme will incur considerable expenses under limited resources. A long-term epidemiological study on the incidence of IEM in Thailand is strongly recommended to ascertain the magnitude of problem.	[Thiboonboon, Kittiphong; Leelahavarong, Pattara; Teerawattananon, Yot] Minist Publ Hlth, HITAP, Nonthaburi, Thailand; [Wattanasirichaigoon, Duangrurdee] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat,Div Med Genet, Bangkok 10700, Thailand; [Vatanavicharn, Nithiwat; Wasant, Pornswan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat,Div Med Genet, Bangkok 10700, Thailand; [Shotelersuk, Vorasuk] Chulalongkorn Univ, Ctr Excellence Med Genet, Fac Med, Dept Pediat, Bangkok, Thailand; [Pangkanon, Suthipong; Kuptanon, Chulaluck] Queen Sirikit Natl Inst Child Hlth, Minist Publ Hlth, Dept Med Serv, Genet Unit,Dept Pediat, Bangkok, Thailand; [Chaisomchit, Sumonta] Neonatal Screening Operat Ctr, Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Chulalongkorn University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Thiboonboon, K (corresponding author), Minist Publ Hlth, HITAP, Nonthaburi, Thailand.	kittiphong.t@hitap.net		Thiboonboon, Kittiphong/0000-0003-3922-4362; Shotelersuk, Vorasuk/0000-0002-1856-0589; Teerawattananon, Yot/0000-0003-2217-2930	National Health Security Office (NHSO) of Thailand; Thailand Research Fund under the Senior Research Scholar on Health Technology Assessment [RTA5580010]; National Health Security Office; Thai Health Promotion Foundation; Health System Research Institute; Bureau of Health Policy and Strategy, Ministry of Public Health; Thaihealth-Global Link Initiative Project (TGLIP); Faculty of Medicine Ramathibodi Hospital; Mahidol University [75/2557]; Thailand Research Fund [RTA5680003]	National Health Security Office (NHSO) of Thailand; Thailand Research Fund under the Senior Research Scholar on Health Technology Assessment; National Health Security Office; Thai Health Promotion Foundation; Health System Research Institute; Bureau of Health Policy and Strategy, Ministry of Public Health; Thaihealth-Global Link Initiative Project (TGLIP); Faculty of Medicine Ramathibodi Hospital; Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF))	The study was funded by National Health Security Office (NHSO) of Thailand. The Health Intervention and Technology Assessment Program (HITAP) is funded by the Thailand Research Fund under the Senior Research Scholar on Health Technology Assessment (RTA5580010), the National Health Security Office, the Thai Health Promotion Foundation, the Health System Research Institute, and the Bureau of Health Policy and Strategy, Ministry of Public Health. HITAP international activities, including academic journal publications, are also supported by the Thaihealth-Global Link Initiative Project (TGLIP). DW is a recipient of the Research Career Development Awards from the Faculty of Medicine Ramathibodi Hospital, and grant from Mahidol University (75/2557). VS is supported by the Thailand Research Fund (RTA5680003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, interpretations, and conclusions expressed in this paper do not necessarily reflect the views of the funding agencies.	Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112; [Anonymous], 1975, HUMANGENETIK, V30, P273; [Anonymous], 1996, PEDIATRICS 1, V98, P473; [Anonymous], 2011, STAT THAIL 2011; [Anonymous], 2012, NEWB SCREEN PROGR DI; [Anonymous], 2010, NAT HLTH ACC HLTH PR; [Anonymous], 2012, LABOR FORECE SURVEY; [Anonymous], 2012, REP CONS PRIC IND TH; [Anonymous], SCREEN STAT; Aoki K, 1988, Acta Paediatr Jpn, V30, P429; Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; Autti-Ramo I, 2005, ACTA PAEDIATR, V94, P1126, DOI 10.1080/08035250510029497; Baieli S, 2003, J AUTISM DEV DISORD, V33, P201, DOI 10.1023/A:1022999712639; Banta-Wright SA, 2004, J PERINAT NEONAT NUR, V18, P41, DOI 10.1097/00005237-200401000-00005; Barbieri M, 2005, VALUE HEALTH, V8, P10, DOI 10.1111/j.1524-4733.2005.03070.x; Briggs A, 2006, DECISION MODELLING H; Bundhamcharoen K, 2002, BRUDEN DIS INJURIES; Hernandez DC, 2010, REV PANAM SALUD PUBL, V27, P309; Carroll AE, 2006, PEDIATRICS, V117, pS287, DOI 10.1542/peds.2005-2633H; Ceglarek U, 2009, MOL CELL ENDOCRINOL, V301, P266, DOI 10.1016/j.mce.2008.10.013; Chaiyakunapruk Nathom, 2008, J Med Assoc Thai, V91 Suppl 2, pS16; Charoensiriwatana Wiyada, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P94; Cipriano LE, 2007, VALUE HEALTH, V10, P83, DOI 10.1111/j.1524-4733.2006.00156.x; Dionisi-Vici C, 2006, J INHERIT METAB DIS, V29, P383, DOI 10.1007/s10545-006-0278-z; DOBSON JC, 1977, PEDIATRICS, V60, P822; Drummond M F, 1992, Int J Technol Assess Health Care, V8, P671; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Eiser C, 2000, CHILD CARE HLTH DEV, V26, P401, DOI 10.1046/j.1365-2214.2000.00154.x; Eiser C, 2001, J DEV BEHAV PEDIATR, V22, P248, DOI 10.1097/00004703-200108000-00007; Ensenauer R, 2005, GENET MED, V7, P339, DOI 10.1097/01.GIM.0000164548.54482.9D; Feuchtbaum L, 2006, PEDIATRICS, V117, pS280, DOI 10.1542/peds.2005-2633G; FISCH RO, 1976, MINN MED, V59, P306; Gonzalez MJ, 2011, MOL GENET METAB, V104, pS73, DOI 10.1016/j.ymgme.2011.07.015; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Grunert SC, 2012, J INHERIT METAB DIS, V35, P41, DOI 10.1007/s10545-011-9419-0; Grunert SC, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-9; Haddix AC, 2003, PREVENTION EFFECTIVE; Hanley WB, 1997, EARLY HUM DEV, V47, P87, DOI 10.1016/S0378-3782(96)01846-4; Insinga RP, 2002, J PEDIATR-US, V141, P524, DOI 10.1067/mpd.2002.128116; Kulpeng W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-122; Leelahavarong Pattara, 2014, Journal of the Medical Association of Thailand, V97, pS65; Matza LS, 2005, PHARMACOECONOMICS, V23, P777, DOI 10.2165/00019053-200523080-00004; McCandless SE, 2004, PRIMARY CARE, V31, P583, DOI 10.1016/j.pop.2004.04.004; Morton DH, 2002, PEDIATRICS, V109, P999, DOI 10.1542/peds.109.6.999; Niu DM, 2010, J INHERIT METAB DIS, V33, pS295, DOI 10.1007/s10545-010-9129-z; Norman R, 2009, PEDIATRICS, V123, P451, DOI 10.1542/peds.2008-0911; Norman R, 2009, HEALTH POLICY, V89, P252, DOI 10.1016/j.healthpol.2008.08.003; Ozben T, 2013, CLIN CHEM LAB MED, V51, P157, DOI 10.1515/cclm-2012-0472; Pandor A, 2004, HEALTH TECHNOL ASSES, V8, P1; Permsuwan Unchalee, 2008, J Med Assoc Thai, V91 Suppl 2, pS53; Pollitt R J, 1997, Health Technol Assess, V1, pi; Pollitt RI, 1997, HEALTH TECHNOL ASSES, V1, pi; Riewpaiboon Arthorn, 2008, J Med Assoc Thai, V91 Suppl 2, pS28; Roscher A., 2000, Journal of Inherited Metabolic Disease, V23, P4; Sakthong Phantipa, 2008, J Med Assoc Thai, V91 Suppl 2, pS43; Schoen EJ, 2002, PEDIATRICS, V110, P781, DOI 10.1542/peds.110.4.781; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Shi XT, 2012, JIMD REP, V6, P79, DOI 10.1007/8904_2011_119; Sonntag M, 2013, PHARMACOECONOMICS, V31, P1131, DOI 10.1007/s40273-013-0107-9; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tarride JE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-12; Thavorncharoensap Montarat, 2014, Journal of the Medical Association of Thailand, V97, pS43; The Subcommittee for Development of the National List of Essential Medicines, 2007, THRESH INT BEC COST; Thomason MJ, 1998, J PUBLIC HEALTH MED, V20, P331, DOI 10.1093/oxfordjournals.pubmed.a024777; Tiwana SK, 2012, VALUE HEALTH, V15, P613, DOI 10.1016/j.jval.2012.02.007; Tongsiri S., 2009, THAI POPULATION PREF; Tongsiri S, 2011, VALUE HEALTH, V14, P1142, DOI 10.1016/j.jval.2011.06.005; Tsuchiya A, 2001, EC EVALUATION HLTH C, P22; Ungar WJ, 2011, PHARMACOECONOMICS, V29, P641, DOI 10.2165/11591570-000000000-00000; Yamaguchi Seiji, 2008, Ann Acad Med Singap, V37, P13	70	12	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134782	10.1371/journal.pone.0134782	http://dx.doi.org/10.1371/journal.pone.0134782			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO7PJ	26258410	Green Published, gold, Green Submitted			2022-12-26	WOS:000359352600024
J	Black, G; Sheringham, J; Spencer-Hughes, V; Ridge, M; Lyons, M; Williams, C; Fulop, N; Pritchard-Jones, K				Black, Georgia; Sheringham, Jessica; Spencer-Hughes, Vicki; Ridge, Melanie; Lyons, Mairead; Williams, Charlotte; Fulop, Naomi; Pritchard-Jones, Kathy			Patients' Experiences of Cancer Diagnosis as a Result of an Emergency Presentation: A Qualitative Study	PLOS ONE			English	Article							COLORECTAL-CANCER; HELP-SEEKING; LUNG-CANCER; CARE; MODEL; SYMPTOMS; DELAY; UNDERSTAND; PATHWAYS; BARRIERS	Introduction Cancers diagnosed following visits to emergency departments (ED) or emergency admissions (emergency presentations) are associated with poor survival and may result from preventable diagnostic delay. To improve outcomes for these patients, a better understanding is needed about how emergency presentations arise. This study sought to capture patients' experiences of this diagnostic pathway in the English NHS. Methods Eligible patients were identified in a service evaluation of emergency presentations and invited to participate. Interviews, using an open-ended biographical structure, captured participants' experiences of healthcare services before diagnosis and were analysed thematically, informed by the Walter model of Pathways to Treatment and NICE guidance in an iterative process. Results Twenty-seven interviews were conducted. Three typologies were identified: A: Rapid investigation and diagnosis, and B: Repeated cycles of healthcare seeking and appraisal without resolution, with two variants where B1 appears consistent with guidance and B2 has evidence that management was not consistent with guidance. Most patients' (23/27) experiences fitted types B1 and B2. Potentially avoidable breakdowns in diagnostic pathways caused delays when patients were conflicted by escalating symptoms and a benign diagnosis given earlier by doctors. ED was sometimes used as a conduit to rapid testing by primary care clinicians, although this pathway was not always successful. Conclusions This study draws on patients' experiences of their diagnosis to provide novel insights into how emergency presentations arise. Through these typologies, we show that the typical experience of patients diagnosed through an emergency presentation diverges significantly from normative pathways even when there is no evidence of serious service failures. Consultations were not a conduit to diagnosis when they inhibited patients' capacity to appraise their own symptoms appropriately and when they resulted in a reluctance to seek further healthcare. Recommendations The findings also point to potentially avoidable breakdowns in the diagnostic process. In particular, to encourage patients to return to the GP if symptoms escalate, a stronger emphasis is needed on diagnostic uncertainty in discussions between patients and doctors in both primary and secondary care. To improve appropriate access to rapid investigations, systems are needed for primary care to communicate directly with secondary care at the time of referral.	[Black, Georgia; Sheringham, Jessica; Fulop, Naomi] UCL, UCL Dept Appl Hlth Res, London, England; [Ridge, Melanie; Lyons, Mairead; Williams, Charlotte; Pritchard-Jones, Kathy] UCL Partners, London, England; [Spencer-Hughes, Vicki] Lambeth & Southwark Local Author, LKSS Publ Hlth Training Programme, London, England; [Spencer-Hughes, Vicki] Lambeth & Southwark Local Author, Publ Hlth Serv, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Sheringham, J (corresponding author), UCL, UCL Dept Appl Hlth Res, London, England.	j.sheringham@ucl.ac.uk	; Pritchard-Jones, Kathryn/F-4286-2014	Fulop, Naomi/0000-0001-5306-6140; Pritchard-Jones, Kathryn/0000-0002-2384-9475; Sheringham, Jessica/0000-0003-3468-129X; Spencer-Hughes, Victoria/0000-0001-9171-9667; Black, Georgia/0000-0003-2676-5071	Department of Health	Department of Health	The study was funded through a direct grant from the Department of Health (www.dh.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain NSC, 2000, FAM PRACT, V17, P475, DOI 10.1093/fampra/17.6.475; Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; Boehmer UE, 2001, PSYCHO-ONCOL, V10, P147, DOI 10.1002/pon.504; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Department of Health, 2011, IMPR OUTC STRAT CANC; Dixon-Woods M, 2001, LANCET, V357, P670, DOI 10.1016/S0140-6736(00)04130-1; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Evans J, 2007, FAM PRACT, V24, P48, DOI 10.1093/fampra/cml063; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; Gascoigne P, 1999, PSYCHO-ONCOL, V8, P144, DOI 10.1002/(SICI)1099-1611(199903/04)8:2<144::AID-PON349>3.3.CO;2-G; Hamilton W, 2012, BRIT J CANCER, V107, P1205, DOI 10.1038/bjc.2012.423; Hamilton W, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660751; King J, 2011, BMJ QUAL SAF, V20, P718, DOI 10.1136/bmjqs.2010.044313; McLachlan SA, 2012, PATIENT EDUC COUNS, V86, P137, DOI 10.1016/j.pec.2011.04.010; McPhail S, 2013, BRIT J CANCER, V109, P2027, DOI 10.1038/bjc.2013.569; Mitchell ED, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660760; National Cancer Intelligence Network, 2013, ROUT DIAGN EXPL EM P; National Institute for Health and Care Excellence, 2005, REF GUID SUSP CANC N; National Institute for Health and Care Excellence, 2012, METH DEV NICE PUBL H; QSR International, 2012, NVIVO QUAL DAT AN SO; Raine R, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5479; Rubin G, 2013, BRIT J CANCER, V108, P1550, DOI 10.1038/bjc.2013.105; Salander P, 1999, FAM PRACT, V16, P143, DOI 10.1093/fampra/16.2.143; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Sheringham JR, 2014, BRIT J CANCER, V111, P1490, DOI 10.1038/bjc.2014.424; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Walton L, 2013, FAM PRACT, V30, P436, DOI 10.1093/fampra/cmt001; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Whitaker KL, 2015, BRIT J CANCER, V112, pS27, DOI 10.1038/bjc.2015.39; Whitaker KL, 2015, BRIT J GEN PRACT, V65, pE96, DOI 10.3399/bjgp15X683533	32	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135027	10.1371/journal.pone.0135027	http://dx.doi.org/10.1371/journal.pone.0135027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252203	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100107
J	Haskew, J; Ro, G; Turner, K; Kimanga, D; Sirengo, M; Sharif, S				Haskew, John; Ro, Gunnar; Turner, Kenrick; Kimanga, Davies; Sirengo, Martin; Sharif, Shahnaaz			Implementation of a Cloud-Based Electronic Medical Record to Reduce Gaps in the HIV Treatment Continuum in Rural Kenya	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; AFRICA; CARE; DIAGNOSIS; SETTINGS; AIDS; ERA	Background Electronic medical record (EMR) systems are increasingly being adopted to support the delivery of health care in developing countries and their implementation can help to strengthen pathways of care and close gaps in the HIV treatment cascade by improving access to and use of data to inform clinical and public health decision-making. Methods This study implemented a novel cloud-based electronic medical record system in an HIV outpatient setting in Western Kenya and evaluated its impact on reducing gaps in the HIV treatment continuum including missing data and patient eligibility for ART. The impact of the system was assessed using a two-sample test of proportions pre-and post-implementation of EMR-based data verification and clinical decision support. Results Significant improvements in data quality and provision of clinical care were recorded through implementation of the EMR system, helping to ensure patients who are eligible for HIV treatment receive it early. A total of 2,169 and 764 patient records had missing data pre-implementation and post-implementation of EMR-based data verification and clinical decision support respectively. A total of 1,346 patients were eligible for ART, but not yet started on ART, pre-implementation compared to 270 patients pre-implementation. Conclusion EMR-based data verification and clinical decision support can reduce gaps in HIV care, including missing data and eligibility for ART. A cloud-based model of EMR implementation removes the need for local clinic infrastructure and has the potential to enhance data sharing at different levels of health care to inform clinical and public health decision-making. A number of issues, including data management and patient confidentiality, must be considered but significant improvements in data quality and provision of clinical care are recorded through implementation of this EMR model.	[Haskew, John; Ro, Gunnar] Uamuzi Bora, Kakamega, Kenya; [Ro, Gunnar] Univ Durham, Durham, England; [Turner, Kenrick] British Antarctic Survey, Med Unit, Plymouth, Devon, England; [Kimanga, Davies] Elizabeth Glazer Paediat AIDS Fdn, Nairobi, Kenya; [Sirengo, Martin] Natl AIDS & STI Control Program, Nairobi, Kenya; [Sharif, Shahnaaz] Minist Hlth, Nairobi, Kenya	Durham University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Haskew, J (corresponding author), WHO, Amman, Jordan.	john.haskew@uamuzibora.org	Rø, Gunnar/AAZ-2356-2020	Turner, Kenrick/0000-0002-1835-6924	Rising Stars in Global Health grant from Canadian Grand Challenges; Vestergaard Frandsen; NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish	Rising Stars in Global Health grant from Canadian Grand Challenges; Vestergaard Frandsen; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a Rising Stars in Global Health grant from Canadian Grand Challenges and Vestergaard Frandsen. Grand Challenges and Vestergaard Frandsen had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, nor exerted any editorial control.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bora Uamuzi, 2014, UAM BOR HIV EMR IND; Bora Uamuzi, 2014, AB UAM BOR; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; Eslami S, 2008, INT J MED INFORM, V77, P365, DOI 10.1016/j.ijmedinf.2007.10.001; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fraser Hamish S F, 2005, Inform Prim Care, V13, P83; Fraser Hamish Sf, 2010, AMIA Annu Symp Proc, V2010, P232; Mamlin Burke W, 2006, AMIA Annu Symp Proc, P529; Menendez MD, 2012, REV CALID ASSIST, V27, P334, DOI 10.1016/j.cali.2012.01.010; Ministry of Medical Services Repubic of Kenya, 2011, GUID ANT THER KEN; Ministry of Public Health and Sanitation, 2010, STAND GUID EL MED RE; NASCOP, 2013, KEN AIDS IND SURV 20; Nordberg E, 1996, TROP MED INT HEALTH, V1, P107, DOI 10.1046/j.1365-3156.1996.d01-2.x; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Oluoch T, 2012, INT J MED INFORM, V81, pE83, DOI 10.1016/j.ijmedinf.2012.07.010; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; UNAIDS, 2012, TREATM 2015 JOINT UN; Were MC, 2010, J AM MED INFORM ASSN, V17, P237, DOI 10.1136/jamia.2009.002303; Were MC, 2010, INT J MED INFORM, V79, P90, DOI 10.1016/j.ijmedinf.2009.11.006; WHO, 2013, GLOB UPD HIV TREATM; Williams F, 2008, INT J INFORM MANAGE, V28, P503, DOI 10.1016/j.ijinfomgt.2008.01.016; World Health Organization, 2010, UN ACC SCAL PRIOR HI	25	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135361	10.1371/journal.pone.0135361	http://dx.doi.org/10.1371/journal.pone.0135361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252212	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100155
J	Lafta, R; Al-Shatari, S; Cherewick, M; Galway, L; Mock, C; Hagopian, A; Flaxman, A; Takaro, T; Greer, A; Kushner, A; Burnham, G				Lafta, Riyadh; Al-Shatari, Sahar; Cherewick, Megan; Galway, Lindsay; Mock, Charles; Hagopian, Amy; Flaxman, Abraham; Takaro, Tim; Greer, Anna; Kushner, Adam; Burnham, Gilbert			Injuries, Death, and Disability Associated with 11 Years of Conflict in Baghdad, Iraq: A Randomized Household Cluster Survey	PLOS ONE			English	Article							RURAL AREA; POPULATION; COMMUNITY; BURDEN; CARE; EPIDEMIOLOGY; URBAN	Background The objective of this study was to characterize injuries, deaths, and disabilities arising during 11 years of conflict in Baghdad. Methods Using satellite imagery and administrative population estimated size for Baghdad, 30 clusters were selected, proportionate to population size estimates. Interviews were conducted during April and May 2014 in 900 households containing 5148 persons. Details about injuries and disabilities occurring from 2003 through May 2014 and resultant disabilities were recorded. Findings There were 553 injuries reported by Baghdad residents, 225 of which were intentional, and 328 unintentional. For intentional injuries, the fatality rate was 39.1% and the disability rate 56.0%. Gunshots where the major cause of injury through 2006 when blasts/explosions became the most common cause and remained so through 2014. Among unintentional injuries, the fatality rate was 7.3% and the disability rate 77.1%. The major cause of unintentional injuries was falls (131) which have increased dramatically since 2008, followed by traffic related injuries (81), which have steadily increased. The proportion of injuries ending in disabilities remained fairly constant through the survey period. Interpretation Intentional injuries added substantially to the burden of unintentional injuries for the population. For Baghdad, the phases of the Iraqi conflict are reflected in the patterns of injuries and consequent deaths reported. The scale of injuries during conflict is most certainly under-reported. Difficulties recalling injuries in a survey covering 11 years is a limitation, but it is likely that minor injuries were under-reported more than severe injuries. The in-and out-migration of Baghdad populations likely had effects on the events reported which we could not measure or estimate. Damage to the health infrastructure and the flight of health workers may have contributed to mortality and morbidity. Civilian injuries as well as mortality should be measured during conflicts, though not currently done.	[Lafta, Riyadh] Al Munstansiriya Univ, Coll Med, Baghdad, Iraq; [Al-Shatari, Sahar] Minist Hlth, Human Dev & Training Ctr, Baghdad, Iraq; [Cherewick, Megan; Kushner, Adam; Burnham, Gilbert] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Galway, Lindsay; Takaro, Tim] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Mock, Charles] Univ Washington, Harborview Injury Prevent & Res Canter, Seattle, WA 98195 USA; [Hagopian, Amy; Flaxman, Abraham] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Greer, Anna] Univ Washington, Sch Med, Seattle, WA USA	Ministry of Health Iraq; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Simon Fraser University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burnham, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	gburnha1@jhu.edu		Al-Shatari, sahar/0000-0002-7282-7926; Kushner, Adam/0000-0002-7797-4837	Surgeons OverSeas; Surgeons OverSeas	Surgeons OverSeas; Surgeons OverSeas	This work was supported by Surgeons OverSeas, http://www.surgeonsoverseas.org/. RL received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; Ahmed M, 1999, TROP MED INT HEALTH, V4, P846, DOI 10.1046/j.1365-3156.1999.00490.x; Al Hilfi TK, 2013, LANCET, V381, P939, DOI 10.1016/S0140-6736(13)60320-7; Alkhuzai AH, 2008, NEW ENGL J MED, V358, P484, DOI 10.1056/NEJMsa0707782; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Burnham G, 2012, INT J HEALTH PLAN M, V27, pe51, DOI 10.1002/hpm.1091; Burnham GM, 2009, SOC SCI MED, V69, P172, DOI 10.1016/j.socscimed.2009.05.021; Cardona M, 2008, INJURY PREV, V14, P232, DOI 10.1136/ip.2007.018259; Council on Foreign Relations, THE IRAQ WAR; Donaldson RI, 2012, PREHOSP DISASTER MED, V27, P153, DOI 10.1017/S1049023X12000519; Donaldson RI, 2010, J TRAUMA, V69, P1379, DOI 10.1097/TA.0b013e318203190f; El Tayeb S, 2014, INT J INJ CONTROL SA, V21, P144, DOI 10.1080/17457300.2013.792283; Galway LP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-12; Grais RF, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-8; Hagopian A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001533; Hyder AA, 2009, J TRAUMA, V66, P888, DOI 10.1097/TA.0b013e3181627614; Kobusingye O, 2001, Inj Prev, V7, P46, DOI 10.1136/ip.7.1.46; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maziak W, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-63; Mock C, 1999, INT J EPIDEMIOL, V28, P750, DOI 10.1093/ije/28.4.750; Mock CN, 1999, B WORLD HEALTH ORGAN, V77, P955; Moshiro C, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-11; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navaratne KV, 2009, INJURY PREV, V15, P170, DOI 10.1136/ip.2008.019943; Olawale OA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-246; Petroze RT, 2015, WORLD J SURG, V39, P62, DOI 10.1007/s00268-014-2544-9; Rezapur-Shahkolai F, 2009, PUBLIC HEALTH, V123, P384, DOI 10.1016/j.puhe.2009.03.010; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; Stewart KAA, 2013, JAMA SURG, V148, P463, DOI 10.1001/jamasurg.2013.1341; Tercero F, 2006, PUBLIC HEALTH, V120, P106, DOI 10.1016/j.puhe.2005.07.005; World Health Organization, THE INJURY PYRAMID V; World Health Organization, 2004, GUIDELINES CONDUCTIN; Zangi M, 2014, INT J INJ CONTROL SA, V22, P1	33	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0131834	10.1371/journal.pone.0131834	http://dx.doi.org/10.1371/journal.pone.0131834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252879	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100008
J	Li, QQS; Parrado, AR; Samtani, MN; Narayan, VA				Li, Qingqin S.; Parrado, Antonio R.; Samtani, Mahesh N.; Narayan, Vaibhav A.		Alzheimer's Dis Neuroimaging Init	Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid A beta(1-42) Level	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; GENOTYPE IMPUTATION; TAU LEVELS; COMMON VARIANTS; CSF BIOMARKERS; EPHA1; CD33; CHOLESTEROL	Proteolytic fragments of amyloid and post-translational modification of tau species in Cerebrospinal fluid (CSF) as well as cerebral amyloid deposition are important biomarkers for Alzheimer's Disease. We conducted genome-wide association study to identify genetic factors influencing CSF biomarker level, cerebral amyloid deposition, and disease progression. The genome-wide association study was performed via a meta-analysis of two non-overlapping discovery sample sets to identify genetic variants other than APOE epsilon 4 predictive of the CSF biomarker level (A beta(1-42), t-Tau, p-Tau(181P), t-Tau: A beta(1-42) ratio, and p-Tau(181P):A beta(1-42) ratio) in patients enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Loci passing a genome-wide significance threshold of P < 5 x 10(-8) were followed-up for replication in an independent sample set. We also performed joint meta-analysis of both discovery sample sets together with the replication sample set. In the discovery phase, we identified variants in FRA10AC1 associated with CSF A beta(1-42) level passing the genome-wide significance threshold (directly genotyped SNV rs10509663 P-FE = 1.1 x 10(-9), imputed SNV rs116953792 P-FE = 3.5 x 10(-10)), rs116953792 (Pone-sided = 0.04) achieved replication. This association became stronger in the joint meta-analysis (directly genotyped SNV rs10509663 P-FE = 1.7 x 10(-9), imputed SNV rs116953792 P-FE = 7.6 x 10(-11)). Additionally, we identified locus 15q21 (imputed SNV rs1503351 P-FE = 4.0 x 10(-8)) associated with CSF A beta(1-42) level. No other variants passed the genome-wide significance threshold for other CSF biomarkers in either the discovery sample sets or joint analysis. Gene set enrichment analyses suggested that targeted genes mediated by miR-33, miR-146, and miR-193 were enriched in various GWAS analyses. This finding is particularly important because CSF biomarkers confer disease susceptibility and may be predictive of the likelihood of disease progression in Alzheimer's Disease.	[Li, Qingqin S.; Narayan, Vaibhav A.] Janssen Res & Dev LLC, Neurosci Therapeut Area, Titusville, NJ 08560 USA; [Parrado, Antonio R.] Janssen Res & Dev LLC, Discovery Sci, Spring House, PA 19002 USA; [Samtani, Mahesh N.] Janssen Res & Dev LLC, Adv PK PD Modeling & Simulat, Clin Pharmacol, Raritan, NJ 08869 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Li, QQS (corresponding author), Janssen Res & Dev LLC, Neurosci Therapeut Area, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA.	qli2@its.jnj.com			Janssen Research & Development, LLC, Titusville, N.J., USA	Janssen Research & Development, LLC, Titusville, N.J., USA	The study was funded by Janssen Research & Development, LLC, Titusville, N.J., USA. Drs. Li, Parrado, Samtani, and Narayan are employees of Janssen Research & Development, LLC. The funder provided support in the form of salaries for authors QSL, ARP, MNS and VAN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder however approved the intention to publish the final manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson C, 2008, NEUROBIOL AGING, V29, P1466, DOI 10.1016/j.neurobiolaging.2007.03.027; [Anonymous], 1998, Neurobiol Aging, V19, P109; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Carrasquillo MM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-54; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Cruchaga C, 2013, NEURON, V78, P256, DOI 10.1016/j.neuron.2013.02.026; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Frank RA, 2003, NEUROBIOL AGING, V24, P521, DOI 10.1016/S0197-4580(03)00002-2; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hu X, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.50; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kim S, 2011, NEUROLOGY, V76, P69, DOI 10.1212/WNL.0b013e318204a397; Kong Y, 2014, CURR ALZHEIMER RES, V11, P882; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Miyata S, 2007, BRAIN RES, V1150, P200, DOI 10.1016/j.brainres.2007.02.066; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Perez-Nievas BG, 2013, BRAIN, V136, P2510, DOI 10.1093/brain/awt171; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramanan VK, 2014, MOL PSYCHIATR, V19, P351, DOI 10.1038/mp.2013.19; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rotllan N, 2012, CHOLESTEROL, DOI 10.1155/2012/847849; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Samtani MN, 2013, BRIT J CLIN PHARMACO, V75, P146, DOI 10.1111/j.1365-2125.2012.04308.x; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Wang LL, 2012, MED HYPOTHESES, V78, P398, DOI 10.1016/j.mehy.2011.11.019; Zhang R, 2014, J NEUROL SCI, V338, P57, DOI 10.1016/j.jns.2013.12.017	39	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134000	10.1371/journal.pone.0134000	http://dx.doi.org/10.1371/journal.pone.0134000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252872	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100032
J	Song, ZC; Liu, WY; Xiao, Y; Zhang, MH; Luo, Y; Yuan, WW; Xu, Y; Yu, GZ; Hu, YD				Song, Zongchang; Liu, Wenying; Xiao, Yu; Zhang, Minghui; Luo, Yan; Yuan, Weiwei; Xu, Yu; Yu, Guanzhen; Hu, Yide			PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer	PLOS ONE			English	Article							TRIPLE-HELIX REPEAT; CELL-PROLIFERATION; EXPRESSION; LATEXIN; OVEREXPRESSION; PROGRESSION; CARCINOMA; INVASION; PROTEIN	PRR11 is a potential candidate oncogene that has been implicated in the pathogenesis of lung cancer, however the role of PRR11 in gastric cancer is currently unclear. In the present study, we investigated the role of PRR11 in gastric cancer by evaluating its expression status in samples from a cohort of 216 patients with gastric cancer. PRR11 was found to be overexpressed in 107 (49.5%) patients by immunohistochemistry of tissue microarrays generated using the patient samples. Furthermore, PRR11 overexpression was found to correlate significantly with clinicopathologic features such as tumor invasion, tumor differentiation, and disease stage. Survival analysis of the cohort revealed that PRR11 is an independent prognostic factor for gastric cancer patients. PRR11 was stably silenced in a gastric carcinoma cell line using an shRNA-based approach, and treated cells showed decreased cellular proliferation and colony formation in vitro and cell growth in vivo, companied by decreased expression of CTHRC1 and increased expression of LXN, proteins involved in tumor progression. Evaluation of human gastric cancer samples demonstrated that PRR11 expression was also associated with increased CTHRC1 and decreased LXN expression. These data indicate that PRR11 may be widely activated in human gastric cancer and are consistent with the hypothesis that PRR11 functions as an oncogene in the development and progression of gastric cancer.	[Song, Zongchang; Liu, Wenying; Xiao, Yu; Zhang, Minghui; Luo, Yan; Yuan, Weiwei; Xu, Yu; Hu, Yide] Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol 3, Chongqing 400037, Peoples R China; [Yu, Guanzhen] Shanghai East Hosp, Dept Med Oncol, Shanghai 200120, Peoples R China; [Yu, Guanzhen] Changzheng Hosp, Dept Med Oncol, Shanghai 200070, Peoples R China	Army Medical University; Naval Medical University	Hu, YD (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Oncol 3, Chongqing 400037, Peoples R China.	huyideprr11@163.com						Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chen Y, 2015, ONCOTARGET; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gao YS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-520; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji Y, 2013, INT J BIOCHEM CELL B, V45, P645, DOI 10.1016/j.biocel.2012.12.002; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Jin GZ, 2013, J HEPATOL, V59, P510, DOI 10.1016/j.jhep.2013.04.028; Kim HC, 2014, ONCOTARGET, V5, P519, DOI 10.18632/oncotarget.1714; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-121; Muthusamy V, 2013, J INVEST DERMATOL, V133, P1827, DOI 10.1038/jid.2013.48; Ni QF, 2014, ONCOL REP, V31, P1364, DOI 10.3892/or.2014.2966; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Qiu MZ, 2014, INT J CANCER, V134, P2468, DOI 10.1002/ijc.28559; Sakashita K, 2008, ANN SURG ONCOL, V15, P2293, DOI 10.1245/s10434-008-9904-3; Tameda M, 2014, INT J ONCOL, V45, P541, DOI 10.3892/ijo.2014.2445; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Tang SC, 2014, WORLD J GASTROENTERO, V20, P10825, DOI 10.3748/wjg.v20.i31.10825; Tsamandas AC, 2009, ANTICANCER RES, V29, P703; Yamada Y, 2013, ANN ONCOL, V24, P2560, DOI 10.1093/annonc/mdt238; Yu GZ, 2009, J CANCER RES CLIN, V135, P1331, DOI 10.1007/s00432-009-0574-8; Yu GZ, 2009, CLIN CANCER RES, V15, P1821, DOI 10.1158/1078-0432.CCR-08-2138; Zhou FH, 2014, INT J CLIN EXP PATHO, V7, P8692	26	32	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0128943	10.1371/journal.pone.0128943	http://dx.doi.org/10.1371/journal.pone.0128943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252227	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100003
J	Fernandez-Balbuena, S; Belza, MJ; Zulaica, D; Martinez, JL; Marcos, H; Rifa, B; Arrillaga, A; de la Fuente, L; Hoyos, J				Fernandez-Balbuena, Sonia; Jose Belza, Maria; Zulaica, Daniel; Luis Martinez, Jose; Marcos, Henar; Rifa, Benet; Arrillaga, Arantxa; de la Fuente, Luis; Hoyos, Juan		Working Grp	Widening the Access to HIV Testing: The Contribution of Three In-Pharmacy Testing Programmes in Spain	PLOS ONE			English	Article							COMMUNITY PHARMACIES; PERSONS AWARE; OPPORTUNITIES; CATALONIA; UNAWARE; IMPACT; VIRUS	Background and Objective Spain has implemented several in-pharmacy HIV testing programmes performed by pharmacists as part of their everyday routine. We aim to assess the feasibility and the main outcomes of three programmes implemented in three Spanish regions with different sociological profiles and also different epidemiology for HIV. Methods The characteristics of the 24151 people tested between 2009 and 2013 at 74 urban pharmacies are studied. We compare the main outcomes of the programmes with those of each Regional HIV Surveillance System (RHSS) assessing the contribution to the total new diagnosis in each region and if priority groups are being reached. Results 45.7% were heterosexual men (MSW), 14.4% men who have sex with men (MSM), and 27% women. The 35% were younger than 30 and 9.6% foreigners. The 52% were previously untested, and women were the most likely to be untested. The three programmes altogether diagnosed 226 people, resulting in a global prevalence of 0.9% (95% CI: 0.8-1.1); 3.4% in MSM (95% CI: 2.8-4.0). The prevalence among Spaniards was 0.8% (0.7-1.0) vs. 2.2 (1.6-2.9) among foreigners. The percentages of MSM diagnosed by all three programmes were higher than the one reported by their respective RHSS. Thirty four percent of the reactive MSM and the 71.4% of the reactive MSW did not have a previous HIV test although big testing history differences were observed across the programmes. Altogether, these services contributed with the 10.6% of all HIV diagnoses in these regions. Conclusions In-pharmacy HIV testing programmes are a valuable testing option, having been able to uncover 1 out of 10 the new diagnoses reported in each region. They showed a good capacity of reaching and diagnosing previously untested populations, not only a priority population such as MSM but also heterosexual population who are more affected by delayed diagnosis. They seem to be particularly suitable for regions without large cities and specific HIV diagnostic services.	[Fernandez-Balbuena, Sonia; Jose Belza, Maria] Carlos III Hlth Inst, Natl Sch Hlth, Madrid, Spain; [Fernandez-Balbuena, Sonia; Jose Belza, Maria; de la Fuente, Luis; Hoyos, Juan] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Zulaica, Daniel; Arrillaga, Arantxa] Basque Hlth Serv, San Sebastian, Spain; [Luis Martinez, Jose; Rifa, Benet] Publ Hlth Agcy Catalonia, Sect Surveillance Prevent Control STIs & HIV, Off Surveillance & Response Publ Hlth Emergencies, Dept Hlth Reg Govt Catalonia, Barcelona, Spain; [Marcos, Henar] Reg Minist Hlth Castilla & Leon, Publ Hlth Directorate, Epidemiol Surveillance Serv, Valladolid, Spain; [de la Fuente, Luis] Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Belza, MJ (corresponding author), Carlos III Hlth Inst, Natl Sch Hlth, Madrid, Spain.	mbelza@isciii.es		Fernandez-Balbuena, Sonia/0000-0002-2447-2956; Tamames, Sonia/0000-0001-5548-2594; Hoyos, Juan/0000-0003-3772-2771; Belza Egozcue, Maria Jose/0000-0003-4816-7750; De la Fuente, Luis/0000-0003-4527-1608	Foundation for Research and Prevention of AIDS in Spain (FIPSE) [240961/10]; Ministry of Health, Social Services and Equality [MSSSI EC11-279]	Foundation for Research and Prevention of AIDS in Spain (FIPSE); Ministry of Health, Social Services and Equality	This study was supported by Foundation for Research and Prevention of AIDS in Spain (FIPSE) grant [240961/10] and The Ministry of Health, Social Services and Equality grant [MSSSI EC11-279]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amesty S, 2012, J AM PHARM ASSOC, V52, P472, DOI 10.1331/JAPhA.2012.10194; Bagaria G, 2011, FARMACEUTICOS, P14; Bailey AC, 2009, SEX TRANSM INFECT, V85, P145, DOI 10.1136/sti.2008.032359; Belza MJ, 2014, EUROSURVEIL IN PRESS; Calderon Y, 2013, AIDS PATIENT CARE ST, V27, P467, DOI 10.1089/apc.2013.0076; Centers for Disease Control and Prevention, 2011, ANN REP 2011 ACC PRO; Centro Nacional de Epidemiologia, 2013, VIG EP VIH SID ESP S; Darin KM, 2003, J AM PHARM ASSOC, pe7; de la Fuente L, 2009, J EPIDEMIOL COMMUN H, V63, P552, DOI 10.1136/jech.2008.076240; Dhairyawan R, 2012, SEX TRANSM INFECT, V88, P184, DOI 10.1136/sextrans-2011-050232; Dugdale C, 2014, J MANAG CARE SPEC PH, V20, P339, DOI 10.18553/jmcp.2014.20.4.339; European Centre for Disease Prevention and Control, 2012, NOV APPR TEST SEX TR; European Centre for Disease Prevention and Control, 2011, HIV TEST INCR UP EFF; Fernandez-Balbuena S, 2014, HIV MED IN PRESS; Fernandez-Lopez L, 2010, INT J STD AIDS, V21, P388, DOI 10.1258/ijsa.2008.008459; Gimenez Masat A, 2010, VIENN AUSTR 18 INT A; Gorostiza I, 2013, GAC SANIT, V27, P164, DOI 10.1016/j.gaceta.2012.02.010; Grupo EPI-VIH, EST PROSP PREV VIH P; Guayta-Escolies R, 2010, BILB S TEST RAP VIH; Guayta-Escolies R, 2014, GAC SANIT, V28, P253, DOI [10.1016/j.gaceta.2012.02.010, 10.1016/j.gaceta.2013.07.005]; Gubbins PO, 2014, J AM PHARM ASSOC, V54, P163, DOI 10.1331/JAPhA.2014.13167; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Menoyo C, 2010, BILB S TEST RAP VIH; Meulbroek M, 2013, HIV MED, V14, P25, DOI 10.1111/hiv.12054; Meyerson BE, 2013, AIDS BEHAV      0216; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Pedro Rivero, 2010, BILB S TEST RAP VIH; Ryder PT, 2013, J AM PHARM ASSOC, V53, P595, DOI 10.1331/JAPhA.2013.12240; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Vogler S, 2014, HEALTH POLICY, V117, P311, DOI 10.1016/j.healthpol.2014.06.001; Weidle PJ, 2014, J AM PHARM ASSOC, V54, P486, DOI 10.1331/JAPhA.2014.14045; WHO Regional Office for Europe, 2010, SCAL HIV TEST COUNS; World Health Organization Regional Office for Europe (WHO), 2012, EUR PLAN HIV AIDS 20	34	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134631	10.1371/journal.pone.0134631	http://dx.doi.org/10.1371/journal.pone.0134631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247367	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300053
J	Hong, L; Guo, YN; BasuRay, S; Agola, JO; Romero, E; Simpson, DS; Schroeder, CE; Simons, P; Waller, A; Garcia, M; Carter, M; Ursu, O; Gouveia, K; Golden, JE; Aube, J; Wandinger-Ness, A; Sklar, LA				Hong, Lin; Guo, Yuna; BasuRay, Soumik; Agola, Jacob O.; Romero, Elsa; Simpson, Denise S.; Schroeder, Chad E.; Simons, Peter; Waller, Anna; Garcia, Matthew; Carter, Mark; Ursu, Oleg; Gouveia, Kristine; Golden, Jennifer E.; Aube, Jeffrey; Wandinger-Ness, Angela; Sklar, Larry A.			A Pan-GTPase Inhibitor as a Molecular Probe	PLOS ONE			English	Article							ONCOGENIC K-RAS; FLOW-CYTOMETRY; RHO-GTPASES; RATIONAL DESIGN; EFFECTOR INTERACTIONS; NUCLEOTIDE-BINDING; MULTIPLEX ASSAY; SITE INHIBITOR; CANCER-THERAPY; PROTEIN	Overactive GTPases have often been linked to human diseases. The available inhibitors are limited and have not progressed far in clinical trials. We report here a first-in-class small molecule pan-GTPase inhibitor discovered from a high throughput screening campaign. The compound CID1067700 inhibits multiple GTPases in biochemical, cellular protein and protein interaction, as well as cellular functional assays. In the biochemical and protein interaction assays, representative GTPases from Rho, Ras, and Rab, the three most generic subfamilies of the GTPases, were probed, while in the functional assays, physiological processes regulated by each of the three subfamilies of the GTPases were examined. The chemical functionalities essential for the activity of the compound were identified through structural derivatization. The compound is validated as a useful molecular probe upon which GTPase-targeting inhibitors with drug potentials might be developed.	[Hong, Lin; Guo, Yuna; BasuRay, Soumik; Agola, Jacob O.; Romero, Elsa; Simons, Peter; Waller, Anna; Garcia, Matthew; Carter, Mark; Gouveia, Kristine; Wandinger-Ness, Angela; Sklar, Larry A.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Hong, Lin; Simons, Peter; Waller, Anna; Garcia, Matthew; Carter, Mark; Ursu, Oleg; Gouveia, Kristine; Sklar, Larry A.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Ursu, Oleg; Wandinger-Ness, Angela; Sklar, Larry A.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM USA; [Ursu, Oleg] Univ New Mexico, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Simpson, Denise S.; Schroeder, Chad E.; Golden, Jennifer E.; Aube, Jeffrey] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66045 USA; [Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico; University of Kansas; University of Kansas	Sklar, LA (corresponding author), Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA.	lsklar@salud.unm.edu	Jean-Louis, Denise/AAD-5029-2021; aubertin, rebeckah/O-9624-2015	Golden, Jennifer/0000-0002-6813-3710; Waller, Anna/0000-0003-3676-2501; aubertin, rebeckah/0000-0002-0558-7571	UNMCMD MLPCN NIH grant [U54MH084690, R01HL081062]; NSF [MCB0956027]; MLP grant [R03 MH081231-01]; NCI [R21 CA170375-01, P30 CA118100]; KUSCC MLPCN NIH grant [U54HG005031]; NINDS [R21NS066435]; NATIONAL CANCER INSTITUTE [P30CA118100, R21CA170375] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081062] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH081231, U54MH084690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066435] Funding Source: NIH RePORTER	UNMCMD MLPCN NIH grant; NSF(National Science Foundation (NSF)); MLP grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); KUSCC MLPCN NIH grant; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by UNMCMD MLPCN NIH grant U54MH084690 and R01HL081062 to Larry A. Sklar; NSF MCB0956027 and MLP grant R03 MH081231-01 to Angela Wandinger-Ness; NCI R21 CA170375-01 to Angela Wandinger-Ness, Laurie G. Hudson and Jennifer Golden; KUSCC MLPCN NIH grant U54HG005031 to Jeffrey Aube; NINDS R21NS066435 to Angela Wandinger-Ness and Larry A. Sklar; NCI P30 CA118100 and P30 CA118100 for Shared Flow Cytometry Resources at the Cancer Research and Treatment Center of the University of New Mexico to Angela Wandinger-Ness and Larry A. Sklar.	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Agola JO, 2012, ACS CHEM BIOL, V7, P1095, DOI 10.1021/cb3001099; Ather F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056112; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Buranda T, 2013, ANAL BIOCHEM, V442, P149, DOI 10.1016/j.ab.2013.07.039; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Chigaev A, 2011, METHODS MOL BIOL, V757, P3, DOI 10.1007/978-1-61779-166-6_1; Chigaev A, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-28; Copeland RA, 2005, EVALUATION ENZYME IN; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goud B, 2002, NAT CELL BIOL, V4, pE77, DOI 10.1038/ncb0402-e77; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hong L, 2013, J BIOL CHEM, V288, P8531, DOI 10.1074/jbc.M112.435941; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Keely PJ, 2007, METHOD ENZYMOL, V426, P27, DOI 10.1016/S0076-6879(07)26002-1; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kusakabe K, 2013, J MED CHEM, V56, P4343, DOI 10.1021/jm4000215; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; Lemoine M, 2012, BLOOD, V119, P4017, DOI 10.1182/blood-2011-01-331421; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Moniz S, 2008, CELL SIGNAL, V20, P1762, DOI 10.1016/j.cellsig.2008.06.002; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; NOONAN T, 1991, J MED CHEM, V34, P1302, DOI 10.1021/jm00108a010; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Preuss E, 2013, J BIOL CHEM, V288, P35287, DOI 10.1074/jbc.M113.495986; Rosnizeck IC, 2012, ANGEW CHEM INT EDIT, V51, P10647, DOI 10.1002/anie.201204148; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sanz-Rodriguez F, 1999, BRIT J HAEMATOL, V107, P825, DOI 10.1046/j.1365-2141.1999.01762.x; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz SL, 2008, ANAL BIOCHEM, V381, P258, DOI 10.1016/j.ab.2008.06.039; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Skak K, 2008, NAT REV DRUG DISCOV, V7, P231, DOI 10.1038/nrd2482; Skorobogata O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036489; Spiegel J, 2014, ANGEW CHEM INT EDIT, V53, P2498, DOI 10.1002/anie.201308568; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Surviladze Z, 2012, METHODS MOL BIOL, V827, P253, DOI 10.1007/978-1-61779-442-1_17; Surviladze Z, 2010, J BIOMOL SCREEN, V15, P10, DOI 10.1177/1087057109352240; Venturelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073097; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang YF, 2008, J CLIN PHARMACOL, V48, P763, DOI 10.1177/0091270008318006; Wolin R, 1996, BIOORG MED CHEM LETT, V6, P195, DOI 10.1016/0960-894X(95)00574-D; Yanochko GM, 2013, TOXICOL SCI, V135, P451, DOI 10.1093/toxsci/kft161; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	58	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134317	10.1371/journal.pone.0134317	http://dx.doi.org/10.1371/journal.pone.0134317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247207	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300032
J	Lee, KH; Jung, HJ; Park, DU; Ryu, SH; Kim, B; Ha, KC; Kim, S; Yi, G; Yoon, C				Lee, Kyong-Hui; Jung, Hye-Jung; Park, Dong-Uk; Ryu, Seung-Hun; Kim, Boowook; Ha, Kwon-Chul; Kim, Seungwon; Yi, Gwangyong; Yoon, Chungsik			Occupational Exposure to Diesel Particulate Matter in Municipal Household Waste Workers	PLOS ONE			English	Article							BLACK CARBON; ELEMENTAL CARBON; ORGANIC-CARBON; LUNG-CANCER; EXHAUST; PARTICLES; AEROSOLS; MINERS; EMISSIONS; DUST	Objective The purposes of this study were to determine the following: 1) the exposure levels of municipal household waste (MHW) workers to diesel particulate matter (DPM) using elemental carbon (EC), organic carbon (OC), total carbon (TC), black carbon (BC), and fine particulate matter (PM 2.5) as indicators; 2) the correlations among the indicators; 3) the optimal indicator for DPM; and 4) factors that influence personal exposure to DPM. Methods A total of 72 workers in five MHW collection companies were assessed over a period of 7 days from June to September 2014. Respirable EC/OC samples were quantified using the thermal optical transmittance method. BC and PM 2.5 were measured using real-time monitors, an aethalometer and a laser photometer. All results were statistically analyzed for occupational and environmental variables to identify the exposure determinants of DPM. Results The geometric mean of EC, OC, TC, BC and PM 2.5 concentrations were 4.8, 39.6, 44.8, 9.1 and 62.0 mu g/m(3), respectively. EC concentrations were significantly correlated with the concentrations of OC, TC and BC, but not with those of PM 2.5. The exposures of the MHW collectors to EC, OC, and TC were higher than those of the drivers (p<0.05). Workers of trucks meeting Euro 3 emission standard had higher exposures to EC, OC, TC and PM 2.5 than those working on Euro 4 trucks (p<0.05). Multiple regression analysis revealed that the job task, European engine emission standard, and average driving speed were the most influential factors in determining worker exposure. Conclusions We assessed MHW workers' exposure to DPM using parallel sampling of five possible indicators. Of these five indicators, EC was shown to be the most useful indicator of DPM exposure for MHW workers, and the job task, European emission standard, and average driving speed were the main determinants of EC exposure.	[Lee, Kyong-Hui; Yoon, Chungsik] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea; [Jung, Hye-Jung] Catholic Kwandong Univ, Int St Marys Hosp, Hlth Promot Ctr, Inchon, South Korea; [Park, Dong-Uk] Korea Natl Open Univ, Dept Environm Hlth, Seoul, South Korea; [Ryu, Seung-Hun] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Kim, Boowook] Korea Workers Compensat & Welf Serv, Occupat Lung Dis Inst, Inchon, South Korea; [Ha, Kwon-Chul] Changwon Natl Univ, Chang Won, South Korea; [Kim, Seungwon] Keimyung Univ, Taegu, South Korea; [Yi, Gwangyong] KOSHA, Occupat Safety & Hlth Res Inst, Ulsan, South Korea	Seoul National University (SNU); Catholic Kwandong University; Korea National Open University; Korea University; Korea University Medicine (KU Medicine); Changwon National University; Keimyung University	Yoon, C (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth, Seoul, South Korea.	csyoon@snu.ac.kr		Ryu, Seung-Hun/0000-0003-3853-2523	Occupational Safety AMP; Health Research Institute (OSHRI), Korea Occupational Safety Health Agency; OSHRI [2014-OSHRI-793]	Occupational Safety AMP; Health Research Institute (OSHRI), Korea Occupational Safety Health Agency; OSHRI	This work was supported by the Occupational Safety & Health Research Institute (OSHRI), Korea Occupational Safety & Health Agency and funded by the research project (No. 2014-OSHRI-793) of the OSHRI. (URL: http://eoshri.kosha.or.kr/en/main) The funder had role in data collection and analysis but not in study design, decision to publish, preparation of the manuscript, or publication fee.	ACGIH (American Conference of Governmental Industrial Hygienists), 2020, TLVS BEIS BAS DOC TH; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Attfield MD, 2012, JNCI-J NATL CANCER I, V104, P869, DOI 10.1093/jnci/djs035; Bakke B, 2001, AIHAJ, V62, P457, DOI 10.1080/15298660108984647; Ballach J, 2001, ATMOS ENVIRON, V35, P2089, DOI 10.1016/S1352-2310(00)00499-4; Birch M., 2003, NIOSH MANUAL ANAL ME; Birch ME, 1996, ANALYST, V121, P1183, DOI 10.1039/an9962101183; Bond TC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007315; CHDS, 2002, HLTH HAZ ADV DIES EN; Chow JC, 2001, AEROSOL SCI TECH, V34, P23, DOI 10.1080/02786820119073; Clark NN, 2002, J AIR WASTE MANAGE, V52, P84, DOI 10.1080/10473289.2002.10470755; Coble JB, 2010, ANN OCCUP HYG, V54, P747, DOI 10.1093/annhyg/meq024; Davis ME, 2007, J OCCUP ENVIRON HYG, V4, P848, DOI 10.1080/15459620701643347; DRNM, 2012, SAFETY BULLETIN, V127; FUNG K, 1990, AEROSOL SCI TECH, V12, P122, DOI 10.1080/02786829008959332; Groves J, 2000, ANN OCCUP HYG, V44, P435, DOI 10.1093/annhyg/44.6.435; Hewett P, 2014, J OCCUP ENVIRON HYG, V11, P645, DOI 10.1080/15459624.2014.899239; IPCS (International Programme on Chemical Safety), 1996, ENV HLTH CRIT, V171; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Jeong CH, 2004, ATMOS ENVIRON, V38, P5193, DOI 10.1016/j.atmosenv.2004.02.065; Jeong J, 2008, P 46 M KOSAE, P258; Kauppinen T, 2000, OCCUP ENVIRON MED, V57, P10, DOI 10.1136/oem.57.1.10; Kim J, 2008, ATMOS ENVIRON, V42, P4778, DOI 10.1016/j.atmosenv.2008.01.040; Kim KH, 2003, CHEMOSPHERE, V51, P707, DOI 10.1016/S0045-6535(03)00036-5; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; KoreaMOE, 2013, AIR QUAL STAND; Lavoie J, 2006, SCI TOTAL ENVIRON, V370, P23, DOI 10.1016/j.scitotenv.2006.05.016; LIN C, 1988, ATMOS ENVIRON, V22, P605, DOI 10.1016/0004-6981(88)90206-5; Liukonen LR, 2002, AIHA J, V63, P610, DOI 10.1080/15428110208984747; MOLIT, 2012, REG MOT VEH STAT; MSHA, 2001, DIES PART MATT EXP U, P5706; Ng I. P., 2007, SAE TECHNICAL PAPER, V2007-01-0334; NIOSH, 1999, 9703042695 NIOSH; NOVAKOV T, 1995, MIKROCHIM ACTA, V119, P157, DOI 10.1007/BF01244864; OSHRI, 2014, EST OCC EXP DIES ENG; Park D, 2013, J OCCUP HEALTH, V55, P503, DOI 10.1539/joh.13-0166-FS; Pio C, 2011, ATMOS ENVIRON, V45, P6121, DOI 10.1016/j.atmosenv.2011.08.045; POULSEN OM, 1995, SCI TOTAL ENVIRON, V170, P1, DOI 10.1016/0048-9697(95)04524-5; Ramachandran G, 2005, J ENVIRON MONITOR, V7, P728, DOI 10.1039/b503854e; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Salako GO, 2012, AEROSOL AIR QUAL RES, V12, P1, DOI 10.4209/aaqr.2011.09.0150; Schauer JJ, 2003, J EXPO ANAL ENV EPID, V13, P443, DOI 10.1038/sj.jea.7500298; Schuetzle D, 1986, Dev Toxicol Environ Sci, V13, P41; Seshagiri B, 2003, AIHA J, V64, P338, DOI 10.1202/423.1; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; USEPA USEPA, 2002, HLTH ASS DOC DIES EN; Verma D K, 1999, Appl Occup Environ Hyg, V14, P701; Verma Dave K, 2003, Appl Occup Environ Hyg, V18, P25, DOI 10.1080/10473220301386; Wang Y, 2010, ATMOS CHEM PHYS, V10, P11447, DOI 10.5194/acp-10-11447-2010; Yelverton TLB, 2014, ENVIRON ENG SCI, V31, P209, DOI 10.1089/ees.2014.0038	50	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135229	10.1371/journal.pone.0135229	http://dx.doi.org/10.1371/journal.pone.0135229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248196	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300109
J	Park, DR; Shawl, AI; Ha, TG; Park, KH; Kim, SY; Kim, UH				Park, Dae-Ryoung; Shawl, Asif Iqbal; Ha, Tae-Geun; Park, Kwang-Hyun; Kim, Seon-Young; Kim, Uh-Hyun			Arginine Thiazolidine Carboxylate Stimulates Insulin Secretion through Production of Ca2+-Mobilizing Second Messengers NAADP and cADPR in Pancreatic Islets	PLOS ONE			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; CALCIUM-MOBILIZING METABOLITE; NITRIC-OXIDE; BETA-CELLS; L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID; NAD GLYCOHYDROLASE; HYDROGEN-SULFIDE; CYCLASE ACTIVITY; L-CYSTEINE	Oxothiazolidine carboxylic acid is a prodrug of cysteine that acts as an anti-diabetic agent via insulin secretion and the formation of the Ca2+-mobilizing second messenger, cyclic ADP-ribose (cADPR). Here we show that a hybrid compound, arginine thiazolidine carboxylate (ATC), increases cytoplasmic Ca2+ in pancreatic beta-cells, and that the ATC-induced Ca2+ signals result from the sequential formation of two Ca2+-mobilizing second messengers: nicotinic acid adenine dinucleotide phosphate (NAADP) and cADPR. Our data demonstrate that ATC has potent insulin-releasing properties, due to the additive action of its two components; thiazolidine carboxylate (TC) and L-arginine. TC increases glutathione (GSH) levels, resulting in cAMP production, followed by a cascade pathway of NAADP/nitric oxide (NO)/cGMP/cADPR synthesis. L-arginine serves as the substrate for NO synthase (NOS), which results in cADPR synthesis via cGMP formation. Neuronal NOS is specifically activated in pancreatic beta-cells upon ATC treatment. These results suggest that ATC is an ideal candidate as an anti-diabetic, capable of modulating the physiological Ca2+ signalling pathway to stimulate insulin secretion.	[Park, Dae-Ryoung; Shawl, Asif Iqbal; Ha, Tae-Geun; Park, Kwang-Hyun; Kim, Seon-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju, South Korea; [Park, Dae-Ryoung; Shawl, Asif Iqbal; Ha, Tae-Geun; Park, Kwang-Hyun; Kim, Seon-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Natl Creat Res Lab Signaling Network Ca2, Jeonju, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation Grant - Korean government [2012R1A3A2026453]	National Research Foundation Grant - Korean government(National Research Foundation of Korea)	This work was supported by the National Research Foundation Grant 2012R1A3A2026453 funded by the Korean government (to U.-H.K.).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; AMMON HPT, 1982, N-S ARCH PHARMACOL, V319, P243, DOI 10.1007/BF00495873; An NH, 2001, BIOCHEM BIOPH RES CO, V282, P781, DOI 10.1006/bbrc.2001.4654; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Bramato C, 1982, Minerva Dietol Gastroenterol, V28, P65; Cho YS, 1998, COMP BIOCHEM PHYS B, V120, P175, DOI 10.1016/S0305-0491(98)10006-8; FITZPATRICK PF, 1982, J BIOL CHEM, V257, P1166; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GLICK DL, 1991, CELL REGUL, V2, P211, DOI 10.1091/mbc.2.3.211; Graeff RM, 2003, COMB CHEM HIGH T SCR, V6, P367; Han MK, 2002, J BIOL CHEM, V277, P5315, DOI 10.1074/jbc.M106439200; HAN MK, 1994, J LEUKOCYTE BIOL, V56, P792, DOI 10.1002/jlb.56.6.792; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Institute of Laboratory Animal Research Commision of Life Sciences National Research Council, 1996, GUIDE OF THE CARE AN; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Kaneko Y, 2009, FEBS LETT, V583, P377, DOI 10.1016/j.febslet.2008.12.026; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Kim HL, 2004, ACTA CRYSTALLOGR D, V60, P948, DOI 10.1107/S0907444904005591; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; KONG SK, 1994, BIOCHEM BIOPH RES CO, V199, P234, DOI 10.1006/bbrc.1994.1219; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2006, MOL MED, V12, P317, DOI 10.2119/2006-00086.Lee; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lee YC, 2004, FASEB J, V18, P1917, DOI 10.1096/fj.04-2212fje; Looms DK, 2001, BIOCHEM J, V355, P87, DOI 10.1042/bj3550087; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lundquist I, 2003, AM J PHYSIOL-ENDOC M, V285, pE1055, DOI 10.1152/ajpendo.00498.2002; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; MESINA JE, 1989, BRAIN RES, V478, P181, DOI 10.1016/0006-8993(89)91494-7; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; MUKHERJEE SP, 1979, BIOCHIM BIOPHYS ACTA, V568, P224, DOI 10.1016/0005-2744(79)90289-4; Oiry J, 1999, J MED CHEM, V42, P4733, DOI 10.1021/jm980289j; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; PORTA P, 1991, J PHARMACOL EXP THER, V257, P331; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; SCHMIDT HHHW, 1992, SCIENCE, V255, P721, DOI 10.1126/science.1371193; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tang G, 2013, DIABETOLOGIA, V56, P533, DOI 10.1007/s00125-012-2806-8; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Vita JA, 1998, J CLIN INVEST, V101, P1408, DOI 10.1172/JCI1155; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; WILLIAMSON JM, 1981, P NATL ACAD SCI-BIOL, V78, P936, DOI 10.1073/pnas.78.2.936; Willmott N, 1996, J BIOL CHEM, V271, P3699; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; WLODEK L, 1993, BIOCHEM PHARMACOL, V46, P1917, DOI 10.1016/0006-2952(93)90632-7; You H, 2011, AM J PHYSIOL-ENDOC M, V300, pE435, DOI 10.1152/ajpendo.00398.2010	55	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134962	10.1371/journal.pone.0134962	http://dx.doi.org/10.1371/journal.pone.0134962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247205	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300082
J	Sidhu, S; Datta, A				Sidhu, Swati; Datta, Aparajita			Tracking Seed Fates of Tropical Tree Species: Evidence for Seed Caching in a Tropical Forest in North-East India	PLOS ONE			English	Article							SCATTER-HOARDING RODENTS; MOIST EVERGREEN FOREST; ARUNACHAL-PRADESH; SUBTROPICAL FOREST; DISPERSAL; PREDATION; REMOVAL; SIZE; RECRUITMENT; ABUNDANCE	Rodents affect the post-dispersal fate of seeds by acting either as on-site seed predators or as secondary dispersers when they scatter-hoard seeds. The tropical forests of north-east India harbour a high diversity of little-studied terrestrial murid and hystricid rodents. We examined the role played by these rodents in determining the seed fates of tropical evergreen tree species in a forest site in north-east India. We selected ten tree species (3 mammal-dispersed and 7 bird-dispersed) that varied in seed size and followed the fates of 10,777 tagged seeds. We used camera traps to determine the identity of rodent visitors, visitation rates and their seed-handling behavior. Seeds of all tree species were handled by at least one rodent taxon. Overall rates of seed removal (44.5%) were much higher than direct on-site seed predation (9.9%), but seed-handling behavior differed between the terrestrial rodent groups: two species of murid rodents removed and cached seeds, and two species of porcupines were on-site seed predators. In addition, a true cricket, Brachytrupes sp., cached seeds of three species underground. We found 309 caches formed by the rodents and the cricket; most were single-seeded (79%) and seeds were moved up to 19 m. Over 40% of seeds were re-cached from primary cache locations, while about 12% germinated in the primary caches. Seed removal rates varied widely amongst tree species, from 3% in Beilschmiedia assamica to 97% in Actinodaphne obovata. Seed predation was observed in nine species. Chisocheton cumingianus (57%) and Prunus ceylanica (25%) had moderate levels of seed predation while the remaining species had less than 10% seed predation. We hypothesized that seed traits that provide information on resource quantity would influence rodent choice of a seed, while traits that determine resource accessibility would influence whether seeds are removed or eaten. Removal rates significantly decreased (p < 0.001) while predation rates increased (p = 0.06) with seed size. Removal rates were significantly lower for soft seeds (p = 0.002), whereas predation rates were significantly higher on soft seeds (p = 0.01). Our results show that murid rodents play a very important role in affecting the seed fates of tropical trees in the Eastern Himalayas. We also found that the different rodent groups differed in their seed handling behavior and responses to changes in seed characteristics.	[Sidhu, Swati; Datta, Aparajita] Nat Conservat Fdn, Eastern Himalaya Programme, Mysore, Karnataka, India		Sidhu, S (corresponding author), Nat Conservat Fdn, Eastern Himalaya Programme, Mysore, Karnataka, India.	swati@ncf-india.org			NAT GEO CRE Grant [8924-11]; National Geographic Society Committee for Research Exploration	NAT GEO CRE Grant; National Geographic Society Committee for Research Exploration(National Geographic Society)	Funding provided by NAT GEO CRE Grant 8924-11; http://www.nationalgeographic.com/explorers/bios/aparajita-datta/, National Geographic Society Committee for Research & Exploration to AD.	Andresen E, 2001, J TROP ECOL, V17, P61, DOI 10.1017/S0266467401001043; BECKER P, 1985, BIOTROPICA, V17, P230, DOI 10.2307/2388223; BERG RY, 1975, AUST J BOT, V23, P475, DOI 10.1071/BT9750475; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Bolker BM., 2007, ECOLOGICAL MODELS AN; Brodie JF, 2009, ECOLOGY, V90, P688, DOI 10.1890/08-0111.1; Champion H. G., 1968, REVISED SURVEY FORES, P404; Cheng JR, 2005, FOREST ECOL MANAG, V216, P331, DOI 10.1016/j.foreco.2005.05.045; Corlett Richard T., 1998, Forktail, V13, P23; Crawley M.J., 2007, R BOOK; Datta A, 1998, ORYX, V32, P285, DOI 10.1017/S0030605300030088; Datta A, 2003, BIOTROPICA, V35, P208, DOI 10.1111/j.1744-7429.2003.tb00280.x; Datta A., 2001, THESIS; Datta A, 2008, CURR SCI INDIA, V95, P895; Datta A, 2008, TROP CONSERV SCI, V1, P163, DOI 10.1177/194008290800100302; DUBOST G, 1988, J ZOOL, V214, P107, DOI 10.1111/j.1469-7998.1988.tb04990.x; Duthie C, 2006, SCIENCE, V311, P1575, DOI 10.1126/science.1123544; Forget P.-M., 2004, SEED FATE PREDATION; Forget P.M., 2002, SEED DISPERSAL FRUGI, P241; Forget PM, 1996, J TROP ECOL, V12, P751, DOI 10.1017/S0266467400009998; FORGET PM, 1991, OECOLOGIA, V87, P596, DOI 10.1007/BF00320426; FORGET PM, 1990, J TROP ECOL, V6, P459, DOI 10.1017/S0266467400004867; FORGET PM, 1994, BIOTROPICA, V26, P420, DOI 10.2307/2389236; Forget PM, 1996, DYNAMICS OF TROPICAL, P25; Geluso K, 2005, J MAMMAL, V86, P1186, DOI 10.1644/05-MAMM-A-016R1.1; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Hoshizaki Kazuhiko, 2002, P227, DOI 10.1079/9780851995250.0227; Jansen P. A., 2001, Nouragues: dynamics and plant-animal interactions in a neotropical rainforest, P275; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; Jansen PA, 2010, J TROP ECOL, V26, P473, DOI 10.1017/S0266467410000337; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Kitamura S, 2004, J TROP ECOL, V20, P545, DOI 10.1017/S0266467404001518; Kitamura S, 2004, J TROP ECOL, V20, P421, DOI 10.1017/S0266467404001555; Kitamura S, 2008, ECOL RES, V23, P169, DOI 10.1007/s11284-007-0350-7; Maron JL, 1997, OECOLOGIA, V111, P76, DOI 10.1007/s004420050210; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; R Development Core Team, 2009, R A LANGUAGE AND ENV; Sethi P, 2012, J TROP ECOL, V28, P531, DOI 10.1017/S0266467412000648; Sethi P, 2009, CONSERV BIOL, V23, P710, DOI 10.1111/j.1523-1739.2008.01155.x; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; Steele MA, 2011, ACTA OECOL, V37, P554, DOI 10.1016/j.actao.2011.05.002; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Velho N, 2012, BIOL CONSERV, V153, P32, DOI 10.1016/j.biocon.2012.04.028; Velho N, 2012, OECOLOGIA, V169, P995, DOI 10.1007/s00442-012-2252-9; Velho N, 2009, J TROP ECOL, V25, P507, DOI 10.1017/S0266467409990083; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Xiao ZS, 2008, ANIM BEHAV, V75, P1235, DOI 10.1016/j.anbehav.2007.08.017; Xiao ZS, 2013, J ECOL, V101, P1256, DOI 10.1111/1365-2745.12113; Xiao ZS, 2006, FOREST ECOL MANAG, V222, P46, DOI 10.1016/j.foreco.2005.10.020; Xiao ZS, 2005, PLANT ECOL, V177, P249, DOI 10.1007/s11258-005-2321-9; Xiao ZS, 2004, FOREST ECOL MANAG, V196, P405, DOI 10.1016/j.foreco.2004.04.001; Xiao ZS, 2004, FOREST ECOL MANAG, V195, P141, DOI 10.1016/j.foreco.2004.02.041; Yasuda M., 2000, Journal of Tropical Forest Science, V12, P164; Zhang HM, 2008, OECOLOGIA, V158, P57, DOI 10.1007/s00442-008-1114-y; Zwolak R, 2012, OIKOS, V121, P20, DOI 10.1111/j.1600-0706.2011.19849.x	64	12	12	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134658	10.1371/journal.pone.0134658	http://dx.doi.org/10.1371/journal.pone.0134658			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247616	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300055
J	Phelps, NBD; Mor, SK; Armien, AG; Pelican, KM; Goyal, SM				Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Pelican, Katharine M.; Goyal, Sagar M.			Description of the Microsporidian Parasite, Heterosporis sutherlandae n. sp., Infecting Fish in the Great Lakes Region, USA	PLOS ONE			English	Article								Heterosporosis is an increasingly important microsporidian disease worldwide, impacting wild and farmed raised fishes in both marine and freshwater environments. A previously undescribed species (Heterosporis sp.), with widespread distribution in the Great Lakes region, was the subject of this study. Three angler-caught fish were submitted to the Minnesota Veterinary Diagnostic Laboratory from 2009-2010 with lesions caused by intracellular proliferation of parasitic spores, resulting in destruction and eventual widespread necrosis of the host skeletal muscles. Mature ovoid (5.8 x 3.5 mu m) spores of a microsporidian parasite, consistent with the genus Heterosporis, were observed by light and electron microscopy. Molecular identification was performed using primer walking to obtain a near-complete rRNA gene sequence (similar to 3,600 bp). A unique species of Heterosporis was identified, demonstrating less than 96% sequence identity to other published Heterosporis sp. on the basis of partial rRNA gene sequence analysis. Heterosporis sutherlandae n. sp. (formerly Heterosporis sp.) was identified in yellow perch (Perca flavescens), northern pike (Esox lucius) and walleye (Sander vitreus) from inland lakes in Minnesota and Wisconsin. Previous research suggests this species may be even more widespread in the Great Lakes region and should be reexamined using molecular techniques to better understand the distribution of this novel species.	[Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Goyal, Sagar M.] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Phelps, Nicholas B. D.; Mor, Sunil K.; Armien, Anibal G.; Pelican, Katharine M.; Goyal, Sagar M.] Univ Minnesota, Vet Populat Med Dept, Coll Vet Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Mor, SK (corresponding author), Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, 1333 Gortner Ave, St Paul, MN 55108 USA.	kumars@umn.edu	Mor, Sunil Kumar/M-6325-2018	Mor, Sunil Kumar/0000-0002-1112-088X; Phelps, Nicholas/0000-0003-3116-860X	Minnesota Environmental and Natural Resources Trust Fund	Minnesota Environmental and Natural Resources Trust Fund	This study was funded by the Minnesota Environmental and Natural Resources Trust Fund.	Al-Quraishy S, 2012, PARASITOLOGY, V139, P454, DOI 10.1017/S0031182011001971; Canning EU, 1986, MICROSPORIDIA VERTEB, V1; Coste Francoise, 1998, Bulletin of the European Association of Fish Pathologists, V18, P157; Diamant A, 2010, DIS AQUAT ORGAN, V91, P137, DOI 10.3354/dao02256; Drummond AJ, GENEIOUS V5 4; Dykova I., 1995, P149; Egidius E., 1986, Bulletin of the European Association of Fish Pathologists, V6, P13; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIGUERAS A, 1992, DIS AQUAT ORGAN, V14, P127, DOI 10.3354/dao014127; Hoshina T, 1951, J TOKYO U FISH, V38, P35; Joh SJ, 2007, J VET SCI, V8, P147, DOI 10.4142/jvs.2007.8.2.147; Lom J, 2003, INT J PARASITOL, V33, P107, DOI 10.1016/S0020-7519(02)00252-7; Lom J, 2000, DIS AQUAT ORGAN, V43, P225, DOI 10.3354/dao043225; Matthews RA, 1980, J FISH DIS, V11, P251; MICHEL C, 1989, DIS AQUAT ORGAN, V7, P103, DOI 10.3354/dao007103; Miller PE, 2009, THESIS U WISCONSIN L; Phelps NBD, 2008, J AQUAT ANIM HEALTH, V20, P45, DOI 10.1577/H07-029.1; PULSFORD A, 1991, J FISH DIS, V14, P67, DOI 10.1111/j.1365-2761.1991.tb00577.x; Shaw Ross W., 1999, P418; SPRENGEL G, 1991, DIS AQUAT ORGAN, V11, P31, DOI 10.3354/dao011031; SUMMERFELT ROBERT C., 1964, TRANS AMER FISH SOC, V93, P6, DOI 10.1577/1548-8659(1964)93[6:ANMPFT]2.0.CO;2; Sutherland D., 2000, P 62 MIDW FISH WILDL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai SJ, 2002, DIS AQUAT ORGAN, V49, P199, DOI 10.3354/dao049199; Wiklund T, 1996, DIS AQUAT ORGAN, V26, P163, DOI 10.3354/dao026163	25	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132027	10.1371/journal.pone.0132027	http://dx.doi.org/10.1371/journal.pone.0132027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244983	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400016
J	Prados, J; Stenz, L; Somm, E; Stouder, C; Dayer, A; Paoloni-Giacobino, A				Prados, Julien; Stenz, Ludwig; Somm, Emmanuel; Stouder, Christelle; Dayer, Alexandre; Paoloni-Giacobino, Ariane			Prenatal Exposure to DEHP Affects Spermatogenesis and Sperm DNA Methylation in a Strain-Dependent Manner	PLOS ONE			English	Article							IN-UTERO EXPOSURE; EPIGENETIC TRANSGENERATIONAL ACTIONS; PARKIN COREGULATED GENE; FETAL-RAT TESTIS; DI-(2-ETHYLHEXYL) PHTHALATE; ENDOCRINE DISRUPTORS; TESTOSTERONE PRODUCTION; DIETHYLHEXYL PHTHALATE; ANOGENITAL DISTANCE; LEYDIG-CELLS	Di-(2-ethylhexyl)phtalate (DEHP) is a plasticizer with endocrine disrupting properties found ubiquitously in the environment and altering reproduction in rodents. Here we investigated the impact of prenatal exposure to DEHP on spermatogenesis and DNA sperm methylation in two distinct, selected, and sequenced mice strains. FVB/N and C57BL/6J mice were orally exposed to 300 mg/kg/day of DEHP from gestation day 9 to 19. Prenatal DEHP exposure significantly decreased spermatogenesis in C57BL/6J (fold-change = 0.6, p-value = 8.7*10(-4)), but not in FVB/N (fold-change = 1, p-value = 0.9). The number of differentially methylated regions (DMRs) by DEHP-exposure across the entire genome showed increased hyper- and decreased hypo-methylation in C57BL/6J compared to FVB/N. At the promoter level, three important subsets of genes were massively affected. Promoters of vomeronasal and olfactory receptors coding genes globally followed the same trend, more pronounced in the C57BL/6J strain, of being hyper-methylated in DEHP related conditions. In contrast, a large set of micro-RNAs were hypo-methylated, with a trend more pronounced in the FVB/N strain. We additionally analyze both the presence of functional genetic variations within genes that were associated with the detected DMRs and that could be involved in spermatogenesis, and DMRs related with the DEHP exposure that affected both strains in an opposite manner. The major finding in this study indicates that prenatal exposure to DEHP can decrease spermatogenesis in a strain-dependent manner and affects sperm DNA methylation in promoters of large sets of genes putatively involved in both sperm chemotaxis and post-transcriptional regulatory mechanisms.	[Prados, Julien; Dayer, Alexandre] Univ Hosp Geneva, Div Psychiat Specialties, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Prados, Julien] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland; [Somm, Emmanuel] CHU Vaudois, Endocrinol Diabet & Metab Serv, CH-1011 Lausanne, Switzerland; [Somm, Emmanuel] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Stenz, Ludwig; Stouder, Christelle; Paoloni-Giacobino, Ariane] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Stenz, Ludwig; Stouder, Christelle; Paoloni-Giacobino, Ariane] Univ Hosp, Geneva, Switzerland; [Paoloni-Giacobino, Ariane] Univ Geneva, Sch Med, Swiss Ctr Appl Human Toxicol, CH-1211 Geneva, Switzerland; [Dayer, Alexandre] Univ Geneva, Sch Med, Dept Basic Neurosci, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Stenz, L (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	Ludwig.stenz@unige.ch	Giacobino, Ariane/AHC-7144-2022; Stenz, L/N-7605-2017	Stenz, L/0000-0002-2339-9451; Prados, Julien/0000-0002-8546-241X; Dayer, Alexandre/0000-0002-4490-9780; Giacobino, Ariane/0000-0001-9432-1785	Swiss Centre for Applied Human Toxicology (SCAHT); Federal Office for Public Health (FOPH)	Swiss Centre for Applied Human Toxicology (SCAHT); Federal Office for Public Health (FOPH)	Funding was provided to AG by the Swiss Centre for Applied Human Toxicology (SCAHT) in the core project 2 "Environmentally-induced epigenetic changes and male infertility" and by the Federal Office for Public Health (FOPH).	Ablake M, 2004, INT J ANDROL, V27, P274, DOI 10.1111/j.1365-2605.2004.00482.x; ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379; Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Anway MD, 2006, ENDOCRINOLOGY, V147, pS43, DOI 10.1210/en.2005-1058; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arguelles DBM, 2013, TOXICOL APPL PHARM, V266, P95, DOI 10.1016/j.taap.2012.10.027; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avena JS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004666; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Baker MA, 2008, PROTEOMICS, V8, P1720, DOI 10.1002/pmic.200701020; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Brody KM, 2008, BRAIN RES, V1201, P177, DOI 10.1016/j.brainres.2008.01.050; Campioli E, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.13; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; CHAILLET JR, 1995, GENE DEV, V9, P1177, DOI 10.1101/gad.9.10.1177; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; Di Giacomo M, 2013, MOL CELL, V50, P601, DOI 10.1016/j.molcel.2013.04.026; Doyle TJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106104; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GAUNT IF, 1982, FOOD CHEM TOXICOL, V20, P215, DOI 10.1016/S0278-6915(82)80252-4; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano R, 2000, J CELL BIOL, V148, P1107, DOI 10.1083/jcb.148.6.1107; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Ho SM, 2006, CANCER RES, V66, P5624, DOI 10.1158/0008-5472.CAN-06-0516; Hong JY, 2007, REPRODUCTION, V133, P395, DOI 10.1530/REP-06-0180; Hu YH, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-72; Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093; Huang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050465; Ibarra CA, 2012, SCIENCE, V337, P1360, DOI 10.1126/science.1224839; Jarczowski F, 2008, BIOCHEMISTRY-US, V47, P6946, DOI 10.1021/bi8001506; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kember RL, 2012, BRAIN BEHAV, V2, P455, DOI 10.1002/brb3.69; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049; Lan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022226; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee IJ, 2014, MOL BIOL CELL, V25, P2735, DOI 10.1091/mbc.E13-11-0699; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lee YJ, 2011, ARCH TOXICOL, V85, P975, DOI 10.1007/s00204-010-0618-5; Lo JCY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002969; Lorenzetti D, 2004, P NATL ACAD SCI USA, V101, P8402, DOI 10.1073/pnas.0401832101; Martinez-Arguelles DB, 2014, ENDOCRINOLOGY, V155, P1667, DOI 10.1210/en.2013-1921; Meltzer D, 2015, REPROD TOXICOL, V51, P47, DOI 10.1016/j.reprotox.2014.12.005; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Niermann S, 2015, REPROD TOXICOL, V53, P23, DOI 10.1016/j.reprotox.2015.02.013; Ohtsuka Y, 2000, AM J PHYSIOL-LUNG C, V278, pL469, DOI 10.1152/ajplung.2000.278.3.L469; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Pocar P, 2012, ENDOCRINOLOGY, V153, P937, DOI 10.1210/en.2011-1450; Rajesh P, 2014, J ENDOCRINOL, V223, P47, DOI 10.1530/JOE-14-0111; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006; Saillenfait AM, 2013, J APPL TOXICOL, V33, P1027, DOI 10.1002/jat.2896; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Sekaran S, 2015, HUM EXP TOXICOL, V34, P575, DOI 10.1177/0960327114555926; Sekaran S, 2015, J CELL BIOCHEM, V116, P1466, DOI 10.1002/jcb.25108; Skinner MK, 2007, PEDIATR RES, V61, p48R, DOI 10.1203/pdr.0b013e3180457671; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song Xiao-feng, 2009, Zhonghua Nan Ke Xue, V15, P195; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Stenz L, 2015, NEUROSCI RES, V91, P1, DOI 10.1016/j.neures.2014.10.003; Svechnikov K, 2008, REPROD TOXICOL, V25, P485, DOI 10.1016/j.reprotox.2008.05.057; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Vo TTB, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-104; Walensky LD, 1998, MOL MED, V4, P502, DOI 10.1007/BF03401755; Wang Wei, 2004, Zhonghua Nan Ke Xue, V10, P807; Weichman K, 1997, MOL CELL BIOL, V17, P5269, DOI 10.1128/MCB.17.9.5269; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72; Wu Sheng-de, 2009, Zhonghua Nan Ke Xue, V15, P876; Wu SD, 2010, INT J TOXICOL, V29, P193, DOI 10.1177/1091581809355488; Xi W, 2012, ENVIRON SCI POLLUT R, V19, P2515, DOI 10.1007/s11356-012-0827-y; Yadav RP, 2014, MOL CELL ENDOCRINOL, V382, P498, DOI 10.1016/j.mce.2013.04.015; Ye T, 2014, AQUAT TOXICOL, V146, P115, DOI 10.1016/j.aquatox.2013.10.025; Zhang LD, 2013, BIOL RES, V46, P139, DOI 10.4067/S0716-97602013000200004	84	31	32	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132136	10.1371/journal.pone.0132136	http://dx.doi.org/10.1371/journal.pone.0132136			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244509	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400018
J	Shie, FS; Shiao, YJ; Yeh, CW; Lin, CH; Tzeng, TT; Hsu, HC; Huang, FL; Tsay, HJ; Liu, HK				Shie, Feng-Shiun; Shiao, Young-Ji; Yeh, Chih-Wen; Lin, Chien-Hung; Tzeng, Tsai-Teng; Hsu, Hao-Chieh; Huang, Fong-Lee; Tsay, Huey-Jen; Liu, Hui-Kang			Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 Mice	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; A-BETA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; INFLAMMATION; DYSFUNCTION; MODEL	Diabesity-associated metabolic stresses modulate the development of Alzheimer's disease (AD). For further insights into the underlying mechanisms, we examine whether the genetic background of APPswe/PS1dE9 at the prodromal stage of AD affects peripheral metabolism in the context of diabesity. We characterized APPswe/PS1dE9 transgenic mice treated with a combination of high-fat diet with streptozotocin (HFSTZ) in the early stage of AD. HFSTZ-treated APPswe/PS1dE9 transgenic mice exhibited worse metabolic stresses related to diabesity, while serum beta-amyloid levels were elevated and hepatic steatosis became apparent. Importantly, two-way analysis of variance shows a significant interaction between HFSTZ and genetic background of AD, indicating that APPswe/PS1dE9 transgenic mice are more vulnerable to HFSTZ treatment. In addition, body weight gain, high hepatic triglyceride, and hyperglycemia were positively associated with serum beta-amyloid, as validated by Pearson's correlation analysis. Our data suggests that the interplay between genetic background of AD and HFSTZ-induced metabolic stresses contributes to the development of obesity and hepatic steatosis. Alleviating metabolic stresses including dysglycemia, obesity, and hepatic steatosis could be critical to prevent peripheral beta-amyloid accumulation at the early stage of AD.	[Shie, Feng-Shiun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Zhunan, Taiwan; [Shiao, Young-Ji; Liu, Hui-Kang] Natl Res Inst Chinese Med, Div Basic Chinese Med, Taipei, Taiwan; [Shiao, Young-Ji; Tzeng, Tsai-Teng] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Yeh, Chih-Wen; Tsay, Huey-Jen] Natl Yang Ming Univ, Brain Res Ctr, Inst Neurosci, Taipei 112, Taiwan; [Lin, Chien-Hung; Hsu, Hao-Chieh; Huang, Fong-Lee] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Liu, Hui-Kang] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Research Institute of Chinese Medicine; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Tsay, HJ (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Inst Neurosci, Taipei 112, Taiwan.	hjtsay@ym.edu.tw; hk.liu@nricm.edu.tw	Shiao, Young-Ji/AAA-9647-2022	Yeh, Chih-Wen/0000-0002-3833-2364	National Research Institute of Chinese Medicine [NRICM-101-pp-02]; Ministry of Science and Technology [MOST-102-2320-B-077-003, MOST-103-2311-B-010-008]	National Research Institute of Chinese Medicine; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was funded by National Research Institute of Chinese Medicine (grant no. NRICM-101-pp-02) to YJS, Ministry of Science and Technology (grant no. MOST-102-2320-B-077-003) to HKL, and Ministry of Science and Technology (MOST-103-2311-B-010-008) to HJT.	Abdullah L, 2009, MOL MED, V15, P95, DOI 10.2119/molmed.2008.00118; Biessels GJ, 2014, LANCET DIABETES ENDO, V2, P246, DOI 10.1016/S2213-8587(13)70088-3; Clarke JR, 2015, EMBO MOL MED, V7, P190, DOI 10.15252/emmm.201404183; Correia SC, 2011, AGEING RES REV, V10, P264, DOI 10.1016/j.arr.2011.01.001; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Dineley KT, 2014, NEUROBIOL DIS, V72, P92, DOI 10.1016/j.nbd.2014.09.001; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Jimenez-Palomares M, 2012, AM J PHYSIOL-ENDOC M, V302, pE1373, DOI 10.1152/ajpendo.00500.2011; Juan YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/349807; Kandimalla KK, 2005, J PHARMACOL EXP THER, V313, P1370, DOI 10.1124/jpet.104.081901; Luchsinger JA, 2012, J ALZHEIMERS DIS, V30, pS185, DOI 10.3233/JAD-2012-111433; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Maesako M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.028; Marques MA, 2009, J ALZHEIMERS DIS, V16, P325, DOI 10.3233/JAD-2009-0964; Mody N, 2011, DIABETOLOGIA, V54, P2143, DOI 10.1007/s00125-011-2160-2; Panza F, 2009, DRUG AGING, V26, P537, DOI 10.2165/11315770-000000000-00000; Peters R, 2009, INT J GERIATR PSYCH, V24, P452, DOI 10.1002/gps.2153; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Takeda S, 2010, P NATL ACAD SCI USA, V107, P7036, DOI 10.1073/pnas.1000645107; Thambisetty M, 2013, JAMA NEUROL, V70, P1167, DOI 10.1001/jamaneurol.2013.284; Zhang Y, 2013, DIABETES, V62, P1159, DOI 10.2337/db12-0670; Zhang Y, 2012, DIABETES, V61, P1434, DOI 10.2337/db11-0499	27	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134531	10.1371/journal.pone.0134531	http://dx.doi.org/10.1371/journal.pone.0134531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244977	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400086
J	Weng, WC; Jiang, GJA; Chang, CF; Lu, WY; Lin, CY; Lee, WT; Shieh, JS				Weng, Wen-Chin; Jiang, George J. A.; Chang, Chi-Feng; Lu, Wen-Yu; Lin, Chun-Yen; Lee, Wang-Tso; Shieh, Jiann-Shing			Complexity of Multi-Channel Electroencephalogram Signal Analysis in Childhood Absence Epilepsy	PLOS ONE			English	Article							MULTISCALE ENTROPY; EEG-FMRI; APPROXIMATE ENTROPY; SAMPLE ENTROPY; TIME-SERIES; SEIZURES; SPIKE; NETWORKS; LONG; RATS	Absence epilepsy is an important epileptic syndrome in children. Multiscale entropy (MSE), an entropy-based method to measure dynamic complexity at multiple temporal scales, is helpful to disclose the information of brain connectivity. This study investigated the complexity of electroencephalogram (EEG) signals using MSE in children with absence epilepsy. In this research, EEG signals from 19 channels of the entire brain in 21 children aged 5-12 years with absence epilepsy were analyzed. The EEG signals of pre-ictal (before seizure) and ictal states (during seizure) were analyzed by sample entropy (SamEn) and MSE methods. Variations of complexity index (CI), which was calculated from MSE, from the pre-ictal to the ictal states were also analyzed. The entropy values in the pre-ictal state were significantly higher than those in the ictal state. The MSE revealed more differences in analysis compared to the SamEn. The occurrence of absence seizures decreased the CI in all channels. Changes in CI were also significantly greater in the frontal and central parts of the brain, indicating fronto-central cortical involvement of "cortico-thalamo-cortical network" in the occurrence of generalized spike and wave discharges during absence seizures. Moreover, higher sampling frequency was more sensitive in detecting functional changes in the ictal state. There was significantly higher correlation in ictal states in the same patient in different seizures but there were great differences in CI among different patients, indicating that CI changes were consistent in different absence seizures in the same patient but not from patient to patient. This implies that the brain stays in a homogeneous activation state during the absence seizures. In conclusion, MSE analysis is better than SamEn analysis to analyze complexity of EEG, and CI can be used to investigate the functional brain changes during absence seizures.	[Weng, Wen-Chin] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Weng, Wen-Chin; Lu, Wen-Yu; Lin, Chun-Yen; Lee, Wang-Tso] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Weng, Wen-Chin; Lee, Wang-Tso] Natl Taiwan Univ Childrens Hosp, Dept Pediat Neurol, Taipei, Taiwan; [Jiang, George J. A.; Chang, Chi-Feng; Shieh, Jiann-Shing] Yuan Ze Univ, Dept Mech Engn, Taoyuan, Chung Li, Taiwan; [Lee, Wang-Tso] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Shieh, Jiann-Shing] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Shieh, Jiann-Shing] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Chungli, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Yuan Ze University; National Taiwan University; National Central University; Yuan Ze University	Lee, WT (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, 1 Chang Te St, Taipei 10016, Taiwan.	leeped@hotmail.com		weng, wen-chin/0000-0002-6923-9138; Lee, Wang-Tso/0000-0003-3231-9764	National Science Council (NSC) of Taiwan [NSC 99-2221-E-155-046-MY3]; Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - NSC [NSC 102-2911-I-008-001]	National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan); Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan - NSC	This research was financially supported by the National Science Council (NSC) of Taiwan (grant number: NSC 99-2221-E-155-046-MY3). This research was also supported by the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan which is sponsored by NSC (grant number: NSC 102-2911-I-008-001).	Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; Carney PW, 2012, NEUROLOGY, V78, P1157, DOI 10.1212/WNL.0b013e31824f801d; Carney PW, 2010, NEUROLOGY, V75, P904, DOI 10.1212/WNL.0b013e3181f11c06; Catarino A, 2011, CLIN NEUROPHYSIOL, V122, P2375, DOI 10.1016/j.clinph.2011.05.004; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Gao JB, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00122; Gao JB, 2012, NONLINEAR DYNAM, V68, P431, DOI 10.1007/s11071-011-0281-2; Gao JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024331; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; Groening K, 2009, NEUROIMAGE, V46, P827, DOI 10.1016/j.neuroimage.2009.02.026; Gupta D, 2011, MED BIOL ENG COMPUT, V49, P555, DOI 10.1007/s11517-011-0778-3; Hu J, 2010, ANN BIOMED ENG, V38, P854, DOI 10.1007/s10439-009-9863-2; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Li QF, 2009, EPILEPSY RES, V87, P160, DOI 10.1016/j.eplepsyres.2009.08.018; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Luttjohann A, 2012, NEUROBIOL DIS, V47, P49, DOI 10.1016/j.nbd.2012.03.023; Masterton RAJ, 2013, EPILEPSIA, V54, P801, DOI 10.1111/epi.12163; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; PENRY JK, 1975, BRAIN, V98, P427, DOI 10.1093/brain/98.3.427; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; SATO S, 1983, NEUROLOGY, V33, P1590, DOI 10.1212/WNL.33.12.1590; Serletis D, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056008; Sitnikova E, 2006, EPILEPSY RES, V71, P159, DOI 10.1016/j.eplepsyres.2006.06.008; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; van Luijtelaar G, 2011, CLIN NEUROPHYSIOL, V122, P687, DOI 10.1016/j.clinph.2010.10.038; Westmijse I, 2009, EPILEPSIA, V50, P2538, DOI 10.1111/j.1528-1167.2009.02162.x; Yuedong Song, 2010, Journal of Biomedical Science & Engineering, V3, P556, DOI 10.4236/jbise.2010.36078	35	20	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134083	10.1371/journal.pone.0134083	http://dx.doi.org/10.1371/journal.pone.0134083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244497	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400067
J	Claudino, MA; Leiria, LOS; da Silva, FH; Alexandre, EC; Renno, A; Monica, FZ; de Nucci, G; Fertrin, KY; Antunes, E; Costa, FF; Franco-Penteado, CF				Claudino, Mario Angelo; Silveira Leiria, Luiz Osorio; da Silva, Fabio Henrique; Alexandre, Eduardo Costa; Renno, Andre; Monica, Fabiola Zakia; de Nucci, Gilberto; Fertrin, Kleber Yotsumoto; Antunes, Edson; Costa, Fernando Ferreira; Franco-Penteado, Carla Fernanda			Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice	PLOS ONE			English	Article							NOCTURNAL ENURESIS; CONTRACTION; DETRUSOR; CHILDREN; TRACT; OUTCOMES; CA2+; PATHOPHYSIOLOGY; COMPLICATIONS; ACETYLCHOLINE	Background Urological complications associated with sickle cell disease (SCD), include nocturia, enuresis, urinary infections and urinary incontinence. However, scientific evidence to ascertain the underlying cause of the lower urinary tract symptoms in SCD is lacking. Objective Thus, the aim of this study was to evaluate urinary function, in vivo and ex vivo, in the Berkeley SCD murine model (SS). Methods Urine output was measured in metabolic cage for both wild type and SS mice (25-30 g). Bladder strips and urethra rings were dissected free and mounted in organ baths. In isolated detrusor smooth muscle (DSM), relaxant response to mirabegron and isoproterenol (1 nM-10 mu M) and contractile response to (carbachol (CCh; 1 nM-100 mu M), KCl (1 mM-300mM), CaCl2 (1 mu M-100mM), alpha,beta-methylene ATP (1, 3 and 10 mu M) and electrical field stimulation (EFS; 1-32 Hz) were measured. Phenylephrine (Phe; 10nM-100 mu M) was used to evaluate the contraction mechanism in the urethra rings. Cystometry and histomorphometry were also performed in the urinary bladder. Results SS mice present a reduced urine output and incapacity to produce typical bladder contractions and bladder emptying (ex vivo), compared to control animals. In DSM, relaxation in response to a selective beta 3-adrenergic agonist (mirabegron) and to a non-selective beta-adrenergic (isoproterenol) agonist were lower in SS mice. Additionally, carbachol, alpha,beta-methylene ATP, KCl, extracellular Ca2+ and electrical-field stimulation promoted smaller bladder contractions in SS group. Urethra contraction induced by phenylephrine was markedly reduced in SS mice. Histological analyses of SS mice bladder revealed severe structural abnormalities, such as reductions in detrusor thickness and bladder volume, and cell infiltration. Conclusions Taken together, our data demonstrate, for the first time, that SS mice display features of urinary bladder dysfunction, leading to impairment in urinary continence, which may have an important role in the pathogenesis of the enuresis and infections observed the SCD patients.	[Claudino, Mario Angelo; Silveira Leiria, Luiz Osorio; Alexandre, Eduardo Costa; Renno, Andre; Monica, Fabiola Zakia; de Nucci, Gilberto; Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Campinas, SP, Brazil; [da Silva, Fabio Henrique; Costa, Fernando Ferreira; Franco-Penteado, Carla Fernanda] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Fertrin, Kleber Yotsumoto] Univ Estadual Campinas, Fac Med Sci, Dept Clin Pathol, Campinas, SP, Brazil; [Claudino, Mario Angelo] Univ Sao Francisco, Sch Med, Lab Multidisciplinary Res, BR-12900000 Braganca Paulista, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Sao Francisco	Franco-Penteado, CF (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	carlapenteado@gmail.com	Monica, Fabiola Zakia/B-4191-2013; Alexandre, Eduardo/D-3797-2013; Costa, Fernando F/D-1566-2012; De Nucci, Gilberto/J-5990-2012; Claudino, Mário A/D-5367-2014; Silva, Fábio/D-5412-2013; De Nucci, Gilberto/ABB-7380-2021; Fertrin, Kleber/M-4175-2013; ANTUNES, EDSON/F-6731-2012	Monica, Fabiola Zakia/0000-0002-8449-6677; Alexandre, Eduardo/0000-0002-9482-6799; Costa, Fernando F/0000-0002-4632-572X; De Nucci, Gilberto/0000-0002-4346-7941; Silva, Fábio/0000-0003-3374-5570; De Nucci, Gilberto/0000-0002-4346-7941; Fertrin, Kleber/0000-0003-2637-3297; Claudino, Mario Angelo/0000-0002-3590-9607; ANTUNES, EDSON/0000-0003-2201-8247	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/57441-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [481761/2008-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from the Brazilian funding bodies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), Grant number: 2008/57441-0 FFC, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), Grant number: 481761/2008-0 CFFP.	Abrams P, 2006, UROLOGY, V68, P17, DOI 10.1016/j.urology.2006.05.044; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Anele UA, 2016, NEUROUROL URODYNAM, V35, P642, DOI 10.1002/nau.22777; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; BAILL IC, 1990, INT J GYNECOL OBSTET, V33, P19, DOI 10.1016/0020-7292(90)90649-6; Barakat LP, 2001, J DEV BEHAV PEDIATR, V22, P300, DOI 10.1097/00004703-200110000-00004; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2011, BJU INT, V107, P192, DOI 10.1111/j.1464-410X.2010.09926.x; Chapple CR, 2015, EUR UROL, V68, P351, DOI 10.1016/j.eururo.2015.02.030; Claudino MA, 2012, ANEMIA, V2012, DOI 10.1155/2012/723520; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Conran N, 2009, HEMOGLOBIN, V33, P1, DOI 10.1080/03630260802625709; Field JJ, 2008, UROLOGY, V72, P81, DOI 10.1016/j.urology.2008.02.006; FIGUEROA TE, 1995, J UROLOGY, V153, P1987, DOI 10.1016/S0022-5347(01)67386-5; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Frazier EP, 2008, N-S ARCH PHARMACOL, V377, P449, DOI 10.1007/s00210-007-0208-0; Hagglof B, 1997, SCAND J UROL NEPHROL, V31, P79; Hamdi IM, 2002, SAUDI MED J, V23, P1455; Hsu L, 2006, BLOOD, V107, P3414, DOI 10.1182/blood-2005-11-4500; Igawa Y, 2004, J UROLOGY, V172, P2460, DOI 10.1097/01.ju.0000138054.77785.4a; Jans SMPJ, 2010, INT J CLIN PRACT, V64, P1688, DOI 10.1111/j.1742-1241.2010.02451.x; Kato GJ, 2008, JAMA-J AM MED ASSOC, V300, P2638, DOI 10.1001/jama.2008.598; Kennedy C, 2007, J NEUROSCI, V27, P845, DOI 10.1523/JNEUROSCI.3115-06.2007; Kumar V, 2004, J UROLOGY, V172, P744, DOI 10.1097/01.ju.0000131244.67160.f4ABSTRACT; Leiria LOS, 2011, BRIT J PHARMACOL, V163, P1276, DOI 10.1111/j.1476-5381.2011.01311.x; Masters JG, 1999, BRIT J PHARMACOL, V127, P996, DOI 10.1038/sj.bjp.0702640; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; MILLER JM, 1983, SOUTHERN MED J, V76, P962, DOI 10.1097/00007611-198308000-00004; Nath KA, 2015, NAT REV NEPHROL, V11, P161, DOI 10.1038/nrneph.2015.8; Nomiya M, 2015, INT J UROL, V22, P40, DOI 10.1111/iju.12652; Osman NI, 2014, EUR UROL, V65, P389, DOI 10.1016/j.eururo.2013.10.015; Pastore LM, 1999, EPIDEMIOLOGY, V10, P282, DOI 10.1097/00001648-199905000-00016; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pinna C, 2006, LIFE SCI, V79, P1301, DOI 10.1016/j.lfs.2006.03.035; Portocarrero ML, 2012, J UROLOGY, V187, P1037, DOI 10.1016/j.juro.2011.10.171; READETT DRJ, 1990, ARCH DIS CHILD, V65, P615, DOI 10.1136/adc.65.6.615; Silva IV, 2015, EUR J HAEMATOL, V94, P157, DOI 10.1111/ejh.12411; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; TARRY WF, 1987, J UROLOGY, V138, P592, DOI 10.1016/S0022-5347(17)43267-8; Tita ATN, 2007, OBSTET GYNECOL, V110, P1113, DOI 10.1097/01.AOG.0000285995.41769.83; UCHIDA W, 1994, N-S ARCH PHARMACOL, V350, P398; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Wuest M, 2007, EUR J PHARMACOL, V565, P180, DOI 10.1016/j.ejphar.2007.02.046; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517; ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133996	10.1371/journal.pone.0133996	http://dx.doi.org/10.1371/journal.pone.0133996			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241312	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942700031
J	Taki, K; Ohmuraya, M; Tanji, E; Komatsu, H; Hashimoto, D; Semba, K; Araki, K; Kawaguchi, Y; Baba, H; Furukawa, T				Taki, K.; Ohmuraya, M.; Tanji, E.; Komatsu, H.; Hashimoto, D.; Semba, K.; Araki, K.; Kawaguchi, Y.; Baba, H.; Furukawa, T.			GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm	ONCOGENE			English	Article							FREQUENT GNAS MUTATIONS; STIMULATORY G-PROTEIN; ACTIVATING MUTATIONS; ADENOMA; ALPHA; GSP	Intraductal papillary mucinous neoplasm (IPMN), the most common pancreatic cystic neoplasm, is known to progress to invasive ductal adenocarcinoma. IPMNs commonly harbor activating somatic mutations in GNAS and KRAS, primarily GNAS(R201H) and KRAS(G12D). GNAS encodes the stimulatory G-protein alpha subunit (Gs alpha) that mediates a stimulatory signal to adenylyl cyclase to produce cyclic adenosine monophosphate (cAMP), subsequently activating cAMP-dependent protein kinase A. The GNAS(R201H) mutation results in constitutive activation of Gs alpha. To study the potential role of GNAS in pancreatic tumorigenesis in vivo, we generated lines of transgenic mice in which the transgene consisted of Lox-STOP-Lox (LSL)-GNAS(R201H) under the control of the CAG promoter (Tg(CAG-LSL-GNAS)). These mice were crossed with pancreatic transcription factor 1a (Ptf1a)-Cre mice (Ptf1a(Cre/+)), generating Tg(CAG-LSL-GNAS); Ptf1a(Cre/+) mice. This mouse line showed elevated cAMP levels, small dilated tubular complex formation, loss of acinar cells and fibrosis in the pancreas; however, no macroscopic tumorigenesis was apparent by 2 months of age. We then crossed Tg(CAG-LSL-GNAS); Ptf1a(Cre/+) mice with LSL-Kras(G12D) mice, generating Tg(CAG-LSL-GNAS); LSL-Kras(G12D); Ptf1a(Cre/+) mice. We used these mice to investigate a possible cooperative effect of GNAS(R201H) and Kras(G12D) in pancreatic tumorigenesis. Within 5 weeks, Tg(CAG-LSL-GNAS); LSL-Kras(G12D); Ptf1a(Cre/+) mice developed a cystic tumor consisting of marked dilated ducts lined with papillary dysplastic epithelia in the pancreas, which closely mimicked the human IPMN. Our data strongly suggest that activating mutations in GNAS and Kras cooperatively promote murine pancreatic tumorigenesis, which recapitulates IPMN. Our mouse model may serve as a unique in vivo platform to find biomarkers and effective drugs for diseases associated with GNAS mutations.	[Taki, K.; Ohmuraya, M.; Semba, K.; Araki, K.] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan; [Taki, K.; Hashimoto, D.; Baba, H.] Kumamoto Univ, Dept Gastroenterol Surg, Kumamoto, Japan; [Tanji, E.; Komatsu, H.; Furukawa, T.] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan; [Kawaguchi, Y.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Kumamoto University; Kumamoto University; Tokyo Women's Medical University; Kyoto University	Furukawa, T (corresponding author), Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan.	furukawa.toru@twmu.ac.jp	Furukawa, Toru/AAF-5596-2021; Hashimoto, Daisuke/AAE-7134-2020	Furukawa, Toru/0000-0002-1083-2324; 	Ministry of Education, Culture, Sports, Science and Technology [26110003]; Japan Society for the Promotion of Science [24659167]; Grants-in-Aid for Scientific Research [25640052] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr David A Tuveson (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA) for providing LSL-Kras<SUP>G12D</SUP> mouse, Dr Takeshi Tanaka and Dr Emiko Hayama (Department of Pediatric Cardiology, Tokyo Women's Medical University) for their work preparing the anti-Gs alpha antibody and Ms Yuko Fukuchi and Ms Michiyo Nakata (Institute of Resource Development and Analysis, Kumamoto University) for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Ministry of Education, Culture, Sports, Science and Technology (26110003) to MO and a Grant-in-Aid for Challenging Exploratory Research, Japan Society for the Promotion of Science (24659167) to TF.	Adsay NV., 2010, PATHOLOGY GENETICS T, P304; Delaney D, 2009, MODERN PATHOL, V22, P718, DOI 10.1038/modpathol.2009.32; Dhanasekaran Danny N, 2006, Sci STKE, V2006, ppe31, DOI 10.1126/stke.3472006pe31; Fragoso MCBV, 1998, J CLIN ENDOCR METAB, V83, P2074, DOI 10.1210/jc.83.6.2074; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Hata T, 2013, PANCREATOLOGY, V13, P615, DOI 10.1016/j.pan.2013.09.003; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Komatsu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087875; Kuboki Y, 2015, PANCREAS, V44, P227, DOI 10.1097/MPA.0000000000000253; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Matsubara A, 2013, J PATHOL, V229, P579, DOI 10.1002/path.4153; Matthaei H, 2014, AM J SURG PATHOL, V38, P360, DOI 10.1097/PAS.0000000000000117; Nishikawa G, 2013, BRIT J CANCER, V108, P951, DOI 10.1038/bjc.2013.47; OSULLIVAN C, 1991, MOL CARCINOGEN, V4, P345, DOI 10.1002/mc.2940040503; Semba K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003204; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yamada M, 2012, J PATHOL, V228, P113, DOI 10.1002/path.4012	22	52	54	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2407	2412		10.1038/onc.2015.294	http://dx.doi.org/10.1038/onc.2015.294			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26257060				2022-12-26	WOS:000376165000013
J	Ansari, IUH; Longacre, MJ; Paulusma, CC; Stoker, SW; Kendrick, MA; MacDonald, MJ				Ansari, Israr-ul H.; Longacre, Melissa J.; Paulusma, Coen C.; Stoker, Scott W.; Kendrick, Mindy A.; MacDonald, Michael J.			Characterization of P4 ATPase Phospholipid Translocases (Flippases) in Human and Rat Pancreatic Beta Cells THEIR GENE SILENCING INHIBITS INSULIN SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; PYRUVATE-CARBOXYLASE; LIPID FLIPPASES; ISLETS; MEMBRANE; GLUCOSE; GRANULES; CALCIUM; PROTEIN	The negative charge of phosphatidylserine in lipid bilayers of secretory vesicles and plasma membranes couples the domains of positively charged amino acids of secretory vesicle SNARE proteins with similar domains of plasma membrane SNARE proteins enhancing fusion of the two membranes to promote exocytosis of the vesicle contents of secretory cells. Our recent study of insulin secretory granules (ISG) (MacDonald, M. J., Ade, L., Ntambi, J. M., Ansari, I. H., and Stoker, S. W. (2015) Characterization of phospholipids in insulin secretory granules in pancreatic beta cells and their changes with glucose stimulation. J. Biol. Chem. 290, 1107511092) suggested that phosphatidylserine and other phospholipids, such as phosphatidylethanolamine, in ISG could play important roles in docking and fusion of ISG to the plasma membrane in the pancreatic beta cell during insulin exocytosis. P4 ATPase flippases translocate primarily phosphatidylserine and, to a lesser extent, phosphatidylethanolamine across the lipid bilayers of intracellular vesicles and plasma membranes to the cytosolic leaflets of these membranes. CDC50A is a protein that forms a heterodimer with P4 ATPases to enhance their translocase catalytic activity. We found that the predominant P4 ATPases in pure pancreatic beta cells and human and rat pancreatic islets were ATP8B1, ATP8B2, and ATP9A. ATP8B1 and CDC50A were highly concentrated in ISG. ATP9A was concentrated in plasma membrane. Gene silencing of individual P4 ATPases and CDC50A inhibited glucose-stimulated insulin release in pure beta cells and in human pancreatic islets. This is the first characterization of P4 ATPases in beta cells. The results support roles for P4 ATPases in translocating phosphatidylserine to the cytosolic leaflets of ISG and the plasma membrane to facilitate the docking and fusion of ISG to the plasma membrane during insulin exocytosis.	[MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA; [Paulusma, Coen C.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands	University of Wisconsin System; University of Wisconsin Madison; University of Amsterdam; Academic Medical Center Amsterdam	MacDonald, MJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA.	mjmacdon@wisc.edu	Regan, Clinton/E-6250-2012; Paulusma, Coen/AAR-7943-2021	ANSARI, Israrul/0000-0003-0326-0329; Paulusma, Coen/0000-0001-7284-1974; MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the InFaith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the InFaith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the InFaith Community Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Aronson N N Jr, 1974, Methods Enzymol, V31, P90; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Domanska MK, 2010, BIOPHYS J, V99, P2936, DOI 10.1016/j.bpj.2010.09.011; Folmer DE, 2012, J HISTOCHEM CYTOCHEM, V60, P205, DOI 10.1369/0022155411435705; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jacquot A, 2012, J BIOL CHEM, V287, P44580, DOI 10.1074/jbc.A111.313916; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; KOWLURU A, 1985, ARCH BIOCHEM BIOPHYS, V242, P72, DOI 10.1016/0003-9861(85)90481-3; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P348, DOI 10.1016/0167-4889(94)90040-X; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2015, J BIOL CHEM, V290, P11075, DOI 10.1074/jbc.M114.628420; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; RANA RS, 1986, HORM METAB RES, V18, P659, DOI 10.1055/s-2007-1012400; RANA RS, 1986, J CELL BIOCHEM, V32, P143, DOI 10.1002/jcb.240320206; RANA RS, 1986, ARCH BIOCHEM BIOPHYS, V245, P411, DOI 10.1016/0003-9861(86)90232-8; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; Rodrigues RB, 2014, BIOCHEMISTRY-US, V53, P566, DOI 10.1021/bi401096m; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	54	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23110	23123		10.1074/jbc.M115.655027	http://dx.doi.org/10.1074/jbc.M115.655027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26240149	hybrid, Green Published			2022-12-26	WOS:000361685500023
J	Foltynski, P; Ladyzynski, P; Ciechanowska, A; Migalska-Musial, K; Judzewicz, G; Sabalinska, S				Foltynski, Piotr; Ladyzynski, Piotr; Ciechanowska, Anna; Migalska-Musial, Karolina; Judzewicz, Grzegorz; Sabalinska, Stanislawa			Wound Area Measurement with Digital Planimetry: Improved Accuracy and Precision with Calibration Based on 2 Rulers	PLOS ONE			English	Article							DIABETIC FOOT SYNDROME; RELIABILITY; ULCERS	Introduction In the treatment of chronic wounds the wound surface area change over time is useful parameter in assessment of the applied therapy plan. The more precise the method of wound area measurement the earlier may be identified and changed inappropriate treatment plan. Digital planimetry may be used in wound area measurement and therapy assessment when it is properly used, but the common problem is the camera lens orientation during the taking of a picture. The camera lens axis should be perpendicular to the wound plane, and if it is not, the measured area differ from the true area. Results Current study shows that the use of 2 rulers placed in parallel below and above the wound for the calibration increases on average 3.8 times the precision of area measurement in comparison to the measurement with one ruler used for calibration. The proposed procedure of calibration increases also 4 times accuracy of area measurement. It was also showed that wound area range and camera type do not influence the precision of area measurement with digital planimetry based on two ruler calibration, however the measurements based on smartphone camera were significantly less accurate than these based on D-SLR or compact cameras. Area measurement on flat surface was more precise with the digital planimetry with 2 rulers than performed with the Visitrak device, the Silhouette Mobile device or the AreaMe software-based method. Conclusion The calibration in digital planimetry with using 2 rulers remarkably increases precision and accuracy of measurement and therefore should be recommended instead of calibration based on single ruler.	[Foltynski, Piotr; Ladyzynski, Piotr; Ciechanowska, Anna; Migalska-Musial, Karolina; Judzewicz, Grzegorz; Sabalinska, Stanislawa] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Foltynski, P (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	pfoltynski@ibib.waw.pl	Foltynski, Piotr/D-7708-2013; Ladyzynski, Piotr/U-2741-2019; Ciechanowska, Anna/ABB-9106-2021	Foltynski, Piotr/0000-0002-6678-1968; Ladyzynski, Piotr/0000-0003-3268-9896; Ciechanowska, Anna/0000-0002-8941-0166; Sabalinska, Stanislawa/0000-0001-5870-3647				Ahn Chulhyun, 2008, Adv Skin Wound Care, V21, P85, DOI 10.1097/01.ASW.0000305411.58350.7d; Foltynski P, 2014, ARTIF ORGANS, V38, P346, DOI 10.1111/aor.12169; Foltynski P, 2013, DIABETES TECHNOL THE, V15, P711, DOI 10.1089/dia.2013.0026; Foltynski P, 2011, ARTIF ORGANS, V35, P176, DOI 10.1111/j.1525-1594.2010.01046.x; Gethin G, 2006, J CLIN NURS, V15, P422, DOI 10.1111/j.1365-2702.2006.01364.x; Gilman T, 2003, BR J DERMAT, V149, P885; Hallam MJ, 2013, J PLAST RECONSTR AES, V66, pE271, DOI 10.1016/j.bjps.2013.06.021; Hammond CE, 2011, J WOUND OSTOMY CONT, V38, P260, DOI 10.1097/WON.0b013e318215fc60; Ladyzynski P, 2011, DIABETES TECHNOL THE, V13, P1101, DOI 10.1089/dia.2011.0082; Langemo Diane, 2008, Adv Skin Wound Care, V21, P42, DOI 10.1097/01.ASW.0000284967.69863.2f; Lavery LA, 2008, DIABETES CARE, V31, P26, DOI 10.2337/dc07-1300; Molik M, 2010, BIOCYBERN BIOMED ENG, V30, P3; Plassmann P, 1995, J Wound Care, V4, P269; Rennert R, 2009, ADV SKIN WOUND CARE, V22, P32, DOI 10.1097/01.ASW.0000343718.30567.cb; Shaw J, 2007, DIABETES CARE, V30, P2641, DOI 10.2337/dc07-0122; Shetty R, 2012, INDIAN J PLAST SURG, V45, P425, DOI [10.4103/0970-0358.105996, 10.4103/0970-0358.101333]; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Treuillet S, 2009, IEEE T MED IMAGING, V28, P752, DOI 10.1109/TMI.2008.2012025; van Rijswijk L, 1994, Ostomy Wound Manage, V40, P40; Wunderlich RP, 2000, DIABETES RES CLIN PR, V49, P87, DOI 10.1016/S0168-8227(00)00145-5	20	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134622	10.1371/journal.pone.0134622	http://dx.doi.org/10.1371/journal.pone.0134622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252747	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100063
J	Ip, EH; Zhang, Q; Sowinski, T; Simpson, SL				Ip, Edward H.; Zhang, Qiang; Sowinski, Tomasz; Simpson, Sean L.			Analysis of Feedback Mechanisms with Unknown Delay Using Sparse Multivariate Autoregressive Method	PLOS ONE			English	Article							CIRCADIAN OSCILLATIONS; DIETARY PATTERNS; MODEL; SELECTION	This paper discusses the study of two interacting processes in which a feedback mechanism exists between the processes. The study was motivated by problems such as the circadian oscillation of gene expression where two interacting protein transcriptions form both negative and positive feedback loops with long delays to equilibrium. Traditionally, data of this type could be examined using autoregressive analysis. However, in circadian oscillation the order of an autoregressive model cannot be determined a priori. We propose a sparse multivariate autoregressive method that incorporates mixed linear effects into regression analysis, and uses a forward-backward greedy search algorithm to select nonzero entries in the regression coefficients, the number of which is constrained not to exceed a pre-specified number. A small simulation study provides preliminary evidence of the validity of the method. Besides the circadian oscillation example, an additional example of blood pressure variations using data from an intervention study is used to illustrate the method and the interpretation of the results obtained from the sparse matrix method. These applications demonstrate how sparse representation can be used for handling high dimensional variables that feature dynamic, reciprocal relationships.	[Ip, Edward H.; Zhang, Qiang; Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Sowinski, Tomasz] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA	Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ip, EH (corresponding author), Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA.	eip@wakehealth.edu			National Institutes of Health (US) [U01HL101066-01, NIH 1R21AG042761-01, K25 EB012236-01A1]; National Science Foundation (US) [SES-1424875]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL101066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042761] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (US)(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work has been supported by the following grants from the National Institutes of Health (US): U01HL101066-01, NIH 1R21AG042761-01, K25 EB012236-01A1, and the National Science Foundation (US) SES-1424875. The funder approved the study design, data collection and analysis. The funder had no role in decision to publish or preparation of the manuscript.	Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Basu S, ARXIV PREPRINT ARXIV; Blumensath T, 2007, TECHNICAL REPORT; de Waele S, 2003, IEEE T SIGNAL PROCES, V51, P427, DOI 10.1109/TSP.2002.806905; Donoho DL, 2012, IEEE T INFORM THEORY, V58, P1094, DOI 10.1109/TIT.2011.2173241; Finkel SE, 1995, CAUSAL ANALYSIS WITH; Fujita A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-39; Funatogawa I, 2008, STAT MED, V27, P6367, DOI 10.1002/sim.3456; Giacomini R, 2006, ECONOMETRICA, V74, P1545, DOI 10.1111/j.1468-0262.2006.00718.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Harrison L, 2003, NEUROIMAGE, V19, P1477, DOI 10.1016/S1053-8119(03)00160-5; Hsu D., 2009, ADV NEURAL INFORM PR, P772; HURVICH CM, 1990, AM STAT, V44, P214, DOI 10.2307/2685338; Kabaila P, 2009, INT STAT REV, V77, P405, DOI 10.1111/j.1751-5823.2009.00089.x; Lozano AC, 2009, BIOINFORMATICS, V25, pI110, DOI 10.1093/bioinformatics/btp199; Moore TJ, 1999, HYPERTENSION, V34, P472, DOI 10.1161/01.HYP.34.3.472; Priestley MB., 1981, SPECTRAL ANALYSIS AN; Simpson SL, 2013, STAT METHODS MED RES, V22, P296, DOI 10.1177/0962280210395741; Smolen P, 2004, BIOPHYS J, V86, P2786, DOI 10.1016/S0006-3495(04)74332-5; Smolen P, 2002, BIOPHYS J, V83, P2349, DOI 10.1016/S0006-3495(02)75249-1; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stock JH, 2002, J AM STAT ASSOC, V97, P1167, DOI 10.1198/016214502388618960; Tropp JA, 2007, IEEE T INFORM THEORY, V53, P4655, DOI 10.1109/TIT.2007.909108; Walls TA., 2013, INTENSIVE LONGITUDIN; Wei W. W.-S., 1994, TIME SERIES ANAL; Zhang T, 2011, IEEE T INFORM THEORY, V57, P4689, DOI 10.1109/TIT.2011.2146690	27	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0131371	10.1371/journal.pone.0131371	http://dx.doi.org/10.1371/journal.pone.0131371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252637	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000359121100006
J	Mendoza, MLR; Jacobson, JO; Morales-Miranda, S; Alarcon, CAS; Nunez, RL				Rubio Mendoza, Martha Lucia; Owen Jacobson, Jerry; Morales-Miranda, Sonia; Sierra Alarcon, Clara Angela; Luque Nunez, Ricardo			High HIV Burden in Men Who Have Sex with Men across Colombia's Largest Cities: Findings from an Integrated Biological and Behavioral Surveillance Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RISK; MSM; PREVALENCE; INFECTION; EPIDEMIC; TYPE-2; AIDS	Background Among Latin America's concentrated HIV epidemics, little is known about men who have sex with men (MSM) in Colombia, the region's third largest country. To date, surveillance studies have been limited to Bogota, while 80% of HIV cases and deaths originate from Colombia's other cities and departments. The extent to which interventions should prioritize MSM outside of Bogota is unknown. Methods We recruited 2603 MSM using respondent-driven sampling from seven of Colombia's largest cities. HIV prevalence was estimated by site from dried blood spot samples. Behavioral data were collected through face-to-face interviews and risk factors for HIV infection analyzed using weighted, multi-level logistical regression models accounting for recruitment patterns. Results Across cities, HIV prevalence averaged 15%, varied from 6% to 24% and was highest in Cali, Bogota, and Barranquilla. In the past 12 months, 65% of MSM had >= 5 casual male partners and 23% had a female partner. Across partnerships (i.e., casual, stable, and commercial), the proportion of MSM engaging in unprotected sex was >= 52% with male partners and >= 66% with female partners. Self-reported history of STI (24%) and past-year illicit drug use (38%) were also common. In multivariate analysis, age >= 35 (adjusted odds ratio [AOR], 19.2) and 25-39 (AOR, 5.6) relative to <= 18-24 years, identifying as homosexual relative to heterosexual (AOR 0.1), meeting casual partners on the Internet (adjusted odds ratio [AOR], 3.1) and age of sexual debut of <= 13 years (AOR, 3.1) predicted HIV infection. HIV testing and prevention messaging reached just 24% of MSM in the past year. Conclusions Findings support consistently elevated HIV burden among MSM throughout Colombia's largest cities and a need for enhanced behavioral prevention and HIV testing, emphasizing men who use the Internet as well as physical venues to meet sex partners.	[Rubio Mendoza, Martha Lucia; Sierra Alarcon, Clara Angela] UNFPA, United Nations Populat Fund, Bogota, Colombia; [Owen Jacobson, Jerry] Pan Amer Hlth Org, Bogota, Colombia; [Morales-Miranda, Sonia] Valle Univ, Ctr Hlth Studies, Guatemala City, Guatemala; [Luque Nunez, Ricardo] Minist Hlth & Social Protect, Bogota, Colombia	United Nations Population Fund; Pan American Health Organization	Mendoza, MLR (corresponding author), UNFPA, United Nations Populat Fund, Bogota, Colombia.	rubio@unfpa.org			Ministry of Health and Social Protection of Colombia; UNAIDS Latin America regional office; Colombia office of UNFPA; Colombia office of PAHO	Ministry of Health and Social Protection of Colombia; UNAIDS Latin America regional office; Colombia office of UNFPA; Colombia office of PAHO	The study was funded by the Ministry of Health and Social Protection of Colombia, Colombia offices of UNFPA and PAHO and the UNAIDS Latin America regional office.	Adam PCG, 2009, JAIDS-J ACQ IMM DEF, V52, pS143, DOI 10.1097/QAI.0b013e3181baf111; Arrivillaga M, 2012, INT J STD AIDS, V23, P815, DOI 10.1258/ijsa.2012.011468; Badal H., 2013, REACHING MEN WHO HAV; Barron-Limon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-433; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; Bautista CT, 2004, SEX TRANSM INFECT, V80, P498, DOI 10.1136/sti.2004.013094; Berbesi D, 2013, SALUD MENT, V36, P27, DOI 10.17711/SM.0185-3325.2013.004; Beymer M., 2012, GRINDR OTHER GEOSOCI; Beyrer C, 2012, LANCET; Brown EL, 2006, AM J EPIDEMIOL, V164, P733, DOI 10.1093/aje/kwj270; Castro Diaz JA, 2009, 7 ESTUDIO N IN PRESS; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Consejo Nacional de Politica Economicay Social, 2005, PLAN ACC FOC SUBS SE; Creswell J, 2012, SEX TRANSM INFECT, V88, P633, DOI 10.1136/sextrans-2012-050521; De Boni R, 2013, EPIDEMIOLOGY HIV LAT; Departamento Administrativo Nacional de Estadistica (DANE), DEP ADM NAC EST DANE; Family Health International (FHI), 2000, BEH SURV SURV BSS GU; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gonzalez MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-605; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; HIV/AIDS JUNPo, 2013, GLOB AIDS RESP PROGR; Human Rights Watch, 2012, WORLD REP 2012 JORD; Jacobson JO, 2014, AIDS BEHAV, V18, P88, DOI 10.1007/s10461-013-0478-0; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Landovitz RJ, 2012, J URBAN HEALTH, P1; Lorimer K, 2012, SYSTEMATIC REV REV B; Magis-Rodriguez C, 2005, J PSYCHOACTIVE DRUGS, V37, P333, DOI 10.1080/02791072.2005.10400528; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministerio de la Proteccion Social (MPS), 2012, RES SIT EP VIH SIDA; Ministerio de la Proteccion Social (MPS) Fondo de Poblacion de Naciones Unidas (UNFPA), 2012, COMP SEX PREV VIH HO; Ministerio de Saludy Protection Social de Colombia, 2012, INF MUND AV LUCH SID; Montgomery JE, 2013, EDINB STUD CLASS ARA, P1, DOI 10.3366/edinburgh/9780748683321.001.0001; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Reisen CA, 2014, AIDS EDUC PREV, V26, P328, DOI 10.1521/aeap.2014.26.4.328; Rendina HJ, 2013, AIDS BEHAV, P1; Rossi Diana, 2006, Cad. Saúde Pública, V22, P741, DOI 10.1590/S0102-311X2006000400013; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Szwarcwald CL, 2011, JAIDS-J ACQ IMM DEF, V57, pS129, DOI 10.1097/QAI.0b013e31821e9a36; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, GUID SURV POP MOST R; UNDP, 2013, HUMAN DEV REPORT; United Nations Department of Economic and Social Affairs Population Division (UN), 2013, ESAPWP228 UN DEP EC; Zea MC, 2013, CULT HEALTH SEX, V15, P788, DOI 10.1080/13691058.2013.779028; Zea MC, 2015, AM J PUBLIC HEALTH, pe1	48	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0131040	10.1371/journal.pone.0131040	http://dx.doi.org/10.1371/journal.pone.0131040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252496	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100005
J	Wang, N; Jiang, JH; Li, XC; Tan, HW; Zheng, JM; Chen, GJ; Jia, ZC				Wang, Nan; Jiang, Jiahong; Li, Xichen; Tan, Hongwei; Zheng, Jimin; Chen, Guangju; Jia, Zongchao			Molecular Dynamics Simulation Studies of dTTP Binding and Catalysis Mediated by YhdE Dimerization	PLOS ONE			English	Article							AMBER FORCE-FIELD; CONTINUUM SOLVENT; ESCHERICHIA-COLI; MAF; IDENTIFICATION; STABILITY; MECHANICS	YhdE is a Maf-like (multicopy associated filamentation) protein that primarily acts as dTTPase to hydrolyze dTTP into dTMP and two phosphate molecules in cell metabolism pathway. Two crystal structures of YhdE have been previously determined, representing the open and closed active site conformations, respectively. Based on the structures, we have carried out molecular dynamics simulations and free energy calculations to investigate dTTP binding to and hydrolysis by YhdE. Our results suggest that YhdE closed state is structurally more compact than its open state at room temperature. YhdE open state is a favorable conformation for dTTP binding and closed state is a structurally favorable conformation for catalytic reaction. This observation is supported by the structure of YhdE homolog in complex with a nucleotide analog. Free energy calculations reveal that YhdE dimerization occurs preferentially in dTTP binding and is favorable for successive cooperative reaction. The key residues R11, R12 and K80, are found to contribute to the substrate stabilization. Further, YhdE dimerization and binding of dTTP induce the cooperative effect through a direct allosteric communication network in YhdE from the dTTP binding sites in the catalytic center to the intermolecular beta-strand in YhdE dimer.	[Wang, Nan; Jiang, Jiahong; Li, Xichen; Tan, Hongwei; Zheng, Jimin; Chen, Guangju] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China; [Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Beijing Normal University; Queens University - Canada	Zheng, JM (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	jimin_z@bnu.edu.cn; jia@queensu.ca	li, xichen/C-7324-2017	li, xichen/0000-0002-1643-4327; Wang, Nan/0000-0001-7129-6089	National Natural Science Foundation of China [21131003, 21073015, 21273023]; Major State Basic Research Development Programs [2011CB808500]; Canadian Institutes of Health Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Natural Science Foundation of China (no. 21131003, 21073015, and 21273023), Major State Basic Research Development Programs (grant no. 2011CB808500) and Canadian Institutes of Health Research.	Briley K, 2011, MOL MICROBIOL, V81, P23, DOI 10.1111/j.1365-2958.2011.07695.x; BUTLER YX, 1993, J BACTERIOL, V175, P3139, DOI 10.1128/JB.175.10.3139-3145.1993; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 1998, J BIOMOL STRUCT DYN, V16, P265, DOI 10.1080/07391102.1998.10508245; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Flyvbjerg HP, 1989, J CHEM PHYS, V91; Hess B., 2002, J CHEM PHYS, V116; Hwang KY, 1999, NAT STRUCT BIOL, V6, P691; Jin Jin, 2015, PLOS ONE, V6; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Meng HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086104; Minasov G, 2000, P NATL ACAD SCI USA, V97, P6328, DOI 10.1073/pnas.97.12.6328; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OKADA Y, 1994, J BACTERIOL, V176, P917, DOI 10.1128/jb.176.3.917-922.1994; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Tchigvintsev A, 2013, CHEM BIOL, V20, P1386, DOI 10.1016/j.chembiol.2013.09.011; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053841; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035159; Zheng JM, 2005, STRUCTURE, V13, P1511, DOI 10.1016/j.str.2005.07.007	23	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134879	10.1371/journal.pone.0134879	http://dx.doi.org/10.1371/journal.pone.0134879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252214	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100083
J	Ye, WW; Wang, Y; Wang, YC				Ye, Wenwu; Wang, Yang; Wang, Yuanchao			Bioinformatics Analysis Reveals Abundant Short Alpha-Helices as a Common Structural Feature of Oomycete RxLR Effector Proteins	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; GENOME SEQUENCE; WEB SERVER; PHYTOPHTHORA; TRANSCRIPTOME; ADAPTATION; REPERTOIRE; MECHANISMS; CELLS	RxLR effectors represent one of the largest and most diverse effector families in oomycete plant pathogens. These effectors have attracted enormous attention since they can be delivered inside the plant cell and manipulates host immunity. With the exceptions of a signal peptide and the following RxLR-dEER and C-terminal W/Y/L motifs identified from the sequences themselves, nearly no functional domains have been found. Recently, protein structures of several RxLRs were revealed to comprise alpha-helical bundle repeats. However, approximately half of all RxLRs lack obvious W/Y/L motifs, which are associated with helical structures. In this study, secondary structure prediction of the putative RxLR proteins was performed. We found that the C-terminus of the majority of these RxLR proteins, irrespective of the presence of W/Y/L motifs, contains abundant short alpha-helices. Since a large-scale experimental determination of protein structures has been difficult to date, results of the current study extend our understanding on the oomycete RxLR effectors in protein secondary structures from individual members to the entire family. Moreover, we identified less alpha-helix-rich proteins from secretomes of several oomycete and fungal organisms in which RxLRs have not been identified, providing additional evidence that these organisms are unlikely to harbor RxLR-like proteins. Therefore, these results provide additional information that will aid further studies on the evolution and functional mechanisms of RxLR effectors.	[Ye, Wenwu; Wang, Yang; Wang, Yuanchao] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, YC (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	wangyc@njau.edu.cn	Ye, Wenwu/J-5624-2014; wang, yuanchao/G-9667-2011; Ye, Wenwu/AAE-4961-2022	Ye, Wenwu/0000-0001-7347-8935; wang, yuanchao/0000-0001-5803-5343; Ye, Wenwu/0000-0001-7347-8935	National Natural Science Foundation of China [31401688, 31430073]; Fundamental Research Funds for the Central Universities [KJQN201507]; Natural Science Foundation of Jiangsu Province [BK20140698]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants to WY from the National Natural Science Foundation of China (31401688), the Fundamental Research Funds for the Central Universities (KJQN201507), and the Natural Science Foundation of Jiangsu Province (BK20140698); and by grants to YuW from National Natural Science Foundation of China (31430073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B. N., 2013, PLoS ONE, V8, pe75072, DOI 10.1371/journal.pone.0075072; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Chou S, 2011, P NATL ACAD SCI USA, V108, P13323, DOI 10.1073/pnas.1109791108; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Goss EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079347; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Leonelli L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002428; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Stassen JHM, 2012, MOL PLANT PATHOL, V13, P719, DOI 10.1111/j.1364-3703.2011.00780.x; Sun FR, 2013, MOL PLANT MICROBE IN, V26, P330, DOI 10.1094/MPMI-07-12-0184-R; Tian MY, 2011, MOL PLANT MICROBE IN, V24, P543, DOI 10.1094/MPMI-08-10-0185; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002400; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108	31	13	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135240	10.1371/journal.pone.0135240	http://dx.doi.org/10.1371/journal.pone.0135240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252511	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100142
J	Buzdugan, R; Mccoy, SI; Watadzaushe, C; Dufour, MSK; Petersen, M; Dirawo, J; Mushavi, A; Mujuru, HA; Mahomva, A; Musarandega, R; Hakobyan, A; Mugurungi, O; Cowan, FM; Padian, NS				Buzdugan, Raluca; Mccoy, Sandra I.; Watadzaushe, Constancia; Dufour, Mi-Suk Kang; Petersen, Maya; Dirawo, Jeffrey; Mushavi, Angela; Mujuru, Hilda Angela; Mahomva, Agnes; Musarandega, Reuben; Hakobyan, Anna; Mugurungi, Owen; Cowan, Frances M.; Padian, Nancy S.			Evaluating the Impact of Zimbabwe's Prevention of Mother-to-Child HIV Transmission Program: Population-Level Estimates of HIV-Free Infant Survival Pre-Option A	PLOS ONE			English	Article							MORTALITY; DISTRICT; CARE	Objective We estimated HIV-free infant survival and mother-to-child HIV transmission (MTCT) rates in Zimbabwe, some of the first community-based estimates from a UNAIDS priority country. Methods In 2012 we surveyed mother-infant pairs residing in the catchment areas of 157 health facilities randomly selected from 5 of 10 provinces in Zimbabwe. Enrolled infants were born 9-18 months before the survey. We collected questionnaires, blood samples for HIV testing, and verbal autopsies for deceased mothers/infants. Estimates were assessed among i) all HIV-exposed infants, as part of an impact evaluation of Option A of the 2010 WHO guidelines (rolled out in Zimbabwe in 2011), and ii) the subgroup of infants unexposed to Option A. We compared province-level MTCT rates measured among women in the community with MTCT rates measured using program monitoring data from facilities serving those communities. Findings Among 8568 women with known HIV serostatus, 1107 (12.9%) were HIV-infected. Among all HIV-exposed infants, HIV-free infant survival was 90.9% (95% confidence interval (CI): 88.7-92.7) and MTCT was 8.8% (95% CI: 6.9-11.1). Sixty-six percent of HIV-exposed infants were still breastfeeding. Among the 762 infants born before Option A was implemented, 90.5%(95% CI: 88.1-92.5) were alive and HIV-uninfected at 9-18 months of age, and 9.1% (95% CI: 7.1-11.7) were HIV-infected. In four provinces, the community-based MTCT rate was higher than the facility-based MTCT rate. In Harare, the community and facility-based rates were 6.0% and 9.1%, respectively. Conclusion By 2012 Zimbabwe had made substantial progress towards the elimination of MTCT. Our HIV-free infant survival and MTCT estimates capture HIV transmissions during pregnancy, delivery and breastfeeding regardless of whether or not mothers accessed health services. These estimates also provide a baseline against which to measure the impact of Option A guidelines (and subsequently Option B+).	[Buzdugan, Raluca; Mccoy, Sandra I.; Petersen, Maya; Padian, Nancy S.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Watadzaushe, Constancia; Dirawo, Jeffrey; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res Zimbabwe, Harare, Zimbabwe; [Dufour, Mi-Suk Kang] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Mushavi, Angela; Mugurungi, Owen] Minist Hlth & Child Care, Harare, Zimbabwe; [Mujuru, Hilda Angela] Univ Zimbabwe, Harare, Zimbabwe; [Mahomva, Agnes; Musarandega, Reuben] Elizabeth Glaser Pediat AIDS Fdn, Harare, Zimbabwe; [Hakobyan, Anna] Childrens Investment Fund Fdn, London, England; [Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, London, England	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Zimbabwe; University of London; University College London	Buzdugan, R (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rbuzdugan@berkeley.edu	Mujuru, Hilda Angela/AAF-2511-2020; Musarandega, Reuben/ABD-4711-2022; Musarandega, Reuben/AAG-3731-2022	Mujuru, Hilda Angela/0000-0003-1615-3856; Musarandega, Reuben/0000-0002-0622-2195; Musarandega, Reuben/0000-0002-0622-2195; Cowan, Frances/0000-0003-3087-4422	Children's Investment Fund Foundation (CIFF) [20111425]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Children's Investment Fund Foundation (CIFF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Children's Investment Fund Foundation (CIFF) (www.ciff.org) (grant #20111425, PI: NP). CIFF approved the final draft of this manuscript but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; [Anonymous], 2012, SHORT GUID METH MEAS; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; Chi BH, 2014, B WORLD HEALTH ORGAN, V92, P582, DOI 10.2471/BLT.13.129833; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Goga AE, 2015, J EPIDEMIOL COMMUN H, V69, P240, DOI 10.1136/jech-2014-204535; Grimwood A, 2012, SAMJ S AFR MED J, V102, P81, DOI 10.7196/SAMJ.5294; [ICF International Zimbabwe National Statistics Agency (ZIMSTAT)], 2012, ZIMB DEM HLTH SURV 2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS, 2012, TOG WE WILL END AIDS; Kaur G, 2010, ACCELERATING ELIMINA; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Lopman B, 2010, J EPIDEMIOL COMMUN H, V64, P330, DOI 10.1136/jech.2008.081554; Moses A, 2008, AIDS, V22, P83, DOI 10.1097/QAD.0b013e3282f163b5; Republic of Zimbabwe, 2011, ZIMB NAT HIV AIDS ST; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Ruton H, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-4; Sinunu M a., 2014, PLOS ONE, V9, P1; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2013, PLOS MED, V10; UNAIDS, 2011, ADDR STIGM DISCR HOM; UNAIDS, 2012, UNAIDS HIGHL ZIMB PR; UNICEF World Health Organization UNAIDS Vanderbilt University School of Medicine, 2009, CONS M EV IMP PREV M; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; World Health Organization, 2021, ANT DRUGS TREAT PREG	27	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134571	10.1371/journal.pone.0134571	http://dx.doi.org/10.1371/journal.pone.0134571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248197	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300049
J	Chen, C; Zhang, YZ; Loomis, MM; Upton, MP; Lohavanichbutr, P; Houck, JR; Doody, DR; Mendez, E; Futran, N; Schwartz, SM; Wang, P				Chen, Chu; Zhang, Yuzheng; Loomis, Melissa M.; Upton, Melissa P.; Lohavanichbutr, Pawadee; Houck, John R.; Doody, David R.; Mendez, Eduardo; Futran, Neal; Schwartz, Stephen M.; Wang, Pei			Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CYCLIN D1 AMPLIFICATION; NECK-CANCER PATIENTS; 3P ALLELE LOSS; POOR-PROGNOSIS; CHROMOSOME 3P; PANCREATIC-CANCER; P53 GENE; HOMOZYGOUS DELETIONS; 11Q13 AMPLIFICATION	Oral squamous cell cancer of the oral cavity and oropharynx (OSCC) is associated with high case-fatality. For reasons that are largely unknown, patients with the same clinical and pathologic staging have heterogeneous response to treatment and different probability of recurrence and survival, with patients with Human Papillomavirus (HPV)-positive oropharyngeal tumors having the most favorable survival. To gain insight into the complexity of OSCC and to identify potential chromosomal changes that may be associated with OSCC mortality, we used Affymtrix 6.0 SNP arrays to examine paired DNA from peripheral blood and tumor cell populations isolated by laser capture microdissection to assess genome-wide loss of heterozygosity (LOH) and DNA copy number aberration (CNA) and their associations with risk factors, tumor characteristics, and oral cancer-specific mortality among 75 patients with HPV-negative OSCC. We found a highly heterogeneous and complex genomic landscape of HPV-negative tumors, and identified regions in 4q, 8p, 9p and 11q that seem to play an important role in oral cancer biology and survival from this disease. If confirmed, these findings could assist in designing personalized treatment or in the creation of models to predict survival in patients with HPV-negative OSCC.	[Chen, Chu; Loomis, Melissa M.; Lohavanichbutr, Pawadee; Houck, John R.; Doody, David R.; Mendez, Eduardo; Schwartz, Stephen M.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Chen, Chu; Mendez, Eduardo; Futran, Neal] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Chen, Chu; Schwartz, Stephen M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Zhang, Yuzheng; Wang, Pei] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Biostat & Biomath, Seattle, WA 98104 USA; [Upton, Melissa P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mendez, Eduardo] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Wang, Pei] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai	Chen, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA.	cchen@fredhutch.org		Wang, Pei/0000-0002-6890-6453; Doody, David/0000-0003-2291-6493	National Cancer Institute, National Institutes of Heath, NIH [RO1 CA 095419]; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE [P30CA015704, R01CA095419] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Heath, NIH; Fred Hutchinson Cancer Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is funded by the National Cancer Institute, National Institutes of Heath, NIH RO1 CA 095419 (CC) and by funds from the Fred Hutchinson Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akervall J, 2003, CLIN CANCER RES, V9, P1750; Arai K, 2001, Bull Tokyo Dent Coll, V42, P151, DOI 10.2209/tdcpublication.42.151; Arai K, 2002, ORAL ONCOL, V38, P763, DOI 10.1016/S1368-8375(02)00068-4; Ashman JNE, 2003, BRIT J CANCER, V89, P864, DOI 10.1038/sj.bjc.6601199; Bandres E, 2007, ORAL ONCOL, V43, P713, DOI 10.1016/j.oraloncology.2006.09.002; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Beder LB, 2003, LAB INVEST, V83, P99, DOI 10.1097/01.LAB.0000047489.26246.E1; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; de Quiros SB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-116; Binmadi NO, 2012, AM J PATHOL, V180, P1232, DOI 10.1016/j.ajpath.2011.12.009; Blons H, 1999, INT J CANCER, V84, P410; Bockmuhl U, 2000, AM J PATHOL, V157, P369, DOI 10.1016/S0002-9440(10)64549-X; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chen SF, 2013, J PATHOL, V231, P180, DOI 10.1002/path.4226; Chen YJ, 2004, J PATHOL, V204, P326, DOI 10.1002/path.1640; Chen Y, 2008, HEAD NECK-J SCI SPEC, V30, P1361, DOI 10.1002/hed.20861; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Chuang SC, 2008, INT J CANCER, V123, P2390, DOI 10.1002/ijc.23798; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Daniele G, 2012, CURR ONCOL REP, V14, P111, DOI 10.1007/s11912-012-0225-0; de Koning PJA, 2009, INT J CANCER, V125, P1542, DOI 10.1002/ijc.24507; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Dutt A, 2007, CURR OPIN ONCOL, V19, P43, DOI 10.1097/CCO.0b013e328011a8c1; ELNAGGAR AK, 1995, CANCER RES, V55, P2656; FIELD JK, 1995, BRIT J CANCER, V72, P1180, DOI 10.1038/bjc.1995.483; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Fujii M, 2001, CANCER LETT, V172, P187, DOI 10.1016/S0304-3835(01)00651-6; Fujita Y, 2003, HEPATO-GASTROENTEROL, V50, P1857; Gebhart E, 1998, INT J ONCOL, V12, P1151; Gebhart E, 2004, ARCH MED RES, V35, P385, DOI 10.1016/j.arcmed.2004.06.001; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Goicoechea SM, 2014, ONCOGENE, V33, P1265, DOI 10.1038/onc.2013.68; Gotte K, 2001, INT J ONCOL, V19, P331; Guo W, 2012, ASIAN PAC J CANCER P, V13, P4157, DOI 10.7314/APJCP.2012.13.8.4157; Gupta V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021494; Hama T, 2009, ONCOLOGIST, V14, P900, DOI 10.1634/theoncologist.2009-0058; Hess CJ, 2007, J CLIN ONCOL, V25, P1209, DOI 10.1200/JCO.2006.08.4061; Hogg RP, 2002, EUR J CANCER, V38, P1585, DOI 10.1016/S0959-8049(01)00422-1; Huang MF, 1999, ORAL ONCOL, V35, P296, DOI 10.1016/S1368-8375(98)00119-5; Hyeon J, 2013, DIGEST DIS SCI, V58, P1916, DOI 10.1007/s10620-013-2609-x; Iizuka S, 2014, CANCERS, V6, P396, DOI 10.3390/cancers6010396; Ishwad CS, 1996, INT J CANCER, V69, P1; Janssen JWG, 2002, J HUM GENET, V47, P460, DOI 10.1007/s100380200065; Jin C, 2006, CYTOGENET GENOME RES, V115, P99, DOI 10.1159/000095228; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Katoh M, 2005, INT J ONCOL, V27, P281; Katoh M, 2003, INT J ONCOL, V22, P1375; Kayahara H, 2001, J HUM GENET, V46, P335, DOI 10.1007/s100380170069; Kim SK, 1996, CANCER RES, V56, P2519; Kitagawa Y, 1996, CLIN CANCER RES, V2, P909; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Koy S, 2008, HEAD NECK-J SCI SPEC, V30, P1105, DOI 10.1002/hed.20857; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lazar AD, 1998, CLIN CANCER RES, V4, P2787; Lee DJ, 2010, CANCER BIOL THER, V10, P689, DOI 10.4161/cbt.10.7.12886; Li SY, 2013, CHINESE MED J-PEKING, V126, P655, DOI 10.3760/cma.j.issn.0366-6999.20122184; LIU X., 2011, CALC VAR PDES, V7, P1, DOI DOI 10.1371/J0URNAL.PCBI; Lohavanichbutr P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046575; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Lydiatt WM, 1998, HEAD NECK-J SCI SPEC, V20, P113, DOI 10.1002/(SICI)1097-0347(199803)20:2<113::AID-HED3>3.3.CO;2-F; Malkoski SP, 2012, FEBS LETT, V586, P1984, DOI 10.1016/j.febslet.2012.01.054; Martinez A, 2001, J CLIN PATHOL-MOL PA, V54, P300, DOI 10.1136/mp.54.5.300; Mavros A, 2002, J ORAL PATHOL MED, V31, P270, DOI 10.1034/j.1600-0714.2002.310504.x; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miracca EC, 2000, DIAGN MOL PATHOL, V9, P229, DOI 10.1097/00019606-200012000-00008; Miyahara H, 1998, ACTA OTO-LARYNGOL, V118, P763, DOI 10.1080/00016489850183331; Miyamoto R, 2003, ORAL ONCOL, V39, P610, DOI 10.1016/S1368-8375(03)00048-4; Mountzios G, 2014, ANN ONCOL, V25, P1889, DOI 10.1093/annonc/mdu143; Nakanishi H, 1999, ANTICANCER RES, V19, P29; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Namazie A, 2002, LARYNGOSCOPE, V112, P472, DOI 10.1097/00005537-200203000-00013; Ng IOL, 2000, ORAL ONCOL, V36, P484, DOI 10.1016/S1368-8375(00)00040-3; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Nogueira CP, 1998, LARYNGOSCOPE, V108, P345, DOI 10.1097/00005537-199803000-00007; Nunn J, 1999, CARCINOGENESIS, V20, P2219, DOI 10.1093/carcin/20.12.2219; Oyama T, 2011, DEVELOPMENT, V138, P5235, DOI 10.1242/dev.062802; PARTRIDGE M, 1994, ORAL ONCOL, V30B, P248, DOI 10.1016/0964-1955(94)90006-X; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Pogue-Geile KL, 2006, PLOS MED, V3, P2216, DOI 10.1371/journal.pmed.0030516; Poh CF, 2001, LAB INVEST, V81, P629, DOI 10.1038/labinvest.3780271; Qiu W, 2007, CANCER LETT, V245, P163, DOI 10.1016/j.canlet.2006.01.003; Reis PP, 2002, ONCOGENE, V21, P6480, DOI 10.1038/sj.onc.1205864; Ribeiro IP, 2014, TUMOR BIOL, V35, P4687, DOI 10.1007/s13277-014-1614-9; Ribeiro IP, 2014, CELL ONCOL, V37, P29, DOI 10.1007/s13402-013-0161-5; ROWLEY H, 1995, CLIN OTOLARYNGOL, V20, P266, DOI 10.1111/j.1365-2273.1995.tb01864.x; Sabbir MG, 2006, DIAGN MOL PATHOL, V15, P7, DOI 10.1097/00019606-200603000-00002; Schneider-Stock R, 2004, AM J PATHOL, V164, P1233, DOI 10.1016/S0002-9440(10)63211-7; Scully C, 2000, ORAL ONCOL, V36, P311, DOI 10.1016/S1368-8375(00)00021-X; Shah SI, 2000, ARCH OTOLARYNGOL, V126, P1073, DOI 10.1001/archotol.126.9.1073; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Singh B, 2002, AM J PATHOL, V161, P365, DOI 10.1016/S0002-9440(10)64191-0; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smeets SJ, 2006, ONCOGENE, V25, P2558, DOI 10.1038/sj.onc.1209275; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Song JY, 2013, MOL BIOL REP, V40, P5115, DOI 10.1007/s11033-013-2613-4; Sticht C, 2005, BRIT J CANCER, V92, P770, DOI 10.1038/sj.bjc.6602400; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sugahara K, 2011, INT J ONCOL, V39, P761, DOI 10.3892/ijo.2011.1094; Takebayashi S, 2000, CANCER RES, V60, P3397; Takekoshi T, 2010, J BIOL CHEM, V285, P31876, DOI 10.1074/jbc.M110.118877; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; Tran TN, 2005, J ORAL PATHOL MED, V34, P150, DOI 10.1111/j.1600-0714.2004.00292.x; Tsui IFL, 2009, INT J CANCER, V125, P2219, DOI 10.1002/ijc.24611; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Waber P, 1997, ONCOGENE, V15, P1699, DOI 10.1038/sj.onc.1201336; Waber PG, 1996, ONCOGENE, V12, P365; Wreesmann VB, 2004, J CLIN ONCOL, V22, P3965, DOI 10.1200/JCO.2004.01.094; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yamamoto Nobuharu, 2007, Bull Tokyo Dent Coll, V48, P109, DOI 10.2209/tdcpublication.48.109; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Young LC, 2013, BIOCHEM CELL BIOL, V91, P369, DOI 10.1139/bcb-2012-0054; Zhang SS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0607-7	127	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135074	10.1371/journal.pone.0135074	http://dx.doi.org/10.1371/journal.pone.0135074			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247464	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300094
J	Geraghty, J; Thumbs, A; Kankwatira, A; Andrews, T; Moore, A; Malamba, R; Mtunthama, N; Hellberg, K; Kalongolera, L; O'Toole, P; Varro, A; Pritchard, DM; Gordon, M				Geraghty, Joe; Thumbs, Alexander; Kankwatira, Anstead; Andrews, Tim; Moore, Andrew; Malamba, Rose; Mtunthama, Neema; Hellberg, Kai; Kalongolera, Lughano; O'Toole, Paul; Varro, Andrea; Pritchard, D. Mark; Gordon, Melita			Helicobacter pylori, HIV and Gastric Hypochlorhydria in the Malawian Population	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; POSITIVE PATIENTS; LOW-PREVALENCE; CAMPYLOBACTER-PYLORIDIS; ENDOSCOPIC FINDINGS; PEPTIC-ULCERATION; HEALTHY-SUBJECTS; INFECTION; HYPERGASTRINEMIA; MALABSORPTION	Background HIV and Helicobacter pylori are common chronic infections in sub-Saharan Africa. Both conditions can predispose to gastric hypochlorhydria that may be a risk factor for enteric infections and reduced drug absorption. We have investigated to what extent HIV and H. pylori infections are associated with hypochlorhydria in a Malawian cohort of patients undergoing endoscopy. Methods 104 sequential symptomatic adults referred for gastroscopy at Queen Elizabeth Central Hospital, Blantyre, Malawi, had blood taken for rapid HIV testing and fasting serum gastrin analysis. Gastric fluid was aspirated for pH testing, and gastric biopsies were taken. Results After 9/104 HIV-infected patients who were already established on anti-retroviral therapy were excluded, 17/95 (25.0%) were seropositive for untreated HIV, and 68/95 (71.6%) patients were H. pylori positive by histology. Hypochlorhydria (fasting gastric pH>4.0) was present in 55.8% (53/95) of patients. H. pylori infection was significantly associated with hypochlorhydria (OR 2.91, [1.02-7.75], p=0.046). While single infection with HIV was not significantly independently associated with hypochlorhydria. H. pylori and HIV co-infection was more strongly associated with hypochlorhydria (OR 6.25, [1.33-29.43], p=0.020) than either infection alone, suggesting an additive effect of co-infection. HIV infection was associated with higher serum gastrin levels (91.3pM vs. 53.1pM, p=0.040), while H. pylori infection was not (63.1pM vs. 55.1pM, p=0.610). Irrespective of H. pylori and HIV status, most patients (>90%) exhibited pangastritis. Only three patients had histological evidence of gastric atrophy, of which only one was HIV-infected. Conclusion H. pylori infection was associated with fasting hypochlorhydria, while HIV was not independently associated. HIV and H. pylori co-infection, however, was more strongly associated with hypochlorhydria than H. pylori infection alone. The mechanism of this apparent additive effect between HIV and H. pylori remains unclear, but appears to be related to chronic pangastritis rather than gastric atrophy, and associated with hypergastrinaemia in HIV-infected individuals.	[Kankwatira, Anstead; Malamba, Rose; Mtunthama, Neema; Gordon, Melita] Malawi Liverpool Wellcome Trust, Clin Res Programme, Blantyre 3, Malawi; [Gordon, Melita] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Geraghty, Joe; Moore, Andrew; Pritchard, D. Mark] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Geraghty, Joe; Moore, Andrew; O'Toole, Paul; Pritchard, D. Mark; Gordon, Melita] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England; [Thumbs, Alexander; Hellberg, Kai; Kalongolera, Lughano] Coll Med, Dept Surg, Blantyre, Malawi; [Kankwatira, Anstead] Coll Med, Dept Med, Blantyre, Malawi; [Andrews, Tim] Royal Liverpool Univ Hosp, Dept Pathol, Liverpool, Merseyside, England; [Varro, Andrea] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England	University of Malawi; University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi; University of Malawi; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Liverpool	Gordon, M (corresponding author), Malawi Liverpool Wellcome Trust, Clin Res Programme, POB 30096, Blantyre 3, Malawi.	magordon@liverpool.ac.uk	Gordon, Melita/F-5563-2012	Gordon, Melita/0000-0002-0629-0884; Pritchard, David Mark/0000-0001-7971-3561	Cook Medical	Cook Medical	JG received an unconditional award from Cook Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AliMohamed F, 2002, East Afr Med J, V79, P226; [Anonymous], 1998, CLIN INFECT DIS, V27, P739; [Anonymous], 2013, J INFECT DIS; Bhan MK, 2002, J INFECT DIS, V186, P1857, DOI 10.1086/345762; BINS M, 1984, HEPATO-GASTROENTEROL, V31, P41; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Campbell DI, 2001, HELICOBACTER, V6, P263, DOI 10.1046/j.1083-4389.2001.00047.x; CHRISTIANSEN PM, 1968, SCAND J GASTROENTERO, V3, P497, DOI 10.3109/00365526809179909; CLEMENS J, 1995, J INFECT DIS, V171, P1653, DOI 10.1093/infdis/171.6.1653; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; DOCKRAY GJ, 1980, REGUL PEPTIDES, V1, P169, DOI 10.1016/0167-0115(80)90270-0; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; Fabris P, 2002, ALIMENT PHARM THERAP, V16, P807, DOI 10.1046/j.1365-2036.2002.01234.x; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Fraser A, 2007, ALIMENT PHARM THER, V25, P477, DOI 10.1111/j.1365-2036.2006.03233.x; Geraghty J, 2012, GUT, V61, pA12, DOI 10.1136/gutjnl-2012-302514a.28; GOODWIN CS, 1986, J CLIN PATHOL, V39, P353, DOI 10.1136/jcp.39.4.353; HERZLICH BC, 1992, AM J GASTROENTEROL, V87, P1781; Keane MG, 2012, GUT, V61, pA12, DOI 10.1136/gutjnl-2012-302514a.29; Kelly P, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-72; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lahner E, 2009, ALIMENT PHARM THER, V29, P379, DOI 10.1111/j.1365-2036.2008.03906.x; LAKEBAKAAR G, 1988, ANN INTERN MED, V109, P502, DOI 10.7326/0003-4819-109-6-502; Lv FJ, 2007, WORLD J GASTROENTERO, V13, P5492, DOI 10.3748/wjg.v13.i41.5492; Magen E, 2010, INT J INFECT DIS, V14, pE322, DOI 10.1016/j.ijid.2009.03.036; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARANO BJ, 1993, AM J GASTROENTEROL, V88, P687; MARSHALL BJ, 1984, LANCET, V1, P1311; Orlando LA, 2007, DIGEST DIS SCI, V52, P2482, DOI 10.1007/s10620-006-9419-3; Passaro DJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e87; Robinson M, 1999, ALIMENT PHARM THERAP, V13, P5; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; Ruiz B, 1996, AM J CLIN PATHOL, V105, P96; SHAFFER RT, 1992, AM J GASTROENTEROL, V87, P1777; Shelton MJ, 2000, J ACQ IMMUN DEF SYND, V24, P79; Shelton MJ, 2003, J CLIN PHARMACOL, V43, P171, DOI 10.1177/0091270002239826; SMITH JTL, 1990, GUT, V31, P522, DOI 10.1136/gut.31.5.522; Sud A, 2002, Trop Gastroenterol, V23, P79; VAIRA D, 1995, DIGEST DIS SCI, V40, P1622, DOI 10.1007/BF02212680; Velin D, 2006, DIGESTION, V73, P116, DOI 10.1159/000094043; Welage LS, 1995, CLIN INFECT DIS, V21, P1431, DOI 10.1093/clinids/21.6.1431; WYATT JI, 1987, J CLIN PATHOL, V40, P841, DOI 10.1136/jcp.40.8.841	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132043	10.1371/journal.pone.0132043	http://dx.doi.org/10.1371/journal.pone.0132043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244370	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400017
J	Haque, A; Adnan, N; Motazedian, A; Akter, F; Hossain, S; Kutsuzawa, K; Nag, K; Kobatake, E; Akaike, T				Haque, Amranul; Adnan, Nihad; Motazedian, Ali; Akter, Farhima; Hossain, Sharif; Kutsuzawa, Koichi; Nag, Kakon; Kobatake, Eiry; Akaike, Toshihiro			An Engineered N-Cadherin Substrate for Differentiation, Survival, and Selection of Pluripotent Stem Cell-Derived Neural Progenitors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; IN-VITRO; ADHESION MOLECULES; RETINAL CELLS; IPS CELLS; PRECURSORS; GENERATION	For stem cell-based treatment of neurodegenerative diseases a better understanding of key developmental signaling pathways and robust techniques for producing neurons with highest homogeneity are required. In this study, we demonstrate a method using N-cadherin-based biomimetic substrate to promote the differentiation of mouse embryonic stem cell (ESC)- and induced pluripotent stem cell (iPSC)-derived neural progenitor cells (NPCs) without exogenous neuro-inductive signals. We showed that substrate-dependent activation of N-cadherin reduces Rho/ROCK activation and beta-catenin expression, leading to the stimulation of neurite outgrowth and conversion into cells expressing neural/glial markers. Besides, plating dissociated cells on N-cadherin substrate can significantly increase the differentiation yield via suppression of dissociation-induced Rho/ROCK-mediated apoptosis. Because undifferentiated ESCs and iPSCs have low affinity to N-cadherin, plating dissociated cells on N-cadherin-coated substrate increase the homogeneity of differentiation by purging ESCs and iPSCs (similar to 30%) from a mixture of undifferentiated cells with NPCs. Using this label-free cell selection approach we enriched differentiated NPCs plated as monolayer without ROCK inhibitor. Therefore, N-cadherin biomimetic substrate provide a powerful tool for basic study of cell-material interaction in a spatially defined and substrate-dependent manner. Collectively, our approach is efficient, robust and cost effective to produce large quantities of differentiated cells with highest homogeneity and applicable to use with other types of cells.	[Haque, Amranul; Adnan, Nihad; Motazedian, Ali; Hossain, Sharif; Kutsuzawa, Koichi; Nag, Kakon; Akaike, Toshihiro] Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 227, Japan; [Akter, Farhima; Kobatake, Eiry] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Akaike, T (corresponding author), Fdn Adv Int Sci, Biomat Ctr Regenerat Med Engn, Tsukuba, Ibaraki, Japan.	akaike@fais.or.jp	Adnan, Nihad/ABG-1889-2021	Adnan, Nihad/0000-0002-4999-4793	Japan Society for the Promotion of Science [23220014]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Japan Society for the Promotion of Science (S) No. 23220014.	Ahmed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061878; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Anson BD, 2011, CLIN PHARMACOL THER, V89, P754, DOI 10.1038/clpt.2011.9; Aubert I, 1998, J COMP NEUROL, V399, P1; Benson DL, 1998, J NEUROSCI, V18, P6892; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253; Blagovic K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022892; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Cherry JF, 2014, ACTA BIOMATER, V10, P4113, DOI 10.1016/j.actbio.2014.06.001; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Flannery Richard J, 2012, Front Synaptic Neurosci, V4, P6, DOI 10.3389/fnsyn.2012.00006; Gartner A, 2012, EMBO J, V31, P1893, DOI 10.1038/emboj.2012.41; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003; Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Marthiens W, 2005, MOL CELL NEUROSCI, V28, P715, DOI 10.1016/j.mcn.2004.12.001; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; Mattias L, 2014, BIOMATERIALS, V35, P1797, DOI 10.1016/j.biomaterials.2013.11.042; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Ogawa S, 2005, STEM CELLS, V23, P903, DOI 10.1634/stemcells.2004-0295; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Teo AKK, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.007; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	56	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135170	10.1371/journal.pone.0135170	http://dx.doi.org/10.1371/journal.pone.0135170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244942	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400142
J	Hrudey, EJ; Reynolds, RM; Oostvogels, AJJM; Brouwer, IA; Vrijkotte, TGM				Hrudey, E. Jessica; Reynolds, Rebecca M.; Oostvogels, Adriette J. J. M.; Brouwer, Ingeborg A.; Vrijkotte, Tanja G. M.			The Association between Maternal 25-Hydroxyvitamin D Concentration during Gestation and Early Childhood Cardio-metabolic Outcomes: Is There Interaction with Pre-Pregnancy BMI?	PLOS ONE			English	Article							VITAMIN-D STATUS; AMSTERDAM BORN CHILDREN; INSULIN-RESISTANCE; BIRTH-WEIGHT; PREGNANCY; OBESITY; RISK; COHORT; INFLAMMATION; ADIPOSITY	Both maternal 25-hydroxyvitamin D(25OHD) status and pre-pregnancy BMI(pBMI) may influence offspring cardio-metabolic outcomes. Lower 25OHD concentrations have been observed in women with both low and high pBMIs, but the combined influence of pBMI and 25OHD on offspring cardio-metabolic outcomes is unknown. Therefore, this study investigated the role of pBMI in the association between maternal 25OHD concentration and cardio-metabolic outcomes in 5-6 year old children. Data were obtained from the ABCD cohort study and 1882 mother-child pairs were included. The offspring outcomes investigated were systolic and diastolic blood pressure, heart rate, BMI, body fat percentage(%BF), waist-to-height ratio, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, glucose, C-peptide, and insulin resistance(HOMA2-IR). 62% of the C-peptide samples were below the detection limit and were thus imputed using survival analysis. Models were corrected for maternal and offspring covariates and tested for interaction with pBMI. Interaction with pBMI was observed in the associations with insulin resistance markers: in offspring of overweight mothers(>= 25.0kg/m(2)), a 10 nmol/L increase in maternal 25OHD was associated with a 0.007(99%CI:-0.01,-0.001) nmol/L decrease in C-peptide and a 0.02(99%CI:-0.03,-0.004) decrease in HOMA2-IR. When only non-imputed data were analyzed, there was a trend for interaction in the relationship but the results lost significance. Interaction with pBMI was not observed for the other outcomes. A 10 nmol/L increase in maternal 25OHD was significantly associated with a 0.13%(99%CI:-0.3,-0.003) decrease in %BF after correction for maternal and child covariates. Thus, intrauterine exposure to both low 25OHD and maternal overweight may be associated with increased insulin resistance in offspring, while exposure to low 25OHD in utero may be associated with increased offspring %BF with no interactive effects from pBMI. Due to the limitations of this study, these results are not conclusive, however the observations of this study pose important research questions for future studies to investigate.	[Hrudey, E. Jessica; Oostvogels, Adriette J. J. M.; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1100 DD Amsterdam, Netherlands; [Reynolds, Rebecca M.] Univ Edinburgh, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Dept Hlth Sci, NL-1081 HV Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Edinburgh; Vrije Universiteit Amsterdam	Hrudey, EJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1100 DD Amsterdam, Netherlands.	e.j.hrudey@amc.uva.nl	Reynolds, Rebecca M/C-3044-2008	Reynolds, Rebecca M/0000-0001-6226-8270; Hrudey, E. Jessica/0000-0002-8882-1991; Brouwer, Ingeborg/0000-0002-8762-382X; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research and Development (ZonMw) Grant (TOP) [40-00812-98-11010]; Chief Scientist Office [CZG/2/478] Funding Source: researchfish	Netherlands Organization for Health Research and Development (ZonMw) Grant (TOP); Chief Scientist Office	Funding was provided by the Netherlands Organization for Health Research and Development (ZonMw) Grant (TOP, 40-00812-98-11010), but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardawi MSM, 1997, EUR J ENDOCRINOL, V137, P402, DOI 10.1530/eje.0.1370402; Barker DJP, 2004, ACTA PAEDIATR, V93, P26, DOI 10.1080/08035320410022730; Bodnar LM, 2007, J NUTR, V137, P2437, DOI 10.1093/jn/137.11.2437; Boucher BJ, 1998, BRIT J NUTR, V79, P315, DOI 10.1079/BJN19980055; Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; ClinicalTrials.gov, 2015, SEARCH RES PREGN VIT; Crozier SR, 2012, AM J CLIN NUTR, V96, P57, DOI 10.3945/ajcn.112.037473; de Beer M, 2011, EUROPEAN E J CLIN NU, V6, P223; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Fraser A, 2013, HYPERTENSION, V62, P614, DOI 10.1161/HYPERTENSIONAHA.113.01513; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Health Council of the Netherlands, 2008, 200815 HLTH COUNC NE; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Josefson JL, 2013, J CLIN ENDOCR METAB, V98, P114, DOI 10.1210/jc.2012-2882; Karnchanasorn R, 2012, PANCREAS, V41, P863, DOI 10.1097/MPA.0b013e31823c947c; Kim DW, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.117259; Kovacs C. S., 2008, AM J CLIN NUTR, V88, p520S, DOI DOI 10.1146/ANNUREV-NUTR-071811-150742; Krishnaveni GV, 2011, AM J CLIN NUTR, V93, P628, DOI 10.3945/ajcn.110.003921; Krishnaveni GV, 2005, DIABETES CARE, V28, P2919, DOI 10.2337/diacare.28.12.2919; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; Lamberg-Allardt C, 2006, PROG BIOPHYS MOL BIO, V92, P33, DOI 10.1016/j.pbiomolbio.2006.02.017; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lips P, 2004, J STEROID BIOCHEM, V89-90, P611, DOI 10.1016/j.jsbmb.2004.03.040; Liu NQ, 2011, J IMMUNOL, V186, P5968, DOI 10.4049/jimmunol.1003332; Marwaha RK, 2011, BRIT J NUTR, V106, P1383, DOI 10.1017/S000711451100170X; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Morrison JA, 2008, J PEDIATR-US, V152, P201, DOI 10.1016/j.jpeds.2007.09.010; Narchi H, 2010, J OBSTET GYNAECOL, V30, P137, DOI 10.3109/01443610903315652; Pasco JA, 2008, MED HYPOTHESES, V71, P266, DOI 10.1016/j.mehy.2008.01.033; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; van Buuren S, 2011, J STAT SOFTW, V45, P1; van den Berg G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-591; van Dijk AE, 2014, J DEV ORIG HLTH DIS, P1; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2008, AM J CLIN NUTR, V87, P887, DOI 10.1093/ajcn/87.4.887; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wei JN, 2003, DIABETES CARE, V26, P343, DOI 10.2337/diacare.26.2.343; Williams DM, 2013, HEART, V99, P1849, DOI 10.1136/heartjnl-2013-303678; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang HQ, 2014, DIABETOLOGIA, V57, P2165, DOI 10.1007/s00125-014-3316-7	49	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133313	10.1371/journal.pone.0133313	http://dx.doi.org/10.1371/journal.pone.0133313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244505	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400039
J	Jeong, YJ; Kim, I; Cho, JH; Park, DW; Kwon, JE; Jung, MW; Meng, X; Jo, SM; Song, HS; Cho, YM; Song, SM; Ham, YM; Jung, YH; Kim, CS; Yoon, WJ; Kang, SC				Jeong, Yong Joon; Kim, Inhye; Cho, Joon Hyung; Park, Dae Won; Kwon, Jung Eun; Jung, Moon Won; Meng, Xue; Jo, Se Min; Song, Hae Seong; Cho, Young Mi; Song, Sang Mok; Ham, Young-Min; Jung, Yong-Hwan; Kim, Chang Sook; Yoon, Weon-Jong; Kang, Se Chan			Anti-Osteoarthritic Effects of the Litsea japonica Fruit in a Rat Model of Osteoarthritis Induced by Monosodium Iodoacetate	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; EXPRESSION; INHIBITORS; DISEASE; TIMP-1	Osteoarthritis (OA) is a degenerative chronic disease that affects various tissues surrounding the joints, such as the subchondral bone and articular cartilage. The onset of OA is associated with uncontrolled catabolic and anabolic remodeling processes of the joints, including the cartilage and subchondral bone, to adapt to local biological and biochemical signals. In this study, we determined whether 70% ethanolic (EtOH) extract of Litsea japonica fruit (LJFE) had beneficial effects on the articular cartilage, including structural changes in the tibial subchondral bone, matrix degradation, and inflammatory responses, in OA by using a rat model of monosodium iodoacetate-induced OA. Our results showed that administration of LJFE increased the bone volume and cross-section thickness, but the mean number of objects per slice in this group was lower than that in the OA control (OAC) group. In addition, the LJFE decreased the expression of inflammatory cytokines. Compared to the OAC group, the group treated with high doses of LJFE (100 and 200 mg/kg) showed a more than 80% inhibition of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Our results suggest that LJFE can be used as a potential anti-osteoarthritic agent.	[Jeong, Yong Joon; Park, Dae Won; Kwon, Jung Eun; Jung, Moon Won; Meng, Xue; Jo, Se Min; Song, Hae Seong; Cho, Young Mi; Kang, Se Chan] Gachon Univ, Dept Life Sci, Songnam, South Korea; [Kim, Inhye] Hanyang Univ, Dept Food & Nutr, Seoul 133791, South Korea; [Cho, Joon Hyung] Dongguk Univ, Dept Biol & Environm Sci, Seoul, South Korea; [Song, Sang Mok; Ham, Young-Min; Jung, Yong-Hwan; Kim, Chang Sook; Yoon, Weon-Jong] Jeju Biodivers Res Inst, Jeju, South Korea	Gachon University; Hanyang University; Dongguk University	Yoon, WJ (corresponding author), Jeju Biodivers Res Inst, Jeju, South Korea.	yyjkl@jejutp.or.kr; sckang73@gachon.ac.kr	Ha, C/GZL-9046-2022; Kim, Il/L-6481-2019		High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (SRAA)	High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (SRAA)	This research was supported by High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (SRAA).	Ahmad R, 2009, OSTEOARTHR CARTILAGE, V17, P1049, DOI 10.1016/j.joca.2009.02.008; Ameye LG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2016; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Benedetti S, 2010, CLIN BIOCHEM, V43, P973, DOI 10.1016/j.clinbiochem.2010.05.004; Braza-Boils A, 2012, EXP GERONTOL, V47, P406, DOI 10.1016/j.exger.2012.03.005; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Cournil C, 2001, ARTHRITIS RES THER, V3; DUNHAM J, 1993, INT J EXP PATHOL, V74, P283; Ghosh P, 1999, SEMIN ARTHRITIS RHEU, V28, P211, DOI 10.1016/S0049-0172(99)80021-3; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Koo HJ, 2014, INT IMMUNOPHARMACOL, V22, P84, DOI 10.1016/j.intimp.2014.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz H, 2006, PROG HISTOCHEM CYTO, V40, P135, DOI 10.1016/j.proghi.2006.02.003; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; Min BS, 2003, J NAT PROD, V66, P1388, DOI 10.1021/np030227i; Mohan G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3543; Naito K, 1999, RHEUMATOLOGY, V38, P510, DOI 10.1093/rheumatology/38.6.510; NII H, 1978, AGR BIOL CHEM TOKYO, V42, P1601; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Sakata K, 2000, INT J ONCOL, V17, P673; Sarzi-Puttini P, 2005, SEMIN ARTHRITIS RHEU, V35, P1, DOI 10.1016/j.semarthrit.2005.01.013; Sharif M, 2000, ANN RHEUM DIS, V59, P71, DOI 10.1136/ard.59.1.71; Sohn E., 2013, EVID-BASED COMPL ALT, V2013; TAKEDA K, 1972, TETRAHEDRON, V28, P3757, DOI 10.1016/S0040-4020(01)93822-0; TANAKA H, 1990, PHYTOCHEMISTRY, V29, P857, DOI 10.1016/0031-9422(90)80033-D; Yang CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079662; Yoon WJ, 2010, J KOREAN SOC APPL BI, V53, P27, DOI 10.3839/jksabc.2010.005; Yoshihara Y, 2000, ANN RHEUM DIS, V59, P455, DOI 10.1136/ard.59.6.455	30	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134856	10.1371/journal.pone.0134856	http://dx.doi.org/10.1371/journal.pone.0134856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244981	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400114
J	Origgi, FC; Tecilla, M; Pilo, P; Aloisio, F; Otten, P; Aguilar-Bultet, L; Sattler, U; Roccabianca, P; Romero, CH; Bloom, DC; Jacobson, ER				Origgi, Francesco C.; Tecilla, Marco; Pilo, Paola; Aloisio, Fabio; Otten, Patricia; Aguilar-Bultet, Lisandra; Sattler, Ursula; Roccabianca, Paola; Romero, Carlos H.; Bloom, David C.; Jacobson, Elliott R.			A Genomic Approach to Unravel Host-Pathogen Interaction in Chelonians: The Example of Testudinid Herpesvirus 3	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INFECTION; TORTOISES; VIRUS; IDENTIFICATION; STOMATITIS; LIZARD; PHYLOGENY; PROGRAM; DISEASE	We report the first de novo sequence assembly and analysis of the genome of Testudinid herpesvirus 3 (TeHV3), one of the most pathogenic chelonian herpesviruses. The genome of TeHV3 is at least 150,080 nucleotides long, is arranged in a type D configuration and comprises at least 102 open reading frames extensively co-linear with those of Human herpesvirus 1. Consistently, the phylogenetic analysis positions TeHV3 among the Alphaherpesvirinae, closely associated with Chelonid herpesvirus 5, a Scutavirus. To date, there has been limited genetic characterization of TeHVs and a resolution beyond the genotype was not feasible because of the lack of informative DNA sequences. To exemplify the potential benefits of the novel genomic information provided by this first whole genome analysis, we selected the glycoprotein B (gB) gene, for detailed comparison among different TeHV3 isolates. The rationale for selecting gB is that it encodes for a well-conserved protein among herpesviruses but is coupled with a relevant antigenicity and is consequently prone to accumulate single nucleotide polymorphisms. These features were considered critical for an ideal phylogenetic marker to investigate the potential existence of distinct TeHV3 genogroups and their associated pathology. Fifteen captive tortoises presumptively diagnosed to be infected with TeHVs or carrying compatible lesions on the basis of either the presence of intranuclear inclusions (presumptively infected) and/or diphtheronecrotic stomatitis-glossitis or pneumonia (compatible lesions) were selected for the study. Viral isolation, TeHV identification, phylogenetic analysis and pathological characterization of the associated lesions, were performed. Our results revealed 1) the existence of at least two distinct TeHV3 genogroups apparently associated with different pathologies in tortoises and 2) the first evidence for a putative homologous recombination event having occurred in a chelonian herpesvirus. This novel information is not only fundamental for the genetic characterization of this virus but is also critical to lay the groundwork for an improved understanding of host-pathogen interactions in chelonians and contribute to tortoise conservation.	[Origgi, Francesco C.; Sattler, Ursula] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Tecilla, Marco; Roccabianca, Paola] Univ Milan, Dept Vet Sci & Publ Hlth DIVET, Milan, Italy; [Pilo, Paola; Aguilar-Bultet, Lisandra] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland; [Aloisio, Fabio] IDEXX Labs Italia Srl, Milan, Italy; [Otten, Patricia] Fasteris SA, Geneva, Switzerland; [Aguilar-Bultet, Lisandra] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Romero, Carlos H.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA; [Bloom, David C.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Jacobson, Elliott R.] Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA	University of Bern; University of Milan; University of Bern; University of Bern; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Origgi, FC (corresponding author), Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland.	Francesco.origgi@vetsuisse.unibe.ch	Tecilla, Marco/L-8871-2019; Aguilar-Bultet, Lisandra/V-2316-2019; Roccabianca, Paola/I-6110-2017; Tecilla, Marco/I-6167-2017	Roccabianca, Paola/0000-0002-3672-4612; Tecilla, Marco/0000-0002-1214-8155; Aguilar-Bultet, Lisandra/0000-0001-7662-7131				Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046623; Alba MM, 2001, GENOME RES, V11, P43, DOI 10.1101/gr.149801; Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bicknese EJ, 2010, J ZOO WILDLIFE MED, V41, P353, DOI 10.1638/2009-0214R.1; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; CLARK HF, 1972, INFECT IMMUN, V5, P559, DOI 10.1128/IAI.5.4.559-569.1972; Coberley SS, 2002, J VIROL, V76, P10553, DOI 10.1128/JVI.76.20.10553-10558.2002; Cowan ML, 2015, AUST VET J, V93, P46, DOI 10.1111/avj.12290; COX WR, 1980, J WILDLIFE DIS, V16, P445, DOI 10.7589/0090-3558-16.3.445; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRYE FL, 1977, J AM VET MED ASSOC, V171, P882; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; Govett PD, 2005, J VET DIAGN INVEST, V17, P474, DOI 10.1177/104063870501700513; HAUSER B, 1983, J COMP PATHOL, V93, P515, DOI 10.1016/0021-9975(83)90057-9; HERBST LH, 1995, ENVIRON HEALTH PERSP, V103, P27, DOI 10.2307/3432408; Hommelsheim CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05052; Hughes-Hanks JM, 2010, J VET DIAGN INVEST, V22, P295, DOI 10.1177/104063871002200224; Jacobson ER, 2012, J WILDLIFE DIS, V48, P747, DOI 10.7589/0090-3558-48.3.747; JACOBSON ER, 1989, J COMP PATHOL, V101, P39, DOI 10.1016/0021-9975(89)90075-3; JACOBSON ER, 1986, J AM VET MED ASSOC, V189, P1020; JACOBSON ER, 1985, J AM VET MED ASSOC, V187, P1227; Johnson AJ, 2005, VET MICROBIOL, V111, P107, DOI 10.1016/j.vetmic.2005.09.008; Jungwirth N, 2014, VET MICROBIOL, V170, P403, DOI 10.1016/j.vetmic.2014.02.029; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Literak L, 2010, J WILDLIFE DIS, V46, P257, DOI 10.7589/0090-3558-46.1.257; Lubinski JM, 1998, J VIROL, V72, P8257, DOI 10.1128/JVI.72.10.8257-8263.1998; Marschang RE, 2015, TIERAERZTL PRAX K H, V43, P166, DOI 10.15654/TPK-140575; Marschang RE, 1997, J VET MED B, V44, P385, DOI 10.1111/j.1439-0450.1997.tb00989.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McCowan C, 2004, AUST VET J, V82, P579; McCowan C, 2004, AUST VET J, V82, P375, DOI 10.1111/j.1751-0813.2004.tb11109.x; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Origgi FC, 2003, J VET DIAGN INVEST, V15, P133, DOI 10.1177/104063870301500207; Origgi FC, 2001, J CLIN MICROBIOL, V39, P3156, DOI 10.1128/JCM.39.9.3156-3163.2001; Origgi Francesco C., 2012, Journal of Herpetological Medicine and Surgery, V22, P42, DOI 10.5818/1529-9651-22.1-2.42; Ossiboff RJ, 2015, J VET DIAGN INVEST, V27, P392, DOI 10.1177/1040638715584793; Ossiboff RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122901; RAYNAUD A, 1976, CR ACAD SCI D NAT, V283, P845; REBELL G, 1975, AM J VET RES, V36, P1221; Sandri-Goldin RM, 2003, PNAS, V100, P7429; Sim RR, 2015, VET MICROBIOL, V175, P218, DOI 10.1016/j.vetmic.2014.11.029; SIMPSON CF, 1979, J AM VET MED ASSOC, V175, P941; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teifke JP, 2000, VET PATHOL, V37, P377, DOI 10.1354/vp.37-5-377; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; WATSON GL, 1993, J VET DIAGN INVEST, V5, P444, DOI 10.1177/104063879300500326; Wellehan JFX, 2005, VET MICROBIOL, V105, P83, DOI 10.1016/j.vetmic.2004.10.012; Wellehan JFX, 2004, J ZOO WILDLIFE MED, V35, P50, DOI 10.1638/03-011; Wilkinson M, 2005, J ZOO WILDLIFE MED, V36, P724, DOI 10.1638/03-067.1; Yonkers SB, 2015, J VET DIAGN INVEST, V27, P408, DOI 10.1177/1040638715589612	60	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134897	10.1371/journal.pone.0134897	http://dx.doi.org/10.1371/journal.pone.0134897			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244892	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400127
J	Reed, P; Vile, R; Osborne, LA; Romano, M; Truzoli, R				Reed, Phil; Vile, Rebecca; Osborne, Lisa A.; Romano, Michela; Truzoli, Roberto			Problematic Internet Usage and Immune Function	PLOS ONE			English	Article							SOCIAL RELATIONSHIPS; COMMON COLD; SELF-ESTEEM; LIFE-STRESS; RISK-FACTOR; ADDICTION; DEPRESSION; LONELINESS; STUDENTS; HEALTH	Problematic internet use has been associated with a variety of psychological comorbidities, but it relationship with physical illness has not received the same degree of investigation. The current study surveyed 505 participants online, and asked about their levels of problematic internet usage (Internet Addiction Test), depression and anxiety (Hospital Anxiety and Depression Scales), social isolation (UCLA Loneliness Questionnaire), sleep problems (Pittsburgh Sleep Quality Index), and their current health -General Health Questionnaire (GHQ-28), and the Immune Function Questionnaire. The results demonstrated that around 30% of the sample displayed mild or worse levels of internet addiction, as measured by the IAT. Although there were differences in the purposes for which males and females used the internet, there were no differences in terms of levels of problematic usage between genders. The internet problems were strongly related to all of the other psychological variables such as depression, anxiety, social-isolation, and sleep problems. Internet addiction was also associated with reduced self-reported immune function, but not with the measure of general health (GHQ-28). This relationship between problematic internet use and reduced immune function was found to be independent of the impact of the co-morbidities. It is suggested that the negative relationship between level of problematic internet use and immune function may be mediated by levels of stress produced by such internet use, and subsequent sympathetic nervous activity, which related to immune-supressants, such as cortisol.	[Reed, Phil; Vile, Rebecca] Univ Milan, Milan, Italy; [Osborne, Lisa A.] Abertawe Bro Morgannwg Univ Hlth Board, Swansea, W Glam, Wales; [Romano, Michela; Truzoli, Roberto] Swansea Univ, Swansea, W Glam, Wales	University of Milan; Swansea University	Reed, P (corresponding author), Univ Milan, Milan, Italy.	p.reed@swansea.ac.uk	Reed, Phil/H-7999-2019; truzoli, roberto/K-8735-2015; TRUZOLI, ROBERTO/Q-1928-2019	Reed, Phil/0000-0002-8157-0747; truzoli, roberto/0000-0001-7420-7053; TRUZOLI, ROBERTO/0000-0001-7420-7053				Aberg KM, 2007, J CLIN INVEST, V117, P3339, DOI 10.1172/JCI31726; Adam Y, 2013, J PSYCHOSOM RES, V74, P69, DOI 10.1016/j.jpsychores.2012.08.013; Akin A., 2011, INT ONLINE J ED SCI, V3, P138; Andrews B, 2004, BRIT J PSYCHOL, V95, P509, DOI 10.1348/0007126042369802; Belanger RE, 2011, PEDIATRICS, V127, pE330, DOI 10.1542/peds.2010-1235; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Besedovsky L, 2012, PFLUG ARCH EUR J PHY, V463, P121, DOI 10.1007/s00424-011-1044-0; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bozoglan B, 2013, SCAND J PSYCHOL, V54, P313, DOI 10.1111/sjop.12049; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; Cao H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-802; Caplan SE, 2003, COMMUN RES, V30, P625, DOI 10.1177/0093650203257842; Caplan SE, INTERNET ADDICTION A, V201, P35; Chang MK, 2008, COMPUT HUM BEHAV, V24, P2597, DOI 10.1016/j.chb.2008.03.001; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Glaser R, 2000, PSYCHOSOM MED, V62, P804, DOI 10.1097/00006842-200011000-00010; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Griffiths M, 2000, ADDICT RES, V8, P413, DOI 10.3109/16066350009005587; Grout P, 1976, J R Coll Gen Pract, V26, P428; Gundogar A, EUROPEAN PSYCHIAT, V27, P1; Haas HS, 2001, ALLERGY, V56, P470, DOI 10.1034/j.1398-9995.2001.056006470.x; Hardie E, 2007, AUST J EMERG TECH SO, V5, P34, DOI DOI 10.1016/S0092-6566(03)00046-1; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Heim C, 2012, AUST NZ J PSYCHIAT, V46, P791, DOI 10.1177/0004867412442407; Hou H, 2012, BIOMED RESEARCH INTE, V2012; IRWIN M, 1990, BIOL PSYCHIAT, V27, P22, DOI 10.1016/0006-3223(90)90016-U; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Jaremka LM, 2013, PSYCHONEUROENDOCRINO, V38, P1310, DOI 10.1016/j.psyneuen.2012.11.016; Jenaro C, 2007, ADDICT RES THEORY, V15, P309, DOI 10.1080/16066350701350247; Jobe LE, 2007, PERS INDIV DIFFER, V42, P1479, DOI 10.1016/j.paid.2006.10.021; Kelley KJ, 2013, J BEHAV ADDICT, V2, P108, DOI 10.1556/JBA.1.2012.016; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kim HC, 2011, J PSYCHOSOM RES, V71, P194, DOI 10.1016/j.jpsychores.2011.01.014; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Kim Y, 2010, NUTR RES PRACT, V4, P51, DOI 10.4162/nrp.2010.4.1.51; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Ko CH, 2014, COMPREHENSIVE PSYCHI; Kuss DJ, 2013, COMPUT HUM BEHAV, V29, P959, DOI 10.1016/j.chb.2012.12.024; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Li ML, 2014, OBESITY, V22, P482, DOI 10.1002/oby.20595; Lin PC, 2013, THE JOURNAL OF CARDI; Lu DW, 2010, CYBERPSYCH BEH SOC N, V13, P371, DOI 10.1089/cyber.2009.0254; MCCLELLAND DC, 1980, J HUM STRESS, V6, P11, DOI 10.1080/0097840X.1980.9934531; MCCLELLAND DC, 1982, J ABNORM PSYCHOL, V91, P61, DOI 10.1037/0021-843X.91.1.61; Nalwa K, 2003, CYBERPSYCHOL BEHAV, V6, P653, DOI 10.1089/109493103322725441; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Niemz K, 2005, CYBERPSYCHOL BEHAV, V8, P562, DOI 10.1089/cpb.2005.8.562; Romano M, 2014, RES AUTISM SPECT DIS, V8, P1521, DOI 10.1016/j.rasd.2014.08.002; Romano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055162; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Sanders CE, 2000, ADOLESCENCE, V35, P237; Senunaite K, IMPACT OF A CHILD WI; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Snaith RP, 1994, HADS HOSPITAL ANXIET; Tonioni F, 2012, GEN HOSP PSYCHIAT, V34, P80, DOI 10.1016/j.genhosppsych.2011.09.013; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; WHO, 2013, WORLD HEALTH ORGANIZ, V88, P225; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Yan WS, 2014, STRESS HEALTH, V30, P3, DOI 10.1002/smi.2490; Yen CF, 2014, COMPREHENSIVE PSYCHI; Yen JY, 2011, CYBERPSYCH BEH SOC N, V14, P649, DOI 10.1089/cyber.2010.0393; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K.S., 2009, INTERNET ADDICTION T; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Zheng H, 2011, FASEB J, V25, P1028; Zhou Y, 2011, EUR J RADIOL, V79, P92, DOI 10.1016/j.ejrad.2009.10.025	73	44	45	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134538	10.1371/journal.pone.0134538	http://dx.doi.org/10.1371/journal.pone.0134538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244339	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400087
J	Van Cauwenberg, J; Van Holle, V; De Bourdeaudhuij, I; Owen, N; Deforche, B				Van Cauwenberg, Jelle; Van Holle, Veerle; De Bourdeaudhuij, Ilse; Owen, Neville; Deforche, Benedicte			Diurnal Patterns and Correlates of Older Adults' Sedentary Behavior	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PATTERNS; TELEVISION VIEWING TIME; ALL-CAUSE MORTALITY; SITTING TIME; HEALTH OUTCOMES; RISK; ASSOCIATIONS; POPULATION; DISEASE; ACCELEROMETRY	Introduction Insights into the diurnal patterns of sedentary behavior and the identification of subgroups that are at increased risk for engaging in high levels of sedentary behavior are needed to inform potential interventions for reducing older adults' sedentary time. Therefore, we examined the diurnal patterns and sociodemographic correlates of older adults' sedentary behavior(s). Methods Stratified cluster sampling was used to recruit 508 non-institutionalized Belgian older adults (>= 65 years). Morning, afternoon, evening and total sedentary time was assessed objectively using accelerometers. Specific sedentary behaviors, total sitting time and sociodemographic attributes were assessed using an interviewer-administered questionnaire. Results Participants self-reported a median of 475 (Q1-Q3 = 383-599) minutes/day of total sitting time and they accumulated a mean of 580 +/- 98 minutes/day of accelerometer-derived sedentary time. Sedentary time was lowest during the morning and highest during the evening. Older participants were as sedentary as younger participants during the evening, but they were more sedentary during daytime. Compared to married participants, widowers were more sedentary during daytime. Younger participants (< 75 years), men and the higher educated were more likely to engage in (high levels of) sitting while driving a car and using the computer. Those with tertiary education viewed 29% and 22% minutes/day less television compared to those with primary or secondary education, respectively. Older participants accumulated 35 sedentary minutes/day more than did younger participants and men accumulated 32 sedentary minutes/day more than did women. Conclusion These findings highlight diurnal variations and potential opportunities to tailor approaches to reducing sedentary time for subgroups of the older adult population.	[Van Cauwenberg, Jelle; Deforche, Benedicte] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium; [Van Cauwenberg, Jelle; Deforche, Benedicte] Vrije Univ Brussel, Fac Phys Educ & Phys Therapy, Dept Human Biometry & Biomech, Brussels, Belgium; [Van Cauwenberg, Jelle; Van Holle, Veerle] Fund Sci Res Flanders FWO, Brussels, Belgium; [Van Holle, Veerle; De Bourdeaudhuij, Ilse] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Owen, Neville] Univ Melbourne, Univ Queensland, Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Monash Univ, Melbourne, Vic 3004, Australia	Ghent University; Vrije Universiteit Brussel; Ghent University; Baker Heart and Diabetes Institute; University of Melbourne; University of Queensland; Monash University	Van Cauwenberg, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth, B-9000 Ghent, Belgium.	jelle.vancauwenberg@ugent.be	Owen, Neville/K-5986-2012; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Owen, Neville/0000-0003-2784-4820; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Cauwenberg, Jelle/0000-0003-1292-6241	Research Foundation Flanders (FWO) [11N0313N, 11O3115N]; National Health and Medical Research Council of Australia [569940, 1003960]	Research Foundation Flanders (FWO)(FWO); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Research Foundation Flanders (FWO) (www.fwo.be, 11N0313N and 11O3115N): JVC and VVH, National Health and Medical Research Council of Australia Program Grant (#569940), a Senior Principal Research Fellowship (#1003960) and by the Victorian Government's Operational Infrastructure Support program: NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Belgian Federal Government, 2013, ENQ NAAR ARB EAK; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cerin E, 2012, J AGING PHYS ACTIV, V20, P402, DOI 10.1123/japa.20.4.402; Chastin SFM, 2013, PLOS ONE, V8; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Datawarehouse Arbeidsmarkt & Sociale Bescherming bij de KSZ (Bewerking Steunpunt WSE), 2013, GEM UITTR BELG GEW 1; Davis MG, 2007, EUR J APPL PHYSIOL, V100, P581, DOI 10.1007/s00421-006-0320-8; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Drieskens S., 2013, HLTH INTERVIEW SURVE; Eurostat, 2013, CIT STAT ILL; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gardiner PA, 2011, J AM GERIATR SOC, V59, P788, DOI 10.1111/j.1532-5415.2011.03390.x; George SM, 2010, AM J PUBLIC HEALTH, V100, P2288, DOI 10.2105/AJPH.2009.180828; Gomez-Cabello A, 2012, MATURITAS, V73, P337, DOI 10.1016/j.maturitas.2012.09.001; Government F, 2008, ONDERZOEK VERPLAATSI; Grimm EK, 2012, J AGING PHYS ACTIV, V20, P64, DOI 10.1123/japa.20.1.64; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamer M, 2013, PLOS ONE, V8; Haustein S, 2014, J TRANSP GEOGR, V41, P45, DOI 10.1016/j.jtrangeo.2014.08.001; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; Kesse-Guyot E, 2012, PLOS ONE, V7; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Rasbash J, 2009, MANUAL SUPPLEMENT ML; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sallis JF, 2000, ANN BEHAV MED, V22, P294, DOI 10.1007/BF02895665; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Stad Gent, 2014, GENT IN CIJF; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; United Nations, 2014, IND COUNTR 2014 HUM; Van Cauwenberg J, 2014, J AGING PHYS ACTIV, V22, P508, DOI [10.1123/japa.2013-0015, 10.1123/JAPA.2013-0015]; Van Cauwenberg J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-734; van der Goot M, 2012, AGEING SOC, V32, P147, DOI 10.1017/S0144686X1100016X; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11; Ware J.E., 1994, SF 36 PHYS MENTAL HL	53	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133175	10.1371/journal.pone.0133175	http://dx.doi.org/10.1371/journal.pone.0133175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244676	Green Published, gold			2022-12-26	WOS:000359061400034
J	Wathan, J; Burrows, AM; Waller, BM; McComb, K				Wathan, Jen; Burrows, Anne M.; Waller, Bridget M.; McComb, Karen			EquiFACS: The Equine Facial Action Coding System	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; RHESUS MACAQUE; EXPRESSION; DOMESTICATION; MOVEMENT; MUSCLES; HORSE; EVOLUTION; CONTEXTS; BEHAVIOR	Although previous studies of horses have investigated their facial expressions in specific contexts, e.g. pain, until now there has been no methodology available that documents all the possible facial movements of the horse and provides a way to record all potential facial configurations. This is essential for an objective description of horse facial expressions across a range of contexts that reflect different emotional states. Facial Action Coding Systems (FACS) provide a systematic methodology of identifying and coding facial expressions on the basis of underlying facial musculature and muscle movement. FACS are anatomically based and document all possible facial movements rather than a configuration of movements associated with a particular situation. Consequently, FACS can be applied as a tool for a wide range of research questions. We developed FACS for the domestic horse (Equus caballus) through anatomical investigation of the underlying musculature and subsequent analysis of naturally occurring behaviour captured on high quality video. Discrete facial movements were identified and described in terms of the underlying muscle contractions, in correspondence with previous FACS systems. The reliability of others to be able to learn this system (EquiFACS) and consistently code behavioural sequences was high-and this included people with no previous experience of horses. A wide range of facial movements were identified, including many that are also seen in primates and other domestic animals (dogs and cats). EquiFACS provides a method that can now be used to document the facial movements associated with different social contexts and thus to address questions relevant to understanding social cognition and comparative psychology, as well as informing current veterinary and animal welfare practices.	[Wathan, Jen; McComb, Karen] Univ Sussex, Sch Psychol, Mammal Commun & Cognit Res, Brighton, E Sussex, England; [Burrows, Anne M.] Univ Portsmouth, Ctr Comparat & Evolutionary Psychol, Dept Psychol, Portsmouth, Hants, England; [Waller, Bridget M.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA	University of Sussex; University of Portsmouth; Duquesne University	Wathan, J (corresponding author), Univ Sussex, Sch Psychol, Mammal Commun & Cognit Res, Brighton, E Sussex, England.	j.wathan@sussex.ac.uk; karenm@sussex.ac.uk	Burrows, Anne M/AAP-3577-2021; aubertin, rebeckah/O-9624-2015	Burrows, Anne M/0000-0002-9952-8125; Wathan, Jen/0000-0003-0939-6200; aubertin, rebeckah/0000-0002-0558-7571; Waller, Bridget/0000-0001-6303-7458	Biotechnology and Biological Sciences Research Council (BBSRC); University of Sussex; Leverhulme Trust [RPG-2013-069]; Biotechnology and Biological Sciences Research Council [1091382] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Sussex; Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JW was supported by a studentship from the Biotechnology and Biological Sciences Research Council (BBSRC-www.bbsrc.ac.uk) and the University of Sussex, and also an Alumni Travel Grant from the University of Sussex (www.sussex.ac.uk). KM was supported by a Leverhulme Trust Research Grant number RPG-2013-069 (www.leverhulme.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashdown RR, 2011, COLOR ATLAS VET ANAT, V2; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bruce V., 2013, FACE PERCEPTION; Budras K.D., 2012, ANATOMY HORSE AARON; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Burrows AM, 2003, ANAT REC PART A, V274A, P827, DOI 10.1002/ar.a.10093; Burrows AM, 2011, ANAT REC, V294, P645, DOI 10.1002/ar.21355; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Bussieres G, 2008, RES VET SCI, V85, P294, DOI 10.1016/j.rvsc.2007.10.011; Caeiro CC, 2013, INT J PRIMATOL, V34, P115, DOI 10.1007/s10764-012-9652-x; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Diogo R, 2009, J ANAT, V215, P300, DOI 10.1111/j.1469-7580.2009.01111.x; Ekman P., 2002, MANUAL INVESTIGATORS; Gleerup KB, 2015, VET ANAESTH ANALG, V42, P103, DOI 10.1111/vaa.12212; Gregory, 1929, OUR FACE FISH MAN PO; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Harman AM, 1999, EQUINE VET J, V31, P384, DOI 10.1111/j.2042-3306.1999.tb03837.x; Hinde R. A., 1983, PRIMATE SOCIAL RELAT, P1; Hole Graham, 2010, FACE PROCESSING PSYC; Huber E, 1931, EVOLUTION FACIAL MUS; Jochle W, 1989, Equine Vet J Suppl, P111, DOI 10.1111/j.2042-3306.1989.tb05668.x; Klingel H., 1977, ANIMALS COMMUNICATE; Land MF, 2002, ANIMAL EYES; McDonnell S.M, 2003, EQUID ETHOGRAM PRACT; Miller PE, 1995, J AM VET MED ASSOC, V207, P1623; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Parr LA, 2007, EMOTION, V7, P172, DOI 10.1037/1528-3542.7.1.172; Sandem AI, 2005, APPL ANIM BEHAV SCI, V95, P233, DOI 10.1016/j.applanim.2005.04.011; SCHILDER MBH, 1984, Z TIERPSYCHOL, V66, P11; SISSON S, 1962, ANATOMY DOMESTIC ANI; TIMNEY B, 1992, VISION RES, V32, P2289, DOI 10.1016/0042-6989(92)90092-W; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Waller BM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0974; Waller B. M., 2013, CATFACS; Waller BM, 2007, J COMP PSYCHOL, V121, P398, DOI 10.1037/0735-7036.121.4.398; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Waller BM, 2013, EMOT REV, V5, P54, DOI 10.1177/1754073912451503; Waller BM, 2012, INT J PRIMATOL, V33, P809, DOI 10.1007/s10764-012-9611-6; Waring G.H., 2003, HORSE BEHAV, V2; Wathan J, 2014, CURR BIOL, V24, pR677, DOI 10.1016/j.cub.2014.06.023; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617	47	79	79	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131738	10.1371/journal.pone.0131738	http://dx.doi.org/10.1371/journal.pone.0131738			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244573	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400012
J	Prudnikova, TY; Villamar-Cruz, O; Rawat, SJ; Cai, KQ; Chernoff, J				Prudnikova, T. Y.; Villamar-Cruz, O.; Rawat, S. J.; Cai, K. Q.; Chernoff, J.			Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells	ONCOGENE			English	Article							BETA-CATENIN; SIGNALING PATHWAY; TUMOR-FORMATION; WILD-TYPE; PAK1; TRANSFORMATION; ACTIVATION; BLOCKS; GROWTH; AMPLIFICATION	p21-activated kinases (Paks) are Cdc42/Rac-activated serine-threonine protein kinases that regulate several key cancer-relevant signaling pathways, such as the Mek/Erk, PI3K/Akt and Wnt/b-catenin signaling pathways. Pak1 is frequently overexpressed and/or hyperactivated in different human cancers, including human breast, ovary, prostate and brain cancer, due to amplification of the PAK1 gene in an 11q13 amplicon. Genetic or pharmacological inactivation of Pak1 has been shown to reduce proliferation of different cancer cells in vitro and reduce tumor progression in vivo. In this work, we examined the roles of Pak1 in cellular and animal models of PAK1-amplified ovarian cancer. We found that inhibition of Pak1 leads to decreased proliferation and migration in PAK1-amplified/overexpressed ovarian cancer cells, and has no effect in cell that lack such amplification/overexpression. Further, we observed that loss of Pak1 function causes 11q13-amplified ovarian cancer cells to arrest in the G2/M phase of the cell cycle. This arrest correlates with activation of p53 and p21(Cip) and decreased expression of cyclin B1. These findings suggest that small-molecule inhibitors of Pak1 may have a therapeutic role in the similar to 25% of ovarian cancers characterized by PAK1 gene amplification.	[Prudnikova, T. Y.; Villamar-Cruz, O.; Rawat, S. J.; Chernoff, J.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA; [Cai, K. Q.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836; Villamar-Cruz, Olga/0000-0003-4265-9367	National Institutes of Health [R01-CA142928, R01-CA148805]; Ovarian SPORE [P50 CA083638]; Fox Chase Cancer Center [P30-CA006927]; State of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA148805, P50CA083638, R01CA142928, P30CA006927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fox Chase Cancer Center; State of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Einarson (Fox Chase Cancer Center, High Throughput and Translational Core Facility) for assistance with cell cycle analysis and the Cell Culture Facility. We thank D. Connolly (FCCC), N. Tonks (CSHL) and G. Mills (MD Anderson) for ovarian cancer cell lines and for insightful comments on the manuscript. This work was supported by grants from the National Institutes of Health to JC (R01-CA142928 and R01-CA148805), Ovarian SPORE P50 CA083638 (Pilot Award to JC), Fox Chase Cancer Center (P30-CA006927), as well as by an appropriation from the State of Pennsylvania.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Aprelikova ON, 1999, P NATL ACAD SCI USA, V96, P11866, DOI 10.1073/pnas.96.21.11866; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Chow HY, 2015, ONCOTARGET, V6, P1981, DOI 10.18632/oncotarget.2810; Dadke D, 2003, CANCER RES, V63, P8837; Davidson B, 2008, HUM PATHOL, V39, P1630, DOI 10.1016/j.humpath.2008.03.009; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Fan SJ, 2001, ONCOGENE, V20, P4827, DOI 10.1038/sj.onc.1204666; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Guan YQ, 2012, BIOMATERIALS, V33, P6162, DOI 10.1016/j.biomaterials.2012.05.037; Hashimoto H, 2009, DRUG DISCOV THER, V3, P243; Hashimoto H, 2010, DRUG DISCOV THER, V4, P1; He H, 2008, BBA-MOL CELL RES, V1783, P1943, DOI 10.1016/j.bbamcr.2008.04.016; He H, 2012, CANCER LETT, V317, P65, DOI 10.1016/j.canlet.2011.11.014; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Holm K, 2012, BREAST CANCER RES TR, V133, P583, DOI 10.1007/s10549-011-1817-3; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Lundgren K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2150; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Motwani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066585; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Prudnikova TY, 2015, CLIN CANCER RES, V21, P24, DOI 10.1158/1078-0432.CCR-14-0827; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Tang Y, 1997, MOL CELL BIOL, V17, P4454, DOI 10.1128/MCB.17.8.4454; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Wang ZP, 2013, J BIOL CHEM, V288, P20093, DOI 10.1074/jbc.M112.426023; Wu JY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0014-8; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866	43	19	20	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2178	2185		10.1038/onc.2015.278	http://dx.doi.org/10.1038/onc.2015.278			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26257058	Green Accepted			2022-12-26	WOS:000374986000004
J	Gomez, I; Huovinen, P				Gomez, Ivan; Huovinen, Pirjo			Lack of Physiological Depth Patterns in Conspecifics of Endemic Antarctic Brown Algae: A Trade-Off between UV Stress Tolerance and Shade Adaptation?	PLOS ONE			English	Article							KING-GEORGE ISLAND; POTTER COVE; MARINE MACROALGAE; LAMINARIA-SOLIDUNGULA; DESMARESTIA-ANCEPS; PHOTOSYNTHESIS; LIGHT; RADIATION; BIOMASS; GROWTH	A striking characteristic of endemic Antarctic brown algae is their broad vertical distribution. This feature is largely determined by the shade adaptation in order to cope with the seasonal variation in light availability. However, during spring-summer months, when light penetrates deep in the water column these organisms have to withstand high levels of solar radiation, including UV. In the present study we examine the light use characteristics in parallel to a potential for UV tolerance (measured as content of phenolic compounds, antioxidant activity and maximum quantum yield of fluorescence) in conspecific populations of four Antarctic brown algae (Ascoseira mirabilis, Desmarestia menziesii, D. anceps and Himantothallus grandifolius) distributed over a depth gradient between 5 and 30 m. The main results indicated that a) photosynthetic efficiency was uniform along the depth gradient in all the studied species, and b) short-term (6 h) exposure to UV radiation revealed a high tolerance measured as chlorophyll fluorescence, phlorotannin content and antioxidant capacity. Multivariate analysis of similarity indicated that light requirements for photosynthesis, soluble phlorotannins and antioxidant capacity are the variables determining the responses along the depth gradient in all the studied species. The suite of physiological responses of algae with a shallower distribution (A. mirabilis and D. menziesii) differed from those with deeper vertical range (D. anceps and H. grandifolius). These patterns are consistent with the underwater light penetration that defines two zones: 0-15 m, with influence of UV radiation (1% of UV-B and UV-A at 9 m and 15 m respectively) and a zone below 15 m marked by PAR incidence (1% up to 30 m). These results support the prediction that algae show a UV stress tolerance capacity along a broad depth range according to their marked shade adaptation. The high contents of phlorotannins and antioxidant potential appear to be strongly responsible for the lack of clear depth patterns in light demand characteristics and UV tolerance.	[Gomez, Ivan; Huovinen, Pirjo] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Gomez, I (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	igomezo@uach.cl		Huovinen, Pirjo/0000-0002-7754-4933; Gomez, Ivan/0000-0001-8381-3792	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [Anillo ART1101]; Instituto Antartico Chileno (INACH) [T-20-9]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Instituto Antartico Chileno (INACH)	The study was supported by the following grants to I.G. and P.H: Anillo ART1101, Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT), http://www.conicyt.cl/pia, and T-20-9, Instituto Antartico Chileno (INACH), http://www.inach.cl/inach/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti S, 2010, POLAR BIOL, V33, P1595, DOI 10.1007/s00300-010-0955-0; Amsler C. D., 2012, ECOL STUD, V219, P177; AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; Barnes David K.A., 2012, P255; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brouwer PEM, 1996, POLAR BIOL, V16, P129; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Clarke KR, 2006, GORLEY RN PRIMER V6; Connan S, 2006, BOT MAR, V49, P39, DOI 10.1515/BOT.2006.005; Cruces E, 2013, MAR BIOL, V160, P1, DOI 10.1007/s00227-012-2049-8; Cruces E, 2012, PHOTOCHEM PHOTOBIOL, V88, P58, DOI 10.1111/j.1751-1097.2011.01013.x; Death R, 2014, BIOGEOSCI DISCUSS, V10, P12551, DOI DOI 10.5194/BGD-10-12551-2013; Deregibus D, 2016, POLAR BIOL, V39, P153, DOI 10.1007/s00300-015-1679-y; DREW EA, 1992, PHYCOLOGIA, V31, P262, DOI 10.2216/i0031-8884-31-3-4-262.1; Dring MJ, 1996, EUR J PHYCOL, V31, P293, DOI 10.1080/09670269600651511; Ducklow Hugh, 2012, P121; DUNTON KH, 1990, MAR BIOL, V106, P297, DOI 10.1007/BF01314813; DUNTON KH, 1986, MAR ECOL PROG SER, V31, P57, DOI 10.3354/meps031057; Fairhead VA, 2006, J PHYCOL, V42, P1174, DOI 10.1111/j.1529-8817.2006.00283.x; Franklin LA, 1997, EUR J PHYCOL, V32, P207, DOI 10.1080/09670269710001737149; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Glud R. N., 2007, BIOSCIENCE, V58, P62; Gomez I, 1997, MAR ECOL PROG SER, V148, P281, DOI 10.3354/meps148281; Gomez I, 2004, MAR ECOL PROG SER, V270, P103, DOI 10.3354/meps270103; GOMEZ I, 1995, BOT MAR, V38, P157, DOI 10.1515/botm.1995.38.1-6.157; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gomez I, 2010, PHOTOCHEM PHOTOBIOL, V86, P1056, DOI 10.1111/j.1751-1097.2010.00786.x; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Grzymski J, 1997, J PHYCOL, V33, P408, DOI 10.1111/j.0022-3646.1997.00408.x; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Huovinen P, 2010, MAR FRESHWATER RES, V61, P330, DOI 10.1071/MF09054; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Johansson G, 2002, MAR ECOL PROG SER, V244, P63, DOI 10.3354/meps244063; KIRST GO, 1995, J PHYCOL, V31, P181, DOI 10.1111/j.0022-3646.1995.00181.x; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Koivikko R, 2005, J CHEM ECOL, V31, P195, DOI 10.1007/s10886-005-0984-2; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; LAMB IM, 1977, ANTARCT RES SER, V23, P130, DOI DOI 10.1029/AR023P0130; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; Quartino ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058223; LUNING K, 1985, MAR BIOL, V87, P119, DOI 10.1007/BF00539419; Luning K., 1990, SEAWEEDS; PECKOL P, 1988, J EXP MAR BIOL ECOL, V115, P25, DOI 10.1016/0022-0981(88)90187-6; Quartino ML, 2008, POLAR BIOL, V31, P281, DOI 10.1007/s00300-007-0356-1; Quartino ML, 2001, POLAR BIOL, V24, P349, DOI 10.1007/s003000000218; Ramus J., 1981, BIOL SEAWEEDS, V17, P458; Rautenberger R, 2015, MAR BIOL, V162, P1087, DOI 10.1007/s00227-015-2651-7; Rautenberger R, 2013, POLAR BIOL, V36, P1779, DOI 10.1007/s00300-013-1397-2; Richter A, 2008, REP POLAR MAR RES, V571, P12; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Runcie JW, 2006, EUR J PHYCOL, V41, P223, DOI 10.1080/09670260600645824; Schloss IR, 2002, J MARINE SYST, V36, P129, DOI 10.1016/S0924-7963(02)00183-5; Schoenwaelder MEA, 2002, PHYCOLOGIA, V41, P125, DOI 10.2216/i0031-8884-41-2-125.1; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Smale DA, 2007, AUSTRAL ECOL, V32, P878, DOI 10.1111/j.1442-9993.2007.01776.x; STRACK D, 1989, PHYTOCHEMISTRY, V28, P2071, DOI 10.1016/S0031-9422(00)97922-6; Weykam G, 1996, J EXP MAR BIOL ECOL, V204, P1, DOI 10.1016/0022-0981(96)02576-2; Wiencke C., 2007, Reviews in Environmental Science and Bio/Technology, V6, P95, DOI 10.1007/s11157-006-9106-z; Wiencke C., 2002, BIOL ANTARCTIC SEAWE; Wiencke C, 2009, BOT MAR, V52, P585, DOI 10.1515/BOT.2009.078; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082; ZIELINSKI K, 1990, Polish Polar Research, V11, P95; ZIELINSKI K, 1981, POL POLAR RES, V2, P71	64	11	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134440	10.1371/journal.pone.0134440	http://dx.doi.org/10.1371/journal.pone.0134440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252953	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100057
J	Kilvaer, TK; Khanehkenari, MR; Hellevik, T; Al-Saad, S; Paulsen, EE; Bremnes, RM; Busund, LT; Donnem, T; Martinez, IZ				Kilvaer, Thomas K.; Khanehkenari, Mehrdad Rakaee; Hellevik, Turid; Al-Saad, Samer; Paulsen, Erna-Elise; Bremnes, Roy M.; Busund, Lill-Tove; Donnem, Tom; Martinez, Inigo Z.			Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers	PLOS ONE			English	Article							CELL LUNG-CANCER; PREDICTS POOR-PROGNOSIS; ACTIVATION PROTEIN; EXPRESSION; CARCINOMA; STROMA; ALPHA	Background Cancer Associated Fibroblasts (CAFs) are thought to regulate tumor growth and metastasis. Fibroblast Activating Protein 1 (FAP-1) is a marker for fibroblast activation and by many recognized as the main marker of CAFs. Alpha Smooth Muscle Actin (alpha-SMA) is a general myofibroblast marker, and can be used to identify CAFs. This study investigates the prognostic impact of FAP-1 and alpha-SMA in non-small cell lung cancer (NSCLC) patients and correlates their expression to 105 proteins investigated in the same cohort. Methods Tumor specimens from 536 NSCLC patients were obtained and tissue micro-arrays were constructed. Immunohistochemistry was used to evaluate the expression of FAP-1 and alpha-SMA and explore their impact on survival and association with other tumor molecular markers in NSCLC patients. Results High expression of FAP-1, but not alpha-SMA, in squamous cell carcinoma (SCC, P = 0.043, HR = 0.63 95% CI 0.40-0.99) was significantly associated with increased disease-specific survival. FAP-1 and alpha-SMA were not significantly correlated to each other. Analyses of FAP-1 and alpha-SMA associated with other tumor-related proteins revealed histotype-specific correlation patterns. Conclusion The presence of FAP-1 expressing CAFs is an indicator of positive outcome for NSCLC-SCC patients. In addition, correlation analyses suggest FAP-1 and alpha-SMA to label different	[Kilvaer, Thomas K.; Hellevik, Turid; Paulsen, Erna-Elise; Bremnes, Roy M.; Donnem, Tom] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Kilvaer, Thomas K.; Paulsen, Erna-Elise; Bremnes, Roy M.; Donnem, Tom] UiT, Inst Clin Med, Tromso, Norway; [Khanehkenari, Mehrdad Rakaee; Al-Saad, Samer; Busund, Lill-Tove; Martinez, Inigo Z.] UiT, Inst Med Biol, Tromso, Norway; [Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Kilvaer, TK (corresponding author), Univ Hosp North Norway, Dept Oncol, Tromso, Norway.	kilvaer@gmail.com	Rakaee, Mehrdad/GMX-0729-2022; Kilvaer, Thomas/AAI-7418-2020	Rakaee, Mehrdad/0000-0002-9080-0153; Kilvaer, Thomas/0000-0003-1669-0117; Martinez, Inigo/0000-0001-5408-9088; Hellevik, Turid/0000-0002-7979-5189				Andersen S, 2011, LUNG CANCER, V72, P294, DOI 10.1016/j.lungcan.2010.10.006; Angel H, 2013, CURR OPIN IMMUNOL, V25, P261, DOI 10.1016/j.coi.2013.03.004; [Anonymous], 2014, R LANG ENV STAT COMP; Ariga N, 2001, INT J CANCER, V95, P67, DOI 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U; Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Chen YB, 2014, TUMOR BIOL, V35, P6707, DOI 10.1007/s13277-014-1908-y; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Cortez E, 2014, SEMIN CANCER BIOL, V25, P3, DOI 10.1016/j.semcancer.2013.12.010; Detterbeck FC, 2013, CHEST, V143, pE191, DOI 10.1378/chest.12-2354; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Donnem T, 2015, CLIN CANCER RES, V21, P2635, DOI 10.1158/1078-0432.CCR-14-1905; Eilertsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105038; Fassnacht M, 2005, CLIN CANCER RES, V11, P5566, DOI 10.1158/1078-0432.CCR-05-0699; Fischer E, 2012, CLIN CANCER RES, V18, P6208, DOI 10.1158/1078-0432.CCR-12-0644; Fox J., 2019, R COMPANION APPL REG, V.; Gamer M, 2012, IRR VARIOUS COEFFICI; Hellevik T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-59; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kerr KM, 2014, ANN ONCOL, V25, P1681, DOI 10.1093/annonc/mdu145; Koriyama H, 2015, J CANCER RES CLIN, V141, P1163, DOI 10.1007/s00432-014-1891-0; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li Q, 2013, SCI REP-UK, V3, DOI 10.1038/srep02038; Liao YD, 2013, J CANCER RES CLIN, V139, P1523, DOI 10.1007/s00432-013-1471-8; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116683; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Matsuwaki R, 2014, CANCER SCI, V105, P905, DOI 10.1111/cas.12434; Neri S, 2012, ANN SURG ONCOL, V19, P3953, DOI 10.1245/s10434-012-2421-4; Ono S, 2013, CHEST, V143, P963, DOI 10.1378/chest.12-0913; Paulsson J, 2014, SEMIN CANCER BIOL, V25, P61, DOI 10.1016/j.semcancer.2014.02.006; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stenvold H, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-9; Therneau T.M., 2000, MODELING SURVIVAL DA; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2	42	45	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134965	10.1371/journal.pone.0134965	http://dx.doi.org/10.1371/journal.pone.0134965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252379	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100092
J	Ortiz-Carrillo, I; Estrella-Gomez, NE; Zamudio-Maya, M; Rojas-Herrera, R				Ortiz-Carrillo, Icela; Eloisa Estrella-Gomez, Neyi; Zamudio-Maya, Marcela; Rojas-Herrera, Rafael			Diversity of Vibrio spp in Karstic Coastal Marshes in the Yucatan Peninsula	PLOS ONE			English	Article							POPULATIONS; BACTERIA; WATERS	Coastal bodies of water formed by the combination of seawater, underground rivers and rainwater comprise the systems with the greatest solar energy flow and biomass production on the planet. These characteristics make them reservoirs for a large number species, mainly microorganisms. Bacteria of the genus Vibrio are natural inhabitants of these environments and their presence is determined by variations in the nutrient, temperature and salinity cycles generated by the seasonal hydrologic behavior of these lagoon systems. This study determined the diversity of the genus Vibrio in 4 coastal bodies of water on the Yucatan Peninsula (Celestun Lagoon, Chelem Lagoon, Rosada Lagoon and Sabancuy Estuary). Using the molecular technique of 454 pyrosequencing, DNA extracted from water samples was analyzed and 32,807 reads were obtained belonging to over 20 culturable species of the genus Vibrio and related genera. OTU (operational taxonomic unit) richness and Chao2 and Shannon Weaver diversity indices were obtained with the database from this technique. Physicochemical and environmental parameters were determined and correlated with Vibrio diversity measured in OTUs.	[Ortiz-Carrillo, Icela; Eloisa Estrella-Gomez, Neyi; Zamudio-Maya, Marcela; Rojas-Herrera, Rafael] Univ Autonoma Yucatan, Fac Ingn Quim, Merida 97203, Yucatan, Mexico	Universidad Autonoma de Yucatan	Rojas-Herrera, R (corresponding author), Univ Autonoma Yucatan, Fac Ingn Quim, Perifer Norte Km 33-5,Tablaje Catastral 13615, Merida 97203, Yucatan, Mexico.	rafael.rojas@correo.uady.mx	Rojas Herrera, Rafael Antonio/HHS-2493-2022	Rojas Herrera, Rafael Antonio/0000-0001-8551-2336	FOMIX Yucatan project "Aprovechamiento sustentable del acuifero de Yucatan mediante tecnologia metagenomica para la busqueda de productos biotecnologicos con potencial de alto impacto economico" [0165026]; FOMIX Campeche [200896537]; CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [78008]	FOMIX Yucatan project "Aprovechamiento sustentable del acuifero de Yucatan mediante tecnologia metagenomica para la busqueda de productos biotecnologicos con potencial de alto impacto economico"; FOMIX Campeche; CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work partially was supported by a grant from FOMIX Yucatan project 0165026 "Aprovechamiento sustentable del acuifero de Yucatan mediante tecnologia metagenomica para la busqueda de productos biotecnologicos con potencial de alto impacto economico" and FOMIX Campeche-200896537. Ortiz-Carrillo I was supported during this work by a doctoral fellowship (78008) from CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico).	Asplund ME, 2011, ENVIRON MICROBIOL, V13, P2738, DOI 10.1111/j.1462-2920.2011.02545.x; Bacaro G, 2012, ECOL COMPLEX, V12, P63, DOI 10.1016/j.ecocom.2012.05.007; Baffone W, 2006, ENVIRON MICROBIOL, V8, P1299, DOI 10.1111/j.1462-2920.2006.01011.x; Ceccarelli D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00256; Chan CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072498; Criminger JD, 2007, APPL ENVIRON MICROB, V73, P5959, DOI 10.1128/AEM.00981-07; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Eiler A, 2006, APPL ENVIRON MICROB, V72, P6004, DOI 10.1128/AEM.00917-06; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gonzalez FUT, 2008, ESTUAR COAST SHELF S, V76, P418, DOI 10.1016/j.ecss.2007.07.025; Gonzalez S, 2001, REV BIOL TROP, V49, P31; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Grimes DJ, 2009, MICROB ECOL, V58, P447, DOI 10.1007/s00248-009-9578-9; Herrera SJ, 2006, SOC VENEZ ECOL ECOT, V19, P94; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Johnson CN, 2010, APPL ENVIRON MICROB, V76, P7076, DOI 10.1128/AEM.00697-10; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Martinez-Urtaza J, 2012, ISME J, V6, P994, DOI 10.1038/ismej.2011.156; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Nichols DS, 2003, FEMS MICROBIOL LETT, V219, P1, DOI 10.1016/S0378-1097(02)01200-4; Nishiguchi MK, 2000, APPL ENVIRON MICROB, V66, P3550, DOI 10.1128/AEM.66.8.3550-3555.2000; Nyholm SV, 2008, VIE MILIEU, V58, P175; Ramamurthy T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00091; Riemann L, 2002, APPL ENVIRON MICROB, V68, P5554, DOI 10.1128/AEM.68.11.5554-5562.2002; Rojas-Herrera R, 2008, MOL BIOTECHNOL, V40, P13, DOI 10.1007/s12033-008-9061-8; Romalde JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00413; Schembri Mark A, 2002, Sci STKE, V2002, pre6; Soto W, 2009, MICROB ECOL, V57, P140, DOI 10.1007/s00248-008-9412-9; Soto W, 2014, FRONT MICROBIOL, V5; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Takemura AE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00038; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Thompson JR, 2006, BIOLOGY OF VIBRIOS, P190; Urakawa H, 2006, BIOLOGY OF VIBRIOS, P175; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	44	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134953	10.1371/journal.pone.0134953	http://dx.doi.org/10.1371/journal.pone.0134953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252792	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100088
J	Chialepeh, NW; Sathiyasusuman, A				Chialepeh, Wilson N.; Sathiyasusuman, A.			Associated Risk Factors of STIs and Multiple Sexual Relationships among Youths in Malawi	PLOS ONE			English	Article							HIV-INFECTION; YOUNG MEN; TRANSMISSION; HIV/AIDS; BEHAVIOR; PARTNERSHIP; PREVENTION; ATTITUDES; CARE	Background Having unprotected sex with multiple sexual partners (MSP) is the greatest risk factor for human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs) among youths. Young people with MSPs are less likely to use a condom and the greater the risk for STIs. This study examines the associated risk factors of STIs and multiple sexual partnerships among youths aged 15-24 years. Data and Methods The Malawi Demographic Health Survey 2010 data was used. Out of a sample of 2,987 males and 9,559 females aged 15-24 years, 2,026 males and 6,470 females were considered in the study. Chi square test and logistic regression techniques were performed. Analysis was performed using Statistical Package for Social Sciences (SPSS) version 22. Findings The results indicate that 1,399 (69.0%) males and 2,290 (35.4%) females reported multiple sexual partnerships (MSP). Within the rural area, females (n = 1779) were more likely to report MSP than males (n = 1082) and within the urban areas, a higher proportion of females (n = 511) still reported MSP, with males (n = 316). About 78% rural females aged 20-24 years, and about 79% rural males aged 15-19 years reported MSP. The likelihood of MSP was higher among females in the poorest households (OR = 1.31), being married (OR = 5.71) and Catholic males (OR = 1.63), who were married (OR = 1.59). Catholic males (OR = 1.82) in the rural areas, who were married (OR = 1.80) and rural females in the northern region (OR = 1.26) were more likely to have MSP. The odds ratios were higher among urban females in the poorest (OR = 3.45) households who were married (OR = 4.22). Conclusions Having more than one sexual partner increases the risk of STIs and sexuality education programs should be introduced that emphasize the danger that surrounds MSP.	[Chialepeh, Wilson N.; Sathiyasusuman, A.] Univ Western Cape, Dept Stat & Populat Studies, Cape Town, South Africa	University of the Western Cape	Sathiyasusuman, A (corresponding author), Univ Western Cape, Dept Stat & Populat Studies, Cape Town, South Africa.	sappunni@uwc.ac.za	Ningpuanyeh, Wilson/AAT-1808-2021		Research Development Office, University of the Western Cape, Bellville, Cape Town, South Africa	Research Development Office, University of the Western Cape, Bellville, Cape Town, South Africa	Article writing fellowships were received from the Research Development Office, University of the Western Cape, 7535 Bellville, Cape Town, South Africa.	Amon E, 2011, J PUBLIC HLTH; Ankomah A, 2011, ADOLESC HEALTH MED T, V2, P75, DOI 10.2147/AHMT.S23649; [Anonymous], 2010, JOINT UN PROGR AIDS; Benefo KD, 2008, ARCH SEX BEHAV, V37, P517, DOI 10.1007/s10508-007-9243-7; Borne F., 2005, TRYING SURVIVE TIMES; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Chow EPF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-549; Cohen D, 2014, 27 HIV DEV PROGR; Cox CM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003680; Dimbuene ZT, 2014, GLOBAL HLTH ACTION, V7; Dorina O., 2014, J PUBLIC HLTH, V6, P1; Durevall D, 2012, WORLD DEV, V40, P1435, DOI 10.1016/j.worlddev.2011.12.003; Exavery A, 2015, SOCIO DEMOGRAPHIC DR, V7, P105; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Kagimu M, 2012, AFR HEALTH SCI, V12, P17; Kalichman SC, 2007, SEX TRANSM INFECT, V83, P371, DOI 10.1136/sti.2006.023630; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Kimuna SR, 2005, INT FAM PLAN PERSPEC, V31, P83, DOI 10.1363/3108305; Kongnyuy Eugene J, 2006, BMC Int Health Hum Rights, V6, P11, DOI 10.1186/1472-698X-6-11; Kongnyuy EJ, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-7; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lurie MN, 2006, J ETHN MIGR STUD, V32, P649, DOI 10.1080/13691830600610056; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Macro International, 2011, MAL DEM HLTH SURV 20; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Masatu MC, 2009, AIDS BEHAV, V13, P94, DOI 10.1007/s10461-007-9292-x; Mavhu W, 2011, AIDS CARE, V23, P52, DOI 10.1080/09540121.2010.490257; Mishra V, 2009, CONCURRENT PARTNERSH; Mishra V., 2009, ROLE PARTNER REDUCTI; Morris M, 2007, SEXUAL NETWORKS CONC; Munthali AC, 2004, 15 AL GUTTM I; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; National Statistical Office (NSO) and ICF Macro, 2011, MAL DEM HLTH SURV 20; Newcomb ME, 2014, ARCH SEX BEHAV, V43, P61, DOI 10.1007/s10508-013-0207-9; Nikula M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-256; Ningpuanyeh WC, 2014, J ASIAN AFRICA STUDI; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; NSO MACRO, 2000, DEM HLTH SURV 2000; Olaniran AA, 2013, J COMMUNITY MED PRIM, V25, P11; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Oster E, 2005, Q J ECON, V120, P467; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Shelton JD, 2009, LANCET, V374, P367, DOI 10.1016/S0140-6736(09)61399-4; Tarkang E, 2009, KNOWL ATT PERC REG H; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; Uchudi J, MULTILEVEL ANAL DETE; UNGASS, 2010, MAL HIV AIDS MON EV; Uthman Olalekan A, 2008, BMC Int Health Hum Rights, V8, P9, DOI 10.1186/1472-698X-8-9; Wiseman C, 2009, MULTIPLE CONCURRENT; Yi S, 2014, AM J PUBLIC HLTH RES, V2, P211, DOI DOI 10.12691/AJPHR-2-5-5; Zuma K., 2014, AFR J REPROD HEALTH, V14, P47	53	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134286	10.1371/journal.pone.0134286	http://dx.doi.org/10.1371/journal.pone.0134286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26248328	Green Published, gold			2022-12-26	WOS:000359062300031
J	Crane, EK; Kwan, SY; Izaguirre, DI; Tsang, YTM; Mullany, LK; Zu, ZF; Richards, JS; Gershenson, DM; Wong, KK				Crane, Erin K.; Kwan, Suet-Yan; Izaguirre, Daisy I.; Tsang, Yvonne T. M.; Mullany, Lisa K.; Zu, Zhifei; Richards, JoAnne S.; Gershenson, David M.; Wong, Kwong-Kwok			Nutlin-3 alpha: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas	PLOS ONE			English	Article							CANCER-CELLS; P53 PATHWAY; MUTATIONS; TUMOR; LINE; PATHOGENESIS; LIPOSARCOMA; EXPRESSION; MODELS; ORIGIN	Epithelial ovarian cancer is a diverse molecular and clinical disease, yet standard treatment is the same for all subtypes. TP53 mutations represent a node of divergence in epithelial ovarian cancer histologic subtypes and may represent a therapeutic opportunity in subtypes expressing wild type, including most low-grade ovarian serous carcinomas, ovarian clear cell carcinomas and ovarian endometrioid carcinomas, which represent approximately 25% of all epithelial ovarian cancer. We therefore sought to investigate Nutlin-3a-a therapeutic which inhibits MDM2, activates wild-type p53, and induces apoptosis-as a therapeutic compound for TP53 wild-type ovarian carcinomas. Fifteen epithelial ovarian cancer cell lines of varying histologic subtypes were treated with Nutlin-3a with determination of IC50 values. Western Blot (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) analyses quantified MDM2, p53, and p21 expression after Nutlin-3a treatment. DNA from 15 cell lines was then sequenced for TP53 mutations in exons 2-11 including intron-exon boundaries. Responses to Nutlin-3a were dependent upon TP53 mutation status. By qRT-PCR and WB, levels of MDM2 and p21 were upregulated in wild-type TP53 sensitive cell lines, and p21 induction was reduced or absent in mutant cell lines. Annexin V assays demonstrated apoptosis in sensitive cell lines treated with Nutlin-3a. Thus, Nutlin-3a could be a potential therapeutic agent for ovarian carcinomas expressing wild-type TP53 and warrants further investigation.	[Crane, Erin K.; Kwan, Suet-Yan; Izaguirre, Daisy I.; Tsang, Yvonne T. M.; Zu, Zhifei; Gershenson, David M.; Wong, Kwong-Kwok] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA; [Mullany, Lisa K.; Richards, JoAnne S.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kwan, Suet-Yan; Izaguirre, Daisy I.; Wong, Kwong-Kwok] Univ Texas Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Wong, KK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA.	kkwong@mdanderson.org	kwan, suet yan/AAH-3974-2020	Wong, Kwong-Kwok/0000-0002-0375-6669; Izaguirre, Daisy/0000-0002-1038-9051	National Institutes of Health; University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence in Ovarian Cancer [P50 CA08369, CA181808]; MD Anderson's Cancer Center Support Grant [CA016672]; Sara Brown Musselman Fund for Serous Ovarian Cancer Research; National Cancer Institute-Department of Health and Human Services-National Institutes of Health Training of Academic Oncologists Grant [T32 CA101642]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA101642, R01CA181808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence in Ovarian Cancer; MD Anderson's Cancer Center Support Grant; Sara Brown Musselman Fund for Serous Ovarian Cancer Research; National Cancer Institute-Department of Health and Human Services-National Institutes of Health Training of Academic Oncologists Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported in part by grants from the National Institutes of Health, including The University of Texas MD Anderson Cancer Center Specialized Program of Research Excellence in Ovarian Cancer P50 CA08369 (KKW and DMG), grant CA181808 (KKW and JSR), and MD Anderson's Cancer Center Support Grant CA016672 (KKW and DMG); and the Sara Brown Musselman Fund for Serous Ovarian Cancer Research (DMG). E.K.C. was supported by the National Cancer Institute-Department of Health and Human Services-National Institutes of Health Training of Academic Oncologists Grant (T32 CA101642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; BEHRENS BC, 1987, CANCER RES, V47, P414; BENARD J, 1985, CANCER RES, V45, P4970; Bodurka D. C, 2011, RECLASSIFICATION SER; BUICK RN, 1985, CANCER RES, V45, P3668; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Constantinidou A, 2012, LANCET ONCOL, V13, P1070, DOI 10.1016/S1470-2045(12)70457-6; Dal Bo M, 2010, BRIT J HAEMATOL, V150, P237, DOI 10.1111/j.1365-2141.2010.08185.x; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; FREEDMAN RS, 1978, CANCER, V42, P2352, DOI 10.1002/1097-0142(197811)42:5<2352::AID-CNCR2820420536>3.0.CO;2-#; Gershenson DM, 2009, GYNECOL ONCOL, V114, P48, DOI 10.1016/j.ygyno.2009.03.001; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Gilks CB, 2010, J ONCOL, V2010, DOI 10.1155/2010/740968; Henze J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037776; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; King ER, 2011, GYNECOL ONCOL, V123, P13, DOI 10.1016/j.ygyno.2011.06.016; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Moll UM, 2003, MOL CANCER RES, V1, P1001; Morisawa T, 1988, HUM CELL, V1, P347; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1638, DOI 10.1210/en.2011-2131; Nadler-Milbauer M, 2011, J DRUG TARGET, V19, P859, DOI 10.3109/1061186X.2011.622401; Ohnstad HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-211; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Schiavone MB, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.049; Secchiero P, 2011, CURR PHARM DESIGN, V17, P569, DOI 10.2174/138161211795222586; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Tsang YT, 2013, J PATHOL, V231, P449, DOI 10.1002/path.4252; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vatsyayan R, 2011, MOL CARCINOG; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong KK, 2013, GYNECOL ONCOL, V130, P565, DOI 10.1016/j.ygyno.2013.06.016; Xia M, 2011, ONCOGENE, V30, P346, DOI 10.1038/onc.2010.413; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yan X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-92; Yeudall WA, 2012, CARCINOGENESIS, V33, P442, DOI 10.1093/carcin/bgr270; Yuan G, 1999, J BIOL CHEM, V274, P8175, DOI 10.1074/jbc.274.12.8175	48	23	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135101	10.1371/journal.pone.0135101	http://dx.doi.org/10.1371/journal.pone.0135101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248031	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300098
J	Vriens, K; Cools, TL; Harvey, PJ; Craik, DJ; Spincemaille, P; Cassiman, D; Braem, A; Vleugels, J; Nibbering, PH; Drijfhout, JW; De Coninck, B; Cammue, BPA; Thevissen, K				Vriens, Kim; Cools, Tanne L.; Harvey, Peta J.; Craik, David J.; Spincemaille, Pieter; Cassiman, David; Braem, Annabel; Vleugels, Jozef; Nibbering, Peter H.; Drijfhout, Jan Wouter; De Coninck, Barbara; Cammue, Bruno P. A.; Thevissen, Karin			Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; SATIVUS ANTIFUNGAL PROTEIN-2; HUMAN BETA-DEFENSIN-3; AMPHOTERICIN-B; IN-VITRO; NMR; PEPTIDES; ANTIBIOTICS; INFECTIONS; MECHANISMS	Plant defensins are small, cysteine-rich peptides with antifungal activity against a broad range of yeast and fungi. In this study we investigated the antibiofilm activity of a plant defensin from coral bells (Heuchera sanguinea), i.e. HsAFP1. To this end, HsAFP1 was heterologously produced using Pichia pastoris as a host. The recombinant peptide rHsAFP1 showed a similar antifungal activity against the plant pathogen Fusarium culmorum as native HsAFP1 purified from seeds. NMR analysis revealed that rHsAFP1 consists of an alpha-helix and a triple-stranded antiparallel beta-sheet stabilised by four intramolecular disulfide bonds. We found that rHsAFP1 can inhibit growth of the human pathogen Candida albicans as well as prevent C. albicans biofilm formation with a BIC50 (i.e. the minimum rHsAFP1 concentration required to inhibit biofilm formation by 50% as compared to control treatment) of 11.00 +/- 1.70 mu M. As such, this is the first report of a plant defensin exhibiting inhibitory activity against fungal biofilms. We further analysed the potential of rHsAFP1 to increase the activity of the conventional antimycotics caspofungin and amphotericin B towards C. albicans. Synergistic effects were observed between rHsAFP1 and these compounds against both planktonic C. albicans cells and biofilms. Most notably, concentrations of rHsAFP1 as low as 0.53 mu M resulted in a synergistic activity with caspofungin against pre-grown C. albicans biofilms. rHsAFP1 was found non-toxic towards human HepG2 cells up to 40 mu M, thereby supporting the lack of a general cytotoxic activity as previously reported for HsAFP1. A structure-function study with 24-mer synthetic peptides spanning the entire HsAFP1 sequence revealed the importance of the gamma-core and its adjacent regions for HsAFP1 antibiofilm activity. These findings point towards broad applications of rHsAFP1 and its derivatives in the field of antifungal and antibiofilm drug development.	[Vriens, Kim; Cools, Tanne L.; De Coninck, Barbara; Cammue, Bruno P. A.; Thevissen, Karin] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium; [Harvey, Peta J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Spincemaille, Pieter; Cassiman, David] Univ Hosp Leuven, Dept Hepatol, Leuven, Belgium; [Spincemaille, Pieter] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Cassiman, David] Univ Hosp Leuven, Metab Ctr, Leuven, Belgium; [Braem, Annabel; Vleugels, Jozef] Katholieke Univ Leuven, Dept Mat Engn, Leuven, Belgium; [Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Drijfhout, Jan Wouter] Leiden Univ, Med Ctr, Dept Immunohematol & Bloodtransfus, Leiden, Netherlands; [De Coninck, Barbara; Cammue, Bruno P. A.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium	KU Leuven; University of Queensland; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Flanders Institute for Biotechnology (VIB); Ghent University	Cammue, BPA (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Leuven, Belgium.	bruno.cammue@biw.kuleuven.be	Craik, David/B-1695-2010; De Coninck, Barbara/M-9234-2016; Vleugels, Jozef/C-8262-2017; Drijfhout, Jan Wouter/ABA-6318-2021; Braem, Annabel/A-4343-2017; Braem, Annabel/AAX-1845-2021; Thevissen, Karin/B-7003-2015; Cassiman, David/H-6813-2014; harvey, peta/D-2048-2017	Craik, David/0000-0003-0007-6796; De Coninck, Barbara/0000-0002-9349-5086; Vleugels, Jozef/0000-0003-4432-4675; Drijfhout, Jan Wouter/0000-0003-4808-5296; Braem, Annabel/0000-0002-4890-0177; Braem, Annabel/0000-0002-4890-0177; Thevissen, Karin/0000-0003-0275-9072; Cassiman, David/0000-0002-6154-0970; harvey, peta/0000-0003-4735-6242	Fonds Wetenschappelijk Onderzoek-Vlaanderen [G0D5113N, FWO/12A7213N, V400314N]; Agentschap voor Innovatie door Wetenschap en Techniek-Vlaanderen, Belgium [SBO 120005, 111016]; Industrial Research Fund, KU Leuven [IOF/KP/12/002, IOFm/05/022]; National Health and Medical Research Council (Australia) [App 1026501]	Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO); Agentschap voor Innovatie door Wetenschap en Techniek-Vlaanderen, Belgium; Industrial Research Fund, KU Leuven; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from Fonds Wetenschappelijk Onderzoek-Vlaanderen (G0D5113N), Agentschap voor Innovatie door Wetenschap en Techniek-Vlaanderen, Belgium (SBO 120005) and from Industrial Research Fund, KU Leuven (IOF/KP/12/002) to BPAC. KT and KV acknowledge the receipt of a post-doctoral grant from Industrial Research Fund, KU Leuven (IOFm/05/022), and a predoctoral grant from Agentschap voor Innovatie door Wetenschap en Techniek-Vlaanderen, Belgium (111016), respectively. BDC acknowledges the receipt of a postdoctoral fellowship from Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO/12A7213N, V400314N). DJC is supported by a National Health and Medical Research Council (Australia) Fellowship (App 1026501). DC is a fundamental-clinical researcher for Fonds Wetenschappelijk Onderzoek-Vlaanderen. http://www.fwo.be/en/, http://www.iwt.be/, http://www.kuleuven.be/industrieelonderzoeksfonds/ and https://www.nhmrc.gov.au/ are the URLs of Fonds Wetenschappelijk Onderzoek- Vlaanderen, Agentschap voor Innovatie door Wetenschap en Techniek-Vlaanderen, Industrial Research Fund KU Leuven and National Health and Medical Research Council, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00047; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; BRUIX M, 1995, BIOPOLYMERS, V36, P751, DOI 10.1002/bip.360360608; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; Chan YS, 2013, CELL BIOCHEM BIOPHYS, V66, P637, DOI 10.1007/s12013-012-9508-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081456; CLSI, 2008, REF METH BROTH DIL A; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; De Brucker K, 2015, ANTIMICROB AGENTS CH, V59, P3052, DOI 10.1128/AAC.04650-14; De Coninck B, 2013, FUNGAL BIOL REV, V26, P109, DOI 10.1016/j.fbr.2012.10.002; De Cremer K, 2015, ANTIMICROB AGENTS CH, V59, P421, DOI 10.1128/AAC.04229-14; de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013; Delattin N, 2014, J ANTIMICROB CHEMOTH, V69, P1035, DOI 10.1093/jac/dkt449; Delattin N, 2014, FUTURE MED CHEM, V6, P77, DOI [10.4155/FMC.13.189, 10.4155/fmc.13.189]; Desai JV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019729; DeSamblanx GW, 1996, PEPTIDE RES, V9, P262; Dosler S, 2014, PEPTIDES, V62, P32, DOI [10.1016/j.peptides.2014.00.021, 10.1016/j.peptides.2014.09.021]; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09; Goblyos A, 2013, J PHARM SCI-US, V102, P3539, DOI 10.1002/jps.23695; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Huang Q, 2014, MOL MED REP, V10, P825, DOI 10.3892/mmr.2014.2309; Hwang IS, 2013, CURR MICROBIOL, V66, P56, DOI 10.1007/s00284-012-0239-8; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Ikeya T, 2006, MAGN RESON CHEM, V44, pS152, DOI 10.1002/mrc.1815; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Keceli SA, 2014, APMIS, V122, P412, DOI 10.1111/apm.12159; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lam SK, 2013, APPL BIOCHEM BIOTECH, V169, P2165, DOI 10.1007/s12010-013-0129-y; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lee JK, 2013, J ENDODONT, V39, P1625, DOI 10.1016/j.joen.2013.07.035; Lin P, 2015, CURR MICROBIOL, V11, P11; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Maiti Soumitra, 2014, Antimicrob Agents Chemother, V58, P6896, DOI 10.1128/AAC.03628-14; Musiol R, 2014, CURR MED CHEM, V21, P870, DOI 10.2174/0929867321666131218094848; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; Palmer A, 1991, J MAGN RESON, V75, P474; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Poon IKH, 2014, ELIFE, V3, DOI 10.7554/eLife.01808; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2007, CELL MICROBIOL, V9, P1491, DOI 10.1111/j.1462-5822.2006.00887.x; Sagaram US, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082485; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sutton JM, 2014, J SURG RES, V186, P99, DOI 10.1016/j.jss.2013.03.077; Tavares PM, 2008, ANTIMICROB AGENTS CH, V52, P4522, DOI 10.1128/AAC.00448-08; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thevissen K, 2000, MOL PLANT MICROBE IN, V13, P54, DOI 10.1094/MPMI.2000.13.1.54; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016; Thevissen K, 2012, MOL MICROBIOL, V84, P166, DOI 10.1111/j.1365-2958.2012.08017.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Troskie AM, 2014, ANTIMICROB AGENTS CH, V58, P3697, DOI 10.1128/AAC.02381-14; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; van Malenstein H, 2013, CANCER LETT, V329, P74, DOI 10.1016/j.canlet.2012.10.021; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zeidler U, 2013, J ANTIMICROB CHEMOTH, V68, P1285, DOI 10.1093/jac/dks538; Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048	80	56	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0132701	10.1371/journal.pone.0132701	http://dx.doi.org/10.1371/journal.pone.0132701			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248029	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300008
J	Zhang, XF; Zhu, CC; Peng, WJ; Tian, B; Chen, LG; Teng, ZZ; Lu, JP; Sadat, U; Saloner, D; Liu, Q				Zhang, Xuefeng; Zhu, Chengcheng; Peng, Wenjia; Tian, Bing; Chen, Luguang; Teng, Zhongzhao; Lu, Jianping; Sadat, Umar; Saloner, David; Liu, Qi			Scan-Rescan Reproducibility of High Resolution Magnetic Resonance Imaging of Atherosclerotic Plaque in the Middle Cerebral Artery	PLOS ONE			English	Article							MRI; DISEASE; BURDEN; 3T	Purpose To evaluate the scan-rescan reproducibility of high-resolution magnetic resonance imaging (MRI) of middle cerebral artery (MCA) plaque, and calculate the number of subjects needed for future longitudinal clinical studies. Material and Methods Twenty two patients with MCA plaque were scanned twice by a T-2-weighted fast-spin-echo sequence at 3T. Areas and volumes of MCA lumen, total vessel and plaque were quantified and compared between two repeated scans. Agreement and measurement error was quantified by intraclass correlation coefficient (ICC) and coefficient of variance (CV) as defined by standard deviation (SD) of pair wise difference / mean. Sample size needed to detect 5% to 20% changes in area/volume was calculated using 80% power and 5% significance level. Results There was no significant different between the area and volume measurements of two repeated scans (p>0.05) with good agreement (ICC range 0.97-0.98 for area and 0.99 for volume). Relatively small measurement errors were observed with CVs range 6.1%-11.8% for area quantification and 4.9%-8.0% for volume quantification. Volume measurements tended to have 19.7% to 32.2% smaller CVs compared with area measurements. Sample size calculation showed a group of 47 patients was sufficient to detect 5% to 10% changes in MCA area/volume. Conclusion High resolution MRI is feasible for quantifying intracranial plaque area and volume in longitudinal clinical studies with low scan-rescan variability. Volume measurement tends to be more reproducible compared with area measurements.	[Zhang, Xuefeng; Peng, Wenjia; Tian, Bing; Chen, Luguang; Lu, Jianping; Liu, Qi] Changhai Hosp, Dept Radiol, Shanghai, Peoples R China; [Zhu, Chengcheng; Saloner, David] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Teng, Zhongzhao] Univ Cambridge, Dept Radiol, Cambridge, England; [Sadat, Umar] Addenbrookes Hosp, Cambridge Vasc Unit, Cambridge, England	Naval Medical University; University of California System; University of California San Francisco; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zhu, CC (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Chengcheng.Zhu@ucsf.edu; liuqimd@126.com	Zhu, Chengcheng/Q-2225-2019	Zhu, Chengcheng/0000-0001-6898-549X; Saloner, David/0000-0002-6989-8547; Teng, Zhongzhao/0000-0003-3973-6157	NIH [5R01NS059944, 5R01HL114118]; twelfth five-year-plan of medical key project of the People's Liberation Army, China [BWS12J026]; emerging frontier technology joint research program of Shanghai municipal hospital, China [SHDC12013110]; National Nature Science Foundation of China (NSFC) [31470910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); twelfth five-year-plan of medical key project of the People's Liberation Army, China; emerging frontier technology joint research program of Shanghai municipal hospital, China; National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CZ and DS are supported by NIH grants 5R01NS059944 and 5R01HL114118. XZ, WP, BT, LC, JL and QL are supported by the twelfth five-year-plan of medical key project of the People's Liberation Army, China (grant number BWS12J026); the emerging frontier technology joint research program of Shanghai municipal hospital, China (grant number SHDC12013110); and the National Nature Science Foundation of China (NSFC) (grant number 31470910).	Ahn S, 2015, P INT SOC MAG RESON, V23, P3579; Balu N, 2007, MAGN RESON MED, V57, P592, DOI 10.1002/mrm.21160; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Dieleman N, 2014, CIRCULATION, V130, P192, DOI 10.1161/CIRCULATIONAHA.113.006919; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Li L, 2014, RADIOLOGY, DOI DOI 10.1148/RADIOL.14131717; Ma N, 2010, NEUROLOGY, V75, P253, DOI 10.1212/WNL.0b013e3181e8e714; Mugler JP, 2014, J MAGN RESON IMAGING, V39, P745, DOI 10.1002/jmri.24542; Qiao Y, 2014, RADIOLOGY, V271, P534, DOI 10.1148/radiol.13122812; Saam T, 2005, J CARDIOVASC MAGN R, V7, P799, DOI 10.1080/10976640500287703; Swartz RH, 2009, NEUROLOGY, V72, P627, DOI 10.1212/01.wnl.0000342470.69739.b3; van der Kolk AG, 2011, STROKE, V42, P2478, DOI 10.1161/STROKEAHA.111.620443; Wang JN, 2016, MAGN RESON MED, V75, P831, DOI 10.1002/mrm.25667; Xu WH, 2010, ATHEROSCLEROSIS, V212, P507, DOI 10.1016/j.atherosclerosis.2010.06.035; Yang WQ, 2014, EUR J RADIOL, V83, pE49, DOI 10.1016/j.ejrad.2013.10.003; Zhu CC, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0061-5; Zhu XJ, 2013, AM J NEURORADIOL, V34, P1717, DOI 10.3174/ajnr.A3573	19	22	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134913	10.1371/journal.pone.0134913	http://dx.doi.org/10.1371/journal.pone.0134913			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247869	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300077
J	Jablonka, W; Kotsyfakis, M; Mizurini, DM; Monteiro, RQ; Lukszo, J; Drake, SK; Ribeiro, JMC; Andersen, JF				Jablonka, Willy; Kotsyfakis, Michalis; Mizurini, Daniella M.; Monteiro, Robson Q.; Lukszo, Jan; Drake, Steven K.; Ribeiro, Jose M. C.; Andersen, John F.			Identification and Mechanistic Analysis of a Novel Tick-Derived Inhibitor of Thrombin	PLOS ONE			English	Article							HAEMAPHYSALIS-LONGICORNIS; BINDING INHIBITOR; CRYSTAL-STRUCTURE; SALIVARY-GLAND; COMPLEX; ACTIVATION; IXODIDAE; PROTEIN	A group of peptides from the salivary gland of the tick Hyalomma marginatum rufipes, a vector of Crimean Congo hemorrhagic fever show weak similarity to the madanins, a group of thrombin-inhibitory peptides from a second tick species, Haemaphysalis longicornis. We have evaluated the anti-serine protease activity of one of these H. marginatum peptides that has been given the name hyalomin-1. Hyalomin-1 was found to be a selective inhibitor of thrombin, blocking coagulation of plasma and inhibiting S2238 hydrolysis in a competitive manner with an inhibition constant (Ki) of 12 nM at an ionic strength of 150 mM. It also blocks the thrombin-mediated activation of coagulation factor XI, thrombin-mediated platelet aggregation, and the activation of coagulation factor V by thrombin. Hyalomin-1 is cleaved at a canonical thrombin cleavage site but the cleaved products do not inhibit coagulation. However, the C-terminal cleavage product showed non-competitive inhibition of S2238 hydrolysis. A peptide combining the N-terminal parts of the molecule with the cleavage region did not interact strongly with thrombin, but a 24-residue fragment containing the cleavage region and the C-terminal fragment inhibited the enzyme in a competitive manner and also inhibited coagulation of plasma. These results suggest that the peptide acts by binding to the active site as well as exosite I or the autolysis loop of thrombin. Injection of 2.5 mg/kg of hyalomin-1 increased arterial occlusion time in a mouse model of thrombosis, suggesting this peptide could be a candidate for clinical use as an antithrombotic.	[Jablonka, Willy; Ribeiro, Jose M. C.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [Kotsyfakis, Michalis] Acad Sci Czech Republic, Inst Parasitol, CR-37005 Ceske Budejovice, Czech Republic; [Mizurini, Daniella M.; Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil; [Lukszo, Jan] NIAID, Res Technol Branch, NIH, Rockville, MD USA; [Drake, Steven K.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	jandersen@niaid.nih.gov	Monteiro, Robson/GRX-0672-2022; Jablonka, Willy/D-2333-2017; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Kotsyfakis, Michail/G-9525-2014; de Queiroz Monteiro, Robson/M-7097-2019	Monteiro, Robson/0000-0002-5260-2332; Kotsyfakis, Michail/0000-0002-7526-1876; Ribeiro, Jose/0000-0002-9107-0818; Jablonka, Willy/0000-0001-5380-7797	NIAID, National Institutes of Health; Brazilian National Council for Scientific and Technological Development (CNPq); State of Rio de Janeiro Research Foundation (FAPERJ); Grant Agency of the Czech Republic (GACR) [P502/12/2409]; Academy of Sciences of the Czech Republic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Rio de Janeiro Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the NIAID, National Institutes of Health, the Brazilian National Council for Scientific and Technological Development (CNPq) for WJ, RQM and DMM, The State of Rio de Janeiro Research Foundation (FAPERJ) for RQM and DM, the Grant Agency of the Czech Republic (GACR grant P502/12/2409 to MK) and by the Academy of Sciences of the Czech Republic (Jan Evangelista Purkyne Fellowship and Intramural support to MK).	Alarcon-Chaidez FJ, 2007, INSECT BIOCHEM MOLEC, V37, P48, DOI 10.1016/j.ibmb.2006.10.002; Corral-Rodriguez MA, 2010, J MED CHEM, V53, P3847, DOI 10.1021/jm901743x; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Figueiredo AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071866; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2011, J PROTEOMICS, V74, P2892, DOI 10.1016/j.jprot.2011.07.015; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Huntington JA, 2014, THROMB HAEMOSTASIS, V111, P583, DOI 10.1160/TH13-10-0811; Iwanaga S, 2003, EUR J BIOCHEM, V270, P1926, DOI 10.1046/j.1432-1033.2003.03560.x; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Koh CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026367; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Koh CY, 2009, CHEMBIOCHEM, V10, P2155, DOI 10.1002/cbic.200900371; Ma DY, 2013, BLOOD, V122, P4094, DOI 10.1182/blood-2013-08-517474; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; Nakajima C, 2006, J VET MED SCI, V68, P447, DOI 10.1292/jvms.68.447; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; RYDEL TJ, 1994, J BIOL CHEM, V269, P22000; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x	26	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133991	10.1371/journal.pone.0133991	http://dx.doi.org/10.1371/journal.pone.0133991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244557	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400061
J	Siqueira, RP; Barbosa, EDA; Poleto, MD; Righetto, GL; Seraphim, TV; Salgado, RL; Ferreira, JG; Barros, MVD; de Oliveira, LL; Laranjeira, ABA; Almeida, MR; Silva, A; Fietto, JLR; Kobarg, J; de Oliveira, EB; Teixeira, RR; Borges, JC; Yunes, JA; Bressan, GC				Siqueira, Raoni Pais; Barbosa, Everton de Almeida Alves; Poleto, Marcelo Depolo; Righetto, Germanna Lima; Seraphim, Thiago Vargas; Salgado, Rafael Locatelli; Ferreira, Joana Gasperazzo; de Andrade Barros, Marcus Vincius; de Oliveira, Leandro Licursi; Albertoni Laranjeira, Angelo Brunelli; Almeida, Marcia Rogeria; Silva Junior, Abelardo; Rangel Fietto, Juliana Lopes; Kobarg, Joerg; de Oliveira, Eduardo Basilio; Teixeira, Robson Ricardo; Borges, Julio Cesar; Yunes, Jose Andres; Bressan, Gustavo Costa			Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)	PLOS ONE			English	Article							RNA-SPLICING MACHINERY; RICH PROTEIN-KINASE; CHOROIDAL NEOVASCULARIZATION; HIGH-THROUGHPUT; FORCE-FIELD; PHOSPHORYLATION; ANGIOGENESIS; CANCER; FAMILY; IDENTIFICATION	Dysregulation of pre-mRNA splicing machinery activity has been related to the biogenesis of several diseases. The serine/arginine-rich protein kinase family (SRPKs) plays a critical role in regulating pre-mRNA splicing events through the extensive phosphorylation of splicing factors from the family of serine/arginine-rich proteins (SR proteins). Previous investigations have described the overexpression of SRPK1 and SRPK2 in leukemia and other cancer types, suggesting that they would be useful targets for developing novel antitumor strategies. Herein, we evaluated the effect of selective pharmacological SRPK inhibition by N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl)isonicotinamide (SRPIN340) on the viability of lymphoid and myeloid leukemia cell lines. Along with significant cytotoxic activity, the effect of treatments in regulating the phosphorylation of the SR protein family and in altering the expression of MAP2K1, MAP2K2, VEGF and FAS genes were also assessed. Furthermore, we found that pharmacological inhibition of SRPKs can trigger early and late events of apoptosis. Finally, intrinsic tryptophan fluorescence emission, molecular docking and molecular dynamics were analyzed to gain structural information on the SRPK/SRPIN340 complex. These data suggest that SRPK pharmacological inhibition should be considered as an alternative therapeutic strategy for fighting leukemias. Moreover, the obtained SRPK-ligand interaction data provide useful structural information to guide further medicinal chemistry efforts towards the development of novel drug candidates.	[Siqueira, Raoni Pais; Barbosa, Everton de Almeida Alves; Poleto, Marcelo Depolo; Salgado, Rafael Locatelli; Ferreira, Joana Gasperazzo; Almeida, Marcia Rogeria; Rangel Fietto, Juliana Lopes; Bressan, Gustavo Costa] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Righetto, Germanna Lima] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Seraphim, Thiago Vargas; Borges, Julio Cesar] Univ Sao Paulo, Inst Quim, Sao Carlos, SP, Brazil; [de Andrade Barros, Marcus Vincius; Teixeira, Robson Ricardo] Univ Fed Vicosa, Dept Quim, Vicosa, MG, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Albertoni Laranjeira, Angelo Brunelli; Yunes, Jose Andres] Ctr Infantil Boldrini, Campinas, SP, Brazil; [Silva Junior, Abelardo] Univ Fed Vicosa, Dept Vet, Vicosa, MG, Brazil; [Kobarg, Joerg] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Campinas, SP, Brazil; [de Oliveira, Eduardo Basilio] Univ Fed Vicosa, Dept Engn Alimentos, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Bressan, GC (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil.	gustavo.bressan@ufv.br	Kobarg, Jörg/T-4736-2019; Brunelli Albertoni Laranjeira, Angelo/H-3601-2016; de Oliveira, Eduardo Basílio/N-9475-2013; de Oliveira, Leandro Licursi/D-3616-2009; Seraphim, Thiago V/J-9949-2013; Fietto, Juliana Lopes Rangel/AAY-3153-2020; Polêto, Marcelo D./GVU-7635-2022; Borges, Julio C/C-6160-2008	Kobarg, Jörg/0000-0002-9419-0145; de Oliveira, Eduardo Basílio/0000-0002-2329-2507; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Fietto, Juliana Lopes Rangel/0000-0001-6122-1710; Polêto, Marcelo D./0000-0001-9210-690X; Borges, Julio C/0000-0003-4856-748X; Vargas Seraphim, Thiago/0000-0002-8682-8962; Brunelli Albertoni Laranjeira, Angelo/0000-0002-6772-0956; Siqueira, Raoni Pais/0000-0003-3015-1187; Yunes, Jose Andres/0000-0002-1316-3525; Teixeira, Robson R/0000-0003-3181-1108; Barbosa, Everton/0000-0002-2648-9620	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [485011/2012-3]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [CBB-APQ-01637-13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [CAPES/CNPq 552459/2011-9]; Fundacao Arthur Bernardes (FUNARBE)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Arthur Bernardes (FUNARBE)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br/ (CNPq; grant 485011/2012-3 to GCB); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, http://www.fapemig.br/ (FAPEMIG; grant CBB-APQ-01637-13 to GCB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/ (CAPES; grant CAPES/CNPq 552459/2011-9 to JLRF); Fundacao Arthur Bernardes, www.funarbe.org.br/ (FUNARBE; grant FUNARPEX/2014 to GCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin EM, 2011, CANCER CELL, V20, P768, DOI 10.1016/j.ccr.2011.10.016; Anwar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023246; Aubol BE, 2003, BIOCHEMISTRY-US, V42, P12813, DOI 10.1021/bi035200c; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Bourgeois CF, 2004, PROG NUCLEIC ACID RE, V78, P37, DOI 10.1016/S0079-6603(04)78002-2; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Carneiro FRG, 2006, BIOCHEM BIOPH RES CO, V343, P260, DOI 10.1016/j.bbrc.2006.02.140; Cho S, 2011, NUCLEIC ACIDS RES, V39, P9413, DOI 10.1093/nar/gkr663; Clery A, 2013, P NATL ACAD SCI USA, V110, pE2802, DOI 10.1073/pnas.1303445110; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dong ZY, 2013, MOL VIS, V19, P536; Fedorov O, 2011, CHEM BIOL, V18, P67, DOI 10.1016/j.chembiol.2010.11.009; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Gammons MV, 2014, BRIT J CANCER, V111, P477, DOI 10.1038/bjc.2014.342; Gammons MV, 2013, INVEST OPHTH VIS SCI, V54, P6052, DOI 10.1167/iovs.13-12422; Gammons MVR, 2013, INVEST OPHTH VIS SCI, V54, P5797, DOI 10.1167/iovs.13-11634; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Gout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046539; Hagiwara M, 2009, United States Patent, Patent No. [US7569536 B2, 7569536]; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; Hishizawa M, 2005, BRIT J HAEMATOL, V130, P382, DOI 10.1111/j.1365-2141.2005.05619.x; Hong Y, 2011, J BIOL CHEM, V286, P777, DOI 10.1074/jbc.M110.193441; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021; Karakama Y, 2010, ANTIMICROB AGENTS CH, V54, P3179, DOI 10.1128/AAC.00113-10; Kim H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094978, 10.1371/journal.pone.0098043]; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Mavrou A, 2015, ONCOGENE, V34, P4311, DOI 10.1038/onc.2014.360; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naro Chiara, 2013, Int J Cell Biol, V2013, P151839, DOI 10.1155/2013/151839; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Odunsi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051030; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Salesse S, 2004, LEUKEMIA, V18, P727, DOI 10.1038/sj.leu.2403310; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Silva KP, 2013, BBA-PROTEINS PROTEOM, V1834, P351, DOI 10.1016/j.bbapap.2012.08.004; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wu QQ, 2013, J CANCER, V4, P727, DOI 10.7150/jca.7576; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z	55	56	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134882	10.1371/journal.pone.0134882	http://dx.doi.org/10.1371/journal.pone.0134882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244849	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400120
J	Choi, J; Chung, H; Lee, GW; Koh, SK; Chae, SK; Lee, YH				Choi, Jaehyuk; Chung, Hyunjung; Lee, Gir-Won; Koh, Sun-Ki; Chae, Suhn-Kee; Lee, Yong-Hwan			Genome-Wide Analysis of Hypoxia-Responsive Genes in the Rice Blast Fungus, Magnaporthe oryzae	PLOS ONE			English	Article							TRANSCRIPTIONAL RESPONSE; CRYPTOCOCCUS-NEOFORMANS; LOW-OXYGEN; RNA-SEQ; PATHOGENICITY; GRISEA; INFECTION; METABOLISM; EXPRESSION; VIRULENCE	Rice blast fungus, Magnaporthe oryzae, is the most destructive pathogen in the rice-growing area. This fungus has a biotrophic phase early in infection and later switches to a necrotrophic lifestyle. During the biotrophic phase, the fungus competes with its host for nutrients and oxygen. Continuous uptake of oxygen is essential for successful establishment of blast disease of this pathogen. Here, we report transcriptional responses of the fungus to oxygen limitation. Transcriptome analysis using RNA-Seq identified that 1,047 genes were up-regulated in response to hypoxia. Those genes are involved in mycelial development, sterol biosynthesis, and metal ion transport based on hierarchical GO terms, and are well-conserved among three fungal species. In addition, null mutants of two hypoxia-responsive genes were generated and their roles in fungal development and pathogenicity tested. The mutant for the sterol regulatory element-binding protein gene, MoSRE1, exhibited increased sensitivity to a hypoxia-mimicking agent, increased conidiation, and delayed invasive growth within host cells, which is suggestive of important roles in fungal development. However, such defects did not cause any significant decrease in disease severity. The other null mutant, for the alcohol dehydrogenase gene MoADH1, showed no defect in the hypoxia-mimicking condition (using cobalt chloride) and fungal development. Taken together, this comprehensive transcriptional profiling in response to a hypoxic condition with experimental validations would provide new insights into fungal development and pathogenicity in plant pathogenic fungi.	[Choi, Jaehyuk] Incheon Natl Univ, Coll Life Sci & Bioengn, Div Life Sci, Inchon 406772, South Korea; [Chung, Hyunjung; Lee, Yong-Hwan] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Gir-Won; Lee, Yong-Hwan] Seoul Natl Univ, Fungal Bioinformat Lab, Seoul 151921, South Korea; [Koh, Sun-Ki; Chae, Suhn-Kee] Paichai Univ, Dept Biochem, Taejon 302735, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Ctr Fungal Genet Resources, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151921, South Korea; [Lee, Yong-Hwan] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea	Incheon National University; Seoul National University (SNU); Seoul National University (SNU); Pai Chai University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, YH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	yonglee@snu.ac.kr		Lee, Gil-Won/0000-0002-1621-1713; Chae, Suhn-Kee/0000-0003-2164-1053	National Research Foundation of Korea - Korean government [2014R1A2A1A10051434, 2013-010928]; Rural Development Administration, Republic of Korea [PJ011154]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by National Research Foundation of Korea grants funded by the Korean government (2014R1A2A1A10051434 and 2013-010928), and the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ011154) Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barker BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-62; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Camilo CM, 2010, EUKARYOT CELL, V9, P915, DOI 10.1128/EC.00047-10; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Choi J, 2013, NUCLEIC ACIDS RES, V41, pD714, DOI 10.1093/nar/gks1163; Choi J, 2009, FUNGAL GENET BIOL, V46, P243, DOI 10.1016/j.fgb.2008.11.010; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Khang CH, 2010, PLANT CELL, V22, P1388, DOI 10.1105/tpc.109.069666; Khush GS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P1, DOI 10.1007/978-1-4020-9500-9_1; Koga H, 2004, PHYSIOL MOL PLANT P, V64, P67, DOI 10.1016/j.pmpp.2004.07.002; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; MCCLUNG CR, 1989, NATURE, V339, P558, DOI 10.1038/339558a0; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Ober ES, 1996, J EXP BOT, V47, P447, DOI 10.1093/jxb/47.3.447; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Park J, 2014, PLANT PATHOLOGY J, V30, P136, DOI 10.5423/PPJ.OA.02.2014.0018; Park J, 2013, EUKARYOT CELL, V12, P1547, DOI 10.1128/EC.00234-13; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Rijnders JGHM, 2000, NEW PHYTOL, V147, P497, DOI 10.1046/j.1469-8137.2000.00727.x; Rolletschek H, 2002, J EXP BOT, V53, P1099, DOI 10.1093/jexbot/53.371.1099; Sambrook J., 2001, MOL CLONING LAB MANU; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VALENT B, 1991, GENETICS, V127, P87; van Dongen JT, 2003, PLANT PHYSIOL, V131, P1529, DOI 10.1104/pp.102.017202; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zitomer RS, 1997, KIDNEY INT, V51, P507, DOI 10.1038/ki.1997.71	49	9	10	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134939	10.1371/journal.pone.0134939	http://dx.doi.org/10.1371/journal.pone.0134939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241858	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700083
J	Fusaro, M; Carbonare, LD; Dusso, A; Arcidiacono, MV; Valenti, MT; Aghi, A; Pasho, S; Gallieni, M				Fusaro, Maria; Carbonare, Luca Dalle; Dusso, Adriana; Vittoria Arcidiacono, Maria; Valenti, Maria Teresa; Aghi, Andrea; Pasho, Sabina; Gallieni, Maurizio			Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function	PLOS ONE			English	Article							LONG-TERM WARFARIN; VITAMIN-K; VASCULAR CALCIFICATIONS; VERTEBRAL FRACTURES; ORAL ANTICOAGULANTS; MENAQUINONE-4 VITAMIN-K-2; PHYLLOQUINONE VITAMIN-K-1; OSTEOPOROTIC FRACTURE; ELDERLY-PATIENTS; LUMBAR VERTEBRA	Background Warfarin, a widely used anticoagulant, is a vitamin K antagonist impairing the activity of vitamin K-dependent Bone Gla Protein (BGP or Osteocalcin) and Matrix Gla Protein (MGP). Because dabigatran, a new anticoagulant, has no effect on vitamin K metabolism, the aim of this study was to compare the impact of warfarin and dabigatran administration on bone structure and vascular calcification. Methods Rats with normal renal function received for 6 weeks warfarin, dabigatran or placebo. Bone was evaluated immuno-histochemically and hystomorphometrically after double labelling with declomycin and calcein. Aorta and iliac arteries were examined histologically. Results Histomorphometric analysis of femur and vertebrae showed significantly decreased bone volume and increased trabecular separation in rats treated with warfarin. Vertebra analysis showed that the trabecular number was higher in dabigatran treated rats. Osteoblast activity and resorption parameters were similar among groups, except for maximum erosion depth, which was higher in warfarin treated rats, suggesting a higher osteoclastic activity. Therefore, warfarin treatment was also associated with higher bone formation rate/bone surface and activation frequency. Warfarin treatment may cause an increased bone turnover characterized by increased remodelling cycles, with stronger osteoclast activity compared to the other groups. There were no differences among experimental groups in calcium deposition either in aortic or iliac arteries. Conclusions These findings suggest for the first time that dabigatran has a better bone safety profile than warfarin, as warfarin treatment affects bone by reducing trabecular size and structure, increasing turnover and reducing mineralization. These differences could potentially result in a lower incidence of fractures in dabigatran treated patients.	[Fusaro, Maria] Natl Res Council CNR, Neurosci Inst, Padua, Italy; [Carbonare, Luca Dalle; Valenti, Maria Teresa] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy; [Dusso, Adriana; Vittoria Arcidiacono, Maria] IRB Lleida Lleida Inst Biomed Res, Div Expt Nephrol, Lleida, Spain; [Aghi, Andrea] Univ Padua, Nephrol Unit, Padua, Italy; [Pasho, Sabina; Gallieni, Maurizio] Univ Milan, Nephrol & Dialysis Unit, Osped San Carlo Borromeo, Milan, Italy; [Pasho, Sabina; Gallieni, Maurizio] Univ Milan, Dept Clin & Biomed Sci Luigi Sacco, Milan, Italy	University of Verona; Institut de Recerca Biomedica - IRB Lleida; University of Padua; San Carlo Borromeo Hospital; University of Milan; University of Milan; Luigi Sacco Hospital	Fusaro, M (corresponding author), Natl Res Council CNR, Neurosci Inst, Padua, Italy.	dante.lucia@libero.it	Arcidiacono, Maria Vittoria/G-5827-2016; fusaro, maria/R-3386-2016; Dusso, Adriana S/E-8617-2011; Gallieni, Maurizio/H-2895-2019; Fusaro, Maria/AAY-7487-2020; Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Fusaro, Maria/AAA-5509-2019; Arcidiacono, Maria Vittoria/F-9180-2010	Arcidiacono, Maria Vittoria/0000-0002-4209-6245; fusaro, maria/0000-0001-9478-4851; Gallieni, Maurizio/0000-0002-2011-2160; Fusaro, Maria/0000-0001-9478-4851; Arcidiacono, Maria Vittoria/0000-0002-4209-6245; Dalle Carbonare, Luca/0000-0003-3263-6671	Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran)	Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran)	This study was supported by a grant form Boehringer-Ingelheim Pharma, Germany (manufacturer of Dabigatran). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amizuka N, 2009, J ELECTRON MICROSC, V58, P55, DOI 10.1093/jmicro/dfp008; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Azuma K, 2015, J BONE MINER RES, V30, P1245, DOI 10.1002/jbmr.2463; Binkley N, 2007, J BONE MINER RES, V22, P695, DOI 10.1359/JBMR.070208; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; Caraballo PJ, 1999, OSTEOPOROSIS INT, V9, P441, DOI 10.1007/s001980050169; Carbonare LD, 2005, MICRON, V36, P609, DOI 10.1016/j.micron.2005.07.007; Cheung AM, 2008, PLOS MED, V5, P1461, DOI 10.1371/journal.pmed.0050196; Danziger J, 2008, CLIN J AM SOC NEPHRO, V3, P1504, DOI 10.2215/CJN.00770208; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Eastell R, 2006, NAT CLIN PRACT ENDOC, V2, P484, DOI 10.1038/ncpendmet0274; Fusaro M, 2015, CURR VASC PHARMACOL, V13, P248, DOI 10.2174/15701611113119990146; Fusaro M, 2012, J BONE MINER RES, V27, P2271, DOI 10.1002/jbmr.1677; Fusaro M, 2011, CURR VASC PHARMACOL, V9, P763, DOI 10.2174/157016111797484134; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Haffa A, 2000, J BONE MINER RES, V15, P872, DOI 10.1359/jbmr.2000.15.5.872; Hirota Y, 2013, J BIOL CHEM, V288, P33071, DOI 10.1074/jbc.M113.477356; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; Jamal SA, 1998, ANN INTERN MED, V128, P829, DOI 10.7326/0003-4819-128-10-199805150-00006; KIMMEL DB, 1991, CELL MATER, P11; Kruger T, 2013, ARTERIOSCL THROM VAS, V33, P2618, DOI 10.1161/ATVBAHA.113.302244; Lanham-New SA, 2008, P NUTR SOC, V67, P163, DOI 10.1017/S0029665108007003; LIAN JB, 1984, J CLIN INVEST, V73, P1223, DOI 10.1172/JCI111308; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mamdani M, 2003, PHARMACOTHERAPY, V23, P1, DOI 10.1592/phco.23.1.1.31922; McCabe KM, 2013, KIDNEY INT, V83, P835, DOI 10.1038/ki.2012.477; MELLISH RWE, 1991, J BONE MINER RES, V6, P689; MENON RK, 1987, J CLIN ENDOCR METAB, V64, P59, DOI 10.1210/jcem-64-1-59; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; PETTIFOR JM, 1975, J PEDIATR-US, V86, P459; PHILIP WJU, 1995, QJM-INT J MED, V88, P635; PRICE PA, 1987, THROMB RES, V46, P121, DOI 10.1016/0049-3848(87)90212-X; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; SERRE CM, 1995, J BONE MINER RES, V10, P1158; Stangier J, 2009, CLIN APPL THROMB-HEM, V15, p9S, DOI 10.1177/1076029609343004; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Sugiyama T, 2007, J ENDOCRINOL, V194, P213, DOI 10.1677/JOE-07-0119; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; Torbergsen AC, 2015, CLIN NUTR, V34, P101, DOI 10.1016/j.clnu.2014.01.016; VESTERBY A, 1989, BONE, V10, P7, DOI 10.1016/8756-3282(89)90140-3; Weber P, 2001, NUTRITION, V17, P880, DOI 10.1016/S0899-9007(01)00709-2; WEINSTEIN RS, 1994, J BONE MINER RES, V9, P1797	46	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133847	10.1371/journal.pone.0133847	http://dx.doi.org/10.1371/journal.pone.0133847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241483	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700024
J	Hayrapetyan, H; Tempelaars, M; Groot, MN; Abee, T				Hayrapetyan, Hasmik; Tempelaars, Marcel; Groot, Masja Nierop; Abee, Tjakko			Bacillus cereus ATCC 14579 RpoN (Sigma 54) Is a Pleiotropic Regulator of Growth, Carbohydrate Metabolism, Motility, Biofilm Formation and Toxin Production	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; SIGMA(54)-DEPENDENT GENES; TRANSCRIPTIONAL ACTIVATOR; PTS PERMEASE; EXPRESSION; SUBTILIS; BEHAVIOR; THURINGIENSIS; TYPHIMURIUM; SENSITIVITY	Sigma 54 is a transcriptional regulator predicted to play a role in physical interaction of bacteria with their environment, including virulence and biofilm formation. In order to study the role of Sigma 54 in Bacillus cereus, a comparative transcriptome and phenotypic study was performed using B. cereus ATCC 14579 WT, a markerless rpoN deletion mutant, and its complemented strain. The mutant was impaired in many different cellular functions including low temperature and anaerobic growth, carbohydrate metabolism, sporulation and toxin production. Additionally, the mutant showed lack of motility and biofilm formation at air-liquid interphase, and this correlated with absence of flagella, as flagella staining showed only WT and complemented strain to be highly flagellated. Comparative transcriptome analysis of cells harvested at selected time points during growth in aerated and static conditions in BHI revealed large differences in gene expression associated with loss of phenotypes, including significant down regulation of genes in the mutant encoding enzymes involved in degradation of branched chain amino acids, carbohydrate transport and metabolism, flagella synthesis and virulence factors. Our study provides evidence for a pleiotropic role of Sigma 54 in B. cereus supporting its adaptive response and survival in a range of conditions and environments.	[Hayrapetyan, Hasmik; Tempelaars, Marcel; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, NL-6708 WG Wageningen, Netherlands; [Hayrapetyan, Hasmik; Tempelaars, Marcel; Groot, Masja Nierop; Abee, Tjakko] TIFN, NL-6709 PA Wageningen, Netherlands; [Groot, Masja Nierop] Wageningen UR, Food & Biobased Res, NL-6708 WG Wageningen, Netherlands	Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research	Abee, T (corresponding author), Wageningen Univ, Food Microbiol Lab, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.	tjakko.abee@wur.nl	Tempelaars, Marcel/C-5077-2008	Tempelaars, Marcel/0000-0003-0635-5606	TI Food and Nutrition	TI Food and Nutrition	The project is funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The private partners have contributed to the project through regular discussion.	Ali NO, 2001, J BACTERIOL, V183, P2497; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arous S, 2004, MICROBIOL-SGM, V150, P1581, DOI 10.1099/mic.0.26860-0; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Castelijn GAA, 2013, VET MICROBIOL, V161, P305, DOI 10.1016/j.vetmic.2012.07.047; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Dalet K, 2001, MICROBIOL-SGM, V147, P3263, DOI 10.1099/00221287-147-12-3263; Debarbouille M, 1999, J BACTERIOL, V181, P2059, DOI 10.1128/JB.181.7.2059-2066.1999; DEBARBOUILLE M, 1991, P NATL ACAD SCI USA, V88, P9092, DOI 10.1073/pnas.88.20.9092; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Francke C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-385; Gao T, 2015, MICROBIOLOGYOPEN; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Hao B, 2013, APPL MICROBIOL BIOT, V97, P2575, DOI 10.1007/s00253-012-4372-x; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; Hayrapetyan H, 2015, INT J FOOD MICROBIOL, V200, P72, DOI 10.1016/j.ijfoodmicro.2015.02.005; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hwang JK, 2010, J ANIM VET ADV, V9, P3034; Hwang S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-207; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Iyer VS, 2012, J BACTERIOL, V194, P368, DOI 10.1128/JB.06046-11; JONES DHA, 1994, MICROBIOL-SGM, V140, P1035, DOI 10.1099/13500872-140-5-1035; Jones J, 2007, ENVIRON MICROBIOL, V9, P3046, DOI 10.1111/j.1462-2920.2007.01416.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Lindback T, 2012, ENVIRON MICROBIOL, V14, P2233, DOI 10.1111/j.1462-2920.2012.02766.x; Mattila M, 2012, FOOD MICROBIOL, V32, P152, DOI 10.1016/j.fm.2012.05.005; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Mols M, 2013, J APPL MICROBIOL, V115, P689, DOI 10.1111/jam.12278; Mols M, 2011, ENVIRON MICROBIOL, V13, P2835, DOI 10.1111/j.1462-2920.2011.02490.x; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Okada Y, 2006, FEMS MICROBIOL LETT, V263, P54, DOI 10.1111/j.1574-6968.2006.00405.x; Peng Q, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00407; Peng Q, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0306-3; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Rosenfeld E, 2005, CAN J MICROBIOL, V51, P149, DOI [10.1139/w04-132, 10.1139/W04-132]; Saldias MS, 2008, INFECT IMMUN, V76, P1059, DOI 10.1128/IAI.01167-07; Salvetti S, 2007, MICROBIOL-SGM, V153, P2541, DOI 10.1099/mic.0.2006/005553-0; Sana TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076030; Song FP, 2012, FASEB J, V26, P3336, DOI 10.1096/fj.11-197681; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Voort M, 2009, J APPL MICROBIOL, V107, P795, DOI 10.1111/j.1365-2672.2009.04252.x; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Wiegeshoff F, 2006, J BACTERIOL, V188, P3130, DOI 10.1128/JB.188.8.3130-3133.2006; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Wolfe AJ, 2004, APPL ENVIRON MICROB, V70, P2520, DOI 10.1128/AEM.70.4.2520-2524.2004; Xu YB, 2014, FEMS MICROBIOL LETT, V354, P142, DOI 10.1111/1574-6968.12438; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang Z, 2014, J BACTERIOL, V196, P2934, DOI 10.1128/JB.01675-14; Zhu L, 2010, J BACTERIOL, V192, P346, DOI 10.1128/JB.01038-09	62	34	37	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134872	10.1371/journal.pone.0134872	http://dx.doi.org/10.1371/journal.pone.0134872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241851	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700075
J	Rey, MD; Calderon, MC; Rodrigo, MJ; Zacarias, L; Alos, E; Prieto, P				Rey, Maria-Dolores; Calderon, Maria-Carmen; Jesus Rodrigo, Maria; Zacarias, Lorenzo; Alos, Enriqueta; Prieto, Pilar			Novel Bread Wheat Lines Enriched in Carotenoids Carrying Hordeum chilense Chromosome Arms in the ph1b Background	PLOS ONE			English	Article							YELLOW PIGMENT CONTENT; IN-SITU HYBRIDIZATION; GENETIC-CONTROL; DURUM-WHEAT; IDENTIFICATION; FRUIT; LOCUS; BIOSYNTHESIS; VULGARE; BARLEY	The use of crop wild relative species to improve major crops performance is well established. Hordeum chilense has a high potential as a genetic donor to increase the carotenoid content of wheat. Crosses between the 7H(ch) H. chilense substitution lines in wheat and the wheat pairing homoeologous1b (ph1b) mutant allowed the development of wheat-H. chilense translocation lines for both 7H(ch)alpha and 7H(ch)beta chromosome arms in the wheat background. These translocation lines were characterized by in situ hybridization and using molecular markers. In addition, reverse phase chromatography (HPLC) analysis was carried out to evaluate the carotenoid content and both 7H(ch)alpha.7AL and 7AS.7H(ch)beta disomic translocation lines. The carotenoid content in 7H(ch)alpha.7AL and 7AS.7H(ch)beta disomic translocation lines was higher than the wheat-7H(ch) addition line and double amount of carotenoids than the wheat itself. A proteomic analysis confirmed that the presence of chromosome 7H(ch) introgressions in wheat scarcely altered the proteomic profile of the wheat flour. The Psy1 (Phytoene Synthase1) gene, which is the first committed step in the carotenoid biosynthetic pathway, was also cytogenetically mapped on the 7H(ch)alpha chromosome arm. These new wheat-H. chilense translocation lines can be used as a powerful tool in wheat breeding programs to enrich the diet in bioactive compounds.	[Rey, Maria-Dolores; Calderon, Maria-Carmen; Alos, Enriqueta; Prieto, Pilar] CSIC, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain; [Jesus Rodrigo, Maria; Zacarias, Lorenzo] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Prieto, P (corresponding author), CSIC, Inst Agr Sostenible, Dept Mejora Genet Vegetal, Cordoba, Spain.	pilar.prieto@ias.csic.es	Alos, Enriqueta/E-7674-2012; Rodrigo, Maria J/H-7720-2012; Rey, María-Dolores/I-3931-2018; Prieto, Pilar/N-6394-2014; ZACARIAS, LORENZO/W-2510-2018	Alos, Enriqueta/0000-0003-2878-2617; Rodrigo, Maria J/0000-0003-2668-0684; Rey, María-Dolores/0000-0002-6967-8536; Prieto, Pilar/0000-0002-8160-808X; ZACARIAS, LORENZO/0000-0003-3982-8860	ERC [243118]	ERC(European Research Council (ERC)European Commission)	This work was supported by the ERC Starting Grant 243118 (http://www.ias.csic.es/ercstg-superwheatcrops/).	Altenbach Susan B, 2011, BMC Res Notes, V4, P242, DOI 10.1186/1756-0500-4-242; Alvarez JB, 1998, PLANT BREEDING, V117, P287, DOI 10.1111/j.1439-0523.1998.tb01942.x; Atienza SG, 2007, AUST J AGR RES, V58, P767, DOI 10.1071/AR06338; Atienza SG, 2004, PLANT BREEDING, V123, P303, DOI 10.1111/j.1439-0523.2004.00918.x; Britton G., 1998, CAROTENOIDS BIOSYNTH, V3, P384; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Carmona L, 2012, POSTHARVEST BIOL TEC, V74, P108, DOI 10.1016/j.postharvbio.2012.06.021; Carvalho Luiz Joaquim Castelo Branco, 2012, Open Biochem J, V6, P116, DOI 10.2174/1874091X01206010116; Collado-Romero M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00356; De Angelis M, 2008, J AGR FOOD CHEM, V56, P8619, DOI 10.1021/jf8008876; Calderon MD, 2012, PLANT BREEDING, V131, P733, DOI 10.1111/j.1439-0523.2012.02010.x; Dinesh Yadav, 2011, Asian Journal of Biotechnology, V3, P1, DOI 10.3923/ajbkr.2011.1.21; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fosrter BP, 1990, HEREDITY, V65, P99; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fung PK, 2010, CHEM BIODIVERS, V7, P1098, DOI 10.1002/cbdv.200900313; Greer E, 2012, PLANT CELL, V24, P152, DOI 10.1105/tpc.111.094771; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Hagras AAA, 2005, GENES GENET SYST, V80, P147, DOI 10.1266/ggs.80.147; Halvorsen BL, 2002, J NUTR, V132, P461, DOI 10.1093/jn/132.3.461; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hernandez P, 2001, THEOR APPL GENET, V102, P1259, DOI 10.1007/s001220000514; Islam A. K. M. R., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P309; Islam A.K.M.R., 1978, 5 INT WHEAT GENETICS, P365; ISLAM AKMR, 1981, HEREDITY, V46, P161, DOI 10.1038/hdy.1981.24; JIANG JM, 1994, EUPHYTICA, V73, P199, DOI 10.1007/BF00036700; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Lado J, 2015, PHYSL PLANTARUM; Larre C, 2011, J PROTEOMICS, V74, P1279, DOI 10.1016/j.jprot.2011.03.014; LEPAGE M, 1968, CEREAL CHEM, V45, P600; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Martin A, 2005, CYTOGENET GENOME RES, V109, P378, DOI 10.1159/000082423; Martin A, 1998, TRITICEAE III, P377; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Miller T.E., 1982, INDUCED VARIABILITY, P79; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nadolska-Orczyk A, 2009, J APPL GENET, V50, P185, DOI 10.1007/BF03195672; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; OKAMOTO M., 1957, Wheat Information Service, pp; Pedersen C, 1996, GENOME, V39, P93, DOI 10.1139/g96-013; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Prieto P, 2004, HEREDITAS, V141, P122, DOI 10.1111/j.1601-5223.2004.01825.x; Prieto P, 2001, HEREDITAS, V135, P171, DOI 10.1111/j.1601-5223.2001.t01-1-00171.x; Rayburn A. L., 1986, PLANT MOL BIOL REP, V4, P102, DOI [10.1007/BF02732107, DOI 10.1007/BF02732107, /10.1007/BF02732107]; Rey MD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00160; Rey MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107714; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; RILEY RALPH, 1960, HEREDITY, V15, P407, DOI 10.1038/hdy.1960.106; Roder MS, 1998, GENETICS, V149, P2007; Rodrigo MJ, 2004, J AGR FOOD CHEM, V52, P6724, DOI 10.1021/jf049607f; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Rodriguez-Suarez C, 2012, THEOR APPL GENET, V124, P713, DOI 10.1007/s00122-011-1741-2; Rodriguez-Suarez C, 2010, CROP PASTURE SCI, V61, P743, DOI 10.1071/CP10025; Rodriguez-Suarez C, 2014, PLANT MOL BIOL, V84, P659, DOI 10.1007/s11103-013-0160-y; Rodriguez-Suarez C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-200; Rouseff R, 1996, J AGR FOOD CHEM, V44, P2176, DOI 10.1021/jf950631q; Rubiales D, 2000, EUPHYTICA, V115, P221, DOI 10.1023/A:1004097830103; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Sears E. R., 1981, Wheat science - today and tomorrow., P75; Sears E. R., 1958, Proceedings of the X International Congress of Genetics, McGill University, Montreal, Canada, August 20-27, 1958., V2, P258; SEARS ER, 1977, CAN J GENET CYTOL, V19, P585, DOI 10.1139/g77-063; SEARS ER, 1976, ANNU REV GENET, V10, P31, DOI 10.1146/annurev.ge.10.120176.000335; SEARS ER, 1972, CAN J GENET CYTOL, V14, P736; Tasleem-Tahir A, 2011, PROTEOMICS, V11, P371, DOI 10.1002/pmic.201000333; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; vanGijlswijk RPM, 1997, J HISTOCHEM CYTOCHEM, V45, P375, DOI 10.1177/002215549704500305; Wang XW, 2002, CROP SCI, V42, P1365, DOI 10.2135/cropsci2002.1365; Yousafzai FK, 2010, FUNCT INTEGR GENOMIC, V10, P147, DOI 10.1007/s10142-010-0171-6; Zhang CY, 2011, CROP SCI, V51, P1580, DOI 10.2135/cropsci2010.12.0689	70	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134598	10.1371/journal.pone.0134598	http://dx.doi.org/10.1371/journal.pone.0134598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241856	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700051
J	Yen, SY; Chen, SR; Hsieh, J; Li, YS; Chuang, SE; Chuang, HM; Huang, MH; Lin, SZ; Harn, HJ; Chiou, TW				Yen, S-Y; Chen, S-R; Hsieh, J.; Li, Y-S; Chuang, S-E; Chuang, H-M; Huang, M-H; Lin, S-Z; Harn, H-J; Chiou, T-W			Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; BREAST-CANCER METASTASIS; GLIOBLASTOMA-MULTIFORME; ANGELICA-SINENSIS; HUMAN GLIOMAS; IN-VITRO; BUTYLIDENEPHTHALIDE; GROWTH; CELLS; CHEMOTHERAPY	Glioblastoma multiforme (GBM) is the most common and aggressive brain tumour. The neoplasms are difficult to resect entirely because of their highly infiltration property and leading to the tumour edge is unclear. Gliadel wafer has been used as an intracerebral drug delivery system to eliminate the residual tumour. However, because of its local low concentration and short diffusion distance, patient survival improves non-significantly. Ax1 is an essential regulator in cancer metastasis and patient survival. In this study, we developed a controlled-release polyanhydride polymer loading a novel small molecule, n-butylidenephthalide (BP), which is not only increasing local drug concentration and extending its diffusion distance but also reducing tumour invasion, mediated by reducing Axl expression. First, we determined that BP inhibited the expression of Axl in a dose-and time-dependent manner and reduced the migratory and invasive capabilities of GBM cells. In addition, BP downregulated matrix metalloproteinase activity, which is involved in cancer cell invasion. Furthermore, we demonstrated that BP regulated Axl via the extracellular signal-regulated kinases pathway. Epithelial-to-mesenchymal transition (EMT) is related to epithelial cells in the invasive migratory mesenchymal cells that underlie cancer progression; we demonstrated that BP reduced the expression of EMT-related genes. Furthermore, we used the overexpression of Ax1 in GBM cells to prove that Axl is a crucial target in the inhibition of GBM EMT, migration and invasion. In an in vivo study, we demonstrated that BP inhibited tumour growth and suppressed Axl expression in a dose-dependent manner according to a subcutaneous tumour model. Most importantly, in an intracranial tumour model with BP wafer in situ treatment, we demonstrated that the BP wafer not only significantly increased the survival rate but also decreased Axl expression, and inhibited tumour invasion. These results contribute to the development of a BP wafer for a novel therapeutic strategy for treating GBM invasion and increasing survival in clinical subjects.	[Yen, S-Y; Chen, S-R; Li, Y-S; Chiou, T-W] Natl Dong Hwa Univ, Dept Life Sci, Grad Inst Biotechnol, 1,Sec 2,Da Hsueh Rd, Hualien 97401, Taiwan; [Hsieh, J.] Natl Taiwan Univ, Mol Med Program, Taipei 10764, Taiwan; [Chuang, S-E] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chuang, H-M; Huang, M-H] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lin, S-Z] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Lin, S-Z] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Lin, S-Z] China Med Univ, Beigang Hosp, Dept Neurosurg, Yunlin, Taiwan; [Harn, H-J] China Med Univ Hosp, Dept Pathol, 2 Yude Rd, Taichung 40447, Taiwan; [Chiou, T-W] China Med Univ, Dept Med, Taichung, Taiwan	National Dong Hwa University; National Taiwan University; National Health Research Institutes - Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chiou, TW (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Grad Inst Biotechnol, 1,Sec 2,Da Hsueh Rd, Hualien 97401, Taiwan.; Harn, HJ (corresponding author), China Med Univ Hosp, Dept Pathol, 2 Yude Rd, Taichung 40447, Taiwan.	duke_harn@yahoo.com.tw; twchiou@mail.ndhu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020		Ministry of Science and Technology, Taiwan [MOST 103-2320-B-039-021-MY3, MOST 103-2221-E-259-035]; Ministry of Economic Affairs [102-EC-17-A-19-I1-0051]; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan) [MOHW104-TDU-B-212-124-002]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs; Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (Taiwan); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	We are grateful to Shuang-En Chuang for sharing the plasmid of pcDNA3.0-Axl. This study was funded by the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-039-021-MY3, MOST 103-2221-E-259-035), Ministry of Economic Affairs (102-EC-17-A-19-I1-0051), Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002, Taiwan), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002) and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Bezbradica JS, 2009, NAT IMMUNOL, V10, P333, DOI 10.1038/ni.1713; BLACKLOCK JB, 1986, J NEUROSURG, V64, P284, DOI 10.3171/jns.1986.64.2.0284; DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217; Elliott PJ, 1996, EXP NEUROL, V141, P214, DOI 10.1006/exnr.1996.0156; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Harn HJ CS, 2013, J PHARM PHARMACOL, V1, P36; Harn HJ, 2011, NEURO-ONCOLOGY, V13, P635, DOI 10.1093/neuonc/nor021; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Huang MH, 2014, TUMOR BIOL, V35, P4875, DOI 10.1007/s13277-014-1639-0; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; JELSMAN R, 1967, J NEUROSURG, V27, P388, DOI 10.3171/jns.1967.27.5.0388; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lin PC, 2008, J NEUROCHEM, V106, P1017, DOI 10.1111/j.1471-4159.2008.05432.x; Lin PC, 2011, ANN SURG ONCOL, V18, P3514, DOI 10.1245/s10434-011-1644-0; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; SHAPIRO WR, 1987, J NEUROSURG, V66, P313; Tsai NM, 2005, CLIN CANCER RES, V11, P3475, DOI 10.1158/1078-0432.CCR-04-1827; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Tsitlakidis A, 2010, J NEUROSURG, V112, P1020, DOI 10.3171/2009.7.JNS09758; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	30	27	27	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2156	2165		10.1038/onc.2015.277	http://dx.doi.org/10.1038/onc.2015.277			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26257061	hybrid, Green Published			2022-12-26	WOS:000374986000002
J	Tzenaki, N; Aivaliotis, M; Papakonstanti, EA				Tzenaki, Niki; Aivaliotis, Michalis; Papakonstanti, Evangelia A.			Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110 delta phosphoinositide-3 kinase	FASEB JOURNAL			English	Article						tyrosine phosphorylation; tumor suppressor; RhoA; ROCK	TUMOR-SUPPRESSOR; INSULIN-RESISTANCE; PROTEIN STABILITY; PI3K ISOFORMS; PTEN; RHOA; CELL; ACTIVATION; CANCER; FAK	The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor protein is regulated by various mechanisms that are not fully understood. This includes regulation by Tyr phosphorylation by a mechanism that remains elusive. Here, we show that focal adhesion kinase (FAK) phosphorylates PTEN in vitro, in cell-free systems and in cells. Furthermore, by mass spectrometry, we identified Tyr336 on PTEN as being phosphorylated by FAK. Tyr336 phosphorylation increased phosphatase activity, protein-lipid interaction, and protein stability of PTEN. In cells, including primary mouse macrophages and human cancer cell lines, FAK was found to be negatively regulated by p110 delta phosphoinositide-3 kinase (PI3K), whereas the activation of FAK was positively regulated by RhoA-associated kinase (ROCK). Indeed, the phosphorylation of FAK was unexpectedly increased in macrophages derived frommice expressing kinase-dead p110 delta. Pharmacologic inactivation of RhoA/ROCK reduced the phosphorylation of FAK to normal levels in cells with genetically inactivated p110 delta. Likewise, pharmacologic inactivation of FAK reduced the phosphorylation of PTEN in cells expressing kinase-dead p110 delta and restored the functional defects of p110 delta inactivation, including Akt phosphorylation and cell proliferation. This work identifies FAK as a target of p110 delta PI3K that links RhoA with PTEN and establishes for the first time that PTEN is a substrate of FAK-mediated Tyr phosphorylation.	[Tzenaki, Niki; Papakonstanti, Evangelia A.] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; [Aivaliotis, Michalis] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Papakonstanti, EA (corresponding author), Univ Crete, Fac Med, Room 2B-14, Iraklion 71003, Greece.	epapak@med.uoc.gr	; Aivaliotis, Michalis/D-4841-2011	Papakonstanti, Evangelia/0000-0002-7119-6026; Aivaliotis, Michalis/0000-0003-1173-7705	Research Committee of the University of Crete [KA 4059]; Ministry of Education and Religious Affairs, Amaroysioy, Greece [4078]; European Union; BIOSYS research project, Action KRIPIS [MIS-448301, 2013SE01380036]; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission; Seventh Framework Programme [229823]	Research Committee of the University of Crete; Ministry of Education and Religious Affairs, Amaroysioy, Greece; European Union(European Commission); BIOSYS research project, Action KRIPIS; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission; Seventh Framework Programme(European Commission)	The authors are grateful to Nikos Kountourakis for his help with sample preparation for nLC-MS/MS. The authors are also grateful to Shiaw-Yih Lin for the PTEN<SUP>Tyr336F</SUP> plasmid and to Bart Vanhaesebroeck for his critical reading of the manuscript. This work was supported by the Research Committee of the University of Crete (KA 4059) and by the programme National Strategic Reference Framework 2007-2013, "Education & Lifelong Learning" (Action ARISTEIA II, Project No. 4078) of the Ministry of Education and Religious Affairs, Amaroysioy, Greece, cofinanced by Greece and the European Union. Part of this work was supported by the BIOSYS research project, Action KRIPIS, project No. MIS-448301 (2013SE01380036), which was funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, National Strategic Reference Framework 2007-2013)/European Commission, and by the Seventh Framework Programme agreement 229823 Capacities-FP7-REGPOT-2008-1/project "ProFI" (to M.A.).	Aivaliotis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004777; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bisht B, 2007, DIABETOLOGIA, V50, P1058, DOI 10.1007/s00125-007-0591-6; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carr HS, 2013, MOL CELL BIOL, V33, P2773, DOI 10.1128/MCB.00175-13; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chaturvedi LS, 2011, AM J PHYSIOL-CELL PH, V301, pC1224, DOI 10.1152/ajpcell.00518.2010; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Foukas LC, 2013, EMBO MOL MED, V5, P563, DOI 10.1002/emmm.201201953; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Giorgio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018128; Goundiam O, 2012, CELL BIOL INT, V36, P311, DOI 10.1042/CBI20110069; Gupta A, 2012, MOL BIOL CELL, V23, P3882, DOI 10.1091/mbc.E12-05-0337; Harishchandra RK, 2015, METHODS, V77-78, P125, DOI 10.1016/j.ymeth.2015.02.004; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Kostourou V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3020; Koul D, 2002, ONCOGENE, V21, P2357, DOI 10.1038/sj/onc/1205296; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Nakamura J, 2008, BIOCHEM BIOPH RES CO, V374, P699, DOI 10.1016/j.bbrc.2008.07.123; Nelson VLB, 2014, AM J PHYSIOL-ENDOC M, V306, pE1205, DOI 10.1152/ajpendo.00625.2013; Okahara F, 2006, MOL BIOL CELL, V17, P4888, DOI 10.1091/mbc.E06-04-0301; Okkenhaug K, 2002, SCIENCE, V297, P1031; Owen JL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00159; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Parsons R, 2004, SEMIN CELL DEV BIOL, V15, P171, DOI 10.1016/j.semcdb.2003.12.021; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sinnett-Smith J, 2001, EXP CELL RES, V266, P292, DOI 10.1006/excr.2001.5219; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smith GC, 2012, BIOCHEM J, V442, P161, DOI 10.1042/BJ20111913; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Tups A, 2010, J NEUROENDOCRINOL, V22, P534, DOI 10.1111/j.1365-2826.2010.01975.x; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang SY, 2011, AM J PHYSIOL-CELL PH, V300, pC657, DOI 10.1152/ajpcell.00377.2010; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yagi Y, 2006, EUR J PHARMACOL, V536, P19, DOI 10.1016/j.ejphar.2006.02.024; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yim JH, 2007, CELL DEATH DIFFER, V14, P1872, DOI 10.1038/sj.cdd.4402204; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	66	16	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4840	4852		10.1096/fj.15-274589	http://dx.doi.org/10.1096/fj.15-274589			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26251180				2022-12-26	WOS:000365523600011
J	Eisenberg, T; Nicklas, W; Mauder, N; Rau, J; Contzen, M; Semmler, T; Hofmann, N; Aledelbi, K; Ewers, C				Eisenberg, Tobias; Nicklas, Werner; Mauder, Norman; Rau, Joerg; Contzen, Matthias; Semmler, Torsten; Hofmann, Nicola; Aledelbi, Khayrieh; Ewers, Christa			Phenotypic and Genotypic Characteristics of Members of the Genus Streptobacillus	PLOS ONE			English	Article							RAT-BITE FEVER; POLYMERASE-CHAIN-REACTION; COMPLETE GENOME SEQUENCE; HONGKONGENSIS SP NOV.; FUSOBACTERIUM-NUCLEATUM; INFRARED-SPECTROSCOPY; PHYLOGENETIC ANALYSIS; FOURIER-TRANSFORM; RIBOSOMAL-RNA; MONILIFORMIS	The genus Streptobacillus (S.) remained monotypic for almost 90 years until two new species were recently described. The type species, S. moniliformis, is one of the two etiological agents of rat bite fever, an under-diagnosed, worldwide occurring zoonosis. In a polyphasic approach field isolates and reference strains of S. moniliformis, S. hongkongensis, S. felis as well as divergent isolates were characterized by comparison of molecular data (n = 29) and from the majority also by their physiological as well as proteomic properties (n = 22). Based on growth-independent physiological profiling using VITEK2-compact, API ZYM and the Micronaut system fastidious growth-related difficulties could be overcome and streptobacilli could definitively be typed despite generally few differences. While differing in their isolation sites and dates, S. moniliformis isolates were found to possess almost identical spectra in matrix-assisted laser desorption ionization-time of flight mass spectrometry and Fourier transform infrared spectroscopy. Spectroscopic methods facilitated differentiation of S. moniliformis, S. hongkongensis and S. felis as well as one divergent isolate. Sequencing of 16S rRNA gene as well as functional genes groEL, recA and gyrB revealed only little intraspecific variability, but generally proved suitable for interspecies discrimination between all three taxa and two groups of divergent isolates.	[Eisenberg, Tobias] Hessian State Lab, Dept Vet Med, Giessen, Germany; [Nicklas, Werner] German Canc Res Ctr, Heidelberg, Germany; [Mauder, Norman; Rau, Joerg; Contzen, Matthias] Chem & Vet Invest Off CVUA Stuttgart, Fellbach, Germany; [Semmler, Torsten] Robert Koch Inst, Berlin, Germany; [Hofmann, Nicola] Leibniz Univ Hannover, Inst Multiphase Proc, Hannover, Germany; [Aledelbi, Khayrieh] Merlin Diagnost, Bornheim, Germany; [Ewers, Christa] Inst Hyg & Infect Dis Anim, Giessen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Robert Koch Institute; Leibniz University Hannover	Eisenberg, T (corresponding author), Hessian State Lab, Dept Vet Med, Giessen, Germany.	tobias.eisenberg@lhl.hessen.de	Semmler, Torsten/O-9540-2019; Mauder, Norman/W-6685-2019; Semmler, Torsten/Q-7716-2018; Ewers, Christa/AAL-9186-2020; Eisenberg, Tobias/AAL-9117-2020	Semmler, Torsten/0000-0002-2225-7267; Mauder, Norman/0000-0001-7366-2054; Semmler, Torsten/0000-0002-2225-7267; Eisenberg, Tobias/0000-0002-2888-5475; Ewers, Christa/0000-0001-6167-1340	Hessian Ministry for the Environment, Climate Change, Agriculture and Consumer Protection (HMUKLV); Merlin Diagnostika	Hessian Ministry for the Environment, Climate Change, Agriculture and Consumer Protection (HMUKLV); Merlin Diagnostika	The Hessian State Laboratory (Hessisches Landeslabor) is supported by Hessian Ministry for the Environment, Climate Change, Agriculture and Consumer Protection (HMUKLV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merlin Diagnostika provided support in the form of a salary for author KA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-269; [Anonymous], 2013, 2013M100S23 CLSI; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Berger C, 2001, PEDIATR INFECT DIS J, V20, P1181, DOI 10.1097/00006454-200112000-00021; Bleich A, 2008, BERL MUNCH TIERARZTL, V121, P241, DOI 10.2376/0005-9366-121-241; Boot R, 2002, LAB ANIM-UK, V36, P200, DOI 10.1258/0023677021912352; BOOT R, 1993, LAB ANIM, V27, P350, DOI 10.1258/002367793780745516; COHEN RL, 1968, APPL MICROBIOL, V16, P1655, DOI 10.1128/AEM.16.11.1655-1662.1968; Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493; COSTAS M, 1987, J MED MICROBIOL, V23, P303, DOI 10.1099/00222615-23-4-303; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Ditchfield J, 1961, Can Vet J, V2, P457; EDWARDS R, 1986, J MED MICROBIOL, V21, P39, DOI 10.1099/00222615-21-1-39; Eisenberg T, 2015, INT J SYST IN PRESS; Eisenberg T., 2014, J CLIN MICROBIOL CAS, V2014, P1; Elliott SP, 2007, CLIN MICROBIOL REV, V20, P13, DOI 10.1128/CMR.00016-06; Gaastra W, 2009, VET MICROBIOL, V133, P211, DOI 10.1016/j.vetmic.2008.09.079; Glasman PJ., 2009, BMJ Case Rep, V2009, DOI [10.1136/bcr.04.2009.1795, DOI 10.1136/BCR.04.2009.1795]; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Greenwood JR, 2006, PROKARYOTES HDB BIOL, V7, P983; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon-Smith M, 2010, STAND GENOMIC SCI, V2, P220, DOI 10.4056/sigs.811799; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayashimoto N, 2008, J VET MED SCI, V70, P493, DOI 10.1292/jvms.70.493; Helm D., 1991, MICROBIOLOGY, V137, P69; Hofmann N., 1994, THESIS LEIBNIZ U HAN; HOPKINSON WI, 1981, AUST VET J, V57, P533, DOI 10.1111/j.1751-0813.1981.tb05802.x; Jalava J, 1999, INT J SYST BACTERIOL, V49, P1375, DOI 10.1099/00207713-49-4-1375; Jin J, 2004, J VET MED SCI, V66, P1243, DOI 10.1292/jvms.66.1243; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HS, 2010, J CLIN MICROBIOL, V48, P545, DOI 10.1128/JCM.01631-09; Kimura M, 2008, MICROBIOL IMMUNOL, V52, P9, DOI 10.1111/j.1348-0421.2008.00005.x; Kondruweit M, 2007, J THORAC CARDIOV SUR, V134, P1579, DOI 10.1016/j.jtcvs.2007.08.010; Kuhm AE, 2009, APPL ENVIRON MICROB, V75, P5809, DOI 10.1128/AEM.00206-09; LAMBE DW, 1973, AM J CLIN PATHOL, V60, P854; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; LAWSON PA, 1991, INT J SYST BACTERIOL, V41, P347, DOI 10.1099/00207713-41-3-347; Levaditi C, 1925, CR HEBD ACAD SCI, V180, P1188; Loridant S, 2011, AM J TROP MED HYG, V84, P306, DOI 10.4269/ajtmh.2011.10-0466; MANAFI M, 1991, MICROBIOL REV, V55, P335, DOI 10.1128/MMBR.55.3.335-348.1991; Nakagomi D, 2008, J DERMATOL, V35, P667, DOI 10.1111/j.1346-8138.2008.00541.x; Nolan M, 2009, STAND GENOMIC SCI, V1, P300, DOI 10.4056/sigs.48727; Pins MR, 1996, CLIN INFECT DIS, V22, P471, DOI 10.1093/clinids/22.3.471; Rau J, 2009, BERL MUNCH TIERARZTL, V122, P25, DOI 10.2376/0005-9366-122-25; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rohde J, 2008, PRAKT TIERARZT, V89, P466; ROUGHGARDEN JW, 1965, ARCH INTERN MED, V116, P39, DOI 10.1001/archinte.1965.03870010041007; ROWBOTHAM TJ, 1983, LANCET, V2, P567; RYGG M, 1992, SCAND J INFECT DIS, V24, P535, DOI 10.3109/00365549209052641; SCHLEIFER KH, 1983, ANNU REV MICROBIOL, V37, P143, DOI 10.1146/annurev.mi.37.100183.001043; Shah HN, 2009, ANAEROBE, V15, P179, DOI 10.1016/j.anaerobe.2009.08.003; SMITH C D, 1960, Am J Med Technol, V26, P47; Strauss J, 2008, ANAEROBE, V14, P301, DOI 10.1016/j.anaerobe.2008.12.003; Sun DB, 2013, RES VET SCI, V95, P27, DOI 10.1016/j.rvsc.2013.01.016; Torres L, 2003, EUR J CLIN MICROBIOL, V22, P258, DOI 10.1007/s10096-003-0891-9; Wallet F, 2003, DIAGN MICR INFEC DIS, V47, P623, DOI 10.1016/S0732-8893(03)00167-6; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Washburn R. G., 1995, PRINCIPLES PRACTICE, V2, P2084; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Wellinghausen N, 2007, J CLIN MICROBIOL, V45, P789, DOI 10.1128/JCM.01856-06; Wittler RG, 1974, BERGEYS MANUAL DETER, P378; Woo PCY, 2014, INT J SYST EVOL MICR, V64, P3034, DOI 10.1099/ijs.0.061242-0; Woo PCY, 2010, J ZHEJIANG UNIV-SC B, V11, P391, DOI 10.1631/jzus.B1000056; WULLENWEBER M, 1992, J EXP ANIM SCI, V35, P49; WULLENWEBER M, 1990, LAB ANIM SCI, V40, P608; WULLENWEBER M, 1995, LAB ANIM, V29, P1, DOI 10.1258/002367795780740375; Wullenweber M, 1991, AALAS B, V30, P43; YAMAMOTO R, 1966, VET REC, V79, P95, DOI 10.1136/vr.79.4.95	69	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134312	10.1371/journal.pone.0134312	http://dx.doi.org/10.1371/journal.pone.0134312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252790	Green Published, gold			2022-12-26	WOS:000359121100048
J	Yu, PK; Balaratnasingam, C; Xu, J; Morgan, WH; Mammo, Z; Han, S; Mackenzie, P; Merkur, A; Kirker, A; Albiani, D; Sarunic, MV; Yu, DY				Yu, Paula K.; Balaratnasingam, Chandrakumar; Xu, Jing; Morgan, William H.; Mammo, Zaid; Han, Sherry; Mackenzie, Paul; Merkur, Andrew; Kirker, Andrew; Albiani, David; Sarunic, Marinko V.; Yu, Dao-Yi			Label-Free Density Measurements of Radial Peripapillary Capillaries in the Human Retina	PLOS ONE			English	Article							NERVE-FIBER LAYER; SELECTIVE ATROPHY; VISUAL-FIELD; BLOOD-FLOW; NETWORKS; GLAUCOMA; MICROVASCULATURE; THICKNESS; FLUORESCEIN	Radial peripapillary capillaries (RPCs) comprise a unique network of capillary beds within the retinal nerve fibre layer (RNFL) and play a critical role in satisfying the nutritional requirements of retinal ganglion cell (RGC) axons. Understanding the topographical and morphological characteristics of these networks through in vivo techniques may improve our understanding about the role of RPCs in RGC axonal health and disease. This study utilizes a novel, non-invasive and label-free optical imaging technique, speckle variance optical coherence tomography (svOCT), for quantitatively studying RPC networks in the human retina. Six different retinal eccentricities from 16 healthy eyes were imaged using svOCT. The same eccentricities were histologically imaged in 9 healthy donor eyes with a confocal scanning laser microscope. Donor eyes were subject to perfusion-based labeling techniques prior to retinal dissection, flat mounting and visualization with the microscope. Capillary density and diameter measurements from each eccentricity in svOCT and histological images were compared. Data from svOCT images were also analysed to determine if there was a correlation between RNFL thickness and RPC density. The results are as follows: (1) The morphological characteristics of RPC networks on svOCT images are comparable to histological images; (2) With the exception of the nasal peripapillary region, there were no significant differences in RPC density measurements between svOCT and histological images; (3) Capillary diameter measurements were significantly greater in svOCT images compared to histology; (4) There is a positive correlation between RPC density and RNFL thickness. The findings in this study suggest that svOCT is a reliable modality for analyzing RPC networks in the human retina. It may therefore be a valuable tool for aiding our understanding about vasculogenic mechanisms that are involved in RGC axonopathies. Further work is required to explore the reason for some of the quantitative differences between svOCT and histology.	[Yu, Paula K.; Balaratnasingam, Chandrakumar; Morgan, William H.; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Yu, Paula K.; Balaratnasingam, Chandrakumar; Morgan, William H.; Yu, Dao-Yi] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia; [Xu, Jing; Han, Sherry; Mackenzie, Paul; Sarunic, Marinko V.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC V5A 1S6, Canada; [Balaratnasingam, Chandrakumar; Mammo, Zaid; Mackenzie, Paul; Merkur, Andrew; Kirker, Andrew; Albiani, David] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	University of Western Australia; Lions Eye Institute; University of Western Australia; Simon Fraser University; University of British Columbia	Yu, DY (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia.	dyyu@lei.org	Yu, Paula/B-8486-2008	Yu, Paula/0000-0003-4951-5630; Sarunic, Marinko/0000-0002-5636-9056; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical research Council of Australia; MSFHR; NSERC; CIHR; Brain Canada	National Health and Medical research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MSFHR(Michael Smith Foundation for Health Research); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Brain Canada	Funding provided by National Health and Medical research Council of Australia, MSFHR, NSERC, CIHR, and Brain Canada.	ALTERMAN M, 1968, BRIT J OPHTHALMOL, V52, P26, DOI 10.1136/bjo.52.1.26; [Anonymous], 2010, ENCY EYE; ASHTON N, 1970, BRIT MED BULL, V26, P143, DOI 10.1093/oxfordjournals.bmb.a070766; Balaratnasingam C, 2014, EXP EYE RES, V121, P11, DOI 10.1016/j.exer.2014.02.008; Breidablik A, 2012, ACTA ANAESTH SCAND, V56, P1066, DOI 10.1111/j.1399-6576.2012.02732.x; Chan G, 2015, MICROVASC RES, V100, P32, DOI 10.1016/j.mvr.2015.04.006; Chan G, 2013, INVEST OPHTH VIS SCI, V54, P5175, DOI 10.1167/iovs.13-11945; Chui TYP, 2012, BIOMED OPT EXPRESS, V3, P2537, DOI 10.1364/BOE.3.002537; DAICKER B, 1975, A GRAEF ARCH KLIN EX, V195, P27, DOI 10.1007/BF02390027; ELLIS CG, 1994, CIRC RES, V75, P357, DOI 10.1161/01.RES.75.2.357; Godara P, 2010, OPTOMETRY VISION SCI, V87, P930, DOI 10.1097/OPX.0b013e3181ff9a8b; Gullstand A, 1909, OPTICAL SOC AM, V1924, P351; HENKIND PAUL, 1967, INVEST OPHTHALMOL, V6, P103; Hwang JC, 2012, INVEST OPHTH VIS SCI, V53, P3020, DOI 10.1167/iovs.11-8552; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Katz M, 2012, DUANES OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2011.08.001, DOI 10.1016/J.OPHTHA.2011.08.001]; Kim JM, 2012, INVEST OPHTH VIS SCI, V53, P5609, DOI 10.1167/iovs.12-9783; KORNZWEIG AL, 1968, ARCH OPHTHALMOL-CHIC, V80, P696; Le Grand Y, 1980, PHYSL OPTICS, V1st; Lee S, 2013, INVEST OPHTH VIS SCI, V54, P2864, DOI 10.1167/iovs.12-11521; Matsuyama M, 1975, Nippon Ganka Gakkai Zasshi, V79, P331; Mendis KR, 2010, INVEST OPHTH VIS SCI, V51, P5864, DOI 10.1167/iovs.10-5333; Obrist D, 2010, PHILOS T R SOC A, V368, P2897, DOI 10.1098/rsta.2010.0045; Peppiatt C, 2004, NATURE, V431, P137, DOI 10.1038/431137a; Pinhas A, 2014, INVEST OPHTH VIS SCI, V55, P8056, DOI 10.1167/iovs.14-15136; RADER J, 1994, AM J OPHTHALMOL, V117, P72, DOI 10.1016/S0002-9394(14)73017-X; Scoles D, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-9; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Tong JB, 2010, CURR EYE RES, V35, P425, DOI 10.3109/02713680903514675; Ueno H, 1976, Nippon Ganka Gakkai Zasshi, V80, P267; WELLS RE, 1966, SCIENCE, V151, P995, DOI 10.1126/science.151.3713.995; Xu J, 2015, BR J OPHTHALMOL; Xu J, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.026001; Yu DY, 2013, PROG RETIN EYE RES, V36, P217, DOI 10.1016/j.preteyeres.2013.07.001; Yu PK, 2014, EXP EYE RES, V129, P83, DOI 10.1016/j.exer.2014.10.020; Yu PK, 2010, INVEST OPHTH VIS SCI, V51, P6735, DOI 10.1167/iovs.10-5415; Yu PK, 2010, INVEST OPHTH VIS SCI, V51, P447, DOI 10.1167/iovs.09-3978; Zheng YF, 2009, INVEST OPHTH VIS SCI, V50, P4091, DOI 10.1167/iovs.09-3444	38	47	49	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135151	10.1371/journal.pone.0135151	http://dx.doi.org/10.1371/journal.pone.0135151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252395	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100124
J	Abe, A; Nishimura, R; Tanaka, N; Kurushima, J; Kuwae, A				Abe, Akio; Nishimura, Ryutaro; Tanaka, Naomichi; Kurushima, Jun; Kuwae, Asaomi			The Bordetella Secreted Regulator BspR Is Translocated into the Nucleus of Host Cells via Its N-Terminal Moiety: Evaluation of Bacterial Effector Translocation by the Escherichia coli Type III Secretion System	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; IN-VIVO; BRONCHISEPTICA; PERTUSSIS; PROTEINS; GENE; STARVATION; VIRULENCE; DOMAIN	Bordetella bronchiseptica is genetically related to B. pertussis and B. parapertussis, which cause respiratory tract infections in humans. These pathogens possess a large number of virulence factors, including the type III secretion system (T3SS), which is required for the delivery of effectors into the host cells. In a previous study, we identified a transcriptional regulator, BspR, that is involved in the regulation of the T3SS-related genes in response to iron-starved conditions. A unique feature of BspR is that this regulator is secreted into the extracellular milieu via the T3SS. To further characterize the role of BspR in extracellular localization, we constructed various truncated derivatives of BspR and investigated their translocation into the host cells using conventional translocation assays. In this study, the effector translocation was evaluated by the T3SS of enteropathogenic E. coli (EPEC), since the exogenous expression of BspR triggers severe repression of the Bordetella T3SS expression. The results of the translocation assays using the EPEC T3SS showed that the N-terminal 150 amino acid (aa) residues of BspR are sufficient for translocation into the host cells in a T3SS-dependent manner. In addition, exogenous expression of BspR in HeLa cells demonstrated that the N-terminal 100 aa residues are involved in the nuclear localization. In contrast, the N-terminal 54 aa residues are sufficient for the extracellular secretion into the bacterial culture supernatant via the EPEC T3SS. Thus, BspR is not only a transcriptional regulator in bacteria cytosol, but also functions as an effector that translocates into the nuclei of infected host cells.	[Abe, Akio; Nishimura, Ryutaro; Tanaka, Naomichi; Kurushima, Jun; Kuwae, Asaomi] Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan	Kitasato University	Abe, A (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Tokyo 1088641, Japan.	abe@lisci.kitasato-u.ac.jp	Abe, Akio/AAQ-2464-2020	Kurushima, Jun/0000-0002-8573-6169	MEXT/JSPS KAKENHI [24390108, 25670215, 26460535]; Kitasato University Research Grant; Oyama Health Foundation; Naito Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University Research Grant; Oyama Health Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by MEXT/JSPS KAKENHI (www.jsps.go.jp) Grant Number 24390108 (AA), 25670215 (AA), 26460535 (AK), by a Grant-in-Aid from the Kitasato University Research Grant (www.kitasato-u.ac.jp) for Young Researchers 2005 (AK), 2006 (AK), by a research grant from Oyama Health Foundation (http://www.disclo-koeki.org/10a/01044/index.html) 2011 (AK), and by a research grant from The Naito Foundation (www.naito-f.or.jp/en/) 2012 (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Azar WJ, 2014, ONCOGENE, V33, P578, DOI 10.1038/onc.2012.630; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Brickman TJ, 2011, J BACTERIOL, V193, P4798, DOI 10.1128/JB.05136-11; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; Dworkin MS, 1999, CLIN INFECT DIS, V28, P1095, DOI 10.1086/514761; Gueneron M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/j.1365-2958.2000.01870.x; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Kurushima J, 2012, MICROBIOL IMMUNOL, V56, P356, DOI 10.1111/j.1348-0421.2012.00442.x; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Kuwae A, 2001, J BIOL CHEM, V276, P32230, DOI 10.1074/jbc.M103831200; Kuwae A, 2003, CELL MICROBIOL, V5, P973, DOI 10.1046/j.1462-5822.2003.00341.x; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; Matsuzawa T, 2005, INFECT IMMUN, V73, P6283, DOI 10.1128/IAI.73.10.6283-6289.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mattoo S, 2004, MOL MICROBIOL, V52, P1201, DOI 10.1111/j.1365-2958.2004.04053.x; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Miki T, 2009, J BACTERIOL, V191, P6843, DOI 10.1128/JB.00863-09; Molloy S, 2012, NAT REV MICROBIOL, V10, P236, DOI 10.1038/nrmicro2777; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135140	10.1371/journal.pone.0135140	http://dx.doi.org/10.1371/journal.pone.0135140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247360	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300103
J	Ehehalt, F; Sturm, D; Rosler, M; Distler, M; Weitz, J; Kersting, S; Ludwig, B; Schwanebeck, U; Saeger, HD; Solimena, M; Gruetzmann, R				Ehehalt, Florian; Sturm, Dorothee; Roesler, Manuela; Distler, Marius; Weitz, Juergen; Kersting, Stephan; Ludwig, Barbara; Schwanebeck, Uta; Saeger, Hans-Detlev; Solimena, Michele; Gruetzmann, Robert			Blood Glucose Homeostasis in the Course of Partial Pancreatectomy - Evidence for Surgically Reversible Diabetes Induced by Cholestasis	PLOS ONE			English	Article							METABOLIC SYNDROME; ALANINE AMINOTRANSFERASE; INSULIN SENSITIVITY; RISK; PREDICTS; ENZYMES; CANCER; PREVALENCE; DIAGNOSIS; MELLITUS	Background and Aim Partial pancreatic resection is accompanied not only by a reduction in the islet cell mass but also by a variety of other factors that are likely to interfere with glucose metabolism. The aim of this work was to characterize the patient dynamics of blood glucose homeostasis during the course of partial pancreatic resection and to specify the associated clinico-pathological variables. Methods In total, 84 individuals undergoing elective partial pancreatic resection were consecutively recruited into this observational trial. The individuals were assigned based on their fasting glucose or oral glucose tolerance testing results into one of the following groups: (I) deteriorated, (II) stable or (III) improved glucose homeostasis three months after surgery. Co-variables associated with blood glucose dynamics were identified. Results Of the 84 participants, 25 (30%) displayed a normal oGTT, 17 (20%) showed impaired glucose tolerance, and 10 (12%) exhibited pathological glucose tolerance. Elevated fasting glucose was present in 32 (38%) individuals before partial pancreatic resection. Three months after partial pancreatic resection, 14 (17%) patients deteriorated, 16 (19%) improved, and 54 (64%) retained stable glucose homeostasis. Stability and improvement was associated with tumor resection and postoperative normalization of recently diagnosed glucose dysregulation, preoperatively elevated tumor markers and markers for common bile duct obstruction, acute pancreatitis and liver cell damage. Improvement was linked to preoperatively elevated insulin resistance, which normalized after resection and was accompanied by a decrease in fasting- and glucose-stimulated insulin secretion. Conclusions Surgically reversible blood glucose dysregulation diagnosed concomitantly with a (peri-) pancreatic tumor appears secondary to compromised liver function due to tumor compression of the common bile duct and the subsequent increase in insulin resistance. It can be categorized as "cholestasis-induced diabetes" and thereby distinguished from other forms of hyperglycemic disorders.	[Ehehalt, Florian; Sturm, Dorothee; Distler, Marius; Weitz, Juergen; Kersting, Stephan; Saeger, Hans-Detlev; Gruetzmann, Robert] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept GI Thorac & Vasc Surg, Dresden, Germany; [Ehehalt, Florian; Sturm, Dorothee; Roesler, Manuela; Kersting, Stephan; Ludwig, Barbara; Saeger, Hans-Detlev; Solimena, Michele] Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Ehehalt, Florian; Sturm, Dorothee; Roesler, Manuela; Kersting, Stephan; Ludwig, Barbara; Saeger, Hans-Detlev; Solimena, Michele] Tech Univ Dresden, Fac Med, Dresden, Germany; [Ehehalt, Florian; Roesler, Manuela; Kersting, Stephan; Ludwig, Barbara; Saeger, Hans-Detlev; Solimena, Michele] German Ctr Diabet Res DZD EV, Neuherberg, Germany; [Schwanebeck, Uta] Tech Univ Dresden, Coordinat Ctr Clin Trials, Dresden, Germany; [Ludwig, Barbara] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 3, Dresden, Germany; [Solimena, Michele] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Solimena, M (corresponding author), Tech Univ Dresden, Paul Langerhans Inst Dresden, Helmholtz Ctr Munich, Univ Hosp Carl Gustav Carus, Dresden, Germany.	michele.solimena@tu-dresden.de; robert.gruetzmann@uniklinikum-dresden.de	Kersting, Stephan/AAQ-1889-2020; Kersting, Stephan/ABG-2973-2020; Weitz, Juergen/L-7136-2018; Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011	Kersting, Stephan/0000-0002-2124-3103; 	German Center for Diabetes Research; German Ministry for Education and Research; Innovative Medicines Initiative Joint Undertaking [155005]; European Union	German Center for Diabetes Research; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission)	The work leading to this publication received support from the German Center for Diabetes Research, which is supported by the German Ministry for Education and Research, and from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 155005 (IMIDIA), the resources of which are composed of financial contributions from the European Union's Seventh Framework Program (FP7/2007-2013) and the kind contributions from EFPIA companies.	Basso D, 2006, CLIN CHIMICA ACTA; Bradley David, 2012, Gastroenterology, V143, P897, DOI 10.1053/j.gastro.2012.07.114; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Chari ST, 2008, GASTROENTEROLOGY, V134, P95, DOI 10.1053/j.gastro.2007.10.040; Cho NH, 2007, DIABETES CARE, V30, P2566, DOI 10.2337/dc07-0106; Hanley AJG, 2005, DIABETES, V54, P3140, DOI 10.2337/diabetes.54.11.3140; Hardt PD, 2008, DIABETES CARE, V31, pS165, DOI 10.2337/dc08-s244; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Litwin J, 2008, PANCREAS, V36, P26, DOI 10.1097/mpa.0b013e318137aa61; Mari A, 2005, CURR OPIN CLIN NUTR, V8, P529, DOI 10.1097/01.mco.0000171130.23441.59; Meisterfeld R, 2008, EXP CLIN ENDOCR DIAB, V116, pS7, DOI 10.1055/s-2008-1080918; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Menge BA, 2012, METABOLISM, V61, P620, DOI 10.1016/j.metabol.2011.09.019; Mori Y, 2012, PANCREAS, V41, P455, DOI 10.1097/MPA.0b013e3182319d7c; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; PERMERT J, 1993, BRIT J SURG, V80, P1047, DOI 10.1002/bjs.1800800841; Perry IJ, 1998, DIABETES CARE, V21, P732, DOI 10.2337/diacare.21.5.732; Nguyen QM, 2011, DIABETES CARE, V34, P2603, DOI 10.2337/dc11-0919; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Saruc M, 2003, PANCREAS, V26, P381, DOI 10.1097/00006676-200305000-00012; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Wu JM, 2013, ANN SURG ONCOL, V20, P242, DOI 10.1245/s10434-012-2577-y; Yalniz M, 2005, LANGENBECK ARCH SURG, V390, P66, DOI 10.1007/s00423-004-0469-8	30	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134140	10.1371/journal.pone.0134140	http://dx.doi.org/10.1371/journal.pone.0134140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248027	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300028
J	Epa, AP; Thatcher, TH; Pollock, SJ; Wahl, LA; Lyda, E; Kottmann, RM; Phipps, RP; Sime, PJ				Epa, Amali P.; Thatcher, Thomas H.; Pollock, Stephen J.; Wahl, Lindsay A.; Lyda, Elizabeth; Kottmann, R. M.; Phipps, Richard P.; Sime, Patricia J.			Normal Human Lung Epithelial Cells Inhibit Transforming Growth Factor-beta Induced Myofibroblast Differentiation via Prostaglandin E-2	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; THYROID EYE DISEASE; FIBROBLAST PROLIFERATION; E-PROSTANOID-2 RECEPTOR; ORBITAL FIBROBLASTS; GAMMA LIGANDS; IN-VITRO; EXPRESSION; BLEOMYCIN; PROTEIN	Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease with very few effective treatments. The key effector cells in fibrosis are believed to be fibroblasts, which differentiate to a contractile myofibroblast phenotype with enhanced capacity to proliferate and produce extracellular matrix. The role of the lung epithelium in fibrosis is unclear. While there is evidence that the epithelium is disrupted in IPF, it is not known whether this is a cause or a result of the fibroblast pathology. We hypothesized that healthy epithelial cells are required to maintain normal lung homeostasis and can inhibit the activation and differentiation of lung fibroblasts to the myofibroblast phenotype. To investigate this hypothesis, we employed a novel co-culture model with primary human lung epithelial cells and fibroblasts to investigate whether epithelial cells inhibit myofibroblast differentiation. Measurements and Main Results In the presence of transforming growth factor (TGF)-beta, fibroblasts co-cultured with epithelial cells expressed significantly less alpha-smooth muscle actin and collagen and showed marked reduction in cell migration, collagen gel contraction, and cell proliferation compared to fibroblasts grown without epithelial cells. Epithelial cells from non-matching tissue origins were capable of inhibiting TGF-beta induced myofibroblast differentiation in lung, keloid and Graves' orbital fibroblasts. TGF-beta promoted production of prostaglandin (PG) E-2 in lung epithelial cells, and a PGE(2) neutralizing antibody blocked the protective effect of epithelial cell co-culture. Conclusions We provide the first direct experimental evidence that lung epithelial cells inhibit TGF-beta induced myofibroblast differentiation and pro-fibrotic phenotypes in fibroblasts. This effect is not restricted by tissue origin, and is mediated, at least in part, by PGE(2). Our data support the hypothesis that the epithelium plays a crucial role in maintaining lung homeostasis, and that damaged and/or dysfunctional epithelium contributes to the development of fibrosis.	[Epa, Amali P.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Pathol, Rochester, NY 14642 USA; [Epa, Amali P.; Thatcher, Thomas H.; Pollock, Stephen J.; Wahl, Lindsay A.; Kottmann, R. M.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Epa, Amali P.; Thatcher, Thomas H.; Wahl, Lindsay A.; Lyda, Elizabeth; Kottmann, R. M.; Sime, Patricia J.] Univ Rochester, Dept Med, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Pollock, Stephen J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Sime, PJ (corresponding author), Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, 601 Elmwood Ave, Rochester, NY 14642 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041; Pollock, Stephen/0000-0002-2091-1675	Pulmonary Fibrosis Foundation; Greg Chandler and Guy F. Solimano Fibrosis Research Fund; Parker B. Francis Fellowship;  [HL066988];  [ES001247];  [UL1TR000042];  [TL1TR000096]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096, UL1TR000042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	Pulmonary Fibrosis Foundation; Greg Chandler and Guy F. Solimano Fibrosis Research Fund; Parker B. Francis Fellowship; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Sources of Support: HL066988, ES001247, UL1TR000042, TL1TR000096, the Pulmonary Fibrosis Foundation and The Greg Chandler and Guy F. Solimano Fibrosis Research Fund. RMK was also supported in part by a Parker B. Francis Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GD, 1996, J CLIN INVEST, V97, P2672, DOI 10.1172/JCI118717; ANTONIADES HN, 1990, J CLIN INVEST, V86, P1055, DOI 10.1172/JCI114808; Baglole CJ, 2005, METH MOLEC MED, V117, P115; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brecht K, 2011, FASEB J, V25, P2408, DOI 10.1096/fj.10-179473; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; DIAZ A, 1989, J BIOL CHEM, V264, P11554; Feldon SE, 2005, INVEST OPHTH VIS SCI, V46, P3913, DOI 10.1167/iovs.05-0605; Ferguson HE, 2009, AM J PHYSIOL-LUNG C, V297, pL912, DOI 10.1152/ajplung.00148.2009; Gabasa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065445; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Ivanova V, 2013, EUR J PHARM BIOPHARM, V84, P335, DOI 10.1016/j.ejpb.2012.11.023; Jeon KI, 2014, AM J PATHOL, V184, P1429, DOI 10.1016/j.ajpath.2014.01.026; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; KAPANCI Y, 1995, AM J RESP CRIT CARE, V152, P2163, DOI 10.1164/ajrccm.152.6.8520791; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KLIEN JH, 1989, LAB INVEST, V60, P808; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Kuriyan AE, 2013, INVEST OPHTH VIS SCI, V54, P7370, DOI 10.1167/iovs.13-12741; Lama V, 2002, AM J RESP CELL MOL, V27, P752, DOI 10.1165/rcmb.4857; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Manning CM, 2013, RADIAT RES, V179, P617, DOI 10.1667/RR3279.1; Marneros Alexander G, 2004, J Dtsch Dermatol Ges, V2, P905, DOI 10.1046/j.1439-0353.2004.04077.x; McAnulty RJ, 1997, BIOCHEM J, V321, P639, DOI 10.1042/bj3210639; MCANULTY RJ, 1995, BIOCHEM J, V307, P63, DOI 10.1042/bj3070063; Mio T, 1998, AM J PHYSIOL-LUNG C, V274, pL119, DOI 10.1152/ajplung.1998.274.1.L119; MNICH SJ, 1995, J IMMUNOL, V155, P4437; Olsen KC, 2014, AM J RESP CELL MOL, V50, P737, DOI 10.1165/rcmb.2013-0092OC; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Padilla J, 2000, J IMMUNOL, V165, P6941, DOI 10.4049/jimmunol.165.12.6941; Pan TL, 2001, AM J RESP CELL MOL, V25, P353, DOI 10.1165/ajrcmb.25.3.4004; Perl AKT, 2011, AM J RESP CRIT CARE, V183, P511, DOI 10.1164/rccm.201005-0744OC; Petkova DK, 2003, HISTOPATHOLOGY, V43, P381, DOI 10.1046/j.1365-2559.2003.01718.x; Portnoy J, 2006, AM J PHYSIOL-LUNG C, V290, pL307, DOI 10.1152/ajplung.00102.2005; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Selman Moises, 2006, Proc Am Thorac Soc, V3, P364, DOI 10.1513/pats.200601-003TK; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wei B, 2014, MOLECULES, V19, P4967, DOI 10.3390/molecules19044967; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412	61	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135266	10.1371/journal.pone.0135266	http://dx.doi.org/10.1371/journal.pone.0135266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248335	Green Submitted, gold, Green Published			2022-12-26	WOS:000359062300111
J	Koh, JH; Jung, SM; Lee, JJ; Kang, KY; Kwok, SK; Park, SH; Ju, JH				Koh, Jung Hee; Jung, Seung Min; Lee, Jennifer Jooha; Kang, Kwi Young; Kwok, Seung-Ki; Park, Sung-Hwan; Ju, Ji Hyeon			Radiographic Structural Damage Is Worse in the Dominant than the Non-Dominant Hand in Individuals with Early Rheumatoid Arthritis	PLOS ONE			English	Article							PROSPECTIVE FOLLOW-UP; BONE-MINERAL DENSITY; JOINT DAMAGE; OSTEOARTHRITIS; PROGRESSION; ASSOCIATION; SHARP/VAN; HEIJDE	Objective The relationship between mechanical stress and radiographic progression in rheumatoid arthritis (RA) is unclear. The assumption is that mechanical stress is greater in the dominant hand. Therefore, the aim of the present study was to compare the presence and progression of erosions and joint space narrowing (JSN) in the dominant and non-dominant hand. Methods Data from 194 patients recently diagnosed with seropositive RA, and with hand radiographs taken at the time of diagnosis and at 2-year follow-up, were analyzed retrospectively. Radiographs were scored using the van der Heijde-modified Sharp Score (HSS) method. Each joint group within each hand was rated separately by two independent examiners in a double-blinded manner. Results One hundred and ninety-four patients were enrolled (80% female, 88% positive rheumatoid factor, 92% positive anti-citrullinated protein antibody, and 95.4% right-handed). The baseline, follow-up erosion and JSN HSS were significantly higher in the dominant hand than in the non-dominant hand. The annual rate of radiographic progression was also higher in the dominant hand. The erosive progression in the wrist joints varied significantly according to handedness, but the erosion in the proximal interphalangeal joints and metacarpophalangeal joints was similar in both hands. The radiographic progression was associated with the dominant hand, an abnormal baseline C-reactive protein level, and joint damage at baseline. There was no significant difference in bone mineral density between the right and left hands. Conclusion Radiological damage was worse and progressed faster in the dominant hand, suggesting that mechanical stress is associated with radiographic joint damage in early and active RA.	[Koh, Jung Hee; Jung, Seung Min; Lee, Jennifer Jooha; Kang, Kwi Young; Kwok, Seung-Ki; Park, Sung-Hwan; Ju, Ji Hyeon] Catholic Univ Korea, Dept Internal Med, Coll Med, Div Rheumatol, Seoul, South Korea	Catholic University of Korea	Ju, JH (corresponding author), Catholic Univ Korea, Dept Internal Med, Coll Med, Div Rheumatol, Seoul, South Korea.	juji@catholic.ac.kr		Koh, Jung Hee/0000-0002-6617-1449	Korea Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092258]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2013R1A1A1076125]	Korea Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by a grant from the Korea Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (A092258) and by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2013R1A1A1076125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON RM, 1970, ANN RHEUM DIS, V29, P275, DOI 10.1136/ard.29.3.275; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BERGENUDD H, 1989, CLIN ORTHOP RELAT R, P306; Berglin E, 2003, RHEUMATOLOGY, V42, P268, DOI 10.1093/rheumatology/keg077; Bijsterbosch J, 2011, ANN RHEUM DIS, V70, P68, DOI 10.1136/ard.2010.133017; BLAND JH, 1968, ARTHRITIS RHEUM, V11, P72, DOI 10.1002/art.1780110110; Brandt KD, 2008, RHEUM DIS CLIN N AM, V34, P531, DOI 10.1016/j.rdc.2008.05.011; Bruynesteyn K, 2002, ARTHRITIS RHEUM-US, V46, P913, DOI 10.1002/art.10190; Butz KD, 2012, COMPUT METHOD BIOMEC, V15, P131, DOI 10.1080/10255842.2010.517525; Caspi D, 2001, SEMIN ARTHRITIS RHEU, V30, P321, DOI 10.1053/sarh.2001.19957; Devlin J, 1996, BRIT J RHEUMATOL, V35, P1256; Fex E, 1996, BRIT J RHEUMATOL, V35, P1106; Funck-Brentano T, 2009, RHEUMATOLOGY, V48, P1515, DOI 10.1093/rheumatology/kep279; GLICK EN, 1967, BRIT MED J, V3, P26, DOI 10.1136/bmj.3.5556.26; Graudal N, 2000, J RHEUMATOL, V27, P47; Graudal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106408; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Guler-Yuksel M, 2009, ANN RHEUM DIS, V68, P330, DOI 10.1136/ard.2007.086348; Jung HS, 2009, ERGONOMICS, V52, P1362, DOI 10.1080/00140130903067805; Knevel R, 2013, ANN RHEUM DIS, V72, P345, DOI 10.1136/annrheumdis-2012-201391; Machold KP, 2007, RHEUMATOLOGY, V46, P342, DOI 10.1093/rheumatology/kel237; Moon SJ, 2013, J KOREAN MED SCI, V28, P287, DOI 10.3346/jkms.2013.28.2.287; NAKAMURA R, 1993, J HAND SURG-BRIT EUR, V18B, P540, DOI 10.1016/0266-7681(93)90167-E; Odegard S, 2006, ARTHRITIS RHEUM, V54, P68, DOI 10.1002/art.21548; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; THOMPSON M, 1962, ANN RHEUM DIS, V21, P370, DOI 10.1136/ard.21.4.370; van der Heijde D, 2000, J RHEUMATOL, V27, P261; van der Heijde D, 2011, ANN RHEUM DIS, V70, pI116, DOI 10.1136/ard.2010.140525; VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM-US, V35, P26; Visser AW, 2015, ANN RHEUM DIS, V74, P1842, DOI 10.1136/annrheumdis-2013-205012; Wilder FV, 2006, OSTEOARTHR CARTILAGE, V14, P953, DOI 10.1016/j.joca.2006.04.013	32	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135409	10.1371/journal.pone.0135409	http://dx.doi.org/10.1371/journal.pone.0135409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247204	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300112
J	Schwameis, R; Grimm, C; Petru, E; Natter, C; Staudigl, C; Lamm, W; Koelbl, H; Krainer, M; Brodowicz, T; Reinthaller, A; Polterauer, S				Schwameis, Richard; Grimm, Christoph; Petru, Edgar; Natter, Camilla; Staudigl, Christine; Lamm, Wolfgang; Koelbl, Heinz; Krainer, Michael; Brodowicz, Thomas; Reinthaller, Alexander; Polterauer, Stephan			The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; CANCER; OUTCOMES; THERAPY	Objective C-reactive protein (CRP) has previously been shown to serve as a prognostic parameter in women with gynecologic malignancies. Due to the lack of valid prognostic markers for uterine leiomyosarcoma (ULMS) this study set out to investigate the value of pre-treatment CRP serum levels as prognostic parameter. Methods Data of women with ULMS were extracted from databases of three Austrian centres for gynaecologic oncology. Pre-treatment CRP serum levels were measured and correlated with clinico-pathological parameters. Univariate and multivariable survival analyses were performed. Results In total, 53 patients with ULMS were included into the analysis. Mean (SD) CRP serum level was 3.46 mg/dL (3.96). Solely, an association between pre-treatment CRP serum levels and tumor size (p = 0.04) but no other clinic-pathologic parameter such as tumor stage (p = 0.16), or histological grade (p = 0.07), was observed. Univariate and multivariable survival analyses revealed that CRP serum levels (HR 2.7 [1.1-7.2], p = 0.037) and tumor stage (HR 6.1 [1.9-19.5], p = 0.002) were the only independent prognostic factors for overall survival (OS) in patients with ULMS. Patients with high pre-treatment CRP serum levels showed impaired OS compared to women with low levels (5-year-OS rates: 22.6% and 52.3%, p = 0.007). Conclusion High pre-treatment CRP serum levels were independently associated with impaired prognosis in women with ULMS and might serve as a prognostic parameter in these patients.	[Schwameis, Richard; Grimm, Christoph; Natter, Camilla; Koelbl, Heinz; Reinthaller, Alexander; Polterauer, Stephan] Med Univ Vienna, Dept Gen Gynaecol & Gynaecol Oncol, Gynecol Canc Unit, Ctr Comprehens Canc, Vienna, Austria; [Petru, Edgar] Med Univ Graz, Dept Obstet & Gynaecol, Graz, Austria; [Staudigl, Christine] Barmherzige Schwestern Hosp Linz, Dept Gynaecol, Linz, Austria; [Lamm, Wolfgang; Krainer, Michael; Brodowicz, Thomas] Med Univ Vienna, Div Clin Oncol, Dept Med 1, Ctr Comprehens Canc, Vienna, Austria; [Reinthaller, Alexander] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Graz; Konventhospital Der Barmherzigen Bruder; Medical University of Vienna	Polterauer, S (corresponding author), Med Univ Vienna, Dept Gen Gynaecol & Gynaecol Oncol, Gynecol Canc Unit, Ctr Comprehens Canc, Vienna, Austria.	stephan.polterauer@meduniwien.ac.at	Grimm, Christoph/GSJ-3020-2022; Polterauer, Stephan/AAG-1331-2021	Grimm, Christoph/0000-0003-2948-8129; Polterauer, Stephan/0000-0002-9649-4505; Krainer, Michael/0000-0002-7011-4957	Department of General Gynecology and Gynecologic Oncology, Medical University Vienna	Department of General Gynecology and Gynecologic Oncology, Medical University Vienna	This study was supported by the Department of General Gynecology and Gynecologic Oncology, Medical University Vienna.	Brooks BE, 2004, GYNECOL ONCOL, V93, P204, DOI 10.1016/j.ygyno.2003.12.029; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; D'Angelo E, 2010, GYNECOL ONCOL, V116, P131, DOI 10.1016/j.ygyno.2009.09.023; de Maat M P, 2001, Ital Heart J, V2, P189; Dufresne A, 2015, B CANCER, V102, P6, DOI 10.1016/j.bulcan.2014.12.005; Giuntoli RL, 2003, GYNECOL ONCOL, V89, P460, DOI 10.1016/S0090-8258(03)00137-9; Groblewska M, 2012, CLIN CHIM ACTA, V413, P1583, DOI 10.1016/j.cca.2012.05.009; Hefler LA, 2008, CLIN CANCER RES, V14, P710, DOI 10.1158/1078-0432.CCR-07-1044; Hoang HLT, 2014, INT J SURG ONCOL, V2014, DOI 10.1155/2014/919323; Jain S, 2010, INT J CLIN EXP PATHO, V3, P416; Kapp DS, 2008, CANCER-AM CANCER SOC, V112, P820, DOI 10.1002/cncr.23245; Nakamura T, 2012, CANCER-AM CANCER SOC, V118, P1055, DOI 10.1002/cncr.26353; Polterauer S, 2007, GYNECOL ONCOL, V107, P114, DOI 10.1016/j.ygyno.2007.06.001; Prat J, 2009, INT J GYNECOL OBSTET, V104, P177, DOI 10.1016/j.ijgo.2008.12.008; Ramsey S, 2009, MOL DIAGN THER, V13, P277, DOI 10.2165/11315860-000000000-00000; Rutkowski P, 2002, INT J CANCER, V100, P463, DOI 10.1002/ijc.10496; Samuels BL, 2013, ANN ONCOL, V24, P1703, DOI 10.1093/annonc/mds659; Schmid M, 2007, OBSTET GYNECOL, V110, P1231, DOI 10.1097/01.AOG.0000292085.50987.f2; Scurr M, 2011, CURR TREAT OPTION ON, V12, P32, DOI 10.1007/s11864-011-0140-x; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Ueda SM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.075; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wigmore SJ, 2002, INT J ONCOL, V21, P881; Ye XF, 2014, BRIT J CANCER, V111, P2172, DOI 10.1038/bjc.2014.481; Zivanovic O, 2009, J CLIN ONCOL, V27, P2066, DOI 10.1200/JCO.2008.19.8366	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133838	10.1371/journal.pone.0133838	http://dx.doi.org/10.1371/journal.pone.0133838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248232	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300020
J	Zhong, RQ; Yuan, YX; Spiekerman, JJ; Guley, JT; Egbosiuba, JC; Ye, ZH				Zhong, Ruiqin; Yuan, Youxi; Spiekerman, John J.; Guley, Joshua T.; Egbosiuba, Janefrances C.; Ye, Zheng-Hua			Functional Characterization of NAC and MYB Transcription Factors Involved in Regulation of Biomass Production in Switchgrass (Panicum virgatum)	PLOS ONE			English	Article							SECONDARY WALL SYNTHESIS; CELL-WALL; DIRECT TARGET; BIOSYNTHESIS; ARABIDOPSIS; MAIZE; GENES; RICE; SND1; IDENTIFICATION	Switchgrass is a promising biofuel feedstock due to its high biomass production and low agronomic input requirements. Because the bulk of switchgrass biomass used for biofuel production is lignocellulosic secondary walls, studies on secondary wall biosynthesis and its transcriptional regulation are imperative for designing strategies for genetic improvement of biomass production in switchgrass. Here, we report the identification and functional characterization of a group of switchgrass transcription factors, including several NACs (PvSWNs) and a MYB (PvMYB46A), for their involvement in regulating secondary wall biosynthesis. PvSWNs and PvMYB46A were found to be highly expressed in stems and their expression was closely associated with sclerenchyma cells. Overexpression of PvSWNs and PvMYB46A in Arabidopsis was shown to result in activation of the biosynthetic genes for cellulose, xylan and lignin and ectopic deposition of secondary walls in normally parenchymatous cells. Transactivation and complementation studies demonstrated that PvSWNs were able to activate the SNBE-driven GUS reporter gene and effectively rescue the secondary wall defects in the Arabidopsis snd1 nst1 double mutant, indicating that they are functional orthologs of Arabidopsis SWNs. Furthermore, we showed that PvMYB46A could activate the SMRE-driven GUS reporter gene and complement the Arabidopsis myb46 myb83 double mutant, suggesting that it is a functional ortholog of Arabidopsis MYB46/MYB83. Together, these results indicate that PvSWNs and PvMYB46A are transcriptional switches involved in regulating secondary wall biosynthesis, which provides molecular tools for genetic manipulation of biomass production in switchgrass.	[Zhong, Ruiqin; Yuan, Youxi; Spiekerman, John J.; Guley, Joshua T.; Egbosiuba, Janefrances C.; Ye, Zheng-Hua] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Ye, ZH (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	yh@uga.edu		Spiekerman, John/0000-0003-0776-505X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-03ER15415]; National Science Foundation [ISO-1051900]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by grants from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy (http://science.energy.gov), under the grant number DE-FG02-03ER15415, and from the National Science Foundation (http://www.nsf.gov/) under the grant number ISO-1051900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Burk DH, 2006, J INTEGR PLANT BIOL, V48, P85, DOI 10.1111/j.1744-7909.2006.00202.x; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Hirano K, 2013, PLANT CELL PHYSIOL, V54, P1791, DOI 10.1093/pcp/pct122; HUGHES J, 1975, STAIN TECHNOL, V50, P319, DOI 10.3109/10520297509117082; Kim WC, 2012, PLANT MOL BIOL, V78, P489, DOI 10.1007/s11103-012-9880-7; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; McAbee JM, 2005, PLANT CELL, V17, P1674, DOI 10.1105/tpc.104.029207; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Nageswara-Rao M, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-77; Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Poovaiah CR, 2015, BIOTECHNOL J, V10, P552, DOI 10.1002/biot.201400499; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shen H, 2013, PLANT CELL, V25, P4342, DOI 10.1105/tpc.113.118828; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shen H, 2009, BIOENERG RES, V2, P217, DOI 10.1007/s12155-009-9047-9; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Valdivia ER, 2013, J EXP BOT, V64, P1333, DOI 10.1093/jxb/ers394; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Yamaguchi M, 2011, PLANT J, V66, P579, DOI [10.1111/j.1365-313X.2011.04514.x, 10.1111/j.1365-313x.2011.04514.x]; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383; Zhao KM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-135; Zhong RQ, 1997, PLANT CELL, V9, P2159, DOI 10.1105/tpc.9.12.2159; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.989746; Zhong RQ, 2015, PLANT CELL PHYSIOL, V56, P195, DOI 10.1093/pcp/pcu140; Zhong RQ, 2014, PLANT SCI, V229, P193, DOI 10.1016/j.plantsci.2014.09.009; Zhong RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069219; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185; Zhong RQ, 2011, PLANT CELL PHYSIOL, V52, P1856, DOI 10.1093/pcp/pcr123; Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou GK, 2006, PLANT CELL PHYSIOL, V47, P1229, DOI 10.1093/pcp/pcj093; Zhou JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105726; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	50	35	38	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134611	10.1371/journal.pone.0134611	http://dx.doi.org/10.1371/journal.pone.0134611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248336	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300051
J	Abinaya, E; Narang, P; Bhardwaj, A				Abinaya, E.; Narang, Pankaj; Bhardwaj, Anshu			FROG - Fingerprinting Genomic Variation Ontology	PLOS ONE			English	Article							GENE ONTOLOGY; DATABASE	Genetic variations play a crucial role in differential phenotypic outcomes. Given the complexity in establishing this correlation and the enormous data available today, it is imperative to design machine-readable, efficient methods to store, label, search and analyze this data. A semantic approach, FROG: "FingeRprinting Ontology of Genomic variations" is implemented to label variation data, based on its location, function and interactions. FROG has six levels to describe the variation annotation, namely, chromosome, DNA, RNA, protein, variations and interactions. Each level is a conceptual aggregation of logically connected attributes each of which comprises of various properties for the variant. For example, in chromosome level, one of the attributes is location of variation and which has two properties, allosomes or autosomes. Another attribute is variation kind which has four properties, namely, indel, deletion, insertion, substitution. Likewise, there are 48 attributes and 278 properties to capture the variation annotation across six levels. Each property is then assigned a bit score which in turn leads to generation of a binary fingerprint based on the combination of these properties (mostly taken from existing variation ontologies). FROG is a novel and unique method designed for the purpose of labeling the entire variation data generated till date for efficient storage, search and analysis. A web-based platform is designed as a test case for users to navigate sample datasets and generate fingerprints. The platform is available at http://ab-openlab.csir.res.in/frog.	[Abinaya, E.] SASTRA Univ, Dept Bioinformat, Thanjavur, Tamil Nadu, India; [Narang, Pankaj] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Bhardwaj, Anshu] CSIR, Open Source Drug Discovery Unit, New Delhi 110001, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery	Bhardwaj, A (corresponding author), CSIR, Open Source Drug Discovery Unit, 2 Rafi Marg, New Delhi 110001, India.	anshub@osdd.net		bhardwaj, anshu/0000-0001-5830-2616	CSIR-Genomics and Informatics Solutions for Integrating Biology Project [BSC0121]; Department of Biotechnology, Govt. of India	CSIR-Genomics and Informatics Solutions for Integrating Biology Project; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	AB received funding from CSIR-Genomics and Informatics Solutions for Integrating Biology Project (BSC0121). PN acknowledges the Department of Biotechnology, Govt. of India for providing a BINC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastos HP, 2011, METHODS MOL BIOL, V760, P141, DOI 10.1007/978-1-61779-176-5_9; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Brookes AJ, 2009, HUM MUTAT, V30, P968, DOI 10.1002/humu.20973; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Kohonen-Corish MRJ, 2013, GENET MED, V15, P507, DOI 10.1038/gim.2012.174; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lappalainen I, 2013, NUCLEIC ACIDS RES, V41, pD936, DOI 10.1093/nar/gks1213; Lin KW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076384; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Redaschi N., 2009, UNIPROT RDF TACKLING; Shamnamole K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060066; Sherry ST, 1999, GENOME RES, V9, P677; Vihinen M, 2014, GENOME RES, V24, P356, DOI 10.1101/gr.157495.113; Webb AJ, 2011, HUM MUTAT, V32, P543, DOI 10.1002/humu.21469; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134693	10.1371/journal.pone.0134693	http://dx.doi.org/10.1371/journal.pone.0134693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244889	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400099
J	Oja, R; Zilmer, K; Valdmann, H				Oja, Ragne; Zilmer, Karoline; Valdmann, Harri			Spatiotemporal Effects of Supplementary Feeding of Wild Boar (Sus scrofa) on Artificial Ground Nest Depredation	PLOS ONE			English	Article							WINTER HABITAT SELECTION; BLACK GROUSE; POPULATION-DENSITY; TETRAO-UROGALLUS; BREEDING SUCCESS; BONASA-BONASIA; PREDATION RISK; FOOD; PREY; FRAGMENTATION	Supplementary feeding of ungulates, being widely used in game management, may have unwanted consequences. Its role in agricultural damage is well-studied, but few studies have considered the potential for the practice to attract ground nest predators. Our goal was to identify the factors influencing ground nest predation in the vicinity of year-round supplementary feeding sites for wild boar and to characterise their spatiotemporal scope. We conducted two separate artificial ground nest experiments in five different hunting districts in south-eastern Estonia. The quantity of food provided and distance of a nest from the feeding site were the most important factors determining predation risk. Larger quantities of food resulted in higher predation risk, while predation risk responded in a non-linear fashion to distance from the feeding site. Although predation risk eventually decreases if supplementary feeding is ceased for at least four years, recently abandoned feeding sites still pose a high predation risk.	[Oja, Ragne; Zilmer, Karoline; Valdmann, Harri] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Oja, R (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	ragneoja@ut.ee			Estonian Research Council [IUT-2032]; Environmental Investment Centre	Estonian Research Council(Estonian Research Council); Environmental Investment Centre	This work was supported by the Estonian Research Council (grant IUT-2032; www.etag.ee), and from the Environmental Investment Centre (www.kik.ee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Ackerman JT, 2004, OIKOS, V107, P128; Baldi A, 2000, FOLIA ZOOL, V49, P157; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Bates D., 2013, LME4 LINEAR MIXED EF; Bayne EM, 1997, J WILDLIFE MANAGE, V61, P1227, DOI 10.2307/3802121; Berchtold M, 2013, 31 IUGB C BRUSS BELG, P97; Boitani L, 1995, IBEX J MT ECOL, V3, P197; Booth DT, 2006, ENVIRON MONIT ASSESS, V123, P97, DOI 10.1007/s10661-005-9164-7; Borchtchevski VG, 2003, WILDLIFE BIOL, V9, P275, DOI 10.2981/wlb.2003.015; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cellina S, 2008, THESIS U SUSSEX; Conover MR, 2010, CONDOR, V112, P331, DOI 10.1525/cond.2010.090172; Cooper SM, 2000, WILDLIFE SOC B, V28, P660; Fonseca C, 2008, EUR J WILDLIFE RES, V54, P361, DOI 10.1007/s10344-007-0144-9; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Geisser H, 2004, J WILDLIFE MANAGE, V68, P939, DOI 10.2193/0022-541X(2004)068[0939:EOHFAF]2.0.CO;2; GENOV P, 1981, ACTA THERIOL, V26, P185, DOI 10.4098/AT.arch.81-16; Greenwood RJ, 1998, WILDLIFE SOC B, V26, P219; Gregersen H, 2011, ORNIS NOR, V31, P105; Held S, 2005, ANIM COGN, V8, P114, DOI 10.1007/s10071-004-0242-y; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; Jazek M, 2013, 31 IUGB C; Jones DD, 2002, J WILDLIFE MANAGE, V66, P1112, DOI 10.2307/3802942; Jones DD, 2010, P ANN C SE ASS FISH, P56; Keuling O, 2010, 8 S WILD BOAR OTH SU, P11; Kurki S, 1997, OIKOS, V79, P301, DOI 10.2307/3546014; Lemel J, 2003, WILDLIFE BIOL, V9, P29, DOI 10.2981/wlb.2003.061; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Mendl M, 1997, ANIM BEHAV, V54, P1491, DOI 10.1006/anbe.1997.0564; Merta D, 2009, FOLIA ZOOL, V58, P159; Mestkova Lucie, 2012, Silva Gabreta, V18, P109; Ohashi H, 2013, EUR J WILDLIFE RES, V59, P167, DOI 10.1007/s10344-012-0661-z; Oja R, 2011, THESIS U TARTU; Oja R, 2014, ACTA THERIOL, V59, P553, DOI 10.1007/s13364-014-0190-0; Purger JJ, 2006, BIRD CONSERV INT, V16, P309, DOI 10.1017/S0959270906000451; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rhim SJ, 2012, FOREST ECOL MANAG, V282, P23, DOI 10.1016/j.foreco.2012.06.051; Rosvold J, 2008, RAPP ZOOL SER, V1, P1; Ruzicka RE, 2012, ETHOLOGY, V118, P187, DOI 10.1111/j.1439-0310.2011.01997.x; Sachot S, 2003, BIOL CONSERV, V112, P373, DOI 10.1016/S0006-3207(02)00334-8; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Saniga M, 2002, FOLIA ZOOL, V51, P205; Santos Pedro, 2004, Galemys, V16, P167; Schaefer T, 2004, BIRD STUDY, V51, P170, DOI 10.1080/00063650409461349; Selva N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090740; STORCH I, 1991, ORNIS SCAND, V22, P213, DOI 10.2307/3676592; Suld K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096358; Svobodova J, 2012, EUR J WILDLIFE RES, V58, P315, DOI 10.1007/s10344-011-0582-2; Thurfjell H, 2009, EUR J WILDLIFE RES, V55, P517, DOI 10.1007/s10344-009-0268-1; Tornberg R, 2011, OECOLOGIA, V166, P577, DOI 10.1007/s00442-010-1884-x; Vander Lee BA, 1999, J WILDLIFE MANAGE, V63, P1299, DOI 10.2307/3802848; Volmer A, 2013, THESIS U TARTU; Warren P, 2012, BIRD STUDY, V59, P139, DOI 10.1080/00063657.2011.648606; Wegge P, 2007, ANN ZOOL FENN, V44, P141	56	16	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135254	10.1371/journal.pone.0135254	http://dx.doi.org/10.1371/journal.pone.0135254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244659	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400146
J	Riback, TIS; Honorio, NA; Pereira, RN; Godoy, WAC; Codeco, CT				Riback, Thais I. S.; Honorio, Nildimar A.; Pereira, Renato N.; Godoy, Wesley A. C.; Codeco, Claudia T.			Better to Be in Bad Company than to Be Alone? Aedes Vectors Respond Differently to Breeding Site Quality in the Presence of Others	PLOS ONE			English	Article							INTRASPECIFIC LARVAL COMPETITION; COMPLEX LIFE-CYCLES; ALBOPICTUS DIPTERA; AEGYPTI DIPTERA; INTERSPECIFIC COMPETITION; REACTION NORMS; SOUTH FLORIDA; CULICIDAE; MOSQUITOS; SIZE	This study focuses on two competing species, Aedes aegypti and Aedes albopictus (Diptera: Culicidae), both invasive mosquitoes of the New World. Context-specific competition between immature forms inside containers seems to be an important determinant of the coexistence or displacement of each species in different regions of the world. Here, competition experiments developed at low density (one, two or three larvae) and receiving four different resource food concentration, were designed to test whether Ae. albopictus and Ae. aegypti respond differently to competition, and whether competition can be attributed to a simple division of resources. Three phenotypic traits - larval development, adult survival under starvation and wing length - were used as indicators of performance. Larvae of neither species were limited by resource concentration when they were alone, unlike when they developed with competitors. The presence of conspecifics affected Ae. aegypti and Ae. albopictus, inducing slower development, reduced survival and wing length. The response to resource limitation was different when developing with heterospecifics: Ae. aegypti developing with one heterospecific showed faster development, producing smaller adults with shorter lives, while in the presence of two competitors, development increased and adults lived longer. Aedes albopictus demonstrated a better performance when developing with heterospecifics, with no loss in their development period and improved adult survival. Overall, our results suggest that response to competition can not simply be attributed to the division of resources, and that larvae of both species presented large phenotypic plasticity in their response to the presence or absence of heterospecifics and conspecifics.	[Riback, Thais I. S.; Codeco, Claudia T.] Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil; [Honorio, Nildimar A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil; [Pereira, Renato N.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Rio De Janeiro, Brazil; [Godoy, Wesley A. C.] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade de Sao Paulo	Riback, TIS (corresponding author), Fundacao Oswaldo Cruz, Programa Computacao Cient, Rio De Janeiro, RJ, Brazil.	thaisriback@hotmail.com	Godoy, Wesley AC/B-9787-2012		Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The first author received a PhD fellowship during the development of the present work from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/bolsas/bolsas-no-pais/ds-e-proap). This fellowship is sent directly to the graduation program, and then distributed to the students, for this reason there is not a grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke Monsuru Adebayo, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P673, DOI 10.1016/S2221-1691(13)60137-9; Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Bargielowski I, 2015, ANN ENTOMOL SOC AM; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Bedhomme S, 2005, ECOL ENTOMOL, V30, P1, DOI 10.1111/j.0307-6946.2005.00665.x; Bedhomme S, 2003, J EVOLUTION BIOL, V16, P721, DOI 10.1046/j.1420-9101.2003.00576.x; Blanckenhorn WN, 2009, PHENOTYPIC PLASTICIT; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; CARPENTER SR, 1982, OECOLOGIA, V53, P1, DOI 10.1007/BF00377128; Carvajal JJ, 2013, THESIS FDN OSWALDO C, V126; CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P643; Christophers SR., 1960, AEDES AEGYPTI YELLOW; Costanzo KS, 2011, J MED ENTOMOL, V48, P29, DOI 10.1603/ME10085; Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3; Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2; Grover J. P., 1997, RESOURCE COMPETITION; Hentschel BT, 1999, AM NAT, V154, P549, DOI 10.1086/303263; HO BC, 1989, J MED ENTOMOL, V26, P615, DOI 10.1093/jmedent/26.6.615; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825; Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; MORI A, 1979, Tropical Medicine, V21, P85; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; O'Meara G. F., 1993, American Entomologist, V39, P163; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; R Core Team, 2012, R LANG ENV STAT COMP; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; RIBEIRO JMC, 1988, J MED ENTOMOL, V25, P431, DOI 10.1093/jmedent/25.6.431; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Stearns S.C., 1992, pi; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Timmermann SE, 1996, ENTOMOL EXP APPL, V80, P173, DOI 10.1007/BF00194752; van den Heuvel MJ., 1963, T R ENTOMOL SOC LOND, V115, P197, DOI DOI 10.1111/J.1365-2311.1963.TB00819.X; Vezzani D, 2002, MEM I OSWALDO CRUZ, V97, P789, DOI 10.1590/S0074-02762002000600006; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x	51	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134450	10.1371/journal.pone.0134450	http://dx.doi.org/10.1371/journal.pone.0134450			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244511	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400081
J	Riquelme, F; Villegas-Guzman, G; Gonzalez-Santillan, E; Cordova-Tabares, V; Francke, OF; Piedra-Jimenez, D; Estrada-Ruiz, E; Luna-Castro, B				Riquelme, Francisco; Villegas-Guzman, Gabriel; Gonzalez-Santillan, Edmundo; Cordova-Tabares, Victor; Francke, Oscar F.; Piedra-Jimenez, Dulce; Estrada-Ruiz, Emilio; Luna-Castro, Bibiano			New Fossil Scorpion from the Chiapas Amber Lagerstatte	PLOS ONE			English	Article							MIDDLE AMERICA; BUTHIDAE; PHYLOGENY; SIMOJOVEL; MIOCENE; CLASSIFICATION; CHELICERATA; DOMINICAN; MEXICO	A new species of scorpion is described based on a rare entire adult male preserved in a cloudy amber from Miocene rocks in the Chiapas Highlands, south of Mexico. The amber-bearing beds in Chiapas constitute a Conservation Lagerstatte with outstanding organic preservation inside plant resin. The new species is diagnosed as having putative characters that largely correspond with the genus Tityus Koch, 1836 (Scorpiones, Buthidae). Accordingly, it is now referred to as Tityus apozonalli sp. nov. Its previously unclear phylogenetic relationship among fossil taxa of the family Buthidae from both Dominican and Mexican amber is also examined herein. Preliminarily results indicate a basal condition of T. apozonalli regarding to Tityus geratus Santiago-Blay and Poinar, 1988, Tityus (Brazilotityus) hartkorni Lourenco, 2009, and Tityus azari Lourenco, 2013 from Dominican amber, as was Tityus (Brazilotityus) knodeli Lourenco, 2014 from Mexican amber. Its close relationships with extant Neotropic Tityus-like subclades such as 'Tityus clathratus' and the subgenus Tityus (Archaeotityus) are also discussed. This new taxon adds to the knowledge of New World scorpions from the Miocene that are rarely found trapped in amber.	[Riquelme, Francisco] Univ Autonoma Estado Morelos, Escuela Estudios Super Jicarero, Jicarero 62909, Morelos, Mexico; [Villegas-Guzman, Gabriel; Cordova-Tabares, Victor] Inst Politecn Nacl, Lab Acarol, Escuela Nacl Ciencias Biol, Mexico City 07738, DF, Mexico; [Gonzalez-Santillan, Edmundo; Piedra-Jimenez, Dulce] Univ Nacl Autonoma Mexico, Fac Ciencias, Lab Aracnol, Mexico City 04510, DF, Mexico; [Francke, Oscar F.] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Aracnidos, Mexico City 04510, DF, Mexico; [Estrada-Ruiz, Emilio] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Ecol, Mexico City 07738, DF, Mexico; [Luna-Castro, Bibiano] Museo Ambar Chiapas, San Cristobal de las Casa, Chiapas, Mexico	Universidad Autonoma del Estado de Morelos; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Riquelme, F (corresponding author), Univ Autonoma Estado Morelos, Escuela Estudios Super Jicarero, Jicarero 62909, Morelos, Mexico.	francisco.riquelme@uaem.mx	Riquelme, Francisco/P-8551-2014; Villegas, Gabriel/GQH-5940-2022; Santillán, Edmundo González/B-7648-2014	Riquelme, Francisco/0000-0001-9893-7413; Santillán, Edmundo González/0000-0003-1340-068X; Cordova-Tabares, Victor Manuel/0000-0002-6316-3064				Acosta LE, 2008, J ARACHNOL, V36, P491, DOI 10.1636/H07-28.1; Armas L.F., 2003, REV IBERICA ARACNOLO, V8, P93; Baptista Chris, 2006, Euscorpius, V35, P1; Bartolini C., 2001, W GULF MEXICO BASIN, P183; Boggs S, 2009, PETROLOGY SEDIMENTAR, V2nd; CUNNINGHAM A, 1983, PHYTOCHEMISTRY, V22, P965, DOI 10.1016/0031-9422(83)85031-6; De Armas L. F., 1998, ESC NAC CIENCIAS BIO, V43, P45; de Armas LF, 1988, GARCIANA, V11, P1; de Armas LF, 2004, REV IBER ARACNOL, V10, P53; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; Dunlop JA, 2014, WORLD SPIDER CATALOG; Dunlop JA, 2008, J ARACHNOL, V36, P267, DOI 10.1636/CH07-89.1; Ferrusquia-Villafranca I, 2006, J VERTEBR PALEONTOL, V26, P989, DOI 10.1671/0272-4634(2006)26[989:TFPMRO]2.0.CO;2; Francke OF, 2014, J ARACHNOL, V42, P220, DOI 10.1636/Ha13-33.1; Francke OF, 2014, REV MEX BIODIVERS, V85, pS408, DOI 10.7550/rmb.31914; Frost S.H., 1974, REEF BIOFACIES TERTI; Goloboff P, 2008, CLADISTICS, V24, P91; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Iturralde-Vinent MA, 2001, CARIBB J SCI, V37, P141; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; LANGENHEIM JH, 1966, CIENC MEX, V24, P201; Langenheim JH, 2003, PLANT RESINS CHEM EV, P141; LOURENCO W R, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P349; Lourenco Wilson R., 2006, Boletin de la SEA, V39, P55; Lourenco Wilson R., 2014, Revista Iberica de Aracnologia, V24, P59; Lourenco Wilson R., 2012, Euscorpius, V137, P1; Lourenco Wilson R., 2009, Boletin de la SEA, V45, P231; Lourenco Wilson R., 2009, Boletin de la SEA, V44, P135; Lourenco Wilson R., 2009, Euscorpius, V83, P1; Lourenco Wilson R., 2009, Denisia, P131; Lourenco WR, 2004, CR PALEVOL, V3, P369, DOI 10.1016/j.crpv.2004.06.006; Lourenco WR, 1996, CR ACAD SCI II A, V323, P889; Lourenco WR, 2002, C R PALEVOL, V1, P97, DOI 10.1016/S1631-0683(02)00017-9; Lourenco WR, 2001, CR ACAD SCI II A, V332, P641, DOI 10.1016/S1251-8050(01)01583-X; Lourenco WR, 2009, MITTEILUNGEN GEOLOGI, V79, P183; LOURENCO WR, 2013, EUSCORPIUS, V156, P1; Lourenco WR., 1999, BIOGEOGRAPHICA, V75, P131; Perry M. L., 1995, GREEN RIVER FORMATIO, P131; Poinar GO., 1992, LIFE AMBER; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; Riquelme F., 2014, MAT RES SOC S P, V1618, P169, DOI DOI 10.1557/OPL.2014.466; Riquelme Francisco, 2013, Peckhamia, V106, P1; Riquelme F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105877; Riquelme F, 2014, HIST BIOL, V26, P415, DOI 10.1080/08912963.2013.778843; Riquelme F, 2014, APPL PHYS A-MATER, V116, P97, DOI 10.1007/s00339-013-8185-2; Rohlf F.J., 2013, TPSDIG VER 2 17; Santiago-Blay J. A., 2004, Journal of Systematic Palaeontology, V2, P147, DOI 10.1017/S1477201904001221; Santiago-Blay J.A., 1988, Historical Biology, V1, P345; Santiago-Blay JA, 2013, REV IBERICA ARACNOLO, V10, P7; SANTIAGOBLAY JA, 1993, J ARACHNOL, V21, P147; SANTIAGOBLAY JA, 1990, J ARACHNOL, V18, P115; SCHAWALLER W., 1982, STUTTGARTER BEITRA B, V82, P1; SCHAWALLER W, 1979, STUTTGARTER BEITRA B, V45, P1; Sissom W. David, 2005, P122; Smith A. B., 2009, SYSTEMATICS FOSSIL R; Soleglad M.E., 2003, EUSCORPIUS, V5, P1, DOI [DOI 10.18590/EUSCORPIUS.2003.VOL2003.ISS5.1, 10.18590/euscorpius.2003.vol2003.iss5.1]; Soleglad ME, 2001, SCORPIONS 2001 MEMOR; Soleglad Michael E., 2003, Euscorpius, V11, P1; STAHNKE H L, 1970, Entomological News, V81, P297; VACHON M, 1975, CR ACAD SCI D NAT, V281, P1597; Vachon M., 1974, B MUSEUM NATL HIST N, V140, P859; Volschenk ES, 2008, ZOOL J LINN SOC-LOND, V154, P651, DOI 10.1111/j.1096-3642.2008.00426.x	63	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133396	10.1371/journal.pone.0133396	http://dx.doi.org/10.1371/journal.pone.0133396			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244974	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400044
J	Stein, DC; LeVan, A; Hardy, B; Wang, LC; Zimmerman, L; Song, WX				Stein, Daniel C.; LeVan, Adriana; Hardy, Britney; Wang, Liang-Chun; Zimmerman, Lindsey; Song, Wenxia			Expression of Opacity Proteins Interferes with the Transmigration of Neisseria gonorrhoeae across Polarized Epithelial Cells	PLOS ONE			English	Article							HUMAN FALLOPIAN-TUBES; OPA PROTEINS; PATHOGENIC NEISSERIAE; CYTOPLASMIC DOMAIN; ORGAN-CULTURE; GENITAL-TRACT; ADHESION; INFECTION; RECEPTOR; RECOGNITION	Neisseria gonorrhoeae (GC) establishes infection at the mucosal surface of the human genital tract, most of which is lined with polarized epithelial cells. GC can cause localized as well as disseminated infections, leading to various complications. GC constantly change their surface structures via phase and antigenic variation, which has been implicated as a means for GC to establish infection at various anatomic locations of male and female genital tracks. However, the exact contribution of each surface molecule to bacterial infectivity remains elusive due to their phase variation. Using a GC derivative that is genetically devoid of all opa genes (MS11 Delta Opa), this study shows that Opa expression interferes with GC transmigration across polarized human epithelial cells. MS11 Delta Opa transmigrates across polarized epithelial cells much faster and to a greater extent than MS11Opa+, while adhering at a similar level as MS11Opa+. When MS11Opa+, able to phase vary Opa expression, was inoculated, only those bacteria that turn off Opa expression transmigrate across the polarized epithelial monolayer. Similar to bacteria alone or co-cultured with non-polarized epithelial cells, MS11 Delta Opa fails to form large microcolonies at the apical surface of polarized epithelial cells. Apical inoculation of MS11Opa+, but not MS11 Delta Opa, induces the recruitment of the Opa host-cell receptor carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) to the apical junction and the vicinity of bacterial adherent sites. Our results suggest that Opa expression limits gonococcal ability to invade into subepithelial tissues by forming tight interactions with neighboring bacteria and by inducing CEACAM redistribution to cell junctions.	[Stein, Daniel C.; LeVan, Adriana; Hardy, Britney; Wang, Liang-Chun; Zimmerman, Lindsey; Song, Wenxia] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Stein, DC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dcstein@umd.edu; wenxsong@umd.edu		Stein, Daniel/0000-0003-3397-5720; WANG, LIANG-CHUN/0000-0002-4977-4256	NIH [AI048703, AI068888, AI103796, AI075596]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI048703, R01AI068888, F31AI075596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH AI048703 DCS; NIH AI068888 DCS WS; NIH AI103796 WS DCS; NIH AI075596 AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACALLAO R, 1989, METHOD CELL BIOL, V31, P437; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Bos MP, 2002, INFECT IMMUN, V70, P1715, DOI 10.1128/IAI.70.4.1715-1723.2002; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen ZG, 2008, J IMMUNOL, V180, P6085, DOI 10.4049/jimmunol.180.9.6085; Cole JG, 2010, INFECT IMMUN, V78, P1629, DOI 10.1128/IAI.00996-09; DRAPER DL, 1980, AM J OBSTET GYNECOL, V138, P818, DOI 10.1016/S0002-9378(16)32743-0; Edwards JL, 2001, CELL MICROBIOL, V3, P611, DOI 10.1046/j.1462-5822.2001.00140.x; Edwards VL, 2013, CELL MICROBIOL, V15, P1042, DOI 10.1111/cmi.12099; Harvey HA, 2001, MOL MICROBIOL, V42, P659, DOI 10.1046/j.1365-2958.2001.02666.x; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; Ilver D, 1998, INFECT IMMUN, V66, P469, DOI 10.1128/IAI.66.2.469-473.1998; JAMES JF, 1978, INFECT IMMUN, V19, P332, DOI 10.1128/IAI.19.1.332-340.1978; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Johnson MB, 2015, CELL MICROBIOL, V17, P648, DOI 10.1111/cmi.12389; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LeVan A, 2012, J BACTERIOL, V194, P6468, DOI 10.1128/JB.00969-12; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; MCGEE ZA, 1976, INFECT IMMUN, V13, P608, DOI 10.1128/IAI.13.2.608-618.1976; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; Merz AJ, 1996, MOL MED, V2, P745, DOI 10.1007/BF03401658; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mosleh IM, 1997, INFECT IMMUN, V65, P3391, DOI 10.1128/IAI.65.8.3391-3398.1997; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Patel PC, 2013, J BIOL CHEM, V288, P29654, DOI 10.1074/jbc.M113.504639; PLUMMER FA, 1994, J CLIN INVEST, V93, P1748, DOI 10.1172/JCI117159; Quan DN, 2008, MUCOSAL IMMUNOL, V1, P229, DOI 10.1038/mi.2008.1; Rodriguez-Tirado C, 2012, MICROBES INFECT, V14, P290, DOI 10.1016/j.micinf.2011.11.002; Roth A, 2013, INFECT IMMUN, V81, P2358, DOI 10.1128/IAI.00128-13; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; Sarantis H, 2012, INFECT IMMUN, V80, P345, DOI 10.1128/IAI.05702-11; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; SCHNEIDER H, 1995, J INFECT DIS, V172, P180, DOI 10.1093/infdis/172.1.180; Schumann D, 2001, J BIOL CHEM, V276, P47421, DOI 10.1074/jbc.M109110200; SCHWALBE RS, 1985, INFECT IMMUN, V49, P250, DOI 10.1128/IAI.49.1.250-252.1985; SIMON D, 1992, P NATL ACAD SCI USA, V89, P5512, DOI 10.1073/pnas.89.12.5512; Sintsova A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004341; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Sundberg U, 2002, J CELL SCI, V115, P1273; Sundberg U, 2004, J CELL SCI, V117, P1091, DOI 10.1242/jcs.00944; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; WALDBESER LS, 1994, MOL MICROBIOL, V13, P919, DOI 10.1111/j.1365-2958.1994.tb00483.x; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Wang JA, 2008, INT J MED MICROBIOL, V298, P209, DOI 10.1016/j.ijmm.2007.05.004; WARD ME, 1974, J INFECT DIS, V129, P650, DOI 10.1093/infdis/129.6.650; WHITE LA, 1965, APPL MICROBIOL, V13, P171, DOI 10.1128/AEM.13.2.171-174.1965	55	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134342	10.1371/journal.pone.0134342	http://dx.doi.org/10.1371/journal.pone.0134342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244560	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400075
J	Workenhe, ST; Ketela, T; Moffat, J; Cuddington, BP; Mossman, KL				Workenhe, S. T.; Ketela, T.; Moffat, J.; Cuddington, B. P.; Mossman, K. L.			Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells	ONCOGENE			English	Article							HERPES-SIMPLEX-VIRUS; ANTITUMOR EFFICACY; THERAPEUTIC-EFFICACY; TOPOISOMERASE-I; SR PROTEINS; PHOSPHORYLATION; SPLICEOSOME; APOPTOSIS; GENES; HSV-1	Oncolytic human herpes simplex virus type 1 (HSV-1) shows promising treatment efficacy in late-stage clinical trials. The anticancer activity of oncolytic viruses relies on deregulated pathways in cancer cells, which make them permissive to oncolysis. To identify pathways that restrict HSV-1 KM100-mediated oncolysis, this study used a pooled genome-wide short hairpin RNA library and found that depletion of the splicing factor arginine-rich splicing factor 2 (SRSF2) leads to enhanced cytotoxicity of breast cancer cells by KM100. Serine/arginine-rich (SR) proteins are a family of RNA-binding phosphoproteins that control both constitutive and alternative pre-mRNA splicing. Further characterization showed that KM100 infection of HS578T cells under conditions of low SRSF2 leads to pronounced apoptosis without a corresponding increase in virus replication. As DNA topoisomerase I inhibitors can limit the phosphorylation of SRSF2, we combined a topoisomerase I inhibitor chemotherapeutic with KM100 and observed synergistic anticancer effect in vitro and prolonged survival of tumor-bearing mice in vivo.	[Workenhe, S. T.; Cuddington, B. P.; Mossman, K. L.] McMaster Univ, Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, 1280 Main St West,MDCL 5026, Hamilton, ON L8S 4K1, Canada; [Ketela, T.; Moffat, J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	McMaster University; University of Toronto	Workenhe, ST; Mossman, KL (corresponding author), McMaster Univ, Inst Infect Dis Res, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, 1280 Main St West,MDCL 5026, Hamilton, ON L8S 4K1, Canada.	samuelworkenhe@gmail.com; mossk@mcmaster.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586	Cancer Research Society; Canadian Cancer Society Research Institute	Cancer Research Society; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	These studies were supported by operating grants to KLM from the Cancer Research Society and the Canadian Cancer Society Research Institute.	Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bolyard C, 2014, CLIN CANCER RES, V20, P6479, DOI 10.1158/1078-0432.CCR-14-0463; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Cheema TA, 2011, CLIN CANCER RES, V17, P7383, DOI 10.1158/1078-0432.CCR-11-1762; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciomei M, 2006, CLIN CANCER RES, V12, P2856, DOI 10.1158/1078-0432.CCR-05-1859; Diallo JS, 2010, MOL THER, V18, P1123, DOI 10.1038/mt.2010.67; Edmond V, 2013, CELL CYCLE, V12, P1267, DOI 10.4161/cc.24363; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Hummel JL, 2005, MOL THER, V12, P1101, DOI 10.1016/j.ymthe.2005.07.533; Ilkow CS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003836; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Ketela T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-213; Kumler I, 2013, BREAST CANCER RES TR, V138, P347, DOI 10.1007/s10549-013-2476-3; Mahoney DJ, 2010, CYTOKINE GROWTH F R, V21, P161, DOI 10.1016/j.cytogfr.2010.02.013; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; Mossman KL, 1999, J VIROL, V73, P9726, DOI 10.1128/JVI.73.12.9726-9733.1999; Pilch B, 2001, CANCER RES, V61, P6876; Quidville V, 2013, CANCER RES, V73, P2247, DOI 10.1158/0008-5472.CAN-12-2501; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sobol PT, 2011, MOL THER, V19, P335, DOI 10.1038/mt.2010.264; Solier S, 2010, CANCER RES, V70, P8055, DOI 10.1158/0008-5472.CAN-10-2491; Soret J, 2003, CANCER RES, V63, P8203; Stickeler E, 1999, ONCOGENE, V18, P3574, DOI 10.1038/sj.onc.1202671; Tahara M, 2013, BIOCHEM BIOPH RES CO, V434, P753, DOI 10.1016/j.bbrc.2013.03.128; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Ueno M, 2002, EUR UROL, V42, P390, DOI 10.1016/S0302-2838(02)00321-4; Vanderbeeken MC, 2013, CURR BREAST CANCER R, V5, P31, DOI 10.1007/s12609-012-0098-0; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Workenhe ST, 2013, CANCER IMMUNOL RES, V1, P309, DOI 10.1158/2326-6066.CIR-13-0059-T; Workenhe ST, 2014, MOL THER, V22, P123, DOI 10.1038/mt.2013.238; Workenhe ST, 2009, MOL IMMUNOL, V46, P2955, DOI 10.1016/j.molimm.2009.06.015; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	38	21	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2465	2474		10.1038/onc.2015.303	http://dx.doi.org/10.1038/onc.2015.303			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26257065				2022-12-26	WOS:000376165500005
J	Yao, PL; Chen, LP; Hess, RA; Muller, R; Gonzalez, FJ; Peters, JM				Yao, Pei-Li; Chen, LiPing; Hess, Rex A.; Mueller, Rolf; Gonzalez, Frank J.; Peters, Jeffrey M.			Peroxisome Proliferator-activated Receptor-D (PPARD) Coordinates Mouse Spermatogenesis by Modulating Extracellular Signal-regulated Kinase (ERK)-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERTOLI-CELL NUMBER; MONO-(2-ETHYLHEXYL) PHTHALATE; ABNORMAL SPERMATOGENESIS; SEMINIFEROUS EPITHELIUM; LIGAND ACTIVATION; IN-VITRO; BETA/DELTA; TESTOSTERONE; EXPRESSION; PROTEIN	Ppard(-/-) mice exhibit smaller litter size compared with Ppard(+/+) mice. To determine whether peroxisome proliferator- activated receptor-D (PPARD) could possibly influence this phenotype, the role of PPARD in testicular biology was examined. Atrophic testes and testicular degeneration were observed in Ppard(-/-) mice compared with Ppard(+/+) mice, indicating that PPARD modulates spermatogenesis. Higher expression of p27 and decreased expression of proliferating cellular nuclear antigen in Sertoli cells were observed in Ppard(+/+) mice as compared with Ppard(-/-) mice, and these were associated with decreased Sertoli cell number in Ppard(+/+) mice. Cyclin D1 and cyclin D2 expression was lower in Ppard(+/+) as compared with Ppard(-/-) mice. Ligand activation of PPARD inhibited proliferation of a mouse Sertoli cell line, TM4, and an inverse agonist of PPARD (DG172) rescued this effect. Temporal inhibition of extracellular signal-regulated kinase (ERK) activation by PPARD in the testis was observed in Ppard(+/+) mice and was associated with decreased serum follicle-stimulating hormone and higher claudin-11 expression along the blood-testis barrier. PPARD-dependent ERK activation also altered expression of claudin-11, p27, cyclin D1, and cyclin D2 in TM4 cells, causing inhibition of cell proliferation, maturation, and formation of tight junctions in Sertoli cells, thus confirming a requirement for PPARD in accurate Sertoli cell function. Combined, these results reveal for the first time that PPARD regulates spermatogenesis by modulating the function of Sertoli cells during early testis development.	[Yao, Pei-Li; Chen, LiPing; Peters, Jeffrey M.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Yao, Pei-Li; Chen, LiPing; Peters, Jeffrey M.] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; [Hess, Rex A.] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Reprod Biol & Toxicol, Urbana, IL 61802 USA; [Mueller, Rolf] Univ Marburg, Inst Mol Biol & Tumor Res, Ctr Tumor & Immunobiol, D-35043 Marburg, Germany; [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; Philipps University Marburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peters, JM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, 312 Life Sci Bldg, University Pk, PA 16802 USA.	pxy11@psu.edu; jmp21@psu.edu	Regan, Clinton/E-6250-2012; Müller, Rolf/L-4997-2016	Müller, Rolf/0000-0003-3339-4248; Yao, Pei-Li/0000-0003-0832-3771; Peters, Jeffrey/0000-0003-2782-2998; Hess, Rex/0000-0003-2649-3563	National Institutes of Health [CA124533, CA141029]; NCI Intramural Research Program [ZIABC005561, ZIABC005562, ZIABC005708]; NATIONAL CANCER INSTITUTE [R01CA140369, ZIABC005708, ZIABC005562, R01CA124533, R01CA141029, ZIABC005561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124533 and CA141029 (to J. M. P.) and ZIABC005561, ZIABC005562, and ZIABC005708 from the NCI Intramural Research Program (to F. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Beumer TL, 1999, ENDOCRINOLOGY, V140, P1834, DOI 10.1210/en.140.4.1834; Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583; Burdick AD, 2007, CELL SIGNAL, V19, P1163, DOI 10.1016/j.cellsig.2006.12.007; Chiba K, 2012, J ANDROL, V33, P368, DOI 10.2164/jandrol.111.013664; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; de Kretser DM, 2004, MOL CELL ENDOCRINOL, V225, P57, DOI 10.1016/j.mce.2004.07.008; Dwyer Jessica L, 2012, Spermatogenesis, V2, P104; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Hemendinger RA, 2002, CELL TRANSPLANT, V11, P499; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hogarth CA, 2013, ADV EXP MED BIOL, V786, P105, DOI 10.1007/978-94-007-6621-1_7; Hollingshead HE, 2008, CARCINOGENESIS, V29, P169, DOI 10.1093/carcin/bgm209; Holsberger DR, 2005, BIOL REPROD, V72, P1429, DOI 10.1095/biolreprod.105.040386; Huang JC, 2008, PPAR RES, V2008, DOI 10.1155/2008/732303; Inagaki M, 2006, GENES CELLS, V11, P1125, DOI 10.1111/j.1365-2443.2006.01006.x; Johnson L, 2008, ANIM REPROD SCI, V105, P23, DOI 10.1016/j.anireprosci.2007.11.029; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kanatsu-Shinohara M, 2010, P NATL ACAD SCI USA, V107, P6210, DOI 10.1073/pnas.0914448107; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Khatchadourian K, 2007, MOL REPROD DEV, V74, P341, DOI 10.1002/mrd.20564; Khozoie C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-665; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kopera IA, 2010, PHILOS T R SOC B, V365, P1593, DOI 10.1098/rstb.2009.0251; Lieber S, 2012, J MED CHEM, V55, P2858, DOI 10.1021/jm2017122; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; McCoard SA, 2001, BIOL REPROD, V64, P689, DOI 10.1095/biolreprod64.2.689; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Meyer-Ficca ML, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123661; MOGER WH, 1976, BIOL REPROD, V14, P665, DOI 10.1095/biolreprod14.5.665; Mok KW, 2013, ADV EXP MED BIOL, V763, P334; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mukai M, 2005, BIOL REPROD, V73, P951, DOI 10.1095/biolreprod.105.040980; Nozawa YI, 2014, DEV BIOL, V388, P170, DOI 10.1016/j.ydbio.2014.02.002; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Schultz R, 1999, ENDOCRINOLOGY, V140, P2968, DOI 10.1210/en.140.7.2968; Shimon I, 2006, J ANDROL, V27, P358, DOI 10.2164/jandrol.05140; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Smith LB, 2014, SEMIN CELL DEV BIOL, V30, P2, DOI 10.1016/j.semcdb.2014.02.012; Sonne SB, 2008, INT J ANDROL, V31, P275, DOI 10.1111/j.1365-2605.2007.00855.x; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tarulli GA, 2006, BIOL REPROD, V74, P798, DOI 10.1095/biolreprod.105.050450; Thomas Kelwyn, 2011, Front Biosci (Elite Ed), V3, P1209; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Yao PL, 2014, TOXICOLOGY, V326, P62, DOI 10.1016/j.tox.2014.10.008; Yao PL, 2014, MOL CANCER THER, V13, P1008, DOI 10.1158/1535-7163.MCT-13-0836; Yao PL, 2010, BIOL REPROD, V82, P516, DOI 10.1095/biolreprod.109.080374; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zhu BK, 2014, J BIOL CHEM, V289, P20102, DOI 10.1074/jbc.M114.551069	60	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23416	23431		10.1074/jbc.M115.664508	http://dx.doi.org/10.1074/jbc.M115.664508			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26242735	hybrid, Green Published			2022-12-26	WOS:000361685500046
J	Almukhtar, A; Khambay, B; Ayoub, A; Ju, XY; Al-Hiyali, A; Macdonald, J; Jabar, N; Goto, T				Almukhtar, Anas; Khambay, Balvinder; Ayoub, Ashraf; Ju, Xiangyang; Al-Hiyali, Ali; Macdonald, James; Jabar, Norhayati; Goto, Tazuko			"Direct DICOM Slice Landmarking" A Novel Research Technique to Quantify Skeletal Changes in Orthognathic Surgery	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; MANDIBULAR SETBACK SURGERY; ORTHODONTICS; RELIABILITY; IMAGES	The limitations of the current methods of quantifying the surgical movements of facial bones inspired this study. The aim of this study was the assessment of the accuracy and reproducibility of directly landmarking of 3D DICOM images (Digital Imaging and Communications in Medicine) to quantify the changes in the jaw bones following surgery. The study was carried out on plastic skull to simulate the surgical movements of the jaw bones. Cone beam CT scans were taken at 3mm, 6mm, and 9mm maxillary advancement; together with a 2mm, 4mm, 6mm and 8mm "down graft" which in total generated 12 different positions of the maxilla for the analysis. The movements of the maxilla were calculated using two methods, the standard approach where distances between surface landmarks on the jaw bones were measured and the novel approach where measurements were taken directly from the internal structures of the corresponding 3D DICOME slices. A one sample t-test showed that there was no statistically significant difference between the two methods of measurements for the y and z directions, however, the x direction showed a significant difference. The mean difference between the two absolute measurements were 0.34 +/- 0.20mm, 0.22 +/- 0.16mm, 0.18 +/- 0.13mm in the y, z and x directions respectively. In conclusion, the direct landmarking of 3D DICOM image slices is a reliable, reproducible and informative method for assessment of the 3D skeletal changes. The method has a clear clinical application which includes the analysis of the jaw movements "orthognathic surgery" for the correction of facial deformities.	[Almukhtar, Anas; Ayoub, Ashraf; Ju, Xiangyang; Al-Hiyali, Ali; Macdonald, James] Univ Glasgow, MVLS Coll, Sch Dent, Glasgow, Lanark, Scotland; [Khambay, Balvinder; Jabar, Norhayati; Goto, Tazuko] Univ Hong Kong, Fac Dent, Paediat Dent & Orthodont, Hong Kong, Hong Kong, Peoples R China; [Ju, Xiangyang] NHS Greater Glasgow & Clyde, Dept Clin Phys & Bioengn, Med Device Unit, Glasgow, Lanark, Scotland	University of Glasgow; University of Hong Kong	Ayoub, A (corresponding author), Univ Glasgow, MVLS Coll, Sch Dent, Glasgow, Lanark, Scotland.	Ashraf.Ayoub@glasgow.ac.uk	Almukhtar, Anas/G-4217-2019	Almukhtar, Anas/0000-0003-3696-6424; Ju, Xiangyang/0000-0003-3471-7256; Ayoub, Ashraf/0000-0002-2760-6008				Almeida RC, 2011, INT J ORAL MAX SURG, V40, P353, DOI 10.1016/j.ijom.2010.11.018; Almukhtar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093402; Cevidanes LHS, 2005, AM J ORTHOD DENTOFAC, V128, P16, DOI 10.1016/j.ajodo.2004.03.032; Cevidanes LHS, 2007, AM J ORTHOD DENTOFAC, V131, P44, DOI 10.1016/j.ajodo.2005.03.029; Damstra J, 2011, AM J ORTHOD DENTOFAC, V140, pE107, DOI 10.1016/j.ajodo.2011.02.020; de Oliveira AEF, 2009, ORAL SURG ORAL MED O, V107, P256, DOI 10.1016/j.tripleo.2008.05.039; Jabar N, 2015, INT J ORAL MAXILLOF, VS0901-5027; Jungner M., 2014, INT J ORAL MAXILLOF, V43, P445, DOI [10.1016/j.ijom.2013.08.007, DOI 10.1016/J.IJOM.2013.08.007]; Khambay B, 2015, INT J ORAL MAX SURG, V44, P132, DOI 10.1016/j.ijom.2014.04.007; Kim CS, 2014, J ORAL MAXIL SURG, V72, P779, DOI 10.1016/j.joms.2013.09.033; Kim YK, 2014, J ORAL MAXIL SURG, V72, P1820, DOI 10.1016/j.joms.2014.02.035; Maal TJJ, 2012, INT J ORAL MAX SURG, V41, P1137, DOI 10.1016/j.ijom.2012.04.004; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Park SB, 2012, J CRANIO MAXILL SURG, V40, pE87, DOI 10.1016/j.jcms.2011.05.008; Swennen GRJ, 2006, J CRANIOFAC SURG, V17, P314, DOI 10.1097/00001665-200603000-00019	15	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0131540	10.1371/journal.pone.0131540	http://dx.doi.org/10.1371/journal.pone.0131540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252768	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000359121100007
J	Gresser, AL; Gutzwiller, LM; Gauck, MK; Hartenstein, V; Cook, TA; Gebelein, B				Gresser, Amy L.; Gutzwiller, Lisa M.; Gauck, Mackenzie K.; Hartenstein, Volker; Cook, Tiffany A.; Gebelein, Brian			Rhomboid Enhancer Activity Defines a Subset of Drosophila Neural Precursors Required for Proper Feeding, Growth and Viability	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; GENE-EXPRESSION; PRONEURAL GENE; ORGAN PRECURSORS; SEGMENTAL ORGANIZATION; NEUROBLAST FORMATION; MELANOGASTER MEIGEN; MOLECULAR SWITCH; ADULT DROSOPHILA; DEVELOPING BRAIN	Organismal growth regulation requires the interaction of multiple metabolic, hormonal and neuronal pathways. While the molecular basis for many of these are well characterized, less is known about the developmental origins of growth regulatory structures and the mechanisms governing control of feeding and satiety. For these reasons, new tools and approaches are needed to link the specification and maturation of discrete cell populations with their subsequent regulatory roles. In this study, we characterize a rhomboid enhancer element that selectively labels four Drosophila embryonic neural precursors. These precursors give rise to the hypopharyngeal sensory organ of the peripheral nervous system and a subset of neurons in the deutocerebral region of the embryonic central nervous system. Post embryogenesis, the rhomboid enhancer is active in a subset of cells within the larval pharyngeal epithelium. Enhancer-targeted toxin expression alters the morphology of the sense organ and results in impaired larval growth, developmental delay, defective anterior spiracle eversion and lethality. Limiting the duration of toxin expression reveals differences in the critical periods for these effects. Embryonic expression causes developmental defects and partially penetrant pre-pupal lethality. Survivors of embryonic expression, however, ultimately become viable adults. In contrast, post-embryonic toxin expression results in fully penetrant lethality. To better define the larval growth defect, we used a variety of assays to demonstrate that toxin-targeted larvae are capable of locating, ingesting and clearing food and they exhibit normal food search behaviors. Strikingly, however, following food exposure these larvae show a rapid decrease in consumption suggesting a satiety-like phenomenon that correlates with the period of impaired larval growth. Together, these data suggest a critical role for these enhancer-defined lineages in regulating feeding, growth and viability.	[Gresser, Amy L.; Gutzwiller, Lisa M.; Gauck, Mackenzie K.; Cook, Tiffany A.; Gebelein, Brian] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Cook, Tiffany A.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Ophthalmol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California Los Angeles; Cincinnati Children's Hospital Medical Center	Gebelein, B (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	brian.gebelein@cchmc.org		Cook, Tiffany/0000-0002-3100-5248	National Institutes of Health [GM079428, P30 DK078392]; National Institutes of Health Developmental and Perinatal Endocrinology Training [HD007463]; University of Cincinnati Research Council Postdoctoral Fellowship; NATIONAL EYE INSTITUTE [R01EY017907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Developmental and Perinatal Endocrinology Training; University of Cincinnati Research Council Postdoctoral Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant # GM079428 to BG; National Institutes of Health Developmental and Perinatal Endocrinology Training grant HD007463 to ALG; University of Cincinnati Research Council Postdoctoral Fellowship (http://webcentral.uc.edu/urc2/apply/programinfo.cfm) to ALG; and National Institutes of Health grant P30 DK078392 to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BIER E, 1988, SCIENCE, V240, P913, DOI 10.1126/science.3129785; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BRAND AH, 1993, DEVELOPMENT, V118, P401; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; DAlessio M, 1996, MECH DEVELOP, V58, P217, DOI 10.1016/S0925-4773(96)00583-7; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; EMERY JF, 1995, DEVELOPMENT, V121, P3549; Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007; FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Gendre N, 2004, DEVELOPMENT, V131, P83, DOI 10.1242/dev.00879; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Ghosh A, 2010, DEV BIOL, V347, P271, DOI 10.1016/j.ydbio.2010.08.011; Golembo M, 1996, DEVELOPMENT, V122, P223; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Gutzwiller LM, 2010, DEV BIOL, V348, P231, DOI 10.1016/j.ydbio.2010.09.014; Han DD, 2000, DEVELOPMENT, V127, P573; HARTENSTEIN V, 1994, J COMP NEUROL, V350, P367, DOI 10.1002/cne.903500304; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; Helman A, 2011, CURR BIOL, V21, P1102, DOI 10.1016/j.cub.2011.05.043; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Hertweck H, 1931, Z WISS ZOOL ABT A, V139, P559; Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Iyengar B, 1999, GENETICS, V153, P1809; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Johnson AW, 2013, TRENDS NEUROSCI, V36, P101, DOI 10.1016/j.tins.2013.01.002; JURGENS G, 1986, ROUX ARCH DEV BIOL, V195, P359, DOI 10.1007/BF00402870; Keilin D., 1915, B SCI FR BELG, V49, P15; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Nichols R, 2007, PEPTIDES, V28, P767, DOI 10.1016/j.peptides.2007.01.009; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Okabe M, 1997, DEVELOPMENT, V124, P1045; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Renn SCP, 1999, J NEUROBIOL, V41, P189; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; SAWIN FP, 1994, J INSECT BEHAV, V7, P553, DOI 10.1007/BF02025449; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; SCHWARTZ MB, 1984, DEV BIOL, V103, P85, DOI 10.1016/0012-1606(84)90010-1; Seibert J, 2010, DEV BIOL, V346, P332, DOI 10.1016/j.ydbio.2010.07.024; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004; Sun Y, 1998, DEVELOPMENT, V125, P3731; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532; Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2; Urbach R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-23; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789; Von Ohlen TL, 2009, MECH DEVELOP, V126, P552, DOI 10.1016/j.mod.2009.03.008; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Witt LM, 2010, DEV BIOL, V344, P1060, DOI 10.1016/j.ydbio.2010.05.011; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884; YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7; Zinke I, 1999, DEVELOPMENT, V126, P5275; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	92	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134915	10.1371/journal.pone.0134915	http://dx.doi.org/10.1371/journal.pone.0134915			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252385	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100084
J	Haskew, J; Kenyi, V; William, J; Alum, R; Puri, A; Mostafa, Y; Davis, R				Haskew, John; Kenyi, Veronica; William, Juma; Alum, Rebecca; Puri, Anu; Mostafa, Yehia; Davis, Robert			Use of Mobile Information Technology during Planning, Implementation and Evaluation of a Polio Campaign in South Sudan	PLOS ONE			English	Article							HEALTH	Background Use of mobile information technology may aid collection of real-time, standardised data to inform and improve decision-making for polio programming and response. We utilised Android-based smartphones to collect data electronically from more than 8,000 households during a national round of polio immunisation in South Sudan. The results of the household surveys are presented here, together with discussion of the application of mobile information technology for polio campaign planning, implementation and evaluation in a real-time setting. Methods Electronic questionnaires were programmed onto Android-based smartphones for mapping, supervision and survey activities during a national round of polio immunisation. National census data were used to determine the sampling frame for each activity and select the payam (district). Individual supervisors, in consultation with the local district health team, selected villages and households within each payam. Data visualisation tools were utilised for analysis and reporting. Results Implementation of mobile information technology and local management was feasible during a national round of polio immunisation in South Sudan. Red Cross visits during the polio campaign were equitable according to household wealth index and households who received a Red Cross visit had significantly higher odds of being aware of the polio campaign than those who did not. Nearly 95% of children under five were reported to have received polio immunisation (according to maternal recall) during the immunisation round, which varied by state, county and payam. A total of 11 payams surveyed were identified with less than 90% reported immunisation coverage and the least poor households had significantly higher odds of being vaccinated than the most poor. More than 95% of households were aware of the immunisation round and households had significantly higher odds of being vaccinated if they had prior awareness of the campaign taking place. Conclusion Pre-campaign community education and household awareness of polio is important to increase campaign participation and subsequent immunisation coverage in South Sudan. More emphasis should be placed on ensuring immunisation is equitable according to geographic area and household socio-economic index in future rounds. We demonstrate the utility of mobile information technology for household mapping, supervision and survey activities during a national round of polio immunisation and encourage future studies to compare the effectiveness of electronic data collection and its application in polio planning and programming.	[Haskew, John] Eastern African & Indian Ocean Islands Delegat, Int Federat Red Cross & Red Crescent Soc, Nairobi, Kenya; [Kenyi, Veronica; William, Juma] South Sudan Red Cross Soc, Juba, Sudan; [Alum, Rebecca] Minist Hlth, Juba, Sudan; [Puri, Anu] UNICEF, Juba, Sudan; [Mostafa, Yehia] WHO, Juba, Sudan; [Davis, Robert] Amer Red Cross, Nairobi, Kenya	World Health Organization	Haskew, J (corresponding author), WHO, Amman, Jordan.	haskewj@who.int			Disaster Relief Emergency Fund (DREF) of the International Federation of Red Cross and Red Crescent Societies (IFRC)	Disaster Relief Emergency Fund (DREF) of the International Federation of Red Cross and Red Crescent Societies (IFRC)	This study was supported by funding from the Disaster Relief Emergency Fund (DREF) of the International Federation of Red Cross and Red Crescent Societies (IFRC). IFRC had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, nor exerted any editorial control.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Global Polio Eradication Initiative, 2014, POL ER WEEKL UPD; Global Polio Eradication Initiative, 2010, STRAT PLAN 2010 2012; Global Polio Eradication Initiative, 2012, ASS VACC COV LEV US; Google, 2014, AB GOOGL MAPS; IFRC SSRC, 2014, S SUD RED CROSS POL; International Epidemiology Association, 2007, GOOD EP PRACT IEA GU; Kamadjeu R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-4; King JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074570; Mitchell M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-95; Pezzoli L, 2012, EPIDEMIOL INFECT, V140, P14, DOI 10.1017/S0950268811000331; Schellenberg JAJ, 2003, TANZANIA, V361, P6, DOI [10.1016/S0140-6736(03)12515-9, DOI 10.1016/S0140-6736(03)12515-9]; Southern Sudan Centre for Census Statistics and Evaluation Government of South Sudan, 2010, STAT YB SO SUD; Stensgaard AS, 2009, GEOSPATIAL HEALTH, V3, P127, DOI 10.4081/gh.2009.216; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2013, IND MON POL SUPPL IM; World Health Organization, 2002, HDB GOOD CLIN RES PR	17	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135362	10.1371/journal.pone.0135362	http://dx.doi.org/10.1371/journal.pone.0135362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252383	gold, Green Submitted, Green Published			2022-12-26	WOS:000359121100156
J	Jeyanathan, M; Shao, ZQ; Yu, XF; Harkness, R; Jiang, R; Li, JQ; Xing, Z; Zhu, T				Jeyanathan, Mangalakumari; Shao, Zhongqi; Yu, Xuefeng; Harkness, Robin; Jiang, Rong; Li, Junqiang; Xing, Zhou; Zhu, Tao			AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates	PLOS ONE			English	Article							T-CELL RESPONSES; RHESUS MACAQUES; VACCINE; INFECTION; IMMUNOGENICITY; ADENOVIRUS; AEROSOL; SAFETY; ROBUST; AERAS-402	Persisting high global tuberculosis (TB) morbidity and mortality and poor efficacy of BCG vaccine emphasizes an urgent need for developing effective novel boost vaccination strategies following parenteral BCG priming in humans. Most of the current lead TB vaccine candidates in the global pipeline were developed for parenteral route of immunization. Compelling evidence indicates respiratory mucosal delivery of vaccine to be the most effective way to induce robust local mucosal protective immunity against pulmonary TB. However, despite ample supporting evidence from various animal models, there has been a lack of evidence supporting the safety and protective efficacy of respiratory mucosal TB vaccination in non-human primates (NHP) and humans. By using a rhesus macaque TB model we have evaluated the safety and protective efficacy of a recombinant human serotype 5 adenovirus-based TB vaccine (AdHu5Ag85A) delivered via the respiratory mucosal route. We show that mucosal AdHu5Ag85A boost immunization was safe and well tolerated in parenteral BCG-primed rhesus macaques. A single AdHu5Ag85A mucosal boost immunization in BCG-primed rhesus macaques enhanced the antigen-specific T cell responses. Boost immunization significantly improved the survival and bacterial control following M. tb challenge. Furthermore, TB-related lung pathology and clinical outcomes were lessened in BCG-primed, mucosally boosted animals compared to control animals. Thus, for the first time we show that a single respiratory mucosal boost immunization with a novel TB vaccine enhances protection against pulmonary TB in parenteral BCG-primed NHP. Our study provides the evidence for the protective potential of AdHu5Ag85A as a respiratory mucosal boost TB vaccine for human application.	[Jeyanathan, Mangalakumari; Xing, Zhou] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Jeyanathan, Mangalakumari; Xing, Zhou] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Shao, Zhongqi; Yu, Xuefeng; Harkness, Robin; Jiang, Rong; Li, Junqiang; Zhu, Tao] Tianjin CanSino Biotechnol Inc, Tianjin, Peoples R China	McMaster University; McMaster University	Xing, Z (corresponding author), McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada.	xingz@mcmaster.ca; tao.zhu@cansinotech.com			Chinese National Science and Technology Major Project Fund [2013ZX10003006]; AREAS Global TB Vaccine Foundation; Canadian Institutes for Health Research	Chinese National Science and Technology Major Project Fund; AREAS Global TB Vaccine Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported with funds from Chinese National Science and Technology Major Project Fund (Project No. 2013ZX10003006), from AREAS Global TB Vaccine Foundation, and from the Canadian Institutes for Health Research.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Darrah PA, 2014, J IMMUNOL, V193, P1799, DOI 10.4049/jimmunol.1400676; Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045; Horvath CN, 2012, MUCOSAL IMMUNOL, V5, P420, DOI 10.1038/mi.2012.19; Jeyanathan M, 2013, MUCOSAL IMMUNOL, V6, P612, DOI 10.1038/mi.2012.103; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Johnson MJ, 2012, J IMMUNOL, V188, P6109, DOI 10.4049/jimmunol.1103717; Kaufmann SHE, 2013, SEMIN IMMUNOL, V25, P172, DOI 10.1016/j.smim.2013.04.006; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Laube Beth L, 2014, Transl Respir Med, V2, P3, DOI 10.1186/2213-0802-2-3; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Luciw PA, 2011, AM J PHYSIOL-LUNG C, V301, pL731, DOI 10.1152/ajplung.00120.2011; Magalhaes I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003790; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Rubin BA, 1998, VACCINES, P492; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Scanga CA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018564; Shaler CR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/628293; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Smith DG, 2005, COMPARATIVE MED, V55, P227; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; White AD, 2013, CLIN VACCINE IMMUNOL, V20, P663, DOI 10.1128/CVI.00690-12; WHO, 2014, GLOB TUB REP 2014; Xing Z, 2014, CHEST, V146, P804, DOI 10.1378/chest.14-0439; Zhang J, 2014, TUBERCULOSIS, V94, P634, DOI 10.1016/j.tube.2014.08.005	34	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135009	10.1371/journal.pone.0135009	http://dx.doi.org/10.1371/journal.pone.0135009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252520	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100102
J	Jiang, Y; Huang, SS; Deng, T; Wu, LH; Chen, J; Kang, DY; Xu, XF; Li, RY; Han, DY; Dai, P				Jiang, Yi; Huang, Shasha; Deng, Tao; Wu, Lihua; Chen, Juan; Kang, Dongyang; Xu, Xiufeng; Li, Ruiyu; Han, Dongyi; Dai, Pu			Mutation Spectrum of Common Deafness-Causing Genes in Patients with Non-Syndromic Deafness in the Xiamen Area, China	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; NONSYNDROMIC HEARING-LOSS; CONNEXIN-26 GJB2 GENE; PRELINGUAL DEAFNESS; MOLECULAR ANALYSIS; SLC26A4 MUTATIONS; PENDRED-SYNDROME; ASIAN POPULATIONS; RIBOSOMAL-RNA; HAN CHINESE	In China, approximately 30,000 babies are born with hearing impairment each year. However, the molecular factors causing congenital hearing impairment in the Xiamen area of Fujian province have not been evaluated. To provide accurate genetic testing and counseling in the Xiamen area, we investigated the molecular etiology of non-syndromic deafness in a deaf population from Xiamen. Unrelated students with hearing impairment (n = 155) who attended Xiamen Special Education School in Fujian Province were recruited for this study. Three common deafness-related genes, GJB2, SLC26A4, and mtDNA12SrRNA, were analyzed using all-exon sequencing. GJB2 mutations were detected in 27.1%(42/155) of the entire cohort. The non-syndromic hearing loss (NSHL) hotspot mutations c.109G>A (p.V37I) and c.235delC were found in this population, whereas the Caucasian hotspot mutation c.35delG was not. The allelic frequency of the c.109G>A mutation was 9.03% (28/310), slightly higher than that of c.235delC (8.39%, 26/310), which is the most common GJB2 mutation in most areas of China. The allelic frequency of the c. 109G>A mutation was significantly higher in this Xiamen's deaf population than that in previously reported cohorts (P = 0.00). The SLC26A4 mutations were found in 16.77% (26/155) of this cohort. The most common pathogenic allele was c.IVS7-2A>G (6.13%, 19/310), and the second most common was the c.1079C>T (p. A360V) mutation (1.94%, 6/310) which has rarely been reported as a hotspot mutation in other studies. The mutation rate of mtDNA12SrRNA in this group was 3.87% (6/155), all being the m.A1555G mutation. These findings show the specificity of the common deaf gene-mutation spectrum in this area. According to this study, there were specific hotspot mutations in Xiamen deaf patients. Comprehensive sequencing analysis of the three common deaf genes can help portray the mutation spectrum and develop optimal testing strategies for deaf patients in this area.	[Jiang, Yi; Huang, Shasha; Kang, Dongyang; Han, Dongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Jiang, Yi; Wu, Lihua; Chen, Juan; Li, Ruiyu] Fujian Med Univ, ShengLi Clin Coll, Fujian Prov Hosp, Fuzhou, Peoples R China; [Deng, Tao; Xu, Xiufeng] Beijing Capital Bio Independent Clin Lab, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Fujian Medical University; Fujian Provincial Hospital	Li, RY (corresponding author), Fujian Med Univ, ShengLi Clin Coll, Fujian Prov Hosp, Fuzhou, Peoples R China.	ruiyuli@sina.com; hdy301@263.net; daipu301@vip.sina.com		Jiang, Yi/0000-0002-3725-0148	Minister of Science and Technology of China [2012BAI09B00]; Chinese National Nature Science Foundation [81230020, 81200751]; State 863 High Technology R&D Key Project of China [2012AA020101]; Postdoctoral Science Foundation Grant of China [2013M542450]	Minister of Science and Technology of China; Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); State 863 High Technology R&D Key Project of China(National High Technology Research and Development Program of China); Postdoctoral Science Foundation Grant of China	This work was supported by a grant from the Minister of Science and Technology of China (2012BAI09B00), Chinese National Nature Science Foundation Research Grants (81230020, 81200751), State 863 High Technology R&D Key Project of China (2012AA020101), Postdoctoral Science Foundation Grant of China (2013M542450).	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Chai Y, 2015, CLIN GENET, V87, P350, DOI 10.1111/cge.12387; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Choi BY, 2009, GENET TEST MOL BIOMA, V13, P679, DOI 10.1089/gtmb.2009.0054; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dai P, 2008, GENET MED, V10, P586, DOI [10.1097/GIM.0b013e31817d2ef1, 10.1097GIM.0b013e31817d2ef1]; Dai P, 2007, GENET MED, V9, P283, DOI 10.1097/GIM.0b013e31804d2371; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; Du W, 2013, INT J PEDIATR OTORHI, V77, P1670, DOI 10.1016/j.ijporl.2013.07.023; Gallant E, 2013, AM J MED GENET A, V161, P2148, DOI 10.1002/ajmg.a.36042; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Guo YF, 2008, ACTA OTO-LARYNGOL, V128, P297, DOI 10.1080/00016480701767382; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Hu H, 2007, J HUM GENET, V52, P492, DOI 10.1007/s10038-007-0139-0; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Jacobs HT, 2005, EUR J HUM GENET, V13, P26, DOI 10.1038/sj.ejhg.5201250; Kupka Susan, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9017; Lai CC, 2007, METABOLISM, V56, P1279, DOI 10.1016/j.metabol.2007.05.013; Lee KY, 2008, INT J PEDIATR OTORHI, V72, P1301, DOI 10.1016/j.ijporl.2008.05.007; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Liu Xin, 2006, Zhonghua Yi Xue Za Zhi, V86, P1318; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Okamoto Y, 2014, LARYNGOSCOPE, V124, pE134, DOI 10.1002/lary.24368; Ostergaard E, 2002, CLIN GENET, V62, P303, DOI 10.1034/j.1399-0004.2002.620408.x; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Tekin M, 2003, EUR J PEDIATR, V162, P154, DOI 10.1007/s00431-002-1129-z; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p61S, DOI 10.1177/0003489415575060; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Xin F, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-312; Xu DR, 2011, J TRANSL MED, V9, DOI [10.1186/1479-5876-9-167, 10.1186/1479-5876-9-74]; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yan D, 2003, HUM GENET, V114, P44, DOI 10.1007/s00439-003-1018-1; Yang JJ, 2005, HEARING RES, V199, P22, DOI 10.1016/j.heares.2004.08.007; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zainal SA, 2012, INT J PEDIATR OTORHI, V76, P1175, DOI 10.1016/j.ijporl.2012.04.027	47	22	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135088	10.1371/journal.pone.0135088	http://dx.doi.org/10.1371/journal.pone.0135088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252218	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100115
J	Kamaraj, B; Bogaerts, A				Kamaraj, Balu; Bogaerts, Annemie			Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							AMBIGUOUS DISTANCE RESTRAINTS; TUMOR-SUPPRESSOR PROTEIN; IARC TP53 DATABASE; C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; DNA RECOGNITION; MUTANT P53; BINDING; MECHANISM; DOCKING	The tumor suppressor protein p53 can lose its function upon DNA-contact mutations (R273C and R273H) in the core DNA-binding domain. The activity can be restored by second-site suppressor or rescue mutations (R273C_T284R, R273H_T284R, and R273H_S240R). In this paper, we elucidate the structural and functional consequence of p53 proteins upon DNA-contact mutations and rescue mutations and the underlying mechanisms at the atomic level by means of molecular dynamics simulations. Furthermore, we also apply the docking approach to investigate the binding phenomena between the p53 protein and DNA upon DNA-contact mutations and rescue mutations. This study clearly illustrates that, due to DNA-contact mutants, the p53 structure loses its stability and becomes more rigid than the native protein. This structural loss might affect the p53-DNA interaction and leads to inhibition of the cancer suppression. Rescue mutants (R273C_T284R, R273H_T284R and R273H_S240R) can restore the functional activity of the p53 protein upon DNA-contact mutations and show a good interaction between the p53 protein and a DNA molecule, which may lead to reactivate the cancer suppression function. Understanding the effects of p53 cancer and rescue mutations at the molecular level will be helpful for designing drugs for p53 associated cancer diseases. These drugs should be designed so that they can help to inhibit the abnormal function of the p53 protein and to reactivate the p53 function (cell apoptosis) to treat human cancer.	[Kamaraj, Balu; Bogaerts, Annemie] Univ Antwerp, Res Grp PLASMANT, Dept Chem, B-2610 Antwerp, Belgium	University of Antwerp	Bogaerts, A (corresponding author), Univ Antwerp, Res Grp PLASMANT, Dept Chem, Univ PL 1, B-2610 Antwerp, Belgium.	annemie.bogaerts@uantwerpen.be	Kamaraj, Balu/AAE-2852-2019; Bogaerts, Annemie/L-8338-2016	Kamaraj, Balu/0000-0002-9747-3984; Bogaerts, Annemie/0000-0001-9875-6460	Methusalem funding	Methusalem funding	This research was financially supported by the Methusalem funding.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arciuch VGA, 2011, ONCOTARGET, V2, P1109, DOI 10.18632/oncotarget.380; aroni TE, 2004, P NATL ACAD SCI USA, V101, P4930; Balu K, 2013, CELL BIOCHEM BIOPHYS, V67, P623, DOI 10.1007/s12013-013-9551-6; BARTLETT PA, 1987, SCIENCE, V235, P569, DOI 10.1126/science.3810155; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berns A, 2010, NATURE, V468, P519, DOI 10.1038/468519a; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eldar A, 2013, NUCLEIC ACIDS RES, V41, P8748, DOI 10.1093/nar/gkt630; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; FERSHT AR, 1984, TRENDS BIOCHEM SCI, V9, P145, DOI 10.1016/0968-0004(84)90122-1; Fersht AR, 2004, J MOL BIOL, V342, P801; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Gao JM, 1996, SCIENCE, V272, P535, DOI 10.1126/science.272.5261.535; Gomez-Lazaro M, 2004, J PHYSIOL BIOCHEM, V60, P287, DOI 10.1007/BF03167075; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hock AK, 2012, CELL, V149, P1183, DOI 10.1016/j.cell.2012.05.024; HONIG B, 1995, ADV PROTEIN CHEM, V46, P27, DOI 10.1016/S0065-3233(08)60331-9; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kamapantula BK, 2014, J AMB INTEL HUM COMP, P1, DOI [DOI 10.1080/07391102.2014.915762, 10.1080/07391102.2014.915762]; Kamaraj B, 2013, J MOL MODEL, V19, P5587, DOI 10.1007/s00894-013-2044-0; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Machado ACD, 2012, BIOCHEM MOL BIOL EDU, V40, P400, DOI 10.1002/bmb.20650; Madapura HS, 2012, CELL CYCLE, V11, P4563, DOI 10.4161/cc.22810; Malecka KA, 2009, ONCOGENE, V28, P325, DOI 10.1038/onc.2008.400; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meulmeester E, 2008, CURR CANCER DRUG TAR, V8, P87, DOI 10.2174/156800908783769337; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Paskulin DD, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.116; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Rouaud P, 2012, ONCOTARGET, V3, P586, DOI 10.18632/oncotarget.474; Sakaguchi K, 1997, J PROTEIN CHEM, V16, P553, DOI 10.1023/A:1026334116189; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Turner, 2005, XMGRACE VERSION 51 1; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Wieczorek AM, 1996, NAT MED, V2, P1143, DOI 10.1038/nm1096-1143	63	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134638	10.1371/journal.pone.0134638	http://dx.doi.org/10.1371/journal.pone.0134638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244575	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400096
J	Kim, J; Sato, M; Choi, JW; Kim, HW; Yeh, BI; Larsen, JE; Minna, JD; Cha, JH; Jeong, Y				Kim, Jihye; Sato, Mitsuo; Choi, Jong-Whan; Kim, Hyun-Won; Yeh, Byung-Il; Larsen, Jill E.; Minna, John D.; Cha, Jeong-Heon; Jeong, Yangsik			Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis	PLOS ONE			English	Article							SELECTIVE ESTROGEN-RECEPTOR; BRONCHIAL EPITHELIAL-CELLS; BREAST-CANCER; PPAR-GAMMA; PROSTATE-CANCER; PROMYELOCYTIC LEUKEMIAS; ALPHA GENE; ACTIVATION; MODULATORS; PROTEIN	Lung cancer is caused by combinations of diverse genetic mutations. Here, to understand the relevance of nuclear receptors (NRs) in the oncogene-associated lung cancer pathogenesis, we investigated the expression profile of the entire 48 NR members by using QPCR analysis in a panel of human bronchial epithelial cells (HBECs) that included precancerous and tumorigenic HBECs harboring oncogenic K-ras(V12) and/or p53 alterations. The analysis of the profile revealed that oncogenic alterations accompanied transcriptional changes in the expression of 19 NRs in precancerous HBECs and 15 NRs according to the malignant progression of HBECs. Amongst these, peroxisome proliferator-activated receptor gamma (PPAR gamma), a NR chosen as a proof-of-principle study, showed increased expression in precancerous HBECs, which was surprisingly reversed when these HBECs acquired full in vivo tumorigenicity. Notably, PPAR gamma activation by thiazolidinedione (TZD) treatment reversed the increased expression of pro-inflammatory cyclooxygenase 2 (COX2) in precancerous HBECs. In fully tumorigenic HBECs with inducible expression of PPAR gamma, TZD treatments inhibited tumor cell growth, clonogenecity, and cell migration in a PPAR gamma-sumoylation dependent manner. Mechanistically, the sumoylation of liganded-PPAR gamma decreased COX2 expression and increased 15-hydroxyprostaglandin dehydrogenase expression. This suggests that ligand-mediated sumoylation of PPAR gamma plays an important role in lung cancer pathogenesis by modulating prostaglandin metabolism.	[Kim, Jihye; Choi, Jong-Whan; Kim, Hyun-Won; Yeh, Byung-Il; Jeong, Yangsik] Yonsei Univ, Dept Biochem, Wonju Coll Med, Wonju, Gangwon Do, South Korea; [Kim, Jihye; Jeong, Yangsik] Yonsei Univ, Inst Lifestyle Med, Wonju Coll Med, Wonju, Gangwon Do, South Korea; [Kim, Jihye; Jeong, Yangsik] Yonsei Univ, Nucl Receptor Res Consortium, Wonju Coll Med, Wonju, Gangwon Do, South Korea; [Cha, Jeong-Heon] Yonsei Univ, Dept Oral Biol, Oral Canc Res Inst,Coll Dent, Oral Sci Res Ctr,Project BK21,Res Ctr Orofacial H, Seoul 120749, South Korea; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Sato, Mitsuo] Nagoya Univ, Grad Sch Med, Dept Resp Med, Showa Ku, Nagoya, Aichi 4648601, Japan	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nagoya University	Cha, JH (corresponding author), Yonsei Univ, Dept Oral Biol, Oral Canc Res Inst,Coll Dent, Oral Sci Res Ctr,Project BK21,Res Ctr Orofacial H, Seoul 120749, South Korea.	jcha@yuhs.ac; yjeong@yonsei.ac.kr	Larsen, Jill E/G-3787-2010; Sato, MITSUO/I-7280-2014	Larsen, Jill E/0000-0001-7806-3931; Sato, MITSUO/0000-0001-5458-9576; Cha, Jeong-Heon/0000-0002-9385-2653	Ministry of Education, Science and Technology [NRF-2013R1A1A1A05005075]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	The National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1A05005075 to YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Barish GD, 2004, TRENDS ENDOCRIN MET, V15, P158, DOI 10.1016/j.tem.2004.03.003; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Brown JR, 2004, CLIN CANCER RES, V10, p4266S, DOI 10.1158/1078-0432.CCR-040014; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; CHOMIENNE C, 1990, LEUKEMIA, V4, P802; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; DANIEL MT, 1993, BLOOD, V82, P1858; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Florez JC, 2007, J CLIN ENDOCR METAB, V92, P1502, DOI 10.1210/jc.2006-2275; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Jeong Y, 2012, MOL ENDOCRINOL, V26, P1443, DOI 10.1210/me.2011-1382; Jeong Y, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000378; Jihye Kim YJ., 2012, J LIFESTYLE MED, V2, P30; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joly-Pharaboz MO, 2000, J STEROID BIOCHEM, V73, P237, DOI 10.1016/S0960-0760(00)00076-5; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Levenson AS, 2002, CANCER RES, V62, P4419; Lewis-Wambi JS, 2011, MOL PHARMACOL, V80, P610, DOI 10.1124/mol.111.072249; Liu H, 2003, J NATL CANCER I, V95, P1586, DOI 10.1093/jnci/djg080; LONGO L, 1990, J EXP MED, V172, P1571, DOI 10.1084/jem.172.6.1571; McCormack VA, 2011, CANCER CAUSE CONTROL, V22, P1709, DOI 10.1007/s10552-011-9847-z; Minna JD, 2003, CANCER CELL, V4, P163, DOI 10.1016/S1535-6108(03)00221-6; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Osipo C, 2003, J NATL CANCER I, V95, P1597, DOI 10.1093/jnci/djg079; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ramalingam Sakkaraiappan, 2004, Clin Lung Cancer, V5, P245, DOI 10.3816/CLC.2004.n.006; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Saez E, 2003, NAT MED, V9, P1265, DOI 10.1038/nm928; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sato M, 2013, MOL CANCER RES, V11, P638, DOI 10.1158/1541-7786.MCR-12-0634-T; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; SMITH WE, 1948, J EXP MED, V88, P529, DOI 10.1084/jem.88.5.529; Spears M, 2006, CLIN EXP ALLERGY, V36, P1494, DOI 10.1111/j.1365-2222.2006.02604.x; Sporn MB, 2001, TRENDS MOL MED, V7, P395, DOI 10.1016/S1471-4914(01)02100-1; Wang T, 2008, PROSTATE, V68, P1734, DOI 10.1002/pros.20838; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134842	10.1371/journal.pone.0134842	http://dx.doi.org/10.1371/journal.pone.0134842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244663	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400111
J	Li, L; Ye, DP; Niu, M; Yan, HF; Wen, TL; Li, SJ				Li, Lin; Ye, De-Ping; Niu, Miao; Yan, Hai-Fei; Wen, Tie-Long; Li, Shi-Jin			Thuniopsis: A New Orchid Genus and Phylogeny of the Tribe Arethuseae (Orchidaceae)	PLOS ONE			English	Article							EPIDENDROIDEAE; MATK; SEQUENCES; MODEL	An investigation of a questionable orchid led to the discovery of a new genus and species Thuniopsis cleistogama, endemic to Yunnan province, China. It is characterized by having a subglobose corm, a spike-like (racemose) inflorescence, half opened and spurless flowers, a collar-shaped stigma and subglobose capsules. Based on DNA sequence data from three gene regions (nuclear ribosomal ITS, chloroplast matK and trnL), we investigated its phylogenetic position within the tribe Arethuseae. Phylogenies using maximum likelihood and Bayesian inference support the recognition of Thuniopsis as a distinct genus, and suggest its close relationship to the genera Bletilla, Dilochia, and Thunia. The new genus is circumscribed and a description and illustrations of the new species are provided. The phylogenetic relationships among the genera in Arethuseae are accessed. Moreover, our phylogeny also shed light on the phylogenetic positions of several genera which, to date, remain uncertain.	[Li, Lin; Niu, Miao; Yan, Hai-Fei; Wen, Tie-Long; Li, Shi-Jin] Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Ye, De-Ping] Forest Bur Puer, Puer, Yunnan, Peoples R China; [Niu, Miao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SJ (corresponding author), Chinese Acad Sci, Key Lab Plant Resources Conservat & Sustainable U, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	lisj@scib.ac.cn			National Natural Science Foundation of China [31270248, 31100149]; Science and Technology Basic Work, Project of the Ministry of Science and Technology, China [2013FY112100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Basic Work, Project of the Ministry of Science and Technology, China	This research has been financially supported by grants from the National Natural Science Foundation of China (Grant Nos. 31270248 and 31100149) and Science and Technology Basic Work, Project of the Ministry of Science and Technology, China (Grant No. 2013FY112100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GENERA ORCHIDACEARUM; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; CHASE MW, 2003, ORCHID CONSERVATION; DANNENBAUM C, 1989, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V110, P441; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freudenstein JV, 2015, ANN BOT-LONDON, V115, P665, DOI 10.1093/aob/mcu253; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; Gene Codes Corporation, 2005, SEQ VERS 4 5; Goldman DH, 2004, AM J BOT, V91, P707, DOI 10.3732/ajb.91.5.707; Goldman DH, 2001, SYST BOT, V26, P670; Gravendeel B, 2004, SYST BOT, V29, P50, DOI 10.1600/036364404772973988; Gravendeel B, 2001, AM J BOT, V88, P1915, DOI 10.2307/3558367; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2001, IUCN RED LIST CAT CR; Kocyan A, 2004, PLANT SYST EVOL, V247, P203, DOI 10.1007/s00606-004-0133-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103129; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078112; Lindley J., 1826, ORCHIDEARUM SCELETOS; McNeill J, 2012, REGNUM VEG, V154, P1; Piraee M, 2002, J IND MICROBIOL BIOT, V29, P1, DOI 10.1038/sj.jim.7000263; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2007, SE AL SEQUENCE ALIGN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seidenfaden G, 1986, OPERA BOT, V89, P10; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Xu Z. H., 2010, WILD ORCHIDS YUNNAN; Zwickl DJ., 2006, THESIS	35	11	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132777	10.1371/journal.pone.0132777	http://dx.doi.org/10.1371/journal.pone.0132777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244769	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400028
J	McClure, R; Nudel, K; Massari, P; Tjaden, B; Su, XH; Rice, PA; Genco, CA				McClure, Ryan; Nudel, Kathleen; Massari, Paola; Tjaden, Brian; Su, Xiaohong; Rice, Peter A.; Genco, Caroline A.			The Gonococcal Transcriptome during Infection of the Lower Genital Tract in Women	PLOS ONE			English	Article							EFFLUX PUMP SYSTEM; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; PROTEIN; GENES; FUR; IDENTIFICATION; EXPRESSION; RESISTANCE; LEVEL	Gonorrhea is a highly prevalent disease resulting in significant morbidity worldwide, with an estimated 106 cases reported annually. Neisseria gonorrhoeae, the causative agent of gonorrhea, colonizes and infects the human genital tract and often evades host immune mechanisms until successful antibiotic treatment is used. The alarming increase in antibiotic-resistant strains of N. gonorrhoeae, the often asymptomatic nature of this disease in women and the lack of a vaccine directed at crucial virulence determinants have prompted us to perform transcriptome analysis to understand gonococcal gene expression patterns during natural infection. We sequenced RNA extracted from cervico-vaginal lavage samples collected from women recently exposed to infected male partners and determined the complete N. gonorrhoeae transcriptome during infection of the lower genital tract in women. On average, 3.19% of total RNA isolated from female samples aligned to the N. gonorrhoeae NCCP11945 genome and 1750 gonococcal ORFs (65% of all protein-coding genes) were transcribed. High expression in vivo was observed in genes encoding antimicrobial efflux pumps, iron response, phage production, pilin structure, outer membrane structures and hypothetical proteins. A parallel analysis was performed using the same strains grown in vitro in a chemically defined media (CDM). A total of 140 genes were increased in expression during natural infection compared to growth in CDM, and 165 genes were decreased in expression. Large differences were found in gene expression profiles under each condition, particularly with genes involved in DNA and RNA processing, iron, transposase, pilin and lipoproteins. We specifically interrogated genes encoding DNA binding regulators and iron-scavenging proteins, and identified increased expression of several iron-regulated genes, including tbpAB and fbpAB, during infection in women as compared to growth in vitro, suggesting that during infection of the genital tract in women, the gonococcus is exposed to an iron deplete environment. Collectively, we demonstrate that a large portion of the gonococcal genome is expressed and regulated during mucosal infection including genes involved in regulatory functions and iron scavenging.	[McClure, Ryan; Nudel, Kathleen; Massari, Paola; Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [McClure, Ryan; Genco, Caroline A.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Tjaden, Brian] Wellesley Coll, Dept Comp Sci, Wellesley, MA 02181 USA; [Su, Xiaohong] Chinese Acad Med Sci, Inst Dermatol, STD Clin, Nanjing 210042, Jiangsu, Peoples R China; [Su, Xiaohong] Peking Union Med Coll, Nanjing 210042, Jiangsu, Peoples R China; [Rice, Peter A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA	Boston University; Boston University; Wellesley College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Massachusetts System; University of Massachusetts Worcester	Genco, CA (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, 136 Harrison Ave,M&V 701, Boston, MA 02111 USA.	caroline.genco@tufts.edu		Nudel, Kathleen/0000-0002-5483-0515; Massari, Paola/0000-0003-3106-0711; McClure, Ryan/0000-0003-0573-6917	National Institute of Health/ National Institute of Allergy and Infectious Diseases [R01AI048611, R56AI107821, 1U19AI084048]; National Institute of Health [GM102755]	National Institute of Health/ National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from National Institute of Health/ National Institute of Allergy and Infectious Diseases R01AI048611 and R56AI107821 to CAG, National Institute of Health/ National Institute of Allergy and Infectious Diseases 1U19AI084048 to PAR and CAG, and National Institute of Health / GM102755 to BT.	Agarwal S, 2005, INFECT IMMUN, V73, P4281, DOI 10.1128/IAI.73.7.4281-4287.2005; Agarwal S, 2008, J BACTERIOL, V190, P3129, DOI 10.1128/JB.01830-07; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; CLARK VL, 1988, MICROB PATHOGENESIS, V5, P381, DOI 10.1016/0882-4010(88)90038-1; Clinical Laboratory Standards Institute (CLSI), 2012, M100S22 CLSI, P100; Daou N, 2013, INFECT IMMUN, V81, P3652, DOI 10.1128/IAI.00298-13; Delahay RM, 1997, MICROBIOL-SGM, V143, P2127, DOI 10.1099/00221287-143-7-2127; Du Y, 2006, INFECT IMMUN, V74, P2767, DOI 10.1128/IAI.74.5.2767-2776.2006; Ducey TF, 2009, MICROB PATHOGENESIS, V46, P166, DOI 10.1016/j.micpath.2008.12.003; Nguyen D, 2014, EMERG INFECT DIS, V20, P1211, DOI 10.3201/eid2007.131396; Feavers IM, 1998, MOL MICROBIOL, V30, P647, DOI 10.1046/j.1365-2958.1998.01101.x; Garay H, 2011, BIOCONJUGATE CHEM, V22, P33, DOI 10.1021/bc100299g; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; GRIGGS DW, 1989, J BACTERIOL, V171, P1048, DOI 10.1128/jb.171.2.1048-1054.1989; Hagman KE, 1997, MICROBIOL-SGM, V143, P2117, DOI 10.1099/00221287-143-7-2117; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Isabella VM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-51; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Laskos L, 2004, J BACTERIOL, V186, P8443, DOI 10.1128/JB.186.24.8443-8452.2004; Lin JSL, 1998, J INFECT DIS, V178, P1707, DOI 10.1086/314485; Madico G, 2000, J CLIN MICROBIOL, V38, P1085, DOI 10.1128/JCM.38.3.1085-1093.2000; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McClure R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00456; Mellin JR, 2007, J BACTERIOL, V189, P3686, DOI 10.1128/JB.01890-06; Menendez T, 2011, INT J MED MICROBIOL, V301, P16, DOI 10.1016/j.ijmm.2010.04.020; Muller MG, 2013, J IMMUNOL, V191, P3287, DOI 10.4049/jimmunol.1301153; Newkirk GR, 1996, AM FAM PHYSICIAN, V53, P1127; Nikolaitchouk N, 2008, APMIS, V116, P263, DOI 10.1111/j.1600-0463.2008.00808.x; Oku Y, 2004, MICROBIOL-SGM, V150, P45, DOI 10.1099/mic.0.26706-0; Piekarowicz A, 2006, POL J MICROBIOL, V55, P251; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Rouquette C, 1999, MOL MICROBIOL, V33, P651, DOI 10.1046/j.1365-2958.1999.01517.x; Seed KD, 2014, ELIFE, V3, DOI 10.7554/eLife.03497; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Shepherd J, 2013, FEBS LETT, V587, P2895, DOI 10.1016/j.febslet.2013.07.036; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; WHO, 2012, WORLD HEAL ORGAN, P1; Yuan LF, 2011, SEX TRANSM DIS, V38, P764, DOI 10.1097/OLQ.0b013e318219cdb5; ZHENG HY, 1994, J INFECT DIS, V170, P1209, DOI 10.1093/infdis/170.5.1209	47	47	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133982	10.1371/journal.pone.0133982	http://dx.doi.org/10.1371/journal.pone.0133982			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244506	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400060
J	Dyson, ZA; Tucci, J; Seviour, RJ; Petrovski, S				Dyson, Zoe A.; Tucci, Joseph; Seviour, Robert J.; Petrovski, Steve			Lysis to Kill: Evaluation of the Lytic Abilities, and Genomics of Nine Bacteriophages Infective for Gordonia spp. and Their Potential Use in Activated Sludge Foam Biocontrol	PLOS ONE			English	Article							RHODOCOCCUS; DNA; SEQUENCE; GENES; GENUS; PREDICTION	Nine bacteriophages (phages) infective for members of the genus Gordonia were isolated from wastewater and other natural water environments using standard enrichment techniques. The majority were broad host range phages targeting more than one Gordonia species. When their genomes were sequenced, they all emerged as double stranded DNA Siphoviridae phages, ranging from 17,562 to 103,424 bp in size, and containing between 27 and 127 genes, many of which were detailed for the first time. Many of these phage genomes diverged from the expected modular genome architecture of other characterized Siphoviridae phages and contained unusual lysis gene arrangements. Whole genome sequencing also revealed that infection with lytic phages does not appear to prevent spontaneous prophage induction in Gordonia malaquae lysogen strain BEN700. TEM sample preparation techniques were developed to view both attachment and replication stages of phage infection.	[Dyson, Zoe A.; Tucci, Joseph] La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Seviour, Robert J.; Petrovski, Steve] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia	La Trobe University	Petrovski, S (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia.	steve.petrovski@latrobe.edu.au	Dyson, Zoe Anne/AAW-4294-2021	Dyson, Zoe Anne/0000-0002-8887-3492; seviour, robert/0000-0002-1366-0484; Petrovski, Steve/0000-0002-6304-6853	La Trobe University	La Trobe University	This work was supported by La Trobe University.	Ali Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00098; Arenskotter M, 2004, APPL ENVIRON MICROB, V70, P3195, DOI 10.1128/AEM.70.6.3195-3204.2004; Bajpai R, 2012, J VIROL, V86, P9552, DOI 10.1128/JVI.01529-12; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de los Reyes FL, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P215; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Drzyzga O, 2012, CRIT REV MICROBIOL, V38, P300, DOI 10.3109/1040841X.2012.668134; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; Goodfellow M, 2012, BERGEYS MANUAL SYSTE, P419; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004; HENTHORN KS, 1995, J BACTERIOL, V177, P3185, DOI 10.1128/jb.177.11.3185-3190.1995; KLATTE S, 1994, INT J SYST BACTERIOL, V44, P769, DOI 10.1099/00207713-44-4-769; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LECHEVALIER MP, 1974, INT J SYST BACTERIOL, V24, P278, DOI 10.1099/00207713-24-2-278; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Petrovski S, 2014, ARCH VIROL, V159, P167, DOI 10.1007/s00705-013-1799-z; Petrovski S, 2013, VIRUS GENES, V46, P588, DOI 10.1007/s11262-013-0887-1; Petrovski S, 2013, ARCH VIROL, V158, P601, DOI 10.1007/s00705-012-1530-5; Petrovski S, 2012, APPL ENVIRON MICROB, V78, P42, DOI 10.1128/AEM.05584-11; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P7864, DOI 10.1128/AEM.05692-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P3923, DOI 10.1128/AEM.00025-11; Petrovski S, 2011, WATER RES, V45, P2146, DOI 10.1016/j.watres.2010.12.026; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Pope WH, 2014, J VIROL, V88, P2461, DOI 10.1128/JVI.03363-13; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SODDELL JA, 1990, J APPL BACTERIOL, V69, P145, DOI 10.1111/j.1365-2672.1990.tb01506.x; Soddell JA., 1999, MICROBIOLOGY ACTIVAT; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; Tamaki H, 2012, ENVIRON MICROBIOL, V14, P441, DOI 10.1111/j.1462-2920.2011.02630.x; Thomas JA, 2002, WATER SCI TECHNOL, V46, P511, DOI 10.2166/wst.2002.0527; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	43	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134512	10.1371/journal.pone.0134512	http://dx.doi.org/10.1371/journal.pone.0134512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241321	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700047
J	Lo Gullo, A; Mandraffino, G; Bagnato, G; Aragona, CO; Imbalzano, E; D'Ascola, A; Rotondo, F; Cinquegrani, A; Mormina, E; Saitta, C; Versace, AG; Sardo, MA; Lo Gullo, R; Loddo, S; Saitta, A				Lo Gullo, Alberto; Mandraffino, Giuseppe; Bagnato, Gianluca; Aragona, Caterina Oriana; Imbalzano, Egidio; D'Ascola, Angela; Rotondo, Francesco; Cinquegrani, Antonella; Mormina, Enricomaria; Saitta, Carlo; Versace, Antonio Giovanni; Sardo, Maria Adriana; Lo Gullo, Renato; Loddo, Saverio; Saitta, Antonino			Vitamin D Status in Rheumatoid Arthritis: Inflammation, Arterial Stiffness and Circulating Progenitor Cell Number	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; CD34(+) CELLS; D DEFICIENCY; VASCULAR FUNCTION; DISEASE-ACTIVITY; STEM-CELLS; SUPPLEMENTATION	Background and Aims Suboptimal vitamin D status was recently acknowledged as an independent predictor of cardiovascular diseases and all-cause mortality in several clinical settings, and its serum levels are commonly reduced in Rheumatoid Arthritis (RA). Patients affected by RA present accelerated atherosclerosis and increased cardiovascular morbidity and mortality with respect to the general population. In RA, it has been reported an impairment of the number and the activity of circulating proangiogenic haematopoietic cells (PHCs), including CD34+, that may play a role in endothelial homeostasis. The purpose of the study is to investigate the association between vitamin D levels and PHCs, inflammatory markers, and arterial stiffening in patients with RA. Methods and Results CD34+ cells were isolated from 27 RA patients and 41 controls. Vitamin D levels, C-reactive protein (CRP), fibrinogen, pulse wave velocity (PWV), and carotid intima-media thickness (cIMT) were also evaluated. CD34+ count and vitamin D levels were lower in RA patients as compared to controls, while fibrinogen, CRP, PWV and cIMT were higher in RA patients. CD34+ cell number appeared to be associated with vitamin D levels, and negatively correlated to fibrinogen and early atherosclerosis markers (PWV and cIMT); vitamin D levels appear also to be inversely associated to fibrinogen. Conclusions RA patients with moderate disease activity presented with low vitamin D levels, low CD34+ cell count, increased PWV and cIMT; we found that vitamin D deficiency is associated to CD34+ cell reduction in peripheral blood, and with fibrinogen levels. This suggests that vitamin D might contribute to endothelial homeostasis in patients with RA.	[Lo Gullo, Alberto; Mandraffino, Giuseppe; Bagnato, Gianluca; Aragona, Caterina Oriana; Imbalzano, Egidio; Saitta, Carlo; Versace, Antonio Giovanni; Sardo, Maria Adriana; Lo Gullo, Renato; Saitta, Antonino] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [D'Ascola, Angela; Loddo, Saverio] Univ Messina, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Rotondo, Francesco] Univ Messina, Dept Gen Surg & Oncol, Messina, Italy; [Cinquegrani, Antonella; Mormina, Enricomaria] Univ Messina, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy	University of Messina; University of Messina; University of Messina; University of Messina	Mandraffino, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	gmandraffino@unime.it	Mormina, Enricomaria/K-4664-2016; Gullo, Alberto Lo/AAC-2766-2019; Bagnato, Gianluca/D-5742-2018; Saitta, Carlo/A-1747-2015; Imbalzano, Egidio/A-2063-2015; Mandraffino, Giuseppe/K-4346-2018; Aragona, Oriana/AAN-1310-2020; Loddo, Saverio/I-7397-2012	Mormina, Enricomaria/0000-0003-2716-5772; Bagnato, Gianluca/0000-0002-7594-8520; Imbalzano, Egidio/0000-0003-2656-5467; Mandraffino, Giuseppe/0000-0003-0272-2237; Aragona, Oriana/0000-0002-1314-6602; Sardo, Maria Adriana/0000-0003-2872-2542; Loddo, Saverio/0000-0002-3338-9599; Versace, Antonio Giovanni/0000-0001-5021-1365; Lo Gullo, Alberto/0000-0003-4383-0314; d'ascola, angela/0000-0001-7530-1316; Saitta, Antonino/0000-0002-2577-5676	University of Messina (PRA-Progetto di Ricerca di Ateneo - University of Messina) [J41J1000013005]	University of Messina (PRA-Progetto di Ricerca di Ateneo - University of Messina)	This work was supported by a grant from the University of Messina (PRA-Progetto di Ricerca di Ateneo - J41J1000013005 - University of Messina).	Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032; Andress DL, 2006, KIDNEY INT, V69, P33, DOI 10.1038/sj.ki.5000045; Antico A, 2012, AUTOIMMUN REV, V12, P127, DOI 10.1016/j.autrev.2012.07.007; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barnett D, 1999, CLIN LAB HAEMATOL, V21, P301, DOI 10.1046/j.1365-2257.1999.00253.x; Beveridge LA, 2015, JAMA INTERN MED, V175, P745, DOI 10.1001/jamainternmed.2015.0237; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Chao H, 2010, MICROVASC RES, V79, P169, DOI 10.1016/j.mvr.2010.02.003; Choy E, 2014, RHEUMATOLOGY, V53, P2143, DOI 10.1093/rheumatology/keu224; Cianciolo G, 2011, BLOOD PURIFICAT, V32, P161, DOI 10.1159/000325459; Dalbeni A, 2014, NUTR METAB CARDIOVAS, V24, P861, DOI 10.1016/j.numecd.2014.02.015; de Boer HC, 2011, ARTERIOSCL THROM VAS, V31, P408, DOI 10.1161/ATVBAHA.110.216879; Di Stefano R, 2013, INTERN EMERG MED, V8, pS47, DOI 10.1007/s11739-013-0915-0; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Haque UJ, 2012, ARTHRIT CARE RES, V64, P1497, DOI 10.1002/acr.21715; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hong Q, 2014, RHEUMATOLOGY, V53, P1994, DOI 10.1093/rheumatology/keu173; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Ku IA, 2009, CIRC J, V73, P977, DOI 10.1253/circj.CJ-09-0274; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Lee JH, 2013, ARTERIOSCL THROM VAS, V33, P1622, DOI 10.1161/ATVBAHA.112.301052; Liew JY, 2015, NUTR METAB CARDIOVAS, V25, P274, DOI 10.1016/j.numecd.2014.12.005; Lo Gullo A, 2014, CLIN EXP RHEUMATOL, V32, P922; Lo Gullo A, 2014, SCAND J RHEUMATOL, V43, P184, DOI 10.3109/03009742.2013.836564; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mandraffino G, 2012, EXP GERONTOL, V47, P394, DOI 10.1016/j.exger.2012.03.007; Mandraffino G, 2011, HYPERTENS RES, V34, P876, DOI 10.1038/hr.2011.56; Martini G, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0555-9; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Myasoedova E, 2016, ANN RHEUM DIS, V75, P560, DOI 10.1136/annrheumdis-2014-206411; Park YJ, 2014, ARTHRITIS RHEUMATOL, V66, P1450, DOI 10.1002/art.38352; Pesarin F, 2010, PERMUTATION TESTS FO; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Ranganathan P, 2013, J RHEUMATOL, V40, P1529, DOI 10.3899/jrheum.130012; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Richardson MR, 2011, J MOL CELL CARDIOL, V50, P266, DOI 10.1016/j.yjmcc.2010.07.009; Rigato M, 2015, J CLIN ENDOCR METAB, V100, P2666, DOI 10.1210/jc.2015-1687; Rodriguez-Carrio J, 2015, ANN RHEUM DIS, V74, P921, DOI 10.1136/annrheumdis-2013-204250; Rodriguez-Carrio J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086069; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Rossini M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3195; Seida JC, 2014, J CLIN ENDOCR METAB, V99, P3551, DOI 10.1210/jc.2014-2136; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Silva MC, 2015, NUTR RES, V35, P91, DOI 10.1016/j.nutres.2014.12.008; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8	55	38	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134602	10.1371/journal.pone.0134602	http://dx.doi.org/10.1371/journal.pone.0134602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241902	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942700052
J	Madan, B; Ke, Z; Harmston, N; Ho, SY; Frois, AO; Alam, J; Jeyaraj, DA; Pendharkar, V; Ghosh, K; Virshup, IH; Manoharan, V; Ong, EHQ; Sangthongpitag, K; Hill, J; Petretto, E; Keller, TH; Lee, MA; Matter, A; Virshup, DM				Madan, B.; Ke, Z.; Harmston, N.; Ho, S. Y.; Frois, A. O.; Alam, J.; Jeyaraj, D. A.; Pendharkar, V.; Ghosh, K.; Virshup, I. H.; Manoharan, V.; Ong, E. H. Q.; Sangthongpitag, K.; Hill, J.; Petretto, E.; Keller, T. H.; Lee, M. A.; Matter, A.; Virshup, D. M.			Wnt addiction of genetically defined cancers reversed by PORCN inhibition	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; COLON-CANCER; STEM-CELLS; EXPRESSION; PORCUPINE; PATHWAY; GROWTH; RNF43; TRANSCRIPTION; GENE	Enhanced sensitivity to Wnts is an emerging hallmark of a subset of cancers, defined in part by mutations regulating the abundance of their receptors. Whether these mutations identify a clinical opportunity is an important question. Inhibition of Wnt secretion by blocking an essential post-translational modification, palmitoleation, provides a useful therapeutic intervention. We developed a novel potent, orally available PORCN inhibitor, ETC-1922159 (henceforth called ETC-159) that blocks the secretion and activity of all Wnts. ETC-159 is remarkably effective in treating RSPO-translocation bearing colorectal cancer (CRC) patient-derived xenografts. This is the first example of effective targeted therapy for this subset of CRC. Consistent with a central role of Wnt signaling in regulation of gene expression, inhibition of PORCN in RSPO3-translocated cancers causes a marked remodeling of the transcriptome, with loss of cell cycle, stem cell and proliferation genes, and an increase in differentiation markers. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers.	[Madan, B.; Frois, A. O.; Ghosh, K.; Virshup, I. H.; Virshup, D. M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Ke, Z.; Ho, S. Y.; Alam, J.; Jeyaraj, D. A.; Pendharkar, V.; Manoharan, V.; Ong, E. H. Q.; Sangthongpitag, K.; Hill, J.; Keller, T. H.; Lee, M. A.; Matter, A.] ASTAR, Ctr Expt Therapeut, Biopolis, Singapore, Singapore; [Harmston, N.; Petretto, E.] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Dis, Singapore, Singapore; [Virshup, D. M.] Duke Univ, Dept Pediat, Durham, NC 27706 USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; National University of Singapore; Duke University	Madan, B; Virshup, DM (corresponding author), Duke NUS, Grad Sch Med, Program Canc & Stem Cell Biol, 07-20,8 Coll Rd, Singapore 169857, Singapore.	Babita.Madan@duke-nus.edu.sg; David.Virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Ho, Soo Yei/0000-0001-8535-389X; Petretto, Enrico/0000-0003-2163-5921; HARMSTON, NATHAN/0000-0002-8589-2938; Madan, Babita/0000-0003-1065-8589; Keller, Thomas/0000-0002-7553-6235	National Research Foundation Singapore; Agency for Science, Technology and Research (A*STAR), Singapore; MRC Clinical Sciences Centre, Imperial College, London; MRC [MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112] Funding Source: researchfish	National Research Foundation Singapore(National Research Foundation, Singapore); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); MRC Clinical Sciences Centre, Imperial College, London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the assistance of members of the Virshup lab including Jamal Aliyev, Naushad Moti and Edison and members of Experimental Therapeutics Centre including Shermaine Q Y Lim, Sifang Wang, Yu Wang, Vivien Wei Wen Cheong, and Grace Ruiting Lin. We acknowledge Ivana Mihalek for help with the alignment of PORCN sequences and Ralph Bunte, DVM, for his expert advice with histological analysis. We also acknowledge the assistance of the vivarium staff including Hock Lee. This research is supported in part by the National Research Foundation Singapore and administered by the Singapore Ministry of Health's National Medical Research Council under the STAR Award Program to DMV. The research in Experimental Therapeutics Centre is supported by the Agency for Science, Technology and Research (A*STAR), Singapore. EP and NH acknowledge the support of the MRC Clinical Sciences Centre, Imperial College, London.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Cardona GM, 2014, P 105 ANN M AM ASS C; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Coombs GS, 2012, ONCOGENE, V31, P213, DOI 10.1038/onc.2011.228; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Lee SB, 2013, BIOCHEM BIOPH RES CO, V431, P746, DOI 10.1016/j.bbrc.2013.01.038; Lenz HJ, 2014, CANCER SCI, V105, P1087, DOI 10.1111/cas.12471; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lum L, 2012, SCIENCE, V337, P922, DOI 10.1126/science.1228179; Madan B, 2015, MOL CANCER THER, V14, P1087, DOI 10.1158/1535-7163.MCT-14-1038; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinmura K, 2014, MOL BIOL REP, V41, P5375, DOI 10.1007/s11033-014-3409-x; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wang XL, 2013, J MED CHEM, V56, P2700, DOI 10.1021/jm400159c; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Yu J, 2014, BIOSCIENCE REP, V34, P593, DOI 10.1042/BSR20140119	49	185	197	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2197	2207		10.1038/onc.2015.280	http://dx.doi.org/10.1038/onc.2015.280			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26257057	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000374986000006
J	He, YN; Chen, YH; Mooney, SM; Rajagopalan, K; Bhargava, A; Sacho, E; Weninger, K; Bryan, PN; Kulkarni, P; Orban, J				He, Yanan; Chen, Yihong; Mooney, Steven M.; Rajagopalan, Krithika; Bhargava, Ajay; Sacho, Elizabeth; Weninger, Keith; Bryan, Philip N.; Kulkarni, Prakash; Orban, John			Phosphorylation-induced Conformational Ensemble Switching in an Intrinsically Disordered Cancer/Testis Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENIGN PROSTATIC HYPERPLASIA; C-JUN; ANDROGEN RECEPTOR; STRESS-RESPONSE; BACKBONE DYNAMICS; PROTEIN FOLDS; CANCER; TRANSACTIVATION; NMR; EXPRESSION	Prostate-associated gene 4 (PAGE4) is an intrinsically disordered cancer/testis antigen that is up-regulated in the fetal and diseased human prostate. Knocking down PAGE4 expression results in cell death, whereas its overexpression leads to a growth advantage of prostate cancer cells (Zeng, Y., He, Y., Yang, F., Mooney, S. M., Getzenberg, R. H., Orban, J., and Kulkarni, P. (2011) The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein. J. Biol. Chem. 286, 13985-13994). Phosphorylation of PAGE4 at Thr-51 is critical for potentiating c-Jun transactivation, an important factor in controlling cell growth, apoptosis, and stress response. Using NMR spectroscopy, we show that the PAGE4 polypeptide chain has local and long-range conformational preferences that are perturbed by site-specific phosphorylation at Thr-51. The population of transient turn-like structures increases upon phosphorylation in an similar to 20-residue acidic region centered on Thr-51. This central region therefore becomes more compact and more negatively charged, with increasing intramolecular contacts to basic sequence motifs near the N and C termini. Although flexibility is decreased in the central region of phospho-PAGE4, the polypeptide chain remains highly dynamic overall. PAGE4 utilizes a transient helical structure adjacent to the central acidic region to bind c-Jun with low affinity in vitro. The binding interaction is attenuated by phosphorylation at Thr-51, most likely because of masking the effects of the more compact phosphorylated state. Therefore, phosphorylation of PAGE4 leads to conformational shifts in the dynamic ensemble, with large functional consequences. The changes in the structural ensemble induced by posttranslational modifications are similar conceptually to the conformational switching events seen in some marginally stable ("metamorphic") folded proteins in response to mutation or environmental triggers.	[He, Yanan; Chen, Yihong; Bryan, Philip N.; Orban, John] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [He, Yanan; Chen, Yihong; Orban, John] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Mooney, Steven M.; Rajagopalan, Krithika; Kulkarni, Prakash] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; [Bhargava, Ajay] Shakti BioRes, Woodbridge, CT 06525 USA; [Sacho, Elizabeth; Weninger, Keith] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; University of North Carolina; North Carolina State University	Orban, J (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	pkulkar4@ibbr.umd.edu; jorban@umd.edu	Regan, Clinton/E-6250-2012; Rajagopalan, Krithika/AAZ-7034-2021	Rajagopalan, Krithika/0000-0002-9090-7022; , keith/0000-0001-9543-4992	National Institutes of Health [CA181730, GM62154]; University of Maryland; National Institute of Standards and Technology; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [R21CA181730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grants CA181730 (to J. O. and P. K.) and GM62154 (to J. O. and P. B.). The NMR facility is jointly supported by the University of Maryland, the National Institute of Standards and Technology, and a grant from the W. M. Keck Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Andresen C, 2012, NUCLEIC ACIDS RES, V40, P6353, DOI 10.1093/nar/gks263; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bista M, 2013, P NATL ACAD SCI USA, V110, P17814, DOI 10.1073/pnas.1317398110; Bryan PN, 2010, CURR OPIN STRUC BIOL, V20, P482, DOI 10.1016/j.sbi.2010.06.002; Bull JH, 2001, BRIT J CANCER, V84, P1512, DOI 10.1054/bjoc.2001.1816; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Cordek DG, 2014, J BIOL CHEM, V289, P24397, DOI 10.1074/jbc.M114.589911; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dobrynin P, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/105108; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goddard T.D., 2004, SPARKY 3; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; Hellman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026633; Huang KL, 2013, RNA, V19, P295, DOI 10.1261/rna.037317.112; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li WH, 2007, AM J PATHOL, V171, P1189, DOI 10.2353/ajpath.2007.070285; Lin-Tsai O, 2014, PROSTATE, V74, P669, DOI 10.1002/pros.22785; Mooney SM, 2014, BIOCHEMISTRY-US, V53, P1670, DOI 10.1021/bi500013w; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; ORBAN J, 1995, BIOCHEMISTRY-US, V34, P15291, DOI 10.1021/bi00046a038; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Plaxco KW, 1997, J BIOMOL NMR, V10, P221, DOI 10.1023/A:1018340217891; Prakash K, 2002, P NATL ACAD SCI USA, V99, P7598, DOI 10.1073/pnas.112191399; Rajagopalan K, 2014, BBA-MOL BASIS DIS, V1842, P154, DOI 10.1016/j.bbadis.2013.11.014; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Razzera G, 2010, STRUCTURE, V18, P1011, DOI 10.1016/j.str.2010.05.012; Ruan B, 2004, BIOCHEMISTRY-US, V43, P14539, DOI 10.1021/bi048177j; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Sampson N, 2012, AM J PATHOL, V181, P1443, DOI 10.1016/j.ajpath.2012.06.040; Sato N, 1997, J BIOL CHEM, V272, P17485, DOI 10.1074/jbc.272.28.17485; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stevenson BJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-129; Stott K, 2014, J BIOL CHEM, V289, P29817, DOI 10.1074/jbc.M114.591115; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xiang SQ, 2013, STRUCTURE, V21, P2162, DOI 10.1016/j.str.2013.09.014; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zeng Y, 2013, AM J CLIN EXP UROL, V1, P39; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	64	40	40	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25090	25102		10.1074/jbc.M115.658583	http://dx.doi.org/10.1074/jbc.M115.658583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26242913	Green Published, hybrid			2022-12-26	WOS:000362598300037
J	Georgiou, DK; Dagnino-Acosta, A; Lee, CS; Griffin, DM; Wang, H; Lagor, WR; Pautler, RG; Dirksen, RT; Hamilton, SL				Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Lee, Chang Seok; Griffin, Deric M.; Wang, Hui; Lagor, William R.; Pautler, Robia G.; Dirksen, Robert T.; Hamilton, Susan L.			Ca2+ Binding/Permeation via Calcium Channel, Ca(v)1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE; S-NITROSYLATION; MITOCHONDRIAL-MEMBRANE; INSULIN-RESISTANCE; BETA-OXIDATION; COA; FAT/CD36; PHOSPHORYLATION; EXPRESSION	Ca2+ permeation and/or binding to the skeletal muscle L-type Ca2+ channel (Ca(V)1.1) facilitates activation of Ca2+ /calmodulin kinase type II (CaMKII) and Ca2+ store refilling to reduce muscle fatigue and atrophy (Lee, C. S., Dagnino-Acosta, A., Yarotskyy, V., Hanna, A., Lyfenko, A., Knoblauch, M., Georgiou, D. K., Poche, R. A., Swank, M. W., Long, C., Ismailov, I. I., Lanner, J., Tran, T., Dong, K., Rodney, G. G., Dickinson, M. E., Beeton, C., Zhang, P., Dirksen, R. T., and Hamilton, S. L. (2015) Skelet. Muscle 5, 4). Mice with a mutation (E1014K) in the Cacna1s (alpha(1) subunit of Ca(V)1.1) gene that abolishes Ca2+ binding within the Ca(V)1.1 pore gain more body weight and fat on a chow diet than control mice, without changes in food intake or activity, suggesting that Ca(V)1.1-mediated CaMKII activation impacts muscle energy expenditure. We delineate a pathway (Ca(v)1.1 -> CaMKII -> NOS) in normal skeletal muscle that regulates the intracellular distribution of the fatty acid transport protein, CD36, altering fatty acid metabolism. The consequences of blocking this pathway are decreased mitochondrial beta-oxidation and decreased energy expenditure. This study delineates a previously uncharacterized Ca(V)1.1-mediated pathway that regulates energy utilization in skeletal muscle.	[Georgiou, Dimitra K.; Dagnino-Acosta, Adan; Lee, Chang Seok; Griffin, Deric M.; Wang, Hui; Lagor, William R.; Pautler, Robia G.; Hamilton, Susan L.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Baylor College of Medicine; University of Rochester	Hamilton, SL (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, One Baylor Plaza, Houston, TX 77030 USA.	susanh@bcm.edu	Regan, Clinton/E-6250-2012; Dagnino-Acosta, Adan/K-6786-2012; Wang, Hui J./AAT-7096-2020	Wang, Hui J./0000-0003-2654-0243; Dagnino-Acosta, Adan/0000-0001-8903-807X; Lagor, William/0000-0002-1703-5125; Hamilton, Susan/0000-0003-0241-9369	National Institutes of Health [P30 DK079638]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041802, R01AR053349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff of the BCM core facilities (supported by National Institutes of Health Grant P30 DK079638).	Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005; Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028981; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015; CHANDLER WK, 1976, J PHYSIOL-LONDON, V254, P245, DOI 10.1113/jphysiol.1976.sp011232; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Isaeva E.V., 2003, J PHYSIOL-LONDON, V547, P453; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jeppesen J, 2010, J LIPID RES, V51, P1504, DOI 10.1194/jlr.M003756; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kim S, 2004, MOL CELL BIOL, V24, P330, DOI 10.1128/MCB.24.1.330-337.2004; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Smith BK, 2012, EXERC SPORT SCI REV, V40, P211, DOI 10.1097/JES.0b013e31825eb263; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Stefanyk LE, 2012, METABOLISM, V61, P1518, DOI 10.1016/j.metabol.2012.04.002; Steinbusch LKM, 2011, CELL MOL LIFE SCI, V68, P2525, DOI 10.1007/s00018-011-0690-x; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Tidball JG, 1998, AM J PHYSIOL-CELL PH, V275, pC260, DOI 10.1152/ajpcell.1998.275.1.C260; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yoshida Y, 2013, J PHYSIOL-LONDON, V591, P4415, DOI 10.1113/jphysiol.2012.238451; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	51	23	23	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23751	23765		10.1074/jbc.M115.643544	http://dx.doi.org/10.1074/jbc.M115.643544			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245899	Green Published, hybrid			2022-12-26	WOS:000361816500023
J	Degarege, A; Mekonnen, Z; Levecke, B; Legesse, M; Negash, Y; Vercruysse, J; Erko, B				Degarege, Abraham; Mekonnen, Zeleke; Levecke, Bruno; Legesse, Mengistu; Negash, Yohannes; Vercruysse, Jozef; Erko, Berhanu			Prevalence of Schistosoma haematobium Infection among School-Age Children in Afar Area, Northeastern Ethiopia	PLOS ONE			English	Article							URINARY SCHISTOSOMIASIS; REAGENT STRIPS; AWASH VALLEY; EGG OUTPUT; SCHOOLCHILDREN; DIAGNOSIS; EPIDEMIOLOGY; PRAZIQUANTEL; MORBIDITY	In this study, the prevalence and intensity of Schistosoma haematobium infection was determined among school-age children living in the Middle and Lower Awash Valley, Afar Regional State of Ethiopia. Between February and May 2014, urine samples were collected from 885 school-age children (5-16 years of age) from the Middle (n = 632; 4 villages) and Lower (n = 253; 3 villages) Awash Valley. All samples were processed using urine filtration to detect and quantify S. haematobium eggs. In addition, a subset of the urine samples was tested for hematuria using a urine dipstick (n = 556). The overall prevalence was 20.8% (95% Confidence Interval (CI) = 18.1%, 23.5%), based on urine filtration but the prevalence considerably varied across villages both in the Middle (from 12.5% to 37.0%) and Lower Awash Valley (from 0 to 5.3%). The overall mean urine egg count (UEC) among the infected children was 4.0 eggs/10 ml of urine (95% CI = 2.43, 5.52). The infection intensity varied from 0.4 eggs/10 ml of urine to 7.7 eggs/10 ml of urine in the Middle Awash Valley, and from 0 to 1.1 eggs/10 ml of urine in Lower Awash Valley. Age and sex were not associated with S. haematobium infection based on the multivariable logistic regression model. The prevalence of hematuria was 56.3% (95% CI = 52.2%, 60.4%) among a subset of the study participants (556) examined using the urine dipstick. The prevalence of hematuria also varies with villages from 8.3% to 93.2%. In conclusion, the prevalence of S. haematobium infection in the Middle Awash Valley was high and it varies across villages. Hence, children living in the present study villages of the Middle Awash Valley need to be treated with praziquantel to reduce morbidity and disrupt transmission.	[Degarege, Abraham; Legesse, Mengistu; Negash, Yohannes; Erko, Berhanu] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Degarege, Abraham] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Epidemiol, Miami, FL 33199 USA; [Mekonnen, Zeleke] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Levecke, Bruno; Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Addis Ababa University; State University System of Florida; Florida International University; Jimma University; Ghent University	Degarege, A (corresponding author), Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	abrahamdegarege@yahoo.com	Mekonnen, Zeleke/AAF-3877-2020	Mekonnen, Zeleke/0000-0003-3418-7291; Degarege, Abraham/0000-0002-1537-6639; Levecke, Bruno/0000-0001-8912-5595	Aklilu Lemma Institute of Pathobiology, Addis Ababa University; Addis Ababa University	Aklilu Lemma Institute of Pathobiology, Addis Ababa University; Addis Ababa University	This work was supported by Aklilu Lemma Institute of Pathobiology, Addis Ababa University (www.aau.edu.et/aaubeta/alipb/). AD, ML and BE received the fund from Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1986, ETHIOPIAN MED J, V24, P73; [Anonymous], 2006, PREV CHEM HUM HELM C; Ayele B, 2008, PARASITE, V15, P69, DOI 10.1051/parasite/2008151069; BRADLEY DJ, 1973, T ROY SOC TROP MED H, V67, P491, DOI 10.1016/0035-9203(73)90080-1; Casmo V, 2014, REV INST MED TROP SP, V56, P219, DOI 10.1590/S0036-46652014000300007; Deribew Ketema, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P307, DOI 10.1016/S2221-1691(13)60068-4; DESOLE G, 1978, AM J TROP MED HYG, V27, P928, DOI 10.4269/ajtmh.1978.27.928; Farid Z., 1993, Human schistosomiasis., P159; Fenwick A, 2003, TRENDS PARASITOL, V19, P509, DOI 10.1016/j.pt.2003.09.005; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hamilton JV, 1998, PARASITOLOGY, V117, pS41; Hammad TA, 1997, AM J TROP MED HYG, V57, P464, DOI 10.4269/ajtmh.1997.57.464; Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775; Inobaya MT, 2014, RES REP TROP MED, V5, P65, DOI 10.2147/RRTM.S44274; JEMANEH L, 1993, ETHIOPIAN MED J, V31, P137; JEMANEH L, 1994, E AFR MED J, V71, P679; King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431; KLOOS H, 1977, TROP GEOGR MED, V29, P399; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEMMA A., 1969, Ethiopian Medical Journal, V7, P147; Mafiana CF, 2003, TROP MED INT HEALTH, V8, P78, DOI 10.1046/j.1365-3156.2003.00988.x; Ndyomugyenyi R, 2001, ANN TROP MED PARASIT, V95, P697, DOI 10.1080/00034980120097151; Pennington LF, 2014, IMMUNE RESPONSE PARA, P93; PETERS PA, 1976, B WORLD HEALTH ORGAN, V54, P159; Poggensee G, 2001, ACTA TROP, V79, P193, DOI 10.1016/S0001-706X(01)00086-9; Poggensee G, 2000, B WORLD HEALTH ORGAN, V78, P542; Rudge JW, 2008, ACTA TROP, V105, P45, DOI 10.1016/j.actatropica.2007.09.006; Sacko M, 2011, ACTA TROP, V120, pS142, DOI 10.1016/j.actatropica.2010.12.009; Satayathum SA, 2006, AM J TROP MED HYG, V75, P83, DOI 10.4269/ajtmh.2006.75.83; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STEPHENSON L, 1993, PARASITOLOGY, V107, pS107, DOI 10.1017/S0031182000075545; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; vanEtten L, 1997, AM J TROP MED HYG, V57, P337, DOI 10.4269/ajtmh.1997.57.337; World Health Organization, 2002, WHO TECHN REP SER, V912, P1	36	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133142	10.1371/journal.pone.0133142	http://dx.doi.org/10.1371/journal.pone.0133142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252615	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100014
J	Klofstad, CA; Anderson, RC; Nowicki, S				Klofstad, Casey A.; Anderson, Rindy C.; Nowicki, Stephen			Perceptions of Competence, Strength, and Age Influence Voters to Select Leaders with Lower-Pitched Voices	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; DOMINANCE; FACE; ATTRACTIVENESS; TESTOSTERONE; PREFERENCES; CANDIDATES; INFERENCES; SIGNALS; BIAS	Voters prefer leaders with lower-pitched voices because they are perceived as stronger, having greater physical prowess, more competent, and having greater integrity. An alternative hypothesis that has yet to be tested is that lower-pitched voices are perceived as older and thus wiser and more experienced. Here the relationships between candidate voice pitch, candidate age, and electoral success are examined with two experiments. Study 1 tests whether voters discriminate on candidate age. The results show that male and female candidates in their 40s and 50s, the time in the lifecycle when voice pitch is at its lowest, are preferred over candidates in their 30s, 60s, and 70s. Study 2 shows that the preference for leaders with lower-pitched voices correlates with the perception that speakers with lower voices are stronger, more competent, and older, but the influence of perception of age on vote choice is the weakest of the three.	[Klofstad, Casey A.] Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA; [Klofstad, Casey A.; Anderson, Rindy C.; Nowicki, Stephen] Duke Univ, Dept Biol, Durham, NC USA; [Anderson, Rindy C.] Florida Atlantic Univ, Dept Biol, Boca Raton, FL 33431 USA	University of Miami; Duke University; State University System of Florida; Florida Atlantic University	Klofstad, CA (corresponding author), Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA.	klofstad@gmail.com	Nowicki, Stephen/Y-9690-2019		Office of the Provost at Duke University; Duke University Fuqua School of Business	Office of the Provost at Duke University; Duke University Fuqua School of Business	This study was funded with research support to SN from the Office of the Provost at Duke University and by funding from Bill Mayew and Mohan Venkatachalam of the Duke University Fuqua School of Business. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2012, PLOS ONE, V7; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; Atkinson MD, 2009, Q J POLIT SCI, V4, P229, DOI 10.1561/100.00008062; Baken RJ, 2005, J VOICE, V19, P317, DOI 10.1016/j.jvoice.2004.07.005; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Boersma P., 2013, PRAAT DOING PHONETIC; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Cerrato L, 2000, SPEECH COMMUN, V31, P107, DOI 10.1016/S0167-6393(99)00071-0; Chiao JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003666; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Gregory SW, 2002, SOC PSYCHOL QUART, V65, P298; Hamsberger JD, 2008, J VOICE, V22, P58, DOI 10.1016/j.jvoice.2006.07.004; HARTMAN DE, 1979, J COMMUN DISORD, V12, P53, DOI 10.1016/0021-9924(79)90021-2; Hollien H., 1987, J VOICE, V1, P2, DOI [10.1016/S0892-1997(87)80018-8, DOI 10.1016/S0892-1997(87)80018-8]; Huntley R., 1987, J VOICE, V1, P49, DOI [10.1016/S0892-1997(87)80024-3, DOI 10.1016/S0892-1997(87)80024-3]; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kam CD, 2007, POLIT BEHAV, V29, P343, DOI 10.1007/s11109-007-9030-0; Klofstad C, 2013, MIDWEST POLITICAL SC; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; KORTHASE KM, 1982, PERCEPT MOTOR SKILL, V54, P1251, DOI 10.2466/pms.1982.54.3c.1251; KROODSMA DE, 1990, ANIM BEHAV, V40, P1138, DOI 10.1016/S0003-3472(05)80180-0; KURODA I, 1976, AVIAT SPACE ENVIR MD, V47, P528; Laustsen L, 2014, ANNUAL MEETING OF TH; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Lockenhoff CE, 2009, PSYCHOL AGING, V24, P941, DOI 10.1037/a0016901; MACHLIS L, 1985, Z TIERPSYCHOL, V68, P201; Manning JE, 2013, MEMBERSHIP OF THE 13; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Montepare JM, 2014, J LANG SOC PSYCHOL, V33, P241, DOI 10.1177/0261927X13519080; PILIAVIN JA, 1987, J APPL SOC PSYCHOL, V17, P351, DOI 10.1111/j.1559-1816.1987.tb00318.x; PTACEK PH, 1966, J SPEECH HEAR RES, V9, P273, DOI 10.1044/jshr.0902.273; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Rosenberg S., 1991, POLITICAL BEHAV, V13, P345, DOI [DOI 10.1007/BF00992868, 10.1007/BF00992868]; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P1, DOI 10.1037/a0017673; RYAN WJ, 1974, J COMMUN DISORD, V7, P181, DOI 10.1016/0021-9924(74)90030-6; Scherer KR, 1981, SPEECH EVALUATION IN; SHIPP T, 1969, J SPEECH HEAR RES, V12, P703, DOI 10.1044/jshr.1204.703; SIGELMAN L, 1982, SOC PSYCHOL QUART, V45, P263, DOI 10.2307/3033922; Spisak B. R., 2012, PLOS ONE, V7; Stathopoulos ET, 2011, J SPEECH LANG HEAR R, V54, P1011, DOI 10.1044/1092-4388(2010/10-0036); Tigue CC, 2012, EVOL HUM BEHAV, V33, P210, DOI 10.1016/j.evolhumbehav.2011.09.004; Titze IR, 1994, PRINCIPLES OF VOICE; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Weeks JW, 2012, J ANXIETY DISORD, V26, P811, DOI 10.1016/j.janxdis.2012.07.005; Wittels P, 2002, EUR J APPL PHYSIOL, V87, P278, DOI 10.1007/s00421-002-0625-1	52	50	53	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133779	10.1371/journal.pone.0133779	http://dx.doi.org/10.1371/journal.pone.0133779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252894	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100025
J	Mandl, M; Drechsler, M; Jansen, Y; Neideck, C; Noels, H; Faussner, A; Soehnlein, O; Weber, C; Doring, Y				Mandl, Manuela; Drechsler, Maik; Jansen, Yvonne; Neideck, Carlos; Noels, Heidi; Faussner, Alexander; Soehnlein, Oliver; Weber, Christian; Doering, Yvonne			Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; DIPHTHERIA-TOXIN RECEPTOR; ACUTE LUNG INJURY; ATHEROSCLEROTIC PLAQUE; INTERFERON-ALPHA; VIRAL-INFECTION; IN-VIVO; MICE; DEPLETION; IMMUNITY	Background and Aims Plasmacytoid dendritic cells (pDCs) are a small subset of dendritic cells and the main producers of type I interferons. Besides their contribution to tolerance, they are known to be involved in autoimmune diseases and have recently been implicated in atherosclerosis. However, their precise involvement, particularly in advanced lesion development, remains elusive. Hence, we investigated the role of pDCs in atherogenesis vs atheroprogression by specifically depleting this cell population using the BDCA2-DTR mouse model bred to Apolipoprotein E (Apoe(-/-)) deficient mice. Methods and Results Our results revealed that continuous diphtheria toxin-induced pDC depletion in Apoe(-/-) BDCA2-DTR mice receiving a high-fat diet (HFD) for 4 weeks did not alter lesion size or composition. Instead, these mice displayed increased B cell numbers and altered levels of inflammatory cytokines. Analysis of depletion efficiency showed that complete pDC depletion could only be sustained for one week and reoccurring pDCs sorted after 4 weeks did not express DTR anymore. Consequently, we analyzed lesion development in a model of partial carotid ligation, inducing established lesions after 5 weeks of HFD feeding, and only depleted pDCs during the last week of 5 weeks HFD feeding. Despite short-term, but efficient pDC depletion, we observed no differences in atherosclerotic lesion development, but changes in inflammatory cytokine titers. To assure the functionality of the BDCA2-DTR model in acute settings, we additionally examined the effect of pDC depletion in an indirect acute lung injury (iALI) model. This time, efficient pDC depletion resulted in a significantly reduced macrophage and neutrophil accumulation in the lung 12 hours after LPS challenge, underlining a pro-inflammatory role of pDCs in the innate immune response in iALI. Conclusion Taken together, the BDCA2-DTR mouse model only allows efficient pDC depletion for one week, which subsequently restricts its usability to more acute but not chronic inflammatory disease models.	[Mandl, Manuela; Drechsler, Maik; Jansen, Yvonne; Neideck, Carlos; Faussner, Alexander; Soehnlein, Oliver; Weber, Christian; Doering, Yvonne] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Drechsler, Maik; Soehnlein, Oliver] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Drechsler, Maik; Soehnlein, Oliver; Weber, Christian; Doering, Yvonne] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Noels, Heidi] RWTH Aachen Univ Aachen, Inst Mol Cardiovasc Res, Aachen, Germany	University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; German Centre for Cardiovascular Research; Munich Heart Alliance; RWTH Aachen University	Doring, Y (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	Yvonne.doering@med.uni-muenchen.de	Weber, Christian/AAW-2153-2020; Döring, Yvonne/E-9414-2017; Döring, Yvonne/AAA-3018-2022; Drechsler, Maik/C-3829-2008; Doring, Yvonne/E-1796-2013; Noels, Heidi/AAQ-2622-2020	Weber, Christian/0000-0003-4610-8714; Döring, Yvonne/0000-0001-9307-3396; 	Deutsche Forschungsgemeinschaft [SFB1054, B4 SFB1123]; German Centre for Cardiovascular Research [MHA VD1.2]; Deutsche Forschungsgemeinschaft (LMUexcellent)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Centre for Cardiovascular Research; Deutsche Forschungsgemeinschaft (LMUexcellent)	This work was supported by the Deutsche Forschungsgemeinschaft (SFB1054, B4 SFB1123, A1, A6 and B5; LMUexcellent) and the German Centre for Cardiovascular Research (MHA VD1.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chistiakov DA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00279; Christiaansen AF, 2014, J IMMUNOL METHODS, V406, P58, DOI 10.1016/j.jim.2014.03.005; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Doring Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00230; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Drobits B, 2012, J CLIN INVEST, V122, P575, DOI 10.1172/JCI61034; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Grommes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038917; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Nickel T, 2009, ATHEROSCLEROSIS, V205, P442, DOI 10.1016/j.atherosclerosis.2009.01.002; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Rogers NM, 2013, AM J TRANSPLANT, V13, P1125, DOI 10.1111/ajt.12229; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Schallenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041971; Schmitz I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003362; Shaw J, 2010, BLOOD, V115, P3051, DOI 10.1182/blood-2009-08-239145; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Swiecki M, 2014, J IMMUNOL, V192, P4409, DOI 10.4049/jimmunol.1303135; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; van Blijswijk J, 2013, EUR J IMMUNOL, V43, P22, DOI 10.1002/eji.201243022; Venet F, 2010, AM J PATHOL, V176, P764, DOI 10.2353/ajpath.2010.090765; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atherosclerosis.2004.04.027	40	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134176	10.1371/journal.pone.0134176	http://dx.doi.org/10.1371/journal.pone.0134176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252890	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100041
J	Ma, JQ; Tuersun, H; Jiao, SJ; Zheng, JH; Xiao, JB; Hasim, A				Ma, Jun-Qi; Tuersun, Hatila; Jiao, Shu-Juan; Zheng, Jian-He; Xiao, Jing-Bao; Hasim, Ayshamgul			Functional Role of NRF2 in Cervical Carcinogenesis	PLOS ONE			English	Article							NF-E2-RELATED FACTOR-2 NRF2; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; CANCER CELLS; EXPRESSION; ASSOCIATION; METHYLATION	Nuclear factor erythroid-2-related factor 2 (NFE2L2) is a transcription factor associated with resistance to chemotherapy and increased tumor growth. NRF2 is repressed by the inhibitor Keap1. The Keap1-NRF2 pathway is dysfunctional in multiple tumor types. Among Uighur women, the incidence of cervical squamous cell carcinoma (CSCC) and cervical intra-epithelial neoplasia (CIN) was associated with elevated nuclear expression of NRF2 and decreased cytoplasmic expression of Keap1. Up-regulation of nuclear NRF2 was significantly associated with reduced cytoplasmic Keap1 expression. NRF2 positivity and Keap1 negativity were frequently associated with more advanced tumors (i.e., higher histological grade, lymph node involvement, and higher tumor stages) (p<0.05 for all). Methylated CpG islands in the Keap1 gene promoter in cervical cancer tissue were identified using MassAR-RAY. Moreover, promoter hypermethylation of this gene was significantly associated with decreased protein expression and increased nuclear NRF2 expression in cervical cancer tissues. Overexpression and knockdown of NRF2 in CSCC cell lines showed that NRF2 promotes proliferation, inhibits apoptosis, and enhances migration and invasion. These studies support the concept that epigenetic changes regulate expression of Keap1 in cervical cancer tissues. The association of NRF2 expression with aggressive tumor behavior suggests that NRF2 may be a marker of poor prognosis in patients with cervical cancer.	[Ma, Jun-Qi; Xiao, Jing-Bao] Xinjiang Med Univ, Dept Gynecol, Affiliated Hosp 1, Urumqi, Peoples R China; [Tuersun, Hatila; Jiao, Shu-Juan; Zheng, Jian-He; Hasim, Ayshamgul] Med Univ Xinjiang, Dept Pathol, Urumqi, Peoples R China	Xinjiang Medical University	Hasim, A (corresponding author), Med Univ Xinjiang, Dept Pathol, Urumqi, Peoples R China.	axiangu75@126.com			National Natural Science Foundation of China [81360332]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by the National Natural Science Foundation of China (81360332). The funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; ARLT A, 2013, ONCOGENE, V32, P4825, DOI DOI 10.1038/0NC.2012.493; Ayshamgul H, 2012, PLOS ONE, V7; Barbano R, 2013, EPIGENETICS-US, V8, P105, DOI 10.4161/epi.23319; Bauer G, 2014, ANTICANCER RES, V34, P1467; Choi CY, 2014, ARCH PLAST SURG-APS, V41, P654, DOI 10.5999/aps.2014.41.6.654; De Marco F, 2013, VIRUSES-BASEL, V5, P708, DOI 10.3390/v5020708; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Geismann C, 2014, ONCOTARGETS THER, V7, P1497, DOI 10.2147/OTT.S36624; Hanada N, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-66; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kawasaki Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1008-4; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Ma XD, 2012, CANCER CHEMOTH PHARM, V69, P485, DOI 10.1007/s00280-011-1722-9; Mitsuishi Y, 2012, MOLECULAR AND CELLUL, P2; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Monique GP, 2015, MOLECULAR ONCOLOGY; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Shelton P, 2013, FASEB J, V27, P414, DOI 10.1096/fj.12-217257; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Yamadori T, 2012, ONCOGENE, V31, P4768, DOI 10.1038/onc.2011.628; Yang BH, 2004, INT J CANCER, V109, P418, DOI 10.1002/ijc.11719; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	31	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133876	10.1371/journal.pone.0133876	http://dx.doi.org/10.1371/journal.pone.0133876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247201	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300022
J	Ma, YL; Shabala, S; Li, CD; Liu, CJ; Zhang, WY; Zhou, MX				Ma, Yanling; Shabala, Sergey; Li, Chengdao; Liu, Chunji; Zhang, Wenying; Zhou, Meixue			Quantitative Trait Loci for Salinity Tolerance Identified under Drained and Waterlogged Conditions and Their Association with Flowering Time in Barley (Hordeum vulgare. L)	PLOS ONE			English	Article							PHOTOPERIOD RESPONSE GENE; ABIOTIC STRESS RESPONSES; PLASMA-MEMBRANE CA2+; SALT TOLERANCE; ABILITY; GROWTH; ROOTS; DEFICIENCY; MECHANISMS; JASMONATE	Introduction Salinity is one of the major abiotic stresses affecting crop production via adverse effects of osmotic stress, specific ion toxicity, and stress-related nutritional disorders. Detrimental effects of salinity are also often exacerbated by low oxygen availability when plants are grown under waterlogged conditions. Developing salinity-tolerant varieties is critical to overcome these problems, and molecular marker assisted selection can make breeding programs more effective. Methods In this study, a double haploid (DH) population consisting of 175 lines, derived from a cross between a Chinese barley variety Yangsimai 1 (YSM1) and an Australian malting barley variety Gairdner, was used to construct a high density molecular map which contained more than 8,000 Diversity Arrays Technology (DArT) markers and single nucleotide polymorphism (SNP) markers. Salinity tolerance of parental and DH lines was evaluated under drained (SalinityD) and waterlogged (SalinityW) conditions at two different sowing times. Results Three quantitative trait loci (QTL) located on chromosome 1H, single QTL located on chromosomes 1H, 2H, 4H, 5H and 7H, were identified to be responsible for salinity tolerance under different environments. Waterlogging stress, daylight length and temperature showed significant effects on barley salinity tolerance. The QTL for salinity tolerance mapped on chromosomes 4H and 7H, QSlwd. YG.4H, QSlwd.YG. 7H and QSlww.YG.7H were only identified in winter trials, while the QTL on chromosome 2H QSlsd.YG.2H and QSlsw.YG.2H were only detected in summer trials. Genes associated with flowering time were found to pose significant effects on the salinity QTL mapped on chromosomes 2H and 5H in summer trials. Given the fact that the QTL for salinity tolerance QSlsd.YG.1H and QSlww.YG.1H-1 reported here have never been considered in the literature, this warrants further investigation and evaluation for suitability to be used in breeding programs.	[Ma, Yanling; Shabala, Sergey; Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr & Sch Land & Food, Kings Meadows, Tas 7249, Australia; [Li, Chengdao] Murdoch Univ, Western Barley Genet Alliance, Murdoch, WA 6150, Australia; [Liu, Chunji] CSIRO Plant Ind, St Lucia, Qld 4067, Australia; [Zhang, Wenying; Zhou, Meixue] Yangtze Univ, Sch Agr, Jingzhou 434025, Peoples R China	University of Tasmania; Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Yangtze University	Zhou, MX (corresponding author), Yangtze Univ, Sch Agr, Jingzhou 434025, Peoples R China.	Meixue.Zhou@utas.edu.au	Liu, Chunji/B-5243-2009; Shabala, Sergey/AAF-5449-2020; Ma, Yanling/C-3447-2016; Shabala, Sergey/C-6794-2013; Zhang, Wenying/P-2509-2018; , Meixue/C-2387-2014	Shabala, Sergey/0000-0003-2345-8981; Zhang, Wenying/0000-0002-9926-4115; , Meixue/0000-0003-3009-7854	Grains Research and Development Corporation (GRDC) of Australia; Hubei Collaborative Innovation Center for Grain Industry	Grains Research and Development Corporation (GRDC) of Australia(Grains R&D Corp); Hubei Collaborative Innovation Center for Grain Industry	This work was supported by the Grains Research and Development Corporation (GRDC) of Australia and Hubei Collaborative Innovation Center for Grain Industry.	Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Barrett-Lennard EG, 2013, FUNCT PLANT BIOL, V40, P872, DOI 10.1071/FP12235; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; Cuin TA, 2003, J EXP BOT, V54, P657, DOI 10.1093/jxb/erg072; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Demidchik V, 2003, J CELL SCI, V116, P81, DOI 10.1242/jcs.00201; Demidchik V, 2007, PLANT J, V49, P377, DOI 10.1111/j.1365-313X.2006.02971.x; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Dunford RP, 2002, GENETICS, V161, P825; Eleuch L, 2008, J INTEGR PLANT BIOL, V50, P1004, DOI 10.1111/j.1744-7909.2008.00670.x; English JP, 2011, PLANT SOIL, V348, P379, DOI 10.1007/s11104-011-0924-6; Fan Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1243-8; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; LAURIE DA, 1994, HEREDITY, V72, P619, DOI 10.1038/hdy.1994.85; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Lonergan PF, 2009, NEW PHYTOL, V184, P168, DOI 10.1111/j.1469-8137.2009.02956.x; Malik AI, 2009, ANN BOT-LONDON, V103, P237, DOI 10.1093/aob/mcn142; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pang JY, 2007, FUNCT PLANT BIOL, V34, P221, DOI 10.1071/FP06158; Pang JY, 2004, AUST J AGR RES, V55, P895, DOI 10.1071/AR03097; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Read BJ, 2003, AUST J AGR RES, V54, P1145, DOI 10.1071/AR03037; Rivandi J, 2011, J EXP BOT, V62, P1201, DOI 10.1093/jxb/erq346; Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shabala S, 2011, NEW PHYTOL, V190, P289, DOI 10.1111/j.1469-8137.2010.03575.x; Shabala S, 2009, J EXP BOT, V60, P709, DOI 10.1093/jxb/erp013; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Teakle NL, 2010, PHYSIOL PLANTARUM, V139, P358, DOI 10.1111/j.1399-3054.2010.01373.x; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wada KC, 2010, J PLANT PHYSIOL, V167, P447, DOI 10.1016/j.jplph.2009.10.006; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wu HH, 2013, PHYSIOL PLANTARUM, V149, P515, DOI 10.1111/ppl.12056; Xu RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043079; Xue DW, 2010, J ZHEJIANG UNIV-SC B, V11, P169, DOI 10.1631/jzus.B0900332; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Ying L, 2014, PLANT PHYSIOL BIOCH, V79, P77, DOI 10.1016/j.plaphy.2014.03.004; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zeng FR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00313; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9; Zhou MX, 2012, CROP SCI, V52, P2082, DOI 10.2135/cropsci2012.01.0008	60	18	19	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134822	10.1371/journal.pone.0134822	http://dx.doi.org/10.1371/journal.pone.0134822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247774	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300066
J	Rojas-Caraballo, J; Lopez-Aban, J; Fernandez-Soto, P; Vicente, B; Collia, F; Muro, A				Rojas-Caraballo, Jose; Lopez-Aban, Julio; Fernandez-Soto, Pedro; Vicente, Belen; Collia, Francisco; Muro, Antonio			Gene Expression Profile in the Liver of BALB/c Mice Infected with Fasciola hepatica	PLOS ONE			English	Article							TRICLABENDAZOLE-RESISTANT ISOLATE; FALSE DISCOVERY RATE; IN-VIVO; NORMALIZATION; INHIBITION; MIGRATION; VACCINES; CATTLE; DAMAGE	Background Fasciola hepatica infection still remains one of the helminthic neglected tropical diseases (NTDs). It has a huge worldwide distribution, affecting mainly cattle and, sometimes, human beings. In addition to data reported about the immunological response induced by helminthic infections and that induced by Fasciola hepatica, little is known about the gene expression profile in its organ target, the liver, which is where adult worms are established and live for long periods of time, causing its characteristic pathology. In the present work, we study both the early and late gene expression profiles in the livers of mice infected with F. hepatica metacercariae using a microarray-based methodology. Methodology A total of 9 female-6-week-old BALB/c mice (Charles River Laboratories, Barcelona, Spain) weighing 20 to 35 g were used for the experiments. Two groups of BALB/c mice were orally infected with seven F. hepatica metacercariae, and the other group remained untreated and served as a control. Mice were humanely euthanized and necropsied for liver recovery, histological assessment of hepatic damage, RNA isolation, microarray design and gene expression analysis on the day of infection (t0), seven days post-infection (t7) and twenty-one days post-infection (t21). Results We found that F. hepatica infection induces the differential expression of 128 genes in the liver in the early stage of infection and 308 genes in the late stage, and most of them are up-regulated. The Ingenuity Pathway Analysis revealed significant changes in the pathways related to metabolism, biosynthesis and signaling as well as genes implicated in inducing liver-toxicity, injury and death. Conclusion The present study provides us insights at the molecular level about the underlying mechanisms used by F. hepatica, leading to liver damage and its subsequent pathophysiology. The expression pattern obtained here could also be used to explain the lack of association between infection with F. hepatica and cholangiocarcinoma. However, more studies should be performed to confirm this hypothesis.	[Rojas-Caraballo, Jose; Lopez-Aban, Julio; Fernandez-Soto, Pedro; Vicente, Belen; Muro, Antonio] Univ Salamanca, Fac Farm, Inst Invest Biomed Salamanca, Ctr Invest Enfermedades Trop IBSAL CIETUS, E-37008 Salamanca, Spain; [Rojas-Caraballo, Jose; Lopez-Aban, Julio; Fernandez-Soto, Pedro; Vicente, Belen; Muro, Antonio] Univ Salamanca, Fac Farm, Inst Invest Biomed Salamanca, Ctr Invest Enfermedades Trop IBSAL CIETUS, Castilla, Spain; [Rojas-Caraballo, Jose; Lopez-Aban, Julio; Fernandez-Soto, Pedro; Vicente, Belen; Muro, Antonio] Univ Salamanca, Fac Farm, Inst Invest Biomed Salamanca, Ctr Invest Enfermedades Trop IBSAL CIETUS, Leon, Spain; [Collia, Francisco] Univ Salamanca, Fac Med, Dept Anat & Histol Humanas, E-37008 Salamanca, Spain; [Collia, Francisco] Univ Salamanca, Fac Med, Dept Anat & Histol Humanas, Castilla, Spain; [Collia, Francisco] Univ Salamanca, Fac Med, Dept Anat & Histol Humanas, Leon, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Muro, A (corresponding author), Univ Salamanca, Fac Farm, Inst Invest Biomed Salamanca, Ctr Invest Enfermedades Trop IBSAL CIETUS, E-37008 Salamanca, Spain.	ama@usal.es	López-Abán, Julio/B-3557-2015	López-Abán, Julio/0000-0001-8509-0727; Muro, Antonio/0000-0003-0244-4740	Fundacion Ramon Areces, Madrid-Spain [XV-2010-2013]	Fundacion Ramon Areces, Madrid-Spain	The present study was supported by Fundacion Ramon Areces, Madrid-Spain; Grant number: XV-2010-2013. (www.fundacionareces.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Rojas CA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0715-7; Ashrafi K, 2014, FASCIOLIASIS A WORLD; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENNETT CE, 1975, EXP PARASITOL, V37, P426, DOI 10.1016/0014-4894(75)90013-2; Biasi F, 2009, FREE RADICAL BIO MED, V47, P1731, DOI 10.1016/j.freeradbiomed.2009.09.020; Binder BR, 2002, NEWS PHYSIOL SCI, V17, P56, DOI 10.1152/nips.01369.2001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cwiklinski K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0632-2; Dalton JP, 2013, VET PARASITOL, V195, P272, DOI 10.1016/j.vetpar.2013.04.008; Dawes B., 1962, Journal of Helminthology, V36, P11, DOI 10.1017/S0022149X00022343; Devine C, 2012, VET PARASITOL, V184, P37, DOI 10.1016/j.vetpar.2011.08.006; Devine C, 2011, PARASITOL RES, V109, P981, DOI 10.1007/s00436-011-2304-9; Devine C, 2011, PARASITOLOGY, V138, P224, DOI 10.1017/S0031182010001125; Devine C, 2011, VET PARASITOL, V177, P305, DOI 10.1016/j.vetpar.2010.12.002; Devine C, 2010, PARASITOLOGY, V137, P871, DOI 10.1017/S003118200999148X; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fairweather I, 2005, J HELMINTHOL, V79, P227, DOI 10.1079/JOH2005298; Fairweather I, 2009, J HELMINTHOL, V83, P139, DOI 10.1017/S0022149X09321173; Flynn RJ, 2010, VET PARASITOL, V169, P235, DOI 10.1016/j.vetpar.2010.02.015; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Hillyer GV, 2005, J HELMINTHOL, V79, P241, DOI 10.1079/JOH2005304; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Junking M, 2008, EUR J CANCER, V44, P619, DOI 10.1016/j.ejca.2008.01.014; Jusakul A, 2012, MUTAT RES-FUND MOL M, V731, P48, DOI 10.1016/j.mrfmmm.2011.10.009; Kaplan R M, 2001, Vet Ther, V2, P40; Linseisen J, 2002, CANCER EPIDEM BIOMAR, V11, P1630; Loilome W, 2006, MOL CARCINOGEN, V45, P279, DOI 10.1002/mc.20094; Marcos LA, 2007, J HELMINTHOL, V81, P381, DOI 10.1017/S0022149X07850231; Mas-Coma S, 1999, B WORLD HEALTH ORGAN, V77, P340; Mas-Coma S, 2009, ADV PARASIT, V69, P41, DOI 10.1016/S0065-308X(09)69002-3; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Moll L, 2000, VET PARASITOL, V91, P153, DOI 10.1016/S0304-4017(00)00267-3; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Montero R, 1999, MUTAGENESIS, V14, P217, DOI 10.1093/mutage/14.2.217; Mulcahy G, 1999, FASCIOLOSIS, P341; Olaechea F, 2011, VET PARASITOL, V178, P364, DOI 10.1016/j.vetpar.2010.12.047; Orr M, 2009, R J, V1, P47; Ortiz P, 2013, VET PARASITOL, V195, P118, DOI 10.1016/j.vetpar.2013.01.001; Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107; Sartor MA, 2009, BIOINFORMATICS, V25, P211, DOI 10.1093/bioinformatics/btn592; Silva J, 2003, J BIOL CHEM, V278, P25376, DOI 10.1074/jbc.M301233200; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Talukder S., 2010, Bangladesh Journal of Veterinary Medicine, V8, P35; Wesolowska A, 2013, EXP PARASITOL, V134, P33, DOI 10.1016/j.exppara.2013.01.013; Yoon JH, 2004, HEPATOLOGY, V39, P732, DOI 10.1002/hep.20125	47	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134910	10.1371/journal.pone.0134910	http://dx.doi.org/10.1371/journal.pone.0134910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247779	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300076
J	Fernandez-Pinos, MC; Casado, M; Caballero, G; Zinser, ER; Dachs, J; Pina, B				Fernandez-Pinos, Maria-Carmen; Casado, Marta; Caballero, Gemma; Zinser, Erik R.; Dachs, Jordi; Pina, Benjamin			Clade-Specific Quantitative Analysis of Photosynthetic Gene Expression in Prochlorococcus	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; MARINE CYANOBACTERIUM PROCHLOROCOCCUS; NATURAL PHYTOPLANKTON COMMUNITIES; POLYCHLORINATED-BIPHENYLS; SYNECHOCOCCUS ECOTYPES; MEDITERRANEAN SEA; DIEL VARIATIONS; PHOTOSYSTEM-II; PSBA GENE; LIGHT	Newly designed primers targeting rbcL (CO2 fixation), psbA (photosystem II) and rnpB (reference) genes were used in qRT-PCR assays to assess the photosynthetic capability of natural communities of Prochlorococcus, the most abundant photosynthetic organism on Earth and a major contributor to primary production in oligotrophic oceans. After optimizing sample collection methodology, we analyzed a total of 62 stations from the Malaspina 2010 circumnavigation (including Atlantic, Pacific and Indian Oceans) at three different depths. Sequence and quantitative analyses of the corresponding amplicons showed the presence of high-light (HL) and low-light (LL) Prochlorococcus clades in essentially all 182 samples, with a largely uniform stratification of LL and HL sequences. Synechococcus cross-amplifications were detected by the taxon-specific melting temperatures of the amplicons. Laboratory exposure of Prochlorococcus MED4 (HL) and MIT9313 (LL) strains to organic pollutants (PAHs and organochlorine compounds) showed a decrease of rbcL transcript abundances, and of the rbcL to psbA ratios for both strains. We propose this technique as a convenient assay to evaluate effects of environmental stressors, including pollution, on the oceanic Prochlorococcus photosynthetic function.	[Fernandez-Pinos, Maria-Carmen; Casado, Marta; Caballero, Gemma; Dachs, Jordi; Pina, Benjamin] IDAEA CSIC, Dept Environm Chem, Barcelona, Catalonia, Spain; [Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of Tennessee System; University of Tennessee Knoxville	Pina, B (corresponding author), IDAEA CSIC, Dept Environm Chem, Barcelona, Catalonia, Spain.	bpcbmc@cid.csic.es	Piña, Benjamin/A-1671-2011	Piña, Benjamin/0000-0001-9216-2768; Dachs, Jordi/0000-0002-4237-169X	Spanish Government through the Consolider-Ingenio program [CSD2008-00077]; MICINN grant [CTM2011-439 30471-C02-01, CTM2014-51985-R]; Spanish National Research Council (CSIC); National Science Foundation [OCE0526072, OCE1030518]; Catalan Government [2009SGR01178]	Spanish Government through the Consolider-Ingenio program; MICINN grant(Spanish Government); Spanish National Research Council (CSIC); National Science Foundation(National Science Foundation (NSF)); Catalan Government	This work was supported by the Spanish Government through the Consolider-Ingenio 2010 program (CSD2008-00077) and a MICINN grant (CTM2011-439 30471-C02-01), and CTM2014-51985-R (EMRISK). M.C. Fernandez-Pinos acknowledges a predoctoral fellowship from the Spanish National Research Council (CSIC), and E.R. Zinser acknowledges grants (OCE0526072 and OCE1030518) from the National Science Foundation. Additional funding was received from the Catalan Government through the support to the group on Geochemistry of Climatic and Global Change (2009SGR01178).	Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; Rangel OA, 2009, ENV MICROBIOL REP, V1, P56, DOI 10.1111/j.1758-2229.2008.00005.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berg GM, 2011, AQUAT MICROB ECOL, V65, P1, DOI 10.3354/ame01528; Berrojalbiz N, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003775; Berrojalbiz N, 2011, ENVIRON SCI TECHNOL, V45, P4315, DOI 10.1021/es103742w; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CLARKE AK, 1995, PLANTA, V197, P553; Claustre H, 2002, LIMNOL OCEANOGR, V47, P1637, DOI 10.4319/lo.2002.47.6.1637; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Crosbie ND, 2001, J PLANKTON RES, V23, P809, DOI 10.1093/plankt/23.8.809; Del Vento S, 2002, ENVIRON TOXICOL CHEM, V21, P2099, DOI 10.1002/etc.5620211013; Dorak MT, 2007, REAL TIME PCR; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Echeveste P, 2010, CHEMOSPHERE, V81, P161, DOI 10.1016/j.chemosphere.2010.06.072; Echeveste P, 2010, ENVIRON POLLUT, V158, P299, DOI 10.1016/j.envpol.2009.07.006; Frouin H, 2013, PROG OCEANOGR, V115, P65, DOI 10.1016/j.pocean.2013.05.023; Galban-Malagon C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1858; Galban-Malagon CJ, 2013, ENVIRON SCI TECHNOL, V47, P5578, DOI 10.1021/es400030q; Garcia-Fernandez JM, 1998, ARCH BIOCHEM BIOPHYS, V359, P17, DOI 10.1006/abbi.1998.0862; Garczarek L, 2001, ENVIRON MICROBIOL, V3, P168, DOI 10.1046/j.1462-2920.2001.00173.x; Garczarek L, 2008, ISME J, V2, P937, DOI 10.1038/ismej.2008.46; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Gomez-Baena G, 2009, RES MICROBIOL, V160, P567, DOI 10.1016/j.resmic.2009.08.009; Gomez-Baena G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003416; Huang SJ, 2012, ISME J, V6, P285, DOI 10.1038/ismej.2011.106; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; John DE, 2007, MAR BIOTECHNOL, V9, P747, DOI 10.1007/s10126-007-9027-z; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jurado E, 2005, ENVIRON SCI TECHNOL, V39, P2426, DOI 10.1021/es048599g; Jurado E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034698; Kelly L, 2012, NUCLEIC ACIDS RES, V40, pD632, DOI 10.1093/nar/gkr1022; Kolowrat C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-204; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Lohmann R, 2007, ENVIRON POLLUT, V150, P150, DOI 10.1016/j.envpol.2007.06.051; Malmstrom RR, 2013, ISME J, V7, P184, DOI 10.1038/ismej.2012.89; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Osburne MS, 2010, ENVIRON MICROBIOL, V12, P1978, DOI 10.1111/j.1462-2920.2010.02203.x; Partensky F, 1997, PHOTOSYNTH RES, V51, P209, DOI 10.1023/A:1005807408161; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichard SL, 1996, MAR ECOL PROG SER, V139, P257, DOI 10.3354/meps139257; Pichard SL, 1997, MAR ECOL PROG SER, V149, P239, DOI 10.3354/meps149239; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Schon A, 2002, INT J SYST EVOL MICR, V52, P1383, DOI 10.1099/ijs.0.01983-0; Steglich C, 2003, FEBS LETT, V553, P79, DOI 10.1016/S0014-5793(03)00971-2; Steglich C, 2006, J BACTERIOL, V188, P7796, DOI 10.1128/JB.01097-06; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; UNECE, 1998, 1979 CONV LONG RANG; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Veldhuis MJW, 1997, DEEP-SEA RES PT I, V44, P425, DOI 10.1016/S0967-0637(96)00116-1; Wallberg P, 1999, MAR CHEM, V64, P287, DOI 10.1016/S0304-4203(98)00078-4; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; West NJ, 2011, ISME J, V5, P933, DOI 10.1038/ismej.2010.186; Zeidner G, 2003, ENVIRON MICROBIOL, V5, P212, DOI 10.1046/j.1462-2920.2003.00403.x; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135; Zorz Jackie K., 2015, Life-Basel, V5, P403, DOI 10.3390/life5010403; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	81	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133207	10.1371/journal.pone.0133207	http://dx.doi.org/10.1371/journal.pone.0133207			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244890	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400036
J	Liao, YC; Liu, YT; Tsai, PC; Chang, CC; Huang, YH; Soong, BW; Lee, YC				Liao, Yi-Chu; Liu, Yo-Tsen; Tsai, Pei-Chien; Chang, Chia-Ching; Huang, Yen-Hua; Soong, Bing-Wen; Lee, Yi-Chung			Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; ANTICODON-BINDING DOMAIN; FAMILY; SMA; CMT	Background Mutations in the GARS gene have been identified in a small number of patients with Charcot-Marie-Tooth disease (CMT) type 2D or distal spinal muscular atrophy type V, for whom disease onset typically occurs during adolescence or young adulthood, initially manifesting as weakness and atrophy of the hand muscles. The role of GARS mutations in patients with inherited neuropathies in Taiwan remains elusive. Methodology and Principal Findings Mutational analyses of the coding regions of GARS were performed using targeted sequencing of 54 patients with molecularly unassigned axonal CMT, who were selected from 340 unrelated CMT patients. Two heterozygous mutations in GARS, p. Asp146Tyr and p. Met238Arg, were identified; one in each patient. Both are novel de novo mutations. The p. Asp146Tyr mutation is associated with a severe infantile-onset neuropathy and the p. Met238Arg mutation results in childhood-onset disability. Conclusion GARS mutations are an uncommon cause of CMT in Taiwan. The p. Asp146Tyr and p. Met238Arg mutations are associated with early-onset axonal CMT. These findings broaden the mutational spectrum of GARS and also highlight the importance of considering GARS mutations as a disease cause in patients with early-onset neuropathies.	[Liao, Yi-Chu; Liu, Yo-Tsen; Tsai, Pei-Chien; Soong, Bing-Wen; Lee, Yi-Chung] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Liao, Yi-Chu; Liu, Yo-Tsen; Tsai, Pei-Chien; Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chang, Chia-Ching; Huang, Yen-Hua] Natl Yang Ming Univ, Sch Med, Inst BioMed Informat, Taipei 112, Taiwan; [Chang, Chia-Ching; Huang, Yen-Hua] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Soong, Bing-Wen; Lee, Yi-Chung] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YC (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan.	ycli@vghtpe.gov.tw	Lee, Yi-Chung/GZK-7162-2022; Lee, Yi-Chung/H-8813-2019	Lee, Yi-Chung/0000-0003-0102-164X; Liao, Yi-Chu/0000-0002-9644-2086; Tsai, Pei-Chien/0000-0001-7303-0516	Ministry of Science and Technology, Taiwan [102-2628-B-075-006-MY3]; Taipei Veterans General Hospital [V104C-041]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (102-2628-B-075-006-MY3) and Taipei Veterans General Hospital (V104C-041). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Eskuri JM, 2012, J PERIPHER NERV SYST, V17, P132, DOI 10.1111/j.1529-8027.2012.00370.x; Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826; Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049; Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681; Hamaguchi A, 2010, J NEUROL, V257, P1202, DOI 10.1007/s00415-010-5491-x; James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kawakami Nobuko, 2014, Rinsho Shinkeigaku, V54, P911; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klein CJ, 2014, J NEUROL NEUROSUR PS, V85, P1265, DOI 10.1136/jnnp-2013-306740; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Qin XJ, 2014, J BIOL CHEM, V289, P20359, DOI 10.1074/jbc.M114.557249; Rohkamm B, 2007, J NEUROL SCI, V263, P100, DOI 10.1016/j.jns.2007.06.047; Rossor AM, 2013, NAT REV NEUROL, V9, P562, DOI 10.1038/nrneurol.2013.179; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013; Tsai PC, 2014, NEUROLOGY, V83, P903, DOI 10.1212/WNL.0000000000000758; Vester A, 2013, HUM MUTAT, V34, P191, DOI 10.1002/humu.22210; Villanova M, 1998, NEUROMUSCULAR DISORD, V8, P392, DOI 10.1016/S0960-8966(98)00044-3; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133423	10.1371/journal.pone.0133423	http://dx.doi.org/10.1371/journal.pone.0133423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244500	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400046
J	McMurry, JL; Minamino, T; Furukawa, Y; Francis, JW; Hill, SA; Helms, KA; Namba, K				McMurry, Jonathan L.; Minamino, Tohru; Furukawa, Yukio; Francis, Joshua W.; Hill, Stephanie A.; Helms, Katy A.; Namba, Keiichi			Weak Interactions between Salmonella enterica FlhB and Other Flagellar Export Apparatus Proteins Govern Type III Secretion Dynamics	PLOS ONE			English	Article							HOOK-LENGTH CONTROL; SUBSTRATE-SPECIFICITY; FLII ATPASE; ENERGY; SWITCH; COMPONENTS; MUTATIONS; MOTORS; ROLES; RULER	The bacterial flagellum contains its own type III secretion apparatus that coordinates protein export with assembly at the distal end. While many interactions among export apparatus proteins have been reported, few have been examined with respect to the differential affinities and dynamic relationships that must govern the mechanism of export. FlhB, an integral membrane protein, plays critical roles in both export and the substrate specificity switching that occurs upon hook completion. Reported herein is the quantitative characterization of interactions between the cytoplasmic domain of FlhB (FlhB(C)) and other export apparatus proteins including FliK, FlhA(C) and FliI. FliK and FlhAC bound with micromolar affinity. K-D for FliI binding in the absence of ATP was 84 nM. ATP-induced oligomerization of FliI induced kinetic changes, stimulating fast-on, fast-off binding and lowering affinity. Full length FlhB purified under solubilizing, nondenaturing conditions formed a stable dimer via its transmembrane domain and stably bound FliH. Together, the present results support the previously hypothesized central role of FlhB and elucidate the dynamics of protein-protein interactions in type III secretion.	[McMurry, Jonathan L.; Francis, Joshua W.; Hill, Stephanie A.; Helms, Katy A.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA; [Minamino, Tohru; Furukawa, Yukio; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan	University System of Georgia; Kennesaw State University; Osaka University	McMurry, JL (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	jmcmurr1@kennesaw.edu	Namba, Keiichi/A-9406-2016		NIH grant [GM080701]; KSU College of Science & Mathematics Mentor-Protege Awards	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KSU College of Science & Mathematics Mentor-Protege Awards	This work was supported by NIH grant GM080701 (to J.L.M.) and KSU College of Science & Mathematics Mentor-Protege Awards (to J.W.F. and S.A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9; Bai F, 2014, SCI REP-UK, V4, DOI 10.1038/srep06528; Benoit SL, 2012, BBA-GEN SUBJECTS, V1820, P1519, DOI 10.1016/j.bbagen.2012.06.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Evans LDB, 2014, TRENDS MICROBIOL, V22, P566, DOI 10.1016/j.tim.2014.05.009; Evans LDB, 2013, NATURE, V504, P287, DOI 10.1038/nature12682; Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003; Kazetani K, 2009, BIOCHEM BIOPH RES CO, V388, P323, DOI 10.1016/j.bbrc.2009.08.004; Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001; McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004; McMurry JL, 2011, FEBS J, V278, P4943, DOI 10.1111/j.1742-4658.2011.08395.x; Meshcheryakov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068384; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012; Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2014, BBA-MOL CELL RES, V1843, P1642, DOI 10.1016/j.bbamcr.2013.09.005; Minamino T, 2012, MOL MICROBIOL, V83, P775, DOI 10.1111/j.1365-2958.2011.07964.x; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Moriya N, 2006, J MOL BIOL, V359, P466, DOI 10.1016/j.jmb.2006.03.025; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; PATTERSO.J, 1973, ARCH MIKROBIOL, V90, P107, DOI 10.1007/BF00414513; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Terashima H, 2008, INT REV CEL MOL BIO, V270, P39, DOI 10.1016/S1937-6448(08)01402-0; Uchida K, 2014, J BACTERIOL, V196, P1753, DOI 10.1128/JB.00050-14; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y	40	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134884	10.1371/journal.pone.0134884	http://dx.doi.org/10.1371/journal.pone.0134884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244937	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400121
J	Wang, HD; Liu, SK; Cui, J; Li, CZ; Hu, YC; Zhou, W; Chang, YQ; Qiu, XM; Liu, ZJ; Wang, XL				Wang, Hongdi; Liu, Shikai; Cui, Jun; Li, Chengze; Hu, Yucai; Zhou, Wei; Chang, Yaqing; Qiu, Xuemei; Liu, Zhanjiang; Wang, Xiuli			Identification and Characterization of MicroRNAs from Longitudinal Muscle and Respiratory Tree in Sea Cucumber (Apostichopus japonicus) Using High-Throughput Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; SARCOPLASMIC-RETICULUM; MIRNA EXPRESSION; SMOOTH-MUSCLE; CLONING; MIR-127; PROFILE; REGENERATION; BIOGENESIS	MicroRNAs (miRNAs), as a family of non-coding small RNAs, play important roles in the post-transcriptional regulation of gene expression. Sea cucumber (Apostichopus japonicus) is an important economic species which is widely cultured in East Asia. The longitudinal muscle (LTM) and respiratory tree (RPT) are two important tissues in sea cucumber, playing important roles such as respiration and movement. In this study, we identified and characterized miRNAs in the LTM and RPT of sea cucumber (Apostichopus japonicus) using Illumina HiSeq 2000 platform. A total of 314 and 221 conserved miRNAs were identified in LTM and RPT, respectively. In addition, 27 and 34 novel miRNAs were identified in the LTM and RPT, respectively. A set of 58 miRNAs were identified to be differentially expressed between LTM and RPT. Among them, 9 miRNAs (miR-31a-3p, miR-738, miR-1692, let-7a, miR-72a, miR-100b-5p, miR-31b-5p, miR-429-3p, and miR-2008) in RPT and 7 miRNAs (miR-127, miR-340, miR-381, miR-3543, miR-434-5p, miR-136-3p, and miR-300-3p) in LTM were differentially expressed with foldchange value being greater than 10. A total of 14,207 and 12,174 target genes of these miRNAs were predicted, respectively. Functional analysis of these target genes of miRNAs were performed by GO analysis and pathway analysis. This result provided in this work will be useful for understanding biological characteristics of the LTM and RPT of sea cucumber and assisting molecular breeding of sea cucumber for aquaculture.	[Wang, Hongdi; Cui, Jun; Li, Chengze; Hu, Yucai; Zhou, Wei; Chang, Yaqing; Qiu, Xuemei; Wang, Xiuli] Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian 116023, Peoples R China; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Fish Mol Genet & Biotechnol Lab, Aquat Genom Unit, Auburn, AL 36849 USA; [Liu, Shikai; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Hu, Yucai] Dalian Ocean Univ, Sch Sci, Dalian 116023, Peoples R China	Dalian Ocean University; Ministry of Agriculture & Rural Affairs; Auburn University System; Auburn University; Auburn University System; Auburn University; Dalian Ocean University	Wang, XL (corresponding author), Dalian Ocean Univ, Minist Agr, Key Lab Mariculture & Stock Enhancement North Chi, Dalian 116023, Peoples R China.	xiuliwang417@sina.com	Cui, Jun/P-9378-2015; Liu, Zhanjiang/R-9633-2019; Li, Chengze/AAU-7168-2021; Liu, Shikai/AAO-2247-2021	Li, Chengze/0000-0002-1519-750X; Liu, Shikai/0000-0001-5777-489X	State 863 High-Technology R & D Project of China [2012AA10A412]; Program for Liaoning Excellent Talents in University, China [LR2014022]; Dalian City Oceanic and Fishery Administration, China [2013092]; Dalian Fisheries Association of Industrial Technology Innovation, China [201400486]	State 863 High-Technology R & D Project of China(National High Technology Research and Development Program of China); Program for Liaoning Excellent Talents in University, China; Dalian City Oceanic and Fishery Administration, China; Dalian Fisheries Association of Industrial Technology Innovation, China	This project was supported by the State 863 High-Technology R & D Project of China (No. 2012AA10A412), the Program for Liaoning Excellent Talents in University, China (No. LR2014022), the Dalian City Oceanic and Fishery Administration, China (No. 2013092), and Dalian Fisheries Association of Industrial Technology Innovation, China (No. 201400486).	An JH, 2014, J BONE MINER RES, V29, P644, DOI 10.1002/jbmr.2060; Bao MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106540; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bechtel PJ, 2013, FOOD SCI NUTR, V1, P63, DOI 10.1002/fsn3.12; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chang YQ, 2011, AFR J BIOTECHNOL, V10, P13780; Chang YQ, 2009, MAR ECOL-EVOL PERSP, V30, P455, DOI 10.1111/j.1439-0485.2009.00292.x; Chen BH, 2013, J CHEMOTHERAPY, V25, P229, DOI 10.1179/1973947813Y.0000000092; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen MY, 2014, MAR GENOM, V13, P39, DOI 10.1016/j.margen.2014.01.002; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Dolmatov IY, 2009, CELL TISSUE RES, V336, P41, DOI 10.1007/s00441-009-0761-6; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Elphick MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044492; Enright AJ, 2004, GENOME BIOL, V5; Fernandez S, 2015, ONCOGENE, V34, P3240, DOI 10.1038/onc.2014.267; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; [郭盈莹 Guo Yingying], 2014, [食品科学, Food Science], V35, P335; Ji NJ, 2014, FISH SHELLFISH IMMUN, V38, P400, DOI 10.1016/j.fsi.2014.03.030; Jiang JW, 2014, FISH SHELLFISH IMMUN, V36, P344, DOI 10.1016/j.fsi.2013.12.001; Kadri Sabah H VF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0029217, DOI 10.1371/JOURNAL.PONE.0029217]; Kitahara Y, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109207; Landeira-Fernandez AM, 2000, GLYCOBIOLOGY, V10, P773, DOI 10.1093/glycob/10.8.773; Landeira-Fernandez AM, 2000, COMP BIOCHEM PHYS A, V126, P263, DOI 10.1016/S1095-6433(00)00197-5; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li GX, 2014, J CELL BIOCHEM, V115, P1768, DOI 10.1002/jcb.24843; Li SC, 2010, GENOMICS, V96, P1, DOI 10.1016/j.ygeno.2010.03.009; Li Xia, 2007, Dalian Shuichan Xueyuan Xuebao, V22, P81; [李晓林 Li Xiaolin], 2011, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V41, P65; Liu Xiao-yun, 2005, Marine Sciences (Beijing), V29, P25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mei YL, 2014, MOL BIOL REP, V41, P4985, DOI 10.1007/s11033-014-3365-5; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murray G, 2004, CELL TISSUE RES, V318, P515, DOI 10.1007/s00441-004-0978-3; Papp G, 2014, GENE CHROMOSOME CANC, V53, P168, DOI 10.1002/gcc.22128; Peng W, 2012, GENET MOL RES, V11, P434, DOI 10.4238/2012.February.24.2; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; ROBERTSON DA, 1972, COMP BIOCHEM PHYSIOL, V43, P795, DOI 10.1016/0300-9629(72)90148-X; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Satoh M, 2011, J CARD FAIL, V17, P923, DOI 10.1016/j.cardfail.2011.07.012; Shin JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022481; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song JL, 2012, DEV BIOL, V362, P104, DOI 10.1016/j.ydbio.2011.11.015; Strong AMP, 2014, ARCH BIOCHEM BIOPHYS, V563, P118, DOI 10.1016/j.abb.2014.07.012; Sun HJ, 2013, FISH SHELLFISH IMMUN, V34, P147, DOI 10.1016/j.fsi.2012.10.014; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084146; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Tang Y, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-92; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Wang HJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085484, 10.1371/journal.pone.0097917]; Wang XX, 2010, J ENVIRON SCI HEAL B, V45, P648, DOI 10.1080/03601234.2010.502435; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wu DT, 2008, CLIN COSMET INVESTI, V1, P19; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082062; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100492; Zhao Y, 2014, MAR GENOM, V18, P173, DOI 10.1016/j.margen.2014.07.001; Zhao Y, 2013, COMP BIOCHEM PHYS B, V165, P26, DOI 10.1016/j.cbpb.2013.02.009; Zhu XM, 2013, J CELL MOL MED, V17, P1173, DOI 10.1111/jcmm.12096	66	14	17	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134899	10.1371/journal.pone.0134899	http://dx.doi.org/10.1371/journal.pone.0134899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244987	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400128
J	Wang, YT; Wang, SK; Liu, T; Tu, WJ; Li, WG; Dong, GD; Xu, C; Qin, B; Liu, KH; Yang, J; Chai, J; Shi, XW; Zhang, YF				Wang, Youtao; Wang, Shengkui; Liu, Tong; Tu, Wenji; Li, Wengui; Dong, Guodong; Xu, Cong; Qin, Bo; Liu, Kaihua; Yang, Jie; Chai, Jun; Shi, Xianwei; Zhang, Yifang			CARD15 Gene Polymorphisms Are Associated with Tuberculosis Susceptibility in Chinese Holstein Cows	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; BOVINE TUBERCULOSIS; HOST SUSCEPTIBILITY; CROHNS-DISEASE; NOD2; POPULATION; PARATUBERCULOSIS; NOD2/CARD15; INFECTION; VARIANTS	Bovine tuberculosis (BTB) is a significant veterinary and financial problem in many parts of the world. Associations between specific host genes and susceptibility to mycobacterial infections, such as tuberculosis, have been reported in several species. The objective of this study was to identify and evaluate the relationship of single-nucleotide polymorphisms (SNPs) in the CARD15 gene with susceptibility to BTB in Chinese Holstein cows. DNA samples from 201 Chinese Holstein cows (103 cases and 98 controls) were collected from Kunming City, Yuxi City, and Dali City in China. SNPs in the CARD15 gene were assessed using polymerase chain reaction (PCR) and restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR). Case-control association testing and statistical analysis identified six SNPs associated with susceptibility to BTB in Chinese Holstein cows. The frequency of genotypes C/T, A/G, A/G, A/G, C/T, and A/G in E4 (-37), 208, 1644, 1648, 1799, and E10 (+107), respectively, was significantly higher in cases than in controls, and also the alleles C, A, A, G, T, and A, respectively, were associated with a greater relative risk in cases than in controls. The distribution of two haplotypes, TGGACA and CAGACA, was significantly different between cases and controls. Overall, this case-control study suggested that E4 (-37)(C/T), 208(A/G), 1644(A/G), 1648(A/G), 1799(C/T), and E10 (+107)(A/G) in the CARD15 gene were significantly associated with susceptibility to BTB in Chinese Holstein cows and that haplotypes TGGACA and CAGACA could be used as genetic markers in marker-assisted breeding programs for breeding cows with high resistance to BTB.	[Wang, Youtao; Wang, Shengkui; Liu, Tong; Tu, Wenji; Li, Wengui; Qin, Bo; Liu, Kaihua; Yang, Jie; Shi, Xianwei; Zhang, Yifang] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China; [Chai, Jun] Yunnan Agr Univ, Coll Hydraul & Architectural Engn, Kunming, Yunnan, Peoples R China; [Dong, Guodong] Ctr Anim Dis Control & Prevent Yunnan Prov, Kunming, Yunnan, Peoples R China; [Xu, Cong] Ctr Anim Dis Control & Prevent Yuxi City, Yuxi, Yunnan, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University	Zhang, YF (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Yunnan, Peoples R China.	wytwcj@163.com; zyfkm@qq.com			National Natural Science Foundation [31260598]; Yunnan key Program of Application Basic Research [2011FA014]; Development Plan of Yunnan Key New Product [2014BB004]; Academician Expert Work Station Foundation of Yunnan Province [2014 IC034]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan key Program of Application Basic Research; Development Plan of Yunnan Key New Product; Academician Expert Work Station Foundation of Yunnan Province	This work was supported by National Natural Science Foundation (31260598), the Yunnan key Program of Application Basic Research (2011FA014), the Development Plan of Yunnan Key New Product (2014BB004), and the Academician Expert Work Station Foundation of Yunnan Province (2014 IC034).	Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; Amim L, 2008, MOL BIOL REP, V35, P563, DOI 10.1007/s11033-007-9123-1; Anic GM, 2012, CANCER CAUSE CONTROL, V23, P1443, DOI 10.1007/s10552-012-0018-7; Austin CM, 2008, J INFECT DIS, V197, P1713, DOI 10.1086/588384; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Ben-Selma W, 2011, MOL BIOL REP, V38, P5413, DOI 10.1007/s11033-011-0695-4; Etter E, 2006, ANN NY ACAD SCI, V1081, P61, DOI 10.1196/annals.1373.006; Figueroa C, 2006, EUR CYTOKINE NETW, V17, P125; Finlay EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030545; Gomez LM, 2005, HUM IMMUNOL, V66, P1242, DOI 10.1016/j.humimm.2005.11.008; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kupper JD, 2014, ANIM GENET, V45, P114, DOI 10.1111/age.12097; le Roex N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064494; Li M, 2008, WORLD J GASTROENTERO, V14, P4923, DOI 10.3748/wjg.14.4923; Lian YY, 2010, INFECT GENET EVOL, V10, P517, DOI 10.1016/j.meegid.2010.02.006; Liang L, 2011, INFECT GENET EVOL, V11, P934, DOI 10.1016/j.meegid.2011.02.017; Medici V, 2006, EUR J HUM GENET, V14, P459, DOI 10.1038/sj.ejhg.5201576; Minozzi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011117; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Moller M, 2007, MOL CELL PROBE, V21, P148, DOI 10.1016/j.mcp.2006.10.001; Pinedo PJ, 2009, VET MICROBIOL, V134, P346, DOI 10.1016/j.vetmic.2008.09.052; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Shrivastava P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077680; Sole X, 2005, BIOINFORMATICS, V21, P1776; Song YP, 2014, ACTA HISTOCHEM, V116, P1159, DOI 10.1016/j.acthis.2014.06.004; Sventoraityte J, 2010, WORLD J GASTROENTERO, V16, P359, DOI 10.3748/wjg.v16.i3.359; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; VAZQUEZ P, 2014, VET MED INT, V2014, DOI DOI 10.1155/2014/321327; Vesosky B, 2010, J LEUKOCYTE BIOL, V87, P1153, DOI 10.1189/jlb.1109742; Vind I, 2005, DIGESTION, V72, P156, DOI 10.1159/000088371; Wang C, 2014, INT J BIOL SCI, V10, P103, DOI 10.7150/ijbs.7585; Wu F, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/484535; Zhang YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038918	33	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135085	10.1371/journal.pone.0135085	http://dx.doi.org/10.1371/journal.pone.0135085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244859	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400141
J	Zheng, YL; Wang, SA				Zheng, Yan-Lin; Wang, Shi-An			Stress Tolerance Variations in Saccharomyces cerevisiae Strains from Diverse Ecological Sources and Geographical Locations	PLOS ONE			English	Article							POPULATION-STRUCTURE; BIOETHANOL PRODUCTION; ETHANOL-PRODUCTION; GENE-EXPRESSION; YEAST; FERMENTATION; EVOLUTION; WINE; DIVERGENCE; PARADOXUS	The budding yeast Saccharomyces cerevisiae is a platform organism for bioethanol production from various feedstocks and robust strains are desirable for efficient fermentation because yeast cells inevitably encounter stressors during the process. Recently, diverse S. cerevisiae lineages were identified, which provided novel resources for understanding stress tolerance variations and related shaping factors in the yeast. This study characterized the tolerance of diverse S. cerevisiae strains to the stressors of high ethanol concentrations, temperature shocks, and osmotic stress. The results showed that the isolates from human-associated environments overall presented a higher level of stress tolerance compared with those from forests spared anthropogenic influences. Statistical analyses indicated that the variations of stress tolerance were significantly correlated with both ecological sources and geographical locations of the strains. This study provides guidelines for selection of robust S. cerevisiae strains for bioethanol production from nature.	[Zheng, Yan-Lin] Shandong Univ Sci & Technol, Coll Math & Syst Sci, Qingdao 266590, Peoples R China; [Wang, Shi-An] Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Key Lab Biofuels, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Peoples R China	Shandong University of Science & Technology; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, SA (corresponding author), Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Key Lab Biofuels, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Peoples R China.	wangsa@qibebt.ac.cn			National Natural Science Foundation of China [30900007]; Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents [2015RCJJ054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents	This study was supported by the National Natural Science Foundation of China (No. 30900007) and Scientific Research Foundation of Shandong University of Science and Technology for Recruited Talents (2015RCJJ054).	Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Ayoub MJ, 2006, J APPL MICROBIOL, V100, P699, DOI 10.1111/j.1365-2672.2006.02817.x; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Cromie GA, 2013, G3-GENES GENOM GENET, V3, P2163, DOI 10.1534/g3.113.007492; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fay JC, 2005, GENETICS, V170, P1575, DOI 10.1534/genetics.105.042283; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Hu N, 2012, APPL MICROBIOL BIOT, V95, P1359, DOI 10.1007/s00253-012-4240-8; Hu XH, 2007, GENETICS, V175, P1479, DOI 10.1534/genetics.106.065292; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Mukherjee V, 2014, APPL MICROBIOL BIOT, V98, P9483, DOI 10.1007/s00253-014-6090-z; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; PIPER PW, 1995, FEMS MICROBIOL LETT, V134, P121, DOI 10.1016/0378-1097(95)00431-9; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; Tao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031235; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Wang QM, 2012, MOL ECOL, V21, P5404, DOI 10.1111/j.1365-294X.2012.05732.x; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Warringer Jonas, 2008, BMC Chemical Biology, V8, P3, DOI 10.1186/1472-6769-8-3; Will JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000893; Wimalasena TT, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-47; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001	44	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133889	10.1371/journal.pone.0133889	http://dx.doi.org/10.1371/journal.pone.0133889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244846	Green Published, gold			2022-12-26	WOS:000359061400057
J	Galbavy, W; Kaczocha, M; Puopolo, M; Liu, LX; Rebecchi, MJ				Galbavy, William; Kaczocha, Martin; Puopolo, Michelino; Liu, Lixin; Rebecchi, Mario J.			Neuroimmune and Neuropathic Responses of Spinal Cord and Dorsal Root Ganglia in Middle Age	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; SATELLITE GLIAL-CELLS; CHRONIC CONSTRICTION; SCIATIC-NERVE; CHRONIC PAIN; MECHANICAL ALLODYNIA; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; NITRIC-OXIDE; MOUSE MODEL	Prior studies of aging and neuropathic injury have focused on senescent animals compared to young adults, while changes in middle age, particularly in the dorsal root ganglia (DRG), have remained largely unexplored. 14 neuroimmune mRNA markers, previously associated with peripheral nerve injury, were measured in multiplex assays of lumbar spinal cord (LSC), and DRG from young and middle-aged (3, 17 month) naive rats, or from rats subjected to chronic constriction injury (CCI) of the sciatic nerve (after 7 days), or from aged-matched sham controls. Results showed that CD2, CD3e, CD68, CD45, TNF-alpha, IL6, CCL2, ATF3 and TGF beta 1 mRNA levels were substantially elevated in LSC from naive middle-aged animals compared to young adults. Similarly, LSC samples from older sham animals showed increased levels of T-cell and microglial/macrophage markers. CCI induced further increases in CCL2, and IL6, and elevated ATF3 mRNA levels in LSC of young and middle-aged adults. Immunofluorescence images of dorsal horn microglia from middle-aged naive or sham rats were typically hypertrophic with mostly thickened, de-ramified processes, similar to microglia following CCI. Unlike the spinal cord, marker expression profiles in naive DRG were unchanged across age (except increased ATF3); whereas, levels of GFAP protein, localized to satellite glia, were highly elevated in middle age, but independent of nerve injury. Most neuroimmune markers were elevated in DRG following CCI in young adults, yet middle-aged animals showed little response to injury. No age-related changes in nociception (heat, cold, mechanical) were observed in naive adults, or at days 3 or 7 post-CCI. The patterns of marker expression and microglial morphologies in healthy middle age are consistent with development of a para-inflammatory state involving microglial activation and T-cell marker elevation in the dorsal horn, and neuronal stress and satellite cell activation in the DRG. These changes, however, did not affect the establishment of neuropathic pain.	[Galbavy, William; Kaczocha, Martin; Puopolo, Michelino; Liu, Lixin; Rebecchi, Mario J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rebecchi, MJ (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Mario.Rebecchi@stonybrookmedicine.edu		Kaczocha, Martin/0000-0002-2527-1398; Galbavy, William/0000-0003-0948-9538	Department of Anesthesiology, Stony Brook University School of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035949] Funding Source: NIH RePORTER	Department of Anesthesiology, Stony Brook University School of Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was entirely supported by internal funds of the Department of Anesthesiology, Stony Brook University School of Medicine.	Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P450, DOI 10.1016/j.bbi.2009.01.016; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Chung JY, 2010, NEUROCHEM RES, V35, P620, DOI 10.1007/s11064-009-0108-4; CHUNG JM, 1995, NEUROSCI LETT, V183, P54, DOI 10.1016/0304-3940(94)11113-W; Chung YH, 2005, J MOL HISTOL, V36, P325, DOI 10.1007/s10735-005-9001-x; Conde JR, 2006, NEUROBIOL AGING, V27, P1451, DOI 10.1016/j.neurobiolaging.2005.07.012; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Crisp T, 2006, BEHAV BRAIN RES, V166, P159, DOI 10.1016/j.bbr.2005.07.006; Crisp T, 2003, NEUROSCI LETT, V339, P103, DOI 10.1016/S0304-3940(03)00009-0; Di Ieva A, 2014, NEUROSCIENTIST, V20, P403, DOI 10.1177/1073858413513927; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Franceschi C, 2001, AGING-CLIN EXP RES, V13, P163, DOI 10.1007/BF03351475; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062456; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gemechu JM, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00038; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Godbout JP, 2006, NEUROL CLIN, V24, P521, DOI 10.1016/j.ncl.2006.03.010; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P503, DOI 10.1016/j.bbi.2010.11.018; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoozemans JJM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-171; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Huang CY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-7; Huang LYM, 2013, GLIA, V61, P1571, DOI 10.1002/glia.22541; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Iwata K, 2004, J OROFAC PAIN, V18, P293; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; KIM YI, 1995, NEUROSCI LETT, V199, P158, DOI 10.1016/0304-3940(95)12038-6; Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Latremoliere A, 2008, J NEUROSCI, V28, P8489, DOI 10.1523/JNEUROSCI.2552-08.2008; Leboeuf-Yde C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-39; Lee WH, 2010, NEUROSCI LETT, V476, P89, DOI 10.1016/j.neulet.2010.04.009; Leite-Almeida H, 2009, PAIN, V144, P57, DOI 10.1016/j.pain.2009.02.024; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Li K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/901420; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Lovell JA, 2000, PHARMACOL BIOCHEM BE, V66, P873, DOI 10.1016/S0091-3057(00)00285-9; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nakayamada S, 2012, CURR OPIN IMMUNOL, V24, P297, DOI 10.1016/j.coi.2012.01.014; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Novak JC, 1999, BRAIN RES, V833, P308, DOI 10.1016/S0006-8993(99)01522-X; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pickering G, 2006, EUR J PAIN, V10, P749, DOI 10.1016/j.ejpain.2005.12.002; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ramer MS, 1998, J COMP NEUROL, V394, P38; Rustoen T, 2005, CLIN J PAIN, V21, P513, DOI 10.1097/01.ajp.0000146217.31780.ef; Sacerdote P, 2008, NEUROSCI LETT, V436, P210, DOI 10.1016/j.neulet.2008.03.023; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sansoni P, 2008, EXP GERONTOL, V43, P61, DOI 10.1016/j.exger.2007.06.008; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sieber MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026288; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Stichel CC, 2007, NEUROBIOL AGING, V28, P1507, DOI 10.1016/j.neurobiolaging.2006.07.022; Streit WJ, 2010, AGING DIS, V1, P254; Stuesse SL, 2001, EXP BRAIN RES, V137, P219, DOI 10.1007/s002210000630; Stuesse SL, 2000, NEUROSCI LETT, V287, P121, DOI 10.1016/S0304-3940(00)01142-3; Sweitzer SM, 2002, PAIN, V100, P163, DOI 10.1016/S0304-3959(02)00257-9; Takeda M, 2009, NEUROSCI BIOBEHAV R, V33, P784, DOI 10.1016/j.neubiorev.2008.12.005; Tsuda M, 2009, P NATL ACAD SCI USA, V106, P8032, DOI 10.1073/pnas.0810420106; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Xie W, 2009, NEUROSCIENCE, V160, P847, DOI 10.1016/j.neuroscience.2009.03.016; Yezierski RP, 2010, J GERONTOL A-BIOL, V65, P353, DOI 10.1093/gerona/glq024; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043	89	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134394	10.1371/journal.pone.0134394	http://dx.doi.org/10.1371/journal.pone.0134394			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241743	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700042
J	Gignoux-Wolfsohn, SA; Vollmer, SV				Gignoux-Wolfsohn, Sarah A.; Vollmer, Steven V.			Identification of Candidate Coral Pathogens on White Band Disease-Infected Staghorn Coral	PLOS ONE			English	Article							PLAGUE-LIKE DISEASE; BACTERIAL COMMUNITIES; REEF CORAL; HEALTHY; DIVERSITY; DYNAMICS; SEAWATER; ECOLOGY; SHIFTS; AGENT	Bacterial diseases affecting scleractinian corals pose an enormous threat to the health of coral reefs, yet we still have a limited understanding of the bacteria associated with coral diseases. White band disease is a bacterial disease that affects the two Caribbean acroporid corals, the staghorn coral Acropora cervicornis and the elkhorn coral A. palmate. Species of Vibrio and Rickettsia have both been identified as putative WBD pathogens. Here we used Illumina 16S rRNA gene sequencing to profile the bacterial communities associated with healthy and diseased A. cervicornis collected from four field sites during two different years. We also exposed corals in tanks to diseased and healthy (control) homogenates to reduce some of the natural variation of field-collected coral bacterial communities. Using a combination of multivariate analyses, we identified community-level changes between diseased and healthy corals in both the field-collected and tank-exposed datasets. We then identified changes in the abundances of individual operational taxonomic units (OTUs) between diseased and healthy corals. By comparing the diseased and healthy-associated bacteria in field-collected and tank-exposed corals, we were able to identify 16 healthy-associated OTUs and 106 consistently disease-associated OTUs, which are good candidates for putative WBD pathogens. A large percentage of these disease-associated OTUs belonged to the order Flavobacteriales. In addition, two of the putative pathogens identified here belong to orders previously suggested as WBD pathogens: Vibronales and Rickettsiales.	[Gignoux-Wolfsohn, Sarah A.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Gignoux-Wolfsohn, SA (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	gignoux-wolfsohn.s@husky.neu.edu		Gignoux-Wolfsohn, Sarah/0000-0002-9037-1088	National Science Foundation [OCE 0751666]	National Science Foundation(National Science Foundation (NSF))	Supported by National Science Foundation grant to SVV (OCE 0751666).	Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, ENDANGERED THREATENE; Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Bayer T, 2013, APPL ENV MICROBIOLOG, V79; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Bullock GL, 1986, COLUMNARIS DIS FISHE, P129; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Casas V, 2004, ENVIRON MICROBIOL, V6, P1137, DOI 10.1111/j.1462-2920.2004.00647.x; Ceh J, 2013, MICROB ECOL, V65, P227, DOI 10.1007/s00248-012-0105-z; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Closek CJ, 2014, ISME J, V8, P2411, DOI 10.1038/ismej.2014.85; Cook GM, 2013, CORAL REEFS, V32, P375, DOI 10.1007/s00338-012-0989-6; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Davis HS, 1922, NEW BACTERIAL DIS FR; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedman CS, 2000, INT J SYST EVOL MICR, V50, P847, DOI 10.1099/00207713-50-2-847; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Gignoux-Wolfsohn SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00804; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Goreau TJ, 1998, REV BIOL TROP, V46, P157; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Jari Oksanen F.G.B, 2013, VEGAN COMMUNITY ECOL; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Kline DI, 2011, SCI REP-UK, V1, DOI 10.1038/srep00007; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Lesser MP, 2014, FEMS MICROBIOL ECOL, V88, P457, DOI 10.1111/1574-6941.12311; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; PETERS EC, 1983, J INVERTEBR PATHOL, V41, P394, DOI 10.1016/0022-2011(83)90260-4; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Richardson LL, 1998, TRENDS ECOLOGY EVOLU, V13; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Sere MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083746; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Stoddard R, 2005, EMERGING INFECT DIS, V11; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Tiirola M, 2002, DIS AQUAT ORGAN, V51, P93, DOI 10.3354/dao051093; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Walker DH., 1996, MED MICROBIOLOGY, V4th; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zwart MP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002122	84	44	44	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134416	10.1371/journal.pone.0134416	http://dx.doi.org/10.1371/journal.pone.0134416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241853	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942700043
J	Thomsen, LB; Burkhart, A; Moos, T				Thomsen, Louiza Bohn; Burkhart, Annette; Moos, Torben			A Triple Culture Model of the Blood-Brain Barrier Using Porcine Brain Endothelial cells, Astrocytes and Pericytes	PLOS ONE			English	Article							IN-VITRO MODEL; DRUG TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PERMEABILITY; VIVO; ESTABLISHMENT; INTEGRITY; SYSTEM	In vitro blood-brain barrier (BBB) models based on primary brain endothelial cells (BECs) cultured as monoculture or in co-culture with primary astrocytes and pericytes are useful for studying many properties of the BBB. The BECs retain their expression of tight junction proteins and efflux transporters leading to high trans-endothelial electric resistance (TEER) and low passive paracellular permeability. The BECs, astrocytes and pericytes are often isolated from small rodents. Larger species as cows and pigs however, reveal a higher yield, are readily available and have a closer resemblance to humans, which make them favorable high-throughput sources for cellular isolation. The aim of the present study has been to determine if the preferable combination of purely porcine cells isolated from the 6 months old domestic pigs, i.e. porcine brain endothelial cells (PBECs) in co-culture with porcine astrocytes and pericytes, would compare with PBECs co-cultured with astrocytes and pericytes isolated from newborn rats with respect to TEER value and low passive permeability. The astrocytes and pericytes were grown both as contact and non-contact co-cultures as well as in triple culture to examine their effects on the PBECs for barrier formation as revealed by TEER, passive permeability, and expression patterns of tight junction proteins, efflux transporters and the transferrin receptor. This syngenic porcine in vitro BBB model is comparable to triple cultures using PBECs, rat astrocytes and rat pericytes with respect to TEER formation, low passive permeability, and expression of hallmark proteins signifying the brain endothelium (tight junction proteins claudin 5 and occludin, the efflux transporters P-glycoprotein (PgP) and breast cancer related protein (BCRP), and the transferrin receptor).	[Thomsen, Louiza Bohn; Burkhart, Annette; Moos, Torben] Aalborg Univ, Dept Hlth Sci & Technol, Neurobiol Lab, Aalborg, Denmark	Aalborg University	Thomsen, LB (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Neurobiol Lab, Aalborg, Denmark.	lbt@hst.aau.dk		Thomsen, Louiza Bohn/0000-0002-3144-7150; Larsen, Annette Burkhart/0000-0003-2086-4693; Moos, Torben/0000-0001-9989-0207	Obel Family Foundation; Obel.com; A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk	Obel Family Foundation; Obel.com; A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk	This work was partly supported by the Obel Family Foundation, Obel.com and the A.P. Moeller Foundation "Fonden til Laegevidenskabens Fremme", apmollerfonde.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BAUER HC, 1993, DEV BRAIN RES, V75, P269, DOI 10.1016/0165-3806(93)90031-5; BOWMAN PD, 1983, ANN NEUROL, V14, P396, DOI 10.1002/ana.410140403; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Cantrill CA, 2012, BRAIN RES, V1479, P17, DOI 10.1016/j.brainres.2012.08.031; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gad S. C., 2008, PRECLINICAL DEV HDB; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gaillard PJ, 2000, EUR J PHARM SCI, V12, P95, DOI 10.1016/S0928-0987(00)00152-4; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lamszus K, 1999, J NEUROSCI RES, V55, P370, DOI 10.1002/(SICI)1097-4547(19990201)55:3<370::AID-JNR12>3.0.CO;2-U; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544, 10.1111/j.1471-4159.2009.06544.x]; Malina KCK, 2009, BRAIN RES, V1284, P12, DOI 10.1016/j.brainres.2009.05.072; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nakhlband A, 2011, BIOIMPACTS, V1, P153, DOI 10.5681/bi.2011.021; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Patabendige A, 2013, BRAIN RES, V1521, P16, DOI 10.1016/j.brainres.2013.04.006; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Skinner RA, 2009, BRIT J PHARMACOL, V156, P1115, DOI 10.1111/j.1476-5381.2008.00129.x; Smith M, 2007, J DRUG TARGET, V15, P253, DOI 10.1080/10611860701288539; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016; Zhang Y, 2006, DRUG METAB DISPOS, V34, P1935, DOI 10.1124/dmd.105.006437	34	86	91	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134765	10.1371/journal.pone.0134765	http://dx.doi.org/10.1371/journal.pone.0134765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241648	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700065
J	Lambrot, R; Lafleur, C; Kimmins, S				Lambrot, Romain; Lafleur, Christine; Kimmins, Sarah			The histone demethylase KDM1A is essential for the maintenance and differentiation of spermatogonial stem cells and progenitors	FASEB JOURNAL			English	Article						epigenetics; histone modifications; spermatogenesis	MALE GERM-CELLS; SEMEN QUALITY; SELF-RENEWAL; LSD1; METHYLATION; EXPRESSION; SPERM; POPULATION; CHROMATIN; PLZF	Little is known of the fundamental processes governed by epigenetic mechanisms in the supplier cells of spermatogenesis, the spermatogonial stem cells (SSCs). The histone H3 lysine demethylase KDM1A is expressed in spermatogonia. We hypothesized that KDM1A serves in transcriptional regulation of SSCs and fertility. Using a conditional deletion of Kdm1a [conditional knockout (cKO)] in mouse spermatogonia, we determined that Kdm1a is essential for spermatogenesis as adult cKO males completely lack germ cells. Analysis of postnatal testis development revealed that undifferentiated and differentiating spermatogonial populations form in Kdm1a-cKO animals, yet the majority fail to enter meiosis. Loss of germ cells in the cKO was rapid with none remaining by postnatal day (PND) 21. To gain insight into the mechanistic implications of Kdm1a ablation, we isolated PND 6 spermatogonia enriched for SSCs and analyzed their transcriptome by RNA sequencing. Loss of Kdm1a was associated with altered transcription of 1206 genes. Importantly, differentially expressed genes between control and Kdm1a-cKO animals included those that are essential for SSC and progenitormaintenance and spermatogonial differentiation. The complete loss of fertility and failure to establish spermatogenesis indicate that Kdm1a is a master controller of gene transcription in spermatogonia and is required for SSC and progenitor maintenance and differentiation.	[Lambrot, Romain; Lafleur, Christine; Kimmins, Sarah] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Kimmins, Sarah] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University	Kimmins, S (corresponding author), McGill Univ, Dept Anim Sci, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	sarah.kimmins@mcgill.ca			Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. Michael G. Rosenfeld and Jianxun Wang for the Kdm1a<SUP>fl/fl</SUP> mice. They also thank Dr. Makoto Nagano (McGill University, Montreal, QC, Canada) for his advice and critical reading of the manuscript, Ken MacDonald (McGill University, Montreal, QC, Canada) for the flow cytometry, and Julien Tremblay (Genome Quebec, Montreal, QC, Canada) for bioinformatic support. This research was funded by the Canadian Institute of Health Research (to S.K.). R.L. and S.K. conceived and designed the experiments. R.L. and C.L. performed the experiments and analyzed the data. R.L. and S.K. wrote the manuscript. The authors declare no conflicts of interest.	Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chan F, 2014, GENE DEV, V28, P1351, DOI 10.1101/gad.240465.114; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; Fisch H, 1996, UROLOGY, V48, P909, DOI 10.1016/S0090-4295(96)00301-9; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Godmann M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012727; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grasso M, 2012, REPRODUCTION, V143, P325, DOI 10.1530/REP-11-0385; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Hao J, 2008, STEM CELLS, V26, P1587, DOI 10.1634/stemcells.2007-0502; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; Ishii K, 2012, DEVELOPMENT, V139, P1734, DOI 10.1242/dev.076539; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Kaucher AV, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097386; Kleiman SE, 2008, FERTIL STERIL, V89, P1728, DOI [10.1016/j.fertnstert.2007.05.068, 10.1016/j.fertnstert.2007.12.033]; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lambrot R, 2011, INT J ANDROL, V34, P110, DOI 10.1111/j.1365-2605.2010.01063.x; McCarrey JR, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110502; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nagano MC, 2003, BIOL REPROD, V69, P701, DOI 10.1095/biolreprod.103.016352; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKAKKEBAEK NE, 1972, LANCET, V2, P516; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu X, 2010, BIOL REPROD, V82, P1103, DOI 10.1095/biolreprod.109.083097; Yang QE, 2014, CURR TOP DEV BIOL, V107, P235, DOI 10.1016/B978-0-12-416022-4.00009-3; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	71	28	32	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4402	4416		10.1096/fj.14-267328	http://dx.doi.org/10.1096/fj.14-267328			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26243864				2022-12-26	WOS:000364514700002
J	Fairweather, SJ; Broer, A; Subramanian, N; Turner, E; Cheng, Q; Schmoll, D; O'Mara, ML; Broer, S				Fairweather, Stephen J.; Broeer, Angelika; Subramanian, Nandhitha; Turner, Ennrah; Cheng, Qi; Schmoll, Dieter; O'Mara, Megan L.; Broeer, Stefan			Molecular Basis for the Interaction of the Mammalian Amino Acid Transporters B(0)AT1 and B(0)AT3 with Their Ancillary Protein Collectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; BRAIN GABA TRANSPORTER; XENOPUS-LAEVIS OOCYTES; ENZYME 2 HOMOLOG; SYNTAXIN 1A; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; DYNAMICS SIMULATIONS; HARTNUP DISORDER; PLASMA-MEMBRANE	Many solute carrier 6 (SLC6) family transporters require ancillary subunits to modify their expression and activity. The main apical membrane neutral amino acid transporters in mouse intestine and kidney, B(0)AT1 and B(0)AT3, require the ancillary protein collectrin or ACE2 for plasma membrane expression. Expression and activity of SLC6 neurotransmitter transporters are modulated by interaction with syntaxin 1A. Utilizing monocarboxylate-B(0)AT1/3 fusion constructs, we discovered that collectrin is also necessary for B(0)AT1 and B(0)AT3 catalytic function. Syntaxin 1A and syntaxin 3 inhibit the membrane expression of B(0)AT1 by competing with collectrin for access. A mutagenesis screening approach identified residues on trans-membrane domains 1 alpha, 5, and 7 on one face of B(0)AT3 as a key region involved in interaction with collectrin. Mutant analysis established residues that were involved in collectrin-dependent functions as follows: plasma membrane expression of B(0)AT3, catalytic activation, or both. These results identify a potential binding site for collectrin and other SLC6 ancillary proteins.	[Fairweather, Stephen J.; Broeer, Angelika; Turner, Ennrah; Cheng, Qi; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Subramanian, Nandhitha; O'Mara, Megan L.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Schmoll, Dieter] Sanofi Aventis Deutschland GmbH, Ind Pk Hoechst, D-65926 Frankfurt, Germany	Australian National University; Australian National University; Sanofi-Aventis	Broer, S (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Biol, Bldg 134, Canberra, ACT 2601, Australia.	stefan.broeer@anu.edu.au	O'Mara, Megan L/A-4962-2011; O'Mara, Megan/AAY-5934-2021; Fairweather, Stephen James/AFK-2946-2022; Broer, Stefan/A-1286-2008; O'Mara, Megan/ABF-8913-2020	O'Mara, Megan L/0000-0002-8764-1585; O'Mara, Megan/0000-0002-8764-1585; Fairweather, Stephen James/0000-0003-1530-7876; Broer, Stefan/0000-0002-8040-1634; Cheng, Qi/0000-0003-0811-6369; Schmoll, Dieter/0000-0003-2578-3366; Subramanian, Nandhitha/0000-0003-2491-0474	Sanofi [525415]; National Health and Medical Research Council [525415]	Sanofi; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a sponsored research agreement with Sanofi and National Health and Medical Research Council Grant 525415 (to S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binda F, 2006, NEUROPHARMACOLOGY, V50, P354, DOI 10.1016/j.neuropharm.2005.09.012; Blakely RD, 2000, NAT NEUROSCI, V3, P969, DOI 10.1038/79898; Bohmer C, 2005, BIOCHEM J, V389, P745; Bril A, 2014, M S-MED SCI, V30, P136, DOI 10.1051/medsci/20143002007; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer S, 2013, CURR OPIN NEPHROL HY, V22, P539, DOI 10.1097/MNH.0b013e328363fff6; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Broer S, 2008, J CLIN INVEST, V118, P3881, DOI 10.1172/JCI36625; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Broer Stefan, 2013, Curr Mol Pharmacol, V6, P74; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cechova S, 2013, CIRCULATION, V128, P1770, DOI 10.1161/CIRCULATIONAHA.113.003301; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; de Macedo SM, 2014, PEPTIDES, V62, P189, DOI 10.1016/j.peptides.2014.10.005; De Mello WC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00016; de Wit H, 2010, BIOCHEM SOC T, V38, P192, DOI 10.1042/BST0380192; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Egan BM, 2013, CIRCULATION, V128, P1727, DOI 10.1161/CIRCULATIONAHA.113.005695; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Esterhazy D, 2012, BIOL CHEM, V393, P473, DOI 10.1515/hsz-2012-0104; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Fan H, 2004, PROTEIN SCI, V13, P211, DOI 10.1110/ps.03381404; Fan HP, 2006, J BIOL CHEM, V281, P28174, DOI 10.1074/jbc.M601382200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Fenollar-Ferrer C, 2014, BIOCHEMISTRY-US, V53, P5444, DOI 10.1021/bi500637f; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Fraser R, 2014, MOL PHARMACOL, V86, P76, DOI 10.1124/mol.114.091926; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Ganeshan R, 2003, J BIOL CHEM, V278, P2876, DOI 10.1074/jbc.M211790200; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; Horton N, 2001, MOL MEMBR BIOL, V18, P39; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang Y, 2015, MOL METAB, V4, P406, DOI 10.1016/j.molmet.2015.02.003; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lang Thorsten, 2008, V184, P107; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Lopez-Corcuera B, 2001, BIOCHEM SOC T, V29, P742, DOI 10.1042/0300-5127:0290742; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Patel SK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00227; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Quick MW, 2006, HANDB EXP PHARM, V175, P181; Quick MW, 2002, P NATL ACAD SCI USA, V99, P5686, DOI 10.1073/pnas.082712899; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Saisho K, 2009, BIOCHEM BIOPH RES CO, V389, P133, DOI 10.1016/j.bbrc.2009.08.111; Saxena S, 2000, CURR OPIN NEPHROL HY, V9, P523, DOI 10.1097/00041552-200009000-00011; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schwartz JH, 2007, KIDNEY INT, V72, P1310, DOI 10.1038/sj.ki.5002500; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Singer D, 2009, J BIOL CHEM, V284, P19953, DOI 10.1074/jbc.M109.011171; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Sung U, 2003, J NEUROSCI, V23, P1697; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Vanslambrouck JM, 2010, BIOCHEM J, V428, P397, DOI 10.1042/BJ20091667; Vuille-Dit-Bille RN, 2015, AMINO ACIDS, V47, P693, DOI 10.1007/s00726-014-1889-6; Wang D, 2003, MOL PHARMACOL, V64, P905, DOI 10.1124/mol.64.4.905; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Yamagata K, 2007, DIABETES OBES METAB, V9, P40, DOI 10.1111/j.1463-1326.2007.00773.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yasuhara A, 2008, CIRCULATION, V118, P2146, DOI 10.1161/CIRCULATIONAHA.108.787259; Zhong HL, 2012, BIOCHEM PHARMACOL, V83, P435, DOI 10.1016/j.bcp.2011.09.020	85	32	33	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24308	24325		10.1074/jbc.M115.648519	http://dx.doi.org/10.1074/jbc.M115.648519			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26240152	Green Published, hybrid			2022-12-26	WOS:000362218900021
J	Momiuchi, Y; Kumada, K; Kuraishi, T; Takagaki, T; Aigaki, T; Oshima, Y; Kurata, S				Momiuchi, Yoshiki; Kumada, Kohei; Kuraishi, Takayuki; Takagaki, Takeshi; Aigaki, Toshiro; Oshima, Yoshiteru; Kurata, Shoichiro			The Role of the Phylogenetically Conserved Cochaperone Protein Droj2/DNAJA3 in NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN-RECOGNITION PROTEIN; ANTIMICROBIAL PEPTIDE GENES; INNATE IMMUNE RECOGNITION; TOLL-LIKE-RECEPTORS; DROSOPHILA-MELANOGASTER; FACTOR RELISH; ANTIBACTERIAL DEFENSE; FUNGAL-INFECTIONS; HUMAN HOMOLOG; HUMAN DNAJ	The NF-kappa B pathway is a phylogenetically conserved signaling pathway with a central role in inflammatory and immune responses. Here we demonstrate that a cochaperone protein, Droj2/DNAJA3, is involved in the activation of canonical NF-kappa B signaling in flies and in human cultured cells. Overexpression of Droj2 induced the expression of an antimicrobial peptide in Drosophila. Conversely, Droj2 knockdown resulted in reduced expression of antimicrobial peptides and higher susceptibility to Gram-negative bacterial infection in flies. Similarly, Toll-like receptor-stimulated I kappa B phosphorylation and NF-kappa B activation were suppressed by DNAJA3 knockdown in HEK293 cells. I kappa B kinase overexpression-induced NF-kappa B phosphorylation was also compromised in DNAJA3 knockdown cells. Our study reveals a novel conserved regulator of the NF-kappa B pathway acting at the level of I kappa B phosphorylation.	[Momiuchi, Yoshiki; Kumada, Kohei; Kuraishi, Takayuki; Takagaki, Takeshi; Oshima, Yoshiteru; Kurata, Shoichiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Kuraishi, Takayuki] Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Tokyo 3320012, Japan; [Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tohoku University; Japan Science & Technology Agency (JST); Tokyo Metropolitan University	Kurata, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	kurata@m.tohoku.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24390014, 21117005, 21310134, 14657577, 13143202]; Promotion of Basic Research Activities for Innovative Biosciences; Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); Takeda Science Foundation; Kao Foundation for Arts and Sciences; Uehara Memorial Foundation; Futaba Electronics Memorial Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Promotion of Basic Research Activities for Innovative Biosciences; Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kao Foundation for Arts and Sciences; Uehara Memorial Foundation(Uehara Memorial Foundation); Futaba Electronics Memorial Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Japan Science and Technology Agency; by Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) Grants 24390014, 21117005, 21310134, 14657577, and 13143202; by the Program for the Promotion of Basic Research Activities for Innovative Biosciences; by a Global COE (Centers of Excellence) research grant (Tohoku University Ecosystem Adaptability); by the Takeda Science Foundation; by the Kao Foundation for Arts and Sciences; by the Uehara Memorial Foundation; and by the Futaba Electronics Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Elwi AN, 2012, INT J BIOCHEM CELL B, V44, P1366, DOI 10.1016/j.biocel.2012.05.004; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Goto A, 2010, J BIOL CHEM, V285, P15731, DOI 10.1074/jbc.M109.082115; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hofius D, 2007, J VIROL, V81, P11870, DOI 10.1128/JVI.01525-07; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2006, MOL CELL BIOL, V26, P7821, DOI 10.1128/MCB.00548-06; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; REICHHART JM, 1992, EMBO J, V11, P1469, DOI 10.1002/j.1460-2075.1992.tb05191.x; Shibata T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003970; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Toba G, 1999, GENETICS, V151, P725; Towb P, 1998, DEVELOPMENT, V125, P2443; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang YJ, 2003, DEV BIOL, V262, P350, DOI 10.1016/S0012-1606(03)00396-8; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837	67	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23816	23825		10.1074/jbc.M115.664193	http://dx.doi.org/10.1074/jbc.M115.664193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245905	Green Published, hybrid			2022-12-26	WOS:000361816500028
J	Riling, C; Kamadurai, H; Kumar, S; O'Leary, CE; Wu, KP; Manion, EE; Ying, M; Schulman, BA; Oliver, PM				Riling, Christopher; Kamadurai, Hari; Kumar, Suresh; O'Leary, Claire E.; Wu, Kuen-Phon; Manion, Erica E.; Ying, Mingjie; Schulman, Brenda A.; Oliver, Paula M.			Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; HECT-DOMAIN; STRUCTURAL BASIS; C2 DOMAIN; PY MOTIFS; AUTOINHIBITION; PHOSPHORYLATION; ACTIVATION; NEDD4; INFLAMMATION	Nedd4-family E3 ubiquitin ligases regulate an array of biologic processes. Autoinhibition maintains these catalytic ligases in an inactive state through several mechanisms. However, although some Nedd4 family members are activated by binding to Nedd4 family-interacting proteins (Ndfips), how binding activates E3 function remains unclear. Our data reveal how these two regulatory processes are linked functionally. In the absence of Ndfip1, the Nedd4 family member Itch can bind an E2 but cannot accept ubiquitin onto its catalytic cysteine. This is because Itch is autoinhibited by an intramolecular interaction between its HECT (homologous to the E6-AP carboxy terminus domain) and two central WW domains. Ndfip1 binds these WW domains to release the HECT, allowing trans-thiolation and Itch catalytic activity. This molecular switch also regulates the closely related family member WWP2. Importantly, multiple PY motifs are required for Ndfip1 to activate Itch, functionally distinguishing Ndfips from single PY-containing substrates. These data establish a novel mechanism for control of the function of a subfamily of Nedd4 E3 ligases at the level of E2-E3 trans-thiolation.	[Riling, Christopher; O'Leary, Claire E.; Oliver, Paula M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kamadurai, Hari; Wu, Kuen-Phon; Schulman, Brenda A.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Kumar, Suresh; Manion, Erica E.] Progenra Inc, Malvern, PA 19355 USA; [Ying, Mingjie; Oliver, Paula M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Schulman, Brenda A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Oliver, Paula M.] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; University of Pennsylvania	Oliver, PM (corresponding author), Childrens Hosp Philadelphia, Cell Pathol Div ARC 816F, Philadelphia, PA 19104 USA.	paulao@mail.med.upenn.edu	Wu, Kuen-Phon/B-7983-2009; Regan, Clinton/E-6250-2012; Wu, Kuen-Phon/I-1789-2019	Wu, Kuen-Phon/0000-0002-1525-6004; Wu, Kuen-Phon/0000-0002-1525-6004; O'Leary, Claire/0000-0001-9052-4593; Kumar, Suresh/0000-0001-5682-0938; Kamadurai, Hari/0000-0001-9021-0279	National Institutes of Health [R37GM065930]; American Asthma Foundation scholar award; Institute for Translational Medicine and Therapeutics award; American Lebanese Syrian Associated Charities; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI109256, R01AI114515, R01AI093566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM069530, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation scholar award; Institute for Translational Medicine and Therapeutics award; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37GM065930 (to B. A. S.). This work was also supported by an American Asthma Foundation scholar award and an Institute for Translational Medicine and Therapeutics award (to P. M. O.), by American Lebanese Syrian Associated Charities, and by the Howard Hughes Medical Institute (to B. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2011, NAT IMMUNOL, V12, P1176, DOI 10.1038/ni.2157; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beal AM, 2012, NAT IMMUNOL, V13, P77, DOI 10.1038/ni.2154; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Chou YC, 2012, J BIOL CHEM, V287, P268, DOI 10.1074/jbc.M111.316265; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda M, 2001, J VIROL, V75, P5711, DOI 10.1128/JVI.75.12.5711-5718.2001; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kathania M, 2015, J IMMUNOL, V194, P2160, DOI 10.4049/jimmunol.1402742; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Marblestone JG, 2012, BBA-MOL CELL RES, V1823, P2094, DOI 10.1016/j.bbamcr.2012.06.013; Mari S, 2014, STRUCTURE, V22, P1639, DOI 10.1016/j.str.2014.09.006; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rotin D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00212; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	42	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23875	23887		10.1074/jbc.M115.649269	http://dx.doi.org/10.1074/jbc.M115.649269			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245901	hybrid, Green Published			2022-12-26	WOS:000361816500033
J	Zaanan, A; Okamoto, K; Kawakami, H; Khazaie, K; Huang, SB; Sinicrope, FA				Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Khazaie, Khashayarsha; Huang, Shengbing; Sinicrope, Frank A.			The Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL Antagonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER CELLS; BH3 MIMETIC ABT-737; MEK INHIBITION; COLON-CANCER; MEDIATED APOPTOSIS; DRIVEN CANCERS; ACTIVATION; LUNG; PHOSPHORYLATION; COMBINATION	In colorectal cancers with oncogenic GTPase Kras (KRAS) mutations, inhibition of downstream MEK/ERK signaling has shown limited efficacy, in part because of failure to induce a robust apoptotic response. We studied the mechanism of apoptosis resistance in mutant KRAS cells and sought to enhance the efficacy of a KRAS-specific MEK/ERK inhibitor, GDC-0623. GDC-0623 was shown to potently up-regulate BIM expression to a greater extent versus other MEK inhibitors in isogenic KRAS HCT116 and mutant KRAS SW620 colon cancer cells. ERK silencing enhanced BIM up-regulation by GDC-0623 that was due to its loss of phosphorylation at Ser(69), confirmed by a BIM-EL phosphorylation-defective mutant (S69G) that increased protein stability and blocked BIM induction. Despite BIM and BIK induction, the isogenic KRAS mutant versus wildtype cells remained resistant to GDC-0623-induced apoptosis, in part because of up-regulation of BCL-XL. KRAS knockdown by a doxycycline-inducible shRNA attenuated BCL-XL expression. BCL-XL knockdown sensitized KRAS mutant cells to GDC-0623- mediated apoptosis, as did the BH3 mimetic ABT-263. GDC-0623 plus ABT-263 induced a synergistic apoptosis by a mechanism that includes release of BIM from its sequestration by BCL-XL. Furthermore, mutant KRAS activated p-STAT3 (Tyr(705)) in the absence of IL-6 secretion, and STAT3 knockdown reduced BCL-XL mRNA and protein expression. These data suggest that BCL-XL up-regulation by STAT3 contributes to mutant KRAS-mediated apoptosis resistance. Such resistance can be overcome by potent BIM induction and concurrent BCL-XL antagonism to enable a synergistic apoptotic response.	[Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Dept Med, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Gastroenterol Res Unit, Rochester, MN 55905 USA; [Zaanan, Aziz; Okamoto, Koichi; Kawakami, Hisato; Huang, Shengbing; Sinicrope, Frank A.] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA; [Khazaie, Khashayarsha] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, Dept Med, Gastroenterol Res Unit, 200 First St,SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu	Kawakami, Hisato/L-6845-2019	Kawakami, Hisato/0000-0002-3280-4850; Zaanan, Aziz/0000-0001-8372-5653	NCI/National Institutes of Health [5 K05 CA142885, CA113681]; Mayo Cancer Center Core [CA15083]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; French Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA113681, R01CA160436, K05CA142885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Cancer Center Core; Mayo Clinic Center for Cell Signaling in Gastroenterology; French Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grants 5 K05 CA142885 and CA113681 (to F. A. S.). This work was also supported by Mayo Cancer Center Core Grant CA15083 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the French Multi-Organizational Thematic Institute for Cancer and the French National Cancer Institute.; Supported by the Uehara Memorial Foundation.	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; [Anonymous], 2014, R LANG ENV STAT COMP; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bennouna J, 2011, INVEST NEW DRUG, V29, P1021, DOI 10.1007/s10637-010-9392-8; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Huang Y, 2013, INFLAMMATION, V36, P1064, DOI 10.1007/s10753-013-9638-7; INFANTE JR, 2010, J CLIN ONCOL S, V28, pS15; Kasper S, 2013, ONCOGENE, V32, P2873, DOI 10.1038/onc.2012.302; Kawabata T, 2012, J BIOL CHEM, V287, P10289, DOI 10.1074/jbc.M111.319426; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Meng JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013026; Milella M, 2002, BLOOD, V99, P3461, DOI 10.1182/blood.V99.9.3461; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Okamoto K, 2015, MOL CANCER RES, V13, P659, DOI 10.1158/1541-7786.MCR-14-0476; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Stintzing S, 2015, HEMATOL ONCOL CLIN N, V29, P43, DOI 10.1016/j.hoc.2014.09.009; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang J, 2005, CANCER RES, V65, P939; Yang JY, 2010, CANCER RES, V70, P4709, DOI 10.1158/0008-5472.CAN-09-4524; Yoon HH, 2014, CLIN CANCER RES, V20, P3033, DOI 10.1158/1078-0432.CCR-13-3140; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83	43	41	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23838	23849		10.1074/jbc.M115.657833	http://dx.doi.org/10.1074/jbc.M115.657833			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26245900	Green Published, hybrid			2022-12-26	WOS:000361816500030
J	Chatterjee, A; Ratner, DM; Ryan, CM; Johnson, PJ; O'Keefe, BR; Secor, WE; Anderson, DJ; Robbins, PW; Samuelson, J				Chatterjee, Aparajita; Ratner, Daniel M.; Ryan, Christopher M.; Johnson, Patricia J.; O'Keefe, Barry R.; Secor, W. Evan; Anderson, Deborah J.; Robbins, Phillips W.; Samuelson, John			Anti-Retroviral Lectins Have Modest Effects on Adherence of Trichomonas vaginalis to Epithelial Cells In Vitro and on Recovery of Tritrichomonas foetus in a Mouse Vaginal Model	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; CHLAMYDIA-TRACHOMATIS; CYANOVIRIN-N; HIV-1; GRIFFITHSIN; EXPRESSION; INFECTION; GLYCANS; LIPOPHOSPHOGLYCAN; OLIGOSACCHARIDE	Trichomonas vaginalis causes vaginitis and increases the risk of HIV transmission by heterosexual sex, while Tritrichomonas foetus causes premature abortion in cattle. Our goals were to determine the effects, if any, of anti-retroviral lectins, which are designed to prevent heterosexual transmission of HIV, on adherence of Trichomonas to ectocervical cells and on Tritrichomonas infections in a mouse model. We show that Trichomonas Asn-linked glycans (N-glycans), like those of HIV, bind the mannose-binding lectin (MBL) that is part of the innate immune system. N-glycans of Trichomonas and Tritrichomonas bind anti-retroviral lectins (cyanovirin-N and griffithsin) and the 2G12 monoclonal antibody, each of which binds HIV N-glycans. Binding of cyanovirin-N appears to be independent of susceptibility to metronidazole, the major drug used to treat Trichomonas. Anti-retroviral lectins, MBL, and galectin-1 cause Trichomonas to self-aggregate and precipitate. The anti-retroviral lectins also increase adherence of ricin-resistant mutants, which are less adherent than parent cells, to ectocervical cell monolayers and to organotypic EpiVaginal tissue cells. Topical application of either anti-retroviral lectins or yeast N-glycans decreases by 40 to 70% the recovery of Tritrichomonas from the mouse vagina. These results, which are explained by a few simple models, suggest that the anti-retroviral lectins have a modest potential for preventing or treating human infections with Trichomonas.	[Chatterjee, Aparajita; Ratner, Daniel M.; Robbins, Phillips W.; Samuelson, John] Boston Univ, Dept Mol & Cell Biol, Sch Dent Med, Boston, MA 02215 USA; [Ryan, Christopher M.; Johnson, Patricia J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [O'Keefe, Barry R.] Frederick Natl Lab Canc Res, Ctr Canc Res, Mol Targets Lab, Frederick, MD USA; [Secor, W. Evan] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Anderson, Deborah J.] Boston Med Ctr, Dept Obstet & Gynecol, Boston, MA USA	Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; Boston Medical Center	Samuelson, J (corresponding author), Boston Univ, Dept Mol & Cell Biol, Sch Dent Med, Boston, MA 02215 USA.	jsamuels@bu.edu			Boston University Flow Cytometry Core Facility; National Institutes of Health, General Medical Science; National Institutes of Allergy and Infectious Diseases [GM031318, AI105779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031318, R37GM031318] Funding Source: NIH RePORTER	Boston University Flow Cytometry Core Facility; National Institutes of Health, General Medical Science; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Boston University Flow Cytometry Core Facility, the National Institutes of Health, General Medical Science, GM031318 National Institutes of Allergy and Infectious Diseases, AI105779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010; ARROYO R, 1993, MOL MICROBIOL, V7, P299, DOI 10.1111/j.1365-2958.1993.tb01121.x; Ayehunie S, 2011, TOXICOLOGY, V279, P130, DOI 10.1016/j.tox.2010.10.001; Azadi Parastoo, 2009, V534, P37, DOI 10.1007/978-1-59745-022-5_3; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Barroso L, 2014, VACCINE, V32, P1218, DOI 10.1016/j.vaccine.2013.06.056; Bastida-Corcuera FD, 2005, EUKARYOT CELL, V4, P1951, DOI 10.1128/EC.4.11.1951-1958.2005; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Bulla R, 2010, MOL IMMUNOL, V48, P281, DOI 10.1016/j.molimm.2010.07.016; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Cobo ER, 2011, AM J TROP MED HYG, V85, P667, DOI 10.4269/ajtmh.2011.11-0123; Conrad MD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001573; Corbeil LB, 2001, AM J REPROD IMMUNOL, V45, P310, DOI 10.1111/j.8755-8920.2001.450507.x; Crowell AL, 2003, ANTIMICROB AGENTS CH, V47, P1407, DOI 10.1128/AAC.47.4.1407-1409.2003; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; de Miguel N, 2010, MOL CELL PROTEOMICS, V9, P1554, DOI 10.1074/mcp.M000022-MCP201; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Ferir G, 2011, VIROLOGY, V417, P253, DOI 10.1016/j.virol.2011.07.004; Fichorova RN, 2013, SEX TRANSM INFECT, V89, P460, DOI 10.1136/sextrans-2013-051052; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Henning T, 2011, J MED PRIMATOL, V40, P214, DOI 10.1111/j.1600-0684.2011.00488.x; Henning TR, 2014, J INFECT DIS, V210, P1239, DOI 10.1093/infdis/jiu240; Hirt RP, 2015, CURR OPIN INFECT DIS, V28, P72, DOI 10.1097/QCO.0000000000000128; Hirt RP, 2013, SEX TRANSM INFECT, V89, P439, DOI 10.1136/sextrans-2013-051105; Huang KY, 2012, INFECT IMMUN, V80, P3900, DOI 10.1128/IAI.00611-12; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jain A, 2014, HUM REPROD, V29, P242, DOI 10.1093/humrep/det423; Jenikova G, 2011, VACCINE, V29, P9529, DOI 10.1016/j.vaccine.2011.09.126; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Kirkcaldy RD, 2012, EMERG INFECT DIS, V18, P939, DOI 10.3201/eid1806.111590; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Kucknoor AS, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-5; Kusdian G, 2014, MOL BIOCHEM PARASIT, V198, P92, DOI 10.1016/j.molbiopara.2015.01.004; Kusdian G, 2013, CELL MICROBIOL, V15, P1707, DOI 10.1111/cmi.12144; Luallen RJ, 2010, GLYCOBIOLOGY, V20, P280, DOI 10.1093/glycob/cwp184; Lustig G, 2013, INFECT IMMUN, V81, P1411, DOI 10.1128/IAI.01244-12; MARTINOTTI MG, 1986, EUR J CLIN MICROBIOL, V5, P320, DOI 10.1007/BF02017789; Nixon B, 2013, J VIROL, V87, P6257, DOI 10.1128/JVI.00012-13; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Okumura CYM, 2008, CELL MICROBIOL, V10, P2078, DOI 10.1111/j.1462-5822.2008.01190.x; Patton DL, 2006, SEX TRANSM DIS, V33, P743, DOI 10.1097/01.olq.0000218871.89901.61; Ryan CM, 2011, J BIOL CHEM, V286, P40494, DOI 10.1074/jbc.M111.280578; Ryan CM, 2011, ESSAYS BIOCHEM, V51, P161, DOI [10.1042/BSE0510161, 10.1042/bse0510161]; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Singh BN, 2009, GLYCOCONJUGATE J, V26, P3, DOI 10.1007/s10719-008-9157-1; Smith J, 2014, VACCINE, V32, P1588, DOI 10.1016/j.vaccine.2013.07.050; Takebe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064449; Twu O, 2014, P NATL ACAD SCI USA, V111, P8179, DOI 10.1073/pnas.1321884111; Twu O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003482; van den Berg LM, 2013, ADV EXP MED BIOL, V762, P45, DOI 10.1007/978-1-4614-4433-6_2; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496	60	18	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135340	10.1371/journal.pone.0135340	http://dx.doi.org/10.1371/journal.pone.0135340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252012	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100154
J	Fonvig, CE; Chabanova, E; Andersson, EA; Ohrt, JD; Pedersen, O; Hansen, T; Thomsen, HS; Holm, JC				Fonvig, Cilius Esmann; Chabanova, Elizaveta; Andersson, Ehm Astrid; Ohrt, Johanne Dam; Pedersen, Oluf; Hansen, Torben; Thomsen, Henrik S.; Holm, Jens-Christian			H-1-MRS Measured Ectopic Fat in Liver and Muscle in Danish Lean and Obese Children and Adolescents	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CARDIOVASCULAR RISK-FACTORS; CHRONIC CARE TREATMENT; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; HEPATIC STEATOSIS; LIPID-CONTENT; SENSITIVITY; DISEASE; ASSOCIATION	Objectives This cross sectional study aims to investigate the associations between ectopic lipid accumulation in liver and skeletal muscle and biochemical measures, estimates of insulin resistance, anthropometry, and blood pressure in lean and overweight/obese children. Methods Fasting plasma glucose, serum lipids, serum insulin, and expressions of insulin resistance, anthropometry, blood pressure, and magnetic resonance spectroscopy of liver and muscle fat were obtained in 327 Danish children and adolescents aged 8-18 years. Results In 287 overweight/obese children, the prevalences of hepatic and muscular steatosis were 31% and 68%, respectively, whereas the prevalences in 40 lean children were 3% and 10%, respectively. A multiple regression analysis adjusted for age, sex, body mass index z-score (BMI SDS), and pubertal development showed that the OR of exhibiting dyslipidemia was 4.2 (95% CI: [1.8; 10.2], rho = 0.0009) when hepatic steatosis was present. Comparing the simultaneous presence of hepatic and muscular steatosis with no presence of steatosis, the OR of exhibiting dyslipidemia was 5.8 (95% CI: [2.0; 18.6], rho = 0.002). No significant associations between muscle fat and dyslipidemia, impaired fasting glucose, or blood pressure were observed. Liver and muscle fat, adjusted for age, sex, BMI SDS, and pubertal development, associated to BMI SDS and glycosylated hemoglobin, while only liver fat associated to visceral and subcutaneous adipose tissue and intramyocellular lipid associated inversely to high density lipoprotein cholesterol. Conclusion Hepatic steatosis is associated with dyslipidemia and liver and muscle fat depositions are linked to obesity-related metabolic dysfunctions, especially glycosylated hemoglobin, in children and adolescents, which suggest an increased cardiovascular disease risk.	[Fonvig, Cilius Esmann; Ohrt, Johanne Dam; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark; [Fonvig, Cilius Esmann; Andersson, Ehm Astrid; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Fac Med & Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen O, Denmark; [Chabanova, Elizaveta; Thomsen, Henrik S.] Copenhagen Univ Hosp Herlev, Dept Diagnost Radiol, Herlev, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Thomsen, Henrik S.; Holm, Jens-Christian] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen N, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Southern Denmark; University of Copenhagen	Fonvig, CE (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Pediat, Childrens Obes Clin, Holbaek, Denmark.	crfo@regionsjaelland.dk	Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Holm, Jens-Christian/T-4594-2017; Fonvig, Cilius/I-1234-2013	Pedersen, Oluf/0000-0002-3321-3972; Holm, Jens-Christian/0000-0003-4653-342X; Fonvig, Cilius/0000-0002-5031-0125; Hansen, Torben/0000-0001-8748-3831	Danish Innovation Foundation [0603-00484B]; Region Zealand Health and Medical Research Foundation	Danish Innovation Foundation; Region Zealand Health and Medical Research Foundation	This study was funded by the Danish Innovation Foundation (grant number 0603-00484B) and by the Region Zealand Health and Medical Research Foundation (TH CEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Alkhouri N, 2011, CLIN LIPIDOL, V6, P305, DOI 10.2217/CLP.11.19; Bennett B, 2012, OBESITY, V20, P371, DOI 10.1038/oby.2011.264; Bille DS, 2012, CLIN OBES, V2, P41, DOI 10.1111/j.1758-8111.2012.00038.x; Brown RJ, 2014, PEDIATR DIABETES, V15, P151, DOI 10.1111/pedi.12146; Brumbaugh DE, 2012, J CLIN ENDOCR METAB, V97, pE1099, DOI 10.1210/jc.2011-3243; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Caserta CA, 2010, AM J EPIDEMIOL, V171, P1195, DOI 10.1093/aje/kwq073; Chabanova E, 2013, ABDOM IMAGING, V38, P315, DOI 10.1007/s00261-012-9930-2; Chan DFY, 2004, INT J OBESITY, V28, P1257, DOI 10.1038/sj.ijo.0802734; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Craig ME, 2014, PEDIATR DIABETES, V15, P4, DOI 10.1111/pedi.12186; Georgoff P, 2012, AM J ROENTGENOL, V199, P2, DOI 10.2214/AJR.11.7384; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Hagman E, 2014, INT J OBESITY, V38, P40, DOI 10.1038/ijo.2013.124; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Kurtoglu Selim, 2010, J Clin Res Pediatr Endocrinol, V2, P100, DOI 10.4274/jcrpe.v2i3.100; Larson-Meyer DE, 2011, DIABETOLOGIA, V54, P869, DOI 10.1007/s00125-010-2022-3; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463, DOI 10.1093/ajcn/58.4.463; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Li CY, 2009, DIABETES CARE, V32, P342, DOI 10.2337/dc08-1128; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Mencin AA, 2011, PEDIATR CLIN N AM, V58, P1375, DOI 10.1016/j.pcl.2011.09.005; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Moro C, 2009, J CLIN ENDOCR METAB, V94, P3440, DOI 10.1210/jc.2009-0053; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Sartorio A, 2007, EUR J CLIN NUTR, V61, P877, DOI 10.1038/sj.ejcn.1602588; Saukkonen T, 2010, EUR J ENDOCRINOL, V163, P413, DOI 10.1530/EJE-10-0186; Schrauwen-Hinderling VB, 2006, OBESITY, V14, P357, DOI 10.1038/oby.2006.47; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135018	10.1371/journal.pone.0135018	http://dx.doi.org/10.1371/journal.pone.0135018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252778	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100104
J	Kong, XM; Zhao, Q; Xing, XY; Zhang, B; Zhang, XL; Hong, J; Yang, WY				Kong, Xiaomu; Zhao, Qi; Xing, Xiaoyan; Zhang, Bo; Zhang, Xuelian; Hong, Jing; Yang, Wenying			Genetic Variants Associated with Lipid Profiles in Chinese Patients with Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; LOCI; RISK; POPULATION; TRANSCRIPTION; PREVALENCE; PROTEIN; TRAITS	Dyslipidemia is a strong risk factor for cardiovascular disease among patients with type 2 diabetes (T2D). The aim of this study was to identify lipid-related genetic variants in T2D patients of Han Chinese ancestry. Among 4,908 Chinese T2D patients who were not taking lipid-lowering medications, single nucleotide polymorphisms (SNPs) in seven genes previously found to be associated with lipid traits in genome-wide association studies conducted in populations of European ancestry (ABCA1, GCKR, BAZ1B, TOMM40, DOCK7, HNF1A, and HNF4A) were genotyped. After adjusting for multiple covariates, SNPs in ABCA1, GCKR, BAZ1B, TOMM40, and HNF1A were identified as significantly associated with triglyceride levels in T2D patients (P < 0.05). The associations between the SNPs in ABCA1 (rs3890182), GCKR (rs780094), and BAZ1B (rs2240466) remained significant even after correction for multiple testing (P = 8.85x10(-3), 7.88x10(-7), and 2.03x10(-6), respectively). BAZ1B (rs2240466) also was associated with the total cholesterol level (P = 4.75x10(-2)). In addition, SNP rs157580 in TOMM40 was associated with the low-density lipoprotein cholesterol level (P = 6.94x10(-3)). Our findings confirm that lipid-related genetic loci are associated with lipid profiles in Chinese patients with type 2 diabetes.	[Kong, Xiaomu; Xing, Xiaoyan; Zhang, Bo; Zhang, Xuelian; Hong, Jing; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Qi] Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA	China-Japan Friendship Hospital; Tulane University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywying_1010@163.com	Zhao, Qi/Y-9866-2019; Zhang, Bo/ABE-8008-2020	Kong, Xiaomu/0000-0002-5920-4759; Yang, Wenying/0000-0002-7997-9404	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program [2011CB504001]; China Postdoctoral Science Foundation [2012M520200]; Fogarty International Center of the National Institutes of Health [D43TW009107]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER	Chinese Medical Association Foundation; Sanofi (China) Investment Company Limited; National 973 Program(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Chinese National Diabetes and Metabolic Disorders Study was supported by grants from the Chinese Medical Association Foundation (http://en.cma.org.cn), Sanofi (China) Investment Company Limited (http://www.sanofi.cn/l/cn/zh/index.jsp) and the National 973 Program (2011CB504001) (http://www.973.gov.cn). XK was supported by Award Number 2012M520200 from the China Postdoctoral Science Foundation Grant (http://res.chinapostdoctor.org.cn) and the Award Number D43TW009107 from the Fogarty International Center of the National Institutes of Health (http://www.fic.nih.gov). QZ was supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (http://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barnett C, 2011, BIOCHEM CELL BIOL, V89, P12, DOI 10.1139/O10-114; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Feulner TM, 2010, MOL PSYCHIATR, V15, P756, DOI 10.1038/mp.2008.141; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Huang YD, 2010, CURR OPIN LIPIDOL, V21, P337, DOI 10.1097/MOL.0b013e32833af368; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Irwin DM, 2014, MOL PHYLOGENET EVOL, V70, P195, DOI 10.1016/j.ympev.2013.09.016; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolovou GD, 2006, CURR MED CHEM, V13, P771, DOI 10.2174/092986706776055580; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kong XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104486; Kong XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071399; Li Ge, 2013, IUBMB Life, DOI [10.1002/iub.1165, 10.1002/iub.01165]; Ling Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-66; Liu Y, 2011, J LIPID RES, V52, P354, DOI 10.1194/jlr.P007476; Lorber D, 2014, DIABET METAB SYND OB, V7, P169, DOI 10.2147/DMSO.S61438; Maestro MA, 2007, ENDOCR DEV, V12, P33, DOI 10.1159/000109603; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shang Xiaorui, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P626; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yang Z, 2011, MOL BIOL REP, V38, P1145, DOI 10.1007/s11033-010-0212-1; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027305; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091790	37	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135145	10.1371/journal.pone.0135145	http://dx.doi.org/10.1371/journal.pone.0135145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252223	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100123
J	Maheswaran, E; Pedersen, CB; Ditzel, HJ; Gjerstorff, MF				Maheswaran, Emeaga; Pedersen, Christina B.; Ditzel, Henrik J.; Gjerstorff, Morten F.			Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer	PLOS ONE			English	Article							T-CELL RESPONSES; TESTIS ANTIGENS; MELANOMA; NY-ESO-1; GAUGE; SP17; IDENTIFICATION; TOXICITY; PROTEINS; ANTIBODY	Immunotherapy is emerging as a supplement to conventional cancer treatment, and identifying antigen targets for specific types of cancer is critical to optimizing therapeutic efficacy. Cancer/testis antigens are highly promising targets for immunotherapy due to their cancer-specific expression and antigenic properties, but the expression patterns of most of the more than 200 identified cancer/testis antigens in various cancers remain largely uncharacterized. In this study, we investigated the expression of the cancer/testis antigens ADAM2, CALR3 and SAGE1 in lung and breast cancer, the two most frequent human cancers, with the purpose of providing novel therapeutic targets for these diseases. We used a set of previously uncharacterized antibodies against the cancer/testis antigens ADAM2, CALR3 and SAGE1 to investigate their expression in a large panel of normal tissues as well as breast and lung cancers. Staining for the well-characterized MAGE-A proteins was included for comparison. Immunohistochemical staining confirmed previous mRNA analysis demonstrating that ADAM2, CALR3 and SAGE1 proteins are confined to testis in normal individuals. Negative tissues included plancenta, which express many other CT antigens, such as MAGE-A proteins. Surprisingly, we detected no ADAM2, CALR3 and SAGE1 in the 67 lung cancers (mainly non-small lung cancer) and 189 breast cancers, while MAGE-A proteins were present in 15% and 7-16% of these tumor types, respectively. Treatment with DNA methyltransferase inhibitors has been proposed as an attractive strategy to increase the expression of cancer/testis antigens in tumors before immunotargeting; however, neither ADAM2, CALR3 nor SAGE1 could be significantly induced in lung and breast cancer cell lines using this strategy. Our results suggest that ADAM2, CALR3 and SAGE1 cancer/testis antigens are not promising targets for immunotherapy of breast and lung cancer.	[Maheswaran, Emeaga; Pedersen, Christina B.; Ditzel, Henrik J.; Gjerstorff, Morten F.] Univ Southern Denmark, Dept Canc & Inflammat Res, Inst Mol Med, Odense, Denmark; [Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Gjerstorff, MF (corresponding author), Univ Southern Denmark, Dept Canc & Inflammat Res, Inst Mol Med, Odense, Denmark.	mgjerstorff@health.sdu.dk		Ditzel, Henrik J./0000-0003-3927-5135; gjerstorff, morten/0000-0002-0845-1952	Danish Research Council; Danish Cancer Society; Danish Cancer Research Foundation	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation	This study was supported by the Danish Research Council, the Danish Cancer Society and the Danish Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Ayyoub M, 2003, CANCER RES, V63, P5601; Bazhin AV, 2007, CANCER LETT, V251, P258, DOI 10.1016/j.canlet.2006.11.022; Bolli M, 2005, INT J CANCER, V115, P960, DOI 10.1002/ijc.20953; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Curigliano G, 2011, ANN ONCOL, V22, P98, DOI 10.1093/annonc/mdq325; dos Santos NR, 2000, CANCER RES, V60, P1654; Ehmsen S, 2015, INT J CANCER, V137, P2093, DOI 10.1002/ijc.29582; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Gjerstorff MF, 2012, TISSUE ANTIGENS, V80, P523, DOI 10.1111/tan.12015; Gjerstorff MF, 2015, ONCOTARGET; Gjerstorff MF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-466; Gjerstorff MF, 2010, EXPERT OPIN BIOL TH, V10, P1061, DOI 10.1517/14712598.2010.485188; Gnjatic S, 2003, P NATL ACAD SCI USA, V100, P8862, DOI 10.1073/pnas.1133324100; Hayashi E, 2007, CLIN CANCER RES, V13, P6267, DOI 10.1158/1078-0432.CCR-07-1374; Heidebrecht HJ, 2006, CLIN CANCER RES, V12, P4804, DOI 10.1158/1078-0432.CCR-06-0186; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Luftl M, 2004, BRIT J DERMATOL, V151, P1213, DOI 10.1111/j.1365-2133.2004.06260.x; Martelange V, 2000, CANCER RES, V60, P3848; Mirandola L, 2015, ONCOTARGET, V6, P2812, DOI 10.18632/oncotarget.2802; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Ohue Y, 2012, INT J CANCER, V131, pE649, DOI 10.1002/ijc.27359; Otte M, 2001, CANCER RES, V61, P6682; Schultz-Thater E, 2011, INT J CANCER, V129, P1137, DOI 10.1002/ijc.25777; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Tsuji T, 2009, J IMMUNOL, V183, P4800, DOI 10.4049/jimmunol.0900903	29	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134967	10.1371/journal.pone.0134967	http://dx.doi.org/10.1371/journal.pone.0134967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252478	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100093
J	Ramsey, LB; Janke, LJ; Payton, MA; Cai, XJ; Paugh, SW; Karol, SE; Kamdem, LK; Cheng, C; Williams, RT; Jeha, S; Pui, CH; Evans, WE; Relling, MV				Ramsey, Laura B.; Janke, Laura J.; Payton, Monique A.; Cai, Xiangjun; Paugh, Steven W.; Karol, Seth E.; Kamdem, Landry Kamdem; Cheng, Cheng; Williams, Richard T.; Jeha, Sima; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.			Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							MOUSE MODEL; INDUCED OSTEONECROSIS; MULTIPLE-MYELOMA; GLUCOCORTICOID RESISTANCE; PEDIATRIC-PATIENTS; IMPROVES SURVIVAL; INITIATING CELLS; GENE-EXPRESSION; CHILDREN; CHILDHOOD	Osteonecrosis is one of the most common, serious, toxicities resulting from the treatment of acute lymphoblastic leukemia. In recent years, pediatric acute lymphoblastic leukemia clinical trials have used discontinuous rather than continuous dosing of dexamethasone in an effort to reduce the incidence of osteonecrosis. However, it is not known whether discontinuous dosing would compromise antileukemic efficacy of glucocorticoids. Therefore, we tested the efficacy of discontinuous dexamethasone against continuous dexamethasone in murine models bearing human acute lymphoblastic leukemia xenografts (n = 8 patient samples) or murine BCR-ABL+ acute lymphoblastic leukemia. Plasma dexamethasone concentrations (7.9 to 212 nM) were similar to those achieved in children with acute lymphoblastic leukemia using conventional dosages. The median leukemia-free survival ranged from 16 to 59 days; dexamethasone prolonged survival from a median of 4 to 129 days in all seven dexamethasone-sensitive acute lymphoblastic leukemias. In the majority of cases (7 of 8 xenografts and the murine BCR-ABL model) we demonstrated equal efficacy of the two dexamethasone dosing regimens; whereas for one acute lymphoblastic leukemia sample, the discontinuous regimen yielded inferior antileukemic efficacy (log-rank p = 0.002). Our results support the clinical practice of using discontinuous rather than continuous dexamethasone dosing in patients with acute lymphoblastic leukemia.	[Ramsey, Laura B.; Payton, Monique A.; Cai, Xiangjun; Paugh, Steven W.; Karol, Seth E.; Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Janke, Laura J.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Kamdem, Landry Kamdem] Harding Univ Coll Pharm, Searcy, AR USA; [Cheng, Cheng] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Williams, Richard T.] Puma Biotechnol Inc, Los Angeles, CA USA; [Jeha, Sima; Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Relling, MV (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Cheng, Cheng/N-8075-2018; Janke, Laura/N-8121-2018; Evans, William E./C-2069-2012; Relling, Mary/N-5032-2018; Ramsey, Laura/ABD-6113-2020; Jeha, Sima C/N-8163-2018; Pui, Ching-Hon/N-8076-2018; Karol, Seth/N-2102-2018	Janke, Laura/0000-0002-9871-6239; Evans, William E./0000-0002-9333-5322; Ramsey, Laura/0000-0001-6417-3961; Pui, Ching-Hon/0000-0003-0303-5658; Karol, Seth/0000-0001-8113-8180	NIH; Puma Biotechnology Inc; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA142665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puma Biotechnology Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grants provided by the NIH to MVR and WEE. Puma Biotechnology Inc provided support in the form of salary for author RTW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Berenson JR, 2002, BLOOD, V99, P3163, DOI 10.1182/blood.V99.9.3163; Boulos N, 2011, BLOOD, V117, P3585, DOI 10.1182/blood-2010-08-301267; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Coleman M, 2003, SEMIN ONCOL, V30, P270, DOI 10.1053/sonc.2003.50044; Dutch Children's Oncology Group, 2014, TREATM STUD PROT DUT; GAYNON PS, 1995, J PEDIAT HEMATOL ONC, V17, P1, DOI 10.1097/00043426-199502000-00001; GLUCK OS, 1981, ARTHRITIS RHEUM-US, V24, P892, DOI 10.1002/art.1780240705; HARTER JG, 1963, NEW ENGL J MED, V269, P591, DOI 10.1056/NEJM196309192691201; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Hyakuna N, 2014, J PEDIAT HEMATOL ONC, V36, P22, DOI 10.1097/MPH.0000000000000039; Jabs K, 1996, TRANSPLANTATION, V61, P31, DOI 10.1097/00007890-199601150-00008; Janke LJ, 2013, AM J PATHOL, V183, P19, DOI 10.1016/j.ajpath.2013.03.004; Jeha S, 2009, HEMATOL ONCOL CLIN N, V23, P973, DOI 10.1016/j.hoc.2009.07.009; Jing DH, 2015, BLOOD, V125, P273, DOI 10.1182/blood-2014-05-576470; Kawedia JD, 2012, COMPARATIVE MED, V62, P466; Kawedia JD, 2011, BLOOD, V117, P2340, DOI 10.1182/blood-2010-10-311969; Kimura Y, 2000, J RHEUMATOL, V27, P2018; Kuhlen M, 2014, KLIN PADIATR, V226, P154, DOI 10.1055/s-0033-1358723; Lacy MQ, 2010, LEUKEMIA, V24, P1934, DOI 10.1038/leu.2010.190; Lacy MQ, 2011, BLOOD, V118, P2970, DOI 10.1182/blood-2011-04-348896; Lee JA, 2002, J COMPUT ASSIST TOMO, V26, P839, DOI 10.1097/00004728-200209000-00030; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Liu C, 2012, LEUKEMIA, V26, P2303, DOI 10.1038/leu.2012.102; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Maloney KW, 2011, BRIT J HAEMATOL, V155, P420, DOI 10.1111/j.1365-2141.2011.08846.x; Mattano Jr LA, 2014, BLOOD; Mattano LA, 2000, J CLIN ONCOL, V18, P3262, DOI 10.1200/JCO.2000.18.18.3262; Mattano LA, 2012, LANCET ONCOL, V13, P906, DOI 10.1016/S1470-2045(12)70274-7; MIGLIARESI S, 1994, LUPUS, V3, P37, DOI 10.1177/096120339400300108; Miller AL, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-35; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Patel B, 2008, LEUKEMIA, V22, P308, DOI 10.1038/sj.leu.2405032; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Ramsey LB, 2014, PHARMACOGENET GENOM, V24, P263, DOI 10.1097/FPC.0000000000000044; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rytting ME, 2014, CANCER; Sarna S, 1997, J CLIN ENDOCR METAB, V82, P75, DOI 10.1210/jc.82.1.75; Seibel NL, 2008, BLOOD, V111, P2548, DOI 10.1182/blood-2007-02-070342; Skoner DP, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.2.e23; SMITH RW, 1950, SCIENCE, V112, P295, DOI 10.1126/science.112.2907.295; Stary J, 2013, J CLIN ONCOL, V3, P174; Vora A, 2011, BRIT J HAEMATOL, V155, P549, DOI 10.1111/j.1365-2141.2011.08871.x; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Winkel MLT, 2011, J CLIN ONCOL, V29, P4143, DOI 10.1200/JCO.2011.37.3217; Wong NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-416; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733	52	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135134	10.1371/journal.pone.0135134	http://dx.doi.org/10.1371/journal.pone.0135134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252865	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100120
J	Russo, A; Scognamiglio, PL; Enriquez, RPH; Santambrogio, C; Grandori, R; Marasco, D; Giordano, A; Scoles, G; Fortuna, S				Russo, Anna; Scognamiglio, Pasqualina Liana; Enriquez, Rolando Pablo Hong; Santambrogio, Carlo; Grandori, Rita; Marasco, Daniela; Giordano, Antonio; Scoles, Giacinto; Fortuna, Sara			In Silico Generation of Peptides by Replica Exchange Monte Carlo: Docking-Based Optimization of Maltose-Binding-Protein Ligands	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; ACTIVE-TRANSPORT; TERMINAL DOMAIN; PDZ DOMAINS; RECEPTORS; SELECTION; CLUSTERS; INSIGHTS	Short peptides can be designed in silico and synthesized through automated techniques, making them advantageous and versatile protein binders. A number of docking-based algorithms allow for a computational screening of peptides as binders. Here we developed ex-novo peptides targeting the maltose site of the Maltose Binding Protein, the prototypical system for the study of protein ligand recognition. We used a Monte Carlo based protocol, to computationally evolve a set of octapeptides starting from a polialanine sequence. We screened in silico the candidate peptides and characterized their binding abilities by surface plasmon resonance, fluorescence and electrospray ionization mass spectrometry assays. These experiments showed the designed binders to recognize their target with micromolar affinity. We finally discuss the obtained results in the light of further improvement in the ex-novo optimization of peptide based binders.	[Russo, Anna; Scoles, Giacinto; Fortuna, Sara] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Russo, Anna] Univ Siena, Policlin Le Scotte, Dept Med Biotechnol, I-53100 Siena, Italy; [Scognamiglio, Pasqualina Liana; Marasco, Daniela] Univ Naples Federico II, DFM Scarl, CIRPEB Ctr Interuniv Ric Peptidi Bioatt, Dept Pharm, Naples, Italy; [Enriquez, Rolando Pablo Hong] IIT, Dept Drug Discovery & Dev, Genoa, Italy; [Santambrogio, Carlo; Grandori, Rita] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Giordano, Antonio] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Giordano, Antonio] Temple Univ, Ctr Biotechnol, Philadelphia, PA 19122 USA; [Giordano, Antonio] Univ Siena, Dept Med Surg & Neurosci, I-53100 Siena, Italy; [Scoles, Giacinto] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	University of Udine; University of Siena; University of Naples Federico II; Istituto Italiano di Tecnologia - IIT; University of Milano-Bicocca; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Marasco, D (corresponding author), Univ Naples Federico II, DFM Scarl, CIRPEB Ctr Interuniv Ric Peptidi Bioatt, Dept Pharm, Naples, Italy.	daniela.marasco@unina.it; sara.fortuna@uniud.it	Giordano, Antonio/AAU-1201-2020; Fortuna, Sara/G-2356-2014; Santambrogio, Carlo/W-6070-2019; Giordano, Antonio/F-1927-2010; Scognamiglio, Pasqualina Liana/X-9429-2019	Giordano, Antonio/0000-0002-5959-016X; Fortuna, Sara/0000-0002-8059-6064; Santambrogio, Carlo/0000-0003-3986-6971; Giordano, Antonio/0000-0002-5959-016X; Scognamiglio, Pasqualina Liana/0000-0002-1444-8039; daniela, Marasco/0000-0002-6618-2949	AIRC; ERC [269051]	AIRC(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission)	This work has been funded by "AIRC 5 per mille Special program 2011" (www.airc.it) with the project "Application of advanced Nanotechnology in the development of Cancer Diagnostics tools". Further, we would like to gratefully aknowledge partial finacial support by the ERC Ideas Program (http://erc.europa.eu/) through a senior grant to GS entitled: MOlecular NAnotechnology for LIfe Science Applications: QUantitative Interactomics for Diagnostics, PROteomics and QUantitative Oncology (MONALISA QUIDPROQUO) Grant agreement no.: 269051 (2011-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; Anisimov VM, 2011, J COMPUT AID MOL DES, V25, P1071, DOI 10.1007/s10822-011-9484-3; Balan A, 2005, PROTEIN EXPRES PURIF, V43, P103, DOI 10.1016/j.pep.2005.03.018; Ball HJ, 1998, METH MOL B, V104, P127; Belda I, 2005, J COMPUT AID MOL DES, V19, P585, DOI 10.1007/s10822-005-9015-1; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; CARTER PB, 1986, VET CLIN N AM-SMALL, V16, P1171, DOI 10.1016/S0195-5616(86)50135-2; DEAVEN DM, 1995, PHYS REV LETT, V75, P288, DOI 10.1103/PhysRevLett.75.288; Deaven DM, 1996, CHEM PHYS LETT, V256, P195, DOI 10.1016/0009-2614(96)00406-X; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donsky E, 2011, BIOINFORMATICS, V27, P2836, DOI 10.1093/bioinformatics/btr498; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Enriquez RPH, 2012, J CHEM THEORY COMPUT, V8, P1121, DOI 10.1021/ct200873y; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fortuna S, 2010, J PHYS CHEM B, V114, P10151, DOI 10.1021/jp103950m; Fortuna S, 2009, J PHYS CHEM B, V113, P9877, DOI 10.1021/jp9030442; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gilardi G, 1997, PROTEIN ENG, V10, P479, DOI 10.1093/protein/10.5.479; GOLDBERG ME, 1993, CURR OPIN IMMUNOL, V5, P278, DOI 10.1016/0952-7915(93)90018-N; Grandori Rita, 2009, Biotechnology Journal, V4, P73, DOI 10.1002/biot.200800250; Harlow E, 1988, ANTIBODIES A LABORAT; Heurich M, 2013, TOXINS, V5, P1202, DOI 10.3390/toxins5061202; HOHL D, 1988, J CHEM PHYS, V89, P6823, DOI 10.1063/1.455356; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Li HL, 2004, BIOORG MED CHEM LETT, V14, P4671, DOI 10.1016/j.bmcl.2004.06.091; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Medintz IL, 2003, BIOCONJUGATE CHEM, V14, P909, DOI 10.1021/bc020062+; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Moret MA, 1998, J COMPUT CHEM, V19, P647, DOI 10.1002/(SICI)1096-987X(19980430)19:6<647::AID-JCC6>3.0.CO;2-R; Poletto M, 2013, BIOCHEM J, V452, P545, DOI 10.1042/BJ20121277; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider S, 1999, NAT BIOTECHNOL, V17, P170, DOI 10.1038/6172; Scognamiglio PL, 2014, BBA-GEN SUBJECTS, V1840, P2050, DOI 10.1016/j.bbagen.2014.02.017; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yagi Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-11; Zeng J, 2001, PROTEIN ENG, V14, P39, DOI 10.1093/protein/14.1.39; Zhang ZW, 2000, NAT BIOTECHNOL, V18, P71, DOI 10.1038/71951; Zheng F, 2015, J MOL BIOL, V427, P491, DOI 10.1016/j.jmb.2014.10.014; Zhou P, 2013, CURR MED CHEM, V20, P1985, DOI 10.2174/0929867311320150005	55	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133571	10.1371/journal.pone.0133571	http://dx.doi.org/10.1371/journal.pone.0133571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252476	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100021
J	Artinger, K; Kirsch, AH; Aringer, I; Schabhuttl, C; Rosenkranz, AR; Eller, P; Rho, E; Eller, K				Artinger, Katharina; Kirsch, Alexander H.; Aringer, Ida; Schabhuettl, Corinna; Rosenkranz, Alexander R.; Eller, Philipp; Rho, Elena; Eller, Kathrin			The Spleen Plays No Role in Nephrotoxic Serum Nephritis, but Constitutes a Place of Compensatory Haematopoiesis	PLOS ONE			English	Article							RENAL INJURY; CELLS; SPLENECTOMY; GLOMERULONEPHRITIS; ANEMIA; CXCR4	Background The spleen has been implicated in the pathogenesis of immune-complex glomerulonephritis by initiating and resolving adaptive immune responses. Thus, we aimed to evaluate the role of the spleen in experimental nephrotoxic serum nephritis (NTS). Methods In order to accelerate the disease, animals were subjected to NTS by preimmunizing male C57BL/6J mice with rabbit IgG three days before injecting the rabbit anti-glomerular basement antiserum, or were immunized only. A group underwent splenectomy before NTS induction. Results We observed enlargement of the spleen with a maximum at 14 days after NTS induction or immunization only. Splenectomized mice were found to develop albuminuria and renal histological changes comparable to sham-operated controls. Nevertheless, anaemia was aggravated in mice after splenectomy. During the course of NTS, we detected CD41(+) megakaryocytes and Ter119(+) erythroid precursor cells in the spleen of mice with NTS and of immunized mice. Ter119(+) Cxcr4(+) cells and the binding partner Cxcl12 increased in the spleen, and decreased in the bone marrow. This was accompanied by a significant systemic increase of interferon-gamma in the serum. Conclusions In summary, splenectomy does not influence the course of NTS per se, but is involved in concomitant anaemia. Extramedullary haematopoiesis in the spleen is probably facilitated through the migration of Cxcr4+ erythroid precursor cells from the bone marrow to the spleen via a Cxcl12 gradient and likely arises from the suppressive capacity of chronic inflammation on the bone marrow.	[Artinger, Katharina; Kirsch, Alexander H.; Aringer, Ida; Schabhuettl, Corinna; Rosenkranz, Alexander R.; Rho, Elena; Eller, Kathrin] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Eller, Philipp] Med Univ Graz, Dept Internal Med, Intens Care Unit, Graz, Austria; [Rho, Elena] Osped La Carita, Clin Div Internal Med, Locarno, Switzerland	Medical University of Graz; Medical University of Graz	Eller, K (corresponding author), Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria.	kathrin.eller@medunigraz.at	Rho, Elena/HHZ-1029-2022	Kirsch, Alexander/0000-0001-6711-7834; Artinger, Katharina/0000-0002-5677-3171; Eller, Kathrin/0000-0002-6214-5008	Austrian Academy of Sciences; Austrian Science Fund (FWF) [P-27537]; Baxter	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Baxter	A.H.K. is a recipient of a DOC Fellowship of the Austrian Academy of Sciences. A.H.K. and K.A. are enrolled in the PhD program in molecular medicine and I.A. in the MOLIN PhD program at the Medical University of Graz. This work was supported by the Austrian Science Fund (FWF) to P.E. (P-27537). The work was further supported by an unrestricted grant from Baxter to A.R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaev NN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003406; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Eller K, 2010, J AM SOC NEPHROL, V21, P42, DOI 10.1681/ASN.2009020133; Gordon S, 2011, EUR J IMMUNOL, V41, P2472, DOI 10.1002/eji.201141715; Hochegger K, 2005, EUR J IMMUNOL, V35, P3074, DOI 10.1002/eji.200526250; Hopfer H, 2012, KIDNEY INT, V82, P60, DOI 10.1038/ki.2012.73; Johns JL, 2012, VET PATHOLOGY ONLINE; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; MORINO M, 1994, PEDIATR NEPHROL, V8, P345, DOI 10.1007/BF00866358; Panzer U, 2007, J AM SOC NEPHROL, V18, P2071, DOI 10.1681/ASN.2006111237; Patel S, 2010, JCR-J CLIN RHEUMATOL, V16, P280, DOI 10.1097/RHU.0b013e3181eeb761; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Rosenkranz AR, 1999, J CLIN INVEST, V103, P649, DOI 10.1172/JCI5183; SCHRIJVER G, 1990, KIDNEY INT, V38, P86, DOI 10.1038/ki.1990.171; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Ubara Y, 2000, AM J KIDNEY DIS, V35, P1186, DOI 10.1016/S0272-6386(00)70057-6; Weindel C, 2014, J IMMUNOL, V192; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Weiss G, 2013, NAT REV RHEUMATOL, V9, P205, DOI 10.1038/nrrheum.2012.183; Wolf D, 2005, J AM SOC NEPHROL, V16, P1360, DOI 10.1681/ASN.2004100837; Zhuang H, 2013, ARTHRITIS RHEUM 1230, V66, P140	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135087	10.1371/journal.pone.0135087	http://dx.doi.org/10.1371/journal.pone.0135087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247770	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300096
J	Furukawa, T; Sakamoto, N; Suzuki, M; Kimura, M; Nagasawa, H; Sakuda, S				Furukawa, Tomohiro; Sakamoto, Naoko; Suzuki, Michio; Kimura, Makoto; Nagasawa, Hiromichi; Sakuda, Shohei			Precocene II, a Trichothecene Production Inhibitor, Binds to Voltage-Dependent Anion Channel and Increases the Superoxide Level in Mitochondria of Fusarium graminearum	PLOS ONE			English	Article							ANTI-JUVENILE HORMONES; OXIDATIVE STRESS; ULTRASTRUCTURAL-CHANGES; LIQUID CULTURES; CORPORA ALLATA; VDAC; BIOSYNTHESIS; GENES; DEOXYNIVALENOL; PERMEABILITY	Precocene II, a constituent of essential oils, shows antijuvenile hormone activity in insects and inhibits trichothecene production in fungi. We investigated the molecular mechanism by which precocene II inhibits trichothecene production in Fusarium graminearum, the main causal agent of Fusarium head blight and trichothecene contamination in grains. Voltage-dependent anion channel (VDAC), a mitochondrial outer membrane protein, was identified as the precocene II-binding protein by an affinity magnetic bead method. Precocene II increased the superoxide level in mitochondria as well as the amount of oxidized mitochondrial proteins. Ascorbic acid, glutathione, and a-tocopherol promoted trichothecene production by the fungus. These antioxidants compensated for the inhibitory activity of precocene II on trichothecene production. These results suggest that the binding of precocene II to VDAC may cause high superoxide levels in mitochondria, which leads to stopping of trichothecene production.	[Furukawa, Tomohiro; Sakamoto, Naoko; Suzuki, Michio; Nagasawa, Hiromichi; Sakuda, Shohei] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Kimura, Makoto] Nagoya Univ, Dept Biol Mech & Funct, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	University of Tokyo; Nagoya University	Sakuda, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	asakuda@mail.ecc.u-tokyo.ac.jp	Furukawa, Tomohiro/AAV-1732-2020; Kimura, Makoto/I-6906-2014	Furukawa, Tomohiro/0000-0002-7384-1703; Kimura, Makoto/0000-0001-5310-2893; Sakuda, Shohei/0000-0001-7966-1167	Science and Technology Research Promoting Program for Agriculture, Forestry, Fisheries and Food; Research Project for Improving Food Safety and Animal Health	Science and Technology Research Promoting Program for Agriculture, Forestry, Fisheries and Food; Research Project for Improving Food Safety and Animal Health	This work was supported by grants from the Science and Technology Research Promoting Program for Agriculture, Forestry, Fisheries and Food and from the Research Project for Improving Food Safety and Animal Health.	ALERTSEN AR, 1955, ACTA CHEM SCAND, V9, P1725, DOI 10.3891/acta.chem.scand.09-1725; BALDWIN RC, 1975, TOXICOL APPL PHARM, V32, P298, DOI 10.1016/0041-008X(75)90220-3; Bay DC, 2008, BIOPHYS J, V94, P457, DOI 10.1529/biophysj.107.115196; Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113; BOWERS WS, 1976, SCIENCE, V193, P542, DOI 10.1126/science.986685; Chen CJ, 2007, PEST MANAG SCI, V63, P1201, DOI 10.1002/ps.1449; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049; FISHER NL, 1982, PHYTOPATHOLOGY, V72, P151, DOI 10.1094/Phyto-72-151; Hammond A H, 1995, J Biochem Toxicol, V10, P265, DOI 10.1002/jbt.2570100507; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jiao F, 2008, FEMS MICROBIOL LETT, V285, P212, DOI 10.1111/j.1574-6968.2008.01235.x; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Lee AC, 1998, J MEMBRANE BIOL, V161, P173, DOI 10.1007/s002329900324; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lee YJ, 1997, TISSUE CELL, V29, P715, DOI 10.1016/S0040-8166(97)80047-X; Lustgarten MS, 2012, BIOCHEM BIOPH RES CO, V422, P515, DOI 10.1016/j.bbrc.2012.05.055; Nasmith CG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002266; Nogueira JHC, 2010, INT J FOOD MICROBIOL, V137, P55, DOI 10.1016/j.ijfoodmicro.2009.10.017; Noriega Fernando G., 2014, ISRN Zoology, P967361, DOI 10.1155/2014/967361; OHTA T, 1977, CHEM PHARM BULL, V25, P2788; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; PIULACHS MD, 1989, CELL TISSUE RES, V258, P91, DOI 10.1007/BF00223148; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; Ponts N, 2007, FEBS LETT, V581, P443, DOI 10.1016/j.febslet.2007.01.003; Ponts N, 2009, FEMS MICROBIOL LETT, V293, P255, DOI 10.1111/j.1574-6968.2009.01521.x; Sakamoto N, 2013, TOXINS, V5, P2258, DOI 10.3390/toxins5112258; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shimada H, 2009, J BIOL CHEM, V284, P28642, DOI 10.1074/jbc.M109.033431; Tikunov A, 2010, ARCH BIOCHEM BIOPHYS, V495, P174, DOI 10.1016/j.abb.2010.01.008; Tsuyuki R, 2011, J AGR FOOD CHEM, V59, P1760, DOI 10.1021/jf103969d; UNNITHAN GC, 1977, J INSECT PHYSIOL, V23, P1081, DOI 10.1016/0022-1910(77)90137-8; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yaguchi A, 2009, J AGR FOOD CHEM, V57, P846, DOI 10.1021/jf802813h	38	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135031	10.1371/journal.pone.0135031	http://dx.doi.org/10.1371/journal.pone.0135031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248339	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300091
J	Gopu, V; Meena, CK; Shetty, PH				Gopu, Venkadesaperumal; Meena, Chetan Kumar; Shetty, Prathapkumar Halady			Quercetin Influences Quorum Sensing in Food Borne Bacteria: In-Vitro and In-Silico Evidence	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ANTIBIOFILM; CINNAMALDEHYDE; EXPRESSION; VIRULENCE	Quorum sensing (QS) plays a vital role in regulating the virulence factor of many food borne pathogens, which causes severe public health risk. Therefore, interrupting the QS signaling pathway may be an attractive strategy to combat microbial infections. In the current study QS inhibitory activity of quercetin and its anti-biofilm property was assessed against foodborne pathogens using a bio-sensor strain. In addition in-silico techniques like molecular docking and molecular dynamics simulation studies were applied to screen the quercetin's potentiality as QS inhibitor. Quercetin (80 mu g/ml) showed the significant reduction in QS-dependent phenotypes like violacein production, biofilm formation, exopolysaccharide (EPS) production, motility and alginate production in a concentration-dependent manner. Synergistic activity of conventional antibiotics with quercetin enhanced the susceptibility of all tested pathogens. Furthermore, Molecular docking analysis revealed that quercetin binds more rigidly with LasR receptor protein than the signaling compound with docking score of -9.17Kcal/mol. Molecular dynamics simulation predicted that QS inhibitory activity of quercetin occurs through the conformational changes between the receptor and quercetin complex. Above findings suggest that quercetin can act as a competitive inhibitor for signaling compound towards LasR receptor pathway and can serve as a novel QS-based antibacterial/anti-biofilm drug to manage food-borne pathogens.	[Gopu, Venkadesaperumal; Shetty, Prathapkumar Halady] Pondicherry Univ, Dept Food Sci & Technol, Pondicherry, India; [Meena, Chetan Kumar] Pondicherry Univ, Dept Bioinformat, Pondicherry, India	Pondicherry University; Pondicherry University	Shetty, PH (corresponding author), Pondicherry Univ, Dept Food Sci & Technol, Pondicherry, India.	pkshalady@yahoo.co.uk		Gopu, Venkadesaperumal/0000-0002-2123-5007	ICMR-Senior Research Fellowship [3/1/2/14/2013-Nut]	ICMR-Senior Research Fellowship	This work was supported by ICMR-Senior Research Fellowship" (3/1/2/14/2013-Nut).	Abraham SVPI, 2011, ARCH MED RES, V42, P658, DOI 10.1016/j.arcmed.2011.12.002; Bai AJ, 2011, COMPR REV FOOD SCI F, V10, P184, DOI 10.1111/j.1541-4337.2011.00150.x; Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0; Bottomley MJ, 2007, J BIOL CHEM, V282, P13592, DOI 10.1074/jbc.M700556200; Brackman G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-149; Bridier A, 2015, FOOD MICROBIOL, V45, P167, DOI 10.1016/j.fm.2014.04.015; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Choo JH, 2006, LETT APPL MICROBIOL, V42, P637, DOI 10.1111/j.1472-765X.2006.01928.x; Christensen AB, 2003, MICROBIOL-SGM, V149, P471, DOI 10.1099/mic.0.25575-0; Damte D, 2013, J MICROBBIOCHEM TECH, V5, P42; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; El-Mowafy SA, 2014, MICROB PATHOGENESIS, V74, P25, DOI 10.1016/j.micpath.2014.07.008; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996; GUNSTEREN WV, 1987, GRONINGEN MOL SIMULA; Huston AL, 2004, APPL ENVIRON MICROB, V70, P3321, DOI 10.1128/AEM.70.6.3321-3328.2004; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Limsuwan S, 2008, FEMS IMMUNOL MED MIC, V53, P429, DOI 10.1111/j.1574-695X.2008.00445.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Nadoshan S. M., 2010, Journal of Medicinal Plants, V9, P124; Niu C, 2006, LETT APPL MICROBIOL, V43, P489, DOI 10.1111/j.1472-765X.2006.02001.x; Owlia P., 2007, RES J BIO SCI, V2, P237; Packiavathy IASV, 2012, FOOD RES INT, V45, P85, DOI 10.1016/j.foodres.2011.10.022; Parker CT, 2009, CELL MICROBIOL, V11, P363, DOI 10.1111/j.1462-5822.2008.01272.x; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ragaert P, 2007, POSTHARVEST BIOL TEC, V44, P185, DOI 10.1016/j.postharvbio.2007.01.001; Rogers SA, 2010, ANTIMICROB AGENTS CH, V54, P2112, DOI 10.1128/AAC.01418-09; Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Thenmozhi R, 2009, FEMS IMMUNOL MED MIC, V57, P284, DOI 10.1111/j.1574-695X.2009.00613.x; Timurkaynak F, 2006, INT J ANTIMICROB AG, V27, P224, DOI 10.1016/j.ijantimicag.2005.10.012; Vasavi HS, 2014, J MICROBIOL IN PRESS; Zhang JM, 2014, FOOD CONTROL, V42, P125, DOI 10.1016/j.foodcont.2014.02.001	35	128	136	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134684	10.1371/journal.pone.0134684	http://dx.doi.org/10.1371/journal.pone.0134684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248208	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300059
J	Kyougoku, M; Teraoka, M; Masuda, N; Ooura, M; Abe, Y				Kyougoku, Makoto; Teraoka, Mutsumi; Masuda, Noriko; Ooura, Mariko; Abe, Yasushi			Development of the Assessment of Belief Conflict in Relationship-14 (ABCR-14)	PLOS ONE			English	Article							QUESTIONNAIRE; STRESS	Purpose Nurses and other healthcare workers frequently experience belief conflict, one of the most important, new stress-related problems in both academic and clinical fields. Methods In this study, using a sample of 1,683 nursing practitioners, we developed The Assessment of Belief Conflict in Relationship-14 (ABCR-14), a new scale that assesses belief conflict in the healthcare field. Standard psychometric procedures were used to develop and test the scale, including a qualitative framework concept and item-pool development, item reduction, and scale development. We analyzed the psychometric properties of ABCR-14 according to entropy, polyserial correlation coefficient, exploratory factor analysis, confirmatory factor analysis, average variance extracted, Cronbach's alpha, Pearson product-moment correlation coefficient, and multidimensional item response theory (MIRT). Results The results of the analysis supported a three-factor model consisting of 14 items. The validity and reliability of ABCR-14 was suggested by evidence from high construct validity, structural validity, hypothesis testing, internal consistency reliability, and concurrent validity. The result of the MIRT offered strong support for good item response of item slope parameters and difficulty parameters. However, the ABCR-14 Likert scale might need to be explored from the MIRT point of view. Yet, as mentioned above, there is sufficient evidence to support that ABCR-14 has high validity and reliability. Conclusion The ABCR-14 demonstrates good psychometric properties for nursing belief conflict. Further studies are recommended to confirm its application in clinical practice.	[Kyougoku, Makoto] Kibi Int Univ, Sch Hlth Sci, Dept Occupat Therapy, Okayama, Japan; [Teraoka, Mutsumi; Masuda, Noriko] Kibi Int Univ, Grad Sch Hlth Sci, Doctor Course, Okayama, Japan; [Teraoka, Mutsumi] Oosugi Hosp, Okayama, Japan; [Masuda, Noriko] Kyouseikai Sakurai Hosp, Tokyo, Japan; [Ooura, Mariko] Okayama Univ, Grad Sch Hlth Sci, Okayama, Japan; [Abe, Yasushi] Asahikawa Med Univ Hosp, Dept Palliat Care, Asahikawa, Hokkaido, Japan	Okayama University; Asahikawa Medical College	Kyougoku, M (corresponding author), Kibi Int Univ, Sch Hlth Sci, Dept Occupat Therapy, Okayama, Japan.	kyougoku@kiui.ac.jp			JSPS KAKENHI Grant [24792478]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24792478 (to MK). http:// www.jsps.go.jp/english/index.html.	Asparouhov T., 2010, MPLUS TECHNICAL APPE; Chou LP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004185; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Ikeda K, 2014, JAPANESE J STRUCTURA, V6, P135; Ilhan MN, 2008, J ADV NURS, V61, P100, DOI 10.1111/j.1365-2648.2007.04476.x; International Labour Organization, 1984, PSYCHOSOCIAL FACTORS; Ishikawa K, 2013, J GIFU COLL NURSING, V13, P55; Karasek R., 1985, JOB CONTENT QUESTION; Katayama Y, 2005, JAPAN J NURSING SCI, V25, P20; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Kim SY, 2013, MULTIVAR BEHAV RES, V48, P563, DOI 10.1080/00273171.2013.802647; Kline P., 1986, HDB TEST CONSTRUCTIO; Kline R.B., 2011, PRINCIPLES PRACTICE; Kobayashi M, 2010, J NIIGATA SEIRYO ACA, V3, P99; Kobayashi Y, 2012, 46 JAP OCC THER C EX; Kono T, 2014, 16 INT C WORLD FED O; Kyougoku M, 2011, JAPANESE J NURSING E, V52, P436; Kyougoku M, 2013, 47 JAP OCC THER C EX; Kyougoku M, 2013, OSAKA J ACUPUNCTURE, V29, P130; Kyougoku M, 2011, DISSOLUTION APPROACH; Kyougoku M., 2012, INTRO DISSOLUTION AP; Kyougoku M., 2014, PROBLEM CLARIFICATIO; Kyougoku M., 2012, J JAPAN ACAD DIABETE, V16, P44; Leka S, 2005, WORK ORG STRESS SYST; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Mahoney M. J., 2003, CONSTRUCTIVE PSYCHOT; Masuda N, 2013, 18 C JAP SOC PALL ME; McVicar A, 2003, J ADV NURS, V44, P633, DOI 10.1046/j.0309-2402.2003.02853.x; Nakamura Y, 2011, NURSING STRESSOR INV; Oshima TC, 1997, J EDUC MEAS, V34, P253, DOI 10.1111/j.1745-3984.1997.tb00518.x; Ozaki F., 1988, B OSAKA PREFECTURE C, V10, P17; Peterson U., 2008, STRESS BURNOUT HEALT; Ramsay M A, 2001, Proc (Bayl Univ Med Cent), V14, P138; Saijo T, 2005, WHAT IS STRUCTURE CO; Shimazu A, 1997, JOB STRESS RES, V4, P41; Shimizu H, 2012, 7 ANN C JAP SOC QUAL, P292; Sugamura G, 2006, HORIZONS BUDDHIST PS, P379; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Takeda S., 2004, PHENOMENOLOGY THINKI; Tanabe K, 2010, JAPANESE J STRUCTURA, V4, P44; Thomas ML, 2013, J CLIN EXP NEUROPSYC, V35, P225, DOI 10.1080/13803395.2012.762974; Van Laar D, 2007, J ADV NURS, V60, P325, DOI 10.1111/j.1365-2648.2007.04409.x; Yamamori M, 2014, 16 INT C WORLD FED O	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0129349	10.1371/journal.pone.0129349	http://dx.doi.org/10.1371/journal.pone.0129349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26247356	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300003
J	Honjo, K				Honjo, Keita			Cooperative Emissions Trading Game: International Permit Market Dominated by Buyers	PLOS ONE			English	Article							CLIMATE-CHANGE; KYOTO PROTOCOL; POWER; CORE; NEGOTIATIONS; ALLOCATION; ECONOMY; IMPACT; POLICY	Rapid reduction of anthropogenic greenhouse gas emissions is required to mitigate disastrous impacts of climate change. The Kyoto Protocol introduced international emissions trading (IET) to accelerate the reduction of carbon dioxide (CO2) emissions. The IET controls CO2 emissions through the allocation of marketable emission permits to sovereign countries. The costs for acquiring additional permits provide buyers with an incentive to reduce their CO2 emissions. However, permit price has declined to a low level during the first commitment period (CP1). The downward trend in permit price is attributed to deficiencies of the Kyoto Protocol: weak compliance enforcement, the generous allocation of permits to transition economies (hot air), and the withdrawal of the US. These deficiencies created a buyer's market dominated by price-making buyers. In this paper, I develop a coalitional game of the IET, and demonstrate that permit buyers have dominant bargaining power. In my model, called cooperative emissions trading (CET) game, a buyer purchases permits from sellers only if the buyer forms a coalition with the sellers. Permit price is determined by bargaining among the coalition members. I evaluated the demand-side and supply-side bargaining power (DBP and SBP) using Shapley value, and obtained the following results: (1) Permit price is given by the product of the buyer's willingness-to-pay and the SBP (= 1 - DBP). (2) The DBP is greater than or equal to the SBP. These results indicate that buyers can suppress permit price to low levels through bargaining. The deficiencies of the Kyoto Protocol enhance the DBP, and contribute to the demand-side dominance in the international permit market.	Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki, Japan	National Institute for Environmental Studies - Japan	Honjo, K (corresponding author), Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki, Japan.	honjo.keita@nies.go.jp	Honjo, Keita/AAY-3032-2020	Honjo, Keita/0000-0002-0597-7051	Japan Society for the Promotion of Science [24-790]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The author was supported by Research Fellowship for Young Scientists (DC1, 24-790) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) between April 2012 and March 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakre S, 2010, EUR UNION POLIT, V11, P427, DOI 10.1177/1465116510369265; Ackerman F, 2012, ECONOMICS-KIEL, V6, DOI 10.5018/economics-ejournal.ja.2012-10; [Anonymous], 2011, ASAHI SHIMBUN   1213; [Anonymous], 2012, ENV NATURAL RESOURCE; Asheim GB, 2006, J ENVIRON ECON MANAG, V51, P93, DOI 10.1016/j.jeem.2005.04.004; Bailey M, 2010, FISH RES, V102, P1, DOI 10.1016/j.fishres.2009.11.003; BARRETT S, 1994, OXFORD ECON PAP, V46, P878, DOI 10.1093/oep/46.Supplement_1.878; Barrett S, 2008, OXFORD REV ECON POL, V24, P239, DOI 10.1093/oxrep/grn015; Baumol WJ., 1988, THEORY ENV POLICY, V2, DOI 10.1017/CBO9781139173513; Bohringer C, 2002, ENERGY J, V23, P51; CARRARO C, 1993, J PUBLIC ECON, V52, P309, DOI 10.1016/0047-2727(93)90037-T; Carraro C, 1998, EUR ECON REV, V42, P561, DOI 10.1016/S0014-2921(97)00118-9; Chander P, 1997, INT J GAME THEORY, V26, P379, DOI 10.1007/BF01263279; Curry B., 2011, GLOBE MAIL; DeCanio SJ, 2013, ECOL ECON, V85, P177, DOI 10.1016/j.ecolecon.2011.04.016; Dinar A, 1997, J ENVIRON MANAGE, V49, P183, DOI 10.1006/jema.1995.0088; Duffield JS, 2011, ENERG POLICY, V39, P3741, DOI 10.1016/j.enpol.2011.04.002; Dutta PK, 2004, P NATL ACAD SCI USA, V101, P5174, DOI 10.1073/pnas.0400489101; Edenhofer O., 2014, CONTRIBUTION WORKING; Federation of Electric Power Companies of Japan, 2015, EL GEN PURCH FEB 201; Field C.B., 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Finus M, 2013, ENVIRON RESOUR ECON, V56, P211, DOI 10.1007/s10640-012-9570-6; FOLEY DK, 1970, ECONOMETRICA, V38, P66, DOI 10.2307/1909241; Gately D., 1974, INT ECON REV, V15, P195, DOI [10.2307/2526099, DOI 10.2307/2526099, https://doi.org/10.2307/2526099]; Godal O, 2010, BE J ECON ANAL POLI, V10; Hagem C, 2001, 20011 CICERO, V2001, P1; HAHN RW, 1984, Q J ECON, V99, P753, DOI 10.2307/1883124; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Honjo K, 2014, REG SCI POLICY PRACT, V6, P13, DOI 10.1111/rsp3.12013; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Kossoy A., 2009, STATE TRENDS CARBON, P24; Kossoy A, 2013, MAPPING CARBON PRICI; Kossoy A, 2010, STATE TRENDS CARBON; Linacre N., 2011, STATE TRENDS CARBON; LOEHMAN E, 1979, WATER RESOUR RES, V15, P193, DOI 10.1029/WR015i002p00193; Madani K, 2014, J HYDROL, V519, P732, DOI 10.1016/j.jhydrol.2014.07.061; Madani K, 2013, ECOL ECON, V90, P68, DOI 10.1016/j.ecolecon.2013.02.011; Madani K, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010849; Madani K, 2010, J HYDROL, V381, P225, DOI 10.1016/j.jhydrol.2009.11.045; Maeda A, 2003, J REGUL ECON, V24, P293, DOI 10.1023/A:1025602922918; Manne A, 2004, ENERG POLICY, V32, P447, DOI 10.1016/S0301-4215(03)00147-2; MONTGOMERY WD, 1972, J ECON THEORY, V5, P395, DOI 10.1016/0022-0531(72)90049-X; New Energy and Industrial Technology Development Organization Japan, 2012, KYOT MECH; Nordhaus WD, 2001, SCIENCE, V294, P1283, DOI 10.1126/science.1065007; Oberthur S., 1999, KYOTO PROTOCOL INT C; Parrachino I, 2006, 4074 WORLD BANK; Parrachino I, 2006, 4072 WORLD BANK; Peleg B., 2007, INTRO THEORY COOPERA; Pittel K, 2008, ECOL ECON, V68, P210, DOI 10.1016/j.ecolecon.2008.02.020; Read L, 2014, J ENVIRON MANAGE, V133, P343, DOI 10.1016/j.jenvman.2013.11.045; Shapley LS, 1954, AM POLIT SCI REV, V48, P787, DOI 10.2307/1951053; Shapley Lloyd S., 1953, CONTRIBUTIONS THEORY, P307, DOI [10.3390/atmos10110723, DOI 10.1515/9781400881970-018]; SHAPLEY LS, 1969, AM ECON REV, V59, P678; Siebert H., 2008, EC ENV THEORY POLICY; Springer U, 2004, ENERG POLICY, V32, P611, DOI 10.1016/S0301-4215(02)00313-0; Springer U, 2003, ENERG ECON, V25, P527, DOI 10.1016/S0140-9883(02)00103-2; Tietenberg T., 2006, EMISSIONS TRADING PR; United Nations, 1998, KYOTO PROTOCOL UN FR; United Nations Framework Convention on Climate Change, 2014, TOT CO2 EM LAND US L; United Nations Framework Convention on Climate Change, 2002, C PART ITS 7 SESS HE, VIII; Uzawa H., 1999, ENV EC POLICY STUD, V2, P1, DOI [10.1007/BF03353901, DOI 10.1007/BF03353901]; von Neumann J., 2004, THEORY GAMES EC BEHA; Walsh C., 2002, ECONOMICS; Wood PJ, 2011, ANN NY ACAD SCI, V1219, P153, DOI 10.1111/j.1749-6632.2010.05891.x; Zara S, 2006, 4073 WORLD BANK	65	4	4	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132272	10.1371/journal.pone.0132272	http://dx.doi.org/10.1371/journal.pone.0132272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244778	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400021
J	Wells, SA; van der Kamp, MW; McGeagh, JD; Mulholland, AJ				Wells, Stephen A.; van der Kamp, Marc W.; McGeagh, John D.; Mulholland, Adrian J.			Structure and Function in Homodimeric Enzymes: Simulations of Cooperative and Independent Functional Motions	PLOS ONE			English	Article							SCAVENGER DECAPPING ENZYME; NORMAL-MODE CALCULATIONS; ACETYL-COA ENOLIZATION; CITRATE SYNTHASE; MOLECULAR-DYNAMICS; GEOMETRIC SIMULATION; MALATE-DEHYDROGENASE; PROTEIN FLEXIBILITY; DOMAIN MOTIONS; MECHANISM	Large-scale conformational change is a common feature in the catalytic cycles of enzymes. Many enzymes function as homodimers with active sites that contain elements from both chains. Symmetric and anti-symmetric cooperative motions in homodimers can potentially lead to correlated active site opening and/or closure, likely to be important for ligand binding and release. Here, we examine such motions in two different domain-swapped homodimeric enzymes: the DcpS scavenger decapping enzyme and citrate synthase. We use and compare two types of all-atom simulations: conventional molecular dynamics simulations to identify physically meaningful conformational ensembles, and rapid geometric simulations of flexible motion, biased along normal mode directions, to identify relevant motions encoded in the protein structure. The results indicate that the opening/closure motions are intrinsic features of both unliganded enzymes. In DcpS, conformational change is dominated by an anti-symmetric cooperative motion, causing one active site to close as the other opens; however a symmetric motion is also significant. In CS, we identify that both symmetric (suggested by crystallography) and asymmetric motions are features of the protein structure, and as a result the behaviour in solution is largely non-cooperative. The agreement between two modelling approaches using very different levels of theory indicates that the behaviours are indeed intrinsic to the protein structures. Geometric simulations correctly identify and explore large amplitudes of motion, while molecular dynamics simulations indicate the ranges of motion that are energetically feasible. Together, the simulation approaches are able to reveal unexpected functionally relevant motions, and highlight differences between enzymes.	[Wells, Stephen A.] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [van der Kamp, Marc W.; McGeagh, John D.; Mulholland, Adrian J.] Univ Bristol, Sch Chem, Ctr Computat Chem, Bristol, Avon, England	University of Bath; University of Bristol	Wells, SA (corresponding author), Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England.	saw42@bath.ac.uk	van der Kamp, Marc/AAJ-8176-2020; Wells, Stephen/L-2064-2014; van der Kamp, Marc/F-6000-2013	Mulholland, Adrian/0000-0003-1015-4567; van der Kamp, Marc/0000-0002-8060-3359; Wells, Stephen/0000-0002-3920-3644	Engineering and Physical Sciences Research Council [EP/G007705/1, BB/L018756/1, EP/K004956/1]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/L01386X/1, BB/L018756/1, BB/K016601/1] Funding Source: UKRI; EPSRC [EP/K004956/1, EP/M022609/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1274908, BB/L018756/1, BB/K016601/1, BB/L01386X/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M022609/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AJM and MWvdK are supported by the Engineering and Physical Sciences Research Council (grant numbers EP/G007705/1 and BB/L018756/1). JDM (with AJM) were funded by the Biotechnology and Biological Sciences Research Council. SAW is supported by the Engineering and Physical Sciences Research Council (programme grant number EP/K004956/1). Funder URLs: www.epsrc.ac.uk and www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, J CHEM INF MODEL, V51, P1604, DOI 10.1021/ci100461k; Amin NT, 2013, BIOCHEM J, V450, P321, DOI 10.1042/BJ20121635; BEECKMANS S, 1981, EUR J BIOCHEM, V117, P527; Bell GS, 2002, EUR J BIOCHEM, V269, P6250, DOI 10.1046/j.1432-1033.2002.03344.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burkoff NS, 2012, BIOPHYS J, V102, P878, DOI 10.1016/j.bpj.2011.12.053; Chen N, 2005, J MOL BIOL, V347, P707, DOI 10.1016/j.jmb.2005.01.062; Daidone I, 2004, J MOL BIOL, V339, P515, DOI 10.1016/j.jmb.2004.04.007; David CC, 2011, J MOL GRAPH MODEL, V31, P41, DOI 10.1016/j.jmgm.2011.08.004; ELKETTANI MAEC, 1992, BIOPOLYMERS, V32, P561, DOI 10.1002/bip.360320512; Erskine PT, 2015, ACTA CRYSTALLOGR D, V71, P615, DOI 10.1107/S1399004714026704; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gu MG, 2004, MOL CELL, V14, P67, DOI 10.1016/S1097-2765(04)00180-7; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P5741, DOI 10.1073/pnas.77.10.5741; Hooft RWW, 1996, PROTEINS, V26, P363; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jimenez-Roldan JE, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016008; JOHANSSON CJ, 1974, EUR J BIOCHEM, V42, P383, DOI 10.1111/j.1432-1033.1974.tb03350.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KOLLMANNKOCH A, 1989, EUR J BIOCHEM, V185, P441, DOI 10.1111/j.1432-1033.1989.tb15134.x; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; LESK AM, 1984, J MOL BIOL, V174, P175, DOI 10.1016/0022-2836(84)90371-1; Li HL, 2012, PROTEIN SCI, V21, P1269, DOI 10.1002/pro.2111; Liu SW, 2008, J BIOL CHEM, V283, P16427, DOI 10.1074/jbc.M800341200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; McGeagh JD, 2011, CONFORMATION COOPERA; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; Mulholland AJ, 1997, PROTEINS, V27, P9; MYERS JA, 1984, BIOCHEMISTRY-US, V23, P1264, DOI 10.1021/bi00301a038; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Pentikainen U, 2008, PROTEINS, V70, P498, DOI 10.1002/prot.21540; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; Roccatano D, 2001, J MOL BIOL, V310, P1039, DOI 10.1006/jmbi.2001.4808; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schrodinger L., 2020, PYMOL; Seeber M, 2011, J COMPUT CHEM, V32, P1183, DOI 10.1002/jcc.21688; Snow C, 2007, PROTEINS, V67, P325, DOI 10.1002/prot.21280; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; SUMEGI B, 1980, BIOCHIM BIOPHYS ACTA, V616, P158, DOI 10.1016/0005-2744(80)90134-5; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; van der Kamp MW, 2008, CHEM COMMUN, P1874, DOI 10.1039/b800496j; van der Kamp MW, 2007, PROTEINS, V69, P521, DOI 10.1002/prot.21482; van der Kamp MW, 2008, J R SOC INTERFACE, V5, pS173, DOI 10.1098/rsif.2008.0105.focus; Wells SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046005; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Wells SA, 2014, PROTEINS, V82, P2657, DOI 10.1002/prot.24630	53	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133372	10.1371/journal.pone.0133372	http://dx.doi.org/10.1371/journal.pone.0133372			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241964	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700013
J	Cha, YH; Chakrapani, S				Cha, Yoon-Hee; Chakrapani, Shruthi			Voxel Based Morphometry Alterations in Mal de Debarquement Syndrome	PLOS ONE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; FUNCTIONAL CONNECTIVITY; HUMAN CEREBELLUM; STIMULATION; MOTION; PERCEPTION; ANXIETY; CORTEX; BRAIN; FMRI	Background Mal de debarquement syndrome (MdDS) is a disorder of chronic self-motion perception that occurs though entrainment to rhythmic background motion, such as from sea voyage, and involves the perception of low-frequency rocking that can last for months or years. The neural basis of this persistent sensory perception abnormality is not well understood. Methods We investigated grey matter volume differences underlying persistent MdDS by performing voxel-based morphometry on whole brain and pre-specified ROIs in 28 individuals with MdDS and comparing them to 18 age, sex, and handedness matched controls. Results MdDS participants exhibited greater grey matter volume in the left inferior parietal lobule, right inferior occipital gyrus (area V3v), right temporal pole, bilateral cerebellar hemispheric lobules VIII/IX and left lobule VIIa/VIIb. Grey matter volumes were lower in bilateral inferior frontal, orbitofrontal, pregenual anterior cingulate cortex (pgACC) and left superior medial gyri (t = 3.0, p<0.005(uncorr)). In ROI analyses, there were no volume differences in the middle occipital gyrus (region of V5/MT) or parietal operculum 2 (region of the parietoinsular vestibular cortex). Illness duration was positively related to grey matter volume in bilateral inferior frontal gyrus/anterior insula (IFG/AI), right posterior insula, superior parietal lobule, left middle occipital gyrus (V5/MT), bilateral postcentral gyrus, anterior cerebellum, and left cerebellar hemisphere and vermian lobule IX. In contrast, illness duration was negatively related to volume in pgACC, posterior middle cingulate gyrus (MCC), left middle frontal gyrus (dorsolateral prefrontal cortex-DLPFC), and right cerebellar hemispheric lobule VIIIb (t = 3.0, p<0.005(uncorr)). The most significant differences were decreased volume in the pgACC and increased volume in the left IFG/AI with longer illness duration (qFDR(corr) <0.05). Concurrent medication use did not correlate with these findings or have a relationship with duration of illness. MdDS participants showed positive correlations between grey matter volume in pgACC and bilateral cerebellar lobules VIII/IX, which was not seen in controls. Conclusions Individuals with MdDS show brain volume differences from healthy controls as well as duration of illness dependent volume changes in (a) visual-vestibular processing areas (IPL, SPL, V3, V5/MT), (b) default mode network structures (cerebellar IX, IPL, ACC), (c) salience network structures (ACC and IFG/AI) (d) somatosensory network structures (postcentral gyrus, MCC, anterior cerebellum, cerebellar lobule VIII), and (e) a structure within the central executive network (DLPFC). The identification of these associations may enhance future investigations into how exposure to oscillating environments can modulate brain function and affect motion perception as well cognitive and affective control.	[Cha, Yoon-Hee] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Cha, Yoon-Hee; Chakrapani, Shruthi] Univ Calif Los Angeles, Los Angeles, CA USA; [Chakrapani, Shruthi] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	Laureate Institute for Brain Research, Inc.; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cha, YH (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	ycha@laureateinstitute.org	Stevens, David/F-4683-2015		National Institute on Deafness and Other Communication Disorders at the National Institutes of Health [R03-DC010451]; National Center for Research Resources [M01-RR000865]; MdDS (Mal de Debarquement Syndrome) Balance Disorders Foundation; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06RR012169, C06RR015431, S10OD011939]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Capital Group Companies Charitable Foundation; William M. and Linda R. Dietel Philanthropic Fund; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, C06RR015431, M01RR000865] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011939] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MdDS (Mal de Debarquement Syndrome) Balance Disorders Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; Ahmanson Foundation; Capital Group Companies Charitable Foundation; William M. and Linda R. Dietel Philanthropic Fund; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (R03-DC010451); the National Center for Research Resources granted to the University of California Los Angeles General Clinical Research Center (M01-RR000865); and the MdDS (Mal de Debarquement Syndrome) Balance Disorders Foundation. The authors are grateful for the generous support from the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, Capital Group Companies Charitable Foundation, William M. and Linda R. Dietel Philanthropic Fund, and Northstar Fund. Research reported in this publication was also partially supported by the National Center for Research Resources and by the Office of the Director of the National Institutes of Health under award numbers C06RR012169, C06RR015431 and S10OD011939. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, 8 INT C FUNCT MAPP H; Arroll M, 2014, J HEALTH PSYCHOL, P1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bernard JA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00031; Best C, 2009, J NEUROL, V256, P58, DOI 10.1007/s00415-009-0038-8; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; BROWN JJ, 1987, AM J OTOLARYNG, V8, P219, DOI 10.1016/S0196-0709(87)80007-8; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cha YH, 2008, J NEUROL, V255, P1038, DOI 10.1007/s00415-008-0837-3; Cha YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049560; Cha YH, 2013, OTOL NEUROTOL, V34, P175, DOI 10.1097/MAO.0b013e318278bf7c; Cha YH, 2009, SEMIN NEUROL, V29, P520, DOI 10.1055/s-0029-1241038; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Dieterich M, 2001, NEUROIMAG CLIN N AM, V11, P263; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Eulenburg PZ, 2010, ANN NEUROL, V68, P241, DOI 10.1002/ana.22063; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grunbauer WM, 1998, NEUROREPORT, V9, P1807; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hain TC, 1999, ARCH OTOLARYNGOL, V125, P615, DOI 10.1001/archotol.125.6.615; Helmchen C, 2011, J NEUROL NEUROSUR PS, V82, P309, DOI 10.1136/jnnp.2010.204925; Hufner K, 2007, HIPPOCAMPUS, V17, P471, DOI 10.1002/hipo.20283; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kong J, 2006, HUM BRAIN MAPP, V27, P715, DOI 10.1002/hbm.20213; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macke A, 2012, J NEUROL, V259, P1326, DOI 10.1007/s00415-011-6349-6; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Mast FW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00044; Mobbs D, 2009, J NEUROSCI, V29, P12236, DOI 10.1523/JNEUROSCI.2378-09.2009; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Rossi, 2013, HDB CEREBELLUM CEREB, V10, P1257, DOI [10.1007/978-94-007-1333-8_55, DOI 10.1007/978-94-007-1333-8_55]; Schiller D, 2008, J NEUROSCI, V28, P11517, DOI 10.1523/JNEUROSCI.2265-08.2008; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Wiest G, 2004, NEUROLOGY, V62, P473, DOI 10.1212/01.WNL.0000106948.17561.55; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776	54	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135021	10.1371/journal.pone.0135021	http://dx.doi.org/10.1371/journal.pone.0135021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252893	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100105
J	Mantovani, A; Pernigo, M; Bergamini, C; Bonapace, S; Lipari, P; Pichiri, I; Bertolini, L; Valbusa, F; Barbieri, E; Zoppini, G; Bonora, E; Targher, G				Mantovani, Alessandro; Pernigo, Matteo; Bergamini, Corinna; Bonapace, Stefano; Lipari, Paola; Pichiri, Isabella; Bertolini, Lorenzo; Valbusa, Filippo; Barbieri, Enrico; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni			Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; TISSUE DOPPLER; FILLING PRESSURES; MYOCARDIAL-INFARCTION; OBESE ADOLESCENTS; CARDIAC-FUNCTION; ECTOPIC FAT; ECHOCARDIOGRAPHY; RISK; MELLITUS	Accumulating evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with left ventricular diastolic dysfunction (LVDD) in nondiabetic individuals. To date, there are very limited data on this topic in patients with type 2 diabetes and it remains uncertain whether NAFLD is independently associated with the presence of LVDD in this patient population. We performed a liver ultrasonography and trans-thoracic echocardiography (with speckle-tracking strain analysis) in 222 (156 men and 66 women) consecutive type 2 diabetic outpatients with no previous history of ischemic heart disease, chronic heart failure, valvular diseases and known hepatic diseases. Binary logistic regression analysis was used to examine the association between NAFLD and the presence/severity of LVDD graded according to the current criteria of the American Society of Echocardiography, and to identify the variables that were independently associated with LVDD, which was included as the dependent variable. Patients with ultrasound-diagnosed NAFLD (n = 158; 71.2% of total) were more likely to be female, overweight/obese, and had longer diabetes duration, higher hemoglobin A1c and lower estimated glomerular filtration rate (eGFR) than those without NAFLD. Notably, they also had a remarkably greater prevalence of mild and/or moderate LVDD compared with those without NAFLD (71% vs. 33%; P<0.001). Age, hypertension, smoking, medication use, E/A ratio, LV volumes and mass were comparable between the two groups of patients. NAFLD was associated with a three-fold increased odds of mild and/or moderate LVDD after adjusting for age, sex, body mass index, hypertension, diabetes duration, hemoglobin A1c, eGFR, LV mass index and ejection fraction (adjusted-odds ratio 3.08, 95% CI 1.5-6.4, P = 0.003). In conclusion, NAFLD is independently associated with early LVDD in type 2 diabetic patients with preserved systolic function.	[Mantovani, Alessandro; Pichiri, Isabella; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Pernigo, Matteo; Bergamini, Corinna] Univ & Azienda Osped Univ Integrata Verona, Dept Med, Cardiol Sect, Verona, Italy; [Bonapace, Stefano; Lipari, Paola; Barbieri, Enrico] Sacro Cuore Hosp, Div Cardiol, Negrar, VR, Italy; [Bertolini, Lorenzo; Valbusa, Filippo] Sacro Cuore Hosp, Div Gen Med, Negrar, VR, Italy; [Bertolini, Lorenzo; Valbusa, Filippo] Sacro Cuore Hosp, Diabet Unit, Negrar, VR, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria	Targher, G (corresponding author), Univ & Azienda Osped Univ Integrata Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.	giovanni.targher@univr.it	zoppini, giacomo/AAA-9000-2022; Pernigo, Matteo/AAJ-4230-2020; Mantovani, Alessandro/AAB-9015-2019; Targher, Giovanni/AAB-9008-2019; Bonora, Enzo/AAA-5300-2022	zoppini, giacomo/0000-0003-1085-554X; Mantovani, Alessandro/0000-0002-7271-6329; Targher, Giovanni/0000-0002-4325-3900; BONORA, Enzo/0000-0003-1074-5164; Bonapace, Stefano/0000-0001-9122-2642; Valbusa, Filippo/0000-0001-7527-6974				Alp H, 2013, CAN J CARDIOL, V29, P1118, DOI 10.1016/j.cjca.2012.07.846; Andersen MJ, 2012, CIRC-HEART FAIL, V5, P444, DOI 10.1161/CIRCHEARTFAILURE.112.967919; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Bonapace S, 2011, CIRC-CARDIOVASC IMAG, V4, P408, DOI 10.1161/CIRCIMAGING.110.962951; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Chapman CB, 2013, ECHOCARDIOGR-J CARD, V30, P1022, DOI 10.1111/echo.12185; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Galderisi M, 2006, J AM COLL CARDIOL, V48, P1548, DOI 10.1016/j.jacc.2006.07.033; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Lim S, 2013, INT J CARDIOL, V169, P166, DOI 10.1016/j.ijcard.2013.08.077; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ommen SR, 2000, CIRCULATION, V102, P1788; Pacifico L, 2014, HEPATOLOGY, V59, P461, DOI 10.1002/hep.26610; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Portillo-Sanchez P, 2015, J CLIN ENDOCR METAB, V100, P2231, DOI 10.1210/jc.2015-1966; Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2010, J AM COLL CARDIOL, V56, P225, DOI 10.1016/j.jacc.2010.02.049; Rivas-Gotz C, 2003, J AM COLL CARDIOL, V42, P1463, DOI 10.1016/S0735-1097(03)01034-9; Sert A, 2013, AM J CARDIOL, V112, P436, DOI 10.1016/j.amjcard.2013.03.056; Singh GK, 2013, J PEDIATR-US, V162, P1160, DOI 10.1016/j.jpeds.2012.11.024; Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Targher G, 2013, J CLIN ENDOCR METAB, V98, P483, DOI 10.1210/jc.2012-3093; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; van der Meer RW, 2009, CIRCULATION, V119, P2069, DOI 10.1161/CIRCULATIONAHA.108.803916; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Woo JS, 2013, ARTERIOSCL THROM VAS, V33, P2252, DOI 10.1161/ATVBAHA.113.301586	42	63	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135329	10.1371/journal.pone.0135329	http://dx.doi.org/10.1371/journal.pone.0135329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252899	Green Submitted, gold, Green Published			2022-12-26	WOS:000359121100153
J	Tong, WY; Maira, M; Gagnon, M; Saragovi, HU				Tong, Wenyong; Maira, Mario; Gagnon, Martin; Saragovi, H. Uri			Ligands Binding to Cell Surface Ganglioside GD2 Cause Src-Dependent Activation of N-Methyl-D-Aspartate Receptor Signaling and Changes in Cellular Morphology	PLOS ONE			English	Article							TRK NEUROTROPHIN RECEPTORS; ANTI-GD2 ANTIBODY THERAPY; PHASE-I TRIAL; FAMILY KINASES; NEUROBLASTOMA; PAIN; PHOSPHORYLATION; GABAPENTIN; MELANOMA; EXPRESSION	Ganglioside GD2 is a plasma membrane glycosphinogolipid. In healthy adults it is expressed at low levels, but it is over-expressed in many cancers. For cancer therapy, GD2 is targeted with anti-GD2 monoclonal antibodies (mAbs), and one adverse side effect is severe visceral pain. Pain is not neuropathic, cannot be blocked with morphine, and stops on discontinuation of mAb therapy. Here, we provide evidence that ligand binding to cell surface GD2 induces rapid and transient activation of Src-family kinases, followed by Src-dependent phosphorylation of NMDA-receptor NR2B subunits selectively, activation of Ca++ fluxes, production of cAMP, and changes in cellular morphology. These GD2-ligand activated signals differ in kinetics and in pharmacology from activation of the same signals in the same cells by BDNF, the growth factor agonist of the TrkB receptor, suggesting biological specificity. Hence, cell surface GD2 regulates pathways that can be associated with neoplasia and with morphine-intractable pain; and this can explain why expression of GD2 correlates with these two pathologies.	[Tong, Wenyong; Maira, Mario; Gagnon, Martin; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Tong, Wenyong; Saragovi, H. Uri] McGill Univ, Pharmacol & Therapeut, Montreal, PQ, Canada; [Gagnon, Martin; Saragovi, H. Uri] McGill Univ, Segal Ctr Translat Res, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, 3755 Cote St,E-535, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca		Gagnon, Martin/0000-0002-3920-4858	Canadian Institutes of Health Research; FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec)	HUS received a grant from the Canadian Institutes of Health Research. WT received a scholarship from the FRSQ.	Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Cheung NKV, 1998, INT J ONCOL, V12, P1299; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Frank C, 2004, FEBS LETT, V566, P25, DOI 10.1016/j.febslet.2004.03.113; Gagnon M, 2002, EXPERT OPIN THER PAT, V12, P1215; Gillin S, 1998, ANESTH ANALG, V86, P111, DOI 10.1097/00000539-199801000-00022; Hakomori S, 1997, CHEM BIOL, V4, P97, DOI 10.1016/S1074-5521(97)90253-2; Hamamura K, 2011, J BIOL CHEM, V286, P18526, DOI 10.1074/jbc.M110.164798; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; HOLTHOFER H, 1994, KIDNEY INT, V45, P123, DOI 10.1038/ki.1994.14; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Kushner BH, 2001, J CLIN ONCOL, V19, P4189, DOI 10.1200/JCO.2001.19.22.4189; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Li S, 2011, J NEUROSCI RES, V89, P1869, DOI 10.1002/jnr.22719; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Modak S, 2007, CANCER INVEST, V25, P67, DOI 10.1080/07357900601130763; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; SALEH MN, 1992, CANCER RES, V52, P4342; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schneider B, 2007, TRAFFIC, V8, P226, DOI 10.1111/j.1600-0854.2006.00525.x; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Slart R, 1997, PAIN, V69, P119, DOI 10.1016/S0304-3959(96)03247-2; Stanfa LC, 1997, NEUROREPORT, V8, P587, DOI 10.1097/00001756-199702100-00002; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Tong WY, 2010, CHEM BIOL, V17, P183, DOI 10.1016/j.chembiol.2010.01.012; Wallace MS, 1997, ANESTH ANALG, V85, P794, DOI 10.1097/00000539-199710000-00014; Xiao WH, 1997, PAIN, V69, P145, DOI 10.1016/S0304-3959(96)03280-0; Xu F, 2006, BRAIN RES, V1121, P22, DOI 10.1016/j.brainres.2006.08.129; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yu AL, 1998, J CLIN ONCOL, V16, P2169, DOI 10.1200/JCO.1998.16.6.2169; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yuki N, 1997, J NEUROL SCI, V149, P127, DOI 10.1016/S0022-510X(97)05390-2	43	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134255	10.1371/journal.pone.0134255	http://dx.doi.org/10.1371/journal.pone.0134255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252487	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100045
J	Tonnang, HEZ; Mohamed, SF; Khamis, F; Ekesi, S				Tonnang, Henri E. Z.; Mohamed, Samira F.; Khamis, Fathiya; Ekesi, Sunday			Identification and Risk Assessment for Worldwide Invasion and Spread of Tuta absoluta with a Focus on Sub-Saharan Africa: Implications for Phytosanitary Measures and Management	PLOS ONE			English	Article							MEYRICK LEPIDOPTERA-GELECHIIDAE; TOMATO LEAFMINER; 1ST RECORD; STRATEGIES; PREDICTION; MODELS; SYSTEM; THREAT	To support management decisions, molecular characterization of data and geo-reference of incidence records of Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) were combined with data on the biology and ecology of the pest to estimate its climatic suitability and potential spread at regional and global scale. A CLIMEX model was developed and used for the global prediction of current and future climate-induced changes in the distributional shifts of T. absoluta. Results revealed that temperature and moisture characterized T. absoluta population growth while the pest ability to survive the cold, hot, wet and dry stress conditions are the primary characteristics defining its range frontiers. Simulated irrigation also played an important role in the model optimization. Model predictions suggest that T. absoluta represents an important threat to Africa, Asia, Australia, Northern Europe, New Zealand, Russian Federation and the United States of America (USA). Under climate change context, future predictions on distribution of T. absoluta indicated that the invasive nature of this pest will result in significant crop losses in certain locations whereas some parts of Africa may witness diminution in ranges. The following scenarios may occur: 1) T. absoluta damage potential may upsurge moderately in areas of Africa where the pest currently exists; 2) a range diminution in temperate to Sahel region with moderate upsurge in damage potential; 3) a range expansion in tropical Africa with reasonable upsurge of damage potential. These possible outcomes could be explained by the fact that the continent is already warm, with the average temperature in majority of localities near the threshold temperatures for optimal development and survival of T. absoluta. Outputs from this study should be useful in helping decision-makers in their assessment of site-specific risks of invasion and spread of T. absoluta with a view to developing appropriate surveillance, phytosanitary measures and management strategies.	[Tonnang, Henri E. Z.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Tonnang, Henri E. Z.; Mohamed, Samira F.; Khamis, Fathiya; Ekesi, Sunday] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Tonnang, HEZ (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya.	h.tonnang@cgiar.org	TONNANG, Henri/AAQ-2206-2021; Ekesi, Sunday/P-8944-2019	TONNANG, Henri/0000-0002-9424-9186; 	German Ministry of Economic Cooperation and Development (BMZ)	German Ministry of Economic Cooperation and Development (BMZ)	The authors thank the German Ministry of Economic Cooperation and Development (BMZ) for financial support to the Tuta absoluta IPM project.	Abbes K., 2012, Bulletin OEPP, V42, P226, DOI 10.1111/epp.2559; Abolmaaty SM, 2011, NAT SCI, V9, P156; [Anonymous], 2014, EPPO B, V44, P3, DOI [10.1111/epp.12088, DOI 10.1111/EPP.12088]; [Anonymous], FAOCLIM 2 WORLD WID; Barrientos Z R, 1998, CIENC E; Brevault T, 2014, AFR ENTOMOL, V22, P441, DOI 10.4001/003.022.0202; Cabello T, 2012, J ECON ENTOMOL, V105, P2085, DOI 10.1603/EC12221; Cherif A, BIOL ASPECTS TOMATO; Cuthbertson AG, 2013, POPULATION DEV TUTA; de Villiers M, 2013, B ENTOMOL RES, V103, P60, DOI 10.1017/S0007485312000454; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Duric Zorica, 2014, Polish Journal of Entomology, V83, P121, DOI 10.2478/pjen-2014-0009; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EPPO, 2014, 2014015 EPPO; Erdogan P, 2014, LIFE TABLE TOMATO LE; Ferracini C, 2012, J ECON ENTOMOL, V105, P1311, DOI 10.1603/EC11394; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hrncic Snjezana, 2012, Bulletin OEPP, V42, P341, DOI 10.1111/epp.2582; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Karadjova O., 2013, Bulgarian Journal of Agricultural Science, V19, P563; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lobos E, 2013, NEOTROP ENTOMOL, V42, P448, DOI 10.1007/s13744-013-0141-5; Macfadyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040313; MAMAY M, 2012, TURK ENTOMOL B, V2, P189; Miller J, 2010, GEOGR COMPASS, V4, P490, DOI 10.1111/j.1749-8198.2010.00351.x; Miranda MMM, 1998, BIOCONTROL SCI TECHN, V8, P597, DOI 10.1080/09583159830117; Mohamed E. S. I., 2012, Bulletin OEPP, V42, P325, DOI 10.1111/epp.2578; Parry ML, 2007, CLIMATE CHANGE 2007; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047675; Pfeiffer DG, 2013, FLA ENTOMOL, V96, P661, DOI 10.1653/024.096.0241; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Polaszek A, 2012, BIOCONTROL, V57, P21, DOI 10.1007/s10526-011-9361-y; PORTER JH, 1991, AGR FOREST METEOROL, V57, P221, DOI 10.1016/0168-1923(91)90088-8; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Spasov D, 2011, CONTROL OF POPULATIO, P79; Sporleder M, 2013, CABI INVASIVE SER, P412, DOI 10.1079/9781845938291.0412; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonnang HEZ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-111; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Vivan LM, 2002, REV BIOL TROP, V50, P145	53	85	91	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135283	10.1371/journal.pone.0135283	http://dx.doi.org/10.1371/journal.pone.0135283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252204	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100147
J	Garcia, AP; Aitta-aho, T; Schaaf, L; Heeley, N; Heuschmid, L; Bai, YJ; Barrantes, FJ; Apergis-Schoute, J				Garcia, Ana P.; Aitta-aho, Teemu; Schaaf, Laura; Heeley, Nicholas; Heuschmid, Lena; Bai, Yunjing; Barrantes, Francisco J.; Apergis-Schoute, John			Nicotinic alpha 4 Receptor-Mediated Cholinergic Influences on Food Intake and Activity Patterns in Hypothalamic Circuits	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; OREXIN NEURONS; ACETYLCHOLINE-RECEPTORS; SUBSTANTIA INNOMINATA; LATERAL HYPOTHALAMUS; FEEDING-BEHAVIOR; NEUROPEPTIDE-Y; MICE LACKING; C-FOS; RAT	Nicotinic acetylcholine receptors (nAChRs) play an important role in regulating appetite and have been shown to do so by influencing neural activity in the hypothalamus. To shed light on the hypothalamic circuits governing acetylcholine's (ACh) regulation of appetite this study investigated the influence of hypothalamic nAChRs expressing the alpha 4 subunit. We found that antagonizing the alpha 4 beta 2 nAChR locally in the lateral hypothalamus with di-hydro-beta-erythroidine (DH beta E), an alpha 4 nAChR antagonist with moderate affinity, caused an increase in food intake following free access to food after a 12 hour fast, compared to saline-infused animals. Immunocytochemical analysis revealed that orexin/hypocretin (HO), oxytocin, and tyrosine hydroxylase (TH)-containing neurons in the A13 and A12 of the hypothalamus expressed the nAChR alpha 4 subunit in varying amounts (34%, 42%, 50%, and 51%, respectively) whereas melanin concentrating hormone (MCH) neurons did not, suggesting that DH beta E-mediated increases in food intake may be due to a direct activation of specific hypothalamic circuits. Systemic DH beta E (2 mg/kg) administration similarly increased food intake following a 12 hour fast. In these animals a subpopulation of orexin/hypocretin neurons showed elevated activity compared to control animals and MCH neuronal activity was overall lower as measured by expression of the immediate early gene marker for neuronal activity cFos. However, oxytocin neurons in the paraventricular hypothalamus and TH-containing neurons in the A13 and A12 did not show differential activity patterns. These results indicate that various neurochemically distinct hypothalamic populations are under the influence of alpha 4 beta 2 nAChRs and that cholinergic inputs to the lateral hypothalamus can affect satiety signals through activation of local alpha 4 beta 2 nAChR-mediated transmission.	[Garcia, Ana P.; Aitta-aho, Teemu; Schaaf, Laura; Heuschmid, Lena; Bai, Yunjing; Apergis-Schoute, John] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Garcia, Ana P.; Barrantes, Francisco J.] Catholic Univ Argentina, Fac Med Sci, UCA CONICET, Mol Neurobiol Lab,Biomed Res Inst BIOMED, Buenos Aires, DF, Argentina; [Heeley, Nicholas; Apergis-Schoute, John] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 1QJ, England; [Bai, Yunjing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Chinese Academy of Sciences; Institute of Psychology, CAS	Apergis-Schoute, J (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	ja451@cam.ac.uk	; Barrantes, Francisco J./HCH-0258-2022	Aitta-aho, Teemu/0000-0001-9332-3340; Barrantes, Francisco J./0000-0002-4745-681X	Royal Society; European Union (Latin America/European Liason, LAEL); Sigrid Juselius Foundation	Royal Society(Royal Society of London); European Union (Latin America/European Liason, LAEL); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	The study was funded by the Royal Society to JA-S, the European Union (Latin America/European Liason, LAEL) to FJB and APG, and the Sigrid Juselius Foundation to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apergis-Schoute J, 2015, J NEUROSCI, V35, P5435, DOI 10.1523/JNEUROSCI.5269-14.2015; ARLETTI R, 1989, PEPTIDES, V10, P89, DOI 10.1016/0196-9781(89)90082-X; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Bayer L, 1999, NEUROSCIENCE, V91, P1087, DOI 10.1016/S0306-4522(98)00678-2; BENELLI A, 1991, NEUROPEPTIDES, V20, P57, DOI 10.1016/0143-4179(91)90040-P; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2006, NEURON, V50, P711, DOI 10.1016/j.neuron.2006.04.032; Cai XJ, 2001, DIABETES, V50, P105, DOI 10.2337/diabetes.50.1.105; Chaves VE, 2013, PEPTIDES, V45, P9, DOI 10.1016/j.peptides.2013.04.010; Chintoh A, 2003, PHARMACOL BIOCHEM BE, V76, P53, DOI 10.1016/S0091-3057(03)00196-5; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; GROVE EA, 1988, J COMP NEUROL, V277, P347, DOI 10.1002/cne.902770303; HALLANGER AE, 1988, J COMP NEUROL, V274, P483, DOI 10.1002/cne.902740403; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Jimenez A, 2013, BRAIN RES, V1513, P41, DOI 10.1016/j.brainres.2013.03.031; Jo YH, 2005, J NEUROSCI, V25, P11133, DOI 10.1523/JNEUROSCI.3638-05.2005; Jo YH, 2002, J NEUROPHYSIOL, V88, P2501, DOI 10.1152/jn.00352.2002; Kotz CM, 2002, REGUL PEPTIDES, V104, P27, DOI 10.1016/S0167-0115(01)00346-9; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; LEIBOWITZ SF, 1979, BRAIN RES, V172, P101, DOI 10.1016/0006-8993(79)90898-9; Li DP, 2001, AM J PHYSIOL-REG I, V281, pR1105, DOI 10.1152/ajpregu.2001.281.4.R1105; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Marubio LM, 2003, EUR J NEUROSCI, V17, P1329, DOI 10.1046/j.1460-9568.2003.02564.x; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Miyata G, 1999, SURGERY, V126, P255, DOI 10.1016/S0039-6060(99)70163-7; OOMURA Y, 1969, ANN NY ACAD SCI, V157, P642, DOI 10.1111/j.1749-6632.1969.tb12912.x; Pasumarthi RK, 2006, EUR J PHARMACOL, V535, P172, DOI 10.1016/j.ejphar.2006.02.021; PERKINS KA, 1991, PSYCHOPHARMACOLOGY, V103, P103, DOI 10.1007/BF02244083; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; REN T, 1992, BRAIN RES BULL, V29, P589, DOI 10.1016/0361-9230(92)90127-J; SCHECHTER MD, 1976, EUR J PHARMACOL, V38, P63, DOI 10.1016/0014-2999(76)90201-6; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; SHIMAZU T, 1976, SCIENCE, V194, P535, DOI 10.1126/science.9692; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; TAGO H, 1987, BRAIN RES, V415, P49, DOI 10.1016/0006-8993(87)90268-X; Takase K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099961; Tsutsui-Kimura I, 2010, EUR J PHARMACOL, V641, P148, DOI 10.1016/j.ejphar.2010.05.028; VANDENPOL AN, 1986, J NEUROSCI, V6, P877; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WAGNER CK, 1995, BRAIN RES, V677, P229, DOI 10.1016/0006-8993(95)00128-D; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Yang ZJ, 1999, PHARMACOL BIOCHEM BE, V64, P155, DOI 10.1016/S0091-3057(99)00111-2	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133327	10.1371/journal.pone.0133327	http://dx.doi.org/10.1371/journal.pone.0133327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247203	Green Published, gold			2022-12-26	WOS:000359062300012
J	Han, QX; Higashi, H; Mitsui, Y; Setoguchi, H				Han, Qingxiang; Higashi, Hiroyuki; Mitsui, Yuki; Setoguchi, Hiroaki			Distinct Phylogeographic Structures of Wild Radish (Raphanus sativus L. var. raphanistroides Makino) in Japan	PLOS ONE			English	Article							CALYSTEGIA-SOLDANELLA CONVOLVULACEAE; RECENT POPULATION BOTTLENECKS; ALLELE FREQUENCY DATA; CHLOROPLAST DNA; GENETIC DIVERSITY; HISTORICAL BIOGEOGRAPHY; NORTHWESTERN PACIFIC; RYUKYU ARCHIPELAGO; KOREAN POPULATIONS; HOMOZYGOSITY TEST	Coastal plants with simple linear distribution ranges along coastlines provide a suitable system for improving our understanding of patterns of intra-specific distributional history and genetic variation. Due to the combination of high seed longevity and high dispersibility of seeds via seawater, we hypothesized that wild radish would poorly represent phylogeographic structure at the local scale. On the other hand, we also hypothesized that wild radish populations might be geographically differentiated, as has been exhibited by their considerable phenotypic variations along the islands of Japan. We conducted nuclear DNA microsatellite loci and chloroplast DNA haplotype analyses for 486 samples and 144 samples, respectively, from 18 populations to investigate the phylogeographic structure of wild radish in Japan. Cluster analysis supported the existence of differential genetic structures between the Ryukyu Islands and mainland Japan populations. A significant strong pattern of isolation by distance and significant evidence of a recent bottleneck were detected. The chloroplast marker analysis resulted in the generation of eight haplotypes, of which two haplotypes (A and B) were broadly distributed in most wild radish populations. High levels of variation in microsatellite loci were identified, whereas cpDNA displayed low levels of genetic diversity within populations. Our results indicate that the Kuroshio Current would have contributed to the sculpting of the phylogeographic structure by shaping genetic gaps between isolated populations. In addition, the Tokara Strait would have created a geographic barrier between the Ryukyu Islands and mainland Japan. Finally, extant habitat disturbances (coastal erosion), migration patterns (linear expansion), and geographic characteristics (small islands and sea currents) have influenced the expansion and historical population dynamics of wild radish. Our study is the first to record the robust phylogeographic structure in wild radish between the Ryukyu Islands and mainland Japan, and might provide new insight into the genetic differentiation of coastal plants across islands.	[Han, Qingxiang; Higashi, Hiroyuki; Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Mitsui, Yuki] Tokyo Univ Agr, Fac Agr, Atsugi, Kanagawa, Japan	Kyoto University; Tokyo University of Agriculture	Han, QX (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Yoshida Nihonmatsu Cho, Kyoto, Japan.	han.qingxiang.88r@st.kyoto-u.ac.jp	Setoguchi, Hiroaki/AAM-5312-2021		KAKENHI [24247013, 25128708]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Science Research (KAKENHI no. 24247013) to H. S. (https://kaken.nii.ac.jp/d/p/24247013.ja.html) and Grants-in-Aid for Science Research (KAKENHI no. 25128708) to H.S. (https://kaken.nii.ac.jp/d/p/25128708.ja.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafeh R, 2006, J BIOGEOGR, V33, P1461, DOI 10.1111/j.1365-2699.2006.01512.x; BANKS JA, 1985, P NATL ACAD SCI USA, V82, P6950, DOI 10.1073/pnas.82.20.6950; Bond JM, 2005, ECOGRAPHY, V28, P374, DOI 10.1111/j.0906-7590.2005.04148.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Clausing G, 2000, MOL ECOL, V9, P1823, DOI 10.1046/j.1365-294x.2000.01083.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; CRANDALL KA, 1993, GENETICS, V134, P959; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Escudero M, 2010, MOL ECOL, V19, P352, DOI 10.1111/j.1365-294X.2009.04449.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng M, 2000, J PHYS OCEANOGR, V30, P2257, DOI 10.1175/1520-0485(2000)030<2257:SAVOTK>2.0.CO;2; Franks SJ, 2004, AM J BOT, V91, P1345, DOI 10.3732/ajb.91.9.1345; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamilton MB, 1999, MOL ECOL, V8, P521; Hashida T, 2013, BREEDING SCI, V63, P218, DOI 10.1270/jsbbs.63.218; Huh MK, 2002, BREEDING SCI, V52, P79, DOI 10.1270/jsbbs.52.79; Huh MK, 2001, GENES GENET SYST, V76, P15, DOI 10.1266/ggs.76.15; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jonsson B. Olle., 2000, Diversity and Distributions, V6, P65, DOI 10.1046/j.1472-4642.2000.00072.x; Kadereit J. W., 2007, Watsonia, V26, P229; Kadereit JW, 2005, TAXON, V54, P861, DOI 10.2307/25065473; KIM ST, 1995, ISR J PLANT SCI, V43, P213, DOI 10.1080/07929978.1995.10676606; Kubota Y, 2014, J BIOGEOGR, V41, P1267, DOI 10.1111/jbi.12290; Lambracht E, 2007, FLORA, V202, P79, DOI 10.1016/j.flora.2006.05.001; Langella O, 2000, POPULATIONS LOGICIEL; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MANTEL N, 1967, CANCER RES, V27, P209; MARUYAMA T, 1985, GENETICS, V111, P675; Nakamura K, 2010, J BIOGEOGR, V37, P1907, DOI 10.1111/j.1365-2699.2010.02342.x; Nakatsuji R, 2011, BREEDING SCI, V61, P413, DOI 10.1270/jsbbs.61.413; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1978, GENETICS, V89, P583; Noda A, 2011, BIOL J LINN SOC, V102, P51, DOI 10.1111/j.1095-8312.2010.01554.x; Nordborg M., 2001, HDB STAT GENETICS; Ohsako T, 2007, SCI REPORTS KYOTO PR; Ohsako T, 2010, BREEDING SCI, V60, P195, DOI 10.1270/jsbbs.60.195; Ohtsuki T, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr021; Okaura T, 2007, GENES GENET SYST, V82, P465, DOI 10.1266/ggs.82.465; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seo Akihiro, 2004, APG Acta Phytotaxonomica et Geobotanica, V55, P29; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takayama K, 2008, MOL ECOL, V17, P2730, DOI 10.1111/j.1365-294X.2008.03799.x; UJIIE H, 1991, MAR MICROPALEONTOL, V18, P115, DOI 10.1016/0377-8398(91)90008-T; Ujiie H, 1999, MAR MICROPALEONTOL, V37, P23, DOI 10.1016/S0377-8398(99)00010-9; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1986, GENETICS, V112, P899; Weising K, 2007, ZOOL ANZ, V246, P279, DOI 10.1016/j.jcz.2007.07.005; Westberg E, 2009, J BIOGEOGR, V36, P1398, DOI 10.1111/j.1365-2699.2008.01973.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yamagishi H, 2003, PLANT CELL REP, V22, P52, DOI 10.1007/s00299-003-0655-0; Yin W, 2009, ZOOL SCI, V26, P467, DOI 10.2108/zsj.26.467	66	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135132	10.1371/journal.pone.0135132	http://dx.doi.org/10.1371/journal.pone.0135132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247202	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300102
J	Skrepnek, GH; Mills, JL; Armstrong, DG				Skrepnek, Grant H.; Mills, Joseph L., Sr.; Armstrong, David G.			A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010	PLOS ONE			English	Article							ETHNIC DISPARITIES; CARE; COST; INDIVIDUALS; PHYSICIAN; VISITS; RACE	Objectives To evaluate the magnitude and impact of diabetic foot ulcers (DFUs) in emergency department (ED) settings from 2006-2010 in the United States (US). Methods This cross-sectional study utilized Agency for Healthcare Research and Quality (AHRQ) Healthcare Cost and Utilization Project (HCUP) National Emergency Department Sample (NEDS) discharge records of ED cases among persons >= 18 years with any-listed diagnosis of DFUs. Multivariable analyses were conducted for clinical outcomes of patient disposition from the ED and economic outcomes of charges and lengths of stay based upon patient demographic and socioeconomic factors, hospital characteristics, and comorbid disease states. Results Overall, 1,019,861 cases of diabetic foot complications presented to EDs in the US from 2006-2010, comprising 1.9% of the 54.2 million total diabetes cases. The mean patient age was 62.5 years and 59.4% were men. The national bill was $1.9 billion per year in the ED and $8.78 billion per year (US$ 2014) including inpatient charges among the 81.2% of cases that were admitted. Clinical outcomes included mortality in 2.0%, sepsis in 9.6% of cases and amputation in 10.5% (major-minor amputation ratio of 0.46). Multivariable analyses found that those residing in non-urban locations were associated with +51.3%, +14.9%, and +41.4% higher odds of major amputation, minor amputation, and inpatient death, respectively (p<0.05). Medicaid beneficiaries incurred +21.1% and +25.1% higher odds for major or minor amputations, respectively, than Medicare patients (p<0.05). Persons within the lowest income quartile regions were associated with a +38.5% higher odds of major amputation (p<0.05) versus the highest income regions. Conclusion Diabetic foot complications exact a substantial clinical and economic toll in acute care settings, particularly among the rural and working poor. Clear opportunities exist to reduce costs and improve outcomes for this systematically-neglected condition by establishing effective practice paradigms for screening, prevention, and coordinated care.	[Skrepnek, Grant H.; Mills, Joseph L., Sr.; Armstrong, David G.] Univ Arizona, Coll Med, Div Vasc & Endovasc Surg, Southern Arizona Limb Salvage Alliance,Dept Surg, Tucson, AZ USA	University of Arizona	Skrepnek, GH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73190 USA.	grant-skrepnek@ouhsc.edu	Mills, Joseph L./L-2023-2019; Mills, Joseph/J-2966-2019	Mills, Joseph/0000-0002-4955-4384				Apelqvist J, 2008, DIABETES-METAB RES, V24, pS181, DOI 10.1002/dmrr.848; Barshes NR, 2013, DIABET FOOT ANKLE, V4, DOI 10.3402/dfa.v4i0.21847; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2008, PHYS THER, V88, P1436, DOI 10.1093/ptj/88.11.1436; Cavanagh P, 2012, DIABETES-METAB RES, V28, P107, DOI 10.1002/dmrr.2245; Cone DC, 2003, ACAD EMERG MED, V10, P1176, DOI 10.1197/S1069-6563(03)00486-X; Crawford F, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-22; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Egede LE, 2004, DIABETES CARE, V27, P1748, DOI 10.2337/diacare.27.7.1748; Gaskin DJ, 2014, AM J PUBLIC HEALTH, V104, P2147, DOI 10.2105/AJPH.2013.301420; Gibson TB, 2014, INT WOUND J, V11, P641, DOI 10.1111/iwj.12021; Ginde AA, 2008, DIABETES CARE, V31, P511, DOI 10.2337/dc07-1790; Johnson PJ, 2012, MED CARE, V50, P1020, DOI 10.1097/MLR.0b013e318270bad4; Kerr M, 2014, DIABETIC MED, V31, P1498, DOI 10.1111/dme.12545; LaVeist TA, 2002, J NATL MED ASSOC, V94, P937; Lavery LA, 2006, DIABETES CARE, V29, P1288, DOI 10.2337/dc05-2425; Malik RA, 2013, DIABETIC MED, V30, P893, DOI 10.1111/dme.12169; Menchine MD, 2012, AM J EMERG MED, V30, P754, DOI 10.1016/j.ajem.2011.02.028; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; O'Malley AS, 2002, WOMEN HEALTH ISS, V12, P191, DOI 10.1016/S1049-3867(02)00138-X; Oliver MN, 2001, J NATL MED ASSOC, V93, P380; Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409; Pezzin LE, 2007, ACAD EMERG MED, V14, P149, DOI 10.1197/j.aem.2006.08.020; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Richards CF, 2003, ACAD EMERG MED, V10, P1169, DOI 10.1197/S1069-6563(03)00485-8; Shi LY, 2003, AM J PUBLIC HEALTH, V93, P138, DOI 10.2105/AJPH.93.1.138; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Skrepnek Grant H., 2012, Pharmaceuticals Policy and Law, V14, P105, DOI 10.3233/PPL-2011-0345; Skrepnek Grant H, 2005, J Manag Care Pharm, V11, P240; Skrepnek GH, 2014, J VASC SURG, V60, P1255, DOI 10.1016/j.jvs.2014.04.071; Skrepnek GH, 2014, DIABETES CARE, V37, pE196, DOI 10.2337/dc14-0079; Sloan FA, 2010, HEALTH SERV RES, V45, P1740, DOI 10.1111/j.1475-6773.2010.01157.x; Sohn MW, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-27; Wang W, 2011, DIABETES EDUCATOR, V37, P536, DOI 10.1177/0145721711410717; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65	39	80	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134914	10.1371/journal.pone.0134914	http://dx.doi.org/10.1371/journal.pone.0134914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MQ	26248037	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300078
J	Zhang, N; Zhao, SM; Zhang, SH; Chen, JZ; Lu, DR; Shen, M; Li, CT				Zhang, Na; Zhao, Shumin; Zhang, Su-Hua; Chen, Jinzhong; Lu, Daru; Shen, Min; Li, Chengtao			Intra-Monozygotic Twin Pair Discordance and Longitudinal Variation of Whole-Genome Scale DNA Methylation in Adults	PLOS ONE			English	Article							EPIGENETIC DIFFERENCES; PHYLOGENETIC ANALYSIS; GENE-REGULATION; AGE; DISEASE; PATTERN; TISSUE; CELLS; BIRTH; ENVIRONMENT	Monozygotic twins share identical genomic DNA and are indistinguishable using conventional genetic markers. Increasing evidence indicates that monozygotic twins are epigenetically distinct, suggesting that a comparison between DNA methylation patterns might be useful to approach this forensic problem. However, the extent of epigenetic discordance between healthy adult monozygotic twins and the stability of CpG loci within the same individual over a short time span at the whole-genome scale are not well understood. Here, we used Infinium HumanMethylation450 Beadchips to compare DNA methylation profiles using blood collected from 10 pairs of monozygotic twins and 8 individuals sampled at 0, 3, 6, and 9 months. Using an effective and unbiased method for calling differentially methylated (DM) CpG sites, we showed that 0.087%-1.530% of the CpG sites exhibit differential methylation in monozygotic twin pairs. We further demonstrated that, on whole-genome level, there has been no significant epigenetic drift within the same individuals for up to 9 months, including one monozygotic twin pair. However, we did identify a subset of CpG sites that vary in DNA methylation over the 9-month period. The magnitude of the intra-pair or longitudinal methylation discordance of the CpG sites inside the CpG islands is greater than those outside the CpG islands. The CpG sites located on shores appear to be more suitable for distinguishing between MZ twins.	[Zhang, Na; Zhao, Shumin; Zhang, Su-Hua; Shen, Min; Li, Chengtao] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai 200063, Peoples R China; [Zhang, Na; Zhang, Su-Hua; Chen, Jinzhong; Lu, Daru] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Institute of Forensic Science Ministry of Justice PRC; Fudan University	Li, CT (corresponding author), Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai 200063, Peoples R China.	lichengtaohla@163.com		Li, Chengtao/0000-0001-6852-9144; Zhang, Suhua/0000-0002-3984-9728; Shen, Min/0000-0001-8979-0122	National Natural Science Foundation of China [81222041, 81172908]; National Key Technology Research & Development Program of the Ministry of Science and Technology of China [2012BAK16B01]; Science and Technology Commission of Shanghai Municipality [12R21421700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program of the Ministry of Science and Technology of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by funds from the National Natural Science Foundation of China [grant numbers 81222041, 81172908], the National Key Technology Research & Development Program of the Ministry of Science and Technology of China [grant number 2012BAK16B01], and the Science and Technology Commission of Shanghai Municipality [grant number 12R21421700]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accomando WP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r50; Andrew T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022332; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova Marina, 2009, V507, P149, DOI 10.1007/978-1-59745-522-0_12; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Davies MN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r43; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dolinoy DC, 2007, REPROD TOXICOL, V23, P297, DOI 10.1016/j.reprotox.2006.08.012; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Fleischmann T, 2007, EMERG MED AUSTRALAS, V19, P300, DOI 10.1111/j.1742-6723.2007.00991.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Gordon L, 2012, GENOME RES, V22, P1395, DOI 10.1101/gr.136598.111; Gordon L, 2011, EPIGENETICS-US, V6, P579, DOI 10.4161/epi.6.5.15072; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Lu TP, 2014, SCI REP-UK, V4, DOI 10.1038/srep04351; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Martino D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r42; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Riggs AD, 1998, CIBA F SYMP, V214, P214; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; von Wurmb-Schwark Nicole, 2004, Leg Med (Tokyo), V6, P125, DOI 10.1016/j.legalmed.2003.12.002; Wang DL, 2012, EPIGENETICS-US, V7, P594, DOI 10.4161/epi.20117; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361	50	13	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135022	10.1371/journal.pone.0135022	http://dx.doi.org/10.1371/journal.pone.0135022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248206	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300089
J	Butzlaff, M; Weigel, A; Ponimaskin, E; Zeug, A				Butzlaff, Malte; Weigel, Arwed; Ponimaskin, Evgeni; Zeug, Andre			eSIP: A Novel Solution-Based Sectioned Image Property Approach for Microscope Calibration	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; CONFOCAL MICROSCOPY; REFRACTIVE-INDEX; RESOLUTION; LAYERS; SYSTEMS; QUALITY; PROFILE; FRET	Fluorescence confocal microscopy represents one of the central tools in modern sciences. Correspondingly, a growing amount of research relies on the development of novel microscopic methods. During the last decade numerous microscopic approaches were developed for the investigation of various scientific questions. Thereby, the former qualitative imaging methods became replaced by advanced quantitative methods to gain more and more information from a given sample. However, modern microscope systems being as complex as they are, require very precise and appropriate calibration routines, in particular when quantitative measurements should be compared over longer time scales or between different setups. Multispectral beads with sub-resolution size are often used to describe the point spread function and thus the optical properties of the microscope. More recently, a fluorescent layer was utilized to describe the axial profile for each pixel, which allows a spatially resolved characterization. However, fabrication of a thin fluorescent layer with matching refractive index is technically not solved yet. Therefore, we propose a novel type of calibration concept for sectioned image property (SIP) measurements which is based on fluorescent solution and makes the calibration concept available for a broader number of users. Compared to the previous approach, additional information can be obtained by application of this extended SIP chart approach, including penetration depth, detected number of photons, and illumination profile shape. Furthermore, due to the fit of the complete profile, our method is less susceptible to noise. Generally, the extended SIP approach represents a simple and highly reproducible method, allowing setup independent calibration and alignment procedures, which is mandatory for advanced quantitative microscopy.	[Butzlaff, Malte; Ponimaskin, Evgeni; Zeug, Andre] Hannover Med Sch, Ctr Physiol, Cellular Neurophysiol, Hannover, Germany; [Weigel, Arwed] Carl Zeiss Microscopy GmbH, Munich, Germany	Hannover Medical School; Carl Zeiss AG	Zeug, A (corresponding author), Hannover Med Sch, Ctr Physiol, Cellular Neurophysiol, Hannover, Germany.	Zeug.Andre@mh-hannover.de	Zeug, Andre/X-3208-2019	Zeug, Andre/0000-0001-9858-5841; Ponimaskin, evgeni/0000-0002-4570-5130; Butzlaff, Malte/0000-0001-6365-419X	BMBF (Federal Ministry of Education and Research, Germany) [0315690D]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [PO732]; BMBF; Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH [EXC 62/3]; Carl Zeiss Microscopy GmbH; Neuron EraNet (project TargetECM) [01EW1308B]	BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH; Carl Zeiss Microscopy GmbH; Neuron EraNet (project TargetECM)	Financial support was provided by the BMBF (Federal Ministry of Education and Research, Germany, Grant 0315690D) to MB and AZ, and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, Grant PO732), the BMBF and Neuron EraNet (project TargetECM, 01EW1308B) and the Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH (EXC 62/3) to MB, EP and AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Carl Zeiss Microscopy GmbH provided support in the form of salaries for author AW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antonini A, 2014, OPT EXPRESS, V22, P14293, DOI 10.1364/OE.22.014293; ARMSTRONG BH, 1967, J QUANT SPECTROSC RA, V7, P61, DOI 10.1016/0022-4073(67)90057-X; Besseling TH, 2015, J MICROSC-OXFORD, V257, P142, DOI 10.1111/jmi.12194; Brakenhoff GJ, 2005, J MICROSC-OXFORD, V219, P122, DOI 10.1111/j.1365-2818.2005.01504.x; Cole RW, 2013, MICROSC MICROANAL, V19, P1653, DOI 10.1017/S1431927613013470; Cole RW, 2011, NAT PROTOC, V6, P1929, DOI 10.1038/nprot.2011.407; HELL S, 1993, J MICROSC-OXFORD, V169, P391, DOI 10.1111/j.1365-2818.1993.tb03315.x; Hng KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079879; Ida T, 2000, J APPL CRYSTALLOGR, V33, P1311, DOI 10.1107/S0021889800010219; Inoue S., 2006, HDB BIOL CONFOCAL MI, P1, DOI [10.1007/978-0-387-45524-2_1, DOI 10.1007/978-0-387-45524-2_1]; Kedziora KM, 2011, J MICROSC-OXFORD, V244, P101, DOI [10.1111/j.1365-2818.2011.03514.x, 10.1111/j.1365-2818.20.11.03514.x]; Kuypers LC, 2004, SCANNING, V26, P256, DOI 10.1002/sca.4950260507; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Model MA, 2008, J MICROSC-OXFORD, V229, P12, DOI 10.1111/j.1365-2818.2007.01880.x; Oomen LCJM, 2008, J MICROSC-OXFORD, V232, P353, DOI 10.1111/j.1365-2818.2008.02106.x; Prasad S, 2013, METHOD CELL BIOL, V117, P243, DOI 10.1016/B978-0-12-408143-7.00014-1; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Royon A, 2013, IMAGING MICROSCOPY; Schrader M, 1998, J MICROSC-OXFORD, V191, P135, DOI 10.1046/j.1365-2818.1998.00361.x; Schropp M, 2014, J MICROSC-OXFORD, V256, P23, DOI 10.1111/jmi.12154; Schwertner M, 2005, J MICROSC-OXFORD, V217, P184, DOI 10.1111/j.1365-2818.2005.01431.x; Siegel J, 2003, APPL OPTICS, V42, P2995, DOI 10.1364/AO.42.002995; Theer P, 2014, NAT METHODS, V11, P981, DOI 10.1038/nmeth.3102; Waters JC, 2014, METHOD CELL BIOL, V123, P1, DOI 10.1016/B978-0-12-420138-5.00001-X; Weigel A, 2009, THESIS; WERTHEIM GK, 1974, REV SCI INSTRUM, V45, P1369, DOI 10.1063/1.1686503; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Zucker RM, 2005, MICROSC RES TECHNIQ, V68, P307, DOI 10.1002/jemt.20249; Zucker RM, 2007, CYTOM PART A, V71A, P174, DOI 10.1002/cyto.a.20371; Zwier JM, 2008, J MICROSC-OXFORD, V231, P59, DOI 10.1111/j.1365-2818.2008.02017.x; Zwier JM, 2004, J MICROSC-OXFORD, V216, P15, DOI 10.1111/j.0022-2720.2004.01390.x; Zwier JM, 2006, IMAGING MICROSCOPY, p[8, 54], DOI [DOI 10.1002/IMIC.200790043, 10.1002/imic.200790043]	33	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134980	10.1371/journal.pone.0134980	http://dx.doi.org/10.1371/journal.pone.0134980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244982	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400135
J	Duan, XH; Wang, YL; Han, XW; Ren, JZ; Li, TF; Zhang, JH; Zhang, K; Chen, PF				Duan, Xu-Hua; Wang, Yan-Li; Han, Xin-Wei; Ren, Jian-Zhuang; Li, Teng-Fei; Zhang, Jian-Hao; Zhang, Kai; Chen, Peng-Fei			Intraductal Radiofrequency Ablation Followed by Locoregional Tumor Treatments for Treating Occluded Biliary Stents in Non-Resectable Malignant Biliary Obstruction: A Single-Institution Experience	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; PALLIATIVE TREATMENT; RANDOMIZED-TRIAL; CHOLANGIOCARCINOMA; FEASIBILITY; MANAGEMENT; JAUNDICE; SAFE	Objectives To determine the safety and feasibility of intraductal radiofrequency ablation (RFA) followed by locoregional tumor treatments in patients with non-resectable malignant biliary obstruction and stent re-occlusion. Methods Fourteen patients with malignant biliary obstruction and blocked metal stents were studied retrospectively. All had intraductal RFA followed by locoregional tumor treatments and were monitored clinically and radiologically. The practicality, safety, postoperative complications, jaundice remission, stent patency and survival time were analyzed. Results Combination treatment was successful for all patients. There were no severe complications during RFA or local treatments. All patients had stent patency restored, with a decline in serum bilirubin. Three patients had recurrent jaundice by 195, 237 and 357 days; two patients underwent repeat intraductal RFA; and one required an internal-external biliary drain. The average stent patency time was 234 days (range 187-544 days). With a median follow-up of 384 days (range 187-544 days), six patients were alive, while eight had died. There was no mortality at 30 days. The 3, 6, 12 and 18 month survival rates were 100%, 100%, 64.3% and 42.9%, respectively. Conclusion Intraductal RFA followed by locoregional tumor treatments for occluded metal stents is safe and practically feasible and potential increase stent patency and survival times.	[Duan, Xu-Hua; Wang, Yan-Li; Han, Xin-Wei; Ren, Jian-Zhuang; Li, Teng-Fei; Zhang, Jian-Hao; Zhang, Kai; Chen, Peng-Fei] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Henan Province, Peoples R China	Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, 1 East Jian She Rd, Zhengzhou 450052, Henan Province, Peoples R China.	hanxinwei2006@163.com; rjzjrk@126.com	han, wei/ABG-2691-2021		National Natural Science Foundation of China [81401494]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81401494).	Abraham NS, 2002, GASTROINTEST ENDOSC, V56, P835, DOI 10.1067/mge.2002.129868; ANDERSEN JR, 1989, GUT, V30, P1132, DOI 10.1136/gut.30.8.1132; Bode MK, 2005, J SURG ONCOL, V91, P102, DOI 10.1002/jso.20290; Brown DB, 2007, J VASC INTERV RADIOL, V18, P1469, DOI 10.1016/j.jvir.2007.08.027; Dolak W, 2014, SURG ENDOSC, V28, P854, DOI 10.1007/s00464-013-3232-9; Gusani NJ, 2008, J GASTROINTEST SURG, V12, P129, DOI 10.1007/s11605-007-0312-y; Knuppel M, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/190708; Kullman E, 2010, GASTROINTEST ENDOSC, V72, P915, DOI 10.1016/j.gie.2010.07.036; Li Mao-quan, 2008, Zhonghua Yi Xue Za Zhi, V88, P2743; Li TF, 2014, CLIN RADIOL, V69, P13, DOI 10.1016/j.crad.2013.05.096; Loew BJ, 2009, GASTROINTEST ENDOSC, V70, P445, DOI 10.1016/j.gie.2008.11.018; Mao Eric J, 2014, J Gastrointest Cancer, V45 Suppl 1, P55, DOI 10.1007/s12029-013-9538-y; Mizandari M, 2013, CARDIOVASC INTER RAD, V36, P814, DOI 10.1007/s00270-012-0529-3; Monga A, 2011, GASTROINTEST ENDOSC, V74, P935, DOI 10.1016/j.gie.2010.10.018; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Nishigaki Y, 2013, HEPATOL RES, V43, P467, DOI 10.1111/j.1872-034X.2012.01095.x; Pai M, 2014, CARDIOVASC INTER RAD, V37, P235, DOI 10.1007/s00270-013-0688-x; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Qian XJ, 2006, WORLD J GASTROENTERO, V12, P331, DOI 10.3748/wjg.v12.i2.331; Ridtitid W, 2012, WORLD J GASTRO ENDOS, V4, P157, DOI 10.4253/wjge.v4.i5.157; Rustagi T, 2014, DIGEST DIS SCI, V59, P2635, DOI 10.1007/s10620-014-3237-9; Shah T, 2012, DIGEST DIS SCI, V57, P2765, DOI 10.1007/s10620-012-2272-7; Steel AW, 2011, GASTROINTEST ENDOSC, V73, P149, DOI 10.1016/j.gie.2010.09.031	23	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134857	10.1371/journal.pone.0134857	http://dx.doi.org/10.1371/journal.pone.0134857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244367	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400115
J	Giotis, ES; Rothwell, L; Scott, A; Hu, TJ; Talbot, R; Todd, D; Burt, DW; Glass, EJ; Kaiser, P				Giotis, Efstathios S.; Rothwell, Lisa; Scott, Alistair; Hu, Tuanjun; Talbot, Richard; Todd, Daniel; Burt, David W.; Glass, Elizabeth J.; Kaiser, Pete			Transcriptomic Profiling of Virus-Host Cell Interactions following Chicken Anaemia Virus (CAV) Infection in an In Vivo Model	PLOS ONE			English	Article							IMMUNE-RESPONSE; T-CELLS; SIGNAL-TRANSDUCTION; MICROARRAY DATA; DISEASE VIRUS; PROTEIN; APOPTOSIS; EXPRESSION; APOPTIN; AGENT	Chicken Anaemia Virus (CAV) is an economically important virus that targets lymphoid and erythroblastoid progenitor cells leading to immunosuppression. This study aimed to investigate the interplay between viral infection and the host's immune response to better understand the pathways that lead to CAV-induced immunosuppression. To mimic vertical transmission of CAV in the absence of maternally-derived antibody, day-old chicks were infected and their responses measured at various time-points post-infection by qRT-PCR and gene expression microarrays. The kinetics of mRNA expression levels of signature cytokines of innate and adaptive immune responses were determined by qRT-PCR. The global gene expression profiles of mock-infected (control) and CAV-infected chickens at 14 dpi were also compared using a chicken immune-related 5K microarray. Although in the thymus there was evidence of induction of an innate immune response following CAV infection, this was limited in magnitude. There was little evidence of a Th1 adaptive immune response in any lymphoid tissue, as would normally be expected in response to viral infection. Most cytokines associated with Th1, Th2 or Treg subsets were down-regulated, except IL-2, IL-13, IL-10 and IFN gamma, which were all up-regulated in thymus and bone marrow. From the microarray studies, genes that exhibited significant (greater than 1.5-fold, false discovery rate <0.05) changes in expression in thymus and bone marrow on CAV infection were mainly associated with T-cell receptor signalling, immune response, transcriptional regulation, intracellular signalling and regulation of apoptosis. Expression levels of a number of adaptor proteins, such as src-like adaptor protein (SLA), a negative regulator of T-cell receptor signalling and the transcription factor Special AT-rich Binding Protein 1 (SATB1), were significantly down-regulated by CAV infection, suggesting potential roles for these genes as regulators of viral infection or cell defence. These results extend our understanding of CAV-induced immunosuppression and suggest a global immune dysregulation following CAV infection.	[Giotis, Efstathios S.; Todd, Daniel] Agri Food & Biosci Inst, Belfast, Antrim, North Ireland; [Giotis, Efstathios S.; Scott, Alistair] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Giotis, Efstathios S.; Talbot, Richard; Burt, David W.; Glass, Elizabeth J.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Giotis, Efstathios S.; Talbot, Richard; Burt, David W.; Glass, Elizabeth J.] Univ Edinburgh, R D SVS, Edinburgh, Midlothian, Scotland; [Rothwell, Lisa; Hu, Tuanjun; Kaiser, Pete] Inst Anim Hlth, Compton, CA USA	Agri-Food & Biosciences Institute; Queens University Belfast; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Giotis, ES (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England.	e.giotis@imperial.ac.uk	Giotis, Efstathios S/AAI-9779-2021; Burt, David W/C-7802-2013; Glass, Elizabeth J/L-4612-2016; Giotis, Efstathios S/C-4976-2011	Giotis, Efstathios S/0000-0001-8908-7824; Burt, David W/0000-0002-9991-1028; Glass, Elizabeth J/0000-0002-6183-0185; Giotis, Efstathios S/0000-0002-5991-3678	Biotechnology and Biological Sciences Research Council [BBS/B/00182, BBS/B/00360, BBS/B/0028X]; Biotechnology and Biological Sciences Research Council (Institute Strategic Programme Grants); European Animal Disease Genomics Network of Excellence for Animal Health and Food Safety (EU) [FOOD-CT-2004-506416]; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, G20297, G18647, BBS/E/D/20320000, BB/D013704/1] Funding Source: researchfish; BBSRC [BBS/E/D/20241864, BBS/E/D/20320000, BB/D013704/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (Institute Strategic Programme Grants); European Animal Disease Genomics Network of Excellence for Animal Health and Food Safety (EU); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was undertaken with the financial support of the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) (grant numbers BBS/B/00182, BBS/B/00360 and BBS/B/0028X and Institute Strategic Programme Grants to IAH and The Roslin Institute) and the European Animal Disease Genomics Network of Excellence for Animal Health and Food Safety (http://www.eadgene.info) (EU Contract No. FOOD-CT-2004-506416).	Adair BM, 2000, DEV COMP IMMUNOL, V24, P247, DOI 10.1016/S0145-305X(99)00076-2; Antonsson B, 2000, EXP CELL RES, V256, P50, DOI 10.1006/excr.2000.4839; Avota E, 2004, J VIROL, V78, P9552, DOI 10.1128/JVI.78.17.9552-9559.2004; Baird D, 2004, BIOINFORMATICS, V20, P3196, DOI 10.1093/bioinformatics/bth384; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Bullenkamp J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.34; Burek M, 2006, ONCOGENE, V25, P2213, DOI 10.1038/sj.onc.1209258; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Crampton SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007841; Crowley TM, 2011, VIRAL IMMUNOL, V24, P3, DOI 10.1089/vim.2010.0064; DanenVanOorschot AAAM, 1997, P NATL ACAD SCI USA, V94, P5843; Daniel PT, 2003, ESSAYS BIOCHEM, V39, P73, DOI 10.1042/bse0390073; Degen WGJ, 2005, VET MICROBIOL, V105, P163, DOI 10.1016/j.vetmic.2004.12.001; Dragone LL, 2009, IMMUNOL REV, V232, P218, DOI 10.1111/j.1600-065X.2009.00827.x; Dragone LL, 2006, J IMMUNOL, V176, P335, DOI 10.4049/jimmunol.176.1.335; Eldaghayes I, 2006, VIRAL IMMUNOL, V19, P83, DOI 10.1089/vim.2006.19.83; Fukumoto R, 2007, J VIROL, V81, P9088, DOI 10.1128/JVI.02703-06; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Heidari M, 2010, VIRAL IMMUNOL, V23, P309, DOI 10.1089/vim.2009.0079; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HOOP RK, 1992, AVIAN PATHOL, V21, P493, DOI 10.1080/03079459208418867; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; JEURISSEN SHM, 1992, J VIROL, V66, P7383, DOI 10.1128/JVI.66.12.7383-7388.1992; Kaffashi A, 2008, AVIAN PATHOL, V37, P109, DOI 10.1080/03079450701812965; Kaiser P, J VIROLOGY, V77, P762; Kalland ME, 2011, J IMMUNOL, V187, P5233, DOI 10.4049/jimmunol.1101804; Karaca G, 2004, VIROLOGY, V318, P102, DOI 10.1016/j.virol.2003.09.025; McKenna GE, 2003, AVIAN DIS, V47, P1339, DOI 10.1637/7005; MCNULTY MS, 1989, AVIAN DIS, V33, P691, DOI 10.2307/1591146; MCNULTY MS, 1988, AVIAN PATHOL, V17, P315, DOI 10.1080/03079458808436450; MCNULTY MS, 1991, AVIAN PATHOL, V20, P187, DOI 10.1080/03079459108418756; MCNULTY MS, 1991, AVIAN DIS, V35, P263, DOI 10.2307/1591175; Miller MM, 2004, AVIAN DIS, V48, P734, DOI 10.1637/7271-090304R; Munir S, 2003, J VIROL, V77, P4899, DOI 10.1128/JVI.77.8.4899-4910.2003; Myers MD, 2005, J CELL BIOL, V170, P285, DOI 10.1083/jcb.200501164; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; NOTEBORN MHM, 1995, AVIAN PATHOL, V24, P11, DOI 10.1080/03079459508419046; NOTEBORN MHM, 1994, J VIROL, V68, P346, DOI 10.1128/JVI.68.1.346-351.1994; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Peters MA, 2003, IMMUNOLOGY, V110, P358, DOI 10.1046/j.1365-2567.2003.01744.x; Powell FL, 2009, PARASITE IMMUNOL, V31, P312, DOI 10.1111/j.1365-3024.2009.01113.x; Prasetyo AA, 2009, VIROLOGY, V385, P85, DOI 10.1016/j.virol.2008.10.043; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Reemers SS, 2009, VET IMMUNOL IMMUNOP, V132, P91, DOI 10.1016/j.vetimm.2009.04.021; Rimondi A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0102-y; Rohn JL, 2002, J BIOL CHEM, V277, P50820, DOI 10.1074/jbc.M208557200; Rothwell L, 2012, DEV COMP IMMUNOL, V36, P475, DOI 10.1016/j.dci.2011.08.013; Rue CA, 2011, J GEN VIROL, V92, P931, DOI 10.1099/vir.0.025486-0; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; Smith J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-49; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH JA, 1993, AVIAN DIS, V37, P324, DOI 10.2307/1591656; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Tan JM, 2005, J GEN VIROL, V86, P1327, DOI 10.1099/vir.0.80599-0; Todd D, 2004, VET MICROBIOL, V98, P169, DOI 10.1016/j.vetmic.2003.10.010; TODD D, 1995, AVIAN PATHOL, V24, P171, DOI 10.1080/03079459508419057; TODD D, 1992, J CLIN MICROBIOL, V30, P1661, DOI 10.1128/JCM.30.7.1661-1666.1992; Todd D, 2008, POULTRY DIS, P398; Viertlboeck B, 2008, AVIAN IMMUNOLOGY, P91, DOI 10.1016/B978-012370634-8.50008-1; Villiers E-M, 2009, CURR TOP MICROBIOL, V331, P151; Vucic D, 2009, J EXP MED, V206, P2309, DOI 10.1084/jem.20092160	63	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134866	10.1371/journal.pone.0134866	http://dx.doi.org/10.1371/journal.pone.0134866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244502	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000359061400116
J	Krawczyk, KK; Mattisson, IY; Ekman, M; Oskolkov, N; Grantinge, R; Kotowska, D; Olde, B; Hansson, O; Albinsson, S; Miano, JM; Rippe, C; Sward, K				Krawczyk, Katarzyna K.; Mattisson, Ingrid Yao; Ekman, Mari; Oskolkov, Nikolay; Grantinge, Rebecka; Kotowska, Dorota; Olde, Bjorn; Hansson, Ola; Albinsson, Sebastian; Miano, Joseph M.; Rippe, Catarina; Sward, Karl			Myocardin Family Members Drive Formation of Caveolae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; CELL-DIFFERENTIATION; REGULATES CAVEOLIN-1; GENE-TRANSCRIPTION; UP-REGULATION; EXPRESSION; SERUM; CAVIN; ACTIVATION	Caveolae are membrane organelles that play roles in glucose and lipid metabolism and in vascular function. Formation of caveolae requires caveolins and cavins. The make-up of caveolae and their density is considered to reflect cell-specific transcriptional control mechanisms for caveolins and cavins, but knowledge regarding regulation of caveolae genes is incomplete. Myocardin (MYOCD) and its relative MRTF-A (MKL1) are transcriptional co-activators that control genes which promote smooth muscle differentiation. MRTF-A communicates changes in actin polymerization to nuclear gene transcription. Here we tested if myocardin family proteins control biogenesis of caveolae via activation of caveolin and cavin transcription. Using human coronary artery smooth muscle cells we found that jasplakinolide and latrunculin B (LatB), substances that promote and inhibit actin polymerization, increased and decreased protein levels of caveolins and cavins, respectively. The effect of LatB was associated with reduced mRNA levels for these genes and this was replicated by the MRTF inhibitor CCG-1423 which was non-additive with LatB. Overexpression of myocardin and MRTF-A caused 5-10-fold induction of caveolins whereas cavin-1 and cavin-2 were induced 2-3-fold. PACSIN2 also increased, establishing positive regulation of caveolae genes from three families. Full regulation of CAV1 was retained in its proximal promoter. Knock down of the serum response factor (SRF), which mediates many of the effects of myocardin, decreased cavin-1 but increased caveolin-1 and -2 mRNAs. Viral transduction of myocardin increased the density of caveolae 5-fold in vitro. A decrease of CAV1 was observed concomitant with a decrease of the smooth muscle marker calponin in aortic aneurysms from mice (C57Bl/6) infused with angiotensin II. Human expression data disclosed correlations of MYOCD with CAV1 in a majority of human tissues and in the heart, correlation with MKL2 (MRTF-B) was observed. The myocardin family of transcriptional coactivators therefore drives formation of caveolae and this effect is largely independent of SRF.	[Krawczyk, Katarzyna K.; Mattisson, Ingrid Yao; Ekman, Mari; Grantinge, Rebecka; Kotowska, Dorota; Albinsson, Sebastian; Rippe, Catarina; Sward, Karl] Lund Univ, Dept Expt Med Sci, BMC D12, Lund, Sweden; [Oskolkov, Nikolay; Olde, Bjorn; Hansson, Ola] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Miano, Joseph M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	Lund University; Lund University; University of Rochester	Rippe, C (corresponding author), Lund Univ, Dept Expt Med Sci, BMC D12, Lund, Sweden.	catarina.rippe@med.lu.se	Oskolkov, Nikolay/AAH-2349-2019; Hansson, Ola/F-1793-2011; Miano, Joseph/L-5634-2018; Albinsson, Sebastian/B-4105-2010	Hansson, Ola/0000-0002-7394-7639; Yao Mattisson, Ingrid/0000-0002-5954-5334; Sward, Karl/0000-0002-7255-5510; Miano, Joseph/0000-0001-7522-3207; Albinsson, Sebastian/0000-0001-6936-3967	Swedish Research Council (Vetenskapsradet) [K2015-65X-22662-01-3, K2013-99X-22245-01-5]; European Union Marie Curie Initial Training Network SMARTER; National Institutes of Health [HL-117907]; Crafoord Foundation; Heart and Lung foundation (Hjart-lungfonden) [20130451, 20120382, 20120298]; Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117907] Funding Source: NIH RePORTER	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); European Union Marie Curie Initial Training Network SMARTER; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crafoord Foundation; Heart and Lung foundation (Hjart-lungfonden); Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The current work was funded by The Swedish Research Council (Vetenskapsradet, http://www.vr.se/), K2015-65X-22662-01-3 (KS) and K2013-99X-22245-01-5 (SA); European Union Marie Curie Initial Training Network SMARTER (http://www.smallartery.eu/) (KKK); National Institutes of Health (http://www.nih.gov/), HL-117907 (JMM); Crafoord Foundation (http://en.crafoord.se/) (CR and ME); Heart and Lung foundation (Hjart-lungfonden, http://www.hjart-lungfonden.se/) 20130451, 20120382, 20120298 (SA); and the Royal Physiographic Society (Kungliga Fysiografiska Sallskapet, http://www.fysiografen.se/) (SA, CR, ME).	Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Benson CC, 2011, PHYSIOL GENOMICS, V43, P1038, DOI 10.1152/physiolgenomics.00098.2011; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Boopathi E, 2011, AM J PATHOL, V178, P2236, DOI 10.1016/j.ajpath.2011.01.038; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; GABELLA G, 1971, J CELL SCI, V8, P601; Grossi M, 2014, BIOSCIENCE REP, V34, P729, DOI 10.1042/BSR20140140; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hernandez VJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00905; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Huang JH, 2012, J CLIN INVEST, V122, P3678, DOI 10.1172/JCI63635; ISHIKAWA H, 1968, J CELL BIOL, V38, P51, DOI 10.1083/jcb.38.1.51; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Kovtun O, 2014, DEV CELL, V31, P405, DOI 10.1016/j.devcel.2014.10.002; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Meadows SM, 2008, P NATL ACAD SCI USA, V105, P1545, DOI 10.1073/pnas.0703918105; Meng FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126056; Miano JM, 2015, J BIOMED RES, V29, P3, DOI 10.7555/JBR.29.20140151; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Oh JY, 2005, P NATL ACAD SCI USA, V102, P15122, DOI 10.1073/pnas.0507346102; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; R Core Team, 2013, R LANGUAGE ENV STAT; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P38121; Regazzetti C, 2015, ENDOCRINOLOGY, V156, P789, DOI 10.1210/en.2014-1656; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez-Feo JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002612; Roy UKB, 2008, MOL CARCINOGEN, V47, P947, DOI 10.1002/mc.20451; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Senda T, 1997, EXP CELL RES, V230, P163, DOI 10.1006/excr.1996.3414; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Swad K, 2013, PHYSIOL REP, V1, DOI [10.1002/PHY2.8, 10.1002/phy2.8]; Sward K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092428; Thyberg J, 1997, LAB INVEST, V77, P93; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Weinl C, 2013, J CLIN INVEST, V123, P2193, DOI 10.1172/JCI64201; Whitmarsh AJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01428; Xie L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-301; YAMADA E, 1955, J HISTOCHEM CYTOCHEM, V3, P309, DOI 10.1177/3.4.309; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200	65	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133931	10.1371/journal.pone.0133931	http://dx.doi.org/10.1371/journal.pone.0133931			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244347	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400059
J	Witte, M; Ninaus, M; Kober, SE; Neuper, C; Wood, G				Witte, Matthias; Ninaus, Manuel; Kober, Silvia Erika; Neuper, Christa; Wood, Guilherme			Neuronal Correlates of Cognitive Control during Gaming Revealed by Near-Infrared Spectroscopy	PLOS ONE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; BRAIN NETWORKS; MOTOR IMAGERY; VIDEO GAMES; ACTIVATION; NIRS; HEMODYNAMICS; ATTENTION; SELECTION	In everyday life we quickly build and maintain associations between stimuli and behavioral responses. This is governed by rules of varying complexity and past studies have identified an underlying fronto-parietal network involved in cognitive control processes. However, there is only limited knowledge about the neuronal activations during more natural settings like game playing. We thus assessed whether near-infrared spectroscopy recordings can reflect different demands on cognitive control during a simple game playing task. Sixteen healthy participants had to catch falling objects by pressing computer keys. These objects either fell randomly (RANDOM task), according to a known stimulus-response mapping applied by players (APPLY task) or according to a stimulus-response mapping that had to be learned (LEARN task). We found an increased change of oxygenated and deoxygenated hemoglobin during LEARN covering broad areas over right frontal, central and parietal cortex. Opposed to this, hemoglobin changes were less pronounced for RANDOM and APPLY. Along with the findings that fewer objects were caught during LEARN but stimulus-response mappings were successfully identified, we attribute the higher activations to an increased cognitive load when extracting an unknown mapping. This study therefore demonstrates a neuronal marker of cognitive control during gaming revealed by near-infrared spectroscopy recordings.	[Witte, Matthias; Ninaus, Manuel; Kober, Silvia Erika; Neuper, Christa; Wood, Guilherme] Graz Univ, Dept Psychol, A-8010 Graz, Austria; [Witte, Matthias; Neuper, Christa; Wood, Guilherme] BioTechMed Graz, Graz, Austria; [Neuper, Christa] Graz Univ Technol, Inst Knowledge Discovery, Lab Brain Comp Interfaces, A-8010 Graz, Austria	University of Graz; Graz University of Technology	Witte, M (corresponding author), Graz Univ, Dept Psychol, Univ Pl 2, A-8010 Graz, Austria.	matthias.witte@uni-graz.at	Ninaus, Manuel/AAC-6951-2020	Ninaus, Manuel/0000-0002-4664-8430; Maia de Oliveira Wood, Guilherme/0000-0001-5055-5336	Games and Learning Alliance (GaLA) - Network of Excellence for Serious Games under European Community Seventh Framework Programme (FP7) [258169]	Games and Learning Alliance (GaLA) - Network of Excellence for Serious Games under European Community Seventh Framework Programme (FP7)	This work was supported by Games and Learning Alliance (GaLA) - Network of Excellence for Serious Games (http://www.galanoe.eu/) under the European Community Seventh Framework Programme (FP7/2007 2013, Grant Agreement no. 258169). Possible inaccuracies of information are under the responsibility of the project team. The text reflects solely the views of its authors. The European Commission is not liable for any use that may be made of information contained therein.	Anderson BA, 2014, PSYCHOL SCI, V25, P547, DOI 10.1177/0956797613511086; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Balaguer RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001175; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Cai XL, 2011, BRAIN RES, V1408, P17, DOI 10.1016/j.brainres.2011.06.056; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chen AT, 2007, BIOL PSYCHOL, V76, P230, DOI 10.1016/j.biopsycho.2007.08.007; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crescentini C, 2011, J NEUROSCI, V31, P7763, DOI 10.1523/JNEUROSCI.4579-10.2011; de Leeuw J, 2009, J STAT SOFTW, V31, P1; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Edelman S, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00045; Ehlis AC, 2008, J PSYCHIATR RES, V42, P1060, DOI 10.1016/j.jpsychires.2007.11.011; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Fuster J, 2005, NEUROIMAGE, V26, P215, DOI 10.1016/j.neuroimage.2005.01.055; Han DH, 2012, J PSYCHIATR RES, V46, P507, DOI 10.1016/j.jpsychires.2012.01.004; Hatakenaka M, 2007, NEUROIMAGE, V34, P109, DOI 10.1016/j.neuroimage.2006.08.014; Heaton R.K., 1993, WISCONSIN CARD SORTI; Herve PY, 2012, NEUROIMAGE, V61, P1255, DOI 10.1016/j.neuroimage.2012.03.073; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kober SE, 2014, NEUROIMAGE, V93, P1, DOI 10.1016/j.neuroimage.2014.02.019; Kober SE, 2014, BIOL PSYCHOL, V95, P21, DOI 10.1016/j.biopsycho.2013.05.005; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Li FH, 2012, PSYCHOPHYSIOLOGY, V49, P1266, DOI 10.1111/j.1469-8986.2012.01403.x; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Lohmann G, 2002, IEEE T MED IMAGING, V21, P485, DOI 10.1109/TMI.2002.1009384; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Matsuda G, PREFRONTAL CORTEX DE, P101; Matsui M, 2007, PSYCHIAT CLIN NEUROS, V61, P31, DOI 10.1111/j.1440-1819.2007.01607.x; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI 10.1109/MSP.2008.4408445; McKendrick R, 2014, NEUROIMAGE, V85, P1014, DOI 10.1016/j.neuroimage.2013.05.103; Nagamitsu S, 2006, BRAIN DEV-JPN, V28, P315, DOI 10.1016/j.braindev.2005.11.008; Ninaus M, 2014, 2014 6TH INTERNATION, P1; Nunez-Pena MI, 2004, COGNITIVE BRAIN RES, V18, P130, DOI 10.1016/j.cogbrainres.2003.09.010; Oei AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058546; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Reverberi C, 2005, NEUROPSYCHOLOGIA, V43, P460, DOI 10.1016/j.neuropsychologia.2004.06.008; Rips LJ., 1999, THE MIT ENCYCLOPEDIA, P225; Sato T, 2007, NEUROSCI RES, V58, P297, DOI 10.1016/j.neures.2007.03.014; Seger CA, 2006, CEREB CORTEX, V16, P1546, DOI 10.1093/cercor/bhj092; Shallice T., 1997, THE HAYLING AND BRIX; Shinkareva SV, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/796183; Sitaram R, 2009, NEURAL NETWORKS, V22, P1320, DOI 10.1016/j.neunet.2009.05.009; Soul JS, 2000, PEDIATR RES, V48, P445, DOI 10.1203/00006450-200010000-00005; Specht K, 2009, HUM BRAIN MAPP, V30, P1734, DOI 10.1002/hbm.20637; Sun YJ, 2012, BEHAV BRAIN RES, V233, P563, DOI 10.1016/j.bbr.2012.05.005; Toronov V, 2001, MED PHYS, V28, P521, DOI 10.1118/1.1354627; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740	58	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134816	10.1371/journal.pone.0134816	http://dx.doi.org/10.1371/journal.pone.0134816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244781	Green Published, gold			2022-12-26	WOS:000359061400105
J	Borrill, P; Fahy, B; Smith, AM; Uauy, C				Borrill, Philippa; Fahy, Brendan; Smith, Alison M.; Uauy, Cristobal			Wheat Grain Filling Is Limited by Grain Filling Capacity rather than the Duration of Flag Leaf Photosynthesis: A Case Study Using NAM RNAi Plants	PLOS ONE			English	Article							STARCH SYNTHESIS; SPRING WHEAT; STAY-GREEN; YIELD; SENESCENCE; PROTEIN; BARLEY; IDENTIFICATION; TEMPERATURE; EXPRESSION	It has been proposed that delayed leaf senescence can extend grain filling duration and thus increase yields in cereal crops. We found that wheat (Triticum aestivum) NAM RNAi plants with delayed senescence carried out 40% more flag leaf photosynthesis after anthesis than control plants, but had the same rate and duration of starch accumulation during grain filling and the same final grain weight. The additional photosynthate available in NAM RNAi plants was in part stored as fructans in the stems, whereas stem fructans were remobilised during grain filling in control plants. In both genotypes, activity of starch synthase was limiting for starch synthesis in the later stages of grain filling. We suggest that in order to realise the potential yield gains offered by delayed leaf senescence, this trait should be combined with increased grain filling capacity.	[Borrill, Philippa; Fahy, Brendan; Smith, Alison M.; Uauy, Cristobal] John Innes Ctr, Norwich, Norfolk, England; [Uauy, Cristobal] Natl Inst Agr Bot, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Uauy, C (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England.	cristobal.uauy@jic.ac.uk	Uauy, Cristobal/T-4382-2019	Uauy, Cristobal/0000-0002-9814-1770; Borrill, Philippa/0000-0002-7623-8256	Biotechnology and Biological Sciences Research Council [BB/K006517/1, BB/J004588/1, BB/J004561/1]; HarvestPlus Challenge Program [6242]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BB/M014045/1, BBS/E/J/000C0628, BBS/E/J/000CA530] Funding Source: researchfish; BBSRC [BB/K006517/1, BBS/E/J/000C0628, BB/M014045/1, BBS/E/J/000CA530] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HarvestPlus Challenge Program; John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) (BB/K006517/1, BB/J004588/1, and BB/J004561/1, to BF, AS, and CU), grant 6242 from the HarvestPlus Challenge Program (CU), and a studentship grant from the John Innes Foundation (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZCONBIETO J, 1983, PLANT PHYSIOL, V73, P681, DOI 10.1104/pp.73.3.681; Beed FD, 2007, J AGR SCI, V145, P63, DOI 10.1017/S0021859606006678; Birecka H., 1963, ACTA SOC BOT POL, V32, P631; Bogard M, 2011, J EXP BOT, V62, P3621, DOI 10.1093/jxb/err061; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borrell AK, 2000, CROP SCI, V40, P1037, DOI 10.2135/cropsci2000.4041037x; BUTTROSE MS, 1962, AUST J BIOL SCI, V15, P611, DOI 10.1071/BI9620611; Derkx AP, 2012, J INTEGR PLANT BIOL, V54, P555, DOI 10.1111/j.1744-7909.2012.01144.x; Driever SM, 2014, J EXP BOT, V65, P4959, DOI 10.1093/jxb/eru253; EVANS LT, 1970, AUST J BIOL SCI, V23, P245, DOI 10.1071/BI9700245; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; Gaju O, 2014, FIELD CROP RES, V155, P213, DOI 10.1016/j.fcr.2013.09.003; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Guttieri MJ, 2013, PLANT SOIL, V371, P573, DOI 10.1007/s11104-013-1713-1; HARGREAVES JA, 1988, PHYTOCHEMISTRY, V27, P1627, DOI 10.1016/0031-9422(88)80416-3; HAWKER JS, 1993, AUST J PLANT PHYSIOL, V20, P197, DOI 10.1071/PP9930197; Hawkesford MJ, 2013, FOOD ENERGY SECUR, V2, P34, DOI 10.1002/fes3.15; Hurkman WJ, 2003, PLANT SCI, V164, P873, DOI 10.1016/S0168-9452(03)00076-1; JENNER CF, 1994, AUST J PLANT PHYSIOL, V21, P17, DOI 10.1071/PP9940017; KEELING PL, 1993, PLANTA, V191, P342, DOI 10.1007/BF00195691; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING RW, 1967, PLANTA, V77, P261, DOI 10.1007/BF00385296; KRIEDEMANN P, 1966, ANN BOT-LONDON, V30, P349, DOI 10.1093/oxfordjournals.aob.a084081; KUHBAUCH W, 1989, J PLANT PHYSIOL, V134, P243, DOI 10.1016/S0176-1617(89)80063-X; Li ZY, 1999, PLANT PHYSIOL, V120, P1147, DOI 10.1104/pp.120.4.1147; Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613; Lopes MS, 2012, J EXP BOT, V63, P3789, DOI 10.1093/jxb/ers071; Maydup ML, 2010, FIELD CROP RES, V119, P48, DOI 10.1016/j.fcr.2010.06.014; Parrott DL, 2012, J EXP BOT, V63, P1329, DOI 10.1093/jxb/err360; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Rosti S, 2006, J EXP BOT, V57, P3619, DOI 10.1093/jxb/erl110; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; Sandana PA, 2009, FIELD CROP RES, V114, P233, DOI 10.1016/j.fcr.2009.08.003; SCHNYDER H, 1993, NEW PHYTOL, V123, P233, DOI 10.1111/j.1469-8137.1993.tb03731.x; Serrago RA, 2013, FIELD CROP RES, V150, P42, DOI 10.1016/j.fcr.2013.05.016; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; SLAFER GA, 1994, FIELD CROP RES, V37, P39, DOI 10.1016/0378-4290(94)90080-9; Stamova Boryana S, 2009, Int J Plant Genomics, V2009, P407426, DOI 10.1155/2009/407426; STAMP P, 1976, Z PFLANZENZUCHT, V77, P330; STOY V, 1963, PHYSIOL PLANTARUM, V16, P851, DOI 10.1111/j.1399-3054.1963.tb08363.x; Thomas H, 2014, J EXP BOT, V65, P3889, DOI 10.1093/jxb/eru037; Tomlinson K, 2003, ADV BOT RES, V40, P1, DOI 10.1016/S0065-2296(05)40001-4; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; Wang ZL, 1998, PHOTOSYNTHETICA, V35, P453, DOI 10.1023/A:1006976605148; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; Weichert N, 2010, PLANT PHYSIOL, V152, P698, DOI 10.1104/pp.109.150854; Yang JC, 2004, PLANT PHYSIOL, V135, P1621, DOI 10.1104/pp.104.041038; Zhang CH, 2010, J CEREAL SCI, V51, P226, DOI 10.1016/j.jcs.2009.12.002	50	44	45	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134947	10.1371/journal.pone.0134947	http://dx.doi.org/10.1371/journal.pone.0134947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241955	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942700085
J	Thien, TDV; Zadra, A; Labelle, MA; Petit, D; Soucy, JP; Montplaisir, J				Thien Thanh Dang-Vu; Zadra, Antonio; Labelle, Marc-Antoine; Petit, Dominique; Soucy, Jean-Paul; Montplaisir, Jacques			Sleep Deprivation Reveals Altered Brain Perfusion Patterns in Somnambulism	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; CEREBRAL-CORTEX; SLEEPWALKING; TERRORS; PET	Background Despite its high prevalence, relatively little is known about the pathophysiology of somnambulism. Increasing evidence indicates that somnambulism is associated with functional abnormalities during wakefulness and that sleep deprivation constitutes an important drive that facilitates sleepwalking in predisposed patients. Here, we studied the neural mechanisms associated with somnambulism using Single Photon Emission Computed Tomography (SPECT) with Tc-99m-Ethylene Cysteinate Dimer (ECD), during wakefulness and after sleep deprivation. Methods Ten adult sleepwalkers and twelve controls with normal sleep were scanned using Tc-99m-ECD SPECT in morning wakefulness after a full night of sleep. Eight of the sleepwalkers and nine of the controls were also scanned during wakefulness after a night of total sleep deprivation. Between-group comparisons of regional cerebral blood flow (rCBF) were performed to characterize brain activity patterns during wakefulness in sleepwalkers. Results During wakefulness following a night of total sleep deprivation, rCBF was decreased bilaterally in the inferior temporal gyrus in sleepwalkers compared to controls. Conclusions Functional neural abnormalities can be observed during wakefulness in somnambulism, particularly after sleep deprivation and in the inferior temporal cortex. Sleep deprivation thus not only facilitates the occurrence of sleepwalking episodes, but also uncovers patterns of neural dysfunction that characterize sleepwalkers during wakefulness.	[Thien Thanh Dang-Vu; Zadra, Antonio; Petit, Dominique; Montplaisir, Jacques] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Thien Thanh Dang-Vu] Concordia Univ, Ctr Studies Behav Neurobiol, PERFORM Ctr, Montreal, PQ H3G 1M8, Canada; [Thien Thanh Dang-Vu] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Thien Thanh Dang-Vu] Univ Montreal, Ctr Rech, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Thien Thanh Dang-Vu] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Zadra, Antonio; Labelle, Marc-Antoine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Soucy, Jean-Paul] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Soucy, Jean-Paul] Ctr Hosp Univ Montreal, Dept Nucl Med, Montreal, PQ, Canada; [Montplaisir, Jacques] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Montplaisir, Jacques] Univ Montreal, Canada Res Chair Sleep Med, Montreal, PQ, Canada	Universite de Montreal; Concordia University - Canada; Concordia University - Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Zadra, A (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	antonio.zadra@umontreal.ca; jy.montplaisir@umontreal.ca		Dang Vu, Thien Thanh/0000-0002-7235-2721	Canadian Institutes of Health Research (CIHR) [MOP 97865]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR grant # MOP 97865). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AASM, 2005, INT CLASS SLEEP DIS; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Bell-McGinty S, 2004, CEREB CORTEX, V14, P496, DOI 10.1093/cercor/bhh011; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BROUGHTON R, 1994, SLEEP, V17, P253; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Dang-Vu TT, 2007, SLEEP MED, V8, P349, DOI 10.1016/j.sleep.2007.03.006; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Desautels A, 2013, SLEEP MED, V14, P1187, DOI 10.1016/j.sleep.2013.04.029; Espa F, 2000, CLIN NEUROPHYSIOL, V111, P929, DOI 10.1016/S1388-2457(00)00249-2; Jaar O, 2010, SLEEP, V33, P1511, DOI 10.1093/sleep/33.11.1511; Joo EY, 2005, NEUROIMAGE, V28, P410, DOI 10.1016/j.neuroimage.2005.06.019; KAVEY NB, 1993, PSYCHOSOMATICS, V34, P86, DOI 10.1016/S0033-3182(93)71932-5; Labelle MA, 2015, J SLEEP RES IN PRESS; Mazza S, 2006, NEUROLOGY, V67, P1618, DOI 10.1212/01.wnl.0000242879.39415.49; Montplaisir J, 2011, J CLIN SLEEP MED, V7, P219; Ohayon MM, 1999, J CLIN PSYCHIAT, V60, P268, DOI 10.4088/JCP.v60n0413; Oliviero A, 2007, J NEUROL, V254, P1066, DOI 10.1007/s00415-006-0489-0; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Zadra A, 2004, J SLEEP RES, V13, P279, DOI 10.1111/j.1365-2869.2004.00404.x; Zadra A, 2008, ANN NEUROL, V63, P513, DOI 10.1002/ana.21339; Zadra A, 2013, LANCET NEUROL, V12, P285, DOI 10.1016/S1474-4422(12)70322-8	22	15	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133474	10.1371/journal.pone.0133474	http://dx.doi.org/10.1371/journal.pone.0133474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241047	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700014
J	Chakraborty, A; Wakamiya, M; Venkova-Canova, T; Pandita, RK; Aguilera-Aguirre, L; Sarker, AH; Singh, DK; Hosoki, K; Wood, TG; Sharma, G; Cardenas, V; Sarkar, PS; Sur, S; Pandita, TK; Boldogh, I; Hazra, TK				Chakraborty, Anirban; Wakamiya, Maki; Venkova-Canova, Tatiana; Pandita, Raj K.; Aguilera-Aguirre, Leopoldo; Sarker, Altaf H.; Singh, Dharniendra Kumar; Hosoki, Koa; Wood, Thomas G.; Sharma, Gulshan; Cardenas, Victor; Sarkar, Partha S.; Sur, Sanjiv; Pandita, Tej K.; Boldogh, Istvan; Hazra, Tapas K.			Neil2-null Mice Accumulate Oxidized DNA Bases in the Transcriptionally Active Sequences of the Genome and Are Susceptible to Innate Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; GLYCOSYLASE NEIL1; ENDONUCLEASE-III; MAMMALIAN-CELLS; GENE-EXPRESSION; EXCISION-REPAIR; COUPLED REPAIR; MOUSE; IDENTIFICATION; 8-OXOGUANINE	Why mammalian cells possess multiple DNA glycosylases (DGs) with overlapping substrate ranges for repairing oxidatively damaged bases via the base excision repair (BER) pathway is a long-standing question. To determine the biological role of these DGs, null animal models have been generated. Here, we report the generation and characterization of mice lacking Neil2 (Nei-like 2). As in mice deficient in each of the other four oxidized base-specific DGs (OGG1, NTH1, NEIL1, and NEIL3), Neil2-null mice show no overt phenotype. However, middle-aged to old Neil2-null mice show the accumulation of oxidative genomic damage, mostly in the transcribed regions. Immunopulldown analysis from wild-type (WT) mouse tissue showed the association of NEIL2 with RNA polymerase II, along with Cockayne syndrome group B protein, TFIIH, and other BER proteins. Chromatin immunoprecipitation analysis from mouse tissue showed co-occupancy of NEIL2 and RNA polymerase II only on the transcribed genes, consistent with our earlier in vitro findings on NEIL2's role in transcription-coupled BER. This study provides the first in vivo evidence of genomic region-specific repair in mammals. Furthermore, telomere loss and genomic instability were observed at a higher frequency in embryonic fibroblasts from Neil2-null mice than from the WT. Moreover, Neil2-null mice are much more responsive to inflammatory agents than WT mice. Taken together, our results underscore the importance of NEIL2 in protecting mammals from the development of various pathologies that are linked to genomic instability and/or inflammation. NEIL2 is thus likely to play an important role in long term genomic maintenance, particularly in long- lived mammals such as humans.	[Chakraborty, Anirban; Venkova-Canova, Tatiana; Hosoki, Koa; Sharma, Gulshan; Cardenas, Victor; Sur, Sanjiv; Hazra, Tapas K.] Univ Texas Med Branch, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Wakamiya, Maki; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci, Galveston, TX 77555 USA; [Wakamiya, Maki; Sarkar, Partha S.] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX 77555 USA; [Aguilera-Aguirre, Leopoldo; Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Wood, Thomas G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wakamiya, Maki] Univ Texas Med Branch, Transgen Mouse Core Facil, Galveston, TX 77555 USA; [Pandita, Raj K.; Singh, Dharniendra Kumar; Pandita, Tej K.] Houston Methodist Res Inst, Dept Radiat Oncol, Houston, TX 77030 USA; [Sarker, Altaf H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; The Methodist Hospital System; The Methodist Hospital - Houston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	Pandita, Tej K/AAM-9188-2020; CHAKRABORTY, ANIRBAN/ABC-6552-2020; Sharma, Gulshan/AAC-5804-2019; Wood, Thomas/GWZ-2481-2022; Aguilera-Aguirre, Leopoldo/B-9864-2012	Wood, Thomas/0000-0001-8962-8571; Aguilera-Aguirre, Leopoldo/0000-0001-7964-7402; Hosoki, Koa/0000-0003-4228-2176	National Institutes of Health from USPHS [NS073976];  [RO1 CA129537];  [RO1 CA154320];  [P30 ES 06676]; NATIONAL CANCER INSTITUTE [R01CA154320, R01CA129537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007254, P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073976] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073976 from USPHS (to T. K. H.), RO1 CA129537 and RO1 CA154320 (to T. K. P.), and Grant P30 ES 06676 (to NIEHS Center Cell Biology Core and Molecular Geno<INF>m</INF>ics Core of UTMB's NIEHS Center for DNA sequencing). The authors declare that they have no conflicts of interest with the contents of this article.	Aamann MD, 2014, MECH AGEING DEV, V135, P1, DOI 10.1016/j.mad.2013.12.008; Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Arai T, 2006, TOXICOLOGY, V221, P179, DOI 10.1016/j.tox.2006.01.004; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bacsi A, 2007, MECH AGEING DEV, V128, P637, DOI 10.1016/j.mad.2007.09.005; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Bah A, 2012, INT J BIOCHEM CELL B, V44, P1055, DOI 10.1016/j.biocel.2012.03.021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Chatterjee A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004749; Choudhary S, 2013, J BIOL CHEM, V288, P14612, DOI 10.1074/jbc.M113.464081; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Das A, 2005, J BIOL CHEM, V280, P35272, DOI 10.1074/jbc.M505526200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2013, P NATL ACAD SCI USA, V110, pE3090, DOI 10.1073/pnas.1304231110; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jamaluddin M, 2007, CELL SIGNAL, V19, P1419, DOI 10.1016/j.cellsig.2007.01.020; KASAI H, 1991, OXIDATIVE STRESS OXI, P99; Kawakami H, 1996, BIOCHEM BIOPH RES CO, V221, P199, DOI 10.1006/bbrc.1996.0569; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026; KUDRYCKI K, 1993, MOL CELL BIOL, V13, P3002, DOI 10.1128/MCB.13.5.3002; Lee Choogon, 2007, Methods Mol Biol, V362, P385; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li GP, 2012, FREE RADICAL BIO MED, V52, P392, DOI 10.1016/j.freeradbiomed.2011.10.490; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Mabley JG, 2004, FASEB J, V18, P290, DOI 10.1096/fj.04-2278fje; Maiti AK, 2008, DNA REPAIR, V7, P1213, DOI 10.1016/j.dnarep.2008.03.025; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Nijland R, 2014, MAR DRUGS, V12, P4260, DOI 10.3390/md12074260; Ocampo MTA, 2002, MOL CELL BIOL, V22, P6111, DOI 10.1128/MCB.22.17.6111-6121.2002; Osorio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004256; Pandita RK, 2015, CANCER RES, V75, P858, DOI 10.1158/0008-5472.CAN-14-2289; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Reis AMC, 2012, NUCLEIC ACIDS RES, V40, P206, DOI 10.1093/nar/gkr704; Sailaja BS, 2012, METHODS MOL BIOL, V809, P353, DOI 10.1007/978-1-61779-376-9_24; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Suganya R, 2015, DNA REPAIR, V27, P40, DOI 10.1016/j.dnarep.2015.01.003; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torisu K, 2005, J BIOCHEM, V138, P763, DOI 10.1093/jb/mvi168; Vallabhaneni H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003639; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zhai XD, 2008, CLIN CANCER RES, V14, P4345, DOI 10.1158/1078-0432.CCR-07-5282; Zhang JH, 1998, J BIOL CHEM, V273, P23454, DOI 10.1074/jbc.273.36.23454	80	57	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24636	24648		10.1074/jbc.M115.658146	http://dx.doi.org/10.1074/jbc.M115.658146			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26245904	hybrid, Green Published			2022-12-26	WOS:000362598300001
J	Mottershead, DG; Sugimura, S; Al-Musawi, SL; Li, JJ; Richani, D; White, MA; Martin, GA; Trotta, AP; Ritter, LJ; Shi, J; Mueller, TD; Harrison, CA; Gilchrist, RB				Mottershead, David G.; Sugimura, Satoshi; Al-Musawi, Sara L.; Li, Jing-Jie; Richani, Dulama; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Mueller, Thomas D.; Harrison, Craig A.; Gilchrist, Robert B.			Cumulin, an Oocyte-secreted Heterodimer of the Transforming Growth Factor-beta Family, Is a Potent Activator of Granulosa Cells and Improves Oocyte Quality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-15; DIFFERENTIATION FACTOR 9; IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; GROWTH-DIFFERENTIATION-FACTOR-9 COOPERATE; BINDING-SPECIFICITY; SUBSEQUENT EMBRYO; MOLECULAR-BASIS; SINGLE RESIDUE; OVULATION RATE	Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are oocyte-specific growth factors with central roles in mammalian reproduction, regulating species-specific fecundity, ovarian follicular somatic cell differentiation, and oocyte quality. In the human, GDF9 is produced in a latent form, the mechanism of activation being an open question. Here, we produced a range of recombinant GDF9 and BMP15 variants, examined their in silico and physical interactions and their effects on ovarian granulosa cells (GC) and oocytes. We found that the potent synergistic actions of GDF9 and BMP15 on GC can be attributed to the formation of a heterodimer, which we have termed cumulin. Structural modeling of cumulin revealed a dimerization interface identical to homodimeric GDF9 and BMP15, indicating likely formation of a stable complex. This was confirmed by generation of recombinant heterodimeric complexes of pro/mature domains (pro-cumulin) and covalent mature domains (cumulin). Both pro-cumulin and cumulin exhibited highly potent bioactivity on GC, activating both SMAD2/3 and SMAD1/5/8 signaling pathways and promoting proliferation and expression of a set of genes associated with oocyte-regulated GC differentiation. Cumulin was more potent than pro-cumulin, pro-GDF9, pro-BMP15, or the two combined on GC. However, on cumulus-oocyte complexes, pro-cumulin was more effective than all other growth factors at notably improving oocyte quality as assessed by subsequent day 7 embryo development. Our results support a model of activation for human GDF9 dependent on cumulin formation through heterodimerization with BMP15. Oocyte-secreted cumulin is likely to be a central regulator of fertility in mono-ovular mammals.	[Mottershead, David G.; Sugimura, Satoshi; Li, Jing-Jie; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Gilchrist, Robert B.] Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Mottershead, David G.; Sugimura, Satoshi; Li, Jing-Jie; White, Melissa A.; Martin, Georgia A.; Trotta, Andrew P.; Ritter, Lesley J.; Shi, Junyan; Gilchrist, Robert B.] Sch Paediat & Reprod Hlth, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Ritter, Lesley J.] Univ Adelaide, Australian Res Council, Ctr Excellence Nanoscale BioPhoton, Adelaide, SA 5005, Australia; [Mottershead, David G.] Mottasis Oy Ltd, Helsinki 00430, Finland; [Sugimura, Satoshi] Tokyo Univ Agr & Technol, Dept Biol Prod, Inst Agr, Tokyo 1830057, Japan; [Al-Musawi, Sara L.; Harrison, Craig A.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Li, Jing-Jie] Sun Yat Sen Univ, Ctr Reprod Med, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Richani, Dulama; Gilchrist, Robert B.] Univ New S Wales, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW 2052, Australia; [Mueller, Thomas D.] Univ Wurzburg, Dept Plant Physiol & Biophys, Julius Von Sachs Inst, D-97082 Wurzburg, Germany	Robinson Research Institute; University of Adelaide; Tokyo University of Agriculture & Technology; Hudson Institute of Medical Research; Sun Yat Sen University; University of New South Wales Sydney; University of Wurzburg	Gilchrist, RB (corresponding author), Univ New S Wales, Royal Hosp Women, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW, Australia.	r.gilchrist@unsw.edu.au	Ritter, Lesley/R-5608-2016; Richani, Dulama/H-5807-2019; Sugimura, Satoshi/B-9877-2015	Ritter, Lesley/0000-0001-5942-851X; Richani, Dulama/0000-0003-1886-0423; Sugimura, Satoshi/0000-0002-6473-5941; Mottershead, David G./0000-0003-2593-0725; Mueller, Thomas/0000-0003-1862-7357; Harrison, Craig/0000-0003-1059-3682; Gilchrist, Robert/0000-0003-1611-7142	National Health and Medical Research Council of Australia [627151, 1024358, 1062762, 1017484, 1076004, 1023210, 1013533]; Cook Medical; Sun Yat-sen University International Program Fund 985 Project; Japanese Society for Promotion of Science Postdoctoral Fellowship for Research Abroad; Grants-in-Aid for Scientific Research [15K18768] Funding Source: KAKEN	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cook Medical; Sun Yat-sen University International Program Fund 985 Project; Japanese Society for Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Health and Medical Research Council of Australia through Project Grants 627151, 1024358, and 1062762, Development Grants 1017484 and 1076004, and Fellowships 1023210 and 1013533. This work was also supported by research grants from Cook Medical, Sun Yat-sen University International Program Fund 985 Project (to J. J. L.) and from the Japanese Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (to S. S.). R. B. G. is listed as an inventor on Patent US20140073052A1 owned by the University of Adelaide. R. B. G. and D. G. M. are listed on a distribution of benefits agreement in connection with Patent US20140073052A1.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Crawford JL, 2012, MOL CELL ENDOCRINOL, V348, P339, DOI 10.1016/j.mce.2011.09.033; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dragovic RA, 2007, BIOL REPROD, V76, P848, DOI 10.1095/biolreprod.106.057471; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Gilchrist RB, 2011, REPRODUCTION, V142, P647, DOI 10.1530/REP-11-0196; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Harrison CA, 2011, GROWTH FACTORS, V29, P174, DOI 10.3109/08977194.2011.608666; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Kaivo-Oja N, 2005, J CLIN ENDOCR METAB, V90, P271, DOI 10.1210/jc.2004-1288; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Li JJ, 2015, MOL ENDOCRINOL, V29, P40, DOI 10.1210/me.2014-1173; Li QL, 2009, MOL HUM REPROD, V15, P779, DOI 10.1093/molehr/gap062; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Marchal R, 2002, THERIOGENOLOGY, V57, P1523, DOI 10.1016/S0093-691X(02)00655-6; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; McIntosh CJ, 2008, BIOL REPROD, V79, P889, DOI 10.1095/biolreprod.108.068163; McMahon HE, 2008, ENDOCRINOLOGY, V149, P812, DOI 10.1210/en.2007-1439; McNatty KP, 2005, REPRODUCTION, V129, P481, DOI 10.1530/rep.1.00517; McNatty KP, 2005, REPRODUCTION, V129, P473, DOI 10.1530/rep.1.0511; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; MCPHERRON AC, 1993, J BIOL CHEM, V268, P3444; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Mottershead DG, 2013, P NATL ACAD SCI USA, V110, pE2257, DOI 10.1073/pnas.1303459110; Mottershead DG, 2012, MOL HUM REPROD, V18, P121, DOI 10.1093/molehr/gar056; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Peng J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.123158; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Pulkki MM, 2012, ENDOCRINOLOGY, V153, P1509, DOI 10.1210/en.2010-1390; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Reader KL, 2016, REPROD FERT DEVELOP, V28, P491, DOI 10.1071/RD14099; Richani D, 2013, MOL HUM REPROD, V19, P500, DOI 10.1093/molehr/gat028; Ritter LJ, 2015, ENDOCRINOLOGY, V156, P2299, DOI 10.1210/en.2014-1884; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Sudiman J, 2014, J ASSIST REPROD GEN, V31, P295, DOI 10.1007/s10815-013-0152-5; Sudiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103563; Sugimura S, 2015, DEV BIOL, V403, P139, DOI 10.1016/j.ydbio.2015.05.008; Sugimura S, 2014, MOL HUM REPROD, V20, P499, DOI 10.1093/molehr/gau013; Sutton-McDowall ML, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102061; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Watson LN, 2012, ENDOCRINOLOGY, V153, P4544, DOI 10.1210/en.2012-1181; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140; Yoshioka K, 2008, J REPROD DEVELOP, V54, P208, DOI 10.1262/jrd.20001; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	63	94	104	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					24007	24020		10.1074/jbc.M115.671487	http://dx.doi.org/10.1074/jbc.M115.671487			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26254468	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000361816500044
J	Cao, Y; Zhang, SP; Yuan, N; Wang, J; Li, X; Xu, F; Lin, WW; Song, L; Fang, YX; Wang, ZJ; Wang, Z; Zhang, H; Zhang, Y; Zhao, WL; Hu, SY; Zhang, XG; Wang, JR				Cao, Yan; Zhang, Suping; Yuan, Na; Wang, Jian; Li, Xin; Xu, Fei; Lin, Weiwei; Song, Lin; Fang, Yixuan; Wang, Zhijian; Wang, Zhen; Zhang, Han; Zhang, Yi; Zhao, Wenli; Hu, Shaoyan; Zhang, Xueguang; Wang, Jianrong			Hierarchal Autophagic Divergence of Hematopoietic System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES LIPID-METABOLISM; MESENCHYMAL STEM-CELLS; BASAL AUTOPHAGY; IN-VIVO; DIFFERENTIATION; MAINTENANCE; MICE; GENE; MITOCHONDRIA; EXPRESSION	Autophagy is integral to hematopoiesis and protects against leukemogenesis. However, the fundamentals of the required molecular machinery have yet to be fully explored. Using conditional mouse models to create strategic defects in the hematopoietic hierarchy, we have shown that recovery capacities in stem cells and somatic cells differ if autophagy is impaired or flawed. An in vivo Atg7 deletion in hematopoietic stem cells completely ablates the autophagic response, leading to irreversible and ultimately lethal hematopoiesis. However, while no adverse phenotype is manifested in vivo by Atg7-deficient myeloid cells, they maintain active autophagy that is sensitive to brefeldin A, an inhibitor targeting Golgi-derived membranes destined for autophagosome formation in alternative autophagy. Removing Rab9, a key regulatory protein, in alternative autophagy, disables autophagy altogether in Atg7-deficient macrophages. Functional analysis indicates that ATG7-dependent canonical autophagy is physiologically active in both hematopoietic stem cells and in terminally differentiated hematopoietic cells; however, only terminally differentiated cells such as macrophages are rescued by alternative autophagy if canonical autophagy is ineffective. Thus, it appears that hematopoietic stem cells rely solely on ATG7-dependent canonical autophagy, whereas terminally differentiated or somatic cells are capable of alternative autophagy in the event that ATG7-mediated autophagy is dysfunctional. These findings offer new insight into the transformational trajectory of hematopoietic stem cells, which in our view renders the autophagic machinery in stem cells more vulnerable to disruption.	[Cao, Yan; Zhang, Suping; Yuan, Na; Wang, Jian; Li, Xin; Xu, Fei; Lin, Weiwei; Song, Lin; Fang, Yixuan; Wang, Zhijian; Wang, Zhen; Zhang, Han; Zhang, Yi; Zhao, Wenli; Hu, Shaoyan; Zhang, Xueguang; Wang, Jianrong] Soochow Univ, Affiliated Childrens Hosp, Collaborat Innovat Ctr Hematol,Jiangsu Key Lab S, Sch Med,Jiangsu Inst Hematol,Hematol Ctr,Cyrus Ta, Suzhou 215123, Peoples R China	Soochow University - China	Wang, JR (corresponding author), Soochow Univ, Hematol Ctr, Sch Med, Cyrus Tang Med Inst, 199 Renai Rd, Suzhou 215123, Peoples R China.	jrwang@suda.edu.cn	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [31071258, 81272336, 31271526, 31201073]; Ministry of Science and Technology of China [2011CB512101]; Department of Science and Technology of Jiangsu Province of China [BK20130333]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (No.31071258, No.81272336, No.31271526, and No.31201073), The Ministry of Science and Technology of China (No. 2011CB512101), The Department of Science and Technology of Jiangsu Province of China (No. BK20130333), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cao Y, 2015, STEM CELLS DEV, V24, P2660, DOI 10.1089/scd.2015.0176; Cao Y, 2015, EXP HEMATOL, V43, P488, DOI 10.1016/j.exphem.2015.01.001; Cao Y, 2015, EXP HEMATOL, V43, P229, DOI 10.1016/j.exphem.2014.11.002; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colosetti P, 2009, AUTOPHAGY, V5, P1092, DOI 10.4161/auto.5.8.9889; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Lee Y, 2013, J CELL BIOCHEM, V114, P79, DOI 10.1002/jcb.24303; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124; Pan HZ, 2013, EMBO MOL MED, V5, P327, DOI 10.1002/emmm.201201999; Sanchez-Aguilera A, 2011, P NATL ACAD SCI USA, V108, P9607, DOI 10.1073/pnas.1102018108; Seino J, 2013, J BIOL CHEM, V288, P26898, DOI 10.1074/jbc.M113.464503; Shimizu S, 2010, AUTOPHAGY, V6, P290, DOI 10.4161/auto.6.2.11127; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tra T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027485; Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526; Wang JR, 2008, J BIOL CHEM, V283, P25596, DOI 10.1074/jbc.M801716200; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127	43	21	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23050	23063		10.1074/jbc.M115.650028	http://dx.doi.org/10.1074/jbc.M115.650028			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26245898	hybrid, Green Published			2022-12-26	WOS:000361685500019
J	Nijaguna, MB; Patil, V; Urbach, S; Shwetha, SD; Sravani, K; Hegde, AS; Chandramouli, BA; Arivazhagan, A; Marin, P; Santosh, V; Somasundaram, K				Nijaguna, Mamatha Bangalore; Patil, Vikas; Urbach, Serge; Shwetha, Shivayogi D.; Sravani, Kotha; Hegde, Alangar S.; Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan; Marin, Philippe; Santosh, Vani; Somasundaram, Kumaravel			Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; POSSIBLE INVOLVEMENT; FACTOR-I; CANCER; PROGRESSION; EXPRESSION; SURVIVAL; MICROENVIRONMENT; CYTOKINE; CELLS	Glioblastoma (grade IV glioma/GBM) is the most common primary adult malignant brain tumor with poor prognosis. To characterize molecular determinants of tumor-stroma interaction in GBM, we profiled 48 serum cytokines and identified macrophage colony-stimulating factor (MCSF) as one of the elevated cytokines in sera from GBM patients. Both MCSF transcript and protein were up-regulated in GBM tissue samples through a spleen tyrosine kinase (SYK)-dependent activation of the PI3K-NF kappa B pathway. Ectopic overexpression and silencing experiments revealed that glioma-secreted MCSF has no role in autocrine functions and M2 polarization of macrophages. In contrast, silencing expression of MCSF in glioma cells prevented tube formation of human umbilical vein endothelial cells elicited by the supernatant from monocytes/microglial cells treated with conditioned medium from glioma cells. Quantitative proteomics based on stable isotope labeling by amino acids in cell culture showed that glioma-derived MCSF induces changes in microglial secretome and identified insulin-like growth factor-binding protein 1 (IGFBP1) as one of the MCSF-regulated proteins secreted by microglia. Silencing IGFBP1 expression in microglial cells or its neutralization by an antibody reduced the ability of supernatants derived from microglial cells treated with glioma cell-conditioned medium to induce angiogenesis. In conclusion, this study shows up-regulation of MCSF in GBM via a SYK-PI3K-NF kappa B-dependent mechanism and identifies IGFBP1 released by microglial cells as a novel mediator of MCSF-induced angiogenesis, of potential interest for developing targeted therapy to prevent GBM progression.	[Nijaguna, Mamatha Bangalore; Patil, Vikas; Somasundaram, Kumaravel] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Urbach, Serge; Marin, Philippe] CNRS UMR 5203, Inst Genom Fonct, F-34094 Montpellier, France; [Urbach, Serge; Marin, Philippe] INSERM U1191, F-34094 Montpellier, France; [Urbach, Serge; Marin, Philippe] Univ Montpellier, F-34094 Montpellier, France; [Shwetha, Shivayogi D.; Sravani, Kotha] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Chandramouli, Bangalore A.; Arivazhagan, Arimappamagan] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Hegde, Alangar S.] Sri Satya Sai Inst Higher Med Sci, Bangalore 560066, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India	Somasundaram, K (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	skumar@mcbl.iisc.ernet.in			Indian Institute of Science and the Department of Biotechnology; CNRS; INSERM; la Fondation pour la Recherche Medicale (Equipe FRM); la Region Languedoc-Roussillon; Department of Biotechnology, Government of India; J. C. Bose Fellow of the Department of Science and Technology	Indian Institute of Science and the Department of Biotechnology; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); la Region Languedoc-Roussillon(Region Occitanie); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); J. C. Bose Fellow of the Department of Science and Technology	Supported by a fellowship from the Indian Institute of Science and the Department of Biotechnology.; Supported by grants from CNRS, INSERM, la Fondation pour la Recherche Medicale (Equipe FRM 2009), and la Region Languedoc-Roussillon.; Supported by the Department of Biotechnology, Government of India; a J. C. Bose Fellow of the Department of Science and Technology.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; ALTERMAN RL, 1994, MOL CHEM NEUROPATHOL, V21, P177, DOI 10.1007/BF02815350; Arimappamagan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062042; Badie B, 2001, MICROSC RES TECHNIQ, V54, P106, DOI 10.1002/jemt.1125; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Bender AM, 2010, CANCER RES, V70, P3557, DOI 10.1158/0008-5472.CAN-09-4674; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483, DOI 10.1002/jlb.49.5.483; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Chuang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095180; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elmlinger MW, 2001, ENDOCRINOLOGY, V142, P1652, DOI 10.1210/en.142.4.1652; Eming SA, 2011, EXP DERMATOL, V20, P605, DOI 10.1111/j.1600-0625.2011.01309.x; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243; Gadducci A, 1998, GYNECOL ONCOL, V70, P111, DOI 10.1006/gyno.1998.4259; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gutmann DH, 2015, NEURO-ONCOLOGY, V17, P171, DOI 10.1093/neuonc/nou346; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Hao CH, 2002, ACTA NEUROPATHOL, V103, P171; Hatton O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042610; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Kogan M, 2012, DNA CELL BIOL, V31, P279, DOI 10.1089/dna.2011.1357; KOHN EC, 1995, P NATL ACAD SCI USA, V92, P1307, DOI 10.1073/pnas.92.5.1307; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Lee OH, 2000, BRIT J CANCER, V82, P385; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Leu JIJ, 2007, GENE DEV, V21, P3095, DOI 10.1101/gad.1567107; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mattern Ralph-Heiko, 2005, Cancer Ther, V3A, P325; Menke J, 2012, CANCER RES, V72, P187, DOI 10.1158/0008-5472.CAN-11-1232; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nash GF, 2001, LANCET ONCOL, V2, P608, DOI 10.1016/S1470-2045(01)00518-6; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Santosh V, 2010, CANCER EPIDEM BIOMAR, V19, P1399, DOI 10.1158/1055-9965.EPI-09-1213; SAWADA M, 1990, BRAIN RES, V509, P119, DOI 10.1016/0006-8993(90)90317-5; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Steuerwald NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081974; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Thouvenot E, 2008, J PROTEOME RES, V7, P4409, DOI 10.1021/pr8003858; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006	65	54	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					23401	23415		10.1074/jbc.M115.664037	http://dx.doi.org/10.1074/jbc.M115.664037			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26245897	Green Published, hybrid			2022-12-26	WOS:000361685500045
J	Haldorsen, IS; Popa, M; Fonnes, T; Brekke, N; Kopperud, R; Visser, NC; Rygh, CB; Pavlin, T; Salvesen, HB; McCormack, E; Krakstad, C				Haldorsen, Ingfrid S.; Popa, Mihaela; Fonnes, Tina; Brekke, Njal; Kopperud, Reidun; Visser, Nicole C.; Rygh, Cecilie B.; Pavlin, Tina; Salvesen, Helga B.; McCormack, Emmet; Krakstad, Camilla			Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma	PLOS ONE			English	Article							TUMOR XENOGRAFTS; CANCER; THERAPY; GROWTH; MICE	Background Orthotopic endometrial cancer models provide a unique tool for studies of tumour growth and metastatic spread. Novel preclinical imaging methods also have the potential to quantify functional tumour characteristics in vivo, with potential relevance for monitoring response to therapy. Methods After orthotopic injection with luc-expressing endometrial cancer cells, eleven mice developed disease detected by weekly bioluminescence imaging (BLI). In parallel the same mice underwent positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) employing F-18-fluorodeoxyglocose (F-18-FDG) or F-18-fluorothymidine (F-18-FLT) and contrast reagent, respectively. The mice were sacrificed when moribund, and post-mortem examination included macroscopic and microscopic examination for validation of growth of primary uterine tumours and metastases. PET-CT was also performed on a patient derived model (PDX) generated from a patient with grade 3 endometrioid endometrial cancer. Results Increased BLI signal during tumour growth was accompanied by increasing metabolic tumour volume (MTV) and increasing MTV x mean standard uptake value of the tumour (SUVmean) in F-18-FDG and F-18-FLT PET-CT, and MRI conspicuously depicted the uterine tumour. At necropsy 82% (9/11) of the mice developed metastases detected by the applied imaging methods. F-18-FDG PET proved to be a good imaging method for detection of patient derived tumour tissue. Conclusions We demonstrate that all imaging modalities enable monitoring of tumour growth and metastatic spread in an orthotopic mouse model of endometrial carcinoma. Both PET tracers, F-18-FDG and F-18-FLT, appear to be equally feasible for detecting tumour development and represent, together with MRI, promising imaging tools for monitoring of patient-derived xenograft (PDX) cancer models.	[Haldorsen, Ingfrid S.] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway; [Haldorsen, Ingfrid S.] Univ Bergen, Sect Radiol, Dept Clin Med, Bergen, Norway; [Popa, Mihaela; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Fonnes, Tina; Kopperud, Reidun; Salvesen, Helga B.; Krakstad, Camilla] Univ Bergen, Ctr Canc Biomarkers, Dept Clin Sci, Bergen, Norway; [Brekke, Njal] Haukeland Hosp, Dept Radiol, PET Ctr, N-5021 Bergen, Norway; [Visser, Nicole C.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Rygh, Cecilie B.; Pavlin, Tina] Univ Bergen, Mol Imaging Ctr, Dept Biomed, Bergen, Norway; [Salvesen, Helga B.; Krakstad, Camilla] Haukeland Hosp, Dept Obstet & Gynaecol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Radboud University Nijmegen; University of Bergen; University of Bergen; Haukeland University Hospital	Krakstad, C (corresponding author), Univ Bergen, Ctr Canc Biomarkers, Dept Clin Sci, Bergen, Norway.	camilla.krakstad@med.uib.no	Cormack, Emmet Mc/D-2922-2012; Visser, Nicole/AAX-7809-2021; salvesen, Helga B/C-1187-2017; Visser, Nicole/P-1762-2015; Krakstad, Camilla/AAB-5138-2020	Cormack, Emmet Mc/0000-0002-7621-4625; salvesen, Helga B/0000-0002-4438-8831; Visser, Nicole/0000-0003-3919-3922; Krakstad, Camilla/0000-0002-0174-8139; Haldorsen, Ingfrid S./0000-0001-9313-7564	Bergen Research Foundation; Western Norway Regional Health Authority; Norwegian Research Council; University of Bergen; Meltzer Foundation; Norwegian Cancer Society (The Harald Andersen's legacy); MedViz	Bergen Research Foundation; Western Norway Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen; Meltzer Foundation; Norwegian Cancer Society (The Harald Andersen's legacy)(Norwegian Cancer Society); MedViz	Supported by Bergen Research Foundation, The Western Norway Regional Health Authority, Norwegian Research Council, The University of Bergen, The Meltzer Foundation, The Norwegian Cancer Society (The Harald Andersen's legacy), and MedViz (www.medviz.uib.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Bai B, 2013, THERANOSTICS, V3, P787, DOI 10.7150/thno.5629; Cabrera S, 2012, CLIN EXP METASTAS, V29, P217, DOI 10.1007/s10585-011-9444-2; Che Q, 2014, INT J CANCER, V135, P282, DOI 10.1002/ijc.28679; Che Q, 2014, BIOCHEM BIOPH RES CO, V446, P167, DOI 10.1016/j.bbrc.2014.02.080; Doll A, 2009, INT J CANCER, V125, P257, DOI 10.1002/ijc.24330; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Helland O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089527; Kamat AA, 2007, CLIN CANCER RES, V13, P7487, DOI 10.1158/1078-0432.CCR-07-1017; Kocher B, 2013, CANCER DISCOV, V3, P616, DOI 10.1158/2159-8290.CD-12-0503; Liebsch L, 2013, BRIT J CANCER, V109, P658, DOI 10.1038/bjc.2013.356; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; McKinley ET, 2013, J NUCL MED, V54, P424, DOI 10.2967/jnumed.112.108456; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Moestue SA, 2013, J MAGN RESON IMAGING, V38, P1043, DOI 10.1002/jmri.24079; O'Farrell AC, 2013, BRIT J PHARMACOL, V169, P719, DOI 10.1111/bph.12155; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Pillozzi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00285; Sanghera B, 2014, INDIAN J NUCL MED, V29, P65, DOI 10.4103/0972-3919.130274; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Theisen ER, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-752; Vollmer G, 2003, ENDOCR-RELAT CANCER, V10, P23, DOI 10.1677/erc.0.0100023; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Wolf Gunter, 2013, Recent Results Cancer Res, V187, P257, DOI 10.1007/978-3-642-10853-2_9	26	25	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135220	10.1371/journal.pone.0135220	http://dx.doi.org/10.1371/journal.pone.0135220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252891	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100137
J	Zhang, C; Hedrick, TL; Mittal, R				Zhang, Chao; Hedrick, Tyson L.; Mittal, Rajat			Centripetal Acceleration Reaction: An Effective and Robust Mechanism for Flapping Flight in Insects	PLOS ONE			English	Article							LEADING-EDGE VORTEX; HOVERING FLIGHT; AERODYNAMICS; FORCE; BODY; FLOW; MOMENT; ROTATION; MOTION; BODIES	Despite intense study by physicists and biologists, we do not fully understand the unsteady aerodynamics that relate insect wing morphology and kinematics to lift generation. Here, we formulate a force partitioning method (FPM) and implement it within a computational fluid dynamic model to provide an unambiguous and physically insightful division of aerodynamic force into components associated with wing kinematics, vorticity, and viscosity. Application of the FPM to hawkmoth and fruit fly flight shows that the leading-edge vortex is the dominant mechanism for lift generation for both these insects and contributes between 72-85% of the net lift. However, there is another, previously unidentified mechanism, the centripetal acceleration reaction, which generates up to 17% of the net lift. The centripetal acceleration reaction is similar to the classical inviscid added-mass in that it depends only on the kinematics (i.e. accelerations) of the body, but is different in that it requires the satisfaction of the no-slip condition, and a combination of tangential motion and rotation of the wing surface. Furthermore, the classical added-mass force is identically zero for cyclic motion but this is not true of the centripetal acceleration reaction. Furthermore, unlike the lift due to vorticity, centripetal acceleration reaction lift is insensitive to Reynolds number and to environmental flow perturbations, making it an important contributor to insect flight stability and miniaturization. This force mechanism also has broad implications for flow-induced deformation and vibration, underwater locomotion and flows involving bubbles and droplets.	[Zhang, Chao; Mittal, Rajat] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Hedrick, Tyson L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Mittal, R (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	mittal@jhu.edu	Hedrick, Tyson/GZH-3140-2022	Hedrick, Tyson/0000-0002-6573-9602; Mittal, Rajat/0000-0002-8107-9499	Air Force Office of Scientific Research [FA9550-10-1-006]; National Science Foundation [CBET-1357819, IOS-1124804, PLR-1246317, IOS-0920358]; Directorate For Geosciences [1246317] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by Air Force Office of Scientific Research FA9550-10-1-006 RM TH; National Science Foundation CBET-1357819, IOS-1124804, PLR-1246317 RM; and National Science Foundation IOS-0920358 TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jr JD, 1989, INTRODUCTION TO FLIG; Aono H., 2006, J BIOMECHAN SCI ENG, V1, P234, DOI [10.1299/jbse.1.234, DOI 10.1299/JBSE.1.234]; Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Batchelor GK, 1967, AN INTRODUCTION TO F; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Birch JM, 2003, J EXP BIOL, V206, P2257, DOI 10.1242/jeb.00381; Birch JM, 2004, J EXP BIOL, V207, P1063, DOI 10.1242/jeb.00848; Bomphrey RJ, 2005, J EXP BIOL, V208, P1079, DOI 10.1242/jeb.01471; Chakraborty S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116813; Daniel T L, 1984, ZOOLOGIST, V24, P121, DOI DOI 10.1093/ICB/24.1.121; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Fontaine EI, 2009, J EXP BIOL, V212, P1307, DOI 10.1242/jeb.025379; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Gatesy SM, 2010, J EXP ZOOL PART A, V313A, P244, DOI 10.1002/jez.588; HOWE MS, 1995, Q J MECH APPL MATH, V48, P401, DOI 10.1093/qjmam/48.3.401; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Kang CK, 2011, J FLUID MECH, V689, P32, DOI 10.1017/jfm.2011.428; Lamb H., 1945, HYDRODYNAMICS; Magnaudet J, 2011, J FLUID MECH, V689, P564, DOI 10.1017/jfm.2011.363; Meng XG, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4914042; Mittal R, 2008, J COMPUT PHYS, V227, P4825, DOI 10.1016/j.jcp.2008.01.028; Noca F, 1999, J FLUID STRUCT, V13, P551, DOI 10.1006/jfls.1999.0219; QUARTAPELLE L, 1983, AIAA J, V21, P911, DOI 10.2514/3.8171; Ramamurti R, 2002, J EXP BIOL, V205, P1507; Ristroph L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178103; Sane SP, 2001, J EXP BIOL, V204, P2607; Sedov LI., 1965, TWO DIMENSIONAL PROB; Shyy W, 2007, AIAA J, V45, P2817, DOI 10.2514/1.33205; SPEDDING GR, 1986, J FLUID MECH, V165, P247, DOI 10.1017/S0022112086003087; Theriault DH, 2014, J EXP BIOL, V217, P1843, DOI 10.1242/jeb.100529; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; Wang CJ, 2013, THEOR COMP FLUID DYN, V27, P577, DOI 10.1007/s00162-012-0279-5; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Wang ZJ, 2004, J EXP BIOL, V207, P449, DOI 10.1242/jeb.00739; Whitney JP, 2010, J FLUID MECH, V660, P197, DOI 10.1017/S002211201000265X; Wu JZ, 2007, J FLUID MECH, V576, P265, DOI 10.1017/S0022112006004551; WU JC, 1981, AIAA J, V19, P432, DOI 10.2514/3.50966; Yih CS., 1977, FLUID MECHANICS A CO; Zheng LX, 2013, J FLUID MECH, V721, P118, DOI 10.1017/jfm.2013.46	41	16	18	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0132093	10.1371/journal.pone.0132093	http://dx.doi.org/10.1371/journal.pone.0132093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252016	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100010
J	Chen, YM; Xu, HY; Zhou, MY; Wang, Y; Wang, SM; Zhang, JF				Chen, Yunmei; Xu, Haiyang; Zhou, Mengyi; Wang, Yang; Wang, Shiming; Zhang, Jianfa			Salecan Enhances the Activities of beta-1,3-Glucanase and Decreases the Biomass of Soil-Borne Fungi	PLOS ONE			English	Article							PLANT-GROWTH; MICROBIAL COMMUNITIES; BIOLOGICAL-CONTROL; BACILLUS-SUBTILIS; CELL-WALL; ANTIFUNGAL ACTIVITY; FUSARIUM-WILT; POSSIBLE MODE; X-B; BIOCONTROL	Salecan, a linear extracellular polysaccharide consisting of beta-1,3-D-glucan, has potential applications in the food, pharmaceutical and cosmetic industries. The objective of this study was to evaluate the effects of salecan on soil microbial communities in a vegetable patch. Compositional shifts in the genetic structure of indigenous soil bacterial and fungal communities were monitored using culture-dependent dilution plating, culture-independent PCR-denaturing gradient gel electrophoresis (DGGE) and quantitative PCR. After 60 days, soil microorganism counts showed no significant variation in bacterial density and a marked decrease in the numbers of fungi. The DGGE profiles revealed that salecan changed the composition of the microbial community in soil by increasing the amount of Bacillus strains and decreasing the amount of Fusarium strains. Quantitative PCR confirmed that the populations of the soil-borne fungi Fusarium oxysporum and Trichoderma spp. were decreased approximately 6-and 2-fold, respectively, in soil containing salecan. This decrease in the amount of fungi can be explained by salecan inducing an increase in the activities of beta-1,3-glucanase in the soil. These results suggest the promising application of salecan for biological control of pathogens of soil-borne fungi.	[Chen, Yunmei; Xu, Haiyang; Zhou, Mengyi; Wang, Yang; Wang, Shiming; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Wang, SM (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Jiangsu, Peoples R China.	bioeng@mail.njust.edu.cn; jfzhang@mail.njust.edu.cn			Fundamental Research Funds for the Central Universities [30920130121013]; National Natural Science Foundation of China [31300111]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Fundamental Research Funds for the Central Universities (30920130121013) and by the National Natural Science Foundation of China (31300111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita M, 2005, FEMS MICROBIOL LETT, V248, P9, DOI 10.1016/j.femsle.2005.05.009; Aktuganov G, 2008, CAN J MICROBIOL, V54, P577, DOI [10.1139/W08-043, 10.1139/w08-043]; Alamri S, 2012, BIOCONTROL SCI, V17, P155, DOI 10.4265/bio.17.155; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Borrero C, 2006, SOIL BIOL BIOCHEM, V38, P1631, DOI 10.1016/j.soilbio.2005.11.017; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Budi SW, 2000, APPL SOIL ECOL, V15, P191, DOI 10.1016/S0929-1393(00)00095-0; BURGE WD, 1969, APPL MICROBIOL, V17, P545, DOI 10.1128/AEM.17.4.545-550.1969; CABIB E, 1988, MICROBIOL SCI, V5, P370; Campbell CD, 1997, J MICROBIOL METH, V30, P33, DOI 10.1016/S0167-7012(97)00041-9; Castoria R, 1997, POSTHARVEST BIOL TEC, V12, P293, DOI 10.1016/S0925-5214(97)00061-6; Chatterton S, 2009, CAN J MICROBIOL, V55, P356, DOI [10.1139/w08-156, 10.1139/W08-156]; Chen P, 2012, J APPL TOXICOL, V32, P796, DOI 10.1002/jat.1694; Chen P, 2011, BIOSCI BIOTECH BIOCH, V75, P1990, DOI 10.1271/bbb.110412; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Cruz AF, 2012, BIOL OPEN, V1, P52, DOI 10.1242/bio.2011014; DasGupta SM, 2006, CURR MICROBIOL, V53, P502, DOI 10.1007/s00284-006-0261-9; El-Hassan SA, 2006, J PHYTOPATHOL, V154, P148, DOI 10.1111/j.1439-0434.2006.01075.x; FARKAS V, 1985, FUNGAL PROTOPLASTS A, P3; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; FRIDLENDER M, 1993, SOIL BIOL BIOCHEM, V25, P1211, DOI 10.1016/0038-0717(93)90217-Y; Furtado GP, 2011, PROCESS BIOCHEM, V46, P1202, DOI 10.1016/j.procbio.2011.01.037; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hagn A, 2007, J MICROBIOL METH, V69, P86, DOI 10.1016/j.mimet.2006.12.004; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; Helisto P, 2001, J CHROMATOGR B, V758, P197, DOI 10.1016/S0378-4347(01)00181-5; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; Hong TY, 2003, APPL MICROBIOL BIOT, V61, P472, DOI 10.1007/s00253-003-1249-z; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Hu XY, 2014, CARBOHYD POLYM, V105, P135, DOI 10.1016/j.carbpol.2014.01.051; Kennedy AC, 1999, AGR ECOSYST ENVIRON, V74, P65, DOI 10.1016/S0167-8809(99)00030-4; Khan MR, 2011, BIOL CONTROL, V59, P130, DOI 10.1016/j.biocontrol.2011.04.007; Kim PI, 2004, FEMS MICROBIOL LETT, V234, P177, DOI 10.1111/j.1574-6968.2004.tb09530.x; Kim YR, 2013, BIOPROC BIOSYST ENG, V36, P721, DOI 10.1007/s00449-013-0896-4; Latge JP, 2014, CURR OPIN MICROBIOL, V20, P111, DOI 10.1016/j.mib.2014.05.009; Leelasuphakul W, 2006, ENZYME MICROB TECH, V38, P990, DOI 10.1016/j.enzmictec.2005.08.030; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; LETHBRIDGE G, 1978, SOIL BIOL BIOCHEM, V10, P389, DOI 10.1016/0038-0717(78)90063-9; LOUW ME, 1993, APPL MICROBIOL BIOT, V38, P507, DOI 10.1007/BF00242946; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Lugtenberg BJJ, 2002, ANTON LEEUW INT J G, V81, P373, DOI 10.1023/A:1020596903142; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Masih EI, 2002, CURR MICROBIOL, V44, P391, DOI 10.1007/s00284-001-0011-y; Mehboob I, 2009, CRIT REV PLANT SCI, V28, P432, DOI 10.1080/07352680903187753; Morrissey JP, 2004, EMBO REP, V5, P922, DOI 10.1038/sj.embor.7400263; Nagarajkumar M, 2004, MICROBIOL RES, V159, P73, DOI 10.1016/j.micres.2004.01.005; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; Nielsen P, 1997, FEMS MICROBIOL ECOL, V22, P183, DOI 10.1016/S0168-6496(96)00089-X; NISHIKIORI T, 1986, J ANTIBIOT, V39, P755, DOI 10.7164/antibiotics.39.755; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; PITSON SM, 1993, ENZYME MICROB TECH, V15, P178, DOI 10.1016/0141-0229(93)90136-P; Rademaker JLW, 1999, MOL MICROBIAL ECOLOG, P1; SAHAI AS, 1993, FEMS MICROBIOL REV, V11, P317, DOI 10.1111/j.1574-6976.1993.tb00004.x; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Singh PP, 1999, PHYTOPATHOLOGY, V89, P92, DOI 10.1094/PHYTO.1999.89.1.92; Smith I.M., 1988, Q REV BIOL, DOI [DOI 10.1002/9781444314199, 10.1002/9781444314199]; Spiess B, 2007, J CLIN MICROBIOL, V45, P3743, DOI 10.1128/JCM.00942-07; Staddon WJ, 1997, MICROB ECOL, V34, P125, DOI 10.1007/s002489900042; Stotzky G, 1972, CRC Crit Rev Microbiol, V2, P59, DOI 10.3109/10408417209108383; TABERNERO C, 1994, APPL ENVIRON MICROB, V60, P1213, DOI 10.1128/AEM.60.4.1213-1220.1994; Teng D, 2006, APPL MICROBIOL BIOT, V72, P705, DOI 10.1007/s00253-006-0329-2; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; vanElsas JD, 1997, BIOL FERT SOILS, V24, P188, DOI 10.1007/s003740050230; Viterbo A, 2001, FEMS MICROBIOL LETT, V200, P169, DOI 10.1111/j.1574-6968.2001.tb10710.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Xiu AH, 2011, FOOD HYDROCOLLOID, V25, P1719, DOI 10.1016/j.foodhyd.2011.03.013; Xiu AH, 2010, CARBOHYD POLYM, V82, P623, DOI 10.1016/j.carbpol.2010.05.027; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zhang Y, 2013, BRIT J NUTR, V109, P254, DOI 10.1017/S0007114512000980; Zhou MY, 2014, BRIT J NUTR, V111, P1822, DOI 10.1017/S000711451300442X; Zhou MY, 2014, CARBOHYD POLYM, V102, P772, DOI 10.1016/j.carbpol.2013.10.091; Zhou MY, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-52	75	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134799	10.1371/journal.pone.0134799	http://dx.doi.org/10.1371/journal.pone.0134799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247592	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300065
J	Lee, YS; Lee, MJ; Kim, MJ; Im, YJ; Kim, SW; Lim, NL; Han, SW				Lee, Yong Seung; Lee, Mi-Jung; Kim, Myung-Joon; Im, Young Jae; Kim, Sang Woon; Lim, Neddy Lee; Han, Sang Won			Is Increased Echogenicity Related to a Decrease in Glomerular Filtration Rate? Objective Measurements in Pediatric Solitary Kidney Patients-A Retrospective Analysis	PLOS ONE			English	Article							RENAL-CORTEX; CHILDREN; HYDRONEPHROSIS; OBSTRUCTION; DISEASE; GROWTH	Quantitative measurements of renal echogenicity using a graphic program show close correlation with renal histology in adult patients, but this has neither been applied in pediatric patients nor correlated with glomerular filtration rate (GFR). To determine the direct relationship between echogenicity and GFR, we retrospectively analyzed 91 patients with a solitary functioning kidney under the age of 10, who underwent ultrasonography and serum cystatin C evaluation on a single day between January 2013 and December 2014. Echogenicity was quantified as previously reported. Echogenicity and kidney length were correlated with age-matched values of serum cystatin C-based GFR. Evaluation was performed at a median age of 17.1 months. GFR was low for age in eight of 54 right solitary kidney patients and four of 37 left solitary kidney patients. The right kidney-liver ratio was significantly elevated in the right decreased GFR group, while the left kidney-spleen ratio was not different in the left decreased GFR group. Age-matched longitudinal kidney length ratios were similar between the decreased and normal GFR groups for both sides. This is the first report to objectively prove the relationship between echogenicity and renal function in patients with a right solitary kidney. The right kidney-liver echogenicity ratio, measured objectively, showed feasibility in clinical practice as it showed a close relationship with decreased renal function when increased. However, absolute kidney echogenicity values, or the left kidney-spleen echogenicity ratio, were not independent markers for decreased renal function.	[Lee, Yong Seung; Im, Young Jae; Kim, Sang Woon; Lim, Neddy Lee; Han, Sang Won] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Lee, Yong Seung; Im, Young Jae; Kim, Sang Woon; Lim, Neddy Lee; Han, Sang Won] Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea; [Lee, Mi-Jung; Kim, Myung-Joon] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, SW (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.	swhan@yuhs.ac		Han, Sang Won/0000-0003-0941-1300; Kim, Sang Woon/0000-0002-5790-1948; Lee, Yong Seung/0000-0003-3778-9888; Lee, Mi-Jung/0000-0003-3244-9171; Kim, Myung-Joon/0000-0002-4608-0275				Chi T, 2006, J UROLOGY, V175, P1898, DOI 10.1016/S0022-5347(05)00930-4; FERNBACH SK, 1993, PEDIATR RADIOL, V23, P478, DOI 10.1007/BF02012459; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; HAN BK, 1985, AM J ROENTGENOL, V145, P611, DOI 10.2214/ajr.145.3.611; Hershkovitz R, 2011, ARCH GYNECOL OBSTET, V284, P807, DOI 10.1007/s00404-010-1738-0; Kim SS, 2007, DISCREPANCY MEASURED, V48, P77, DOI [10.4111/kju.2007.48.1.77, DOI 10.4111/KJU.2007.48.1.77]; LAUFER I, 1971, AMER J ROENTGENOL RA, V113, P464, DOI 10.2214/ajr.113.3.464; Lee YS, 2012, J PEDIATR SURG, V47, P1682, DOI 10.1016/j.jpedsurg.2012.03.051; Manley JA, 2001, AM J KIDNEY DIS, V37, P706, DOI 10.1016/S0272-6386(01)80118-9; Moghazi S, 2005, KIDNEY INT, V67, P1515, DOI 10.1111/j.1523-1755.2005.00230.x; Peerboccus M, 2013, PEDIATR RADIOL, V43, P1557, DOI 10.1007/s00247-013-2748-4; PETERS CA, 1993, J UROLOGY, V150, P597, DOI 10.1016/S0022-5347(17)35559-3; Sambasivan AS, 2005, CLIN CHEM, V51, P2215, DOI 10.1373/clinchem.2005.056150; Spira EM, 2009, ARCH DIS CHILD, V94, P693, DOI 10.1136/adc.2008.153601; Uemura O, 2015, CLIN EXP NEPHROL, V19, P683, DOI 10.1007/s10157-014-1042-6; Van Vuuren SH, 2012, ULTRASOUND OBST GYN, V40, P665, DOI 10.1002/uog.11168; Wiersma F, 2008, AM J ROENTGENOL, V190, P240, DOI 10.2214/AJR.07.2606	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133577	10.1371/journal.pone.0133577	http://dx.doi.org/10.1371/journal.pone.0133577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247587	Green Published, gold, Green Submitted			2022-12-26	WOS:000359062300015
J	Lomonosova, AV; Ovchinnikova, EV; Kazakov, AS; Denesyuk, AI; Sofin, AD; Mikhailov, RV; Ulitin, AB; Mirzabekov, TA; Permyakov, EA; Permyakov, SE				Lomonosova, Anna V.; Ovchinnikova, Elena V.; Kazakov, Alexei S.; Denesyuk, Alexander I.; Sofin, Alexander D.; Mikhailov, Roman V.; Ulitin, Andrei B.; Mirzabekov, Tajib A.; Permyakov, Eugene A.; Permyakov, Sergei E.			Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEINS; COMBINATORIAL LIBRARIES; SULFOLOBUS-SOLFATARICUS; PYROCOCCUS-HORIKOSHII; CHEMICAL DENATURATION; MOLECULAR RECOGNITION; HUMAN FIBRONECTIN; III DOMAIN; THERMOSTABILITY; ANTIBODIES	Due to their remarkably high structural stability, proteins from extremophiles are particularly useful in numerous biological applications. Their utility as alternative protein scaffolds could be especially valuable in small antibody mimetic engineering. These artificial binding proteins occupy a specific niche between antibodies and low molecular weight substances, paving the way for development of innovative approaches in therapeutics, diagnostics, and reagent use. Here, the 50S ribosomal RNA-binding protein L35Ae from the extremophilic archaea Pyrococcus horikoshii has been probed for its potential to serve as a backbone in alternative scaffold engineering. The recombinant wild type L35Ae has a native-like secondary structure, extreme thermal stability (mid-transition temperature of 90 degrees C) and a moderate resistance to the denaturation by guanidine hydrochloride (half-transition at 2.6 M). Chemical crosslinking and dynamic light scattering data revealed that the wild type L35Ae protein has a propensity for multimerization and aggregation correlating with its non-specific binding to a model cell surface of HEK293 cells, as evidenced by flow cytometry. To suppress these negative features, a 10-amino acid mutant (called L35Ae 10X) was designed, which lacks the interaction with HEK293 cells, is less susceptible to aggregation, and maintains native-like secondary structure and thermal stability. However, L35Ae 10X also shows lowered resistance to guanidine hydrochloride (half-transition at 2.0M) and is more prone to oligomerization. This investigation of an extremophile protein's scaffolding potential demonstrates that lowered resistance to charged chemical denaturants and increased propensity to multimerization may limit the utility of extremophile proteins as alternative scaffolds.	[Lomonosova, Anna V.; Ovchinnikova, Elena V.; Kazakov, Alexei S.; Denesyuk, Alexander I.; Sofin, Alexander D.; Permyakov, Eugene A.; Permyakov, Sergei E.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia; [Denesyuk, Alexander I.] Abo Akad Univ, Dept Biosci, FIN-20520 Turku, Finland; [Mikhailov, Roman V.; Ulitin, Andrei B.; Mirzabekov, Tajib A.] Antherix, Pushchino 142290, Moscow Region, Russia; [Mirzabekov, Tajib A.] Biomirex Inc, Watertown, MA 02472 USA	Russian Academy of Sciences; Abo Akademi University	Permyakov, SE (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Inst Skaya Str 7, Pushchino 142290, Moscow Region, Russia.	permyakov.s@gmail.com	Permyakov, Eugene A./M-8707-2014; Permyakov, Sergei/O-1386-2019; Kazakov, Alexey S./M-9129-2014; Permyakov, Sergei E./B-8156-2011; Lomonosova, Anna/M-9201-2014	Permyakov, Eugene A./0000-0002-9099-1148; Permyakov, Sergei/0000-0003-4086-3137; Kazakov, Alexey S./0000-0002-1586-7649; Permyakov, Sergei E./0000-0003-4086-3137; Lomonosova, Anna/0000-0003-2134-0277; Ulitin, Andrey/0000-0001-8467-4472	Russian Academy of Sciences; Russian Foundation for Basic Research [14-44-03604]; Ministry of Investments and Innovations of the Moscow region; Sigrid Juselius Foundation; Antherix; Biomirex Inc.	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Investments and Innovations of the Moscow region; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Antherix; Biomirex Inc.	Programs of the Russian Academy of Sciences "Fundamental science for medicine" (S.E.P.) and "Molecular and cellular biology" (E.A.P.), a grant No. 14-44-03604 from the Russian Foundation for Basic Research and the Ministry of Investments and Innovations of the Moscow region (S.E.P.), and a grant from the Sigrid Juselius Foundation (A.I.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Antherix provided support in the form of salaries for authors RVM, ABU and TAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biomirex Inc. provided support in the form of salaries for author TAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Baloch AR, 2016, CRIT REV BIOTECHNOL, V36, P268, DOI 10.3109/07388551.2014.958431; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Beste G, 1999, P NATL ACAD SCI USA, V96, P1898, DOI 10.1073/pnas.96.5.1898; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Boschek CB, 2009, PROTEIN ENG DES SEL, V22, P325, DOI 10.1093/protein/gzp007; Burstein EA, 1996, PHOTOCHEM PHOTOBIOL, V64, P316, DOI 10.1111/j.1751-1097.1996.tb02464.x; Campochiaro PA, 2013, AM J OPHTHALMOL, V155, P697, DOI 10.1016/j.ajo.2012.09.032; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Cheung YY, 2005, BIOCHEMISTRY-US, V44, P4601, DOI 10.1021/bi047832k; Das S, 2012, J BIOL CHEM, V287, P41499, DOI 10.1074/jbc.M112.384388; Del Vecchio P, 2002, BIOCHEM J, V367, P857, DOI 10.1042/BJ20020695; Farrar JE, 2008, BLOOD, V112, P1582, DOI 10.1182/blood-2008-02-140012; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Granata V, 2006, BIOCHEMISTRY-US, V45, P719, DOI 10.1021/bi050479d; Hackel M, 1999, BIOPHYS CHEM, V82, P35, DOI 10.1016/S0301-4622(99)00104-0; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; HOZUMI N, 1993, CANCER INVEST, V11, P714, DOI 10.3109/07357909309046945; Jost C, 2014, CURR OPIN STRUC BIOL, V27, P102, DOI 10.1016/j.sbi.2014.05.011; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; Kawarabayasi Y, 1998, DNA Res, V5, P147, DOI 10.1093/dnares/5.2.147; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Kroes RA, 2000, CANCER LETT, V156, P191, DOI 10.1016/S0304-3835(00)00462-6; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lopez CD, 2002, CANCER LETT, V180, P195, DOI 10.1016/S0304-3835(02)00024-1; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Markland W, 1996, BIOCHEMISTRY-US, V35, P8058, DOI 10.1021/bi952629y; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MASULLO M, 1991, EUR J BIOCHEM, V199, P529, DOI 10.1111/j.1432-1033.1991.tb16151.x; Matsui I, 2000, J BIOL CHEM, V275, P4871, DOI 10.1074/jbc.275.7.4871; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Mross K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083232; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Permyakov SE, 2006, PROTEINS, V65, P984, DOI 10.1002/prot.21159; Permyakoy SE, 2008, PROTEINS, V72, P822, DOI 10.1002/prot.21974; Privalov P L, 1986, Methods Enzymol, V131, P4; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Ribatti D, 2014, IMMUNOL LETT, V161, P96, DOI 10.1016/j.imlet.2014.05.010; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Rudnick SI, 2009, CANCER BIOTHER RADIO, V24, P155, DOI 10.1089/cbr.2009.0627; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; Schneider L, 2007, J ALLERGY CLIN IMMUN, V120, P416, DOI 10.1016/j.jaci.2007.04.028; Seeger MA, 2013, PROTEIN SCI, V22, P1239, DOI 10.1002/pro.2312; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Snyder DA, 2012, PROTEINS, V80, P1901, DOI 10.1002/prot.24071; Sorensen J, 2014, J NUCL MED, V55, P730, DOI 10.2967/jnumed.113.131243; Souied EH, 2014, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2014.05.037, DOI 10.1016/J.AJ0.2014.05.037]; Souriau C, 2003, EXPERT OPIN BIOL TH, V3, P305, DOI 10.1517/eobt.3.2.305.21159; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tanaka T, 2006, FEBS LETT, V580, P4224, DOI 10.1016/j.febslet.2006.06.084; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; ULBRICH N, 1980, J BIOL CHEM, V255, P7010; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109657; Wang W, 2010, AGGREGATION OF THERA; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Wurch T, 2012, TRENDS BIOTECHNOL, V30, P575, DOI 10.1016/j.tibtech.2012.07.006; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; Zuraw B, 2010, NAT REV DRUG DISCOV, V9, P189, DOI 10.1038/nrd3125	76	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134906	10.1371/journal.pone.0134906	http://dx.doi.org/10.1371/journal.pone.0134906			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247602	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300075
J	Ronke, C; Dannemann, M; Halbwax, M; Fischer, A; Helmschrodt, C; Brugel, M; Andre, C; Atencia, R; Mugisha, L; Scholz, M; Ceglarek, U; Thiery, J; Paabo, S; Prufer, K; Kelso, J				Ronke, Claudius; Dannemann, Michael; Halbwax, Michel; Fischer, Anne; Helmschrodt, Christin; Bruegel, Mathias; Andre, Claudine; Atencia, Rebeca; Mugisha, Lawrence; Scholz, Markus; Ceglarek, Uta; Thiery, Joachim; Paeaebo, Svante; Pruefer, Kay; Kelso, Janet			Lineage-Specific Changes in Biomarkers in Great Apes and Humans	PLOS ONE			English	Article							BILIRUBIN INDUCES APOPTOSIS; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN-CHOLESTEROL; APPROVED RECOMMENDATION 1985; CHIMPANZEES PAN-TROGLODYTES; RAT-BRAIN NEURONS; SERUM BILIRUBIN; ENDOPLASMIC-RETICULUM; 2-OXOGLUTARATE AMINOTRANSFERASE; UDP-GLUCURONOSYLTRANSFERASES	Although human biomedical and physiological information is readily available, such information for great apes is limited. We analyzed clinical chemical biomarkers in serum samples from 277 wild- and captive-born great apes and from 312 healthy human volunteers as well as from 20 rhesus macaques. For each individual, we determined a maximum of 33 markers of heart, liver, kidney, thyroid and pancreas function, hemoglobin and lipid metabolism and one marker of inflammation. We identified biomarkers that show differences between humans and the great apes in their average level or activity. Using the rhesus macaques as an outgroup, we identified human-specific differences in the levels of bilirubin, cholinesterase and lactate dehydrogenase, and bonobo-specific differences in the level of apolipoprotein A-I. For the remaining twenty-nine biomarkers there was no evidence for lineage-specific differences. In fact, we find that many biomarkers show differences between individuals of the same species in different environments. Of the four lineage-specific biomarkers, only bilirubin showed no differences between wild- and captive-born great apes. We show that the major factor explaining the human-specific difference in bilirubin levels may be genetic. There are human-specific changes in the sequence of the promoter and the protein-coding sequence of uridine diphosphoglucuronosyltransferase 1 (UGT1A1), the enzyme that transforms bilirubin and toxic plant compounds into water-soluble, excretable metabolites. Experimental evidence that UGT1A1 is down-regulated in the human liver suggests that changes in the promoter may be responsible for the human-specific increase in bilirubin. We speculate that since cooking reduces toxic plant compounds, consumption of cooked foods, which is specific to humans, may have resulted in relaxed constraint on UGT1A1 which has in turn led to higher serum levels of bilirubin in humans.	[Ronke, Claudius; Helmschrodt, Christin; Bruegel, Mathias; Scholz, Markus; Ceglarek, Uta; Thiery, Joachim] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Dannemann, Michael; Halbwax, Michel; Fischer, Anne; Paeaebo, Svante; Pruefer, Kay; Kelso, Janet] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Andre, Claudine] Lola Ya Bonobo Sanctuary, Kinshasa, DEM REP CONGO; [Atencia, Rebeca] Jane Goodall Inst, Reserve Nat Sanctuaire Chimpanzes Tchimpounga, Pointe Noire, Rep Congo; [Mugisha, Lawrence] Conservat & Ecosyst Hlth Alliance, Kampala, Uganda; [Mugisha, Lawrence] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda	Leipzig University; Max Planck Society; Leipzig University; Makerere University	Ronke, C (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	claudius@ronke.org	Helmschrodt, Christin/AAZ-4872-2020; Mugisha, Lawrence/N-4916-2017; Ceglarek, Uta/GOE-5561-2022; Kelso, Janet/N-1812-2019	Mugisha, Lawrence/0000-0003-4932-3356; Kelso, Janet/0000-0002-3618-322X	Max Planck Society; European Research Council (ERC) [233297]; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [SFB1052]; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)); University of Leipzig	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council (ERC)(European Research Council (ERC)); German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); University of Leipzig	The authors acknowledge financial support from the Max Planck Society as well as grants from the European Research Council (ERC) (grant 233297, TWOPAN) to S.P., the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) SFB1052 "Obesity mechanisms" (project A02) to J.K and from the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) and the University of Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL M, 1985, KLIN PADIATR, V197, P392, DOI 10.1055/s-2008-1034010; Amato M, 2009, NEONATOLOGY, V66, P288; Amitay M, 2009, PROTEINS, V77, P370, DOI 10.1002/prot.22442; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armstrong V, 1985, ARZTL LAB, V31, P325; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Barre L, 2005, FEBS J, V272, P1063, DOI 10.1111/j.1742-4658.2005.04548.x; Belanger S, 1997, BIOL NEONATE, V71, P233; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P497; BERGMEYER HU, 1986, J CLIN CHEM CLIN BIO, V24, P481; BERK PD, 1969, J CLIN INVEST, V48, P2176, DOI 10.1172/JCI106184; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; Borucki K, 2009, CLIN BIOCHEM, V42, P1635, DOI 10.1016/j.clinbiochem.2009.08.011; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Burtis C., 2012, TIETZ TEXTBOOK OF CL; Carmody R, GENETIC EVIDENCE OF; Chuniaud L, 1996, CLIN CHIM ACTA, V256, P103, DOI 10.1016/S0009-8981(96)06407-8; Dannemann M, 2012, GENOME BIOL EVOL, V4, P552, DOI 10.1093/gbe/evs033; DIEPLINGER H, 1995, J LIPID RES, V36, P813; DIMAGNO EP, 1989, MAYO CLIN PROC, V64, P1226, DOI 10.1016/S0025-6196(12)61285-3; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Doumas BT, 1997, CLIN CHIM ACTA, V258, P21, DOI 10.1016/S0009-8981(96)06447-9; Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6; Egger M, 2003, GOOGLE PATENTS; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ernst E, 1984, MESSUNG DES KOLLOIDO, P20; Farrell CM, 2014, NUCLEIC ACIDS RES, V42, pD865, DOI 10.1093/nar/gkt1059; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Gagneux P, 2001, AM J PHYS ANTHROPOL, V115, P99, DOI 10.1002/ajpa.1061; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grojean S, 2000, EXP NEUROL, V166, P334, DOI 10.1006/exnr.2000.7518; GVOZDENOVIC LV, 1993, HUM EXP TOXICOL, V12, P279, DOI 10.1177/096032719301200404; Hajer GR, 2008, CLIN ENDOCRINOL, V69, P870, DOI 10.1111/j.1365-2265.2008.03250.x; Hall D, 1999, PHARMACOGENETICS, V9, P591, DOI 10.1097/01213011-199910000-00006; Hanko E, 2005, PEDIATR RES, V57, P179, DOI 10.1203/01.PDR.0000148711.11519.A5; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Harte RA, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas008; Henry R, 1974, CLINICAL CHEMISTRY P; Herndon JG, 2001, COMPARATIVE MED, V51, P60; Hoffman DJ, 1996, PEDIATR RES, V40, P804, DOI 10.1203/00006450-199612000-00005; Horsfall LJ, 2012, CIRCULATION, V126, P2556, DOI 10.1161/CIRCULATIONAHA.112.114066; Horsfall LJ, 2011, JAMA-J AM MED ASSOC, V305, P691, DOI 10.1001/jama.2011.124; Hoyle N.R., 1994, J BIOLUMIN CHEMILUMI, V9, P289; Jenkins DJA, 2003, JAMA-J AM MED ASSOC, V290, P502, DOI 10.1001/jama.290.4.502; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; JOHNSTONE RE, 1976, CLIN CHEM, V22, P217; Kim CY, 2005, J MED PRIMATOL, V34, P96, DOI 10.1111/j.1600-0684.2005.00097.x; Konopka G, 2012, NEURON, V75, P601, DOI 10.1016/j.neuron.2012.05.034; KRAMSCH DM, 1981, NEW ENGL J MED, V305, P1483, DOI 10.1056/NEJM198112173052501; Kratzsch J, 2005, CLIN CHEM, V51, P1480, DOI 10.1373/clinchem.2004.047399; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Laakkonen L, 2010, MOL PHARMACOL, V77, P931, DOI 10.1124/mol.109.063289; LEE JA, 1976, BIOCHEM MED METAB B, V16, P116, DOI 10.1016/0006-2944(76)90014-4; Leonard WR, 2007, ANNU REV NUTR, V27, P311, DOI 10.1146/annurev.nutr.27.061406.093659; LEUTENEGGER W, 1977, Primates, V18, P117, DOI 10.1007/BF02382954; Lin JP, 2010, CLIN CHEM, V56, P1535, DOI 10.1373/clinchem.2010.151043; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x; Matsuzaki Y, 1996, J ANAL BIOSC, V19, P419; MCCLURE HM, 1972, FOLIA PRIMATOL, V18, P300, DOI 10.1159/000155485; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Neumann U, 1987, Eur Patent, Patent No. 207252; O'Bleness M, 2012, NAT REV GENET, V13, P853, DOI 10.1038/nrg3336; PAABO S, 1987, CELL, V50, P311, DOI 10.1016/0092-8674(87)90226-1; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perlstein TS, 2008, AM J MED, V121, P781, DOI 10.1016/j.amjmed.2008.03.045; PRICE CP, 1987, J IMMUNOL METHODS, V99, P205, DOI 10.1016/0022-1759(87)90129-3; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2012, NATURE; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rifai N, 1998, CLIN CHEM, V44, P1242; Rilling JK, 2008, YEARB PHYS ANTHROPOL, V51, P2, DOI 10.1002/ajpa.20947; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; Rovirosa-Hernandez MJ, 2011, J MED PRIMATOL, V40, P294, DOI 10.1111/j.1600-0684.2011.00474.x; ROWE AW, 1994, J MED PRIMATOL, V23, P415, DOI 10.1111/j.1600-0684.1994.tb00130.x; Santarpia L, 2013, J CACHEXIA SARCOPENI, V4, P31, DOI 10.1007/s13539-012-0083-5; SCHMIDT E, 1992, EUR J CLIN CHEM CLIN, V30, P247; SCHMIDT FH, 1961, KLIN WOCHENSCHR, V39, P1244, DOI 10.1007/BF01506150; Schultz, 1969, LIFE PRIMATES; Schumann G, 2003, CLIN CHIM ACTA, V327, P69, DOI 10.1016/S0009-8981(02)00341-8; Seppen J, 2012, CIRCULATION, V126, P2547, DOI 10.1161/CIRCULATIONAHA.112.147082; SIEDEL J, 1983, CLIN CHEM, V29, P1075; SIEDEL J, 1988, CLIN CHEM, V34, P1821; Siekmeier R, 1996, LAB MED, V20, P294; Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stone GA, 2000, J MED PRIMATOL, V29, P324, DOI 10.1034/j.1600-0684.2000.290503.x; Strassburg CP, 2008, PHARMACOGENOMICS, V9, P703, DOI 10.2217/14622416.9.6.703; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Takenaka A, 2000, PRIMATES, V41, P299, DOI 10.1007/BF02557599; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Thomas L., 2008, LABOR UND DIAGNOSE I; Town M-H., 1985, J CLIN CHEM CLIN BIO; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Vacha J., 1983, RED BLOOD CELLS DOME, P67; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Videan EN, 2009, COMPARATIVE MED, V59, P287; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vitek L, 2009, CURR PHARM DESIGN, V15, P2869, DOI 10.2174/138161209789058237; Wahlefeld AW, 1972, SCAND J CLIN LAB INV, V29; WEICHSELBAUM T E, 1946, Am J Clin Pathol, V10, P40; WIEBE DA, 1984, CLIN CHEM, V30, P352	115	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134548	10.1371/journal.pone.0134548	http://dx.doi.org/10.1371/journal.pone.0134548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247603	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300045
J	Wu, SX; Xia, B; Han, F; Xie, RF; Song, T; Lu, LX; Yu, W; Deng, XW; He, QC; Zhao, C; Xie, CH				Wu, Shixiu; Xia, Bing; Han, Fei; Xie, Ruifei; Song, Tao; Lu, Lixia; Yu, Wei; Deng, Xiaowu; He, Qiancheng; Zhao, Cong; Xie, Conghua			Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							PRIMARY TUMOR VOLUME; RADIATION-THERAPY; CHEMOTHERAPY; CANCER; EXPERIENCE; TRIAL; STAGE; METAANALYSIS; PREDICTIONS; CONCURRENT	This study was aimed to define possible predictors of overall survival in nasopharyngeal carcinoma (NPC). Patients were treated with intensity-modulated radiation therapy (IMRT), to establish an effective prognostic nomogram that could provide individualized predictions of treatment outcome in this setting. We reviewed the records of 533 patients with non-metastatic NPC who underwent IMRT with or without concurrent chemotherapy at the Department of Radiation Oncology of Sun Yat-Sen University from 2002 to 2009; none of these patients received induction or adjuvant chemotherapy. These data sets were used to construct a nomogram based on Cox regression. Nomogram performance was determined via a concordance index (C-index) and a calibration curve which was compared with the TNM staging system for NPC. The results were validated in an external cohort of 442 patients from the Department of Radiation Oncology of Wenzhou Medical College who were treated during the same period. Results showed that the greatest influence on survival were primary gross tumor volume, age, tumor stage and nodal stage (2002 Union for International Cancer Control [UICC] staging system), which were selected into the nomogram. The C-index of the nomogram for predicting survival was 0.748 (95% CI, 0.704-0.785), which was statistically higher than that of TNM staging system (0.684, P<0.001). The calibration curve exhibited agreement between nomogram-predicted and the actual observed probabilities for overall survival. In the validation cohort, the nomogram discrimination was superior to the TNM staging system (C-index: 0.768 vs 0.721; P = 0.026). In conclusion, the nomogram proposed in this study resulted in more-accurate prognostic prediction for patients with NPC after IMRT and compared favorably to the TNM staging system; this individualized information will aid in patient counseling and may be used for de-escalation trials in the future.	[Wu, Shixiu; Xie, Conghua] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430072, Hubei, Peoples R China; [Wu, Shixiu; Xie, Conghua] Wuhan Univ, Hubei Canc Clin Study Ctr, Wuhan 430072, Hubei, Peoples R China; [Wu, Shixiu; Xia, Bing; Xie, Ruifei] Hangzhou Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Han, Fei; Lu, Lixia; Deng, Xiaowu; Zhao, Cong] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Han, Fei; Lu, Lixia; Deng, Xiaowu; Zhao, Cong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Han, Fei; Lu, Lixia; Deng, Xiaowu; Zhao, Cong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Song, Tao; Yu, Wei; He, Qiancheng] Wenzhou Med Coll Canc Ctr, Dept Radiat Oncol, Wenzhou, Zhejiang, Peoples R China	Wuhan University; Wuhan University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, CH (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430072, Hubei, Peoples R China.	xiechonghuast@yeah.net	Han, Fei/AAD-7348-2021	Han, Fei/0000-0002-1598-9048; Deng, Xiaowu/0000-0003-2923-1251				Abu-Rustum NR, 2010, GYNECOL ONCOL, V116, P399, DOI 10.1016/j.ygyno.2009.11.027; Ali S, 2013, JAMA OTOLARYNGOL, V139, P698, DOI 10.1001/jamaoto.2013.3347; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Chen CB, 2011, JPN J CLIN ONCOL, V41, P537, DOI 10.1093/jjco/hyq242; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Guo R, 2012, RADIOTHER ONCOL, V104, P294, DOI 10.1016/j.radonc.2012.09.001; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; JOHNSON CR, 1995, INT J RADIAT ONCOL, V33, P281, DOI 10.1016/0360-3016(95)00119-J; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kwong DLW, 2004, J CLIN ONCOL, V22, P2643, DOI 10.1200/JCO.2004.05.173; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; Lee CC, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-20; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Lee N, 2009, J CLIN ONCOL, V27, P3684, DOI 10.1200/JCO.2008.19.9109; Liang W, 2015, J CLIN ONCOLOGY; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Ma J, 2001, J CLIN ONCOL, V19, P1350, DOI 10.1200/JCO.2001.19.5.1350; Marks JE, 1998, CANCER, V83, P582, DOI 10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2-R; Montero PH, 2014, CANCER-AM CANCER SOC, V120, P214, DOI 10.1002/cncr.28407; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Polterauer S, 2012, BRIT J CANCER, V107, P918, DOI 10.1038/bjc.2012.340; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Velazquez ER, 2014, RADIOTHER ONCOL, V113, P324, DOI 10.1016/j.radonc.2014.09.005; Wang Y, 2013, CANCER EPIDEMIOL, V37, P793, DOI 10.1016/j.canep.2013.08.008; Wu SX, 2006, INT J RADIAT ONCOL, V66, pS40, DOI 10.1016/j.ijrobp.2005.12.041; Wu Z, 2013, HEAD NECK-J SCI SPEC, V35, P689, DOI 10.1002/hed.23010; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Xu ZJ, 2013, CHIN J CANCER, V32, P453, DOI 10.5732/cjc.013.10118; Yip TTC, 2014, ORAL ONCOL, V50, P527, DOI 10.1016/j.oraloncology.2013.12.011	34	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134491	10.1371/journal.pone.0134491	http://dx.doi.org/10.1371/journal.pone.0134491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248338	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300041
J	Ye, F; Ao, D; Feng, Y; Wang, L; Chen, J; Huntington, D; Wang, HJ; Wang, Y				Ye, Fang; Ao, Deng; Feng, Yao; Wang, Lin; Chen, Jie; Huntington, Dale; Wang, Haijun; Wang, Yan		Econ Impact Maternal Deaths China	Impact of Maternal Death on Household Economy in Rural China: A Prospective Path Analysis	PLOS ONE			English	Article							HEALTH	Objectives The present study aimed to explore the inter-relationships among maternal death, household economic status after the event, and potential influencing factors. Methods We conducted a prospective cohort study of households that had experienced maternal death (n = 195) and those that experienced childbirth without maternal death (n = 384) in rural China. All the households were interviewed after the event occurred and were followed up 12 months later. Structural equation modeling was used to test the relationship model, utilizing income and expenditure per capita in the following year after the event as the main outcome variables, maternal death as the predictor, and direct costs, the amount of money offset by positive and negative coping strategies, whether the husband remarried, and whether the newborn was alive as the mediators. Results In the following year after the event, the path analysis revealed a direct effect from maternal death to lower income per capita (standardized coefficient = -0.43, p = 0.041) and to lower expenditure per capita (standardized coefficient = -0.51, p<0.001). A significant indirect effect was found from maternal death to lower income and expenditure per capita mediated by the influencing factors of higher direct costs, less money from positive coping methods, more money from negative coping, and the survival of the newborn. Conclusion This study analyzed the direct and indirect effects of maternal death on a household economy. The results provided evidence for better understanding the mechanism of how this event affects a household economy and provided a reference for social welfare policies to target the most vulnerable households that have suffered from maternal deaths.	[Ye, Fang; Wang, Lin; Chen, Jie] China Japan Friendship Hosp, Dept Prevent Hlth Care, Beijing, Peoples R China; [Ao, Deng; Feng, Yao; Wang, Yan] Peking Univ, Div Maternal & Child Hlth, Sch Publ Hlth, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org Western Pacific Reg Off, Asia Pacific Observ Hlth Syst & Policies, Manila, Philippines; [Wang, Haijun] Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, Beijing 100871, Peoples R China	China-Japan Friendship Hospital; Peking University; World Health Organization; Peking University	Wang, HJ (corresponding author), Peking Univ, Inst Child & Adolescent Hlth, Sch Publ Hlth, 38 Xueyuan Rd, Beijing 100871, Peoples R China.	whjun1@bjmu.edu.cn; wangyan@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland;  [A65403]	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland; 	The study was supported by a grant from the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization, Geneva, Switzerland. (http://www.who.int/reproductivehealth/en/). The grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Greene M.E., 2005, POVERTY REDUCTION DO; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Islam MK, 2006, COSTS MATERNAL NEWBO; Muthen B., 2010, MPLUS USERS GUIDE; Reed HE., 2000, CONSEQUENCES MATERNA; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076624; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467	11	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134756	10.1371/journal.pone.0134756	http://dx.doi.org/10.1371/journal.pone.0134756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247210	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300062
J	Chasapi, A; Wachowicz, P; Niknejad, A; Collin, P; Krapp, A; Cano, E; Simanis, V; Xenarios, I				Chasapi, Anastasia; Wachowicz, Paulina; Niknejad, Anne; Collin, Philippe; Krapp, Andrea; Cano, Elena; Simanis, Viesturs; Xenarios, Ioannis			An Extended, Boolean Model of the Septation Initiation Network in S-pombe Provides Insights into Its Regulation	PLOS ONE			English	Article							SPINDLE-POLE BODY; YEAST SCHIZOSACCHAROMYCES-POMBE; ANAPHASE-PROMOTING COMPLEX; GTPASE-ACTIVATING PROTEIN; FISSION YEAST; CELL-CYCLE; SEPTUM FORMATION; SIN ASYMMETRY; BUDDING YEAST; DROSOPHILA-MELANOGASTER	Cytokinesis in fission yeast is controlled by the Septation Initiation Network (SIN), a protein kinase signaling network using the spindle pole body as scaffold. In order to describe the qualitative behavior of the system and predict unknown mutant behaviors we decided to adopt a Boolean modeling approach. In this paper, we report the construction of an extended, Boolean model of the SIN, comprising most SIN components and regulators as individual, experimentally testable nodes. The model uses CDK activity levels as control nodes for the simulation of SIN related events in different stages of the cell cycle. The model was optimized using single knock-out experiments of known phenotypic effect as a training set, and was able to correctly predict a double knock-out test set. Moreover, the model has made in silico predictions that have been validated in vivo, providing new insights into the regulation and hierarchical organization of the SIN.	[Chasapi, Anastasia; Niknejad, Anne; Xenarios, Ioannis] SIB, Vital IT Grp, Lausanne, Switzerland; [Wachowicz, Paulina; Collin, Philippe; Krapp, Andrea; Cano, Elena; Simanis, Viesturs] Ecole Polytech Fed Lausanne, Cell Cycle Control Lab, SV ISREC, CH-1015 Lausanne, Switzerland; [Xenarios, Ioannis] SIB, Swiss Prot Grp, Geneva, Switzerland	Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; University of Geneva	Simanis, V (corresponding author), Ecole Polytech Fed Lausanne, Cell Cycle Control Lab, SV ISREC, CH-1015 Lausanne, Switzerland.	viesturs.simanis@epfl.ch; ioannis.xenarios@isb-sib.ch	Xenarios, Ioannis/ABD-5045-2021	Xenarios, Ioannis/0000-0002-3413-6841; Chasapi, Anastasia/0000-0003-1986-5007; NIKNEJAD, Anne/0000-0003-3308-6245	SINERGIA grant from the Swiss National Science Foundation [CRSII3_132392]; Swiss National Science Foundation grant [31003A_138176, 109454]; State Secretariat for Research and Innovation (SEFRI)	SINERGIA grant from the Swiss National Science Foundation; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); State Secretariat for Research and Innovation (SEFRI)	This work was funded by a SINERGIA grant from the Swiss National Science Foundation (CRSII3_132392), a Swiss National Science Foundation grant to VS (31003A_138176) and PC (109454) and State Secretariat for Research and Innovation (SEFRI) for IX and AN. PC contributed to the study while being affiliated to VS's research group, before his association with his current affiliation with the Horizon Discovery Group. The Horizon Discovery Group had no funding role, and no input into the design or execution of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alcaide-Gavilan M, 2014, GENETICS, V196, P455, DOI 10.1534/genetics.113.155218; Azpeitia E, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00092; Bajpai A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003147; Balasubramanian MK, 1997, METHOD ENZYMOL, V283, P494; Balasubramanian MK, 1998, GENETICS, V149, P1265; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Bateman A, 2010, BIOINFORMATICS, V26, P991, DOI 10.1093/bioinformatics/btq101; Baum B, 1997, EMBO J, V16, P4676, DOI 10.1093/emboj/16.15.4676; Cerutti L, 1999, J CELL SCI, V112, P2313; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; Chang L, 2001, MOL CELL BIOL, V21, P6681, DOI 10.1128/MCB.21.19.6681-6694.2001; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Chaves M, 2006, IEE P SYST BIOL, V153, P154, DOI 10.1049/ip-syb:20050079; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chew TG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040017; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Csikasz-Nagy A, 2007, CURR GENET, V51, P245, DOI 10.1007/s00294-007-0123-4; Daga RR, 2005, EMBO J, V24, P2436, DOI 10.1038/sj.emboj.7600705; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Dischinger S, 2008, J CELL SCI, V121, P843, DOI 10.1242/jcs.021584; FANKHAUSER C, 1994, EMBO J, V13, P3011, DOI 10.1002/j.1460-2075.1994.tb06600.x; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Fennessy D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097683; Feoktistova A, 2012, MOL BIOL CELL, V23, P1636, DOI 10.1091/mbc.E11-09-0792; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Furge KA, 1999, J BIOL CHEM, V274, P11339, DOI 10.1074/jbc.274.16.11339; Furge KA, 1998, CURR BIOL, V8, P947, DOI 10.1016/S0960-9822(98)70394-X; Garcia-Cortes JC, 2009, J CELL BIOL, V186, P739, DOI 10.1083/jcb.200902116; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Garg A, 2012, METHODS MOL BIOL, V786, P397, DOI 10.1007/978-1-61779-292-2_22; Garg A, 2009, BIOINFORMATICS, V25, pI101, DOI 10.1093/bioinformatics/btp214; Giacomantonio CE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000936; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Grallert A, 2004, GENE DEV, V18, P1007, DOI 10.1101/gad.296204; Grallert A, 2002, EMBO J, V21, P3096, DOI 10.1093/emboj/cdf294; Grallert A, 2013, NAT CELL BIOL, V15, P88, DOI 10.1038/ncb2633; Grallert A, 2012, NAT CELL BIOL, V14, P738, DOI 10.1038/ncb2514; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; Guertin DA, 2001, J BIOL CHEM, V276, P28185, DOI 10.1074/jbc.M103802200; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Helikar T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-58; HIRANO T, 1988, J CELL BIOL, V106, P1171, DOI 10.1083/jcb.106.4.1171; Hou MC, 2000, CURR BIOL, V10, P619, DOI 10.1016/S0960-9822(00)00492-9; Hou MC, 2004, MOL CELL BIOL, V24, P3262, DOI 10.1128/MCB.24.8.3262-3276.2004; Ingalls BP, 2007, CANCER INFORM, V3, P357; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Kahlem P, 2011, SYSTEMS AND COMPUTAT; Kauffman S. A., 1993, ORIGINS ORDER; Kochi N, 2012, BIOSYSTEMS, V108, P14, DOI 10.1016/j.biosystems.2011.12.001; Krapp A, 2003, CURR BIOL, V13, P168, DOI 10.1016/S0960-9822(02)01417-3; Krapp A, 2001, CURR BIOL, V11, P1559, DOI 10.1016/S0960-9822(01)00478-X; Krapp A, 2008, J CELL SCI, V121, P601, DOI 10.1242/jcs.022772; Krien MJE, 1998, J CELL SCI, V111, P967; KUMADA K, 1995, J CELL SCI, V108, P895; Lahoz A, 2010, GENETICS, V186, P1261, DOI 10.1534/genetics.110.121368; Li CX, 2000, J BIOL CHEM, V275, P14381, DOI 10.1074/jbc.275.19.14381; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; MARKS J, 1992, J CELL SCI, V101, P801; Mehta S, 2006, J BIOL CHEM, V281, P9935, DOI 10.1074/jbc.M600160200; MINET M, 1979, J BACTERIOL, V137, P440, DOI 10.1128/JB.137.1.440-446.1979; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Naldi A, 2007, LECT NOTES COMPUT SC, V4695, P233; Poux S, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau016; Rachfall N, 2014, MOL BIOL CELL; Rosenberg JA, 2006, MOL BIOL CELL, V17, P3793, DOI 10.1091/mbc.e06-01-0039; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Salimova E, 2000, J CELL SCI, V113, P1695; Samaga R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000438; Sanchez L, 1997, J THEOR BIOL, V189, P377, DOI 10.1006/jtbi.1997.0523; Schlatter R, 2012, BRIEF BIOINFORM, V13, P365, DOI 10.1093/bib/bbr065; Schlatter R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000595; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; Schmitter D, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-6; Seshan A, 2004, CURR OPIN CELL BIOL, V16, P41, DOI 10.1016/j.ceb.2003.11.003; Simanis V, 2003, J CELL SCI, V116, P4261, DOI 10.1242/jcs.00777; Simanis V, 2015, J CELL SCI, V128, P1465, DOI 10.1242/jcs.094821; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; Tanaka K, 2001, EMBO J, V20, P1259, DOI 10.1093/emboj/20.6.1259; Tomlin GC, 2002, MOL BIOL CELL, V13, P1203, DOI 10.1091/mbc.01-09-0455; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191; Veliz-Cuba A, 2011, J COMPUT BIOL, V18, P783, DOI 10.1089/cmb.2011.0031; Wachowicz P, 2015, J CELL SCI, V128, P741, DOI 10.1242/jcs.160150; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; WOODS A, 1989, J CELL SCI, V93, P491; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x	97	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134214	10.1371/journal.pone.0134214	http://dx.doi.org/10.1371/journal.pone.0134214			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244885	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400071
J	Che, PL; Chen, YJ; Lu, RJ; Peng, N; Gannon, M; Wyss, JM; Jiao, K; Wang, Q				Che, Pulin; Chen, Yunjia; Lu, Roujian; Peng, Ning; Gannon, Mary; Wyss, J. Michael; Jiao, Kai; Wang, Qin			Spinophilin Is Indispensable for the alpha(2B) Adrenergic Receptor-Elicited Hypertensive Response	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD INTRACELLULAR LOOP; ALPHA(2B)-ADRENERGIC RECEPTOR; ALPHA(2)-ADRENERGIC RECEPTORS; ALPHA(2A)-ADRENERGIC RECEPTOR; IN-VIVO; BINDING-PROTEIN; BETA-ARRESTINS; TRAFFICKING; SUBTYPE	The alpha(2) adrenergic receptor (AR) subtypes are important for blood pressure control. When activated, the alpha(2A) subtype elicits a hypotensive response whereas the alpha(2B) subtype mediates a hypertensive effect that counteracts the hypotensive response by the alpha(2A) subtype. We have previously shown that spinophilin attenuates the alpha(2A)AR-dependent hypotensive response; in spinophilin null mice, this response is highly potentiated. In this study, we demonstrate that spinophilin impedes arrestin-dependent phosphorylation and desensitization of the alpha(2B)AR subtype by competing against arrestin binding to this receptor subtype. The Del301-303 alpha(2B)AR, a human variation that shows impaired phosphorylation and desensitization and is linked to hypertension in certain populations, exhibits preferential interaction with spinophilin over arrestin. Furthermore, Del301-303 alpha(2B)AR-induced ERK signaling is quickly desensitized in cells without spinophilin expression, showing a profile similar to that induced by the wild type receptor in these cells. Together, these data suggest a critical role of spinophilin in sustaining alpha(2B)AR signaling. Consistent with this notion, our in vivo study reveals that the alpha(2B)AR-elicited hypertensive response is diminished in spinophilin deficient mice. In arrestin 3 deficient mice, where the receptor has a stronger binding to spinophilin, the same hypertensive response is enhanced. These data suggest that interaction with spinophilin is indispensable for the alpha(2B)AR to elicit the hypertensive response. This is opposite of the negative role of spinophilin in regulating alpha(2A)AR-mediated hypotensive response, suggesting that spinophilin regulation of these closely related receptor subtypes can result in distinct functional outcomes in vivo. Thus, spinophilin may represent a useful therapeutic target for treatment of hypertension.	[Che, Pulin; Chen, Yunjia; Peng, Ning; Gannon, Mary; Wyss, J. Michael; Wang, Qin] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Lu, Roujian] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Alabama System; University of Alabama Birmingham	Wang, Q (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu		Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020; Wyss, J Michael/0000-0003-1094-2934	National Institute of Mental Health [MH081917]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported by National Institute of Mental Health grant MH081917 to QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; DeGraff JL, 1999, J BIOL CHEM, V274, P11253, DOI 10.1074/jbc.274.16.11253; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; JEWELLMOTZ EA, 1995, BIOCHEMISTRY-US, V34, P11946, DOI 10.1021/bi00037a036; Kable JW, 2000, J PHARMACOL EXP THER, V293, P1; Kintsurashvili E, 2003, J HYPERTENS, V21, P961, DOI 10.1097/00004872-200305000-00021; Kintsurashvili E, 2001, HYPERTENSION, V38, P1075, DOI 10.1161/hy1101.093426; Knaus AE, 2007, NEUROCHEM INT, V51, P277, DOI 10.1016/j.neuint.2007.06.036; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kurko D, 2014, BRAIN RES BULL, V107, P89, DOI 10.1016/j.brainresbull.2014.07.005; Link RE, 1996, SCIENCE, V273, P803, DOI 10.1126/science.273.5276.803; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; MacDonald E, 1997, TRENDS PHARMACOL SCI, V18, P211; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Makaritsis KP, 1999, HYPERTENSION, V33, P14, DOI 10.1161/01.HYP.33.1.14; Menard L, 1997, MOL PHARMACOL, V51, P800, DOI 10.1124/mol.51.5.800; Muszkat M, 2010, J HYPERTENS, V28, P278, DOI 10.1097/HJH.0b013e328333d212; Ohlin B, 2007, J HYPERTENS, V25, P1613; Olli-Lahdesmaki T, 2003, EUR J CELL BIOL, V82, P231, DOI 10.1078/0171-9335-00311; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; von Wowern F, 2004, HYPERTENSION, V43, P592, DOI 10.1161/01.HYP.0000116224.51189.80; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	41	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135030	10.1371/journal.pone.0135030	http://dx.doi.org/10.1371/journal.pone.0135030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244553	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400138
J	Chu, YH; Li, HH; Tan, HS; Koh, V; Lai, J; Phyo, WM; Choudhury, Y; Kanesvaran, R; Chau, NM; Toh, CK; Ng, QS; Tan, PH; Chowbay, B; Tan, MH				Chu, Ying-Hsia; Li, Huihua; Tan, Hui Shan; Koh, Valerie; Lai, Johnathan; Phyo, Wai Min; Choudhury, Yukti; Kanesvaran, Ravindran; Chau, Noan Minh; Toh, Chee Keong; Ng, Quan Sing; Tan, Puay Hoon; Chowbay, Balram; Tan, Min-Han			Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; 1ST-LINE SUNITINIB; PREDICTIVE FACTORS; ANTITUMOR-ACTIVITY; INTERFERON-ALPHA; MDR1 GENE; CANCER; VEGF	Sunitinib is a tyrosine kinase inhibitor used as first-line treatment for metastatic renal cell carcinoma (mRCC). Asian ethnicity has been previously associated with lower clearance and greater toxicities for sunitinib treatment, relative to Caucasian ethnicity. Research focusing on identifying corresponding biomarkers of efficacy and toxicity has been hitherto conducted in Caucasian populations, and few of the reported associations have been externally validated. Our work thus aims to investigate candidate biomarkers in Asian patients receiving sunitinib, comparing the observed genotype effects with those reported in Caucasian populations. Using data from 97 Asian mRCC patients treated with sunitinib, we correlated 7 polymorphisms in FLT3, ABCB1, VEGFR2, ABCG2 and BIMwith patient toxicities, response, and survival. We observed a stronger association of FLT3 738T genotype with leucopenia in our Asian dataset than that previously reported in Caucasian mRCC patients (odds ratio [OR] =8.0; P=0.03). We observed significant associations of FLT3 738T (OR=2.7), ABCB11236T (OR=0.3), ABCB1 3435T (OR=0.1), ABCB1 2677T (OR=0.4), ABCG2 421A (OR=0.3) alleles and ABCB1 3435, 1236, 2677 TTT haplotype (OR=0.1) on neutropenia. Primary resistance (OR=0.1, P=0.004) and inferior survival (progression-free: hazard ratio [HR]=5.5, P=0.001; overall: HR=5.0, P=0.005) were associated with the ABCB1 3435, 1236, 2677 TTT haplotype. In conclusion, ABCB1 and FLT3 polymorphisms may be helpful in predicting sunitinib toxicities, response and survival benefit in Asian mRCC patients. We have also validated the association between FLT3 738T and sunitinib-induced leucopenia previously reported in Caucasian populations, but have not validated other reported genetic associations.	[Chu, Ying-Hsia; Lai, Johnathan; Phyo, Wai Min; Choudhury, Yukti; Tan, Min-Han] Inst Bioengn & Nanotechnol, Singapore, Singapore; [Li, Huihua] Singapore Gen Hosp, Hlth Serv Res, Singapore, Singapore; [Tan, Hui Shan; Kanesvaran, Ravindran; Chau, Noan Minh; Toh, Chee Keong; Ng, Quan Sing; Tan, Min-Han] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Koh, Valerie; Tan, Puay Hoon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Chowbay, Balram] Natl Canc Ctr Singapore, Div Med Sci, Lab Clin Pharmacol, Singapore, Singapore; [Chowbay, Balram] SingHealth, Clin Pharmacol Core, Singapore, Singapore; [Chowbay, Balram] Duke NUS Grad Med Sch, Clin Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Singapore General Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; National Cancer Centre Singapore (NCCS); National University of Singapore	Tan, MH (corresponding author), Inst Bioengn & Nanotechnol, Singapore, Singapore.	mhtan@ibn.a-star.edu.sg	Toh, Chee-Keong/AAC-9610-2020; Chu, Ying-Hsia/J-4738-2019; Tan, Min/GQQ-2702-2022	Chu, Ying-Hsia/0000-0002-8289-7418; Toh, Chee-Keong/0000-0002-5691-6144; Kanesvaran, Ravindran/0000-0002-2351-881X	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR))	This work is supported by the Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore), funding granted to MHT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuselinck B, 2013, BRIT J CANCER, V108, P887, DOI 10.1038/bjc.2012.548; Beuselinck B, 2014, ACTA ONCOL, V53, P1413, DOI 10.3109/0284186X.2014.918276; Beuselinck B, 2014, ACTA ONCOL, V53, P103, DOI 10.3109/0284186X.2013.770600; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Diekstra MHM, 2014, CLIN PHARMACOL THER, V96, P81, DOI 10.1038/clpt.2014.47; Eechoute K, 2012, CLIN PHARMACOL THER, V92, P503, DOI 10.1038/clpt.2012.136; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Houk BE, 2009, CLIN CANCER RES, V15, P2497, DOI 10.1158/1078-0432.CCR-08-1893; Jeannesson E, 2007, FUND CLIN PHARMACOL, V21, P411, DOI 10.1111/j.1472-8206.2007.00507.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Kim HS, 2011, ONCOLOGY-BASEL, V80, P395, DOI 10.1159/000330361; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Maeng CH, 2013, ANTICANCER RES, V33, P4619; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Naik E, 2011, J EXP MED, V208, P1351, DOI 10.1084/jem.20100951; National Cancer Institute, 2006, COMM TERM CRIT ADV E; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Onizuka M, 2011, BONE MARROW TRANSPL, V46, P1113, DOI 10.1038/bmt.2010.273; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Rutkowski P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-107; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Singh O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051771; Tan HS, 2015, CLIN GENITOURIN CANC, V13, pE285, DOI 10.1016/j.clgc.2014.11.004; Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456; van der Veldt AAM, 2011, CLIN CANCER RES, V17, P620, DOI 10.1158/1078-0432.CCR-10-1828; van Erp NP, 2009, J CLIN ONCOL, V27, P4406, DOI 10.1200/JCO.2008.21.7679; Yang F, 2010, MOL CANCER RES, V8, P35, DOI 10.1158/1541-7786.MCR-09-0220	40	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134102	10.1371/journal.pone.0134102	http://dx.doi.org/10.1371/journal.pone.0134102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244574	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400068
J	Li, SM; Li, SY; Kang, MT; Zhou, YH; Liu, LR; Li, H; Wang, YP; Zhan, SY; Gopinath, B; Mitchell, P; Wang, NL				Li, Shi-Ming; Li, Si-Yuan; Kang, Meng-Tian; Zhou, Yuehua; Liu, Luo-Ru; Li, He; Wang, Yi-Peng; Zhan, Si-Yan; Gopinath, Bamini; Mitchell, Paul; Wang, Ningli		Anyang Childhood Eye Study Grp	Near Work Related Parameters and Myopia in Chinese Children: the Anyang Childhood Eye Study	PLOS ONE			English	Article							RISK-FACTORS; NEARWORK; ONSET; SCHOOLCHILDREN; ACHIEVEMENT; REFRACTION; SAMPLE; LIGHT	Purpose To examine the associations of near work related parameters with spherical equivalent refraction and axial length in Chinese children. Methods A total of 1770 grade 7 students with mean age of 12.7 years were examined with cycloplegic autorefraction and axial length. Questions were asked regarding time spent in near work and outdoors per day, and near work related parameters. Results Multivariate models revealed the following associations with greater odds of myopia: continuous reading (> 45min), odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8; close television viewing distance (<= 3m), OR, 1.7; 95% CI, 1.2-2.3; head tilt when writing, OR, 1.3; 95% CI, 1.1-1.7, and desk lighting using fluorescent vs. incandescent lamp, OR, 1.5; 95% CI, 1.2-2.0. These factors, together with close reading distance and close nib-to-fingertip distance were significantly associated with greater myopia (P<0.01). Among near work activities, only reading more books for pleasure was significantly associated with greater myopia (P=0.03). Television viewing distance (<= 3 m), fluorescent desk light, close reading distance (<= 20 cm) and close nib-to-fingertip distance (<= 2 cm) were significantly associated with longer axial length (P<0.01). Reading distance, desk light, and reading books for pleasure had significant interaction effects with parental myopia. Conclusions Continuous reading, close distances of reading, television viewing and nib-to-fingertip, head tilt when writing, reading more books for pleasure and use of fluorescent desk light were significantly associated with myopia in 12-year-old Chinese children, which indicates that visual behaviors and environments may be important factors mediating the effects of near work on myopia.	[Li, Shi-Ming; Li, Si-Yuan; Kang, Meng-Tian; Zhou, Yuehua; Wang, Ningli] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Liu, Luo-Ru; Li, He; Wang, Yi-Peng] Anyang Eye Hosp, Anyang, Henan Province, Peoples R China; [Zhan, Si-Yan] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing 100871, Peoples R China; [Gopinath, Bamini; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Gopinath, Bamini; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	Capital Medical University; Peking University; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Wang, NL (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.	wningli@vip.163.com	Gopinath, Bamini/K-4286-2019; Mitchell, Paul/P-1498-2014	Gopinath, Bamini/0000-0003-3573-359X; 	Major State Basic Research Development Program of China ("973" Program) of the Ministry of Science and Technology [2011CB504601]; Major International (Regional) Joint Research Project of the National Natural Science Foundation of China [81120108007]; Beijing Nova Program [Z121107002512055]; National Natural Science Foundation of China [81300797]	Major State Basic Research Development Program of China ("973" Program) of the Ministry of Science and Technology; Major International (Regional) Joint Research Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of China ("973" Program, 2011CB504601) of the Ministry of Science and Technology, the Major International (Regional) Joint Research Project of the National Natural Science Foundation of China (81120108007), Beijing Nova Program (Z121107002512055) and the National Natural Science Foundation of China (81300797).	BEAR JC, 1981, CLIN GENET, V19, P462; Chen L, 2014, INT J OPHTHALMOL-CHI, V7, P163, DOI 10.3980/j.issn.2222-3959.2014.01.30; Czepita Damian, 2005, Ann Acad Med Stetin, V51, P33; French AN, 2013, OPHTHALMOLOGY, V120, P2100, DOI 10.1016/j.ophtha.2013.02.035; Guggenheim JA, 2003, BRIT J OPHTHALMOL, V87, P580, DOI 10.1136/bjo.87.5.580; Gwiazda J, 2005, OPTOMETRY VISION SCI, V82, P273, DOI 10.1097/01.OPX.0000159363.07082.7D; GWIAZDA J, 1993, INVEST OPHTH VIS SCI, V34, P690; Hartwig A, 2011, VISION RES, V51, P1712, DOI 10.1016/j.visres.2011.05.014; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Jones-Jordan LA, 2011, INVEST OPHTH VIS SCI, V52, P1841, DOI 10.1167/iovs.09-4997; Leung TW, 2011, OPHTHAL PHYSL OPT, V31, P137, DOI 10.1111/j.1475-1313.2010.00814.x; Li SM, 2013, OPHTHAL EPIDEMIOL, V20, P348, DOI 10.3109/09286586.2013.842596; MCBRIEN NA, 1993, INVEST OPHTH VIS SCI, V34, P205; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2006, INVEST OPHTH VIS SCI, V47, P837, DOI 10.1167/iovs.05-0888; Mutti DO, 2002, INVEST OPHTH VIS SCI, V43, P3633; Mutti DO, 2009, OPTOMETRY VISION SCI, V86, P76, DOI 10.1097/OPX.0b013e31819974ae; Neil Charman W, 2011, OPHTHALMIC PHYSL OPT; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Parssinen O, 2014, ACTA OPHTHALMOL; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2000, OPTOMETRY VISION SCI, V77, P549, DOI 10.1097/00006324-200010000-00009; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P855, DOI 10.1136/bjo.85.7.855; Saw SM, 2001, LANCET, V357, P390, DOI 10.1016/S0140-6736(05)71520-8; Walline JJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004916.pub3; Wang YW, 2013, VISION RES, V86, P43, DOI 10.1016/j.visres.2013.03.007; WONG L, 1993, J EPIDEMIOL COMMUN H, V47, P50, DOI 10.1136/jech.47.1.50; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668; Yu Y, 2011, OPHTHALMIC RES, V46, P80, DOI 10.1159/000323179	30	94	105	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134514	10.1371/journal.pone.0134514	http://dx.doi.org/10.1371/journal.pone.0134514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244865	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400085
J	Lucero, JE; Allen, PS; McMillan, BR				Lucero, Jacob E.; Allen, Phil S.; McMillan, Brock R.			Increased Primary Production from an Exotic Invader Does Not Subsidize Native Rodents	PLOS ONE			English	Article							APPARENT COMPETITION; PLANT INVASION; ASSOCIATIONAL SUSCEPTIBILITY; PEROMYSCUS-MANICULATUS; DESERT GRANIVORES; BIOTIC RESISTANCE; SAGEBRUSH-STEPPE; GREAT-BASIN; SEED; COMMUNITIES	Invasive plants have tremendous potential to enrich native food webs by subsidizing net primary productivity. Here, we explored how a potential food subsidy, seeds produced by the aggressive invader cheatgrass (Bromus tectorum), is utilized by an important guild of native consumers -granivorous small mammals-in the Great Basin Desert, USA. In a series of field experiments we examined 1) how cheatgrass invasion affects the density and biomass of seed rain at the ecosystem-level; 2) how seed resources from cheatgrass numerically affect granivorous small mammals; and 3) how the food preferences of native granivores might mediate the trophic integration of cheatgrass seeds. Relative to native productivity, cheatgrass invasion increased the density and biomass of seed rain by over 2000% (P < 0.01) and 3500% (P < 0.01), respectively. However, granivorous small mammals in native communities showed no positive response in abundance, richness, or diversity to experimental additions of cheatgrass seeds over one year. This lack of response correlated with a distinct preference for seeds from native grasses over seeds from cheatgrass. Our experiments demonstrate that increased primary productivity associated with exotic plant invasions may not necessarily subsidize consumers at higher trophic levels. In this context, cheatgrass invasion could disrupt native food webs by providing less-preferred resources that fail to enrich higher trophic levels.	[Lucero, Jacob E.; Allen, Phil S.; McMillan, Brock R.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA	Brigham Young University	Lucero, JE (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	lucero.jacob.e@gmail.com	Lucero, Jacob E./AAE-6249-2020		Brigham Young University through the Mentoring Environment Grant; Plant and Wildlife Science Department; Montana Institute on Ecosystems; NSF EPSCoR Track-1 [EPS-1101342]; University of Montana Division of Biological Sciences; Pittman-Robinson Federal Aid Grant [W-82-R]	Brigham Young University through the Mentoring Environment Grant; Plant and Wildlife Science Department; Montana Institute on Ecosystems; NSF EPSCoR Track-1; University of Montana Division of Biological Sciences; Pittman-Robinson Federal Aid Grant	This work was funded by Brigham Young University through the Mentoring Environment Grant and the Plant and Wildlife Science Department, the Montana Institute on Ecosystems, the NSF EPSCoR Track-1 EPS-1101342 (INSTEP 3), and the University of Montana Division of Biological Sciences. The Great Basin Research Center donated native seeds used in preference trials under the Pittman-Robinson Federal Aid Grant W-82-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY Z, 1983, OECOLOGIA, V57, P328, DOI 10.1007/BF00377176; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Baynes M, 2012, FUNGAL BIOL-UK, V116, P133, DOI 10.1016/j.funbio.2011.10.008; Beckstead J, 2008, INDIRECT EFFECTS CHE; Beckstead J, 2010, J ECOL, V98, P168, DOI 10.1111/j.1365-2745.2009.01599.x; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; BROWN JH, 1989, ECOLOGY, V70, P1507, DOI 10.2307/1938209; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; Buechner HK, 1952, J RANGE MANAGE, V5, P76; Cappuccino N, 2005, BIOL LETTERS, V1, P435, DOI 10.1098/rsbl.2005.0341; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Dangremond EM, 2010, ECOLOGY, V91, P2261, DOI 10.1890/09-0418.1; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; EVERETT RL, 1978, J RANGE MANAGE, V31, P70, DOI 10.2307/3897641; FLAKE LD, 1973, J MAMMAL, V54, P636, DOI 10.2307/1378963; GANO K. A., 1982, NW SCI, V54, P1; Gardner PM, 2011, 20115068 UT GEOL SUR; Hall LK, 2012, SOUTHWEST NAT, V57, P166, DOI 10.1894/0038-4909-57.2.166; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; HIRONAKA M, 1963, ECOLOGY, V44, P810, DOI 10.2307/1933038; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1987, AM NAT, V130, P412, DOI 10.1086/284718; Humphrey LD, 2001, WEST N AM NATURALIST, V61, P85; KELRICK MI, 1985, J RANGE MANAGE, V38, P65, DOI 10.2307/3899336; KELRICK MI, 1986, OECOLOGIA, V68, P327, DOI 10.1007/BF01036734; Kohl Michel T., 2012, Rangelands, V34, P24; Krebs C.J., 1999, ECOLOGICAL METHODOLO; KRITZMAN EB, 1974, J MAMMAL, V55, P172, DOI 10.2307/1379265; LARRISON E J, 1973, Great Basin Naturalist, V33, P255; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Luce M, 2013, THESIS U MONTANA; Lucero Jacob E., 2012, Seed Technology, V34, P217; MACK RN, 1981, AGRO-ECOSYSTEMS, V7, P145, DOI 10.1016/0304-3746(81)90027-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacMahon JA, 2000, ANNU REV ECOL SYST, V31, P265, DOI 10.1146/annurev.ecolsys.31.1.265; MALONE CR, 1967, WEEDS-U, V15, P381, DOI 10.2307/4041016; McMillan Brock R., 2005, Prairie Naturalist, V37, P29; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; OFARRELL MJ, 1978, J MAMMAL, V59, P657, DOI 10.2307/1380131; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Ortega YK, 2004, ECOL APPL, V14, P241, DOI 10.1890/02-5276; Ostoja SM, 2013, FUNCT ECOL, V27, P775, DOI 10.1111/1365-2435.12091; Ostoja SM, 2013, OIKOS, V122, P563, DOI 10.1111/j.1600-0706.2012.19969.x; Ostoja SM, 2009, DIVERS DISTRIB, V15, P863, DOI 10.1111/j.1472-4642.2009.00593.x; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Pearson DE, 2008, ECOL APPL, V18, P1489, DOI 10.1890/07-1789.1; Pearson DE, 2011, ECOLOGY, V92, P1748, DOI 10.1890/11-0164.1; Price MV, 1997, ECOLOGY, V78, P764; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; R Core Team, 2020, R LANG ENV STAT COMP; Rieder JP, 2010, BIOL INVASIONS, V12, P2429, DOI 10.1007/s10530-009-9653-7; Rowe CLJ, 2011, EVOL APPL, V4, P485, DOI 10.1111/j.1752-4571.2010.00162.x; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; SCHREIBER RK, 1979, J MAMMAL, V60, P416, DOI 10.2307/1379820; SIEG CH, 1986, NORTHWEST SCI, V60, P81; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; STEWART G, 1949, ECOLOGY, V30, P58, DOI 10.2307/1932277; Story JM, 1995, ENVIRON ENTOMOL, V24, P1467, DOI 10.1093/ee/24.6.1467; VALONE TJ, 1989, ECOLOGY, V70, P1800, DOI 10.2307/1938113; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WHISENANT SG, 1990, USDA INTERM, V276, P4; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; WINKWORTH R. E., 1962, JOUR RANGE MANAGEMENT, V15, P194, DOI 10.2307/3895247	67	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131564	10.1371/journal.pone.0131564	http://dx.doi.org/10.1371/journal.pone.0131564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244345	Green Submitted, gold, Green Published			2022-12-26	WOS:000359061400010
J	Safra, N; Hayward, LJ; Aguilar, M; Sacks, BN; Westropp, JL; Mohr, FC; Mellersh, CS; Bannasch, DL				Safra, Noa; Hayward, Louisa J.; Aguilar, Miriam; Sacks, Benjamin N.; Westropp, Jodi L.; Mohr, F. Charles; Mellersh, Cathryn S.; Bannasch, Danika L.			DNA Sequence Variants in the Five Prime Untranslated Region of the Cyclooxygenase-2 Gene Are Commonly Found in Healthy Dogs and Gray Wolves	PLOS ONE			English	Article							JUVENILE RENAL-DISEASE; ULTRASONOGRAPHIC FINDINGS; DYSPLASIA; EXPRESSION; NEPHROPATHY; PROMOTER; PROGRAM; ASPIRIN	The aim of this study was to investigate the frequency of regional DNA variants upstream to the translation initiation site of the canine Cyclooxygenase-2 (Cox-2) gene in healthy dogs. Cox-2 plays a role in various disease conditions such as acute and chronic inflammation, osteoarthritis and malignancy. A role for Cox-2 DNA variants in genetic predisposition to canine renal dysplasia has been proposed and dog breeders have been encouraged to select against these DNA variants. We sequenced 272-422 bases in 152 dogs unaffected by renal dysplasia and found 19 different haplotypes including 11 genetic variants which had not been described previously. We genotyped 7 gray wolves to ascertain the wildtype variant and found that the wolves we analyzed had predominantly the second most common DNA variant found in dogs. Our results demonstrate an elevated level of regional polymorphism that appears to be a feature of healthy domesticated dogs.	[Safra, Noa; Aguilar, Miriam; Bannasch, Danika L.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Hayward, Louisa J.; Mellersh, Cathryn S.] Anim Hlth Trust, Newmarket, Suffolk, England; [Sacks, Benjamin N.] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Davis, CA 95616 USA; [Westropp, Jodi L.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Mohr, F. Charles] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; Animal Health Trust; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Safra, N (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA.	nsafra@ucdavis.edu	Bannasch, Danika/GZL-8044-2022	Bannasch, Danika/0000-0002-7614-7207				Abraham LA, 2003, AUST VET J, V81, P336, DOI 10.1111/j.1751-0813.2003.tb11507.x; [Anonymous], 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049703; Auton A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003984; Batchelor DJ, 2013, DOMEST ANIM ENDOCRIN, V44, P139, DOI 10.1016/j.domaniend.2012.12.001; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOOTH K, 1990, VET REC, V127, P596; Bovee KC, 2003, P 28 WORLD C WORLD S; Brown SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028496; Bruder MC, 2010, TOXICOL PATHOL, V38, P1051, DOI 10.1177/0192623310382558; deMorais HSA, 1996, J AM VET MED ASSOC, V209, P792; DIBARTOLA SP, 1983, J AM VET MED ASSOC, V183, P693; Donald M, 2006, PATHOLOGIC BASIS VET, V1, P488; Dore M, 2011, VET PATHOL, V48, P254, DOI 10.1177/0300985810379434; Dudley A, 2013, J VET INTERN MED, V27, P141, DOI 10.1111/jvim.12022; Felkai C, 1997, ACTA VET HUNG, V45, P397; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; GIERSE JK, 1995, BIOCHEM J, V305, P479, DOI 10.1042/bj3050479; Greco DS, 2001, VET CLIN N AM-SMALL, V31, P393, DOI 10.1016/S0195-5616(01)50211-9; Hamajima Nobuyuki, 2001, Asian Pac J Cancer Prev, V2, P57; Hoppe A, 2000, J SMALL ANIM PRACT, V41, P422, DOI 10.1111/j.1748-5827.2000.tb03237.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lees GE, 1996, VET CLIN N AM-SMALL, V26, P1379, DOI 10.1016/S0195-5616(96)50133-6; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lobetti RG, 1996, J SMALL ANIM PRACT, V37, P552, DOI 10.1111/j.1748-5827.1996.tb02319.x; MORTON LD, 1990, VET PATHOL, V27, P455, DOI 10.1177/030098589902700612; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; OBRIEN TD, 1982, J AM VET MED ASSOC, V180, P658; Ogino S, 2007, J MOL DIAGN, V9, P1, DOI 10.2353/jmoldx.2007.060081; Ohara K, 2001, J VET MED SCI, V63, P1127, DOI 10.1292/jvms.63.1127; Olenick CL, 1999, CAN VET J, V40, P425; Pedersen N, 2013, J ANIM BREED GENET, V130, P236, DOI 10.1111/jbg.12017; PICUT CA, 1987, VET PATHOL, V24, P156, DOI 10.1177/030098588702400209; Rachakonda PS, 2008, ARTHRITIS RHEUM-US, V58, P2088, DOI 10.1002/art.23598; Rai MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025749; Roels S, 1997, J SMALL ANIM PRACT, V38, P115, DOI 10.1111/j.1748-5827.1997.tb03331.x; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Schulze C, 1998, VET QUART, V20, P146, DOI 10.1080/01652176.1998.9694861; Seiler GS, 2010, VET RADIOL ULTRASOUN, V51, P453, DOI 10.1111/j.1740-8261.2010.01674.x; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Whiteley MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016684; Young AE, 2008, ANIM BIOTECHNOL, V19, P1, DOI 10.1080/10495390701638328	42	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133127	10.1371/journal.pone.0133127	http://dx.doi.org/10.1371/journal.pone.0133127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244515	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400032
J	Thor, SW; Nguyen, H; Balish, A; Hoang, AN; Gustin, KM; Nhung, PT; Jones, J; Thu, NN; Davis, W; Ngoc, TNT; Jang, YH; Sleeman, K; Villanueva, J; Kile, J; Gubareva, LV; Lindstrom, S; Tumpey, TM; Davis, CT; Long, NT				Thor, Sharmi W.; Nguyen, Hieu; Balish, Amanda; Anh Nguyen Hoang; Gustin, Kortney M.; Pham Thi Nhung; Jones, Joyce; Ngoc Nguyen Thu; Davis, William; Thao Nguyen Thi Ngoc; Jang, Yunho; Sleeman, Katrina; Villanueva, Julie; Kile, James; Gubareva, Larisa V.; Lindstrom, Stephen; Tumpey, Terrence M.; Davis, C. Todd; Nguyen Thanh Long			Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; SINGLE AMINO-ACID; A VIRUS; PROINFLAMMATORY CYTOKINES; INCREASED VIRULENCE; MOLECULAR-BASIS; HEMAGGLUTININ; PATHOGENESIS; INFECTION; CELL	Highly pathogenic avian influenza (HPAI) H5N1 is endemic in Vietnamese poultry and has caused sporadic human infection in Vietnam since 2003. Human infections with HPAI H5N1 are of concern due to a high mortality rate and the potential for the emergence of pandemic viruses with sustained human-to-human transmission. Viruses isolated from humans in southern Vietnam have been classified as clade 1 with a single genome constellation (VN3) since their earliest detection in 2003. This is consistent with detection of this clade/genotype in poultry viruses endemic to the Mekong River Delta and surrounding regions. Comparison of H5N1 viruses detected in humans from southern Vietnamese provinces during 2012 and 2013 revealed the emergence of a 2013 reassortant virus with clade 1.1.2 hemagglutinin (HA) and neuraminidase (NA) surface protein genes but internal genes derived from clade 2.3.2.1a viruses (A/Hubei/1/2010-like; VN12). Closer analysis revealed mutations in multiple genes of this novel genotype (referred to as VN49) previously associated with increased virulence in animal models and other markers of adaptation to mammalian hosts. Despite the changes identified between the 2012 and 2013 genotypes analyzed, their virulence in a ferret model was similar. Antigenically, the 2013 viruses were less cross-reactive with ferret antiserum produced to the clade 1 progenitor virus, A/Vietnam/1203/2004, but reacted with antiserum produced against a new clade 1.1.2 WHO candidate vaccine virus (A/Cambodia/W0526301/2012) with comparable hemagglutination inhibition titers as the homologous antigen. Together, these results indicate changes to both surface and internal protein genes of H5N1 viruses circulating in southern Vietnam compared to 2012 and earlier viruses.	[Thor, Sharmi W.; Balish, Amanda; Gustin, Kortney M.; Jones, Joyce; Davis, William; Jang, Yunho; Sleeman, Katrina; Villanueva, Julie; Kile, James; Gubareva, Larisa V.; Lindstrom, Stephen; Tumpey, Terrence M.; Davis, C. Todd] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30322 USA; [Nguyen, Hieu; Anh Nguyen Hoang; Pham Thi Nhung; Ngoc Nguyen Thu; Thao Nguyen Thi Ngoc; Nguyen Thanh Long] Natl Influenza Ctr 2, Inst Pasteur Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Kile, James] Ctr Dis Control & Prevent Vietnam, Influenza Program, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA	Davis, CT (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30322 USA.	ctdavis@cdc.gov; longpasteurhcm@yahoo.com						[Anonymous], 2012, Wkly Epidemiol Rec, V87, P369; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Balish AL, 2010, AVIAN DIS, V54, P329, DOI 10.1637/8903-042909-Reg.1; Belser JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002569; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Chen H., 2014, LANCET; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Creanga A, 2013, VIROLOGY, V444, P12, DOI 10.1016/j.virol.2013.06.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO, 2011, FAO OIE WHO TECHNICA; Fiebig L, 2011, EURO SURVEILL, V16; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Golebiewski L, 2011, J VIROL, V85, P10639, DOI 10.1128/JVI.05070-11; Hai R, 2010, J VIROL, V84, P4442, DOI 10.1128/JVI.02717-09; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033092; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Ilyushina NA, 2005, VIROLOGY, V341, P102, DOI 10.1016/j.virol.2005.07.003; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Li Q, 2012, P NATL ACAD SCI USA, V109, P18897, DOI 10.1073/pnas.1211037109; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Le MQ, 2013, EMERG INFECT DIS, V19, P1674, DOI 10.3201/eid1910.130730; Maines TR, 2011, VIROLOGY, V413, P226, DOI 10.1016/j.virol.2011.02.005; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Min JY, 2013, J VIROL, V87, P10884, DOI 10.1128/JVI.01016-13; Nagarajan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031844; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nguyen HT, 2010, ANTIMICROB AGENTS CH, V54, P3671, DOI 10.1128/AAC.00581-10; OIE, 2014, UPDATE ON HIGHLY PAT; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Rith S, 2014, J VIROL, V88, P13897, DOI 10.1128/JVI.01887-14; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Uchida Y, 2012, VIRUS RES, V170, P109, DOI 10.1016/j.virusres.2012.09.004; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Reeth K, 2000, VET RES, V31, P187, DOI 10.1051/vetres:2000113; Vergara-Alert J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-7; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WHO/ OIE/ FAO H5N1 Evolution Working Group, 2008, EMERGING INFECTIOUS, V14; World Health Organization, 2013, CUMULATIVE NUMBER OF; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133867	10.1371/journal.pone.0133867	http://dx.doi.org/10.1371/journal.pone.0133867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244768	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400056
J	Yee, DA; Kaufman, MG; Ezeakacha, NF				Yee, Donald A.; Kaufman, Michael G.; Ezeakacha, Nnaemeka F.			How Diverse Detrital Environments Influence Nutrient Stoichiometry between Males and Females of the Co-Occurring Container Mosquitoes Aedes albopictus, Ae. aegypti, and Culex quinquefasciatus	PLOS ONE			English	Article							TREE-HOLE MOSQUITO; INTERSPECIFIC COMPETITION; FEEDING-BEHAVIOR; TRISERIATUS DIPTERA; LARVAL COMPETITION; INVASIVE MOSQUITO; STABLE-ISOTOPES; CULICIDAE; RESOURCE; FOOD	Allocation patterns of carbon and nitrogen in animals are influenced by food quality and quantity, as well as by inherent metabolic and physiological constraints within organisms. Whole body stoichiometry also may vary between the sexes who differ in development rates and reproductive allocation patterns. In aquatic containers, such as tree holes and tires, detrital inputs, which vary in amounts of carbon and nitrogen, form the basis of the mosquito-dominated food web. Differences in development times and mass between male and female mosquitoes may be the result of different reproductive constraints, which could also influence patterns of nutrient allocation. We examined development time, survival, and adult mass for males and females of three co-occurring species, Aedes albopictus, Ae. aegypti, and Culex quinquefasciatus, across environments with different ratios of animal and leaf detritus. We quantified the contribution of detritus to biomass using stable isotope analysis and measured tissue carbon and nitrogen concentrations among species and between the sexes. Development times were shorter and adults were heavier for Aedes in animal versus leaf-only environments, whereas Culex development times were invariant across detritus types. Aedes displayed similar survival across detritus types whereas C. quinquefasciatus showed decreased survival with increasing leaf detritus. All species had lower values of N-15 and C-13 in leaf-only detritus compared to animal, however, Aedes generally had lower tissue nitrogen compared to C. quinquefasciatus. There were no differences in the C:N ratio between male and female Aedes, however, Aedes were different than C. quinquefasciatus adults, with male C. quinquefasciatus significantly higher than females. Culex quinquefasciatus was homeostatic across detrital environments. These results allow us to hypothesize an underlying stoichiometric explanation for the variation in performance of different container species under similar detrital environments, and if supported may assist in explaining the production of vector populations in nature.	[Yee, Donald A.; Ezeakacha, Nnaemeka F.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Kaufman, Michael G.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Southern Mississippi; Michigan State University	Yee, DA (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	donald.yee@usm.edu			Department of Biological Sciences at the University of Southern Mississippi; National Institutes of Health [R15[AI]-924040-1A1, 5R37AI021884]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI092404, R37AI021884] Funding Source: NIH RePORTER	Department of Biological Sciences at the University of Southern Mississippi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Biological Sciences at the University of Southern Mississippi and by a grant to DA Yee from the National Institutes of Health (R15[AI]-92404-01A1). MG Kaufman was supported by a grant from the National Institutes of Health (5R37AI021884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgood DW, 2014, MED VET ENTOMOL, V28, P273, DOI 10.1111/mve.12047; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; CARPENTER SR, 1982, OECOLOGIA, V53, P1, DOI 10.1007/BF00377128; Costanzo KS, 2011, ECOL ENTOMOL, V36, P605, DOI 10.1111/j.1365-2311.2011.01302.x; Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2; Crawley KR, 2007, J EXP MAR BIOL ECOL, V349, P370, DOI 10.1016/j.jembe.2007.05.025; DAHL C, 1988, ANN ENTOMOL SOC AM, V81, P105, DOI 10.1093/aesa/81.1.105; Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2; Duguma D, 2014, J VECTOR ECOL, V39, P1, DOI 10.1111/j.1948-7134.2014.12063.x; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Foster WA, 2002, MED ENTOMOL, P245; Fry B., 2006, STABLE ISOTOPE ECOLO; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Gilbreath TM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-353; Goedkoop W, 2006, FRESHWATER BIOL, V51, P878, DOI 10.1111/j.1365-2427.2006.01539.x; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Hood-Nowotny R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045222; HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397; Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325; Kaufman MG, 2002, AQUAT MICROB ECOL, V29, P73, DOI 10.3354/ame029073; Kaufman MG, 2006, J MED ENTOMOL, V43, P677, DOI 10.1603/0022-2585(2006)43[677:IEOSNO]2.0.CO;2; Kaufman MG, 2010, ECOL ENTOMOL, V35, P586, DOI 10.1111/j.1365-2311.2010.01217.x; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kitching RL, 2001, ANNU REV ENTOMOL, V46, P729, DOI 10.1146/annurev.ento.46.1.729; KLECKNER CA, 1995, ECOLOGY, V76, P1242, DOI 10.2307/1940931; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; LIVDAHL TP, 1991, SCIENCE, V253, P189, DOI 10.1126/science.1853204; Lopes J, 2004, BRAZ ARCH BIOL TECHN, V47, P739, DOI 10.1590/S1516-89132004000500009; LOUNIBOS LP, 1993, OIKOS, V66, P114, DOI 10.2307/3545203; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Markow TA, 1999, FUNCT ECOL, V13, P78, DOI 10.1046/j.1365-2435.1999.00285.x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2; O'Donnell DL, 2007, J MED ENTOMOL, V44, P984, DOI 10.1603/0022-2585(2007)44[984:COLFBO]2.0.CO;2; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Pucat A. M., 1965, Quaestiones Entomologicae, V1, P41; Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Skiff JJ, 2014, J MED ENTOMOL, V51, P375, DOI 10.1603/ME13159; SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; SUBRA R, 1981, INSECT SCI APPL, V1, P319, DOI 10.1017/S1742758400000618; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Walker ED, 1997, CAN J ZOOL, V75, P706, DOI 10.1139/z97-091; WALKER ED, 1988, J MED ENTOMOL, V25, P551, DOI 10.1093/jmedent/25.6.551; Wehi PM, 2010, J INSECT PHYSIOL, V56, P1877, DOI 10.1016/j.jinsphys.2010.08.005; Winters AE, 2012, ECOL ENTOMOL, V37, P56, DOI 10.1111/j.1365-2311.2011.01337.x; Yee DA, 2014, J MED ENTOMOL, V51, P89, DOI 10.1603/ME13182; Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132; Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2004, J VECTOR ECOL, V29, P315; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; Yee DA, 2007, J ANIM ECOL, V76, P1105, DOI 10.1111/j.1365-2656.2007.01297.x; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	71	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133734	10.1371/journal.pone.0133734	http://dx.doi.org/10.1371/journal.pone.0133734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244643	Green Published, gold			2022-12-26	WOS:000359061400055
J	Bapat, PR; Satav, AR; Husain, AA; Shekhawat, SD; Kawle, AP; Chu, JJ; Purohit, HJ; Daginawala, HF; Taori, GM; Kashyap, RS				Bapat, Prachi R.; Satav, Ashish R.; Husain, Aliabbas A.; Shekhawat, Seema D.; Kawle, Anuja P.; Chu, Justin J.; Purohit, Hemant J.; Daginawala, Hatim F.; Taori, Girdhar M.; Kashyap, Rajpal S.			Differential Levels of Alpha-2-Macroglobulin, Haptoglobin and Sero-Transferrin as Adjunct Markers for TB Diagnosis and Disease Progression in the Malnourished Tribal Population of Melghat, India	PLOS ONE			English	Article							ANTIGEN-85 COMPLEX; IMMUNE-RESPONSE; TUBERCULOSIS; PULMONARY; LEPTIN; PROTEIN; MALNUTRITION; BIOMARKERS; INFECTION; NUTRITION	Lack of diagnostic capacity has been a crucial barrier preventing an effective response to the challenges of malnutrition and tuberculosis (TB). Point-of-care diagnostic tests for TB in immuno-incompetent, malnourished population are thus needed to ensure rapid and accurate detection. The aim of the study was to identify potential biomarkers specific for TB infection and progression to overt disease in the malnourished population of Melghat. A prospective cohort study was conducted in the year 2009 through 2011 in six villages of the Melghat region. 275 participants consisting of malnourished cases with a) active TB (n = 32), b) latent TB infection (n = 90), c) with no clinical or bacteriological signs of active or latent TB (n = 130) and healthy control subjects (n = 23) were recruited for the study. The proteome changes of the host serum in response to Mycobacterium tuberculosis (M. tb) infection were investigated using one dimensional electrophoresis in combination with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Three most differentially expressed proteins; alpha-2-macroglobulin (A-2-M), sero-transferrin and haptoglobin were identified by MALDI-TOF MS analysis, which were up-regulated in the malnourished patients with active TB and down-regulated in the malnourished patients compared with the healthy controls. Additionally, follow-up studies indicated that the expression of these proteins increased to nearly two folds in patients who developed active disease from latent state. Our preliminary results suggest that A-2-M, sero-transferrin and haptoglobin may be clinically relevant host biomarkers for TB diagnosis and disease progression in the malnourished population. This study provides preliminary framework for an in-depth analysis of the biomarkers in larger well-characterized cohorts. Evaluation of these biomarkers in follow-up cases may further aid in improving TB diagnosis.	[Bapat, Prachi R.; Husain, Aliabbas A.; Shekhawat, Seema D.; Kawle, Anuja P.; Daginawala, Hatim F.; Taori, Girdhar M.; Kashyap, Rajpal S.] Cent India Inst Med Sci, Biochem Res Ctr, Nagpur, Maharashtra, India; [Satav, Ashish R.] Mahatma Gandhi Tribal Hosp, Meditat AIDS Hlth Addict & Nutr MAHAN Trust, Tahsil Dharni, Maharashtra, India; [Chu, Justin J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies,Dept Mic, Singapore 117595, Singapore; [Purohit, Hemant J.] CSIR, Environm Genom Unit, Natl Environm Engn Res Inst NEERI, Nagpur, Maharashtra, India	National University of Singapore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI)	Kashyap, RS (corresponding author), Cent India Inst Med Sci, Biochem Res Ctr, Nagpur, Maharashtra, India.	raj_ciims@rediffmail.com	Chu, Justin Jang Hann/ABA-8297-2021; Kashyap, Rajpal/AAP-8461-2020	Chu, Justin Jang Hann/0000-0002-1673-6819	Central India Institute of Medical Sciences	Central India Institute of Medical Sciences	This was an in house study funded by Central India Institute of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedapo KS, 2006, AFR J BIOMED RES, V9, P169; [Anonymous], 1989, Ann N Y Acad Sci, V557, P1; Ariga Haruyuki, 2011, Tuberc Res Treat, V2011, P940642, DOI 10.1155/2011/940642; Banh L, 2006, PRACT GASTROENTEROL, V30, P46; Borelli Primavera, 2004, Rev. Bras. Hematol. Hemoter., V26, P49, DOI 10.1590/S1516-84842004000100010; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Bresnahan KA, 2014, ADV NUTR, V5, P702, DOI 10.3945/an.114.006361; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fu YR, 2012, CLIN MICROBIOL INFEC, V18, P1241, DOI 10.1111/j.1469-0691.2012.03824.x; GRANGE JM, 1984, TUBERCLE, V65, P23, DOI 10.1016/0041-3879(84)90027-8; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Husain AA, 2013, EUR J EXP BIOL, V3, P35; Jain RK, 2013, DIS MARKERS, V2013, P311, DOI 10.1155/2013/309816; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Kashyap RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074652; Kashyap RS, 2010, BIOMARK INSIGHTS, V5, P87; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Kashyap RS, 2006, CEREBROSPINAL FLUID, V3, P1, DOI 10.1186/1743-8454-3-5; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Keusch GT, 2003, J NUTR, V133, p336S, DOI 10.1093/jn/133.1.336S; Klein S, 2002, SLEISENGER FORDTRANS, P265; KNOLLE P, 1995, Z GASTROENTEROL, V33, P613; Kumar Ghantasala S Sameer, 2012, Clin Proteomics, V9, P12, DOI 10.1186/1559-0275-9-12; Kumar NP, 2013, CLIN VACCINE IMMUNOL, V20, P704, DOI 10.1128/CVI.00038-13; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; Opolot JO, 2015, LUNG, V193, P13, DOI 10.1007/s00408-014-9680-8; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; RAGHU B, 1993, BIOCHEM MOL BIOL INT, V31, P341; Raja A, 2004, INDIAN J MED RES, V120, P213; Rytter MJH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105017; Saka AO, 2012, GLOBAL J MED RES, V12, P1; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schlaudecker EP, 2011, CURR OPIN INFECT DIS, V24, P496, DOI 10.1097/QCO.0b013e328349287d; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Serafin-Lopez J, 2004, SCAND J IMMUNOL, V60, P329, DOI 10.1111/j.0300-9475.2004.01482.x; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Vandevyver S, 2014, EMBO MOL MED, V6, P2, DOI 10.1002/emmm.201303524; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; Wilson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015248	48	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133928	10.1371/journal.pone.0133928	http://dx.doi.org/10.1371/journal.pone.0133928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241963	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000358942700029
J	Bostrom, EA; Kindstedt, E; Sulniute, R; Palmqvist, P; Majster, M; Holm, CK; Zwicker, S; Clark, R; Onell, S; Johansson, I; Lerner, UH; Lundberg, P				Bostrom, Elisabeth A.; Kindstedt, Elin; Sulniute, Rima; Palmqvist, Py; Majster, Mirjam; Holm, Cecilia Koskinen; Zwicker, Stephanie; Clark, Reuben; Onell, Sebastian; Johansson, Ingegerd; Lerner, Ulf H.; Lundberg, Pernilla			Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; KAPPA-B KINASE; CREVICULAR FLUID; CLINICAL-PARAMETERS; SMOOTH-MUSCLE; TNF-ALPHA; ATHEROSCLEROSIS; EXPRESSION; CHEMOKINES	Periodontitis is a chronic inflammatory disease of tooth supporting tissues resulting in periodontal tissue destruction, which may ultimately lead to tooth loss. The disease is characterized by continuous leukocyte infiltration, likely mediated by local chemokine production but the pathogenic mechanisms are not fully elucidated. There are no reliable serologic biomarkers for the diagnosis of periodontitis, which is today based solely on the degree of local tissue destruction, and there is no available biological treatment tool. Prompted by the increasing interest in periodontitis and systemic inflammatory mediators we mapped serum cytokine and chemokine levels from periodontitis subjects and healthy controls. We used multivariate partial least squares (PLS) modeling and identified monocyte chemoattractant protein-1 (MCP-1) and eotaxin as clearly associated with periodontitis along with C-reactive protein (CRP), years of smoking and age, whereas the number of remaining teeth was associated with being healthy. Moreover, body mass index correlated significantly with serum MCP-1 and CRP, but not with eotaxin. We detected higher MCP-1 protein levels in inflamed gingival connective tissue compared to healthy but the eotaxin levels were undetectable. Primary human gingival fibroblasts displayed strongly increased expression of MCP-1 and eotaxin mRNA and protein when challenged with tumor necrosis factor-alpha (TNF-alpha and interleukin-1 beta (IL-1 beta), key mediators of periodontal inflammation. We also demonstrated that the upregulated chemokine expression was dependent on the NF-kappa B pathway. In summary, we identify higher levels of CRP, eotaxin and MCP-1 in serum of periodontitis patients. This, together with our finding that both CRP and MCP-1 correlates with BMI points towards an increased systemic inflammatory load in patients with periodontitis and high BMI. Targeting eotaxin and MCP-1 in periodontitis may result in reduced leukocyte infiltration and inflammation in periodontitis and maybe prevent tooth loss.	[Bostrom, Elisabeth A.; Majster, Mirjam; Zwicker, Stephanie; Clark, Reuben] Karolinska Inst, Div Periodontol, Dept Dent Med, Stockholm, Sweden; [Kindstedt, Elin; Sulniute, Rima; Palmqvist, Py; Holm, Cecilia Koskinen; Onell, Sebastian; Lerner, Ulf H.; Lundberg, Pernilla] Umea Univ, Dept Mol Periodontol, Umea, Sweden; [Johansson, Ingegerd] Umea Univ, Dept Cariol, Umea, Sweden; [Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Ctr Bone & Arthrit Res, Gothenburg, Sweden	Karolinska Institutet; Umea University; Umea University; University of Gothenburg	Lundberg, P (corresponding author), Umea Univ, Dept Mol Periodontol, Umea, Sweden.	pernilla.lundberg@odont.umu.se		Lerner, Ulf/0000-0002-3579-1960; Kindstedt, Elin/0000-0003-2448-4049	Swedish Research Council; Stockholm County Council/ ALF Project; Karolinska Institutet Funds; Swedish Patent Revenue Fund; Ollie and Elof Ericssons Stiftelse; Tore Nilsson Stiftelse; Faculty of Medicine, Umea University; County Council of Vasterbotten; Swedish Rheumatism Association; Swedish Dental Society; COMBINE; ALF/LUA Research Grant in Gothenburg; Lundberg Foundation; Royal 80 Year Fund of King Gustav V	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council/ ALF Project(Stockholm County Council); Karolinska Institutet Funds; Swedish Patent Revenue Fund; Ollie and Elof Ericssons Stiftelse; Tore Nilsson Stiftelse; Faculty of Medicine, Umea University; County Council of Vasterbotten; Swedish Rheumatism Association; Swedish Dental Society; COMBINE; ALF/LUA Research Grant in Gothenburg; Lundberg Foundation(European Commission); Royal 80 Year Fund of King Gustav V	This study was supported by funds from the Swedish Research Council (http://www.vr.se/) (EAB, UL), Stockholm County Council/ ALF Project (http://www.sll.se/) (EAB), Karolinska Institutet Funds (http://www.ki.se) (EAB), the Swedish Patent Revenue Fund (EAB), Ollie and Elof Ericssons Stiftelse (http://www.oestiftelse.se/) (EAB), Tore Nilsson Stiftelse (http://www.torenilsonsstiftelse.nu/) (EAB), Faculty of Medicine, Umea University (http://www.medfak.umu.se/) (PL), County Council of Vasterbotten (https://www.vll.se) (PL, UL), the Swedish Rheumatism Association (https://reumatikerforbundet.org/) (PL, UL), Swedish Dental Society (http://www.tandlakarforbundet.se/Om-oss/Svenska-Tandlakare-Sallskapet/) (PL, EK, MM), COMBINE, the ALF/LUA Research Grant in Gothenburg, the Lundberg Foundation, and the Royal 80 Year Fund of King Gustav V (UL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil S, 2013, J PERIODONTOL, V84, pE23, DOI 10.1902/jop.2013.120666; Boesing F, 2009, OBES REV, V10, P290, DOI 10.1111/j.1467-789X.2008.00555.x; Bostrom EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081665; Buduneli N, 2011, J CLIN PERIODONTOL, V38, P85, DOI 10.1111/j.1600-051X.2010.01670.x; Casanova L, 2014, BRIT DENT J, V217, P433, DOI 10.1038/sj.bdj.2014.907; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; Chami B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101622; Darkoh C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093144; Queiroz Adriana Corrêa de, 2008, Braz. Dent. J., V19, P3, DOI 10.1590/S0103-64402008000100001; Dou W, 2014, INT IMMUNOPHARMACOL, V23, P170, DOI 10.1016/j.intimp.2014.08.025; Ertugrul AS, 2013, J PERIODONTAL RES, V48, P44, DOI 10.1111/j.1600-0765.2012.01500.x; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Fujita Y, 2012, ODONTOLOGY, V100, P215, DOI 10.1007/s10266-011-0042-1; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gaspersic R, 2003, J PERIODONTAL RES, V38, P198, DOI 10.1034/j.1600-0765.2003.01395.x; Goldbergova MP, 2012, MOL IMMUNOL, V52, P273, DOI 10.1016/j.molimm.2012.06.006; Gupta M, 2013, CYTOKINE, V61, P892, DOI 10.1016/j.cyto.2012.12.012; Haley KJ, 2000, CIRCULATION, V102, P2185; Halvorsen B, 2014, CARDIOVASC RES, V102, P148, DOI 10.1093/cvr/cvu036; Haytural O, 2015, CLIN ORAL INVEST, V19, P979, DOI 10.1007/s00784-014-1314-2; Holmlund A, 2004, J CLIN PERIODONTOL, V31, P475, DOI 10.1111/j.1600-051X.2004.00504.x; Hosokawa Y, 2013, CELL PHYSIOL BIOCHEM, V31, P960, DOI 10.1159/000350114; Hou LT, 2003, J PERIODONTAL RES, V38, P247, DOI 10.1034/j.1600-0765.2003.02601.x; Idris AI, 2010, FASEB J, V24, P4545, DOI 10.1096/fj.10-164095; Irshad M, 2013, J PERIODONTAL RES, V48, P647, DOI 10.1111/jre.12051; Kalburgi V, 2014, ANN MED HEALTH SCI R, V4, P388, DOI 10.4103/2141-9248.133465; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim HO, 2012, CLIN EXP DERMATOL, V37, P521, DOI 10.1111/j.1365-2230.2011.04295.x; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; KOIDE M, 1995, J ORAL PATHOL MED, V24, P420, DOI 10.1111/j.1600-0714.1995.tb01212.x; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Mayer Y, 2009, J PERIODONTOL, V80, P1414, DOI 10.1902/jop.2009.090015; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Miyamasu M, 1999, INT IMMUNOL, V11, P1001, DOI 10.1093/intimm/11.6.1001; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Palmqvist P, 2008, J DENT RES, V87, P558, DOI 10.1177/154405910808700614; Pradeep AR, 2009, CYTOKINE, V47, P77, DOI 10.1016/j.cyto.2009.05.012; Richard MO, 2006, DRUG DISCOV TODAY, V11, P342, DOI 10.1016/j.drudis.2006.02.009; Routsias JG, 2011, RHEUMATOLOGY, V50, P1189, DOI 10.1093/rheumatology/ker090; Sawada S, 2013, BIOMED RES-TOKYO, V34, P31, DOI 10.2220/biomedres.34.31; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Souto GR, 2014, IMMUNOBIOLOGY, V219, P633, DOI 10.1016/j.imbio.2014.03.014; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Sun QZ, 2012, J IMMUNOL, V188, P3506, DOI 10.4049/jimmunol.1102635; Tervahartiala T, 2001, J DENT RES, V80, P1535, DOI 10.1177/00220345010800061101; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; Tonetti M S, 1998, Ann Periodontol, V3, P88; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; YU XH, 1995, J PERIODONTOL, V66, P80, DOI 10.1902/jop.1995.66.1.80; YU XH, 1993, INFECT IMMUN, V61, P4622, DOI 10.1128/IAI.61.11.4622-4628.1993; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8	54	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134608	10.1371/journal.pone.0134608	http://dx.doi.org/10.1371/journal.pone.0134608			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241961	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700053
J	Koppes, E; Himes, KP; Chaillet, JR				Koppes, Erik; Himes, Katherine P.; Chaillet, J. Richard			Partial Loss of Genomic Imprinting Reveals Important Roles for Kcnq1 and Peg10 Imprinted Domains in Placental Development	PLOS ONE			English	Article							BECKWITH-WIEDEMANN; DNA METHYLATION; MOUSE MODEL; MICE LEADS; GENE; GROWTH; DIFFERENTIATION; RETROTRANSPOSON; MAINTENANCE; OVERGROWTH	Mutations in imprinted genes or their imprint control regions (ICRs) produce changes in imprinted gene expression and distinct abnormalities in placental structure, indicating the importance of genomic imprinting to placental development. We have recently shown that a very broad spectrum of placental abnormalities associated with altered imprinted gene expression occurs in the absence of the oocyte-derived DNMT1o cytosine methyltransferase, which normally maintains parent-specific imprinted methylation during preimplantation. The absence of DNMT1o partially reduces inherited imprinted methylation while retaining the genetic integrity of imprinted genes and their ICRs. Using this novel system, we undertook a broad and inclusive approach to identifying key ICRs involved in placental development by correlating loss of imprinted DNA methylation with abnormal placental phenotypes in a mid-gestation window (E12.5-E15.5). To these ends we measured DNA CpG methylation at 15 imprinted gametic differentially methylated domains (gDMDs) that overlap known ICRs using EpiTYPER-mass array technology, and linked these epigenetic measurements to histomorphological defects. Methylation of some imprinted gDMDs, most notably Dlk1, was nearly normal in mid-gestation DNMT1o-deficient placentas, consistent with the notion that cells having lost methylation on these DMDs do not contribute significantly to placental development. Most imprinted gDMDs however showed a wide range of methylation loss among DNMT1o-deficient placentas. Two striking associations were observed. First, loss of DNA methylation at the Peg10 imprinted gDMD associated with decreased embryonic viability and decreased labyrinthine volume. Second, loss of methylation at the Kcnq1 imprinted gDMD was strongly associated with trophoblast giant cell (TGC) expansion. We conclude that the Peg10 and Kcnq1 ICRs are key regulators of mid-gestation placental function.	[Koppes, Erik] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Program Integrat Mol Biol, Pittsburgh, PA USA; [Himes, Katherine P.; Chaillet, J. Richard] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Chaillet, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	Chaillet@pitt.edu		Koppes, Erik/0000-0002-4175-7777	National Institutes of Health USA [P01-HD069316, UL1-RR0241153, UL1-TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD069316] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by P01-HD069316, UL1-RR0241153, and UL1-TR000005, all from the National Institutes of Health USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Abu-Amero S, 2010, J MED GENET, V47, P150, DOI 10.1136/jmg.2009.071316; Andrews SC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-53; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Calvello M, 2013, EPIGENETICS-US, V8, P1053, DOI 10.4161/epi.25812; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Choufani S, 2011, GENOME RES, V21, P465, DOI 10.1101/gr.111922.110; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Cirio MC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-9; Cirio MC, 2008, DEV BIOL, V324, P139, DOI 10.1016/j.ydbio.2008.09.015; Coan PM, 2008, J PHYSIOL-LONDON, V586, P5023, DOI 10.1113/jphysiol.2008.157313; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frank D, 2002, P NATL ACAD SCI USA, V99, P7490, DOI 10.1073/pnas.122039999; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Fuke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060105; Green K, 2007, MAMM GENOME, V18, P32, DOI 10.1007/s00335-006-0092-9; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Himes KP, 2015, PLACENTA, V36, P389, DOI 10.1016/j.placenta.2015.01.012; Himes KP, 2013, DEV BIOL, V373, P72, DOI 10.1016/j.ydbio.2012.10.010; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hu D, 2010, INT J DEV BIOL, V54, P341, DOI 10.1387/ijdb.082768dh; Jacob KJ, 2013, CLIN GENET, V84, P326, DOI 10.1111/cge.12143; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Oh-McGinnis R, 2011, DEV BIOL, V351, P277, DOI 10.1016/j.ydbio.2011.01.008; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Reinhart B, 2006, MOL CELL BIOL, V26, P8347, DOI 10.1128/MCB.00981-06; Salas M, 2004, MECH DEVELOP, V121, P1199, DOI 10.1016/j.mod.2004.05.017; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Smith AC, 2007, PEDIATR RES, V61, p43R, DOI 10.1203/pdr.0b013e3180457660; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Wylie AA, 2003, AM J PATHOL, V162, P321, DOI 10.1016/S0002-9440(10)63823-0	44	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0135202	10.1371/journal.pone.0135202	http://dx.doi.org/10.1371/journal.pone.0135202			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241757	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000358942700098
J	Lin, CJ; Liou, TC; Pan, CF; Wu, PC; Sun, FJ; Liu, HL; Chen, HH; Wu, CJ				Lin, Cheng-Jui; Liou, Tai-Cherng; Pan, Chi-Feng; Wu, Pei-Chen; Sun, Fang-Ju; Liu, Hsuan-Liang; Chen, Han-Hsiang; Wu, Chih-Jen			The Role of Liver in Determining Serum Colon-Derived Uremic Solutes	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; P-CRESOL SULFATE; INDOXYL SULFATE; HEMODIALYSIS-PATIENTS; OXIDATIVE STRESS; TOXINS; DYSFUNCTION; PROGRESSION; MORTALITY; REMOVAL	Evidence has shown that indoxyl sulfate (IS) and p-cresyl sulfate (PCS) may be alternative predictors of clinical outcomes in chronic kidney disease (CKD). Both toxins are derived from the gastrointestinal tract and metabolised in the liver. However, it is unclear whether the liver affects the production of IS and PCS. Here, we explore the association between IS and PCS levels in liver cirrhosis and a CKD-based cohort (N = 115). Liver and kidney function was assessed and classified by a Child-Pugh score (child A-C) and a modified version of the Modification of Diet in Renal Disease (MDRD) equation (Stages 1-4), respectively. An animal model was also used to confirm the two toxin levels in a case of liver fibrosis. In patients with early liver cirrhosis (child A), IS and PCS were significantly associated with CKD stages. In contrast, serum IS and PCS did not significantly change in advanced liver cirrhosis (child C). A stepwise multiple linear regression analysis also showed that T-PCS was significantly associated with stages of liver cirrhosis after adjusting for other confounding factors (B = -2.29, p = 0.012). Moreover, the serum and urine levels of T-PCS and T-IS were significantly lower in rats with liver failure than in those without (p<0.01, p<0.05 and p<0.01, p<0.05, respectively). These results indicated that in addition to the kidneys, the liver was an essential and independent organ in determining serum IS and PCS levels. The production rate of IS and PCS was lower in patients with advanced liver cirrhosis.	[Lin, Cheng-Jui; Pan, Chi-Feng; Wu, Pei-Chen; Chen, Han-Hsiang; Wu, Chih-Jen] Mackay Mem Hosp, Div Nephrol, Taipei, Taiwan; [Lin, Cheng-Jui; Liou, Tai-Cherng; Pan, Chi-Feng; Wu, Pei-Chen; Chen, Han-Hsiang; Wu, Chih-Jen] Mackay Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Liou, Tai-Cherng] Mackay Mem Hosp, Div Gastroenterol, Taipei, Taiwan; [Lin, Cheng-Jui; Pan, Chi-Feng; Sun, Fang-Ju; Chen, Han-Hsiang] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Lin, Cheng-Jui; Liu, Hsuan-Liang] Natl Taipei Univ, Inst Biotechnol, Taipei, Taiwan; [Liou, Tai-Cherng; Wu, Chih-Jen] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Sun, Fang-Ju] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wu, Chih-Jen] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; National Taipei University; Mackay Medical College; Mackay Memorial Hospital; Taipei Medical University	Lin, CJ (corresponding author), Mackay Mem Hosp, Div Nephrol, Taipei, Taiwan.	lincj@mmh.org.tw			Taiwan National Science Council [NSC 102-2314-B-195-004]; Mackay Memorial Hospital [MMH-103-12, MMH-102-25, MMH 102-29]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This study was supported in part by a Grant from Taiwan National Science Council (NSC 102-2314-B-195-004) and Mackay Memorial Hospital (MMH-103-12, MMH-102-25 and MMH 102-29).	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Arroyo V, 2002, GASTROENTEROLOGY, V122, P1658, DOI 10.1053/gast.2002.33575; Bammens B, 2005, AM J KIDNEY DIS, V46, P512, DOI 10.1053/j.ajkd.2005.05.016; Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; De Smet R, 2003, CLIN CHEM, V49, P470, DOI 10.1373/49.3.470; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Elekima OTL, 2000, LIVER, V20, P45, DOI 10.1034/j.1600-0676.2000.020001045.x; Eloot S, 2007, AM J KIDNEY DIS, V50, P279, DOI 10.1053/j.ajkd.2007.05.009; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin C.Y., 2015, PLOS ONE, V10; Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456; Martinez AW, 2005, J AM SOC NEPHROL, V16, P3430, DOI 10.1681/ASN.2005030310; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, NEPHROL DIAL TRANSPL, V25, P219, DOI 10.1093/ndt/gfp414; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; Owada S, 2008, AM J NEPHROL, V28, P446, DOI 10.1159/000112823; Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211; Schulman G, 2006, AM J KIDNEY DIS, V47, P565, DOI 10.1053/j.ajkd.2005.12.036; Schulman G, 2015, J AM SOC NEPHROL, V26, P1732, DOI 10.1681/ASN.2014010042; Slack A, 2010, CRIT CARE, V14, DOI 10.1186/cc8855; Takayama F, 2003, AM J KIDNEY DIS, V41, pS142, DOI 10.1053/ajkd.2003.50104; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2011, NEPHROL DIAL TRANSPL, V26, P1464, DOI 10.1093/ndt/gfr056; VANHOLDER RC, 1992, CLIN CHEM, V38, P1429; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610	34	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134590	10.1371/journal.pone.0134590	http://dx.doi.org/10.1371/journal.pone.0134590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258409	Green Submitted, gold, Green Published			2022-12-26	WOS:000359352600016
J	Bai, H; Post, S; Kang, P; Tatar, M				Bai, Hua; Post, Stephanie; Kang, Ping; Tatar, Marc			Drosophila Longevity Assurance Conferred by Reduced Insulin Receptor Substrate Chico Partially Requires d4eBP	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; CAENORHABDITIS-ELEGANS; EIF4E-BINDING PROTEIN; DIETARY RESTRICTION; CELL-GROWTH; C-ELEGANS; RAPAMYCIN; HOMOLOG; TARGET	Mutations of the insulin/IGF signaling (IIS) pathway extend Drosophila lifespan. Based on genetic epistasis analyses, this longevity assurance is attributed to downstream effects of the FOXO transcription factor. However, as reported FOXO accounts for only a portion of the observed longevity benefit, suggesting there are additional outputs of IIS to mediate aging. One candidate is target of rapamycin complex 1 (TORC1). Reduced TORC1 activity is reported to slow aging, whereas reduced IIS is reported to repress TORC1 activity. The eukaryotic translation initiation factor 4E binding protein (4E-BP) is repressed by TORC1, and activated 4E-BP is reported to increase Drosophila lifespan. Here we use genetic epistasis analyses to test whether longevity assurance mutants of chico, the Drosophila insulin receptor substrate homolog, require Drosophila d4eBP to slow aging. In chico heterozy-gotes, which are robustly long-lived, d4eBP is required but not sufficient to slow aging. Remarkably, d4eBP is not required or sufficient for chico homozygotes to extend longevity. Likewise, chico heterozygote females partially require d4eBP to preserve age-dependent locomotion, and both chico genotypes require d4eBP to improve stress-resistance. Reproduction and most measures of growth affected by either chico genotype are always independent of d4eBP. In females, chico heterozygotes paradoxically produce more rather than less phosphorylated 4E-BP (p4E-BP). Altered IRS function within the IIS pathway of Drosophila appears to have partial, conditional capacity to regulate aging through an unconventional interaction with 4E-BP.	[Bai, Hua; Post, Stephanie; Kang, Ping; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Div Biol & Med, Providence, RI 02912 USA	Brown University	Tatar, M (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Div Biol & Med, Providence, RI 02912 USA.	Marc_Tatar@Brown.edu		Whipple, Stephanie/0000-0003-2354-736X; Tatar, Marc/0000-0003-3232-6884	National Institutes of Health/National Institute on Aging [R37 AG024360, T32 AG 41688]; NATIONAL INSTITUTE ON AGING [R37AG024360, K99AG048016, T32AG041688] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health/National Institute on Aging (www.nia.nih.gov) grant R37 AG024360 to MT. SP was supported by National Institutes of Health/National Institute on Aging (www.nia.nih.gov) training grant T32 AG 41688. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bernal AR, 2004, DROSOPH INF SERV, V87, P81; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504; DORMAN JB, 1995, GENETICS, V141, P1399; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Gancz D, 2013, DEVELOPMENT, V140, P4145, DOI 10.1242/dev.093773; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Harrison B, 2010, GERIATR GERONTOL INT, V10, P110, DOI 10.1111/j.1447-0594.2009.00569.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Igreja C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5790; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleijn M, 2002, FEBS LETT, V532, P319, DOI 10.1016/S0014-5793(02)03694-3; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; LaFever L., 2010, THESIS; Lavoie CA, 1996, J BIOL CHEM, V271, P16393, DOI 10.1074/jbc.271.27.16393; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; MARINHINCAPIE M, 1995, ENDOCRINOLOGY, V136, P2357, DOI 10.1210/en.136.6.2357; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pallares-Cartes C, 2012, DEV CELL, V22, P172, DOI 10.1016/j.devcel.2011.10.029; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Poltilove RMK, 2000, J BIOL CHEM, V275, P23346, DOI 10.1074/jbc.M003579200; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rodriguez A, 1996, GENETICS, V143, P929; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Schleich S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006305; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science. 1068094; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tsai S, 2015, J CLIN INVEST IN PRE; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Villa-Cuesta E, 2014, J CELL SCI, V127, P2282, DOI 10.1242/jcs.142026; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wessells R, 2009, AGING CELL, V8, P542, DOI 10.1111/j.1474-9726.2009.00504.x; Yamamoto R, 2011, AGING CELL, V10, P729, DOI 10.1111/j.1474-9726.2011.00716.x; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	60	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134415	10.1371/journal.pone.0134415	http://dx.doi.org/10.1371/journal.pone.0134415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252766	Green Published, gold			2022-12-26	WOS:000359121100055
J	Ferrer-Martin, RM; Martin-Oliva, D; Sierra-Martin, A; Carrasco, MC; Martin-Estebane, M; Calvente, R; Martin-Guerrero, SM; Marin-Teva, JL; Navascues, J; Cuadros, MA				Ferrer-Martin, Rosa M.; Martin-Oliva, David; Sierra-Martin, Ana; Carrasco, Maria-Carmen; Martin-Estebane, Maria; Calvente, Ruth; Martin-Guerrero, Sandra M.; Marin-Teva, Jose L.; Navascues, Julio; Cuadros, Miguel A.			Microglial Activation Promotes Cell Survival in Organotypic Cultures of Postnatal Mouse Retinal Explants	PLOS ONE			English	Article							INDUCED PHOTORECEPTOR DEGENERATION; HIPPOCAMPAL SLICE CULTURES; NECROSIS-FACTOR-ALPHA; RETINITIS-PIGMENTOSA; NEURONAL DEATH; MULLER CELLS; TNF-ALPHA; MINOCYCLINE; NEUROPROTECTION; BRAIN	The role of microglia during neurodegeneration remains controversial. We investigated whether microglial cells have a neurotoxic or neuroprotective function in the retina. Retinal explants from 10-day-old mice were treated in vitro with minocycline to inhibit microglial activation, with LPS to increase microglial activation, or with liposomes loaded with clodronate (Lip-Clo) to deplete microglial cells. Flow cytometry was used to assess the viability of retinal cells in the explants and the TUNEL method to show the distribution of dead cells. The immunophenotypic and morphological features of microglia and their distribution were analyzed with flow cytometry and immunocytochemistry. Treatment of retinal explants with minocycline reduced microglial activation and simultaneously significantly decreased cell viability and increased the presence of TUNEL-labeled cell profiles. This treatment also prevented the migration of microglial cells towards the outer nuclear layer, where cell death was most abundant. The LPS treatment increased microglial activation but had no effect on cell viability or microglial distribution. Finally, partial microglial removal with Lip-Clo diminished the cell viability in the retinal explants, showing a similar effect to that of minocycline. Hence, cell viability is diminished in retinal explants cultured in vitro when microglial cells are removed or their activation is inhibited, indicating a neurotrophic role for microglia in this system.	[Ferrer-Martin, Rosa M.; Martin-Oliva, David; Sierra-Martin, Ana; Carrasco, Maria-Carmen; Martin-Estebane, Maria; Calvente, Ruth; Martin-Guerrero, Sandra M.; Marin-Teva, Jose L.; Navascues, Julio; Cuadros, Miguel A.] Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain	University of Granada	Cuadros, MA (corresponding author), Univ Granada, Fac Ciencias, Dept Biol Celular, Granada, Spain.	macuadro@ugr.es	Martín-Oliva, David/L-8472-2014; ESTEBANÉ, MARÍA MARTÍN/AAR-5385-2020; Martín-Guerrero, Sandra María/P-9333-2018; MARTÍN, ANA SIERRA/Q-6241-2016; Cuadros, Miguel A/L-3954-2014	Martín-Oliva, David/0000-0002-8095-5442; ESTEBANÉ, MARÍA MARTÍN/0000-0002-9680-581X; Martín-Guerrero, Sandra María/0000-0003-1489-4757; MARTÍN, ANA SIERRA/0000-0002-9392-9374; Cuadros, Miguel A/0000-0003-4259-1649; Navascues, Julio/0000-0003-2958-2705	Junta de Andalucia, Spain [P07-CVI-03008]; Ministerio de Economia y Competitividad, Spain [BFU2010-19981]	Junta de Andalucia, Spain(Junta de Andalucia); Ministerio de Economia y Competitividad, Spain	This work was supported by Junta de Andalucia, Spain, Grant P07-CVI-03008 (http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html), and Ministerio de Economia y Competitividad, Spain, Grant BFU2010-19981 (http://www.mineco.gob.es/portal/site/mineco/idi).	Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Arroba AI, 2011, INVEST OPHTH VIS SCI, V52, P9124, DOI 10.1167/iovs.11-7736; Baptiste DC, 2005, NEUROSCIENCE, V134, P575, DOI 10.1016/j.neuroscience.2005.04.011; Baptiste DC, 2004, MOL PHARMACOL, V66, P1113, DOI 10.1124/mol.104.001081; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bronstein DM, 1995, BRAIN RES, V704, P112, DOI 10.1016/0006-8993(95)01189-7; Bruban J, 2011, NEUROBIOL DIS, V42, P55, DOI 10.1016/j.nbd.2011.01.004; Carrasco MC, 2011, DEV NEUROBIOL, V71, P296, DOI 10.1002/dneu.20860; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Ding Ye, 2008, Neurosci Bull, V24, P209, DOI 10.1007/s12264-008-0408-8; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Elkabes S, 1996, J NEUROSCI, V16, P2508; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Ferrer-Martin RM, 2014, EXP EYE RES, V121, P42, DOI 10.1016/j.exer.2014.02.015; Fischer AJ, 2015, GLIA, V63, P313, DOI 10.1002/glia.22752; Fischer AJ, 2014, GLIA, V62, P1608, DOI 10.1002/glia.22703; Garcia-Valenzuela E, 1999, J NEUROBIOL, V40, P55, DOI 10.1002/(SICI)1097-4695(199907)40:1<55::AID-NEU5>3.0.CO;2-E; Giuliani F, 2005, J LEUKOCYTE BIOL, V78, P135, DOI 10.1189/jlb.0804477; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Halder SK, 2013, J NEUROCHEM, V126, P243, DOI 10.1111/jnc.12262; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hughes EH, 2004, EXP EYE RES, V78, P1077, DOI 10.1016/j.exer.2004.02.002; Jackson AC, 2007, J VIROL, V81, P6248, DOI 10.1128/JVI.00323-07; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Jung S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00089; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kauppinen UM, 2005, J IMMUNOL, V174, P2288, DOI 10.4049/jimmunol.174.4.2288; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kumamaru H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-116; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; LINDEN R, 2006, APOPTOSIS RETINA, P13; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; Montero M, 2009, BRAIN RES, V1291, P140, DOI 10.1016/j.brainres.2009.06.097; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Narantuya D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011746; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Pinkernelle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073422; Potter EG, 2009, J NEUROSCI RES, V87, P1356, DOI 10.1002/jnr.21963; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Ripps H, 2002, EXP EYE RES, V74, P327, DOI 10.1006/exer.2002.1155; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-221; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; Salido EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061656; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Sasahara M, 2008, AM J PATHOL, V172, P1693, DOI 10.2353/ajpath.2008.080024; Shen AG, 2009, NEUROCHEM RES, V34, P333, DOI 10.1007/s11064-008-9780-z; Shigemoto-Mogami Y, 2014, J NEUROSCI, V34, P2231, DOI 10.1523/JNEUROSCI.1619-13.2014; Sokolowski JD, 2011, AM J PATHOL, V178, P1416, DOI 10.1016/j.ajpath.2010.12.051; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; THANOS S, 1992, BRAIN RES, V588, P21, DOI 10.1016/0006-8993(92)91340-K; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Yang LC, 2003, J NEUROSCI RES, V74, P278, DOI 10.1002/jnr.10709; Yang LP, 2007, MOL VIS, V13, P2048; Yang LP, 2007, MOL VIS, V13, P1073; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zelinka CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044477; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang C, 2005, MOL VIS, V11, P887; Zhang C, 2004, INVEST OPHTH VIS SCI, V45, P2753, DOI 10.1167/iovs.03-1344; Zhang C, 2003, J NEUROSCI RES, V73, P840, DOI 10.1002/jnr.10713; Zhao L, 2011, AM J PATHOL, V179, P1265, DOI 10.1016/j.ajpath.2011.05.042; Zhou WT, 2012, EXP NEUROL, V238, P192, DOI 10.1016/j.expneurol.2012.08.029	84	22	22	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135238	10.1371/journal.pone.0135238	http://dx.doi.org/10.1371/journal.pone.0135238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252475	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100141
J	Huckesfeld, S; Schoofs, A; Schlegel, P; Miroschnikow, A; Pankratz, MJ				Hueckesfeld, Sebastian; Schoofs, Andreas; Schlegel, Philipp; Miroschnikow, Anton; Pankratz, Michael J.			Localization of Motor Neurons and Central Pattern Generators for Motor Patterns Underlying Feeding Behavior in Drosophila Larvae	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; NEURAL CIRCUITS; EXPRESSION; LOCOMOTION; RESPONSES; PATHWAYS; LAMPREY; PROTEIN; BRAIN	Motor systems can be functionally organized into effector organs (muscles and glands), the motor neurons, central pattern generators (CPG) and higher control centers of the brain. Using genetic and electrophysiological methods, we have begun to deconstruct the motor system driving Drosophila larval feeding behavior into its component parts. In this paper, we identify distinct clusters of motor neurons that execute head tilting, mouth hook movements, and pharyngeal pumping during larval feeding. This basic anatomical scaffold enabled the use of calcium-imaging to monitor the neural activity of motor neurons within the central nervous system (CNS) that drive food intake. Simultaneous nerve- and muscle-recordings demonstrate that the motor neurons innervate the cibarial dilator musculature (CDM) ipsi- and contra-laterally. By classical lesion experiments we localize a set of CPGs generating the neuronal pattern underlying feeding movements to the subesophageal zone (SEZ). Lesioning of higher brain centers decelerated all feeding-related motor patterns, whereas lesioning of ventral nerve cord (VNC) only affected the motor rhythm underlying pharyngeal pumping. These findings provide a basis for progressing upstream of the motor neurons to identify higher regulatory components of the feeding motor system.	[Hueckesfeld, Sebastian; Schoofs, Andreas; Schlegel, Philipp; Miroschnikow, Anton; Pankratz, Michael J.] Univ Bonn, LIMES Inst, D-53115 Bonn, Germany	University of Bonn	Pankratz, MJ (corresponding author), Univ Bonn, LIMES Inst, D-53115 Bonn, Germany.	pankratz@uni-bonn.de		Miroschnikow, Anton/0000-0002-2276-3434; Huckesfeld, Sebastian/0000-0003-0236-6375	Deutsche Forschungsgemeinschaft (DFG) [PA 787, EXC 1023]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) grant PA 787 and EXC 1023.	Bassler U, 1998, BRAIN RES REV, V27, P65, DOI 10.1016/S0165-0173(98)00006-X; BENJAMIN PR, 1979, J EXP BIOL, V80, P93; Berni J, 2012, CURR BIOL, V22, P1861, DOI 10.1016/j.cub.2012.07.048; BRODFUEHRER PD, 1995, J NEUROBIOL, V27, P403, DOI 10.1002/neu.480270312; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; COHEN AH, 1987, J COMP PHYSIOL A, V160, P181, DOI 10.1007/BF00609725; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; FRIESEN WO, 1989, J COMP PHYSIOL A, V166, P205, DOI 10.1007/BF00193465; GORCZYCA MG, 1991, J NEUROBIOL, V22, P391, DOI 10.1002/neu.480220407; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Harris-Warrick R, 1988, NEURAL CONTROL RHYTH, P285; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hinsey JC, 1930, ARCH NEURO PSYCHIATR, V24, P966, DOI 10.1001/archneurpsyc.1930.02220170086010; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lin HH, 2013, SCIENCE, V340, P1338, DOI 10.1126/science.1236693; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Olsen SR, 2008, TRENDS NEUROSCI, V31, P512, DOI 10.1016/j.tins.2008.07.006; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Schoofs A, 2014, J INSECT PHYSIOL, V69, P118, DOI 10.1016/j.jinsphys.2014.05.022; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Schoofs A, 2010, J INSECT PHYSIOL, V56, P695, DOI 10.1016/j.jinsphys.2009.12.008; Schoofs A, 2009, J INSECT PHYSIOL, V55, P218, DOI 10.1016/j.jinsphys.2008.11.011; Selverston AI, 2010, PHILOS T R SOC B, V365, P2329, DOI 10.1098/rstb.2009.0270; Simpson JH, 2009, ADV GENET, V65, P79, DOI 10.1016/S0065-2660(09)65003-3; SOKOLOWSKI MB, 1982, ANIM BEHAV, V30, P1252, DOI 10.1016/S0003-3472(82)80218-2; Spiess R, 2008, J MORPHOL, V269, P272, DOI 10.1002/jmor.10581; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tissot M, 1998, J NEUROBIOL, V37, P237, DOI 10.1002/(SICI)1097-4695(19981105)37:2<237::AID-NEU4>3.3.CO;2-6; WILSON DM, 1961, J EXP BIOL, V38, P471; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zinke I, 1999, DEVELOPMENT, V126, P5275	40	24	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135011	10.1371/journal.pone.0135011	http://dx.doi.org/10.1371/journal.pone.0135011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252658	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100103
J	Lochhead, RB; Zachary, JF; Dalla Rosa, L; Ma, Y; Weis, JH; O'Connell, RM; Weis, JJ				Lochhead, Robert B.; Zachary, James F.; Dalla Rosa, Luciana; Ma, Ying; Weis, John H.; O'Connell, Ryan M.; Weis, Janis J.			Antagonistic Interplay between MicroRNA-155 and IL-10 during Lyme Carditis and Arthritis	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; GENE-EXPRESSION; INFLAMMATORY RESPONSES; LABORATORY MICE; HOST-DEFENSE; IFN-GAMMA; DISEASE; MIR-155; CELLS; ACTIVATION	MicroRNA-155 has been shown to play a role in immune activation and inflammation, and is suppressed by IL-10, an important anti-inflammatory cytokine. The established involvement of IL-10 in the murine model of Borrelia burgdorferi-induced Lyme arthritis and carditis allowed us to assess the interplay between IL-10 and miR-155 in vivo. As reported previously, Mir155 was highly upregulated in joints from infected severely arthritic B6 Il10(-/-) mice, but not in mildly arthritic B6 mice. In infected hearts, Mir155 was upregulated in both strains, suggesting a role of miR- 155 in Lyme carditis. Using B. burgdorferi-infected B6, Mir155(-/-), Il10(-/-), and Mir155(-/-) Il10(-/-) double-knockout (DKO) mice, we found that anti-inflammatory IL-10 and pro-inflammatory miR- 155 have opposite and somewhat compensatory effects on myeloid cell activity, cytokine production, and antibody response. Both IL-10 and miR-155 were required for suppression of Lyme carditis. Infected Mir155(-/-) mice developed moderate/severe carditis, had higher B. burgdorferi numbers, and had reduced Th1 cytokine expression in hearts. In contrast, while Il10(-/-) and DKO mice also developed severe carditis, hearts had reduced bacterial numbers and elevated Th1 and innate cytokine expression. Surprisingly, miR-155 had little effect on Lyme arthritis. These results show that antagonistic interplay between IL-10 and miR-155 is required to balance host defense and immune activation in vivo, and this balance is particularly important for suppression of Lyme carditis. These results also highlight tissue-specific differences in Lyme arthritis and carditis pathogenesis, and reveal the importance of IL-10-mediated regulation of miR-155 in maintaining healthy immunity.	[Lochhead, Robert B.; Ma, Ying; Weis, John H.; O'Connell, Ryan M.; Weis, Janis J.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Zachary, James F.] Univ Illinois, Dept Vet Pathobiol, Urbana, IL USA; [Dalla Rosa, Luciana] Univ Fed Santa Maria, Dept Microbiol & Parasitol, BR-97119900 Santa Maria, RS, Brazil	Utah System of Higher Education; University of Utah; University of Illinois System; University of Illinois Urbana-Champaign; Universidade Federal de Santa Maria (UFSM)	Weis, JJ (corresponding author), Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	janis.weis@path.utah.edu	Lochhead, Robert/AAT-9942-2020	Lochhead, Robert/0000-0001-7726-0466	NIH [NIAID T32 AI055434]; NIH New Innovator Award [DP2GM111099-01]; NHLBI Pathway to Independence Award [R00HL102228-05]; American Cancer Society Research Grant; NIAID [R01 AI32223]; NIAMS [R01 AR43521]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL102228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434, R01AI032223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007258, R01AR043521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Pathway to Independence Award; American Cancer Society Research Grant(American Cancer Society); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	RBL was supported by a training grant from the NIH (NIAID T32 AI055434). RMO was supported by the NIH New Innovator Award (DP2GM111099-01), the NHLBI Pathway to Independence Award (R00HL102228-05), and an American Cancer Society Research Grant. JJW was supported by the NIAID (R01 AI32223) and the NIAMS (R01 AR43521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; ARMSTRONG AL, 1992, AM J TROP MED HYG, V47, P249, DOI 10.4269/ajtmh.1992.47.249; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BARTHOLD SW, 1992, AM J TROP MED HYG, V47, P605, DOI 10.4269/ajtmh.1992.47.605; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Bramwell KKC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00076; Brown CR, 2008, INFECT IMMUN, V76, P5500, DOI 10.1128/IAI.00808-08; Brown CR, 2006, J INTERF CYTOK RES, V26, P390, DOI 10.1089/jir.2006.26.390; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Carroll JA, 2003, MICROBIOL-SGM, V149, P1819, DOI 10.1099/mic.0.26165-0; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Doyle MK, 1998, J INFECT DIS, V177, P242, DOI 10.1086/517364; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fabani MM, 2010, NUCLEIC ACIDS RES, V38, P4466, DOI 10.1093/nar/gkq160; Fairfax KA, 2015, J LEUKOCYTE BIOL, V97, P71, DOI 10.1189/jlb.2A0314-178R; Hu RZ, 2014, IMMUNITY, V41, P605, DOI 10.1016/j.immuni.2014.09.015; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lazarus JJ, 2008, INFECT IMMUN, V76, P1153, DOI 10.1128/IAI.01404-07; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Lochhead RB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004212; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; Ma Y, 2014, J IMMUNOL, V193, P6050, DOI 10.4049/jimmunol.1401746; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Miller JC, 2008, EXP MOL PATHOL, V85, P20, DOI 10.1016/j.yexmp.2008.03.004; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Olson CM, 2009, J IMMUNOL, V182, P3728, DOI 10.4049/jimmunol.0804111; Ray G, 2013, MMWR-MORBID MORTAL W, V62, P993; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; RUBERTI G, 1991, HUM IMMUNOL, V31, P20, DOI 10.1016/0198-8859(91)90044-A; Sonderegger FL, 2012, J IMMUNOL, V188, P1381, DOI 10.4049/jimmunol.1102359; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Strle K, 2012, ARTHRITIS RHEUM-US, V64, P1497, DOI 10.1002/art.34383; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Yang RC, 2005, J IMMUNOL, V174, P7912, DOI 10.4049/jimmunol.174.12.7912	54	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135142	10.1371/journal.pone.0135142	http://dx.doi.org/10.1371/journal.pone.0135142			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252010	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100122
J	Shen, JH; Huang, KYA; Chen, CY; Chen, CJ; Lin, TY; Huang, YC				Shen, Jen-Hsiang; Huang, Kuan-Ying Arthur; Chen Chao-Yu; Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering			Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007	PLOS ONE			English	Article							POPULATION-BASED SURVEY; GENITAL HERPES; UNITED-STATES; INFECTION; WOMEN; PREVALENCE; ANTIBODIES; ACQUISITION; HEPATITIS; GINGIVOSTOMATITIS	Background Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) are common human pathogens and might cause severe illness. Following primary infection, the viruses establish lifelong latent infection and are transmitted by close contact, both sexual and nonsexual. However, the information about the seroprevalence of HSV-1 and HSV-2 across all age groups is limited. Methods Residual sera collected during the nationwide serosurvey in 2007 in Taiwan were selected for the study. The enzyme-linked immunosorbent assay was used to detect anti-HSV-1 and anti-HSV-2 type-specific glycoprotein IgG. Demographics and personal health data were used for risk analysis. Results A total of 1411 and 1072 serum samples were included for anti-HSV-1 and anti-HSV-2 seroprevalence analysis, respectively. The weighted overall seroprevalence was 63.2% for HSV-1, and 7.7% for HSV-2, respectively. The HSV-1 seropositive rate was 19.2% for those less than 5 years old, increased to 46.4% for those aged 5-13 years, 60.9% for those aged 14-29 years, and reached as much as 95.0% for those aged over 30 years. In contrast, the HSV-2 seropositve rate was 1.6% for those less than 30 years old, rose to 10.1% for those age 30-39 years, and was up to 31.2% for those aged over 60 years. A significantly higher HSV-2 seropositive rate was noted in females than males aged over 40 years (26.3% v.s. 16.8%), and the overall HSV-2 seropositive rate was almost twice higher in females than males. Smoking history, drinking habit, and educational level were associated with the HSV-1 seropositivity. Female gender and rural residence were independent factors for the HSV-2 seropositivity. Conclusions An obvious increase of primary HSV-1 infection occurred in late adolescents and young adults, joined by the rise of HSV-2 infection in middle-aged adults, especially females. The acquistion and transmission of HSV warrant further studies in the susceptible population.	[Shen, Jen-Hsiang; Chen Chao-Yu; Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Shen, Jen-Hsiang; Huang, Kuan-Ying Arthur; Chen Chao-Yu; Chen, Chih-Jung; Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Taoyuan, Taiwan; [Huang, Kuan-Ying Arthur] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	ychuang@cgmh.org.tw	Shen, Jen-Hsiang/GVS-5543-2022; Chen, Chao-Yu/HGE-7352-2022	Chen, Chao-Yu/0000-0003-0302-2347	Chang Gung Memorial Hospital [CMRPG470132]; Medical Foundation in Memory of Dr. Deh-Lin Cheng	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Medical Foundation in Memory of Dr. Deh-Lin Cheng	This study was supported by Chang Gung Memorial Hospital (CMRPG470132) and partly supported by Medical Foundation in Memory of Dr. Deh-Lin Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Arama V, 2010, INT J INFECT DIS, V14, pE25, DOI 10.1016/j.ijid.2009.07.026; Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Becker TM, 1996, SEX TRANSM DIS, V23, P138, DOI 10.1097/00007435-199603000-00009; Belshe RB, 2014, J INFECT DIS, V209, P828, DOI 10.1093/infdis/jit651; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Beydoun HA, 2010, INT J INFECT DIS, V14, pE154, DOI 10.1016/j.ijid.2009.12.007; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; BRYSON Y, 1993, J INFECT DIS, V167, P942, DOI 10.1093/infdis/167.4.942; Chen CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115836; Chen CJ, 2012, VACCINE, V30, P6721, DOI 10.1016/j.vaccine.2012.05.019; Chen CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024440; Chong EM, 2004, AM J OPHTHALMOL, V138, P474, DOI 10.1016/j.ajo.2004.04.027; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Cunningham AL, 2006, SEX TRANSM INFECT, V82, P164, DOI 10.1136/sti.2005.016899; Doi Y, 2009, J EPIDEMIOL, V19, P56, DOI 10.2188/jea.JE20080061; Evans BA, 2003, INT J STD AIDS, V14, P30, DOI 10.1258/095646203321043237; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Harel L, 2004, CLIN INFECT DIS, V39, P636, DOI 10.1086/422643; JOHNSON JR, 1992, CLIN INFECT DIS, V14, P38, DOI 10.1093/clinids/14.1.38; Kasubi MJ, 2006, J CLIN MICROBIOL, V44, P2801, DOI 10.1128/JCM.00180-06; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kolokotronis A, 2006, CLIN MICROBIOL INFEC, V12, P202, DOI 10.1111/j.1469-0691.2005.01336.x; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; Lazcano-Ponce E, 2001, SEX TRANSM DIS, V28, P270, DOI 10.1097/00007435-200105000-00005; Lin HJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-69; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; Malkin JE, 2002, SEX TRANSM INFECT, V78, P201, DOI 10.1136/sti.78.3.201; MAYBERRY RM, 1985, AM J PUBLIC HEALTH, V75, P676, DOI 10.2105/AJPH.75.6.676; NAHMIAS AJ, 1973, NEW ENGL J MED, V289, P719, DOI 10.1056/NEJM197310042891404; NASH AA, 1985, HERPESVIRUSES, V4, P87; Nienaber JHJC, 2012, DIAGN MICR INFEC DIS, V72, P181, DOI 10.1016/j.diagmicrobio.2011.10.005; Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850; Peng T, 1998, J VIROL, V72, P65, DOI 10.1128/JVI.72.1.65-72.1998; Posavad CM, 1998, NAT MED, V4, P381, DOI 10.1038/nm0498-381; Roest RW, 2001, INT J EPIDEMIOL, V30, P580, DOI 10.1093/ije/30.3.580; Sauerbrei A, 2011, EURO SURVEILL, V16; Schneider JA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-59; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; SIMMONS A, 1985, J VIROL, V53, P944, DOI 10.1128/JVI.53.3.944-948.1985; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Sopori ML, 1998, J NEUROIMMUNOL, V83, P148, DOI 10.1016/S0165-5728(97)00231-2; STANBERRY LR, 1994, CLIN INFECT DIS, V18, P401, DOI 10.1093/clinids/18.3.401; Wald A, 2002, J INFECT DIS, V186, pS34, DOI 10.1086/342969; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Wutzler P, 2000, J MED VIROL, V61, P201, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;201::AID-JMV5&gt;3.0.CO;2-P; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	56	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134178	10.1371/journal.pone.0134178	http://dx.doi.org/10.1371/journal.pone.0134178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252011	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100042
J	Conrad, J; Habs, M; Brandt, T; Dieterich, M				Conrad, Julian; Habs, Maximilian; Brandt, Thomas; Dieterich, Marianne			Acute Unilateral Vestibular Failure Does Not Cause Spatial Hemineglect	PLOS ONE			English	Article							VISUAL NEGLECT; LINE BISECTION; STIMULATION; CORTEX; TASK; PSEUDONEGLECT; METAANALYSIS; ANATOMY; DAMAGE	Objectives Visuo-spatial neglect and vestibular disorders have common clinical findings and involve the same cortical areas. We questioned (1) whether visuo-spatial hemineglect is not only a disorder of spatial attention but may also reflect a disorder of higher cortical vestibular function and (2) whether a vestibular tone imbalance due to an acute peripheral dysfunction can also cause symptoms of neglect or extinction. Therefore, patients with an acute unilateral peripheral vestibular failure (VF) were tested for symptoms of hemineglect. Methods Twenty-eight patients with acute VF were assessed for signs of vestibular deficits and spatial neglect using clinical measures and various common standardized paper-pencil tests. Neglect severity was evaluated further with the Center of Cancellation method. Pathological neglect test scores were correlated with the degree of vestibular dysfunction determined by the subjective visual vertical and caloric testing. Results Three patients showed isolated pathological scores in one or the other neglect test, either ipsilesionally or contralesionally to the VF. None of the patients fulfilled the diagnostic criteria of spatial hemineglect or extinction. Conclusions A vestibular tone imbalance due to unilateral failure of the vestibular endorgan does not cause spatial hemineglect, but evidence indicates it causes mild attentional deficits in both visual hemifields.	[Conrad, Julian; Habs, Maximilian; Dieterich, Marianne] Univ Munich, Dept Neurol, D-80539 Munich, Germany; [Conrad, Julian; Habs, Maximilian; Brandt, Thomas; Dieterich, Marianne] German Ctr Vertigo & Balance Disorders IFBLMU DSG, Munich, Germany; [Brandt, Thomas] Univ Munich, Clin Neurosci, D-80539 Munich, Germany; [Dieterich, Marianne] Univ Munich, Munich Cluster Syst Neurol SyNergy, D-80539 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Conrad, J (corresponding author), Univ Munich, Dept Neurol, D-80539 Munich, Germany.	julian.conrad@med.uni-muenchen.de		Conrad, Julian/0000-0001-7912-0571	German Federal Ministry of Education and Research (BMBF) [01 EO 0901]; Hertie-Foundation; German Foundation for Neurology	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Hertie-Foundation; German Foundation for Neurology	This work was supported by funds from the German Federal Ministry of Education and Research (http://www.bmbf.de/en/index.php; BMBF grant code 01 EO 0901 to MD, TB) and the Hertie-Foundation (http://www.ghst.de/en/hertie-foundation/; to TB), and the German Foundation for Neurology (http://www.deutsche-stiftung-neurologie.de/; to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Andersson G, 2003, OTOL NEUROTOL, V24, P289, DOI 10.1097/00129492-200303000-00026; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brandt T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00047; Brandt T, 2012, BIOL CYBERN, V106, P681, DOI 10.1007/s00422-012-0517-3; CAPPA S, 1987, NEUROPSYCHOLOGIA, V25, P775, DOI 10.1016/0028-3932(87)90115-1; Choi KD, 2014, NEUROL SCI, V35, P341, DOI 10.1007/s10072-013-1472-z; Conrad J, 2014, J VESTIBUL RES-EQUIL, V24, P375, DOI 10.3233/VES-140534; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P2084, DOI 10.1016/S0028-3932(02)00049-0; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; FULLERTON KJ, 1986, LANCET, V1, P430; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Jongkees JB, 1962, PRACT OTORHINOLARYNG, V24, P65; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; KARNATH HO, 1994, BRAIN, V117, P1001, DOI 10.1093/brain/117.5.1001; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Rorden C, 2010, NEUROPSYCHOLOGIA, V48, P2758, DOI 10.1016/j.neuropsychologia.2010.04.018; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Sturt R, 2013, NEUROPSYCHOL REHABIL, V23, P299, DOI 10.1080/09602011.2012.755831; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VENTRE J, 1986, EXP BRAIN RES, V62, P654; Ventre-Dominey J, 1999, NEUROPSYCHOLOGIA, V37, P715, DOI 10.1016/S0028-3932(98)00114-6; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Zheng YW, 2009, BEHAV BRAIN RES, V203, P113, DOI 10.1016/j.bbr.2009.04.027; Zheng YW, 2009, HIPPOCAMPUS, V19, P480, DOI 10.1002/hipo.20533	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135147	10.1371/journal.pone.0135147	http://dx.doi.org/10.1371/journal.pone.0135147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247469	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300104
J	Natarajan, V; Wilson, CL; Hayward, SL; Kidambi, S				Natarajan, Vaishaali; Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan			Titanium Dioxide Nanoparticles Trigger Loss of Function and Perturbation of Mitochondrial Dynamics in Primary Hepatocytes	PLOS ONE			English	Article							RAT-LIVER CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; ACUTE TOXICITY; DISEASE; PROTEIN; FIBROBLASTS; DYSFUNCTION; FUTURE; CYTOTOXICITY	Titanium dioxide (TiO2) nanoparticles are one of the most highly manufactured and employed nanomaterials in the world with applications in copious industrial and consumer products. The liver is a major accumulation site for many nanoparticles, including TiO2, directly through intentional exposure or indirectly through unintentional ingestion via water, food or animals and increased environmental contamination. Growing concerns over the current usage of TiO2 coupled with the lack of mechanistic understanding of its potential health risk is the motivation for this study. Here we determined the toxic effect of three different TiO2 nanoparticles (commercially available rutile, anatase and P25) on primary rat hepatocytes. Specifically, we evaluated events related to hepatocyte functions and mitochondrial dynamics: (1) urea and albumin synthesis using colorimetric and ELISA assays, respectively; (2) redox signaling mechanisms by measuring reactive oxygen species (ROS) production, manganese superoxide dismutase (MnSOD) activity and mitochondrial membrane potential (MMP); (3) OPA1 and Mfn-1 expression that mediates the mitochondrial dynamics by PCR; and (4) mitochondrial morphology by MitoTracker Green FM staining. All three TiO2 nanoparticles induced a significant loss (p < 0.05) in hepatocyte functions even at concentrations as low as 50 ppm with commercially used P25 causing maximum damage. TiO2 nanoparticles induced a strong oxidative stress in primary hepatocytes. TiO2 nanoparticles exposure also resulted in morphological changes in mitochondria and substantial loss in the fusion process, thus impairing the mitochondrial dynamics. Although this study demonstrated that TiO2 nanoparticles exposure resulted in substantial damage to primary hepatocytes, more in vitro and in vivo studies are required to determine the complete toxicological mechanism in primary hepatocytes and subsequently liver function.	[Natarajan, Vaishaali; Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center	Kidambi, S (corresponding author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.	skidambi2@unl.edu	Natarajan, Vaishaali/AAC-6405-2020; Kidambi, Srivatsan/A-5689-2015	Natarajan, Vaishaali/0000-0002-3668-2803; Kidambi, Srivatsan/0000-0002-0282-0411	University of Nebraska-Lincoln (UNL), Layman's Award; Materials Research Science and Engineering Center (MRSEC) Seed Grant; UNL Interdisciplinary Award	University of Nebraska-Lincoln (UNL), Layman's Award; Materials Research Science and Engineering Center (MRSEC) Seed Grant; UNL Interdisciplinary Award	This work was funded by the startup funds from University of Nebraska-Lincoln (UNL), Layman's Award, Materials Research Science and Engineering Center (MRSEC) Seed Grant, and UNL Interdisciplinary Award.	Alarifi S, 2014, BIOL TRACE ELEMENT R, P1; Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097; Anselmann R, 2001, J NANOPART RES; Arduini Alessandro, 2012, Front Biosci (Elite Ed), V4, P2233; Arias Irwin, 2011, LIVER BIOL PATHOBIOL; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Blinova I, 2010, ENVIRON POLLUT, V158, P41, DOI 10.1016/j.envpol.2009.08.017; Braydich-Stolle LK, 2009, J NANOPART RES, V11, P1361, DOI 10.1007/s11051-008-9523-8; Candas D, 2014, ANTIOXID REDOX SIGN, V20, P1599, DOI 10.1089/ars.2013.5305; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen Z, 2006, TOXICOL LETT, V163, P109, DOI 10.1016/j.toxlet.2005.10.003; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001; Emerich DF, 2003, EXPERT OPIN BIOL TH, V3, P655, DOI 10.1517/eobt.3.4.655.21202; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Fujishima A, 2006, CR CHIM, V9, P750, DOI 10.1016/j.crci.2005.02.055; Garcia A, 2011, DESALINATION, V269, P136, DOI 10.1016/j.desal.2010.10.052; Harris AJ, 2004, MUTAT RES-FUND MOL M, V549, P79, DOI 10.1016/j.mrfmmm.2003.11.014; Hassanein T, 2004, MITOCHONDRION, V4, P609, DOI 10.1016/j.mito.2004.07.015; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Kermanizadeh A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-28; Kidambi S, 2004, J AM CHEM SOC, V126, P16286, DOI 10.1021/ja046188u; Kidambi S, 2007, MACROMOL BIOSCI, V7, P344, DOI 10.1002/mabi.200600205; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0; Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005; Liu SC, 2010, TOXICOLOGY, V267, P172, DOI 10.1016/j.tox.2009.11.012; Lowe T, 2002, ADV MATER PROCESS, V160, P63; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8; Meena R, 2012, TOXICOL ENVIRON CHEM, V94, P146, DOI 10.1080/02772248.2011.638441; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ohashi K, 2008, HEPATOL RES, V38, pS76, DOI 10.1111/j.1872-034X.2008.00431.x; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Ramesh V, 2012, MOL CELL BIOCHEM, V363, P225, DOI 10.1007/s11010-011-1174-x; Santos SM, 2014, TOXICOL SCI, V138, P117, DOI 10.1093/toxsci/kft327; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Sha BY, 2014, J APPL TOXICOL, V34, P345, DOI 10.1002/jat.2900; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Singh AV, 2014, ACS NANO, V8, P2196, DOI 10.1021/nn405253d; Treem WR, 1998, DISORDERS MITOCHONDR; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang Kun, 2002, J Toxicol Sci, V27, P229, DOI 10.2131/jts.27.229; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Xu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070618; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zheng MH, 2010, CYTOTHERAPY, V12, P349, DOI 10.3109/14653240903479655	55	43	44	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134541	10.1371/journal.pone.0134541	http://dx.doi.org/10.1371/journal.pone.0134541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247363	Green Published, gold			2022-12-26	WOS:000359062300043
J	Petrakova, L; Doering, BK; Vits, S; Engler, H; Rief, W; Schedlowski, M; Grigoleit, JS				Petrakova, Liubov; Doering, Bettina K.; Vits, Sabine; Engler, Harald; Rief, Winfried; Schedlowski, Manfred; Grigoleit, Jan-Sebastian			Psychosocial Stress Increases Salivary Alpha-Amylase Activity Independently from Plasma Noradrenaline Levels	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; SYMPATHETIC ACTIVITY; ADRENERGIC ACTIVITY; SEX-DIFFERENCES; PAROTID-GLAND; SECRETION; CATECHOLAMINES; ASSOCIATIONS; STIMULATION; HUMANS	Salivary alpha-amylase activity (sAA) and plasma noradrenaline (NA) concentrations are often considered to be surrogate markers of sympathetic activation in response to stress. However, despite accumulating evidence for a close association between sAA and noradrenaline and other indicators of sympathetic activity, reliability and generality of this relation remains unclear. We employed the Trier Social Stress Test (TSST) in order to directly compare the responses in sAA and NA to psychological stress in healthy volunteers (n = 23). The TSST significantly increased sAA and NA plasma levels with no significant differences in females and males. However, when subjects were divided according to their NA responses into low versus high responders, both groups did not significantly differ in their sAA before, during or after stress exposure. These data suggest that in response to acute psychological stress both plasma NA levels and sAA reflect sympathetic activity, however seemed to increase independently from each other.	[Petrakova, Liubov; Vits, Sabine; Engler, Harald; Schedlowski, Manfred; Grigoleit, Jan-Sebastian] Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Doering, Bettina K.; Rief, Winfried] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany; [Grigoleit, Jan-Sebastian] Salk Inst Biol Studies, Lab Neuronal Struct & Funct, La Jolla, CA 92037 USA	University of Duisburg Essen; Philipps University Marburg; Salk Institute	Grigoleit, JS (corresponding author), Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	jgrigoleit@salk.edu	Rief, Winfried/ABD-4994-2021; Engler, Harald/H-8773-2017; Doering, Bettina Katharina/AAC-8122-2019	Rief, Winfried/0000-0002-7019-2250; Engler, Harald/0000-0001-6329-1990; Doering, Bettina Katharina/0000-0003-0199-8362	Biologische Heilmittel Heel GmbH, Baden-Baden, Germany	Biologische Heilmittel Heel GmbH, Baden-Baden, Germany	This study was funded by sponsor Biologische Heilmittel Heel GmbH, Dr. Reckeweg-Str. 2-4, 76532 Baden-Baden, Germany (http://www.heel.com/). This study is part of a larger project aiming to evaluate the efficacy of a drug in experimental stress conditions (EudraCT number: 2012-002359-40, ClinicalTrials.gov identifier: NCT01703832). The sponsor was involved in study design but not in data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LC, 1984, J PHYSIOL-LONDON, V352, P163, DOI 10.1113/jphysiol.1984.sp015284; ASKING B, 1985, ACTA PHYSIOL SCAND, V124, P535, DOI 10.1111/j.1748-1716.1985.tb00045.x; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Carter JR, 2009, AM J PHYSIOL-HEART C, V296, pH847, DOI 10.1152/ajpheart.01234.2008; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; Ditzen B, 2014, BIOL PSYCHOL, V103, P15, DOI 10.1016/j.biopsycho.2014.08.001; Golatowski C, 2013, CLIN CHIM ACTA, V419, P42, DOI 10.1016/j.cca.2013.01.013; Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001; Grigoleit JS, 2013, PSYCHONEUROENDOCRINO, V38, P1819, DOI 10.1016/j.psyneuen.2013.01.003; Kelly MM, 2008, J BEHAV THER EXP PSY, V39, P87, DOI 10.1016/j.jbtep.2007.02.003; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Laux L., 1981, DAS STATE TRAIT ANGS; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; SCANNAPIECO FA, 1993, CRIT REV ORAL BIOL M, V4, P301, DOI 10.1177/10454411930040030701; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; SPEIRS RL, 1974, ARCH ORAL BIOL, V19, P747, DOI 10.1016/0003-9969(74)90161-7; Thoma MV, 2012, BIOL PSYCHOL, V91, P342, DOI 10.1016/j.biopsycho.2012.07.008	18	50	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134561	10.1371/journal.pone.0134561	http://dx.doi.org/10.1371/journal.pone.0134561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247781	gold, Green Submitted, Green Published			2022-12-26	WOS:000359062300046
J	Sun, YS; Fang, WH; Kao, TW; Yang, HF; Peng, TC; Wu, LW; Chang, YW; Chou, CY; Chen, WL				Sun, Yu-Shan; Fang, Wen-Hui; Kao, Tung-Wei; Yang, Hui-Fang; Peng, Tao-Chun; Wu, Li-Wei; Chang, Yaw-Wen; Chou, Chang-Yi; Chen, Wei-Liang			Components of Metabolic Syndrome as Risk Factors for Hearing Threshold Shifts	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; ADIPONECTIN LEVELS; AUDITORY FUNCTION; NITRIC-OXIDE; US ADULTS; PREVALENCE; AGE; HYPERLIPOPROTEINEMIA	Background Hearing loss was a common, chronically disabling condition in the general population and had been associated with several inflammatory diseases. Metabolic syndrome, which was associated with insulin resistance and visceral obesity, was considered a chronic inflammatory disease. To date, few attempts had been made to establish a direct relationship between hearing loss and metabolic syndrome. The aim of the present study was to investigate the relationship between metabolic syndrome and hearing loss by analyzing the data in the reports of the National Health and Nutrition Examination Survey 1999-2004. Methods This study included 2100 participants aged <= 65 years who enrolled in the National Health and Nutrition Examination Survey (1999-2004). We examined the relationship between the presence of different features of metabolic syndrome in the participants and their pure-tone air-conduction hearing thresholds, including low-frequency and high-frequency thresholds. Results After adjusting for potential confounders, such as age, medical conditions, and smoking status, the participants with more components of metabolic syndrome were found to have higher hearing thresholds than those with fewer components of metabolic syndrome (p < 0.05 for a trend). The low-frequency hearing threshold was associated with individual components of metabolic syndrome, such as abdominal obesity, high blood pressure, elevated triglycerides, and a low level of high-density lipoprotein cholesterol (HDL-C) (p < 0.05 for all parameters). Conclusions The results indicated that the presence of a greater number of components of metabolic syndrome was significantly associated with the hearing threshold in the US adult population. Among the components of metabolic syndrome, the most apparent association was observed between low HDL and hearing loss.	[Sun, Yu-Shan; Fang, Wen-Hui; Kao, Tung-Wei; Yang, Hui-Fang; Peng, Tao-Chun; Wu, Li-Wei; Chang, Yaw-Wen; Chen, Wei-Liang] Triserv Gen Hosp, Div Family Med, Dept Family & Community Med, Taipei, Taiwan; [Sun, Yu-Shan; Fang, Wen-Hui; Kao, Tung-Wei; Yang, Hui-Fang; Peng, Tao-Chun; Wu, Li-Wei; Chang, Yaw-Wen; Chou, Chang-Yi; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei; Yang, Hui-Fang; Wu, Li-Wei; Chang, Yaw-Wen; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Chou, Chang-Yi] Triserv Gen Hosp, Div Plast Surg, Dept Surg, Taipei, Taiwan; [Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center	Chen, WL (corresponding author), Triserv Gen Hosp, Div Family Med, Dept Family & Community Med, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020; Peng, Tao‑Chun/AAY-7035-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Barrenas ML, 2005, J CLIN ENDOCR METAB, V90, P4452, DOI 10.1210/jc.2005-0385; Beddhu S, 2005, AM J KIDNEY DIS, V46, P577, DOI 10.1053/j.ajkd.2005.06.014; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Blackwell DL, 2012, VITAL HLTH STAT, V10, P1; BRECHTELSBAUER PB, 1994, HEARING RES, V77, P38, DOI 10.1016/0378-5955(94)90251-8; Chen WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108989; Chien CY, 2015, OTOLARYNG HEAD NECK, V153, P105, DOI 10.1177/0194599815575713; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; de Moraes Marchiori Luciana Lozza, 2006, Braz J Otorhinolaryngol, V72, P533; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Erdem T, 2003, EUR ARCH OTO-RHINO-L, V260, P62, DOI 10.1007/s00405-002-0519-1; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guenther M, 2014, TRANSL RES, V164, P270, DOI 10.1016/j.trsl.2014.04.008; Heinrich UR, 2012, NITRIC OXIDE-BIOL CH, V27, P106, DOI 10.1016/j.niox.2012.05.005; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2009, OBESITY, V17, P1796, DOI 10.1038/oby.2009.66; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim TS, 2014, CLIN ENDOCRINOL, V80, P368, DOI 10.1111/cen.12184; Lalwani AK, 2013, LARYNGOSCOPE, V123, P3178, DOI 10.1002/lary.24244; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Mitchell P, 2009, DIABETIC MED, V26, P483, DOI 10.1111/j.1464-5491.2009.02710.x; Moore DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107720; National Center for Health Statistics, NAT HLTH NUTR EXAM S; Nigro E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/658913; ROSEN S, 1964, Trans Am Acad Ophthalmol Otolaryngol, V68, P433; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; SAITO T, 1986, ARCH OTO-RHINO-LARYN, V243, P242, DOI 10.1007/BF00464438; Satar B, 2001, OTOL NEUROTOL, V22, P786, DOI 10.1097/00129492-200111000-00012; Schneider J, 2010, AGE AGEING, V39, P458, DOI 10.1093/ageing/afq051; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Verschuur CA, 2012, AGE AGEING, V41, P92, DOI 10.1093/ageing/afr140	40	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134388	10.1371/journal.pone.0134388	http://dx.doi.org/10.1371/journal.pone.0134388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247614	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300035
J	Banajee, KH; Embers, ME; Langohr, IM; Doyle, LA; Hasenkampf, NR; Macaluso, KR				Banajee, Kaikhushroo H.; Embers, Monica E.; Langohr, Ingeborg M.; Doyle, Lara A.; Hasenkampf, Nicole R.; Macaluso, Kevin R.			Amblyomma maculatum Feeding Augments Rickettsia parkeri Infection in a Rhesus Macaque Model: A Pilot Study	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; GULF-COAST TICKS; ACUTE-PHASE RESPONSE; PHYLOGENETIC ANALYSIS; CYTOKINE RESPONSES; IXODES-SCAPULARIS; HOST DEFENSES; MURINE MODEL; ANDEANAE; MICE	Rickettsia parkeri is an emerging eschar-causing human pathogen in the spotted fever group of Rickettsia and is transmitted by the Gulf coast tick, Amblyomma maculatum. Tick saliva has been shown to alter both the cellular and humoral components of the innate and adaptive immune systems. However, the effect of this immunomodulation on Rickettsia transmission and pathology in an immunocompetent vertebrate host has not been fully examined. We hypothesize that, by modifying the host immune response, tick feeding enhances infection and pathology of pathogenic spotted fever group Rickettsia sp. In order to assess this interaction in vivo, a pilot study was conducted using five rhesus macaques that were divided into three groups. One group was intradermally inoculated with low passage R. parkeri (Ports-mouth strain) alone (n = 2) and another group was inoculated during infestation by adult, R. parkeri-free A. maculatum(n = 2). The final macaque was infested with ticks alone (tick feeding control group). Blood, lymph node and skin biopsies were collected at several time points post-inoculation/infestation to assess pathology and quantify rickettsial DNA. As opposed to the tick-only animal, all Rickettsia-inoculated macaques developed inflammatory leukograms, elevated C-reactive protein concentrations, and elevated TH1 (interferon-gamma, interleukin-15) and acute phase inflammatory cytokines (interleukin-6) post-inoculation, with greater neutrophilia and interleukin-6 concentrations in the tick plus R. parkeri group. While eschars formed at all R. parkeri inoculation sites, larger and slower healing eschars were observed in the tick feeding plus R. parkeri group. Furthermore, dissemination of R. parkeri to draining lymph nodes early in infection and increased persistence at the inoculation site were observed in the tick plus R. parkeri group. This study indicates that rhesus macaques can be used to model R. parkeri rickettsiosis, and suggests that immunomodulatory factors introduced during tick feeding may enhance the pathogenicity of spotted fever group Rickettsia.	[Banajee, Kaikhushroo H.; Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA; [Embers, Monica E.; Hasenkampf, Nicole R.] Tulane Univ Hlth Sci, Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA USA; [Langohr, Ingeborg M.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Doyle, Lara A.] Tulane Univ Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Div Vet Med, Covington, LA USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Tulane University	Macaluso, KR (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA.	kmacaluso@vetmed.lsu.edu	Langohr, Ingeborg M/H-5570-2019	Langohr, Ingeborg M/0000-0001-7366-4391; Embers, Monica/0000-0003-4051-7592	National Institutes of Health [5P20GM103458, AI077784]; T32 training grant [OD011124-08]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR021309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011124, P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (http://www.nih.gov/; grant numbers: 5P20GM103458, AI077784). KB was supported by T32 training grant# OD011124-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Bechah Y, 2007, MICROBES INFECT, V9, P898, DOI 10.1016/j.micinf.2007.03.008; Blair PJ, 2004, J CLIN MICROBIOL, V42, P4961, DOI 10.1128/JCM.42.11.4961-4967.2004; Brossard M, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P186, DOI 10.1017/CBO9780511551802.010; Bruce AG, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-2; Carvalho-Costa TM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0634-7; Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Cragun WC, 2010, ARCH DERMATOL, V146, P641, DOI 10.1001/archdermatol.2010.48; Cray C, 2009, COMPARATIVE MED, V59, P517; Dumler JS, 2010, J CLIN INVEST, V120, P3087, DOI 10.1172/JCI44402; Embers ME, 2013, JOVE-J VIS EXP, DOI 10.3791/50617; Eremeeva ME, 2003, ANN NY ACAD SCI, V990, P468, DOI 10.1111/j.1749-6632.2003.tb07412.x; FENG HM, 1993, AM J PATHOL, V142, P1471; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Ferrari FAG, 2013, J MED ENTOMOL, V50, P1118, DOI 10.1603/ME13010; Ferrari FAG, 2012, EMERG INFECT DIS, V18, P1705, DOI 10.3201/eid1810.120250; Flores-Mendoza C, 2013, VECTOR-BORNE ZOONOT, V13, P505, DOI 10.1089/vbz.2012.1028; Fornadel CM, 2011, VECTOR-BORNE ZOONOT, V11, P1535, DOI 10.1089/vbz.2011.0654; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Graf PCF, 2008, CLIN INFECT DIS, V46, P70, DOI 10.1086/524018; Grasperge BJ, 2014, J MED ENTOMOL, V51, P855, DOI 10.1603/ME13248; Grasperge BJ, 2012, INFECT IMMUN, V80, P1846, DOI 10.1128/IAI.00109-12; Hajnicka V, 2005, PARASITOLOGY, V130, P333, DOI 10.1017/S0031182004006535; Horta MC, 2010, VECTOR-BORNE ZOONOT, V10, P959, DOI 10.1089/vbz.2009.0149; Hoshino K, 1999, J IMMUNOL, V162, P3749; IMHOF BA, 1995, ADV IMMUNOL, V58, P345, DOI 10.1016/S0065-2776(08)60623-9; Jiang J, 2005, ANN NY ACAD SCI, V1063, P337, DOI 10.1196/annals.1355.054; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Jordan JM, 2008, INFECT IMMUN, V76, P3717, DOI 10.1128/IAI.00311-08; Kaskas NM, 2014, J AM ACAD DERMATOL, V71, pE87, DOI 10.1016/j.jaad.2014.03.024; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Kubes M, 2002, PARASITE IMMUNOL, V24, P23, DOI 10.1046/j.0141-9838.2001.00434.x; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; La Scola B, 2009, MICROB PATHOGENESIS, V47, P128, DOI 10.1016/j.micpath.2009.06.004; Leydet BF, 2013, TICKS TICK-BORNE DIS, V4, P191, DOI 10.1016/j.ttbdis.2012.12.002; LOCKSLEY RM, 1987, ANN INST PASTEUR IMM, V138, P744, DOI 10.1016/S0769-2625(87)80030-2; Lopez JE, 2014, J INFECT DIS, V210, P1639, DOI 10.1093/infdis/jiu306; Luce-Fedrow A, 2012, FEMS IMMUNOL MED MIC, V64, P74, DOI 10.1111/j.1574-695X.2011.00905.x; Monje LD, 2014, TICKS TICK-BORNE DIS, V5, P924, DOI 10.1016/j.ttbdis.2014.07.002; Moraru GM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-70; MULLER I, 1989, ANNU REV IMMUNOL, V7, P561, DOI 10.1146/annurev.iy.07.040189.003021; Murphy K., 2012, JANEWAYS IMMUNOBIOLO, V8th ed, P75; Nadolny RM, 2014, TICKS TICK-BORNE DIS, V5, P53, DOI 10.1016/j.ttbdis.2013.09.001; Nuttall PA, 2004, PARASITOLOGY, V129, pS177, DOI 10.1017/S0031182004005633; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2015, TICKS TICK BORNE DIS; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Paddock CD, 2010, APPL ENVIRON MICROB, V76, P2689, DOI 10.1128/AEM.02737-09; Petchampai N, 2014, INSECT MOL BIOL, V23, P42, DOI 10.1111/imb.12059; Peterkova K, 2008, MED VET ENTOMOL, V22, P167, DOI 10.1111/j.1365-2915.2008.00726.x; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Portillo A, 2013, AM J TROP MED HYG, V89, P1203, DOI 10.4269/ajtmh.13-0436; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Reif KE, 2011, VECTOR-BORNE ZOONOT, V11, P963, DOI 10.1089/vbz.2010.0137; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Romer Y, 2014, AM J TROP MED HYG, V91, P1156, DOI 10.4269/ajtmh.14-0334; Romer Y, 2011, EMERG INFECT DIS, V17, P1169, DOI 10.3201/eid1707.101857; SAMMONS LS, 1977, LAB ANIM SCI, V27, P229; Schoeler GB, 2000, PARASITE IMMUNOL, V22, P31, DOI 10.1046/j.1365-3024.2000.00272.x; Schoeler GB, 2001, ANN TROP MED PARASIT, V95, P755, DOI 10.1080/0003498012011118; Schoeler GB, 1999, EXP PARASITOL, V92, P239, DOI 10.1006/expr.1999.4426; Sonenshine DE, 2004, PARASITOLOGY, V129, pS405, DOI 10.1017/S003118200400486X; Stockham SL, 2008, FUNDAMENTALS VET CLI, V2nd, P53; Troughton DR, 2007, J MED ENTOMOL, V44, P732, DOI 10.1603/0022-2585(2007)44[732:LCOSIT]2.0.CO;2; Vancova I, 2007, PARASITE IMMUNOL, V29, P169, DOI 10.1111/j.1365-3024.2006.00931.x; Varela-Stokes AS, 2011, EMERG INFECT DIS, V17, P2350, DOI 10.3201/eid1712.110789; Vitale G, 2001, J INFECTION, V42, P33, DOI 10.1053/jinf.2000.0758; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; WEISS E, 1973, BACTERIOL REV, V37, P259, DOI 10.1128/MMBR.37.3.259-283.1973; Whitman TJ, 2007, EMERG INFECT DIS, V13, P334, DOI 10.3201/eid1302.061295; Wikel S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00337; Wright CL, 2011, EMERG INFECT DIS, V17, P896, DOI 10.3201/eid1705.101836	73	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0135175	10.1371/journal.pone.0135175	http://dx.doi.org/10.1371/journal.pone.0135175			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244337	Green Published, gold			2022-12-26	WOS:000359061400143
J	Stamnaes, J; Iversen, R; du Pre, MF; Chen, X; Sollid, LM				Stamnaes, Jorunn; Iversen, Rasmus; du Pre, M. Fleur; Chen, Xi; Sollid, Ludvig M.			Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization	PLOS ONE			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; PLASMA-CELLS; ANTIGEN; AUTOANTIBODIES; SPECIFICITY; ACTIVATION; COMPLEXES; TRANSAMIDATION	A hallmark of the gluten-driven enteropathy celiac disease is autoantibody production towards the enzyme transglutaminase 2 (TG2) that catalyzes the formation of covalent protein-protein cross-links. Activation of TG2-specific B cells likely involves gluten-specific CD4 T cells as production of the antibodies is dependent on disease-associated HLA-DQ allotypes and dietary intake of gluten. IgA plasma cells producing TG2 antibodies with few mutations are abundant in the celiac gut lesion. These plasma cells and serum antibodies to TG2 drop rapidly after initiation of a gluten-free diet, suggestive of extrafollicular responses or germinal center reactions of short duration. High antigen avidity is known to promote such responses, and is also important for breakage of self-tolerance. We here inquired whether TG2 avidity could be a feature relevant to celiac disease. Using recombinant enzyme we show by dynamic light scattering and gel electrophoresis that TG2 efficiently utilizes itself as a substrate due to conformation-dependent homotypic association, which involves the C-terminal domains of the enzyme. This leads to the formation of covalently linked TG2 multimers. The presence of exogenous substrate such as gluten peptide does not inhibit TG2 self-cross-linking, but rather results in formation of TG2-TG2-gluten complexes. The celiac disease autoantibody epitopes, clustered in the N-terminal part of TG2, are conserved in the TG2-multimers as determined by mass spectrometry and immunoprecipitation analysis. TG2 multimers are superior to TG2 monomer in activating A20 B cells transduced with TG2-specific B-cell receptor, and uptake of TG2-TG2-gluten multimers leads to efficient activation of gluten-specific T cells. Efficient catalytic self-multimerization of TG2 and generation of multivalent TG2 antigen decorated with gluten peptides suggest a mechanism by which self-reactive B cells are activated to give abundant numbers of plasma cells in celiac disease. Importantly, high avidity of the antigen could explain why TG2-specific plasma cells show signs of an extrafollicular generation pathway.	[Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; Univ Oslo, Dept Immunol, Oslo, Norway; Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	l.m.sollid@medisin.uio.no	Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Iversen, Rasmus/0000-0002-3292-1766; Stamnaes, Jorunn/0000-0002-0257-2112; du Pre, M. Fleur/0000-0001-9231-643X	European Commission [ERC-2010-Ad-268541]; Research Council of Norway (through its Centres of Excellence) [179573/V40]; South-Eastern Norway Regional Health Authority [2012085, 2015095]	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway (through its Centres of Excellence)(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work was supported by the European Commission (grant ERC-2010-Ad-268541), the South-Eastern Norway Regional Health Authority and by grants from the Research Council of Norway (partially through its Centres of Excellence funding scheme, grant 179573/V40). The DLS experiments were done at the Regional Core Facility for Structural Biology and Bioinformatics, supported by the South-Eastern Norway Regional Health Authority (grants no. 2012085 and 2015095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRCKBICHLER PJ, 1977, BIOCHEM BIOPH RES CO, V78, P1, DOI 10.1016/0006-291X(77)91213-X; Bjorck S, 2010, J PEDIATR GASTR NUTR, V50, P49, DOI 10.1097/MPG.0b013e3181b477a6; Chackerian B, 2008, J IMMUNOL, V180, P5816, DOI 10.4049/jimmunol.180.9.5816; Chan TD, 2012, IMMUNOL REV, V247, P11, DOI 10.1111/j.1600-065X.2012.01118.x; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Di Niro R, 2015, MUCOSAL IMMUNOLOGY; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dorum S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014056; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; Hoffmann BR, 2011, J BIOL CHEM, V286, P32220, DOI 10.1074/jbc.M111.255562; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Rifkin IR, 2000, J IMMUNOL, V165, P1626, DOI 10.4049/jimmunol.165.3.1626; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; SONG WX, 1995, J IMMUNOL, V155, P4255; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Steinsbo O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5041; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; WOODRUFF MF, 1967, NATURE, V215, P591, DOI 10.1038/215591a0	38	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134922	10.1371/journal.pone.0134922	http://dx.doi.org/10.1371/journal.pone.0134922			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244572	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400131
J	Swinburne, IA; Mosaliganti, KR; Green, AA; Megason, SG				Swinburne, Ian A.; Mosaliganti, Kishore R.; Green, Amelia A.; Megason, Sean G.			Improved Long-Term Imaging of Embryos with Genetically Encoded alpha-Bungarotoxin	PLOS ONE			English	Article							DENTAL AFFERENT NEURONS; ZEBRAFISH EMBRYO; MICROSCOPY; ANESTHESIA; CURRENTS; EUGENOL; RECONSTRUCTION; EXPRESSION; ISOEUGENOL; MIGRATION	Rapid advances in microscopy and genetic labeling strategies have created new opportunities for time-lapse imaging of embryonic development. However, methods for immobilizing embryos for long periods while maintaining normal development have changed little. In zebrafish, current immobilization techniques rely on the anesthetic tricaine. Unfortunately, prolonged tricaine treatment at concentrations high enough to immobilize the embryo produces undesirable side effects on development. We evaluate three alternative immobilization strategies: combinatorial soaking in tricaine and isoeugenol, injection of alpha-bungarotoxin protein, and injection of alpha-bungarotoxin mRNA. We find evidence for co-operation between tricaine and isoeugenol to give immobility with improved health. However, even in combination these anesthetics negatively affect long-term development. alpha-bungarotoxin is a small protein from snake venom that irreversibly binds and inactivates acetylcholine receptors. We find that alpha-bungarotoxin either as purified protein from snakes or endogenously expressed in zebrafish from a codon-optimized synthetic gene can immobilize embryos for extended periods of time with few health effects or developmental delays. Using alpha-bungarotoxin mRNA injection we obtain complete movies of zebrafish embryogenesis fromthe 1-cell stage to 3 days post fertilization, with normal health and no twitching. These results demonstrate that endogenously expressed abungarotoxin provides unprecedented immobility and health for time-lapse microscopy.	[Swinburne, Ian A.; Mosaliganti, Kishore R.; Green, Amelia A.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA	Harvard University; Harvard Medical School	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02138 USA.	megason@hms.harvard.edu	Green, Amelia/K-4780-2014	Green, Amelia/0000-0002-3674-4242	NIH [DC010791, F32HL097599]; Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K25HD071969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation Emerging Research Grant; Novartis Fellowship in Systems Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by NIH grant DC010791 to SGM. IAS is supported by NIH fellowship F32HL097599, a Hearing Health Foundation Emerging Research Grant. This study was partly funded by a Novartis Fellowship in Systems Biology which is a postdoctoral fellowship administered by the Department of Systems Biology at Harvard Medical School. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to	AMREIN R, 1995, EUR J ANAESTH, V12, P5; Behra M, 2002, NAT NEUROSCI, V5, P111, DOI 10.1038/nn788; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; Chung G, 2008, J DENT RES, V87, P137, DOI 10.1177/154405910808700201; Culver JC, 2010, MICROCIRCULATION, V17, P164, DOI 10.1111/j.1549-8719.2010.00025.x; Dempsey WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032888; FRAZIER DT, 1975, EUR J PHARMACOL, V33, P313, DOI 10.1016/0014-2999(75)90175-2; Gladden JN, 2010, AM J VET RES, V71, P859, DOI 10.2460/ajvr.71.8.859; Granato M, 1996, DEVELOPMENT, V123, P399; Grush J, 2004, ZEBRAFISH, V1, P46, DOI 10.1089/154585404774101671; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ingvast-Larsson JC, 2003, AM J VET RES, V64, P690, DOI 10.2460/ajvr.2003.64.690; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishore S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3086; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Malone MH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-40; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; NEUMCKE B, 1981, PFLUG ARCH EUR J PHY, V390, P230, DOI 10.1007/BF00658267; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Park CK, 2006, J DENT RES, V85, P900, DOI 10.1177/154405910608501005; Trapani JG, 2010, METHOD CELL BIOL, V100, P219, DOI 10.1016/B978-0-12-384892-5.00008-6; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Wu SH, 2008, DEV DYNAM, V237, P2554, DOI 10.1002/dvdy.21680; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	34	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134005	10.1371/journal.pone.0134005	http://dx.doi.org/10.1371/journal.pone.0134005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244658	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400062
J	Cisler, JM; Bush, K; James, GA; Smitherman, S; Kilts, CD				Cisler, Josh M.; Bush, Keith; James, G. Andrew; Smitherman, Sonet; Kilts, Clinton D.			Decoding the Traumatic Memory among Women with PTSD: Implications for Neurocircuitry Models of PTSD and Real-Time fMRI Neurofeedback	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POSITRON-EMISSION-TOMOGRAPHY; PSYCHOPHYSIOLOGICAL ASSESSMENT; BRAIN ACTIVITY; INFORMATION; ACTIVATION; STATES; NETWORKS; IMAGERY; RISK	Posttraumatic Stress Disorder (PTSD) is characterized by intrusive recall of the traumatic memory. While numerous studies have investigated the neural processing mechanisms engaged during trauma memory recall in PTSD, these analyses have only focused on group-level contrasts that reveal little about the predictive validity of the identified brain regions. By contrast, a multivariate pattern analysis (MVPA) approach towards identifying the neural mechanisms engaged during trauma memory recall would entail testing whether a multivariate set of brain regions is reliably predictive of (i.e., discriminates) whether an individual is engaging in trauma or non-trauma memory recall. Here, we use a MVPA approach to test 1) whether trauma memory vs neutral memory recall can be predicted reliably using a multivariate set of brain regions among women with PTSD related to assaultive violence exposure (N=16), 2) the methodological parameters (e.g., spatial smoothing, number of memory recall repetitions, etc.) that optimize classification accuracy and reproducibility of the feature weight spatial maps, and 3) the correspondence between brain regions that discriminate trauma memory recall and the brain regions predicted by neurocircuitry models of PTSD. Cross-validation classification accuracy was significantly above chance for all methodological permutations tested; mean accuracy across participants was 76% for the methodological parameters selected as optimal for both efficiency and accuracy. Classification accuracy was significantly better for a voxel-wise approach relative to voxels within restricted regions-of-interest (ROIs); classification accuracy did not differ when using PTSD-related ROIs compared to randomly generated ROIs. ROI-based analyses suggested the reliable involvement of the left hippocampus in discriminating memory recall across participants and that the contribution of the left amygdala to the decision function was dependent upon PTSD symptom severity. These results have methodological implications for real-time fMRI neurofeedback of the trauma memory in PTSD and conceptual implications for neurocircuitry models of PTSD that attempt to explain core neural processing mechanisms mediating PTSD.	[Cisler, Josh M.; James, G. Andrew; Smitherman, Sonet; Kilts, Clinton D.] Univ Arkansas Med Sci, Dept Psychiat, Brain Imaging Res Ctr, Little Rock, AR 72205 USA; [Bush, Keith] Univ Arkansas Med Sci, Dept Comp Sci, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Cisler, JM (corresponding author), Univ Arkansas Med Sci, Dept Psychiat, Brain Imaging Res Ctr, Little Rock, AR 72205 USA.	jcisler@uams.edu	Cisler, Josh/L-8940-2016; James, George Andrew/J-6903-2015	James, George Andrew/0000-0002-2940-2746	National Institute of Mental Health [R21MH097784, R21MH106860]; National Institute on Drug Abuse [R01DA036360]; Brain and Behavioral Foundation NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH106860, R21MH097784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036360] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Brain and Behavioral Foundation NARSAD Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Portions of this work were supported through grants R21MH097784 (JMC) from the National Institute of Mental Health, R21MH106860 (JMC) from the National Institute of Mental Health, R01DA036360 (CDK) from the National Institute on Drug Abuse, and a Brain and Behavioral Foundation NARSAD Young Investigator Award (JMC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Brain and Behavior Foundation.	Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, V5th; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; COX R, 1996, AFNI SOFTWARE ANAL V; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; Etzel JA, 2011, NEUROIMAGE, V54, P1159, DOI 10.1016/j.neuroimage.2010.08.050; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Kilpatrick DG, 2000, J CONSULT CLIN PSYCH, V68, P19, DOI 10.1037/0022-006X.68.1.19; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, NEUROIMAGE, V38, P649, DOI 10.1016/j.neuroimage.2007.02.022; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Michael BF, 2002, STRUCTURED CLIN INTE; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Op de Beeck HP, 2010, NEUROIMAGE, V50, P567, DOI 10.1016/j.neuroimage.2009.12.072; Orr SP, 1998, J CONSULT CLIN PSYCH, V66, P906, DOI 10.1037/0022-006X.66.6.906; Orr SP, 1993, PSYCHOPHYSIOLOGICAL, P152; Papageorgiou TD, 2013, P NATL ACAD SCI USA, V110, P13630, DOI 10.1073/pnas.1210738110; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Pitman RK, 1987, PSYCHOPHYSIOLOGIC AS, P970; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; SHALEV AY, 1993, AM J PSYCHIAT, V150, P620; SHALEV AY, 1992, J CLIN PSYCHIAT, V53, P324; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Young KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088785; Zotev V, 2014, NEUROIMAGE, V85, P985, DOI 10.1016/j.neuroimage.2013.04.126; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	45	11	13	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134717	10.1371/journal.pone.0134717	http://dx.doi.org/10.1371/journal.pone.0134717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241958	Green Submitted, gold, Green Published			2022-12-26	WOS:000358942700061
J	Fu, LY; Zhang, HR; Lu, J; Zang, H; Lou, MH; Wang, GX				Fu, Liyong; Zhang, Huiru; Lu, Jun; Zang, Hao; Lou, Minghua; Wang, Guangxing			Multilevel Nonlinear Mixed-Effect Crown Ratio Models for Individual Trees of Mongolian Oak (Quercus mongolica) in Northeast China	PLOS ONE			English	Article							HEIGHT-DIAMETER MODEL; AREA INCREMENT MODEL; EVEN-AGED STANDS; PONDEROSA PINE; STONE PINE; SCOTS PINE; GROWTH; PREDICTION; ERROR; IMPACT	In this study, an individual tree crown ratio (CR) model was developed with a data set from a total of 3134 Mongolian oak (Quercus mongolica) trees within 112 sample plots allocated in Wangqing Forest Bureau of northeast China. Because of high correlation among the observations taken from the same sampling plots, the random effects at levels of both blocks defined as stands that have different site conditions and plots were taken into account to develop a nested two-level nonlinear mixed-effect model. Various stand and tree characteristics were assessed to explore their contributions to improvement of model prediction. Diameter at breast height, plot dominant tree height and plot dominant tree diameter were found to be significant predictors. Exponential model with plot dominant tree height as a predictor had a stronger ability to account for the heteroskedasticity. When random effects were modeled at block level alone, the correlations among the residuals remained significant. These correlations were successfully reduced when random effects were modeled at both block and plot levels. The random effects from the interaction of blocks and sample plots on tree CR were substantially large. The model that took into account both the block effect and the interaction of blocks and sample plots had higher prediction accuracy than the one with the block effect and population average considered alone. Introducing stand density into the model through dummy variables could further improve its prediction. This implied that the developed method for developing tree CR models of Mongolian oak is promising and can be applied to similar studies for other tree species.	[Fu, Liyong; Zhang, Huiru; Lu, Jun; Zang, Hao; Lou, Minghua] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing 100091, Peoples R China; [Wang, Guangxing] Cent South Univ Forestry & Technol, Res Ctr Forestry Remote Sensing & Informat Engn, Changsha 410004, Hunan, Peoples R China; [Wang, Guangxing] So Illinois Univ, Dept Geog & Environm Resources, Carbondale, IL 62901 USA	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; Central South University of Forestry & Technology; Southern Illinois University System; Southern Illinois University	Wang, GX (corresponding author), Cent South Univ Forestry & Technol, Res Ctr Forestry Remote Sensing & Informat Engn, Changsha 410004, Hunan, Peoples R China.	gxwang@siu.edu		zhang, huiru/0000-0003-4415-985X	National Science and Technology Support Project of the Twelfth Five-year Plan of China [2012BAD22B02]; Chinese National Natural Science Foundation [31300534]; Central South University of Forestry and Technology [112-0990]	National Science and Technology Support Project of the Twelfth Five-year Plan of China; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Central South University of Forestry and Technology	The authors acknowledge the National Science and Technology Support Project of the Twelfth Five-year Plan of China (Nos. 2012BAD22B02), the Chinese National Natural Science Foundation (Nos. 31300534), and the Central South University of Forestry and Technology (Nos. 112-0990) for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Assmann E., 1970, PRINCIPLES FOREST YI; BELLA IE, 1971, FOREST SCI, V17, P364; Bragg Don C., 2001, Northern Journal of Applied Forestry, V18, P22; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Clutter JL, 1983, TIMBER MANAGEMENT QU; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Davidian M., 1995, NONLINEAR MODELS REP; Du JiShan, 2000, Scientia Silvae Sinicae, V36, P26; Eerikainen K, 2003, FOREST ECOL MANAG, V175, P355, DOI 10.1016/S0378-1127(02)00138-X; F.S. Popoola, 2012, Journal of forest and environmental science, V28, P63; Fang ZX, 2001, FOREST SCI, V47, P287; Fiala ACS, 2006, FOREST ECOL MANAG, V232, P188, DOI 10.1016/j.foreco.2006.05.069; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu LY, 2013, FOREST ECOL MANAG, V302, P210, DOI 10.1016/j.foreco.2013.03.036; Fuller W.A., 2009, MEASUREMENT ERROR MO; GERTNER GZ, 1990, CAN J FOREST RES, V20, P800, DOI 10.1139/x90-105; GHOSH S, 1995, FOREST SCI, V41, P235; Gregoire TG, 1995, CAN J FOREST RES, V1, P25, DOI DOI 10.1139/X95-017; Hall DB, 2001, FOREST SCI, V47, P311; Hasenauer H, 1996, FOREST ECOL MANAG, V84, P49, DOI 10.1016/0378-1127(96)03768-1; HENDERSON CR, 1959, BIOMETRICS, V15, P192, DOI 10.2307/2527669; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Huuskonen S, 2007, FOREST ECOL MANAG, V241, P49, DOI 10.1016/j.foreco.2006.12.024; KERSHAW JA, 1990, CAN J FOREST RES, V20, P1690, DOI 10.1139/x90-225; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; McGaughey R.J., 1997, P 1997 ACSM ASPRS AN, V4, P248; MCROBERTS RE, 1994, CAN J FOREST RES, V24, P1766, DOI 10.1139/x94-228; Meng SX, 2009, FOREST SCI, V55, P238; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Nanos N, 2004, FOREST ECOL MANAG, V195, P221, DOI 10.1016/j.foreco.2004.02.031; Navratil S., 1997, Proceedings of a commercial thinning workshop, Whitecourt, Alberta, October 17-18, 1996., P29; NICHOLAS NS, 1991, CAN J FOREST RES, V21, P698, DOI 10.1139/x91-095; O'Hara KL, 1999, FOREST ECOL MANAG, V118, P57, DOI 10.1016/S0378-1127(98)00486-1; OMULE SAY, 1980, FOREST CHRON, V56, P222, DOI 10.5558/tfc56222-5; Pinheiro J. C., 1995, J COMPUTATIONAL GRAP, V4, P12, DOI [DOI 10.2307/1390625, 10.1080/10618600.1995.10474663, DOI 10.1080/10618600.1995.10474663]; Pinherio JC., 2000, MIXED EFFECTS MODELS; Raulier F, 2003, FOREST ECOL MANAG, V184, P65, DOI 10.1016/S0378-1127(03)00149-X; Reineke LH, 1933, J AGRIC RES, V46, P0627; Rijal B, 2012, FOREST CHRON, V88, P60, DOI 10.5558/tfc2012-011; Sanchez-Gonzalez M, 2007, INVEST AGRAR-SIST R, V16, P76, DOI 10.5424/srf/2007161-00999; Sharma M, 2009, FOREST SCI, V55, P268; Soares P, 2001, ANN FOREST SCI, V58, P193, DOI 10.1051/forest:2001118; Sonmez T, 2009, AFR J AGR RES, V4, P214; SPRINZ PT, 1987, CAN J FOREST RES, V17, P534, DOI 10.1139/x87-089; Spurr S.H., 1980, FOREST ECOLOGY; Tahvanainen T, 2008, FOREST ECOL MANAG, V255, P455, DOI 10.1016/j.foreco.2007.09.035; Tang S., 1998, J BIOMATH, V13, P161; Tang SZ, 2001, ECOL MODEL, V142, P285, DOI 10.1016/S0304-3800(01)00326-X; Temesgen H, 2008, CAN J FOREST RES, V38, P553, DOI 10.1139/X07-104; Temesgen H, 2005, FOREST CHRON, V81, P133, DOI 10.5558/tfc81133-1; Toney C, 2009, WEST J APPL FOR, V24, P76, DOI 10.1093/wjaf/24.2.76; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Uzoh FCC, 2006, FOREST ECOL MANAG, V221, P147, DOI 10.1016/j.foreco.2005.09.012; Venables W., 2013, MODERN APPL STAT S, V53, P86; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; WEST PW, 1984, FOREST ECOL MANAG, V7, P207, DOI 10.1016/0378-1127(84)90068-9; Wykoff W.R., 1982, INT133 USDA; Yang YQ, 2011, CAN J FOREST RES, V41, P1671, DOI [10.1139/x11-071, 10.1139/X11-071]; Yang YQ, 2009, CAN J FOREST RES, V39, P2203, DOI 10.1139/X09-123; Zhao D, 2012, OPEN J FORESTRY, V2, P107	63	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133294	10.1371/journal.pone.0133294	http://dx.doi.org/10.1371/journal.pone.0133294			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241912	gold, Green Submitted, Green Published			2022-12-26	WOS:000358942700012
J	de Mello, PLH; Machado, RB; Nogueira, CD				de Mello, Pietro L. H.; Machado, Ricardo B.; Nogueira, Cristiano de C.			Conserving Biogeography: Habitat Loss and Vicariant Patterns in Endemic Squamates of the Cerrado Hotspot	PLOS ONE			English	Article							BRAZILIAN FOREST CODE; POTENTIAL IMPACTS; CONSERVATION STRATEGY; BIODIVERSITY HOTSPOTS; PROTECTED AREAS; PRIORITY AREAS; REGION; ECOLOGY; VEGETATION; SELECTION	Little is known about the threat levels and impacts of habitat loss over the Cerrado Squamate fauna. The region is under severe habitat loss due to mechanized agriculture, accelerated by changes in the Brazilian National Forest Code. The Squamate fauna of the Cerrado is rich in endemics and is intrinsically associated with its surrounding microhabitats, which make up a mosaic of phitophysiognomies throughout the region. Herein we evaluate current conservation status of Squamate biogeographic patterns in the Brazilian Cerrado, the single savanna among global biodiversity hotspots. To do so, we first updated point locality data on 49 endemic Squamates pertaining to seven non-random clusters of species ranges in the Cerrado. Each cluster was assumed to be representative of different biogeographic regions, holding its own set of species, herein mapped according to their extent of occurrence (EOO). We then contrasted these data in four different scenarios, according to the presence or absence of habitat loss and the presence or absence of the current protected area (PA) cover. We searched for non-random patterns of habitat loss and PA coverage among these biogeographic regions throughout the Cerrado. Finally, with the species EOO as biodiversity layers, we used Zonation to discuss contemporary PA distribution, as well as to highlight current priority areas for conservation within the Cerrado. We ran Zonation under all four conservation scenarios mentioned above. We observed that habitat loss and PA coverage significantly differed between biogeographic regions. The southernmost biogeographic region is the least protected and the most impacted, with priority areas highly scattered in small, disjunct fragments. The northernmost biogeographic region (Tocantins-Serra Geral) is the most protected and least impacted, showing extensive priority areas in all Zonation scenarios. Therefore, current and past deforestation trends are severely threatening biogeographic patterns in the Cerrado. Moreover, PA distribution is spatially biased, and does not represent biogeographic divisions of the Cerrado. Consequently, we show that biogeographic patterns and processes are being erased at an accelerated pace, reinforcing the urgent need to create new reserves and to avoid the loss of the last remaining fragments of once continuous biogeographic regions. These actions are fundamental and urgent for conserving biogeographic and evolutionary information in this highly imperiled savanna hotspot.	[de Mello, Pietro L. H.] Univ Brasilia, Inst Ciencias Biol IB, Programa Posgrad Ecol, BR-70910900 Brasilia, DF, Brazil; [Machado, Ricardo B.; Nogueira, Cristiano de C.] Univ Brasilia, Inst Ciencias Biol IB, Dept Zool, BR-70910900 Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Nogueira, CD (corresponding author), MZUSP, Lab Herpetol, Sao Paulo, SP, Brazil.	cnbiogeo@gmail.com	Nogueira, Cristiano de C. de Campos/I-5100-2012; Machado, Ricardo Bomfim/J-5894-2012; de Mello, Pietro/HGA-4294-2022; Machado, Ricardo/GXM-8198-2022	Nogueira, Cristiano de C. de Campos/0000-0003-1835-6761; Machado, Ricardo Bomfim/0000-0002-6508-9005; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided a fellowship to P.L.H.M. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) provided research funds and fellowships to C.N. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided a research grant to R.B.M.	Ab'Saber AN., 1977, GEOMORFOLOGIA, V52; Alexandratos N, 2012, 1203 FAO ESA; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brasil, 2011, PROD INT BRUT 2011; Brasil, 2010, CENS DEM 2010; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown J. H., 1998, BIOGEOGRAPHY; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Casatti L, 2010, BIOTA NEOTROP, V10, P31, DOI 10.1590/S1676-06032010000400002; Collen B, 2008, IUCN RED LIST THREAT, P67; Crawley M.J., 2007, R BOOK; Crisci JV, 2001, J BIOGEOGR, V28, P157, DOI 10.1046/j.1365-2699.2001.00523.x; CROIZAT L, 1974, SYST ZOOL, V23, P265, DOI 10.2307/2412139; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; DaSilva JMC, 1997, BIODIVERS CONSERV, V6, P435, DOI 10.1023/A:1018368809116; Silva VDE, 2014, BIOL CONSERV, V180, P1, DOI 10.1016/j.biocon.2014.09.016; Develey PF, 2010, BIOTA NEOTROP, V10, P43, DOI 10.1590/S1676-06032010000400005; Dimitrakopoulos PG, 2004, GLOBAL ECOL BIOGEOGR, V13, P199, DOI 10.1111/j.1466-822X.2004.00086.x; Diniz JAF, 2004, AMPHIBIA-REPTILIA, V25, P63, DOI 10.1163/156853804322992841; Diniz JAF, 2007, BIODIVERS CONSERV, V16, P997, DOI 10.1007/s10531-006-9010-4; Dudley N, 2008, GUIDELINES APPL PROT, DOI DOI 10.2305/IUCN.CH.2008.PAPS.2.EN; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Environmental Systems Research Institute (ESRI, 2014, SOFTW ARCG PROF GIS; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; Gainsbury AM, 2003, BIOTROPICA, V35, P503, DOI 10.1111/j.1744-7429.2003.tb00607.x; Galetti M, 2010, BIOTA NEOTROP, V10, P47, DOI 10.1590/S1676-06032010000400006; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Guedes TB, 2014, J BIOGEOGR, V41, P919, DOI 10.1111/jbi.12272; Hausdorf B, 2004, J BIOGEOGR, V31, P1751, DOI 10.1111/j.1365-2699.2004.01090.x; Hausdorf B, 2003, SYST BIOL, V52, P717, DOI 10.1080/10635150390235584; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; IBAMA, 2013, PROJ MON DESM BIOM B; IBGE, 2004, MAP BIOM BRAS MAP VE; IUCN, 2014, SUMM STAT GLOB REAT; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; Joppa LN, 2006, PLOS ONE, V4, P1; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Lehtomaki J, 2009, FOREST ECOL MANAG, V258, P2439, DOI 10.1016/j.foreco.2009.08.026; Machado RB, 2004, ESTIMATIVAS PERDA AR; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mesquita DO, 2006, COPEIA, P460, DOI 10.1643/0045-8511(2006)2006[460:EOACLA]2.0.CO;2; Moilanen A, 2006, BIOL CONSERV, V129, P427, DOI 10.1016/j.biocon.2005.11.006; Moilanen A, 2005, P ROY SOC B-BIOL SCI, V272, P1885, DOI 10.1098/rspb.2005.3164; Moilanen A, 2012, ZONATION V 3 1 MANUA; Moilanen A, 2009, SPATIAL CONSERVATION; Moilanen A., 2009, SPATIAL CONSERVATION; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Myers N, 2003, BIOSCIENCE, V53, P916; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Ostro LET, 1999, J WILDLIFE MANAGE, V63, P748, DOI 10.2307/3802665; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Perz SG, 2000, INT MIGR REV, V34, P842, DOI 10.2307/2675947; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Pullin A. S., 2002, CONSERV BIOL; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Redford K.H., 1985, Oryx, V19, P210; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Silva JF, 2006, J BIOGEOGR, V33, P536, DOI 10.1111/j.1365-2699.2005.01422.x; Toledo LF, 2010, BIOTA NEOTROP, V10, P35, DOI 10.1590/S1676-06032010000400003; Valdujo Paula Hanna, 2012, South American Journal of Herpetology, V7, P63; Vie J.C., 2009, WILDLIFE CHANGING WO, DOI 10.2305/IUCN.CH.2009.17.en; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Marques OAV, 2010, BIOTA NEOTROP, V10, P39, DOI 10.1590/S1676-06032010000400004; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Williams PH, 2000, BELGIAN J ENTOMOL, V2, P221	93	8	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133995	10.1371/journal.pone.0133995	http://dx.doi.org/10.1371/journal.pone.0133995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252746	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100031
J	Dong, BA; Shi, ZH; Wang, JP; Wu, J; Yang, ZQ; Fang, KW				Dong, Biao; Shi, Zhihao; Wang, Jiaping; Wu, Jing; Yang, Zhaoqing; Fang, Kewei			IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH-4; SUPPRESSOR PDCD4; GROWTH-FACTOR; MICRORNA-21; CELLS; INTERLEUKIN-6; EXPRESSION; CARCINOMA; RECEPTOR; TRANSFORMATION	Prostate cancer is the most common cancer among men in the Unites States. The cytokine IL-6 activates several prostate cancer pathways, but its upstream trans-signaling pathway remains poorly understood. In this study, we evaluated the role of IL-6 in PDCD4 gene expression and how the microRNA miR-21 regulates this process in prostate cancer cell lines PC-3 and LNCaP. The expression pattern of PDCD4 from samples from human prostate cancer, precancerous lesions, and benign prostatic hyperplasia was investigated by immunohistochemistry. PDCD4 transcription and translation were detected by quantitative real-time PCR (qRT-PCR) and Western blot analysis, respectively. The targeted modulation of PDCD4 by miR-21 was analyzed in PC-3 and LNCaP cells, and the effect of IL-6 on the expression of PDCD4 was studied in vitro. PDCD4 expression in samples from the 3 tissue types progressively increased, and the expression levels of PDCD4 and prostate-specific antigen were negatively correlated. The levels of PDCD4 mRNA and protein in PC-3 and LNCaP cells transfected with anti-miR-21 constructs were lower than those in control cells. The expression of PDCD4 was inhibited by IL-6, but this effect was weakened in cell lines with low expression of miR-21. Our study demonstrates that the regulation of PDCD4 by miR-21 is targeted and IL-6 inhibits expression of the PDCD4 gene in PC-3 and LNCaP cells through the targeted function of miR-21 on PDCD4. These findings support the feasibility of future efforts for diagnosis and gene therapy for prostate cancer that are based on IL-6, miR-21, and PDCD4.	[Dong, Biao; Wang, Jiaping; Fang, Kewei] Kunming Med Univ, Hosp 2, Dept Urol, Kunming, Yunnan, Peoples R China; [Dong, Biao; Fang, Kewei] Urol Inst Yunnan Prov, Kunming, Yunnan, Peoples R China; [Shi, Zhihao] Gen Hosp Jinan Mil Reg, Emergency Ctr, Jinan, Shandong, Peoples R China; [Wu, Jing] Kunming Med Univ, Primary Med Coll, Dept Biochem, Kunming, Yunnan, Peoples R China; [Yang, Zhaoqing] Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Yang, Zhaoqing] Peking Union Med Univ, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Fang, KW (corresponding author), Kunming Med Univ, Hosp 2, Dept Urol, Kunming, Yunnan, Peoples R China.	2482099228@qq.com			Heath Department of Yunnan Province [2010NS053]	Heath Department of Yunnan Province	The authors received specific funding for this work from the Heath Department of Yunnan Province(Grant No. 2010NS053). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chun JY, 2009, CLIN CANCER RES, V15, P4815, DOI 10.1158/1078-0432.CCR-09-0640; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hilliard A, 2006, J IMMUNOL, V177, P8095, DOI 10.4049/jimmunol.177.11.8095; Iacopino F, 2012, ONCOL REP, V28, P370, DOI 10.3892/or.2012.1785; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Ma G, 2007, CHIN J CANC PREV TRE, V14, P249; Ribas J, 2010, CELL CYCLE, V9, P923, DOI 10.4161/cc.9.5.10930; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi GH, 2010, ACTA PHARMACOL SIN, V31, P867, DOI 10.1038/aps.2010.48; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wen YH, 2007, ONCOL REP, V18, P1387; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Yu YJ, 2012, CARCINOGENESIS, V33, P68, DOI 10.1093/carcin/bgr246; Zakowicz H, 2005, RNA, V11, P261, DOI 10.1261/rna.7191905; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	27	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134366	10.1371/journal.pone.0134366	http://dx.doi.org/10.1371/journal.pone.0134366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252635	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100054
J	Jin, XW; Liu, YL; Liu, JJ; Lu, WL; Liang, ZW; Zhang, D; Liu, G; Zhu, HX; Xu, NZ; Liang, SF				Jin, Xuewen; Liu, Yuling; Liu, Jingjing; Lu, Weiliang; Liang, Ziwei; Zhang, Dan; Liu, Gang; Zhu, Hongxia; Xu, Ningzhi; Liang, Shufang			The Overexpression of IQGAP1 and beta-Catenin Is Associated with Tumor Progression in Hepatocellular Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							INVASION; WNT; EXPRESSION; CDC42; PROLIFERATION; METASTASIS; MUTATIONS; MIGRATION; COMPLEX; AXIN1	The IQ-domain GTPase-activating protein 1 (IQGAP1) is a multifunctional scaffold protein, which interacts with diverse proteins to regulate cell adhesion and cell migration. The abnormal expression of IQGAP1 widely exists in many cancers, but biological roles of IQGAP1 cooperation with its interacting proteins to involve in tumorigenesis remain to clarify. In this study, we have found that IQGAP1 interacts with beta-catenin and regulates beta-catenin expression in hepatocellular carcinoma (HCC) cells. The expression levels of IQGAP1 and beta-catenin and their associations have a positive correlation with cell metastasis ability in several HCC cell lines. The up-regulation of IQGAP1 and beta-catenin improves cell proliferation and migration ability of HCC cells, whereas the knockdown of IQGAP1 by small interfering RNA can decrease beta-catenin expression, which results in the reduction of cell proliferation and migration ability in vitro. In addition, a significantly higher expression of IQGAP1 and beta-catenin also usually exists in human HCC tissues, especially their overexpression is clinicopathologically associated with tumor malignancy. Generally the overexpression and interactions of IQGAP1 and beta-catenin contribute to HCC progression by promoting cell proliferation and migration.	[Jin, Xuewen; Liu, Yuling; Liu, Jingjing; Lu, Weiliang; Liang, Ziwei; Zhang, Dan; Liang, Shufang] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Jin, Xuewen; Liu, Yuling; Liu, Jingjing; Lu, Weiliang; Liang, Ziwei; Zhang, Dan; Liang, Shufang] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Ctr Canc, Chengdu 610041, Peoples R China; [Liu, Gang] Sichuan Univ, West China Hosp, Dept Rheumatol, Chengdu 610041, Peoples R China; [Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, Lab Cell & Mol Biol, Beijing 100034, Peoples R China; [Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Inst & Canc Hosp, State Key Lab Mol Oncol, Beijing 100034, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Liang, SF (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, 17,3rd Sect Peoples South Rd, Chengdu 610041, Peoples R China.	zizi2006@scu.edu.cn	Liang, Shufang/AAW-8143-2021		National Key Basic Research Program of China [2013CB911303, 2011CB910703]; National 863 High Tech Foundation [2014AA020608]; National Natural Sciences Foundation of China [31470810, 31071235, 30970654]; Doctoral Program of Higher Education [20120181110025]; Sichuan Province Program [2012SZ0002]	National Key Basic Research Program of China(National Basic Research Program of China); National 863 High Tech Foundation(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sichuan Province Program	This work was financially supported by the grants from National Key Basic Research Program of China (2013CB911303, 2011CB910703, www.most.gov.cn), the National 863 High Tech Foundation (2014AA020608, www.most.gov.cn), National Natural Sciences Foundation of China (31470810, 31071235, 30970654, www.nsfc.gov.cn), and the Doctoral Program of Higher Education (20120181110025, www.moe.gov.cn). The authors also acknowledged the financially support of Sichuan Province Program (2012SZ0002, www.scst.gov.cn). SL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Ding YJ, 2014, J CELL SCI, V127, P4833, DOI 10.1242/jcs.146977; Dong PX, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-77; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Goto T, 2013, J BIOL CHEM, V288, P36351, DOI 10.1074/jbc.M113.520528; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lam AP, 2011, AM J RESP CELL MOL, V45, P915, DOI 10.1165/rcmb.2010-0113OC; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liang SF, 2008, IUBMB LIFE, V60, P534, DOI 10.1002/iub.75; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Miyoshi T, 2005, PATHOL INT, V55, P419, DOI 10.1111/j.1440-1827.2005.01847.x; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Qi M, 2015, TUMOR BIOL, V36, P3565, DOI 10.1007/s13277-014-2993-7; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Sobin LH, 2009, TNM CLASSIFICATION O; Suare I, 2015, ANN HEPATOL, V14, P64; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Wang XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096501; WANG ZP, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0072846; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; Zucman-Rossi J, 2007, ONCOGENE, V26, P774, DOI 10.1038/sj.onc.1209824	37	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133770	10.1371/journal.pone.0133770	http://dx.doi.org/10.1371/journal.pone.0133770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252773	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100024
J	Li, Y; Zheng, B; Li, Y; Zhu, SN; Xue, F; Liu, J				Li, Ya; Zheng, Bo; Li, Yun; Zhu, Sainan; Xue, Feng; Liu, Jian			Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ENOLPYRUVYL TRANSFERASE; GENE FOSA3; PHOSPHONOMYCIN; TROMETHAMINE; ECO.SENS; STRAINS; MURA	Escherichia coli is one of the most common pathogens in nosocomial and community-acquired infections in humans. Fosfomycin is a broad-spectrum antibiotic which inhibits peptidoglycan synthesis responsible for bacterial cell wall formation. Although low, the exact E. coli susceptibility to fosfomycin as well as the mechanisms of resistance in the population from Mainland China are mostly unknown. 1109 non-duplicate clinical E. coli strains isolated from urine, sputum, blood and pus samples in 20 widely dispersed tertiary hospitals from Mainland China were collected from July 2009 to June 2010, followed by determination of minimum inhibitory concentrations of fosfomycin. Detection of the murA, glpT, uhpT, fosA, fosA(3) and fosC genes was performed in fosfomycin non-susceptible E. coli strains and conjugation experiments were employed to determine the mobility of fosA(3) gene. In this study, 7.8% (86/1109) E. coli strains were fosfomycin non-susceptible. Amino acid substitutions in GlpT and MurA were found in six and four E. coli strains, respectively, while the uhpT gene was absent in eighteen E. coli strains. Twenty-nine isolates carried the transferable plasmid with the fosA3 gene at high frequencies of around 10(-6) to 10(-7) per donor cell in broth mating. The majority of isolates were susceptible to fosfomycin, showing that the drug is still viable in clinical applications. Also, the main mechanism of E. coli resistance in Mainland China was found to be due to the presence of the fosA(3) gene.	[Li, Ya; Zheng, Bo; Li, Yun; Xue, Feng; Liu, Jian] Peking Univ, Inst Clin Pharmacol, Hosp 1, Beijing 100871, Peoples R China; [Zhu, Sainan] Peking Univ, Dept Biostat, Hosp 1, Beijing 100871, Peoples R China	Peking University; Peking University	Zheng, B (corresponding author), Peking Univ, Inst Clin Pharmacol, Hosp 1, Beijing 100871, Peoples R China.	doctorzhengbo@163.com			National Science & Technology Pillar Program [2012EP001002]	National Science & Technology Pillar Program	This study was supported by grants from the Key Projects in the National Science & Technology Pillar Program (2012EP001002).	Clinical and Laboratory Standards Institute, 2014, M100S24 CLIN LAB STA; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Hou JX, 2013, J ANTIMICROB CHEMOTH, V68, P766, DOI 10.1093/jac/dks465; Hou JX, 2012, ANTIMICROB AGENTS CH, V56, P2135, DOI 10.1128/AAC.05104-11; KADNER RJ, 1973, J BACTERIOL, V113, P895, DOI 10.1128/JB.113.2.895-900.1973; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; Knottnerus BJ, 2008, J ANTIMICROB CHEMOTH, V62, P356, DOI 10.1093/jac/dkn177; Lai B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-66; MARQUARDT JL, 1992, J BACTERIOL, V174, P5748, DOI 10.1128/JB.174.17.5748-5752.1992; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; Patel SS, 1997, DRUGS, V53, P637, DOI 10.2165/00003495-199753040-00007; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; TSURUOKA T, 1978, J ANTIBIOT, V31, P192, DOI 10.7164/antibiotics.31.192; TSURUOKA T, 1975, J ANTIBIOT, V28, P906, DOI 10.7164/antibiotics.28.906; VENKATESWARAN PS, 1972, J BACTERIOL, V110, P935, DOI 10.1128/JB.110.3.935-944.1972; Wachino J, 2010, ANTIMICROB AGENTS CH, V54, P3061, DOI 10.1128/AAC.01834-09; Yi H, 2012, J BACTERIOL, V194, P3742, DOI 10.1128/JB.00641-12; Zhu JY, 2012, J BIOL CHEM, V287, P12657, DOI 10.1074/jbc.M112.342725	21	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135269	10.1371/journal.pone.0135269	http://dx.doi.org/10.1371/journal.pone.0135269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252888	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100145
J	Bonomi, R; Mukhopadhyay, U; Shavrin, A; Yeh, HH; Majhi, A; Dewage, SW; Najjar, A; Lu, X; Cisneros, GA; Tong, WP; Alauddin, MM; Liu, RS; Mangner, TJ; Turkman, N; Gelovani, JG				Bonomi, Robin; Mukhopadhyay, Uday; Shavrin, Aleksandr; Yeh, Hsien-Hsien; Majhi, Anjoy; Dewage, Sajeewa W.; Najjar, Amer; Lu, Xin; Cisneros, G. Andres; Tong, William P.; Alauddin, Mian M.; Liu, Ren-Shuan; Mangner, Thomas J.; Turkman, Nashaat; Gelovani, Juri G.			Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO; CATALYTIC-ACTIVITY; INHIBITION; SPECIFICITY; ROLES; HDACS	Histone deacetylases (HDAC's) became increasingly important targets for therapy of various diseases, resulting in a pressing need to develop HDAC class-and isoform-selective inhibitors. Class IIa deacetylases possess only minimal deacetylase activity against acetylated histones, but have several other client proteins as substrates through which they participate in epigenetic regulation. Herein, we report the radiosyntheses of the second generation of HDAC class IIa-specific radiotracers: 6-(di-fluoroacetamido)-1-hexanoicanilide (DFAHA) and 6-(tri-fluoroacetamido)-1-hexanoicanilide ([F-18]-TFAHA). The selectivity of these radiotracer substrates to HDAC class IIa enzymes was assessed in vitro, in a panel of recombinant HDACs, and in vivo using PET/CT imaging in rats. [F-18] TFAHA showed significantly higher selectivity for HDAC class IIa enzymes, as compared to [F-18] DFAHA and previously reported [F-18] FAHA. PET imaging with [F-18] TFAHA can be used to visualize and quantify spatial distribution and magnitude of HDAC class IIa expression-activity in different organs and tissues in vivo. Furthermore, PET imaging with [F-18] TFAHA may advance the understanding of HDACs class IIa mediated epigenetic regulation of normal and pathophysiological processes, and facilitate the development of novel HDAC class IIa-specific inhibitors for therapy of different diseases.	[Bonomi, Robin; Shavrin, Aleksandr; Majhi, Anjoy; Lu, Xin; Turkman, Nashaat; Gelovani, Juri G.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Mangner, Thomas J.] Wayne State Univ, Positron Emiss Tomog Ctr, Detroit, MI 48202 USA; [Dewage, Sajeewa W.; Cisneros, G. Andres] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Najjar, Amer; Tong, William P.; Alauddin, Mian M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Mukhopadhyay, Uday] Univ Texas MD Anderson Canc Ctr, Ctr Adv Biomed Imaging, Houston, TX 77030 USA; [Yeh, Hsien-Hsien; Liu, Ren-Shuan] Natl Yang Ming Univ, Natl Cyclotron & Radiochem Ctr, Taipei 112, Taiwan; [Yeh, Hsien-Hsien; Liu, Ren-Shuan] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	Wayne State University; Wayne State University; Wayne State University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Gelovani, JG (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	juri.gelovani@wayne.edu	Cisneros, G. Andres/H-5197-2017	Cisneros, G. Andres/0000-0001-6629-3430; Walimuni Dewage, Sajeewa/0000-0003-0443-137X; MAJHI, ANJOY/0000-0003-0142-4940	NCI CCSG Core Grant (NIH/NIDA) [CA 016672, RC2 DA028912-01]; NIH [P30 CA022453]; Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; NATIONAL CANCER INSTITUTE [P30CA022453, P30CA016672, R01CA140314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028912] Funding Source: NIH RePORTER	NCI CCSG Core Grant (NIH/NIDA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NCI CCSG Core Grant CA 016672 and RC2 DA028912-01 (NIH/NIDA) to JG. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30 CA022453 to the Karmanos Cancer Institute at Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University.	BioSolveIT GmbH, LEADIT2 1 7 ZIEG; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guo H, 2007, NUCL MED BIOL, V34, P483, DOI 10.1016/j.nucmedbio.2007.03.008; HABERKORN U, 2007, EUR J NUCL MED MO S2, V34, pS395; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hendricks JA, 2011, J MED CHEM, V54, P5576, DOI 10.1021/jm200620f; Hooker JM, 2010, ACS CHEM NEUROSCI, V1, P65, DOI 10.1021/cn9000268; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lange G, 2010, REULECKE; Leskovac, 2003, COMPREHENSIVE ENZYME; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Logan J., J CEREB BLOOD FLOW M, V10, P740; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Meng QQ, 2013, ACS MED CHEM LETT, V4, P858, DOI 10.1021/ml400191z; Morris MJ, 2013, INT J DEV NEUROSCI, V31, P370, DOI 10.1016/j.ijdevneu.2013.02.005; Mukhopadhyay U, 2006, J LABELLED COMPD RAD, V49, P997, DOI 10.1002/jlcr.1122; Nishii R M U, 2007, J NUCL MED, V48, P336; Park JH, 2004, CLIN CANCER RES, V10, P5271, DOI 10.1158/1078-0432.CCR-03-0709; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price V, 2013, J NEUROSCI RES, V91, P407, DOI 10.1002/jnr.23170; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reid AE, 2009, NUCL MED BIOL, V36, P247, DOI 10.1016/j.nucmedbio.2008.12.005; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Riester D, 2004, BIOCHEM BIOPH RES CO, V324, P1116, DOI 10.1016/j.bbrc.2004.09.155; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Ron S, 2006, J MOL NEUROSCI, V07, P47; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanabria SM, 2008, NEUROIMAGE, V41, pT15, DOI 10.1016/j.neuroimage.2008.04.189; Sankaranarayanapillai M, 2008, MOL IMAGING, V7, P92, DOI 10.2310/7290.2008.0011; Sankaranarayanapillai M, 2006, MOL CANCER THER, V5, P1325, DOI 10.1158/1535-7163.MCT-05-0494; Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2; Seo YJ, 2013, BIOORG MED CHEM LETT, V23, P6700, DOI 10.1016/j.bmcl.2013.10.038; SRea Williams, 2010, AM J HUMAN GENETICS, V87; Tang W, 2014, AM J NUCL MED MOLEC, V4, P324; Thomas EA, 2009, MOL NEUROBIOL, V40, P33, DOI 10.1007/s12035-009-8067-y; Wang CN, 2014, J MED CHEM, V57, P7999, DOI 10.1021/jm500872p; Watson C, 2006, RAT BRAIN STEREOTAXI; WATSON G, 2006, RAT BRAIN STEREOTAXI; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; Yeh HH, 2013, BRAIN RES, V1504, P16, DOI 10.1016/j.brainres.2013.02.012; Yeh HH, 2013, NEUROIMAGE, V64, P630, DOI 10.1016/j.neuroimage.2012.09.019; Zeglis BM, 2011, NUCL MED BIOL, V38, P683, DOI 10.1016/j.nucmedbio.2010.12.008	52	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133512	10.1371/journal.pone.0133512	http://dx.doi.org/10.1371/journal.pone.0133512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244761	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400049
J	Duplouy, A; Couchoux, C; Hanski, I; van Nouhuys, S				Duplouy, Anne; Couchoux, Christelle; Hanski, Ilkka; van Nouhuys, Saskya			Wolbachia Infection in a Natural Parasitoid Wasp Population	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; BUTTERFLY HYPOLIMNAS-BOLINA; MALE-KILLING WOLBACHIA; DROSOPHILA-SIMULANS; ENDOSYMBIONT WOLBACHIA; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; HOST; DYNAMICS; SYMBIONT	The maternally transmitted bacterium Wolbachia pipientis is well known for spreading and persisting in insect populations through manipulation of the fitness of its host. Here, we identify three new Wolbachia pipientis strains, wHho, wHho2 and wHho3, infecting Hyposoter horticola, a specialist wasp parasitoid of the Glanville fritillary butterfly. The wHho strain (ST435) infects about 50% of the individuals in the Aland islands in Finland, with a different infection rate in the two mitochondrial (COI) haplotypes of the wasp. The vertical transmission rate of Wolbachia is imperfect, and lower in the haplotype with lower infection rate, suggesting a fitness trade-off. We found no association of the wHho infection with fecundity, longevity or dispersal ability of the parasitoid host. However, preliminary results convey spatial associations between Wolbachia infection, host mitochondrial haplotype and parasitism of H. horticola by its hyperparasitoid, Mesochorus cf. stigmaticus. We discuss the possibility that Wolbachia infection protects H. horticola against hyperparasitism.	[Duplouy, Anne; Hanski, Ilkka; van Nouhuys, Saskya] Univ Helsinki, Metapopulat Res Ctr, Dept Biosci, FI-00014 Helsinki, Finland; [Couchoux, Christelle] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [van Nouhuys, Saskya] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of Helsinki; University of Sussex; Cornell University	Duplouy, A (corresponding author), Univ Helsinki, Metapopulat Res Ctr, Dept Biosci, POB 65, FI-00014 Helsinki, Finland.	anne.duplouy@helsinki.fi	Duplouy, Anne/J-2182-2015; van Nouhuys, Saskya/C-6813-2013	van Nouhuys, Saskya/0000-0003-2206-1368; Duplouy, Anne/0000-0002-7147-5199	Academy of Finland [255553, 213547, 250444, 266021]; Otto Malm foundation	Academy of Finland(Academy of Finland); Otto Malm foundation	The project was funded by the Academy of Finland (grant #255553 to SvN, 213547 and 250444 to SvN and IH, and 266021 to AD) and the Otto Malm foundation (grant to AD).	Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2004, MOL BIOL EVOL, V21, P428, DOI 10.1093/molbev/msh028; Bonte D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-243; BREEUWER JAJ, 1993, GENETICS, V135, P565; Charlat S, 2005, MOL ECOL, V14, P3525, DOI 10.1111/j.1365-294X.2005.02678.x; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Charlat S, 2006, CURR BIOL, V16, P2453, DOI 10.1016/j.cub.2006.10.062; Charlat S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-64; Correa CC, 2012, J INVERTEBR PATHOL, V111, P197, DOI 10.1016/j.jip.2012.08.003; Couchoux C, 2015, CONSERV GENET RESOUR, V7, P595, DOI 10.1007/s12686-015-0437-3; Couchoux C, 2015, BEHAVIOUR, V152, P1257, DOI 10.1163/1568539X-00003277; Couchoux C, 2014, J INSECT BEHAV, V27, P283, DOI 10.1007/s10905-013-9420-6; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876; Dudley R, 2000, ANNU REV PHYSIOL, V62, P135, DOI 10.1146/annurev.physiol.62.1.135; Duplouy A, 2010, J EVOLUTION BIOL, V23, P231, DOI 10.1111/j.1420-9101.2009.01891.x; Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrokhi S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14127; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x; Groenenboom MAC, 2002, P ROY SOC B-BIOL SCI, V269, P2509, DOI 10.1098/rspb.2002.2197; Gyllenberg M, 2002, B MATH BIOL, V64, P959, DOI 10.1006/bulm.2002.0309; Hancock PA, 2012, J R SOC INTERFACE, V9, P3045, DOI 10.1098/rsif.2012.0253; Hanski I, 2005, ANN ZOOL FENN, V42, P379; HOFFMANN AA, 1990, GENETICS, V126, P933; Hsiao TH, 1996, SYST ASSOC, P51; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2003, GENETICS, V164, P5; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Jousimo J, 2014, SCIENCE, V344, P1289, DOI 10.1126/science.1253621; Kankare M, 2005, ANN ENTOMOL SOC AM, V98, P382, DOI 10.1603/0013-8746(2005)098[0382:GDAHCS]2.0.CO;2; Kankare M, 2005, OECOLOGIA, V143, P77, DOI 10.1007/s00442-004-1782-1; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; Lewis Z, 2011, BIOL LETTERS, V7, P187, DOI 10.1098/rsbl.2010.0605; Martinez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035081; Miller WJ, 2012, HOST MANIPULATION BY PARASITES, P119; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Montovan KJ, 2015, AM NAT, V185, P538, DOI 10.1086/680036; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; Niitepold K, 2010, J EXP BIOL, V213, P1042, DOI 10.1242/jeb.034132; Ojanen SP, 2013, ECOL EVOL, V3, P3713, DOI 10.1002/ece3.733; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Russell JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051027; SHAW M.R., 2009, ECOLOGY BUTTERFLIES; Shoemaker DD, 2003, ENVIRON ENTOMOL, V32, P1329, DOI 10.1603/0046-225X-32.6.1329; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Team RDC, 2009, R LANG ENV STAT COMP; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Toju H, 2011, MOL ECOL, V20, P853, DOI 10.1111/j.1365-294X.2010.04980.x; TURELLI M, 1992, GENETICS, V132, P713; TURELLI M, 1995, GENETICS, V140, P1319; van Nouhuys S, 2002, J ANIM ECOL, V71, P639, DOI 10.1046/j.1365-2656.2002.00627.x; van Nouhuys S, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P99; Vavre F, 2001, EVOLUTION, V55, P1710, DOI 10.1111/j.0014-3820.2001.tb00691.x; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wahlberg N, 2007, EUR J ENTOMOL, V104, P675, DOI 10.14411/eje.2007.085; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren J., 1997, INFLUENCIAL PASSENGE; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zug R, 2015, BIOL REV, V90, P89, DOI 10.1111/brv.12098; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	79	14	15	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134843	10.1371/journal.pone.0134843	http://dx.doi.org/10.1371/journal.pone.0134843			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244782	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400112
J	Freitas, LA; Russo, CAM; Voloch, CM; Mutaquiha, OCF; Marques, LP; Schrago, CG				Freitas, Lucas A.; Russo, Claudia A. M.; Voloch, Carolina M.; Mutaquiha, Olivio C. F.; Marques, Lucas P.; Schrago, Carlos G.			Diversification of the Genus Anopheles and a Neotropical Clade from the Late Cretaceous	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SEQUENCE ALIGNMENT; MOLECULAR CLOCK; DIPTERA; CULICIDAE; EVOLUTION; LIKELIHOOD; INFERENCE; MITOCHONDRIAL; PERFORMANCE	The Anopheles genus is a member of the Culicidae family and consists of approximately 460 recognized species. The genus is composed of 7 subgenera with diverse geographical distributions. Despite its huge medical importance, a consensus has not been reached on the phylogenetic relationships among Anopheles subgenera. We assembled a comprehensive dataset comprising the COI, COII and 5.8S rRNA genes and used maximum likelihood and Bayesian inference to estimate the phylogeny and divergence times of six out of the seven Anopheles subgenera. Our analysis reveals a monophyletic group composed of the three exclusively Neotropical subgenera, Stethomyia, Kerteszia and Nyssorhynchus, which began to diversify in the Late Cretaceous, at approximately 90 Ma. The inferred age of the last common ancestor of the Anopheles genus was ca. 110 Ma. The monophyly of all Anopheles subgenera was supported, although we failed to recover a significant level of statistical support for the monophyly of the Anopheles genus. The ages of the last common ancestors of the Neotropical clade and the Anopheles and Cellia subgenera were inferred to be at the Late Cretaceous (ca. 90 Ma). Our analysis failed to statistically support the monophyly of the Anopheles genus because of an unresolved polytomy between Bironella and A. squamifemur.	[Freitas, Lucas A.; Russo, Claudia A. M.; Voloch, Carolina M.; Mutaquiha, Olivio C. F.; Marques, Lucas P.; Schrago, Carlos G.] Univ Fed Rio de Janeiro, Dept Genet, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Schrago, CG (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, BR-21941 Rio De Janeiro, RJ, Brazil.	carlos.schrago@gmail.com	Freitas, Lucas/S-2923-2016; Russo, Claudia/R-7432-2019; Russo, Claudia/N-8063-2019; Schrago, Carlos/E-4612-2012; Russo, Claudia A M/I-1217-2012; de Moraes Russo, Claudia Augusta/N-6361-2019; Freitas, Lucas/M-2950-2019; Voloch, Carolina M/F-8874-2013	Freitas, Lucas/0000-0002-8766-0890; Russo, Claudia/0000-0002-1252-9206; Schrago, Carlos/0000-0001-6257-8906; Russo, Claudia A M/0000-0002-1252-9206; Freitas, Lucas/0000-0002-8766-0890; Voloch, Carolina M/0000-0001-5182-4366	Brazilian Research Council-CNPq [307982/2012-2]; Rio de Janeiro State Science Foundation-FAPERJ grants [110.028/2011, 111.831/2011]; CNPq grant [481843/2013-2]; Brazilian Ministry of Education (CAPES); Rio de Janeiro State Science Foundation	Brazilian Research Council-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Science Foundation-FAPERJ grants; CNPq grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro State Science Foundation	CGS was funded by the Brazilian Research Council-CNPq grant 307982/2012-2 and the Rio de Janeiro State Science Foundation-FAPERJ grants 110.028/2011 and 111.831/2011. CMV was funded through CNPq grant 481843/2013-2. LAF was financially supported by a scholarship from the Brazilian Ministry of Education (CAPES). CAMR was funded by a fellowship from the Brazilian Research Council-CNPq and a grant from the Rio de Janeiro State Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davalos LA, 2008, GENOMICS, V91, P433, DOI 10.1016/j.ygeno.2008.01.006; Djadid ND, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-6; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harbach RE, 2007, ZOOTAXA, P591; Harbach RE, 2005, P ENTOMOL SOC WASH, V107, P750; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Kampen H, 2005, PARASITOL RES, V97, P118, DOI 10.1007/s00436-005-1393-8; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krzywinski J, 2001, SYST BIOL, V50, P540, DOI 10.1080/106351501750435095; Krzywinski J, 2001, MOL PHYLOGENET EVOL, V18, P479, DOI 10.1006/mpev.2000.0894; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Logue K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-64; Marinucci M, 1999, INSECT MOL BIOL, V8, P469, DOI 10.1046/j.1365-2583.1999.00140.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pacheco MA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-299; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P119; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; Rich SM, 2006, EMERG INF DIS 21ST C, P125; Ricklefs RE, 2010, SCIENCE, V329, P226, DOI 10.1126/science.1188954; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Sallum MAM, 2000, ANN ENTOMOL SOC AM, V93, P745, DOI 10.1603/0013-8746(2000)093[0745:POADCB]2.0.CO;2; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schrago CG, 2014, GENOME BIOL EVOL, V6, P3105, DOI 10.1093/gbe/evu244; Sermwittayawong N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-36; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Zavortink TJ, 2000, ANN ENTOMOL SOC AM, V93, P1230, DOI 10.1603/0013-8746(2000)093[1230:ANDSND]2.0.CO;2	43	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134462	10.1371/journal.pone.0134462	http://dx.doi.org/10.1371/journal.pone.0134462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244561	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400082
J	O'Hara, M; Auersperg, AMI; Bugnyar, T; Huber, L				O'Hara, Mark; Auersperg, Alice M. I.; Bugnyar, Thomas; Huber, Ludwig			Inference by Exclusion in Goffin Cockatoos (Cacatua goffini)	PLOS ONE			English	Article							MONKEYS CEBUS-APELLA; HIDDEN FOOD; GREAT APES; SEA LIONS; LOCATION; DOG; INFORMATION; CORVIDS	Inference by exclusion, the ability to base choices on the systematic exclusion of alternatives, has been studied in many nonhuman species over the past decade. However, the majority of methodologies employed so far are hard to integrate into a comparative framework as they rarely use controls for the effect of neophilia. Here, we present an improved approach that takes neophilia into account, using an abstract two-choice task on a touch screen, which is equally feasible for a large variety of species. To test this approach we chose Goffin cockatoos (Cacatua goffini), a highly explorative Indonesian parrot species, which have recently been reported to have sophisticated cognitive skills in the technical domain. Our results indicate that Goffin cockatoos are able to solve such abstract two-choice tasks employing inference by exclusion but also highlight the importance of other response strategies.	[O'Hara, Mark; Auersperg, Alice M. I.; Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [O'Hara, Mark; Huber, Ludwig] Univ Vienna, Messerli Res Inst, Univ Vet Med Vienna, Med Univ Vienna, Vienna, Austria; [Auersperg, Alice M. I.] Univ Oxford, Dept Zool, Behav Ecol Res Grp, Oxford OX1 3PS, England	University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Oxford	O'Hara, M (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	mark.ohara@univie.ac.at	O'Hara, Mark/AAW-9716-2021	Auersperg, Alice/0000-0001-7405-9791; Huber, Ludwig/0000-0002-0217-136X	doctoral college program "Cognition & Communication" of the Austrian Science Fund FWF [W1234-G17]; FWF [J 3404-B19]; Austrian Science Fund (FWF) [J 3404] Funding Source: researchfish	doctoral college program "Cognition & Communication" of the Austrian Science Fund FWF; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	MO was funded by the doctoral college program "Cognition & Communication" of the Austrian Science Fund FWF -http://www.fwf.ac.at/en/ (No. W1234-G17). The Goffin Lab and AA are supported by the FWF http://www.fwf.ac.at/en/ (No. J 3404-B19).	Auersperg AMI, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0972; Auersperg AMI, 2015, J COMP PSYCHOL, V129, P62, DOI 10.1037/a0038314; Auersperg AMI, 2014, J COMP PSYCHOL, V128, P88, DOI 10.1037/a0033272; Auersperg AMI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068979; Auersperg AMI, 2012, CURR BIOL, V22, pR903, DOI 10.1016/j.cub.2012.09.002; Aust U, 2008, ANIM COGN, V11, P587, DOI 10.1007/s10071-008-0149-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2004, J COMP PSYCHOL, V118, P232, DOI 10.1037/0735-7036.118.2.232; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2006, ANIM COGN, V9, P393, DOI 10.1007/s10071-006-0037-4; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg Russell, 2003, P175; Guthrie ER, 1930, PSYCHOL REV, V37, P412, DOI 10.1037/h0072172; Heimbauer LA, 2012, ANIM COGN, V15, P45, DOI 10.1007/s10071-011-0430-5; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Hill A, 2012, J COMP PSYCHOL, V126, P243, DOI 10.1037/a0024449; Hill A, 2011, J COMP PSYCHOL, V125, P91, DOI 10.1037/a0020867; Hojsgaard S, 2014, DOBY GROUPWISE STAT; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Jelbert SA, 2015, J COMP PSYCHOL; Jepson P, 2001, ORYX, V35, P224, DOI 10.1046/j.1365-3008.2001.00179.x; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; Maille A, 2012, ANIM COGN, V15, P1075, DOI 10.1007/s10071-012-0531-9; Marsh HL, 2012, ANIM COGN, V15, P293, DOI 10.1007/s10071-011-0453-y; Mikolasch S, 2012, ANIM COGN, V15, P73, DOI 10.1007/s10071-011-0434-1; Mikolasch S, 2011, BIOL LETTERS, V7, P875, DOI 10.1098/rsbl.2011.0500; Nawroth C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093534; Ogawa A, 2010, NEUROIMAGE, V52, P1603, DOI 10.1016/j.neuroimage.2010.05.040; Paukner A, 2009, J COMP PSYCHOL, V123, P26, DOI 10.1037/a0013128; PEARCE JM, 1987, PSYCHOL REV, V94, P61, DOI 10.1037/0033-295X.94.1.61; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Pepperberg IM, 2013, J COMP PSYCHOL, V127, P272, DOI 10.1037/a0031641; Petit O, 2015, ANIM COGN; PREMACK D, 1994, COGNITION, V50, P347, DOI 10.1016/0010-0277(94)90035-3; Premack D., 1995, ORIGINS HUMAN BRAIN, P286; R Core Team, 2021, R LANGUAGE ENV STAT; Riehl C, 2015, ANIM COGN, V18, P75, DOI 10.1007/s10071-014-0778-4; Sabbatini G, 2008, J COMP PSYCHOL, V122, P156, DOI 10.1037/0735-7036.122.2.156; Schloegl C, 2009, EXCLUSION PERFORMANC; Schloegl C, 2012, P ROY SOC B-BIOL SCI, V279, P4135, DOI 10.1098/rspb.2012.1292; Schloegl C, 2011, J COMP PSYCHOL, V125, P162, DOI 10.1037/a0023045; Schloegl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006368; Schmitt V, 2009, J COMP PSYCHOL, V123, P316, DOI 10.1037/a0016218; SCHUSTERMAN RJ, 1984, PSYCHOL REC, V34, P3, DOI 10.1007/BF03394849; Shaw RC, 2013, J COMP PSYCHOL, V127, P428, DOI 10.1037/a0032010; Steurer MM, 2012, BEHAV RES METHODS, V44, P909, DOI 10.3758/s13428-012-0198-9; Watanabe, 2012, LOGIC SENSIBILITY, P23; Watanabe S, 2006, ANIM COGN, V9, P235, DOI 10.1007/s10071-006-0043-6; Wickham H, 2009, GGPLOT2	53	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134894	10.1371/journal.pone.0134894	http://dx.doi.org/10.1371/journal.pone.0134894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244692	Green Published, gold, Green Submitted			2022-12-26	WOS:000359061400125
J	Sun, J; Hu, CY; Zhu, YH; Sun, R; Fang, YJ; Fan, YH; Xu, F				Sun, Jian; Hu, Chongyu; Zhu, Yinghui; Sun, Rui; Fang, Yujing; Fan, Yuhua; Xu, Fei			LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor	PLOS ONE			English	Article							C-MYC; PROSTATE-CANCER; CARCINOMA; ACTIVATION; GLYCOLYSIS; RECEPTOR; PROLIFERATION; PROGRESSION; METASTASIS; METABOLISM	Oxidative stress is thought to contribute to cancer development. Epstein-Barr virus (EBV) and its encoded oncoprotein, latent membrane protein 1 (LMP1), are closely associated with the transformation of nasopharyngeal carcinoma (NPC) and Burkitt's lymphoma (BL). In this study, we used LMP1-transformed NP cells and EBV-related malignant cell lines to assess the effects of LMP1 on reactive oxygen species (ROS) accumulation and glycolytic activity. Using NPC tissue samples and a tissue array to address clinical implications, we report that LMP1 activates NAD(P) H oxidases to generate excessive amount of ROS in EBV-related malignant diseases. By evaluating NAD(P) H oxidase (NOX) subunit expression, we found that the expression of the NAD(P) H oxidase regulatory subunit p22(phox) was significantly upregulated upon LMP1-induced transformation. Furthermore, this upregulation was mediated by the c-Jun N-terminal kinase (JNK) pathway. In addition, LMP1 markedly stimulated anaerobic glycolytic activity through the PI3K/Akt pathway. Additionally, in both NPC cells and tissue samples, p22(phox) expression correlated with LMP1 expression. The NAD(P) H oxidase inhibitor diphenyleneiodonium (DPI) also exerted a marked cytotoxic effect in LMP1-transformed and malignant cells, providing a novel strategy for anticancer therapy.	[Sun, Jian; Zhu, Yinghui; Sun, Rui; Fang, Yujing; Xu, Fei] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Hu, Chongyu] Hunan Prov Peoples Hosp, Changsha 410005, Hunan, Peoples R China; [Fan, Yuhua] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Fan, YH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China.	fanyuhua@mail.sysu.edu.cn; xufei@sysucc.org.cn						Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cao JY, 2012, J VIROL, V86, P382, DOI 10.1128/JVI.05648-11; CARCANGIU ML, 1990, AM J CLIN PATHOL, V94, P247, DOI 10.1093/ajcp/94.3.247; Cerimele F, 2005, P NATL ACAD SCI USA, V102, P175, DOI 10.1073/pnas.0408381102; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; Gonzalez-Dosal R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002250; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Ha YJ, 2004, J IMMUNOL, V172, P231, DOI 10.4049/jimmunol.172.1.231; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Hu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041055; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; Laborde RR, 2012, LARYNGOSCOPE, V122, P2707, DOI 10.1002/lary.23516; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Manea A, 2008, ARTERIOSCL THROM VAS, V28, P878, DOI 10.1161/ATVBAHA.108.163592; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Xiao L, 2014, ONCOGENE, V33, P4568, DOI 10.1038/onc.2014.32; Xu RH, 2005, CANCER RES, V65, P613; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134896	10.1371/journal.pone.0134896	http://dx.doi.org/10.1371/journal.pone.0134896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244812	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400126
J	Tanaka, Y; Kohno, N				Tanaka, Yoshihiro; Kohno, Naoki			A New Late Miocene Odobenid (Mammalia: Carnivora) from Hokkaido, Japan Suggests Rapid Diversification of Basal Miocene Odobenids	PLOS ONE			English	Article							ASTORIA FORMATION; ORIGIN	The modern walrus, Odobenus rosmarus, is specialized and only extant member of the family Odobenidae. They were much more diversified in the past, and at least 16 genera and 20 species of fossil walruses have been known. Although their diversity increased in the late Miocene and Pliocene (around 8-2 Million years ago), older records are poorly known. A new genus and species of archaic odobenid, Archaeodobenus akamatsui, gen.etsp.nov. from the late Miocene (ca. 10.0-9.5 Ma) top of the Ichibangawa Formation, Hokkaido, northern Japan, suggests rapid diversification of basal Miocene walruses. Archaeodobenus akamatsui is the contemporaneous Pseudotaria muramotoi from the same formation, but they are distinguishable from each other in size and shape of the occipital condyle, foramen magnum and mastoid process of the cranium, and other postcranial features. Based on our phylogenetic analysis, A. akamatsui might have split from P. muramotoi at the late Miocene in the western North Pacific. This rapid diversification of the archaic odobenids occurred with a combination of marine regression and transgression, which provided geological isolation among the common ancestors of extinct odobenids.	[Tanaka, Yoshihiro] Hokkaido Univ Museum, Kita Ku, Sapporo, Hokkaido 0600808, Japan; [Tanaka, Yoshihiro] Univ Otago, Dept Geol, Dunedin 9054, New Zealand; [Tanaka, Yoshihiro] Numata Fossil Museum, Numata Town, Hokkaido 0782202, Japan; [Kohno, Naoki] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Kohno, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058752, Japan	Hokkaido University; University of Otago; National Museum of Nature and Science; University of Tsukuba	Tanaka, Y (corresponding author), Hokkaido Univ Museum, Kita Ku, Kita 8 Nishi 5, Sapporo, Hokkaido 0600808, Japan.	yoshihiro.tanaka@otago.ac.nz		Tanaka, Yoshihiro/0000-0001-9598-5583	Department of Geology and Paleontology, National Museum of Nature and Science	Department of Geology and Paleontology, National Museum of Nature and Science	Field and lab work were supported by the Department of Geology and Paleontology, National Museum of Nature and Science.	Barnes L. G., 1995, ISL ARC, V3, P329, DOI DOI 10.1111/J.1440-1738.1994; BIGELOW PK, 1994, J PALEONTOL, V68, P680, DOI 10.1017/S0022336000026032; Boessenecker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054311; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Churchill M, 2015, COPES RULE EVOLUTION; Churchill M, 2014, J ANAT, V225, P232, DOI 10.1111/joa.12199; Demere TA, 2001, J VERTEBR PALEONTOL, V21, P279, DOI 10.1671/0272-4634(2001)021[0279:AROPRF]2.0.CO;2; Demere TA, 2002, SM C PALEOB, P113; Demere Thomas A., 1994, Proceedings of the San Diego Society of Natural History, V29, P99; Goloboff P, 2008, CLADISTICS, V24, P91; Huggett JM, 1997, J GEOL SOC LONDON, V154, P897, DOI 10.1144/gsjgs.154.5.0897; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Kohno N, 2006, J VERTEBR PALEONTOL, V26, P411, DOI 10.1671/0272-4634(2006)26[411:ANMOMC]2.0.CO;2; KOHNO N, 1994, J VERTEBR PALEONTOL, V14, P414, DOI 10.1080/02724634.1994.10011568; Kohno N., 1995, ISL ARC, V3, P285, DOI DOI 10.1111/J.1440-1738.1994.TB00117.X; Kohno Naoki, 1996, Transactions and Proceedings of the Palaeontological Society of Japan New Series, V181, P388; Kohno Naoki, 2005, Fossils (Tokyo), V77, P34; Maddison WP, 2011, MESQUITE MODULAR SYS; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Obasi CC, 2011, J SEDIMENT RES, V81, P479, DOI 10.2110/jsr.2011.42; Pyenson ND, 2009, GEOLOGY, V37, P519, DOI 10.1130/G25509A.1; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Sivertsen E., 1954, Norske Vidensk-Akad Oslo (Sci Res Norweg Antarct Exped 1927-1928, VNo. 36, P1; Suto I, 2012, PALAEOGEOGR PALAEOCL, V339, P39, DOI 10.1016/j.palaeo.2012.04.014; Takano O, 1995, EARTH SCI, V49, P253; Takano O, 1996, EARTH SCI, V50, P9, DOI DOI 10.1002/9781119188230.SASEAS0247; The Kabato Collaborative Research Group, 1995, EARTH SCI, V49, P363, DOI [10.15080/agcjchikyukagaku.49.6_363, DOI 10.15080/AGCJCHIKYUKAGAKU.49.6_363]; Tsuji T, 1992, RES REPORTS JAPAN PE, V8, P1; Valenzuela-Toro AM, 2013, J VERTEBR PALEONTOL, V33, P216, DOI 10.1080/02724634.2012.710282; Yanagisawa Y., 1998, J GEOL SOC JPN, V104, P395, DOI DOI 10.5575/GE0S0C.104.395	30	11	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131856	10.1371/journal.pone.0131856	http://dx.doi.org/10.1371/journal.pone.0131856			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244784	Green Published, gold			2022-12-26	WOS:000359061400014
J	Alabady, MS; Rogers, WL; Malmberg, RL				Alabady, Magdy S.; Rogers, Willie L.; Malmberg, Russell L.			Development of Transcriptomic Markers for Population Analysis Using Restriction Site Associated RNA Sequencing (RARseq)	PLOS ONE			English	Article							TARGET-ENRICHMENT; SNP DISCOVERY; SARRACENIA; PLANT; GENOME	We describe restriction site associated RNA sequencing (RARseq), an RNAseq-based genotype by sequencing (GBS) method. It includes the construction of RNAseq libraries from double stranded cDNA digested with selected restriction enzymes. To test this, we constructed six single-and six-dual-digested RARseq libraries from six F2 pitcher plant individuals and sequenced them on a half of a Miseq run. On average, the de novo approach of population genome analysis detected 544 and 570 RNA SNPs, whereas the reference transcriptome- based approach revealed an average of 1907 and 1876 RNA SNPs per individual, from single-and dual-digested RARseq data, respectively. The average numbers of RNA SNPs and alleles per loci are 1.89 and 2.17, respectively. Our results suggest that the RARseq protocol allows good depth of coverage per loci for detecting RNA SNPs and polymorphic loci for population genomics and mapping analyses. In non-model systems where complete genomes sequences are not always available, RARseq data can be analyzed in reference to the transcriptome. In addition to enriching for functional markers, this method may prove particularly useful in organisms where the genomes are not favorable for DNA GBS.	[Alabady, Magdy S.; Rogers, Willie L.; Malmberg, Russell L.] Univ Georgia, Dept Plant Biol, Athens, GA 30604 USA	University System of Georgia; University of Georgia	Alabady, MS (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30604 USA.	malabady@uga.edu	Alabady, Magdy/AGZ-6286-2022	Alabady, Magdy/0000-0002-1601-682X; Malmberg, Russell/0000-0002-7448-5034				Azevedo H, 2003, PLANT MOL BIOL REP, V21, P333, DOI 10.1007/BF02772582; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barbazuk WB, 2011, METHODS MOL BIOL, V729, P225, DOI 10.1007/978-1-61779-065-2_15; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers WL, 2010, CONSERV GENET RESOUR, V2, P75, DOI 10.1007/s12686-009-9165-x; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Stephens JD, 2015, MOL PHYLOGENET EVOL, V85, P76, DOI 10.1016/j.ympev.2015.01.015; Stumpf MPH, 2004, EUR J HUM GENET, V12, P469, DOI 10.1038/sj.ejhg.5201179; Zhou LC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-703	16	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134855	10.1371/journal.pone.0134855	http://dx.doi.org/10.1371/journal.pone.0134855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241739	gold, Green Submitted, Green Published			2022-12-26	WOS:000358942700074
J	Franklin, C; Cesko, E; Hillen, U; Schilling, B; Brandau, S				Franklin, Cindy; Cesko, Elvir; Hillen, Uwe; Schilling, Bastian; Brandau, Sven			Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT PROJECT; REGULATORY T-CELLS; DENDRITIC CELLS; SUPPRESSOR-CELLS; CLINICAL-TRIALS; L-ARGININE; PHOTOCHEMOTHERAPY; INDUCTION; MONOCYTES; TRANSPLANTATION	Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell transplantation and a major cause of morbidity and mortality in affected patients. Especially skin, eyes and oral mucosa are affected. This can lead to pain and functional impairment. Extracorporeal photopheresis (ECP) is an effective immunomodulatory therapy with minimal side effects but its mode of action is still largely unknown. The objective of the present study was to examine the effects of ECP on neutrophil granulocytes in patients with cGVHD. Analysis of leukocytes from cGVHD patients obtained from the ECP device during treatment showed that neutrophil granulocytes account for the majority of cells treated during ECP. Neutrophils from healthy donors treated in vitro with 8-methoxypsoralen and UVA light as well as neutrophils from buffy coats of patients with cGVHD treated by ECP showed increased apoptosis and decreased half-life. In remaining non-apoptotic cells chemoirradiation resulted in loss of activation markers and reduced effector functions. This was accompanied by an increase in extracellular arginase-1 activity. Additional comparison of neutrophils isolated from blood of cGVHD patients before and 24h after ECP revealed a decreased half-life and reduction of effector functions of post-ECP neutrophils ex vivo. These observations strongly suggest that ECP induces both apoptosis and physiological changes in neutrophils and that these changes also take place in vivo. This study is the first to show that ECP modulates apoptosis and inflammatory activity in neutrophil granulocytes, indicating that neutrophils may significantly contribute to the overall immunomodulatory effects attributed to this treatment.	[Franklin, Cindy; Cesko, Elvir; Hillen, Uwe; Schilling, Bastian] Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany; [Franklin, Cindy; Brandau, Sven] Univ Hosp Essen, Dept Otorhinolaryngol, Div Res, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Franklin, C (corresponding author), Univ Hosp Essen, Dept Dermatol Venereol & Allergol, Essen, Germany.	cindy.franklin@uk-essen.de	Schilling, Bastian/AAY-8646-2020; Franklin, Cindy/AAU-4915-2021	Schilling, Bastian/0000-0001-8859-4103; Franklin, Cindy/0000-0001-9142-5423; Brandau, Sven/0000-0002-2702-4163	MERCUR Foundation [AN-2012-0030]; IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen	MERCUR Foundation; IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen	This work was supported by a grant from the MERCUR Foundation to BS (AN-2012-0030). CF was supported by an IFORES-scholarship of the Medical Faculty of the University Duisburg-Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarax N, 2003, BONE MARROW TRANSPL, V31, P459, DOI 10.1038/sj.bmt.1703871; Baird K, 2013, BIOL BLOOD MARROW TR, V19, P632, DOI 10.1016/j.bbmt.2013.01.013; Berger C, 2010, BLOOD, V116, P4838, DOI 10.1182/blood-2009-11-256040; Bladon J, 2006, J DERMATOL SCI, V43, P85, DOI 10.1016/j.jdermsci.2006.05.004; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Couriel D, 2006, BIOL BLOOD MARROW TR, V12, P375, DOI 10.1016/j.bbmt.2006.02.003; Di Renzo M, 2008, CLIN EXP IMMUNOL, V151, P407, DOI 10.1111/j.1365-2249.2007.03577.x; Di Renzo M, 2005, BRIT J DERMATOL, V153, P59, DOI 10.1111/j.1365-2133.2005.06482.x; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; EDELSON RL, 1989, YALE J BIOL MED, V62, P565; Edelson RL, 2013, TRANSFUSION APHERESI; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Florek M, 2014, BLOOD, V124, P1832, DOI 10.1182/blood-2014-02-555128; Flowers MED, 2008, BLOOD, V112, P2667, DOI 10.1182/blood-2008-03-141481; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gatza E, 2008, BLOOD, V112, P1515, DOI 10.1182/blood-2007-11-125542; Gonzalez AL, 2014, CLIN EXP IMMUNOL, V175, P449, DOI 10.1111/cei.12231; Gorgun G, 2002, BLOOD, V100, P941, DOI 10.1182/blood-2002-01-0068; Greinix Hildegard T., 1998, Blood, V92, P3098; Hasermann P, 2008, DERMATOLOGY, V216, P287, DOI 10.1159/000113941; Hannani D, 2010, TRANSPLANTATION, V89, P492, DOI 10.1097/TP.0b013e3181c6ffd3; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Just U, 2012, EXP DERMATOL, V21, P443, DOI 10.1111/j.1600-0625.2012.01491.x; Knobler R, 2009, J AM ACAD DERMATOL, V61, P652, DOI 10.1016/j.jaad.2009.02.039; Lamioni A, 2005, TRANSPLANTATION, V79, P846, DOI 10.1097/01.TP.0000157278.02848.C7; Lotze MT, 2007, CLIN IMMUNOL, V124, P1, DOI 10.1016/j.clim.2007.02.006; Maeda A, 2005, J IMMUNOL, V174, P5968, DOI 10.4049/jimmunol.174.10.5968; Maeda A, 2008, J IMMUNOL, V181, P5956, DOI 10.4049/jimmunol.181.9.5956; Marshall SR, 2006, NAT CLIN PRACT ONCOL, V3, P302, DOI 10.1038/ncponc0511; McKenna KE, 2006, BRIT J DERMATOL, V154, P7, DOI 10.1111/j.1365-2133.2005.06857.x; Merlin E, 2011, TRANSPL IMMUNOL, V24, P100, DOI 10.1016/j.trim.2010.10.007; Ochoa JB, 2001, JPEN-PARENTER ENTER, V25, P23, DOI 10.1177/014860710102500123; Rieber N, 2014, BONE MARROW TRANSPL, V49, P545, DOI 10.1038/bmt.2013.236; Rodriguez PC, 2007, BLOOD, V109, P1568, DOI 10.1182/blood-2006-06-031856; Schwab L, 2014, NAT MED, V20, P648, DOI 10.1038/nm.3517; Seaton ED, 2003, BLOOD, V102, P1217, DOI 10.1182/blood-2002-11-3351; Setterblad N, 2008, TRANSFUSION, V48, P169, DOI 10.1111/j.1537-2995.2007.01502.x; Socie G, 1999, NEW ENGL J MED, V341, P14, DOI 10.1056/NEJM199907013410103; SULLIVAN KM, 1992, BONE MARROW TRANSPL, V10, P127; SULLIVAN KM, 1988, BLOOD, V72, P555; SUSSKIND BM, 1987, J IMMUNOL, V139, P905; TRAUTINGER F, 1991, ANN NY ACAD SCI, V636, P383, DOI 10.1111/j.1749-6632.1991.tb33473.x; Trellakis S, 2011, INT J IMMUNOPATH PH, V24, P683, DOI 10.1177/039463201102400314; Wang H, 2014, IMMUNOL REV, V258, P30, DOI 10.1111/imr.12151; Ward DM, 2011, J CLIN APHERESIS, V26, P276, DOI 10.1002/jca.20300; Wolf D, 2012, BLOOD, V119, P16, DOI 10.1182/blood-2011-08-339465; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011; Worel N, 2002, BONE MARROW TRANSPL, V30, P619, DOI 10.1038/sj.bmt.1703677; Xia CQ, 2009, CURR OPIN ORGAN TRAN, V14, P338, DOI 10.1097/MOT.0b013e32832ce943	51	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134518	10.1371/journal.pone.0134518	http://dx.doi.org/10.1371/journal.pone.0134518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241482	Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700048
J	Sternemalm, J; Geimer, S; Frikstad, KAM; Schink, KO; Stokke, T; Patzke, S				Sternemalm, Johan; Geimer, Stefan; Frikstad, Kari-Anne M.; Schink, Kay O.; Stokke, Trond; Patzke, Sebastian			CSPP-L Associates with the Desmosome of Polarized Epithelial Cells and Is Required for Normal Spheroid Formation	PLOS ONE			English	Article							MICROTUBULE ORGANIZATION; JOUBERT SYNDROME; PRIMARY CILIA; STRUCTURED ILLUMINATION; CENTROSOMAL PROTEIN; ADHERENS JUNCTIONS; ZONULA ADHERENS; DISEASE; MUTATIONS; CANCER	Deleterious mutations of the Centrosome/Spindle Pole associated Protein 1 gene, CSPP1, are causative for Joubert-syndrome and Joubert-related developmental disorders. These disorders are defined by a characteristic mal-development of the brain, but frequently involve renal and hepatic cyst formation. CSPP-L, the large protein isoform of CSPP1 localizes to microtubule ends of the mitotic mid-spindle and the ciliary axoneme, and is required for ciliogenesis. We here report the microtubule independent but Desmoplakin dependent localization of CSPP-L to Desmosomes in apical-basal polarized epithelial cells. Importantly, siRNA conferred depletion of CSPP-L or Desmoplakin promoted multi-lumen spheroid formation in 3D-cultures of non-ciliated human colon carcinoma Caco-2 cells. Multi-lumen spheroids of CSPP1 siRNA transfectants showed disrupted apical cell junction localization of the cytoskeleton organizing RhoGEF ECT2. Our results hence identify a novel, non-ciliary role for CSPP-L in epithelial morphogenesis.	[Sternemalm, Johan; Frikstad, Kari-Anne M.; Stokke, Trond; Patzke, Sebastian] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol,Div Canc Med Surg & Transplantat, Oslo, Norway; [Geimer, Stefan] Univ Bayreuth, Cell Biol Electron Microscopy, Bayreuth, Germany; [Schink, Kay O.] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol,Div Canc Med Surg & Transplant, Oslo, Norway; [Schink, Kay O.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of Oslo; University of Bayreuth; University of Oslo; University of Oslo	Patzke, S (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol,Div Canc Med Surg & Transplantat, Oslo, Norway.	sebastip@rr-research.no	Patzke, Sebastian/G-9909-2019	Patzke, Sebastian/0000-0001-6821-197X; Schink, Kay Oliver/0000-0002-5903-4059; Frikstad, Kari-Anne Myrum/0000-0001-9923-3485	Regional Health Authorities of South-Eastern Norway; Norwegian Cancer Society	Regional Health Authorities of South-Eastern Norway; Norwegian Cancer Society(Norwegian Cancer Society)	This project was financially supported through grants from the Regional Health Authorities of South-Eastern Norway (S.P.) and Norwegian Cancer Society (S.P., T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; El-Amraoui A, 2013, PROG MOL BIOL TRANSL, V116, P361, DOI 10.1016/B978-0-12-394311-8.00016-9; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Guo J, 2006, MOL BIOL CELL, V17, P680, DOI 10.1091/mbc.E05-04-0360; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kuehn EW, 2007, CANCER RES, V67, P4537, DOI 10.1158/0008-5472.CAN-07-0391; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Mans DA, 2008, BIOCH BIOPHYS ACTA; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Nekrasova O, 2013, TRENDS CELL BIOL, V23, P537, DOI 10.1016/j.tcb.2013.06.004; Nelson WJ, 2013, PROG MOL BIOL TRANSL, V116, P3, DOI 10.1016/B978-0-12-394311-8.00001-7; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Patel DM, 2014, J CELL BIOL, V206, P779, DOI 10.1083/jcb.201312110; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2012, CILIA, V1, P36; Patzke S, 2006, J CELL PHYSIOL, V209, P199, DOI 10.1002/jcp.20725; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Romani M, 2013, LANCET NEUROL, V12, P894, DOI 10.1016/S1474-4422(13)70136-4; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Scheffers MS, 2002, HUM MOL GENET, V11, P59, DOI 10.1093/hmg/11.1.59; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shaheen R, 2014, AM J HUM GENET, V94, P73, DOI 10.1016/j.ajhg.2013.11.010; Silberberg M, 2005, AM J PHYSIOL-RENAL, V288, pF1153, DOI 10.1152/ajprenal.00008.2005; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Sternemalm J, 2014, BRIT J CANCER, V111, P326, DOI 10.1038/bjc.2014.297; Sumigray Kaelyn D, 2011, Bioarchitecture, V1, P221; Sumigray KD, 2011, J CELL BIOL, V194, P631, DOI 10.1083/jcb.201104009; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Toftgard R, 2009, NAT MED, V15, P994, DOI 10.1038/nm0909-994; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; WACKER IU, 1992, J CELL BIOL, V117, P813, DOI 10.1083/jcb.117.4.813; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Weigel A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3083439	53	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134789	10.1371/journal.pone.0134789	http://dx.doi.org/10.1371/journal.pone.0134789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241740	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700066
J	Yang, WH; Su, YH; Hsu, WH; Wang, CC; Arbiser, JL; Yang, MH				Yang, W-H; Su, Y-H; Hsu, W-H; Wang, C-C; Arbiser, J. L.; Yang, M-H			Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation	ONCOGENE			English	Article							TREATMENT STRATEGIES; TRANSCRIPTION; ACTIVATION; TRANSITION; PLASTICITY; CELLS; MECHANISMS; METASTASES; CARCINOMA; SNAIL	The unique characteristic of head and neck squamous cell carcinoma (HNSCC) is that local invasion rather than distant metastasis is the major route for dissemination. Therefore, targeting the locally invasive cancer cells is more important than preventing systemic metastasis in HNSCC and other invasive-predominant cancers. We previously demonstrate a specific mechanism for HNSCC local invasion: the epithelial-mesenchymal transition (EMT) regulator Twist1 represses microRNA let-7i expression, leading to the activation of the small GTPase Rac1 and engendering the mesenchymal-mode movement in three-dimensional (3D) culture. However, targeting the EMT regulator is relatively difficult because of its transcription factor nature and the strategy for confining HNSCC invasion to facilitate local treatment is limited. Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion. Here we demonstrate that in HNSCC cells, a noncytotoxic dose of IB represses mesenchymal-mode migration in two-and-a-half-dimensional/3D culture system. IB suppresses EMT and stemness of HNSCC cells through inhibition of Twist1-mediated let-7i downregulation and Rac1 activation and the EMT signalling. Mechanistically, IB inhibits reactive oxygen species-induced nuclear factor-kappa B pathway activation. Importantly, IB promotes degradation of the EMT inducer Twist1 by enhancing F-box and leucine-rich repeat protein 14 (FBXL14)-mediated polyubiquitination of Twist1. Together, this study demonstrates the potent anti-invasion and EMT-inhibition effect of IB, suggesting the potential of IB in treating local invasion-predominant cancers.	[Yang, W-H; Su, Y-H; Hsu, W-H; Yang, M-H] Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 11221, Taiwan; [Wang, C-C] Taichung Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taichung, Taiwan; [Wang, C-C] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Wang, C-C] Chung Shan Med Univ, Sch Speech Language Pathol & Audiol, Taichung 40201, Taiwan; [Arbiser, J. L.] Emory Sch Med, Dept Dermatol, Atlanta, GA USA; [Arbiser, J. L.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA; [Yang, M-H] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Yang, M-H] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Yang, M-H] Taipei Vet Gen Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; Emory University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Yang, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 11221, Taiwan.; Arbiser, JL (corresponding author), Emory Sch Med, Dept Dermatol, Atlanta, GA USA.; Arbiser, JL (corresponding author), Atlanta Vet Adm Med Ctr, Atlanta, GA USA.; Arbiser, JL (corresponding author), Winship Canc Inst, Dept Dermatol, Atlanta, GA USA.; Arbiser, JL (corresponding author), Emory Univ, Sch Med, Atlanta Vet Adm Hosp, WMB 5309,1639 Pierce Dr, Atlanta, GA 30322 USA.	jarbise@emory.edu; mhyang2@vghtpe.gov.tw	Yang, Muh-Hwa/AAE-4691-2020	Hsu, Wen-Hao/0000-0001-9050-8227; Su, Yen-Hao/0000-0001-8288-3772	Ministry of Science and Technology [103-2321-B-010-019, 103-2314-B-010-034, 103-2633-H-010-001, 103-2314-B-010-035]; Taipei Veterans General Hospital [V104-E8-001]; Ministry of Education, Aim for the Top University Plan; Ministry of Health and Welfare, Center of Excellence for Cancer Research [MOHW104-TDU-B-211-124-001]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Ministry of Health and Welfare, Center of Excellence for Cancer Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Professor Victor M Diaz (Universitat Pompeu Fabra, Barcelona, Spain) for the generous gifts of pcDNA3-myc-FBXL14 and pcDNA3-FBXL14 Delta F plasmids. We thank Professor Kuo-Wei Chang (National Yang-Ming University, Taiwan) for providing OECM-1 cell line. This work was supported by Ministry of Science and Technology (103-2321-B-010-019, 103-2314-B-010-034, 103-2633-H-010-001, and 103-2314-B-010-035 to M-HY), Taipei Veterans General Hospital (V104-E8-001 to M-HY), a grant from Ministry of Education, Aim for the Top University Plan (to M-HY) and a grant from the Ministry of Health and Welfare, Center of Excellence for Cancer Research (MOHW104-TDU-B-211-124-001 to M-HY).	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Carlsson SK, 2014, EMBO MOL MED, V6, P1359, DOI 10.15252/emmm.201302627; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Di CH, 2010, ANTI-CANCER AGENT ME, V10, P543, DOI 10.2174/187152010793498618; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Forastiere AA, 2013, J CLIN ONCOL, V31, P845, DOI 10.1200/JCO.2012.43.6097; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Garavello W, 2006, ARCH OTOLARYNGOL, V132, P762, DOI 10.1001/archotol.132.7.762; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Li CW, 2012, CANCER RES, V72, P1290, DOI 10.1158/0008-5472.CAN-11-3123; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michael J Morgan, 2011, Cell Research, V21, P103; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; NEWTON HB, 1992, CANCER, V69, P2149, DOI 10.1002/1097-0142(19920415)69:8<2149::AID-CNCR2820690822>3.0.CO;2-G; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang WH, 2013, BIOCHEM BIOPH RES CO, V433, P24, DOI 10.1016/j.bbrc.2013.02.076; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Zhong JT, 2013, DISCOV MED, V15, P7	35	36	36	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2287	2298		10.1038/onc.2015.291	http://dx.doi.org/10.1038/onc.2015.291			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26257063	Green Accepted			2022-12-26	WOS:000376165000002
J	Barfoot, T; Herdendorf, TJ; Behning, BR; Stohr, BA; Gao, Y; Kreuzer, KN; Nelson, SW				Barfoot, Tasida; Herdendorf, Timothy J.; Behning, Bryanna R.; Stohr, Bradley A.; Gao, Yang; Kreuzer, Kenneth N.; Nelson, Scott W.			Functional Analysis of the Bacteriophage T4 Rad50 Homolog (gp46) Coiled-coil Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; MRE11 COMPLEX; DNA-REPAIR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; PROTEIN COMPLEX; ZINC-HOOK; COORDINATION; ROLES; ENDS	Rad50 and Mre11 form a complex involved in the detection and processing of DNA double strand breaks. Rad50 contains an anti-parallel coiled-coil with two absolutely conserved cysteine residues at its apex. These cysteine residues serve as a dimerization domain and bind a Zn2+ cation in a tetrathiolate coordination complex known as the zinc-hook. Mutation of the zinc-hook in bacteriophage T4 is lethal, indicating the ability to bind Zn2+ is critical for the functioning of the MR complex. In vitro, we found that complex formation between Rad50 and a peptide corresponding to the C-terminal domain of Mre11 enhances the ATPase activity of Rad50, supporting the hypothesis that the coiled-coil is a major conduit for communication between Mre11 and Rad50. We constructed mutations to perturb this domain in the bacteriophage T4 Rad50 homolog. Deletion of the Rad50 coiled-coil and zinc-hook eliminates Mre11 binding and ATPase activation but does not affect its basal activity. Mutation of the zinc-hook or disruption of the coiled-coil does not affect Mre11 or DNA binding, but their activation of Rad50 ATPase activity is abolished. Although these mutants excise a single nucleotide at a normal rate, they lack processivity and have reduced repetitive exonuclease rates. Restricting the mobility of the coiled-coil eliminates ATPase activation and repetitive exonuclease activity, but the ability to support single nucleotide excision is retained. These results suggest that the coiled-coiled domain adopts at least two conformations throughout the ATPase/nuclease cycle, with one conformation supporting enhanced ATPase activity and processivity and the other supporting nucleotide excision.	[Barfoot, Tasida; Herdendorf, Timothy J.; Behning, Bryanna R.; Gao, Yang; Nelson, Scott W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Stohr, Bradley A.; Kreuzer, Kenneth N.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Iowa State University; Duke University	Nelson, SW (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	swn@iastate.edu	Regan, Clinton/E-6250-2012; Gao, Yang/O-3445-2016		National Institutes of Health [RO1 GM066934]; Carver Trust Young Investigator [10-3603]; National Science Foundation [MCB-1121693]; Div Of Molecular and Cellular Bioscience [1121693] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Trust Young Investigator; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM066934 (to K. N. K). This work was also supported by Carver Trust Young Investigator Grant 10-3603 (to S. W. N.), Iowa State University institutional support (to S. W. N), and National Science Foundation Grant MCB-1121693 (to S. W. N). The authors declare that they have no conflicts of interest with the contents of this article.	ALANI E, 1989, GENETICS, V122, P47; Albrecht DW, 2012, J BIOL CHEM, V287, P31371, DOI 10.1074/jbc.M112.392316; Almond JR, 2013, GENETICS, V195, P739, DOI 10.1534/genetics.113.154872; Anderson DE, 2001, J BIOL CHEM, V276, P37027, DOI 10.1074/jbc.M106179200; Assenmacher N, 2004, CHROMOSOMA, V113, P157, DOI 10.1007/s00412-004-0306-4; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Connelly JC, 2002, TRENDS BIOCHEM SCI, V27, P410, DOI 10.1016/S0968-0004(02)02144-8; Das D, 2010, J MOL BIOL, V397, P647, DOI 10.1016/j.jmb.2010.01.049; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; Decottignies Anabelle, 2013, Frontiers in Genetics, V4, P48, DOI 10.3389/fgene.2013.00048; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Gao Y, 2014, J BIOL CHEM, V289, P26505, DOI 10.1074/jbc.M114.583625; Gell DA, 2012, ADV EXP MED BIOL, V747, P19, DOI 10.1007/978-1-4614-3229-6_2; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Harvey SH, 2002, GENOME BIOL, V3; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Herdendorf T. J., 2011, BIOCHEMISTRY, P6030; Herdendorf TJ, 2014, BIOCHEMISTRY-US, V53, P5647, DOI 10.1021/bi500558d; Herdendorf TJ, 2011, J BIOL CHEM, V286, P2382, DOI 10.1074/jbc.M110.178871; Hohl M, 2015, MOL CELL, V57, P479, DOI 10.1016/j.molcel.2014.12.018; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafrance-Vanasse J, 2015, PROG BIOPHYS MOL BIO, V117, P182, DOI 10.1016/j.pbiomolbio.2014.12.004; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2013, J BIOL CHEM, V288, P12840, DOI 10.1074/jbc.M113.460378; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Mosig G, 2001, P NATL ACAD SCI USA, V98, P8306, DOI 10.1073/pnas.131007398; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shcherbakov VP, 2006, DNA REPAIR, V5, P773, DOI 10.1016/j.dnarep.2006.03.007; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stohr BA, 2002, GENETICS, V162, P1019; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008	48	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23905	23915		10.1074/jbc.M115.675132	http://dx.doi.org/10.1074/jbc.M115.675132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26242734	Green Published, hybrid			2022-12-26	WOS:000361816500036
J	Chung, S; Dwabe, S; Elshimali, Y; Sukhija, H; Aroh, C; Vadgama, JV				Chung, Seyung; Dwabe, Sami; Elshimali, Yayha; Sukhija, Hemlata; Aroh, Clement; Vadgama, Jaydutt V.			Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array	PLOS ONE			English	Article							SERUM INTERLEUKIN-6 LEVELS; COLON-CANCER; GROWTH; EXPRESSION; INFLAMMATION; RESECTION; GENE	Colorectal cancer (CRC) is one of the three leading causes for cancer mortality. CRC kills over 600,000 people annually worldwide. The most common cause of death from CRC is the metastasis to distant organs. However, biomarkers for CRC metastasis remain ill-defined. We compared primary and metastatic CRC cell lines for their angiogenesis-protein profiles and intracellular signaling profiles to identify novel biomarkers for CRC metastasis. To this end, we used primary and metastatic CRC cell lines as a model system and normal human colon cell line as a control. The angiogenesis profiles two isogenic CRC cell lines, SW480 and SW620, and HT-29 and T84 revealed that VEGF was upregulated in both SW620 and T84 whereas coagulation factor III, IGFBP-3, DPP IV, PDGF AA/AB, endothelin I and CXCL16 were downregulated specifically in metastatic cell lines. Furthermore, we found that TIMP-1, amphiregulin, endostatin, angiogenin were upregulated in SW620 whereas downregulated in T84. Angiogenin was downregulated in T84 and GM-CSF was also downregulated in SW620. To induce CRC cell metastasis, we treated cells with proinflammatory cytokine IL-6. Upon IL-6 treatment, epithelial-mesenchymal transition was induced in CRC cells. When DLD-1 and HT-29 cells were treated with IL-6; Akt, STAT3, AMPK alpha and Bad phosphorylation levels were increased. Interestingly, SW620 showed the same signal activation pattern with IL-6 treatment of HT-29 and DLD-1. Our data suggest that Akt, STAT3, AMPK alpha and Bad activation can be biomarkers for metastatic colorectal cancer. IL-6 treatment specifically reduced phosphorylation levels of EGFR, HER2 receptor, Insulin R and IGF-1R in receptor tyrosine kinase array study with HT-29. Taken together, we have identified novel biomarkers for metastatic CRC through the angiogenesis- antibody array and intracellular signaling array studies. Present study suggests that those novel biomarkers can be used as CRC prognosis biomarkers, and as potential targets for the metastatic CRC therapy.	[Chung, Seyung; Dwabe, Sami; Elshimali, Yayha; Sukhija, Hemlata; Aroh, Clement; Vadgama, Jaydutt V.] Charles R Drew Univ Med & Sci, Dept Med, Div Canc Res & Training, Los Angeles, CA 90059 USA; [Vadgama, Jaydutt V.] Univ Calif Los Angeles, David Geffen UCLA Sch Med, Los Angeles, CA USA	Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vadgama, JV (corresponding author), Charles R Drew Univ Med & Sci, Dept Med, Div Canc Res & Training, 1731 120th St, Los Angeles, CA 90059 USA.	jayvadgama@cdrewu.edu			National Institutes of Health (NIH, NCI, NIMHD, NCATS) [U54 CA143931, U54MD007598, UL1TR000124]; Clinical Research Education and Career Development; NIMHD [U54MD007598, 5MD007610, U54CA143931]; NATIONAL CANCER INSTITUTE [U54CA143931] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007598, R25MD007610] Funding Source: NIH RePORTER	National Institutes of Health (NIH, NCI, NIMHD, NCATS); Clinical Research Education and Career Development; NIMHD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health (NIH, NCI, NIMHD, NCATS) Grants to J. V. Vadgama: U54 CA143931, U54MD007598, UL1TR000124. S. Steven Chung is a scholar supported by the Clinical Research Education and Career Development by the NIMHD 5MD007610, pilot award from U54MD007598 and career development support from U54CA143931.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Cazaubon S, 2006, M S-MED SCI, V22, P416, DOI 10.1051/medsci/2006224416; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Chen X, 2006, ADV EXP MED BIOL, V575, P27; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; CUBBAGE ML, 1990, J BIOL CHEM, V265, P12642; Culouscou JM, 1993, GROWTH FACTORS, V7, P195; Fan JW, 2008, CANCER-AM CANCER SOC, V113, P266, DOI 10.1002/cncr.23551; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Francisco-Cruz A, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0774-6; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Galizia G, 2012, ARCH SURG-CHICAGO, V147, P18, DOI 10.1001/archsurg.2011.795; HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kirsch M, 2004, CANC TREAT, V117, P285; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Manfredi S, 2006, BRIT J SURG, V93, P1115, DOI 10.1002/bjs.5349; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pilati P, 2012, ANN SURG ONCOL, V19, P402, DOI 10.1245/s10434-011-2132-2; Reichenstein M, 2004, MOL CELL ENDOCRINOL, V215, P109, DOI 10.1016/j.mce.2003.11.011; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Waldner MJ, 2012, INT J BIOL SCI, V8, P1248, DOI 10.7150/ijbs.4614; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	30	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0134948	10.1371/journal.pone.0134948	http://dx.doi.org/10.1371/journal.pone.0134948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258407	Green Published, gold, Green Submitted			2022-12-26	WOS:000359352600032
J	Brummitt, NA; Bachman, SP; Griffiths-Lee, J; Lutz, M; Moat, JF; Farjon, A; Donaldson, JS; Hilton-Taylor, C; Meagher, TR; Albuquerque, S; Aletrari, E; Andrews, AK; Atchison, G; Baloch, E; Barlozzini, B; Brunazzi, A; Carretero, J; Celesti, M; Chadburn, H; Cianfoni, E; Cockel, C; Coldwell, V; Concetti, B; Contu, S; Crook, V; Dyson, P; Gardiner, L; Ghanim, N; Greene, H; Groom, A; Harker, R; Hopkins, D; Khela, S; Lakeman-Fraser, P; Lindon, H; Lockwood, H; Loftus, C; Lombrici, D; Lopez-Poveda, L; Lyon, J; Malcolm-Tompkins, P; McGregor, K; Moreno, L; Murray, L; Nazar, K; Power, E; Tuijtelaars, MQ; Salter, R; Segrott, R; Thacker, H; Thomas, LJ; Tingvoll, S; Watkinson, G; Wojtaszekova, K; Lughadha, EMN				Brummitt, Neil A.; Bachman, Steven P.; Griffiths-Lee, Janine; Lutz, Maiko; Moat, Justin F.; Farjon, Aljos; Donaldson, John S.; Hilton-Taylor, Craig; Meagher, Thomas R.; Albuquerque, Sara; Aletrari, Elina; Andrews, A. Kei; Atchison, Guy; Baloch, Elisabeth; Barlozzini, Barbara; Brunazzi, Alice; Carretero, Julia; Celesti, Marco; Chadburn, Helen; Cianfoni, Eduardo; Cockel, Chris; Coldwell, Vanessa; Concetti, Benedetta; Contu, Sara; Crook, Vicki; Dyson, Philippa; Gardiner, Lauren; Ghanim, Nadia; Greene, Hannah; Groom, Alice; Harker, Ruth; Hopkins, Della; Khela, Sonia; Lakeman-Fraser, Poppy; Lindon, Heather; Lockwood, Helen; Loftus, Christine; Lombrici, Debora; Lopez-Poveda, Lucia; Lyon, James; Malcolm-Tompkins, Patricia; McGregor, Kirsty; Moreno, Laura; Murray, Linda; Nazar, Keara; Power, Emily; Tuijtelaars, Mireya Quiton; Salter, Ruth; Segrott, Robert; Thacker, Hannah; Thomas, Leighton J.; Tingvoll, Sarah; Watkinson, Gemma; Wojtaszekova, Katerina; Lughadha, Eimear M. Nic			Green Plants in the Red: A Baseline Global Assessment for the IUCN Sampled Red List Index for Plants	PLOS ONE			English	Article							CONSERVATION ASSESSMENT; EXTINCTION RISK; BIODIVERSITY; PROGRESS; TRENDS; CONVENTION; DIVERSITY; THREAT	Plants provide fundamental support systems for life on Earth and are the basis for all terrestrial ecosystems; a decline in plant diversity will be detrimental to all other groups of organisms including humans. Decline in plant diversity has been hard to quantify, due to the huge numbers of known and yet to be discovered species and the lack of an adequate baseline assessment of extinction risk against which to track changes. The biodiversity of many remote parts of the world remains poorly known, and the rate of new assessments of extinction risk for individual plant species approximates the rate at which new plant species are described. Thus the question 'How threatened are plants?' is still very difficult to answer accurately. While completing assessments for each species of plant remains a distant prospect, by assessing a randomly selected sample of species the Sampled Red List Index for Plants gives, for the first time, an accurate view of how threatened plants are across the world. It represents the first key phase of ongoing efforts to monitor the status of the world's plants. More than 20% of plant species assessed are threatened with extinction, and the habitat with the most threatened species is overwhelmingly tropical rain forest, where the greatest threat to plants is anthropogenic habitat conversion, for arable and livestock agriculture, and harvesting of natural resources. Gymnosperms (e.g. conifers and cycads) are the most threatened group, while a third of plant species included in this study have yet to receive an assessment or are so poorly known that we cannot yet ascertain whether they are threatened or not. This study provides a baseline assessment from which trends in the status of plant biodiversity can be measured and periodically reassessed.	[Brummitt, Neil A.; Aletrari, Elina; Atchison, Guy; Contu, Sara; Greene, Hannah; Harker, Ruth; Hopkins, Della; Lindon, Heather; Lopez-Poveda, Lucia] Nat Hist Museum, London SW7 5BD, England; [Bachman, Steven P.; Griffiths-Lee, Janine; Lutz, Maiko; Moat, Justin F.; Farjon, Aljos; Albuquerque, Sara; Aletrari, Elina; Andrews, A. Kei; Baloch, Elisabeth; Barlozzini, Barbara; Brunazzi, Alice; Carretero, Julia; Celesti, Marco; Chadburn, Helen; Cianfoni, Eduardo; Cockel, Chris; Coldwell, Vanessa; Concetti, Benedetta; Contu, Sara; Crook, Vicki; Dyson, Philippa; Gardiner, Lauren; Ghanim, Nadia; Groom, Alice; Harker, Ruth; Khela, Sonia; Lakeman-Fraser, Poppy; Lindon, Heather; Lockwood, Helen; Loftus, Christine; Lombrici, Debora; Lopez-Poveda, Lucia; Lyon, James; Malcolm-Tompkins, Patricia; McGregor, Kirsty; Moreno, Laura; Murray, Linda; Nazar, Keara; Power, Emily; Tuijtelaars, Mireya Quiton; Salter, Ruth; Segrott, Robert; Thacker, Hannah; Thomas, Leighton J.; Tingvoll, Sarah; Watkinson, Gemma; Wojtaszekova, Katerina; Lughadha, Eimear M. Nic] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Bachman, Steven P.; Moat, Justin F.] Univ Nottingham, Sch Geog, Nottingham NG7 2RD, England; [Donaldson, John S.] KRC, South African Natl Biodivers Inst, Claremont, South Africa; [Hilton-Taylor, Craig] IUCN Red List Unit, Cambridge, England; [Meagher, Thomas R.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Aletrari, Elina] Kings Coll London, London WC2R 2LS, England	Natural History Museum London; Royal Botanic Gardens, Kew; University of Nottingham; South African National Biodiversity Institute; University of St Andrews; University of London; King's College London	Brummitt, NA (corresponding author), Nat Hist Museum, Cromwell Rd, London SW7 5BD, England.	n.brummitt@nhm.ac.uk	Nic Lughadha, Eimear/N-4560-2014; Celesti, Marco/M-6738-2019; Donaldson, John/F-6833-2011	Nic Lughadha, Eimear/0000-0002-8806-4345; Celesti, Marco/0000-0001-7249-7106; Donaldson, John/0000-0002-7930-1695; Carretero, Julia/0000-0002-3697-1947; Bachman, Steven/0000-0003-1085-6075; Moat, Justin/0000-0002-5513-3615; Lutz, Maiko/0000-0002-6695-8380; Gardiner, Lauren/0000-0002-8843-0317	Charles Wolfson Charitable Trust; Esmee Fairbairn Foundation; Rio Tinto plc.; World Summit on Sustainable Development Implementation Fund of the Department of Environment; Food and Rural Affairs (Defra) of the United Kingdom government; World Collections Programme; Natural History Museum; Royal Botanic Gardens, Kew; Rufford Foundation; MAVA Foundation; Environment Agency of Abu Dhabi; NERC [NE/L013045/1] Funding Source: UKRI	Charles Wolfson Charitable Trust; Esmee Fairbairn Foundation; Rio Tinto plc.; World Summit on Sustainable Development Implementation Fund of the Department of Environment; Food and Rural Affairs (Defra) of the United Kingdom government; World Collections Programme; Natural History Museum; Royal Botanic Gardens, Kew; Rufford Foundation; MAVA Foundation; Environment Agency of Abu Dhabi; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding and support for the first phase of the IUCN Sampled Red List Index for Plants has been provided by the Charles Wolfson Charitable Trust, the Esmee Fairbairn Foundation, Rio Tinto plc., the World Summit on Sustainable Development Implementation Fund of the Department of Environment, Food and Rural Affairs (Defra) of the United Kingdom government and the World Collections Programme, as well as The Natural History Museum and the Royal Botanic Gardens, Kew. The IUCN Red List Unit is generously supported by the Rufford Foundation, the MAVA Foundation and the Environment Agency of Abu Dhabi. Artisan Plant Nurseries did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rio Tinto plc. contributed to the funding of digitisation of specimen data and Red List assessment generation during the course of the project, but in no way did this hold any influence over the scientific outputs of this project. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Bland LM, 2014, CONSERVATION BIOL, DOI 10.111/cobi.12372; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; Brummitt N. A., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P539; Brummitt NA, PHILOS T B IN PRESS; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; BUTCHART SHM, 2005, PHILOS T R SOC B, V360, P359; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cardoso Domingos Benício Oliveira Silva, 2007, Rodriguésia, V58, P379, DOI 10.1590/2175-7860200758212; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carwardine J, 2011, CONSERV LETT, V2, P4; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Clausnitzer V, 2009, BIOL CONSERV, V142, P1864, DOI 10.1016/j.biocon.2009.03.028; Collen B, 2004, GLOBAL ECOL BIOGEOGR, V13, P459, DOI 10.1111/j.1466-822X.2004.00121.x; Convention on Biological Diversity Secretariat, 2010, C PART CONV BIOL DIV; Cumberlidge N, 2009, BIOL CONSERV, V142, P1665, DOI 10.1016/j.biocon.2009.02.038; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Faber-Langendoen D, 2012, NATURESERVE CONSERVA; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Giam XL, 2011, J BIOGEOGR, V38, P55, DOI 10.1111/j.1365-2699.2010.02383.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN, 2014, IUCN RED LIST VERS 2; IUCN Standards and Petitions Subcommittee, 2017, GUID US IUCN RED LIS; IUCN  U.-W, 2010, WORLD DAT PROT AR; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kenicer G, 2005, ENDINB J BOT, V62, P195; Lamoreux J, 2003, TRENDS ECOL EVOL, V18, P214, DOI 10.1016/S0169-5347(03)00090-9; Lewis OT, 2011, J INSECT CONSERV, V15, P121, DOI 10.1007/s10841-010-9329-8; Lughadha EN, 2005, PHILOS T ROY SOC B, V360, P359, DOI 10.1098/rstb.2004.1596; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; MEA, 2005, EC HUM WELL BEING SC; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Newton A. C., 2008, Endangered Species Research, V6, P137, DOI 10.3354/esr00148; Newton AC, 2011, CONSERV LETT, V4, P264, DOI 10.1111/j.1755-263X.2011.00167.x; Oldfield S., 1998, WORLD LIST THREATENE; Oliveira AT, 2013, S AFR J BOT, V89, P42, DOI 10.1016/j.sajb.2013.06.010; de Queiroz LP, 2006, SYST ASSOC SPEC VOL, P121; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2010, FRONT ECOL ENVIRON, V8, P458, DOI 10.1890/10.WB.23; PIELOU E C, 1969, P286; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Raimondo DC, 2013, ANN MO BOT GARD, V99, P221, DOI 10.3417/2011111; Richman NI, PHILOS T B IN PRESS; Rivers MC, 2011, BIOL CONSERV, V144, P2541, DOI 10.1016/j.biocon.2011.07.014; Rivers MC, 2010, BIODIVERS CONSERV, V19, P2071, DOI 10.1007/s10531-010-9826-9; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schmeller DS, 2015, J NAT CONSERV, V25, P51, DOI 10.1016/j.jnc.2015.03.003; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Villasenor JL, 2007, DIVERS DISTRIB, V13, P871, DOI 10.1111/j.1472-4642.2007.00385.x; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; WCS, 2005, LAST WILD PROJ VERS; Willis F, 2003, BIODIVERS CONSERV, V12, P1537, DOI 10.1023/A:1023679329093; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Zamin TJ, 2010, CONSERV BIOL, V24, P1012, DOI 10.1111/j.1523-1739.2010.01492.x	74	177	185	1	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135152	10.1371/journal.pone.0135152	http://dx.doi.org/10.1371/journal.pone.0135152			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252495	Green Published, gold			2022-12-26	WOS:000359121100125
J	Han, Y; Jia, CY; Cong, XL; Yu, F; Cai, HD; Fang, SY; Cai, L; Yang, HQ; Sun, Y; Li, D; Liu, J; Xie, RT; Yuan, XY; Zhong, XM; Li, M; Wei, Q; Lv, ZW; Fu, D; Ma, YS				Han, Yang; Jia, Chengyou; Cong, Xianling; Yu, Fei; Cai, Haidong; Fang, Suyun; Cai, Li; Yang, Huiqiong; Sun, Yu; Li, Dan; Liu, Jin; Xie, Ruting; Yuan, Xueyu; Zhong, Xiaoming; Li, Ming; Wei, Qing; Lv, Zhongwei; Fu, Da; Ma, Yushui			Increased Expression of TGF beta R2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; SIGNAL-TRANSDUCTION; RADIATION-THERAPY; PREDICTS SURVIVAL; BETA SUPERFAMILY; SIGNATURES; PROGNOSIS; PATHWAYS; SOCIETY; WEB	To investigate the prognostic significance of TGF beta R2 expression and chemotherapy in Chinese non-small cell lung cancer (NSCLC) patients, TGF beta R2 expression NSCLC was analyzed in silico using the Oncomine database, and subsequently analyzed with quantitative RT-PCR in 308 NSCLC biopsies, 42 of which were paired with adjacent non-neoplastic tissues. Our results show that TGF beta R2 expression was also increased in NSCLC biopsies relative to normal tissue samples and correlated with poor prognosis. TGF beta R2 expression was also significantly correlated with other clinical parameters such as tumor differentiation, invasion of lung membrane, and chemotherapy. Moreover, overall survival (OS) and disease free survival (DFS) was increased in patients with low TGF beta R2 expressing NSCLC and who had undergone chemotherapy. Thus, high expression of TGF beta R2 is a significant risk factor for decreased OS and DFS in NSCLC patients. Thus, TGF beta R2 is a potential prognostic tumor biomarker for chemotherapy.	[Han, Yang; Jia, Chengyou; Yu, Fei; Cai, Haidong; Fang, Suyun; Cai, Li; Yang, Huiqiong; Sun, Yu; Li, Dan; Liu, Jin; Yuan, Xueyu; Lv, Zhongwei; Fu, Da; Ma, Yushui] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Cong, Xianling] Jilin Univ, China Japan Union Hosp, Tissue Bank, Changchun 130023, Peoples R China; [Xie, Ruting; Wei, Qing] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Pathol, Shanghai 200092, Peoples R China; [Zhong, Xiaoming] Jiangxi Prov Tumor Hosp, Dept Radiol, Nanchang, Peoples R China; [Li, Ming] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Resp Med, Shanghai 200092, Peoples R China	Tongji University; Jilin University; Tongji University; Tongji University	Lv, ZW (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China.	Zongwei_Lv@126.com; fu800da900@126.com; mayushui2015@126.com	han, yang/GRS-2388-2022; ma, yushui/HGC-6206-2022; Fu, Da/GXF-2656-2022; Jia, Chengyou/AAV-1153-2021		National Natural Science Foundation of China [81371595, 81372175, 81301993, 81472501, 81201535, 81472202, 81302065]; Nature Science Foundation of Shanghai [12ZR1436000]; Shanghai Municipal Science and Technology Commission [14441901300, 14DZ1940606]; Shanghai Municipal Commission of Health and Family Planning [XBR2013112, 2013SY036]; Youth Innovation Promotion Association, Chinese Academy of Sciences [Y219J11311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Commission of Health and Family Planning; Youth Innovation Promotion Association, Chinese Academy of Sciences	This study was supported partly by grants from the National Natural Science Foundation of China (81371595, 81372175, 81301993, 81472501, 81201535, 81472202 and 81302065), Nature Science Foundation of Shanghai (12ZR1436000), Shanghai Municipal Science and Technology Commission (14441901300, 14DZ1940606), Shanghai Municipal Commission of Health and Family Planning (XBR2013112, 2013SY036) and Youth Innovation Promotion Association, Chinese Academy of Sciences (Y219J11311).	Busch S, 2015, ONCOGENE, V34, P27, DOI 10.1038/onc.2013.527; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Corradi L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S10; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FIGLIN RA, 1988, NEW ENGL J MED, V318, P1300, DOI 10.1056/NEJM198805193182004; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Gumienny Tina L, 2013, WormBook, P1, DOI 10.1895/wormbook.1.22.2; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; HOLOYE PY, 1977, JAMA-J AM MED ASSOC, V237, P1221, DOI 10.1001/jama.237.12.1221; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalemkerian GP, 2014, LANCET ONCOL, V15, P13, DOI 10.1016/S1470-2045(13)70555-2; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Miettinen OS, 2001, NEW ENGL J MED, V344, P935; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Parums DV, 2014, DRUG TODAY, V50, P503, DOI [10.1358/dot.2014.50.07.2185913, 10.1358/dot.2014.50.7.2185913]; Pisters KMW, 2007, J CLIN ONCOL, V25, P5506, DOI 10.1200/JCO.2007.14.1226; Port JL, 2003, CHEST, V124, P1828, DOI 10.1378/chest.124.5.1828; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shimizu K, 2004, CANCER SCI, V95, P328, DOI 10.1111/j.1349-7006.2004.tb03211.x; Soria JC, 2003, LANCET ONCOL, V4, P659, DOI 10.1016/S1470-2045(03)01244-0; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Valdimarsdottir G, 2005, APMIS, V113, P773, DOI 10.1111/j.1600-0463.2005.apm_3181.x; Van Laar RK, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-30; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yanagisawa K, 2000, ONCOGENE, V19, P2305, DOI 10.1038/sj.onc.1203591; Zhu LB, 2010, ANTI-CANCER DRUG, V21, P669, DOI 10.1097/CAD.0b013e32833ad5aa	37	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134682	10.1371/journal.pone.0134682	http://dx.doi.org/10.1371/journal.pone.0134682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252213	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100067
J	Hopper, N; Wardale, J; Brooks, R; Power, J; Rushton, N; Henson, F				Hopper, Niina; Wardale, John; Brooks, Roger; Power, Jonathan; Rushton, Neil; Henson, Frances			Peripheral Blood Mononuclear Cells Enhance Cartilage Repair in in vivo Osteochondral Defect Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CIRCULATING CD14(+) MONOCYTES; AUTOGENOUS PERIOSTEAL GRAFTS; CONTINUOUS PASSIVE MOTION; FULL-THICKNESS DEFECTS; BONE-MARROW; ARTICULAR-CARTILAGE; BIOLOGICAL CHARACTERISTICS; HYALURONIC-ACID; JOINT SURFACES	This study characterized peripheral blood mononuclear cells (PBMC) in terms of their potential in cartilage repair and investigated their ability to improve the healing in a pre-clinical large animal model. Human PBMCs were isolated with gradient centrifugation and adherent PBMC's were evaluated for their ability to differentiate into adipogenic, chondrogenic and osteogenic lineages and also for their expression of musculoskeletal genes. The phenotype of the PBMCs was evaluated using Stro-1, CD34, CD44, CD45, CD90, CD106, CD105, CD146 and CD166 cell surface markers. Osteochondral defects were created in the medial femoral condyle (MFC) of 24 Welsh mountain sheep and evaluated at a six month time point. Four cell treatment groups were evaluated in combination with collagen-GAG-scaffold: (1) MSC alone; (2) MSCs and PBMCs at a ratio of 20:1; (3) MSCs and PBMC at a ratio of 2:1 and (4) PBMCs alone. Samples from the surgical site were evaluated for mechanical properties, ICRS score and histological repair. Fresh PBMC samples were 90% positive for hematopoietic cell surface markers and negative for the MSC antibody panel (<1%, p = 0.006). However, the adherent PBMC population expressed mesenchymal stem cell markers in hypoxic culture and lacked CD34/45 positive cells (<0.2%). This finding demonstrated that the adherent cells had acquired an MSC-like phenotype and transformed in hypoxia from their original hematopoietic lineage. Four key genes in muskuloskeletal biology were significantly upregulated in adherent PBMCs by hypoxia: BMP2 4.2-fold (p = 0.0007), BMP6 10.7-fold (p = 0.0004), GDF5 2.0-fold (p = 0.002) and COL1 5.0-fold (p = 0.046). The monolayer multilineage analysis confirmed the trilineage mesenchymal potential of the adherent PBMCs. PBMC cell therapy was equally good as bone marrow MSC therapy for defects in the ovine large animal model. Our results show that PBMCs support cartilage healing and oxygen tension of the environment was found to have a key effect on the derivation of a novel adherent cell population with an MSC-like phenotype. This study presents a novel and easily attainable point-of-care cell therapy with PBMCs to treat osteochondral defects in the knee avoiding any cell manipulations outside the surgical room.	[Hopper, Niina; Wardale, John; Brooks, Roger; Rushton, Neil] Univ Cambridge, Addenbrookes Hosp, Div Trauma & Orthopaed Surg, Cambridge BC2 0QQ, England; [Power, Jonathan] Univ Chester, Dept Biol Sci, Chester CH1 4BJ, Cheshire, England; [Henson, Frances] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Chester; University of Cambridge	Hopper, N (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Trauma & Orthopaed Surg, Cambridge BC2 0QQ, England.	nmh39@cam.ac.uk	, Roger/N-7021-2019; Henson, Frances/D-7540-2013	Henson, Frances/0000-0002-3518-1492; Hopper, Niina/0000-0002-5718-7174	UK Technology Strategy Board [RG52235]; John Insall Foundation	UK Technology Strategy Board; John Insall Foundation	This study was supported by the UK Technology Strategy Board RG52235 (to NR) (https://www.gov.uk/government/organisations/innovate-uk) and the John Insall Foundation, Ph.D stundentship (Charitable Organization) (to NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilok G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt319; Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100; Bakhshayesh M, 2012, INFLAMMATION, V35, P138, DOI 10.1007/s10753-011-9298-4; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bekkers JEJ, 2013, OSTEOARTHR CARTILAGE, V21, P950, DOI 10.1016/j.joca.2013.03.015; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470; CONVERY FR, 1972, CLIN ORTHOP RELAT R, P253; Dewan AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/272481; Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891; Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018; Fu WL, 2014, KNEE, V21, P609, DOI 10.1016/j.knee.2013.10.010; Fu WL, 2014, AM J SPORT MED, V42, P592, DOI 10.1177/0363546513512778; Fu WL, 2012, TISSUE ENG PT A, V18, P1793, DOI [10.1089/ten.tea.2011.0530, 10.1089/ten.TEA.2011.0530]; Fu WL, 2011, CHINESE MED J-PEKING, V124, P3959, DOI 10.3760/cma.j.issn.0366-6999.2011.23.022; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Getgood Alan, 2014, J Exp Orthop, V1, P13, DOI 10.1186/s40634-014-0013-x; Getgood A, 2012, CARTILAGE, V3, P351, DOI 10.1177/1947603512444597; Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Grogan SP, 2006, TISSUE ENG, V12, P2141, DOI 10.1089/ten.2006.12.2141; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387; Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361; Hoff P, 2013, CELL MOL IMMUNOL, V10, P151, DOI 10.1038/cmi.2012.56; Hopper N, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/323454; HURTIG MB, 1988, CAN J VET RES, V52, P137; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kodama H, 2005, STEM CELLS DEV, V14, P676, DOI 10.1089/scd.2005.14.676; Krenning G, 2013, J TISSUE ENG REGEN M, V7, P118, DOI 10.1002/term.503; Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lynn AK, 2010, J BIOMED MATER RES A, V92A, P1057, DOI 10.1002/jbm.a.32415; Miyamoto A, 2012, CYTOTECHNOLOGY, V64, P331, DOI 10.1007/s10616-012-9442-5; Naito M, 1997, MICROSC RES TECHNIQ, V39, P350, DOI 10.1002/(SICI)1097-0029(19971115)39:4<350::AID-JEMT5>3.0.CO;2-L; O'Driscoll SW, 2001, CLIN ORTHOP RELAT R, pS397; ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008; ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017; Paschos NK, 2015, J TISSUE ENG REGEN M, V9, P488, DOI 10.1002/term.1870; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Romagnani P, 2005, CIRC RES, V97, P314, DOI 10.1161/01.RES.0000177670.72216.9b; Saw KY, 2013, ARTHROSCOPY, V29, P684, DOI 10.1016/j.arthro.2012.12.008; Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054; Semenza GL, 2000, GENE DEV, V14, P1983; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007; Song FL, 2014, INT J CLIN EXP PATHO, V7, P1415; STEINMAN RM, 1985, CRIT REV IMMUNOL, V5, P331; Turajane Thana, 2013, Journal of the Medical Association of Thailand, V96, P580; Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005; Yanai T, 2005, J BONE JOINT SURG BR, V87B, P721, DOI 10.1302/0301-620X.87B5.15542; Yu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt234; Zhang M, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt139; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	59	43	45	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0133937	10.1371/journal.pone.0133937	http://dx.doi.org/10.1371/journal.pone.0133937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252391	Green Published, gold, Green Submitted			2022-12-26	WOS:000359121100028
J	Pelletier-Baldelli, A; Bernard, JA; Mittal, VA				Pelletier-Baldelli, Andrea; Bernard, Jessica A.; Mittal, Vijay A.			Intrinsic Functional Connectivity in Salience and Default Mode Networks and Aberrant Social Processes in Youth at Ultra-High Risk for Psychosis	PLOS ONE			English	Article							CLINICAL HIGH-RISK; RESTING-STATE CONNECTIVITY; SCHIZOPHRENIA; INDIVIDUALS; RECOGNITION; PREDICTION; ROBUST; OPTIMIZATION; REGISTRATION; METAANALYSIS	Social processes are key to navigating the world, and investigating their underlying mechanisms and cognitive architecture can aid in understanding disease states such as schizophrenia, where social processes are highly impacted. Evidence suggests that social processes are impaired in individuals at ultra high-risk for the development of psychosis (UHR). Understanding these phenomena in UHR youth may clarify disease etiology and social processes in a period that is characterized by significantly fewer confounds than schizophrenia. Furthermore, understanding social processing deficits in this population will help explain these processes in healthy individuals. The current study examined resting state connectivity of the salience (SN) and default mode networks (DMN) in association with facial emotion recognition (FER), an integral aspect of social processes, as well as broader social functioning (SF) in UHR individuals and healthy controls. Consistent with the existing literature, UHR youth were impaired in FER and SF when compared with controls. In the UHR group, we found increased connectivity between the SN and the medial prefrontal cortex, an area of the DMN relative to controls. In UHR youth, the DMN exhibited both positive and negative correlations with the somatosensory cortex/cerebellum and precuneus, respectively, which was linked with better FER performance. For SF, results showed that sensory processing links with the SN might be important in allowing for better SF for both groups, but especially in controls where sensory processing is likely to be unimpaired. These findings clarify how social processing deficits may manifest in psychosis, and underscore the importance of SN and DMN connectivity for social processing more generally.	[Pelletier-Baldelli, Andrea; Bernard, Jessica A.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Pelletier-Baldelli, Andrea] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Bernard, Jessica A.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA; [Mittal, Vijay A.] Northwestern Univ, Dept Psychol, Evanston, IL USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; Northwestern University	Pelletier-Baldelli, A (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.	andrea.pelletier@colorado.edu		MITTAL, VIJAY/0000-0001-9017-5119	National Institute of Mental Health [R01MH094650, 1F31MH100821-01A1, 1F32MH102898-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH102898, R01MH094650, F31MH100821] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (http://www.nimh.nih.gov/ index.shtml) R01MH094650 to V.A.M; 1F31MH100821-01A1 to A.P.; 1F32MH102898-01 to J.A.B. The funders had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	Addington J, 2008, BRIT J PSYCHIAT, V192, P67, DOI 10.1192/bjp.bp.107.039784; Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allott KA, 2014, SCHIZOPHR RES, V153, P25, DOI 10.1016/j.schres.2014.01.037; Amminger GP, 2012, SCHIZOPHRENIA BULL, V38, P1030, DOI 10.1093/schbul/sbr015; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Auther AM., 2006, GLOBAL FUNCTIONING S; Bernard JA, 2013, CEREBELLUM, V12, P721, DOI 10.1007/s12311-013-0481-z; Bernard JA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00031; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Carter CS, 2009, SCHIZOPHRENIA BULL, V35, P153, DOI 10.1093/schbul/sbn157; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Cornblatt BA, 2007, SCHIZOPHRENIA BULL, V33, P688, DOI 10.1093/schbul/sbm029; Cornblatt BA, 2012, SCHIZOPHRENIA BULL, V38, P1247, DOI 10.1093/schbul/sbr136; Dodell-Feder D, 2014, SCHIZOPHR RES, V156, P87, DOI 10.1016/j.schres.2014.03.031; First M.B., 2016, STRUCTURED CLIN INTE; Fusar-Poli P, 2010, J PSYCHIATR RES, V44, P294, DOI 10.1016/j.jpsychires.2009.08.016; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Green MF, 2012, SCHIZOPHRENIA BULL, V38, P854, DOI 10.1093/schbul/sbq171; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Karlsgodt KH, 2009, BIOL PSYCHIAT, V66, P562, DOI 10.1016/j.biopsych.2009.03.013; Lencz T, 2004, SCHIZOPHR RES, V68, P37, DOI 10.1016/S0920-9964(03)00214-7; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; McCabe C, 2011, MOL PSYCHIATR, V16, P592, DOI 10.1038/mp.2010.138; McGlashan T.H., 2001, INSTRUMENT ASSESSMEN, P135, DOI DOI 10.1007/978-94-010-0892-1_7; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mothersill O, 2014, SCHIZOPHR RES, V157, P225, DOI 10.1016/j.schres.2014.05.023; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; National Institue of Mental Health, SOC PROC WORKGR P 20; Niendam TA, 2007, SCHIZOPHRENIA BULL, V33, P772, DOI 10.1093/schbul/sbm020; Orr JM, 2014, NEUROIMAGE-CLIN, V4, P343, DOI 10.1016/j.nicl.2014.01.006; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Pelletier AL, 2012, SCHIZOPHR RES, V137, P269, DOI 10.1016/j.schres.2012.01.033; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Ruiz S, 2013, HUM BRAIN MAPP, V34, P200, DOI 10.1002/hbm.21427; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; Stanford AD, 2011, SCHIZOPHR RES, V131, P11, DOI 10.1016/j.schres.2011.06.005; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tarbox SI, 2014, PSYCHIAT RES, V215, P52, DOI 10.1016/j.psychres.2013.10.006; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Wotruba D, 2014, SCHIZOPHRENIA BULL, V40, P1095, DOI 10.1093/schbul/sbt161	71	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134936	10.1371/journal.pone.0134936	http://dx.doi.org/10.1371/journal.pone.0134936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252525	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100086
J	Gao, T; Jin, KR; Chen, PH; Jin, H; Yang, LL; Xie, XM; Yang, ML; Hu, C; Yu, XM				Gao, Ting; Jin, Kairui; Chen, Peihong; Jin, Hua; Yang, Lili; Xie, Xinmiao; Yang, Meili; Hu, Cheng; Yu, Xuemei			Circulating Betatrophin Correlates with Triglycerides and Postprandial Glucose among Different Glucose Tolerance Statuses-A Case-Control Study	PLOS ONE			English	Article							LIPASIN; WOMEN	Purpose Previous researches of betatrophin on glucose and lipids metabolism under insulin-resistant condition have reached controversial conclusions. To further identify the possible impact of betatrophin, we measured the circulating betatrophin levels in newly diagnosed type 2 diabetes (T2DM) patients, and in subjects with both impaired glucose tolerance (IGT) and normal glucose tolerance (NGT) and investigated the relationship between serum betatrophin and other clinical parameters in these patients with different glucose tolerance statuses. Methods A total of 460 permanent residents of the Fengxian District, aged 40-60 years, were enrolled. Based on the results of a 75 g oral glucose tolerance test, we selected newly diagnosed T2DM (n = 50) patients and subjects with IGT (n = 51) and NGT (n = 50) according to their age, gender and body mass index (18-28 kg/m(2)). Anthropometric parameters, glycosylated haemoglobin, blood lipids and fasting insulin were measured. Serum betatrophin concentrations were determined via ELISA. Results Serum betatrophin levels in T2DM patients were increased significantly compared with IGT and NGT groups, and decreased in subjects with better islet beta cell function. Serum betatrophin was positively correlated with triglyceride, 2-hour postprandial glucose, alanine aminotransferase and aspartate transaminase after adjusting for age, sex and body mass index in all subjects. Multiple regression analysis showed that 2-hour postprandial glucose was independently associated with serum betatrophin significantly. Conclusions Circulating betatrophin is increased in newly-diagnosed T2DM patients and positively correlated with the triglycerides and postprandial glucose levels. The results suggest that betatrophin may participate in glucose and triglycerides metabolism.	[Gao, Ting; Chen, Peihong; Jin, Hua; Yang, Lili; Xie, Xinmiao; Yang, Meili; Yu, Xuemei] South Dist Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Fengxian Cent Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Jin, Kairui] Fudan Univ, Shanghai Med Coll, Dept Clin Med, Shanghai 200433, Peoples R China; [Hu, Cheng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Shanghai Diabet Inst,Shanghai Key Lab Diabet Mell, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Yu, XM (corresponding author), South Dist Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Fengxian Cent Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.	xuemeiyu12@163.com	Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386	Shanghai Committee of Science and Technology, China [134119b2500]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This work was funded by grants from the Shanghai Committee of Science and Technology (134119b2500), China.	Bagust A, 2003, QJM-INT J MED, V96, P281, DOI 10.1093/qjmed/hcg040; Espes D, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/323407; Espes D, 2014, DIABETOLOGIA, V57, P50, DOI 10.1007/s00125-013-3071-1; Fenzl A, 2014, DIABETOLOGIA, V57, P1204, DOI 10.1007/s00125-014-3208-x; Fu ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05013; Gomez-Ambrosi J, 2014, J CLIN ENDOCR METAB, V99, pE2004, DOI 10.1210/jc.2014-1568; Guo KF, 2015, OBESITY, V23, P793, DOI 10.1002/oby.21038; Gusarova V, 2014, CELL, V159, P691, DOI 10.1016/j.cell.2014.09.027; Hu H, 2014, DIABETES CARE, V37, P2718, DOI 10.2337/dc14-0602; Jiao Y, 2014, DIABETES, V63, P1283, DOI 10.2337/db13-1435; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Sanchis-Gomar F, 2014, ADIPOCYTE, V3, P67, DOI 10.4161/adip.27370; Stolar MW, 2008, J MANAGE CARE PHARM, V14, pS2; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Xie XM, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0019-2; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yi P, 2014, CELL, V159, P467, DOI 10.1016/j.cell.2014.09.028; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008; Zhang R, 2013, BIOCHEM BIOPH RES CO, V432, P401, DOI 10.1016/j.bbrc.2013.01.129; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	21	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133640	10.1371/journal.pone.0133640	http://dx.doi.org/10.1371/journal.pone.0133640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247824	gold, Green Published, Green Submitted			2022-12-26	WOS:000359062300017
J	Gerke, C; Colucci, AM; Giannelli, C; Sanzone, S; Vitali, CG; Sollai, L; Rossi, O; Martin, LB; Auerbach, J; Di Cioccio, V; Saul, A				Gerke, Christiane; Colucci, Anna Maria; Giannelli, Carlo; Sanzone, Silvia; Vitali, Claudia Giorgina; Sollai, Luigi; Rossi, Omar; Martin, Laura B.; Auerbach, Jochen; Di Cioccio, Vito; Saul, Allan			Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; GLOBAL ENTERIC MULTICENTER; ESCHERICHIA-COLI; DISEASE; BURDEN; PROTECTION; VIRULENCE; COUNTRIES; ACYLATION; CHILDREN	Recently, we developed a high yield production process for outer membrane particles from genetically modified bacteria, called Generalized Modules of Membrane Antigens (GMMA), and the corresponding simple two step filtration purification, enabling economic manufacture of these particles for use as vaccines. Using a Shigella sonnei strain that was genetically modified to produce penta-acylated lipopolysaccharide (LPS) with reduced endotoxicity and to maintain the virulence plasmid encoding for the immunodominant O antigen component of the LPS, scale up of the process to GMP pilot scale was straightforward and gave high yields of GMMA with required purity and consistent results. GMMA were formulated with Alhydrogel and were highly immunogenic in mice and rabbits. In mice, a single immunization containing 29 ng protein and 1.75 ng of O antigen elicited substantial anti-LPS antibody levels. As GMMA contain LPS and lipoproteins, assessing potential reactogenicity was a key aspect of vaccine development. In an in vitro monocyte activation test, GMMA from the production strain showed a 600-fold lower stimulatory activity than GMMA with unmodified LPS. Two in vivo tests confirmed the low potential for reactogenicity. We established a modified rabbit pyrogenicity test based on the European Pharmacopoeia pyrogens method but using intramuscular administration of the full human dose (100 mu g of protein). The vaccine elicited an average temperature rise of 0.5 degrees C within four hours after administration, which was considered acceptable and showed that the test is able to detect a pyrogenic response. Furthermore, a repeat dose toxicology study in rabbits using intramuscular (100 mu g/dose), intranasal (80 mu g/dose), and intradermal (10 mu g/dose) administration routes showed good tolerability of the vaccine by all routes and supported its suitability for use in humans. The S. sonnei GMMA vaccine is now in Phase 1 dose-escalation clinical trials.	[Gerke, Christiane; Colucci, Anna Maria; Giannelli, Carlo; Sanzone, Silvia; Sollai, Luigi; Rossi, Omar; Martin, Laura B.; Auerbach, Jochen; Di Cioccio, Vito; Saul, Allan] Sclavo Behring Vaccines Inst Global Hlth Srl, Siena, Italy; [Vitali, Claudia Giorgina] Novartis Vaccines & Diagnost Srl, Siena, Italy	Novartis	Gerke, C (corresponding author), Sclavo Behring Vaccines Inst Global Hlth Srl, Siena, Italy.	gerkechris@gmail.com	Rossi, Omar/AAT-6743-2020; Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; Gerke, Christiane/0000-0001-9446-8031	Novartis; European Union [261472]	Novartis(Novartis); European Union(European Commission)	This work was supported by Novartis and by the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement 261472 'STOPENTERICS'. During the course of the study, CGe, AMC, CGi, SS, LS, LBM, JA, VDC, and AS were employed by Novartis Vaccines Institute for Global Health S.r.l. (now part of the GSK family and called Sclavo Behring Vaccines Institute for Global Health). CGV was employed by Novartis Vaccines and Diagnostics S.r.l., (now a GSK company). Novartis provided support in the form of salaries for authors CGe, AMC, CGi, SS, LS, LBM, JA, VDC, AS and CGV but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section. The European Commission had no role in these activities.	[Anonymous], 2013, EUROPEAN PHARMACOPOE, V8th; Ashkenazi Shai, 2013, Ther Adv Vaccines, V1, P113, DOI 10.1177/2051013613500428; Chang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052515; Claassen I, 1996, VACCINE, V14, P1001, DOI 10.1016/0264-410X(96)00020-5; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; COHEN D, 1989, J CLIN MICROBIOL, V27, P162, DOI 10.1128/JCM.27.1.162-167.1989; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Cohen D, 1997, LANCET, V349, P155, DOI 10.1016/S0140-6736(96)06255-1; DUPONT HL, 1972, J INFECT DIS, V125, P12, DOI 10.1093/infdis/125.1.12; Ekdahl L, 2005, J INFECTION, V51, P222, DOI 10.1016/j.jinf.2005.02.002; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; FORMAL SB, 1966, J BACTERIOL, V92, P17, DOI 10.1128/JB.92.1.17-22.1966; GREISMAN SE, 1969, P SOC EXP BIOL MED, V131, P1154, DOI 10.3181/00379727-131-34059; Gu B, 2013, J BIOMED RES, V27, P103, DOI 10.7555/JBR.27.20120125; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010; Jiang Y, 2005, PLASMID, V54, P149, DOI 10.1016/j.plasmid.2005.03.002; Kaminski RW, 2009, EXPERT REV VACCINES, V8, P1693, DOI 10.1586/ERV.09.127; Koeberling O, 2014, VACCINE, V32, P2688, DOI 10.1016/j.vaccine.2014.03.068; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Martinez-Becerra FJ, 2012, INFECT IMMUN, V80, P1222, DOI 10.1128/IAI.06174-11; Micoli F, 2013, ANAL BIOCHEM, V434, P136, DOI 10.1016/j.ab.2012.10.038; Micoli F, 2011, VACCINE, V29, P712, DOI 10.1016/j.vaccine.2010.11.022; Moscardo Elena, 2007, Journal of Pharmacological and Toxicological Methods, V56, P239, DOI 10.1016/j.vascn.2007.03.007; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050; Prunier AL, 2007, MICROBIOL-SGM, V153, P2363, DOI 10.1099/mic.0.2007/006916-0; Robbins JB, 2009, P NATL ACAD SCI USA, V106, P7974, DOI 10.1073/pnas.0900891106; Rossi O, 2014, MOL BIOTECH IN PRESS; Rossi O, 2014, J BIOL CHEM, V289, P24922, DOI 10.1074/jbc.M114.566570; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Scorza FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035616; Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09; Venkatesan MM, 2006, EXPERT REV VACCINES, V5, P669, DOI 10.1586/14760584.5.5.669; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Zhang WL, 2011, J ANTIMICROB CHEMOTH, V66, P2527, DOI 10.1093/jac/dkr341	43	85	88	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134478	10.1371/journal.pone.0134478	http://dx.doi.org/10.1371/journal.pone.0134478			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248044	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300038
J	Yeh, CF; Liu, TP; Cheng, CW; Chang, SC; Lee, MH; Lu, JJ				Yeh, Chun-Fu; Liu, Tsui-Ping; Cheng, Chun-Wen; Chang, Shih-Cheng; Lee, Ming-Hsun; Lu, Jang-Jih			Molecular Characteristics of Disease-Causing and Commensal Staphylococcus lugdunensis Isolates from 2003 to 2013 at a Tertiary Hospital in Taiwan	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; CLINICAL SPECIMENS; AUREUS; AGR; IDENTIFICATION; STRAINS; SUSCEPTIBILITY; EPIDEMIOLOGY; INFECTIONS; BACTEREMIA	Objectives Staphylococcus lugdunensis can cause community-and healthcare-associated infections. This study investigated the molecular characteristics of S. lugdunensis isolates collected at our hospital and compared the characteristics of the infectious and commensal isolates. Methods We collected the S. lugdunensis isolates between 2003 and 2013. The antimicrobial resistance test, SCCmec typing, accessory gene regulator (agr) typing, pulsed-field gel electrophoresis (PFGE), and delta-like hemolysin activity were performed. Results In total, 118 S. lugdunensis isolates were collected, of which 67 (56.8%) were classified into the infection group and 51 (43.2%) into the commensal group. The oxacillin resistance rate was 36.4%. The most common SCCmec types were SCCmec types V (51.4%) and II (32.6%). In total, 34 pulsotypes were identified. The PFGE typing revealed five clones (pulsotypes A, J, M, N, and P) at our hospital. Pulsotypes A and N caused the spread of high oxacillin resistance. In total, 10.2% (12 of 118) of the isolates lacked d-like hemolysin activity. Compared with the infection group, the commensal group showed a higher percentage of multiple drug resistance and carried a higher percentage of SCCmec type II (11 of 22, 50% and 3 of 21, 14.3%) and a lower percentage of SCCmec type V (8 of 22, 36.4% and 14 of 21, 66.7%). The commensal group (27 PFGE types) showed higher genetic diversity than did the infection group (20 PFGE types). No difference was observed in the distribution of the five main pulsotypes, agr typing, and the presence of delta-like hemolysin activity between the two groups. Conclusions Five main clones were identified at our hospital. The commensal group showed higher genetic diversity, had a higher percentage of multidrug resistance, and carried a higher percentage of SCCmec type II and a lower percentage of SCCmec type V than did the infection group.	[Yeh, Chun-Fu; Cheng, Chun-Wen; Lee, Ming-Hsun] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Div Infect Dis,Dept Internal Med, Taoyuan, Taiwan; [Yeh, Chun-Fu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Liu, Tsui-Ping; Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Mem Hosp Linkou, Dept Lab Med, Taoyuan, Taiwan; [Chang, Shih-Cheng; Lu, Jang-Jih] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lu, JJ (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Div Infect Dis,Dept Internal Med, Taoyuan, Taiwan.	janglu45@gmail.com		Cheng, Chun Wen/0000-0001-9891-2953	Chang Gung Memorial Hospital [CMRPG3D1771]; National Science Council of Republic of China (Taiwan), Taiwan [NSC-101-2320-B-182A-002-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Republic of China (Taiwan), Taiwan	This work was supported by grants from Chang Gung Memorial Hospital (CMRPG3D1771) (CF, Yeh) and the National Science Council of Republic of China (Taiwan) (NSC-101-2320-B-182A-002-MY3) (JJ Lu), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Choi SH, 2010, J CLIN MICROBIOL, V48, P3346, DOI 10.1128/JCM.00609-10; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; David MD, 2006, J HOSP INFECT, V64, P244, DOI 10.1016/j.jhin.2006.06.022; Donvito B, 1997, FEMS MICROBIOL LETT, V151, P139, DOI 10.1016/S0378-1097(97)00149-3; Donvito B, 1997, INFECT IMMUN, V65, P95, DOI 10.1128/IAI.65.1.95-100.1997; Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002; Fadel HJ, 2011, J CLIN MICROBIOL, V49, P1697, DOI 10.1128/JCM.02058-10; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; HEBERT GA, 1990, J CLIN MICROBIOL, V28, P2425; Hellbacher C, 2006, CLIN MICROBIOL INFEC, V12, P43, DOI 10.1111/j.1469-0691.2005.01296.x; HERCHLINE TE, 1991, J CLIN MICROBIOL, V29, P419, DOI 10.1128/JCM.29.3.419-421.1991; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kleiner E, 2010, CLIN INFECT DIS, V51, P801, DOI 10.1086/656280; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Lin JF, 2015, J MICROBIOL IMMUNOL, V48, P406, DOI 10.1016/j.jmii.2013.12.010; Liu CJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-168; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Morrison MA, 2006, J HOSP INFECT, V62, P241, DOI 10.1016/j.jhin.2005.07.011; Noguchi N, 2010, DIAGN MICR INFEC DIS, V66, P120, DOI 10.1016/j.diagmicrobio.2009.03.028; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shin JH, 2007, JPN J INFECT DIS, V60, P312; Souvenir D, 1998, J CLIN MICROBIOL, V36, P1923, DOI 10.1128/JCM.36.7.1923-1926.1998; Szabados F, 2010, J MED MICROBIOL, V59, P787, DOI 10.1099/jmm.0.016733-0; Tseng SP, 2015, J MICROBIOL IMMUNOL, V48, P397, DOI 10.1016/j.jmii.2013.11.006; VANDENESCH F, 1993, CLIN INFECT DIS, V17, P871, DOI 10.1093/clinids/17.5.871; Widerstrom M, 2006, J HOSP INFECT, V64, P177, DOI 10.1016/j.jhin.2006.06.013; Wu AB, 2011, J CLIN MICROBIOL, V49, P3015, DOI 10.1128/JCM.01138-11; Yen TY, 2016, J MICROBIOL IMMUNOL, V49, P885, DOI 10.1016/j.jmii.2014.11.018; Zinkernagel AS, 2008, INFECTION, V36, P314, DOI 10.1007/s15010-008-7287-9	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134859	10.1371/journal.pone.0134859	http://dx.doi.org/10.1371/journal.pone.0134859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248332	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300071
J	Zhang, HB; Ehrenkaufer, GM; Manna, D; Hall, N; Singh, U				Zhang, Hanbang; Ehrenkaufer, Gretchen M.; Manna, Dipak; Hall, Neil; Singh, Upinder			High Throughput Sequencing of Entamoeba 27nt Small RNA Population Reveals Role in Permanent Gene Silencing But No Effect on Regulating Gene Expression Changes during Stage Conversion, Oxidative, or Heat Shock Stress	PLOS ONE			English	Article							ANTISENSE SMALL RNAS; MAMMALIAN-CELLS; HISTOLYTICA; INTERFERENCE; ENCYSTATION; MICRORNA; INVADENS; DIFFERENTIATION; TRANSCRIPTOME; PARASITES	The human parasite Entamoeba histolytica has an active RNA interference (RNAi) pathway with an extensive repertoire of 27nt small RNAs that silence genes. However the role of this pathway in regulating amebic biology remains unknown. In this study, we address whether silencing via 27nt small RNAs may be a mechanism for controlling gene expression changes during conversion between the trophozoite and cyst stages of the parasite. We sequenced small RNA libraries generated from trophozoites, early cysts, mature cysts, and excysting cells and mapped them to the E. invadens genome. Our results show that, as in E. histolytica, small RNAs in E. invadens are largely similar to 27nt in length, have an unusual 5'-poly-phosphate structure and mediate gene silencing. However, when comparing the libraries from each developmental time-point we found few changes in the composition of the small RNA populations. Furthermore, genes targeted by small RNAs were permanently silenced with no changes in transcript abundance during development. Thus, the E. invadens 27nt small RNA population does not mediate gene expression changes during development. In order to assess the generalizability of our observations, we examined whether small RNAs may be regulating gene expression changes during stress response in E. histolytica. Comparison of the 27nt small RNA populations from E. histolytica trophozoites from basal conditions, or after heat shock or exposure to oxidative stress showed few differences. Similar to data in E. invadens development, genes targeted by small RNAs were consistently silenced and did not change expression under tested stress conditions. Thus, the biological roles of the 27nt small RNA population in Entamoeba remain elusive. However, as the first characterization of the RNAi pathway in E. invadens these data serve as a useful resource for the study of Entamoeba development and open the door to the development of RNAi-based gene silencing tools in E. invadens.	[Zhang, Hanbang; Ehrenkaufer, Gretchen M.; Manna, Dipak; Singh, Upinder] Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA; [Hall, Neil] Univ Liverpool, Ctr Genom Res, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Singh, Upinder] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA USA	Stanford University; University of Liverpool; Stanford University	Singh, U (corresponding author), Stanford Univ, Sch Med, Dept Internal Med, Div Infect Dis, Stanford, CA 94305 USA.	usingh@stanford.edu	Manna, Dipak/AAH-7306-2019	Hall, Neil/0000-0003-2808-0009; Ehrenkaufer, Gretchen/0000-0002-5009-1399; Singh, Upinder/0000-0003-0630-0306	NIH [AI094887, NIH AI085178]; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: researchfish; Medical Research Council [MR/K002279/1] Funding Source: researchfish; BBSRC [BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MR/K002279/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085178, R21AI094887] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by NIH (Grants AI094887 and NIH AI085178 to US) and the sequencing was done by NH at the Centre for Genomic Research, University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ali IKM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001643; [Anonymous], 1997, B WORLD HEALTH ORGAN, V75, P291; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Bracha Rivka, 2006, PLoS Pathog, V2, pe48, DOI 10.1371/journal.ppat.0020048; Bruchhaus I, 2002, MOL MICROBIOL, V44, P1063, DOI 10.1046/j.1365-2958.2002.02941.x; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; De Cadiz AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074840; Djikeng A, 2001, RNA, V7, P1522; Ehrenkaufer GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r77; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; Hackney JA, 2007, NUCLEIC ACIDS RES, V35, P2141, DOI 10.1093/nar/gkm028; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huguenin M, 2010, PARASITOLOGY, V137, P619, DOI 10.1017/S0031182009991363; Jeelani G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037740; Kawasaki H, 2005, CELL CYCLE, V4, P442, DOI 10.4161/cc.4.3.1520; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lorenzi Hernan, 2008, BMC Genomics, V9, P595, DOI 10.1186/1471-2164-9-595; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mitre BN, 2010, INT J PARASITOL, V40, P751, DOI 10.1016/j.ijpara.2009.11.012; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Ojha S, 2014, MOL BIOCHEM PARASIT, V195, P6, DOI 10.1016/j.molbiopara.2014.05.003; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sonda S, 2010, MOL MICROBIOL, V76, P48, DOI 10.1111/j.1365-2958.2010.07062.x; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Weedall GD, 2011, RES MICROBIOL, V162, P637, DOI 10.1016/j.resmic.2011.01.007; Zhang HB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-53; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	46	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0134481	10.1371/journal.pone.0134481	http://dx.doi.org/10.1371/journal.pone.0134481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248204	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300039
J	Bentchikou, E; Chagneau, C; Long, E; Matelot, M; Allemand, JF; Michel, B				Bentchikou, Esma; Chagneau, Carine; Long, Emilie; Matelot, Melody; Allemand, Jean-Francois; Michel, Benedicte			Are the SSB-Interacting Proteins RecO, RecG, PriA and the DnaB-Interacting Protein Rep Bound to Progressing Replication Forks in Escherichia coli?	PLOS ONE			English	Article							E. COLI; BINDING PROTEIN; LIVE CELLS; MOLECULE; HELICASES; CLAMP; CHROMOSOME; MACHINERY; MUTATIONS; REPLISOME	In all organisms several enzymes that are needed upon replication impediment are targeted to replication forks by interaction with a replication protein. In most cases these proteins interact with the polymerase clamp or with single-stranded DNA binding proteins (SSB). In Escherichia coli an accessory replicative helicase was also shown to interact with the DnaB replicative helicase. Here we have used cytological observation of Venus fluorescent fusion proteins expressed from their endogenous loci in live E. coli cells to determine whether DNA repair and replication restart proteins that interact with a replication protein travel with replication forks. A custom-made microscope that detects active replisome molecules provided that they are present in at least three copies was used. Neither the recombination proteins RecO and RecG, nor the replication accessory helicase Rep are detected specifically in replicating cells in our assay, indicating that either they are not present at progressing replication forks or they are present in less than three copies. The Venus-PriA fusion protein formed foci even in the absence of replication forks, which prevented us from reaching a conclusion.	[Bentchikou, Esma; Chagneau, Carine; Long, Emilie; Matelot, Melody; Michel, Benedicte] Univ Paris 11, Inst Integrat Biol Cell I2BC, CEA, CNRS, Gif Sur Yvette, France; [Allemand, Jean-Francois] Univ Paris 06, Lab Phys Stat, Dept Phys, Ecole Normale Super,UMR CNRS 8550, Paris, France; [Allemand, Jean-Francois] Univ Paris Diderot, Paris, France; [Allemand, Jean-Francois] Ecole Normale Super, IBENS, Dept Biol, UMR CNRS 8542, F-75231 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Michel, B (corresponding author), Univ Paris 11, Inst Integrat Biol Cell I2BC, CEA, CNRS, Gif Sur Yvette, France.	benedicte.michel@i2bc.paris-saclay.fr		Allemand, Jean - Francois/0000-0001-7496-0977; LONG, Emilie/0000-0003-0922-381X	Agence Nationale de la Recherche [ANR 11 BSV5 006 01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, Grant ANR 11 BSV5 006 01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Cattoni DI, 2012, CURR OPIN MICROBIOL, V15, P758, DOI 10.1016/j.mib.2012.10.007; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; CHURCHWARD G, 1984, GENE, V31, P165, DOI 10.1016/0378-1119(84)90207-5; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Mawer JSP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004485; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Moolman MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6820; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Ozaki S, 2013, CELL REP, V4, P985, DOI 10.1016/j.celrep.2013.07.040; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Rudolph CJ, 2009, MOL MICROBIOL, V73, P352, DOI 10.1111/j.1365-2958.2009.06773.x; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6503; Sandler SJ, 1996, GENETICS, V143, P5; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Su XC, 2014, BIOCHEMISTRY-US, V53, P1925, DOI 10.1021/bi5001867; Taucher-Scholz G, 1983, MECH DNA REPLICATION, P65; Uphoff S, 2013, P NATL ACAD SCI USA, V110, P8063, DOI 10.1073/pnas.1301804110; Upton AL, 2014, NUCLEIC ACIDS RES, V42, P5702, DOI 10.1093/nar/gku228; UZEST M, 1995, MOL MICROBIOL, V17, P1177, DOI 10.1111/j.1365-2958.1995.mmi_17061177.x; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	42	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134892	10.1371/journal.pone.0134892	http://dx.doi.org/10.1371/journal.pone.0134892			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244508	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400123
J	Delebinski, CI; Twardziok, M; Kleinsimon, S; Hoff, F; Mulsow, K; Rolff, J; Jager, S; Eggert, A; Seifert, G				Delebinski, Catharina I.; Twardziok, Monika; Kleinsimon, Susann; Hoff, Florian; Mulsow, Katharina; Rolff, Jana; Jaeger, Sebastian; Eggert, Angelika; Seifert, Georg			A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; MYELOID-LEUKEMIA CELLS; CDDO-ME; BETULINIC ACID; OLEANOLIC ACID; INDUCED APOPTOSIS; GAMMA-CYCLODEXTRIN; MISTLETOE EXTRACT; HUMAN NEUTROPHILS; DOWN-REGULATION	Aqueous Viscum album L. extracts are widely used in complementary cancer medicine. Hydrophobic triterpene acids also possess anti-cancer properties, but due to their low solubility they do not occur in significant amounts in aqueous extracts. Using cyclodextrins we solubilised mistletoe triterpenes (mainly oleanolic acid) and investigated the effect of a mistletoe whole plant extract on human acute myeloid leukaemia cells in vitro, ex vivo and in vivo. Single Viscum album L. extracts containing only solubilised triterpene acids (TT) or lectins (viscum) inhibited cell proliferation and induced apoptosis in a dose-dependent manner in vitro and ex vivo. The combination of viscum and TT extracts (viscumTT) enhanced the induction of apoptosis synergistically. The experiments demonstrated that all three extracts are able to induce apoptosis via caspase-8 and -9 dependent pathways with downregulation of members of the inhibitor of apoptosis and Bcl-2 families of proteins. Finally, the acute myeloid leukaemia mouse model experiment confirmed the therapeutic effectiveness of viscumTT-treatment resulting in significant tumour weight reduction, comparable to the effect in cytarabine-treated mice. These results suggest that the combination viscumTT may have a potential therapeutic value for the treatment AML.	[Delebinski, Catharina I.; Twardziok, Monika; Kleinsimon, Susann; Eggert, Angelika; Seifert, Georg] Charite, Dept Paediat Oncol Haematol, Otto Heubner Ctr Paediat & Adolescent Med OHC, D-13353 Berlin, Germany; [Hoff, Florian] Univ Marburg, Dept Cell Biol & Cell Pathol, Marburg, Germany; [Mulsow, Katharina] Free Univ Berlin, Inst Pharm, Berlin, Germany; [Rolff, Jana] EPO GmbH, Berlin, Germany; [Jaeger, Sebastian] Birken AG, Niefern Oeschelbronn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; Free University of Berlin	Seifert, G (corresponding author), Charite, Dept Paediat Oncol Haematol, Otto Heubner Ctr Paediat & Adolescent Med OHC, D-13353 Berlin, Germany.	georg.seifert@charite.de	Eggert, Angelika/AAE-6907-2022	Eggert, Angelika/0000-0003-3476-8184; Delebinski, Catharina/0000-0003-2527-4385	Software AG-Stiftung; EPO GmbH; Birken AG	Software AG-Stiftung; EPO GmbH; Birken AG	This work was supported by the Software AG-Stiftung. EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad R, 2010, MOL CANCER RES, V8, P986, DOI 10.1158/1541-7786.MCR-10-0154; Amer B, 2013, PHARM BIOL, V51, P981, DOI 10.3109/13880209.2013.773520; Assefa H, 1999, BIOORG MED CHEM LETT, V9, P1889, DOI 10.1016/S0960-894X(99)00314-5; Bantel H, 1999, CANCER RES, V59, P2083; Baracchini C, 2006, J CEREBR BLOOD F MET, V26, P899, DOI 10.1038/sj.jcbfm.9600260; BENE MC, 1995, LEUKEMIA, V9, P1783; Bi Y, 2013, MED CHEM, V9, P920, DOI 10.2174/1573406411309070005; Braun JM, 2002, ANTICANCER RES, V22, P4187; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Bussing A, 1999, CYTOMETRY, V37, P133; Bussing A, 1998, CANCER LETT, V130, P57, DOI 10.1016/S0304-3835(98)00124-4; Bussing A, 1996, CANCER LETT, V99, P59, DOI 10.1016/0304-3835(95)04038-2; Bussing A., 2000, MISTLETOE GENUS VISC, P123; Cho HJ, 2014, EUR J PEDIATR, V173, P823, DOI 10.1007/s00431-014-2283-9; Deeb D, 2013, MOLECULES, V18, P3250, DOI 10.3390/molecules18033250; Deeb D, 2009, PROSTATE, V69, P851, DOI 10.1002/pros.20937; Delebinski CI, 2012, CELL PROLIF; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Fulda S, 1999, INT J CANCER, V82, P435, DOI 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Gao XH, 2013, ANTICANCER RES, V33, P215; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Gheorgheosu D, 2014, ANTI-CANCER AGENT ME, V14, P936, DOI 10.2174/1871520614666140223192148; Guo GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072079; Guo MQ, 2003, J MASS SPECTROM, V38, P723, DOI 10.1002/jms.486; Hajto T, 2009, EVIDBASED COMPLEMENT; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hua Y, 2009, INVESTIGATIONAL NEW; Huang YY, 2008, J SEP SCI, V31, P283, DOI 10.1002/jssc.200700430; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Kim HK, 2007, J TRACE ELEM MED BIO, V21, P204, DOI 10.1016/j.jtemb.2007.03.001; Kim MS, 2000, GEN PHARMACOL-VASC S, V34, P349, DOI 10.1016/S0306-3623(01)00072-6; Klingbeil MFG, 2013, ONCOL REP, V30, P2316, DOI 10.3892/or.2013.2732; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Konopleva M, 2005, LEUKEMIA, V19, P1350, DOI 10.1038/sj.leu.2403828; Konopleva M, 2004, MOL CANCER THER, V3, P1249; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Li R, 2009, AAPS PHARMSCITECH, V10, P1137, DOI 10.1208/s12249-009-9317-z; Li W, 2013, ARCH PHARM RES, V36, P768, DOI 10.1007/s12272-013-0042-5; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Lucio KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028596; Ma Hong, 2012, Zhonghua Nan Ke Xue, V18, P783; MacEwen EG, 2004, J CELL BIOCHEM, V92, P77, DOI 10.1002/jcb.20046; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; MONTGOMERY C A, 1990, Cancer Bulletin (Houston), V42, P230; Nhiem NX, 2013, J NAT PROD, V76, P495, DOI 10.1021/np300490v; Orhan DD, 2006, Z NATURFORSCH C, V61, P26; Ovesna Z, 2004, NEOPLASMA, V51, P327; Pan SX, 2014, ELECTRON J QUAL THEO, P1; Park HJ, 2010, BIOCHEM BIOPH RES CO, V396, P721, DOI 10.1016/j.bbrc.2010.04.169; Park YK, 2012, ONCOL REP, V28, P2227, DOI 10.3892/or.2012.2026; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; Ryu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-187; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Samudio I, 2008, MOL CANCER THER, V7, P1130, DOI 10.1158/1535-7163.MCT-07-0553; Schad F, 2014, INTEGR CANCER THER, V13, P332, DOI 10.1177/1534735413513637; Schaeffer P, 2006, EUR J PHARMACOL, V529, P172, DOI 10.1016/j.ejphar.2005.11.005; Schaller G, 1998, PLANTA MED, V64, P677, DOI 10.1055/s-2006-957553; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; Simon MM, 2013, HUM EXP TOXICOL, V32, P1097, DOI 10.1177/0960327112468910; Society AC, 2014, AMERICAN CANCER SOCI; Soica C, 2014, INT J MOL SCI, V15, P8235, DOI 10.3390/ijms15058235; Soica C, 2014, MOLECULES, V19, P4924, DOI 10.3390/molecules19044924; Struh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062168; Struh CM, 2012, PHYTOTHERRES; Tabiasco J, 2002, EUR J BIOCHEM, V269, P2591, DOI 10.1046/j.1432-1033.2002.02932.x; Urech K, 2005, J PHARM PHARMACOL, V57, P101, DOI 10.1211/0022357055083; Urech K, 2006, ARZNEIMITTEL-FORSCH, V56, P428; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; Wang J, 2013, APOPTOSIS, V18, P751, DOI 10.1007/s10495-013-0820-z; Webb RJ, 1963, ENZYME AND METABOLIC, V1; Wei JT, 2012, ONCOL REP, V28, P1339, DOI 10.3892/or.2012.1921; Xiao Yi-Jun, 2008, Zhongguo Zhong Yao Za Zhi, V33, P427; Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050902; Yue P, 2006, CANCER BIOL THER, V5, P492, DOI 10.4161/cbt.5.5.2565; Zhang WS, 2014, J CANCER RES THER, V10, P14, DOI 10.4103/0973-1482.139746; Zou W, 2007, CANCER BIOL THER, V6, P1614, DOI 10.4161/cbt.6.10.4763	86	32	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133892	10.1371/journal.pone.0133892	http://dx.doi.org/10.1371/journal.pone.0133892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244918	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400058
J	Leivers, S; Simmons, LW; Rhodes, G				Leivers, Samantha; Simmons, Leigh W.; Rhodes, Gillian			Men's Sexual Faithfulness Judgments May Contain a Kernel of Truth	PLOS ONE			English	Article							EMOTIONAL EXPRESSIONS; TRUSTWORTHINESS; ATTRACTIVENESS; SOCIOSEXUALITY; BEHAVIOR; FACES; RECOGNITION; PREFERENCES; INFIDELITY; CONSENSUS	Mechanisms enabling men to identify women likely to engage in extra-pair copulations (EPCs) would be advantageous in avoiding cuckoldry. Men's judgments of female sexual faithfulness often show high consensus, but accuracy appears poor. We examined whether accuracy of these judgments made to images of women could be improved through i) employing a forced choice task, in which men were asked to select the more faithful of two women and/or ii) providing men with full person images. In Experiment 1, men rated 34 women, for whom we had self-reported EPC behavior, on faithfulness, trustworthiness or attractiveness from either face or full person photographs. They then completed a forced choice task, selecting the more faithful of two woman from 17 pairs of images, each containing one woman who had reported no EPCs and one who had reported two or more EPCs. Men were unable to rate faithfulness with any accuracy, replicating previous findings. However, when asked to choose the more faithful of two women, they performed significantly above chance, although the ability to judge faithfulness at above-chance levels did not generalize to all pairs of women. Although there was no significant difference in accuracy for face and full person image pairs, only judgments from faces were significantly above chance. In Experiment 2, we showed that this accuracy for faces was repeatable in a new sample of men. We also showed that individual variation in accuracy was unrelated to variation in preferences for faithfulness in a long-term partner. Overall, these results show that men's judgments of faithfulness made from faces of unfamiliar women may contain a kernel of truth.	[Leivers, Samantha; Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Crawley 6009, Australia; [Leivers, Samantha; Simmons, Leigh W.] Univ Western Australia, Sch Anim Biol, Crawley 6009, Australia; [Leivers, Samantha; Simmons, Leigh W.; Rhodes, Gillian] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Its Disorders, Crawley 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Leivers, S (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Crawley 6009, Australia.	sleivers@grs.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474; Rhodes, Gillian/0000-0002-3631-8518	ARC Centre of Excellence in Cognition and its Disorders [CE110001021]; ARC [DP110104594, DP0877379]; ARC Discovery Outstanding Researcher Award [DP130102300]	ARC Centre of Excellence in Cognition and its Disorders(Australian Research Council); ARC(Australian Research Council); ARC Discovery Outstanding Researcher Award(Australian Research Council)	This research was supported by the ARC Centre of Excellence in Cognition and its Disorders (CE110001021) to GR, ARC Professorial Fellowships (DP110104594) to LWS and (DP0877379) to GR. ARC Discovery Outstanding Researcher Award (DP130102300) to GR.	Anderson KG, 2006, CURR ANTHROPOL, V47, P513, DOI 10.1086/504167; Andersson Malte, 1994; Andrews PW, 2008, HUM NATURE-INT BIOS, V19, P347, DOI 10.1007/s12110-008-9051-3; Arnocky S, 2015, EVOL BEHAV SCI, V9, P186, DOI [10.1037/ebs0000021, DOI 10.1037/EBS0000021]; Blackman MC, 1998, J EXP SOC PSYCHOL, V34, P164, DOI 10.1006/jesp.1997.1347; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; Boothroyd LG, 2011, PERS INDIV DIFFER, V50, P422, DOI 10.1016/j.paid.2010.10.017; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buston PM, 2003, P NATL ACAD SCI USA, V100, P8805, DOI 10.1073/pnas.1533220100; Caulfield F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097644; DeBruine LM, 2013, BEHAV ECOL, V24, P591, DOI 10.1093/beheco/ars098; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P51, DOI 10.1007/s10508-010-9601-8; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Field A., 2013, DISCOVERING STAT USI; Geary DC, 2004, J SEX RES, V41, P27, DOI 10.1080/00224490409552211; Goetz AT, 2006, FEMALE INFIDELITY AND PATERNAL UNCERTAINTY: EVOLUTIONARY PERSPECTIVES ON MALE ANTI-CUCKOLDRY TACTICS, P82, DOI 10.1017/CBO9780511617812.005; GREENWALD AG, 1976, PSYCHOL BULL, V83, P314, DOI 10.1037/0033-2909.83.2.314; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Lee AJ, 2014, EVOL HUM BEHAV, V35, P193, DOI 10.1016/j.evolhumbehav.2014.01.003; Leppanen JM, 2004, PSYCHIAT RES, V128, P123, DOI 10.1016/j.psychres.2004.05.020; Mattingly BA, 2011, J SOC PSYCHOL, V151, P222, DOI 10.1080/00224540903536162; Moore MM, 2010, J SEX RES, V47, P171, DOI 10.1080/00224490903402520; Mueller U, 1997, BEHAV ECOL, V8, P569; O'Connor JJM, 2011, EVOL PSYCHOL-US, V9, P64, DOI 10.1177/147470491100900109; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; Peters M, 2007, ANIM BEHAV, V73, P937, DOI 10.1016/j.anbehav.2006.07.012; Regan P. C., 2000, J PSYCHOL HUMAN SEX, V12, P1, DOI DOI 10.1300/J056V12N03_01; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0908; Rule NO, 2013, J PERS SOC PSYCHOL, V104, P409, DOI 10.1037/a0031050; Said CP, 2009, EMOTION, V9, P260, DOI 10.1037/a0014681; Saxton TK, 2009, EVOL HUM BEHAV, V30, P398, DOI 10.1016/j.evolhumbehav.2009.06.004; Schmitt DP, 2001, J PERS SOC PSYCHOL, V80, P894, DOI 10.1037/0022-3514.80.6.894; Schutzwohl A, 2006, BIOL PSYCHOL, V71, P223, DOI 10.1016/j.biopsycho.2005.04.005; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; SEAL DW, 1994, SEX ROLES, V31, P1, DOI 10.1007/BF01560274; Shackelford TK, 1997, PERS SOC PSYCHOL B, V23, P1034, DOI 10.1177/01461672972310004; SIMPSON JA, 1992, J PERS, V60, P31, DOI 10.1111/j.1467-6494.1992.tb00264.x; Singh D, 2004, J SEX RES, V41, P43, DOI 10.1080/00224490409552212; Sunderani S, 2013, ARCH SEX BEHAV, V42, P533, DOI 10.1007/s10508-012-9974-y; Todorov A., 2011, OXFORD HDB FACE PERC, P631, DOI 10.1093/oxfordhb/9780199559053.013.0032; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Wilson RK, 2006, POLIT RES QUART, V59, P189, DOI 10.1177/106591290605900202; Wood D, 2009, J PERS SOC PSYCHOL, V96, P1226, DOI 10.1037/a0015300; Zaidel DW, 2003, LATERALITY, V8, P225, DOI 10.1080/13576500244000120; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zebrowitz L. A., 1997, READING FACES WINDOW; Zebrowitz LA, 1996, FDN STEREOTYPES STER	49	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134007	10.1371/journal.pone.0134007	http://dx.doi.org/10.1371/journal.pone.0134007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244776	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400063
J	Panzer, S; Mc Coy, MR; Hitzl, W; Piombino-Mascali, D; Jankauskas, R; Zink, AR; Augat, P				Panzer, Stephanie; Mc Coy, Mark R.; Hitzl, Wolfgang; Piombino-Mascali, Dario; Jankauskas, Rimantas; Zink, Albert R.; Augat, Peter			Checklist and Scoring System for the Assessment of Soft Tissue Preservation in CT Examinations of Human Mummies	PLOS ONE			English	Article							MULTIDETECTOR CT; HUMAN REMAINS; ANCIENT; ATHEROSCLEROSIS; PALEORADIOLOGY; QUALITY	The purpose of this study was to develop a checklist for standardized assessment of soft tissue preservation in human mummies based on whole-body computed tomography examinations, and to add a scoring system to facilitate quantitative comparison of mummies. Computed tomography examinations of 23 mummies from the Capuchin Catacombs of Palermo, Sicily (17 adults, 6 children; 17 anthropogenically and 6 naturally mummified) and 7 mummies from the crypt of the Dominican Church of the Holy Spirit of Vilnius, Lithuania (5 adults, 2 children; all naturally mummified) were used to develop the checklist following previously published guidelines. The scoring system was developed by assigning equal scores for checkpoints with equivalent quality. The checklist was evaluated by intra-and inter-observer reliability. The finalized checklist was applied to compare the groups of anthropogenically and naturally mummified bodies. The finalized checklist contains 97 checkpoints and was divided into two main categories, "A. Soft Tissues of Head and Musculoskeletal System" and "B. Organs and Organ Systems", each including various subcategories. The complete checklist had an intra-observer reliability of 98% and an inter-observer reliability of 93%. Statistical comparison revealed significantly higher values in anthropogenically compared to naturally mummified bodies for the total score and for three subcategories. In conclusion, the developed checklist allows for a standardized assessment and documentation of soft tissue preservation in whole-body computed tomography examinations of human mummies. The scoring system facilitates a quantitative comparison of the soft tissue preservation status between single mummies or mummy collections.	[Panzer, Stephanie] Trauma Ctr Murnau, Dept Radiol, Murnau, Germany; [Panzer, Stephanie; Augat, Peter] Trauma Ctr Murnau, Inst Biomech, Murnau, Germany; [Panzer, Stephanie; Augat, Peter] Paracelsus Med Univ, Salzburg, Austria; [Mc Coy, Mark R.] Paracelsus Med Univ, Div Neuroradiol, SALK,Christian Doppler Klin, Gemeinnutzige Salzburger Landeskliniken Betriebsg, Salzburg, Austria; [Hitzl, Wolfgang] Paracelsus Med Univ, Biostat, Res Off, Salzburg, Austria; [Piombino-Mascali, Dario; Jankauskas, Rimantas] Vilnius Univ, Dept Anat Histol & Anthropol, Fac Med, Vilnius, Lithuania; [Zink, Albert R.] EURAC Inst Mummies & Iceman, Bolzano, Italy	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Vilnius University; European Academy of Bozen-Bolzano	Panzer, S (corresponding author), Trauma Ctr Murnau, Dept Radiol, Murnau, Germany.	stephanie.panzer@bgu-murnau.de	Jankauskas, Rimantas/Q-7689-2017; Augat, Peter/A-2051-2011; Piombino-Mascali, Dario/ACG-0789-2022; Zink, Albert/P-4024-2015	Jankauskas, Rimantas/0000-0001-7611-2576; Augat, Peter/0000-0003-4805-2128; Zink, Albert/0000-0002-1461-747X; Hitzl, Wolfgang/0000-0002-7696-1479	Foundation Sudtiroler Sparkasse	Foundation Sudtiroler Sparkasse	For the Sicilian mummies: This study was supported by Dr. Dariusch Rafiy, 3W Production, Munich, Germany (http://www.3w-production.com) and the Foundation Sudtiroler Sparkasse (http://www.stiftungsparkasse.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (see also in: Panzer S, Piombino-Mascali D, Zink AR. Herniation pits in human mummies: A CT investigation in the Capuchin Catacombs of Palermo Sicily. PLOS ONE. 2012; 7(5): e36537.). For the Lithuanian mummies the authors have no support or funding to report.	Aufderheide A.C., 2003, SCI STUDY MUMMIES; Aufderheide AC, 2000, JAMA-J AM MED ASSOC, V284, P2571, DOI 10.1001/jama.284.20.2571; Aufderheide AC, 2000, THE OASIS PAPERS, V4, P137; Bichelmeyer B., 2003, CHECKLIST FORMATTING; Buikstra J., 2006, BIOARCHEOLOGY CONTEX; Cesarani F, 2003, AM J ROENTGENOL, V180, P597, DOI 10.2214/ajr.180.3.1800597; Chhem R.K., 2008, PALEORADIOLOGY IMAGI, DOI [10.1007/978-3-540-48833-0, DOI 10.1007/978-3-540-48833-0]; Gostner P, 2013, J ARCHAEOL SCI, V40, P1003, DOI 10.1016/j.jas.2012.10.011; Gostner P, 2011, J ARCHAEOL SCI, V38, P3425, DOI 10.1016/j.jas.2011.08.003; Haglund WD, 1996, METHOD THEORY FORENS; Hales B, 2008, INT J QUAL HEALTH C, V20, P22, DOI 10.1093/intqhc/mzm062; Hales BM, 2006, J CRIT CARE, V21, P231, DOI 10.1016/j.jcrc.2006.06.002; HARWOODNASH DCF, 1979, J COMPUT ASSIST TOMO, V3, P768; Hawass Z, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8268; Hoffman H, 2002, RADIOGRAPHICS, V22, P377, DOI 10.1148/radiographics.22.2.g02mr13377; HUBENER KH, 1981, FORTSCHR RONTG NEUEN, V135, P213; Jankauskas R., 2012, PALEOPATH NEWSL, V159, P12; Lynnerup N, 2007, YEARB PHYS ANTHROPOL, V50, P162, DOI 10.1002/ajpa.20728; Monsalve MV, 2008, AM J PHYS ANTHROPOL, V137, P348, DOI 10.1002/ajpa.20864; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; O'Brien JJ, 2009, INT J OSTEOARCHAEOL, V19, P90, DOI 10.1002/oa.967; Ohrstrom LM, 2015, SKELETAL RADIOL, V44, P811, DOI 10.1007/s00256-015-2103-y; Ohrstrom LM, 2013, RADIOGRAPHICS, V33, P291, DOI 10.1148/rg.331125711; Oh CS, 2011, ANN ANAT, V193, P544, DOI 10.1016/j.aanat.2011.02.005; Panzer S, 2013, ROFO-FORTSCHR RONTG, V185, P670, DOI 10.1055/s-0033-1335266; Panzer S, 2012, PLOS ONE, V7, DOI [10.1371/ journal. pone. 0036537, DOI 10.1371/J0URNAL.P0NE.0036537]; Panzer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089528; Panzer S, 2013, ANN ANAT, V195, P401, DOI 10.1016/j.aanat.2013.03.009; Panzer S, 2013, SKELETAL RADIOL, V42, P1527, DOI 10.1007/s00256-013-1696-2; Panzer S, 2010, RADIOGRAPHICS, V30, P1123, DOI 10.1148/rg.304095174; Piombino-Mascali D., 2010, MUMMIES WORLD DREAM, P357; Piombino-Mascali D, 2014, AM J HUM BIOL, V26, P676, DOI 10.1002/ajhb.22578; Piombino-Mascali Dario, 2014, Papers on Anthropology University of Tartu, V23, P118; Previgliano CH, 2003, AM J ROENTGENOL, V181, P1473, DOI 10.2214/ajr.181.6.1811473; Ruhli FJ, 2000, INT J OSTEOARCHAEOL, V10, P153; Ruhli FJ, 2004, CAN ASSOC RADIOL J, V55, P218; Simpson SQ, 2007, AACN ADV CRIT CARE, V18, P183, DOI 10.1097/01.AACN.0000269262.37288.bf; Stufflebeam D.L., 2000, GUIDELINES DEVELOPIN; Sydler C, 2015, ANAT REC, V298, P1162, DOI 10.1002/ar.23144; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Weissleder R, 1997, PRIMER DIAGNOSTIC IM; Wittmers L, 2011, INT J PALEOPATHOL, V1, P150, DOI 10.1016/j.ijpp.2011.10.003; Zweifel L, 2009, HOMO, V60, P405, DOI 10.1016/j.jchb.2009.07.002	43	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133364	10.1371/journal.pone.0133364	http://dx.doi.org/10.1371/journal.pone.0133364			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244862	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400043
J	Qi, YM; Li, Y; Zhang, YK; Zhang, L; Wang, ZL; Zhang, XZ; Gui, L; Huang, JQ				Qi, Yiming; Li, Ying; Zhang, Yingke; Zhang, Lin; Wang, Zilian; Zhang, Xuzhi; Gui, Lian; Huang, Junqi			IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells	PLOS ONE			English	Article							GENE-EXPRESSION; INTERFERON-ALPHA; G1P3; PROTEIN; CONTRIBUTES; CHILDREN; TRAIL; RNA	Dengue hemorrhagic fever (DHF)/Dengue shock syndrome (DSS) is a fatal infectious disease that demands an effective treatment. Interferon (IFN)-stimulated genes (ISGs) induced by dengue virus (DENV) exert antiviral effects. Among ISGs, IFN-alpha inducible gene 6 (IFI6) was increased in DENV infected human umbilical vascular endothelial cells (HUVECs) by microarray analysis in our previous study. However, its function is incompletely understood. In this study, we confirmed that IFI6 was markedly induced in DENV infection of both primary HUVECs and EA. hy926 cell lines. Recombinant EA. hy926 cell lines in which IFI6 was either over-expressed (IFI6+/+) or knocked-down (IFI6-/-) were generated. The activation of caspase- 3 and intrinsic apoptosis-related protein caspase-9 were down-regulated in IFI6+/+ but up-regulated in IFI6-/-cells at 24-48 hrs post-infection. After incubation with DENV for 48 hrs, the mitochondrial membrane potential (Delta psi(m)) was more stable in IFI6+/+ cells but reduced in IFI6-/-cells, as assayed by fluorescence staining with JC-1. We observed that Bcl-2 expression was increased in IFI6+/+ and decreased in IFI6-/-cells. By contrast, Bax expression was decreased in IFI6+/+ and increased in IFI6-/-cells. It is presumed that the anti-apoptotic function of IFI6 is expressed by regulating the rheostatic balance between bcl2/bax expression and inhibition of (Delta psi(m) depolarization during DENV infection of vascular endothelial cells(VECs). In addition, the pro-apoptotic protein X-linked Inhibitor of Apoptosis (XIAP)-Associated Factor 1(XAF1) expression had been reported to be up-regulated and led to the induction of apoptosis in DENV2-infected VECs, but the relationship between XAF1 and IFI6 dengue virus-induced apoptosis in VECs warrants further study.	[Huang, Junqi] Guangdong Prov Key Lab Organ Donat & Transplant I, Guangzhou, Guangdong, Peoples R China; [Wang, Zilian; Huang, Junqi] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Qi, Yiming; Li, Ying; Zhang, Yingke; Zhang, Lin; Zhang, Xuzhi; Gui, Lian; Huang, Junqi] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510275, Guangdong, Peoples R China; [Qi, Yiming; Li, Ying; Zhang, Yingke; Zhang, Lin; Zhang, Xuzhi; Gui, Lian; Huang, Junqi] Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, JQ (corresponding author), Guangdong Prov Key Lab Organ Donat & Transplant I, Guangzhou, Guangdong, Peoples R China.	junqi_huang@aliyun.com	ZHANG, LIN/GYD-9123-2022; zhan, lin/AAP-5149-2020; gui, lian/HHC-5056-2022		National Natural Science Foundation of China [30872350, 31370870]; Natural Science Foundation of Guangdong Province [s81510008901000017, s2012010009050, s2013020013000]; Guangdong Province Scientific Technology Project [2010B050700008, 2011B040300022]; Guangzhou City Scientific Technology Project [2011J4100084, 2008Z1-E221]; Fundamental Research Funds for the Central Universities [10YKPY31]; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province Scientific Technology Project; Guangzhou City Scientific Technology Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology	This work was supported by the National Natural Science Foundation of China (no. 30872350 and no. 31370870), http://isis.nsfc.gov.cn; the Natural Science Foundation of Guangdong Province (no. s81510008901000017, no. s2012010009050 and no. s2013020013000), http://gdsf.gdstc.gov.cn; the Guangdong Province Scientific Technology Project (no. 2010B050700008 and no. 2011B040300022), http://www.gdstc.gov.cn; the Guangzhou City Scientific Technology Project (no. 2011J4100084 and no. 2008Z1-E221), http://apply.gzsi.gov.cn/; The Fundamental Research Funds for the Central Universities (no. 10YKPY31), http://mso.sysu.edu.cn; and the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (no. 2013A061401007), http://www.gdstc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Cheriyath V, 2012, ONCOGENE, V31, P2222, DOI 10.1038/onc.2011.393; Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122; Dalrymple NA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/840654; Falconar AKI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021024; Fan Fang, 2005, Ann Diagn Pathol, V9, P139, DOI 10.1016/j.anndiagpath.2005.02.003; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; ITZHAKI JE, 1992, NAT GENET, V2, P283, DOI 10.1038/ng1292-283; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222; Lee J, 2012, ONCOGENE, V31, P1242, DOI 10.1038/onc.2011.320; Liao HW, 2010, J MED VIROL, V82, P1392, DOI 10.1002/jmv.21815; Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024; Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016; Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507; Long XG, 2013, FASEB J, V27, P1062, DOI 10.1096/fj.12-213967; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Park Geun-Hee, 2013, Genomics & Informatics, V11, P15, DOI 10.5808/GI.2013.11.1.15; Parker N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-8; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Szegedi K, 2010, EXP DERMATOL, V19, P269, DOI 10.1111/j.1600-0625.2010.01066.x; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7; TURRI MG, 1995, NUCLEIC ACIDS RES, V23, P1854, DOI 10.1093/nar/23.11.1854; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Vivek R, 2014, INT J BIOL MACROMOL, V65, P289, DOI 10.1016/j.ijbiomac.2014.01.054; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69	36	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132743	10.1371/journal.pone.0132743	http://dx.doi.org/10.1371/journal.pone.0132743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244642	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400027
J	Chen, L; Huang, ZC; Yang, B; Cai, B; Su, ZZ; Wang, LL				Chen, Lin; Huang, Zhuochun; Yang, Bin; Cai, Bei; Su, Zhenzhen; Wang, Lanlan			Association of E26 Transformation Specific Sequence 1 Variants with Rheumatoid Arthritis in Chinese Han Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TRANSCRIPTION FACTOR ETS1; CELL-DIFFERENTIATION; GENE; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; BINDING; INDUCTION; PROMOTER	Objective E26 transformation specific sequence 1 (ETS-1) belongs to the ETS family of transcription factors that regulate the expression of various immune-related genes. Increasing evidence indicates that ETS-1 could contribute to the pathogenesis of autoimmune disease. Recent research has provided evidence that ETS-1 might correlate with rheumatoid arthritis (RA), but it's not clearly defined. In this study, we aimed to identify whether polymorphisms of ETS-1 play a role in Rheumatoid arthritis (RA) susceptibility and development in Chinese Han population. Methods Four single nucleotide polymorphisms (SNPs) within ETS-1 were selected based on Hap-Map data and previous associated studies. Whole blood and serum samples were obtained from 158 patients with RA and 192 healthy subjects. Genotyping was performed with polymerase chain reaction-high resolution melting (PCR-HRM) assay and the data was analyzed using SPSS17.0. Results A significantly positive correlation was observed between the SNP rs73013527 of ETS-1 and RA susceptibility, DAS28 and CRP (P<0.001, P = 0.001, and P = 0.028, respectively). Carriers of the haplotype CCT or TCT for rs4937333, rs11221332 and rs73013527 were associated with decreased risk of RA as compared to controls. No statistical significant difference was observed in the distribution of rs10893872, rs4937333 and rs11221332 genotypes between RA patients and controls. Conclusions Our data further supports that ETS-1 has a relevant role in the pathogenesis and development of RA. Allele T of rs73013527 plays a protective role in occurrence of RA but a risk factor in the high disease activity. Rs10893872, rs11221332 and rs4937333 are not associated with RA susceptibility and clinical features.	[Chen, Lin; Huang, Zhuochun; Yang, Bin; Cai, Bei; Su, Zhenzhen; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	WangLanLanhxvip@126.com	Yang, Bin/Q-6463-2019; Yang, Bin/Y-8079-2019	Yang, Bin/0000-0002-0275-3722; Huang, Zhuochun/0000-0002-2957-779X	Natural Science Foundation of China [81202354, 81301496]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China 81202354 to ZCH and the Natural Science Foundation of China 81301496 to BY. (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action) These funders supported our work including study design, data collection and decision to publish.	Babayeva ND, 2010, CELL CYCLE, V9, P3054, DOI 10.4161/cc.9.14.12257; Barton A, 2009, ARTHRIT CARE RES, V61, P1441, DOI 10.1002/art.24672; Biliavska I, 2013, ANN RHEUM DIS, V72, P1335, DOI 10.1136/annrheumdis-2012-201909; Chatzikyriakidou A, 2013, SCAND J RHEUMATOL, V42, P11, DOI 10.3109/03009742.2012.711367; Dang J, 2014, TISSUE ANTIGENS, V83, P401, DOI 10.1111/tan.12349; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fu JY, 2011, HUM MOL GENET, V20, pR206, DOI 10.1093/hmg/ddr386; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Gaudreau MC, 2015, CLIN EXP IMMUNOL, V180, P393, DOI 10.1111/cei.12587; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Hikami K, 2011, ARTHRITIS RHEUM-US, V63, P755, DOI 10.1002/art.30188; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; John S, 2014, MOL CELL BIOL, V34, P522, DOI 10.1128/MCB.00612-13; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Peterson JC, 2012, ANN RHEUM DIS, V71, P635, DOI 10.1136/annrheumdis-2011-200473; Ramirez K, 2012, IMMUNITY, V36, P921, DOI 10.1016/j.immuni.2012.04.006; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Reynolds RJ, 2014, ARTHRITIS RHEUMATOL, V66, P3274, DOI 10.1002/art.38855; Robinson L, 1997, P NATL ACAD SCI USA, V94, P7170, DOI 10.1073/pnas.94.14.7170; Russell L, 2010, CYTOKINE, V51, P217, DOI 10.1016/j.cyto.2010.03.006; Sasaki I, 2014, CURR TOP MICROBIOL, V381, P257, DOI 10.1007/82_2014_378; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Song KS, 2012, MUCOSAL IMMUNOL, V5, P207, DOI 10.1038/mi.2011.67; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Tsao HW, 2013, P NATL ACAD SCI USA, V110, P15776, DOI 10.1073/pnas.1304343110; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yarwood A., 2014, RHEUMATOLOGY; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134875	10.1371/journal.pone.0134875	http://dx.doi.org/10.1371/journal.pone.0134875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241881	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700076
J	Magnone, M; Ameri, P; Salis, A; Andraghetti, G; Emionite, L; Murialdo, G; De Flora, A; Zocchi, E				Magnone, Mirko; Ameri, Pietro; Salis, Annalisa; Andraghetti, Gabriella; Emionite, Laura; Murialdo, Giovanni; De Flora, Antonio; Zocchi, Elena			Microgram amounts of abscisic acid in fruit extracts improve glucose tolerance and reduce insulinemia in rats and in humans	FASEB JOURNAL			English	Article						plasma glucose; plasma insulin; apricots; OGTT; standard B&L	CYCLIC ADP-RIBOSE; 2ND-MESSENGER; INFLAMMATION	2-Cis,4-trans-abscisic acid (ABA) is a plant hormone that is present also in animals. Several lines of evidence suggest that ABA contributes to the regulation of glycemia in mammals: nanomolar ABA stimulates insulin release from beta-pancreatic cells and glucose transporter-4-mediated glucose uptake by myoblasts and adipocytes in vitro; plasma ABA increases in normal human subjects, but not in diabetic patients, after a glucose load for an oral glucose tolerance test (OGTT). The presence of ABA in fruits prompted an exploration of the bioavailability of dietary ABA and the effect of ABA-rich fruit extracts on glucose tolerance. Rats underwent an OGTT, with or without 1 mu g/kg ABA, either synthetic or present in a fruit extract. Human volunteers underwent an OGTT or a standard breakfast and lunch, with or without a fruit extract, yielding an ABA dose of 0.85 or 0.5 mu g/kg, respectively. Plasma glucose, insulin, and ABA were measured at different time points. Oral ABA at 0.5-1 mu g/kg significantly lowered glycemia and insulinemia in rats and in humans. Thus, the glycemia-lowering effect of low-dose ABA in vivo does not depend on an increased insulin release. Low-dose ABA intake may be proposed as an aid to improving glucose tolerance in patients with diabetes who are deficient in or resistant to insulin.	[Magnone, Mirko; Salis, Annalisa; De Flora, Antonio; Zocchi, Elena] DIMES, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Magnone, Mirko; Salis, Annalisa; De Flora, Antonio; Zocchi, Elena] DIMES, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Ameri, Pietro; Andraghetti, Gabriella; Murialdo, Giovanni] DIMES, Dept Internal Med, I-16132 Genoa, Italy; [Emionite, Laura] Azienda Osped Univ San Martino, Ist Sci Tumori, Ist Ricovero & Cura Carattere Sci, Anim Facil, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Magnone, M (corresponding author), DIMES, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	mirko.magnone@unige.it; ezocchi@unige.it	Emionite, Laura/AAB-3120-2020; Ameri, Pietro/K-8556-2016; Salis, Annalisa/R-9241-2018	Emionite, Laura/0000-0002-5199-6384; Ameri, Pietro/0000-0001-7167-7287; Salis, Annalisa/0000-0002-3082-2908	Italian Ministry of Education, University and Scientific Research [2010MCLBCZ]; Compagnia di S. Paolo [2012-ID-ROL316]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Compagnia di S. Paolo(Compagnia di San Paolo)	This work was supported in part by Grant 2010MCLBCZ from the Italian Ministry of Education, University and Scientific Research [Fondazione Carige (Cassa di Risparmio di Genova e Imperia), Genoa, Italy], and by Grant 2012-ID-ROL316 from Compagnia di S. Paolo (all to E.Z.). The authors declare no conflicts of interest.	Ameri P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115992; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; Bruzzone S, 2012, J CELL PHYSIOL, V227, P2502, DOI 10.1002/jcp.22987; De Flora A., 2014, MESSENGER, V3, P86, DOI DOI 10.1166/MSR.2014.1029; Gomez-Cadenas A, 2002, PHYTOCHEM ANALYSIS, V13, P228, DOI 10.1002/pca.640; Greenberg A. S., 2006, AM J CLIN NUTR, V83, p461S; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Hey SJ, 2010, ANN BOT-LONDON, V105, P197, DOI 10.1093/aob/mcp285; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ledford H, 2013, NATURE, V504, P198, DOI 10.1038/504198a; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Magnone M, 2012, FASEB J, V26, P1261, DOI 10.1096/fj.11-187351; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Tossi V, 2012, TRENDS PLANT SCI, V17, P510, DOI 10.1016/j.tplants.2012.05.007	21	49	50	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4783	4793		10.1096/fj.15-277731	http://dx.doi.org/10.1096/fj.15-277731			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26243865				2022-12-26	WOS:000365523600006
J	Jie, J; Lohr, F; Barbar, E				Jie, Jing; Loehr, Frank; Barbar, Elisar			Interactions of Yeast Dynein with Dynein Light Chain and Dynactin GENERAL IMPLICATIONS FOR INTRINSICALLY DISORDERED DUPLEX SCAFFOLDS IN MULTIPROTEIN ASSEMBLIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; SACCHAROMYCES-CEREVISIAE; SELF-ASSOCIATION; PROTEIN; COMPLEX; DOMAIN; LC8; DYNAMICS; MOTOR	Intrinsically disordered protein (IDP) duplexes composed of two IDP chains cross-linked by bivalent partner proteins form scaffolds for assembly of multiprotein complexes. The N-terminal domain of dynein intermediate chain (N-IC) is one such IDP that forms a bivalent scaffold with multiple dynein light chains including LC8, a hub protein that promotes duplex formation of diverse IDP partners. N-IC also binds a subunit of the dynein regulator, dynactin. Here we characterize interactions of a yeast ortholog of N-IC (N-Pac11) with yeast LC8 (Dyn2) or with the intermediate chain-binding subunit of yeast dynactin (Nip100). Residue level changes in Pac11 structure are monitored by NMR spectroscopy, and binding energetics are monitored by isothermal titration calorimetry (ITC). N-Pac11 is monomeric and primarily disordered except for a single alpha-helix (SAH) at the N terminus and a short nascent helix, LH, flanked by the two Dyn2 recognition motifs. Upon binding Dyn2, the only Pac11 residues making direct protein-protein interactions are in and immediately flanking the recognition motifs. Dyn2 binding also orders LH residues of Pac11. Upon binding Nip100, only Pac11 SAH residues make direct protein-protein interactions, but LH residues at a distant sequence position and L1 residues in an adjacent linker are also ordered. The long distance, ligand-dependent ordering of residues reveals new elements of dynamic structure within IDP linker regions.	[Jie, Jing; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Loehr, Frank] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany	Oregon State University; Goethe University Frankfurt	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Regan, Clinton/E-6250-2012	Barbar, Elisar/0000-0003-4892-5259	National Institutes of Health [GM 084276, 00210]; Oregon State University Environmental Health Sciences Center through NIEHS; Bio-NMR (Frankfurt, Germany) [261863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon State University Environmental Health Sciences Center through NIEHS; Bio-NMR (Frankfurt, Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084276 (to E. B.), the protein core facility in the Oregon State University Environmental Health Sciences Center through NIEHS, National Institutes of Health Grant 00210 and by Bio-NMR, Project Number 261863 (Frankfurt, Germany). The authors declare that they have no conflicts of interest with the contents of this article.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Barbar E, 2015, SEMIN CELL DEV BIOL, V37, P20, DOI 10.1016/j.semcdb.2014.09.016; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Farkasovsky M, 2001, J CELL BIOL, V152, P251, DOI 10.1083/jcb.152.2.251; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Goddard T. D., SPARKY3; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kidane AI, 2013, BIOCHEMISTRY-US, V52, P6011, DOI 10.1021/bi400642u; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kini AR, 2001, CELL MOTIL CYTOSKEL, V48, P52, DOI 10.1002/1097-0169(200101)48:1<52::AID-CM5>3.0.CO;2-X; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Lohr F, 1999, J AM CHEM SOC, V121, P11821, DOI 10.1021/ja991356h; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McKenney RJ, 2011, J BIOL CHEM, V286, P39615, DOI 10.1074/jbc.M111.289017; Morgan JL, 2011, J BIOL CHEM, V286, P39349, DOI 10.1074/jbc.M111.296277; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Rao L, 2013, MOL BIOL CELL, V24, P2362, DOI 10.1091/mbc.E13-03-0166; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siglin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059453; Slevin LK, 2014, J BIOL CHEM, V289, P20727, DOI 10.1074/jbc.M114.576041; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056	48	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23863	23874		10.1074/jbc.M115.649715	http://dx.doi.org/10.1074/jbc.M115.649715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26253171	Green Published, hybrid			2022-12-26	WOS:000361816500032
J	Ding, W; Fan, XL; Xu, X; Huang, JZ; Xu, SH; Geng, Q; Li, R; Chen, D; Yan, GR				Ding, Wen; Fan, Xiao-Lu; Xu, Xuan; Huang, Jin-Zhou; Xu, Song-Hui; Geng, Qian; Li, Rong; Chen, De; Yan, Guang-Rong			Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; PROSTATE-CANCER; TUMOR INVASION; METASTASIS; EXPRESSION; INTEGRIN; SUPPRESSOR; ANGIOGENESIS; MICRORNAS; CARCINOMA	The loss of ITGA2 plays an important role in cancer metastasis in several solid cancers. However, the molecular mechanism of ITGA2 loss in primary cancers remains unclear. In this study, we found that a lower ITGA2 protein level was observed in breast cancers compared to adjacent non-cancerous breast tissues. Interestingly, the reduction degree of ITGA2 at the protein level was far more than that at the mRNA level. We further showed that the translation of ITGA2 mRNA was directly inhibited by miR-373 through binding to ITGA2-3'UTR. Silencing of ITGA2 detached cell-cell interactions, induced the deploymerization of stress fiber F-actin and stimulated cancer cell migration, similar to the effect of miR-373 over-expression. The co-expression of ITGA2, not ITGA2-3'UTR, could abrogate miR-373-induced cancer cell migration because that the expression of ITGA2-3'UTR was inhibited by co-transfected miR-373. ITGA2 protein level was inversely associated with miR-373 level in breast cancers (r = -0.663, P<0.001). 73.33% of breast cancer patients with high miR-373 and low ITGA2 expression exhibited the lymph node-positive metastases. Together, our results show that epigenetic silencing of ITGA2 by miR-373 stimulates breast cancer migration, and miR-373(high)/ITGA2(low) may be as a prognosis biomarker for breast cancer patients.	[Ding, Wen; Fan, Xiao-Lu; Xu, Xuan; Huang, Jin-Zhou; Xu, Song-Hui; Yan, Guang-Rong] Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China; [Ding, Wen; Fan, Xiao-Lu; Xu, Xuan; Huang, Jin-Zhou; Xu, Song-Hui; Chen, De; Yan, Guang-Rong] Guangzhou Med Univ, Affiliated Hosp 3, Biomed Res Ctr, Guangzhou, Guangdong, Peoples R China; [Ding, Wen; Fan, Xiao-Lu; Xu, Xuan; Huang, Jin-Zhou; Xu, Song-Hui; Chen, De; Yan, Guang-Rong] Guangzhou Med Univ, Affiliated Hosp 3, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Geng, Qian; Li, Rong] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, De; Yan, Guang-Rong] Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Key Lab Major Obstetr Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Jinan University; Guangzhou Medical University; Guangzhou Medical University; Southern Medical University - China	Yan, GR (corresponding author), Jinan Univ, Inst Life & Hlth Engn, Guangzhou, Guangdong, Peoples R China.	ynlirong@vip.sina.com; drchende@gzhmu.edu.cn; jxygr007@yahoo.com	xu, songhui/L-6615-2019		National Natural Science Foundation of China [81071618, 81272285]; Zhujiang Science & Technology New Star Projects of Guangzhou [2011J2200042]; Natural Science Foundation of Guangdong Province of China [S2012010008882]; R&D plan of Guangzhou and Panyu [2011B031800043, 2011-Z03-29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhujiang Science & Technology New Star Projects of Guangzhou; Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); R&D plan of Guangzhou and Panyu	This work was supported by the National Natural Science Foundation of China (81071618, 81272285), Zhujiang Science & Technology New Star Projects of Guangzhou (2011J2200042) and the Natural Science Foundation of Guangdong Province of China (S2012010008882) and the R&D plan of Guangzhou and Panyu (2011B031800043, 2011-Z03-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augoff K, 2011, MOL CANCER RES, V9, P1500, DOI 10.1158/1541-7786.MCR-11-0311; Chen DL, 2013, CARCINOGENESIS, V34, P803, DOI 10.1093/carcin/bgs400; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chin SP, 2015, PROSTATE, V75, P723, DOI 10.1002/pros.22954; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Ferraro A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115276; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kinose Y, 2015, ONCOTARGET, V6, P11342, DOI 10.18632/oncotarget.3604; Kinouchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115936; Liu H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-80; Liu JF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-43; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Loayza-Puch F, 2010, ONCOGENE, V29, P2638, DOI 10.1038/onc.2010.23; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Pan HJ, 2009, BREAST CANCER RES TR, V118, P197, DOI 10.1007/s10549-008-0179-y; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robertson JH, 2009, CLIN EXP METASTAS, V26, P769, DOI 10.1007/s10585-009-9276-5; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu SH, 2015, J PATHOL, V236, P175, DOI 10.1002/path.4515; Yan GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063656; Yan GR, 2012, PROTEOMICS, V12, P2391, DOI 10.1002/pmic.201100652; Yan GR, 2011, PROTEOMICS, V11, P912, DOI 10.1002/pmic.201000539; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; Yuan KF, 2013, GASTROENTEROLOGY, V145, P853, DOI 10.1053/j.gastro.2013.06.008	35	39	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2015	10	8							e0135128	10.1371/journal.pone.0135128	http://dx.doi.org/10.1371/journal.pone.0135128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO7PJ	26258411	gold, Green Published, Green Submitted			2022-12-26	WOS:000359352600040
J	Cardinale, V; Puca, R; Carpino, G; Scafetta, G; Renzi, A; De Canio, M; Sicilia, F; Nevi, L; Casa, D; Panetta, R; Berloco, PB; Reid, LM; Federici, G; Gaudio, E; Maroder, M; Alvaro, D				Cardinale, Vincenzo; Puca, Rosa; Carpino, Guido; Scafetta, Gaia; Renzi, Anastasia; De Canio, Michele; Sicilia, Francesca; Nevi, Lorenzo; Casa, Domenico; Panetta, Rocco; Berloco, Pasquale Bartolomeo; Reid, Lola M.; Federici, Giorgio; Gaudio, Eugenio; Maroder, Marella; Alvaro, Domenico			Adult Human Biliary Tree Stem Cells Differentiate to beta-Pancreatic Islet Cells by Treatment with a Recombinant Human Pdx1 Peptide	PLOS ONE			English	Article							MULTIPOTENT STEM/PROGENITOR CELLS; PROGENITOR CELLS; IN-VIVO; LIVER; HEPATOCYTES; MICE; POPULATIONS; NEUROGENIN3; LINEAGES; INJURY	Generation of beta-pancreatic cells represents a major goal in research. The aim of this study was to explore a protein-based strategy to induce differentiation of human biliary tree stem cells (hBTSCs) towards beta-pancreatic cells. A plasmid containing the sequence of the human pancreatic and duodenal homeobox 1 (PDX1) has been expressed in E. coli. Epithelial-Cell-Adhesion-Molecule positive hBTSCs or mature human hepatocyte cell line, HepG2, were grown in medium to which Pdx1 peptide was added. Differentiation toward pancreatic islet cells were evaluated by the expression of the beta-cell transcription factors, Pdx1 and musculoapo-neurotic fibrosarcoma oncogene homolog A, and of the pancreatic hormones, insulin, glucagon, and somatostatin, investigated by real time polymerase chain reaction, western blot, light microscopy and immunofluorescence. C-peptide secretion in response to high glucose was also measured. Results indicated how purified Pdx1 protein corresponding to the primary structure of the human Pdx1 by mass spectroscopy was efficiently produced in bacteria, and transduced into hBTSCs. Pdx1 exposure triggered the expression of both intermediate and mature stage beta-cell differentiation markers only in hBTSCs but not in HepG2 cell line. Furthermore, hBTSCs exposed to Pdx1 showed up-regulation of insulin, glucagon and somatostatin genes and formation of 3-dimensional islet-like structures intensely positive for insulin and glucagon. Finally, Pdx1-induced islet-like structures exhibited glucose-regulated C-peptide secretion. In conclusion, the human Pdx1 is highly effective in triggering hBTSC differentiation toward functional beta-pancreatic cells.	[Cardinale, Vincenzo; Puca, Rosa; Scafetta, Gaia; Nevi, Lorenzo; Maroder, Marella; Alvaro, Domenico] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy; [Carpino, Guido] Univ Rome Foro Italico, Dept Hlth Sci, Rome, Italy; [De Canio, Michele; Sicilia, Francesca; Federici, Giorgio] Univ Roma Tor Vergata, Dept Sci, Rome, Italy; [De Canio, Michele; Sicilia, Francesca; Federici, Giorgio] Univ Roma Tor Vergata, Dept Chem Technol, Rome, Italy; [Casa, Domenico; Panetta, Rocco] Italian Federat Juvenile Diabet FDG, Rome, Italy; [Berloco, Pasquale Bartolomeo] Univ Roma La Sapienza, Dept Gen Surg & Organ Transplantat, I-00185 Rome, Italy; [Reid, Lola M.] Univ N Carolina, Sch Med, Program Mol Biol & Biotechnol, Dept Cell Physiol, Chapel Hill, NC USA; [Reid, Lola M.] Univ N Carolina, Sch Med, Program Mol Biol & Biotechnol, Dept Mol Physiol, Chapel Hill, NC USA; [Renzi, Anastasia; Gaudio, Eugenio] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, I-00185 Rome, Italy; [Alvaro, Domenico] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy	Sapienza University Rome; Foro Italico University of Rome; Italfarmaco; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Sapienza University Rome	Alvaro, D (corresponding author), Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	domenico.alvaro@uniroma1.it	Cardinale, Vincenzo/AAB-9296-2019; ALVARO, Domenico/J-8600-2018; Carpino, Guido/AAB-9692-2019; Nevi, Lorenzo/B-3289-2017; De Canio, Michele/AAY-2283-2021	Cardinale, Vincenzo/0000-0003-0234-3341; ALVARO, Domenico/0000-0003-3771-9644; Nevi, Lorenzo/0000-0003-0924-2551; De Canio, Michele/0000-0003-2552-7178; CARPINO, Guido/0000-0001-8570-2519	University "Sapienza" of Rome, FIRB grant [RBAP10Z7FS_001]; FIRB grant [RBAP10Z7FS_ 004]; PRIN grant [2009X84L84_001, 2009X84L84_002]; Italian Federation of Juvenile Diabetes (FDG); Consorzio Interuniversitario Trapianti d'Organo, Rome, Italy; Vesta Therapeutics (Bethesda, MD); Fondazione Roma	University "Sapienza" of Rome, FIRB grant; FIRB grant(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Federation of Juvenile Diabetes (FDG); Consorzio Interuniversitario Trapianti d'Organo, Rome, Italy; Vesta Therapeutics (Bethesda, MD); Fondazione Roma(Fondazione RomaEuropean Commission)	EG was supported by research project grant from the University "Sapienza" of Rome, FIRB grant # RBAP10Z7FS_001 and by PRIN grant # 2009X84L84_001. DA was supported by FIRB grant # RBAP10Z7FS_ 004 and by PRIN grant # 2009X84L84_002. The study was supported by Italian Federation of Juvenile Diabetes (FDG), by Consorzio Interuniversitario Trapianti d'Organo, Rome, Italy, by a sponsored research agreement (SRAs) from Vesta Therapeutics (Bethesda, MD), and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Cardinale V, 2012, NAT REV GASTRO HEPAT, V9, P231, DOI 10.1038/nrgastro.2012.23; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Carpino G, 2014, J HEPATOL, V60, P1194, DOI 10.1016/j.jhep.2014.01.026; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Chen NKF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001734; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Delisle Juliette Cuvelier, 2009, BMC Res Notes, V2, P3, DOI 10.1186/1756-0500-2-3; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Igarashi S, 2013, WORLD J HEPATOL, V5, P425, DOI 10.4254/wjh.v5.i8.425; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Lanzoni G, 2013, STEM CELLS, V31, P2047, DOI 10.1002/stem.1457; Marzioni M, 2013, J HEPATOL, V58, P750, DOI 10.1016/j.jhep.2012.11.033; Offield MF, 1996, DEVELOPMENT, V122, P983; Riccio M, 2014, J HEPATOL, V61, P1097, DOI 10.1016/j.jhep.2014.06.016; Sahu S, 2009, J ENDOCRINOL, V202, P13, DOI 10.1677/JOE-09-0097; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Semeraro R, 2012, J HEPATOL, V57, P987, DOI 10.1016/j.jhep.2012.07.013; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Sumazaki R, 2004, NAT GENET, V36, P83, DOI 10.1038/ng1273; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wang Y, 2013, STEM CELLS IN PRESS; Wang YF, 2013, STEM CELLS, V31, P1966, DOI 10.1002/stem.1460; Wang YF, 2010, HEPATOLOGY, V52, P1443, DOI 10.1002/hep.23829; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134677	10.1371/journal.pone.0134677	http://dx.doi.org/10.1371/journal.pone.0134677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252949	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100065
J	Wang, J; Geiss, LS; Williams, DE; Gregg, EW				Wang, Jing; Geiss, Linda S.; Williams, Desmond E.; Gregg, Edward W.			Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011	PLOS ONE			English	Article							TO-TARGET TRIAL; NPH INSULIN; GLUCOSE CONTROL; TYPE-2; THERAPY; COMPLICATIONS; ASSOCIATION; MELLITUS; DETEMIR; EVENTS	Background Despite concerns about hypoglycemia events from overly aggressive glycemic reduction, population trends in hypoglycemia and hyperglycemic crisis incidence are unclear. To address this gap, we examined changes in emergency department (ED) visit rates for hypoglycemia and hyperglycemic crisis 2006-2011. Methods Using data from the Nationwide Emergency Department Sample, we estimated the number of ED visits for hypoglycemia and hyperglycemic crisis via ICD-9-CM among adults with diabetes. Using data from the National Health Interview Survey, we estimated the population of adults with diabetes and calculated ED visit rates. Results From 2006 to 2011, ED visit rates for hypoglycemia declined by 22% from 1.8 to 1.4 per 100 adults (p = 0.003). The rates decreased in all age groups (all P<0.05) except those aged 18 to 44 years (P = 0.31). Hypoglycemia rates displayed a J-shaped curve across age, with the highest rates among adults aged 75 years or older (P <0.001). ED visit rates for hyperglycemic crisis did not change overall but increased 17% for adults aged 65 to 74 years (P = 0.02) and 29% for women (P = 0.01). Hyperglycemic crisis rates were highest among adults aged 18 to 44 years (P <0.001). Conclusions Hypoglycemia rates have declined for all adults but persons aged 18-44 years while rates for hyperglycemic crisis remained stable. Future preventive efforts should target on the susceptible population of adults aged 18 to 44 years and those aged 75 years or older.	[Wang, Jing; Geiss, Linda S.; Williams, Desmond E.; Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Wang, J (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30329 USA.	zrr4@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; [Anonymous], 2014, CDCP NAT DIAB STAT R; Barranco RJ, 2015, DIABET MED; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Cheung NW, 2009, MED J AUSTRALIA, V191, P339, DOI 10.5694/j.1326-5377.2009.tb02819.x; Del Prato S, 2007, INT J CLIN PRACT, V61, P38, DOI 10.1111/j.1742-1241.2007.01439.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Geller AI, 2014, JAMA INTERN MED, V174, P678, DOI 10.1001/jamainternmed.2014.136; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Ginde AA, 2008, DIABETES CARE, V31, P511, DOI 10.2337/dc07-1790; Ginde AA, 2006, DIABETES CARE, V29, P2117, DOI 10.2337/dc06-0627; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Holstein A, 2003, EXP CLIN ENDOCR DIAB, V111, P364, DOI 10.1055/s-2003-42728; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Johnson ES, 2002, J CLIN EPIDEMIOL, V55, P253, DOI 10.1016/S0895-4356(01)00479-6; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Lipska KJ, 2014, JAMA INTERN MED, V174, P1116, DOI 10.1001/jamainternmed.2014.1824; Lipska KJ, 2014, JAMA-J AM MED ASSOC, V311, P2331, DOI 10.1001/jama.2014.6316; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Sreenan S, 2008, INT J CLIN PRACT, V62, P1971, DOI 10.1111/j.1742-1241.2008.01939.x; Turner LW, 2014, DIABETES CARE, V37, P985, DOI 10.2337/dc13-2097; Wong ND, 2013, DIABETES VASC DIS RE, V10, P505, DOI 10.1177/1479164113496828; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	30	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134917	10.1371/journal.pone.0134917	http://dx.doi.org/10.1371/journal.pone.0134917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252486	gold, Green Published			2022-12-26	WOS:000359121100085
J	Yu, ZL; Cai, YN; Qin, WR; Lin, JX; Qiu, JP				Yu, Zhiliang; Cai, Yuanning; Qin, Wangrong; Lin, Jianxun; Qiu, Juanping			Polymyxin E Induces Rapid Paenibacillus polymyxa Death by Damaging Cell Membrane while Ca2+ Can Protect Cells from Damage	PLOS ONE			English	Article							OLEOYL-CHITOSAN NANOPARTICLES; ALANYL-LIPOTEICHOIC ACID; ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; DERIVATIVES; INHIBITION; SUBSTANCES; VIRULENCE; GENE	Polymyxin E, produced by Paenibacillus polymyxa, is an important antibiotic normally against Gram-negative pathogens. In this study, we found that polymyxin E can kill its producer P. polymyxa, a Gram-positive bacterium, by disrupting its cell membrane. Membrane damage was clearly revealed by detecting the leakage of intracellular molecules. The observation using scanning electron microscopy also supported that polymyxin E can destroy the cell membrane and cause an extensive cell surface alteration. On the other hand, divalent cations can give protection against polymyxin E. Compared with Mg2+, Ca2+ can more effectively alleviate polymyxin E-induced damage to the cell membrane, thus remarkably increasing the P. polymyxa survival. Our findings would shed light on a not yet described bactericidal mechanism of polymyxin E against Gram-positive bacteria and more importantly the nature of limited fermentation output of polymyxin E from P. polymyxa.	[Yu, Zhiliang; Cai, Yuanning; Qin, Wangrong; Qiu, Juanping] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China; [Lin, Jianxun] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	Zhejiang University of Technology; Columbia University	Yu, ZL (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	zlyu@zjut.edu.cn; qiujping@zjut.edu.cn			Regional Demonstration of Marine Economy Innovative Development Project, China [12PYY001SF08]	Regional Demonstration of Marine Economy Innovative Development Project, China	This work was supported by Regional Demonstration of Marine Economy Innovative Development Project, China (No. 12PYY001SF08) to ZY (www.soa.gov.cn).	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Azzopardi EA, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.04.008; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Cao X, 2011, INT J NANOMED, V6, P3335, DOI 10.2147/IJN.S27370; CHIHARA S, 1974, AGR BIOL CHEM TOKYO, V38, P521, DOI 10.1080/00021369.1974.10861184; Choi SK, 2009, J BACTERIOL, V191, P3350, DOI 10.1128/JB.01728-08; Clausell A, 2003, TALANTA, V60, P225, DOI 10.1016/S0039-9140(03)00078-X; DAVIS SD, 1971, J INFECT DIS, V124, P610, DOI 10.1093/infdis/124.6.610; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Huang YL, 2013, BIORESOURCE TECHNOL, V134, P17, DOI 10.1016/j.biortech.2013.02.009; Khattar ZA, 2009, J BACTERIOL, V191, P7063, DOI 10.1128/JB.00892-09; Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001; Li J, 2007, CLIN INFECT DIS, V45, P594, DOI 10.1086/520658; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Naghmouchi K, 2012, ARCH MICROBIOL, V194, P363, DOI 10.1007/s00203-011-0764-z; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Pristovsek P, 2004, CURR TOP MED CHEM, V4, P1185, DOI 10.2174/1568026043388105; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Wang ZW, 2008, BIORESOURCE TECHNOL, V99, P8245, DOI 10.1016/j.biortech.2008.03.039; WITZKE NM, 1976, J ANTIBIOT, V29, P1349, DOI 10.7164/antibiotics.29.1349; Xing K, 2008, CARBOHYD POLYM, V74, P114, DOI 10.1016/j.carbpol.2008.01.024; Xing K, 2009, CARBOHYD POLYM, V76, P17, DOI 10.1016/j.carbpol.2008.09.016; Yu ZL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/679109	27	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135198	10.1371/journal.pone.0135198	http://dx.doi.org/10.1371/journal.pone.0135198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252512	Green Published, Green Submitted, gold			2022-12-26	WOS:000359121100134
J	Palfree, RGE; Bennett, HPJ; Bateman, A				Palfree, Roger G. E.; Bennett, Hugh P. J.; Bateman, Andrew			The Evolution of the Secreted Regulatory Protein Progranulin	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR PCDGF; CYSTEINE PROTEASE; PHYTOPHTHORA-INFESTANS; NEURITE OUTGROWTH; GENE-EXPRESSION; HOST-DEFENSE; CELL-LINE; CLUSTAL-W; GENOME	Progranulin is a secreted growth factor that is active in tumorigenesis, wound repair, and inflammation. Haploinsufficiency of the human progranulin gene, GRN, causes frontotemporal dementia. Progranulins are composed of chains of cysteine-rich granulin modules. Modules may be released from progranulin by proteolysis as 6kDa granulin polypeptides. Both intact progranulin and some of the granulin polypeptides are biologically active. The granulin module occurs in certain plant proteases and progranulins are present in early diverging metazoan clades such as the sponges, indicating their ancient evolutionary origin. There is only one Grn gene in mammalian genomes. More gene-rich Grn families occur in teleost fish with between 3 and 6 members per species including short-form Grns that have no tetrapod counterparts. Our goals are to elucidate progranulin and granulin module evolution by investigating (i): the origins of metazoan progranulins (ii): the evolutionary relationships between the single Grn of tetrapods and the multiple Grn genes of fish (iii): the evolution of granulin module architectures of vertebrate progranulins (iv): the conservation of mammalian granulin polypeptide sequences and how the conserved granulin amino acid sequences map to the known three dimensional structures of granulin modules. We report that progranulin-like proteins are present in unicellular eukaryotes that are closely related to metazoa suggesting that progranulin is among the earliest extracellular regulatory proteins still employed by multicellular animals. From the genomes of the elephant shark and coelacanth we identified contemporary representatives of a precursor for short-from Grn genes of ray-finned fish that is lost in tetrapods. In vertebrate Grns pathways of exon duplication resulted in a conserved module architecture at the amino-terminus that is frequently accompanied by an unusual pattern of tandem nearly identical module repeats near the carboxyl-terminus. Polypeptide sequence conservation of mammalian granulin modules identified potential structure-activity relationships that may be informative in designing progranulin based therapeutics.	[Bateman, Andrew] McGill Univ, Res Inst, Ctr Hlth, Endocrine Res Lab,Expt Therapeut & Metab, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Res Inst, Ctr Hlth, Endocrine Res Lab,Expt Therapeut & Metab, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Bateman, A (corresponding author), McGill Univ, Res Inst, Ctr Hlth, Endocrine Res Lab,Expt Therapeut & Metab, Montreal, PQ, Canada.	andrew.bateman@muhc.mcgill.ca		Bateman, Andrew/0000-0003-0597-769X	Canadian Cancer Society Research Institute [CCSRI 700379]; Natural Sciences and Engineering [RGPIN/327185-2011]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Natural Sciences and Engineering	This study was supported by grants from Canadian Cancer Society Research Institute (CCSRI 700379) and Natural Sciences and Engineering Grant number (RGPIN/327185-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; [Anonymous], 2005, PHYLIP PHYLOGENY INF; BABA T, 1993, FEBS LETT, V322, P89, DOI 10.1016/0014-5793(93)81544-A; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; BELCOURT DR, 1995, J LEUKOCYTE BIOL, V57, P94, DOI 10.1002/jlb.57.1.94; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bozkurt TO, 2011, P NATL ACAD SCI USA, V108, P20832, DOI 10.1073/pnas.1112708109; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chen HJ, 2006, J PLANT PHYSIOL, V163, P863, DOI 10.1016/j.jplph.2005.08.008; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Chong T, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-69; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Deloffre L, 1999, B SOC ZOOL FR, V124, P337; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032422; Hanington PC, 2008, INSECT BIOCHEM MOLEC, V38, P596, DOI 10.1016/j.ibmb.2008.02.002; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kaschani F, 2010, PLANT PHYSIOL, V154, P1794, DOI 10.1104/pp.110.158030; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Matsumura N, 2006, CLIN CANCER RES, V12, P1402, DOI 10.1158/1078-0432.CCR-05-2003; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Miyanishi M, 2007, ONCOL REP, V17, P329; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; NAKAKURA N, 1992, EUR J BIOCHEM, V204, P147, DOI 10.1111/j.1432-1033.1992.tb16617.x; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Pattengale ND, 2011, IEEE ACM T COMPUT BI, V8, P902, DOI 10.1109/TCBB.2011.28; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Ray A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-224; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Smout MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000611; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Tauffenberger A, 2013, HUM MOL GENET, V22, P782, DOI 10.1093/hmg/dds485; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Tolkatchev D, 2001, J PEPT RES, V57, P227, DOI 10.1046/j.1397-002X.2000.00828.x; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yamada K, 2001, PLANT PHYSIOL, V127, P1626, DOI 10.1104/pp.010551; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-206; Zhang Y, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/173748; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	90	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133749	10.1371/journal.pone.0133749	http://dx.doi.org/10.1371/journal.pone.0133749			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26248158	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300019
J	Hsu, CY; Shu, JC; Lin, MH; Chong, KY; Chen, CC; Wen, SM; Hsieh, YT; Liao, WT				Hsu, Chi-Yu; Shu, Jwu-Ching; Lin, Mei-Hui; Chong, Kowit-Yu; Chen, Chien-Cheng; Wen, Shu-Min; Hsieh, Yi-Ting; Liao, Wan-Ting			High Glucose Concentration Promotes Vancomycin-Enhanced Biofilm Formation of Vancomycin-Non-Susceptible Staphylococcus aureus in Diabetic Mice	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; FOOT INFECTIONS; VIRULENCE; SYSTEM; AGR	We previously demonstrated that vancomycin treatment increased acquisition of eDNA and enhanced biofilm formation of drug-resistant Staphylococcus aureus through a cidA-mediated autolysis mechanism. Recently we found that such enhancement became more significant under a higher glucose concentration in vitro. We propose that besides improper antibiotic treatment, increased glucose concentration environment in diabetic animals may further enhance biofilm formation of drug-resistant S. aureus. To address this question, the diabetic mouse model infected by vancomycin-resistant S. aureus (VRSA) was used under vancomycin treatment. The capacity to form biofilms was evaluated through a catheter-associated biofilm assay. A 10- and 1000-fold increase in biofilm-bound bacterial colony forming units was observed in samples from diabetic mice without and with vancomycin treatment, respectively, compared to healthy mice. By contrast, in the absence of glucose vancomycin reduced propensity to form biofilms in vitro through the increased production of proteases and DNases from VRSA. Our study highlights the potentially important role of increased glucose concentration in enhancing biofilm formation in vancomycin-treated diabetic mice infected by drug-resistant S. aureus.	[Hsu, Chi-Yu; Shu, Jwu-Ching; Lin, Mei-Hui; Chong, Kowit-Yu; Wen, Shu-Min; Hsieh, Yi-Ting; Liao, Wan-Ting] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan 333, Taiwan; [Shu, Jwu-Ching; Lin, Mei-Hui] Chang Gung Univ, Res Ctr Pathogen Bacteria, Taoyuan 333, Taiwan; [Shu, Jwu-Ching; Lin, Mei-Hui] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan 333, Taiwan; [Chen, Chien-Cheng] Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung 824, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; National Kaohsiung Normal University	Shu, JC (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan.	shujc@mail.cgu.edu.tw		Chong, Kowit Yu/0000-0003-0974-0673; Lin, Mei-Hui/0000-0002-3498-9377; Shu, Jwu-Ching/0000-0003-4862-6056	Ministry of Science and Technology, Taiwan [NSC102-2320-B-182-021]; Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1B0081similar to3, CMRPD1B0111similar to2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan	This work was supported by the grants from Ministry of Science and Technology, Taiwan, http://www.most.gov.tw/mp.aspx?mp=7 (grant no. NSC102-2320-B-182-021), and the Research Program for Chang Gung Memorial Hospital, Taoyuan, Taiwan https://www.cgmh.org.tw/eng2002/index.asp (contract no. CMRPD1B0081 similar to 3 and CMRPD1B0111 similar to 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bascones-Martinez A, 2013, ADV EXP MED BIOL, V771, P76; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024472; Gutierrez J, 2013, WORLD J UROL, V31, P1135, DOI 10.1007/s00345-012-0836-y; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Hsu CY, 2011, FEMS IMMUNOL MED MIC, V63, P236, DOI 10.1111/j.1574-695X.2011.00846.x; Hsueh PR, 2010, INT J ANTIMICROB AG, V36, P307, DOI 10.1016/j.ijantimicag.2010.06.035; Ishiguro T, 2013, INTERNAL MED, V52, P317, DOI 10.2169/internalmedicine.52.8830; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Jaruratanasirikul Sutep, 2010, Journal of the Medical Association of Thailand, V93, P172; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; Kwiecinski J, 2015, CURR MICROBIOL, V70, P698, DOI 10.1007/s00284-014-0770-x; Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08; Lee JH, 2013, KOREAN J UROL, V54, P59, DOI 10.4111/kju.2013.54.1.59; Lister JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luong TT, 2009, INFECT IMMUN, V77, P335, DOI 10.1128/IAI.00872-08; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; Malik A, 2013, DIABETES METAB SYND, V7, P101, DOI 10.1016/j.dsx.2013.02.006; McKane CK, 2014, J CRIT CARE, V29, P70, DOI 10.1016/j.jcrc.2013.08.019; Niveditha S, 2012, J CLIN DIAGN RES, V6, P1478, DOI 10.7860/JCDR/2012/4367.2537; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Percival SL, 2012, WOUND REPAIR REGEN, V20, P647, DOI 10.1111/j.1524-475X.2012.00836.x; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Roberts AD, 2012, SEMIN VASC SURG, V25, P75, DOI 10.1053/j.semvascsurg.2012.04.010; Rochford ETJ, 2012, CLIN MICROBIOL INFEC, V18, P1162, DOI 10.1111/j.1469-0691.2012.04002.x; Schlag S, 2007, J BACTERIOL, V189, P7911, DOI 10.1128/JB.00598-07; Skhirtladze K, 2006, ANTIMICROB AGENTS CH, V50, P1372, DOI 10.1128/AAC.50.4.1372-1375.2006; Trautner BW, 2005, CURR OPIN INFECT DIS, V18, P37, DOI 10.1097/00001432-200502000-00007; Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005; Walz J Matthias, 2010, J Intensive Care Med, V25, P131, DOI 10.1177/0885066609358952; Watters C, 2014, INFECT IMMUN, V82, P92, DOI 10.1128/IAI.00651-13; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Yano H, 2012, INFECT IMMUN, V80, P4409, DOI 10.1128/IAI.00787-12; Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x	38	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134852	10.1371/journal.pone.0134852	http://dx.doi.org/10.1371/journal.pone.0134852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244880	gold, Green Submitted, Green Published			2022-12-26	WOS:000359061400113
J	Abdai, J; Gergely, A; Petro, E; Topal, J; Miklosi, A				Abdai, Judit; Gergely, Anna; Petro, Eszter; Topal, Jozsef; Miklosi, Adam			An Investigation on Social Representations: Inanimate Agent Can Mislead Dogs (Canis familiaris) in a Food Choice Task	PLOS ONE			English	Article							OWNERS	The nature of mental representation of others plays a crucial role in social interactions. Dogs present an ideal model species for the investigation of such mental representations because they develop social ties with both conspecifics and heterospecifics. Former studies found that dogs' preference for larger food quantity could be reversed by humans who indicate the smaller quantity. The question is whether this social bias is restricted to human partners. We suggest that after a short positive social experience, an unfamiliar moving inanimate agent (UMO) can also change dogs' choice between two food quantities. We tested four groups of dogs with different partners: In the (1) Helper UMO and (2) Helper UMO Control groups the partner was an interactive remote control car that helped the dog to obtain an otherwise unreachable food. In the (3) Non-helper UMO and (4) Human partner groups dogs had restricted interaction with the remote control car and the unfamiliar human partners. In the Human partner, Helper UMO and Helper UMO Control groups the partners were able to revert dogs' choice for the small amount by indicating the small one, but the Non-helper UMO was not. We suggest that dogs are able to generalize their wide range of experiences with humans to another type of agent as well, based on the recognition of similarities in simple behavioural patterns.	[Abdai, Judit; Gergely, Anna; Petro, Eszter; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Gergely, Anna; Topal, Jozsef] Hungarian Acad Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Miklosi, Adam] MTA ELTE Comparat Ethol Res Grp, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; MTA-ELTE Comparative Ethology Research Group	Abdai, J (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	abdai.judit@gmail.com	Abdai, Judit/S-6287-2019; Miklosi, Adam/N-5147-2017	Abdai, Judit/0000-0003-1219-2858; Miklosi, Adam/0000-0003-4831-8985	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX [CRSI22 133059]; Hungarian Academy of Sciences [MTA 01 031]; Hungarian Scientific Research Fund [OTKA K 112138]	Swiss National Science Foundation (SNSF) Sinergia project SWARMIX(Swiss National Science Foundation (SNSF)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research was supported by the Swiss National Science Foundation (SNSF) Sinergia project SWARMIX (project number CRSI22 133059), the Hungarian Academy of Sciences (MTA 01 031) and the Hungarian Scientific Research Fund (OTKA K 112138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetta B., 2000, ANIMAL COGNITION, V3, P107, DOI [10.1007/s100710000070, DOI 10.1007/S100710000070, DOI 10.1177/0963721416667718]; Gergely A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072727; Beran MJ, 2008, ANIM BEHAV, V75, P1793, DOI 10.1016/j.anbehav.2007.10.035; Hegedus D, 2013, BEHAVIOUR, V150, P427, DOI 10.1163/1568539X-00003060; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Marshall-Pescini S, 2011, ANIM COGN, V14, P137, DOI 10.1007/s10071-010-0340-y; Marshall-Pescini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035437; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Milgram NW, 1999, LEARN MEMORY, V6, P54; Pfungst O., 1911, CONTRIBUTION EXPT AN, DOI [10.5962/bhl.title.56164, DOI 10.5962/BHL.TITLE.56164]; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Schmidjell T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00558; Topal J, 2005, J CULT EVOL PSYCHOL, V3, P223, DOI DOI 10.1556/JCEP.3.2005.3-4.1; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x	15	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134575	10.1371/journal.pone.0134575	http://dx.doi.org/10.1371/journal.pone.0134575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241747	gold, Green Published, Green Submitted			2022-12-26	WOS:000358942700050
J	Famlia, C; Dennison, SR; Quintas, A; Phoenix, DA				Famlia, Carlos; Dennison, Sarah R.; Quintas, Alexandre; Phoenix, David A.			Prediction of Peptide and Protein Propensity for Amyloid Formation	PLOS ONE			English	Article							SECONDARY-STRUCTURE; SEQUENCE DETERMINANTS; FEATURE-SELECTION; AGGREGATION; SEGMENTS; FIBRILS; REGIONS; SERVER; MODEL	Understanding which peptides and proteins have the potential to undergo amyloid formation and what driving forces are responsible for amyloid-like fiber formation and stabilization remains limited. This is mainly because proteins that can undergo structural changes, which lead to amyloid formation, are quite diverse and share no obvious sequence or structural homology, despite the structural similarity found in the fibrils. To address these issues, a novel approach based on recursive feature selection and feed-forward neural networks was undertaken to identify key features highly correlated with the self-assembly problem. This approach allowed the identification of seven physicochemical and biochemical properties of the amino acids highly associated with the self-assembly of peptides and proteins into amyloid-like fibrils (normalized frequency of beta-sheet, normalized frequency of beta-sheet from LG, weights for beta-sheet at the window position of 1, isoelectric point, atom-based hydrophobic moment, helix termination parameter at position j+1 and Delta G degrees values for peptides extrapolated in 0 M urea). Moreover, these features enabled the development of a new predictor (available at http://cran.r-project.org/web/packages/appnn/index.html) capable of accurately and reliably predicting the amyloidogenic propensity from the polypeptide sequence alone with a prediction accuracy of 84.9 % against an external validation dataset of sequences with experimental in vitro, evidence of amyloid formation.	[Famlia, Carlos] Univ Cent Lancashire, Sch Forens & Invest Sci, Preston PR1 2HE, Lancs, England; [Famlia, Carlos; Quintas, Alexandre] Inst Super Ciencias Saude Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz, P-2829511 Monte De Caparica, Caparica, Portugal; [Dennison, Sarah R.] Univ Cent Lancashire, UCLan Biomed Res Facil, Res & Innovat Off, Preston PR1 2HE, Lancs, England; [Dennison, Sarah R.; Phoenix, David A.] London S Bank Univ, Sch Appl Sci, London SE1 0AA, England	University of Central Lancashire; Instituto Superior de Ciencias da Saude Egas Moniz; University of Central Lancashire; London South Bank University	Phoenix, DA (corresponding author), London S Bank Univ, Sch Appl Sci, 103 Borough Rd, London SE1 0AA, England.	phoenixd@lsbu.ac.uk	Quintas, Alexandre/J-6436-2012; Familia, Carlos/A-4535-2013	Quintas, Alexandre/0000-0002-5188-0453; Familia, Carlos/0000-0001-5059-2487				ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Baskakov IV, 2005, AMYLOID PROTEINS: THE BETA SHEET CONFORMATION AND DISEASE, VOLS 1 AND 2, P65, DOI 10.1002/9783527619344.ch4; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; Canty A, 2014, BOOT BOOTSTRAP R S P; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Davison AC, 1997, BOOTSTRAP METHODS TH; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DePas WH, 2012, RES MICROBIOL, V163, P592, DOI 10.1016/j.resmic.2012.10.009; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Eva Z., 2002, EUR J BIOCHEM, V269, P3362, DOI [10.1046/j.1432-1033.2002.03024.x, DOI 10.1046/J.1432-1033.2002.03024.X]; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINKELSTEIN AV, 1991, PROTEINS, V10, P287, DOI 10.1002/prot.340100403; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamodrakas SJ, 2007, INT J BIOL MACROMOL, V41, P295, DOI 10.1016/j.ijbiomac.2007.03.008; Hamodrakas SJ, 2011, FEBS J, V278, P2428, DOI 10.1111/j.1742-4658.2011.08164.x; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hu HJ, 2004, IEEE T NANOBIOSCI, V3, P265, DOI 10.1109/TNB.2004.837906; Idicula-Thomas S, 2007, CURR SCI INDIA, V92, P758; Jimenez LO, 1998, IEEE T SYST MAN CY C, V28, P39, DOI 10.1109/5326.661089; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105; Oliveberg M, 2010, NAT METHODS, V7, P187, DOI 10.1038/nmeth0310-187; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PALAU J, 1982, INT J PEPT PROT RES, V19, P394; Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Python Software Foundation, 2013, PYTH VERS 2 7 5; Qian N, 1988, J MOL BIOL, V202, P865, DOI 10.1016/0022-2836(88)90564-5; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; R Core Team, 2018, R LANG ENV STAT COMP; Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SASAGAWA F, 1993, COMPUT APPL BIOSCI, V9, P147; Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SIPE J, 2005, WILEY VCH VERLAG GMB, P49, DOI DOI 10.1002/9783527619344; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tartaglia GG, 2005, PREDICTION AGGREGATI, DOI [10.1110/ps.051471205, DOI 10.1110/PS.051471205]; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; The MathWorks I, NEUR NETW TOOLB MATL; The MathWorks I, MATLAB 2011; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Yoon S, 2005, PROTEINS, V60, P110, DOI 10.1002/prot.20477; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zamani M., 2012, Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW), P22, DOI 10.1109/BIBMW.2012.6470326; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	81	28	28	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134679	10.1371/journal.pone.0134679	http://dx.doi.org/10.1371/journal.pone.0134679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241652	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000358942700057
J	Honey, C; Schnupp, J				Honey, Christian; Schnupp, Jan			Neural Resolution of Formant Frequencies in the Primary Auditory Cortex of Rats	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; CAT; NEURONS; RESPONSES; REPRESENTATION; TOPOGRAPHY; DISCRIMINATION; COLUMNAR; LAMINAR; FIELDS	Pulse-resonance sounds play an important role in animal communication and auditory object recognition, yet very little is known about the cortical representation of this class of sounds. In this study we shine light on one simple aspect: how well does the firing rate of cortical neurons resolve resonant ("formant") frequencies of vowel-like pulse-resonance sounds. We recorded neural responses in the primary auditory cortex (A1) of anesthetized rats to two-formant pulse-resonance sounds, and estimated their formant resolving power using a statistical kernel smoothing method which takes into account the natural variability of cortical responses. While formant-tuning functions were diverse in structure across different penetrations, most were sensitive to changes in formant frequency, with a frequency resolution comparable to that reported for rat cochlear filters.	[Schnupp, Jan] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Schnupp, J (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	jan.schnupp@dpag.ox.ac.uk		schnupp, jan w h/0000-0002-2604-0057; Honey, Christian/0000-0002-3408-7744	BBSRC grant; Wellcome Trust 4-year doctoral program; BBSRC [BB/H008608/1] Funding Source: UKRI	BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust 4-year doctoral program(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Christian Honey is supported by a Wellcome Trust 4-year doctoral program. Both authors are supported by a BBSRC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1970, J NEUROPHYSIOL, V33, P172, DOI 10.1152/jn.1970.33.1.172; Aubie B, 2014, J NEUROPHYSIOL; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Bizley JK, 2009, J NEUROSCI, V29, P2064, DOI 10.1523/JNEUROSCI.4755-08.2009; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; CLAREY JC, 1994, J NEUROPHYSIOL, V72, P2383, DOI 10.1152/jn.1994.72.5.2383; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Diehl RL, 2008, PHILOS T R SOC B, V363, P965, DOI 10.1098/rstb.2007.2153; ELBARBARY A, 1991, HEARING RES, V54, P91, DOI 10.1016/0378-5955(91)90139-Z; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Eriksson JL, 2006, BEHAV PROCESS, V73, P348, DOI 10.1016/j.beproc.2006.08.005; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Grimsley JMS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051646; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Harrington IA, 2008, HEARING RES, V240, P22, DOI 10.1016/j.heares.2008.02.004; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Hubel D, 1968, J PHYSL LOND; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Linden MSJF, 2003, ADV NEURAL INFORM PR, V15, P125; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; MENDELSON JR, 1993, EXP BRAIN RES, V94, P65; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Obleser J, 2003, NEUROIMAGE, V20, P1839, DOI 10.1016/j.neuroimage.2003.07.019; Ohl FW, 1997, P NATL ACAD SCI USA, V94, P9440, DOI 10.1073/pnas.94.17.9440; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Patterson R., 2007, AUDITORY PERCEPTION, P43; Patterson RD, 2007, P INT C AC, P1; Paxinos G., 2007, THE RAT BRAIN IN STE; PHILLIPS DP, 1981, J NEUROPHYSIOL, V45, P48, DOI 10.1152/jn.1981.45.1.48; Prather JF, 2009, NAT NEUROSCI, V12, P221, DOI 10.1038/nn.2246; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; Ruggero MA, 2005, P NATL ACAD SCI USA, V102, P18614, DOI 10.1073/pnas.0509323102; Schnupp J, 2011, AUDITORY NEUROSCIENC; Schnupp J, 2006, NEURON, V51, P278, DOI 10.1016/j.neuron.2006.07.016; Shadlen M N, 1995, Curr Opin Neurobiol, V5, P248, DOI 10.1016/0959-4388(95)80033-6; Sugimoto S, 1997, HEARING RES, V112, P175, DOI 10.1016/S0378-5955(97)00119-6; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; Syka J, 2005, HEARING RES, V206, P177, DOI 10.1016/j.heares.2005.01.013; Syka J, 1996, HEARING RES, V100, P107, DOI 10.1016/0378-5955(96)00101-3; Szymanski FD, 2011, J NEUROSCI, V31, P15787, DOI 10.1523/JNEUROSCI.1416-11.2011; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Talwar SK, 1998, HEARING RES, V126, P135, DOI 10.1016/S0378-5955(98)00162-2; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; Winkowski DE, 2013, J NEUROSCI, V33, P1498, DOI 10.1523/JNEUROSCI.3101-12.2013	53	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134078	10.1371/journal.pone.0134078	http://dx.doi.org/10.1371/journal.pone.0134078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252382	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100036
J	Lee, K; Fooks, G; Wander, N; Fang, J				Lee, Kelley; Fooks, Gary; Wander, Nathaniel; Fang, Jennifer			Smoke Rings: Towards a Comprehensive Tobacco Free Policy for the Olympic Games	PLOS ONE			English	Article							INDUSTRY	Background The tobacco industry has long sought affiliation with major sporting events, including the Olympic Games, for marketing, advertising and promotion purposes. Since 1988, each Olympic Games has adopted a tobacco-free policy. Limited study of the effectiveness of the smoke-free policy has been undertaken to date, with none examining the tobacco industry's involvement with the Olympics or use of the Olympic brand. Methods and Findings A comparison of the contents of Olympic tobacco-free policies from 1988 to 2014 was carried out by searching the websites of the IOC and host NOCs. The specific tobacco control measures adopted for each Games were compiled and compared with measures recommended by the WHO Tobacco Free Sports Initiative and Article 13 of the Framework Convention on Tobacco Control (FCTC). This was supported by semi-structured interviews of key informants involved with the adoption of tobacco-free policies for selected games. To understand the industry's interests in the Olympics, the Legacy Tobacco Documents Library (http://legacy.library.ucsf.edu) was systematically searched between June 2013 and August 2014. Company websites, secondary sources and media reports were also searched to triangulate the above data sources. This paper finds that, while most direct associations between tobacco and the Olympics have been prohibited since 1988, a variety of indirect associations undermine the Olympic tobacco-free policy. This is due to variation in the scope of tobacco-free policies, limited jurisdiction and continued efforts by the industry to be associated with Olympic ideals. Conclusions The paper concludes that, compatible with the IOC's commitment to promoting healthy lifestyles, a comprehensive tobacco-free policy with standardized and binding measures should be adopted by the International Olympic Committee and all national Olympic committees.	[Lee, Kelley; Fang, Jennifer] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Fooks, Gary] Aston Univ, Sch Languages & Social Sci, Birmingham B4 7ET, W Midlands, England; [Wander, Nathaniel] Cayo Pajaro Chico, Ranchito, Corozal, Belize	Simon Fraser University; Aston University	Lee, K (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	kelley_lee@sfu.ca	Lee, Kelley/AAE-1588-2019	Lee, Kelley/0000-0002-3625-1915; Fooks, Gary/0000-0003-0080-4802	National Cancer Institute, US National Institutes of Health [R01-CA091021]; NATIONAL CANCER INSTITUTE [R01CA091021] Funding Source: NIH RePORTER	National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Cancer Institute, US National Institutes of Health, Grant No. R01-CA091021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action on Smoking and Health, 1984, ASH SMOKING HLTH MAY; American Cancer Society, 2014, HIST GREAT AM SMOK; Andreff W., 2006, HDB EC SPORT, P308; [Anonymous], 2004, ASS PRESS       1021; [Anonymous], 2000, NEWSWEEK; [Anonymous], 2012, TIMES INDIA; [Anonymous], 2001, SPORTS DEV PROGRAMS; [Anonymous], 1991, ADVERTISING AGE; [Anonymous], 1996, SPORTS ILLUSTRATED; [Anonymous], 2008, SPORTS ILLUSTRATED; [Anonymous], 2014, E COMMUNICATION 0510; [Anonymous], 2014, COMMUNICATION; [Anonymous], 1996, ATLANTAS HOSPITALITY; [Anonymous], 2014, COMMUNICATION; Augustine-Schlossinger L., 2003, JS MOORAD SPORTS L J, V10; Baker M, 1992, PROPOSED SPONSORSHIP; Balletin M, 1994, PROMOT ED, V1, P46; Barford V., 2013, BBC NEWS; Barrett JR, 2011, ENVIRON HEALTH PERSP, V119, pA259, DOI 10.1289/ehp.119-a259b; BAT, 2000, BENS HEDG MONTHL STA; BAT, 1996, Q COMP ACT REP; BAT, 1996, MYANM CO PLAN 1996 1; BAT, 1992, MILLBANK MATTERS MAR; BAT, 1995, BAT B; BAT, 1995, UZBAT NEWS       SEP, V1; BAT, 1976, OL GOLD GUID SEAS MA; Black G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092338; Blum A, 1988, TOBACCO IND SPONSORS; Brennan RJ, 1997, MED J AUSTRALIA, V167, P595, DOI 10.5694/j.1326-5377.1997.tb138908.x; Brown, 2000, MARK CONS COMM PRINC; Canadian Council on Smoking and Health, 1988, SMOKING HLTH UPDATE, V5, P3; Capreol G, 1996, ULTIMATE GAMES GUIDE; Carter RV, HLTH PROMOT INT; CDC, 2014, TOB FREE SPORTS IN; CHILCOTE S, 1992, COMMUNICATION; China's High-Altitude Training Centres, 2008, CHINA SPORTS TODAY; Coe S, 2011, COMMUNICATION; Collin J, 2004, LANCET, V364, P1107, DOI 10.1016/S0140-6736(04)17118-3; Cornwell TB, 1997, J CONSUM AFF, V31, P238, DOI 10.1111/j.1745-6606.1997.tb00390.x; Costa C, 1992, AIRPORT DISPLAY STRA; Crompton J., 1993, J SPORT SOC ISSUES, V17, P143; Crompton J. L., 2004, Managing Leisure, V9, P1, DOI 10.1080/1360671042000182964; Crossman M, 1997, ADVERTISING OPPORTUN; Cruz Souza, 2000, MARKETING CODE MARKE; Dean M, 2006, EMPTY CRIBS IMPACT S, P91; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Deering KN, 2012, SEX TRANSM INFECT, V88, P301, DOI 10.1136/sextrans-2011-050235; Doolittle DE., 1993, TOBACCO REPORTER NOV; Dull G., 1995, OFFICIAL CIGARETTE 9; Edwards J, 2012, BUSINESS INSIDE 0418; Elliot AJ, 2013, PUBLIC HEALTH, V127, P777, DOI 10.1016/j.puhe.2013.05.007; Enock K.E., 2008, PUB HLTH, V122, P1229; Flynn NJ, 1998, PUSH HOT TECHNOLOGY; Gaylord Group Ltd, 1997, VANT CHALL; Hawken PD, 2000, MARLBORO BAR NIGHTS; International Olympic Committee, 1998, OL REV, VXXVI-20; IOC, 2001, OLYMPICS MARKETING N, V19, P1; IOC, 2010, OL MARK FACT FIL; IOC, OL CHART; Jin D, 2010, HLTH LEGACY BEIJING; Johnson C, 2001, WASHINGTON TIMES; Jorm Louisa, 2003, N S W Public Health Bull, V14, P43; Katering Marketing, 1990, RJR OL BING TRAD; Lai J., 1996, YEAR DATE CONTRIBUTI; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Laufer D., 1987, CALGARY OLYMPICS SMO; Lee DM, 2000, FW MARLBORO BAR NIGH; Lindegren L, 1994, COMMUNICATION; Linehan KM, 1991, COMMUNICATION; Liu H, 2008, TOBACCO CHINA   0514; Liu SY, 2008, TOBACCO CHINA   0610; Longman J., 1992, ALBERTVILLE JUST NEE; Lorillard, 2003, CORPORATE PRINCIPLES; Lorillard, 2002, 2003 YOUTH SMOKING P; Lorillard, 1998, SPORTS ILL ADV; Lorillard, 2002, WIPE OUT K CLARK BIO; Louganis G., 1988, COMMUNICATION; Magtani KR, 2013, BMJ OPEN, V3; MANGIACASALE A, 1985, NEW YORK STATE J MED, V85, P439; Manual M, 1995, ATLANTA J CONST 0617; Meehan P, 1998, JAMA-J AM MED ASSOC, V279, P1469, DOI 10.1001/jama.279.18.1469; Moser T, 1999, COMMUNICATION; Neal RE, 1987, SPORTS ILLUSTRATED W; Non-Smokers Rights Association, 1985, N Y STATE J MED, V85, P440; Opukah S, 1992, TOBACCO NEWS SHILLIN; Ozanian M, 2013, FORBES          1011; Palacpac OS, 1998, REORGANIZED PHILIPPI; Payne M, 2006, OLYMPIC TURNAROUND O; PM, 1989, BENS HEDG 1989 MARK; PM, 1996, P MORR ACC PROGR 199; PM, 1998, PM CHAIRM BRIEF BOOK; PM, 1999, ACC PROGR TEST MARK; PM, 1996, ANN REP DRAFT ACC PR; PM, 2000, COMP ACT REP; PM, 1996, INTR TOB ISS ADV NO; PM, 1996, P MORR WRO 1996 CAL; PM, 2000, NON BRAND NAM MERCH; PM, 1996, ACC PROGR GEORG RES; PM, 1996, SLID ACC PROGR; PM, 1995, 8 AIRP LOUNG OP ACC; Pollack K., 1993, HIGHLIGHTS WEEK ENDI; POLLAY RW, 1992, J ADVERTISING, V21, P45, DOI 10.1080/00913367.1992.10673359; Preuss H., 2005, EC STAGING OLYMPICS; Preuss H, 2008, ASIAN BUS MANAG, V7, P243, DOI 10.1057/abm.2008.3; Prideaux M, 1996, SYDNEY OLYMPICS 2000; Profis V, 1994, 1995 1996 RJ REYNOLD; Reynolds Jones v RJ, 2005, TRANSCR P CIRC COURT; RJR, 1996, MONTHL STAT; RJR, 1970, RJR US SKI TEAMS 5 Y; RJR, 1983, PROM PLAN; RJR, 2004, OUR OP PHIL; RJR, 1996, OL RES; RJR, 1936, KIT KLEIN SPEED QUEE; RJR, 1996, SUMM OL PLAN PROP; Schmitz J. K., 2004, NW J TECHNOLOGY INTE, V3, P203; Selig M., 1987, SPORTS ILLUSTRATED 1; Sheridan M, 2008, SUNDAY TIMES; Sheridan PD., 2010, SPORTS LAWYER J, V17; Simpson D, 2004, TOB CONTROL, V13, P214; Simpson D, 1996, TOB CONTROL, V5, P189; Smith S, 2005, ADWEEK          0621; Sparks R., 2005, Global sport sponsorship, P19; Sutherland M., 2000, J BRAND MANAG, V7, P412, DOI [10.1057/bm.2000.33, DOI 10.1057/BM.2000.33]; Thompkins DL., 1996, SALEM DPC; Ticehurst JM., 1992, COMMUNICATION   0409; TMA Publications, 2005, GREECE PREPARES SUMM; Tobacco Documentation Center, 1993, SMOK ISS STAT BOOK A; Tomlinson A., 2005, RES SOCIOLOGY SPORT, V3, P179; Vancouver Coastal Health, 2010 OL PAR WINT GAM; Vardavas C, 2011, TOB INDUC DIS, V9; Villalbi J R, 1994, Promot Educ, V1, P10, DOI 10.1177/102538239400100305; Voronin D., 1998, KOMERSANT DAILY 0528; Walsh RA, 2000, AUST NZ J PUBL HEAL, V24, P455, DOI 10.1111/j.1467-842X.2000.tb01614.x; Watson S., 2003, YOUTH SMOKING PREVEN; WHO, 2002, ENT STAD TOB FREE SP; WHO, 2005, FRAM CONV TOB CONTR; WHO, GUID IMPL ART 13 WHO; WHO Representative Office in China, 2010, 8 FACTS TOB FREE OL; WHO Western Pacific Regional Office, 2010, GUID TOB FRE MEG; World Health Organization, TOB FREE OL; Zhang XW, 2005, CHINA TODAY	141	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0130091	10.1371/journal.pone.0130091	http://dx.doi.org/10.1371/journal.pone.0130091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO4HF	26252397	Green Published, Green Accepted, gold			2022-12-26	WOS:000359121100004
J	Singh, AK; Drolia, R; Bai, XJ; Bhunia, AK				Singh, Atul K.; Drolia, Rishi; Bai, Xingjian; Bhunia, Arun K.			Streptomycin Induced Stress Response in Salmonella enterica Serovar Typhimurium Shows Distinct Colony Scatter Signature	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; LISTERIA-MONOCYTOGENES; UNITED-STATES; HEAT-SHOCK; LABEL-FREE; IDENTIFICATION; WORLD; CLASSIFICATION; ORGANIZATION	We investigated the streptomycin-induced stress response in Salmonella enterica serovars with a laser optical sensor, BARDOT (bacterial rapid detection using optical scattering technology). Initially, the top 20 S. enterica serovars were screened for their response to streptomycin at 100 mu g/mL. All, but four S. enterica serovars were resistant to streptomycin. The MIC of streptomycin-sensitive serovars (Enteritidis, Muenchen, Mississippi, and Schwarzengrund) varied from 12.5 to 50 mu g/mL, while streptomycin-resistant serovar (Typhimurium) from 125-250 mu g/mL. Two streptomycin-sensitive serovars (Enteritidis and Mississippi) were grown on brain heart infusion (BHI) agar plates containing sub-inhibitory concentration of streptomycin (1.25-5 mu g/mL) and a streptomycin-resistant serovar (Typhimurium) was grown on BHI containing 25-50 mu g/mL of streptomycin and the colonies (1.2 +/- 0.1 mm diameter) were scanned using BARDOT. Data show substantial qualitative and quantitative differences in the colony scatter patterns of Salmonella grown in the presence of streptomycin than the colonies grown in absence of antibiotic. Mass-spectrometry identified overexpression of chaperonin GroEL, which possibly contributed to the observed differences in the colony scatter patterns. Quantitative RT-PCR and immunoassay confirmed streptomycin-induced GroEL expression while, aminoglycoside adenylyltransferase (aadA), aminoglycoside efflux pump (aep), multidrug resistance subunit acrA, and ribosomal protein S12 (rpsL), involved in streptomycin resistance, were unaltered. The study highlights suitability of the BARDOT as a non-invasive, label-free tool for investigating stress response in Salmonella in conjunction with the molecular and immunoassay methods.	[Singh, Atul K.; Drolia, Rishi; Bai, Xingjian; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bhunia, AK (corresponding author), Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, Smith Hall, W Lafayette, IN 47907 USA.	bhunia@purdue.edu	Bhunia, Arun K./K-7639-2012; Singh, Atul Kumar/H-6629-2019; Drolia, Rishi/AEA-0919-2022	Bhunia, Arun K./0000-0003-3640-1554; Singh, Atul Kumar/0000-0001-7343-3577; Drolia, Rishi/0000-0002-8405-2961	Agricultural Research Service of the US Department of Agriculture [1935-42000-072-02G]; Center for Food Safety Engineering at Purdue University	Agricultural Research Service of the US Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Center for Food Safety Engineering at Purdue University	This research was supported through a cooperative agreement with the Agricultural Research Service of the US Department of Agriculture project number 1935-42000-072-02G and the Center for Food Safety Engineering at Purdue University.	Ahmed WM, 2013, IEEE J BIOMED HEALTH, V17, P232, DOI 10.1109/TITB.2012.2222654; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bae E, 2011, J BIOPHOTONICS, V4, P236, DOI 10.1002/jbio.201000051; Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028; Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053; Barker KF, 1999, BRIT J CLIN PHARMACO, V48, P109, DOI 10.1046/j.1365-2125.1999.00997.x; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Ben-Jacob E, 2000, PHYSICA A, V282, P247, DOI 10.1016/S0378-4371(00)00093-5; Bergonzelli GE, 2006, INFECT IMMUN, V74, P425, DOI 10.1128/IAI.74.1.425-434.2006; Bhunia AK, 2012, OMICS, MICROBIAL MODELING AND TECHNOLOGIES FOR FOODBORNE PATHOGENS, P553; Biendo M, 2005, INT J ANTIMICROB AG, V26, P219, DOI 10.1016/j.ijantimicag.2005.05.003; BISWAS DK, 1972, P NATL ACAD SCI USA, V69, P2141, DOI 10.1073/pnas.69.8.2141; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Capita R, 2013, CRIT REV FOOD SCI, V53, P11, DOI 10.1080/10408398.2010.519837; Cardoso K, 2010, J MED MICROBIOL, V59, P1061, DOI 10.1099/jmm.0.020339-0; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; Center for Disease Control and Prevention (CDC), 2011, NAT ENT DIS SURV SAL; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Chen S, 2004, APPL ENVIRON MICROB, V70, P1, DOI 10.1128/AEM.70.1.1-7.2004; COOPER AL, 1968, PROC R SOC SER B-BIO, V171, P175, DOI 10.1098/rspb.1968.0063; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Doran G, 2006, INT J ANTIMICROB AG, V27, P538, DOI 10.1016/j.ijantimicag.2006.03.005; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006; Fluit AC, 2001, CLIN MICROBIOL REV, V14, P836, DOI 10.1128/CMR.14.4.836-871.2001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goltermann L, 2013, J BIOL CHEM, V288, P10483, DOI 10.1074/jbc.M112.420380; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; He YP, 2015, FOOD MICROBIOL, V47, P28, DOI 10.1016/j.fm.2014.11.004; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Holberger LE, 2009, J BIOL CHEM, V284, P32188, DOI 10.1074/jbc.M109.062745; Huff K, 2012, MICROB BIOTECHNOL, V5, P607, DOI 10.1111/j.1751-7915.2012.00349.x; Jackson BR, 2013, EMERG INFECT DIS, V19, P1239, DOI 10.3201/eid1908.121511; Jagadeesan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020694; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Keinanen-Toivola MM, 2006, FEMS MICROBIOL LETT, V257, P182, DOI 10.1111/j.1574-6968.2006.00167.x; Kim H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00537; Koskiniemi S, 2011, MOL MICROBIOL, V80, P1464, DOI 10.1111/j.1365-2958.2011.07657.x; Lang KS, 2012, APPL ENVIRON MICROB, V78, P3379, DOI 10.1128/AEM.07199-11; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Molla B, 2006, J VET MED B, V53, P28, DOI 10.1111/j.1439-0450.2006.00900.x; Olkkola S, 2010, MICROB DRUG RESIST, V16, P105, DOI 10.1089/mdr.2009.0128; Petri JR., 1887, CENTRALBLATT BACTERI, V1, P279; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rodriguez-Rojas A, 2013, INT J MED MICROBIOL, V303, P293, DOI 10.1016/j.ijmm.2013.02.004; Rodicio MR, 2011, REV MED MICROBIOL, V22, P55, DOI 10.1097/MRM.0b013e328346d87d; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh AK, 2015, J MICROBIOL METH, V109, P56, DOI 10.1016/j.mimet.2014.12.012; Singh AK, 2014, MBIO, V5, DOI 10.1128/mBio.01019-13; Su PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048098; Tang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105272; Ting K.M., 2011, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8_157, DOI 10.1007/978-0-387-30164-8_157]; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; Zou Y, 2012, LETT APPL MICROBIOL, V55, P274, DOI 10.1111/j.1472-765X.2012.03288.x	66	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0135035	10.1371/journal.pone.0135035	http://dx.doi.org/10.1371/journal.pone.0135035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252374	Green Submitted, Green Published, gold			2022-12-26	WOS:000359121100108
J	Machado, BAS; Barreto, GD; Costa, AS; Costa, SS; Silva, RPD; da Silva, DF; Brandao, HN; da Rocha, JLC; Nunes, SB; Umsza-Guez, MA; Padilha, FF				Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu; Costa, Aline Silva; Costa, Samantha Serra; Dantas Silva, Rejane Pina; da Silva, Danielle Figueredo; Brandao, Hugo Neves; Carneiro da Rocha, Jose Luiz; Nunes, Silmar Baptista; Umsza-Guez, Marcelo Andres; Padilha, Francine Ferreira			Determination of Parameters for the Supercritical Extraction of Antioxidant Compounds from Green Propolis Using Carbon Dioxide and Ethanol as Co-Solvent	PLOS ONE			English	Article							GIGANTEUM L. OLEORESIN; GRAPE SEED OIL; FLUID EXTRACTION; BRAZILIAN PROPOLIS; PHENOLIC-COMPOUNDS; CO2 EXTRACTION; ARTEPILLIN-C; IN-VITRO; BACCHARIS-DRACUNCULIFOLIA; ANTIMICROBIAL ACTIVITY	The aim of this study was to determine the best processing conditions to extract Brazilian green propolis using a supercritical extraction technology. For this purpose, the influence of different parameters was evaluated such as S/F (solvent mass in relation to solute mass), percentage of co-solvent (1 and 2% ethanol), temperature (40 and 50 degrees C) and pressure (250, 350 and 400 bar) using supercritical carbon dioxide. The Global Yield Isotherms (GYIs) were obtained through the evaluation of the yield, and the chemical composition of the extracts was also obtained in relation to the total phenolic compounds, flavonoids, antioxidant activity and 3,5-diprenyl-4-hydroxicinnamic acid (Artepillin C) and acid 4-hydroxycinnamic (p-coumaric acid). The best results were identified at 50 degrees C, 350 bar, 1% ethanol (co-solvent) and S/F of 110. These conditions, a content of 8.93 +/- 0.01 and 0.40 +/- 0.05 g/100 g of Artepillin C and p-coumaric acid, respectively, were identified indicating the efficiency of the extraction process. Despite of low yield of the process, the extracts obtained had high contents of relevant compounds, proving the viability of the process to obtain green propolis extracts with important biological applications due to the extracts composition.	[Souza Machado, Bruna Aparecida; Padilha, Francine Ferreira] Univ Tiradentes, Inst Res & Technol, Aracaju, Sergipe, Brazil; [Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu; Costa, Aline Silva; Costa, Samantha Serra; Dantas Silva, Rejane Pina; Nunes, Silmar Baptista] Natl Serv Ind Learning SENAI, SENAI CIMATEC, Fac Technol, Salvador, BA, Brazil; [da Silva, Danielle Figueredo; Brandao, Hugo Neves; Carneiro da Rocha, Jose Luiz] State Univ Feira de Santana, Fac Pharm, Feira De Santana, BA, Brazil; [Umsza-Guez, Marcelo Andres] Univ Fed Bahia, Biotechnol, Salvador, BA, Brazil	Universidade Tiradentes; Faculdade de Tecnologia Senai Cimatec; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia	Machado, BAS (corresponding author), Univ Tiradentes, Inst Res & Technol, Aracaju, Sergipe, Brazil.	brunamachado17@hotmail.com	padilha, francine/C-1349-2014; Machado, Bruna/AAP-6877-2021; Umsza-Guez, Marcelo Andrés/AAL-1315-2020; Neves Brandão, Hugo/C-4553-2018; Umsza-Guez, Marcelo/AAV-8564-2020; Machado, Bruna Aparecida Souza/C-3130-2016; Umsza-Guez, Marcelo Andres/I-3117-2016	padilha, francine/0000-0002-5892-4252; Neves Brandão, Hugo/0000-0001-5198-5039; Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Umsza-Guez, Marcelo Andres/0000-0003-3145-6935; Barreto, Gabriele/0000-0002-0180-281X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the research scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SC, 2014, ANIM FEED SCI TECH, V193, P148, DOI 10.1016/j.anifeedsci.2014.04.006; Albuquerque CLC, 2012, J SUPERCRIT FLUID, V66, P86, DOI 10.1016/j.supflu.2012.01.004; [Anonymous], SITIENTIBUS BIOL SCI; AOAC, 1997, OFFICIAL METHODS ANA; Attia YA, 2014, LIVEST SCI, V164, P87, DOI 10.1016/j.livsci.2014.03.005; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bastos EMAF, 2011, BRAZ J BIOL, V71, P727, DOI 10.1590/S1519-69842011000400018; Begnini KR, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/639856; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; Bitencourt RG, 2014, J SUPERCRIT FLUID, V92, P272, DOI 10.1016/j.supflu.2014.06.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BONVEHI JS, 1994, J AM OIL CHEM SOC, V71, P529, DOI 10.1007/BF02540666; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Budel JM, 2008, REV BRAS FARMACOGN, V18, P761, DOI 10.1590/S0102-695X2008000500022; Budel Jane Manfron, 2004, Acta Farmaceutica Bonaerense, V23, P477; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Capuzzo A, 2013, MOLECULES, V18, P7194, DOI 10.3390/molecules18067194; Carvalho AA, 2011, FOOD CHEM, V126, P1239, DOI 10.1016/j.foodchem.2010.12.035; Catchpole OJ, 2004, J SUPERCRIT FLUID, V29, P97, DOI 10.1016/S0896-8446(03)00033-0; Chan GCF, 2013, CLIN REV ALLERG IMMU, V44, P262, DOI 10.1007/s12016-012-8322-2; Chen CR, 2007, J CHIN INST CHEM ENG, V38, P191, DOI 10.1016/j.jcice.2007.04.004; Chen CR, 2009, J TAIWAN INST CHEM E, V40, P130, DOI 10.1016/j.jtice.2008.07.014; Choudhari MK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/928280; Da Porto C, 2014, J SUPERCRIT FLUID, V87, P59, DOI 10.1016/j.supflu.2013.12.013; Frozza COD, 2013, FOOD CHEM TOXICOL, V52, P137, DOI 10.1016/j.fct.2012.11.013; Danielski L, 2007, J FOOD ENG, V78, P1054, DOI 10.1016/j.jfoodeng.2005.12.016; Daugsch A., 2007, THESIS STATE U CAMPI; de Campos LMAS, 2008, BIORESOURCE TECHNOL, V99, P8413, DOI 10.1016/j.biortech.2008.02.058; De Zordi N, 2014, J SUPERCRIT FLUID, V95, P491, DOI 10.1016/j.supflu.2014.10.006; Dias LG, 2012, FOOD CHEM TOXICOL, V50, P4246, DOI 10.1016/j.fct.2012.08.056; Duba KS, 2015, J SUPERCRIT FLUID, V98, P33, DOI 10.1016/j.supflu.2014.12.021; Erdogan S, 2011, FOOD CHEM TOXICOL, V49, P1592, DOI 10.1016/j.fct.2011.04.006; Falcao SI, 2013, IND CROP PROD, V49, P805, DOI 10.1016/j.indcrop.2013.07.021; FATTORI M, 1988, J AM OIL CHEM SOC, V65, P968, DOI 10.1007/BF02544522; Ferreira SRS, 1999, J SUPERCRIT FLUID, V14, P235, DOI 10.1016/S0896-8446(98)00092-8; Ferreira SRS, 2002, J FOOD ENG, V54, P263, DOI 10.1016/S0260-8774(01)00212-6; Fiori L, 2010, CHEM ENG PROCESS, V49, P866, DOI 10.1016/j.cep.2010.06.001; Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956; Funakoshi-Tago M, 2015, INT IMMUNOPHARMACOL, V25, P189, DOI 10.1016/j.intimp.2015.01.012; Funari Cristiano S., 2006, Food Sci. Technol (Campinas), V26, P171, DOI 10.1590/S0101-20612006000100028; Garmus TT, 2015, J SUPERCRIT FLUID, V99, P68, DOI 10.1016/j.supflu.2015.01.016; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; Gomes PB, 2007, J SUPERCRIT FLUID, V41, P50, DOI 10.1016/j.supflu.2006.08.018; Gregory AG, 2008, J FOOD ENG, V88, P341, DOI 10.1016/j.jfoodeng.2008.02.019; Gressler LT, 2012, RES VET SCI, V93, P1314, DOI 10.1016/j.rvsc.2012.02.007; Guimaraes NSS, 2012, FOOD CHEM TOXICOL, V50, P1091, DOI 10.1016/j.fct.2011.11.014; Hata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048072; Ito J, 2001, J NAT PROD, V64, P1278, DOI 10.1021/np010211x; Kai H, 2014, J FUNCT FOODS, V8, P214, DOI 10.1016/j.jff.2014.03.019; Kandiel MMM, 2014, J ADV RES, V5, P671, DOI 10.1016/j.jare.2013.10.004; Kimoto T, 2001, ANTICANCER RES, V21, P221; Kimoto T, 1998, CANCER DETECT PREV, V22, P506, DOI 10.1046/j.1525-1500.1998.00020.x; Kitzberger CSG, 2009, J FOOD ENG, V90, P35, DOI 10.1016/j.jfoodeng.2008.05.034; Lee YN, 2007, SEP PURIF TECHNOL, V54, P130, DOI 10.1016/j.seppur.2006.08.028; Lewicki PP, 2004, J FOOD ENG, V61, P483, DOI 10.1016/S0260-8774(03)00219-X; Li QS, 2003, FLUID PHASE EQUILIBR, V207, P183, DOI 10.1016/S0378-3812(03)00022-0; Lin CH, 2015, J SUPERCRIT FLUID, V98, P17, DOI 10.1016/j.supflu.2014.12.025; Machado BAS, 2014, MACHADO BAS, Patent No. BR1020140320121; Machmudah S, 2008, J SUPERCRIT FLUID, V44, P301, DOI 10.1016/j.supflu.2007.09.024; Machmudah S, 2007, J SUPERCRIT FLUID, V41, P421, DOI 10.1016/j.supflu.2006.12.011; Marcucci MC, 1998, Z NATURFORSCH C, V53, P117; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Marques JL, 2013, J SUPERCRIT FLUID, V82, P238, DOI 10.1016/j.supflu.2013.07.005; Massaro FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081297; Matsushige K, 1996, J TRADI MED, V13, P217; Meireles M.A.A., 2008, SUPERCRITICAL FLUID, P243; Meireles MAA, 2003, CURR OPIN SOLID ST M, V7, P321, DOI 10.1016/j.cossms.2004.01.001; Mendiola JA, 2007, J CHROMATOGR A, V1152, P234, DOI 10.1016/j.chroma.2007.02.046; Mendonca LS, 2011, THESIS TIRADENTES U; Mezzomo N, 2009, J SUPERCRIT FLUID, V51, P10, DOI 10.1016/j.supflu.2009.07.008; Michielin EMZ, 2005, J SUPERCRIT FLUID, V33, P131, DOI 10.1016/j.supflu.2004.07.004; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Moreira T. F., 1986, Rev. Bras. Farmacogn., V1, P12; Morrison R, 1996, ORGANIC CHEM; [National Institute of Metrology Standardization and Industrial Quality INMETRO], 2011, GUID CHEM TEST METH; Nedji N., 2014, Asian Pacific Journal of Tropical Disease, V4, P433, DOI 10.1016/S2222-1808(14)60601-0; Novak EM, 2014, J FUNCT FOODS, V11, P91, DOI 10.1016/j.jff.2014.09.008; Pardo-Castano C, 2015, J SUPERCRIT FLUID, V97, P165, DOI 10.1016/j.supflu.2014.09.044; Park YK, 2004, J AGR FOOD CHEM, V52, P1100, DOI 10.1021/jf021060m; Paviani LC, 2012, BRAZ J CHEM ENG, V29, P243, DOI 10.1590/S0104-66322012000200005; Paviani LC, 2010, J FOOD PROCESS ENG, V33, P15, DOI 10.1111/j.1745-4530.2008.00256.x; Pereira CG, 2007, J SUPERCRIT FLUID, V40, P232, DOI 10.1016/j.supflu.2006.07.001; Piantino CR, 2008, J SUPERCRIT FLUID, V47, P209, DOI 10.1016/j.supflu.2008.07.012; Pourmortazavi SM, 2007, J CHROMATOGR A, V1163, P2, DOI 10.1016/j.chroma.2007.06.021; Quispe-Condori S, 2005, J SUPERCRIT FLUID, V36, P40, DOI 10.1016/j.supflu.2005.03.003; Rasouli M, 2012, INT J INFECT DIS, V16, pE312, DOI 10.1016/j.ijid.2012.05.1010; Reverchon E, 2006, J SUPERCRIT FLUID, V38, P146, DOI 10.1016/j.supflu.2006.03.020; Robards K, 2003, J CHROMATOGR A, V1000, P657, DOI 10.1016/S0021-9673(03)00058-X; Rodrigues VM, 2002, J SUPERCRIT FLUID, V22, P21, DOI 10.1016/S0896-8446(01)00108-5; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Sforcin JM, 2011, J ETHNOPHARMACOL, V133, P253, DOI 10.1016/j.jep.2010.10.032; Shimizu K, 2005, MOL CARCINOGEN, V44, P293, DOI 10.1002/mc.20148; Silva GF, 2008, BRAZ J CHEM ENG, V25, P419, DOI 10.1590/S0104-66322008000200019; Silva JC, 2012, FOOD CHEM TOXICOL, V50, P1790, DOI 10.1016/j.fct.2012.02.097; Silva-Carvalho R, 2014, J FUNCT FOODS, V11, P160, DOI 10.1016/j.jff.2014.09.009; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Machado BAS, 2013, SEP SCI TECHNOL, V48, P2741, DOI 10.1080/01496395.2013.811422; Teles F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116535; Tylkowski B, 2010, J MEMBRANE SCI, V348, P124, DOI 10.1016/j.memsci.2009.10.049; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; Veggi PC, 2014, J FOOD ENG, V131, P96, DOI 10.1016/j.jfoodeng.2014.01.027; Wang BJ, 2004, FOOD CHEM, V86, P237, DOI 10.1016/j.foodchem.2003.09.031; Wang K, 2014, J ETHNOPHARMACOL, V155, P300, DOI 10.1016/j.jep.2014.05.037; Wilson MB, 2015, J INVERTEBR PATHOL, V124, P44, DOI 10.1016/j.jip.2014.10.005; Wu J, 2000, CN Patent, Patent No. [CN1258511, 1258511]; You GS, 2002, J CHIN INST CHEM ENG, V33, P233; Ziemons E, 2005, J SUPERCRIT FLUID, V33, P53, DOI 10.1016/j.supflu.2004.04.001	109	42	42	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2015	10	8							e0134489	10.1371/journal.pone.0134489	http://dx.doi.org/10.1371/journal.pone.0134489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO4HF	26252491	gold, Green Published, Green Submitted			2022-12-26	WOS:000359121100061
J	Doebler, S				Doebler, Stefanie			Relationships between Religion and Two Forms of Homonegativity in Europe-A Multilevel Analysis of Effects of Believing, Belonging and Religious Practice	PLOS ONE			English	Article							MORAL COMMUNITIES; POLITICAL TOLERANCE; ATTITUDES; HOMOSEXUALITY; FUNDAMENTALISM; ORIENTATION; PREJUDICE; ORTHODOXY; IDENTITY; MODELS	This paper examines relationships between religion and two forms of homonegativity across 43 European countries using a bivariate response binary logistic multilevel model. The model analyzes effects of religious believing, belonging and practice on two response variables: a) a moral rejection of homosexuality as a practice and b) intolerance toward homosexuals as a group. The findings indicate that both forms of homonegativity are prevalent in Europe. Traditional doctrinal religious believing (belief in a personal God) is positively related to a moral rejection of homosexuality but to a much lesser extent associated with intolerance toward homosexuals as a group. Members of religious denominations are more likely than non-members to reject homosexuality as morally wrong and to reject homosexuals as neighbors. The analysis found significant differences between denominations that are likely context-dependent. Attendance at religious services is positively related to homonegativity in a majority of countries. The findings vary considerably across countries: Religion is more strongly related to homonegativity in Western than in Eastern Europe. In the post-soviet countries homonegativity appears to be largely a secular phenomenon. National contexts of high religiosity, high perceived government corruption, high income inequality and shortcomings in the implementation of gay rights in the countries' legislations are statistically related to higher levels of both moralistic homonegativity and intolerance toward homosexuals as a group.	Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast, Antrim, North Ireland	Queens University Belfast	Doebler, S (corresponding author), Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast, Antrim, North Ireland.	s.doebler@qub.ac.uk		Doebler, Stefanie/0000-0002-8611-4601				Adamczyk A, 2009, SOC SCI RES, V38, P338, DOI 10.1016/j.ssresearch.2009.01.002; Agadjanian A, 2001, EUROPE-ASIA STUD, V53, P473, DOI 10.1080/09668130120045898; ALLPORT GW, 1967, J PERS SOC PSYCHOL, V5, P432, DOI 10.1037/h0021212; Altemeyer Bob, 1992, INT J PSYCHOL RELIG, V2, P113, DOI DOI 10.1207/S15327582IJPR0202_5; Ammaturo FR, 2015, SOCIOLOGY, V49, P1151, DOI 10.1177/0038038514559324; Andersen R, 2008, AM J POLIT SCI, V52, P942, DOI 10.1111/j.1540-5907.2008.00352.x; Anzulovic B., 1999, HEAVENLY SERBIA; Asbrock F, 2010, EUR J PERSONALITY, V24, P324, DOI 10.1002/per.746; Bader C., 2005, INTERDISCIPLINARY J, V1, P1; BBC, 2014, BBC; BBC News, 2013, BBC NEWS; Bingham J, 2013, GAY MARRIAGE CATHOLI; Bogardus ES, 1933, SOCIOL SOC RES, V17, P265; Burdette AM, 2005, SOCIOL INQ, V75, P177, DOI 10.1111/j.1475-682X.2005.00118.x; Cecco JPD, 1984, HOMOPHOBIA AN OVERVI; Cesari J, 2004, ISLAM IN THE WEST MO; Chen JS, 2013, STAT MED, V32, P335, DOI 10.1002/sim.5528; Clairmont DA, 2007, AMERICAN RELIGIONS A, P3; Crocket A, 2003, SOCIOLOGICAL RESEARC, V4; DAVIE G, 1990, SOC COMPASS, V37, P455, DOI 10.1177/003776890037004004; Duck RJ., 1999, INT J PSYCHOL RELIG, V9, P157, DOI [10.1207/s15327582ijpr0903_1, DOI 10.1207/S15327582IJPR0903_1]; Durkheim E, 1912, THE ELEMENTARY FORMS; Eisenstein MA, 2006, POLIT BEHAV, V28, P327, DOI 10.1007/s11109-006-9014-5; Emerson MO, 2006, ANNU REV SOCIOL, V32, P127, DOI 10.1146/annurev.soc.32.061604.123141; EVS, 2010, 4TH WAVE INTEGRATED; Ferguson DS, 2011, THEOL TODAY, V68, P26, DOI 10.1177/0040573610394923; FITZMAURICE GM, 1995, J AM STAT ASSOC, V90, P845, DOI 10.2307/2291318; Fontaine JohnnyR.J., 2005, INT J PSYCHOL RELIG, V15, P123, DOI DOI 10.1207/S15327582IJPR1502_2; Froese P, 2008, SOCIOL QUART, V49, P689, DOI 10.1111/j.1533-8525.2008.00132.x; Froese P, 2008, SOCIOL RELIG, V69, P29, DOI 10.1093/socrel/69.1.29; Gera V, 2012, HUFFINGTON POST; Gerhards J, 2010, INT SOCIOL, V25, P5, DOI 10.1177/0268580909346704; GESIS, 2015, METADATA INDEX DATAS; GESIS, 2014, EUROPEAN VALUES STUD; GESIS, 2010, REPORT NO 2010 10, DOI [10.4232/1.10059, DOI 10.4232/1.10059]; Glendinning T, 2006, BRIT J SOCIOL, V57, P399, DOI 10.1111/j.1468-4446.2006.00117.x; Goldstein H., 2011, MULTILEVEL STATISTIC; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Greenwood PA, 2007, GUARDIAN; Griffiths B, 2001, AUST J PSYCHOL, V53, P12, DOI 10.1080/00049530108255116; HAYES BC, 1995, BRIT J SOCIOL, V46, P457, DOI 10.2307/591851; HAYES BC, 1995, SOCIOL RELIG, V56, P177, DOI 10.2307/3711762; Hayes BC, 2009, J YOUTH STUD, V12, P385, DOI 10.1080/13676260902866504; Herek G.M., 2004, SEXUALITY RES SOCIAL, V1, P6, DOI [10.1525/srsp.2004.1.2.6, DOI 10.1525/SRSP.2004.1.2.6]; HEREK GM, 1987, PERS SOC PSYCHOL B, V13, P34, DOI 10.1177/0146167287131003; Herek GM, 2013, ANNU REV PSYCHOL, V64, P309, DOI 10.1146/annurev-psych-113011-143826; Hervieu-Leger D, 1998, INT SOCIOL, V13, P213, DOI 10.1177/026858098013002005; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; ILGA, 2015, 2015 ILGA STATE SPON; ILGA, 2009, ILGA STATE SPONSORED; IMF, 2007, IMF WORLD ECONOMIC O; Inglehart R, 2003, FOREIGN POLICY, P62, DOI 10.2307/3183594; Inglehart R., 2005, MODERNIZATION CULTUR; Inglehart R, 2010, PERSPECT POLIT, V8, P551, DOI 10.1017/S1537592710001258; Ivekovic I, 2002, SOC COMPASS, V49, P523, DOI 10.1177/0037768602049004004; KIRKPATRICK LA, 1993, J SCI STUD RELIG, V32, P256, DOI 10.2307/1386664; Laythe B, 2002, J SCI STUD RELIG, V41, P623, DOI 10.1111/1468-5906.00142; Lee MR, 2004, SOC FORCES, V82, P1001, DOI 10.1353/sof.2004.0044; Leeming DA, 2010, ENCYCLOPEDIA OF PSYC; Loftus J, 2001, AM SOCIOL REV, V66, P762, DOI 10.2307/3088957; Marsh T, 2011, J RELIG HEALTH, V50, P575, DOI 10.1007/s10943-009-9286-2; Mavrogordatos GT, 2003, WEST EUR POLIT, V26, P117, DOI 10.1080/01402380412331300227; Mayfield W, 2001, J HOMOSEXUAL, V41, P53, DOI 10.1300/J082v41n02_04; Mole R, 2011, NATIONS NATL, V17, P540, DOI 10.1111/j.1469-8129.2010.00476.x; Nannestad P, 2008, ANNU REV POLIT SCI, V11, P413, DOI 10.1146/annurev.polisci.11.060606.135412; Norris P, 2002, COMP SOCIOL, V1, P235, DOI 10.1163/156913302100418592; NORRIS PIPPA, 2004, SACRED AND SECULAR R; O'Neil James, 1999, DEFENSE MECHANISMS A, P89; Ohlander J, 2005, SOC SCI RES, V34, P781, DOI 10.1016/j.ssresearch.2004.12.004; Pace E, 2006, EVERYDAY RELIGION OB; Parrillo VN, 2005, SOC SCI J, V42, P257, DOI 10.1016/j.soscij.2005.03.011; PETTIGREW TF, 1995, EUR J SOC PSYCHOL, V25, P57, DOI 10.1002/ejsp.2420250106; Plugge-Foust C., 2000, J SEX EDUC THER, V25, P240, DOI [DOI 10.1080/01614576.2000.11074356, 10.1080/01614576.200.11074356]; Pollack D, 2007, BRIT J SOCIOL, V58, P603, DOI 10.1111/j.1468-4446.2007.00168.x; Puar J.K, 2017, TERRORIST ASSEMBLAGE; Puar J, 2013, INT J MIDDLE E STUD, V45, P336, DOI 10.1017/S002074381300007X; PUTNAM ROBERT D., 2010, AMERICAN GRACE; QUILLIAN L, 1995, AM SOCIOL REV, V60, P586, DOI 10.2307/2096296; Regnerus MD, 2003, SOCIOL QUART, V44, P523, DOI 10.1111/j.1533-8525.2003.tb00524.x; Rios K, 2013, J EXP SOC PSYCHOL, V49, P1177, DOI 10.1016/j.jesp.2013.05.013; Ritchie J, 2015, ANTIPODE, V47, P616, DOI 10.1111/anti.12100; Rye BJ, 2010, CAN J BEHAV SCI, V42, P158, DOI 10.1037/a0018237; Rye M., 2000, FORGIVENESS THEORY R; Scheepers P, 2002, SOCIOL RELIG, V63, P157, DOI 10.2307/3712563; Scheepers P, 2002, REV RELIG RES, V43, P242, DOI 10.2307/3512331; Schwartz JP., 2005, INT J PSYCHOL RELIG, V15, P145, DOI [10.1207/s15327582ijpr1502_3, DOI 10.1207/S15327582IJPR1502_3, DOI 10.1207/s15327582ijpr1502_3]; SERDAHELY WJ, 1984, J HOMOSEXUAL, V10, P109, DOI 10.1300/J082v10n01_08; Seul JR, 1999, J PEACE RES, V36, P553, DOI 10.1177/0022343399036005004; Sona R, 2011, COMBATTING HOMOPHOBI; Stark R, 1996, SOCIOL RELIG, V57, P163, DOI 10.2307/3711948; Stark R, 1996, RELIGION DEVIANCE AN; Stark R, 1968, AMERICAN PIETY THE N; Stouffer SA, 1966, COMMUNISM CONFORMITY; Symons J, 2015, INT THEOR, V7, P61, DOI 10.1017/S1752971914000384; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Takacs J., 2013, DRUZBOSLOVNE RAZPRAV, V29, P11; Takacs J, 2015, STOCKHOLM SWEDISH IN, P1; Takacs J, 2011, EQUAL DIVERS INCL, V30, P356, DOI 10.1108/02610151111150627; Taqi-ud-Din Al-Hilali M, 1998, THE NOBLE QURAN ENGL; Transparency International, 2011, TRANSPARENCY INTERNA; Traunmuller R, 2011, EUR SOCIOL REV, V27, P346, DOI 10.1093/esr/jcq011; Van Assche J, 2014, J ETHN MIGR STUD, V40, P1414, DOI 10.1080/1369183X.2013.876895; van den Akker H, 2013, INT J PUBLIC OPIN R, V25, P64, DOI 10.1093/ijpor/edr058; Vaticana, 2011, CATECHISM OF THE CAT; Voas D, 2009, EUR SOCIOL REV, V25, P155, DOI 10.1093/esr/jcn044; Vytautas V, 2013, HUFFINGTON POST; Walter O., 1984, PUBLIC OPIN QUART, V48, P318, DOI [10.1093/poq/48.1B.318, DOI 10.1093/POQ/48.1B.318, DOI 10.1093/P0Q/48.1B.318]; WEINBERG George, 1972, SOCIETY AND THE HEAL; Whitehead AL, 2014, J SCI STUD RELIG, V53, P479, DOI 10.1111/jssr.12130; Whitehead AL, 2010, SOC SCI QUART, V91, P63, DOI 10.1111/j.1540-6237.2010.00681.x; Wilkinson RG, 2010, THE SPIRIT LEVEL WHY; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Woodberry RD, 1998, ANNU REV SOCIOL, V24, P25, DOI 10.1146/annurev.soc.24.1.25; WYLIE L, 1992, PSYCHOL REP, V71, P1291, DOI 10.2466/PR0.71.8.1291-1298	114	22	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0133538	10.1371/journal.pone.0133538	http://dx.doi.org/10.1371/journal.pone.0133538			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CO3MQ	26247352	Green Published, Green Submitted, gold			2022-12-26	WOS:000359062300013
J	Huan, P; Wang, HX; Liu, BZ				Huan, Pin; Wang, Hongxia; Liu, Baozhong			A Label-Free Proteomic Analysis on Competent Larvae and Juveniles of the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							MARINE-INVERTEBRATE LARVAE; GENE-EXPRESSION; PEPTIDE IDENTIFICATION; METAMORPHOSIS; SETTLEMENT; MECHANISMS; GASTROPOD; PROTEINS	Current understandings on the molecular mechanisms underlying bivalve metamorphosis are still fragmentary, and a comprehensive description is required. In this study, using a large-scale label-free proteomic approach, we described and compared the proteomes of competent larvae (CL) and juveniles (JU) of the Pacific oyster, Crassostrea gigas. A total of 788 proteins were identified: 392 in the CL proteome and 636 in the JU proteome. Gene Ontology analysis of the proteome from each sample revealed active metabolic processes in both stages. Further quantitative analyses revealed 117 proteins that were differentially expressed between the two samples. These proteins were divided into eight groups: cytoskeleton and cell adhesion, protein synthesis and degradation, immunity and stress response, development of particular tissues, signal regulation, metabolism and energy supply, transport, and other proteins. A certification experiment using real-time PCR assay confirmed 20 of 30 examined genes exhibited the same trends at the mRNA and protein levels. The differentially expressed proteins may play roles in tissue remodeling, signal transduction, and organ development during and after metamorphosis. Novel roles were proposed for some differentially expressed proteins, such as chymotrypsin. The results of this work provide an overview of metamorphosis and post-metamorphosis development of C. gigas at the protein level. Future studies on the functions of the differentially expressed proteins will help to obtain a more in-depth understanding of bivalve metamorphosis.	[Huan, Pin; Wang, Hongxia; Liu, Baozhong] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS	Liu, BZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	bzliu@qdio.ac.cn		Huan, Pin/0000-0001-9802-9992; Liu, Baozhong/0000-0002-6090-4867	National Natural Science Foundation of China [31472265]; National Basic Research Program of China [2010CB126403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was financially supported by the National Natural Science Foundation of China (31472265) and the National Basic Research Program of China (2010CB126403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONAR DB, 1990, B MAR SCI, V46, P484; Boutte AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022446; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carpizo-Ituarte E, 2003, BIOL BULL-US, V204, P114, DOI 10.2307/1543547; COON SL, 1985, J EXP MAR BIOL ECOL, V94, P211, DOI 10.1016/0022-0981(85)90059-0; COON SL, 1987, NEUROSCIENCE, V23, P1169, DOI 10.1016/0306-4522(87)90190-4; Damjanovski S, 2000, ANN NY ACAD SCI, V926, P180; Degnan BM, 1997, DEV GENES EVOL, V206, P464, DOI 10.1007/s004270050076; DEGNAN BM, 1995, ROUX ARCH DEV BIOL, V205, P97, DOI 10.1007/BF00188848; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fujimoto K, 2007, DEV GROWTH DIFFER, V49, P131, DOI 10.1111/j.1440-169x.2007.00916.x; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hadfield MG, 2000, SEMIN CELL DEV BIOL, V11, P437, DOI 10.1006/scdb.2000.0197; Hadfield MG, 1998, BIOFOULING, V12, P9, DOI 10.1080/08927019809378343; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Hodin J, 2006, INTEGR COMP BIOL, V46, P719, DOI 10.1093/icb/icl038; Huan P, 2012, J PROTEOMICS, V75, P3855, DOI 10.1016/j.jprot.2012.04.051; Huan P, 2011, FISH SHELLFISH IMMUN, V31, P1186, DOI 10.1016/j.fsi.2011.10.014; Inoue M, 2004, REDOX REP, V9, P237, DOI 10.1179/135100004225006010; Jackson D, 2005, MAR BIOL, V147, P681, DOI 10.1007/s00227-005-1603-z; Johnson J, 2013, COMP BIOCHEM PHYS C, V158, P101, DOI 10.1016/j.cbpc.2013.05.003; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mok FSY, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-44; MORSE DE, 1979, SCIENCE, V204, P407, DOI 10.1126/science.204.4391.407; MORSE DE, 1990, B MAR SCI, V46, P465; Nie JZ, 2013, J PROTEOME RES, V12, P3843, DOI 10.1021/pr301044b; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Royer V, 2004, DEV GENES EVOL, V214, P115, DOI 10.1007/s00427-004-0389-1; Shi YB, 2007, PHARMACOL THERAPEUT, V116, P391, DOI 10.1016/j.pharmthera.2007.07.005; Su ZX, 2007, AQUACULTURE, V271, P377, DOI 10.1016/j.aquaculture.2007.02.039; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YANG B, 2014, MATH PROBL ENG, P1; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v	46	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2015	10	8							e0135008	10.1371/journal.pone.0135008	http://dx.doi.org/10.1371/journal.pone.0135008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MQ	26247880	Green Submitted, Green Published, gold			2022-12-26	WOS:000359062300087
J	Boa, BCS; Barros, CMMR; Souza, MDGC; Castiglione, RC; Cyrino, FZGA; Bouskela, E				Boa, Beatriz C. S.; Barros, Carlos M. M. R.; Souza, Maria das Gracas C.; Castiglione, Raquel C.; Cyrino, Fatima Z. G. A.; Bouskela, Eliete			alpha-Tocopherol Improves Microcirculatory Dysfunction on Fructose Fed Hamsters	PLOS ONE			English	Article							VITAMIN-E; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CHEEK POUCH; MICROVASCULAR DYSFUNCTION; INSULIN SENSITIVITY; DIABETES-MELLITUS; LIPID-PEROXIDATION; SKELETAL-MUSCLE; ANTIOXIDANT	Fructose, an everyday component of western diet associated to chronic hyperglycemia and enhanced free radical production, impairs endothelial function and supplementation with antioxidants might improve it. In this study we investigated if vitamin E could reverse the microvascular damage elicited by fructose. Male Syrian golden hamsters drank either 10% fructose solution (F) or filtered water (C), combined with three concentrations of vitamin E in their chows [zero, normal (VE) or 5X (5XVE)] during 60 days. Microvascular reactivity in response to topical application of acetylcholine (Ach; endothelium-dependent vasodilator) or sodium nitroprusside (SNP; endothelium-independent vasodilator) and macromolecular permeability increase induced by either 30 min ischemia followed by reperfusion (I/R) or topical application of histamine (5 mu M) were assessed using the cheek pouch preparation. Compared to controls (drinking filtered water), fructose-drinking animals showed decreased vasodilatation to acetylcholine in all concentrations tested (-56.2% for 10(-9)M, -53.9% for 10(-7)M and -43.7% for 10(-5)M). On the other hand, vitamin E supplementation resulted in increased responses for both water and fructose drinking groups (177.4% for F vs. F/5XVE and 241.6% for C vs. C/5XVE for 10(-5)M Ach). Endothelial-independent vasodilatation explored by topical application of SNP was restored and even enhanced with the supplementation of 5X vitamin E in both groups (80.1% for F vs. F/5XVE; 144.2% for C vs. C/5XVE; 3.4% of difference for C/5XVE vs. F/5XVE on 10-5M SNP). The number of leaky sites after I/R and histamine stimuli in vitamin E supplemented animals decreased (-25.1% and -15.3% for F vs. F/5XVE; and -21.7% and -16% of leaky sites comparing C vs. C/5XVE, respectively for I/R and histamine stimuli) pointing to tightening of the endothelial barrier for macromolecular permeability. Our results strongly suggest that vitamin E could improve the endothelial function and permeability barrier and also reverse impairments elicited by sugar overload.	[Boa, Beatriz C. S.; Barros, Carlos M. M. R.; Souza, Maria das Gracas C.; Castiglione, Raquel C.; Cyrino, Fatima Z. G. A.; Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Boa, BCS (corresponding author), Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, Brazil.	beatrizcsb@gmail.com			National Research Council [CNPq - 474116/2008-5]; Research Supporting Agency of Rio de Janeiro State [FAPERJ - E-26/111.732/2011]	National Research Council; Research Supporting Agency of Rio de Janeiro State	This study was supported by grants from the National Research Council (CNPq - 474116/2008-5) and the Research Supporting Agency of Rio de Janeiro State (FAPERJ - E-26/111.732/2011). Further information concerning those agencies are founded on the following URLs: CNPq: http://www.cnpq.br/. FAPERJ: http://www.faperj.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2011, CAN J PHYSIOL PHARM, V89, P497, DOI 10.1139/Y11-053; Abdel-Azeem Amal S., 2013, Journal of Dietary Supplements, V10, P195, DOI 10.3109/19390211.2013.822450; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS15; Anderson TJ, 1999, J AM COLL CARDIOL, V34, P631, DOI 10.1016/S0735-1097(99)00259-4; Antonios TFT, 2001, EUR HEART J, V22, P1144, DOI 10.1053/euhj.2000.2442; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Barrett EJ, 2009, DIABETOLOGIA, V52, P752, DOI 10.1007/s00125-009-1313-z; Barros CMMR, 2007, CLINICS, V62, P327, DOI 10.1590/S1807-59322007000300019; Beeton Christine, 2007, J Vis Exp, P266, DOI 10.3791/266; Boa BCS, 2014, MICROVASC RES, V93, P34, DOI 10.1016/j.mvr.2014.02.012; Bohlen HG, 2004, AM J PHYSIOL-HEART C, V286, pH492, DOI 10.1152/ajpheart.00818.2003; BOUSKELA E, 1993, J CARDIOVASC PHARM, V22, P225, DOI 10.1097/00005344-199308000-00009; Bouskela E, 1999, J VASC RES, V36, P11, DOI 10.1159/000054069; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478, DOI 10.1152/ajpheart.1992.262.2.H478; Clerk LH, 2006, DIABETES, V55, P1436, DOI 10.2337/db05-1373; Dhein S, 2003, J PHARMACOL EXP THER, V305, P114, DOI 10.1124/jpet.102.045740; Du YT, 2014, ACTA DIABETOL, V51, P225, DOI 10.1007/s00592-013-0498-2; DULING BR, 1973, MICROVASC RES, V5, P423, DOI 10.1016/0026-2862(73)90059-9; Economides PA, 2005, DIABETES, V54, P204, DOI 10.2337/diabetes.54.1.204; Eringa EC, 2007, MICROCIRCULATION, V14, P389, DOI 10.1080/10739680701303584; Faure P, 2007, J TRACE ELEM MED BIO, V21, P113, DOI 10.1016/j.jtemb.2006.12.005; Feletou M, 2003, ACTA PHARMACOL SIN, V24, P207; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; GLASCOTT PA, 1992, MOL PHARMACOL, V41, P1155; Hansel B, 2004, J CLIN ENDOCR METAB, V89, P4963, DOI 10.1210/jc.2004-0305; Hornig B, 1998, CIRCULATION, V97, P363; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; Hyakukoku M, 2003, HYPERTENS RES, V26, P169, DOI 10.1291/hypres.26.169; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kotchen TA, 1997, AM J HYPERTENS, V10, P1020, DOI 10.1016/S0895-7061(97)00164-7; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Lamprecht M, 2009, INT J SPORT NUTR EXE, V19, P385, DOI 10.1123/ijsnem.19.4.385; Meininger CJ, 2004, FASEB J, V18, P1900, DOI 10.1096/fj.04-1702fje; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Padilla DJ, 2006, AM J PHYSIOL-HEART C, V291, pH2439, DOI 10.1152/ajpheart.00290.2006; Patel J, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/120801; PERSSON NH, 1985, INT J MICROCIRC, V4, P257; Plantinga Y, 2007, AM J HYPERTENS, V20, P392, DOI 10.1016/j.amjhyper.2006.09.021; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; SAX FL, 1987, NEW ENGL J MED, V317, P1366, DOI 10.1056/NEJM198711263172202; Serne EH, 2007, HYPERTENSION, V50, P204, DOI 10.1161/HYPERTENSIONAHA.107.089680; Serne EH, 2006, ESSAYS BIOCHEM, V42, P163, DOI 10.1042/bse0420163; SVENSJO E, 1978, PROSTAG LEUKOTR ESS, V1, P397, DOI 10.1016/0161-4630(78)90126-X; Takagawa Y, 2002, HYPERTENS RES, V25, P197, DOI 10.1291/hypres.25.197; TAPPEL AL, 1970, AM J CLIN NUTR, V23, P1137; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Wray DW, 2012, HYPERTENSION, V59, P818, DOI 10.1161/HYPERTENSIONAHA.111.189456	52	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134740	10.1371/journal.pone.0134740	http://dx.doi.org/10.1371/journal.pone.0134740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244369	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400101
J	Brajon, S; Laforest, JP; Schmitt, O; Devillers, N				Brajon, Sophie; Laforest, Jean-Paul; Schmitt, Oceane; Devillers, Nicolas			The Way Humans Behave Modulates the Emotional State of Piglets	PLOS ONE			English	Article							COGNITIVE BIAS; JUDGMENT BIAS; MINIATURE PIGS; STRESS; SHEEP; EXHIBIT; RESPONSES; ANIMALS; HANDLER; ABILITY	The emotional state can influence decision-making under ambiguity. Cognitive bias tests (CBT) proved to be a promising indicator of the affective valence of animals in a context of farm animal welfare. Although it is well-known that humans can influence the intensity of fear and reactions of animals, research on cognitive bias often focusses on housing and management conditions and neglects the role of humans on emotional states of animals. The present study aimed at investigating whether humans can modulate the emotional state of weaned piglets. Fifty-four piglets received a chronic experience with humans: gentle (GEN), rough (ROU) or minimal contact (MIN). Simultaneously, they were individually trained on a go/no-go task to discriminate a positive auditory cue, associated with food reward in a trough, from a negative one, associated with punishments (e.g. water spray). Independently of the treatment (P = 0.82), 59% of piglets completed the training. Successfully trained piglets were then subjected to CBT, including ambiguous cues in presence or absence of a human observer. As hypothesized, GEN piglets showed a positive judgement bias, as shown by their higher percentage of go responses following an ambiguous cue compared to ROU (P = 0.03) and MIN (P = 0.02) piglets, whereas ROU and MIN piglets did not differ (P > 0.10). The presence of an observer during CBT did not modulate the percentage of go responses following an ambiguous cue (P > 0.10). However, regardless of the treatment, piglets spent less time in contact with the trough following positive cues during CBT in which the observer was present than absent (P < 0.0001). This study originally demonstrates that the nature of a chronic experience with humans can induce a judgement bias indicating that the emotional state of farm animals such as piglets can be affected by the way humans interact with them.	[Brajon, Sophie; Schmitt, Oceane; Devillers, Nicolas] Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ J1M 0C8, Canada; [Brajon, Sophie; Laforest, Jean-Paul] Univ Laval, Dept Anim Sci, Quebec City, PQ G1V 0A6, Canada	Agriculture & Agri Food Canada; Laval University	Devillers, N (corresponding author), Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, 2000 Coll St, Sherbrooke, PQ J1M 0C8, Canada.	Nicolas.Devillers@agr.gc.ca		brajon, sophie/0000-0003-2951-9888; Devillers, Nicolas/0000-0002-5866-9394; Schmitt, Oceane/0000-0003-4932-3743	Agriculture Agri-Food Canada [RBPI1693]	Agriculture Agri-Food Canada(Agriculture & Agri Food Canada)	This study was supported by Agriculture Agri-Food Canada (Project Nos RBPI1693, http://www.agr.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarella U., 2007, PIGS HUMANS 10000 YE; Allen NB, 2006, PROG NEURO-PSYCHOPH, V30, P815, DOI 10.1016/j.pnpbp.2006.01.007; Bateson M, 2011, CURR BIOL, V21, P1070, DOI 10.1016/j.cub.2011.05.017; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Brajon S, 2015, PERCEPTION IN PRESS; Brajon S, 2015, APPL ANIM BEHAV SCI, V162, P9, DOI 10.1016/j.applanim.2014.11.009; Canadian Council on Animal Care, 2009, TEACHING TESTING, VII, P103; Cussen VA, 2014, ANIM BEHAV, V89, P123, DOI 10.1016/j.anbehav.2013.12.022; Daros RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098429; DeBoer SP, 2013, APPL ANIM BEHAV SCI, V143, P96, DOI 10.1016/j.applanim.2012.10.007; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Dupjan S, 2013, J VET BEHAV, V8, P485, DOI 10.1016/j.jveb.2013.05.007; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Freymond SB, 2014, APPL ANIM BEHAV SCI, V158, P34, DOI 10.1016/j.applanim.2014.06.006; Gaddy MA, 2014, CLIN PSYCHOL REV, V34, P402, DOI 10.1016/j.cpr.2014.06.001; Gieling E, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-4; GONYOU HW, 1986, APPL ANIM BEHAV SCI, V16, P269, DOI 10.1016/0168-1591(86)90119-X; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hemsworth PH, 2011, APPL ANIM BEHAV SCI, V135, P24, DOI 10.1016/j.applanim.2011.09.007; Hemsworth PH, 1996, APPL ANIM BEHAV SCI, V50, P71, DOI 10.1016/0168-1591(96)01065-9; HEMSWORTH PH, 1986, APPL ANIM BEHAV SCI, V15, P303, DOI 10.1016/0168-1591(86)90123-1; Houpt KA, 2011, DOMESTIC ANIMAL BEHA, P22; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Murphy E, 2013, APPL ANIM BEHAV SCI, V148, P64, DOI 10.1016/j.applanim.2013.07.011; Murphy E, 2013, ANIM COGN, V16, P883, DOI 10.1007/s10071-013-0621-3; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; Rygula R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051959; Sanger ME, 2011, APPL ANIM BEHAV SCI, V131, P94, DOI 10.1016/j.applanim.2011.02.001; Schick A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00272; Scollo A, 2014, APPL ANIM BEHAV SCI, V153, P26, DOI [10.1016/j.applanim.2014.01.006, 10.1016/j.appl]; TANIDA H, 1995, APPL ANIM BEHAV SCI, V42, P249, DOI 10.1016/0168-1591(94)00545-P; Tanida H, 1998, APPL ANIM BEHAV SCI, V56, P149, DOI 10.1016/S0168-1591(97)00095-6; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Yardimci M, 2013, ANIMAL, V7, P143, DOI 10.1017/S1751731112001449	40	32	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133408	10.1371/journal.pone.0133408	http://dx.doi.org/10.1371/journal.pone.0133408			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244335	gold, Green Published, Green Submitted			2022-12-26	WOS:000359061400045
J	Garcia-Castellanos, D; Jimenez-Munt, I				Garcia-Castellanos, Daniel; Jimenez-Munt, Ivone			Topographic Evolution and Climate Aridification during Continental Collision: Insights from Computer Simulations	PLOS ONE			English	Article							TARIM BASIN; LITHOSPHERIC STRENGTH; SPATIAL VARIATIONS; RIVER TRANSPORT; TIAN-SHAN; EROSION; MODEL; DEFORMATION; TECTONICS; PRECIPITATION	How do the feedbacks between tectonics, sediment transport and climate work to shape the topographic evolution of the Earth? This question has been widely addressed via numerical models constrained with thermochronological and geomorphological data at scales ranging from local to orogenic. Here we present a novel numerical model that aims at reproducing the interaction between these processes at the continental scale. For this purpose, we combine in a single computer program: 1) a thin-sheet viscous model of continental deformation; 2) a stream-power surface-transport approach; 3) flexural isostasy allowing for the formation of large sedimentary foreland basins; and 4) an orographic precipitation model that reproduces basic climatic effects such as continentality and rain shadow. We quantify the feedbacks between these processes in a synthetic scenario inspired by the India-Asia collision and the growth of the Tibetan Plateau. We identify a feedback between erosion and crustal thickening leading locally to a <50% increase in deformation rates in places where orographic precipitation is concentrated. This climatically-enhanced deformation takes place preferentially at the upwind flank of the growing plateau, specially at the corners of the indenter (syntaxes). We hypothesize that this may provide clues for better understanding the mechanisms underlying the intriguing tectonic aneurisms documented in the Himalayas. At the continental scale, however, the overall distribution of topographic basins and ranges seems insensitive to climatic factors, despite these do have important, sometimes counter-intuitive effects on the amount of sediments trapped within the continent. The dry climatic conditions that naturally develop in the interior of the continent, for example, trigger large intra-continental sediment trapping at basins similar to the Tarim Basin because they determine its endorheic/exorheic drainage. These complex climatic-drainage-tectonic interactions make the development of steady-state topography at the continental scale unlikely.	[Garcia-Castellanos, Daniel; Jimenez-Munt, Ivone] Inst Ciencias Tierra Jaume Almera ICTJA CSIC, Grp Dynam Lithosphere, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN)	Garcia-Castellanos, D (corresponding author), Inst Ciencias Tierra Jaume Almera ICTJA CSIC, Grp Dynam Lithosphere, Barcelona, Spain.	d.g.c@csic.es	Jimenez-Munt, Ivone/B-7073-2009; Jiménez-Munt, Ivone/AAA-8214-2021	Jimenez-Munt, Ivone/0000-0003-4178-3585; 	Spanish Government [CGL2011-26670, CGL2009-09662-BTE]	Spanish Government(Spanish GovernmentEuropean Commission)	Funding came from the Spanish Government through the projects TECLA (CGL2011-26670) and ATIZA (CGL2009-09662-BTE).	Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; Avouac JP, 1996, J GEOPHYS RES-SOL EA, V101, P17747, DOI 10.1029/96JB01344; Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Beaumont C., 1992, THRUST TECTONICS, P1, DOI DOI 10.1007/978-94-011-3066-0_1; BEAUMONT C., 1992, EROSIONAL CONTROL AC; Berger AL, 2008, NAT GEOSCI, V1, P793, DOI 10.1038/ngeo334; BIRD P, 1989, J GEOPHYS RES-SOLID, V94, P3967, DOI 10.1029/JB094iB04p03967; BIRD P, 1988, SCIENCE, V239, P1501, DOI 10.1126/science.239.4847.1501; Braun J, 2001, GEOL SOC SPEC PUBL, V184, P165, DOI 10.1144/GSL.SP.2001.184.01.09; Burbank DW, 2012, CR GEOSCI, V344, P610, DOI 10.1016/j.crte.2012.10.010; BURBANK DW, 1992, NATURE, V359, P483, DOI 10.1038/359483a0; Burov E, 2007, GLOBAL PLANET CHANGE, V58, P141, DOI 10.1016/j.gloplacha.2007.02.009; Cai MT, 2012, GLOBAL PLANET CHANGE, V94-95, P72, DOI 10.1016/j.gloplacha.2012.07.002; Carroll AR, 1999, GEOLOGY, V27, P99, DOI 10.1130/0091-7613(1999)027<0099:SCOALB>2.3.CO;2; Charreau J, 2006, GEOLOGY, V34, P181, DOI 10.1130/G22106.1; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; COBBOLD PR, 1993, SEDIMENT GEOL, V86, P77, DOI 10.1016/0037-0738(93)90134-Q; Copley A, 2011, NATURE, V472, P79, DOI 10.1038/nature09926; DeCelles PG, 1996, BASIN RES, V8, P105, DOI 10.1046/j.1365-2117.1996.01491.x; Dupont-Nivet G, 2008, GEOLOGY, V36, P987, DOI 10.1130/G25063A.1; ENGLAND P, 1985, NATURE, V315, P297, DOI 10.1038/315297a0; ENGLAND P, 1983, GEOPHYS J ROY ASTR S, V73, P523, DOI 10.1111/j.1365-246X.1983.tb03328.x; England P, 1989, EXTENSION CONTINENTA, V94; Fillon C, 2013, GEOLOGY, V41, P83, DOI 10.1130/G33531.1; Gan WJ, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004120; Garcia-Castellanos D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002073; Garcia-Castellanos D, 2002, BASIN RES, V14, P89, DOI 10.1046/j.1365-2117.2002.00174.x; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Garcia-Castellanos D, 2006, GEOL SOC AM SPEC PAP, V398, P283, DOI 10.1130/2006.2398(17); Garcia-Castellanos D, 2007, EARTH PLANET SC LETT, V257, P372, DOI 10.1016/j.epsl.2007.02.039; Garcia-Castellanos D, 2012, TECTONICS OF SEDIMENTARY BASINS: RECENT ADVANCES, P152; Gaudemer Y, 1998, CRUSTAL THICKENING G, P1; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; Jimenez-Munt I, 2005, TECTONICS, V24, DOI 10.1029/2004TC001754; Jimenez-Munt I, 2005, TECTONOPHYSICS, V407, P239, DOI 10.1016/j.tecto.2005.08.015; Jimenez-Munt I, 2001, EARTH PLANET SC LETT, V192, P175, DOI 10.1016/S0012-821X(01)00442-3; Jimenez-Munt I, 2006, TECTONICS, V25, DOI 10.1029/2006TC001963; Koons P.O., 2013, TREATISE GEOMORPHOLO, V5, P318; Kuhni A, 2001, BASIN RES, V13, P169, DOI 10.1046/j.1365-2117.2001.00146.x; [刘绍文 LIU Shaowen], 2006, [地质学报, Acta Geologica Sinica], V80, P344; Lynch HD, 1987, TENSILE STRENGTH LIT; Marotta AM, 2001, GEOPHYS J INT, V144, pF8, DOI 10.1046/j.1365-246x.2001.00373.x; Metivier F, 1998, TECTONICS, V17, P823, DOI 10.1029/98TC02764; MOLNAR P, 1981, EARTH PLANET SC LETT, V52, P107, DOI 10.1016/0012-821X(81)90213-2; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Montgomery DR, 2006, GEOMORPHOLOGY, V82, P4, DOI 10.1016/j.geomorph.2005.08.021; Mugnier JL, 1997, GEOLOGY, V25, P427, DOI 10.1130/0091-7613(1997)025<0427:TGCBEA>2.3.CO;2; Neil EA, 1997, TECTONICS, V16, P571, DOI 10.1029/97TC01413; Norton K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1590; Persson KS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2002JB002274; POLLACK HN, 1977, TECTONOPHYSICS, V38, P279, DOI 10.1016/0040-1951(77)90215-3; Purves RS, 2000, INT J CLIMATOL, V20, P1809, DOI 10.1002/1097-0088(20001130)20:14<1809::AID-JOC587>3.0.CO;2-R; Reiners PW, 2003, NATURE, V426, P645, DOI 10.1038/nature02111; Robert A, J GEOL SOC LOND; Roe GH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001521; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Ruddiman WF, 1997, UPLIFT CLIM CHANGE; Seidl M.A., 1992, FUNCTIONAL GEOMORPHO, V23, P101; Sklar LS, 2006, GEOMORPHOLOGY, V82, P58, DOI 10.1016/j.geomorph.2005.08.019; Sobel ER, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001883; Sobouti F, 1996, GEOPHYS J INT, V126, P805, DOI 10.1111/j.1365-246X.1996.tb04704.x; SONDER LJ, 1986, EARTH PLANET SC LETT, V77, P81, DOI 10.1016/0012-821X(86)90134-2; Stuwe K, 2008, TECTONICS, V27; Sun JM, 2009, GEOLOGY, V37, P159, DOI 10.1130/G25338A.1; Tarapoanca M., 2004, ARCHIT 3D GEOM TECTO; TOMMASI A, 1995, J GEOPHYS RES-SOL EA, V100, P22083, DOI 10.1029/95JB02042; Tucker G.E., 1994, J GEOPHYS RES SOLID, V99, P12, DOI DOI 10.1029/94JB00320; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; van der Beek P, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002125; van der Beek P, 2002, GEOLOGY, V30, P471, DOI 10.1130/0091-7613(2002)030<0471:CODDOD>2.0.CO;2; VANWEES JD, 1994, GEOPHYS J INT, V117, P179, DOI 10.1111/j.1365-246X.1994.tb03311.x; Vernant P, 2013, GEOLOGY, V41, P467, DOI 10.1130/G33942.1; VILOTTE JP, 1986, GEOPHYS J INT, V84, P279, DOI 10.1111/j.1365-246X.1986.tb04357.x; Vilotte JP, 1982, NUMERICAL MODELING I, V87; Watts AB, 2003, EARTH PLANET SC LETT, V213, P113, DOI 10.1016/S0012-821X(03)00289-9; Wessel P., 1995, EOS T AM GEOPHYS UN, V79, P329, DOI [10.1029/95EO00198, DOI 10.1029/95EO00198]; Whipple KX, 2014, SCIENCE, V346, P918, DOI 10.1126/science.aaa0887; Whipple KX, 2009, NAT GEOSCI, V2, P97, DOI 10.1038/ngeo413; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whipple KX, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000019; Willett S., 1999, J GEOPHYS RES SOLID; Willett SD, 2002, GEOLOGY, V30, P175, DOI 10.1130/0091-7613(2002)030<0175:OSSIMB>2.0.CO;2; Yang YQ, 2002, TECTONICS, V21, DOI 10.1029/2001TC001300; Yi HS, 2008, ACTA GEOL SIN-ENGL, V82, P206	86	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0132252	10.1371/journal.pone.0132252	http://dx.doi.org/10.1371/journal.pone.0132252			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244662	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400020
J	Liu, J; Cheng, Y; Lau, JTF; Wu, AMS; Tse, VWS; Zhou, SL				Liu, Jing; Cheng, Yu; Lau, Joseph T. F.; Wu, Anise M. S.; Tse, Vincent W. S.; Zhou, Shenglai			The Majority of the Migrant Factory Workers of the Light Industry in Shenzhen, China May Be Physically Inactive	PLOS ONE			English	Article							LIFE-STYLE FACTORS; SOCIAL SUPPORT; HEALTH BEHAVIORS; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; JOB STRAIN; CARDIOVASCULAR-DISEASE; MARITAL TRANSITIONS; SEDENTARY BEHAVIOR; URBAN CHINA	Physical inactivity is a strong risk factor of non-communicable diseases (NCD). In China, there are 250 million migrant factory workers, who are susceptible to physical inactivity and hence NCD because of work nature and setting. With random stratified sampling, 807 such workers of the light industry were recruited in Shenzhen, China and completed a self-administered questionnaire with informed consent. The prevalence of inadequate physical activity (defined according to the World Health Organization's recommendation on level of moderate/vigorous physical activity) was 95.4%. Of all participants, 69.1% showed "a very low level of physical activity" (VLLPA), defined as <= 30 minutes of weekly moderate/vigorous physical activity, which was significantly associated with female sex (Odds ratio [OR] = 1.65), lower education level (OR=0.10 to 0.33, primary education as the reference group) and married status (OR=0.63, single status as the reference group). Adjusted for these factors, perceived social support (Adjusted OR=0.87) was negatively associated with VLLPA, while job stress due to workload, which was significant in the univariate analysis (OR=0.98), became non-significant (p=0.184). Significant interaction between perceived social support and perceived job stress onto VLLPA was found (p=0.044), implying that the negative association between job stress and VLLPA, which might reflect a potential response to cope with stress by performing exercises, was stronger among those with weaker social support. The extremely low level of physical activity rings an alarm, as it implies high risk of NCD, and as there are no existing programs promoting physical activity in this group. Interventions need to take into account social support, potential coping to job stress, and structural factors of the factory setting, while involving factories' management.	[Liu, Jing; Zhou, Shenglai] Tsinghua Univ, Sch Econ & Management, Res Ctr Healthcare Management, Beijing 100084, Peoples R China; [Cheng, Yu] Sun Yat Sen Univ, Sch Sociol & Anthropol, Guangzhou 510275, Guangdong, Peoples R China; [Cheng, Yu] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Lau, Joseph T. F.] Chinese Univ Hong Kong, Prince Wales Hosp, Div Hlth Improvement, JC Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [Lau, Joseph T. F.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Wu, Anise M. S.] Univ Macau, Fac Social Sci, Dept Psychol, Taipa, Peoples R China; [Tse, Vincent W. S.] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Hong Kong, Peoples R China; [Zhou, Shenglai] Beijing Anzhen Hosp, Beijing, Peoples R China	Tsinghua University; Sun Yat Sen University; Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen; University of Macau; Chinese University of Hong Kong; Capital Medical University	Lau, JTF (corresponding author), Tsinghua Univ, Sch Econ & Management, Res Ctr Healthcare Management, Beijing 100084, Peoples R China.	jlau@cuhk.edu.hk	Wu, Anise M.S./AAJ-4293-2020	Wu, Anise M.S./0000-0001-8174-6581	China Medical Board seed grant (A Comparative Study on Mental Health Between Two Generations of Migrant Worker)	China Medical Board seed grant (A Comparative Study on Mental Health Between Two Generations of Migrant Worker)	This study was supported by a China Medical Board seed grant (Project Name: A Comparative Study on Mental Health Between Two Generations of Migrant Worker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Allen J, 2001, PSYCHOSOM MED, V63, P609, DOI 10.1097/00006842-200107000-00014; Allgower A, 2001, HEALTH PSYCHOL, V20, P223, DOI 10.1037//0278-6133.20.3.223; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Bull F.C., 2004, PHYS INACTIVITY, V1, P729; Caplan RD, 1975, PUBLICATION, V75-160; Chen WQ, 2008, J OCCUP HEALTH, V50, P262, DOI 10.1539/joh.L7149; Chu C, 2000, HEALTH PROMOT INT, V15, P155, DOI 10.1093/heapro/15.2.155; Cohen S, 1984, HANDBOOK OF PSYCHOLO, VIV; Conn VS, 2011, AM J PUBLIC HEALTH, V101, P751, DOI 10.2105/AJPH.2010.194381; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Da Silva MA, 2012, EUR J EPIDEMIOL, V27, P537, DOI 10.1007/s10654-012-9692-8; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Elwood PC, 1999, J EPIDEMIOL COMMUN H, V53, P9, DOI 10.1136/jech.53.1.9; Eng PM, 2005, J EPIDEMIOL COMMUN H, V59, P56, DOI 10.1136/jech.2004.020073; Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9; EZOE S, 1994, PREV MED, V23, P98, DOI 10.1006/pmed.1994.1014; FARMER ME, 1988, AM J EPIDEMIOL, V128, P1340, DOI 10.1093/oxfordjournals.aje.a115087; FREDERICK T, 1988, PREV MED, V17, P173, DOI 10.1016/0091-7435(88)90061-8; Fritjers P, 2009, THE MENTAL HEALTH CO; Glanz K, 2008, HLTH BEHAV HLTH ED T, DOI 10.1007/s12160-008-9042-y; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Grzywacz JG, 2007, J OCCUP ENVIRON MED, V49, P1302, DOI 10.1097/JOM.0b013e31815ae9bc; Gu CL, 2006, PROG PLANN, V66, P249, DOI 10.1016/j.progress.2006.10.001; Hagihara A, 2003, J STUD ALCOHOL, V64, P874, DOI 10.15288/jsa.2003.64.874; He XS, 2013, INT J SOC PSYCHIATR, V59, P114, DOI 10.1177/0020764011423467; Heesch KC, 2004, WOMEN HEALTH, V39, P45, DOI 10.1300/j013v39n03_04; Hellerstedt WL, 1997, INT J EPIDEMIOL, V26, P575, DOI 10.1093/ije/26.3.575; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Ingledew DK, 1996, BRIT J HEALTH PSYCH, V1, P263, DOI 10.1111/j.2044-8287.1996.tb00508.x; JOHANSSON G, 1991, SOC SCI MED, V32, P837, DOI 10.1016/0277-9536(91)90310-9; Kerr JL, 2012, WORK, V43, P279, DOI 10.3233/WOR-2012-1390; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koo A, 2012, BRIT J SOCIOL EDUC, V33, P547, DOI 10.1080/01425692.2012.678755; Kouvonen A, 2005, PREV MED, V41, P532, DOI 10.1016/j.ypmed.2005.01.004; Kwag KH, 2011, INT J AGING HUM DEV, V72, P137, DOI 10.2190/AG.72.2.c; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Li Xiaoming, 2006, World Health Popul, V8, P5; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Mutrie N., 2000, PHYS ACTIVITY PSYCHO; Napolitano MA, 2003, ANN BEHAV MED, V25, P92, DOI 10.1207/S15324796ABM2502_04; National Bureau of Statistics of China, 2011, 2010 NAT POP CENS; National Bureau of Statistics of China, 2012, 2011 RES REP RUR MIG; National Centers for Chronic and Noncommunicable Disease Control and Prevention Chinese Center for Disease Control and Prevention, 2012, CHIN CHRON DIS RISK, P57; Neilson C, 2012, HLTH BEHAV PUBLIC HL, V2, P1; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Nomaguchi KM, 2004, J MARRIAGE FAM, V66, P413, DOI 10.1111/j.1741-3737.2004.00029.x; Osborn CY, 2011, AM J HEALTH BEHAV, V35, P118; Pan SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-21; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Reichert FF, 2007, AM J PUBLIC HEALTH, V97, P515, DOI 10.2105/AJPH.2005.070144; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Sallis JF, 2002, HLTH BEHAV HLTH ED T, V3, P462; SEEMAN M, 1983, AM SOCIOL REV, V48, P60, DOI 10.2307/2095145; Shenzhen Bureau of Statistics, 2012, 2011 SHENZHEN STATIS; Shenzhen Bureau of Statistics, 2013, ECONOMY OF SHENZHEN; Smits JAJ, 2008, DEPRESS ANXIETY, V25, P689, DOI 10.1002/da.20411; Snow DL, 2003, WORK STRESS, V17, P241, DOI 10.1080/02678370310001625630; Solinger Dorothy, 1999, CONTESTING CITIZENSH; Steptoe A, 1996, J PSYCHOSOM RES, V41, P171, DOI 10.1016/0022-3999(96)00095-5; Stewart R, 2001, J AM GERIATR SOC, V49, P263, DOI 10.1046/j.1532-5415.2001.4930263.x; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Tan S, 2000, RES PAP POL, V42, P292; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; TREIBER FA, 1991, PREV MED, V20, P737, DOI 10.1016/0091-7435(91)90068-F; USDHHS, 1996, PHYS ACT HLTH REP SU; von Wagner C, 2007, J EPIDEMIOL COMMUN H, V61, P1086, DOI 10.1136/jech.2006.053967; Vuori I, 2004, HLTH ENHANCING PHYS, P29; Wang WFWN, 2012, EURASIAN GEOGR ECON, V53, P731, DOI 10.2747/1539-7216.53.6.731; Warburton DER, 2001, CAN J APPL PHYSIOL, V26, P217, DOI 10.1139/h01-013; Ward C., 2001, THE PSYCHOLOGY OF CU; Wong DFK, 2008, SOC PSYCH PSYCH EPID, V43, P483, DOI 10.1007/s00127-008-0341-1; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; World Health Organization, 2010, GLOBAL RECOMMENDATIO; Xiang B, 2004, RES PAPER SERIES; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang XL, 2012, J OCCUP ENVIRON MED, V54, P303, DOI 10.1097/JOM.0b013e318240df39; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yu MC, 2009, SOC BEHAV PERSONAL, V37, P365, DOI 10.2224/sbp.2009.37.3.365; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3	87	5	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0131734	10.1371/journal.pone.0131734	http://dx.doi.org/10.1371/journal.pone.0131734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO3MH	26244514	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400011
J	Na, LX; Han, TS; Zhang, W; Wu, XY; Na, GQ; Du, SS; Li, Y; Sun, CH				Na, Lixin; Han, Tianshu; Zhang, Wei; Wu, Xiaoyan; Na, Guanqiong; Du, Shanshan; Li, Ying; Sun, Changhao			A Snack Dietary Pattern Increases the Risk of Hypercholesterolemia in Northern Chinese Adults: A Prospective Cohort Study	PLOS ONE			English	Article							HEART-DISEASE RISK; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; DIABETES-MELLITUS; BLOOD-LIPIDS; CHOLESTEROL; SUPPLEMENTATION; CONSUMPTION; ENERGY; WOMEN	The evidence about the effect of dietary patterns on blood cholesterol from cohort studies was very scarce. The study was to identify the association of dietary patterns with lipid profile, especially cholesterol, in a cohort in north China. Using a 1-year food frequency questionnaire, we assessed the dietary intake of 4515 adults from the Harbin People's Health Study in 2008, aged 20-74 years. Principle component analysis was used to identify dietary patterns. The follow-up was completed in 2012. Fasting blood samples were collected for the determination of blood lipid concentrations. Logistic regression models were used to evaluate the association of dietary patterns with the incidence of hypercholesterolemia, hypertriglyceridemia, and low-HDL cholesterolemia. Five dietary patterns were identified ("staple food", "vegetable, fruit and milk", "potato, soybean and egg", "snack", and "meat"). The relative risk (RR) between the extreme tertiles of the snack dietary pattern scores was 1.72 (95% CI = 1.14, 2.59, P = 0.004) for hypercholesterolemia, 1.39 (1.13, 1.75, P = 0.036) for hypertriglyceridemia, after adjustment for age, sex, education, body mass index, smoking, alcohol consumption, energy intake, exercise and baseline lipid concentrations. There was a significant positive association between the snack dietary pattern scores and fasting serum total cholesterol (SRC (standardized regression coefficient) = 0.262, P = 0.025), LDL-c (SRC = 0.324, P = 0.002) and triglycerides (SRC = 0.253, P = 0.035), after adjustment for the multiple variables above. Moreover, the adjusted RR of hypertriglyceridemia between the extreme tertiles was 0.73 (0.56, 0.94, P = 0.025) for the vegetable, fruit and milk dietary pattern, and 1.86 (1.33, 2.41, P = 0.005) for the meat dietary pattern. The snack dietary pattern was a newly emerged dietary pattern in northern Chinese adults. It appears conceivable that the risk of hypercholesterolemia can be reduced by changing the snack dietary pattern.	[Na, Lixin; Han, Tianshu; Zhang, Wei; Wu, Xiaoyan; Na, Guanqiong; Du, Shanshan; Li, Ying; Sun, Changhao] Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China	Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	liying_helen@163.com; changhaosun2002@163.com	SUN, CHANG/GXM-3680-2022	ying, li/0000-0002-7595-2474	National Natural Science Foundation of China [81130049, 81202188, 81202282]; Danone Research and Education grant [DIC2013-01]; Wu Liande Grant of Harbin Medical University [WLD-QN1406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danone Research and Education grant(Danone Nutricia); Wu Liande Grant of Harbin Medical University	This work was supported by funds from the National Natural Science Foundation of China (81130049) received by CHS, the National Natural Science Foundation of China (81202188) received by LXN, the National Natural Science Foundation of China (81202282) received by XYW, Danone Research and Education grant (DIC2013-01) received by LXN, and the Wu Liande Grant of Harbin Medical University (WLD-QN1406) received by LXN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attas O, 2014, CLIN MED INSIGHTS-EN, V7, P1, DOI 10.4137/CMED.S13573; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bae YJ, 2011, BIOL TRACE ELEM RES, V141, P224, DOI 10.1007/s12011-010-8714-1; Bai PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122140; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Fechner A, 2014, J NUTR, V144, P599, DOI 10.3945/jn.113.186858; Fernandez ML, 2012, CURR OPIN CLIN NUTR, V15, P117, DOI 10.1097/MCO.0b013e32834d2259; Fernandez ML, 2010, CURR ATHEROSCLER REP, V12, P377, DOI 10.1007/s11883-010-0130-7; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gato N, 2013, ANN NUTR METAB, V62, P1, DOI 10.1159/000343787; Hampl JS, 2003, J HUM NUTR DIET, V16, P3, DOI 10.1046/j.1365-277X.2003.00417.x; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Herron KL, 2002, J AM COLL NUTR, V21, P250, DOI 10.1080/07315724.2002.10719218; Houston DK, 2011, NUTR METAB CARDIOVAS, V21, P430, DOI 10.1016/j.numecd.2009.11.007; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Huang LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027703; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Kanter MM, 2012, ADV NUTR, V3, P711, DOI 10.3945/an.111.001321; Kim MH, 2013, BIOL TRACE ELEM RES, V153, P69, DOI 10.1007/s12011-013-9656-1; Klangjareonchai T, 2012, J LIPIDS, V2012, DOI 10.1155/2012/672720; Lecerf JM, 2011, BRIT J NUTR, V106, P6, DOI 10.1017/S0007114511000237; Mayurasakorn Korapat, 2008, Journal of the Medical Association of Thailand, V91, P400; McNamara DJ, 2014, P NUTR SOC, V73, P161, DOI 10.1017/S0029665113003844; Mierzecki A, 2013, MED SCI MONITOR, V19, P733, DOI 10.12659/MSM.889087; Franco BM, 2014, NUTR HOSP, V30, P1279, DOI 10.3305/nh.2014.30.6.7778; Olinto MTA, 2012, EUR J NUTR, V51, P281, DOI 10.1007/s00394-011-0213-4; Samaha Frederick F, 2005, Curr Atheroscler Rep, V7, P412, DOI 10.1007/s11883-005-0057-6; Shin HJ, 2014, J NUTR, V144, P1247, DOI 10.3945/jn.113.188441; van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; Vergetaki A, 2011, APPETITE, V57, P278, DOI 10.1016/j.appet.2011.05.309; Villegas R, 2010, INT J EPIDEMIOL, V39, P889, DOI 10.1093/ije/dyq008; Waheed P, 2013, J PAK MED ASSOC, V63, P340; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337; Yang YX., 2009, CHINA FOOD COMPOSITI	36	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134294	10.1371/journal.pone.0134294	http://dx.doi.org/10.1371/journal.pone.0134294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244510	Green Submitted, Green Published, gold			2022-12-26	WOS:000359061400074
J	Nogeire, TM; Lawler, JJ; Schumaker, NH; Cypher, BL; Phillips, SE				Nogeire, Theresa M.; Lawler, Joshua J.; Schumaker, Nathan H.; Cypher, Brian L.; Phillips, Scott E.			Land Use as a Driver of Patterns of Rodenticide Exposure in Modeled Kit Fox Populations	PLOS ONE			English	Article							NONTARGET SMALL MAMMALS; ANTICOAGULANT RODENTICIDES; COUNTRYSIDE BIOGEOGRAPHY; CONSERVATION; WILDLIFE; BRODIFACOUM; BIRDS; BIODIVERSITY; CARNIVORES; ANIMALS	Although rodenticides are increasingly regulated, they nonetheless cause poisonings in many non-target wildlife species. Second-generation anticoagulant rodenticide use is common in agricultural and residential landscapes. Here, we use an individual-based population model to assess potential population-wide effects of rodenticide exposures on the endangered San Joaquin kit fox (Vulpes macrotis mutica). We estimate likelihood of rodenticide exposure across the species range for each land cover type based on a database of reported pesticide use and literature. Using a spatially-explicit population model, we find that 36% of modeled kit foxes are likely exposed, resulting in a 7-18% decline in the range-wide modeled kit fox population that can be linked to rodenticide use. Exposures of kit foxes in low-density developed areas accounted for 70% of the population-wide exposures to rodenticides. We conclude that exposures of non-target kit foxes could be greatly mitigated by reducing the use of second-generation anticoagulant rodenticides in low-density developed areas near vulnerable populations.	[Nogeire, Theresa M.; Lawler, Joshua J.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Schumaker, Nathan H.] US EPA, Western Ecol Div, Corvallis, OR USA; [Cypher, Brian L.; Phillips, Scott E.] Calif State Univ Stanislaus, Endangered Species Recovery Program, Turlock, CA 95382 USA	University of Washington; University of Washington Seattle; United States Environmental Protection Agency; California State University System; California State University Stanislaus	Nogeire, TM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	tnogeire@gmail.com		Schumaker, Nathan/0000-0002-4331-825X	United States Environmental Protection Agency Pesticide Registration Improvement Act Partnership Grants [IPM-834896]	United States Environmental Protection Agency Pesticide Registration Improvement Act Partnership Grants	The United States Environmental Protection Agency Pesticide Registration Improvement Act Partnership Grants (http://www.epa.gov/pesp/pria2/), grant #IPM-834896, funded salary for TN for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CA, 2010, ARCH ENVIRON CON TOX, V58, P451, DOI 10.1007/s00244-009-9402-z; [Anonymous], 1998, RECOVERY PLAN UPLAND; [Anonymous], 2010, P 24 VERTEBRATE PEST; Bartos M, 2012, CITIES ENV, V4, P12; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Brakes CR, 2005, J APPL ECOL, V42, P118, DOI 10.1111/j.1365-2664.2005.00997.x; Brosi BJ, 2006, ENDANGERED SPECIES A, V2, P256; California Department of Pesticide Regulation, 2012, PEST US DAT; Coeurdassier M, 2014, CONSERV BIOL, V28, P315, DOI 10.1111/cobi.12230; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cypher B. L., 2014, CITIES ENV, V7, P8; Cypher BL, 2000, WILDLIFE MONOGR, P1; Cypher BL., 2003, WILD MAMMALS N AM BI, P511; Cypher BL, 2013, F11AC01341 US FISH W; Cypher Brian L., 2013, Canid News, V16, P25; Cypher Brian L., 2010, P49; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Eason CT, 2002, ECOTOXICOLOGY, V11, P35, DOI 10.1023/A:1013793029831; EPA, 2007, PROP RISK MIT DEC 9; EPA, 2008, RISK MIT DEC 10 ROD; Erickson W., 2004, POTENTIAL RISKS 9 RO; Fournier-Chambrillon C, 2004, J WILDLIFE DIS, V40, P688, DOI 10.7589/0090-3558-40.4.688; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Geduhn A, 2014, SCI TOTAL ENVIRON, V496, P328, DOI 10.1016/j.scitotenv.2014.07.049; Giddings J, 2004, PROBABILISTIC ASSESS; Haight RG, 2004, BIOL CONSERV, V117, P61, DOI 10.1016/S0006-3207(03)00263-5; Hansen AJ, 2002, CONSERV BIOL, V16, P1112, DOI 10.1046/j.1523-1739.2002.00545.x; Hassan R., 2005, ECOSYSTEMS HUMAN WEL; Hoare JM, 2006, NEW ZEAL J ECOL, V30, P157; Hosea RC, 2000, PROC VERTEBR PEST C, P236; Jacquot M, 2013, J APPL ECOL, V50, P1406, DOI 10.1111/1365-2664.12151; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Koopman Marni E., 2001, Transactions of the Western Section of the Wildlife Society, V37, P77; Maestas JD, 2003, CONSERV BIOL, V17, P1425, DOI 10.1046/j.1523-1739.2003.02371.x; McMillin SC, 2008, P VERTEBR PEST C, V23, P163; Mendenhall CD, 2014, ECOLOGY, V95, P856, DOI 10.1890/12-2017.1; MORRELL S, 1972, CALIF FISH GAME, V58, P162; Morzillo AT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00120.1; Morzillo AT, 2011, URBAN ECOSYST, V14, P243, DOI 10.1007/s11252-010-0152-5; Murray M, 2011, J ZOO WILDLIFE MED, V42, P88, DOI 10.1638/2010-0188.1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Neal G.T., 1987, Current Mammalogy, V1, P443; Oehme FW, 2013, MERCK VET MANUAL VET; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Ralls K, 2001, J MAMMAL, V82, P858, DOI 10.1644/1545-1542(2001)082<0858:KSRADS>2.0.CO;2; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Riley SPD, 2007, J WILDLIFE MANAGE, V71, P1874, DOI 10.2193/2005-615; Sanchez-Barbudo IS, 2012, SCI TOTAL ENVIRON, V420, P280, DOI 10.1016/j.scitotenv.2012.01.028; Schmolke A, 2010, ENVIRON TOXICOL CHEM, V29, P1006, DOI 10.1002/etc.120; Schumaker NH, 2013, HEXSIM VERSION 2 4; Standley WG, 1992, 106272157 EGG US DOE; Thomas PJ, 2011, ENVIRON INT, V37, P914, DOI 10.1016/j.envint.2011.03.010; Thompson C, 2014, CONSERV LETT, V7, P91, DOI 10.1111/conl.12038; Tosh DG, 2012, ECOTOXICOLOGY, V21, P1325, DOI 10.1007/s10646-012-0886-3; U.S. Fish & Wildlife Service, 2010, SAN JOAQ KIT 5 YEAR; Walker LA, 2013, ANTICOAGULANT RODENT; Warrick GD, 1998, J WILDLIFE MANAGE, V62, P707, DOI 10.2307/3802347; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	58	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0133351	10.1371/journal.pone.0133351	http://dx.doi.org/10.1371/journal.pone.0133351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26244655	Green Published, Green Submitted, gold			2022-12-26	WOS:000359061400041
J	Brinkmann, BH; Patterson, EE; Vite, C; Vasoli, VM; Crepeau, D; Stead, M; Howbert, JJ; Cherkassky, V; Wagenaar, JB; Litt, B; Worrell, GA				Brinkmann, Benjamin H.; Patterson, Edward E.; Vite, Charles; Vasoli, Vincent M.; Crepeau, Daniel; Stead, Matt; Howbert, J. Jeffry; Cherkassky, Vladimir; Wagenaar, Joost B.; Litt, Brian; Worrell, Gregory A.			Forecasting Seizures Using Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TEMPORAL-LOBE; ANTIEPILEPTIC DRUGS; ANIMAL-MODELS; PREDICTION; ELECTROENCEPHALOGRAPHY; SYSTEM; BRAIN; DOGS; LEVETIRACETAM	Management of drug resistant focal epilepsy would be greatly assisted by a reliable warning system capable of alerting patients prior to seizures to allow the patient to adjust activities or medication. Such a system requires successful identification of a preictal, or seizure-prone state. Identification of preictal states in continuous long-duration intracranial electroenceph-alographic (iEEG) recordings of dogs with naturally occurring epilepsy was investigated using a support vector machine (SVM) algorithm. The dogs studied were implanted with a 16-channel ambulatory iEEG recording device with average channel reference for a mean (st. dev.) of 380.4 (+87.5) days producing 220.2 (+104.1) days of intracranial EEG recorded at 400 Hz for analysis. The iEEG records had 51.6 (+52.8) seizures identified, of which 35.8 (+30.4) seizures were preceded by more than 4 hours of seizure-free data. Recorded iEEG data were stratified into 11 contiguous, non-overlapping frequency bands and binned into one-minute synchrony features for analysis. Performance of the SVM classifier was assessed using a 5-fold cross validation approach, where preictal training data were taken from 90 minute windows with a 5 minute pre-seizure offset. Analysis of the optimal preictal training time was performed by repeating the cross validation over a range of preictal windows and comparing results. We show that the optimization of feature selection varies for each subject, i.e. algorithms are subject specific, but achieve prediction performance significantly better than a time-matched Poisson random predictor (p<0.05) in 5/5 dogs analyzed.	[Brinkmann, Benjamin H.; Vasoli, Vincent M.; Crepeau, Daniel; Stead, Matt; Worrell, Gregory A.] Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA; [Patterson, Edward E.] Univ Minnesota, Ctr Vet Med, St Paul, MN 55108 USA; [Vite, Charles] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Howbert, J. Jeffry] NeuroVista Inc, Seattle, WA USA; [Cherkassky, Vladimir] Univ Minnesota, Dept Elect & Comp Engn, St Paul, MN 55108 USA; [Wagenaar, Joost B.; Litt, Brian] Univ Penn, Penn Ctr Neuroengn & Therapeut, Philadelphia, PA 19104 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Brinkmann, BH (corresponding author), Mayo Clin, Mayo Syst Electrophysiol Lab, Rochester, MN 55905 USA.	brinkmann.benjamin@mayo.edu		Brinkmann, Benjamin/0000-0002-2392-8608; Vasoli, Vincent/0000-0001-8004-748X; Wagenaar, Joost/0000-0003-0837-7120	National Institute of Neurological Disorders and Stroke at National Institutes of Health [U01-NS073557, R01-NS630391]; Mayo Clinic; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073557, R01NS092882, U24NS063930] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke at National Institutes of Health; Mayo Clinic; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Neurological Disorders and Stroke at National Institutes of Health (U01-NS073557, R01-NS630391), and Mayo Clinic supported this work. The authors are grateful for the access provided by NeuroVista to parts of its internal statistical data analysis pipeline. The funding agencies had no part in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1999, EPILEPSIA, V40, P1484, DOI 10.1111/j.1528-1157.1999.tb02030.x; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Baumgartner C, 1998, J NUCL MED, V39, P978; Berendt M, 1999, ACTA NEUROL SCAND, V99, P276, DOI 10.1111/j.1600-0404.1999.tb00676.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Brinkmann BH, 2009, J NEUROSCI METH, V180, P185, DOI 10.1016/j.jneumeth.2009.03.022; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 2004, NEURAL NETWORKS, V17, P113, DOI 10.1016/S0893-6080(03)00169-2; Cherkassky V, 2013, PREDICTIVE LEARNING; Cherkassky V, 2011, IEEE T NEURAL NETWOR, V22, P1241, DOI 10.1109/TNN.2011.2157522; Coles LD, 2013, EPILEPSY RES, V106, P456, DOI 10.1016/j.eplepsyres.2013.06.007; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Davis KA, 2011, EPILEPSY RES, V96, P116, DOI 10.1016/j.eplepsyres.2011.05.011; Dudek FE, 2011, EPILEPSY RES, V97, P324, DOI 10.1016/j.eplepsyres.2011.10.017; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Engel Jerome Jr, 2003, Epilepsy Curr, V3, P37, DOI 10.1046/j.1535-7597.2003.03201.x; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Gadhoumi K, 2013, CLIN NEUROPHYSIOL, V124, P1745, DOI 10.1016/j.clinph.2013.04.006; Gowers S, 1885, EPILEPSY OTHER CHRON; Howbert JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081920; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Long S, 2014, J VET INTERN MED, V28, P189, DOI 10.1111/jvim.12235; MARCIANI MG, 1986, EPILEPSIA, V27, P423, DOI 10.1111/j.1528-1157.1986.tb03562.x; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Murray G, 1994, GLOBAL COMP ASSESSME; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Patterson EE, 2008, J VET PHARMACOL THER, V31, P253, DOI 10.1111/j.1365-2885.2008.00948.x; Patterson EE, 2014, ILAR J, V55, P182, DOI 10.1093/ilar/ilu021; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; PODELL M, 1993, J VET INTERN MED, V7, P318, DOI 10.1111/j.1939-1676.1993.tb01025.x; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Schulze-Bonhage A, 2010, EPILEPSY BEHAV, V18, P388, DOI 10.1016/j.yebeh.2010.05.008; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Stacey W, 2011, EPILEPSY RES, V97, P243, DOI 10.1016/j.eplepsyres.2011.07.012; Teixeira C, 2012, IEEE ENG MED BIO, P6530, DOI 10.1109/EMBC.2012.6347490; Thomas WB, 2010, VET CLIN N AM-SMALL, V40, P161, DOI 10.1016/j.cvsm.2009.09.004; Van Gompel JJ, 2008, NEUROSURGERY, V63, P498, DOI 10.1227/01.NEU.0000324996.37228.F8; Vapnik V, 2009, NEURAL NETWORKS, V22, P544, DOI 10.1016/j.neunet.2009.06.042; Vermeulen J, 1995, EPILEPSY RES, V22, P65, DOI 10.1016/0920-1211(95)00047-X; Volk HA, 2008, VET J, V176, P310, DOI 10.1016/j.tvjl.2007.03.002; Warren CP, 2010, J NEUROPHYSIOL, V104, P3530, DOI 10.1152/jn.00368.2010; Weinand ME, 1997, J NEUROSURG, V86, P226, DOI 10.3171/jns.1997.86.2.0226; Weintraub D, 2007, EPILEPSY BEHAV, V10, P105, DOI 10.1016/j.yebeh.2006.08.008; Witt JA, 2013, EPILEPSY BEHAV, V29, P141, DOI 10.1016/j.yebeh.2013.07.013; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006	50	54	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133900	10.1371/journal.pone.0133900	http://dx.doi.org/10.1371/journal.pone.0133900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241907	Green Published, Green Submitted, gold			2022-12-26	WOS:000358942700028
J	Dhanjal, JK; Sreenidhi, AK; Bafna, K; Katiyar, SP; Goyal, S; Grover, A; Sundar, D				Dhanjal, Jaspreet Kaur; Sreenidhi, Anith Kumar; Bafna, Khushboo; Katiyar, Shashank Prakash; Goyal, Sukriti; Grover, Abhinav; Sundar, Durai			Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti-Inflammatory Target COX-2	PLOS ONE			English	Article							POTENTIAL FUNCTIONS; ACCURATE DOCKING; FORCE-FIELD; PROTEIN; CYCLOOXYGENASE; GLIDE; ENVIRONMENT; PEPTIDES; MODEL	Cyclooxygenase-2 (COX-2) produces prostaglandins in inflamed tissues and hence has been considered as an important target for the development of anti-inflammatory drugs since long. Administration of traditional non-steroidal anti-inflammatory drugs (NSAIDs) and other COX-2 selective inhibitors (COXIBS) for the treat of inflammation has been found to be associated with side effects, which mainly includes gastro-intestinal (GI) toxicity. The present study involves developing a virtual library of novel molecules with high druglikeliness using structure-based de novo drug designing and 2D fingerprinting approach. A library of 2657 drug like molecules was generated. 2D fingerprinting based screening of the designed library gave a unique set of compounds. Molecular docking approach was then used to identify two compounds highly specific for COX-2 isoform. Molecular dynamics simulations of protein-ligand complexes revealed that the candidate ligands were dynamically stable within the cyclooxygenase binding site of COX-2. The ligands were further analyzed for their druglikeliness, ADMET properties and synthetic accessibility using knowledge based set of rules. The results revealed that the molecules are predicted to selectively bind to COX-2 enzyme thereby potentially overcoming the limitations posed by the drugs in clinical use.	[Dhanjal, Jaspreet Kaur; Sreenidhi, Anith Kumar; Bafna, Khushboo; Katiyar, Shashank Prakash; Sundar, Durai] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Sreenidhi, Anith Kumar] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Goyal, Sukriti] Banasthali Univ, Apaji Inst Math & Appl Comp Technol, Tonk, Rajasthan, India; [Grover, Abhinav] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Hyderabad; Banasthali Vidyapith; Jawaharlal Nehru University, New Delhi	Sundar, D (corresponding author), Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India.	sundar@dbeb.iitd.ac.in	Dhanjal, Jaspreet Kaur/AAQ-3504-2020	Dhanjal, Jaspreet Kaur/0000-0003-4226-3063; Sundar, Durai/0000-0002-6549-6663; Katiyar, Shashank/0000-0002-8496-5103; Bafna, Khushboo/0000-0002-1893-1175	IIT Delhi	IIT Delhi	We thank Atul Nag (Summer Faculty Research Fellow-2011 at IIT Delhi) for the development of an algorithm to calculate the Tanimoto coefficients and Akanksha Gupta for her contribution to this work. We also thank Yaxia Yuan, Peking University, Beijing, China, for his guidance with designing the library of molecules using LigBuilder. We are also thankful to Yoshifumi Fukunishi of the 3D Drug Design Team at the Molecular Profiling Research Center for Drug Discovery of National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan, for assistance with the calculation of SA scores. AKS was a Summer Research Fellow in the laboratory of DS under the Summer Research Fellowship Program of IIT Delhi for M.Tech/M.E. students 2012. The authors acknowledge the DBT Bioinformatics facility at the Distributed Information Sub Centre, Department of Biochemical Engineering and Biotechnology, IIT Delhi and the Bioinformatics Infrastructure Facility at the School of Life Sciences, University of Hyderabad, supported by the Department of Biotechnology (DBT), Govt. of India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2008, SYBYL; Bowers KJ, 2006, P 2006 ACMIEEE C SUP, P4343; Brooks PM, 2000, MED J AUSTRALIA, V173, P433, DOI 10.5694/j.1326-5377.2000.tb139277.x; Chandrasekharan NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-241; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Claria J, 2003, CURR PHARM DESIGN, V9, P2177, DOI 10.2174/1381612033454054; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Fukunishi Y, 2014, J CHEM INFORM MODELI; GIERCKSKY KE, 1989, SCAND J GASTROENTERO, V24, P3, DOI 10.3109/00365528909091168; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Goodsell DS, 2000, STEM CELLS, V18, P227, DOI 10.1634/stemcells.18-3-227; Gromiha MM, 2004, J MOL BIOL, V337, P285, DOI 10.1016/j.jmb.2004.01.033; Grover A, 2012, BBA-PROTEINS PROTEOM, V1824, P1476, DOI 10.1016/j.bbapap.2012.05.016; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Ingrassia S, 2005, TECHNOMETRICS, V47, P297, DOI 10.1198/004017005000000058; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mand NP, 2012, ARTIFICIAL NEURAL NE; MILLER AS, 1992, MED BIOL ENG COMPUT, V30, P449, DOI 10.1007/BF02457822; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang RX, 2000, J MOL MODEL, V6, P498, DOI 10.1007/s0089400060498; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Yuan YX, 2011, J CHEM INF MODEL, V51, P1083, DOI 10.1021/ci100350u	46	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0134691	10.1371/journal.pone.0134691	http://dx.doi.org/10.1371/journal.pone.0134691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241744	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700058
J	Mutsaerts, HJMM; van Dalen, JW; Heijtel, DFR; Groot, PFC; Majoie, CBLM; Petersen, ET; Richard, E; Nederveen, AJ				Mutsaerts, H. J. M. M.; van Dalen, J. W.; Heijtel, D. F. R.; Groot, P. F. C.; Majoie, C. B. L. M.; Petersen, E. T.; Richard, E.; Nederveen, A. J.			Cerebral Perfusion Measurements in Elderly with Hypertension Using Arterial Spin Labeling	PLOS ONE			English	Article							BRAIN; MRI; AGE; REPRODUCIBILITY; HEMODYNAMICS; EFFICIENCY; ALGORITHM	Purpose The current study assesses the feasibility and value of crushed cerebral blood flow (CBFcrushed) and arterial transit time (ATT) estimations for large clinical imaging studies in elderly with hypertension. Material and Methods Two pseudo-continuous arterial spin labeling (ASL) scans with (CBFcrushed) and without flow crushers (CBFnon-crushed) were performed in 186 elderly with hypertension, from which CBF and ATT maps were calculated. Standard flow territory maps were subdivided into proximal, intermediate and distal flow territories, based on the measured ATT. The coefficient of variation (CV) and physiological correlations with age and gender were compared between the three perfusion parameters. Results There was no difference in CV between CBFcrushed and CBFnon-crushed (15-24%, p>0.4) but the CV of ATT (4-9%) was much smaller. The total gray matter correlations with age and gender were most significant with ATT (p =.016 and p<.001 respectively), in between for CBFcrushed (p =.206 and p =.019) and least significant for CBFnon-crushed (p =.236 and p =.100). Conclusion These data show the feasibility and added value of combined measurements of both crushed CBF and ATT for group analyses in elderly with hypertension. The obtained flow territories provide knowledge on vascular anatomy of elderly with hypertension and can be used in future studies to investigate regional vascular effects.	[Mutsaerts, H. J. M. M.; Heijtel, D. F. R.; Groot, P. F. C.; Majoie, C. B. L. M.; Nederveen, A. J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van Dalen, J. W.; Richard, E.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Petersen, E. T.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Richard, E.] Radboud Univ Nijmegen, Dept Neurol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Copenhagen; Radboud University Nijmegen	Mutsaerts, HJMM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	hjmutsaerts@amc.uva.nl	Mutsaerts, Henk JMM/T-8656-2017; Richard, Edo/A-7065-2015; Richard, Edo/AAT-7173-2020; Richard, Edo/N-8460-2016; Petersen, Esben Thade/Q-8266-2019; van Dalen, Jan Willem/K-9169-2018	Mutsaerts, Henk JMM/0000-0003-0894-0307; Richard, Edo/0000-0002-7250-3390; Richard, Edo/0000-0002-7250-3390; Richard, Edo/0000-0002-7250-3390; Petersen, Esben Thade/0000-0001-7529-3432; van Dalen, Jan Willem/0000-0002-3439-8841; Nederveen, Aart/0000-0002-5477-973X	Dutch Ministry of Health, Welfare and Sports [50-50110-98-020]; Dutch Innovation fund of collaborative health insurances [05-234]; Netherlands Organization for Health Research and Development [62000015]; "Internationale Stichting Alzheimer Onderzoek" (ISAO) [10507]; Dutch non-governmental organization NutsOhra	Dutch Ministry of Health, Welfare and Sports; Dutch Innovation fund of collaborative health insurances; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); "Internationale Stichting Alzheimer Onderzoek" (ISAO); Dutch non-governmental organization NutsOhra	This study was carried out within the context of the preDIVA study which was supported by the Dutch Ministry of Health, Welfare and Sports (grant# 50-50110-98-020), the Dutch Innovation fund of collaborative health insurances grant# 05-234 and the Netherlands Organization for Health Research and Development (grant# 62000015). The MRI substudy was supported by the "Internationale Stichting Alzheimer Onderzoek" (ISAO, grant# 10507) and the Dutch non-governmental organization NutsOhra. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Chen YF, 2012, MAGN RESON MATER PHY, V25, P135, DOI 10.1007/s10334-011-0276-5; Dai WY, 2013, MAGN RESON MED, V69, P1014, DOI 10.1002/mrm.24335; de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Donahue J, 2014, J NEURORADIOLOGY, V41, P234, DOI 10.1016/j.neurad.2013.11.002; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hendrikse J, 2008, RADIOLOGY, V246, P572, DOI 10.1148/radiol.2461062100; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Lawrence KSS, 2005, MAGN RESON MED, V53, P425, DOI 10.1002/mrm.20364; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; MacIntosh BJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00060; Nowinski WL, 2011, NEUROIMAGE, V55, P986, DOI 10.1016/j.neuroimage.2010.12.079; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Sadaghiani S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00020; Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420; Szabo K, 2009, STROKE, V40, P2042, DOI 10.1161/STROKEAHA.108.536144; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wentland AL, 2010, AM J NEURORADIOL, V31, P448, DOI 10.3174/ajnr.A1858; [张旭东 Zhang Xudong], 2012, [计量学报, Acta Metrologica Sinica], V33, P1	33	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2015	10	8							e0133717	10.1371/journal.pone.0133717	http://dx.doi.org/10.1371/journal.pone.0133717			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO1VB	26241897	Green Submitted, Green Published, gold			2022-12-26	WOS:000358942700020
